data_3phy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3phy _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.516 2.852 0 CA-C-O 121.237 0.541 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.538 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 1.5 mm -54.21 -67.29 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.275 -0.89 . . . . 0.0 110.493 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 11' ' ' ILE . 19.8 pt-20 -35.06 -47.59 0.38 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -63.69 -47.84 79.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.858 -1.151 . . . . 0.0 109.106 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 14' ' ' THR . 13.1 m -69.57 -13.33 62.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.537 -0.727 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.503 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 18.4 mt -95.43 -16.35 22.34 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.772 -1.205 . . . . 0.0 109.502 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.384 0 O-C-N 121.144 -0.973 . . . . 0.0 108.535 178.761 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.905 0.383 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.37 27.85 18.5 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mt -84.62 -172.01 3.94 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.951 -1.323 . . . . 0.0 109.028 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.35 -5.93 14.08 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.496 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 10.3 p90 -124.12 117.22 24.16 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.27 -0.894 . . . . 0.0 108.648 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -57.06 141.03 43.97 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.419 ' HB2' HD23 ' A' ' 15' ' ' LEU . . . -117.17 114.82 24.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.851 -1.382 . . . . 0.0 108.047 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.513 HG22 ' CE1' ' A' ' 42' ' ' TYR . 1.6 pp -118.22 150.12 20.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.896 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 2.1 mt-30 -117.47 172.51 7.29 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.475 HD11 ' CE2' ' A' ' 63' ' ' PHE . 27.9 mt -152.8 149.49 28.38 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.12 -0.988 . . . . 0.0 109.247 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 36' ' ' ASP . 3.2 m-20 -119.25 133.16 55.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.141 -0.974 . . . . 0.0 109.417 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -7.58 70.0 0.0 OUTLIER Glycine 0 N--CA 1.514 3.873 0 C-N-CA 124.618 1.104 . . . . 0.0 113.273 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER 161.25 -23.84 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.68 23.05 10.38 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 3.3 m120 -86.08 123.51 31.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.417 -1.049 . . . . 0.0 108.792 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.429 HG21 ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -56.32 136.19 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 121.913 0.863 . . . . 0.0 110.884 -178.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 5.6 mt -108.13 -30.83 8.2 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.405 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -159.96 160.6 33.61 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.518 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 2.7 t80 -140.08 -42.47 0.42 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.362 -1.461 . . . . 0.0 109.975 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER 87.54 171.58 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.35 -15.38 21.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.004 -1.06 . . . . 0.0 112.637 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.77 -67.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.386 -1.446 . . . . 0.0 110.135 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 12.0 pt-20 -63.71 -44.95 92.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 109.021 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.43 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -61.11 -13.85 36.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 14.8 t70 -87.24 -32.72 19.59 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.627 -1.513 . . . . 0.0 108.819 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -48.47 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.883 0.849 . . . . 0.0 108.731 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.503 HG22 ' CD ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -95.09 -29.54 14.53 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.371 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 100.94 -2.69 55.54 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.589 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.527 ' CZ ' ' CG1' ' A' ' 66' ' ' VAL . 1.1 mtt85 -47.52 -58.72 3.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.968 -1.313 . . . . 0.0 111.027 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.2 OUTLIER 68.46 152.45 0.13 Allowed Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.85 -50.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.78 1.654 . . . . 0.0 111.312 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.4 pttt -57.99 -18.47 24.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 110.344 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -96.1 -43.19 7.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 0.0 109.411 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 52' ' ' ARG . 32.3 m -82.51 3.96 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.646 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.429 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -70.04 123.6 24.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.8 -22.86 36.95 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -79.99 130.59 35.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -1.054 . . . . 0.0 109.25 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.23 125.55 26.74 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.135 -0.978 . . . . 0.0 108.568 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.511 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 90.2 t80 -71.88 -6.22 40.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.896 -1.128 . . . . 0.0 110.263 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.475 ' CE2' HD11 ' A' ' 33' ' ' LEU . 30.0 m-85 -96.4 -41.69 8.49 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.935 -1.103 . . . . 0.0 111.545 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.79 -15.39 4.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.705 -1.247 . . . . 0.0 111.522 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.73 -2.35 30.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.679 -1.263 . . . . 0.0 110.858 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.527 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 45.7 t -131.79 -47.89 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 120.732 -1.23 . . . . 0.0 108.504 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.96 106.7 18.15 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.61 2.36 6.49 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.765 1.643 . . . . 0.0 111.662 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.9 p -99.31 -27.69 13.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.889 -1.132 . . . . 0.0 109.234 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.479 HG23 ' CE1' ' A' ' 75' ' ' PHE . 18.0 p -72.13 -5.95 39.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -0.823 . . . . 0.0 109.965 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -89.66 51.72 2.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.018 -1.051 . . . . 0.0 108.742 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.466 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -128.43 178.82 1.47 Allowed Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.07 -0.15 10.42 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 122.095 1.864 . . . . 0.0 111.447 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 5.4 mm-40 -107.85 -28.19 9.78 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.813 -1.18 . . . . 0.0 109.453 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.539 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.9 t80 -102.67 -69.15 0.8 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.487 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 26.0 t80 -69.67 -17.92 63.52 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.18 -62.12 5.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -63.42 -15.58 58.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.519 -0.989 . . . . 0.0 109.593 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 10.9 t80 -81.66 -34.79 30.57 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -8.13 58.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 2.0 mt-10 -96.13 -42.47 8.2 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -66.83 -41.22 93.66 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.484 HG23 ' CE1' ' A' ' 118' ' ' TYR . 93.1 t -62.02 -40.09 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.654 -0.909 . . . . 0.0 109.508 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.64 -4.92 58.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -0.871 . . . . 0.0 110.43 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.5 t -96.09 -25.58 15.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.92 -1.112 . . . . 0.0 109.87 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.92 28.89 27.5 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -179.02 59.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.303 -1.116 . . . . 0.0 109.058 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.42 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 6.2 tt -49.0 121.54 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.332 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.401 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 62.1 t-20 -160.69 88.27 0.77 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.394 -0.816 . . . . 0.0 109.032 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 t -149.15 167.17 26.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 110.189 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -150.04 167.1 27.74 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.635 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 10.2 p90 -175.93 153.84 1.4 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.971 -1.081 . . . . 0.0 110.042 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -82.21 116.49 21.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.944 . . . . 0.0 109.167 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.96 175.24 6.0 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.0 m -140.81 111.99 7.24 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.476 ' CZ ' HG23 ' A' ' 122' ' ' VAL . 18.6 m-30 -82.81 93.64 7.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.135 -0.978 . . . . 0.0 109.2 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -115.35 32.78 5.84 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.329 -0.857 . . . . 0.0 108.963 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.59 155.5 29.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.506 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.8 mt-30 -0.85 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.466 0.706 . . . . 0.0 112.394 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.2 ttp 178.12 -154.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.465 -0.772 . . . . 0.0 109.653 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.448 ' CB ' ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -92.12 176.89 2.39 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 108.975 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 101' ' ' THR . 36.4 Cg_endo -78.31 106.51 2.15 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.919 1.746 . . . . 0.0 110.2 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 96' ' ' PHE . 4.2 m -101.07 143.83 30.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -117.0 139.24 50.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.461 ' HB ' HG11 ' A' ' 122' ' ' VAL . 7.7 m -156.25 141.62 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.771 -1.205 . . . . 0.0 111.261 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.43 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -91.05 114.78 27.39 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.635 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -87.07 161.24 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.807 -1.183 . . . . 0.0 110.543 -176.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -159.74 99.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.45 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -110.64 148.41 32.29 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.452 -0.78 . . . . 0.0 109.628 -177.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.611 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 2.3 ttmt -145.51 -179.01 6.38 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.483 -1.287 . . . . 0.0 109.423 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -87.42 109.23 19.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.933 -1.105 . . . . 0.0 109.185 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.421 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -53.67 140.52 28.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.566 -0.709 . . . . 0.0 109.868 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.6 -179.039 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.466 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.613 0.72 . . . . 0.0 110.434 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.484 ' CE1' HG23 ' A' ' 83' ' ' VAL . 24.7 m-85 -151.03 112.32 4.37 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.637 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 15.8 p-90 -114.68 140.99 48.4 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 118.578 -1.249 . . . . 0.0 112.373 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.45 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 21.2 t -116.42 108.62 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.637 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 15.3 m-30 -92.49 121.33 33.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.396 -0.815 . . . . 0.0 109.65 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.476 HG23 ' CZ ' ' A' ' 96' ' ' PHE . 1.4 t -103.95 117.35 49.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.403 -0.81 . . . . 0.0 108.927 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 28' ' ' PHE . 2.7 tttm -98.97 110.57 23.16 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HA ' HG11 ' A' ' 105' ' ' VAL . 33.4 ttt180 -56.27 135.85 53.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.847 -1.158 . . . . 0.0 109.528 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.346 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 N--CA 1.51 2.56 0 CA-C-O 120.75 0.31 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.537 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 3.0 mm -56.98 -67.45 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.645 0 O-C-N 121.051 -1.031 . . . . 0.0 109.594 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.6 pt-20 -37.31 -29.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.836 -0.54 . . . . 0.0 112.205 -178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' ILE . 5.0 m-20 -76.97 -53.13 8.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.805 -1.184 . . . . 0.0 109.906 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -62.85 -40.05 96.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.192 -0.943 . . . . 0.0 109.357 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.503 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 28.9 mt -61.03 -24.0 65.84 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 O-C-N 121.416 -0.802 . . . . 0.0 108.961 179.204 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.4 p30 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.963 0.411 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.38 31.8 8.09 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.493 HD21 ' CE1' ' A' ' 28' ' ' PHE . 15.5 mt -103.31 121.85 43.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.461 -1.023 . . . . 0.0 108.765 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.01 -12.09 7.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 109.965 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.493 ' CE1' HD21 ' A' ' 26' ' ' LEU . 10.3 p90 -121.49 116.96 25.67 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.003 -1.06 . . . . 0.0 109.289 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -55.14 148.64 24.18 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . . . -128.61 100.88 5.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.833 -1.392 . . . . 0.0 108.222 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.564 HG21 ' CD1' ' A' ' 42' ' ' TYR . 2.2 pp -105.6 159.99 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.718 0.77 . . . . 0.0 110.953 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.45 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 33.7 mt-30 -122.08 174.86 6.67 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 22.7 mt -154.37 151.93 29.61 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.951 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.11 165.63 11.05 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.65 -20.65 0.14 Allowed Glycine 0 N--CA 1.499 2.884 0 O-C-N 121.792 -0.568 . . . . 0.0 113.507 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.58 20.02 19.32 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 119.814 1.807 . . . . 0.0 111.227 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.38 25.25 68.65 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.2 m-20 -90.0 125.22 35.31 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.051 -1.264 . . . . 0.0 110.767 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -59.5 139.2 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.869 -1.145 . . . . 0.0 110.706 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 9.2 mt -108.43 -31.31 7.87 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.444 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -157.69 -176.49 5.97 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.564 ' CD1' HG21 ' A' ' 31' ' ' ILE . 20.5 t80 -160.01 -72.81 0.07 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.706 -1.247 . . . . 0.0 111.488 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.9 p-10 105.28 179.34 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 C-N-CA 123.719 0.808 . . . . 0.0 109.096 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.26 -26.64 15.33 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.948 -1.095 . . . . 0.0 113.287 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -50.12 -64.63 0.75 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.332 -1.48 . . . . 0.0 110.796 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 1.9 pt-20 -57.86 -53.08 62.24 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 121.671 -0.643 . . . . 0.0 110.03 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.38 -15.42 23.84 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.376 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.83 -34.23 39.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.894 -1.356 . . . . 0.0 108.892 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.414 HG23 ' CG2' ' A' ' 50' ' ' THR . 0.3 OUTLIER -84.86 -54.41 8.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.423 -0.798 . . . . 0.0 109.673 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.424 ' CB ' ' OH ' ' A' ' 98' ' ' TYR . 1.2 p -84.99 -23.11 28.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 110.34 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.36 -13.65 61.37 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' NH2' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -47.89 107.23 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.184 -1.186 . . . . 0.0 110.817 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.455 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -74.39 153.71 87.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.2 -48.81 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.579 1.519 . . . . 0.0 111.13 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -18.26 60.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.077 -1.014 . . . . 0.0 110.281 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -88.61 -41.99 12.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.947 -1.096 . . . . 0.0 109.66 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 26.4 m -73.22 -5.55 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.236 -0.915 . . . . 0.0 109.741 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.458 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -70.27 122.82 22.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.1 -1.0 . . . . 0.0 108.357 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.31 -16.58 59.47 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -79.25 139.91 37.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -1.204 . . . . 0.0 109.336 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -79.45 97.39 6.38 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.539 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 1.3 t80 -46.94 -39.9 13.24 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.508 -0.745 . . . . 0.0 110.63 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CG ' ' CD1' ' A' ' 76' ' ' TYR . 23.9 m-85 -86.1 -23.94 26.47 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.708 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.06 43.98 2.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 109.586 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 61' ' ' ASN . 19.5 t0 -174.46 -20.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.766 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 62' ' ' PHE . 5.4 t -117.96 -59.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 120.354 -1.466 . . . . 0.0 109.706 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -106.08 103.25 43.98 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.592 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.54 1.52 7.9 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.875 1.717 . . . . 0.0 110.97 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 p -106.39 -20.89 13.24 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.886 -1.134 . . . . 0.0 109.976 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 35.2 p -81.74 2.32 30.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.089 -1.007 . . . . 0.0 110.049 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -95.14 55.01 1.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.899 -1.125 . . . . 0.0 108.877 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -135.9 176.31 2.93 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.524 -0.735 . . . . 0.0 109.348 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.5 Cg_endo -77.04 77.86 3.63 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 122.413 2.075 . . . . 0.0 110.492 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.06 -36.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.5 t80 -105.63 -66.02 1.02 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.566 ' CD1' ' CG ' ' A' ' 63' ' ' PHE . 5.7 t80 -77.6 -20.51 53.84 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.032 -1.042 . . . . 0.0 108.265 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.39 -60.41 7.12 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -66.23 -15.43 63.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.752 -0.852 . . . . 0.0 110.085 -179.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.494 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 5.1 t80 -84.15 -36.41 22.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -10.92 59.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 1.1 pp20? -97.5 -36.01 10.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.87 -39.63 85.33 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 98.5 t -58.31 -56.2 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.89 -0.77 . . . . 0.0 109.408 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.39 -20.14 65.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 0.0 109.948 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 -29.25 51.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.9 24.1 42.96 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -172.68 57.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.42 -1.047 . . . . 0.0 108.991 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -49.4 124.7 9.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.804 . . . . 0.0 109.993 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -161.02 88.92 0.77 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.459 -0.776 . . . . 0.0 109.043 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 t -156.75 168.21 28.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.018 -1.051 . . . . 0.0 110.728 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -145.57 170.21 16.87 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.607 ' CD1' HG23 ' A' ' 107' ' ' VAL . 13.3 p90 -176.31 158.37 1.87 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.893 -1.129 . . . . 0.0 110.307 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -92.08 116.25 28.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.979 -1.076 . . . . 0.0 109.289 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.38 -175.23 3.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.03 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.6 m -150.06 114.15 5.12 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.471 ' CE2' HG23 ' A' ' 122' ' ' VAL . 16.7 m-30 -85.83 118.88 25.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.148 -0.97 . . . . 0.0 110.394 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -131.4 35.93 3.82 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.711 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -80.5 80.72 6.9 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 123.032 1.396 . . . . 0.0 111.201 -178.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 98' ' ' TYR . 2.4 mm100 72.9 27.19 2.17 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 119.925 -1.734 . . . . 0.0 109.051 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -150.11 168.84 22.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.234 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -52.25 171.09 0.21 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 109.37 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.1 Cg_endo -76.59 79.45 3.03 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.927 1.751 . . . . 0.0 110.421 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.1 m -72.96 133.52 44.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 109.573 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.477 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.1 OUTLIER -106.45 148.55 28.02 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.251 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 104' ' ' LYS . 19.7 m -158.31 140.41 5.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 118.578 -1.249 . . . . 0.0 110.536 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -87.43 130.92 34.5 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 103.309 -2.848 . . . . 0.0 103.309 175.066 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.607 HG23 ' CD1' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -104.67 160.06 5.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 120.543 -1.348 . . . . 0.0 110.513 -176.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -156.84 101.6 1.97 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.453 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -117.02 149.07 40.89 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.23 -0.919 . . . . 0.0 110.136 -177.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.7 tttt -145.28 -176.94 5.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.674 -1.266 . . . . 0.0 109.297 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -89.67 109.13 20.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.805 -1.184 . . . . 0.0 108.893 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.443 ' HB2' ' CB ' ' A' ' 117' ' ' SER . . . -60.61 137.46 58.17 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.358 -0.839 . . . . 0.0 109.868 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.943 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.464 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.267 0.556 . . . . 0.0 109.822 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.471 ' CE1' HG23 ' A' ' 83' ' ' VAL . 28.1 m-85 -154.07 109.33 3.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.303 -0.873 . . . . 0.0 108.883 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.667 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 11.0 p-90 -108.62 143.43 37.69 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 118.646 -1.221 . . . . 0.0 111.914 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.453 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 21.3 t -122.83 104.77 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.489 0.661 . . . . 0.0 109.248 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.667 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 8.7 m-30 -85.8 114.22 22.57 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.471 HG23 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -98.17 115.8 39.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.149 -1.021 . . . . 0.0 109.224 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.477 ' CG ' ' HB3' ' A' ' 28' ' ' PHE . 4.1 tttm -98.64 125.86 44.05 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -63.66 144.45 57.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.576 -1.328 . . . . 0.0 109.212 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 104' ' ' LYS . 22.6 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.594 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 14' ' ' THR . 6.6 m-20 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.58 HG23 ' CZ ' ' A' ' 121' ' ' PHE . 3.1 mm -80.54 -63.78 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.69 0 O-C-N 121.465 -0.772 . . . . 0.0 111.294 -176.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -44.2 -27.08 0.37 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.949 . . . . 0.0 110.962 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -90.0 -38.48 13.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.988 . . . . 0.0 108.359 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.405 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.3 m -75.39 -6.78 51.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.515 -0.74 . . . . 0.0 109.269 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.505 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 38.4 mt -98.82 -27.5 13.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.193 -0.942 . . . . 0.0 109.07 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.589 -0.694 . . . . 0.0 109.837 -179.557 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 120.935 0.398 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.41 33.97 6.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.48 147.8 33.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.236 -1.155 . . . . 0.0 109.293 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -93.23 22.35 5.21 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.797 0.808 . . . . 0.0 109.312 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.549 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -155.69 115.8 3.72 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -51.04 126.95 27.88 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -106.71 82.58 1.73 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.49 HG23 ' CD1' ' A' ' 42' ' ' TYR . 1.6 pp -91.77 153.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.374 -0.829 . . . . 0.0 110.817 -177.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.482 ' HG3' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -127.19 166.36 17.86 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.451 ' CD2' ' HB2' ' A' ' 62' ' ' PHE . 84.3 mt -147.63 163.32 36.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.664 -1.273 . . . . 0.0 109.885 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 36' ' ' ASP . 17.6 p-10 -134.07 122.3 22.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.104 -0.998 . . . . 0.0 110.725 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.08 -78.75 0.0 OUTLIER Glycine 0 N--CA 1.5 2.966 0 C-N-CA 124.424 1.011 . . . . 0.0 113.3 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 34' ' ' ASP . 27.8 t70 -70.84 -2.35 14.66 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.763 -0.845 . . . . 0.0 110.796 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 88.95 13.53 62.19 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.6 m-20 -66.99 148.09 52.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.903 -1.351 . . . . 0.0 108.02 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.482 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 2.4 tp -70.36 137.75 23.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.133 0.968 . . . . 0.0 112.648 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CD1' ' HB2' ' A' ' 32' ' ' GLN . 3.3 mt -107.59 -31.39 8.13 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 175.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 6.4 tp-100 -164.25 166.71 20.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.727 -0.608 . . . . 0.0 109.634 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.558 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 1.4 t80 -147.12 -69.41 0.24 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.166 -0.959 . . . . 0.0 110.289 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.2 p-10 102.88 152.3 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.26 -14.82 59.68 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.102 -0.999 . . . . 0.0 112.405 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.79 -62.09 2.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.623 -1.298 . . . . 0.0 109.565 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.558 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 14.0 pt-20 -64.81 -42.81 94.71 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.139 -0.976 . . . . 0.0 108.887 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.449 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -59.26 -16.6 35.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -86.18 -30.64 22.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.77 -1.429 . . . . 0.0 109.465 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.75 -42.05 24.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.18 1.7 20.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.437 -0.789 . . . . 0.0 109.81 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 81.84 -2.4 83.5 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.897 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CD ' HG12 ' A' ' 66' ' ' VAL . 1.3 mtm-85 -79.33 81.42 5.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.797 -1.414 . . . . 0.0 111.327 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.455 ' CB ' ' CD ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -64.46 -179.65 0.31 Allowed Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 53' ' ' ASP . 34.2 Cg_endo -77.65 -35.63 1.46 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.681 1.587 . . . . 0.0 110.487 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -73.09 -24.57 60.66 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.193 -0.942 . . . . 0.0 109.634 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -84.68 -43.46 14.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.461 HG12 ' CE2' ' A' ' 42' ' ' TYR . 35.9 m -71.6 -6.55 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.607 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.482 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -71.06 119.84 18.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 O-C-N 121.114 -0.991 . . . . 0.0 108.354 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.17 -19.85 52.16 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -78.79 143.41 36.1 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.41 -1.053 . . . . 0.0 108.911 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.59 123.95 34.12 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.561 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 65.3 t80 -56.44 -15.61 4.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.024 -1.047 . . . . 0.0 110.8 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -122.06 36.83 4.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.932 -1.105 . . . . 0.0 109.539 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.86 -52.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 110.32 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.24 10.04 8.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.977 -1.077 . . . . 0.0 110.778 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.561 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 41.1 t -115.82 -33.95 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.867 -1.146 . . . . 0.0 108.533 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB2' HG22 ' A' ' 70' ' ' THR . . . -152.42 91.23 3.61 Favored Pre-proline 0 C--N 1.291 -1.964 0 O-C-N 121.41 -0.806 . . . . 0.0 109.146 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -73.64 -11.54 24.21 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.96 1.773 . . . . 0.0 110.123 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.9 p -86.41 -27.84 23.93 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.308 -0.87 . . . . 0.0 108.985 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.495 HG23 ' CE1' ' A' ' 75' ' ' PHE . 18.4 p -72.04 -4.96 31.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.619 -0.676 . . . . 0.0 110.161 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.22 74.84 9.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.075 -1.016 . . . . 0.0 108.651 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.31 172.37 5.55 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.346 -0.846 . . . . 0.0 109.228 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.54 77.13 3.97 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 122.579 2.186 . . . . 0.0 110.42 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.1 tt0 173.13 -37.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.575 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.9 t80 -105.98 -65.76 1.04 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.562 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 10.4 t80 -77.33 -17.84 57.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.427 ' O ' ' CG ' ' A' ' 81' ' ' GLU . . . -62.5 -59.4 9.4 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 10.7 mmtt -62.12 -19.36 62.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.689 -0.889 . . . . 0.0 109.399 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.562 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 11.4 t80 -76.11 -40.41 52.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.275 -0.89 . . . . 0.0 108.729 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -6.6 55.45 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.211 -0.93 . . . . 0.0 108.887 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 77' ' ' GLY . 1.5 mm-40 -95.44 -39.6 9.91 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.16 58.1 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.507 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 48.5 t -59.01 -37.6 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.776 -0.838 . . . . 0.0 109.58 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 -4.25 48.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 111.067 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -101.89 -16.91 16.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.845 -1.159 . . . . 0.0 110.025 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.15 17.35 74.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.03 85.97 0.53 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -1.202 . . . . 0.0 108.663 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.432 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -81.23 119.0 23.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.413 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 2.9 p30 -160.5 89.01 0.81 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.439 HG22 ' CE ' ' A' ' 109' ' ' MET . 1.6 t -138.77 171.51 14.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.075 -1.015 . . . . 0.0 110.569 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.452 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -158.3 148.27 19.9 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.639 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 12.6 p90 -168.96 153.25 5.57 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.7 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.4 115.32 23.07 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.82 -176.56 2.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.129 -0.982 . . . . 0.0 110.113 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.7 m -151.23 110.8 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -83.52 110.62 18.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -133.32 42.43 3.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.829 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 21.4 p90 -77.33 137.07 38.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER 4.5 64.36 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 CA-C-O 121.447 0.642 . . . . 0.0 111.893 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.7 OUTLIER -175.84 -176.2 0.82 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.117 -0.989 . . . . 0.0 109.749 -177.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.426 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.2 t -64.14 150.95 91.35 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 108.86 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 31.5 Cg_endo -73.76 130.52 14.75 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 121.846 1.697 . . . . 0.0 110.682 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.3 m -123.46 142.84 50.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.495 -0.753 . . . . 0.0 109.222 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.411 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -118.06 139.77 50.73 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.468 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 11.0 m -154.36 144.71 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.962 -1.086 . . . . 0.0 110.399 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -94.2 116.02 28.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.639 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -89.24 164.24 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 122.307 1.051 . . . . 0.0 111.232 -175.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -160.57 102.65 1.36 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.456 ' HB3' ' O ' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -114.35 151.12 33.51 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.393 -0.817 . . . . 0.0 110.203 -177.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.584 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 3.3 tttt -147.66 176.24 10.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.552 -1.343 . . . . 0.0 109.114 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.432 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 4.4 ttpt -85.02 107.39 17.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.923 -1.111 . . . . 0.0 109.45 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' A' ' 117' ' ' SER . . . -56.69 152.16 12.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.415 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.112 -0.992 . . . . 0.0 110.197 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 112' ' ' ALA . 1.6 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.421 0.629 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.507 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 8.9 m-85 -147.21 106.75 3.92 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.657 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 9.9 p-90 -103.23 139.38 38.77 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.783 -1.167 . . . . 0.0 112.557 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.49 HG12 ' CE1' ' A' ' 75' ' ' PHE . 30.1 t -116.61 110.46 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.657 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.6 m-30 -92.69 118.53 31.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.313 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -101.3 122.77 53.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.955 -1.091 . . . . 0.0 109.355 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -99.13 123.11 43.18 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.45 ' HA ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -75.05 118.45 18.01 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.931 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.412 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t0 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.553 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 14.2 mm -61.9 -57.11 13.56 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.226 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.9 mt-10 -35.87 -43.21 0.3 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.875 -0.516 . . . . 0.0 111.709 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -76.3 -42.42 45.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.009 -1.057 . . . . 0.0 108.986 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 11' ' ' ILE . 7.2 m -66.53 -14.04 61.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.665 -0.647 . . . . 0.0 110.233 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.506 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 9.6 mt -97.34 -23.13 16.26 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.918 -1.114 . . . . 0.0 109.051 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.34 -0.85 . . . . 0.0 109.609 179.487 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 p30 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.75 21.18 42.78 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.458 HD21 ' CE1' ' A' ' 28' ' ' PHE . 14.6 mt -68.41 152.29 45.63 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.972 -1.311 . . . . 0.0 108.759 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.56 9.03 17.12 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 1.2 p90 -153.5 117.29 4.74 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' HA3' ' HG2' ' A' ' 46' ' ' GLU . . . -53.97 161.61 3.8 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.382 -0.913 . . . . 0.0 110.859 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.425 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -136.88 116.0 12.48 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.5 HG23 ' CE1' ' A' ' 42' ' ' TYR . 1.5 pp -118.9 157.7 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.212 -0.93 . . . . 0.0 109.733 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.44 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 12.3 mt-30 -123.04 168.08 12.81 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 15.9 mt -151.69 150.38 30.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.007 . . . . 0.0 110.001 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.402 ' HB2' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -104.85 168.79 8.83 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -46.5 -29.44 3.95 Favored Glycine 0 N--CA 1.504 3.174 0 CA-C-N 118.621 0.646 . . . . 0.0 112.959 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.16 9.98 13.51 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.485 -1.597 . . . . 0.0 110.581 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 26.22 67.18 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 13.6 m120 -93.25 134.14 35.76 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.227 -1.16 . . . . 0.0 111.229 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.61 138.25 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 111.058 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.44 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 5.7 mt -109.68 -29.23 8.44 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -161.66 159.32 27.32 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.575 ' CE2' ' OE2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -138.02 -50.63 0.59 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.38 -1.45 . . . . 0.0 109.311 -178.361 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 0.5 OUTLIER 87.57 171.25 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.03 -15.36 22.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.015 -1.053 . . . . 0.0 112.822 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.17 -64.74 0.83 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.429 -1.419 . . . . 0.0 109.488 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.575 ' OE2' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -59.72 -51.74 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 109.3 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' N ' ' OE2' ' A' ' 46' ' ' GLU . . . -56.96 -15.92 15.66 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.6 -40.73 48.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.821 -1.399 . . . . 0.0 108.181 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -73.33 -59.29 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.428 -0.795 . . . . 0.0 108.89 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.529 HG22 ' HD3' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -78.15 -8.55 58.41 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.347 -0.846 . . . . 0.0 110.319 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 82.77 -3.47 83.21 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.401 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.529 ' HD3' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -60.91 165.73 3.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.743 -1.445 . . . . 0.0 110.078 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.406 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 7.1 m-20 -133.05 168.11 19.58 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 53' ' ' ASP . 34.4 Cg_endo -77.27 -38.38 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.475 1.45 . . . . 0.0 110.074 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -79.04 -24.56 43.52 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.312 -0.867 . . . . 0.0 109.487 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -45.3 18.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 42' ' ' TYR . 20.4 m -69.28 -9.66 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.198 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.98 120.72 16.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.96 -24.31 32.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -78.9 130.38 35.57 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.466 ' ND2' ' ND2' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -79.19 132.58 36.57 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.567 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.554 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 64.9 t80 -60.32 -14.37 18.01 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.068 -1.02 . . . . 0.0 110.118 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 99.5 m-85 -124.31 33.39 5.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.019 -1.051 . . . . 0.0 110.378 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -154.57 -40.7 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.882 -1.136 . . . . 0.0 110.377 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.53 7.86 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.007 -1.058 . . . . 0.0 110.881 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 94.3 t -114.11 -33.85 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 120.673 -1.267 . . . . 0.0 108.448 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.06 100.62 2.31 Favored Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.544 -0.722 . . . . 0.0 109.182 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.97 -1.23 10.94 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.913 1.742 . . . . 0.0 110.876 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.5 p -97.37 -25.32 15.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.133 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.468 HG22 ' CE2' ' A' ' 62' ' ' PHE . 67.7 p -66.98 -10.68 52.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.638 -0.663 . . . . 0.0 110.187 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.28 64.62 8.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 109.626 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.416 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -147.44 172.53 5.09 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.181 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -76.66 78.4 3.35 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 122.514 2.142 . . . . 0.0 110.314 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.8 tt0 169.36 -36.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.478 ' CD1' ' HE2' ' A' ' 109' ' ' MET . 1.3 t80 -104.21 -68.06 0.87 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.509 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 14.4 t80 -75.53 -20.69 58.53 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.69 -59.08 9.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 8.5 mmtt -66.45 -14.17 61.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.523 -0.986 . . . . 0.0 109.915 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.509 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 15.7 t80 -83.33 -35.02 25.51 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.371 -0.83 . . . . 0.0 109.048 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -11.95 59.88 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.157 -0.964 . . . . 0.0 109.246 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 23.5 pt-20 -97.84 -42.2 7.68 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.437 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -61.61 -38.49 95.94 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.705 -2.158 . . . . 0.0 107.705 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 98.0 t -65.07 -40.15 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.795 -0.827 . . . . 0.0 110.042 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.61 0.36 57.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.0 111.135 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 t -109.74 -19.64 13.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.879 -1.138 . . . . 0.0 109.998 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.21 14.59 81.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -144.31 59.07 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -1.203 . . . . 0.0 109.275 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.413 ' CB ' ' HB2' ' A' ' 111' ' ' LYS . 0.2 OUTLIER -68.25 113.48 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.656 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -161.04 79.44 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.386 -0.822 . . . . 0.0 108.908 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.2 t -120.92 167.8 12.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.031 -1.043 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 4.0 ttt -154.88 154.33 32.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.78 . . . . 0.0 109.222 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 15.4 p90 -176.85 178.04 1.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -0.95 . . . . 0.0 109.869 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.91 100.23 10.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.047 -1.033 . . . . 0.0 108.299 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.6 151.72 21.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 110.06 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -119.01 111.09 17.88 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.476 ' CZ ' ' CG2' ' A' ' 122' ' ' VAL . 19.1 m-30 -79.28 115.78 19.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.402 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -137.51 46.3 2.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -85.32 43.95 1.06 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.623 -0.673 . . . . 0.0 111.688 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER 100.9 27.82 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.698 0 CA-C-O 121.603 0.716 . . . . 0.0 109.271 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -139.28 175.15 9.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.407 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 19.5 p -54.52 161.27 2.18 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.024 -1.048 . . . . 0.0 109.287 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.4 Cg_endo -75.94 96.66 1.07 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.776 1.65 . . . . 0.0 110.049 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.42 125.09 50.32 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.377 -0.827 . . . . 0.0 109.8 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.45 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -88.7 159.92 17.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 175.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.484 ' HA ' HG21 ' A' ' 125' ' ' VAL . 35.6 m -156.17 142.49 10.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.599 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -79.13 103.5 9.12 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 175.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.549 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 33.7 m -94.8 151.88 3.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.806 -1.184 . . . . 0.0 110.24 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -153.96 103.3 2.56 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.478 ' HE2' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -104.75 131.82 51.74 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.079 -1.013 . . . . 0.0 109.297 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.56 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 3.9 tttt -130.34 -174.69 3.41 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.209 -1.396 . . . . 0.0 109.894 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 10.7 tttt -99.79 102.64 14.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.102 -0.999 . . . . 0.0 108.713 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.487 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -56.03 142.36 36.48 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.349 -0.844 . . . . 0.0 110.056 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.88 . . . . 0.0 109.985 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.52 0.676 . . . . 0.0 110.104 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.485 ' CE1' HG23 ' A' ' 83' ' ' VAL . 14.9 m-85 -151.91 111.35 3.94 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.666 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 20.1 p-90 -113.01 149.79 32.84 Favored 'General case' 0 C--O 1.202 -1.405 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.531 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.468 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 46.6 t -128.24 106.25 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.726 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.666 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 7.5 m-30 -91.72 128.31 37.51 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.476 ' CG2' ' CZ ' ' A' ' 96' ' ' PHE . 1.7 t -105.96 129.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.625 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.599 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -101.34 153.43 19.66 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -101.51 127.87 48.0 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.277 -1.369 . . . . 0.0 109.068 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.484 HG21 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.437 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.0 t0 . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.553 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 4.4 mm -90.82 -59.45 2.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.302 -0.874 . . . . 0.0 110.553 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -22.92 0.77 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.578 -1.327 . . . . 0.0 110.558 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -94.29 -36.81 11.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 109.399 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -69.51 -59.8 2.74 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.48 ' CD1' HG23 ' A' ' 11' ' ' ILE . 18.1 mt -40.76 -34.61 0.4 Allowed 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.434 0.635 . . . . 0.0 109.793 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.485 -0.759 . . . . 0.0 109.865 -179.689 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.958 0.409 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.09 29.23 12.97 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 120.824 -1.172 . . . . 0.0 110.282 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mt -105.35 -177.01 3.24 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.051 -1.264 . . . . 0.0 109.025 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.44 4.5 48.41 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.499 ' HB3' ' HD3' ' A' ' 123' ' ' LYS . 8.1 p90 -135.96 129.24 31.85 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -63.41 122.49 26.99 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -100.88 96.3 7.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.074 -1.25 . . . . 0.0 107.752 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.507 HG23 ' CD1' ' A' ' 42' ' ' TYR . 1.3 pp -98.24 148.82 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 110.787 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -113.56 167.32 10.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD12 ' CE2' ' A' ' 63' ' ' PHE . 55.4 mt -155.46 139.89 16.79 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.165 -0.959 . . . . 0.0 108.91 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 36' ' ' ASP . 8.1 t0 -120.52 131.71 54.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.919 -1.113 . . . . 0.0 110.433 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 35.87 -77.04 0.0 OUTLIER Glycine 0 N--CA 1.501 2.978 0 C-N-CA 124.71 1.148 . . . . 0.0 113.403 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -73.37 2.56 7.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.659 -0.907 . . . . 0.0 111.109 -178.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 82.4 17.34 69.09 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -72.58 136.34 45.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.087 -1.243 . . . . 0.0 108.693 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.453 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -64.44 135.59 27.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.224 -0.922 . . . . 0.0 111.094 -178.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' CD2' ' HB2' ' A' ' 34' ' ' ASP . 1.5 mt -105.56 -29.39 10.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.445 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -163.51 164.09 24.47 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.632 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 7.4 t80 -133.36 -75.95 0.48 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 119.955 -1.716 . . . . 0.0 110.599 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.632 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 8.0 t-20 134.25 150.04 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.691 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -77.47 -55.88 5.01 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.335 -0.853 . . . . 0.0 109.834 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -34.0 -57.58 0.46 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' CD ' ' CE2' ' A' ' 42' ' ' TYR . 15.5 pt-20 -64.22 -46.73 82.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.948 -1.095 . . . . 0.0 109.676 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . -62.63 -12.2 39.51 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.08 -32.87 17.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.631 -1.511 . . . . 0.0 110.355 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.65 -35.08 11.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.179 -0.951 . . . . 0.0 108.899 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.439 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -107.3 -21.46 12.94 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.029 -179.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 97.93 -3.33 60.47 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.546 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.538 ' CZ ' ' CG1' ' A' ' 66' ' ' VAL . 1.8 mtt85 -68.09 95.23 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.86 -1.376 . . . . 0.0 110.666 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.415 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -72.52 162.29 74.79 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.98 -29.53 5.16 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.959 1.773 . . . . 0.0 110.569 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.79 -33.97 34.43 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.269 -0.894 . . . . 0.0 109.899 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -41.73 49.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.717 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 34.1 m -74.26 -4.48 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 109.914 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.21 123.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.82 -19.37 52.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -82.66 133.69 35.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -1.139 . . . . 0.0 109.102 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.469 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -75.0 119.78 19.65 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.204 -0.935 . . . . 0.0 108.501 179.2 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.477 ' CE2' HG22 ' A' ' 70' ' ' THR . 90.9 t80 -66.32 -8.89 28.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.895 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.413 ' CE2' HD12 ' A' ' 33' ' ' LEU . 34.3 m-85 -96.93 -60.19 1.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.202 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -112.96 20.89 15.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.902 -1.124 . . . . 0.0 110.851 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.469 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.4 OUTLIER -137.01 -14.91 1.54 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.872 -1.142 . . . . 0.0 111.44 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.538 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 31.5 t -122.43 -47.99 2.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 120.55 -1.344 . . . . 0.0 108.559 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.413 ' HB3' ' NH2' ' A' ' 52' ' ' ARG . . . -122.65 109.96 32.19 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -75.17 0.79 8.55 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.912 1.742 . . . . 0.0 111.505 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.2 p -98.68 -24.84 14.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.87 -1.144 . . . . 0.0 109.658 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.477 HG22 ' CE2' ' A' ' 62' ' ' PHE . 61.2 p -73.67 -4.04 31.9 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.332 -0.855 . . . . 0.0 109.863 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -88.44 50.82 2.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.014 -1.054 . . . . 0.0 109.148 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -127.1 174.84 3.82 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 34.8 Cg_endo -76.77 -1.33 11.45 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 122.101 1.867 . . . . 0.0 111.387 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 14.9 mp0 -105.34 -28.42 10.9 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.916 -1.115 . . . . 0.0 109.357 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.521 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.7 t80 -100.57 -71.99 0.69 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.44 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 11.4 t80 -72.96 -16.11 61.54 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 120.947 -1.096 . . . . 0.0 108.234 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.65 -62.6 4.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.481 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 2.2 mmtp -64.06 -14.89 57.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.672 -0.899 . . . . 0.0 109.551 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 118' ' ' TYR . 3.3 t80 -80.53 -41.18 24.66 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -9.35 58.51 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 108.689 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 85' ' ' SER . 2.1 mm-40 -95.9 -40.17 9.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.7 95.02 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.522 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 61.8 t -62.96 -40.61 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.943 -0.74 . . . . 0.0 109.975 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.37 1.4 54.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.256 -0.902 . . . . 0.0 111.218 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 81' ' ' GLU . 97.5 p -104.69 -24.13 12.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.863 -1.148 . . . . 0.0 110.142 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.03 21.17 47.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -160.16 57.08 0.35 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -1.189 . . . . 0.0 109.333 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 1.5 tt -66.29 102.39 0.85 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.422 -0.798 . . . . 0.0 109.447 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -161.6 82.95 0.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -139.79 174.58 10.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.904 -1.123 . . . . 0.0 110.233 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.75 168.77 22.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.636 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 8.8 p90 -174.47 154.29 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.079 -1.013 . . . . 0.0 109.929 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -80.47 117.16 20.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.41 -0.806 . . . . 0.0 108.943 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.03 169.3 11.8 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.249 -0.907 . . . . 0.0 109.435 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.406 HG22 ' CD ' ' A' ' 104' ' ' LYS . 0.7 OUTLIER -140.19 111.31 7.04 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.376 -0.828 . . . . 0.0 109.313 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.426 ' CZ ' ' CG2' ' A' ' 122' ' ' VAL . 20.6 m-30 -79.64 85.04 5.4 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.455 -0.778 . . . . 0.0 109.12 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.99 29.47 5.43 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.548 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -77.59 153.39 33.32 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 98' ' ' TYR . 10.0 mt-30 -2.0 67.35 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 123.365 0.666 . . . . 0.0 112.457 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.9 -157.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.0 109.845 -178.236 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -91.22 174.17 4.7 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 0.0 108.882 179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.3 Cg_endo -76.71 87.79 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.949 1.766 . . . . 0.0 110.509 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 m -87.52 106.9 18.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.443 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.406 ' CD ' HG22 ' A' ' 95' ' ' THR . 0.0 OUTLIER -85.42 139.33 31.61 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.51 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 13.7 m -149.94 146.14 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.131 -0.981 . . . . 0.0 110.115 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.22 115.79 29.09 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 175.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.636 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -85.97 159.96 3.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 120.82 -1.175 . . . . 0.0 110.925 -175.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -157.15 98.42 1.73 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -109.09 149.38 29.4 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.395 -0.816 . . . . 0.0 109.748 -177.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.633 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -141.07 -175.04 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.374 -1.33 . . . . 0.0 109.695 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -89.63 101.79 14.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 109.258 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.471 ' HB2' ' CB ' ' A' ' 117' ' ' SER . . . -56.85 156.93 6.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.615 -0.678 . . . . 0.0 110.871 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.305 -1.331 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.471 ' CB ' ' HB2' ' A' ' 112' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.31 0.576 . . . . 0.0 109.929 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.522 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 1.7 m-85 -149.74 127.54 11.76 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.653 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 10.2 p-90 -123.8 148.24 46.86 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.968 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 11.7 t -123.0 109.49 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.314 0.578 . . . . 0.0 109.827 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.653 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 9.2 m-30 -88.24 126.37 35.12 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.457 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.2 t -103.88 114.71 44.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -89.52 111.79 22.8 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.429 ' HA ' HG11 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -66.95 109.03 2.79 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.948 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.161 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.53 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 4.9 mm -83.6 -56.77 5.23 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 110.732 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -40.35 -29.23 0.08 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.773 . . . . 0.0 111.559 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 11' ' ' ILE . 4.8 m120 -89.37 -40.83 12.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.966 -1.083 . . . . 0.0 108.258 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 m -69.2 -10.18 56.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.719 -0.613 . . . . 0.0 109.794 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 11' ' ' ILE . 15.4 mt -97.48 -24.54 15.54 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.019 -1.05 . . . . 0.0 109.172 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.423 -0.798 . . . . 0.0 109.627 179.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.96 30.09 9.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.8 mt -80.17 128.3 33.36 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.51 -0.994 . . . . 0.0 109.207 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.17 -13.78 8.42 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.599 0.714 . . . . 0.0 109.227 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.52 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 14.6 p90 -129.16 150.7 50.44 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.068 -1.02 . . . . 0.0 108.843 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.478 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -76.69 152.03 40.32 Favored Glycine 0 C--N 1.293 -1.81 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.7 90.61 3.31 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.832 -1.393 . . . . 0.0 107.536 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.534 HG23 ' CD1' ' A' ' 42' ' ' TYR . 1.1 pp -94.71 142.6 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.489 -0.757 . . . . 0.0 110.762 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.453 ' CG ' ' HB3' ' A' ' 41' ' ' GLN . 2.0 mm100 -114.11 168.33 9.91 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 31' ' ' ILE . 73.3 mt -153.94 146.92 24.49 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.842 -1.161 . . . . 0.0 110.379 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 36' ' ' ASP . 45.1 m-20 -123.63 124.07 41.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.394 -0.816 . . . . 0.0 109.659 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.54 -77.32 0.0 OUTLIER Glycine 0 N--CA 1.5 2.951 0 C-N-CA 124.561 1.077 . . . . 0.0 113.679 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -70.57 -2.86 15.51 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.598 -0.942 . . . . 0.0 111.197 -177.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 88.02 20.52 49.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -75.5 130.16 38.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.086 -1.244 . . . . 0.0 108.201 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.464 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -59.78 139.01 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 110.561 -178.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 2.7 mt -107.07 -26.59 11.07 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 0.9 OUTLIER -160.31 142.11 12.66 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.001 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.534 ' CD1' HG23 ' A' ' 31' ' ' ILE . 6.2 t80 -121.95 -64.22 1.23 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.756 -1.215 . . . . 0.0 110.729 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 3.2 p-10 101.86 175.6 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.59 -19.42 19.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.855 -1.153 . . . . 0.0 112.615 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.84 -63.44 1.2 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.51 -1.369 . . . . 0.0 110.163 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.502 ' OE1' ' CE1' ' A' ' 42' ' ' TYR . 1.9 pt-20 -60.77 -53.18 60.46 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.579 -0.701 . . . . 0.0 109.392 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -57.96 -14.38 16.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.46 -30.78 20.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.786 -1.42 . . . . 0.0 110.205 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.413 HG23 HG21 ' A' ' 50' ' ' THR . 1.2 mp -83.36 -38.12 14.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.122 -0.986 . . . . 0.0 109.074 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.42 ' HA ' ' CE ' ' A' ' 100' ' ' MET . 0.7 OUTLIER -102.86 -18.28 15.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.5 -0.75 . . . . 0.0 109.669 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 92.72 -3.76 74.89 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.49 ' HD3' ' OH ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -58.39 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.239 . . . . 0.0 109.213 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 12.1 m-20 -54.74 152.93 11.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 108.919 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.55 -42.81 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 122.07 1.847 . . . . 0.0 110.68 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.73 -27.81 60.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.13 -0.981 . . . . 0.0 109.94 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -80.66 -39.65 26.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.613 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 24.0 m -76.66 -1.99 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.837 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.464 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -71.71 122.1 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.061 -1.024 . . . . 0.0 108.48 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.06 -13.13 65.58 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 35.1 mmtt -79.13 136.23 37.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.048 -1.266 . . . . 0.0 108.93 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.433 ' N ' ' HB3' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -72.41 95.03 1.71 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.459 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 30.1 t80 -53.92 -22.71 10.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 109.794 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -91.78 -31.98 15.55 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.72 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -138.15 44.98 2.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 109.114 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.433 ' HB3' ' N ' ' A' ' 61' ' ' ASN . 34.0 t0 -164.26 -31.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 110.517 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.47 HG12 ' NH1' ' A' ' 52' ' ' ARG . 3.9 t -112.2 -50.57 5.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 O-C-N 120.754 -1.216 . . . . 0.0 108.674 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.63 94.74 48.36 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.709 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.22 -6.02 17.82 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.886 1.724 . . . . 0.0 110.462 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.7 p -77.82 -32.87 52.54 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.151 -0.968 . . . . 0.0 108.692 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 p -69.1 -9.44 52.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.604 -0.685 . . . . 0.0 109.764 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.87 76.74 9.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.997 -1.064 . . . . 0.0 108.635 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -165.07 173.46 3.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 109.085 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.6 Cg_endo -77.4 76.71 4.12 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 122.497 2.132 . . . . 0.0 110.416 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 3.6 tt0 174.27 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.441 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.3 t80 -105.65 -64.03 1.19 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.506 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.4 t80 -79.61 -20.43 46.85 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.081 -1.012 . . . . 0.0 108.56 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.46 -57.81 13.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 12.1 mmtt -65.38 -16.69 63.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.658 -0.907 . . . . 0.0 109.802 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.506 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 9.4 t80 -82.62 -35.12 27.29 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -76.32 -12.88 60.14 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.103 -0.998 . . . . 0.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 18.7 pt-20 -96.92 -41.34 8.46 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.441 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -60.18 -39.86 96.48 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 107.454 -2.258 . . . . 0.0 107.454 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 99.1 t -59.88 -47.59 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.794 -0.827 . . . . 0.0 109.296 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.76 5.58 45.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.386 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.3 m -102.0 -25.75 13.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.042 -1.037 . . . . 0.0 109.612 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.78 22.29 64.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -166.03 58.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.134 -1.216 . . . . 0.0 109.51 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.425 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.5 OUTLIER -52.94 116.35 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.895 . . . . 0.0 109.515 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.414 ' ND2' ' HE3' ' A' ' 110' ' ' LYS . 2.4 t-20 -160.2 78.34 0.66 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.168 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.1 t -136.44 154.91 50.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.96 163.0 34.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 0.0 108.923 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.658 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 8.6 p90 -175.27 151.59 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.041 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 1.5 pt-20 -81.73 112.39 18.86 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.195 -0.941 . . . . 0.0 108.636 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.79 -179.63 3.71 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.181 -0.949 . . . . 0.0 109.99 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.3 m -147.52 107.56 4.02 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.455 ' CE2' HG23 ' A' ' 122' ' ' VAL . 17.8 m-30 -84.13 92.58 7.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.377 -0.827 . . . . 0.0 109.718 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -108.01 25.21 11.85 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.264 -0.898 . . . . 0.0 109.338 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.576 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -78.65 155.39 29.54 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.52 ' C ' ' O ' ' A' ' 98' ' ' TYR . 24.1 mt-30 -0.32 65.85 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.187 0 CA-C-O 121.631 0.729 . . . . 0.0 112.099 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.576 ' N ' ' O ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER 173.64 158.36 0.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -53.68 168.44 0.4 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.114 -0.991 . . . . 0.0 109.088 179.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 32.8 Cg_endo -74.75 113.34 3.77 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.831 1.688 . . . . 0.0 110.194 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.3 m -116.25 114.93 25.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.844 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.438 ' O ' HG11 ' A' ' 105' ' ' VAL . 5.4 tttt -92.05 136.65 33.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.504 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 32.6 m -147.44 146.27 18.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.146 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -91.71 116.37 28.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 175.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.658 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -88.27 164.12 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.787 -1.196 . . . . 0.0 111.516 -175.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -150.83 98.7 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 119' ' ' TRP . 19.5 mtm -96.85 125.4 41.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.682 -1.261 . . . . 0.0 109.503 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.553 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 3.9 tttt -132.15 172.12 12.79 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 117.525 -1.67 . . . . 0.0 109.706 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.425 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 2.1 tttp -90.29 107.68 19.29 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.979 -1.076 . . . . 0.0 108.384 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.454 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -52.21 -177.17 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.28 0.562 . . . . 0.0 110.154 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.027 . . . . 0.0 110.461 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.502 2.163 0 CA-C-O 120.661 0.267 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.426 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 12.6 m-85 -127.3 122.8 34.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.742 -1.224 . . . . 0.0 109.227 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.686 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 22.1 p-90 -128.11 152.42 48.02 Favored 'General case' 0 C--O 1.201 -1.455 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.919 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.449 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 60.9 t -132.36 110.31 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.305 0.574 . . . . 0.0 109.648 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.686 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 9.1 m-30 -94.34 122.09 36.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 108.987 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.488 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -103.03 116.84 47.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.01 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.52 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 1.6 tptp -88.09 114.18 24.45 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.427 ' HA ' HG11 ' A' ' 105' ' ' VAL . 1.2 ttp85 -67.85 111.6 4.42 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.456 -1.297 . . . . 0.0 108.544 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.504 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.058 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.532 HG13 ' CE2' ' A' ' 121' ' ' PHE . 1.9 mm -88.64 -67.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.117 -0.989 . . . . 0.0 111.142 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -41.16 -36.06 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.624 -0.672 . . . . 0.0 111.592 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -77.54 -42.76 34.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.872 -1.143 . . . . 0.0 108.455 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.43 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.0 m -76.03 -4.38 40.95 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.531 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 81.2 mt -97.85 -23.03 16.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.855 -1.153 . . . . 0.0 109.149 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 O-C-N 121.483 -0.761 . . . . 0.0 108.994 179.522 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.16 28.88 13.68 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 1.7 mt -73.68 -171.91 1.14 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.128 -1.219 . . . . 0.0 108.798 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.85 13.22 23.63 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.527 ' CZ ' HD13 ' A' ' 11' ' ' ILE . 18.8 p90 -146.12 177.2 9.16 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.684 -0.635 . . . . 0.0 109.509 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.491 ' HA3' ' CB ' ' A' ' 46' ' ' GLU . . . -108.66 118.8 5.44 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.454 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -94.81 89.39 5.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.919 -1.342 . . . . 0.0 109.061 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.523 ' CG2' ' CE1' ' A' ' 42' ' ' TYR . 1.1 pp -96.0 161.47 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.494 -0.754 . . . . 0.0 109.403 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.446 ' HB2' ' HG3' ' A' ' 41' ' ' GLN . 8.9 mt-30 -132.16 175.77 8.96 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 22.3 mt -155.77 146.25 21.88 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 14.6 t70 -99.16 169.96 9.02 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.86 -21.82 1.74 Allowed Glycine 0 N--CA 1.499 2.893 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.449 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -94.98 13.51 24.77 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.547 -1.56 . . . . 0.0 110.549 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.07 26.68 65.9 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 2.0 m-20 -97.25 126.22 42.31 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.987 -1.302 . . . . 0.0 111.929 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -53.09 133.41 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.117 -0.99 . . . . 0.0 110.709 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 34' ' ' ASP . 11.6 mt -102.74 -32.2 9.95 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -155.54 -175.16 5.29 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.533 ' CE2' ' CG ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -160.62 -62.8 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.97 -1.081 . . . . 0.0 110.239 -178.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.8 p-10 103.92 176.49 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.22 -37.03 11.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.974 -1.079 . . . . 0.0 110.758 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.76 -48.18 20.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.233 -0.917 . . . . 0.0 111.047 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.533 ' CG ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -61.83 -47.51 84.78 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.388 -0.82 . . . . 0.0 109.34 -177.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.474 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . -61.27 -15.87 46.71 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -80.64 -32.32 36.24 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.121 -1.223 . . . . 0.0 109.464 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.433 HG21 HG21 ' A' ' 50' ' ' THR . 0.6 OUTLIER -85.06 -50.61 14.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.075 -1.015 . . . . 0.0 109.441 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.47 ' HA ' ' CE ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -88.58 -13.88 38.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.759 -1.213 . . . . 0.0 109.524 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 89.09 -11.77 68.35 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' OE2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -57.78 175.54 0.19 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -1.165 . . . . 0.0 109.525 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.413 ' O ' HG12 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -127.86 158.85 69.2 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 108.943 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.97 -37.99 1.8 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.865 1.71 . . . . 0.0 110.656 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -89.23 -25.26 21.83 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.171 -0.955 . . . . 0.0 109.279 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 1.2 tt0 -73.89 -37.88 64.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 108.689 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.507 HG12 ' CE2' ' A' ' 42' ' ' TYR . 26.6 m -70.9 -8.45 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.815 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.405 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -70.97 122.56 23.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.08 -19.7 51.71 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -78.73 130.94 36.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.451 -1.029 . . . . 0.0 108.927 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 128.1 34.66 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.529 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 63.2 t80 -62.33 -11.53 15.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.584 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -122.52 32.17 5.86 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.95 -1.094 . . . . 0.0 110.271 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -150.09 -45.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.07 . . . . 0.0 110.563 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -128.15 4.33 5.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.994 -1.067 . . . . 0.0 110.762 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 39.2 t -113.62 -28.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.801 -1.187 . . . . 0.0 108.72 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.58 88.79 2.74 Favored Pre-proline 0 C--N 1.292 -1.915 0 O-C-N 121.346 -0.847 . . . . 0.0 109.214 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -74.61 -4.41 15.37 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.986 1.791 . . . . 0.0 110.158 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.5 p -94.27 -27.63 16.03 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.355 -0.84 . . . . 0.0 109.074 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 69.9 p -64.41 -18.89 65.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.62 -0.675 . . . . 0.0 109.666 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -60.5 91.84 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.052 -1.03 . . . . 0.0 108.842 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.95 172.8 1.11 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.229 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.16 -4.44 14.33 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 122.599 2.199 . . . . 0.0 111.729 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 17.7 mt-10 -102.46 -29.95 11.3 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.754 -1.216 . . . . 0.0 109.822 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 70' ' ' THR . 1.6 t80 -101.62 -68.91 0.8 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.469 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.8 t80 -73.62 -17.32 61.18 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 81' ' ' GLU . . . -64.84 -61.42 5.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -65.03 -14.66 60.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.646 -0.914 . . . . 0.0 109.841 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.469 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 7.9 t80 -82.89 -36.75 25.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -78.32 -9.47 59.26 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 77' ' ' GLY . 1.3 mm-40 -95.61 -39.6 9.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 88' ' ' LEU . . . -65.25 -41.69 96.66 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.511 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 66.3 t -59.67 -40.57 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.788 -0.831 . . . . 0.0 109.585 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.66 1.17 53.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.275 -0.891 . . . . 0.0 111.503 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -106.39 -20.1 13.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.808 -1.182 . . . . 0.0 110.147 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.63 26.03 57.4 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -168.66 67.26 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.397 -1.06 . . . . 0.0 109.217 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.433 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -71.37 115.88 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.905 . . . . 0.0 110.032 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 64.1 t-20 -162.03 88.4 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.541 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.403 ' CG2' ' SD ' ' A' ' 109' ' ' MET . 4.6 t -128.92 168.32 16.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.992 -1.068 . . . . 0.0 109.96 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.413 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 0.6 OUTLIER -155.14 151.11 27.87 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.543 ' CD2' HG23 ' A' ' 107' ' ' VAL . 12.3 p90 -173.03 -176.58 1.42 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.293 -0.88 . . . . 0.0 109.547 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.82 100.03 8.6 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.19 179.12 4.7 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.591 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.3 m -144.03 105.9 4.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.383 -0.823 . . . . 0.0 109.271 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.482 ' CE2' HG23 ' A' ' 122' ' ' VAL . 15.5 m-30 -80.59 110.15 15.8 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -134.7 43.26 2.76 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.364 -0.835 . . . . 0.0 109.485 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 21.4 p90 -77.41 139.58 39.72 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.533 ' C ' ' O ' ' A' ' 98' ' ' TYR . 3.3 pt20 2.31 66.98 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.191 0 CA-C-O 121.879 0.847 . . . . 0.0 111.783 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.531 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.6 tmm? -176.85 -179.38 0.94 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 p -65.0 163.08 32.67 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.0 109.06 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.02 148.67 27.98 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.147 1.898 . . . . 0.0 110.416 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.2 m -151.36 118.87 6.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 110.116 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -95.36 142.9 27.21 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.48 ' CA ' HG22 ' A' ' 125' ' ' VAL . 32.5 m -144.12 146.67 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 118.266 -1.373 . . . . 0.0 112.411 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -78.8 95.33 5.34 Favored 'General case' 0 C--O 1.2 -1.536 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 175.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.543 HG23 ' CD2' ' A' ' 92' ' ' PHE . 33.3 m -87.63 152.6 3.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 120.731 -1.231 . . . . 0.0 110.151 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -160.44 97.53 1.22 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.46 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -106.12 142.27 36.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.188 -0.945 . . . . 0.0 109.327 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.551 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 5.3 tttt -133.01 -162.49 1.24 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.753 -1.217 . . . . 0.0 109.416 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -110.84 98.53 7.64 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.119 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.505 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -52.49 123.97 12.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 tp . . . . . 0 C--N 1.301 -1.541 0 O-C-N 121.037 -1.039 . . . . 0.0 109.695 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.493 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.037 0 CA-C-O 121.103 0.478 . . . . 0.0 111.534 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.511 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 15.9 m-85 -128.75 127.45 42.07 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.037 -1.04 . . . . 0.0 110.106 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.643 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 17.6 p-90 -125.56 146.87 49.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.601 -1.312 . . . . 0.0 112.269 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.46 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 40.7 t -123.32 117.85 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.741 -0.599 . . . . 0.0 109.949 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.643 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.0 m-30 -100.92 120.0 39.53 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.988 -1.07 . . . . 0.0 108.639 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.482 HG23 ' CE2' ' A' ' 96' ' ' PHE . 1.4 t -105.58 111.71 35.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 122.244 1.021 . . . . 0.0 108.297 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 105' ' ' VAL . 1.5 tptp -92.71 154.49 18.3 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HD3' ' CD1' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -91.47 123.55 34.98 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.493 -1.379 . . . . 0.0 109.008 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.48 HG22 ' CA ' ' A' ' 105' ' ' VAL . 9.3 t . . . . . 0 C--N 1.305 -1.355 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.481 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.595 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 2.9 mm -82.48 -56.14 6.45 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 111.464 -177.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -40.43 -27.91 0.06 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.454 -0.779 . . . . 0.0 111.524 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' ILE . 96.6 m-20 -86.79 -42.52 13.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 109.007 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -70.48 -14.42 62.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.347 -0.846 . . . . 0.0 110.21 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 11' ' ' ILE . 8.9 mt -93.56 -18.92 21.7 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.014 -1.054 . . . . 0.0 109.069 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 108.824 179.172 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.916 0.389 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.51 35.53 4.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 13.6 mt -121.27 149.64 42.58 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.487 -1.008 . . . . 0.0 109.352 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.04 24.58 4.2 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.029 0.918 . . . . 0.0 108.851 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.642 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 1.2 p90 -153.53 134.12 13.66 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -68.18 125.2 21.07 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.96 -1.115 . . . . 0.0 110.857 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.432 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -106.21 110.41 22.64 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.516 ' CG2' ' CD1' ' A' ' 42' ' ' TYR . 1.4 pp -117.11 151.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.939 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -113.0 167.91 10.13 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 13.2 mt -150.07 139.9 21.83 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.916 -1.115 . . . . 0.0 110.036 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' N ' HD22 ' A' ' 40' ' ' LEU . 37.1 t70 -92.14 167.56 11.97 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -48.93 -21.04 2.14 Favored Glycine 0 N--CA 1.497 2.747 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.421 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.51 12.52 22.65 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.458 -1.613 . . . . 0.0 110.498 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 75.3 26.9 64.89 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 69.1 m-20 -97.4 127.83 43.69 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.013 -1.287 . . . . 0.0 111.872 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.9 OUTLIER -59.52 134.83 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.86 -1.15 . . . . 0.0 110.528 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 2.3 mt -106.47 -29.56 9.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -155.46 161.38 40.97 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.59 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 3.7 t80 -143.7 -60.93 0.4 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.552 -1.342 . . . . 0.0 109.972 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.498 ' OD1' ' HG2' ' A' ' 46' ' ' GLU . 3.5 p-10 99.89 173.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 123.745 0.818 . . . . 0.0 108.871 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.59 -13.73 25.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.755 -1.215 . . . . 0.0 111.84 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.93 -65.06 0.73 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.585 -1.322 . . . . 0.0 109.904 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.59 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 7.0 pt-20 -60.31 -50.0 75.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.959 . . . . 0.0 109.737 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -56.47 -18.64 23.4 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.13 -38.47 56.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.829 -1.395 . . . . 0.0 108.422 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -79.32 -59.5 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.45 -0.781 . . . . 0.0 109.294 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.459 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 19.0 p -78.36 -9.63 59.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.275 -0.891 . . . . 0.0 110.474 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.444 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 81.0 -2.34 81.23 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.488 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 1.3 mtt-85 -73.86 84.71 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.169 -1.195 . . . . 0.0 109.925 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.408 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -54.29 173.73 0.21 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.301 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 35.8 Cg_endo -77.94 -32.22 2.7 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.018 1.812 . . . . 0.0 110.856 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -80.97 -33.42 33.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.193 -0.942 . . . . 0.0 109.987 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -71.56 -42.67 67.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.097 -1.002 . . . . 0.0 109.658 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.489 HG23 ' CG ' ' A' ' 42' ' ' TYR . 28.6 m -68.65 -9.08 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.963 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.11 123.16 23.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.8 -14.67 59.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -79.51 127.45 32.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.266 -1.138 . . . . 0.0 109.18 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -67.53 128.01 34.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 108.659 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.528 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 78.2 t80 -62.21 -14.2 35.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 0.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.4 5.72 11.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.057 -1.027 . . . . 0.0 111.12 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 4.5 mttt -151.45 47.26 0.81 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.785 -1.197 . . . . 0.0 109.825 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER 163.56 -22.59 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.609 -0.682 . . . . 0.0 109.683 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 21.2 t -112.76 -28.66 2.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.22 -0.925 . . . . 0.0 108.505 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.81 94.99 1.64 Allowed Pre-proline 0 C--N 1.293 -1.864 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.947 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.88 -18.53 16.84 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.856 1.704 . . . . 0.0 109.241 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.7 p -79.45 -20.35 47.64 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.532 -0.73 . . . . 0.0 109.376 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.7 p -80.94 5.82 15.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 110.032 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -89.28 52.58 2.41 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.937 -1.102 . . . . 0.0 108.402 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.48 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.8 p -125.39 -179.42 0.87 Allowed Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.99 -12.81 14.44 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 122.146 1.897 . . . . 0.0 111.593 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.6 OUTLIER -96.37 -26.68 15.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.835 -1.165 . . . . 0.0 109.746 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CE1' ' HE1' ' A' ' 109' ' ' MET . 0.7 OUTLIER -100.59 -72.61 0.67 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.277 -0.89 . . . . 0.0 108.604 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 5.8 t80 -72.24 -18.91 61.79 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.032 -1.042 . . . . 0.0 109.045 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -64.44 -59.77 7.89 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 2.0 mmtp -65.14 -14.58 60.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.633 -0.922 . . . . 0.0 109.983 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.489 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 9.5 t80 -84.95 -36.14 21.6 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.387 -0.821 . . . . 0.0 109.39 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -76.1 -12.32 60.09 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 108.84 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 25.2 pt-20 -97.27 -41.43 8.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.437 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -59.6 -39.52 95.21 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.461 -2.256 . . . . 0.0 107.461 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 97.5 t -63.93 -44.79 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.91 -0.759 . . . . 0.0 110.113 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.58 4.39 51.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.181 -0.949 . . . . 0.0 110.729 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.3 t -106.21 -25.35 12.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.932 -1.105 . . . . 0.0 109.87 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.73 29.31 32.56 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -171.88 60.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -1.17 . . . . 0.0 109.212 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.3 tt -60.03 119.3 7.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.711 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.423 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 18.8 p-10 -160.34 85.1 0.72 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 109.254 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.5 t -134.36 149.48 50.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.031 -1.043 . . . . 0.0 109.99 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.6 ptp -140.33 166.07 25.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.426 -0.796 . . . . 0.0 108.987 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.54 ' CD1' HG23 ' A' ' 107' ' ' VAL . 20.4 p90 176.4 178.16 0.23 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.812 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -105.14 114.92 29.4 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.94 173.88 6.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.274 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.2 m -146.45 108.63 4.42 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.473 ' CE2' HG23 ' A' ' 105' ' ' VAL . 16.6 m-85 -81.1 120.88 25.39 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.131 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.78 47.23 2.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 108.75 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -79.02 72.83 5.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.068 -0.395 . . . . 0.0 111.274 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.472 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 64.58 31.41 12.26 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.318 -0.864 . . . . 0.0 109.9 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.69 -177.82 6.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.236 -0.915 . . . . 0.0 108.844 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.443 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 0.5 OUTLIER -55.14 152.67 14.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 109.253 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.443 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 32.1 Cg_endo -73.45 82.72 1.6 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.716 1.61 . . . . 0.0 109.883 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.423 HG23 ' CG1' ' A' ' 105' ' ' VAL . 1.9 m -69.64 93.71 0.73 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.648 -0.658 . . . . 0.0 109.846 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.9 137.14 47.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.476 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 4.1 m -146.37 147.0 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.48 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.85 150.75 36.05 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 173.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.54 HG23 ' CD1' ' A' ' 92' ' ' PHE . 30.2 m -137.77 149.28 25.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 119.945 -1.722 . . . . 0.0 109.366 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -160.2 101.87 1.41 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.43 ' CG ' HG11 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -109.03 140.42 42.57 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.241 -178.308 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.6 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 9.7 tttt -135.23 -162.48 1.26 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.571 -1.331 . . . . 0.0 109.888 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -108.14 103.26 12.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.928 . . . . 0.0 108.83 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.459 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -51.07 147.71 5.03 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.599 -0.688 . . . . 0.0 110.443 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.451 -0.781 . . . . 0.0 110.047 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.471 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.307 0.575 . . . . 0.0 109.813 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 117' ' ' SER . 14.7 m-85 -152.0 116.39 5.03 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.652 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 14.6 p-90 -118.69 153.74 33.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.06 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.43 HG11 ' CG ' ' A' ' 109' ' ' MET . 24.0 t -127.5 112.6 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.652 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 12.5 m-30 -96.47 104.11 16.07 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -92.6 115.11 30.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.339 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.642 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -90.7 142.42 27.77 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -89.46 119.37 29.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.516 -1.365 . . . . 0.0 108.961 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.312 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.514 HG23 ' CZ ' ' A' ' 121' ' ' PHE . 4.5 mm -78.43 -59.67 2.85 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.517 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -40.95 -31.22 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.511 -0.743 . . . . 0.0 111.716 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.64 -40.23 16.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.802 -1.186 . . . . 0.0 108.577 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -71.32 -10.88 60.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.627 -0.671 . . . . 0.0 110.055 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.5 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 13.4 mt -96.7 -9.31 29.33 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.952 -1.093 . . . . 0.0 109.747 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.041 -1.037 . . . . 0.0 109.134 179.481 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.93 0.395 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.75 28.07 15.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.506 ' CD2' ' CZ ' ' A' ' 28' ' ' PHE . 18.8 mt -98.6 164.27 12.32 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.204 -1.174 . . . . 0.0 108.333 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.42 19.35 9.75 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 2.7 p90 -152.89 179.2 8.87 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -107.69 125.8 8.08 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.491 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -96.06 96.88 9.16 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.027 -1.278 . . . . 0.0 108.465 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.486 HG23 ' CD1' ' A' ' 42' ' ' TYR . 1.4 pp -102.63 146.18 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.23 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.441 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 12.6 mt-30 -119.65 171.88 8.07 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 72.0 mt -152.78 147.11 25.67 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 109.738 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' ASP . 1.9 m-20 -119.05 136.49 54.11 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.358 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -9.01 71.06 0.0 OUTLIER Glycine 0 N--CA 1.51 3.629 0 C-N-CA 124.659 1.123 . . . . 0.0 113.428 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER 161.64 -24.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.03 17.53 24.92 Favored Glycine 0 N--CA 1.481 1.697 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 69.2 m-80 -82.7 128.67 34.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -1.123 . . . . 0.0 108.426 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -62.45 138.51 22.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 122.059 0.933 . . . . 0.0 111.568 -178.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 6.0 mt -105.0 -31.18 9.33 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.434 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -158.4 -176.33 5.84 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.531 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 1.6 t80 -161.11 -62.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.072 -1.018 . . . . 0.0 109.677 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 3.3 p-10 100.42 175.55 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.493 0 C-N-CA 123.666 0.786 . . . . 0.0 109.48 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.89 -15.68 22.27 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.004 -1.06 . . . . 0.0 111.983 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.9 -64.95 0.73 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.662 -1.274 . . . . 0.0 109.846 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 13.2 pt-20 -64.43 -43.29 94.79 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.219 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.435 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -60.11 -16.01 39.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -87.26 -28.53 22.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.723 -1.457 . . . . 0.0 109.673 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -82.22 -39.62 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.542 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.91 -0.31 14.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.833 -0.542 . . . . 0.0 110.627 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.81 -3.26 70.46 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.649 -1.263 . . . . 0.0 110.942 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.569 ' HD3' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.87 91.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.826 -1.397 . . . . 0.0 110.388 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 14.5 m-20 -72.32 158.46 87.46 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.97 -42.04 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.85 1.7 . . . . 0.0 110.821 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -27.55 67.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.992 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -84.87 -42.49 15.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.0 109.612 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 34.7 m -78.42 -0.03 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.0 109.743 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.446 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.6 OUTLIER -70.42 122.01 21.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.013 -1.054 . . . . 0.0 108.702 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.98 -19.72 52.65 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -80.06 137.42 36.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.276 -1.132 . . . . 0.0 108.894 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.49 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -77.58 97.98 5.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.466 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 62.3 t80 -56.35 -18.29 10.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.665 -0.647 . . . . 0.0 110.337 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.453 ' CD1' ' CD1' ' A' ' 76' ' ' TYR . 3.0 m-85 -95.42 -30.87 13.66 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.065 -1.022 . . . . 0.0 110.458 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -139.15 42.1 2.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 110.027 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.49 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -157.34 -37.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.048 -1.033 . . . . 0.0 110.254 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.569 HG13 ' HD3' ' A' ' 52' ' ' ARG . 1.8 t -104.9 -58.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 122.902 1.335 . . . . 0.0 108.923 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.454 ' CB ' ' NH2' ' A' ' 52' ' ' ARG . . . -106.56 100.99 33.56 Favored Pre-proline 0 C--N 1.289 -2.061 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.563 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.59 -4.04 14.7 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.845 1.696 . . . . 0.0 110.698 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.1 p -88.19 -24.75 23.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.959 -1.088 . . . . 0.0 109.332 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 p -76.58 -2.0 30.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.285 -0.885 . . . . 0.0 109.866 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.31 50.53 1.52 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.889 -1.132 . . . . 0.0 108.23 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.481 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -113.97 178.99 0.85 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -77.96 -14.44 15.34 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 122.072 1.848 . . . . 0.0 111.227 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 29.9 mt-10 -100.54 -22.8 14.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.782 -1.199 . . . . 0.0 109.545 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.453 ' CE1' HG12 ' A' ' 120' ' ' VAL . 0.8 OUTLIER -100.48 -73.45 0.64 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 9.2 t80 -70.35 -19.24 63.06 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.878 -1.139 . . . . 0.0 108.873 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.93 -59.75 8.66 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -63.56 -15.3 57.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.453 -1.028 . . . . 0.0 109.682 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.537 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 13.1 t80 -81.88 -38.05 25.95 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.545 -0.722 . . . . 0.0 109.788 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -11.9 60.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.021 -1.05 . . . . 0.0 109.362 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 12.9 pt-20 -97.28 -41.73 8.13 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.445 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -61.32 -39.54 97.38 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.491 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 85.1 t -63.52 -41.57 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.862 -0.787 . . . . 0.0 110.009 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.2 4.78 53.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.246 -0.909 . . . . 0.0 111.036 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.4 p -106.11 -26.74 11.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.89 -1.131 . . . . 0.0 110.131 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.09 23.52 37.73 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -171.39 87.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -1.125 . . . . 0.0 109.036 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.43 ' O ' ' CG ' ' A' ' 110' ' ' LYS . 1.9 tt -84.36 123.09 29.81 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.306 -0.872 . . . . 0.0 109.787 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -160.56 81.78 0.67 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.235 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -121.85 154.34 37.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.118 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -148.02 139.26 23.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.788 . . . . 0.0 109.04 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.547 ' CD2' HG23 ' A' ' 107' ' ' VAL . 8.9 p90 -162.83 -174.92 4.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.053 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -112.91 108.76 17.82 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.65 -179.48 3.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.35 -0.844 . . . . 0.0 110.083 -178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.7 m -149.47 108.51 3.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.521 -0.737 . . . . 0.0 109.062 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -81.09 92.28 6.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.351 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -105.67 24.24 12.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.251 -0.906 . . . . 0.0 109.637 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.554 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.69 155.72 29.32 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.506 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 0.28 65.72 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 CA-C-O 121.549 0.69 . . . . 0.0 112.317 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER 175.66 164.78 0.34 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.427 -0.796 . . . . 0.0 109.126 -178.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.448 ' CB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -57.75 175.66 0.27 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.302 -0.874 . . . . 0.0 108.883 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' A' ' 101' ' ' THR . 34.6 Cg_endo -76.6 107.64 2.49 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.846 1.697 . . . . 0.0 109.801 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -109.38 122.54 47.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.807 . . . . 0.0 110.365 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -102.59 145.06 30.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.463 ' CA ' HG22 ' A' ' 125' ' ' VAL . 22.7 m -152.01 145.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.654 -1.279 . . . . 0.0 111.859 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 7.5 mptt -77.44 117.13 18.61 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 102.876 -3.009 . . . . 0.0 102.876 174.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.547 HG23 ' CD2' ' A' ' 92' ' ' PHE . 35.7 m -102.31 151.14 5.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 117.898 -1.521 . . . . 0.0 109.767 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -154.9 103.68 2.43 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.461 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -105.66 139.16 40.68 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.457 -0.777 . . . . 0.0 109.335 -178.344 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.58 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.9 ttmt -137.57 -157.77 0.8 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.562 -1.336 . . . . 0.0 109.476 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -105.37 137.87 42.47 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 108.994 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.485 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -98.89 -179.07 4.16 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 110.058 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.481 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.25 0.548 . . . . 0.0 109.625 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.491 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 12.3 m-85 -147.64 123.08 10.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.261 -0.899 . . . . 0.0 108.739 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.662 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 18.6 p-90 -127.14 146.32 50.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 118.386 -1.326 . . . . 0.0 112.833 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.461 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 58.9 t -118.58 110.36 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.636 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.662 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 12.4 m-30 -95.44 133.53 39.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.984 -1.073 . . . . 0.0 108.406 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.441 ' O ' ' CB ' ' A' ' 28' ' ' PHE . 1.5 t -116.01 113.57 43.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 C-N-CA 119.054 -1.059 . . . . 0.0 109.532 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 5.2 tptp -90.02 131.13 36.07 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.21 123.93 28.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.53 -1.356 . . . . 0.0 109.561 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.463 HG22 ' CA ' ' A' ' 105' ' ' VAL . 5.3 t . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.612 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.533 ' CG2' ' CD1' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -79.63 -69.2 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.973 -1.079 . . . . 0.0 110.513 -177.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' HG2' ' N ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -44.73 -25.79 0.32 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 111.134 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.427 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -75.4 -49.21 19.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.036 -1.04 . . . . 0.0 109.501 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -61.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.533 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 72.6 mt -37.27 -32.42 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.363 0.601 . . . . 0.0 110.676 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 110.165 -179.272 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.996 0.427 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.14 34.77 5.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.53 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 7.3 mt -110.41 158.93 17.94 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.408 -1.054 . . . . 0.0 109.282 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.94 6.93 33.37 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.45 0.643 . . . . 0.0 109.349 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.53 ' CE2' ' HB3' ' A' ' 26' ' ' LEU . 26.3 p90 -134.04 -169.67 2.36 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.273 -0.892 . . . . 0.0 108.868 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -118.3 149.57 18.34 Favored Glycine 0 C--N 1.297 -1.595 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -126.14 84.8 2.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.754 -1.439 . . . . 0.0 107.936 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.581 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.3 pp -91.71 149.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.168 0.985 . . . . 0.0 110.862 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 3.2 mm100 -115.23 162.43 17.08 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 21.7 mt -150.09 146.08 26.72 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.404 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' HD22 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -99.28 173.62 6.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -40.06 -57.08 2.59 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 121.619 -0.324 . . . . 0.0 113.001 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.83 -17.64 61.65 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.63 -1.512 . . . . 0.0 110.337 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.42 28.73 6.26 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 7.0 m120 -84.74 136.68 33.61 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.442 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.55 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 3.0 tp -63.73 135.85 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.762 -1.211 . . . . 0.0 111.387 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 0.7 OUTLIER -110.06 -28.49 8.67 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -159.76 153.02 22.11 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.581 ' CD1' HG21 ' A' ' 31' ' ' ILE . 17.5 t80 -134.76 -66.68 0.58 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.169 -1.582 . . . . 0.0 111.414 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.3 p-10 102.39 174.79 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.657 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.09 -23.97 15.98 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.8 -1.188 . . . . 0.0 112.898 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.68 -62.43 1.65 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.464 -1.398 . . . . 0.0 110.741 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.472 ' OE2' ' CG2' ' A' ' 31' ' ' ILE . 1.1 pt-20 -58.72 -55.25 37.53 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.675 0.75 . . . . 0.0 109.64 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.413 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -56.79 -15.22 11.89 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.015 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -40.61 61.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.783 -1.422 . . . . 0.0 108.799 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -84.74 -56.89 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.414 -0.804 . . . . 0.0 109.235 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.438 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 18.9 p -72.71 -24.66 61.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.509 -0.744 . . . . 0.0 109.916 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 94.37 -19.22 54.65 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' NH2' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -43.9 97.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.608 -0.936 . . . . 0.0 110.626 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' A' ' 56' ' ' GLN . 42.4 m-20 -69.51 158.29 87.28 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.16 -61.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.942 1.762 . . . . 0.0 110.829 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.52 -18.13 61.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.215 -0.928 . . . . 0.0 110.151 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -86.87 -41.37 14.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.016 -1.053 . . . . 0.0 109.528 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HA ' ' HG3' ' A' ' 60' ' ' LYS . 22.4 m -79.61 2.01 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.831 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.55 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -71.24 121.05 20.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 120.979 -1.075 . . . . 0.0 109.034 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.31 -13.68 64.5 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.402 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 16.7 mmtp -78.89 139.8 38.23 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.084 -1.245 . . . . 0.0 109.066 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -80.95 96.52 7.1 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.567 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 16.7 t80 -55.06 -34.46 63.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.024 -1.048 . . . . 0.0 109.722 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 76' ' ' TYR . 2.5 m-85 -80.42 -23.34 40.39 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.251 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -148.1 49.07 1.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.983 -1.073 . . . . 0.0 109.631 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ASN . 8.8 t0 -174.54 -29.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 111.047 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.485 HG13 ' NE ' ' A' ' 52' ' ' ARG . 13.5 t -106.08 -58.41 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.617 -1.302 . . . . 0.0 109.004 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.01 106.65 39.35 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 114.618 -1.173 . . . . 0.0 109.861 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.36 1.41 8.79 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 C-N-CA 121.614 1.543 . . . . 0.0 109.896 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.4 p -107.03 -19.58 13.58 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 121.216 -0.927 . . . . 0.0 109.778 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.435 ' CG2' ' CZ ' ' A' ' 62' ' ' PHE . 11.0 p -85.93 9.57 16.52 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.124 -0.985 . . . . 0.0 110.133 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -106.54 59.9 0.64 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.118 -0.989 . . . . 0.0 108.956 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.452 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -144.3 176.26 2.35 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.352 -0.843 . . . . 0.0 109.675 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 33.6 Cg_endo -76.71 78.64 3.29 Favored 'Trans proline' 0 C--N 1.323 -0.763 0 C-N-CA 122.375 2.05 . . . . 0.0 110.415 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 171.54 -37.86 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CE1' ' HE2' ' A' ' 109' ' ' MET . 1.6 t80 -105.38 -67.68 0.9 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.479 ' CD1' ' CD1' ' A' ' 63' ' ' PHE . 9.3 t80 -73.22 -18.12 61.27 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.1 -63.66 4.21 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.469 ' HA ' ' CG ' ' A' ' 81' ' ' GLU . 10.8 mmtt -61.09 -17.54 53.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -1.047 . . . . 0.0 109.864 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.49 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 6.3 t80 -82.22 -38.24 24.82 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.484 -0.76 . . . . 0.0 109.53 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -13.29 60.37 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 109.382 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.469 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -98.05 -36.46 10.1 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.639 -1.225 . . . . 0.0 108.151 178.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.66 -39.33 96.63 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' ' 118' ' ' TYR . 87.3 t -63.21 -51.87 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.958 -0.731 . . . . 0.0 109.928 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.18 -2.88 46.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -0.922 . . . . 0.0 110.793 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.8 t -96.34 -29.94 13.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.131 . . . . 0.0 109.629 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.06 15.05 46.52 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -165.87 86.87 0.36 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.118 -1.225 . . . . 0.0 109.131 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.437 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.2 OUTLIER -76.98 122.93 25.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.472 -0.768 . . . . 0.0 110.088 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -160.97 82.4 0.64 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 t -127.48 169.5 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 111.212 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 ttm -159.77 149.23 18.08 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.583 ' CD1' HG23 ' A' ' 107' ' ' VAL . 18.7 p90 -172.42 165.55 5.75 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.82 105.77 17.96 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.56 -177.32 3.33 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.817 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' THR . 92.9 m -151.02 108.51 3.63 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -84.06 114.91 22.08 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 109.703 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -139.61 42.29 2.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.665 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.537 ' O ' ' C ' ' A' ' 99' ' ' GLN . 10.1 p90 -78.69 148.06 33.26 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.537 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.0 tt0 1.89 67.95 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 121.781 0.8 . . . . 0.0 111.482 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.9 ttp 177.29 -159.1 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 109.386 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.449 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 2.3 t -85.37 153.61 59.14 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.449 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.5 Cg_endo -75.74 141.18 24.28 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.713 1.609 . . . . 0.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' THR . 1.8 m -140.08 140.17 36.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.336 -0.852 . . . . 0.0 109.605 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -111.18 141.6 44.47 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.499 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 24.5 m -149.68 144.05 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.921 -1.112 . . . . 0.0 110.681 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -86.42 102.31 13.94 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 175.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.583 HG23 ' CD1' ' A' ' 92' ' ' PHE . 18.1 m -85.55 156.91 3.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 110.885 -175.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -160.36 106.88 1.54 Allowed 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.489 ' HE2' ' CE1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -113.92 149.49 35.11 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.477 -0.764 . . . . 0.0 109.606 -177.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.551 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 9.5 ttpt -144.34 170.64 15.62 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.474 -1.391 . . . . 0.0 109.213 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.437 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 11.0 tttt -80.11 104.18 10.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.771 -1.206 . . . . 0.0 108.787 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 117' ' ' SER . . . -52.09 155.51 1.88 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 109.652 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.987 . . . . 0.0 110.119 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.477 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.269 0.557 . . . . 0.0 109.836 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.498 ' CE1' HG23 ' A' ' 83' ' ' VAL . 12.6 m-85 -153.47 108.36 3.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.301 -0.874 . . . . 0.0 109.06 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.651 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 10.2 p-90 -108.22 142.09 39.01 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.695 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.464 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 96.1 t -117.41 118.69 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.651 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 16.0 m-30 -101.86 121.93 43.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.146 -0.971 . . . . 0.0 109.349 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.444 ' CG1' HG13 ' A' ' 105' ' ' VAL . 1.7 t -109.66 116.05 51.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.249 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 6.8 tttm -101.87 133.99 45.76 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.405 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.433 ' CD ' HG13 ' A' ' 49' ' ' ILE . 8.1 ttp85 -73.54 117.89 15.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.983 -1.073 . . . . 0.0 109.65 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.205 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.55 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 2.4 mm -65.39 -67.58 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.212 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 11' ' ' ILE . 3.3 pt-20 -37.55 -30.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.032 0.444 . . . . 0.0 111.656 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' ILE . 1.2 t30 -76.19 -50.36 14.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.022 -1.049 . . . . 0.0 108.673 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 m -67.36 -14.91 63.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.548 -0.72 . . . . 0.0 109.811 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 11.4 mt -96.68 -26.49 15.17 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.094 -1.004 . . . . 0.0 109.168 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.307 -179.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.979 0.419 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.77 35.1 5.08 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 mt -114.74 134.68 54.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.403 -1.057 . . . . 0.0 109.458 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.86 -6.55 27.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.385 0.612 . . . . 0.0 109.792 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.485 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 7.6 p90 -124.01 114.37 19.66 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.027 -1.046 . . . . 0.0 108.324 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.513 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -51.94 158.29 3.05 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' N ' ' OE2' ' A' ' 46' ' ' GLU . . . -139.44 99.52 3.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.066 -1.255 . . . . 0.0 107.973 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.532 HG23 ' CD1' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -99.41 172.36 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.884 0.849 . . . . 0.0 110.511 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -141.61 164.93 28.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 38' ' ' ASN . 28.0 mt -148.32 154.18 39.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.904 -1.122 . . . . 0.0 109.893 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 36' ' ' ASP . 1.3 p30 -116.33 128.83 55.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 108.892 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -15.9 76.53 0.0 OUTLIER Glycine 0 N--CA 1.508 3.486 0 C-N-CA 124.505 1.05 . . . . 0.0 112.951 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.8 OUTLIER 162.58 -23.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.06 17.93 21.3 Favored Glycine 0 N--CA 1.48 1.589 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.428 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -86.16 152.17 23.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.016 -1.285 . . . . 0.0 107.787 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.487 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 2.1 tp -79.52 144.91 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.829 -1.169 . . . . 0.0 113.034 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 2.0 mt -113.11 -33.85 5.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 174.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.537 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 6.5 tp-100 -169.02 158.75 8.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.588 -0.695 . . . . 0.0 110.227 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.569 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 13.2 t80 -135.75 -54.33 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.375 -0.828 . . . . 0.0 110.128 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 0.8 OUTLIER 95.72 177.59 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 C-N-CA 123.02 0.528 . . . . 0.0 109.641 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.12 -22.5 17.27 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.996 -1.065 . . . . 0.0 113.039 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.0 -68.53 0.21 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.428 -1.42 . . . . 0.0 110.012 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 6.2 pt-20 -63.07 -42.79 99.75 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.749 0.785 . . . . 0.0 109.593 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.78 -17.91 51.45 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -83.68 -29.86 27.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.245 . . . . 0.0 108.423 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.426 HG23 ' CG2' ' A' ' 50' ' ' THR . 0.3 OUTLIER -73.65 -57.48 6.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.619 -0.676 . . . . 0.0 109.287 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.426 ' CG2' HG23 ' A' ' 49' ' ' ILE . 15.6 p -89.84 -8.01 52.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.15 -0.969 . . . . 0.0 110.191 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 89.59 -8.1 80.51 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.531 ' NH2' ' CE1' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -53.58 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.315 -1.109 . . . . 0.0 109.809 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.497 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -68.9 162.75 62.08 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.17 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.27 -57.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.839 1.693 . . . . 0.0 111.124 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -18.51 65.4 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.915 -1.116 . . . . 0.0 110.206 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 -31.64 16.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 109.642 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.543 ' HA ' ' HG2' ' A' ' 60' ' ' LYS . 34.5 m -86.7 10.91 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.043 -1.036 . . . . 0.0 109.499 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.487 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -86.87 121.78 38.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 108.487 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.76 -18.56 54.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.56 ' HD2' ' CG2' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -78.19 167.84 20.77 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.924 -1.339 . . . . 0.0 109.898 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.474 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -106.19 103.65 13.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.531 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 3.1 t80 -50.27 -42.74 52.67 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.521 -0.737 . . . . 0.0 112.245 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.536 ' CG ' ' CD1' ' A' ' 76' ' ' TYR . 36.5 m-85 -89.74 1.9 55.52 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.678 -1.264 . . . . 0.0 112.799 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 4.5 tmtm? -154.32 52.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.62 -1.3 . . . . 0.0 110.495 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 169.93 -15.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.163 -0.96 . . . . 0.0 111.641 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.56 ' CG2' ' HD2' ' A' ' 60' ' ' LYS . 1.4 t -120.17 -57.79 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 122.916 1.341 . . . . 0.0 109.582 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.15 101.36 50.07 Favored Pre-proline 0 C--N 1.288 -2.075 0 CA-C-N 114.183 -1.372 . . . . 0.0 109.134 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -72.97 -4.87 16.18 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 122.163 1.909 . . . . 0.0 112.34 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 23.9 p -105.72 -18.53 14.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.727 -1.233 . . . . 0.0 109.57 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.441 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 35.5 p -74.04 -5.35 40.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.996 -1.065 . . . . 0.0 109.486 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -93.28 52.11 1.73 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 108.718 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.495 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -117.04 -178.78 0.56 Allowed Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 36.1 Cg_endo -78.34 -12.54 15.57 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.147 1.898 . . . . 0.0 111.564 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 2.2 mt-10 -100.73 -24.98 14.29 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.867 -1.145 . . . . 0.0 109.618 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.2 t80 -101.31 -70.82 0.73 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 108.702 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CD1' ' CG ' ' A' ' 63' ' ' PHE . 6.0 t80 -72.93 -18.24 61.41 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.981 -1.074 . . . . 0.0 108.672 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.52 -60.89 6.48 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 7.9 mmtt -65.58 -15.22 62.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.938 . . . . 0.0 109.824 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 9.8 t80 -83.14 -35.76 25.3 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -8.93 58.91 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -96.51 -42.35 8.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.432 ' HA3' ' CD1' ' A' ' 88' ' ' LEU . . . -64.2 -39.49 97.14 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.49 HG12 ' CZ ' ' A' ' 118' ' ' TYR . 63.3 t -67.14 -39.62 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.938 -0.743 . . . . 0.0 110.148 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.72 -7.28 59.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.172 -0.955 . . . . 0.0 110.856 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.5 -18.16 13.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.799 -1.188 . . . . 0.0 110.002 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.38 19.68 71.09 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -152.69 57.82 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.247 . . . . 0.0 109.538 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.432 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 0.3 OUTLIER -58.66 120.36 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 109.94 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -160.68 88.78 0.79 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.301 -0.875 . . . . 0.0 108.878 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 t -157.42 158.81 36.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.899 -1.126 . . . . 0.0 110.379 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.9 173.58 11.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 0.0 108.857 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.631 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 7.2 p90 -179.07 152.11 0.54 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.125 -0.984 . . . . 0.0 109.81 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.19 111.38 18.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 109.046 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.57 -178.66 3.46 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.206 -0.934 . . . . 0.0 109.646 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.3 m -151.9 108.74 3.5 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.382 -0.824 . . . . 0.0 109.834 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -81.24 118.7 22.82 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -152.3 48.76 0.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.878 -1.139 . . . . 0.0 110.987 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 22.1 p90 -78.31 139.03 38.86 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 98' ' ' TYR . 7.2 pt20 0.68 68.11 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.268 0 CA-C-O 121.847 0.832 . . . . 0.0 111.937 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 98' ' ' TYR . 20.1 ttp -176.71 174.65 1.79 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -52.71 148.17 13.69 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.048 . . . . 0.0 109.044 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.88 146.41 29.6 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.96 1.773 . . . . 0.0 110.994 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.8 m -140.25 123.39 16.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.775 . . . . 0.0 109.264 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -102.83 140.28 37.31 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.503 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 14.0 m -151.99 143.4 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.905 -1.122 . . . . 0.0 110.697 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -92.35 116.82 29.31 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 176.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.631 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -91.39 164.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 120.966 -1.084 . . . . 0.0 110.086 -176.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -159.94 102.36 1.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.442 ' HB3' ' CG2' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -116.14 147.53 41.27 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.095 -1.003 . . . . 0.0 110.239 -177.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.591 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 11.9 ttmt -144.4 179.66 7.12 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.593 -1.317 . . . . 0.0 109.434 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.16 106.91 18.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.04 -1.037 . . . . 0.0 109.248 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.411 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -55.88 137.44 50.34 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.515 -0.741 . . . . 0.0 109.569 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.809 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.43 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 10.0 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.526 0.679 . . . . 0.0 109.998 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.49 ' CZ ' HG12 ' A' ' 83' ' ' VAL . 28.4 m-85 -149.28 103.0 3.27 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.667 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 11.5 p-90 -103.77 148.03 26.57 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.455 -1.298 . . . . 0.0 112.078 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 109' ' ' MET . 19.3 t -130.48 107.36 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.618 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.667 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 5.1 m-30 -91.53 123.9 35.3 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.294 -0.879 . . . . 0.0 109.609 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 28' ' ' PHE . 1.3 t -105.27 116.8 49.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.019 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.48 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 1.9 tttm -94.96 107.8 19.85 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.43 ' HA ' HG11 ' A' ' 105' ' ' VAL . 18.2 ttp180 -57.47 128.33 36.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.896 -1.127 . . . . 0.0 109.646 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.248 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.506 2.369 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.535 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 4.9 mm -79.22 -57.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.775 -177.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 11' ' ' ILE . 21.4 tt0 -39.36 -29.75 0.05 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.459 -0.776 . . . . 0.0 111.738 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' ILE . 9.8 m-80 -90.59 -40.01 12.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.908 -1.12 . . . . 0.0 108.226 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.2 m -69.11 -9.91 55.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.601 -0.687 . . . . 0.0 109.68 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 11' ' ' ILE . 12.4 mt -96.6 -28.01 14.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.012 -1.055 . . . . 0.0 108.787 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.443 0 O-C-N 121.627 -0.671 . . . . 0.0 109.636 179.651 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.917 0.389 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.41 18.52 51.85 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 mt -54.97 123.36 13.26 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.291 -1.123 . . . . 0.0 109.796 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.01 -18.81 3.91 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.769 0.795 . . . . 0.0 109.075 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.498 ' HB3' ' CD ' ' A' ' 123' ' ' LYS . 17.2 p90 -126.25 148.02 49.57 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.232 -0.918 . . . . 0.0 109.016 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -76.84 144.03 29.6 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -115.91 92.07 3.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.905 -1.35 . . . . 0.0 108.331 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.531 HG21 ' CE1' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -96.32 150.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 -178.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -130.0 161.16 31.58 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 23.3 mt -148.18 155.47 41.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.011 -1.056 . . . . 0.0 109.276 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -123.45 138.9 54.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.0 109.411 178.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -5.31 67.95 0.0 OUTLIER Glycine 0 N--CA 1.514 3.87 0 C-N-CA 124.834 1.207 . . . . 0.0 113.364 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 161.25 -23.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 97.98 18.91 25.71 Favored Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 8.2 p30 -84.39 129.96 34.82 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.217 -1.167 . . . . 0.0 108.831 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 58' ' ' ILE . 1.9 tp -54.5 138.12 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 122.202 1.001 . . . . 0.0 112.998 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 34' ' ' ASP . 3.5 mt -111.35 -31.08 7.17 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.553 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 0.5 OUTLIER -167.39 168.81 12.83 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.541 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.531 ' CE1' HG21 ' A' ' 31' ' ' ILE . 14.9 t80 -146.09 -70.65 0.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.073 -1.017 . . . . 0.0 111.16 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.3 p-10 109.45 178.83 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.858 0 C-N-CA 123.931 0.892 . . . . 0.0 108.749 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.4 -26.55 14.82 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.005 -1.059 . . . . 0.0 113.281 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.78 -65.11 0.61 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.316 -1.49 . . . . 0.0 110.707 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.501 ' CD ' ' CE1' ' A' ' 42' ' ' TYR . 2.0 pt-20 -58.79 -53.76 54.7 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.387 0.613 . . . . 0.0 110.071 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.85 -15.75 14.41 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.095 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.47 -37.42 36.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.775 -1.427 . . . . 0.0 108.98 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.52 -55.18 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 108.886 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.442 ' HB ' ' OH ' ' A' ' 98' ' ' TYR . 59.2 p -76.98 -20.45 56.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.67 -0.644 . . . . 0.0 110.115 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.46 -2.33 78.22 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.577 ' CZ ' ' CG1' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -46.54 -47.14 19.64 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.367 -1.078 . . . . 0.0 111.481 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.88 147.14 0.11 Allowed Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.76 -36.57 1.51 Allowed 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.128 1.885 . . . . 0.0 111.647 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -26.83 62.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.56 -40.52 19.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 109.523 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.421 HG12 ' HB3' ' A' ' 52' ' ' ARG . 27.6 m -73.04 -6.62 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 110.006 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.49 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -70.63 119.56 17.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.081 -1.012 . . . . 0.0 108.386 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.68 -20.95 48.47 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -79.61 145.89 32.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.543 -0.974 . . . . 0.0 108.674 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.85 122.21 32.69 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 108.967 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.428 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 79.4 t80 -60.02 -18.12 43.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.038 -1.039 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.449 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 35.9 m-85 -118.19 32.06 6.34 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.035 -1.041 . . . . 0.0 109.611 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.42 -53.6 0.1 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.013 -1.055 . . . . 0.0 110.954 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.32 16.4 9.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.846 -1.159 . . . . 0.0 111.778 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.577 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 41.0 t -118.88 -56.31 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.388 -1.445 . . . . 0.0 108.5 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -118.19 99.07 51.8 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.66 0.71 7.81 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.926 1.751 . . . . 0.0 111.062 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 p -103.31 -25.95 13.12 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.031 -1.043 . . . . 0.0 109.403 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.449 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 59.9 p -71.69 -7.16 46.25 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.381 -0.824 . . . . 0.0 110.096 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -84.81 72.53 10.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 108.984 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.6 172.61 5.67 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.96 . . . . 0.0 109.643 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.92 77.42 3.93 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.358 2.039 . . . . 0.0 110.304 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER 172.36 -36.85 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.552 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.9 t80 -104.14 -65.9 0.99 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.416 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 8.3 t80 -75.55 -20.3 58.74 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -62.82 -60.67 7.37 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 4.4 mmtp -64.87 -17.54 64.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.424 -1.045 . . . . 0.0 109.953 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.49 ' CE2' ' HB2' ' A' ' 118' ' ' TYR . 4.2 t80 -79.35 -36.29 39.61 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -6.9 56.8 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.35 -0.844 . . . . 0.0 108.741 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.1 mm-40 -96.14 -42.63 8.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.47 -40.59 86.5 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.501 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 79.3 t -62.32 -38.58 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.619 -0.93 . . . . 0.0 109.386 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.17 -5.5 56.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 110.716 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.6 t -98.2 -21.91 16.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.772 -1.205 . . . . 0.0 109.788 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.79 25.51 45.58 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -169.85 70.66 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.332 -1.099 . . . . 0.0 108.935 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 0.5 OUTLIER -69.76 117.66 11.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.088 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -161.59 82.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 t -140.72 172.18 13.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.028 -1.045 . . . . 0.0 110.487 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -152.69 171.03 18.83 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.688 ' CD1' HG23 ' A' ' 107' ' ' VAL . 14.8 p90 179.73 152.32 0.43 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.001 -1.062 . . . . 0.0 109.929 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -78.88 116.26 19.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.135 -0.978 . . . . 0.0 109.322 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.87 175.1 5.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.337 -0.852 . . . . 0.0 109.589 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -146.03 109.98 4.91 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.423 ' CE2' HG23 ' A' ' 122' ' ' VAL . 16.0 m-30 -85.25 119.6 25.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.956 . . . . 0.0 109.632 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -147.93 56.79 1.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.446 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -79.61 66.06 4.96 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.045 -0.409 . . . . 0.0 111.439 -178.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.459 ' CG ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER 73.62 25.74 2.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.066 -1.021 . . . . 0.0 109.658 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.81 -171.52 3.1 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.083 -1.01 . . . . 0.0 108.569 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.444 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 71.6 p -57.65 160.99 6.76 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.165 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 32.7 Cg_endo -75.18 124.95 8.89 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.9 1.734 . . . . 0.0 110.257 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.1 m -118.43 125.76 50.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.431 -0.793 . . . . 0.0 109.408 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -107.51 138.43 43.73 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.508 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 5.7 m -152.69 142.3 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.048 -1.032 . . . . 0.0 110.194 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -91.01 127.69 36.53 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 174.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.688 HG23 ' CD1' ' A' ' 92' ' ' PHE . 1.4 m -97.93 160.19 3.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 O-C-N 120.634 -1.291 . . . . 0.0 111.475 -174.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -158.06 100.47 1.71 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.454 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -111.09 146.7 36.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.584 -0.698 . . . . 0.0 109.535 -177.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.605 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.5 tttm -138.76 -163.47 1.47 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.599 -1.313 . . . . 0.0 109.311 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.1 117.23 34.1 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.064 -1.022 . . . . 0.0 108.807 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.446 ' CB ' ' HB2' ' A' ' 117' ' ' SER . . . -72.0 166.63 21.81 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.382 -0.824 . . . . 0.0 110.615 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.831 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.446 ' HB2' ' CB ' ' A' ' 112' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.543 0.687 . . . . 0.0 110.679 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.501 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 3.6 m-85 -149.71 121.35 8.04 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.637 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 13.5 p-90 -120.34 144.8 47.66 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.182 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.454 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 27.4 t -116.83 112.15 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.759 -0.588 . . . . 0.0 109.78 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.637 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.6 m-30 -95.61 126.7 41.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 109.41 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.448 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -107.11 119.55 56.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 110.037 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.498 ' CD ' ' HB3' ' A' ' 28' ' ' PHE . 3.3 tptp -89.6 109.48 20.43 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.423 ' HA ' HG11 ' A' ' 105' ' ' VAL . 7.2 ttp-105 -68.64 114.82 7.35 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.114 -1.434 . . . . 0.0 109.433 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.096 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.519 HD13 ' CZ ' ' A' ' 28' ' ' PHE . 2.9 mm -81.71 -67.37 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 O-C-N 121.305 -0.872 . . . . 0.0 110.592 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.88 -25.49 0.2 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.017 -1.052 . . . . 0.0 111.462 -178.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -82.87 -46.62 12.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.856 -1.153 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -66.95 -58.29 5.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.51 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 34.7 mt -38.87 -32.72 0.09 Allowed 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.017 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.446 -0.784 . . . . 0.0 109.16 179.813 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 9.4 m-20 . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.32 26.9 22.81 Favored Glycine 0 N--CA 1.491 2.335 0 O-C-N 120.857 -1.152 . . . . 0.0 110.387 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.516 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 4.8 mt -75.57 -175.14 2.74 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.862 -1.376 . . . . 0.0 108.427 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.98 16.0 22.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.559 ' CD1' ' HE2' ' A' ' 123' ' ' LYS . 1.9 p90 -151.44 -173.77 4.62 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -112.65 137.11 14.0 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 42' ' ' TYR . . . -109.43 89.2 2.93 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.39 1.595 . . . . 0.0 107.755 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -99.53 148.51 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.303 -0.873 . . . . 0.0 110.113 -178.022 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 4.1 mt-30 -120.01 164.54 15.95 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.427 HD23 ' CB ' ' A' ' 62' ' ' PHE . 98.5 mt -152.32 146.05 25.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.094 -1.004 . . . . 0.0 109.083 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' ASP . 7.8 m-20 -124.88 129.9 51.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.943 -1.098 . . . . 0.0 110.522 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 37.4 -77.18 0.0 OUTLIER Glycine 0 N--CA 1.503 3.1 0 C-N-CA 124.589 1.09 . . . . 0.0 113.605 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' ASP . 11.3 m-20 -71.46 -0.57 10.7 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.646 -0.914 . . . . 0.0 111.081 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 84.2 17.63 64.41 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.65 131.33 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.922 -1.34 . . . . 0.0 108.919 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.437 HD12 ' NH1' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -59.93 135.33 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 0.0 110.204 -179.018 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 2.0 mt -105.46 -26.68 11.82 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.434 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -167.04 163.15 15.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.522 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 38.4 t80 -135.34 -107.3 0.22 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.353 -1.467 . . . . 0.0 110.69 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 44' ' ' ALA . 14.3 t-20 157.65 145.91 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.744 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -70.14 -53.12 18.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.548 -0.72 . . . . 0.0 111.587 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.67 -54.39 4.05 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.31 -0.869 . . . . 0.0 111.053 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.503 ' CD ' ' CE1' ' A' ' 42' ' ' TYR . 3.8 pt-20 -63.67 -44.1 94.75 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.739 0.781 . . . . 0.0 109.671 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.41 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -59.77 -17.16 41.4 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -85.17 -29.63 24.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.912 -1.346 . . . . 0.0 108.908 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.451 HG23 ' CG2' ' A' ' 50' ' ' THR . 0.5 OUTLIER -77.03 -49.7 22.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.511 -0.743 . . . . 0.0 109.64 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.451 ' CG2' HG23 ' A' ' 49' ' ' ILE . 1.3 p -104.12 -7.23 20.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.963 -1.086 . . . . 0.0 110.748 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 81.83 -2.4 83.48 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.813 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.566 ' NE ' ' CG1' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -39.52 -59.31 1.12 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -1.004 . . . . 0.0 112.666 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.417 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.6 OUTLIER 67.28 146.24 0.11 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.648 -1.282 . . . . 0.0 107.559 -178.108 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.42 -67.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.94 1.76 . . . . 0.0 111.89 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.32 -23.95 1.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.184 -0.948 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.66 -45.48 10.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.788 -1.195 . . . . 0.0 110.081 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.468 HG12 ' CD ' ' A' ' 52' ' ' ARG . 26.0 m -76.87 -0.63 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.056 -1.028 . . . . 0.0 110.036 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.84 124.86 28.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.6 -19.87 52.87 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -79.2 146.38 33.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -1.138 . . . . 0.0 109.138 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -88.55 118.62 28.33 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.427 ' CB ' HD23 ' A' ' 33' ' ' LEU . 74.5 t80 -52.92 -22.11 5.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.515 -0.741 . . . . 0.0 110.22 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -113.11 -10.85 13.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.937 -1.102 . . . . 0.0 111.459 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -135.51 39.74 2.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.78 -1.2 . . . . 0.0 110.217 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 171.93 -14.28 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.91 -1.119 . . . . 0.0 111.966 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.566 ' CG1' ' NE ' ' A' ' 52' ' ' ARG . 10.2 t -115.7 -53.36 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.346 -1.471 . . . . 0.0 109.358 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.411 ' HB2' HG22 ' A' ' 70' ' ' THR . . . -119.43 96.92 50.1 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.059 -177.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.71 -2.46 12.61 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.902 1.735 . . . . 0.0 110.409 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.3 p -95.5 -17.04 21.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.099 -1.001 . . . . 0.0 109.75 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.492 HG21 ' CD2' ' A' ' 75' ' ' PHE . 64.5 p -86.62 11.31 13.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -89.37 54.14 2.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 108.87 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . 3.2 p -139.48 173.17 5.39 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 72' ' ' SER . 35.4 Cg_endo -77.14 3.55 6.58 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 C-N-CA 122.109 1.872 . . . . 0.0 111.781 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 32.7 mt-10 -106.45 -28.0 10.59 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.94 -1.1 . . . . 0.0 109.151 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.572 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 2.0 t80 -102.92 -71.19 0.73 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.6 t80 -71.04 -17.18 62.63 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.47 -60.9 6.82 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -61.87 -17.61 57.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -1.059 . . . . 0.0 109.577 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.49 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 9.4 t80 -81.01 -38.8 26.88 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.488 -0.757 . . . . 0.0 109.768 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -76.11 -11.67 59.98 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 109.491 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 13.6 pt-20 -96.87 -40.36 8.96 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.434 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.89 -39.95 97.86 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.495 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 97.0 t -58.03 -44.24 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.719 -0.871 . . . . 0.0 109.268 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.17 -3.48 58.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 110.652 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 t -94.72 -23.3 17.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.916 -1.115 . . . . 0.0 109.579 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 25.5 50.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -174.28 62.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.347 -1.09 . . . . 0.0 108.991 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 tt -55.51 123.73 14.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.145 -0.972 . . . . 0.0 109.584 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 40.2 t30 -160.21 84.52 0.72 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.381 -0.824 . . . . 0.0 109.118 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -138.11 170.99 15.07 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.915 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -159.6 168.59 25.71 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.667 ' CD1' HG23 ' A' ' 107' ' ' VAL . 11.8 p90 176.69 154.97 0.23 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.035 -1.041 . . . . 0.0 109.987 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 1.4 pt-20 -80.96 107.06 13.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.043 -1.035 . . . . 0.0 108.496 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.06 178.97 4.3 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.363 -0.835 . . . . 0.0 109.825 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.6 m -147.12 110.37 4.82 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.484 ' CZ ' HG23 ' A' ' 122' ' ' VAL . 20.1 m-30 -80.96 118.11 22.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.935 . . . . 0.0 109.472 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -148.27 47.01 1.06 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.272 -0.893 . . . . 0.0 110.132 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 29.1 p90 -78.11 136.83 37.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.529 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 1.96 66.1 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.332 0 CA-C-O 121.696 0.76 . . . . 0.0 112.075 -178.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 98' ' ' TYR . 6.0 ttp -177.01 -174.26 0.51 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 t -63.47 149.2 92.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.944 . . . . 0.0 108.917 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.81 156.28 39.39 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.82 1.68 . . . . 0.0 110.894 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.1 m -147.39 148.45 31.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.5 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.432 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -119.93 140.68 50.51 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.491 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 10.1 m -158.24 144.42 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.092 -1.005 . . . . 0.0 110.489 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.533 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -92.38 112.52 24.5 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 174.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.667 HG23 ' CD1' ' A' ' 92' ' ' PHE . 1.4 m -83.27 161.24 3.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 O-C-N 121.366 -0.834 . . . . 0.0 111.86 -174.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -157.23 98.34 1.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.45 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 13.7 mtm -107.97 144.98 34.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.985 -1.072 . . . . 0.0 110.237 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.604 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 5.0 tttt -141.39 -163.4 1.55 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.169 -1.412 . . . . 0.0 110.168 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -103.28 106.55 17.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.953 . . . . 0.0 109.111 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.445 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -54.45 149.07 10.87 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.445 -0.784 . . . . 0.0 110.174 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.452 -0.78 . . . . 0.0 110.221 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.473 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.424 0.631 . . . . 0.0 110.135 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.495 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 3.7 m-85 -151.11 122.01 7.6 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.642 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 10.2 p-90 -121.25 156.61 32.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.707 -1.245 . . . . 0.0 111.954 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.45 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 46.5 t -124.88 112.52 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.353 0.597 . . . . 0.0 110.373 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.642 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 11.2 m-30 -96.91 112.29 24.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.484 HG23 ' CZ ' ' A' ' 96' ' ' PHE . 1.1 t -100.02 116.58 43.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.39 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.559 ' HE2' ' CD1' ' A' ' 28' ' ' PHE . 5.6 tptp -89.38 120.5 30.77 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.458 ' HA ' HG11 ' A' ' 105' ' ' VAL . 9.2 ttp180 -73.72 117.69 15.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.77 -1.206 . . . . 0.0 109.35 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.229 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.504 2.232 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.553 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 1.1 mm -85.77 -62.0 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 111.318 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -45.54 -24.56 0.34 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.972 -1.08 . . . . 0.0 111.023 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -81.66 -46.14 14.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.091 -1.005 . . . . 0.0 109.428 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -58.45 4.02 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.495 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 43.4 mt -39.47 -31.45 0.09 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.422 0.63 . . . . 0.0 110.102 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 179.882 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.927 0.394 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.73 21.26 34.05 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.482 HD21 ' CZ ' ' A' ' 28' ' ' PHE . 68.8 mt -81.21 140.3 35.01 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.141 -1.211 . . . . 0.0 108.735 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.19 3.83 14.19 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.771 0.796 . . . . 0.0 109.177 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 2.5 p90 -136.55 139.76 42.43 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -74.09 129.5 11.72 Favored Glycine 0 C--N 1.293 -1.832 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.18 117.14 33.87 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.884 -1.363 . . . . 0.0 107.941 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.521 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.1 pp -115.78 144.35 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.33 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.485 ' HB3' HD11 ' A' ' 40' ' ' LEU . 2.9 tt0 -108.71 168.56 9.26 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 21.1 mt -156.64 135.8 12.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.53 -1.356 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -93.96 175.9 6.54 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.87 -55.68 5.43 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.358 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -18.93 57.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.677 -1.484 . . . . 0.0 109.569 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.5 29.09 6.08 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 107.331 -2.307 . . . . 0.0 107.331 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -86.53 130.03 34.64 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.673 -0.898 . . . . 0.0 110.78 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.498 HG21 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -62.73 131.76 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.563 -1.336 . . . . 0.0 110.997 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 2.3 mp -104.76 -19.88 13.78 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' NE2' HD23 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -156.57 161.06 39.98 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.539 ' OH ' ' HD3' ' A' ' 52' ' ' ARG . 9.3 t80 -147.7 -61.96 0.27 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.588 -1.32 . . . . 0.0 111.035 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 1.4 p-10 97.43 175.08 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.5 -17.33 20.59 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.872 -1.143 . . . . 0.0 112.58 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.42 -63.73 1.07 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.549 -1.345 . . . . 0.0 110.298 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 1.6 pt-20 -57.78 -56.44 21.92 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.629 0.728 . . . . 0.0 109.309 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -55.1 -16.56 8.67 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -70.86 -43.62 68.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.733 -1.451 . . . . 0.0 108.759 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 50' ' ' THR . 0.3 OUTLIER -85.1 -55.99 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.443 -0.785 . . . . 0.0 109.552 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.416 HG21 HG23 ' A' ' 49' ' ' ILE . 33.2 p -72.98 -20.18 61.08 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 0.0 110.318 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 84.9 -6.34 79.08 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HD3' ' OH ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -57.19 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -1.182 . . . . 0.0 110.133 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.428 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 2.7 m-20 -61.2 159.67 27.92 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.05 -63.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.791 1.661 . . . . 0.0 110.983 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -56.12 -20.24 16.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.18 -0.95 . . . . 0.0 110.345 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -90.13 -47.37 7.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.914 -1.116 . . . . 0.0 110.021 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 18.4 m -72.86 -4.93 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.03 . . . . 0.0 109.668 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.498 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.78 124.83 26.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.16 -17.05 59.11 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -78.65 138.35 38.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.191 -1.182 . . . . 0.0 109.04 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.448 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -75.55 104.31 6.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.486 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 31.3 t80 -58.52 -19.71 39.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.489 -0.757 . . . . 0.0 110.586 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.443 ' CE2' HD12 ' A' ' 33' ' ' LEU . 22.2 m-85 -85.75 -48.69 8.58 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.297 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.36 37.36 4.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.925 -1.109 . . . . 0.0 109.789 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 1.2 t0 -149.31 -30.91 0.24 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 110.615 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.491 HG12 ' NH1' ' A' ' 52' ' ' ARG . 5.0 t -110.77 -58.91 3.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 120.745 -1.222 . . . . 0.0 108.679 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -104.71 105.66 51.56 Favored Pre-proline 0 C--N 1.29 -1.987 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.594 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.62 3.85 6.08 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.058 1.838 . . . . 0.0 111.26 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.2 p -107.15 -17.06 14.26 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.847 -1.158 . . . . 0.0 109.862 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.425 HG23 ' CZ ' ' A' ' 62' ' ' PHE . 24.8 p -83.5 6.0 21.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.962 . . . . 0.0 110.046 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -97.79 52.29 1.08 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.08 -1.012 . . . . 0.0 108.921 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.7 p -129.63 -179.81 1.11 Allowed Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.23 2.19 8.25 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 122.049 1.833 . . . . 0.0 112.028 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.9 mp0 -109.65 -27.96 9.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.86 -1.15 . . . . 0.0 108.985 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -102.52 -70.76 0.74 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.7 t80 -68.72 -17.48 64.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.81 -62.84 4.89 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 5.3 mmtt -61.64 -16.53 49.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.448 -1.031 . . . . 0.0 109.502 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 17.1 t80 -82.11 -39.43 23.35 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.58 -0.7 . . . . 0.0 110.195 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.9 -12.15 60.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.925 -1.109 . . . . 0.0 109.311 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 19.9 pt-20 -97.1 -41.01 8.55 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.442 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.07 -39.89 98.57 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 97.4 t -60.11 -54.33 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.746 -0.856 . . . . 0.0 109.188 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.86 -2.14 35.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.398 -0.814 . . . . 0.0 110.454 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.1 t -90.63 -34.27 15.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.045 -1.034 . . . . 0.0 109.543 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.31 19.4 30.47 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -175.43 64.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -1.138 . . . . 0.0 108.945 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.444 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -51.27 123.68 10.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.856 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -161.1 89.67 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.115 -0.991 . . . . 0.0 108.77 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.4 t -153.23 172.65 16.65 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.825 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.62 174.51 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.622 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 7.3 p90 178.69 152.79 0.34 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.769 -1.207 . . . . 0.0 110.441 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -79.46 117.18 20.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.893 . . . . 0.0 108.777 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.19 175.18 6.07 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.038 -1.039 . . . . 0.0 110.359 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.7 m -147.25 110.32 4.78 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -80.14 119.79 23.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -131.14 42.41 3.22 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.604 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -78.29 79.55 4.73 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.3 0.572 . . . . 0.0 110.391 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.577 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 5.3 pt20 52.52 38.94 26.94 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.675 0.75 . . . . 0.0 109.656 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.73 -168.9 3.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.387 -0.821 . . . . 0.0 109.369 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.414 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.6 t -67.24 150.54 97.84 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.8 . . . . 0.0 108.921 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.414 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.5 Cg_endo -74.56 82.64 1.87 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.86 1.707 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.4 m -69.93 98.9 1.33 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.497 -0.752 . . . . 0.0 109.607 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.24 133.95 44.13 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.497 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 16.3 m -150.0 146.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.365 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -94.62 116.78 29.17 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 175.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.622 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -88.26 164.4 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.741 -1.224 . . . . 0.0 111.553 -175.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 21.3 t-160 -147.42 146.88 29.74 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 175.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.448 ' CE ' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -152.33 137.86 17.74 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.6 -1.312 . . . . 0.0 109.345 -178.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.592 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 25.4 tttt -150.3 158.9 44.66 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.402 -1.319 . . . . 0.0 109.904 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.444 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 4.7 ttmt -72.36 109.88 6.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 109.048 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.525 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -72.03 176.24 5.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.442 -0.787 . . . . 0.0 111.008 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 O-C-N 121.551 -0.718 . . . . 0.0 109.119 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 55.7 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.584 0.706 . . . . 0.0 110.594 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.485 ' CE1' HG23 ' A' ' 83' ' ' VAL . 16.6 m-85 -132.38 132.11 42.53 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.683 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 17.4 p-90 -136.28 155.24 50.37 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.63 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.448 HG23 ' CE ' ' A' ' 109' ' ' MET . 83.3 t -140.42 109.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.804 -0.56 . . . . 0.0 110.049 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.683 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 3.8 m-30 -91.36 135.13 34.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.991 -1.068 . . . . 0.0 109.319 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.49 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -110.42 119.23 58.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.24 -0.912 . . . . 0.0 109.72 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -89.03 108.55 19.65 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HA ' HG11 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -67.56 116.91 8.82 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.474 -1.29 . . . . 0.0 109.468 -178.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.115 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 121' ' ' PHE . 0.3 OUTLIER -75.16 -68.67 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.529 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.558 -177.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 11' ' ' ILE . 3.2 tm-20 -37.98 -33.63 0.09 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.697 -0.627 . . . . 0.0 111.663 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.39 -44.28 16.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.919 -1.113 . . . . 0.0 108.597 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -69.55 -8.54 48.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.746 -0.597 . . . . 0.0 109.605 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.487 ' CD1' HG21 ' A' ' 11' ' ' ILE . 28.7 mt -97.97 -22.06 16.5 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.819 -1.175 . . . . 0.0 109.316 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.969 -179.563 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 19.4 p30 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.132 0.491 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -100.83 35.83 4.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 28' ' ' PHE . 85.1 mt -99.63 124.57 44.98 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.44 -1.035 . . . . 0.0 109.838 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.12 -12.92 14.05 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.824 0.821 . . . . 0.0 108.916 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.546 ' CE1' HD11 ' A' ' 11' ' ' ILE . 2.7 p90 -113.82 -172.43 2.08 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.164 -0.96 . . . . 0.0 108.612 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -122.98 136.16 10.43 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 108.131 -1.988 . . . . 0.0 108.131 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.91 111.25 21.39 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.894 -1.356 . . . . 0.0 108.318 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.531 HG21 ' CD1' ' A' ' 42' ' ' TYR . 0.8 OUTLIER -120.81 140.27 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.493 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 9.3 mt-30 -107.23 170.55 7.89 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 80.1 mt -151.47 142.84 23.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.988 -1.07 . . . . 0.0 109.971 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -115.11 137.43 52.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.077 -1.014 . . . . 0.0 109.365 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -10.89 71.21 0.0 OUTLIER Glycine 0 N--CA 1.513 3.824 0 C-N-CA 124.674 1.13 . . . . 0.0 113.378 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER 162.58 -24.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.04 18.37 22.44 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 16.3 p-10 -84.9 129.04 34.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.146 -1.208 . . . . 0.0 108.893 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 1.1 mp -63.24 137.26 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.075 0.94 . . . . 0.0 111.282 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 1.7 mt -108.27 -28.45 9.44 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.404 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -155.0 161.14 41.46 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.531 ' CD1' HG21 ' A' ' 31' ' ' ILE . 48.3 t80 -149.14 -73.35 0.18 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.54 -1.35 . . . . 0.0 111.071 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 10.1 p-10 109.06 178.19 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 123.999 0.92 . . . . 0.0 109.641 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.9 15.09 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.051 -1.031 . . . . 0.0 113.258 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -51.75 -63.77 1.03 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.254 -1.528 . . . . 0.0 110.563 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.518 ' OE2' HG21 ' A' ' 31' ' ' ILE . 1.2 pt-20 -57.39 -54.62 44.74 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.625 0.726 . . . . 0.0 109.609 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.41 -14.87 21.81 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.57 -34.89 46.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.874 -1.368 . . . . 0.0 109.478 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.408 HG23 HG21 ' A' ' 50' ' ' THR . 0.5 OUTLIER -86.69 -47.91 15.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.251 -0.905 . . . . 0.0 109.679 -179.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.44 ' HA ' ' CE ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -86.41 -31.92 21.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.176 -0.952 . . . . 0.0 109.74 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.41 -3.41 56.5 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.928 -1.129 . . . . 0.0 110.438 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.54 ' NH2' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -41.9 -48.04 4.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.321 -1.105 . . . . 0.0 112.492 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 66.1 146.18 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.727 -1.233 . . . . 0.0 107.737 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.77 -63.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.949 1.766 . . . . 0.0 112.118 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.22 -21.65 14.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.011 . . . . 0.0 111.193 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -88.07 -41.1 13.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.868 -1.145 . . . . 0.0 109.878 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 52' ' ' ARG . 15.2 m -81.89 3.32 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 110.021 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.44 120.84 20.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.091 -1.006 . . . . 0.0 108.546 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.8 -11.4 70.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -80.36 141.4 35.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.949 -1.324 . . . . 0.0 109.849 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.429 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -81.59 92.99 6.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.907 . . . . 0.0 109.005 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.54 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 25.8 t80 -54.1 -22.33 10.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CD1' ' CD1' ' A' ' 76' ' ' TYR . 7.0 m-85 -85.84 -31.45 22.27 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.48 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.39 47.4 1.39 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 108.935 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.7 OUTLIER -165.47 -33.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.388 -0.82 . . . . 0.0 110.345 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.452 ' CG1' ' HD3' ' A' ' 52' ' ' ARG . 9.9 t -106.93 -56.97 4.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 120.76 -1.213 . . . . 0.0 109.002 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.408 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . . . -104.4 101.26 26.26 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.902 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -75.98 -0.38 10.2 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 C-N-CA 121.803 1.669 . . . . 0.0 110.522 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 p -100.54 -23.2 14.75 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.072 -1.017 . . . . 0.0 109.694 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.495 HG23 ' CE1' ' A' ' 75' ' ' PHE . 10.8 p -82.12 3.88 25.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.168 -0.958 . . . . 0.0 110.044 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -91.21 51.16 1.87 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.924 -1.11 . . . . 0.0 108.77 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.47 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -121.13 179.05 1.01 Allowed Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -78.85 -6.09 14.97 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.931 1.754 . . . . 0.0 111.223 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 14.3 mm-40 -103.18 -24.15 13.59 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.896 -1.127 . . . . 0.0 109.656 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.495 ' CE1' HG23 ' A' ' 70' ' ' THR . 1.5 t80 -103.61 -70.44 0.76 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 21.0 t80 -71.83 -19.67 61.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.92 -1.113 . . . . 0.0 108.442 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.48 -61.51 6.21 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 2.3 mmtp -63.04 -15.78 57.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.964 . . . . 0.0 109.496 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.461 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 6.9 t80 -78.65 -40.49 34.01 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -77.91 -7.02 56.19 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -95.75 -39.51 9.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.27 -43.08 64.3 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.497 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 59.1 t -58.25 -37.3 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.738 -0.86 . . . . 0.0 109.192 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.12 -4.22 46.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.459 -0.776 . . . . 0.0 110.982 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 m -100.38 -18.22 16.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.781 -1.199 . . . . 0.0 110.224 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.77 16.3 77.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.86 63.43 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -1.207 . . . . 0.0 108.846 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.424 ' CB ' ' HB2' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -65.31 112.68 3.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 109.854 -179.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -160.78 85.07 0.69 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.409 -0.807 . . . . 0.0 108.912 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -133.1 144.93 50.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.061 -1.024 . . . . 0.0 110.434 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.5 ptp -132.74 154.64 50.01 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CD2' HG23 ' A' ' 107' ' ' VAL . 9.9 p90 -169.19 -173.3 1.71 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.755 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.63 110.37 20.47 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.95 172.71 6.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.495 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 89.3 m -143.41 111.72 6.27 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.442 -0.787 . . . . 0.0 109.042 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 122' ' ' VAL . 15.5 m-30 -83.8 117.13 23.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.281 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -147.13 47.04 1.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.94 . . . . 0.0 109.88 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 21.3 p90 -78.6 137.08 37.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.515 ' C ' ' O ' ' A' ' 98' ' ' TYR . 5.3 pt20 1.51 66.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.114 0 CA-C-O 121.539 0.685 . . . . 0.0 112.371 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 98' ' ' TYR . 67.7 ttp -162.98 -93.54 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.502 -0.749 . . . . 0.0 109.396 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 100' ' ' MET . 0.2 OUTLIER -149.17 161.5 31.99 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.812 -1.18 . . . . 0.0 108.664 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.95 115.36 4.0 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.024 1.816 . . . . 0.0 110.357 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 m -123.58 128.08 49.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.662 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.42 143.61 33.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.509 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 15.2 m -152.82 141.97 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.773 -1.204 . . . . 0.0 110.777 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -83.43 115.94 22.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 174.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 92' ' ' PHE . 32.7 m -98.85 156.22 3.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 120.838 -1.164 . . . . 0.0 110.929 -175.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -159.99 104.48 1.52 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.482 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 6.4 mtm -110.23 145.53 37.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.429 -0.794 . . . . 0.0 109.772 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.591 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.9 tttm -138.0 -177.59 4.89 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.873 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.424 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 5.1 ttmm -91.04 99.9 12.85 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.07 123.94 6.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.408 -0.807 . . . . 0.0 110.057 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.962 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.592 0.71 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.497 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 22.7 m-85 -139.54 113.46 8.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.724 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 11.1 p-90 -114.95 141.68 47.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.527 -1.269 . . . . 0.0 112.325 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.482 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 61.5 t -113.99 116.23 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.724 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 18.9 m-30 -99.05 127.63 45.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.002 -1.061 . . . . 0.0 109.287 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.46 ' CG2' ' CE2' ' A' ' 96' ' ' PHE . 2.0 t -116.3 113.09 42.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.025 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.1 tttm -96.62 120.73 37.49 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.402 ' HA ' HG11 ' A' ' 105' ' ' VAL . 1.9 ttt180 -65.67 121.34 14.74 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.707 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.509 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.183 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 . . . . . 0 N--CA 1.516 2.848 0 CA-C-O 121.122 0.487 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.571 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 1.2 mm -58.38 -68.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.148 -0.97 . . . . 0.0 110.053 -177.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.89 -28.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.8 -0.562 . . . . 0.0 112.31 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 11' ' ' ILE . 16.1 m120 -72.94 -50.87 20.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.758 -1.213 . . . . 0.0 109.576 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -68.24 -54.85 14.82 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.515 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 51.8 mt -43.34 -32.05 0.75 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.249 0.547 . . . . 0.0 110.244 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.84 -179.47 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.017 0.437 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.56 27.74 16.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mt -71.59 -168.43 0.34 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.149 -1.206 . . . . 0.0 109.13 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.98 -4.24 14.58 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 7.2 p90 -134.68 112.09 10.51 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.216 -0.928 . . . . 0.0 109.072 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.648 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -49.82 161.62 0.92 Allowed Glycine 0 C--N 1.289 -2.048 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HB2' HD12 ' A' ' 15' ' ' LEU . . . -145.49 129.82 17.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.819 -1.401 . . . . 0.0 108.457 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.506 HG22 ' CE1' ' A' ' 42' ' ' TYR . 1.8 pp -131.84 157.63 43.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.772 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.433 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 45.8 mt-30 -116.39 163.27 16.29 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 17.6 mt -147.57 144.0 28.16 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.867 -1.145 . . . . 0.0 110.467 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.435 ' N ' HD22 ' A' ' 40' ' ' LEU . 30.5 t70 -96.54 165.87 11.96 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -44.08 -22.48 0.33 Allowed Glycine 0 N--CA 1.5 2.931 0 C-N-CA 121.336 -0.459 . . . . 0.0 113.281 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.1 15.94 22.71 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.342 -1.681 . . . . 0.0 110.858 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.03 26.25 67.06 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 34.2 m-80 -94.33 131.19 40.21 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.99 -1.3 . . . . 0.0 110.964 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.471 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 1.1 tp -61.83 138.07 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.825 -1.172 . . . . 0.0 111.286 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 34' ' ' ASP . 2.3 mt -110.64 -28.24 8.56 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 177.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.459 ' NE2' ' N ' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -152.68 150.12 29.13 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.536 ' CD1' ' OE2' ' A' ' 46' ' ' GLU . 4.7 t80 -130.89 -54.03 1.06 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.323 -1.486 . . . . 0.0 111.374 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.495 ' OD1' ' HG3' ' A' ' 46' ' ' GLU . 0.4 OUTLIER 89.6 177.77 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.37 -38.39 9.65 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.937 -1.102 . . . . 0.0 113.681 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.87 -62.68 1.13 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.64 -1.287 . . . . 0.0 111.552 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.648 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -59.09 -49.16 78.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.47 -0.769 . . . . 0.0 110.932 -179.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.21 -15.08 42.97 Favored Glycine 0 C--N 1.281 -2.477 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -83.63 -30.0 27.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.96 -1.317 . . . . 0.0 108.888 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.44 HG23 HG21 ' A' ' 50' ' ' THR . 0.2 OUTLIER -82.01 -55.32 8.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.405 -0.809 . . . . 0.0 109.144 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.44 HG21 HG23 ' A' ' 49' ' ' ILE . 1.2 p -84.41 -11.49 56.15 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.242 -0.911 . . . . 0.0 109.903 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.36 -5.84 81.91 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.585 ' NH2' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -52.35 123.6 11.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -1.159 . . . . 0.0 110.478 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.451 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 1.4 m-20 -89.85 154.97 47.93 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 -54.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.708 1.605 . . . . 0.0 111.37 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -22.15 66.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 110.668 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.81 -41.85 11.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.955 -1.091 . . . . 0.0 109.96 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.48 ' CG1' ' HD3' ' A' ' 52' ' ' ARG . 14.4 m -77.61 -1.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.728 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.471 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -71.65 122.48 23.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.64 -15.07 61.25 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -79.13 138.76 38.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.139 -1.212 . . . . 0.0 108.877 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -76.38 109.35 10.02 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.585 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 8.5 t80 -68.79 -20.54 64.34 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.632 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 3.6 m-85 -85.06 -4.05 59.02 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.957 -1.097 . . . . 0.0 111.393 -177.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 23.0 mttt -155.99 -46.37 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.731 -1.231 . . . . 0.0 110.857 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.53 -3.41 53.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.984 -1.072 . . . . 0.0 112.299 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.492 HG12 ' HD3' ' A' ' 52' ' ' ARG . 5.7 t -126.45 -59.37 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 120.304 -1.498 . . . . 0.0 109.286 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.65 106.95 59.67 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.625 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.12 2.32 7.3 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.796 1.664 . . . . 0.0 111.698 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.429 ' O ' ' OH ' ' A' ' 94' ' ' TYR . 30.7 p -105.33 -18.83 13.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.861 -1.149 . . . . 0.0 109.78 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.528 ' CG2' ' CZ ' ' A' ' 62' ' ' PHE . 71.1 p -75.35 -2.12 26.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 110.28 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -90.68 53.31 2.39 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.878 -1.139 . . . . 0.0 108.789 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.469 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -124.71 178.18 1.53 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.488 -0.758 . . . . 0.0 109.237 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.39 -1.2 11.39 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 122.238 1.959 . . . . 0.0 111.428 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.4 mp0 -109.44 -25.83 10.3 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.92 -1.112 . . . . 0.0 109.248 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -100.98 -70.36 0.74 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.063 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -72.12 -18.27 61.91 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.094 -1.004 . . . . 0.0 108.341 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.82 -64.9 3.23 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 1.4 mmtp -62.48 -16.77 57.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.561 -0.964 . . . . 0.0 109.878 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.485 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 9.1 t80 -83.5 -36.98 23.68 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.602 -0.687 . . . . 0.0 109.872 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.22 -12.57 60.11 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.173 -0.954 . . . . 0.0 109.081 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 19.4 pt-20 -97.23 -42.36 7.85 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -60.03 -39.25 95.45 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 107.521 -2.232 . . . . 0.0 107.521 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 90.3 t -60.88 -45.36 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.784 -0.833 . . . . 0.0 109.46 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.19 -3.11 57.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.219 -0.926 . . . . 0.0 110.622 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.49 -24.61 15.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.85 -1.156 . . . . 0.0 109.451 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.71 15.1 74.06 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -156.19 56.01 0.58 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -1.176 . . . . 0.0 108.66 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.24 120.73 4.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 110.113 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.41 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 17.1 p30 -160.52 88.41 0.79 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 108.947 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -146.86 169.02 19.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.209 -0.932 . . . . 0.0 110.129 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -154.98 170.38 21.89 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.648 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 6.5 p90 179.53 152.52 0.42 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.872 -1.142 . . . . 0.0 110.222 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -80.75 111.93 17.65 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.429 ' OH ' ' O ' ' A' ' 69' ' ' CYS . 0.1 OUTLIER -112.88 -178.85 3.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.084 -1.01 . . . . 0.0 109.984 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.6 m -146.09 109.73 4.81 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -79.3 93.41 5.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 108.665 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -115.84 31.17 6.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.37 -0.831 . . . . 0.0 109.686 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.582 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.85 159.11 27.96 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.817 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.494 ' C ' ' O ' ' A' ' 98' ' ' TYR . 1.5 pp0? -4.56 67.65 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 123.532 0.733 . . . . 0.0 112.547 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.582 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.78 -157.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.608 -0.683 . . . . 0.0 109.195 -178.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.419 ' CB ' ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -90.96 174.78 4.15 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 108.834 179.154 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 101' ' ' THR . 36.1 Cg_endo -79.15 103.77 1.68 Allowed 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.07 1.847 . . . . 0.0 110.749 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.42 HG21 HG12 ' A' ' 105' ' ' VAL . 9.2 m -99.11 145.27 27.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.114 -0.991 . . . . 0.0 108.926 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.43 135.82 54.58 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.507 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 11.5 m -153.5 145.67 14.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.973 -1.079 . . . . 0.0 110.862 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 3.0 ptmt -94.28 114.7 26.83 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.573 -2.381 . . . . 0.0 104.573 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.648 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -86.72 164.76 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.882 -1.136 . . . . 0.0 110.315 -176.588 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -159.71 101.94 1.5 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.467 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.89 148.77 36.19 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.109 -0.995 . . . . 0.0 110.002 -177.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.584 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.2 tttt -144.11 178.82 7.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.669 -1.269 . . . . 0.0 109.309 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.49 106.81 15.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.885 -1.134 . . . . 0.0 108.693 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.434 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -52.5 155.55 2.12 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 110.5 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.548 -0.72 . . . . 0.0 109.837 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 112' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.449 0.643 . . . . 0.0 109.904 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.429 ' CE1' HG23 ' A' ' 83' ' ' VAL . 12.0 m-85 -145.76 102.66 3.69 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.657 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 11.2 p-90 -106.32 143.69 34.07 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.551 -1.26 . . . . 0.0 111.973 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.467 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 43.9 t -121.45 107.87 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.497 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.657 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 8.9 m-30 -92.94 123.08 35.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -0.854 . . . . 0.0 109.575 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.447 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -102.56 118.1 48.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.37 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.505 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 1.4 tttp -96.85 106.68 19.04 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HA ' HG11 ' A' ' 105' ' ' VAL . 6.3 ttt180 -53.92 135.92 41.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.795 -1.191 . . . . 0.0 109.671 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.194 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.57 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 3.4 mm -75.1 -57.37 6.54 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 O-C-N 121.372 -0.83 . . . . 0.0 110.428 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.4 tt0 -36.18 -33.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.848 -0.532 . . . . 0.0 112.066 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 11' ' ' ILE . 1.5 m120 -84.74 -43.18 14.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.938 -1.101 . . . . 0.0 108.316 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 11' ' ' ILE . 2.9 m -69.78 -8.1 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.727 -0.608 . . . . 0.0 109.987 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 11' ' ' ILE . 15.2 mt -96.77 -22.2 17.09 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.951 -1.093 . . . . 0.0 109.278 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.399 0 O-C-N 121.328 -0.857 . . . . 0.0 108.77 179.335 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.53 24.65 24.69 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.536 ' CD2' ' CZ ' ' A' ' 28' ' ' PHE . 3.5 mp -77.19 157.21 31.04 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.32 -1.106 . . . . 0.0 108.446 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.32 12.67 13.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -154.06 112.75 3.64 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -49.6 159.03 1.22 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.413 ' N ' ' OE1' ' A' ' 46' ' ' GLU . . . -134.85 114.63 12.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.519 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.6 pp -117.1 158.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 110.636 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.44 ' HB2' ' HG3' ' A' ' 41' ' ' GLN . 24.3 mm-40 -125.89 170.36 11.73 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 63' ' ' PHE . 83.8 mt -157.39 147.56 20.8 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.28 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' ASP . 29.1 m-20 -126.64 127.03 44.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.059 -1.026 . . . . 0.0 109.913 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.02 -77.54 0.0 OUTLIER Glycine 0 N--CA 1.502 3.041 0 C-N-CA 124.578 1.085 . . . . 0.0 113.609 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -69.69 -3.23 14.35 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.535 -0.979 . . . . 0.0 110.933 -178.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 87.36 17.59 58.6 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 34' ' ' ASP . 8.1 p30 -73.7 129.5 38.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -1.199 . . . . 0.0 108.835 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.474 HG21 ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -58.56 136.45 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 110.441 -178.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 6.9 mt -101.6 -29.59 11.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -160.0 176.97 11.22 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 12.9 t80 -156.11 -48.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.695 -1.253 . . . . 0.0 110.076 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 0.6 OUTLIER 89.43 176.5 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.257 0.551 . . . . 0.0 109.929 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.83 -20.54 18.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.244 -0.91 . . . . 0.0 112.485 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.3 -66.62 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.547 -1.345 . . . . 0.0 110.33 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 5.1 pt-20 -61.23 -49.4 77.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.956 . . . . 0.0 110.03 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -61.03 -14.24 37.9 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 21.7 t0 -80.76 -34.11 34.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.725 -1.456 . . . . 0.0 108.846 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.426 HG23 HG21 ' A' ' 50' ' ' THR . 1.0 OUTLIER -82.94 -54.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.197 -0.94 . . . . 0.0 108.849 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.429 ' OG1' ' CD ' ' A' ' 52' ' ' ARG . 26.7 p -78.82 -24.14 44.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.402 -0.811 . . . . 0.0 109.768 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 97.14 -13.8 64.39 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.516 ' NH1' ' CE2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -58.35 90.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -1.207 . . . . 0.0 109.971 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -61.54 166.86 4.97 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.176 -0.952 . . . . 0.0 109.284 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.15 -54.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 122.149 1.899 . . . . 0.0 110.759 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -65.93 -24.23 66.78 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.974 -1.079 . . . . 0.0 109.848 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -44.39 17.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.88 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' A' ' 52' ' ' ARG . 33.1 m -73.96 -3.13 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.189 -0.944 . . . . 0.0 109.836 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.474 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.73 123.31 23.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 120.976 -1.078 . . . . 0.0 108.422 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.41 -18.77 53.75 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -79.64 127.2 31.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.228 -1.16 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.435 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -67.61 104.69 1.67 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.287 -0.883 . . . . 0.0 108.714 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.452 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 84.6 t80 -55.45 -17.21 4.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.48 -0.763 . . . . 0.0 110.651 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.48 ' CE2' HD11 ' A' ' 33' ' ' LEU . 29.3 m-85 -94.11 -38.15 11.25 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.048 -1.032 . . . . 0.0 110.73 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 0.1 OUTLIER -134.67 42.8 2.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.962 -1.086 . . . . 0.0 109.201 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.435 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.3 OUTLIER -159.2 -32.52 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 110.235 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.489 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 9.3 t -109.12 -51.4 6.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 O-C-N 120.787 -1.196 . . . . 0.0 108.14 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.43 97.41 49.89 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.141 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.22 -1.41 10.91 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.113 1.875 . . . . 0.0 111.251 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 p -95.35 -26.73 15.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.655 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 72' ' ' SER . 70.9 p -66.62 -36.37 82.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.387 -0.82 . . . . 0.0 109.744 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.92 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.168 -0.957 . . . . 0.0 109.054 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 177.67 170.52 0.44 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 109.291 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.3 80.83 2.61 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.558 2.172 . . . . 0.0 110.809 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER 168.08 -36.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CD1' ' HE2' ' A' ' 109' ' ' MET . 1.8 t80 -109.84 -67.06 1.01 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 9.3 t80 -75.58 -17.24 60.11 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.68 -58.2 11.97 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -61.89 -18.62 60.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.609 -0.936 . . . . 0.0 109.594 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.515 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 9.7 t80 -81.02 -38.47 27.42 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.452 -0.78 . . . . 0.0 109.639 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.83 -12.42 60.38 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.01 -1.056 . . . . 0.0 109.463 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 12.8 pt-20 -96.85 -41.0 8.65 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -62.21 -39.11 97.26 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.517 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 90.8 t -61.68 -39.85 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.789 -0.83 . . . . 0.0 109.891 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.14 -0.19 53.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.236 -0.915 . . . . 0.0 111.274 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.5 t -104.88 -24.21 12.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.899 -1.126 . . . . 0.0 110.161 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.64 16.17 78.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -148.45 58.85 1.08 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.031 -1.276 . . . . 0.0 109.098 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -68.83 111.99 5.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -0.814 . . . . 0.0 109.694 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -160.14 82.87 0.71 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -131.46 172.8 11.78 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.917 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.54 171.11 19.56 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.659 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 17.2 p90 171.98 -177.11 0.05 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.088 -1.008 . . . . 0.0 109.992 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -109.92 105.59 14.82 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.408 ' HB2' HG12 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -104.41 -179.86 4.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -178.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.1 m -143.83 111.67 6.12 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.41 ' CE2' HG23 ' A' ' 105' ' ' VAL . 13.1 m-30 -86.71 131.02 34.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 108.871 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -160.98 63.89 0.29 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.516 ' CE2' ' NH1' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -84.11 41.08 0.8 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.488 -0.758 . . . . 0.0 111.776 -178.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER 89.61 29.76 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.683 0.754 . . . . 0.0 109.511 179.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.514 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -129.44 -71.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.947 . . . . 0.0 109.636 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.408 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.5 t -159.14 150.18 16.24 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.417 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.408 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 34.9 Cg_endo -76.25 79.75 2.87 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 122.063 1.842 . . . . 0.0 110.89 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 m -84.45 105.63 15.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.701 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -74.51 149.21 40.36 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.443 ' HB ' HG11 ' A' ' 122' ' ' VAL . 4.8 m -156.03 144.86 12.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 118.588 -1.245 . . . . 0.0 111.53 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -78.05 151.41 33.51 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.659 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 4.0 m -128.24 154.04 38.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 117.931 -1.507 . . . . 0.0 110.856 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 6.4 t-160 -147.42 125.59 12.18 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.51 ' HE2' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -133.69 126.97 31.91 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 120.99 -1.069 . . . . 0.0 108.898 -178.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.583 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 17.8 tttm -138.5 157.82 45.44 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.112 -1.435 . . . . 0.0 110.129 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.485 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 ptmt -75.63 94.18 3.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 109.626 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -53.27 123.54 12.15 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.252 -0.905 . . . . 0.0 109.617 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.054 -1.029 . . . . 0.0 110.124 -179.745 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.489 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 121.157 0.503 . . . . 0.0 110.452 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.517 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 7.3 m-85 -125.05 136.03 53.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.658 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 10.6 p-90 -135.6 150.65 49.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.002 -1.061 . . . . 0.0 110.519 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' A' ' 109' ' ' MET . 89.5 t -138.09 105.45 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.741 -0.599 . . . . 0.0 110.326 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.658 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 2.1 m-85 -88.87 138.14 31.68 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.443 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -110.76 114.19 46.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.51 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -81.67 142.38 32.77 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 176.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -98.85 134.42 41.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.495 -1.378 . . . . 0.0 109.637 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.031 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.582 HG23 ' CZ ' ' A' ' 121' ' ' PHE . 0.4 OUTLIER -69.28 -66.26 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.488 0 O-C-N 121.477 -0.764 . . . . 0.0 110.322 -178.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 11' ' ' ILE . 14.4 pt-20 -36.52 -33.74 0.05 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.867 -0.521 . . . . 0.0 111.994 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -82.64 -44.7 15.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.768 -1.208 . . . . 0.0 108.489 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.4 m -67.59 -10.38 51.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.693 -0.629 . . . . 0.0 109.691 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.478 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 42.2 mt -97.79 -20.48 17.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.842 -1.161 . . . . 0.0 109.749 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.33 -0.856 . . . . 0.0 110.16 -179.858 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.22 32.24 7.55 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.15 158.7 16.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.416 -1.049 . . . . 0.0 108.789 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HB2' ' NZ ' ' A' ' 123' ' ' LYS . . . -93.48 14.44 18.69 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.756 -0.59 . . . . 0.0 109.59 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.496 ' CE2' HG12 ' A' ' 11' ' ' ILE . 25.2 p90 -148.9 154.18 39.08 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.175 -0.953 . . . . 0.0 109.596 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.96 114.4 3.85 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.449 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -91.21 87.7 6.62 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.49 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.3 pp -98.48 148.89 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.649 -0.657 . . . . 0.0 109.79 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 18.1 mt-30 -118.25 174.63 6.12 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 108.501 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.423 HD23 ' CB ' ' A' ' 62' ' ' PHE . 62.1 mt -154.33 149.64 27.11 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.21 -0.932 . . . . 0.0 109.171 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 36' ' ' ASP . 30.4 p30 -130.45 121.03 25.11 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.607 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.6 -79.23 0.0 OUTLIER Glycine 0 N--CA 1.5 2.904 0 C-N-CA 124.362 0.982 . . . . 0.0 113.021 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -66.67 -7.59 21.73 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 121.851 -0.794 . . . . 0.0 110.436 -178.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' O ' ' CD2' ' A' ' 33' ' ' LEU . . . 89.89 18.54 50.63 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 m120 -73.26 136.13 44.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.243 . . . . 0.0 108.272 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.13 133.8 27.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.395 -0.815 . . . . 0.0 110.8 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.471 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 10.4 mt -98.85 -32.46 11.33 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.465 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -155.99 -173.73 4.64 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.528 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 1.2 t80 -160.96 -67.98 0.06 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.212 -0.93 . . . . 0.0 108.903 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.2 p-10 107.02 160.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 124.154 0.982 . . . . 0.0 109.169 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.99 -13.93 55.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.293 -0.88 . . . . 0.0 110.819 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB1' ' ND2' ' A' ' 43' ' ' ASN . . . -59.45 -62.33 1.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 0.0 109.803 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 11.5 pt-20 -66.05 -41.6 90.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.094 -1.003 . . . . 0.0 108.614 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -58.57 -18.06 36.08 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -29.55 22.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.778 -1.425 . . . . 0.0 109.579 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -80.31 -41.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.324 -0.86 . . . . 0.0 109.394 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.07 4.08 19.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.607 -0.683 . . . . 0.0 110.189 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.72 -2.2 74.72 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.677 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.53 ' NH2' ' CE2' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -73.33 84.49 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.922 -1.34 . . . . 0.0 111.81 -178.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.413 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -63.99 175.96 0.74 Allowed Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 53' ' ' ASP . 35.5 Cg_endo -77.05 -44.23 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.553 1.502 . . . . 0.0 110.682 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -16.41 63.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.107 -0.996 . . . . 0.0 110.268 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -48.67 6.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.972 -1.08 . . . . 0.0 110.025 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.415 HG12 ' HB3' ' A' ' 52' ' ' ARG . 32.8 m -70.71 -8.27 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.754 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.65 124.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.76 -19.62 50.26 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -79.02 132.88 36.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.317 -1.108 . . . . 0.0 108.976 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.71 125.27 27.09 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.534 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 75.4 t80 -63.97 -10.94 24.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.024 -1.048 . . . . 0.0 110.444 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -112.58 26.06 10.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.959 -1.088 . . . . 0.0 110.275 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -166.71 -58.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.978 -1.076 . . . . 0.0 110.891 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.58 -7.18 55.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.933 -1.105 . . . . 0.0 110.981 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.534 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 17.4 t -117.4 -26.43 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.63 -1.294 . . . . 0.0 109.526 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.71 96.84 1.0 Allowed Pre-proline 0 C--N 1.288 -2.076 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.961 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.42 -2.15 11.99 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.891 1.727 . . . . 0.0 110.564 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.2 p -90.1 -25.06 20.93 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.264 -0.897 . . . . 0.0 109.204 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.47 HG23 ' CD1' ' A' ' 75' ' ' PHE . 46.0 p -72.77 -5.37 37.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.466 -0.771 . . . . 0.0 110.139 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -88.39 59.63 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.967 -1.083 . . . . 0.0 109.317 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.54 171.96 5.79 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.171 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.75 79.54 2.81 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 122.373 2.048 . . . . 0.0 110.292 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.9 OUTLIER 169.21 -34.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.47 ' CD1' HG23 ' A' ' 70' ' ' THR . 1.4 t80 -106.28 -67.07 0.96 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.559 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 27.7 t80 -78.48 -21.94 48.26 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.6 -56.67 21.76 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 4.1 mmtt -65.62 -16.4 63.69 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.57 -0.959 . . . . 0.0 109.334 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.559 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 8.5 t80 -76.73 -37.68 55.57 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.66 -6.38 55.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -95.76 -39.06 10.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.36 -42.49 65.09 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.509 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 57.4 t -59.5 -40.13 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.843 -0.798 . . . . 0.0 109.73 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.14 -17.18 43.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -0.926 . . . . 0.0 110.744 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 m -88.28 -20.87 24.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.944 -1.097 . . . . 0.0 109.805 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.45 21.3 64.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -165.82 57.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -1.151 . . . . 0.0 109.355 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 6.3 tt -46.93 124.62 6.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.531 -0.731 . . . . 0.0 110.222 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -161.42 89.59 0.77 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.0 t -152.27 152.65 32.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.807 -1.183 . . . . 0.0 110.545 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.406 ' C ' ' CD2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -140.13 179.91 6.35 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.586 ' CD1' HG23 ' A' ' 107' ' ' VAL . 18.0 p90 172.47 171.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.838 . . . . 0.0 109.252 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.99 108.95 20.71 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.46 169.94 8.46 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.724 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.412 HG22 ' HD3' ' A' ' 104' ' ' LYS . 87.7 m -136.15 108.36 7.26 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 109.266 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.51 ' CZ ' HG23 ' A' ' 122' ' ' VAL . 12.3 m-30 -80.29 85.62 5.77 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -108.44 34.38 3.67 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.69 158.33 28.37 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.502 ' C ' ' O ' ' A' ' 98' ' ' TYR . 2.0 mt-30 0.08 64.86 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.46 0.704 . . . . 0.0 112.525 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.22 -153.55 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -178.447 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.443 ' CB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -93.7 177.41 1.97 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 0.0 108.726 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 101' ' ' THR . 34.1 Cg_endo -77.07 112.8 3.49 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.686 1.591 . . . . 0.0 110.013 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 95' ' ' THR . 2.8 m -113.29 130.34 56.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.727 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.417 ' O ' HG11 ' A' ' 105' ' ' VAL . 6.1 mmtt -104.52 145.21 30.62 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.462 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 26.3 m -154.57 144.8 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.615 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.26 117.55 19.63 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.586 HG23 ' CD1' ' A' ' 92' ' ' PHE . 23.2 m -99.2 151.96 4.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 117.852 -1.539 . . . . 0.0 108.235 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -156.32 102.68 2.11 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -113.17 144.89 41.9 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.192 -0.942 . . . . 0.0 109.529 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.582 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -141.04 -178.51 5.6 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.653 -1.28 . . . . 0.0 109.815 -179.273 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 103.74 16.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.027 -1.045 . . . . 0.0 108.857 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.444 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -51.59 146.13 8.05 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.616 -0.677 . . . . 0.0 109.884 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.269 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.497 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.271 0.558 . . . . 0.0 109.717 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.509 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 10.4 m-85 -149.9 111.59 4.52 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.722 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 15.1 p-90 -117.16 144.7 44.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.701 -1.249 . . . . 0.0 111.684 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.402 HG11 ' HG3' ' A' ' 109' ' ' MET . 13.8 t -120.85 114.57 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.554 0.692 . . . . 0.0 109.932 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.722 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 13.5 m-30 -95.33 121.9 37.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.51 HG23 ' CZ ' ' A' ' 96' ' ' PHE . 1.3 t -107.02 112.79 41.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.889 -1.125 . . . . 0.0 108.468 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.454 ' CD ' ' HB3' ' A' ' 28' ' ' PHE . 14.3 tptp -89.21 125.17 34.96 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -74.33 123.65 25.01 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.688 -1.258 . . . . 0.0 109.458 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 25.5 t . . . . . 0 C--N 1.301 -1.516 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.699 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.563 ' CG1' ' CE2' ' A' ' 121' ' ' PHE . 3.2 mm -50.73 -51.62 19.29 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.713 0 O-C-N 121.696 -0.628 . . . . 0.0 110.155 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' ILE . 4.0 tt0 -34.19 -41.51 0.11 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.15 -42.35 38.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.806 -1.184 . . . . 0.0 109.263 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' ILE . 1.2 m -60.7 -26.11 66.9 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.522 -0.737 . . . . 0.0 109.855 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 11' ' ' ILE . 5.7 mt -96.77 -17.06 20.51 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.941 -1.1 . . . . 0.0 109.812 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 12' ' ' GLU . . . . . . . . 0 N--CA 1.487 1.401 0 O-C-N 121.047 -1.033 . . . . 0.0 110.198 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.079 0.466 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.74 31.56 8.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -104.1 173.54 6.26 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.159 -1.201 . . . . 0.0 108.888 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.7 21.27 11.61 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 122.262 1.03 . . . . 0.0 108.23 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -160.51 113.1 2.01 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.396 1.093 . . . . 0.0 108.395 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' HA2' ' ND2' ' A' ' 43' ' ' ASN . . . -46.96 143.41 5.31 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.346 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.462 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -125.34 92.34 3.6 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.539 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.2 pp -99.1 167.33 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.454 -0.779 . . . . 0.0 111.109 -177.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -134.22 166.59 22.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 19.2 mt -149.64 148.35 29.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.971 -1.081 . . . . 0.0 110.065 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 36' ' ' ASP . 2.3 p30 -115.86 133.06 56.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.144 -0.972 . . . . 0.0 109.533 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -12.55 74.53 0.0 OUTLIER Glycine 0 N--CA 1.51 3.631 0 C-N-CA 124.697 1.142 . . . . 0.0 113.307 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER 162.44 -24.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.53 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.63 20.7 14.11 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 23.0 m120 -87.67 131.99 34.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -1.139 . . . . 0.0 108.538 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.453 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -67.77 138.39 22.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.113 -0.992 . . . . 0.0 111.161 -178.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 6.4 mt -99.61 -32.1 11.25 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.19 -179.59 6.24 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 52' ' ' ARG . 27.7 t80 -140.63 -95.15 0.15 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.609 -1.307 . . . . 0.0 111.05 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 2.0 t-20 153.91 150.26 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -74.68 -58.45 3.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.4 -0.812 . . . . 0.0 110.173 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -38.94 -59.28 0.99 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.848 -0.533 . . . . 0.0 111.567 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.498 ' OE1' ' CG ' ' A' ' 42' ' ' TYR . 8.0 pt-20 -63.25 -43.58 97.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 0.0 110.009 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.418 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -63.3 -14.37 53.54 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.13 -25.12 20.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.959 -1.318 . . . . 0.0 109.149 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.448 HG23 ' CG2' ' A' ' 50' ' ' THR . 1.1 mp -79.17 -47.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.448 ' CG2' HG23 ' A' ' 49' ' ' ILE . 4.8 p -100.42 -6.83 25.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.438 -0.788 . . . . 0.0 110.217 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 84.75 -5.75 80.81 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' NH2' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -53.26 115.31 1.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.026 -1.279 . . . . 0.0 110.884 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 17.6 m-20 -90.98 156.98 43.84 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.81 -50.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.787 1.658 . . . . 0.0 111.282 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -20.84 65.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 110.329 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -89.95 -42.95 10.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.003 -1.061 . . . . 0.0 109.826 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 19.3 m -76.51 -1.25 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.0 109.824 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.491 HD11 HG22 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -70.59 122.93 23.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.01 -17.47 58.15 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -79.73 135.02 36.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -1.168 . . . . 0.0 109.492 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.43 102.17 3.7 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.582 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 8.3 t80 -63.61 -15.0 57.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 76' ' ' TYR . 2.7 m-85 -88.38 12.68 13.54 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.62 -1.232 . . . . 0.0 110.602 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.04 -52.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 0.0 110.552 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.75 -3.88 24.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.02 -1.05 . . . . 0.0 111.064 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.485 HG12 ' HD3' ' A' ' 52' ' ' ARG . 11.8 t -128.12 -57.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.673 -1.267 . . . . 0.0 109.043 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 70' ' ' THR . . . -109.1 105.64 57.52 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.574 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.63 -1.1 10.63 Favored 'Trans proline' 0 C--N 1.32 -0.934 0 C-N-CA 121.847 1.698 . . . . 0.0 111.557 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.404 ' O ' ' OH ' ' A' ' 94' ' ' TYR . 31.8 p -104.45 -19.89 13.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.836 -1.165 . . . . 0.0 109.665 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.449 HG22 ' CZ ' ' A' ' 62' ' ' PHE . 63.9 p -72.68 -6.11 42.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.965 -1.084 . . . . 0.0 109.915 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -88.86 53.71 2.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.985 -1.072 . . . . 0.0 109.11 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.448 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -126.98 177.49 1.99 Allowed Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.8 Cg_endo -77.94 -3.54 13.59 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.126 1.884 . . . . 0.0 111.45 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -105.8 -25.94 11.97 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.809 -1.182 . . . . 0.0 109.521 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.5 t80 -102.02 -70.39 0.75 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.488 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 9.2 t80 -72.86 -17.7 61.51 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.45 -63.45 4.28 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 5.1 mmtt -63.52 -15.63 58.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.626 -0.926 . . . . 0.0 109.544 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.468 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 8.4 t80 -79.63 -39.63 31.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -79.62 -6.41 57.04 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 108.829 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.86 -40.12 9.48 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.55 -44.33 58.22 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 118' ' ' TYR . 94.3 t -54.32 -38.68 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.952 . . . . 0.0 109.243 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.96 -16.93 34.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.444 -0.785 . . . . 0.0 110.637 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.6 -18.25 30.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.937 -1.102 . . . . 0.0 110.178 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.3 18.13 74.77 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -162.39 57.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.128 -1.219 . . . . 0.0 109.408 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.426 ' O ' ' CG ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -49.25 122.3 5.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.405 -0.81 . . . . 0.0 110.257 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.403 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 58.5 t30 -160.65 83.9 0.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 108.826 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -147.73 153.03 38.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 0.0 110.724 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -137.42 173.66 11.43 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.643 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 6.2 p90 179.52 153.09 0.44 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.027 -1.046 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.67 106.85 13.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.404 ' OH ' ' O ' ' A' ' 69' ' ' CYS . 0.1 OUTLIER -107.78 175.53 5.45 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.249 -0.907 . . . . 0.0 110.163 -178.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.431 ' CG2' ' O ' ' A' ' 103' ' ' THR . 22.2 m -143.35 111.41 6.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CZ ' HG23 ' A' ' 122' ' ' VAL . 17.4 m-30 -79.62 96.46 6.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.182 -0.948 . . . . 0.0 109.147 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -113.44 30.06 7.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.237 -0.914 . . . . 0.0 110.052 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.578 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -79.1 159.56 27.44 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.517 ' C ' ' O ' ' A' ' 98' ' ' TYR . 2.9 pt20 -0.67 65.03 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 123.37 0.668 . . . . 0.0 112.31 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.578 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER 174.39 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.546 -0.721 . . . . 0.0 109.117 -177.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.25 171.69 5.75 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 108.971 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.97 80.75 2.89 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 122.004 1.802 . . . . 0.0 111.277 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.438 HG21 ' N ' ' A' ' 104' ' ' LYS . 3.2 m -70.53 145.88 50.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 109.0 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.438 ' N ' HG21 ' A' ' 103' ' ' THR . 0.0 OUTLIER -116.79 138.85 51.2 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.505 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 15.0 m -155.75 144.81 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.995 -1.065 . . . . 0.0 110.003 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.496 ' HG2' ' CB ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -95.61 114.33 26.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 175.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.643 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -88.04 166.99 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.285 1.041 . . . . 0.0 110.666 -176.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.408 ' N ' HG21 ' A' ' 107' ' ' VAL . 23.3 t-160 -161.47 101.93 1.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.464 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 4.5 mtm -112.5 150.04 31.81 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.267 -0.896 . . . . 0.0 110.57 -177.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.9 tttt -144.65 174.27 11.11 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.181 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.412 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 10.4 tttm -83.17 104.6 13.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.83 -1.169 . . . . 0.0 109.108 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HB2' ' CB ' ' A' ' 117' ' ' SER . . . -52.93 137.48 32.44 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.49 -0.756 . . . . 0.0 109.671 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.593 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.479 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.463 0.649 . . . . 0.0 109.984 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.501 ' CE1' HG23 ' A' ' 83' ' ' VAL . 25.4 m-85 -150.66 104.48 3.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.665 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 11.3 p-90 -106.08 141.5 37.34 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 118.553 -1.259 . . . . 0.0 112.011 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.464 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 57.8 t -116.85 117.77 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.665 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 16.1 m-30 -102.18 118.83 37.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.1 -1.0 . . . . 0.0 109.091 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.435 HG23 ' CZ ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -101.22 129.22 52.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.836 -1.165 . . . . 0.0 110.09 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.514 ' CE ' ' CD2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -102.93 123.55 46.77 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.459 ' HA ' HG11 ' A' ' 105' ' ' VAL . 12.4 ttt180 -77.57 121.14 23.51 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.109 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.236 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.539 HG13 ' CE2' ' A' ' 121' ' ' PHE . 3.8 mm -63.57 -63.1 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -37.85 -33.58 0.09 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.949 -0.469 . . . . 0.0 111.851 -178.012 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -81.06 -44.74 17.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.876 -1.14 . . . . 0.0 108.339 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -70.04 -9.07 54.11 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.642 -0.661 . . . . 0.0 109.724 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.518 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 21.1 mt -97.44 -21.88 16.9 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.954 -1.091 . . . . 0.0 109.197 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 0.0 109.945 -179.747 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.5 t0 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.838 0.352 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.22 32.16 7.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 29.3 mt -105.3 151.46 24.11 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.459 -1.024 . . . . 0.0 108.689 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.24 24.7 4.8 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -160.16 122.14 3.24 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -179.32 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.476 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -58.8 154.55 27.35 Favored Glycine 0 C--N 1.288 -2.099 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.874 -177.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.531 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -127.78 85.15 2.32 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.566 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.1 pp -86.29 144.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.885 0.85 . . . . 0.0 110.724 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 15.3 mm100 -114.24 159.52 20.06 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.449 ' HG ' ' CD1' ' A' ' 31' ' ' ILE . 72.3 mt -151.82 149.7 29.3 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.9 -1.125 . . . . 0.0 109.71 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 36' ' ' ASP . 41.5 p-10 -131.99 123.29 27.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 110.476 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 42.88 -79.36 0.0 OUTLIER Glycine 0 N--CA 1.498 2.798 0 C-N-CA 124.398 0.999 . . . . 0.0 113.053 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -69.52 -5.96 27.62 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.736 -0.861 . . . . 0.0 110.358 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' O ' ' CD2' ' A' ' 33' ' ' LEU . . . 87.4 24.33 36.96 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -78.63 133.09 37.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.137 -1.214 . . . . 0.0 108.102 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.497 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 1.7 tp -56.77 136.38 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 111.711 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 1.3 mt -110.67 -24.41 10.52 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' NE2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -169.74 113.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.399 -0.813 . . . . 0.0 109.422 179.331 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.566 ' CD1' HG21 ' A' ' 31' ' ' ILE . 19.1 t80 -98.71 -67.68 0.84 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.164 -0.96 . . . . 0.0 111.361 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 5.6 p-10 105.86 177.43 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 0 C-N-CA 124.021 0.929 . . . . 0.0 108.863 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.17 15.35 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.845 -1.159 . . . . 0.0 113.171 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.56 -64.31 0.85 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.331 -1.481 . . . . 0.0 110.601 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' CD ' ' CE1' ' A' ' 42' ' ' TYR . 1.5 pt-20 -57.88 -54.4 47.37 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.508 0.671 . . . . 0.0 109.935 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.427 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -57.93 -14.86 18.17 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -76.0 -38.88 56.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.766 -1.432 . . . . 0.0 108.698 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.438 ' CG1' ' NH1' ' A' ' 124' ' ' ARG . 1.0 OUTLIER -82.78 -56.72 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.381 -0.824 . . . . 0.0 109.27 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.428 HG21 HG23 ' A' ' 49' ' ' ILE . 30.0 p -75.24 -24.42 57.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.365 -0.834 . . . . 0.0 109.957 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 95.6 -15.74 62.59 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.55 ' NH2' ' CE1' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -50.07 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.352 -1.087 . . . . 0.0 109.841 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.439 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 15.9 m-20 -64.65 160.87 49.5 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 108.699 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.35 -58.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.877 1.718 . . . . 0.0 110.807 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.62 -19.55 63.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.176 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -88.5 -41.63 12.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 109.828 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 23.4 m -79.59 0.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.822 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.497 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -71.0 121.74 21.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.053 -1.029 . . . . 0.0 108.699 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.49 -15.47 61.31 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -79.3 137.07 37.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.239 . . . . 0.0 109.459 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.95 103.99 6.28 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.529 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 26.1 t80 -60.17 -16.63 34.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -0.885 . . . . 0.0 111.089 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 2.4 m-85 -91.32 15.09 12.75 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.023 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -176.66 -52.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.008 -1.057 . . . . 0.0 110.419 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.15 -6.7 41.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 110.926 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.496 HG12 ' NH1' ' A' ' 52' ' ' ARG . 11.0 t -126.07 -60.43 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 O-C-N 120.636 -1.29 . . . . 0.0 109.07 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 70' ' ' THR . . . -108.87 103.96 53.4 Favored Pre-proline 0 C--N 1.293 -1.874 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.267 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.84 7.26 3.27 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.907 1.738 . . . . 0.0 111.777 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.6 p -108.58 -20.4 13.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.819 -1.176 . . . . 0.0 109.869 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' CB ' ' A' ' 67' ' ' ALA . 30.2 p -77.42 -2.63 36.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.952 . . . . 0.0 110.611 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -88.53 55.2 3.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.125 -0.985 . . . . 0.0 109.156 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -124.84 175.25 3.12 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.46 -0.775 . . . . 0.0 109.124 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.9 Cg_endo -77.56 -2.19 12.36 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 122.265 1.977 . . . . 0.0 111.288 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 59.5 mt-10 -107.96 -25.72 11.04 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.939 -1.101 . . . . 0.0 109.509 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.565 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 2.1 t80 -102.13 -70.53 0.75 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 18.1 t80 -70.59 -17.37 62.9 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.12 -61.2 6.6 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 1.2 mmtp -63.38 -15.92 58.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.999 . . . . 0.0 109.487 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.541 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 10.8 t80 -79.63 -38.17 34.42 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -8.72 58.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -95.52 -40.12 9.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.83 -41.05 89.3 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.52 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 66.4 t -60.0 -40.81 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.662 -0.905 . . . . 0.0 109.497 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.18 -5.06 58.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.284 -0.885 . . . . 0.0 110.785 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.5 p -100.19 -19.06 16.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.836 -1.165 . . . . 0.0 109.945 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.03 16.47 78.79 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -155.62 57.97 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -1.22 . . . . 0.0 109.335 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -56.51 114.17 1.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.823 . . . . 0.0 109.733 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -161.25 83.79 0.64 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.432 -0.792 . . . . 0.0 109.033 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.0 t -139.35 173.8 11.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.073 -1.017 . . . . 0.0 109.952 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -157.9 171.55 20.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.669 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 8.9 p90 178.7 161.01 0.66 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.863 -1.148 . . . . 0.0 110.506 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -88.3 110.12 20.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.45 178.56 4.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.109 -0.995 . . . . 0.0 110.073 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 84.4 m -141.85 107.99 5.22 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -86.53 121.31 28.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.176 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -154.21 48.86 0.62 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.544 ' O ' ' C ' ' A' ' 99' ' ' GLN . 7.5 p90 -78.9 148.07 32.86 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 98' ' ' TYR . 4.6 tt0 2.09 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 CA-C-O 121.851 0.834 . . . . 0.0 111.589 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 98' ' ' TYR . 6.0 ttp 178.29 -149.07 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.28 169.47 8.59 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 0.0 109.233 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.85 155.21 30.49 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 122.16 1.907 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.6 m -149.17 94.79 2.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 109.289 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.418 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 1.2 ptpp? -69.77 142.57 53.19 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.994 -1.066 . . . . 0.0 108.168 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.476 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 10.9 m -156.2 142.17 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.908 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -95.03 111.6 23.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 175.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.669 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 1.4 m -86.29 162.35 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.818 0.818 . . . . 0.0 111.893 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -160.55 102.0 1.35 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.454 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 3.2 mtm -112.66 148.08 35.4 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.56 -0.713 . . . . 0.0 109.435 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.595 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.4 tttm -138.18 -165.47 1.81 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.68 -1.263 . . . . 0.0 108.985 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 12.9 tttt -107.51 98.2 7.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.03 -1.044 . . . . 0.0 109.0 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.473 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -50.74 130.81 25.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 109.435 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.041 -1.037 . . . . 0.0 109.777 -179.803 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.496 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.037 0 CA-C-O 121.138 0.494 . . . . 0.0 110.862 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.52 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 5.4 m-85 -138.58 130.32 27.85 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.136 -0.978 . . . . 0.0 109.358 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.641 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 12.1 p-90 -125.92 138.15 53.76 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.677 -1.264 . . . . 0.0 111.883 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.454 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 61.6 t -113.74 115.87 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.071 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.641 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 15.8 m-30 -100.46 126.91 46.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.178 -0.951 . . . . 0.0 108.84 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.434 HG23 HG23 ' A' ' 105' ' ' VAL . 1.5 t -109.49 122.71 64.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.937 -1.102 . . . . 0.0 110.344 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.561 ' HE2' ' CD2' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -99.22 124.71 44.5 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.438 ' NH1' ' CG1' ' A' ' 49' ' ' ILE . 23.3 ttt180 -74.4 121.89 22.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.64 -1.224 . . . . 0.0 109.125 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.341 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.53 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 0.2 OUTLIER -80.9 -64.84 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.45 0 O-C-N 121.308 -0.87 . . . . 0.0 111.332 -177.155 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -41.78 -26.66 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.174 -0.954 . . . . 0.0 111.457 -177.369 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' ILE . 2.1 t-20 -89.67 -39.27 13.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.046 -1.034 . . . . 0.0 109.516 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -65.88 -59.63 3.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.487 ' CG ' HG21 ' A' ' 11' ' ' ILE . 11.6 mt -49.76 -23.75 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.754 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.665 0 O-C-N 120.849 -1.157 . . . . 0.0 109.31 -179.783 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.898 0.38 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.72 28.75 14.57 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.951 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.0 mt -97.02 -172.68 2.5 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.691 -1.476 . . . . 0.0 109.544 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.52 -0.36 22.19 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.717 0.77 . . . . 0.0 109.288 179.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.503 ' CZ ' HG12 ' A' ' 11' ' ' ILE . 46.0 p90 -141.72 133.53 27.24 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.158 -0.964 . . . . 0.0 109.218 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.507 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -59.1 135.95 51.48 Favored Glycine 0 C--N 1.292 -1.87 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -116.23 113.87 23.62 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.893 -1.357 . . . . 0.0 107.781 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.545 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.4 pp -118.84 160.14 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-O 121.851 0.834 . . . . 0.0 110.303 -178.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 34.2 mt-30 -126.96 168.09 15.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 83.0 mt -152.68 146.79 25.43 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.91 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' ASP . 18.4 m-20 -121.26 123.65 42.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 0.0 110.023 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 37.16 -76.9 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 0 C-N-CA 124.695 1.14 . . . . 0.0 113.647 178.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ASP . 19.7 t0 -69.33 -3.6 14.76 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.658 -0.907 . . . . 0.0 111.011 -178.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.418 ' O ' ' CD2' ' A' ' 33' ' ' LEU . . . 90.21 14.61 58.67 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 19.8 m-80 -70.03 135.59 49.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.931 -1.335 . . . . 0.0 108.425 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.413 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -64.78 140.1 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 122.032 0.92 . . . . 0.0 111.219 -178.328 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 1.8 mt -112.37 -26.06 8.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -163.06 159.4 23.22 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.863 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.545 ' CD1' HG21 ' A' ' 31' ' ' ILE . 23.4 t80 -144.75 -70.62 0.28 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.673 -1.267 . . . . 0.0 110.819 -178.05 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 7.6 p-10 107.09 178.47 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 0 C-N-CA 123.876 0.87 . . . . 0.0 109.098 -179.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.65 -26.03 15.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.99 -1.069 . . . . 0.0 112.849 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.06 -64.09 0.92 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.356 -1.465 . . . . 0.0 110.639 -178.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' OE2' HG21 ' A' ' 31' ' ' ILE . 2.0 pt-20 -58.84 -52.91 63.72 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.0 110.016 -179.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.2 -15.79 24.1 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.048 -178.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -36.14 51.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.717 -1.46 . . . . 0.0 108.746 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -85.94 -55.97 5.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.426 -0.797 . . . . 0.0 109.235 179.76 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.438 ' HB ' ' OH ' ' A' ' 98' ' ' TYR . 29.9 p -78.21 -22.27 48.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.459 -0.776 . . . . 0.0 110.438 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 94.52 -18.4 57.13 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.528 ' NH2' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -45.63 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.493 -1.004 . . . . 0.0 110.254 179.455 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.441 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 95.9 m-20 -67.71 157.83 84.98 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.2 -40.11 0.39 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.739 1.626 . . . . 0.0 110.4 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -25.77 51.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.87 . . . . 0.0 110.126 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 7.6 tp60 -83.8 -44.88 13.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.108 -0.995 . . . . 0.0 109.953 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.458 HG12 ' CD ' ' A' ' 52' ' ' ARG . 24.6 m -69.85 -7.84 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.138 -0.976 . . . . 0.0 109.814 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.413 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -68.8 121.95 19.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 121.053 -1.029 . . . . 0.0 108.349 179.831 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.48 -15.38 58.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 56' ' ' GLN . 67.6 mmtt -79.9 144.06 33.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.17 -1.194 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -81.51 115.2 20.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.293 -0.879 . . . . 0.0 108.822 179.401 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 1.7 t80 -61.08 -34.05 74.31 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.029 -1.044 . . . . 0.0 110.025 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 52.2 m-85 -97.18 13.34 29.65 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 118.472 -1.291 . . . . 0.0 111.96 -177.262 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -139.72 -53.31 0.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.646 -1.284 . . . . 0.0 111.115 -179.719 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.24 16.08 21.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.832 -1.167 . . . . 0.0 112.003 -178.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.511 ' CG1' ' NE ' ' A' ' 52' ' ' ARG . 15.5 t -125.43 -53.1 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.269 -1.519 . . . . 0.0 109.468 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -117.88 103.03 50.79 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.628 -177.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.52 1.37 8.05 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 121.822 1.681 . . . . 0.0 110.577 179.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 p -111.13 -20.69 12.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.975 -1.078 . . . . 0.0 109.802 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.476 HG22 ' CE1' ' A' ' 62' ' ' PHE . 67.2 p -82.58 1.6 37.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.981 . . . . 0.0 110.223 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -88.62 61.47 6.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.945 -1.097 . . . . 0.0 109.259 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -136.01 177.3 2.27 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.188 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 36.5 Cg_endo -79.08 1.46 9.15 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.295 1.997 . . . . 0.0 111.143 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 4.3 mm-40 -107.83 -28.1 9.85 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 120.879 -1.138 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' CE2' HG23 ' A' ' 70' ' ' THR . 1.8 t80 -102.46 -69.82 0.77 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 15.5 t80 -72.06 -16.7 62.04 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.037 -1.039 . . . . 0.0 108.206 177.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.81 -60.94 6.65 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.46 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -63.49 -16.29 60.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.956 . . . . 0.0 109.414 -179.499 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.548 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 8.8 t80 -80.75 -37.9 29.61 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -8.23 57.25 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 108.442 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.91 -40.6 9.22 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.19 -39.61 82.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 178.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.517 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 62.7 t -63.3 -37.19 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.69 -0.888 . . . . 0.0 109.583 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.87 -3.47 55.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 110.83 -179.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.3 t -106.17 -18.67 13.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.79 -1.194 . . . . 0.0 110.124 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.18 19.49 72.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -157.06 55.93 0.52 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -1.222 . . . . 0.0 109.641 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.434 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 1.7 tt -54.61 120.34 6.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.801 . . . . 0.0 110.047 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -160.47 82.49 0.68 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.403 HG22 ' CE ' ' A' ' 109' ' ' MET . 7.3 t -128.34 162.4 27.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 110.44 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.4 ' HG2' ' N ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -154.52 149.06 26.31 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.636 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 12.7 p90 -172.83 149.17 1.93 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.431 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -79.89 107.3 12.57 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.68 172.87 6.57 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.1 -1.0 . . . . 0.0 110.039 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m -143.12 109.58 5.39 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -80.71 115.83 20.42 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 -178.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -128.51 41.69 3.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -78.07 78.89 4.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.807 -0.558 . . . . 0.0 110.126 -179.721 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.568 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER 53.74 37.8 27.05 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.63 -0.668 . . . . 0.0 110.233 -179.512 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -150.08 -179.12 6.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.018 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.431 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 5.2 t -56.54 149.28 40.91 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 108.716 179.159 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.431 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 31.4 Cg_endo -72.91 86.21 1.1 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.55 1.5 . . . . 0.0 110.417 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.414 HG21 HG12 ' A' ' 105' ' ' VAL . 16.0 m -75.9 142.55 42.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.476 -0.765 . . . . 0.0 109.473 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -115.32 136.34 53.19 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.508 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 26.2 m -151.87 144.51 16.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 109.812 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -94.57 109.75 21.63 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 175.789 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.636 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -80.85 162.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 122.339 1.066 . . . . 0.0 110.963 -175.729 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -161.48 101.05 1.19 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.42 ' HB3' HG21 ' A' ' 120' ' ' VAL . 3.4 mtm -113.01 146.19 39.52 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.393 -0.817 . . . . 0.0 109.316 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.8 tttt -141.84 178.94 7.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.459 -1.401 . . . . 0.0 109.785 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.434 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -86.01 102.89 14.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.916 -1.115 . . . . 0.0 109.15 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.59 132.61 30.54 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.455 -0.778 . . . . 0.0 109.812 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.932 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 120.733 0.302 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.517 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 4.7 m-85 -143.37 116.88 9.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.712 -1.242 . . . . 0.0 110.197 -177.482 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.698 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 10.1 p-90 -113.66 142.11 46.41 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.863 -1.148 . . . . 0.0 111.665 179.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 109' ' ' MET . 63.5 t -113.53 125.94 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.698 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 20.0 m-30 -111.74 117.65 33.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.019 -1.05 . . . . 0.0 109.574 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.421 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -100.19 114.41 38.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.499 ' CD ' ' HB3' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -97.76 119.92 37.21 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.099 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HA ' HG11 ' A' ' 105' ' ' VAL . 6.8 ttt-85 -66.97 124.82 24.07 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.983 -1.087 . . . . 0.0 109.61 -178.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.005 . . . . 0.0 109.335 -179.217 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.523 ' CG2' ' CD1' ' A' ' 15' ' ' LEU . 5.1 mm -73.93 -65.58 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.548 0 O-C-N 121.424 -0.797 . . . . 0.0 109.759 -178.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 13' ' ' ASN . 15.7 pt-20 -38.84 -35.92 0.23 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.719 -0.613 . . . . 0.0 111.706 -178.18 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.43 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.1 m120 -81.6 -41.96 20.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.921 -1.112 . . . . 0.0 108.341 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.41 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.9 m -72.1 -7.18 47.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.619 -0.676 . . . . 0.0 109.49 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.523 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 39.8 mt -96.83 0.41 49.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.905 -1.122 . . . . 0.0 109.01 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 O-C-N 121.284 -0.885 . . . . 0.0 109.106 179.737 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.39 16.31 58.06 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.516 ' CD2' ' CZ ' ' A' ' 28' ' ' PHE . 4.0 mt -67.86 168.3 11.87 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.953 -1.322 . . . . 0.0 108.448 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.43 23.0 8.07 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.564 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 3.3 p90 -156.51 -171.1 3.56 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -118.17 154.74 16.43 Favored Glycine 0 C--N 1.291 -1.932 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 178.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -122.88 107.26 11.67 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.32 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.524 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.1 pp -114.93 142.21 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.303 -177.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -112.16 165.96 11.69 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.873 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 97.1 mt -152.27 154.66 36.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.866 -1.147 . . . . 0.0 109.681 -179.129 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 36' ' ' ASP . 5.5 m-20 -129.08 125.74 37.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 110.178 178.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.43 -77.93 0.0 OUTLIER Glycine 0 N--CA 1.5 2.901 0 C-N-CA 124.496 1.046 . . . . 0.0 113.818 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 34' ' ' ASP . 73.4 m-20 -72.65 -1.55 16.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.717 -0.872 . . . . 0.0 111.443 -177.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.32 18.65 52.44 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 53.1 m-80 -72.04 134.99 46.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -1.223 . . . . 0.0 107.772 179.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -64.8 138.44 23.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 O-C-N 121.28 -0.887 . . . . 0.0 111.259 -178.067 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 5.4 mt -109.0 -28.39 9.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -163.29 160.28 23.62 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.897 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.524 ' CD1' HG21 ' A' ' 31' ' ' ILE . 14.6 t80 -142.1 -71.96 0.33 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.715 -1.241 . . . . 0.0 110.774 -178.419 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.3 p-10 109.1 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.785 0 C-N-CA 123.923 0.889 . . . . 0.0 108.876 -179.166 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 45' ' ' ALA . . . -96.99 -52.5 3.84 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.215 -0.928 . . . . 0.0 113.438 -177.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 44' ' ' ALA . . . -34.69 -62.02 0.37 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.418 -0.801 . . . . 0.0 112.96 -177.181 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' OE1' ' CE1' ' A' ' 42' ' ' TYR . 1.9 pt-20 -60.13 -49.4 77.79 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.158 -0.964 . . . . 0.0 110.35 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.401 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -62.36 -13.58 44.39 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -81.53 -36.17 29.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.835 -1.391 . . . . 0.0 109.82 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -84.14 -47.32 17.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.124 -0.985 . . . . 0.0 109.45 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.408 ' HA ' ' CE ' ' A' ' 100' ' ' MET . 2.7 p -89.33 -24.9 21.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.271 -0.893 . . . . 0.0 110.203 -179.079 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 96.49 -3.47 63.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.551 ' NH2' ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -55.68 105.15 0.16 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.032 -1.276 . . . . 0.0 109.941 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.443 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -72.98 154.19 90.86 Favored Pre-proline 0 C--N 1.298 -1.653 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.801 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.02 -53.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.742 1.628 . . . . 0.0 110.528 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HG3' ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -69.75 -20.4 63.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.856 -179.843 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.404 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 1.5 tt0 -85.33 -41.72 15.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.018 -1.051 . . . . 0.0 109.837 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 26.7 m -76.48 -2.31 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.068 -1.02 . . . . 0.0 109.922 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.42 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -70.19 122.42 21.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.025 -1.047 . . . . 0.0 108.429 179.845 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.04 -13.82 62.21 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 56' ' ' GLN . 11.8 mmtp -80.12 137.54 36.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.267 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -78.05 95.93 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.142 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.551 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 14.1 t80 -55.82 -24.65 37.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 0.0 109.932 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.414 ' CE2' HD12 ' A' ' 33' ' ' LEU . 12.3 m-85 -82.09 -32.16 30.38 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.746 -177.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 48.59 1.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.055 . . . . 0.0 109.116 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 61' ' ' ASN . 4.7 t0 -163.54 -36.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.549 -0.719 . . . . 0.0 109.877 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.477 ' CG1' ' HD3' ' A' ' 52' ' ' ARG . 12.7 t -103.09 -56.8 4.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 122.78 1.276 . . . . 0.0 108.388 179.482 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.66 101.46 24.33 Favored Pre-proline 0 C--N 1.29 -1.983 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.181 -178.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -76.13 3.13 6.45 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.719 1.613 . . . . 0.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 p -106.77 -21.58 12.99 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.131 -0.981 . . . . 0.0 109.841 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.49 HG23 ' CE1' ' A' ' 75' ' ' PHE . 7.2 p -81.89 2.54 29.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 110.308 -178.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -95.94 57.1 1.77 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.954 -1.091 . . . . 0.0 108.905 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.442 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -139.5 175.55 3.17 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.412 -0.805 . . . . 0.0 109.507 -179.599 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.7 Cg_endo -77.15 77.29 3.85 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 122.505 2.137 . . . . 0.0 110.369 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 174.28 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.5 ' CD1' ' HE2' ' A' ' 109' ' ' MET . 1.4 t80 -103.3 -68.73 0.82 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.468 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 16.5 t80 -74.83 -19.22 60.27 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.42 -62.26 5.77 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -62.19 -18.28 60.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 109.541 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.468 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 10.1 t80 -76.38 -38.23 56.03 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -5.61 52.89 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 108.757 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.402 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 1.5 mm-40 -95.41 -42.02 8.69 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.41 -40.64 68.67 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 178.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.502 HG23 ' CE1' ' A' ' 118' ' ' TYR . 100.0 t -61.39 -40.27 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.746 -0.855 . . . . 0.0 109.948 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.68 -22.08 40.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.216 -0.927 . . . . 0.0 111.059 -178.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -12.08 28.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.817 -1.177 . . . . 0.0 110.526 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.85 14.58 80.69 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -150.62 100.82 2.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -1.171 . . . . 0.0 108.606 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.74 117.58 32.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 110.109 -179.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.58 75.53 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.506 -0.746 . . . . 0.0 109.118 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -116.21 131.55 56.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.028 -1.045 . . . . 0.0 110.497 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.6 ttt -118.47 126.17 51.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.536 ' CZ ' HG23 ' A' ' 107' ' ' VAL . 2.0 p90 -152.39 -172.5 4.25 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.134 -0.979 . . . . 0.0 110.056 -178.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -121.87 117.42 26.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.409 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 13.0 t80 -126.79 163.65 23.1 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 109.422 -179.134 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 95.2 m -131.77 119.99 22.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -92.01 125.0 36.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.431 -0.793 . . . . 0.0 109.035 179.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -144.41 46.77 1.4 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 14.3 p90 -77.98 141.58 38.86 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.527 ' C ' ' O ' ' A' ' 98' ' ' TYR . 15.0 pt20 3.67 64.73 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.093 0 CA-C-O 121.432 0.634 . . . . 0.0 112.161 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER 179.78 175.52 0.76 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.557 -0.714 . . . . 0.0 109.118 -177.787 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.424 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 0.6 OUTLIER -57.88 151.43 43.62 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.96 . . . . 0.0 109.032 179.348 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 32.9 Cg_endo -74.28 145.08 33.96 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 121.945 1.763 . . . . 0.0 109.972 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -142.32 111.68 6.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.106 -0.996 . . . . 0.0 110.151 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.421 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 25.3 tttm -82.28 151.67 26.67 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.479 ' O ' HG21 ' A' ' 105' ' ' VAL . 28.2 m -153.98 144.09 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 118.526 -1.269 . . . . 0.0 112.09 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -80.75 123.6 28.35 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 102.23 -3.248 . . . . 0.0 102.23 174.675 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.536 HG23 ' CZ ' ' A' ' 92' ' ' PHE . 31.4 m -118.37 152.36 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 121.058 1.754 . . . . 0.0 111.845 -176.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -143.1 104.64 4.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.218 178.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.5 ' HE2' ' CD1' ' A' ' 75' ' ' PHE . 14.2 mtp -99.79 121.18 40.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.891 -1.131 . . . . 0.0 108.913 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.573 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 2.3 tttt -125.79 -165.8 1.47 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 117.625 -1.63 . . . . 0.0 110.309 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -113.11 98.59 7.24 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.138 -0.976 . . . . 0.0 109.167 -179.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.528 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -54.56 135.18 46.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.682 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.723 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.415 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.248 0 CA-C-O 121.281 0.563 . . . . 0.0 110.795 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.502 ' CE1' HG23 ' A' ' 83' ' ' VAL . 3.6 m-85 -125.4 129.35 49.7 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.235 -0.916 . . . . 0.0 110.179 -177.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.672 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 22.7 p-90 -129.17 163.05 26.39 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.343 178.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.45 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 50.2 t -144.23 113.94 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.688 -0.632 . . . . 0.0 109.422 -178.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.672 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.4 m-30 -95.66 140.79 29.96 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.412 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.9 t -117.4 109.53 27.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 118.951 -1.099 . . . . 0.0 110.046 -179.213 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 4.7 tptp -84.53 146.24 27.67 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -96.18 129.88 43.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.702 -1.249 . . . . 0.0 110.181 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.458 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.104 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.562 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 3.7 mm -72.89 -66.86 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 O-C-N 121.488 -0.757 . . . . 0.0 110.444 -178.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -36.46 -49.68 0.74 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.961 -0.462 . . . . 0.0 112.037 -177.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.63 -44.37 82.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.788 -1.195 . . . . 0.0 108.614 179.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -71.24 -8.43 53.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 109.948 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.54 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 42.6 mt -97.79 -24.04 15.62 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.97 -1.081 . . . . 0.0 109.371 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.83 . . . . 0.0 109.576 -179.879 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 120.654 0.264 . . . . 0.0 111.112 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.32 24.35 30.75 Favored Glycine 0 N--CA 1.492 2.429 0 O-C-N 120.525 -1.359 . . . . 0.0 111.041 -178.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.496 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -78.7 -172.28 2.91 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.766 -1.432 . . . . 0.0 108.349 179.168 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.74 20.54 16.08 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.549 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -159.36 137.04 10.06 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.143 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -71.66 139.73 29.28 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.87 89.75 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.498 HG23 ' CE1' ' A' ' 42' ' ' TYR . 1.4 pp -91.98 148.97 4.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.449 -0.782 . . . . 0.0 110.654 -177.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.5 mm100 -116.86 170.51 8.56 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 73.4 mt -152.32 145.63 24.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.876 -1.14 . . . . 0.0 110.187 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' ASP . 8.8 m-20 -115.7 134.67 54.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.257 178.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -11.49 72.39 0.0 OUTLIER Glycine 0 N--CA 1.511 3.679 0 C-N-CA 124.804 1.192 . . . . 0.0 113.294 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER 161.75 -23.33 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.565 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.41 17.9 22.95 Favored Glycine 0 N--CA 1.479 1.551 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.033 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 28.7 m120 -85.25 131.78 34.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.142 -1.211 . . . . 0.0 108.769 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.505 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -65.99 138.81 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.016 -1.053 . . . . 0.0 111.404 -178.37 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.451 HD23 ' CB ' ' A' ' 34' ' ' ASP . 3.0 mt -103.74 -29.48 11.01 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -161.94 142.96 10.74 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.089 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.605 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 15.9 t80 -109.28 -77.24 0.6 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.338 -1.476 . . . . 0.0 111.504 -178.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 39.9 t-20 130.49 142.24 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.857 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -178.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -73.24 -49.09 29.75 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.581 -0.699 . . . . 0.0 111.125 -178.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.76 -55.32 3.69 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.35 -0.844 . . . . 0.0 111.619 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.498 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 14.0 pt-20 -63.75 -44.55 93.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.143 -0.973 . . . . 0.0 110.233 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -63.24 -13.2 48.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.05 -36.72 16.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.328 . . . . 0.0 109.658 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.425 HG22 ' CD ' ' A' ' 124' ' ' ARG . 47.7 mm -77.71 -29.35 16.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 O-C-N 121.043 -1.036 . . . . 0.0 110.249 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 52' ' ' ARG . 1.6 p -114.09 -24.58 8.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 109.504 -178.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 100.55 -2.04 55.89 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.498 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -71.88 85.83 0.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -1.219 . . . . 0.0 109.727 -179.74 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.44 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 38.9 m-20 -60.48 164.42 7.05 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.148 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.49 -50.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.117 1.878 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.85 -29.4 68.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.215 -0.928 . . . . 0.0 109.906 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -78.78 -43.12 26.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 0.0 109.885 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 18.5 m -76.35 -1.81 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.038 -1.038 . . . . 0.0 109.903 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.505 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -70.89 123.58 25.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.016 -1.053 . . . . 0.0 108.446 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.95 -18.2 56.49 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 -178.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -79.25 138.45 37.79 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.184 -1.186 . . . . 0.0 108.992 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.22 104.33 6.69 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.451 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 85.6 t80 -56.08 -20.62 17.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.371 -0.831 . . . . 0.0 110.224 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 7.7 m-85 -100.04 -19.69 16.41 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.083 -1.01 . . . . 0.0 110.401 -178.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.2 46.99 1.42 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.116 -0.99 . . . . 0.0 109.449 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.6 -28.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 111.024 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.498 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 5.1 t -108.48 -58.34 3.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' HA ' ' NH2' ' A' ' 52' ' ' ARG . . . -112.09 100.98 50.87 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.485 -179.184 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.74 1.05 8.5 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.056 1.837 . . . . 0.0 111.336 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.1 p -98.95 -22.88 15.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 109.418 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.439 HG23 ' CE1' ' A' ' 75' ' ' PHE . 31.1 p -76.14 -2.21 29.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.408 -0.808 . . . . 0.0 110.269 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -88.63 56.42 3.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.975 . . . . 0.0 109.255 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -129.04 177.18 2.28 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.413 -0.805 . . . . 0.0 108.941 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -78.04 2.01 8.37 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.219 1.946 . . . . 0.0 111.561 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.4 mt-10 -111.28 -29.52 7.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.86 -1.15 . . . . 0.0 109.319 179.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CE1' ' SD ' ' A' ' 109' ' ' MET . 1.8 t80 -100.29 -69.49 0.77 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.55 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 21.2 t80 -71.22 -15.57 62.46 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.22 -61.56 6.24 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 9.4 mmtt -62.8 -16.49 58.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.607 -0.937 . . . . 0.0 109.287 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.55 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 10.4 t80 -78.72 -37.89 40.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -78.52 -7.41 57.46 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -95.78 -40.76 9.19 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -69.92 -40.04 74.46 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 178.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 118' ' ' TYR . 58.2 t -64.71 -39.78 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.646 -0.914 . . . . 0.0 109.656 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.74 -8.7 55.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.334 -0.854 . . . . 0.0 110.829 -178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 t -102.19 -16.98 16.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.829 -1.169 . . . . 0.0 110.06 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.47 22.48 64.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -163.75 72.11 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -1.104 . . . . 0.0 109.316 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.416 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.3 OUTLIER -72.92 118.35 15.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 109.81 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -160.62 86.79 0.73 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.523 -0.736 . . . . 0.0 109.099 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 t -137.25 161.52 36.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.081 -1.012 . . . . 0.0 109.786 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -149.53 144.04 26.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.415 -0.803 . . . . 0.0 108.982 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.541 ' CD2' HG23 ' A' ' 107' ' ' VAL . 10.8 p90 -156.33 -173.96 4.73 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 109.839 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.26 114.19 26.36 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.59 -176.28 2.89 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.147 -0.971 . . . . 0.0 110.804 -178.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.0 m -154.38 109.77 3.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -85.71 126.6 34.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.643 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -154.3 51.06 0.65 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.738 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 9.9 p90 -77.91 136.42 38.02 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.53 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.7 pt20 5.25 62.95 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.186 0 CA-C-O 121.421 0.629 . . . . 0.0 112.264 -178.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -175.22 -154.43 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.358 -0.839 . . . . 0.0 109.252 -177.98 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.15 159.74 61.69 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.46 157.27 28.94 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.28 1.987 . . . . 0.0 110.521 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.4 m -151.13 85.92 1.35 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.782 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.404 ' C ' HG22 ' A' ' 125' ' ' VAL . 8.7 ttmt -69.83 139.18 53.1 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.45 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 14.8 m -151.77 148.24 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.897 -1.127 . . . . 0.0 111.404 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.482 ' CD ' ' N ' ' A' ' 106' ' ' LYS . 2.8 mptp? -79.36 120.16 23.4 Favored 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 103.22 -2.881 . . . . 0.0 103.22 174.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.541 HG23 ' CD2' ' A' ' 92' ' ' PHE . 34.5 m -104.19 150.91 7.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 117.863 -1.535 . . . . 0.0 110.523 -177.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -149.49 106.91 3.62 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 119' ' ' TRP . 12.8 mtm -108.85 134.55 51.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.057 -1.027 . . . . 0.0 110.369 -178.259 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.576 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.4 tttp -135.09 -169.38 2.36 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.401 -1.437 . . . . 0.0 109.989 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -104.46 100.43 10.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.126 -0.983 . . . . 0.0 108.56 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.452 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -47.02 144.53 2.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.729 . . . . 0.0 110.617 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.452 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.776 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.466 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.344 0.593 . . . . 0.0 109.889 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.501 ' CE1' HG23 ' A' ' 83' ' ' VAL . 13.8 m-85 -152.42 116.28 4.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.649 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 16.6 p-90 -122.06 149.37 43.64 Favored 'General case' 0 C--O 1.202 -1.401 0 C-N-CA 118.705 -1.198 . . . . 0.0 112.075 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.445 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 58.5 t -124.54 107.97 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.649 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 9.9 m-30 -92.03 120.58 32.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.312 -0.867 . . . . 0.0 109.199 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.1 t -102.21 117.92 48.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.839 -1.144 . . . . 0.0 110.837 -179.251 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 4.2 tptp -88.28 113.91 24.37 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.425 ' CD ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -73.94 120.62 19.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.492 -1.38 . . . . 0.0 109.016 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.458 ' CG2' ' HD2' ' A' ' 106' ' ' LYS . 3.7 t . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.319 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.513 2.708 0 CA-C-O 121.415 0.626 . . . . 0.0 111.826 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.635 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 4.9 mm -64.83 -61.96 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.597 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -37.24 -30.51 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.939 -0.476 . . . . 0.0 111.833 -178.13 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' ILE . 54.4 t-20 -84.48 -45.64 12.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.891 -1.131 . . . . 0.0 108.504 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -67.59 -10.6 53.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.591 -0.693 . . . . 0.0 109.665 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.516 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 20.6 mt -96.82 -25.71 15.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.013 -1.054 . . . . 0.0 109.327 -179.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.383 -0.823 . . . . 0.0 109.988 -179.898 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.086 0.47 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.58 22.61 39.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 55.9 mt -70.67 176.65 4.01 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.939 -1.33 . . . . 0.0 108.947 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.15 17.43 21.63 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.505 ' CE1' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -154.81 132.25 11.2 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.186 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.11 129.28 9.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.416 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -102.32 118.78 37.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.946 -1.326 . . . . 0.0 108.513 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.539 HG23 ' CD1' ' A' ' 42' ' ' TYR . 1.1 pp -111.81 148.88 14.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.163 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 8.1 mt-30 -117.99 166.06 12.97 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.465 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 18.3 mt -152.78 140.84 20.32 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.599 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' HD22 ' A' ' 40' ' ' LEU . 16.1 t0 -93.67 167.88 11.38 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.37 -22.23 1.49 Allowed Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.556 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -92.12 11.46 25.4 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.466 -1.608 . . . . 0.0 110.692 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.66 27.24 63.44 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 79.1 m-20 -97.03 127.86 43.42 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.993 -1.298 . . . . 0.0 111.639 -177.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -55.29 135.72 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.12 -0.988 . . . . 0.0 110.67 -179.83 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 34' ' ' ASP . 3.3 mt -111.4 -27.96 8.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -158.08 159.89 36.76 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.812 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.539 ' CD1' HG23 ' A' ' 31' ' ' ILE . 2.8 t80 -143.7 -64.74 0.38 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.601 -1.312 . . . . 0.0 109.246 -178.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 2.0 p-10 99.6 177.58 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 123.36 0.664 . . . . 0.0 109.641 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.25 -14.72 23.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.1 -1.0 . . . . 0.0 112.002 -177.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.22 -63.25 1.33 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.616 -1.302 . . . . 0.0 109.671 -179.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.533 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 7.3 pt-20 -61.6 -49.81 75.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.208 -0.933 . . . . 0.0 109.286 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.426 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -58.74 -14.53 22.89 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -80.55 -39.09 28.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.735 -1.45 . . . . 0.0 109.823 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.432 HG23 HG21 ' A' ' 50' ' ' THR . 0.2 OUTLIER -84.58 -43.43 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.001 -1.062 . . . . 0.0 109.032 -179.644 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.433 ' CB ' ' OH ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -89.47 -31.46 17.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.743 -0.598 . . . . 0.0 109.693 -178.68 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 100.82 -2.91 55.76 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.535 ' NE ' ' CG1' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -68.97 104.19 2.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.02 -1.283 . . . . 0.0 110.592 -179.322 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.17 166.14 43.94 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.87 -38.47 0.86 Allowed 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.948 1.765 . . . . 0.0 110.3 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -22.95 61.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.275 -0.891 . . . . 0.0 109.415 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.429 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 38.1 tt0 -83.14 -47.19 11.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.497 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.5 m -66.57 -11.37 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.599 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.403 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -68.32 121.12 16.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.082 -1.011 . . . . 0.0 108.722 -179.804 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.1 -19.0 52.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -178.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 56' ' ' GLN . 25.8 mmtt -79.87 132.66 36.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.373 -1.075 . . . . 0.0 109.215 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.59 122.71 21.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.603 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 87.2 t80 -68.69 -2.86 10.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 0.0 111.036 -179.313 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.42 ' CE2' HD12 ' A' ' 33' ' ' LEU . 44.9 m-85 -110.94 -17.2 13.36 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.614 -1.304 . . . . 0.0 111.982 -177.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.28 -38.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.767 -1.208 . . . . 0.0 110.631 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -90.58 1.88 56.34 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.083 -1.01 . . . . 0.0 110.585 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 24.2 t -127.5 -75.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -97.97 106.67 35.89 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.416 -179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 34.5 Cg_endo -75.6 0.15 9.48 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.746 1.631 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.2 p -106.08 -19.49 13.71 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.959 -1.088 . . . . 0.0 109.668 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.431 HG23 ' CE1' ' A' ' 75' ' ' PHE . 15.6 p -75.19 -2.24 26.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.177 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -90.12 51.75 2.11 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.857 -1.152 . . . . 0.0 108.869 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -121.01 177.64 1.42 Allowed Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.946 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.8 Cg_endo -78.27 -5.45 15.03 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 122.203 1.935 . . . . 0.0 111.272 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -107.98 -21.14 12.94 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.912 -1.118 . . . . 0.0 109.489 179.799 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.431 ' CE1' HG23 ' A' ' 70' ' ' THR . 1.1 t80 -104.09 -72.19 0.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.221 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 25.0 t80 -70.93 -18.16 62.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.29 -61.57 6.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 1.8 mmtt -61.53 -16.34 46.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.652 -0.91 . . . . 0.0 109.698 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.504 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 11.7 t80 -81.17 -38.2 27.5 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.53 -0.731 . . . . 0.0 109.674 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.01 -11.17 59.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.969 -1.082 . . . . 0.0 109.419 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 17.1 pt-20 -97.25 -38.98 9.47 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -66.51 -39.18 93.92 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 99.1 t -59.76 -39.71 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.636 -0.92 . . . . 0.0 110.667 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.4 -45.57 31.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.003 -1.061 . . . . 0.0 111.038 -178.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -20.84 65.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.098 -179.131 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.64 14.96 80.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -142.84 56.0 1.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.119 -1.224 . . . . 0.0 109.025 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.48 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -54.78 123.38 13.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.498 -0.751 . . . . 0.0 109.491 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.4 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 33.0 p-10 -161.94 87.78 0.66 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.032 -1.042 . . . . 0.0 109.553 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 t -138.78 164.87 28.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.983 -1.073 . . . . 0.0 110.335 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -156.9 146.64 20.74 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.553 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 9.6 p90 -162.1 -175.11 4.43 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 109.637 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.4 102.51 11.61 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -105.65 147.91 27.96 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 110.041 -178.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.6 m -115.71 109.67 18.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.487 ' CE2' HG12 ' A' ' 122' ' ' VAL . 21.3 m-30 -78.97 107.57 11.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.183 -0.948 . . . . 0.0 109.004 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.13 32.75 5.96 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.521 -0.737 . . . . 0.0 109.28 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -79.21 162.4 25.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.895 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 98' ' ' TYR . 7.7 mt-30 -4.38 66.59 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 C-N-CA 123.388 0.675 . . . . 0.0 112.642 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.593 ' N ' ' O ' ' A' ' 98' ' ' TYR . 1.6 ttp 175.67 -158.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.341 -178.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.467 ' CB ' ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -93.74 179.16 1.32 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.788 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 101' ' ' THR . 34.2 Cg_endo -78.09 107.25 2.29 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 121.873 1.715 . . . . 0.0 110.365 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.6 m -106.83 134.13 50.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.419 ' C ' HG21 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -100.78 150.4 22.83 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.548 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.486 ' HB ' HG11 ' A' ' 122' ' ' VAL . 32.6 m -154.75 144.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 118.384 -1.326 . . . . 0.0 112.006 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -81.41 98.25 8.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 175.771 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.553 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 31.4 m -90.45 150.11 3.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 118.144 -1.423 . . . . 0.0 110.734 -176.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -148.15 107.16 3.85 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 119' ' ' TRP . 26.2 mtm -102.98 118.6 37.18 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.773 -1.204 . . . . 0.0 108.952 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.575 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -140.27 145.63 37.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.227 -1.546 . . . . 0.0 110.223 -179.083 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -53.91 138.88 35.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.373 -0.829 . . . . 0.0 109.204 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.441 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -90.53 160.03 16.18 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.333 -0.854 . . . . 0.0 109.45 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.205 -0.935 . . . . 0.0 110.632 -179.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.421 ' C ' ' CG ' ' A' ' 118' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.427 0.632 . . . . 0.0 109.919 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.49 ' CE1' HG23 ' A' ' 83' ' ' VAL . 19.4 m-85 -152.08 114.41 4.51 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.638 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 19.6 p-90 -118.06 165.32 13.89 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.319 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.46 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 84.4 t -146.02 104.54 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.346 0.593 . . . . 0.0 109.488 -178.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.638 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.3 m-30 -84.45 129.14 34.89 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 96' ' ' PHE . 2.2 t -112.4 112.18 39.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.277 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 1.1 tttm -86.63 159.95 19.05 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.432 ' CD ' HG13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -107.06 120.93 43.42 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.743 -1.183 . . . . 0.0 109.869 -179.232 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.419 HG21 ' C ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.175 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.544 HG13 ' CE2' ' A' ' 121' ' ' PHE . 4.6 mm -80.26 -60.59 2.15 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 110.151 -178.494 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -46.83 -23.49 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.541 -1.349 . . . . 0.0 110.992 -178.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.19 -42.42 11.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.909 -1.119 . . . . 0.0 109.808 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -56.88 8.12 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.467 ' CD1' HG23 ' A' ' 11' ' ' ILE . 27.9 mt -38.08 -31.76 0.05 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.189 179.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.763 . . . . 0.0 110.119 -179.659 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.002 0.429 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.71 33.61 6.26 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.482 HD21 ' CE2' ' A' ' 28' ' ' PHE . 4.1 mp -121.61 149.3 43.38 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.305 -1.115 . . . . 0.0 109.052 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.58 8.0 10.77 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.625 -0.672 . . . . 0.0 110.179 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.587 ' CD2' ' HB3' ' A' ' 121' ' ' PHE . 1.5 p90 -133.51 150.82 51.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 109.646 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.34 114.3 3.85 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 178.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.423 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -91.38 97.79 11.3 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.49 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.7 pp -105.26 145.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.095 -177.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -115.36 167.29 10.99 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 62' ' ' PHE . 85.2 mt -153.39 157.24 39.68 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.087 -1.008 . . . . 0.0 109.132 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 36' ' ' ASP . 36.8 p-10 -133.89 121.44 21.74 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.606 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.46 -78.38 0.0 OUTLIER Glycine 0 N--CA 1.502 3.069 0 C-N-CA 124.457 1.027 . . . . 0.0 113.144 178.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 34' ' ' ASP . 26.2 m-20 -68.43 -6.0 22.28 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.653 -0.91 . . . . 0.0 110.415 -178.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 88.81 18.06 55.21 Favored Glycine 0 N--CA 1.479 1.552 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.1 m-80 -72.22 138.83 47.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.078 -1.248 . . . . 0.0 108.338 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.92 136.04 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 122.064 0.935 . . . . 0.0 111.496 -178.043 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -108.5 -29.11 8.96 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -163.36 163.3 25.17 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.946 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.551 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 1.8 t80 -143.83 -65.45 0.37 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.141 -1.6 . . . . 0.0 110.714 -177.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 5.4 p-10 106.84 171.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.586 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.44 -20.7 18.86 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.664 -1.272 . . . . 0.0 112.164 -177.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.16 -59.83 3.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.715 -1.241 . . . . 0.0 110.311 -179.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.551 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 11.1 pt-20 -62.55 -45.95 90.61 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.745 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA2' ' N ' ' A' ' 52' ' ' ARG . . . -59.13 -15.94 31.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.26 -34.65 25.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.805 -1.409 . . . . 0.0 109.99 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.95 -40.88 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.158 -0.964 . . . . 0.0 109.766 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.24 -0.25 26.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.55 -0.719 . . . . 0.0 110.111 -179.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.83 -2.78 72.7 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.627 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' NH1' ' HA ' ' A' ' 66' ' ' VAL . 0.9 OUTLIER -78.13 81.89 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.879 -1.365 . . . . 0.0 110.871 -179.155 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -57.8 176.7 0.23 Allowed Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.886 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 34.2 Cg_endo -76.52 -34.55 2.55 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.792 1.661 . . . . 0.0 110.341 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.2 -23.24 41.12 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -79.0 -41.42 29.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.613 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.489 HG12 ' CD2' ' A' ' 42' ' ' TYR . 26.8 m -71.47 -7.6 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 109.78 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.33 122.9 21.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.66 -23.07 35.67 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -178.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -80.53 136.16 36.23 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.409 -1.053 . . . . 0.0 109.189 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.9 126.84 31.24 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.587 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.593 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 76.3 t80 -61.66 -13.08 19.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.054 -1.029 . . . . 0.0 110.636 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.47 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 38.2 m-85 -118.95 28.94 7.98 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.945 -1.097 . . . . 0.0 110.506 -178.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.38 -50.63 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.767 -1.208 . . . . 0.0 110.826 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -111.86 7.71 20.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.856 -1.153 . . . . 0.0 110.653 -179.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 89.3 t -120.53 -41.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 120.777 -1.202 . . . . 0.0 108.342 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.19 95.35 7.47 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -72.63 -7.84 21.49 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.875 1.717 . . . . 0.0 110.427 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.1 p -94.39 -21.46 18.93 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.232 -0.918 . . . . 0.0 109.042 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.506 HG23 ' CD2' ' A' ' 75' ' ' PHE . 20.7 p -75.3 -0.63 20.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -88.97 55.33 3.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.884 -1.135 . . . . 0.0 108.887 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.457 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -130.48 177.57 2.15 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.858 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -78.08 -2.2 12.31 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.257 1.971 . . . . 0.0 111.418 -179.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 23.1 mm-40 -106.39 -25.98 11.66 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.8 -1.188 . . . . 0.0 109.298 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.506 ' CD2' HG23 ' A' ' 70' ' ' THR . 1.7 t80 -101.99 -71.26 0.72 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.026 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.573 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 10.1 t80 -70.84 -17.7 62.73 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.245 178.024 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.84 -59.8 8.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 6.7 mmtt -64.85 -14.7 60.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.469 -1.018 . . . . 0.0 109.351 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.573 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 10.5 t80 -80.82 -37.44 30.09 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.46 -8.29 58.36 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 108.707 178.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.64 -39.71 9.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA3' ' CD1' ' A' ' 88' ' ' LEU . . . -68.11 -39.83 88.48 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.497 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 98.9 t -62.89 -39.39 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.766 -0.844 . . . . 0.0 109.765 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.95 -3.94 56.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.947 . . . . 0.0 111.104 -178.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.5 t -104.43 -19.68 13.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.082 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.35 19.59 71.36 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -156.27 72.57 0.76 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.096 -1.238 . . . . 0.0 109.287 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -76.1 110.43 10.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 109.629 -179.982 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -160.26 79.83 0.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.079 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -137.62 151.39 48.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 110.262 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -133.38 146.52 51.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.572 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 18.5 p90 -153.58 -175.88 5.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.054 -1.029 . . . . 0.0 109.941 -179.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.71 115.79 30.17 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.408 ' HB2' HG12 ' A' ' 107' ' ' VAL . 0.3 OUTLIER -118.04 176.94 4.97 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.159 -0.963 . . . . 0.0 110.136 -178.417 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.1 m -144.88 109.33 4.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.488 ' CE2' HG23 ' A' ' 122' ' ' VAL . 21.3 m-30 -83.01 119.85 24.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 108.963 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -149.43 47.51 0.97 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.001 -1.062 . . . . 0.0 110.331 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 35.0 p90 -78.56 135.9 37.4 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.134 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.535 ' C ' ' O ' ' A' ' 98' ' ' TYR . 11.7 pt20 3.52 64.07 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 CA-C-O 121.524 0.678 . . . . 0.0 112.106 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.5 tmm? -172.92 175.77 3.22 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.29 162.18 1.21 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.0 109.213 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.28 152.78 30.97 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.05 1.834 . . . . 0.0 110.195 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.424 HG21 HG12 ' A' ' 105' ' ' VAL . 54.5 m -147.76 127.53 13.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 110.305 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -110.44 137.24 48.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.534 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 17.7 m -150.49 142.83 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 118.649 -1.22 . . . . 0.0 111.494 -178.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -82.92 124.21 30.14 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 174.38 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.572 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 33.1 m -108.57 152.12 10.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 120.88 -1.138 . . . . 0.0 111.744 -174.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -142.12 108.46 5.28 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.434 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 119' ' ' TRP . 20.5 mtm -106.42 123.93 48.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.767 -1.208 . . . . 0.0 109.457 -179.139 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.575 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -126.24 -165.89 1.5 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.098 -179.677 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.61 94.21 4.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.546 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.509 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -53.21 127.59 24.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.073 -1.017 . . . . 0.0 109.481 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.066 -1.021 . . . . 0.0 109.638 179.86 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.49 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 121.209 0.528 . . . . 0.0 111.367 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.497 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 8.9 m-85 -123.07 131.1 53.56 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.214 -0.929 . . . . 0.0 110.061 -177.4 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.729 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 15.0 p-90 -130.59 166.47 20.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.836 -1.165 . . . . 0.0 111.853 179.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.444 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 90.7 t -147.71 115.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.767 -0.583 . . . . 0.0 110.441 -178.188 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.729 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.6 m-30 -94.41 104.69 16.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.064 -1.022 . . . . 0.0 108.836 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.488 HG23 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -88.04 105.9 15.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.505 ' HE3' ' CD1' ' A' ' 28' ' ' PHE . 9.5 mttp -89.67 112.42 23.66 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.42 ' HA ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -56.98 133.19 54.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.966 -1.084 . . . . 0.0 109.43 -179.0 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.366 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.542 HG13 ' CE2' ' A' ' 121' ' ' PHE . 5.2 mm -79.16 -56.92 6.0 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.371 -178.083 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -43.04 -26.88 0.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.304 -0.873 . . . . 0.0 111.431 -178.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -91.09 -38.14 12.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.925 -1.109 . . . . 0.0 108.428 178.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.7 m -71.26 -13.01 61.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.627 -0.671 . . . . 0.0 110.02 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 11' ' ' ILE . 11.1 mt -97.62 -21.62 16.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.059 -1.025 . . . . 0.0 109.385 -179.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.873 -179.765 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.0 t0 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 120.797 0.332 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.64 35.02 4.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.469 HD21 ' CZ ' ' A' ' 28' ' ' PHE . 28.7 mt -107.09 129.43 54.82 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.593 -0.945 . . . . 0.0 109.662 -179.639 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.27 -7.24 28.96 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.591 0.71 . . . . 0.0 109.353 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.519 ' CZ ' HD13 ' A' ' 11' ' ' ILE . 6.8 p90 -129.99 135.96 48.89 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.098 -1.001 . . . . 0.0 109.016 179.762 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.44 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -70.03 132.33 23.7 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.327 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -105.1 103.03 12.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.327 . . . . 0.0 108.239 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.515 HG23 ' CD1' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -102.82 143.47 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.558 -178.875 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 22.0 mt-30 -116.92 164.23 15.0 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.243 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.52 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 95.9 mt -148.38 148.49 30.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.017 -1.052 . . . . 0.0 109.945 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 36' ' ' ASP . 4.0 p30 -123.92 122.18 37.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 110.419 179.223 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.32 -79.32 0.0 OUTLIER Glycine 0 N--CA 1.497 2.741 0 C-N-CA 124.028 0.823 . . . . 0.0 113.392 178.276 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -70.14 -5.48 27.44 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.769 -0.841 . . . . 0.0 111.078 -177.762 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 94.02 17.84 39.21 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.768 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 38.5 m-80 -75.41 134.39 40.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.962 -1.316 . . . . 0.0 108.983 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -59.59 138.5 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.938 0.875 . . . . 0.0 111.442 -178.504 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 7.9 mt -104.63 -33.66 8.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.12 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -157.48 -176.55 6.02 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.284 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.515 ' CD1' HG23 ' A' ' 31' ' ' ILE . 6.9 t80 -160.54 -67.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.906 -1.121 . . . . 0.0 110.826 -178.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.6 p-10 103.01 176.27 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.633 0 C-N-CA 123.779 0.832 . . . . 0.0 109.206 -179.379 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.81 -16.51 21.83 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.821 -1.174 . . . . 0.0 112.806 -177.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.24 -62.08 2.1 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.376 -1.453 . . . . 0.0 110.138 -179.131 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.501 ' CD ' ' CE1' ' A' ' 42' ' ' TYR . 3.3 pt-20 -59.61 -53.11 61.8 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.694 0.759 . . . . 0.0 109.569 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.411 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -60.52 -13.78 32.21 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.23 -37.29 33.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.753 -1.439 . . . . 0.0 110.188 -179.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.44 HG23 HG21 ' A' ' 50' ' ' THR . 1.1 mp -84.78 -43.02 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.858 -1.152 . . . . 0.0 109.236 -179.575 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.44 HG21 HG23 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -92.44 -27.8 17.24 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.248 -0.908 . . . . 0.0 109.974 -178.896 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 100.69 -3.32 56.06 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.333 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.485 ' HD3' ' OH ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -60.88 100.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.97 -1.312 . . . . 0.0 109.749 -179.749 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -73.44 162.35 74.75 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 0.0 108.728 179.371 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.47 -51.22 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.187 1.925 . . . . 0.0 110.756 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -26.04 68.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 110.181 -179.5 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -85.12 -42.81 14.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.955 -1.091 . . . . 0.0 109.905 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 27.1 m -74.81 -3.2 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.157 -0.964 . . . . 0.0 109.675 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -71.49 123.13 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 O-C-N 120.947 -1.096 . . . . 0.0 108.058 179.448 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.33 -14.76 60.16 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -178.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -79.9 136.97 36.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -1.205 . . . . 0.0 109.2 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.62 110.01 12.07 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.237 -0.915 . . . . 0.0 108.616 179.392 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.47 ' CZ ' HG22 ' A' ' 70' ' ' THR . 46.5 t80 -64.37 -12.63 44.51 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.52 ' CE2' ' CD1' ' A' ' 33' ' ' LEU . 31.9 m-85 -94.92 13.08 26.02 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.054 -1.029 . . . . 0.0 110.745 -177.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -179.39 -50.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.057 -1.027 . . . . 0.0 109.944 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -14.16 62.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 110.424 -179.038 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.476 HG12 ' CZ ' ' A' ' 52' ' ' ARG . 3.8 t -125.89 -57.64 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 120.679 -1.263 . . . . 0.0 108.736 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.15 98.01 50.54 Favored Pre-proline 0 C--N 1.295 -1.8 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.614 -178.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -74.75 -1.53 11.26 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 121.858 1.705 . . . . 0.0 110.985 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 p -91.65 -26.51 18.63 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.988 -1.07 . . . . 0.0 109.335 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.474 HG23 ' CE1' ' A' ' 75' ' ' PHE . 35.2 p -75.0 -1.62 23.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.509 -0.744 . . . . 0.0 110.067 -179.163 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -89.69 52.13 2.25 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.93 -1.106 . . . . 0.0 108.597 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.463 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -124.87 178.5 1.42 Allowed Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.87 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.4 Cg_endo -78.42 -1.09 11.29 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 122.257 1.971 . . . . 0.0 111.476 -179.655 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 13.5 mt-10 -108.46 -29.02 9.02 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.877 -1.139 . . . . 0.0 109.301 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.2 t80 -100.06 -70.54 0.73 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.067 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.528 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 20.4 t80 -72.4 -15.31 61.84 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.813 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.77 -62.47 5.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 178.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 1.2 mmtt -62.87 -16.09 57.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.562 -0.964 . . . . 0.0 109.251 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 6.9 t80 -77.36 -40.45 43.89 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.12 -7.87 56.51 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.969 . . . . 0.0 109.045 179.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -95.98 -41.17 8.9 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.408 ' HA3' ' CD1' ' A' ' 88' ' ' LEU . . . -69.41 -40.01 80.02 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 178.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.493 HG23 ' CE1' ' A' ' 118' ' ' TYR . 94.0 t -60.01 -38.71 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.693 -0.887 . . . . 0.0 109.535 179.388 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.35 -6.87 58.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.336 -0.853 . . . . 0.0 110.704 -178.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.06 -18.89 16.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.848 -1.157 . . . . 0.0 109.938 -179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.58 16.07 78.44 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.44 66.89 0.39 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.055 -1.262 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.408 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -58.74 124.53 20.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.853 . . . . 0.0 109.985 -179.948 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -161.27 83.78 0.64 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.943 -1.098 . . . . 0.0 109.072 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.411 ' CG2' ' SD ' ' A' ' 109' ' ' MET . 8.8 t -144.73 172.48 12.95 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.055 -1.058 . . . . 0.0 110.754 -179.405 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.8 ptm -157.21 171.07 21.09 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.65 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 7.7 p90 177.82 154.15 0.31 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.03 -1.044 . . . . 0.0 109.94 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.3 128.38 33.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 109.07 179.378 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.08 170.04 16.24 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.13 -0.981 . . . . 0.0 110.061 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.0 m -140.88 118.01 11.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -90.24 121.27 32.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.107 -0.995 . . . . 0.0 109.76 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -142.77 46.27 1.58 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.477 -0.764 . . . . 0.0 109.029 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.499 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -85.36 66.52 9.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.466 -0.771 . . . . 0.0 110.855 -179.302 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.475 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 77.49 30.2 0.51 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.871 0.843 . . . . 0.0 109.318 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -141.34 171.08 14.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.055 -1.028 . . . . 0.0 108.5 179.452 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.44 170.6 0.2 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.015 -1.053 . . . . 0.0 109.235 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.66 92.03 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.007 1.805 . . . . 0.0 110.261 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.7 m -88.18 131.24 34.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 109.895 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -110.24 142.63 41.57 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.872 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.497 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 12.6 m -157.73 144.57 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.412 -179.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.11 119.12 36.19 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 174.782 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.65 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -87.78 162.47 2.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 120.665 -1.272 . . . . 0.0 111.376 -174.844 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -160.46 103.71 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.164 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.461 ' HB3' ' O ' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -112.41 150.59 30.91 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.72 -0.613 . . . . 0.0 110.009 -176.932 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 119' ' ' TRP . 0.1 OUTLIER -150.38 164.94 34.56 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.512 -1.367 . . . . 0.0 109.084 179.041 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 118.87 13.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.879 -1.138 . . . . 0.0 109.739 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.428 ' CB ' ' HB2' ' A' ' 117' ' ' SER . . . -65.65 133.21 50.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 109.424 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.448 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.052 -1.03 . . . . 0.0 110.817 -179.274 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.447 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.354 0.597 . . . . 0.0 109.687 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.493 ' CE1' HG23 ' A' ' 83' ' ' VAL . 3.3 m-85 -150.22 109.31 3.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -0.837 . . . . 0.0 108.834 -179.398 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.641 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 9.7 p-90 -115.37 144.46 43.76 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.583 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.454 HG12 ' CE1' ' A' ' 75' ' ' PHE . 18.8 t -120.01 109.0 24.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.641 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 12.6 m-30 -89.61 134.4 34.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 108.701 179.358 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.459 HG13 ' NH2' ' A' ' 124' ' ' ARG . 1.3 t -111.26 117.96 56.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 121.322 -0.861 . . . . 0.0 108.841 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.531 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 4.9 tptp -90.39 110.15 21.25 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.459 ' NH2' HG13 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -64.74 117.62 7.76 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.205 -179.515 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.317 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.24 -174.28 2.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -173.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.54 138.57 17.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.02 140.39 30.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.728 . . . . 0.0 109.742 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.548 ' CZ ' ' O ' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -61.35 -64.24 1.01 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' O ' ' CD1' ' A' ' 11' ' ' ILE . . . -53.19 -27.71 32.26 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 177.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.559 ' CB ' ' CZ ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER 43.31 -168.73 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.293 1.044 . . . . 0.0 112.236 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 10' ' ' ASP . 11.6 tt0 -55.43 84.58 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.701 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 9' ' ' GLU . 2.2 m-20 22.43 74.66 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.852 0 CA-C-O 121.237 0.541 . . . . 0.0 110.471 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.538 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 1.5 mm -54.21 -67.29 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.275 -0.89 . . . . 0.0 110.493 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 11' ' ' ILE . 19.8 pt-20 -35.06 -47.59 0.38 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -63.69 -47.84 79.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.858 -1.151 . . . . 0.0 109.106 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.459 HG22 ' CD1' ' A' ' 23' ' ' LEU . 13.1 m -69.57 -13.33 62.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.537 -0.727 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.503 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 18.4 mt -95.43 -16.35 22.34 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.772 -1.205 . . . . 0.0 109.502 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.71 -27.21 22.54 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.144 -0.973 . . . . 0.0 108.535 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.0 -1.07 8.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.454 ' CE ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER 63.52 159.45 0.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.847 -1.158 . . . . 0.0 109.674 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' HB2' HG22 ' A' ' 14' ' ' THR . 0.3 OUTLIER -116.61 -154.21 0.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.241 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.27 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.067 -1.021 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.9 47.7 3.2 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.449 ' OE1' ' CA ' ' A' ' 22' ' ' GLN . 0.7 OUTLIER 55.17 26.58 8.51 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.433 -1.039 . . . . 0.0 108.402 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.459 ' CD1' HG22 ' A' ' 14' ' ' THR . 0.7 OUTLIER 43.16 43.99 4.15 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.409 0.623 . . . . 0.0 110.008 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -88.31 4.48 45.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.09 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.37 27.85 18.5 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.0 mt -84.62 -172.01 3.94 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.951 -1.323 . . . . 0.0 109.028 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.35 -5.93 14.08 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.559 ' CZ ' ' CB ' ' A' ' 8' ' ' SER . 10.3 p90 -124.12 117.22 24.16 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.27 -0.894 . . . . 0.0 108.648 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -57.06 141.03 43.97 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.419 ' HB2' HD23 ' A' ' 15' ' ' LEU . . . -117.17 114.82 24.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.851 -1.382 . . . . 0.0 108.047 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.513 HG22 ' CE1' ' A' ' 42' ' ' TYR . 1.6 pp -118.22 150.12 20.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.896 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 2.1 mt-30 -117.47 172.51 7.29 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.475 HD11 ' CE2' ' A' ' 63' ' ' PHE . 27.9 mt -152.8 149.49 28.38 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.12 -0.988 . . . . 0.0 109.247 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 36' ' ' ASP . 3.2 m-20 -119.25 133.16 55.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.141 -0.974 . . . . 0.0 109.417 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -7.58 70.0 0.0 OUTLIER Glycine 0 N--CA 1.514 3.873 0 C-N-CA 124.618 1.104 . . . . 0.0 113.273 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER 161.25 -23.84 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.68 23.05 10.38 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 3.3 m120 -86.08 123.51 31.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.417 -1.049 . . . . 0.0 108.792 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.429 HG21 ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -56.32 136.19 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 121.913 0.863 . . . . 0.0 110.884 -178.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 5.6 mt -108.13 -30.83 8.2 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.405 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -159.96 160.6 33.61 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.518 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 2.7 t80 -140.08 -42.47 0.42 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.362 -1.461 . . . . 0.0 109.975 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER 87.54 171.58 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.35 -15.38 21.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.004 -1.06 . . . . 0.0 112.637 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.77 -67.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.386 -1.446 . . . . 0.0 110.135 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 12.0 pt-20 -63.71 -44.95 92.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 109.021 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -61.11 -13.85 36.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 14.8 t70 -87.24 -32.72 19.59 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.627 -1.513 . . . . 0.0 108.819 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -48.47 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.883 0.849 . . . . 0.0 108.731 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.533 ' CG2' " H3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -95.09 -29.54 14.53 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.371 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 100.94 -2.69 55.54 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.589 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' CZ ' ' CG1' ' A' ' 66' ' ' VAL . 1.1 mtt85 -47.52 -58.72 3.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.968 -1.313 . . . . 0.0 111.027 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.2 OUTLIER 68.46 152.45 0.13 Allowed Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.85 -50.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.78 1.654 . . . . 0.0 111.312 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.4 pttt -57.99 -18.47 24.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 110.344 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -96.1 -43.19 7.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 0.0 109.411 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 52' ' ' ARG . 32.3 m -82.51 3.96 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.646 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.429 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -70.04 123.6 24.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.8 -22.86 36.95 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -79.99 130.59 35.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -1.054 . . . . 0.0 109.25 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.23 125.55 26.74 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.135 -0.978 . . . . 0.0 108.568 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.511 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 90.2 t80 -71.88 -6.22 40.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.896 -1.128 . . . . 0.0 110.263 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.475 ' CE2' HD11 ' A' ' 33' ' ' LEU . 30.0 m-85 -96.4 -41.69 8.49 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.935 -1.103 . . . . 0.0 111.545 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.79 -15.39 4.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.705 -1.247 . . . . 0.0 111.522 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.73 -2.35 30.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.679 -1.263 . . . . 0.0 110.858 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.527 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 45.7 t -131.79 -47.89 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 120.732 -1.23 . . . . 0.0 108.504 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB3' ' C2 ' ' A' ' 126' ' ' HC4 . . . -128.96 106.7 18.15 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.61 2.36 6.49 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.765 1.643 . . . . 0.0 111.662 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.9 p -99.31 -27.69 13.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.889 -1.132 . . . . 0.0 109.234 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.479 HG23 ' CE1' ' A' ' 75' ' ' PHE . 18.0 p -72.13 -5.95 39.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -0.823 . . . . 0.0 109.965 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -89.66 51.72 2.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.018 -1.051 . . . . 0.0 108.742 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.466 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -128.43 178.82 1.47 Allowed Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.07 -0.15 10.42 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 122.095 1.864 . . . . 0.0 111.447 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 5.4 mm-40 -107.85 -28.19 9.78 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.813 -1.18 . . . . 0.0 109.453 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.539 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.9 t80 -102.67 -69.15 0.8 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.487 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 26.0 t80 -69.67 -17.92 63.52 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.18 -62.12 5.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -63.42 -15.58 58.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.519 -0.989 . . . . 0.0 109.593 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 10.9 t80 -81.66 -34.79 30.57 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -8.13 58.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 2.0 mt-10 -96.13 -42.47 8.2 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -66.83 -41.22 93.66 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.484 HG23 ' CE1' ' A' ' 118' ' ' TYR . 93.1 t -62.02 -40.09 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.654 -0.909 . . . . 0.0 109.508 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.64 -4.92 58.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -0.871 . . . . 0.0 110.43 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.5 t -96.09 -25.58 15.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.92 -1.112 . . . . 0.0 109.87 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.92 28.89 27.5 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -179.02 59.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.303 -1.116 . . . . 0.0 109.058 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.42 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 6.2 tt -49.0 121.54 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.332 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.401 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 62.1 t-20 -160.69 88.27 0.77 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.394 -0.816 . . . . 0.0 109.032 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 t -149.15 167.17 26.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 110.189 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -150.04 167.1 27.74 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.635 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 10.2 p90 -175.93 153.84 1.4 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.971 -1.081 . . . . 0.0 110.042 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -82.21 116.49 21.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.944 . . . . 0.0 109.167 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.96 175.24 6.0 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.0 m -140.81 111.99 7.24 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.544 ' CD2' " C6'" ' A' ' 126' ' ' HC4 . 18.6 m-30 -82.81 93.64 7.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.135 -0.978 . . . . 0.0 109.2 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -115.35 32.78 5.84 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.329 -0.857 . . . . 0.0 108.963 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.59 155.5 29.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.506 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.8 mt-30 -0.85 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.466 0.706 . . . . 0.0 112.394 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.2 ttp 178.12 -154.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.465 -0.772 . . . . 0.0 109.653 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.448 ' CB ' ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -92.12 176.89 2.39 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 108.975 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 101' ' ' THR . 36.4 Cg_endo -78.31 106.51 2.15 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.919 1.746 . . . . 0.0 110.2 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 96' ' ' PHE . 4.2 m -101.07 143.83 30.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -117.0 139.24 50.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.461 ' HB ' HG11 ' A' ' 122' ' ' VAL . 7.7 m -156.25 141.62 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.771 -1.205 . . . . 0.0 111.261 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.548 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -91.05 114.78 27.39 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.635 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -87.07 161.24 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.807 -1.183 . . . . 0.0 110.543 -176.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.503 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 15.0 t-160 -159.74 99.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.45 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -110.64 148.41 32.29 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.452 -0.78 . . . . 0.0 109.628 -177.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.611 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 2.3 ttmt -145.51 -179.01 6.38 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.483 -1.287 . . . . 0.0 109.423 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -87.42 109.23 19.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.933 -1.105 . . . . 0.0 109.185 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.421 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -53.67 140.52 28.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.566 -0.709 . . . . 0.0 109.868 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.1 mt -86.93 9.56 18.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.6 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 m -59.68 -19.24 48.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.797 -1.19 . . . . 0.0 109.411 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 116' ' ' ASP . . . 148.75 -29.54 1.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 0.4 OUTLIER 167.96 68.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.5 -1.0 . . . . 0.0 108.668 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.466 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -124.2 -168.07 1.74 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.0 110.434 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.484 ' CE1' HG23 ' A' ' 83' ' ' VAL . 24.7 m-85 -151.03 112.32 4.37 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.637 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 15.8 p-90 -114.68 140.99 48.4 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 118.578 -1.249 . . . . 0.0 112.373 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.45 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 21.2 t -116.42 108.62 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.637 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 15.3 m-30 -92.49 121.33 33.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.396 -0.815 . . . . 0.0 109.65 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.476 HG23 ' CZ ' ' A' ' 96' ' ' PHE . 1.4 t -103.95 117.35 49.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.403 -0.81 . . . . 0.0 108.927 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.495 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 2.7 tttm -98.97 110.57 23.16 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HA ' HG11 ' A' ' 105' ' ' VAL . 33.4 ttt180 -56.27 135.85 53.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.847 -1.158 . . . . 0.0 109.528 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.346 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.544 " C6'" ' CD2' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.291 0.567 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -72.14 132.74 44.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.709 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.92 -177.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.086 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.435 HG13 ' CE ' ' A' ' 123' ' ' LYS . 94.2 t -66.14 159.85 4.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.235 -0.915 . . . . 0.0 109.121 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.12 150.88 48.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.546 -0.722 . . . . 0.0 109.781 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -65.19 -63.59 1.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 11' ' ' ILE . . . -53.1 -28.34 33.25 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 106.723 -2.551 . . . . 0.0 106.723 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER 42.37 -166.73 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 122.275 1.035 . . . . 0.0 112.518 176.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 10' ' ' ASP . 4.4 tt0 -58.25 83.25 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.575 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 9' ' ' GLU . 58.5 m-20 28.63 77.95 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.56 0 CA-C-N 118.37 0.532 . . . . 0.0 110.178 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.537 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 3.0 mm -56.98 -67.45 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.645 0 O-C-N 121.051 -1.031 . . . . 0.0 109.594 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.6 pt-20 -37.31 -29.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.836 -0.54 . . . . 0.0 112.205 -178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' ILE . 5.0 m-20 -76.97 -53.13 8.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.805 -1.184 . . . . 0.0 109.906 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -62.85 -40.05 96.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.192 -0.943 . . . . 0.0 109.357 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.503 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 28.9 mt -61.03 -24.0 65.84 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.31 -23.33 22.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.416 -0.802 . . . . 0.0 108.961 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.37 69.2 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -66.75 152.84 44.72 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.135 -0.978 . . . . 0.0 109.308 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 18' ' ' MET . 0.8 OUTLIER 162.6 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.715 -0.615 . . . . 0.0 110.502 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.3 68.75 9.89 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.14 22.14 66.71 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.457 ' CB ' ' HG2' ' A' ' 18' ' ' MET . 4.2 mt-30 49.82 56.84 7.26 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.698 -0.884 . . . . 0.0 109.697 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.441 HD12 ' CD2' ' A' ' 15' ' ' LEU . 1.2 pt? 40.96 42.66 1.57 Allowed 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.1 0.476 . . . . 0.0 111.201 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.4 p30 -78.13 -7.67 57.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 109.964 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.38 31.8 8.09 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.493 HD21 ' CE1' ' A' ' 28' ' ' PHE . 15.5 mt -103.31 121.85 43.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.461 -1.023 . . . . 0.0 108.765 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.01 -12.09 7.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 109.965 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.554 ' CZ ' ' CB ' ' A' ' 8' ' ' SER . 10.3 p90 -121.49 116.96 25.67 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.003 -1.06 . . . . 0.0 109.289 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -55.14 148.64 24.18 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HB2' ' CD2' ' A' ' 15' ' ' LEU . . . -128.61 100.88 5.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.833 -1.392 . . . . 0.0 108.222 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.564 HG21 ' CD1' ' A' ' 42' ' ' TYR . 2.2 pp -105.6 159.99 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.718 0.77 . . . . 0.0 110.953 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.45 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 33.7 mt-30 -122.08 174.86 6.67 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 22.7 mt -154.37 151.93 29.61 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.951 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.11 165.63 11.05 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.65 -20.65 0.14 Allowed Glycine 0 N--CA 1.499 2.884 0 O-C-N 121.792 -0.568 . . . . 0.0 113.507 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.58 20.02 19.32 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 119.814 1.807 . . . . 0.0 111.227 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.38 25.25 68.65 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.2 m-20 -90.0 125.22 35.31 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.051 -1.264 . . . . 0.0 110.767 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -59.5 139.2 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.869 -1.145 . . . . 0.0 110.706 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 9.2 mt -108.43 -31.31 7.87 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -157.69 -176.49 5.97 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.564 ' CD1' HG21 ' A' ' 31' ' ' ILE . 20.5 t80 -160.01 -72.81 0.07 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.706 -1.247 . . . . 0.0 111.488 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.9 p-10 105.28 179.34 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 C-N-CA 123.719 0.808 . . . . 0.0 109.096 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.26 -26.64 15.33 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.948 -1.095 . . . . 0.0 113.287 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -50.12 -64.63 0.75 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.332 -1.48 . . . . 0.0 110.796 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 1.9 pt-20 -57.86 -53.08 62.24 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 121.671 -0.643 . . . . 0.0 110.03 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.38 -15.42 23.84 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.376 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.83 -34.23 39.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.894 -1.356 . . . . 0.0 108.892 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.414 HG23 ' CG2' ' A' ' 50' ' ' THR . 0.3 OUTLIER -84.86 -54.41 8.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.423 -0.798 . . . . 0.0 109.673 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.424 ' CB ' ' OH ' ' A' ' 98' ' ' TYR . 1.2 p -84.99 -23.11 28.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 110.34 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.36 -13.65 61.37 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' NH2' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -47.89 107.23 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.184 -1.186 . . . . 0.0 110.817 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.455 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -74.39 153.71 87.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.2 -48.81 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.579 1.519 . . . . 0.0 111.13 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -18.26 60.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.077 -1.014 . . . . 0.0 110.281 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -88.61 -41.99 12.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.947 -1.096 . . . . 0.0 109.66 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 26.4 m -73.22 -5.55 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.236 -0.915 . . . . 0.0 109.741 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.458 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -70.27 122.82 22.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.1 -1.0 . . . . 0.0 108.357 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.31 -16.58 59.47 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -79.25 139.91 37.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -1.204 . . . . 0.0 109.336 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -79.45 97.39 6.38 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.539 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 1.3 t80 -46.94 -39.9 13.24 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.508 -0.745 . . . . 0.0 110.63 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CG ' ' CD1' ' A' ' 76' ' ' TYR . 23.9 m-85 -86.1 -23.94 26.47 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.708 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.06 43.98 2.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 109.586 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 61' ' ' ASN . 19.5 t0 -174.46 -20.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.766 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 62' ' ' PHE . 5.4 t -117.96 -59.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 120.354 -1.466 . . . . 0.0 109.706 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -106.08 103.25 43.98 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.592 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.54 1.52 7.9 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.875 1.717 . . . . 0.0 110.97 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 p -106.39 -20.89 13.24 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.886 -1.134 . . . . 0.0 109.976 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 35.2 p -81.74 2.32 30.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.089 -1.007 . . . . 0.0 110.049 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -95.14 55.01 1.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.899 -1.125 . . . . 0.0 108.877 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -135.9 176.31 2.93 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.524 -0.735 . . . . 0.0 109.348 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.5 Cg_endo -77.04 77.86 3.63 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 122.413 2.075 . . . . 0.0 110.492 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.06 -36.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.5 t80 -105.63 -66.02 1.02 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.566 ' CD1' ' CG ' ' A' ' 63' ' ' PHE . 5.7 t80 -77.6 -20.51 53.84 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.032 -1.042 . . . . 0.0 108.265 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.39 -60.41 7.12 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -66.23 -15.43 63.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.752 -0.852 . . . . 0.0 110.085 -179.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.494 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 5.1 t80 -84.15 -36.41 22.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -10.92 59.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 1.1 pp20? -97.5 -36.01 10.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.87 -39.63 85.33 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 98.5 t -58.31 -56.2 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.89 -0.77 . . . . 0.0 109.408 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.39 -20.14 65.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 0.0 109.948 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 -29.25 51.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.9 24.1 42.96 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -172.68 57.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.42 -1.047 . . . . 0.0 108.991 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -49.4 124.7 9.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.804 . . . . 0.0 109.993 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -161.02 88.92 0.77 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.459 -0.776 . . . . 0.0 109.043 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 t -156.75 168.21 28.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.018 -1.051 . . . . 0.0 110.728 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -145.57 170.21 16.87 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.607 ' CD1' HG23 ' A' ' 107' ' ' VAL . 13.3 p90 -176.31 158.37 1.87 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.893 -1.129 . . . . 0.0 110.307 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -92.08 116.25 28.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.979 -1.076 . . . . 0.0 109.289 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.38 -175.23 3.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.03 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.6 m -150.06 114.15 5.12 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.471 ' CE2' HG23 ' A' ' 122' ' ' VAL . 16.7 m-30 -85.83 118.88 25.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.148 -0.97 . . . . 0.0 110.394 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 97' ' ' ASP . 0.9 OUTLIER -131.4 35.93 3.82 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.711 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -80.5 80.72 6.9 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 123.032 1.396 . . . . 0.0 111.201 -178.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 98' ' ' TYR . 2.4 mm100 72.9 27.19 2.17 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 119.925 -1.734 . . . . 0.0 109.051 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -150.11 168.84 22.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.234 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -52.25 171.09 0.21 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 109.37 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.1 Cg_endo -76.59 79.45 3.03 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.927 1.751 . . . . 0.0 110.421 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.1 m -72.96 133.52 44.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 109.573 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.477 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.1 OUTLIER -106.45 148.55 28.02 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.251 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 104' ' ' LYS . 19.7 m -158.31 140.41 5.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 118.578 -1.249 . . . . 0.0 110.536 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -87.43 130.92 34.5 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 103.309 -2.848 . . . . 0.0 103.309 175.066 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.607 HG23 ' CD1' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -104.67 160.06 5.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 120.543 -1.348 . . . . 0.0 110.513 -176.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.414 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 7.8 t-160 -156.84 101.6 1.97 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.453 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -117.02 149.07 40.89 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.23 -0.919 . . . . 0.0 110.136 -177.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.7 tttt -145.28 -176.94 5.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.674 -1.266 . . . . 0.0 109.297 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -89.67 109.13 20.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.805 -1.184 . . . . 0.0 108.893 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.443 ' HB2' ' CB ' ' A' ' 117' ' ' SER . . . -60.61 137.46 58.17 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.358 -0.839 . . . . 0.0 109.868 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.5 mp -71.06 -9.04 57.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.943 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.48 -28.09 4.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.021 -1.049 . . . . 0.0 109.983 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.2 89.6 0.17 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 51.8 31.22 7.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -1.164 . . . . 0.0 109.794 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.464 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.6 OUTLIER -86.63 -175.71 5.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.822 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.471 ' CE1' HG23 ' A' ' 83' ' ' VAL . 28.1 m-85 -154.07 109.33 3.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.303 -0.873 . . . . 0.0 108.883 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.667 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 11.0 p-90 -108.62 143.43 37.69 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 118.646 -1.221 . . . . 0.0 111.914 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.453 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 21.3 t -122.83 104.77 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.489 0.661 . . . . 0.0 109.248 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.667 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 8.7 m-30 -85.8 114.22 22.57 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.471 HG23 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -98.17 115.8 39.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.149 -1.021 . . . . 0.0 109.224 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.494 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 4.1 tttm -98.64 125.86 44.05 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -63.66 144.45 57.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.576 -1.328 . . . . 0.0 109.212 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 104' ' ' LYS . 22.6 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.594 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.497 " H3'" ' HG3' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.7 mtt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.54 123.9 28.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.61 149.75 33.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.919 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 5' ' ' ALA . 0.8 OUTLIER -75.65 -153.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.484 ' N ' ' CG1' ' A' ' 4' ' ' VAL . . . -59.48 -137.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.517 ' CD1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -89.22 46.27 1.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.178 -1.576 . . . . 0.0 107.144 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.508 ' HA3' ' HE3' ' A' ' 123' ' ' LYS . . . 98.96 25.74 9.44 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 -178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.52 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -112.06 107.42 16.36 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.226 -1.161 . . . . 0.0 111.566 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.42 -71.48 0.08 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.167 0.984 . . . . 0.0 109.992 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 14' ' ' THR . 6.6 m-20 -163.22 88.75 0.6 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.58 HG23 ' CZ ' ' A' ' 121' ' ' PHE . 3.1 mm -80.54 -63.78 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.69 0 O-C-N 121.465 -0.772 . . . . 0.0 111.294 -176.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -44.2 -27.08 0.37 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.949 . . . . 0.0 110.962 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -90.0 -38.48 13.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.988 . . . . 0.0 108.359 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.405 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.3 m -75.39 -6.78 51.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.515 -0.74 . . . . 0.0 109.269 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.505 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 38.4 mt -98.82 -27.5 13.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.193 -0.942 . . . . 0.0 109.07 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.29 -26.48 18.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.589 -0.694 . . . . 0.0 109.837 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -104.04 28.04 7.11 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 108.947 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.413 ' CE ' HD21 ' A' ' 23' ' ' LEU . 8.3 tmm? -125.68 142.79 51.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -91.91 -46.53 7.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.293 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -178.82 -36.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.912 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.68 68.71 0.4 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -151.25 -50.3 0.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.424 -1.045 . . . . 0.0 108.976 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' A' ' 43' ' ' ASN . 1.9 pt? -79.6 -1.48 38.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 110.322 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -72.05 -6.89 45.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.853 -1.154 . . . . 0.0 110.306 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.41 33.97 6.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.48 147.8 33.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.236 -1.155 . . . . 0.0 109.293 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -93.23 22.35 5.21 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.797 0.808 . . . . 0.0 109.312 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.549 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -155.69 115.8 3.72 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -51.04 126.95 27.88 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -106.71 82.58 1.73 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.49 HG23 ' CD1' ' A' ' 42' ' ' TYR . 1.6 pp -91.77 153.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.374 -0.829 . . . . 0.0 110.817 -177.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.482 ' HG3' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -127.19 166.36 17.86 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.451 ' CD2' ' HB2' ' A' ' 62' ' ' PHE . 84.3 mt -147.63 163.32 36.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.664 -1.273 . . . . 0.0 109.885 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 36' ' ' ASP . 17.6 p-10 -134.07 122.3 22.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.104 -0.998 . . . . 0.0 110.725 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.08 -78.75 0.0 OUTLIER Glycine 0 N--CA 1.5 2.966 0 C-N-CA 124.424 1.011 . . . . 0.0 113.3 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 34' ' ' ASP . 27.8 t70 -70.84 -2.35 14.66 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.763 -0.845 . . . . 0.0 110.796 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 88.95 13.53 62.19 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.6 m-20 -66.99 148.09 52.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.903 -1.351 . . . . 0.0 108.02 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.482 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 2.4 tp -70.36 137.75 23.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.133 0.968 . . . . 0.0 112.648 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CD1' ' HB2' ' A' ' 32' ' ' GLN . 3.3 mt -107.59 -31.39 8.13 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 175.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 6.4 tp-100 -164.25 166.71 20.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.727 -0.608 . . . . 0.0 109.634 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.558 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 1.4 t80 -147.12 -69.41 0.24 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.166 -0.959 . . . . 0.0 110.289 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.2 p-10 102.88 152.3 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.26 -14.82 59.68 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.102 -0.999 . . . . 0.0 112.405 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.79 -62.09 2.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.623 -1.298 . . . . 0.0 109.565 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.558 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 14.0 pt-20 -64.81 -42.81 94.71 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.139 -0.976 . . . . 0.0 108.887 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.449 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -59.26 -16.6 35.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -86.18 -30.64 22.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.77 -1.429 . . . . 0.0 109.465 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.75 -42.05 24.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.523 HG23 " C3'" ' A' ' 126' ' ' HC4 . 0.6 OUTLIER -109.18 1.7 20.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.437 -0.789 . . . . 0.0 109.81 -179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 81.84 -2.4 83.5 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.897 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CD ' HG12 ' A' ' 66' ' ' VAL . 1.3 mtm-85 -79.33 81.42 5.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.797 -1.414 . . . . 0.0 111.327 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.455 ' CB ' ' CD ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -64.46 -179.65 0.31 Allowed Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 53' ' ' ASP . 34.2 Cg_endo -77.65 -35.63 1.46 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.681 1.587 . . . . 0.0 110.487 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -73.09 -24.57 60.66 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.193 -0.942 . . . . 0.0 109.634 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -84.68 -43.46 14.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.461 HG12 ' CE2' ' A' ' 42' ' ' TYR . 35.9 m -71.6 -6.55 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.607 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.482 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -71.06 119.84 18.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 O-C-N 121.114 -0.991 . . . . 0.0 108.354 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.17 -19.85 52.16 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -78.79 143.41 36.1 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.41 -1.053 . . . . 0.0 108.911 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.59 123.95 34.12 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.561 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 65.3 t80 -56.44 -15.61 4.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.024 -1.047 . . . . 0.0 110.8 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -122.06 36.83 4.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.932 -1.105 . . . . 0.0 109.539 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.86 -52.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 110.32 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.24 10.04 8.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.977 -1.077 . . . . 0.0 110.778 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.561 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 41.1 t -115.82 -33.95 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.867 -1.146 . . . . 0.0 108.533 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB2' HG22 ' A' ' 70' ' ' THR . . . -152.42 91.23 3.61 Favored Pre-proline 0 C--N 1.291 -1.964 0 O-C-N 121.41 -0.806 . . . . 0.0 109.146 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -73.64 -11.54 24.21 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.96 1.773 . . . . 0.0 110.123 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.9 p -86.41 -27.84 23.93 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.308 -0.87 . . . . 0.0 108.985 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.495 HG23 ' CE1' ' A' ' 75' ' ' PHE . 18.4 p -72.04 -4.96 31.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.619 -0.676 . . . . 0.0 110.161 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.22 74.84 9.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.075 -1.016 . . . . 0.0 108.651 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.31 172.37 5.55 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.346 -0.846 . . . . 0.0 109.228 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.54 77.13 3.97 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 122.579 2.186 . . . . 0.0 110.42 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.1 tt0 173.13 -37.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.575 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.9 t80 -105.98 -65.76 1.04 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.562 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 10.4 t80 -77.33 -17.84 57.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' O ' ' CG ' ' A' ' 81' ' ' GLU . . . -62.5 -59.4 9.4 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 10.7 mmtt -62.12 -19.36 62.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.689 -0.889 . . . . 0.0 109.399 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.562 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 11.4 t80 -76.11 -40.41 52.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.275 -0.89 . . . . 0.0 108.729 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -6.6 55.45 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.211 -0.93 . . . . 0.0 108.887 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 77' ' ' GLY . 1.5 mm-40 -95.44 -39.6 9.91 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.16 58.1 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.507 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 48.5 t -59.01 -37.6 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.776 -0.838 . . . . 0.0 109.58 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 -4.25 48.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 111.067 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -101.89 -16.91 16.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.845 -1.159 . . . . 0.0 110.025 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.15 17.35 74.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.03 85.97 0.53 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -1.202 . . . . 0.0 108.663 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.432 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -81.23 119.0 23.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.413 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 2.9 p30 -160.5 89.01 0.81 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.439 HG22 ' CE ' ' A' ' 109' ' ' MET . 1.6 t -138.77 171.51 14.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.075 -1.015 . . . . 0.0 110.569 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.452 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -158.3 148.27 19.9 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.639 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 12.6 p90 -168.96 153.25 5.57 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.7 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.4 115.32 23.07 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.82 -176.56 2.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.129 -0.982 . . . . 0.0 110.113 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.7 m -151.23 110.8 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.5 ' CD1' ' H2 ' ' A' ' 126' ' ' HC4 . 18.5 m-30 -83.52 110.62 18.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -133.32 42.43 3.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.829 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 21.4 p90 -77.33 137.07 38.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER 4.5 64.36 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 CA-C-O 121.447 0.642 . . . . 0.0 111.893 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.7 OUTLIER -175.84 -176.2 0.82 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.117 -0.989 . . . . 0.0 109.749 -177.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.426 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.2 t -64.14 150.95 91.35 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 108.86 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 31.5 Cg_endo -73.76 130.52 14.75 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 121.846 1.697 . . . . 0.0 110.682 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.3 m -123.46 142.84 50.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.495 -0.753 . . . . 0.0 109.222 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.411 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -118.06 139.77 50.73 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.468 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 11.0 m -154.36 144.71 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.962 -1.086 . . . . 0.0 110.399 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.466 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -94.2 116.02 28.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.639 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -89.24 164.24 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 122.307 1.051 . . . . 0.0 111.232 -175.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.465 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 21.2 t-160 -160.57 102.65 1.36 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.456 ' HB3' ' O ' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -114.35 151.12 33.51 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.393 -0.817 . . . . 0.0 110.203 -177.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.584 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 3.3 tttt -147.66 176.24 10.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.552 -1.343 . . . . 0.0 109.114 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.432 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 4.4 ttpt -85.02 107.39 17.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.923 -1.111 . . . . 0.0 109.45 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' A' ' 117' ' ' SER . . . -56.69 152.16 12.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.415 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.41 5.13 46.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.112 -0.992 . . . . 0.0 110.197 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.5 t -62.37 -44.1 97.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.888 -1.133 . . . . 0.0 109.571 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.42 91.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 52.32 36.74 20.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -1.103 . . . . 0.0 109.696 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 112' ' ' ALA . 1.6 t -94.55 174.41 7.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.578 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.507 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 8.9 m-85 -147.21 106.75 3.92 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.657 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 9.9 p-90 -103.23 139.38 38.77 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.783 -1.167 . . . . 0.0 112.557 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.49 HG12 ' CE1' ' A' ' 75' ' ' PHE . 30.1 t -116.61 110.46 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.657 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.6 m-30 -92.69 118.53 31.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.313 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -101.3 122.77 53.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.955 -1.091 . . . . 0.0 109.355 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -99.13 123.11 43.18 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.45 ' HA ' HG11 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -75.05 118.45 18.01 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.931 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.468 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.412 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.523 " C3'" HG23 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 mtt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.79 86.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.368 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 178.55 -35.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.641 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 10' ' ' ASP . 7.2 p -154.7 120.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.142 -0.974 . . . . 0.0 109.734 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.441 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . 52.84 -175.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.845 . . . . 0.0 110.101 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.549 ' CG ' ' CD ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -36.29 -49.15 0.68 Allowed 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 122.566 1.174 . . . . 0.0 109.231 178.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.26 41.18 0.05 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 106.245 -2.742 . . . . 0.0 106.245 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.572 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 2.0 m -74.11 165.07 25.79 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.698 0.761 . . . . 0.0 111.463 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -88.01 58.47 4.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.619 -0.675 . . . . 0.0 109.257 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.403 ' HA ' HG22 ' A' ' 4' ' ' VAL . 20.7 t0 55.84 63.78 1.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.854 -1.154 . . . . 0.0 108.256 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 8' ' ' SER . 14.2 mm -61.9 -57.11 13.56 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.226 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.9 mt-10 -35.87 -43.21 0.3 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.875 -0.516 . . . . 0.0 111.709 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -76.3 -42.42 45.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.009 -1.057 . . . . 0.0 108.986 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.459 HG23 ' CD2' ' A' ' 23' ' ' LEU . 7.2 m -66.53 -14.04 61.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.665 -0.647 . . . . 0.0 110.233 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.506 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 9.6 mt -97.34 -23.13 16.26 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.918 -1.114 . . . . 0.0 109.051 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.97 -12.82 34.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.34 -0.85 . . . . 0.0 109.609 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.39 -63.4 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.038 -1.039 . . . . 0.0 109.466 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.443 ' CG ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 mtt 64.74 147.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.726 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 18' ' ' MET . 0.4 OUTLIER 166.71 -41.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.362 -0.836 . . . . 0.0 109.575 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -87.99 61.24 6.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.235 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.97 78.39 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.443 ' HG3' ' CG ' ' A' ' 18' ' ' MET . 5.5 tt0 58.11 25.62 12.65 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.24 -1.153 . . . . 0.0 109.232 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.459 ' CD2' HG23 ' A' ' 14' ' ' THR . 0.6 OUTLIER 50.99 38.39 20.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.284 -0.885 . . . . 0.0 110.157 179.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.27 -9.44 53.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.128 -0.982 . . . . 0.0 109.767 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.75 21.18 42.78 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.458 HD21 ' CE1' ' A' ' 28' ' ' PHE . 14.6 mt -68.41 152.29 45.63 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.972 -1.311 . . . . 0.0 108.759 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.56 9.03 17.12 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 1.2 p90 -153.5 117.29 4.74 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' HA3' ' HG2' ' A' ' 46' ' ' GLU . . . -53.97 161.61 3.8 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.382 -0.913 . . . . 0.0 110.859 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.425 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -136.88 116.0 12.48 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.5 HG23 ' CE1' ' A' ' 42' ' ' TYR . 1.5 pp -118.9 157.7 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.212 -0.93 . . . . 0.0 109.733 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.44 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 12.3 mt-30 -123.04 168.08 12.81 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 15.9 mt -151.69 150.38 30.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.007 . . . . 0.0 110.001 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.402 ' HB2' HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -104.85 168.79 8.83 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -46.5 -29.44 3.95 Favored Glycine 0 N--CA 1.504 3.174 0 CA-C-N 118.621 0.646 . . . . 0.0 112.959 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.16 9.98 13.51 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.485 -1.597 . . . . 0.0 110.581 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 26.22 67.18 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 13.6 m120 -93.25 134.14 35.76 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.227 -1.16 . . . . 0.0 111.229 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.61 138.25 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 111.058 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.44 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 5.7 mt -109.68 -29.23 8.44 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -161.66 159.32 27.32 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.575 ' CE2' ' OE2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -138.02 -50.63 0.59 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.38 -1.45 . . . . 0.0 109.311 -178.361 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 0.5 OUTLIER 87.57 171.25 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.03 -15.36 22.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.015 -1.053 . . . . 0.0 112.822 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.17 -64.74 0.83 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.429 -1.419 . . . . 0.0 109.488 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.575 ' OE2' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -59.72 -51.74 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 109.3 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' N ' ' OE2' ' A' ' 46' ' ' GLU . . . -56.96 -15.92 15.66 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.6 -40.73 48.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.821 -1.399 . . . . 0.0 108.181 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -73.33 -59.29 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.428 -0.795 . . . . 0.0 108.89 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.529 HG22 ' HD3' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -78.15 -8.55 58.41 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.347 -0.846 . . . . 0.0 110.319 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 82.77 -3.47 83.21 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.401 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' CD ' " H3'" ' A' ' 126' ' ' HC4 . 0.0 OUTLIER -60.91 165.73 3.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.743 -1.445 . . . . 0.0 110.078 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.406 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 7.1 m-20 -133.05 168.11 19.58 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 53' ' ' ASP . 34.4 Cg_endo -77.27 -38.38 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.475 1.45 . . . . 0.0 110.074 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -79.04 -24.56 43.52 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.312 -0.867 . . . . 0.0 109.487 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -45.3 18.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 42' ' ' TYR . 20.4 m -69.28 -9.66 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.198 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.98 120.72 16.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.96 -24.31 32.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -78.9 130.38 35.57 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' ND2' ' ND2' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -79.19 132.58 36.57 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.567 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.554 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 64.9 t80 -60.32 -14.37 18.01 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.068 -1.02 . . . . 0.0 110.118 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 99.5 m-85 -124.31 33.39 5.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.019 -1.051 . . . . 0.0 110.378 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -154.57 -40.7 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.882 -1.136 . . . . 0.0 110.377 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.53 7.86 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.007 -1.058 . . . . 0.0 110.881 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 94.3 t -114.11 -33.85 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 120.673 -1.267 . . . . 0.0 108.448 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' CB ' ' C2 ' ' A' ' 126' ' ' HC4 . . . -155.06 100.62 2.31 Favored Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.544 -0.722 . . . . 0.0 109.182 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.97 -1.23 10.94 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.913 1.742 . . . . 0.0 110.876 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.5 p -97.37 -25.32 15.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.133 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.468 HG22 ' CE2' ' A' ' 62' ' ' PHE . 67.7 p -66.98 -10.68 52.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.638 -0.663 . . . . 0.0 110.187 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.28 64.62 8.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 109.626 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.416 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -147.44 172.53 5.09 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.181 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -76.66 78.4 3.35 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 122.514 2.142 . . . . 0.0 110.314 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.8 tt0 169.36 -36.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.478 ' CD1' ' HE2' ' A' ' 109' ' ' MET . 1.3 t80 -104.21 -68.06 0.87 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.509 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 14.4 t80 -75.53 -20.69 58.53 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.69 -59.08 9.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 8.5 mmtt -66.45 -14.17 61.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.523 -0.986 . . . . 0.0 109.915 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.509 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 15.7 t80 -83.33 -35.02 25.51 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.371 -0.83 . . . . 0.0 109.048 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -11.95 59.88 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.157 -0.964 . . . . 0.0 109.246 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 23.5 pt-20 -97.84 -42.2 7.68 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.437 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -61.61 -38.49 95.94 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.705 -2.158 . . . . 0.0 107.705 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 98.0 t -65.07 -40.15 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.795 -0.827 . . . . 0.0 110.042 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.61 0.36 57.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.0 111.135 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 t -109.74 -19.64 13.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.879 -1.138 . . . . 0.0 109.998 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.21 14.59 81.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -144.31 59.07 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -1.203 . . . . 0.0 109.275 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.413 ' CB ' ' HB2' ' A' ' 111' ' ' LYS . 0.2 OUTLIER -68.25 113.48 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.656 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -161.04 79.44 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.386 -0.822 . . . . 0.0 108.908 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.2 t -120.92 167.8 12.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.031 -1.043 . . . . 0.0 110.181 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 4.0 ttt -154.88 154.33 32.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.78 . . . . 0.0 109.222 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 15.4 p90 -176.85 178.04 1.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -0.95 . . . . 0.0 109.869 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.91 100.23 10.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.047 -1.033 . . . . 0.0 108.299 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.6 151.72 21.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 110.06 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -119.01 111.09 17.88 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.476 ' CZ ' ' CG2' ' A' ' 122' ' ' VAL . 19.1 m-30 -79.28 115.78 19.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.402 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -137.51 46.3 2.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -85.32 43.95 1.06 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.623 -0.673 . . . . 0.0 111.688 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER 100.9 27.82 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.698 0 CA-C-O 121.603 0.716 . . . . 0.0 109.271 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -139.28 175.15 9.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.407 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 19.5 p -54.52 161.27 2.18 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.024 -1.048 . . . . 0.0 109.287 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.4 Cg_endo -75.94 96.66 1.07 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.776 1.65 . . . . 0.0 110.049 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.42 125.09 50.32 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.377 -0.827 . . . . 0.0 109.8 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.45 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -88.7 159.92 17.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 175.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.484 ' HA ' HG21 ' A' ' 125' ' ' VAL . 35.6 m -156.17 142.49 10.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.599 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -79.13 103.5 9.12 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 175.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.549 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 33.7 m -94.8 151.88 3.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.806 -1.184 . . . . 0.0 110.24 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.484 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 3.5 t-160 -153.96 103.3 2.56 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.478 ' HE2' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -104.75 131.82 51.74 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.079 -1.013 . . . . 0.0 109.297 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.56 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 3.9 tttt -130.34 -174.69 3.41 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.209 -1.396 . . . . 0.0 109.894 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 10.7 tttt -99.79 102.64 14.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.102 -0.999 . . . . 0.0 108.713 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.487 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -56.03 142.36 36.48 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.349 -0.844 . . . . 0.0 110.056 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.59 0.52 52.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.88 . . . . 0.0 109.985 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 p -59.03 -20.69 55.5 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.859 -1.15 . . . . 0.0 109.503 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.98 53.36 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 56.67 62.12 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -1.161 . . . . 0.0 109.253 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.7 OUTLIER -111.51 -161.79 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.354 -0.841 . . . . 0.0 110.104 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.485 ' CE1' HG23 ' A' ' 83' ' ' VAL . 14.9 m-85 -151.91 111.35 3.94 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.666 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 20.1 p-90 -113.01 149.79 32.84 Favored 'General case' 0 C--O 1.202 -1.405 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.531 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.468 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 46.6 t -128.24 106.25 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.726 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.666 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 7.5 m-30 -91.72 128.31 37.51 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.476 ' CG2' ' CZ ' ' A' ' 96' ' ' PHE . 1.7 t -105.96 129.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.625 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.599 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -101.34 153.43 19.66 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -101.51 127.87 48.0 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.277 -1.369 . . . . 0.0 109.068 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.484 HG21 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.437 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.539 " H3'" ' CD ' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.6 179.77 5.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.487 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.424 ' O ' HG11 ' A' ' 4' ' ' VAL . 4.3 t-160 62.57 29.96 17.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.853 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' A' ' 5' ' ' ALA . 0.3 OUTLIER 43.17 -161.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.574 0.702 . . . . 0.0 110.342 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' N ' ' CG1' ' A' ' 4' ' ' VAL . . . -63.38 -144.42 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.567 ' CE1' ' HD3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -86.92 46.02 1.33 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.063 -1.023 . . . . 0.0 109.02 178.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.39 16.93 11.22 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.647 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 97.8 p -78.75 165.33 23.72 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.263 -1.139 . . . . 0.0 109.266 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.73 74.9 0.9 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.147 -0.971 . . . . 0.0 110.061 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.0 t0 50.05 84.86 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.647 ' CD1' ' HB2' ' A' ' 8' ' ' SER . 4.4 mm -90.82 -59.45 2.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.302 -0.874 . . . . 0.0 110.553 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -22.92 0.77 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.578 -1.327 . . . . 0.0 110.558 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -94.29 -36.81 11.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 109.399 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.432 HG22 ' CB ' ' A' ' 18' ' ' MET . 1.1 m -69.51 -59.8 2.74 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' CD1' HG23 ' A' ' 11' ' ' ILE . 18.1 mt -40.76 -34.61 0.4 Allowed 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.434 0.635 . . . . 0.0 109.793 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.52 -56.01 7.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.485 -0.759 . . . . 0.0 109.865 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -138.55 85.94 2.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.811 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.482 ' HG2' ' N ' ' A' ' 19' ' ' ASP . 1.3 pmm? -108.82 -170.95 1.75 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 109.169 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.482 ' N ' ' HG2' ' A' ' 18' ' ' MET . 1.3 m-20 -87.41 27.28 1.1 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.941 -1.099 . . . . 0.0 111.192 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 61.34 97.65 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.143 -0.973 . . . . 0.0 109.304 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.19 13.21 20.08 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.42 ' HB2' ' CG ' ' A' ' 18' ' ' MET . 1.7 mt-30 -101.62 -29.52 11.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.14 -1.212 . . . . 0.0 109.345 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.434 HD21 ' CE ' ' A' ' 18' ' ' MET . 0.9 OUTLIER -73.4 -19.47 60.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.903 . . . . 0.0 109.593 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -102.98 0.22 31.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 110.048 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.09 29.23 12.97 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 120.824 -1.172 . . . . 0.0 110.282 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mt -105.35 -177.01 3.24 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.051 -1.264 . . . . 0.0 109.025 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.44 4.5 48.41 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.499 ' HB3' ' HD3' ' A' ' 123' ' ' LYS . 8.1 p90 -135.96 129.24 31.85 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -63.41 122.49 26.99 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -100.88 96.3 7.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.074 -1.25 . . . . 0.0 107.752 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.507 HG23 ' CD1' ' A' ' 42' ' ' TYR . 1.3 pp -98.24 148.82 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 110.787 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -113.56 167.32 10.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD12 ' CE2' ' A' ' 63' ' ' PHE . 55.4 mt -155.46 139.89 16.79 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.165 -0.959 . . . . 0.0 108.91 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 36' ' ' ASP . 8.1 t0 -120.52 131.71 54.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.919 -1.113 . . . . 0.0 110.433 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 35.87 -77.04 0.0 OUTLIER Glycine 0 N--CA 1.501 2.978 0 C-N-CA 124.71 1.148 . . . . 0.0 113.403 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -73.37 2.56 7.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.659 -0.907 . . . . 0.0 111.109 -178.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 82.4 17.34 69.09 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -72.58 136.34 45.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.087 -1.243 . . . . 0.0 108.693 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.453 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -64.44 135.59 27.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.224 -0.922 . . . . 0.0 111.094 -178.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' CD2' ' HB2' ' A' ' 34' ' ' ASP . 1.5 mt -105.56 -29.39 10.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.445 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -163.51 164.09 24.47 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.632 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 7.4 t80 -133.36 -75.95 0.48 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 119.955 -1.716 . . . . 0.0 110.599 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.632 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 8.0 t-20 134.25 150.04 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.691 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -77.47 -55.88 5.01 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.335 -0.853 . . . . 0.0 109.834 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -34.0 -57.58 0.46 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' CD ' ' CE2' ' A' ' 42' ' ' TYR . 15.5 pt-20 -64.22 -46.73 82.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.948 -1.095 . . . . 0.0 109.676 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . -62.63 -12.2 39.51 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.08 -32.87 17.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.631 -1.511 . . . . 0.0 110.355 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.65 -35.08 11.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.179 -0.951 . . . . 0.0 108.899 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.532 HG23 " C3'" ' A' ' 126' ' ' HC4 . 0.2 OUTLIER -107.3 -21.46 12.94 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.029 -179.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 97.93 -3.33 60.47 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.546 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.584 ' CD ' " C3'" ' A' ' 126' ' ' HC4 . 1.8 mtt85 -68.09 95.23 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.86 -1.376 . . . . 0.0 110.666 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.415 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -72.52 162.29 74.79 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.98 -29.53 5.16 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.959 1.773 . . . . 0.0 110.569 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.79 -33.97 34.43 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.269 -0.894 . . . . 0.0 109.899 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -41.73 49.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.717 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 34.1 m -74.26 -4.48 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 109.914 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.21 123.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.82 -19.37 52.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -82.66 133.69 35.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -1.139 . . . . 0.0 109.102 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.469 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -75.0 119.78 19.65 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.204 -0.935 . . . . 0.0 108.501 179.2 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.477 ' CE2' HG22 ' A' ' 70' ' ' THR . 90.9 t80 -66.32 -8.89 28.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.895 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.413 ' CE2' HD12 ' A' ' 33' ' ' LEU . 34.3 m-85 -96.93 -60.19 1.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.202 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -112.96 20.89 15.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.902 -1.124 . . . . 0.0 110.851 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.469 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.4 OUTLIER -137.01 -14.91 1.54 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.872 -1.142 . . . . 0.0 111.44 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.538 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 31.5 t -122.43 -47.99 2.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 120.55 -1.344 . . . . 0.0 108.559 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB3' ' C2 ' ' A' ' 126' ' ' HC4 . . . -122.65 109.96 32.19 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -75.17 0.79 8.55 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.912 1.742 . . . . 0.0 111.505 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.2 p -98.68 -24.84 14.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.87 -1.144 . . . . 0.0 109.658 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.477 HG22 ' CE2' ' A' ' 62' ' ' PHE . 61.2 p -73.67 -4.04 31.9 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.332 -0.855 . . . . 0.0 109.863 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -88.44 50.82 2.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.014 -1.054 . . . . 0.0 109.148 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.41 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -127.1 174.84 3.82 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 34.8 Cg_endo -76.77 -1.33 11.45 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 122.101 1.867 . . . . 0.0 111.387 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 14.9 mp0 -105.34 -28.42 10.9 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.916 -1.115 . . . . 0.0 109.357 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.521 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.7 t80 -100.57 -71.99 0.69 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.44 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 11.4 t80 -72.96 -16.11 61.54 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 120.947 -1.096 . . . . 0.0 108.234 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.65 -62.6 4.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.481 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 2.2 mmtp -64.06 -14.89 57.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.672 -0.899 . . . . 0.0 109.551 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 118' ' ' TYR . 3.3 t80 -80.53 -41.18 24.66 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -9.35 58.51 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 108.689 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 85' ' ' SER . 2.1 mm-40 -95.9 -40.17 9.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.7 95.02 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.522 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 61.8 t -62.96 -40.61 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.943 -0.74 . . . . 0.0 109.975 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.37 1.4 54.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.256 -0.902 . . . . 0.0 111.218 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 81' ' ' GLU . 97.5 p -104.69 -24.13 12.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.863 -1.148 . . . . 0.0 110.142 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.03 21.17 47.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -160.16 57.08 0.35 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -1.189 . . . . 0.0 109.333 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 1.5 tt -66.29 102.39 0.85 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.422 -0.798 . . . . 0.0 109.447 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -161.6 82.95 0.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -139.79 174.58 10.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.904 -1.123 . . . . 0.0 110.233 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.75 168.77 22.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.636 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 8.8 p90 -174.47 154.29 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.079 -1.013 . . . . 0.0 109.929 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -80.47 117.16 20.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.41 -0.806 . . . . 0.0 108.943 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.03 169.3 11.8 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.249 -0.907 . . . . 0.0 109.435 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.406 HG22 ' CD ' ' A' ' 104' ' ' LYS . 0.7 OUTLIER -140.19 111.31 7.04 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.376 -0.828 . . . . 0.0 109.313 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.527 ' CE2' " C6'" ' A' ' 126' ' ' HC4 . 20.6 m-30 -79.64 85.04 5.4 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.455 -0.778 . . . . 0.0 109.12 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.99 29.47 5.43 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.548 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -77.59 153.39 33.32 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 98' ' ' TYR . 10.0 mt-30 -2.0 67.35 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 123.365 0.666 . . . . 0.0 112.457 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.9 -157.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.0 109.845 -178.236 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -91.22 174.17 4.7 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 0.0 108.882 179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.3 Cg_endo -76.71 87.79 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.949 1.766 . . . . 0.0 110.509 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 m -87.52 106.9 18.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.443 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.406 ' CD ' HG22 ' A' ' 95' ' ' THR . 0.0 OUTLIER -85.42 139.33 31.61 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.51 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 13.7 m -149.94 146.14 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.131 -0.981 . . . . 0.0 110.115 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.22 115.79 29.09 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 175.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.636 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -85.97 159.96 3.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 120.82 -1.175 . . . . 0.0 110.925 -175.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.443 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 6.3 t-160 -157.15 98.42 1.73 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -109.09 149.38 29.4 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.395 -0.816 . . . . 0.0 109.748 -177.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.633 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -141.07 -175.04 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.374 -1.33 . . . . 0.0 109.695 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.448 ' CD ' ' HA2' ' A' ' 115' ' ' GLY . 5.0 ttpm? -89.63 101.79 14.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 109.258 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.471 ' HB2' ' CB ' ' A' ' 117' ' ' SER . . . -56.85 156.93 6.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.615 -0.678 . . . . 0.0 110.871 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 0.4 OUTLIER 62.23 15.29 7.41 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.52 23.12 5.66 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.132 -0.98 . . . . 0.0 109.252 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.448 ' HA2' ' CD ' ' A' ' 111' ' ' LYS . . . 140.66 75.56 0.04 OUTLIER Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.003 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 113' ' ' LEU . 0.4 OUTLIER 174.66 -60.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -1.129 . . . . 0.0 109.714 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.471 ' CB ' ' HB2' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -108.57 -168.56 1.37 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.996 -1.065 . . . . 0.0 109.929 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.522 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 1.7 m-85 -149.74 127.54 11.76 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.653 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 10.2 p-90 -123.8 148.24 46.86 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.968 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 11.7 t -123.0 109.49 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.314 0.578 . . . . 0.0 109.827 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.653 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 9.2 m-30 -88.24 126.37 35.12 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.457 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.2 t -103.88 114.71 44.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HD3' ' CE1' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -89.52 111.79 22.8 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.429 ' HA ' HG11 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -66.95 109.03 2.79 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.948 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.161 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.584 " C3'" ' CD ' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.5 mtt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.1 145.29 40.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.283 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.61 -173.06 1.13 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.286 -0.884 . . . . 0.0 109.789 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.431 HG13 ' CB ' ' A' ' 8' ' ' SER . 5.0 t -91.26 107.38 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.446 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . 41.11 -158.28 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.592 0.711 . . . . 0.0 111.195 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -49.85 -55.15 15.36 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.09 31.08 0.28 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -59.1 156.7 11.54 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.595 -0.944 . . . . 0.0 111.251 -178.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.38 60.52 1.93 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.431 ' HA ' HG12 ' A' ' 4' ' ' VAL . 7.6 m-20 54.74 80.8 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.525 -1.359 . . . . 0.0 107.714 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.53 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 4.9 mm -83.6 -56.77 5.23 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 110.732 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -40.35 -29.23 0.08 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.773 . . . . 0.0 111.559 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 11' ' ' ILE . 4.8 m120 -89.37 -40.83 12.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.966 -1.083 . . . . 0.0 108.258 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.433 HG22 ' CD1' ' A' ' 23' ' ' LEU . 4.1 m -69.2 -10.18 56.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.719 -0.613 . . . . 0.0 109.794 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 11' ' ' ILE . 15.4 mt -97.48 -24.54 15.54 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.019 -1.05 . . . . 0.0 109.172 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.56 -15.98 26.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.423 -0.798 . . . . 0.0 109.627 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -128.88 56.54 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.021 -1.049 . . . . 0.0 109.881 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.439 ' CE ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -56.94 150.11 17.38 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.239 -0.913 . . . . 0.0 108.884 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.29 -45.43 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.228 -0.92 . . . . 0.0 110.227 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.78 64.94 7.49 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.84 17.29 67.19 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.435 ' HG2' ' CG ' ' A' ' 18' ' ' MET . 42.1 mt-30 50.51 28.95 3.66 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.495 -1.003 . . . . 0.0 109.448 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.433 ' CD1' HG22 ' A' ' 14' ' ' THR . 1.2 mp 50.93 62.81 2.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.461 -0.774 . . . . 0.0 109.825 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.83 -3.33 57.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.861 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.96 30.09 9.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.8 mt -80.17 128.3 33.36 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.51 -0.994 . . . . 0.0 109.207 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.17 -13.78 8.42 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.599 0.714 . . . . 0.0 109.227 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.533 ' CZ ' ' HB3' ' A' ' 8' ' ' SER . 14.6 p90 -129.16 150.7 50.44 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.068 -1.02 . . . . 0.0 108.843 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.478 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -76.69 152.03 40.32 Favored Glycine 0 C--N 1.293 -1.81 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -123.7 90.61 3.31 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.832 -1.393 . . . . 0.0 107.536 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.534 HG23 ' CD1' ' A' ' 42' ' ' TYR . 1.1 pp -94.71 142.6 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.489 -0.757 . . . . 0.0 110.762 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.453 ' CG ' ' HB3' ' A' ' 41' ' ' GLN . 2.0 mm100 -114.11 168.33 9.91 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 31' ' ' ILE . 73.3 mt -153.94 146.92 24.49 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.842 -1.161 . . . . 0.0 110.379 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 36' ' ' ASP . 45.1 m-20 -123.63 124.07 41.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.394 -0.816 . . . . 0.0 109.659 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.54 -77.32 0.0 OUTLIER Glycine 0 N--CA 1.5 2.951 0 C-N-CA 124.561 1.077 . . . . 0.0 113.679 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -70.57 -2.86 15.51 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.598 -0.942 . . . . 0.0 111.197 -177.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 88.02 20.52 49.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -75.5 130.16 38.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.086 -1.244 . . . . 0.0 108.201 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.464 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -59.78 139.01 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 110.561 -178.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 2.7 mt -107.07 -26.59 11.07 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 0.9 OUTLIER -160.31 142.11 12.66 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.001 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.534 ' CD1' HG23 ' A' ' 31' ' ' ILE . 6.2 t80 -121.95 -64.22 1.23 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.756 -1.215 . . . . 0.0 110.729 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 3.2 p-10 101.86 175.6 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.59 -19.42 19.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.855 -1.153 . . . . 0.0 112.615 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.84 -63.44 1.2 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.51 -1.369 . . . . 0.0 110.163 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.502 ' OE1' ' CE1' ' A' ' 42' ' ' TYR . 1.9 pt-20 -60.77 -53.18 60.46 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.579 -0.701 . . . . 0.0 109.392 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -57.96 -14.38 16.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.46 -30.78 20.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.786 -1.42 . . . . 0.0 110.205 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.413 HG23 HG21 ' A' ' 50' ' ' THR . 1.2 mp -83.36 -38.12 14.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.122 -0.986 . . . . 0.0 109.074 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.507 ' CG2' " H3'" ' A' ' 126' ' ' HC4 . 0.7 OUTLIER -102.86 -18.28 15.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.5 -0.75 . . . . 0.0 109.669 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 92.72 -3.76 74.89 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.534 ' CD ' " C3'" ' A' ' 126' ' ' HC4 . 0.0 OUTLIER -58.39 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.239 . . . . 0.0 109.213 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.442 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 12.1 m-20 -54.74 152.93 11.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 108.919 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.55 -42.81 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 122.07 1.847 . . . . 0.0 110.68 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.73 -27.81 60.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.13 -0.981 . . . . 0.0 109.94 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -80.66 -39.65 26.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.613 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 24.0 m -76.66 -1.99 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.837 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.464 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -71.71 122.1 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.061 -1.024 . . . . 0.0 108.48 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.06 -13.13 65.58 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 35.1 mmtt -79.13 136.23 37.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.048 -1.266 . . . . 0.0 108.93 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.433 ' N ' ' HB3' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -72.41 95.03 1.71 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.459 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 30.1 t80 -53.92 -22.71 10.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 109.794 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -91.78 -31.98 15.55 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.72 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -138.15 44.98 2.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 109.114 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.433 ' HB3' ' N ' ' A' ' 61' ' ' ASN . 34.0 t0 -164.26 -31.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 110.517 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.47 HG12 ' NH1' ' A' ' 52' ' ' ARG . 3.9 t -112.2 -50.57 5.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 O-C-N 120.754 -1.216 . . . . 0.0 108.674 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.63 94.74 48.36 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.709 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.22 -6.02 17.82 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.886 1.724 . . . . 0.0 110.462 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.7 p -77.82 -32.87 52.54 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.151 -0.968 . . . . 0.0 108.692 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 p -69.1 -9.44 52.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.604 -0.685 . . . . 0.0 109.764 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.87 76.74 9.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.997 -1.064 . . . . 0.0 108.635 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -165.07 173.46 3.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 109.085 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.6 Cg_endo -77.4 76.71 4.12 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 122.497 2.132 . . . . 0.0 110.416 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 3.6 tt0 174.27 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.441 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.3 t80 -105.65 -64.03 1.19 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.506 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.4 t80 -79.61 -20.43 46.85 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.081 -1.012 . . . . 0.0 108.56 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.46 -57.81 13.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 12.1 mmtt -65.38 -16.69 63.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.658 -0.907 . . . . 0.0 109.802 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.506 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 9.4 t80 -82.62 -35.12 27.29 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -76.32 -12.88 60.14 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.103 -0.998 . . . . 0.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 18.7 pt-20 -96.92 -41.34 8.46 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.441 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -60.18 -39.86 96.48 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 107.454 -2.258 . . . . 0.0 107.454 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 99.1 t -59.88 -47.59 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.794 -0.827 . . . . 0.0 109.296 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.76 5.58 45.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.386 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.3 m -102.0 -25.75 13.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.042 -1.037 . . . . 0.0 109.612 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.78 22.29 64.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -166.03 58.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.134 -1.216 . . . . 0.0 109.51 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.425 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.5 OUTLIER -52.94 116.35 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.895 . . . . 0.0 109.515 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.414 ' ND2' ' HE3' ' A' ' 110' ' ' LYS . 2.4 t-20 -160.2 78.34 0.66 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.168 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.1 t -136.44 154.91 50.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.96 163.0 34.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 0.0 108.923 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.658 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 8.6 p90 -175.27 151.59 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.041 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 1.5 pt-20 -81.73 112.39 18.86 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.195 -0.941 . . . . 0.0 108.636 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.79 -179.63 3.71 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.181 -0.949 . . . . 0.0 109.99 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.3 m -147.52 107.56 4.02 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.498 ' CD1' ' C2 ' ' A' ' 126' ' ' HC4 . 17.8 m-30 -84.13 92.58 7.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.377 -0.827 . . . . 0.0 109.718 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -108.01 25.21 11.85 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.264 -0.898 . . . . 0.0 109.338 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.576 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -78.65 155.39 29.54 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.52 ' C ' ' O ' ' A' ' 98' ' ' TYR . 24.1 mt-30 -0.32 65.85 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.187 0 CA-C-O 121.631 0.729 . . . . 0.0 112.099 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.576 ' N ' ' O ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER 173.64 158.36 0.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -53.68 168.44 0.4 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.114 -0.991 . . . . 0.0 109.088 179.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 32.8 Cg_endo -74.75 113.34 3.77 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.831 1.688 . . . . 0.0 110.194 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.3 m -116.25 114.93 25.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.844 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.438 ' O ' HG11 ' A' ' 105' ' ' VAL . 5.4 tttt -92.05 136.65 33.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.504 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 32.6 m -147.44 146.27 18.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.146 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.555 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -91.71 116.37 28.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 175.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.658 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -88.27 164.12 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.787 -1.196 . . . . 0.0 111.516 -175.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -150.83 98.7 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 119' ' ' TRP . 19.5 mtm -96.85 125.4 41.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.682 -1.261 . . . . 0.0 109.503 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.553 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 3.9 tttt -132.15 172.12 12.79 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 117.525 -1.67 . . . . 0.0 109.706 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.425 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 2.1 tttp -90.29 107.68 19.29 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.979 -1.076 . . . . 0.0 108.384 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.496 ' CB ' ' HB2' ' A' ' 116' ' ' ASP . . . -52.21 -177.17 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.28 0.562 . . . . 0.0 110.154 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.12 81.21 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.027 . . . . 0.0 110.461 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.7 m 57.02 100.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.656 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 131.35 -11.27 5.54 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.496 ' HB2' ' CB ' ' A' ' 112' ' ' ALA . 13.9 m-20 -147.61 -39.56 0.19 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.211 -1.17 . . . . 0.0 109.546 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 116' ' ' ASP . 4.6 t 77.75 -75.5 0.06 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.307 -0.871 . . . . 0.0 111.146 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.426 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 12.6 m-85 -127.3 122.8 34.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.742 -1.224 . . . . 0.0 109.227 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.686 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 22.1 p-90 -128.11 152.42 48.02 Favored 'General case' 0 C--O 1.201 -1.455 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.919 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.449 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 60.9 t -132.36 110.31 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.305 0.574 . . . . 0.0 109.648 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.686 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 9.1 m-30 -94.34 122.09 36.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 108.987 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.488 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -103.03 116.84 47.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.01 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 1.6 tptp -88.09 114.18 24.45 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.427 ' HA ' HG11 ' A' ' 105' ' ' VAL . 1.2 ttp85 -67.85 111.6 4.42 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.456 -1.297 . . . . 0.0 108.544 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.504 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.058 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.534 " C3'" ' CD ' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.307 0.575 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 59.08 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.27 -0.894 . . . . 0.0 109.741 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 3' ' ' HIS . 3.2 p80 -155.22 67.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.435 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 10.2 p -57.15 114.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.42 -0.8 . . . . 0.0 110.305 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.427 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . 50.75 -175.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.166 -0.958 . . . . 0.0 110.856 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.61 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -42.08 -53.77 3.83 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-O 122.009 0.909 . . . . 0.0 109.138 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.36 42.16 0.18 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.546 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 1.5 m -83.13 -169.49 2.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.908 -0.76 . . . . 0.0 111.28 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -119.07 76.04 1.08 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.477 -0.764 . . . . 0.0 110.628 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.416 ' N ' HG23 ' A' ' 4' ' ' VAL . 14.7 m-20 47.56 86.57 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.975 -1.078 . . . . 0.0 108.482 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.532 HG13 ' CE2' ' A' ' 121' ' ' PHE . 1.9 mm -88.64 -67.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.117 -0.989 . . . . 0.0 111.142 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -41.16 -36.06 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.624 -0.672 . . . . 0.0 111.592 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -77.54 -42.76 34.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.872 -1.143 . . . . 0.0 108.455 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.434 HG22 ' CD2' ' A' ' 23' ' ' LEU . 2.0 m -76.03 -4.38 40.95 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.531 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 81.2 mt -97.85 -23.03 16.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.855 -1.153 . . . . 0.0 109.149 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.9 -29.62 63.29 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.483 -0.761 . . . . 0.0 108.994 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -124.07 62.34 1.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.408 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.43 ' CG ' ' HB3' ' A' ' 22' ' ' GLN . 3.3 ttm -129.03 98.45 4.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.999 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 11.5 t0 -68.48 -52.96 26.65 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 108.61 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER 167.16 92.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.554 -0.716 . . . . 0.0 109.118 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.3 -23.68 3.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.43 ' HB3' ' CG ' ' A' ' 18' ' ' MET . 0.4 OUTLIER -56.26 -47.83 77.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -1.154 . . . . 0.0 109.233 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.436 HD22 ' CD2' ' A' ' 26' ' ' LEU . 0.5 OUTLIER -141.0 69.55 1.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -109.99 -6.58 15.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.935 . . . . 0.0 109.842 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.16 28.88 13.68 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 1.7 mt -73.68 -171.91 1.14 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.128 -1.219 . . . . 0.0 108.798 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.85 13.22 23.63 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.546 ' CZ ' ' HB3' ' A' ' 8' ' ' SER . 18.8 p90 -146.12 177.2 9.16 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.684 -0.635 . . . . 0.0 109.509 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' HA3' ' CB ' ' A' ' 46' ' ' GLU . . . -108.66 118.8 5.44 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.454 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -94.81 89.39 5.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.919 -1.342 . . . . 0.0 109.061 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.523 ' CG2' ' CE1' ' A' ' 42' ' ' TYR . 1.1 pp -96.0 161.47 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.494 -0.754 . . . . 0.0 109.403 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.446 ' HB2' ' HG3' ' A' ' 41' ' ' GLN . 8.9 mt-30 -132.16 175.77 8.96 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 22.3 mt -155.77 146.25 21.88 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 14.6 t70 -99.16 169.96 9.02 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.86 -21.82 1.74 Allowed Glycine 0 N--CA 1.499 2.893 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.449 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -94.98 13.51 24.77 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.547 -1.56 . . . . 0.0 110.549 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.07 26.68 65.9 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 2.0 m-20 -97.25 126.22 42.31 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.987 -1.302 . . . . 0.0 111.929 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -53.09 133.41 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.117 -0.99 . . . . 0.0 110.709 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 34' ' ' ASP . 11.6 mt -102.74 -32.2 9.95 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -155.54 -175.16 5.29 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.533 ' CE2' ' CG ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -160.62 -62.8 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.97 -1.081 . . . . 0.0 110.239 -178.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.8 p-10 103.92 176.49 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.22 -37.03 11.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.974 -1.079 . . . . 0.0 110.758 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.76 -48.18 20.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.233 -0.917 . . . . 0.0 111.047 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.533 ' CG ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -61.83 -47.51 84.78 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.388 -0.82 . . . . 0.0 109.34 -177.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.474 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . -61.27 -15.87 46.71 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -80.64 -32.32 36.24 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.121 -1.223 . . . . 0.0 109.464 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.433 HG21 HG21 ' A' ' 50' ' ' THR . 0.6 OUTLIER -85.06 -50.61 14.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.075 -1.015 . . . . 0.0 109.441 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.47 ' HA ' ' CE ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -88.58 -13.88 38.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.759 -1.213 . . . . 0.0 109.524 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 89.09 -11.77 68.35 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB2' ' OE2' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -57.78 175.54 0.19 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -1.165 . . . . 0.0 109.525 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.413 ' O ' HG12 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -127.86 158.85 69.2 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 108.943 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.97 -37.99 1.8 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.865 1.71 . . . . 0.0 110.656 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -89.23 -25.26 21.83 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.171 -0.955 . . . . 0.0 109.279 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 1.2 tt0 -73.89 -37.88 64.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 108.689 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.507 HG12 ' CE2' ' A' ' 42' ' ' TYR . 26.6 m -70.9 -8.45 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.815 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.405 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -70.97 122.56 23.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.08 -19.7 51.71 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -78.73 130.94 36.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.451 -1.029 . . . . 0.0 108.927 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 128.1 34.66 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.529 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 63.2 t80 -62.33 -11.53 15.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.584 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -122.52 32.17 5.86 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.95 -1.094 . . . . 0.0 110.271 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -150.09 -45.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.07 . . . . 0.0 110.563 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -128.15 4.33 5.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.994 -1.067 . . . . 0.0 110.762 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 39.2 t -113.62 -28.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.801 -1.187 . . . . 0.0 108.72 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' HB3' " C6'" ' A' ' 126' ' ' HC4 . . . -156.58 88.79 2.74 Favored Pre-proline 0 C--N 1.292 -1.915 0 O-C-N 121.346 -0.847 . . . . 0.0 109.214 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -74.61 -4.41 15.37 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.986 1.791 . . . . 0.0 110.158 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.5 p -94.27 -27.63 16.03 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.355 -0.84 . . . . 0.0 109.074 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 69.9 p -64.41 -18.89 65.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.62 -0.675 . . . . 0.0 109.666 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -60.5 91.84 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.052 -1.03 . . . . 0.0 108.842 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.95 172.8 1.11 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.229 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.16 -4.44 14.33 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 122.599 2.199 . . . . 0.0 111.729 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 17.7 mt-10 -102.46 -29.95 11.3 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.754 -1.216 . . . . 0.0 109.822 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 70' ' ' THR . 1.6 t80 -101.62 -68.91 0.8 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.469 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.8 t80 -73.62 -17.32 61.18 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 81' ' ' GLU . . . -64.84 -61.42 5.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -65.03 -14.66 60.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.646 -0.914 . . . . 0.0 109.841 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.469 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 7.9 t80 -82.89 -36.75 25.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -78.32 -9.47 59.26 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.407 ' CG ' ' O ' ' A' ' 77' ' ' GLY . 1.3 mm-40 -95.61 -39.6 9.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 88' ' ' LEU . . . -65.25 -41.69 96.66 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.511 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 66.3 t -59.67 -40.57 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.788 -0.831 . . . . 0.0 109.585 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.66 1.17 53.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.275 -0.891 . . . . 0.0 111.503 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -106.39 -20.1 13.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.808 -1.182 . . . . 0.0 110.147 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.63 26.03 57.4 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -168.66 67.26 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.397 -1.06 . . . . 0.0 109.217 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.433 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 0.4 OUTLIER -71.37 115.88 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.905 . . . . 0.0 110.032 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 64.1 t-20 -162.03 88.4 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.541 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.403 ' CG2' ' SD ' ' A' ' 109' ' ' MET . 4.6 t -128.92 168.32 16.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.992 -1.068 . . . . 0.0 109.96 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.413 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 0.6 OUTLIER -155.14 151.11 27.87 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.543 ' CD2' HG23 ' A' ' 107' ' ' VAL . 12.3 p90 -173.03 -176.58 1.42 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.293 -0.88 . . . . 0.0 109.547 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.82 100.03 8.6 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.19 179.12 4.7 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.591 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.3 m -144.03 105.9 4.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.383 -0.823 . . . . 0.0 109.271 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.49 ' CD1' ' C2 ' ' A' ' 126' ' ' HC4 . 15.5 m-30 -80.59 110.15 15.8 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -134.7 43.26 2.76 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.364 -0.835 . . . . 0.0 109.485 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 21.4 p90 -77.41 139.58 39.72 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.533 ' C ' ' O ' ' A' ' 98' ' ' TYR . 3.3 pt20 2.31 66.98 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.191 0 CA-C-O 121.879 0.847 . . . . 0.0 111.783 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.531 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.6 tmm? -176.85 -179.38 0.94 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 p -65.0 163.08 32.67 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.0 109.06 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.02 148.67 27.98 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.147 1.898 . . . . 0.0 110.416 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.2 m -151.36 118.87 6.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 110.116 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -95.36 142.9 27.21 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.48 ' CA ' HG22 ' A' ' 125' ' ' VAL . 32.5 m -144.12 146.67 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 118.266 -1.373 . . . . 0.0 112.411 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.61 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -78.8 95.33 5.34 Favored 'General case' 0 C--O 1.2 -1.536 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 175.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.543 HG23 ' CD2' ' A' ' 92' ' ' PHE . 33.3 m -87.63 152.6 3.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 120.731 -1.231 . . . . 0.0 110.151 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.409 ' ND1' ' HA ' ' A' ' 5' ' ' ALA . 9.8 t-160 -160.44 97.53 1.22 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.46 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -106.12 142.27 36.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.188 -0.945 . . . . 0.0 109.327 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.551 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 5.3 tttt -133.01 -162.49 1.24 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.753 -1.217 . . . . 0.0 109.416 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -110.84 98.53 7.64 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.119 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.505 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -52.49 123.97 12.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 tp -111.82 -18.11 12.78 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.037 -1.039 . . . . 0.0 109.695 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 m -52.6 -29.71 27.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.007 . . . . 0.0 109.274 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 148.49 43.07 0.03 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 117' ' ' SER . 1.3 m-20 -132.9 -89.08 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.131 -1.217 . . . . 0.0 109.684 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.493 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER 168.07 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.06 -1.025 . . . . 0.0 111.534 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.511 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 15.9 m-85 -128.75 127.45 42.07 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.037 -1.04 . . . . 0.0 110.106 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.643 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 17.6 p-90 -125.56 146.87 49.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.601 -1.312 . . . . 0.0 112.269 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.46 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 40.7 t -123.32 117.85 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.741 -0.599 . . . . 0.0 109.949 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.643 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.0 m-30 -100.92 120.0 39.53 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.988 -1.07 . . . . 0.0 108.639 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.482 HG23 ' CE2' ' A' ' 96' ' ' PHE . 1.4 t -105.58 111.71 35.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 122.244 1.021 . . . . 0.0 108.297 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.549 ' HD3' ' CE1' ' A' ' 6' ' ' PHE . 1.5 tptp -92.71 154.49 18.3 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HD3' ' CD1' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -91.47 123.55 34.98 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.493 -1.379 . . . . 0.0 109.008 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.48 HG22 ' CA ' ' A' ' 105' ' ' VAL . 9.3 t . . . . . 0 C--N 1.305 -1.355 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.481 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.49 ' C2 ' ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.43 0.633 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -95.37 20.12 9.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.262 -0.899 . . . . 0.0 109.648 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.31 45.79 22.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 109.381 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 8' ' ' SER . 7.5 p -63.85 103.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.582 ' O ' ' HB3' ' A' ' 6' ' ' PHE . . . 51.11 61.47 3.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.495 -1.378 . . . . 0.0 110.765 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.582 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 58.1 t80 62.78 20.64 12.27 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 120.844 1.657 . . . . 0.0 106.835 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.48 ' C ' ' HE3' ' A' ' 123' ' ' LYS . . . 96.76 -22.15 42.05 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.631 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -74.96 165.98 24.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.694 1.235 . . . . 0.0 113.142 -177.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -112.83 65.64 0.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 54.25 81.75 0.1 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.595 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 2.9 mm -82.48 -56.14 6.45 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 111.464 -177.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -40.43 -27.91 0.06 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.454 -0.779 . . . . 0.0 111.524 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' ILE . 96.6 m-20 -86.79 -42.52 13.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 109.007 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -70.48 -14.42 62.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.347 -0.846 . . . . 0.0 110.21 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 11' ' ' ILE . 8.9 mt -93.56 -18.92 21.7 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.014 -1.054 . . . . 0.0 109.069 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.61 -41.34 12.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 108.824 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.36 57.57 0.68 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.474 ' HG3' ' CB ' ' A' ' 22' ' ' GLN . 1.0 OUTLIER -108.79 -179.08 3.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.228 -0.92 . . . . 0.0 110.171 -179.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.36 -56.75 0.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.546 -0.721 . . . . 0.0 109.307 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -177.64 -52.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 109.564 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.51 49.1 1.86 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.474 ' CB ' ' HG3' ' A' ' 18' ' ' MET . 0.7 OUTLIER -121.65 -56.02 1.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -1.182 . . . . 0.0 109.484 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -9.49 42.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.271 -0.893 . . . . 0.0 110.453 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -84.72 -2.88 58.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.838 -1.164 . . . . 0.0 110.331 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.51 35.53 4.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 13.6 mt -121.27 149.64 42.58 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.487 -1.008 . . . . 0.0 109.352 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.04 24.58 4.2 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.029 0.918 . . . . 0.0 108.851 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.642 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 1.2 p90 -153.53 134.12 13.66 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -68.18 125.2 21.07 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.96 -1.115 . . . . 0.0 110.857 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.432 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -106.21 110.41 22.64 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.516 ' CG2' ' CD1' ' A' ' 42' ' ' TYR . 1.4 pp -117.11 151.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.939 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -113.0 167.91 10.13 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 13.2 mt -150.07 139.9 21.83 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.916 -1.115 . . . . 0.0 110.036 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' N ' HD22 ' A' ' 40' ' ' LEU . 37.1 t70 -92.14 167.56 11.97 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -48.93 -21.04 2.14 Favored Glycine 0 N--CA 1.497 2.747 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.421 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.51 12.52 22.65 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.458 -1.613 . . . . 0.0 110.498 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 61' ' ' ASN . . . 75.3 26.9 64.89 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 69.1 m-20 -97.4 127.83 43.69 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.013 -1.287 . . . . 0.0 111.872 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 0.9 OUTLIER -59.52 134.83 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.86 -1.15 . . . . 0.0 110.528 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 2.3 mt -106.47 -29.56 9.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -155.46 161.38 40.97 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.59 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 3.7 t80 -143.7 -60.93 0.4 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.552 -1.342 . . . . 0.0 109.972 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.498 ' OD1' ' HG2' ' A' ' 46' ' ' GLU . 3.5 p-10 99.89 173.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 123.745 0.818 . . . . 0.0 108.871 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.59 -13.73 25.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.755 -1.215 . . . . 0.0 111.84 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.93 -65.06 0.73 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.585 -1.322 . . . . 0.0 109.904 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.59 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 7.0 pt-20 -60.31 -50.0 75.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.959 . . . . 0.0 109.737 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -56.47 -18.64 23.4 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.13 -38.47 56.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.829 -1.395 . . . . 0.0 108.422 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -79.32 -59.5 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.45 -0.781 . . . . 0.0 109.294 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.497 ' CG2' " C3'" ' A' ' 126' ' ' HC4 . 19.0 p -78.36 -9.63 59.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.275 -0.891 . . . . 0.0 110.474 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.444 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 81.0 -2.34 81.23 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.488 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 1.3 mtt-85 -73.86 84.71 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.169 -1.195 . . . . 0.0 109.925 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.408 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -54.29 173.73 0.21 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.301 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 35.8 Cg_endo -77.94 -32.22 2.7 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.018 1.812 . . . . 0.0 110.856 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -80.97 -33.42 33.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.193 -0.942 . . . . 0.0 109.987 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -71.56 -42.67 67.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.097 -1.002 . . . . 0.0 109.658 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.489 HG23 ' CG ' ' A' ' 42' ' ' TYR . 28.6 m -68.65 -9.08 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.963 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.11 123.16 23.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.8 -14.67 59.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -79.51 127.45 32.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.266 -1.138 . . . . 0.0 109.18 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -67.53 128.01 34.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 108.659 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.528 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 78.2 t80 -62.21 -14.2 35.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 0.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.4 5.72 11.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.057 -1.027 . . . . 0.0 111.12 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 4.5 mttt -151.45 47.26 0.81 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.785 -1.197 . . . . 0.0 109.825 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER 163.56 -22.59 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.609 -0.682 . . . . 0.0 109.683 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 21.2 t -112.76 -28.66 2.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.22 -0.925 . . . . 0.0 108.505 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.429 ' HB3' ' C2 ' ' A' ' 126' ' ' HC4 . . . -159.81 94.99 1.64 Allowed Pre-proline 0 C--N 1.293 -1.864 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.947 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.88 -18.53 16.84 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.856 1.704 . . . . 0.0 109.241 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.7 p -79.45 -20.35 47.64 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.532 -0.73 . . . . 0.0 109.376 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.7 p -80.94 5.82 15.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 110.032 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -89.28 52.58 2.41 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.937 -1.102 . . . . 0.0 108.402 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.48 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.8 p -125.39 -179.42 0.87 Allowed Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.99 -12.81 14.44 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 122.146 1.897 . . . . 0.0 111.593 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.6 OUTLIER -96.37 -26.68 15.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.835 -1.165 . . . . 0.0 109.746 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CE1' ' HE1' ' A' ' 109' ' ' MET . 0.7 OUTLIER -100.59 -72.61 0.67 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.277 -0.89 . . . . 0.0 108.604 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 5.8 t80 -72.24 -18.91 61.79 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.032 -1.042 . . . . 0.0 109.045 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -64.44 -59.77 7.89 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 2.0 mmtp -65.14 -14.58 60.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.633 -0.922 . . . . 0.0 109.983 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 9.5 t80 -84.95 -36.14 21.6 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.387 -0.821 . . . . 0.0 109.39 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -76.1 -12.32 60.09 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 108.84 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 25.2 pt-20 -97.27 -41.43 8.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.437 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -59.6 -39.52 95.21 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.461 -2.256 . . . . 0.0 107.461 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 97.5 t -63.93 -44.79 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.91 -0.759 . . . . 0.0 110.113 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.58 4.39 51.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.181 -0.949 . . . . 0.0 110.729 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.3 t -106.21 -25.35 12.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.932 -1.105 . . . . 0.0 109.87 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.73 29.31 32.56 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -171.88 60.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -1.17 . . . . 0.0 109.212 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.3 tt -60.03 119.3 7.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.711 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.423 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 18.8 p-10 -160.34 85.1 0.72 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 109.254 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.5 t -134.36 149.48 50.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.031 -1.043 . . . . 0.0 109.99 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.6 ptp -140.33 166.07 25.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.426 -0.796 . . . . 0.0 108.987 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.54 ' CD1' HG23 ' A' ' 107' ' ' VAL . 20.4 p90 176.4 178.16 0.23 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.812 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -105.14 114.92 29.4 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.94 173.88 6.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.274 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.2 m -146.45 108.63 4.42 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.473 ' CE2' HG23 ' A' ' 105' ' ' VAL . 16.6 m-85 -81.1 120.88 25.39 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.131 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.78 47.23 2.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 108.75 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -79.02 72.83 5.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.068 -0.395 . . . . 0.0 111.274 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.472 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 64.58 31.41 12.26 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.318 -0.864 . . . . 0.0 109.9 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.69 -177.82 6.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.236 -0.915 . . . . 0.0 108.844 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.443 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 0.5 OUTLIER -55.14 152.67 14.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 109.253 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.443 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 32.1 Cg_endo -73.45 82.72 1.6 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.716 1.61 . . . . 0.0 109.883 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.423 HG23 ' CG1' ' A' ' 105' ' ' VAL . 1.9 m -69.64 93.71 0.73 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.648 -0.658 . . . . 0.0 109.846 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.9 137.14 47.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.476 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 4.1 m -146.37 147.0 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.48 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.56 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.6 OUTLIER -76.85 150.75 36.05 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 173.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.54 HG23 ' CD1' ' A' ' 92' ' ' PHE . 30.2 m -137.77 149.28 25.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 119.945 -1.722 . . . . 0.0 109.366 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . 10.8 t-160 -160.2 101.87 1.41 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.43 ' CG ' HG11 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -109.03 140.42 42.57 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.241 -178.308 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.6 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 9.7 tttt -135.23 -162.48 1.26 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.571 -1.331 . . . . 0.0 109.888 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -108.14 103.26 12.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.928 . . . . 0.0 108.83 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.459 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -51.07 147.71 5.03 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.599 -0.688 . . . . 0.0 110.443 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.3 -10.26 59.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.451 -0.781 . . . . 0.0 110.047 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.79 -24.64 3.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.098 -1.001 . . . . 0.0 109.713 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.74 100.04 0.52 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.3 p30 41.83 37.62 0.82 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.836 -0.802 . . . . 0.0 110.559 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.471 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.6 OUTLIER -89.24 -177.49 5.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.886 . . . . 0.0 109.813 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 117' ' ' SER . 14.7 m-85 -152.0 116.39 5.03 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.652 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 14.6 p-90 -118.69 153.74 33.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.06 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.43 HG11 ' CG ' ' A' ' 109' ' ' MET . 24.0 t -127.5 112.6 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.652 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 12.5 m-30 -96.47 104.11 16.07 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 122' ' ' VAL . 0.9 OUTLIER -92.6 115.11 30.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.339 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.642 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -90.7 142.42 27.77 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -89.46 119.37 29.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.516 -1.365 . . . . 0.0 108.961 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.312 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.497 " C3'" ' CG2' ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ttt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.264 0.554 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.22 109.19 20.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.363 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -81.08 -70.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 109.575 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.409 ' O ' ' OG ' ' A' ' 8' ' ' SER . 5.2 p 178.82 115.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.298 -0.876 . . . . 0.0 109.364 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.544 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . 58.09 93.59 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.228 -0.92 . . . . 0.0 109.881 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' CE1' ' O ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER 48.62 -89.33 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.366 -0.834 . . . . 0.0 109.691 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . -148.16 53.06 0.53 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -73.17 148.28 43.97 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.606 -0.937 . . . . 0.0 109.881 -178.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.72 67.93 9.69 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.313 -0.867 . . . . 0.0 110.247 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 49.25 75.39 0.15 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.986 -1.071 . . . . 0.0 108.179 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 8' ' ' SER . 4.5 mm -78.43 -59.67 2.85 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.517 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -40.95 -31.22 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.511 -0.743 . . . . 0.0 111.716 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.64 -40.23 16.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.802 -1.186 . . . . 0.0 108.577 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.5 m -71.32 -10.88 60.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.627 -0.671 . . . . 0.0 110.055 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.5 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 13.4 mt -96.7 -9.31 29.33 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.952 -1.093 . . . . 0.0 109.747 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.06 -34.89 12.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.041 -1.037 . . . . 0.0 109.134 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -121.06 76.91 1.26 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.447 ' HG3' ' CB ' ' A' ' 22' ' ' GLN . 3.5 ttp -130.38 179.2 6.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.301 -0.874 . . . . 0.0 110.24 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -142.95 -61.43 0.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 14.6 t70 175.31 104.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.63 23.57 6.19 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.447 ' CB ' ' HG3' ' A' ' 18' ' ' MET . 1.0 OUTLIER -108.67 -24.98 11.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.305 -1.115 . . . . 0.0 109.545 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.433 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 2.0 pt? -116.89 -6.28 11.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.257 -0.902 . . . . 0.0 110.257 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -66.78 -11.3 54.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.829 -1.17 . . . . 0.0 109.936 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.75 28.07 15.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.506 ' CD2' ' CZ ' ' A' ' 28' ' ' PHE . 18.8 mt -98.6 164.27 12.32 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.204 -1.174 . . . . 0.0 108.333 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.42 19.35 9.75 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 8' ' ' SER . 2.7 p90 -152.89 179.2 8.87 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -107.69 125.8 8.08 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.491 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -96.06 96.88 9.16 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.027 -1.278 . . . . 0.0 108.465 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.486 HG23 ' CD1' ' A' ' 42' ' ' TYR . 1.4 pp -102.63 146.18 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.23 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.441 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 12.6 mt-30 -119.65 171.88 8.07 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 72.0 mt -152.78 147.11 25.67 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 109.738 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' ASP . 1.9 m-20 -119.05 136.49 54.11 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.358 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -9.01 71.06 0.0 OUTLIER Glycine 0 N--CA 1.51 3.629 0 C-N-CA 124.659 1.123 . . . . 0.0 113.428 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER 161.64 -24.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.03 17.53 24.92 Favored Glycine 0 N--CA 1.481 1.697 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 69.2 m-80 -82.7 128.67 34.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -1.123 . . . . 0.0 108.426 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -62.45 138.51 22.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 122.059 0.933 . . . . 0.0 111.568 -178.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 6.0 mt -105.0 -31.18 9.33 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.434 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -158.4 -176.33 5.84 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.531 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 1.6 t80 -161.11 -62.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.072 -1.018 . . . . 0.0 109.677 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 3.3 p-10 100.42 175.55 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.493 0 C-N-CA 123.666 0.786 . . . . 0.0 109.48 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.89 -15.68 22.27 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.004 -1.06 . . . . 0.0 111.983 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.9 -64.95 0.73 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.662 -1.274 . . . . 0.0 109.846 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 13.2 pt-20 -64.43 -43.29 94.79 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.219 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.435 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -60.11 -16.01 39.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -87.26 -28.53 22.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.723 -1.457 . . . . 0.0 109.673 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -82.22 -39.62 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.542 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.51 HG23 " C3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -113.91 -0.31 14.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.833 -0.542 . . . . 0.0 110.627 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.81 -3.26 70.46 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.649 -1.263 . . . . 0.0 110.942 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.569 ' HD3' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.87 91.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.826 -1.397 . . . . 0.0 110.388 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 14.5 m-20 -72.32 158.46 87.46 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.97 -42.04 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.85 1.7 . . . . 0.0 110.821 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -27.55 67.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.992 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -84.87 -42.49 15.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.0 109.612 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 34.7 m -78.42 -0.03 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.0 109.743 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.446 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.6 OUTLIER -70.42 122.01 21.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.013 -1.054 . . . . 0.0 108.702 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.98 -19.72 52.65 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -80.06 137.42 36.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.276 -1.132 . . . . 0.0 108.894 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.49 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -77.58 97.98 5.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.466 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 62.3 t80 -56.35 -18.29 10.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.665 -0.647 . . . . 0.0 110.337 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.453 ' CD1' ' CD1' ' A' ' 76' ' ' TYR . 3.0 m-85 -95.42 -30.87 13.66 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.065 -1.022 . . . . 0.0 110.458 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -139.15 42.1 2.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 110.027 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.49 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -157.34 -37.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.048 -1.033 . . . . 0.0 110.254 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.569 HG13 ' HD3' ' A' ' 52' ' ' ARG . 1.8 t -104.9 -58.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 122.902 1.335 . . . . 0.0 108.923 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' HB3' ' C3 ' ' A' ' 126' ' ' HC4 . . . -106.56 100.99 33.56 Favored Pre-proline 0 C--N 1.289 -2.061 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.563 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.59 -4.04 14.7 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.845 1.696 . . . . 0.0 110.698 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.1 p -88.19 -24.75 23.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.959 -1.088 . . . . 0.0 109.332 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 p -76.58 -2.0 30.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.285 -0.885 . . . . 0.0 109.866 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.31 50.53 1.52 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.889 -1.132 . . . . 0.0 108.23 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.481 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -113.97 178.99 0.85 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -77.96 -14.44 15.34 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 122.072 1.848 . . . . 0.0 111.227 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 29.9 mt-10 -100.54 -22.8 14.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.782 -1.199 . . . . 0.0 109.545 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.453 ' CE1' HG12 ' A' ' 120' ' ' VAL . 0.8 OUTLIER -100.48 -73.45 0.64 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 9.2 t80 -70.35 -19.24 63.06 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.878 -1.139 . . . . 0.0 108.873 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.93 -59.75 8.66 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -63.56 -15.3 57.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.453 -1.028 . . . . 0.0 109.682 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.537 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 13.1 t80 -81.88 -38.05 25.95 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.545 -0.722 . . . . 0.0 109.788 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -11.9 60.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.021 -1.05 . . . . 0.0 109.362 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 12.9 pt-20 -97.28 -41.73 8.13 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.445 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -61.32 -39.54 97.38 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.491 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 85.1 t -63.52 -41.57 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.862 -0.787 . . . . 0.0 110.009 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.2 4.78 53.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.246 -0.909 . . . . 0.0 111.036 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.4 p -106.11 -26.74 11.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.89 -1.131 . . . . 0.0 110.131 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.09 23.52 37.73 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -171.39 87.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -1.125 . . . . 0.0 109.036 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.43 ' O ' ' CG ' ' A' ' 110' ' ' LYS . 1.9 tt -84.36 123.09 29.81 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.306 -0.872 . . . . 0.0 109.787 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -160.56 81.78 0.67 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.235 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -121.85 154.34 37.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.118 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -148.02 139.26 23.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.788 . . . . 0.0 109.04 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.547 ' CD2' HG23 ' A' ' 107' ' ' VAL . 8.9 p90 -162.83 -174.92 4.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.053 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -112.91 108.76 17.82 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.65 -179.48 3.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.35 -0.844 . . . . 0.0 110.083 -178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.7 m -149.47 108.51 3.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.521 -0.737 . . . . 0.0 109.062 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -81.09 92.28 6.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.351 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -105.67 24.24 12.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.251 -0.906 . . . . 0.0 109.637 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.554 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.69 155.72 29.32 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.506 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 0.28 65.72 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 CA-C-O 121.549 0.69 . . . . 0.0 112.317 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER 175.66 164.78 0.34 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.427 -0.796 . . . . 0.0 109.126 -178.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.448 ' CB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -57.75 175.66 0.27 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.302 -0.874 . . . . 0.0 108.883 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' A' ' 101' ' ' THR . 34.6 Cg_endo -76.6 107.64 2.49 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.846 1.697 . . . . 0.0 109.801 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -109.38 122.54 47.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.807 . . . . 0.0 110.365 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -102.59 145.06 30.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.463 ' CA ' HG22 ' A' ' 125' ' ' VAL . 22.7 m -152.01 145.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.654 -1.279 . . . . 0.0 111.859 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.56 ' O ' ' CE1' ' A' ' 6' ' ' PHE . 7.5 mptt -77.44 117.13 18.61 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 102.876 -3.009 . . . . 0.0 102.876 174.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.547 HG23 ' CD2' ' A' ' 92' ' ' PHE . 35.7 m -102.31 151.14 5.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 117.898 -1.521 . . . . 0.0 109.767 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.453 ' ND1' ' HA ' ' A' ' 5' ' ' ALA . 2.2 t-160 -154.9 103.68 2.43 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.461 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -105.66 139.16 40.68 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.457 -0.777 . . . . 0.0 109.335 -178.344 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.58 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.9 ttmt -137.57 -157.77 0.8 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.562 -1.336 . . . . 0.0 109.476 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -105.37 137.87 42.47 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 108.994 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.485 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -98.89 -179.07 4.16 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 110.058 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.408 ' HB3' ' CB ' ' A' ' 116' ' ' ASP . 1.0 OUTLIER 58.85 25.57 13.76 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.3 m 61.41 39.49 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.475 -0.766 . . . . 0.0 109.171 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.18 74.19 0.94 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.408 ' CB ' ' HB3' ' A' ' 113' ' ' LEU . 1.6 t0 -176.7 -65.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -1.14 . . . . 0.0 109.389 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.481 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -78.05 -163.64 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.491 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 12.3 m-85 -147.64 123.08 10.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.261 -0.899 . . . . 0.0 108.739 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.662 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 18.6 p-90 -127.14 146.32 50.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 118.386 -1.326 . . . . 0.0 112.833 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.461 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 58.9 t -118.58 110.36 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.636 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.662 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 12.4 m-30 -95.44 133.53 39.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.984 -1.073 . . . . 0.0 108.406 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.441 ' O ' ' CB ' ' A' ' 28' ' ' PHE . 1.5 t -116.01 113.57 43.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 C-N-CA 119.054 -1.059 . . . . 0.0 109.532 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.543 ' HD3' ' CD2' ' A' ' 6' ' ' PHE . 5.2 tptp -90.02 131.13 36.07 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.21 123.93 28.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.53 -1.356 . . . . 0.0 109.561 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.463 HG22 ' CA ' ' A' ' 105' ' ' VAL . 5.3 t . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.612 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.51 " C3'" HG23 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.78 148.56 29.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -82.67 123.2 29.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.798 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' A' ' 10' ' ' ASP . 11.2 p -177.47 121.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.353 -0.842 . . . . 0.0 109.246 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.482 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . . . 62.3 -89.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.811 . . . . 0.0 109.445 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -176.03 45.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.37 35.41 2.68 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 13.1 m -104.69 -166.67 1.26 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.73 -0.865 . . . . 0.0 111.142 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -115.88 64.68 0.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.804 -0.56 . . . . 0.0 110.342 -178.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.456 ' HA ' ' CG2' ' A' ' 4' ' ' VAL . 0.4 OUTLIER 52.7 90.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.499 -1.376 . . . . 0.0 107.947 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.533 ' CG2' ' CD1' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -79.63 -69.2 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.973 -1.079 . . . . 0.0 110.513 -177.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' HG2' ' N ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -44.73 -25.79 0.32 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 111.134 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.427 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -75.4 -49.21 19.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.036 -1.04 . . . . 0.0 109.501 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 18' ' ' MET . 1.0 OUTLIER -70.15 -61.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.533 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 72.6 mt -37.27 -32.42 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.363 0.601 . . . . 0.0 110.676 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.98 -61.33 1.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 110.165 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 68.52 1.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 0.0 109.974 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.486 ' HG3' ' CB ' ' A' ' 22' ' ' GLN . 34.6 ttp -129.63 152.27 49.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -0.886 . . . . 0.0 109.132 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 20' ' ' ASP . 32.6 t0 -92.59 -69.92 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.623 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 21.8 p-10 177.62 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -0.817 . . . . 0.0 108.905 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.01 21.54 5.93 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.486 ' CB ' ' HG3' ' A' ' 18' ' ' MET . 1.1 tt0 -108.13 -19.29 13.54 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.312 -1.111 . . . . 0.0 109.651 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.421 HD21 ' HE2' ' A' ' 18' ' ' MET . 0.8 OUTLIER -109.82 14.02 23.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.141 -0.975 . . . . 0.0 110.225 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.38 -3.21 58.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.966 -1.084 . . . . 0.0 110.208 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.14 34.77 5.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.53 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 7.3 mt -110.41 158.93 17.94 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.408 -1.054 . . . . 0.0 109.282 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.94 6.93 33.37 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.45 0.643 . . . . 0.0 109.349 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.53 ' CE2' ' HB3' ' A' ' 26' ' ' LEU . 26.3 p90 -134.04 -169.67 2.36 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.273 -0.892 . . . . 0.0 108.868 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -118.3 149.57 18.34 Favored Glycine 0 C--N 1.297 -1.595 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -126.14 84.8 2.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.754 -1.439 . . . . 0.0 107.936 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.581 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.3 pp -91.71 149.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.168 0.985 . . . . 0.0 110.862 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 3.2 mm100 -115.23 162.43 17.08 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 21.7 mt -150.09 146.08 26.72 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.404 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' N ' HD22 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -99.28 173.62 6.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -40.06 -57.08 2.59 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 121.619 -0.324 . . . . 0.0 113.001 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.83 -17.64 61.65 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.63 -1.512 . . . . 0.0 110.337 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.42 28.73 6.26 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 7.0 m120 -84.74 136.68 33.61 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.442 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.55 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 3.0 tp -63.73 135.85 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.762 -1.211 . . . . 0.0 111.387 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 0.7 OUTLIER -110.06 -28.49 8.67 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -159.76 153.02 22.11 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.581 ' CD1' HG21 ' A' ' 31' ' ' ILE . 17.5 t80 -134.76 -66.68 0.58 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.169 -1.582 . . . . 0.0 111.414 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.3 p-10 102.39 174.79 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.657 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.09 -23.97 15.98 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.8 -1.188 . . . . 0.0 112.898 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.68 -62.43 1.65 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.464 -1.398 . . . . 0.0 110.741 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.472 ' OE2' ' CG2' ' A' ' 31' ' ' ILE . 1.1 pt-20 -58.72 -55.25 37.53 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.675 0.75 . . . . 0.0 109.64 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.413 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -56.79 -15.22 11.89 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.015 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -40.61 61.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.783 -1.422 . . . . 0.0 108.799 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -84.74 -56.89 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.414 -0.804 . . . . 0.0 109.235 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.438 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 18.9 p -72.71 -24.66 61.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.509 -0.744 . . . . 0.0 109.916 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 94.37 -19.22 54.65 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' NH2' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -43.9 97.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.608 -0.936 . . . . 0.0 110.626 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' A' ' 56' ' ' GLN . 42.4 m-20 -69.51 158.29 87.28 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.16 -61.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.942 1.762 . . . . 0.0 110.829 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.52 -18.13 61.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.215 -0.928 . . . . 0.0 110.151 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -86.87 -41.37 14.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.016 -1.053 . . . . 0.0 109.528 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HA ' ' HG3' ' A' ' 60' ' ' LYS . 22.4 m -79.61 2.01 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.831 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.55 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -71.24 121.05 20.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 120.979 -1.075 . . . . 0.0 109.034 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.31 -13.68 64.5 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.402 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 16.7 mmtp -78.89 139.8 38.23 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.084 -1.245 . . . . 0.0 109.066 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -80.95 96.52 7.1 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.567 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 16.7 t80 -55.06 -34.46 63.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.024 -1.048 . . . . 0.0 109.722 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 76' ' ' TYR . 2.5 m-85 -80.42 -23.34 40.39 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.251 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -148.1 49.07 1.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.983 -1.073 . . . . 0.0 109.631 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ASN . 8.8 t0 -174.54 -29.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 111.047 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.485 HG13 ' NE ' ' A' ' 52' ' ' ARG . 13.5 t -106.08 -58.41 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.617 -1.302 . . . . 0.0 109.004 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB3' ' C3 ' ' A' ' 126' ' ' HC4 . . . -99.01 106.65 39.35 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 114.618 -1.173 . . . . 0.0 109.861 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.36 1.41 8.79 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 C-N-CA 121.614 1.543 . . . . 0.0 109.896 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.4 p -107.03 -19.58 13.58 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 121.216 -0.927 . . . . 0.0 109.778 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.435 ' CG2' ' CZ ' ' A' ' 62' ' ' PHE . 11.0 p -85.93 9.57 16.52 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.124 -0.985 . . . . 0.0 110.133 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -106.54 59.9 0.64 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.118 -0.989 . . . . 0.0 108.956 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.452 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -144.3 176.26 2.35 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.352 -0.843 . . . . 0.0 109.675 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 33.6 Cg_endo -76.71 78.64 3.29 Favored 'Trans proline' 0 C--N 1.323 -0.763 0 C-N-CA 122.375 2.05 . . . . 0.0 110.415 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 171.54 -37.86 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CE1' ' HE2' ' A' ' 109' ' ' MET . 1.6 t80 -105.38 -67.68 0.9 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.479 ' CD1' ' CD1' ' A' ' 63' ' ' PHE . 9.3 t80 -73.22 -18.12 61.27 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.1 -63.66 4.21 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' HA ' ' CG ' ' A' ' 81' ' ' GLU . 10.8 mmtt -61.09 -17.54 53.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -1.047 . . . . 0.0 109.864 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.49 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 6.3 t80 -82.22 -38.24 24.82 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.484 -0.76 . . . . 0.0 109.53 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -13.29 60.37 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 109.382 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.469 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -98.05 -36.46 10.1 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.639 -1.225 . . . . 0.0 108.151 178.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.66 -39.33 96.63 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' ' 118' ' ' TYR . 87.3 t -63.21 -51.87 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.958 -0.731 . . . . 0.0 109.928 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.18 -2.88 46.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -0.922 . . . . 0.0 110.793 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.8 t -96.34 -29.94 13.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.131 . . . . 0.0 109.629 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.06 15.05 46.52 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -165.87 86.87 0.36 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.118 -1.225 . . . . 0.0 109.131 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.437 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.2 OUTLIER -76.98 122.93 25.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.472 -0.768 . . . . 0.0 110.088 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -160.97 82.4 0.64 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.7 t -127.48 169.5 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 111.212 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.8 ttm -159.77 149.23 18.08 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.583 ' CD1' HG23 ' A' ' 107' ' ' VAL . 18.7 p90 -172.42 165.55 5.75 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.82 105.77 17.96 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.56 -177.32 3.33 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.817 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' THR . 92.9 m -151.02 108.51 3.63 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.539 ' CE2' " C6'" ' A' ' 126' ' ' HC4 . 18.7 m-30 -84.06 114.91 22.08 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 109.703 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -139.61 42.29 2.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.665 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.537 ' O ' ' C ' ' A' ' 99' ' ' GLN . 10.1 p90 -78.69 148.06 33.26 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.537 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.0 tt0 1.89 67.95 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 121.781 0.8 . . . . 0.0 111.482 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.9 ttp 177.29 -159.1 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 109.386 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.449 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 2.3 t -85.37 153.61 59.14 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.449 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.5 Cg_endo -75.74 141.18 24.28 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.713 1.609 . . . . 0.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' THR . 1.8 m -140.08 140.17 36.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.336 -0.852 . . . . 0.0 109.605 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -111.18 141.6 44.47 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.499 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 24.5 m -149.68 144.05 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.921 -1.112 . . . . 0.0 110.681 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.504 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -86.42 102.31 13.94 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 175.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.583 HG23 ' CD1' ' A' ' 92' ' ' PHE . 18.1 m -85.55 156.91 3.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 110.885 -175.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -160.36 106.88 1.54 Allowed 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.489 ' HE2' ' CE1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -113.92 149.49 35.11 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.477 -0.764 . . . . 0.0 109.606 -177.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.551 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 9.5 ttpt -144.34 170.64 15.62 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.474 -1.391 . . . . 0.0 109.213 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.437 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 11.0 tttt -80.11 104.18 10.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.771 -1.206 . . . . 0.0 108.787 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 117' ' ' SER . . . -52.09 155.51 1.88 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 109.652 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.85 14.14 32.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.987 . . . . 0.0 110.119 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -24.85 63.67 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.092 -1.005 . . . . 0.0 109.081 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 150.78 68.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 61.19 62.32 1.41 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -1.17 . . . . 0.0 109.239 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.477 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -116.99 -169.61 1.68 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.179 -0.95 . . . . 0.0 109.836 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.498 ' CE1' HG23 ' A' ' 83' ' ' VAL . 12.6 m-85 -153.47 108.36 3.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.301 -0.874 . . . . 0.0 109.06 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.651 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 10.2 p-90 -108.22 142.09 39.01 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.695 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.464 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 96.1 t -117.41 118.69 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.651 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 16.0 m-30 -101.86 121.93 43.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.146 -0.971 . . . . 0.0 109.349 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.444 ' CG1' HG13 ' A' ' 105' ' ' VAL . 1.7 t -109.66 116.05 51.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.249 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.546 ' HD3' ' CD1' ' A' ' 6' ' ' PHE . 6.8 tttm -101.87 133.99 45.76 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.405 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.433 ' CD ' HG13 ' A' ' 49' ' ' ILE . 8.1 ttp85 -73.54 117.89 15.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.983 -1.073 . . . . 0.0 109.65 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.205 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.539 " C6'" ' CE2' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.292 0.568 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -175.4 171.16 2.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.434 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 61.65 97.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 109.207 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.0 t -75.2 160.08 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.204 -0.935 . . . . 0.0 109.61 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.33 129.85 42.32 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.622 -0.674 . . . . 0.0 109.55 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.547 ' CZ ' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -60.85 -59.13 5.87 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.4 -1.32 . . . . 0.0 107.531 178.495 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 11' ' ' ILE . . . -53.61 -27.41 34.6 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 176.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.589 ' CB ' ' CZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER 45.96 -161.48 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.88 0.848 . . . . 0.0 111.565 177.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -69.81 77.29 0.46 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.271 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 9' ' ' GLU . 1.8 m-20 37.43 84.69 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.457 -0.777 . . . . 0.0 109.702 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.55 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 2.4 mm -65.39 -67.58 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.212 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 11' ' ' ILE . 3.3 pt-20 -37.55 -30.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.032 0.444 . . . . 0.0 111.656 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' ILE . 1.2 t30 -76.19 -50.36 14.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.022 -1.049 . . . . 0.0 108.673 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 m -67.36 -14.91 63.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.548 -0.72 . . . . 0.0 109.811 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 11.4 mt -96.68 -26.49 15.17 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.094 -1.004 . . . . 0.0 109.168 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.89 -10.76 27.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.307 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.62 60.49 1.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.865 -1.147 . . . . 0.0 110.212 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.483 ' CE ' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -149.21 157.26 43.21 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' N ' ' HG2' ' A' ' 18' ' ' MET . 49.1 t0 -88.61 -59.61 2.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.87 106.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.154 -0.966 . . . . 0.0 109.124 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.5 22.87 5.63 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.86 -21.38 12.86 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.329 -1.101 . . . . 0.0 109.562 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.483 ' CD2' ' CE ' ' A' ' 18' ' ' MET . 0.7 OUTLIER -110.08 21.14 17.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 110.116 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -88.8 -3.23 58.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.055 . . . . 0.0 110.33 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.77 35.1 5.08 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 mt -114.74 134.68 54.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.403 -1.057 . . . . 0.0 109.458 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.86 -6.55 27.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.385 0.612 . . . . 0.0 109.792 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.589 ' CZ ' ' CB ' ' A' ' 8' ' ' SER . 7.6 p90 -124.01 114.37 19.66 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.027 -1.046 . . . . 0.0 108.324 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.513 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -51.94 158.29 3.05 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' N ' ' OE2' ' A' ' 46' ' ' GLU . . . -139.44 99.52 3.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.066 -1.255 . . . . 0.0 107.973 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.532 HG23 ' CD1' ' A' ' 42' ' ' TYR . 0.7 OUTLIER -99.41 172.36 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.884 0.849 . . . . 0.0 110.511 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -141.61 164.93 28.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 38' ' ' ASN . 28.0 mt -148.32 154.18 39.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.904 -1.122 . . . . 0.0 109.893 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 36' ' ' ASP . 1.3 p30 -116.33 128.83 55.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 108.892 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -15.9 76.53 0.0 OUTLIER Glycine 0 N--CA 1.508 3.486 0 C-N-CA 124.505 1.05 . . . . 0.0 112.951 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.8 OUTLIER 162.58 -23.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.06 17.93 21.3 Favored Glycine 0 N--CA 1.48 1.589 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.428 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 0.8 OUTLIER -86.16 152.17 23.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.016 -1.285 . . . . 0.0 107.787 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.487 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 2.1 tp -79.52 144.91 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.829 -1.169 . . . . 0.0 113.034 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 2.0 mt -113.11 -33.85 5.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 174.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.537 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 6.5 tp-100 -169.02 158.75 8.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.588 -0.695 . . . . 0.0 110.227 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.569 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 13.2 t80 -135.75 -54.33 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.375 -0.828 . . . . 0.0 110.128 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 0.8 OUTLIER 95.72 177.59 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 C-N-CA 123.02 0.528 . . . . 0.0 109.641 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.12 -22.5 17.27 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.996 -1.065 . . . . 0.0 113.039 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.0 -68.53 0.21 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.428 -1.42 . . . . 0.0 110.012 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 6.2 pt-20 -63.07 -42.79 99.75 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.749 0.785 . . . . 0.0 109.593 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.78 -17.91 51.45 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -83.68 -29.86 27.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.245 . . . . 0.0 108.423 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.426 HG23 ' CG2' ' A' ' 50' ' ' THR . 0.3 OUTLIER -73.65 -57.48 6.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.619 -0.676 . . . . 0.0 109.287 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.426 ' CG2' HG23 ' A' ' 49' ' ' ILE . 15.6 p -89.84 -8.01 52.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.15 -0.969 . . . . 0.0 110.191 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 89.59 -8.1 80.51 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.531 ' NH2' ' CE1' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -53.58 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.315 -1.109 . . . . 0.0 109.809 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.497 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -68.9 162.75 62.08 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.17 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.27 -57.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.839 1.693 . . . . 0.0 111.124 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -18.51 65.4 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.915 -1.116 . . . . 0.0 110.206 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 -31.64 16.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 109.642 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.543 ' HA ' ' HG2' ' A' ' 60' ' ' LYS . 34.5 m -86.7 10.91 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.043 -1.036 . . . . 0.0 109.499 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.487 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -86.87 121.78 38.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 108.487 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.76 -18.56 54.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.56 ' HD2' ' CG2' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -78.19 167.84 20.77 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.924 -1.339 . . . . 0.0 109.898 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.474 ' O ' HG22 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -106.19 103.65 13.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.531 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 3.1 t80 -50.27 -42.74 52.67 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.521 -0.737 . . . . 0.0 112.245 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.536 ' CG ' ' CD1' ' A' ' 76' ' ' TYR . 36.5 m-85 -89.74 1.9 55.52 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.678 -1.264 . . . . 0.0 112.799 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 4.5 tmtm? -154.32 52.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.62 -1.3 . . . . 0.0 110.495 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 169.93 -15.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.163 -0.96 . . . . 0.0 111.641 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.56 ' CG2' ' HD2' ' A' ' 60' ' ' LYS . 1.4 t -120.17 -57.79 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 122.916 1.341 . . . . 0.0 109.582 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.429 ' HB2' ' C2 ' ' A' ' 126' ' ' HC4 . . . -111.15 101.36 50.07 Favored Pre-proline 0 C--N 1.288 -2.075 0 CA-C-N 114.183 -1.372 . . . . 0.0 109.134 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -72.97 -4.87 16.18 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 122.163 1.909 . . . . 0.0 112.34 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 23.9 p -105.72 -18.53 14.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.727 -1.233 . . . . 0.0 109.57 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.441 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 35.5 p -74.04 -5.35 40.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.996 -1.065 . . . . 0.0 109.486 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -93.28 52.11 1.73 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 108.718 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.495 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -117.04 -178.78 0.56 Allowed Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 36.1 Cg_endo -78.34 -12.54 15.57 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.147 1.898 . . . . 0.0 111.564 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 2.2 mt-10 -100.73 -24.98 14.29 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.867 -1.145 . . . . 0.0 109.618 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.2 t80 -101.31 -70.82 0.73 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 108.702 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CD1' ' CG ' ' A' ' 63' ' ' PHE . 6.0 t80 -72.93 -18.24 61.41 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.981 -1.074 . . . . 0.0 108.672 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.52 -60.89 6.48 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 7.9 mmtt -65.58 -15.22 62.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.938 . . . . 0.0 109.824 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 9.8 t80 -83.14 -35.76 25.3 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -8.93 58.91 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -96.51 -42.35 8.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.432 ' HA3' ' CD1' ' A' ' 88' ' ' LEU . . . -64.2 -39.49 97.14 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.49 HG12 ' CZ ' ' A' ' 118' ' ' TYR . 63.3 t -67.14 -39.62 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.938 -0.743 . . . . 0.0 110.148 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.72 -7.28 59.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.172 -0.955 . . . . 0.0 110.856 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.5 -18.16 13.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.799 -1.188 . . . . 0.0 110.002 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.38 19.68 71.09 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -152.69 57.82 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.247 . . . . 0.0 109.538 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.432 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 0.3 OUTLIER -58.66 120.36 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 109.94 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -160.68 88.78 0.79 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.301 -0.875 . . . . 0.0 108.878 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 t -157.42 158.81 36.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.899 -1.126 . . . . 0.0 110.379 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.9 173.58 11.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 0.0 108.857 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.631 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 7.2 p90 -179.07 152.11 0.54 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.125 -0.984 . . . . 0.0 109.81 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.19 111.38 18.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 109.046 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.57 -178.66 3.46 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.206 -0.934 . . . . 0.0 109.646 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.3 m -151.9 108.74 3.5 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.382 -0.824 . . . . 0.0 109.834 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CD1' ' H2 ' ' A' ' 126' ' ' HC4 . 15.8 m-30 -81.24 118.7 22.82 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -152.3 48.76 0.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.878 -1.139 . . . . 0.0 110.987 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 22.1 p90 -78.31 139.03 38.86 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 98' ' ' TYR . 7.2 pt20 0.68 68.11 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.268 0 CA-C-O 121.847 0.832 . . . . 0.0 111.937 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 98' ' ' TYR . 20.1 ttp -176.71 174.65 1.79 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -52.71 148.17 13.69 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.048 . . . . 0.0 109.044 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.88 146.41 29.6 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.96 1.773 . . . . 0.0 110.994 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.8 m -140.25 123.39 16.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.775 . . . . 0.0 109.264 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -102.83 140.28 37.31 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.503 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 14.0 m -151.99 143.4 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.905 -1.122 . . . . 0.0 110.697 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -92.35 116.82 29.31 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 176.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.631 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -91.39 164.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 120.966 -1.084 . . . . 0.0 110.086 -176.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 19.0 t-160 -159.94 102.36 1.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.442 ' HB3' ' CG2' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -116.14 147.53 41.27 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.095 -1.003 . . . . 0.0 110.239 -177.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.591 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 11.9 ttmt -144.4 179.66 7.12 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.593 -1.317 . . . . 0.0 109.434 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.16 106.91 18.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.04 -1.037 . . . . 0.0 109.248 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.411 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -55.88 137.44 50.34 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.515 -0.741 . . . . 0.0 109.569 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.91 23.19 7.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.809 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.7 m -87.82 -24.06 23.85 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.125 -0.985 . . . . 0.0 109.359 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 177.13 39.85 0.06 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.2 t0 62.7 63.37 0.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -1.121 . . . . 0.0 109.38 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.43 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 10.0 m -114.57 -159.16 0.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.998 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.49 ' CZ ' HG12 ' A' ' 83' ' ' VAL . 28.4 m-85 -149.28 103.0 3.27 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.667 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 11.5 p-90 -103.77 148.03 26.57 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.455 -1.298 . . . . 0.0 112.078 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 109' ' ' MET . 19.3 t -130.48 107.36 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.618 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.667 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 5.1 m-30 -91.53 123.9 35.3 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.294 -0.879 . . . . 0.0 109.609 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 28' ' ' PHE . 1.3 t -105.27 116.8 49.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.019 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.489 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 1.9 tttm -94.96 107.8 19.85 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.43 ' HA ' HG11 ' A' ' 105' ' ' VAL . 18.2 ttp180 -57.47 128.33 36.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.896 -1.127 . . . . 0.0 109.646 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.248 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.54 " O4'" ' OH ' ' A' ' 42' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 64.81 -178.47 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -156.7 27.23 0.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.805 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.404 ' O ' ' O ' ' A' ' 5' ' ' ALA . 2.7 p -91.17 -177.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.043 -1.036 . . . . 0.0 109.114 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.487 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . -58.1 -161.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.444 -0.785 . . . . 0.0 109.412 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -38.98 -67.23 0.22 Allowed 'General case' 0 N--CA 1.518 2.941 0 CA-C-O 122.205 1.003 . . . . 0.0 109.019 179.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.16 28.21 1.24 Allowed Glycine 0 C--N 1.295 -1.739 0 N-CA-C 106.659 -2.576 . . . . 0.0 106.659 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 2.1 m -65.8 126.12 27.48 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.884 -0.774 . . . . 0.0 109.739 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -70.71 83.22 0.62 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.568 -0.707 . . . . 0.0 110.969 -178.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 9' ' ' GLU . 4.7 p-10 37.55 79.39 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.685 -0.635 . . . . 0.0 109.539 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 8' ' ' SER . 4.9 mm -79.22 -57.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.775 -177.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 11' ' ' ILE . 21.4 tt0 -39.36 -29.75 0.05 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.459 -0.776 . . . . 0.0 111.738 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' ILE . 9.8 m-80 -90.59 -40.01 12.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.908 -1.12 . . . . 0.0 108.226 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.403 HG22 ' CD1' ' A' ' 23' ' ' LEU . 4.2 m -69.11 -9.91 55.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.601 -0.687 . . . . 0.0 109.68 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 11' ' ' ILE . 12.4 mt -96.6 -28.01 14.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.012 -1.055 . . . . 0.0 108.787 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.87 2.1 56.75 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.627 -0.671 . . . . 0.0 109.636 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.14 -48.91 0.45 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.936 -1.102 . . . . 0.0 110.167 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.41 ' HB3' ' HG2' ' A' ' 22' ' ' GLN . 20.4 mmt 59.08 168.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.008 -1.058 . . . . 0.0 108.327 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 18' ' ' MET . 0.1 OUTLIER 172.04 -57.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.754 -1.216 . . . . 0.0 111.131 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -87.68 64.77 8.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.009 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.76 20.48 70.9 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.41 ' HG2' ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER 56.42 29.14 14.71 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.387 -1.067 . . . . 0.0 109.204 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.6 mt 45.47 50.14 10.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.573 -0.705 . . . . 0.0 110.236 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -75.32 -17.62 60.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 109.976 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.41 18.52 51.85 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 16.8 mt -54.97 123.36 13.26 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.291 -1.123 . . . . 0.0 109.796 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.01 -18.81 3.91 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.769 0.795 . . . . 0.0 109.075 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 8' ' ' SER . 17.2 p90 -126.25 148.02 49.57 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.232 -0.918 . . . . 0.0 109.016 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -76.84 144.03 29.6 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -115.91 92.07 3.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.905 -1.35 . . . . 0.0 108.331 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.531 HG21 ' CE1' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -96.32 150.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 -178.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -130.0 161.16 31.58 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 23.3 mt -148.18 155.47 41.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.011 -1.056 . . . . 0.0 109.276 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -123.45 138.9 54.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.0 109.411 178.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -5.31 67.95 0.0 OUTLIER Glycine 0 N--CA 1.514 3.87 0 C-N-CA 124.834 1.207 . . . . 0.0 113.364 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 161.25 -23.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 97.98 18.91 25.71 Favored Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 8.2 p30 -84.39 129.96 34.82 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.217 -1.167 . . . . 0.0 108.831 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 58' ' ' ILE . 1.9 tp -54.5 138.12 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 122.202 1.001 . . . . 0.0 112.998 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 34' ' ' ASP . 3.5 mt -111.35 -31.08 7.17 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.553 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 0.5 OUTLIER -167.39 168.81 12.83 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.541 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.531 ' CE1' HG21 ' A' ' 31' ' ' ILE . 14.9 t80 -146.09 -70.65 0.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.073 -1.017 . . . . 0.0 111.16 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.3 p-10 109.45 178.83 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.858 0 C-N-CA 123.931 0.892 . . . . 0.0 108.749 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.4 -26.55 14.82 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.005 -1.059 . . . . 0.0 113.281 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.78 -65.11 0.61 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.316 -1.49 . . . . 0.0 110.707 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.501 ' CD ' ' CE1' ' A' ' 42' ' ' TYR . 2.0 pt-20 -58.79 -53.76 54.7 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.387 0.613 . . . . 0.0 110.071 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.85 -15.75 14.41 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.095 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.47 -37.42 36.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.775 -1.427 . . . . 0.0 108.98 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.52 -55.18 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 108.886 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.442 ' HB ' ' OH ' ' A' ' 98' ' ' TYR . 59.2 p -76.98 -20.45 56.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.67 -0.644 . . . . 0.0 110.115 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.46 -2.33 78.22 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.577 ' CZ ' ' CG1' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -46.54 -47.14 19.64 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.367 -1.078 . . . . 0.0 111.481 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.88 147.14 0.11 Allowed Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.76 -36.57 1.51 Allowed 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.128 1.885 . . . . 0.0 111.647 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -26.83 62.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.56 -40.52 19.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 109.523 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 HG12 ' HB3' ' A' ' 52' ' ' ARG . 27.6 m -73.04 -6.62 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 110.006 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.49 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -70.63 119.56 17.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.081 -1.012 . . . . 0.0 108.386 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.68 -20.95 48.47 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -79.61 145.89 32.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.543 -0.974 . . . . 0.0 108.674 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -89.85 122.21 32.69 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 108.967 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.428 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 79.4 t80 -60.02 -18.12 43.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.038 -1.039 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.449 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 35.9 m-85 -118.19 32.06 6.34 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.035 -1.041 . . . . 0.0 109.611 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.42 -53.6 0.1 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.013 -1.055 . . . . 0.0 110.954 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.32 16.4 9.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.846 -1.159 . . . . 0.0 111.778 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.577 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 41.0 t -118.88 -56.31 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.388 -1.445 . . . . 0.0 108.5 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -118.19 99.07 51.8 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.66 0.71 7.81 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.926 1.751 . . . . 0.0 111.062 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 p -103.31 -25.95 13.12 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.031 -1.043 . . . . 0.0 109.403 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.449 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 59.9 p -71.69 -7.16 46.25 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.381 -0.824 . . . . 0.0 110.096 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -84.81 72.53 10.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 108.984 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.6 172.61 5.67 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.96 . . . . 0.0 109.643 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.92 77.42 3.93 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.358 2.039 . . . . 0.0 110.304 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER 172.36 -36.85 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.552 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.9 t80 -104.14 -65.9 0.99 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.416 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 8.3 t80 -75.55 -20.3 58.74 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -62.82 -60.67 7.37 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 4.4 mmtp -64.87 -17.54 64.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.424 -1.045 . . . . 0.0 109.953 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.49 ' CE2' ' HB2' ' A' ' 118' ' ' TYR . 4.2 t80 -79.35 -36.29 39.61 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -6.9 56.8 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.35 -0.844 . . . . 0.0 108.741 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.1 mm-40 -96.14 -42.63 8.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.47 -40.59 86.5 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.501 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 79.3 t -62.32 -38.58 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.619 -0.93 . . . . 0.0 109.386 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.17 -5.5 56.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 110.716 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.6 t -98.2 -21.91 16.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.772 -1.205 . . . . 0.0 109.788 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.79 25.51 45.58 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -169.85 70.66 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.332 -1.099 . . . . 0.0 108.935 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 0.5 OUTLIER -69.76 117.66 11.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.088 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -161.59 82.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.8 t -140.72 172.18 13.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.028 -1.045 . . . . 0.0 110.487 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -152.69 171.03 18.83 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.688 ' CD1' HG23 ' A' ' 107' ' ' VAL . 14.8 p90 179.73 152.32 0.43 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.001 -1.062 . . . . 0.0 109.929 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -78.88 116.26 19.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.135 -0.978 . . . . 0.0 109.322 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.87 175.1 5.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.337 -0.852 . . . . 0.0 109.589 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -146.03 109.98 4.91 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.461 ' CD1' ' C2 ' ' A' ' 126' ' ' HC4 . 16.0 m-30 -85.25 119.6 25.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.956 . . . . 0.0 109.632 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -147.93 56.79 1.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.446 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -79.61 66.06 4.96 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.045 -0.409 . . . . 0.0 111.439 -178.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.459 ' CG ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER 73.62 25.74 2.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.066 -1.021 . . . . 0.0 109.658 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.81 -171.52 3.1 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.083 -1.01 . . . . 0.0 108.569 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.444 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 71.6 p -57.65 160.99 6.76 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.165 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 32.7 Cg_endo -75.18 124.95 8.89 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.9 1.734 . . . . 0.0 110.257 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 13.1 m -118.43 125.76 50.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.431 -0.793 . . . . 0.0 109.408 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -107.51 138.43 43.73 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.508 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 5.7 m -152.69 142.3 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.048 -1.032 . . . . 0.0 110.194 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.507 ' O ' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -91.01 127.69 36.53 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 174.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.688 HG23 ' CD1' ' A' ' 92' ' ' PHE . 1.4 m -97.93 160.19 3.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 O-C-N 120.634 -1.291 . . . . 0.0 111.475 -174.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.5 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 1.8 t-160 -158.06 100.47 1.71 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.454 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -111.09 146.7 36.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.584 -0.698 . . . . 0.0 109.535 -177.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.605 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.5 tttm -138.76 -163.47 1.47 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.599 -1.313 . . . . 0.0 109.311 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.468 ' HG2' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -103.1 117.23 34.1 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.064 -1.022 . . . . 0.0 108.807 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.446 ' CB ' ' HB2' ' A' ' 117' ' ' SER . . . -72.0 166.63 21.81 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.382 -0.824 . . . . 0.0 110.615 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.434 ' HB2' ' CB ' ' A' ' 116' ' ' ASP . 1.7 mp 59.94 18.03 7.15 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 m 53.37 29.88 9.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.477 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.468 ' HA2' ' HG2' ' A' ' 111' ' ' LYS . . . 134.3 59.77 0.07 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.341 -1.409 . . . . 0.0 109.78 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.434 ' CB ' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t0 -164.89 -60.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.237 . . . . 0.0 110.228 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.446 ' HB2' ' CB ' ' A' ' 112' ' ' ALA . 0.9 OUTLIER -106.16 -161.44 0.8 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.925 -1.109 . . . . 0.0 110.679 -179.241 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.501 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 3.6 m-85 -149.71 121.35 8.04 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.637 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 13.5 p-90 -120.34 144.8 47.66 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.182 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.454 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 27.4 t -116.83 112.15 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.759 -0.588 . . . . 0.0 109.78 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.637 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.6 m-30 -95.61 126.7 41.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 109.41 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.448 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -107.11 119.55 56.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 110.037 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.562 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 3.3 tptp -89.6 109.48 20.43 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.423 ' HA ' HG11 ' A' ' 105' ' ' VAL . 7.2 ttp-105 -68.64 114.82 7.35 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.114 -1.434 . . . . 0.0 109.433 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.096 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.56 " H3'" ' CD ' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.447 ' HA ' ' CE1' ' A' ' 3' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.49 76.01 1.5 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.403 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 1' ' ' MET . 11.5 p-80 -169.53 -178.61 3.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.283 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.43 ' CG1' ' O ' ' A' ' 4' ' ' VAL . 8.3 p -117.77 99.52 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.949 . . . . 0.0 109.655 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.461 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . 49.43 -153.52 0.12 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.198 -0.939 . . . . 0.0 109.85 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -64.02 -46.85 82.63 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.114 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.74 39.05 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.9 -2.08 . . . . 0.0 107.9 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.559 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -68.03 -173.91 0.42 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.12 0.962 . . . . 0.0 111.405 -178.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -125.98 52.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.96 82.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -177.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 8' ' ' SER . 2.9 mm -81.71 -67.37 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 O-C-N 121.305 -0.872 . . . . 0.0 110.592 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.88 -25.49 0.2 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.017 -1.052 . . . . 0.0 111.462 -178.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -82.87 -46.62 12.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.856 -1.153 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 23' ' ' LEU . 1.1 m -66.95 -58.29 5.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.51 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 34.7 mt -38.87 -32.72 0.09 Allowed 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.017 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.75 -56.63 8.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.446 -0.784 . . . . 0.0 109.16 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.55 67.26 0.65 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.379 -0.825 . . . . 0.0 109.111 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.1 ttp -119.46 153.38 35.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.882 . . . . 0.0 109.76 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.29 -57.95 1.98 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 109.044 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -179.22 -57.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.838 . . . . 0.0 109.438 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.86 33.46 5.35 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.63 -44.59 8.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -1.174 . . . . 0.0 109.701 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HG ' ' CD2' ' A' ' 26' ' ' LEU . 1.9 tp -130.86 11.15 5.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.06 -1.025 . . . . 0.0 110.327 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 9.4 m-20 -71.62 -6.26 39.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.612 -1.305 . . . . 0.0 109.515 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.32 26.9 22.81 Favored Glycine 0 N--CA 1.491 2.335 0 O-C-N 120.857 -1.152 . . . . 0.0 110.387 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.516 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 4.8 mt -75.57 -175.14 2.74 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.862 -1.376 . . . . 0.0 108.427 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.98 16.0 22.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.559 ' CD1' ' HE2' ' A' ' 123' ' ' LYS . 1.9 p90 -151.44 -173.77 4.62 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -112.65 137.11 14.0 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 42' ' ' TYR . . . -109.43 89.2 2.93 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.39 1.595 . . . . 0.0 107.755 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -99.53 148.51 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.303 -0.873 . . . . 0.0 110.113 -178.022 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 4.1 mt-30 -120.01 164.54 15.95 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.427 HD23 ' CB ' ' A' ' 62' ' ' PHE . 98.5 mt -152.32 146.05 25.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.094 -1.004 . . . . 0.0 109.083 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' ASP . 7.8 m-20 -124.88 129.9 51.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.943 -1.098 . . . . 0.0 110.522 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 37.4 -77.18 0.0 OUTLIER Glycine 0 N--CA 1.503 3.1 0 C-N-CA 124.589 1.09 . . . . 0.0 113.605 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' ASP . 11.3 m-20 -71.46 -0.57 10.7 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.646 -0.914 . . . . 0.0 111.081 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 84.2 17.63 64.41 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.65 131.33 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.922 -1.34 . . . . 0.0 108.919 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.437 HD12 ' NH1' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -59.93 135.33 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 0.0 110.204 -179.018 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 2.0 mt -105.46 -26.68 11.82 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.434 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -167.04 163.15 15.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.522 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 38.4 t80 -135.34 -107.3 0.22 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.353 -1.467 . . . . 0.0 110.69 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 44' ' ' ALA . 14.3 t-20 157.65 145.91 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.744 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -70.14 -53.12 18.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.548 -0.72 . . . . 0.0 111.587 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.67 -54.39 4.05 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.31 -0.869 . . . . 0.0 111.053 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' CD ' ' CE1' ' A' ' 42' ' ' TYR . 3.8 pt-20 -63.67 -44.1 94.75 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.739 0.781 . . . . 0.0 109.671 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.41 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -59.77 -17.16 41.4 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -85.17 -29.63 24.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.912 -1.346 . . . . 0.0 108.908 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.451 HG23 ' CG2' ' A' ' 50' ' ' THR . 0.5 OUTLIER -77.03 -49.7 22.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.511 -0.743 . . . . 0.0 109.64 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.451 ' CG2' HG23 ' A' ' 49' ' ' ILE . 1.3 p -104.12 -7.23 20.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.963 -1.086 . . . . 0.0 110.748 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 81.83 -2.4 83.48 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.813 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.566 ' NE ' ' CG1' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -39.52 -59.31 1.12 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -1.004 . . . . 0.0 112.666 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.417 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.6 OUTLIER 67.28 146.24 0.11 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.648 -1.282 . . . . 0.0 107.559 -178.108 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.42 -67.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.94 1.76 . . . . 0.0 111.89 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.32 -23.95 1.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.184 -0.948 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.66 -45.48 10.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.788 -1.195 . . . . 0.0 110.081 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.468 HG12 ' CD ' ' A' ' 52' ' ' ARG . 26.0 m -76.87 -0.63 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.056 -1.028 . . . . 0.0 110.036 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.84 124.86 28.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.6 -19.87 52.87 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -79.2 146.38 33.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -1.138 . . . . 0.0 109.138 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -88.55 118.62 28.33 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.427 ' CB ' HD23 ' A' ' 33' ' ' LEU . 74.5 t80 -52.92 -22.11 5.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.515 -0.741 . . . . 0.0 110.22 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -113.11 -10.85 13.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.937 -1.102 . . . . 0.0 111.459 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -135.51 39.74 2.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.78 -1.2 . . . . 0.0 110.217 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 171.93 -14.28 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.91 -1.119 . . . . 0.0 111.966 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.566 ' CG1' ' NE ' ' A' ' 52' ' ' ARG . 10.2 t -115.7 -53.36 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.346 -1.471 . . . . 0.0 109.358 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.426 ' HB2' ' C2 ' ' A' ' 126' ' ' HC4 . . . -119.43 96.92 50.1 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.059 -177.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.71 -2.46 12.61 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.902 1.735 . . . . 0.0 110.409 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.3 p -95.5 -17.04 21.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.099 -1.001 . . . . 0.0 109.75 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.492 HG21 ' CD2' ' A' ' 75' ' ' PHE . 64.5 p -86.62 11.31 13.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -89.37 54.14 2.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 108.87 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . 3.2 p -139.48 173.17 5.39 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 72' ' ' SER . 35.4 Cg_endo -77.14 3.55 6.58 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 C-N-CA 122.109 1.872 . . . . 0.0 111.781 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 32.7 mt-10 -106.45 -28.0 10.59 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.94 -1.1 . . . . 0.0 109.151 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.572 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 2.0 t80 -102.92 -71.19 0.73 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.6 t80 -71.04 -17.18 62.63 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.47 -60.9 6.82 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -61.87 -17.61 57.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -1.059 . . . . 0.0 109.577 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.49 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 9.4 t80 -81.01 -38.8 26.88 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.488 -0.757 . . . . 0.0 109.768 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -76.11 -11.67 59.98 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 109.491 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 13.6 pt-20 -96.87 -40.36 8.96 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.434 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.89 -39.95 97.86 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.495 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 97.0 t -58.03 -44.24 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.719 -0.871 . . . . 0.0 109.268 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.17 -3.48 58.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 110.652 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 t -94.72 -23.3 17.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.916 -1.115 . . . . 0.0 109.579 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 25.5 50.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -174.28 62.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.347 -1.09 . . . . 0.0 108.991 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 tt -55.51 123.73 14.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.145 -0.972 . . . . 0.0 109.584 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 40.2 t30 -160.21 84.52 0.72 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.381 -0.824 . . . . 0.0 109.118 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -138.11 170.99 15.07 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.915 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -159.6 168.59 25.71 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.667 ' CD1' HG23 ' A' ' 107' ' ' VAL . 11.8 p90 176.69 154.97 0.23 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.035 -1.041 . . . . 0.0 109.987 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 1.4 pt-20 -80.96 107.06 13.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.043 -1.035 . . . . 0.0 108.496 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.06 178.97 4.3 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.363 -0.835 . . . . 0.0 109.825 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.6 m -147.12 110.37 4.82 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.504 ' CD1' ' C2 ' ' A' ' 126' ' ' HC4 . 20.1 m-30 -80.96 118.11 22.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.935 . . . . 0.0 109.472 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -148.27 47.01 1.06 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.272 -0.893 . . . . 0.0 110.132 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 29.1 p90 -78.11 136.83 37.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.529 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 1.96 66.1 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.332 0 CA-C-O 121.696 0.76 . . . . 0.0 112.075 -178.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 98' ' ' TYR . 6.0 ttp -177.01 -174.26 0.51 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 t -63.47 149.2 92.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.944 . . . . 0.0 108.917 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.81 156.28 39.39 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.82 1.68 . . . . 0.0 110.894 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.1 m -147.39 148.45 31.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.5 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.432 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -119.93 140.68 50.51 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.491 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 10.1 m -158.24 144.42 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.092 -1.005 . . . . 0.0 110.489 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.533 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -92.38 112.52 24.5 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 174.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.667 HG23 ' CD1' ' A' ' 92' ' ' PHE . 1.4 m -83.27 161.24 3.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 O-C-N 121.366 -0.834 . . . . 0.0 111.86 -174.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -157.23 98.34 1.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.45 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 13.7 mtm -107.97 144.98 34.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.985 -1.072 . . . . 0.0 110.237 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.604 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 5.0 tttt -141.39 -163.4 1.55 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.169 -1.412 . . . . 0.0 110.168 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -103.28 106.55 17.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.953 . . . . 0.0 109.111 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.445 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -54.45 149.07 10.87 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.445 -0.784 . . . . 0.0 110.174 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.52 0.24 57.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.452 -0.78 . . . . 0.0 110.221 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -45.98 82.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.847 -1.158 . . . . 0.0 109.51 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.12 75.19 0.04 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 57.35 62.92 2.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -1.135 . . . . 0.0 109.18 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.473 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -118.74 -169.91 1.81 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.135 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.495 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 3.7 m-85 -151.11 122.01 7.6 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.642 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 10.2 p-90 -121.25 156.61 32.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.707 -1.245 . . . . 0.0 111.954 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.45 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 46.5 t -124.88 112.52 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.353 0.597 . . . . 0.0 110.373 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.642 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 11.2 m-30 -96.91 112.29 24.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.484 HG23 ' CZ ' ' A' ' 96' ' ' PHE . 1.1 t -100.02 116.58 43.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.39 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.583 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 5.6 tptp -89.38 120.5 30.77 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.458 ' HA ' HG11 ' A' ' 105' ' ' VAL . 9.2 ttp180 -73.72 117.69 15.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.77 -1.206 . . . . 0.0 109.35 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.229 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.532 " H3'" ' HG3' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttp . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 55.01 37.7 29.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.491 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -121.41 -25.93 5.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.121 -0.987 . . . . 0.0 110.271 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.429 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 9.1 p -173.23 113.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.89 -1.131 . . . . 0.0 109.994 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.443 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . 54.84 -166.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.008 -1.058 . . . . 0.0 109.592 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -51.72 -58.26 6.9 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.07 33.03 0.3 Allowed Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 1.4 m -71.38 -174.44 1.06 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.837 -0.802 . . . . 0.0 110.93 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -121.14 70.85 0.93 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.426 -0.796 . . . . 0.0 110.536 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 48.67 83.56 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 8' ' ' SER . 1.1 mm -85.77 -62.0 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 111.318 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -45.54 -24.56 0.34 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.972 -1.08 . . . . 0.0 111.023 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -81.66 -46.14 14.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.091 -1.005 . . . . 0.0 109.428 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.433 HG22 ' CD1' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -69.23 -58.45 4.02 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.495 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 43.4 mt -39.47 -31.45 0.09 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.422 0.63 . . . . 0.0 110.102 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.83 -60.1 4.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.27 31.52 2.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.243 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -106.35 123.89 48.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.387 -0.82 . . . . 0.0 109.553 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -79.52 -51.91 8.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.323 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' OD2' ' CB ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER 176.55 -35.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.418 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.94 27.09 20.23 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.939 -1.265 . . . . 0.0 109.939 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -89.61 -37.58 14.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -1.167 . . . . 0.0 109.444 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.433 ' CD1' HG22 ' A' ' 14' ' ' THR . 3.3 mt -138.03 58.81 1.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.404 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -85.87 -1.86 57.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 110.016 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.73 21.26 34.05 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.482 HD21 ' CZ ' ' A' ' 28' ' ' PHE . 68.8 mt -81.21 140.3 35.01 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.141 -1.211 . . . . 0.0 108.735 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.19 3.83 14.19 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.771 0.796 . . . . 0.0 109.177 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 8' ' ' SER . 2.5 p90 -136.55 139.76 42.43 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -74.09 129.5 11.72 Favored Glycine 0 C--N 1.293 -1.832 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.18 117.14 33.87 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.884 -1.363 . . . . 0.0 107.941 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.521 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.1 pp -115.78 144.35 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.33 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.485 ' HB3' HD11 ' A' ' 40' ' ' LEU . 2.9 tt0 -108.71 168.56 9.26 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 21.1 mt -156.64 135.8 12.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.53 -1.356 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -93.96 175.9 6.54 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.87 -55.68 5.43 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.358 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -18.93 57.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.677 -1.484 . . . . 0.0 109.569 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.5 29.09 6.08 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 107.331 -2.307 . . . . 0.0 107.331 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -86.53 130.03 34.64 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.673 -0.898 . . . . 0.0 110.78 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.498 HG21 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -62.73 131.76 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.563 -1.336 . . . . 0.0 110.997 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 2.3 mp -104.76 -19.88 13.78 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' NE2' HD23 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -156.57 161.06 39.98 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.539 ' OH ' ' HD3' ' A' ' 52' ' ' ARG . 9.3 t80 -147.7 -61.96 0.27 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.588 -1.32 . . . . 0.0 111.035 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 1.4 p-10 97.43 175.08 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.5 -17.33 20.59 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.872 -1.143 . . . . 0.0 112.58 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.42 -63.73 1.07 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.549 -1.345 . . . . 0.0 110.298 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 1.6 pt-20 -57.78 -56.44 21.92 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.629 0.728 . . . . 0.0 109.309 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -55.1 -16.56 8.67 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -70.86 -43.62 68.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.733 -1.451 . . . . 0.0 108.759 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 50' ' ' THR . 0.3 OUTLIER -85.1 -55.99 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.443 -0.785 . . . . 0.0 109.552 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.476 ' CG2' " H3'" ' A' ' 126' ' ' HC4 . 33.2 p -72.98 -20.18 61.08 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 0.0 110.318 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 84.9 -6.34 79.08 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HD3' ' OH ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -57.19 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -1.182 . . . . 0.0 110.133 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.428 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 2.7 m-20 -61.2 159.67 27.92 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' CB ' ' OD2' ' A' ' 20' ' ' ASP . 36.6 Cg_endo -79.05 -63.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.791 1.661 . . . . 0.0 110.983 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -56.12 -20.24 16.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.18 -0.95 . . . . 0.0 110.345 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -90.13 -47.37 7.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.914 -1.116 . . . . 0.0 110.021 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 18.4 m -72.86 -4.93 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.03 . . . . 0.0 109.668 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.498 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.78 124.83 26.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.16 -17.05 59.11 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -78.65 138.35 38.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.191 -1.182 . . . . 0.0 109.04 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.448 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -75.55 104.31 6.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.486 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 31.3 t80 -58.52 -19.71 39.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.489 -0.757 . . . . 0.0 110.586 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.443 ' CE2' HD12 ' A' ' 33' ' ' LEU . 22.2 m-85 -85.75 -48.69 8.58 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.297 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.36 37.36 4.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.925 -1.109 . . . . 0.0 109.789 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 1.2 t0 -149.31 -30.91 0.24 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 110.615 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.491 HG12 ' NH1' ' A' ' 52' ' ' ARG . 5.0 t -110.77 -58.91 3.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 120.745 -1.222 . . . . 0.0 108.679 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.433 ' HB3' ' C3 ' ' A' ' 126' ' ' HC4 . . . -104.71 105.66 51.56 Favored Pre-proline 0 C--N 1.29 -1.987 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.594 -178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.62 3.85 6.08 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.058 1.838 . . . . 0.0 111.26 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.2 p -107.15 -17.06 14.26 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.847 -1.158 . . . . 0.0 109.862 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.425 HG23 ' CZ ' ' A' ' 62' ' ' PHE . 24.8 p -83.5 6.0 21.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.962 . . . . 0.0 110.046 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -97.79 52.29 1.08 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.08 -1.012 . . . . 0.0 108.921 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.7 p -129.63 -179.81 1.11 Allowed Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.23 2.19 8.25 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 122.049 1.833 . . . . 0.0 112.028 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.9 mp0 -109.65 -27.96 9.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.86 -1.15 . . . . 0.0 108.985 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -102.52 -70.76 0.74 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.7 t80 -68.72 -17.48 64.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.81 -62.84 4.89 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 5.3 mmtt -61.64 -16.53 49.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.448 -1.031 . . . . 0.0 109.502 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 17.1 t80 -82.11 -39.43 23.35 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.58 -0.7 . . . . 0.0 110.195 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.9 -12.15 60.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.925 -1.109 . . . . 0.0 109.311 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 19.9 pt-20 -97.1 -41.01 8.55 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.442 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.07 -39.89 98.57 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 97.4 t -60.11 -54.33 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.746 -0.856 . . . . 0.0 109.188 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.86 -2.14 35.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.398 -0.814 . . . . 0.0 110.454 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.1 t -90.63 -34.27 15.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.045 -1.034 . . . . 0.0 109.543 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.31 19.4 30.47 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -175.43 64.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -1.138 . . . . 0.0 108.945 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.444 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -51.27 123.68 10.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.856 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -161.1 89.67 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.115 -0.991 . . . . 0.0 108.77 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.4 t -153.23 172.65 16.65 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.825 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.62 174.51 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.622 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 7.3 p90 178.69 152.79 0.34 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.769 -1.207 . . . . 0.0 110.441 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -79.46 117.18 20.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.893 . . . . 0.0 108.777 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.19 175.18 6.07 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.038 -1.039 . . . . 0.0 110.359 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.7 m -147.25 110.32 4.78 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.517 ' CD1' ' C2 ' ' A' ' 126' ' ' HC4 . 19.7 m-85 -80.14 119.79 23.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -131.14 42.41 3.22 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.604 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -78.29 79.55 4.73 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.3 0.572 . . . . 0.0 110.391 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.577 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 5.3 pt20 52.52 38.94 26.94 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.675 0.75 . . . . 0.0 109.656 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.73 -168.9 3.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.387 -0.821 . . . . 0.0 109.369 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.414 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.6 t -67.24 150.54 97.84 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.8 . . . . 0.0 108.921 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.414 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.5 Cg_endo -74.56 82.64 1.87 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.86 1.707 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.4 m -69.93 98.9 1.33 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.497 -0.752 . . . . 0.0 109.607 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.24 133.95 44.13 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.497 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 16.3 m -150.0 146.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.365 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -94.62 116.78 29.17 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 175.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.622 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -88.26 164.4 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.741 -1.224 . . . . 0.0 111.553 -175.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.437 ' ND1' ' HA ' ' A' ' 5' ' ' ALA . 21.3 t-160 -147.42 146.88 29.74 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 175.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.448 ' CE ' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -152.33 137.86 17.74 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.6 -1.312 . . . . 0.0 109.345 -178.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.592 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 25.4 tttt -150.3 158.9 44.66 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.402 -1.319 . . . . 0.0 109.904 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.444 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 4.7 ttmt -72.36 109.88 6.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 109.048 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.525 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -72.03 176.24 5.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.442 -0.787 . . . . 0.0 111.008 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.28 21.07 12.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.551 -0.718 . . . . 0.0 109.119 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.4 m 55.44 25.17 7.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.318 -0.864 . . . . 0.0 109.076 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 111' ' ' LYS . . . 126.63 74.49 0.21 Allowed Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.508 -1.33 . . . . 0.0 110.13 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 178.52 -42.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.9 -1.353 . . . . 0.0 110.533 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 111' ' ' LYS . 55.7 m -113.8 179.48 3.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.006 -1.059 . . . . 0.0 110.594 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.485 ' CE1' HG23 ' A' ' 83' ' ' VAL . 16.6 m-85 -132.38 132.11 42.53 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.683 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 17.4 p-90 -136.28 155.24 50.37 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.63 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.448 HG23 ' CE ' ' A' ' 109' ' ' MET . 83.3 t -140.42 109.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.804 -0.56 . . . . 0.0 110.049 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.683 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 3.8 m-30 -91.36 135.13 34.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.991 -1.068 . . . . 0.0 109.319 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.49 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -110.42 119.23 58.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.24 -0.912 . . . . 0.0 109.72 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -89.03 108.55 19.65 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HA ' HG11 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -67.56 116.91 8.82 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.474 -1.29 . . . . 0.0 109.468 -178.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.115 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.517 ' C2 ' ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.72 -38.36 67.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.92 . . . . 0.0 109.684 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 63.02 113.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.401 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 6' ' ' PHE . 7.3 p -161.09 146.67 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.508 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . . . 46.22 -85.5 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.307 0.575 . . . . 0.0 111.592 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.604 ' CD1' ' CD ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -164.73 -45.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 -178.179 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.46 24.34 0.96 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.523 ' CB ' ' CZ ' ' A' ' 28' ' ' PHE . 84.0 p -76.94 142.46 40.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -1.082 . . . . 0.0 109.634 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -53.17 -34.96 59.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.234 1.016 . . . . 0.0 108.567 178.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 0.8 OUTLIER 157.74 95.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 121' ' ' PHE . 0.3 OUTLIER -75.16 -68.67 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.529 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.558 -177.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 11' ' ' ILE . 3.2 tm-20 -37.98 -33.63 0.09 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.697 -0.627 . . . . 0.0 111.663 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.39 -44.28 16.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.919 -1.113 . . . . 0.0 108.597 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' MET . 2.7 m -69.55 -8.54 48.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.746 -0.597 . . . . 0.0 109.605 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' CD1' HG21 ' A' ' 11' ' ' ILE . 28.7 mt -97.97 -22.06 16.5 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.819 -1.175 . . . . 0.0 109.316 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.98 -21.3 18.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.969 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -136.0 73.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.831 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' THR . 11.0 tmm? -139.13 116.45 11.17 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.291 -0.881 . . . . 0.0 109.311 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.21 -74.78 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.694 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.87 58.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.077 -1.015 . . . . 0.0 109.611 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.08 37.88 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -132.39 -27.59 1.75 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -1.074 . . . . 0.0 110.483 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -103.33 -13.48 16.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.723 -1.236 . . . . 0.0 110.207 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' N ' HD22 ' A' ' 23' ' ' LEU . 19.4 p30 -68.94 -17.41 63.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.955 -1.09 . . . . 0.0 110.028 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -100.83 35.83 4.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 28' ' ' PHE . 85.1 mt -99.63 124.57 44.98 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.44 -1.035 . . . . 0.0 109.838 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.12 -12.92 14.05 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.824 0.821 . . . . 0.0 108.916 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.546 ' CE1' HD11 ' A' ' 11' ' ' ILE . 2.7 p90 -113.82 -172.43 2.08 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.164 -0.96 . . . . 0.0 108.612 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -122.98 136.16 10.43 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 108.131 -1.988 . . . . 0.0 108.131 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.91 111.25 21.39 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.894 -1.356 . . . . 0.0 108.318 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.531 HG21 ' CD1' ' A' ' 42' ' ' TYR . 0.8 OUTLIER -120.81 140.27 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.493 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 9.3 mt-30 -107.23 170.55 7.89 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 80.1 mt -151.47 142.84 23.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.988 -1.07 . . . . 0.0 109.971 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 36' ' ' ASP . 0.3 OUTLIER -115.11 137.43 52.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.077 -1.014 . . . . 0.0 109.365 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -10.89 71.21 0.0 OUTLIER Glycine 0 N--CA 1.513 3.824 0 C-N-CA 124.674 1.13 . . . . 0.0 113.378 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER 162.58 -24.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.04 18.37 22.44 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 16.3 p-10 -84.9 129.04 34.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.146 -1.208 . . . . 0.0 108.893 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 1.1 mp -63.24 137.26 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.075 0.94 . . . . 0.0 111.282 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 1.7 mt -108.27 -28.45 9.44 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.404 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -155.0 161.14 41.46 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.531 ' CD1' HG21 ' A' ' 31' ' ' ILE . 48.3 t80 -149.14 -73.35 0.18 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.54 -1.35 . . . . 0.0 111.071 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 10.1 p-10 109.06 178.19 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 123.999 0.92 . . . . 0.0 109.641 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.9 15.09 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.051 -1.031 . . . . 0.0 113.258 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -51.75 -63.77 1.03 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.254 -1.528 . . . . 0.0 110.563 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' OE2' HG21 ' A' ' 31' ' ' ILE . 1.2 pt-20 -57.39 -54.62 44.74 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.625 0.726 . . . . 0.0 109.609 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.41 -14.87 21.81 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.57 -34.89 46.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.874 -1.368 . . . . 0.0 109.478 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.408 HG23 HG21 ' A' ' 50' ' ' THR . 0.5 OUTLIER -86.69 -47.91 15.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.251 -0.905 . . . . 0.0 109.679 -179.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.44 ' HA ' ' CE ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -86.41 -31.92 21.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.176 -0.952 . . . . 0.0 109.74 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.41 -3.41 56.5 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.928 -1.129 . . . . 0.0 110.438 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.54 ' NH2' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -41.9 -48.04 4.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.321 -1.105 . . . . 0.0 112.492 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 66.1 146.18 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.727 -1.233 . . . . 0.0 107.737 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.77 -63.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.949 1.766 . . . . 0.0 112.118 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.22 -21.65 14.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.011 . . . . 0.0 111.193 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -88.07 -41.1 13.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.868 -1.145 . . . . 0.0 109.878 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 52' ' ' ARG . 15.2 m -81.89 3.32 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 110.021 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.44 120.84 20.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.091 -1.006 . . . . 0.0 108.546 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.8 -11.4 70.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -80.36 141.4 35.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.949 -1.324 . . . . 0.0 109.849 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -81.59 92.99 6.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.907 . . . . 0.0 109.005 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.54 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 25.8 t80 -54.1 -22.33 10.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CD1' ' CD1' ' A' ' 76' ' ' TYR . 7.0 m-85 -85.84 -31.45 22.27 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.48 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.39 47.4 1.39 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 108.935 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.7 OUTLIER -165.47 -33.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.388 -0.82 . . . . 0.0 110.345 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.452 ' CG1' ' HD3' ' A' ' 52' ' ' ARG . 9.9 t -106.93 -56.97 4.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 120.76 -1.213 . . . . 0.0 109.002 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.415 ' HB2' ' C2 ' ' A' ' 126' ' ' HC4 . . . -104.4 101.26 26.26 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.902 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -75.98 -0.38 10.2 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 C-N-CA 121.803 1.669 . . . . 0.0 110.522 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 p -100.54 -23.2 14.75 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.072 -1.017 . . . . 0.0 109.694 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.495 HG23 ' CE1' ' A' ' 75' ' ' PHE . 10.8 p -82.12 3.88 25.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.168 -0.958 . . . . 0.0 110.044 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -91.21 51.16 1.87 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.924 -1.11 . . . . 0.0 108.77 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.47 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -121.13 179.05 1.01 Allowed Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -78.85 -6.09 14.97 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.931 1.754 . . . . 0.0 111.223 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 14.3 mm-40 -103.18 -24.15 13.59 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.896 -1.127 . . . . 0.0 109.656 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.495 ' CE1' HG23 ' A' ' 70' ' ' THR . 1.5 t80 -103.61 -70.44 0.76 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 21.0 t80 -71.83 -19.67 61.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.92 -1.113 . . . . 0.0 108.442 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.48 -61.51 6.21 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 2.3 mmtp -63.04 -15.78 57.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.964 . . . . 0.0 109.496 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.461 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 6.9 t80 -78.65 -40.49 34.01 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -77.91 -7.02 56.19 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -95.75 -39.51 9.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.27 -43.08 64.3 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.497 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 59.1 t -58.25 -37.3 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.738 -0.86 . . . . 0.0 109.192 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.12 -4.22 46.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.459 -0.776 . . . . 0.0 110.982 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 m -100.38 -18.22 16.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.781 -1.199 . . . . 0.0 110.224 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.77 16.3 77.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.86 63.43 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -1.207 . . . . 0.0 108.846 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.424 ' CB ' ' HB2' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -65.31 112.68 3.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 109.854 -179.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -160.78 85.07 0.69 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.409 -0.807 . . . . 0.0 108.912 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -133.1 144.93 50.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.061 -1.024 . . . . 0.0 110.434 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.5 ptp -132.74 154.64 50.01 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CD2' HG23 ' A' ' 107' ' ' VAL . 9.9 p90 -169.19 -173.3 1.71 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.755 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.63 110.37 20.47 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.95 172.71 6.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.495 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 89.3 m -143.41 111.72 6.27 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.442 -0.787 . . . . 0.0 109.042 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.537 ' CE2' " C5'" ' A' ' 126' ' ' HC4 . 15.5 m-30 -83.8 117.13 23.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.281 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -147.13 47.04 1.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.94 . . . . 0.0 109.88 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 21.3 p90 -78.6 137.08 37.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.515 ' C ' ' O ' ' A' ' 98' ' ' TYR . 5.3 pt20 1.51 66.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.114 0 CA-C-O 121.539 0.685 . . . . 0.0 112.371 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 98' ' ' TYR . 67.7 ttp -162.98 -93.54 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.502 -0.749 . . . . 0.0 109.396 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.404 ' OG1' ' HG2' ' A' ' 100' ' ' MET . 0.2 OUTLIER -149.17 161.5 31.99 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.812 -1.18 . . . . 0.0 108.664 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.95 115.36 4.0 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.024 1.816 . . . . 0.0 110.357 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 m -123.58 128.08 49.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.662 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.42 143.61 33.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.509 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 15.2 m -152.82 141.97 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.773 -1.204 . . . . 0.0 110.777 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.543 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -83.43 115.94 22.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 174.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 92' ' ' PHE . 32.7 m -98.85 156.22 3.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 120.838 -1.164 . . . . 0.0 110.929 -175.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -159.99 104.48 1.52 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.482 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 6.4 mtm -110.23 145.53 37.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.429 -0.794 . . . . 0.0 109.772 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.591 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.9 tttm -138.0 -177.59 4.89 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.873 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.424 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 5.1 ttmm -91.04 99.9 12.85 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.07 123.94 6.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.408 -0.807 . . . . 0.0 110.057 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.63 -17.85 37.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.962 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 m -53.62 -27.46 27.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.009 -1.057 . . . . 0.0 109.188 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -166.18 33.24 0.23 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t70 57.12 33.87 24.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -1.127 . . . . 0.0 109.163 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.48 -163.23 0.77 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.375 -0.828 . . . . 0.0 110.166 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.497 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 22.7 m-85 -139.54 113.46 8.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.724 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 11.1 p-90 -114.95 141.68 47.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.527 -1.269 . . . . 0.0 112.325 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.482 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 61.5 t -113.99 116.23 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.724 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 18.9 m-30 -99.05 127.63 45.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.002 -1.061 . . . . 0.0 109.287 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.46 ' CG2' ' CE2' ' A' ' 96' ' ' PHE . 2.0 t -116.3 113.09 42.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.025 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.604 ' CD ' ' CD1' ' A' ' 6' ' ' PHE . 8.1 tttm -96.62 120.73 37.49 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.402 ' HA ' HG11 ' A' ' 105' ' ' VAL . 1.9 ttt180 -65.67 121.34 14.74 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.707 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.509 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.183 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.537 " C5'" ' CE2' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 57.86 -93.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.834 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -64.43 177.7 0.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.732 -1.23 . . . . 0.0 109.551 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -76.05 -160.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.458 ' N ' ' CG1' ' A' ' 4' ' ' VAL . . . -85.63 133.99 34.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.35 -0.844 . . . . 0.0 110.545 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.548 ' CZ ' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -65.74 -56.84 9.9 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 11' ' ' ILE . . . -54.44 -26.9 39.18 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.55 -2.22 . . . . 0.0 107.55 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER 44.86 -165.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.198 0.999 . . . . 0.0 112.013 177.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -61.08 81.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.98 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' C ' ' O ' ' A' ' 9' ' ' GLU . 69.1 m-20 26.64 76.91 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.848 0 CA-C-N 118.571 0.623 . . . . 0.0 110.29 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.571 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 1.2 mm -58.38 -68.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.148 -0.97 . . . . 0.0 110.053 -177.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.89 -28.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.8 -0.562 . . . . 0.0 112.31 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 11' ' ' ILE . 16.1 m120 -72.94 -50.87 20.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.758 -1.213 . . . . 0.0 109.576 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.424 HG22 ' HB2' ' A' ' 23' ' ' LEU . 1.1 m -68.24 -54.85 14.82 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.515 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 51.8 mt -43.34 -32.05 0.75 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.249 0.547 . . . . 0.0 110.244 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.72 -44.07 29.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.84 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -114.66 62.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.629 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.439 ' CG ' ' HB3' ' A' ' 22' ' ' GLN . 9.0 tmm? -129.4 143.36 50.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.346 -0.846 . . . . 0.0 109.17 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -81.33 -65.8 0.97 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.264 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.25 -48.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.679 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.29 25.92 21.98 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.439 ' HB3' ' CG ' ' A' ' 18' ' ' MET . 15.0 tt0 -88.48 -60.5 1.94 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -1.19 . . . . 0.0 109.274 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 1.8 mp -126.63 60.47 1.34 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 0.0 109.339 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -109.27 -11.03 14.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.092 -1.005 . . . . 0.0 110.038 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.56 27.74 16.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.428 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 1.7 mt -71.59 -168.43 0.34 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.149 -1.206 . . . . 0.0 109.13 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.98 -4.24 14.58 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.576 ' CZ ' ' CB ' ' A' ' 8' ' ' SER . 7.2 p90 -134.68 112.09 10.51 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.216 -0.928 . . . . 0.0 109.072 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.648 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -49.82 161.62 0.92 Allowed Glycine 0 C--N 1.289 -2.048 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HB2' HD12 ' A' ' 15' ' ' LEU . . . -145.49 129.82 17.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.819 -1.401 . . . . 0.0 108.457 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.506 HG22 ' CE1' ' A' ' 42' ' ' TYR . 1.8 pp -131.84 157.63 43.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.772 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.433 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 45.8 mt-30 -116.39 163.27 16.29 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 17.6 mt -147.57 144.0 28.16 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.867 -1.145 . . . . 0.0 110.467 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.435 ' N ' HD22 ' A' ' 40' ' ' LEU . 30.5 t70 -96.54 165.87 11.96 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -44.08 -22.48 0.33 Allowed Glycine 0 N--CA 1.5 2.931 0 C-N-CA 121.336 -0.459 . . . . 0.0 113.281 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.1 15.94 22.71 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.342 -1.681 . . . . 0.0 110.858 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.03 26.25 67.06 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 34.2 m-80 -94.33 131.19 40.21 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.99 -1.3 . . . . 0.0 110.964 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.471 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 1.1 tp -61.83 138.07 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.825 -1.172 . . . . 0.0 111.286 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 34' ' ' ASP . 2.3 mt -110.64 -28.24 8.56 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 177.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.459 ' NE2' ' N ' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -152.68 150.12 29.13 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.589 ' OH ' " O4'" ' A' ' 126' ' ' HC4 . 4.7 t80 -130.89 -54.03 1.06 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.323 -1.486 . . . . 0.0 111.374 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.495 ' OD1' ' HG3' ' A' ' 46' ' ' GLU . 0.4 OUTLIER 89.6 177.77 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.37 -38.39 9.65 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.937 -1.102 . . . . 0.0 113.681 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.87 -62.68 1.13 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.64 -1.287 . . . . 0.0 111.552 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.648 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -59.09 -49.16 78.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.47 -0.769 . . . . 0.0 110.932 -179.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.21 -15.08 42.97 Favored Glycine 0 C--N 1.281 -2.477 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -83.63 -30.0 27.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.96 -1.317 . . . . 0.0 108.888 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.44 HG23 HG21 ' A' ' 50' ' ' THR . 0.2 OUTLIER -82.01 -55.32 8.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.405 -0.809 . . . . 0.0 109.144 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.475 HG23 " C4'" ' A' ' 126' ' ' HC4 . 1.2 p -84.41 -11.49 56.15 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.242 -0.911 . . . . 0.0 109.903 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.36 -5.84 81.91 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.585 ' NH2' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -52.35 123.6 11.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -1.159 . . . . 0.0 110.478 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.451 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 1.4 m-20 -89.85 154.97 47.93 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 -54.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.708 1.605 . . . . 0.0 111.37 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -22.15 66.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 110.668 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.81 -41.85 11.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.955 -1.091 . . . . 0.0 109.96 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.48 ' CG1' ' HD3' ' A' ' 52' ' ' ARG . 14.4 m -77.61 -1.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.728 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.471 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -71.65 122.48 23.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.64 -15.07 61.25 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -79.13 138.76 38.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.139 -1.212 . . . . 0.0 108.877 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -76.38 109.35 10.02 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.585 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 8.5 t80 -68.79 -20.54 64.34 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.632 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.44 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 3.6 m-85 -85.06 -4.05 59.02 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.957 -1.097 . . . . 0.0 111.393 -177.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 23.0 mttt -155.99 -46.37 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.731 -1.231 . . . . 0.0 110.857 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.53 -3.41 53.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.984 -1.072 . . . . 0.0 112.299 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.492 HG12 ' HD3' ' A' ' 52' ' ' ARG . 5.7 t -126.45 -59.37 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 120.304 -1.498 . . . . 0.0 109.286 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.65 106.95 59.67 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.625 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.12 2.32 7.3 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.796 1.664 . . . . 0.0 111.698 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.429 ' O ' ' OH ' ' A' ' 94' ' ' TYR . 30.7 p -105.33 -18.83 13.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.861 -1.149 . . . . 0.0 109.78 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.528 ' CG2' ' CZ ' ' A' ' 62' ' ' PHE . 71.1 p -75.35 -2.12 26.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 110.28 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -90.68 53.31 2.39 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.878 -1.139 . . . . 0.0 108.789 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.469 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -124.71 178.18 1.53 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.488 -0.758 . . . . 0.0 109.237 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.39 -1.2 11.39 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 122.238 1.959 . . . . 0.0 111.428 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.4 mp0 -109.44 -25.83 10.3 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.92 -1.112 . . . . 0.0 109.248 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -100.98 -70.36 0.74 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.063 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -72.12 -18.27 61.91 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.094 -1.004 . . . . 0.0 108.341 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.82 -64.9 3.23 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 1.4 mmtp -62.48 -16.77 57.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.561 -0.964 . . . . 0.0 109.878 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.485 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 9.1 t80 -83.5 -36.98 23.68 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.602 -0.687 . . . . 0.0 109.872 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.22 -12.57 60.11 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.173 -0.954 . . . . 0.0 109.081 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 19.4 pt-20 -97.23 -42.36 7.85 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -60.03 -39.25 95.45 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 107.521 -2.232 . . . . 0.0 107.521 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 90.3 t -60.88 -45.36 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.784 -0.833 . . . . 0.0 109.46 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.19 -3.11 57.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.219 -0.926 . . . . 0.0 110.622 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.49 -24.61 15.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.85 -1.156 . . . . 0.0 109.451 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.71 15.1 74.06 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -156.19 56.01 0.58 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -1.176 . . . . 0.0 108.66 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.24 120.73 4.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 110.113 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.41 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 17.1 p30 -160.52 88.41 0.79 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 108.947 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -146.86 169.02 19.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.209 -0.932 . . . . 0.0 110.129 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -154.98 170.38 21.89 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.648 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 6.5 p90 179.53 152.52 0.42 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.872 -1.142 . . . . 0.0 110.222 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -80.75 111.93 17.65 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.429 ' OH ' ' O ' ' A' ' 69' ' ' CYS . 0.1 OUTLIER -112.88 -178.85 3.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.084 -1.01 . . . . 0.0 109.984 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 79.6 m -146.09 109.73 4.81 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -79.3 93.41 5.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 108.665 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -115.84 31.17 6.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.37 -0.831 . . . . 0.0 109.686 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.582 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.85 159.11 27.96 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.817 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.494 ' C ' ' O ' ' A' ' 98' ' ' TYR . 1.5 pp0? -4.56 67.65 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 123.532 0.733 . . . . 0.0 112.547 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.582 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.78 -157.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.608 -0.683 . . . . 0.0 109.195 -178.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.419 ' CB ' ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -90.96 174.78 4.15 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 108.834 179.154 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 101' ' ' THR . 36.1 Cg_endo -79.15 103.77 1.68 Allowed 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.07 1.847 . . . . 0.0 110.749 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.42 HG21 HG12 ' A' ' 105' ' ' VAL . 9.2 m -99.11 145.27 27.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.114 -0.991 . . . . 0.0 108.926 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.43 135.82 54.58 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.507 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 11.5 m -153.5 145.67 14.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.973 -1.079 . . . . 0.0 110.862 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.548 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 3.0 ptmt -94.28 114.7 26.83 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.573 -2.381 . . . . 0.0 104.573 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.648 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -86.72 164.76 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.882 -1.136 . . . . 0.0 110.315 -176.588 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.492 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 17.6 t-160 -159.71 101.94 1.5 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.467 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.89 148.77 36.19 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.109 -0.995 . . . . 0.0 110.002 -177.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.584 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.2 tttt -144.11 178.82 7.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.669 -1.269 . . . . 0.0 109.309 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.49 106.81 15.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.885 -1.134 . . . . 0.0 108.693 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.434 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -52.5 155.55 2.12 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 110.5 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.1 -15.43 18.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.548 -0.72 . . . . 0.0 109.837 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 t -50.34 -25.31 3.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.13 -0.981 . . . . 0.0 109.651 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 170.84 47.59 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.85 57.12 4.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.29 -1.123 . . . . 0.0 108.828 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -100.64 -157.69 0.62 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.428 -0.795 . . . . 0.0 109.904 -179.44 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.429 ' CE1' HG23 ' A' ' 83' ' ' VAL . 12.0 m-85 -145.76 102.66 3.69 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.657 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 11.2 p-90 -106.32 143.69 34.07 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.551 -1.26 . . . . 0.0 111.973 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.467 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 43.9 t -121.45 107.87 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.497 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.657 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 8.9 m-30 -92.94 123.08 35.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -0.854 . . . . 0.0 109.575 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.447 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -102.56 118.1 48.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.37 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.505 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 1.4 tttp -96.85 106.68 19.04 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HA ' HG11 ' A' ' 105' ' ' VAL . 6.3 ttt180 -53.92 135.92 41.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.795 -1.191 . . . . 0.0 109.671 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.194 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.589 " O4'" ' OH ' ' A' ' 42' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.07 -79.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.226 -0.921 . . . . 0.0 109.603 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -137.23 -172.35 3.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.058 -1.026 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.473 ' O ' ' N ' ' A' ' 8' ' ' SER . 7.6 p -113.76 91.84 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.056 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.492 ' O ' ' OG ' ' A' ' 8' ' ' SER . . . 60.36 50.23 6.28 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.041 -1.037 . . . . 0.0 110.27 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.597 ' CE1' ' CD ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER 68.57 14.73 9.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.866 -1.771 . . . . 0.0 107.134 -178.267 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.549 ' CA ' ' HE3' ' A' ' 123' ' ' LYS . . . 106.24 -10.91 43.71 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 28' ' ' PHE . 1.6 p -80.22 147.2 31.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.887 -1.36 . . . . 0.0 112.594 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -96.81 54.5 1.3 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.77 74.38 0.44 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.57 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 3.4 mm -75.1 -57.37 6.54 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 O-C-N 121.372 -0.83 . . . . 0.0 110.428 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.4 tt0 -36.18 -33.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.848 -0.532 . . . . 0.0 112.066 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 11' ' ' ILE . 1.5 m120 -84.74 -43.18 14.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.938 -1.101 . . . . 0.0 108.316 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 11' ' ' ILE . 2.9 m -69.78 -8.1 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.727 -0.608 . . . . 0.0 109.987 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.495 ' CD2' ' HG ' ' A' ' 23' ' ' LEU . 15.2 mt -96.77 -22.2 17.09 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.951 -1.093 . . . . 0.0 109.278 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.92 -31.04 61.44 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.328 -0.857 . . . . 0.0 108.77 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -133.74 16.01 3.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.269 -0.894 . . . . 0.0 109.698 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.461 ' HA ' ' CE ' ' A' ' 18' ' ' MET . 0.0 OUTLIER 61.13 163.59 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.978 -1.076 . . . . 0.0 109.535 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 18' ' ' MET . 0.1 OUTLIER 167.8 153.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.14 87.41 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.091 -1.006 . . . . 0.0 109.137 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.59 21.38 66.9 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 50.25 35.75 11.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -1.173 . . . . 0.0 109.844 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 1.1 tm? 61.28 81.6 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 109.225 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.34 -39.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 109.197 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.53 24.65 24.69 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.536 ' CD2' ' CZ ' ' A' ' 28' ' ' PHE . 3.5 mp -77.19 157.21 31.04 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.32 -1.106 . . . . 0.0 108.446 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.32 12.67 13.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 8' ' ' SER . 0.7 OUTLIER -154.06 112.75 3.64 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -49.6 159.03 1.22 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.413 ' N ' ' OE1' ' A' ' 46' ' ' GLU . . . -134.85 114.63 12.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.519 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.6 pp -117.1 158.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 110.636 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.44 ' HB2' ' HG3' ' A' ' 41' ' ' GLN . 24.3 mm-40 -125.89 170.36 11.73 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 63' ' ' PHE . 83.8 mt -157.39 147.56 20.8 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.28 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' ASP . 29.1 m-20 -126.64 127.03 44.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.059 -1.026 . . . . 0.0 109.913 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.02 -77.54 0.0 OUTLIER Glycine 0 N--CA 1.502 3.041 0 C-N-CA 124.578 1.085 . . . . 0.0 113.609 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -69.69 -3.23 14.35 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.535 -0.979 . . . . 0.0 110.933 -178.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 87.36 17.59 58.6 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 34' ' ' ASP . 8.1 p30 -73.7 129.5 38.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -1.199 . . . . 0.0 108.835 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.474 HG21 ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -58.56 136.45 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 110.441 -178.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 6.9 mt -101.6 -29.59 11.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -160.0 176.97 11.22 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 12.9 t80 -156.11 -48.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.695 -1.253 . . . . 0.0 110.076 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 0.6 OUTLIER 89.43 176.5 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.257 0.551 . . . . 0.0 109.929 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.83 -20.54 18.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.244 -0.91 . . . . 0.0 112.485 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.3 -66.62 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.547 -1.345 . . . . 0.0 110.33 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.521 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 5.1 pt-20 -61.23 -49.4 77.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.956 . . . . 0.0 110.03 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -61.03 -14.24 37.9 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 21.7 t0 -80.76 -34.11 34.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.725 -1.456 . . . . 0.0 108.846 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.426 HG23 HG21 ' A' ' 50' ' ' THR . 1.0 OUTLIER -82.94 -54.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.197 -0.94 . . . . 0.0 108.849 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.476 ' CG2' " H3'" ' A' ' 126' ' ' HC4 . 26.7 p -78.82 -24.14 44.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.402 -0.811 . . . . 0.0 109.768 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 97.14 -13.8 64.39 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.516 ' NH1' ' CE2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -58.35 90.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -1.207 . . . . 0.0 109.971 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -61.54 166.86 4.97 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.176 -0.952 . . . . 0.0 109.284 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.15 -54.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 122.149 1.899 . . . . 0.0 110.759 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -65.93 -24.23 66.78 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.974 -1.079 . . . . 0.0 109.848 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -44.39 17.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.88 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' A' ' 52' ' ' ARG . 33.1 m -73.96 -3.13 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.189 -0.944 . . . . 0.0 109.836 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.474 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.73 123.31 23.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 120.976 -1.078 . . . . 0.0 108.422 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.41 -18.77 53.75 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -79.64 127.2 31.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.228 -1.16 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.435 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -67.61 104.69 1.67 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.287 -0.883 . . . . 0.0 108.714 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.452 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 84.6 t80 -55.45 -17.21 4.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.48 -0.763 . . . . 0.0 110.651 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.48 ' CE2' HD11 ' A' ' 33' ' ' LEU . 29.3 m-85 -94.11 -38.15 11.25 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.048 -1.032 . . . . 0.0 110.73 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 0.1 OUTLIER -134.67 42.8 2.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.962 -1.086 . . . . 0.0 109.201 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.435 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.3 OUTLIER -159.2 -32.52 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 110.235 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.489 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 9.3 t -109.12 -51.4 6.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 O-C-N 120.787 -1.196 . . . . 0.0 108.14 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' HB3' ' C2 ' ' A' ' 126' ' ' HC4 . . . -116.43 97.41 49.89 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.141 -178.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.22 -1.41 10.91 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.113 1.875 . . . . 0.0 111.251 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 p -95.35 -26.73 15.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.655 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 72' ' ' SER . 70.9 p -66.62 -36.37 82.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.387 -0.82 . . . . 0.0 109.744 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.92 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.168 -0.957 . . . . 0.0 109.054 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 177.67 170.52 0.44 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 109.291 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.3 80.83 2.61 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.558 2.172 . . . . 0.0 110.809 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER 168.08 -36.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CD1' ' HE2' ' A' ' 109' ' ' MET . 1.8 t80 -109.84 -67.06 1.01 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 9.3 t80 -75.58 -17.24 60.11 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.68 -58.2 11.97 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -61.89 -18.62 60.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.609 -0.936 . . . . 0.0 109.594 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.515 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 9.7 t80 -81.02 -38.47 27.42 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.452 -0.78 . . . . 0.0 109.639 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.83 -12.42 60.38 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.01 -1.056 . . . . 0.0 109.463 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 12.8 pt-20 -96.85 -41.0 8.65 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -62.21 -39.11 97.26 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.517 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 90.8 t -61.68 -39.85 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.789 -0.83 . . . . 0.0 109.891 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.14 -0.19 53.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.236 -0.915 . . . . 0.0 111.274 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.5 t -104.88 -24.21 12.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.899 -1.126 . . . . 0.0 110.161 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.64 16.17 78.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -148.45 58.85 1.08 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.031 -1.276 . . . . 0.0 109.098 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -68.83 111.99 5.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -0.814 . . . . 0.0 109.694 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -160.14 82.87 0.71 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -131.46 172.8 11.78 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.917 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.54 171.11 19.56 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.659 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 17.2 p90 171.98 -177.11 0.05 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.088 -1.008 . . . . 0.0 109.992 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -109.92 105.59 14.82 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.408 ' HB2' HG12 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -104.41 -179.86 4.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -178.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.1 m -143.83 111.67 6.12 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.538 ' CD1' ' C2 ' ' A' ' 126' ' ' HC4 . 13.1 m-30 -86.71 131.02 34.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 108.871 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -160.98 63.89 0.29 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.516 ' CE2' ' NH1' ' A' ' 52' ' ' ARG . 0.6 OUTLIER -84.11 41.08 0.8 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.488 -0.758 . . . . 0.0 111.776 -178.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER 89.61 29.76 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.683 0.754 . . . . 0.0 109.511 179.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.514 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -129.44 -71.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.947 . . . . 0.0 109.636 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.408 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.5 t -159.14 150.18 16.24 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.417 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.408 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 34.9 Cg_endo -76.25 79.75 2.87 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 122.063 1.842 . . . . 0.0 110.89 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 m -84.45 105.63 15.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.701 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -74.51 149.21 40.36 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.443 ' HB ' HG11 ' A' ' 122' ' ' VAL . 4.8 m -156.03 144.86 12.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 118.588 -1.245 . . . . 0.0 111.53 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -78.05 151.41 33.51 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.659 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 4.0 m -128.24 154.04 38.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 117.931 -1.507 . . . . 0.0 110.856 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.561 ' HB2' ' CG ' ' A' ' 6' ' ' PHE . 6.4 t-160 -147.42 125.59 12.18 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.51 ' HE2' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -133.69 126.97 31.91 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 120.99 -1.069 . . . . 0.0 108.898 -178.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.583 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 17.8 tttm -138.5 157.82 45.44 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.112 -1.435 . . . . 0.0 110.129 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.485 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 ptmt -75.63 94.18 3.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 109.626 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -53.27 123.54 12.15 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.252 -0.905 . . . . 0.0 109.617 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 pp -109.38 -13.16 14.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.054 -1.029 . . . . 0.0 110.124 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -42.73 69.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.93 -1.106 . . . . 0.0 109.339 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.85 39.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 117' ' ' SER . 74.5 m-20 -135.33 -90.82 0.31 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.243 -1.151 . . . . 0.0 109.23 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.489 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER 164.17 -79.57 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.216 -0.927 . . . . 0.0 110.452 179.486 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.517 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 7.3 m-85 -125.05 136.03 53.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.658 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 10.6 p-90 -135.6 150.65 49.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.002 -1.061 . . . . 0.0 110.519 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' A' ' 109' ' ' MET . 89.5 t -138.09 105.45 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.741 -0.599 . . . . 0.0 110.326 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.658 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 2.1 m-85 -88.87 138.14 31.68 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.443 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -110.76 114.19 46.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.51 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.597 ' CD ' ' CE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -81.67 142.38 32.77 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 176.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -98.85 134.42 41.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.495 -1.378 . . . . 0.0 109.637 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.031 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.538 ' C2 ' ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 ptm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -175.78 45.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 109.544 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -107.71 23.62 14.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.883 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -132.33 -175.11 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.926 -1.109 . . . . 0.0 109.64 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.447 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . -59.17 -160.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 109.538 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.536 ' CD1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -38.07 -41.39 0.57 Allowed 'General case' 0 N--CA 1.517 2.896 0 CA-C-O 122.493 1.14 . . . . 0.0 109.059 178.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.98 39.13 0.05 OUTLIER Glycine 0 N--CA 1.486 1.979 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -67.73 174.96 3.2 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.705 -0.88 . . . . 0.0 110.64 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.33 61.44 0.78 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.61 70.62 0.63 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.582 HG23 ' CZ ' ' A' ' 121' ' ' PHE . 0.4 OUTLIER -69.28 -66.26 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.488 0 O-C-N 121.477 -0.764 . . . . 0.0 110.322 -178.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 11' ' ' ILE . 14.4 pt-20 -36.52 -33.74 0.05 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.867 -0.521 . . . . 0.0 111.994 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -82.64 -44.7 15.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.768 -1.208 . . . . 0.0 108.489 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 18' ' ' MET . 5.4 m -67.59 -10.38 51.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.693 -0.629 . . . . 0.0 109.691 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.478 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 42.2 mt -97.79 -20.48 17.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.842 -1.161 . . . . 0.0 109.749 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.47 -12.37 25.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.33 -0.856 . . . . 0.0 110.16 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.64 -23.34 6.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.937 -1.102 . . . . 0.0 110.286 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.444 ' CB ' ' O ' ' A' ' 14' ' ' THR . 5.9 tmm? -58.27 146.44 34.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.106 -0.996 . . . . 0.0 109.516 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.56 -40.28 9.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p30 174.06 -47.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.502 -0.749 . . . . 0.0 109.691 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.05 56.92 0.55 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.443 ' HB3' ' CG ' ' A' ' 18' ' ' MET . 0.7 OUTLIER -132.51 -40.34 0.99 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -1.194 . . . . 0.0 109.795 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.433 ' CD1' ' HE3' ' A' ' 18' ' ' MET . 1.2 pt? -92.0 8.62 36.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.208 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -71.95 -6.68 43.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.929 -1.107 . . . . 0.0 110.046 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.22 32.24 7.55 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 23' ' ' LEU . 86.9 mt -105.15 158.7 16.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.416 -1.049 . . . . 0.0 108.789 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HB2' ' NZ ' ' A' ' 123' ' ' LYS . . . -93.48 14.44 18.69 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.756 -0.59 . . . . 0.0 109.59 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' CE2' HG12 ' A' ' 11' ' ' ILE . 25.2 p90 -148.9 154.18 39.08 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.175 -0.953 . . . . 0.0 109.596 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.96 114.4 3.85 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.449 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -91.21 87.7 6.62 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.49 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.3 pp -98.48 148.89 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.649 -0.657 . . . . 0.0 109.79 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 18.1 mt-30 -118.25 174.63 6.12 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 108.501 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.423 HD23 ' CB ' ' A' ' 62' ' ' PHE . 62.1 mt -154.33 149.64 27.11 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.21 -0.932 . . . . 0.0 109.171 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 36' ' ' ASP . 30.4 p30 -130.45 121.03 25.11 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.607 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.6 -79.23 0.0 OUTLIER Glycine 0 N--CA 1.5 2.904 0 C-N-CA 124.362 0.982 . . . . 0.0 113.021 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -66.67 -7.59 21.73 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 121.851 -0.794 . . . . 0.0 110.436 -178.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' O ' ' CD2' ' A' ' 33' ' ' LEU . . . 89.89 18.54 50.63 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 m120 -73.26 136.13 44.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.243 . . . . 0.0 108.272 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.13 133.8 27.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.395 -0.815 . . . . 0.0 110.8 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.471 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 10.4 mt -98.85 -32.46 11.33 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.465 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -155.99 -173.73 4.64 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.528 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 1.2 t80 -160.96 -67.98 0.06 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.212 -0.93 . . . . 0.0 108.903 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.2 p-10 107.02 160.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 124.154 0.982 . . . . 0.0 109.169 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.99 -13.93 55.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.293 -0.88 . . . . 0.0 110.819 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB1' ' ND2' ' A' ' 43' ' ' ASN . . . -59.45 -62.33 1.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 0.0 109.803 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 11.5 pt-20 -66.05 -41.6 90.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.094 -1.003 . . . . 0.0 108.614 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -58.57 -18.06 36.08 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -29.55 22.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.778 -1.425 . . . . 0.0 109.579 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -80.31 -41.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.324 -0.86 . . . . 0.0 109.394 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.527 HG23 " C3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -111.07 4.08 19.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.607 -0.683 . . . . 0.0 110.189 -179.531 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.72 -2.2 74.72 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.677 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.53 ' NH2' ' CE2' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -73.33 84.49 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.922 -1.34 . . . . 0.0 111.81 -178.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.413 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -63.99 175.96 0.74 Allowed Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 53' ' ' ASP . 35.5 Cg_endo -77.05 -44.23 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.553 1.502 . . . . 0.0 110.682 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -16.41 63.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.107 -0.996 . . . . 0.0 110.268 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -48.67 6.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.972 -1.08 . . . . 0.0 110.025 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.415 HG12 ' HB3' ' A' ' 52' ' ' ARG . 32.8 m -70.71 -8.27 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.754 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.65 124.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.76 -19.62 50.26 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -79.02 132.88 36.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.317 -1.108 . . . . 0.0 108.976 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.71 125.27 27.09 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.534 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 75.4 t80 -63.97 -10.94 24.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.024 -1.048 . . . . 0.0 110.444 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -112.58 26.06 10.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.959 -1.088 . . . . 0.0 110.275 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -166.71 -58.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.978 -1.076 . . . . 0.0 110.891 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.58 -7.18 55.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.933 -1.105 . . . . 0.0 110.981 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.534 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 17.4 t -117.4 -26.43 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.63 -1.294 . . . . 0.0 109.526 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.51 ' CB ' ' C2 ' ' A' ' 126' ' ' HC4 . . . -163.71 96.84 1.0 Allowed Pre-proline 0 C--N 1.288 -2.076 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.961 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.42 -2.15 11.99 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.891 1.727 . . . . 0.0 110.564 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.2 p -90.1 -25.06 20.93 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.264 -0.897 . . . . 0.0 109.204 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.47 HG23 ' CD1' ' A' ' 75' ' ' PHE . 46.0 p -72.77 -5.37 37.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.466 -0.771 . . . . 0.0 110.139 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -88.39 59.63 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.967 -1.083 . . . . 0.0 109.317 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.54 171.96 5.79 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.171 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.75 79.54 2.81 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 122.373 2.048 . . . . 0.0 110.292 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.9 OUTLIER 169.21 -34.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.47 ' CD1' HG23 ' A' ' 70' ' ' THR . 1.4 t80 -106.28 -67.07 0.96 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.559 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 27.7 t80 -78.48 -21.94 48.26 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -61.6 -56.67 21.76 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 4.1 mmtt -65.62 -16.4 63.69 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.57 -0.959 . . . . 0.0 109.334 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.559 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 8.5 t80 -76.73 -37.68 55.57 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.66 -6.38 55.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -95.76 -39.06 10.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.36 -42.49 65.09 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.509 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 57.4 t -59.5 -40.13 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.843 -0.798 . . . . 0.0 109.73 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.14 -17.18 43.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -0.926 . . . . 0.0 110.744 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 m -88.28 -20.87 24.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.944 -1.097 . . . . 0.0 109.805 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.45 21.3 64.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -165.82 57.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -1.151 . . . . 0.0 109.355 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 6.3 tt -46.93 124.62 6.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.531 -0.731 . . . . 0.0 110.222 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -161.42 89.59 0.77 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.0 t -152.27 152.65 32.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.807 -1.183 . . . . 0.0 110.545 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.406 ' C ' ' CD2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -140.13 179.91 6.35 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.586 ' CD1' HG23 ' A' ' 107' ' ' VAL . 18.0 p90 172.47 171.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.838 . . . . 0.0 109.252 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.99 108.95 20.71 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.46 169.94 8.46 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.724 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.412 HG22 ' HD3' ' A' ' 104' ' ' LYS . 87.7 m -136.15 108.36 7.26 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 109.266 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.524 ' CD2' " C6'" ' A' ' 126' ' ' HC4 . 12.3 m-30 -80.29 85.62 5.77 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -108.44 34.38 3.67 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.69 158.33 28.37 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.502 ' C ' ' O ' ' A' ' 98' ' ' TYR . 2.0 mt-30 0.08 64.86 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.46 0.704 . . . . 0.0 112.525 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.22 -153.55 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -178.447 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.443 ' CB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -93.7 177.41 1.97 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 0.0 108.726 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 101' ' ' THR . 34.1 Cg_endo -77.07 112.8 3.49 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.686 1.591 . . . . 0.0 110.013 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 95' ' ' THR . 2.8 m -113.29 130.34 56.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.727 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.417 ' O ' HG11 ' A' ' 105' ' ' VAL . 6.1 mmtt -104.52 145.21 30.62 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.462 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 26.3 m -154.57 144.8 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.615 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.517 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -78.26 117.55 19.63 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 174.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.586 HG23 ' CD1' ' A' ' 92' ' ' PHE . 23.2 m -99.2 151.96 4.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 117.852 -1.539 . . . . 0.0 108.235 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -156.32 102.68 2.11 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -113.17 144.89 41.9 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.192 -0.942 . . . . 0.0 109.529 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.582 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -141.04 -178.51 5.6 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.653 -1.28 . . . . 0.0 109.815 -179.273 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 103.74 16.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.027 -1.045 . . . . 0.0 108.857 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.444 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -51.59 146.13 8.05 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.616 -0.677 . . . . 0.0 109.884 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.29 12.81 21.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.269 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.54 9.16 12.01 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.045 -1.034 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 136.56 45.58 0.09 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.23 52.88 6.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.114 . . . . 0.0 109.32 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.497 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.8 OUTLIER -93.76 -162.28 0.93 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.882 . . . . 0.0 109.717 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.509 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 10.4 m-85 -149.9 111.59 4.52 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.722 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 15.1 p-90 -117.16 144.7 44.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.701 -1.249 . . . . 0.0 111.684 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.402 HG11 ' HG3' ' A' ' 109' ' ' MET . 13.8 t -120.85 114.57 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.554 0.692 . . . . 0.0 109.932 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.722 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 13.5 m-30 -95.33 121.9 37.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.51 HG23 ' CZ ' ' A' ' 96' ' ' PHE . 1.3 t -107.02 112.79 41.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.889 -1.125 . . . . 0.0 108.468 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.536 ' HD3' ' CD1' ' A' ' 6' ' ' PHE . 14.3 tptp -89.21 125.17 34.96 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -74.33 123.65 25.01 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.688 -1.258 . . . . 0.0 109.458 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 25.5 t . . . . . 0 C--N 1.301 -1.516 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.699 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.527 " C3'" HG23 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -114.06 94.93 5.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.579 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -66.85 95.67 0.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.123 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 8' ' ' SER . 9.7 p -138.53 55.55 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.077 -1.014 . . . . 0.0 110.067 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.497 ' HB3' ' CE1' ' A' ' 108' ' ' HIS . . . 61.86 -152.67 0.36 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.744 -1.222 . . . . 0.0 108.707 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CE1' ' CD ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -85.54 10.56 12.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.955 -1.091 . . . . 0.0 108.728 177.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.487 ' O ' ' CZ ' ' A' ' 28' ' ' PHE . . . 133.27 25.5 0.65 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.545 ' HB3' ' CG1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -104.71 123.62 47.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.24 . . . . 0.0 110.159 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.407 ' N ' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -79.51 71.75 6.11 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.29 50.29 14.62 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.563 ' CG1' ' CE2' ' A' ' 121' ' ' PHE . 3.2 mm -50.73 -51.62 19.29 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.713 0 O-C-N 121.696 -0.628 . . . . 0.0 110.155 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' ILE . 4.0 tt0 -34.19 -41.51 0.11 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.15 -42.35 38.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.806 -1.184 . . . . 0.0 109.263 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.508 ' CG2' ' CE ' ' A' ' 18' ' ' MET . 1.2 m -60.7 -26.11 66.9 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.522 -0.737 . . . . 0.0 109.855 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 11' ' ' ILE . 5.7 mt -96.77 -17.06 20.51 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.941 -1.1 . . . . 0.0 109.812 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 12' ' ' GLU . . . -95.85 -12.24 25.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.047 -1.033 . . . . 0.0 110.198 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.19 61.89 1.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.883 -1.136 . . . . 0.0 109.709 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.558 ' HG2' ' CB ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -150.74 -160.58 1.19 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.165 -0.96 . . . . 0.0 110.203 -179.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.02 -73.37 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.947 . . . . 0.0 110.25 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -171.55 102.9 0.19 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.196 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.0 39.94 0.4 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.558 ' CB ' ' HG2' ' A' ' 18' ' ' MET . 5.4 pm0 -124.62 -36.68 2.58 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.666 -0.902 . . . . 0.0 109.103 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.478 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 2.3 pp -105.18 31.9 4.58 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.5 -15.39 11.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 109.907 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.74 31.56 8.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -104.1 173.54 6.26 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.159 -1.201 . . . . 0.0 108.888 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.7 21.27 11.61 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 122.262 1.03 . . . . 0.0 108.23 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -160.51 113.1 2.01 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.396 1.093 . . . . 0.0 108.395 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' HA2' ' ND2' ' A' ' 43' ' ' ASN . . . -46.96 143.41 5.31 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.346 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.462 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -125.34 92.34 3.6 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.539 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.2 pp -99.1 167.33 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.454 -0.779 . . . . 0.0 111.109 -177.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -134.22 166.59 22.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 19.2 mt -149.64 148.35 29.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.971 -1.081 . . . . 0.0 110.065 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 36' ' ' ASP . 2.3 p30 -115.86 133.06 56.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.144 -0.972 . . . . 0.0 109.533 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -12.55 74.53 0.0 OUTLIER Glycine 0 N--CA 1.51 3.631 0 C-N-CA 124.697 1.142 . . . . 0.0 113.307 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER 162.44 -24.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.53 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.63 20.7 14.11 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 23.0 m120 -87.67 131.99 34.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -1.139 . . . . 0.0 108.538 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.453 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -67.77 138.39 22.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.113 -0.992 . . . . 0.0 111.161 -178.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 6.4 mt -99.61 -32.1 11.25 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.19 -179.59 6.24 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.544 ' CE1' ' CZ ' ' A' ' 52' ' ' ARG . 27.7 t80 -140.63 -95.15 0.15 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.609 -1.307 . . . . 0.0 111.05 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 2.0 t-20 153.91 150.26 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -74.68 -58.45 3.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.4 -0.812 . . . . 0.0 110.173 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -38.94 -59.28 0.99 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.848 -0.533 . . . . 0.0 111.567 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.498 ' OE1' ' CG ' ' A' ' 42' ' ' TYR . 8.0 pt-20 -63.25 -43.58 97.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 0.0 110.009 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.418 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -63.3 -14.37 53.54 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.13 -25.12 20.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.959 -1.318 . . . . 0.0 109.149 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.448 HG23 ' CG2' ' A' ' 50' ' ' THR . 1.1 mp -79.17 -47.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.448 ' CG2' HG23 ' A' ' 49' ' ' ILE . 4.8 p -100.42 -6.83 25.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.438 -0.788 . . . . 0.0 110.217 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 84.75 -5.75 80.81 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' NH2' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -53.26 115.31 1.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.026 -1.279 . . . . 0.0 110.884 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 17.6 m-20 -90.98 156.98 43.84 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.81 -50.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.787 1.658 . . . . 0.0 111.282 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -20.84 65.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 110.329 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -89.95 -42.95 10.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.003 -1.061 . . . . 0.0 109.826 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 19.3 m -76.51 -1.25 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.0 109.824 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.491 HD11 HG22 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -70.59 122.93 23.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.01 -17.47 58.15 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -79.73 135.02 36.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -1.168 . . . . 0.0 109.492 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.43 102.17 3.7 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.582 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 8.3 t80 -63.61 -15.0 57.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 76' ' ' TYR . 2.7 m-85 -88.38 12.68 13.54 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.62 -1.232 . . . . 0.0 110.602 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.04 -52.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 0.0 110.552 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.75 -3.88 24.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.02 -1.05 . . . . 0.0 111.064 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.485 HG12 ' HD3' ' A' ' 52' ' ' ARG . 11.8 t -128.12 -57.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.673 -1.267 . . . . 0.0 109.043 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 70' ' ' THR . . . -109.1 105.64 57.52 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.574 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.63 -1.1 10.63 Favored 'Trans proline' 0 C--N 1.32 -0.934 0 C-N-CA 121.847 1.698 . . . . 0.0 111.557 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.404 ' O ' ' OH ' ' A' ' 94' ' ' TYR . 31.8 p -104.45 -19.89 13.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.836 -1.165 . . . . 0.0 109.665 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.449 HG22 ' CZ ' ' A' ' 62' ' ' PHE . 63.9 p -72.68 -6.11 42.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.965 -1.084 . . . . 0.0 109.915 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -88.86 53.71 2.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.985 -1.072 . . . . 0.0 109.11 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.448 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -126.98 177.49 1.99 Allowed Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.8 Cg_endo -77.94 -3.54 13.59 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.126 1.884 . . . . 0.0 111.45 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -105.8 -25.94 11.97 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.809 -1.182 . . . . 0.0 109.521 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.5 t80 -102.02 -70.39 0.75 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.488 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 9.2 t80 -72.86 -17.7 61.51 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.45 -63.45 4.28 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 5.1 mmtt -63.52 -15.63 58.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.626 -0.926 . . . . 0.0 109.544 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.468 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 8.4 t80 -79.63 -39.63 31.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -79.62 -6.41 57.04 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 108.829 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.86 -40.12 9.48 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.55 -44.33 58.22 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 118' ' ' TYR . 94.3 t -54.32 -38.68 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.952 . . . . 0.0 109.243 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.96 -16.93 34.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.444 -0.785 . . . . 0.0 110.637 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.6 -18.25 30.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.937 -1.102 . . . . 0.0 110.178 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.3 18.13 74.77 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -162.39 57.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.128 -1.219 . . . . 0.0 109.408 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.426 ' O ' ' CG ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -49.25 122.3 5.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.405 -0.81 . . . . 0.0 110.257 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.403 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 58.5 t30 -160.65 83.9 0.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 108.826 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -147.73 153.03 38.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 0.0 110.724 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -137.42 173.66 11.43 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.643 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 6.2 p90 179.52 153.09 0.44 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.027 -1.046 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.67 106.85 13.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.404 ' OH ' ' O ' ' A' ' 69' ' ' CYS . 0.1 OUTLIER -107.78 175.53 5.45 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.249 -0.907 . . . . 0.0 110.163 -178.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.431 ' CG2' ' O ' ' A' ' 103' ' ' THR . 22.2 m -143.35 111.41 6.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CZ ' HG23 ' A' ' 122' ' ' VAL . 17.4 m-30 -79.62 96.46 6.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.182 -0.948 . . . . 0.0 109.147 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -113.44 30.06 7.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.237 -0.914 . . . . 0.0 110.052 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.578 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -79.1 159.56 27.44 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.517 ' C ' ' O ' ' A' ' 98' ' ' TYR . 2.9 pt20 -0.67 65.03 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 123.37 0.668 . . . . 0.0 112.31 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.578 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER 174.39 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.546 -0.721 . . . . 0.0 109.117 -177.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.25 171.69 5.75 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 108.971 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.97 80.75 2.89 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 122.004 1.802 . . . . 0.0 111.277 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.438 HG21 ' N ' ' A' ' 104' ' ' LYS . 3.2 m -70.53 145.88 50.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 109.0 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.438 ' N ' HG21 ' A' ' 103' ' ' THR . 0.0 OUTLIER -116.79 138.85 51.2 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.505 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 15.0 m -155.75 144.81 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.995 -1.065 . . . . 0.0 110.003 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.496 ' HG2' ' CB ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -95.61 114.33 26.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 175.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.643 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -88.04 166.99 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.285 1.041 . . . . 0.0 110.666 -176.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.497 ' CE1' ' HB3' ' A' ' 5' ' ' ALA . 23.3 t-160 -161.47 101.93 1.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.464 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 4.5 mtm -112.5 150.04 31.81 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.267 -0.896 . . . . 0.0 110.57 -177.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.9 tttt -144.65 174.27 11.11 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.181 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.412 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 10.4 tttm -83.17 104.6 13.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.83 -1.169 . . . . 0.0 109.108 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HB2' ' CB ' ' A' ' 117' ' ' SER . . . -52.93 137.48 32.44 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.49 -0.756 . . . . 0.0 109.671 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.67 3.29 54.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.593 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 t -60.8 -35.21 75.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.836 -1.165 . . . . 0.0 109.559 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.72 60.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 60.24 70.7 0.61 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -1.125 . . . . 0.0 109.135 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.479 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.1 OUTLIER -123.59 -168.14 1.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.984 -179.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.501 ' CE1' HG23 ' A' ' 83' ' ' VAL . 25.4 m-85 -150.66 104.48 3.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.665 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 11.3 p-90 -106.08 141.5 37.34 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 118.553 -1.259 . . . . 0.0 112.011 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.464 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 57.8 t -116.85 117.77 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.665 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 16.1 m-30 -102.18 118.83 37.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.1 -1.0 . . . . 0.0 109.091 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.435 HG23 ' CZ ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -101.22 129.22 52.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.836 -1.165 . . . . 0.0 110.09 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.526 ' CD ' ' CE1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -102.93 123.55 46.77 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.459 ' HA ' HG11 ' A' ' 105' ' ' VAL . 12.4 ttt180 -77.57 121.14 23.51 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.109 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.236 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.479 " H2'" ' CE2' ' A' ' 98' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.14 60.56 1.7 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -112.01 119.81 39.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.199 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 8' ' ' SER . 9.7 p -177.03 62.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.738 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.441 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . 59.56 -146.1 0.5 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.094 -1.004 . . . . 0.0 108.391 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.555 ' CD1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -94.66 32.17 1.66 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.771 -1.206 . . . . 0.0 108.263 177.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.506 ' CA ' ' HE3' ' A' ' 123' ' ' LYS . . . 110.75 17.67 8.95 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -93.48 104.47 16.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.333 -1.098 . . . . 0.0 110.362 -179.535 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -71.41 80.53 0.77 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.065 -0.397 . . . . 0.0 110.479 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 9' ' ' GLU . 12.7 m-20 45.11 61.21 2.63 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.147 -0.971 . . . . 0.0 108.884 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.541 ' CG1' ' HB3' ' A' ' 8' ' ' SER . 3.8 mm -63.57 -63.1 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -37.85 -33.58 0.09 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.949 -0.469 . . . . 0.0 111.851 -178.012 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -81.06 -44.74 17.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.876 -1.14 . . . . 0.0 108.339 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.411 ' O ' ' CB ' ' A' ' 18' ' ' MET . 2.6 m -70.04 -9.07 54.11 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.642 -0.661 . . . . 0.0 109.724 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.518 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 21.1 mt -97.44 -21.88 16.9 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.954 -1.091 . . . . 0.0 109.197 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.8 -34.26 14.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 0.0 109.945 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.56 49.72 0.82 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.05 -1.031 . . . . 0.0 108.755 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.424 ' CE ' HD21 ' A' ' 23' ' ' LEU . 5.8 tmm? -133.55 129.26 36.81 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.17 -71.66 0.14 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.446 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.89 -39.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 109.685 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -100.78 52.59 0.92 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.4 ' HB3' ' HG3' ' A' ' 18' ' ' MET . 1.5 tt0 -122.8 -41.11 2.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -1.195 . . . . 0.0 109.215 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD21 ' CE ' ' A' ' 18' ' ' MET . 2.4 pt? -90.58 0.24 57.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 110.079 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -70.16 -6.45 34.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.847 -1.158 . . . . 0.0 110.271 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.22 32.16 7.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 29.3 mt -105.3 151.46 24.11 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.459 -1.024 . . . . 0.0 108.689 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.24 24.7 4.8 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -160.16 122.14 3.24 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -179.32 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.476 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -58.8 154.55 27.35 Favored Glycine 0 C--N 1.288 -2.099 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.874 -177.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.531 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -127.78 85.15 2.32 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.566 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.1 pp -86.29 144.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.885 0.85 . . . . 0.0 110.724 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 15.3 mm100 -114.24 159.52 20.06 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.449 ' HG ' ' CD1' ' A' ' 31' ' ' ILE . 72.3 mt -151.82 149.7 29.3 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.9 -1.125 . . . . 0.0 109.71 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 36' ' ' ASP . 41.5 p-10 -131.99 123.29 27.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 110.476 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 42.88 -79.36 0.0 OUTLIER Glycine 0 N--CA 1.498 2.798 0 C-N-CA 124.398 0.999 . . . . 0.0 113.053 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -69.52 -5.96 27.62 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.736 -0.861 . . . . 0.0 110.358 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' O ' ' CD2' ' A' ' 33' ' ' LEU . . . 87.4 24.33 36.96 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -78.63 133.09 37.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.137 -1.214 . . . . 0.0 108.102 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.497 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 1.7 tp -56.77 136.38 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 111.711 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 1.3 mt -110.67 -24.41 10.52 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' NE2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -169.74 113.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.399 -0.813 . . . . 0.0 109.422 179.331 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.566 ' CD1' HG21 ' A' ' 31' ' ' ILE . 19.1 t80 -98.71 -67.68 0.84 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.164 -0.96 . . . . 0.0 111.361 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 5.6 p-10 105.86 177.43 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 0 C-N-CA 124.021 0.929 . . . . 0.0 108.863 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.17 15.35 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.845 -1.159 . . . . 0.0 113.171 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.56 -64.31 0.85 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.331 -1.481 . . . . 0.0 110.601 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' CD ' ' CE1' ' A' ' 42' ' ' TYR . 1.5 pt-20 -57.88 -54.4 47.37 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.508 0.671 . . . . 0.0 109.935 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.427 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -57.93 -14.86 18.17 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -76.0 -38.88 56.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.766 -1.432 . . . . 0.0 108.698 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.438 ' CG1' ' NH1' ' A' ' 124' ' ' ARG . 1.0 OUTLIER -82.78 -56.72 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.381 -0.824 . . . . 0.0 109.27 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.468 HG23 " C3'" ' A' ' 126' ' ' HC4 . 30.0 p -75.24 -24.42 57.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.365 -0.834 . . . . 0.0 109.957 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 95.6 -15.74 62.59 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.55 ' NH2' ' CE1' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -50.07 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.352 -1.087 . . . . 0.0 109.841 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.439 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 15.9 m-20 -64.65 160.87 49.5 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 108.699 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.35 -58.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.877 1.718 . . . . 0.0 110.807 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.62 -19.55 63.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.176 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -88.5 -41.63 12.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 109.828 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 23.4 m -79.59 0.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.822 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.497 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -71.0 121.74 21.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.053 -1.029 . . . . 0.0 108.699 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.49 -15.47 61.31 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -79.3 137.07 37.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.239 . . . . 0.0 109.459 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.95 103.99 6.28 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.529 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 26.1 t80 -60.17 -16.63 34.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -0.885 . . . . 0.0 111.089 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 2.4 m-85 -91.32 15.09 12.75 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.023 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -176.66 -52.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.008 -1.057 . . . . 0.0 110.419 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.15 -6.7 41.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 110.926 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.496 HG12 ' NH1' ' A' ' 52' ' ' ARG . 11.0 t -126.07 -60.43 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 O-C-N 120.636 -1.29 . . . . 0.0 109.07 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' HB3' ' C2 ' ' A' ' 126' ' ' HC4 . . . -108.87 103.96 53.4 Favored Pre-proline 0 C--N 1.293 -1.874 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.267 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.84 7.26 3.27 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.907 1.738 . . . . 0.0 111.777 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.6 p -108.58 -20.4 13.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.819 -1.176 . . . . 0.0 109.869 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' CB ' ' A' ' 67' ' ' ALA . 30.2 p -77.42 -2.63 36.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.952 . . . . 0.0 110.611 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -88.53 55.2 3.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.125 -0.985 . . . . 0.0 109.156 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -124.84 175.25 3.12 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.46 -0.775 . . . . 0.0 109.124 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.9 Cg_endo -77.56 -2.19 12.36 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 122.265 1.977 . . . . 0.0 111.288 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 59.5 mt-10 -107.96 -25.72 11.04 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.939 -1.101 . . . . 0.0 109.509 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.565 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 2.1 t80 -102.13 -70.53 0.75 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 18.1 t80 -70.59 -17.37 62.9 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.12 -61.2 6.6 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 1.2 mmtp -63.38 -15.92 58.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.999 . . . . 0.0 109.487 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.541 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 10.8 t80 -79.63 -38.17 34.42 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -8.72 58.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -95.52 -40.12 9.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.83 -41.05 89.3 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.52 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 66.4 t -60.0 -40.81 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.662 -0.905 . . . . 0.0 109.497 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.18 -5.06 58.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.284 -0.885 . . . . 0.0 110.785 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.5 p -100.19 -19.06 16.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.836 -1.165 . . . . 0.0 109.945 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.03 16.47 78.79 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -155.62 57.97 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -1.22 . . . . 0.0 109.335 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 111' ' ' LYS . 0.3 OUTLIER -56.51 114.17 1.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.823 . . . . 0.0 109.733 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -161.25 83.79 0.64 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.432 -0.792 . . . . 0.0 109.033 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.0 t -139.35 173.8 11.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.073 -1.017 . . . . 0.0 109.952 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -157.9 171.55 20.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.669 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 8.9 p90 178.7 161.01 0.66 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.863 -1.148 . . . . 0.0 110.506 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -88.3 110.12 20.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.45 178.56 4.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.109 -0.995 . . . . 0.0 110.073 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 84.4 m -141.85 107.99 5.22 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.467 ' CE2' " C6'" ' A' ' 126' ' ' HC4 . 16.5 m-30 -86.53 121.31 28.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.176 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -154.21 48.86 0.62 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.544 ' O ' ' C ' ' A' ' 99' ' ' GLN . 7.5 p90 -78.9 148.07 32.86 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 98' ' ' TYR . 4.6 tt0 2.09 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 CA-C-O 121.851 0.834 . . . . 0.0 111.589 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 98' ' ' TYR . 6.0 ttp 178.29 -149.07 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.28 169.47 8.59 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 0.0 109.233 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.85 155.21 30.49 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 122.16 1.907 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.6 m -149.17 94.79 2.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 109.289 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.418 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 1.2 ptpp? -69.77 142.57 53.19 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.994 -1.066 . . . . 0.0 108.168 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.476 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 10.9 m -156.2 142.17 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.908 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.522 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -95.03 111.6 23.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 175.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.669 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 1.4 m -86.29 162.35 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.818 0.818 . . . . 0.0 111.893 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.502 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 7.7 t-160 -160.55 102.0 1.35 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 175.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.454 ' HG2' ' CG1' ' A' ' 120' ' ' VAL . 3.2 mtm -112.66 148.08 35.4 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.56 -0.713 . . . . 0.0 109.435 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.595 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.4 tttm -138.18 -165.47 1.81 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.68 -1.263 . . . . 0.0 108.985 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 12.9 tttt -107.51 98.2 7.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.03 -1.044 . . . . 0.0 109.0 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.473 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -50.74 130.81 25.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 109.435 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mp -115.96 -18.98 10.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.041 -1.037 . . . . 0.0 109.777 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.98 -27.7 20.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 109.37 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.02 41.92 0.05 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 117' ' ' SER . 4.0 m-20 -127.59 -88.51 0.55 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -1.156 . . . . 0.0 109.552 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.496 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER 165.53 -75.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.216 -0.927 . . . . 0.0 110.862 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.52 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 5.4 m-85 -138.58 130.32 27.85 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.136 -0.978 . . . . 0.0 109.358 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.641 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 12.1 p-90 -125.92 138.15 53.76 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.677 -1.264 . . . . 0.0 111.883 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.454 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 61.6 t -113.74 115.87 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.071 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.641 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 15.8 m-30 -100.46 126.91 46.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.178 -0.951 . . . . 0.0 108.84 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.434 HG23 HG23 ' A' ' 105' ' ' VAL . 1.5 t -109.49 122.71 64.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.937 -1.102 . . . . 0.0 110.344 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.561 ' HE2' ' CD2' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -99.22 124.71 44.5 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.438 ' NH1' ' CG1' ' A' ' 49' ' ' ILE . 23.3 ttt180 -74.4 121.89 22.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.64 -1.224 . . . . 0.0 109.125 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.341 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.522 " C3'" ' CD ' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.73 133.42 12.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 109.344 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -165.97 39.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.3 p -166.66 -166.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 109.194 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.486 ' HB1' ' CD1' ' A' ' 11' ' ' ILE . . . -55.25 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.075 -1.016 . . . . 0.0 109.751 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.556 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -51.29 87.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.0 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 48.41 24.93 4.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 28' ' ' PHE . 68.0 m -63.98 171.57 2.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.985 -1.303 . . . . 0.0 109.317 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.62 57.04 1.57 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 54.84 83.12 0.09 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.53 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 0.2 OUTLIER -80.9 -64.84 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.45 0 O-C-N 121.308 -0.87 . . . . 0.0 111.332 -177.155 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -41.78 -26.66 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.174 -0.954 . . . . 0.0 111.457 -177.369 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' ILE . 2.1 t-20 -89.67 -39.27 13.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.046 -1.034 . . . . 0.0 109.516 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.503 ' CG2' ' CE ' ' A' ' 18' ' ' MET . 1.3 m -65.88 -59.63 3.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' CG ' HG21 ' A' ' 11' ' ' ILE . 11.6 mt -49.76 -23.75 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.754 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.31 62.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.849 -1.157 . . . . 0.0 109.31 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -60.43 -16.57 37.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.518 -0.739 . . . . 0.0 110.606 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.605 ' HG3' ' CB ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -160.01 -150.96 0.23 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.744 -1.223 . . . . 0.0 110.231 -179.462 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -158.04 -38.21 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.785 -1.197 . . . . 0.0 110.679 -178.71 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 38.0 p-10 -155.69 90.68 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.929 -1.107 . . . . 0.0 110.198 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 153.85 -27.65 0.74 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.605 ' CB ' ' HG3' ' A' ' 18' ' ' MET . 0.1 OUTLIER -107.86 -42.71 4.63 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 109.283 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.436 ' CD2' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -77.8 4.16 12.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.511 -0.743 . . . . 0.0 110.238 179.484 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -76.73 -3.01 35.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.51 -1.369 . . . . 0.0 110.129 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.72 28.75 14.57 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.951 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 8.0 mt -97.02 -172.68 2.5 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.691 -1.476 . . . . 0.0 109.544 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.52 -0.36 22.19 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.717 0.77 . . . . 0.0 109.288 179.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 8' ' ' SER . 46.0 p90 -141.72 133.53 27.24 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.158 -0.964 . . . . 0.0 109.218 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.507 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -59.1 135.95 51.48 Favored Glycine 0 C--N 1.292 -1.87 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -116.23 113.87 23.62 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.893 -1.357 . . . . 0.0 107.781 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.545 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.4 pp -118.84 160.14 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-O 121.851 0.834 . . . . 0.0 110.303 -178.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 34.2 mt-30 -126.96 168.09 15.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 83.0 mt -152.68 146.79 25.43 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.91 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' ASP . 18.4 m-20 -121.26 123.65 42.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 0.0 110.023 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 37.16 -76.9 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 0 C-N-CA 124.695 1.14 . . . . 0.0 113.647 178.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ASP . 19.7 t0 -69.33 -3.6 14.76 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.658 -0.907 . . . . 0.0 111.011 -178.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.418 ' O ' ' CD2' ' A' ' 33' ' ' LEU . . . 90.21 14.61 58.67 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 19.8 m-80 -70.03 135.59 49.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.931 -1.335 . . . . 0.0 108.425 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.413 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -64.78 140.1 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 122.032 0.92 . . . . 0.0 111.219 -178.328 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 1.8 mt -112.37 -26.06 8.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -163.06 159.4 23.22 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.863 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.545 ' CD1' HG21 ' A' ' 31' ' ' ILE . 23.4 t80 -144.75 -70.62 0.28 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.673 -1.267 . . . . 0.0 110.819 -178.05 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 7.6 p-10 107.09 178.47 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 0 C-N-CA 123.876 0.87 . . . . 0.0 109.098 -179.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.65 -26.03 15.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.99 -1.069 . . . . 0.0 112.849 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.06 -64.09 0.92 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.356 -1.465 . . . . 0.0 110.639 -178.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' OE2' HG21 ' A' ' 31' ' ' ILE . 2.0 pt-20 -58.84 -52.91 63.72 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.0 110.016 -179.059 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.2 -15.79 24.1 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.048 -178.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.62 -36.14 51.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.717 -1.46 . . . . 0.0 108.746 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -85.94 -55.97 5.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.426 -0.797 . . . . 0.0 109.235 179.76 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.438 ' HB ' ' OH ' ' A' ' 98' ' ' TYR . 29.9 p -78.21 -22.27 48.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.459 -0.776 . . . . 0.0 110.438 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 94.52 -18.4 57.13 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.528 ' NH2' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -45.63 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.493 -1.004 . . . . 0.0 110.254 179.455 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.441 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 95.9 m-20 -67.71 157.83 84.98 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.2 -40.11 0.39 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.739 1.626 . . . . 0.0 110.4 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -25.77 51.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.87 . . . . 0.0 110.126 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 7.6 tp60 -83.8 -44.88 13.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.108 -0.995 . . . . 0.0 109.953 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.458 HG12 ' CD ' ' A' ' 52' ' ' ARG . 24.6 m -69.85 -7.84 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.138 -0.976 . . . . 0.0 109.814 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.413 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -68.8 121.95 19.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 121.053 -1.029 . . . . 0.0 108.349 179.831 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.48 -15.38 58.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 56' ' ' GLN . 67.6 mmtt -79.9 144.06 33.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.17 -1.194 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -81.51 115.2 20.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.293 -0.879 . . . . 0.0 108.822 179.401 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 1.7 t80 -61.08 -34.05 74.31 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.029 -1.044 . . . . 0.0 110.025 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.484 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 52.2 m-85 -97.18 13.34 29.65 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 118.472 -1.291 . . . . 0.0 111.96 -177.262 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -139.72 -53.31 0.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.646 -1.284 . . . . 0.0 111.115 -179.719 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.24 16.08 21.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.832 -1.167 . . . . 0.0 112.003 -178.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.511 ' CG1' ' NE ' ' A' ' 52' ' ' ARG . 15.5 t -125.43 -53.1 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.269 -1.519 . . . . 0.0 109.468 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -117.88 103.03 50.79 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.628 -177.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.52 1.37 8.05 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 121.822 1.681 . . . . 0.0 110.577 179.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 p -111.13 -20.69 12.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.975 -1.078 . . . . 0.0 109.802 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.476 HG22 ' CE1' ' A' ' 62' ' ' PHE . 67.2 p -82.58 1.6 37.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.981 . . . . 0.0 110.223 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -88.62 61.47 6.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.945 -1.097 . . . . 0.0 109.259 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -136.01 177.3 2.27 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.188 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 36.5 Cg_endo -79.08 1.46 9.15 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.295 1.997 . . . . 0.0 111.143 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 4.3 mm-40 -107.83 -28.1 9.85 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 120.879 -1.138 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.451 ' CE2' HG23 ' A' ' 70' ' ' THR . 1.8 t80 -102.46 -69.82 0.77 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 15.5 t80 -72.06 -16.7 62.04 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.037 -1.039 . . . . 0.0 108.206 177.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.81 -60.94 6.65 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.46 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -63.49 -16.29 60.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.956 . . . . 0.0 109.414 -179.499 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.548 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 8.8 t80 -80.75 -37.9 29.61 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -8.23 57.25 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 108.442 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.91 -40.6 9.22 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.19 -39.61 82.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 178.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.517 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 62.7 t -63.3 -37.19 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.69 -0.888 . . . . 0.0 109.583 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.87 -3.47 55.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 110.83 -179.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.3 t -106.17 -18.67 13.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.79 -1.194 . . . . 0.0 110.124 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.18 19.49 72.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -157.06 55.93 0.52 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -1.222 . . . . 0.0 109.641 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.434 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 1.7 tt -54.61 120.34 6.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.801 . . . . 0.0 110.047 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -160.47 82.49 0.68 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.403 HG22 ' CE ' ' A' ' 109' ' ' MET . 7.3 t -128.34 162.4 27.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 110.44 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.4 ' HG2' ' N ' ' A' ' 92' ' ' PHE . 0.1 OUTLIER -154.52 149.06 26.31 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.89 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.636 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 12.7 p90 -172.83 149.17 1.93 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.431 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -79.89 107.3 12.57 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.68 172.87 6.57 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.1 -1.0 . . . . 0.0 110.039 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m -143.12 109.58 5.39 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.507 ' CD1' ' C2 ' ' A' ' 126' ' ' HC4 . 21.3 m-85 -80.71 115.83 20.42 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -128.51 41.69 3.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -78.07 78.89 4.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.807 -0.558 . . . . 0.0 110.126 -179.721 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.568 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER 53.74 37.8 27.05 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.63 -0.668 . . . . 0.0 110.233 -179.512 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -150.08 -179.12 6.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.018 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.431 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 5.2 t -56.54 149.28 40.91 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 108.716 179.159 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.431 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 31.4 Cg_endo -72.91 86.21 1.1 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.55 1.5 . . . . 0.0 110.417 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.414 HG21 HG12 ' A' ' 105' ' ' VAL . 16.0 m -75.9 142.55 42.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.476 -0.765 . . . . 0.0 109.473 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -115.32 136.34 53.19 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.508 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 26.2 m -151.87 144.51 16.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 109.812 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.556 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -94.57 109.75 21.63 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 175.789 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.636 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -80.85 162.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 122.339 1.066 . . . . 0.0 110.963 -175.729 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.431 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 3.7 t-160 -161.48 101.05 1.19 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.42 ' HB3' HG21 ' A' ' 120' ' ' VAL . 3.4 mtm -113.01 146.19 39.52 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.393 -0.817 . . . . 0.0 109.316 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.8 tttt -141.84 178.94 7.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.459 -1.401 . . . . 0.0 109.785 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.434 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -86.01 102.89 14.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.916 -1.115 . . . . 0.0 109.15 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 116' ' ' ASP . . . -51.59 132.61 30.54 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.455 -0.778 . . . . 0.0 109.812 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.63 -33.31 9.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.4 p -54.09 -46.11 71.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.955 . . . . 0.0 109.299 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 154.35 39.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -116.1 -14.03 11.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.059 -1.259 . . . . 0.0 109.444 179.707 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 116' ' ' ASP . 0.3 OUTLIER 80.51 -70.05 0.09 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.478 -0.763 . . . . 0.0 111.66 178.727 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.517 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 4.7 m-85 -143.37 116.88 9.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.712 -1.242 . . . . 0.0 110.197 -177.482 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.698 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 10.1 p-90 -113.66 142.11 46.41 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.863 -1.148 . . . . 0.0 111.665 179.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 109' ' ' MET . 63.5 t -113.53 125.94 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.698 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 20.0 m-30 -111.74 117.65 33.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.019 -1.05 . . . . 0.0 109.574 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.421 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -100.19 114.41 38.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.531 ' HD3' ' CE1' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -97.76 119.92 37.21 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.099 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HA ' HG11 ' A' ' 105' ' ' VAL . 6.8 ttt-85 -66.97 124.82 24.07 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.983 -1.087 . . . . 0.0 109.61 -178.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.005 . . . . 0.0 109.335 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.507 ' C2 ' ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -106.54 163.09 13.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.967 . . . . 0.0 109.725 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.42 172.63 0.62 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 p -77.99 123.66 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.263 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.458 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . 47.65 -158.84 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.317 -0.864 . . . . 0.0 109.836 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.525 ' CD2' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -48.87 -59.04 3.91 Favored 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.8 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.46 32.56 0.26 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 107.255 -2.338 . . . . 0.0 107.255 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.515 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -55.91 -175.84 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.761 -0.847 . . . . 0.0 110.846 -178.566 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -126.82 61.04 1.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.79 70.09 0.66 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -178.427 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.523 ' CG2' ' CD1' ' A' ' 15' ' ' LEU . 5.1 mm -73.93 -65.58 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.548 0 O-C-N 121.424 -0.797 . . . . 0.0 109.759 -178.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 13' ' ' ASN . 15.7 pt-20 -38.84 -35.92 0.23 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.719 -0.613 . . . . 0.0 111.706 -178.18 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.43 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.1 m120 -81.6 -41.96 20.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.921 -1.112 . . . . 0.0 108.341 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.466 ' CG2' ' CD2' ' A' ' 23' ' ' LEU . 2.9 m -72.1 -7.18 47.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.619 -0.676 . . . . 0.0 109.49 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.523 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 39.8 mt -96.83 0.41 49.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.905 -1.122 . . . . 0.0 109.01 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.02 -25.05 16.64 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.284 -0.885 . . . . 0.0 109.106 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -132.27 39.14 3.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.423 ' CB ' ' O ' ' A' ' 14' ' ' THR . 11.1 tmm? -129.21 146.0 51.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.21 -0.932 . . . . 0.0 109.437 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.55 -61.31 1.14 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.293 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -167.15 96.02 0.49 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.378 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.43 -20.83 3.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.402 ' HB3' ' CG ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -81.87 -45.83 14.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.096 -1.238 . . . . 0.0 109.598 179.992 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.466 ' CD2' ' CG2' ' A' ' 14' ' ' THR . 4.2 tp -128.76 45.41 2.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.117 -0.99 . . . . 0.0 109.687 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -93.16 -1.61 56.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.163 -0.961 . . . . 0.0 109.698 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.39 16.31 58.06 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.516 ' CD2' ' CZ ' ' A' ' 28' ' ' PHE . 4.0 mt -67.86 168.3 11.87 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.953 -1.322 . . . . 0.0 108.448 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.43 23.0 8.07 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.564 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 3.3 p90 -156.51 -171.1 3.56 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -118.17 154.74 16.43 Favored Glycine 0 C--N 1.291 -1.932 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 178.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -122.88 107.26 11.67 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.32 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.524 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.1 pp -114.93 142.21 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.303 -177.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -112.16 165.96 11.69 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.873 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 97.1 mt -152.27 154.66 36.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.866 -1.147 . . . . 0.0 109.681 -179.129 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 36' ' ' ASP . 5.5 m-20 -129.08 125.74 37.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 110.178 178.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.43 -77.93 0.0 OUTLIER Glycine 0 N--CA 1.5 2.901 0 C-N-CA 124.496 1.046 . . . . 0.0 113.818 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 34' ' ' ASP . 73.4 m-20 -72.65 -1.55 16.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.717 -0.872 . . . . 0.0 111.443 -177.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.32 18.65 52.44 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 53.1 m-80 -72.04 134.99 46.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -1.223 . . . . 0.0 107.772 179.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -64.8 138.44 23.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 O-C-N 121.28 -0.887 . . . . 0.0 111.259 -178.067 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 5.4 mt -109.0 -28.39 9.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -163.29 160.28 23.62 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.897 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.524 ' CD1' HG21 ' A' ' 31' ' ' ILE . 14.6 t80 -142.1 -71.96 0.33 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.715 -1.241 . . . . 0.0 110.774 -178.419 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.3 p-10 109.1 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.785 0 C-N-CA 123.923 0.889 . . . . 0.0 108.876 -179.166 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 45' ' ' ALA . . . -96.99 -52.5 3.84 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.215 -0.928 . . . . 0.0 113.438 -177.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 44' ' ' ALA . . . -34.69 -62.02 0.37 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.418 -0.801 . . . . 0.0 112.96 -177.181 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' OE1' ' CE1' ' A' ' 42' ' ' TYR . 1.9 pt-20 -60.13 -49.4 77.79 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.158 -0.964 . . . . 0.0 110.35 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.401 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -62.36 -13.58 44.39 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -81.53 -36.17 29.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.835 -1.391 . . . . 0.0 109.82 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -84.14 -47.32 17.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.124 -0.985 . . . . 0.0 109.45 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.424 ' OG1' " H3'" ' A' ' 126' ' ' HC4 . 2.7 p -89.33 -24.9 21.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.271 -0.893 . . . . 0.0 110.203 -179.079 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 96.49 -3.47 63.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.551 ' NH2' ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -55.68 105.15 0.16 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.032 -1.276 . . . . 0.0 109.941 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.443 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -72.98 154.19 90.86 Favored Pre-proline 0 C--N 1.298 -1.653 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.801 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.02 -53.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.742 1.628 . . . . 0.0 110.528 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HG3' ' N ' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -69.75 -20.4 63.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.856 -179.843 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.404 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 1.5 tt0 -85.33 -41.72 15.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.018 -1.051 . . . . 0.0 109.837 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 26.7 m -76.48 -2.31 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.068 -1.02 . . . . 0.0 109.922 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.42 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -70.19 122.42 21.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.025 -1.047 . . . . 0.0 108.429 179.845 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.04 -13.82 62.21 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 56' ' ' GLN . 11.8 mmtp -80.12 137.54 36.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.267 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -78.05 95.93 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.142 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.551 ' CE1' ' NH2' ' A' ' 52' ' ' ARG . 14.1 t80 -55.82 -24.65 37.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 0.0 109.932 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.414 ' CE2' HD12 ' A' ' 33' ' ' LEU . 12.3 m-85 -82.09 -32.16 30.38 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.746 -177.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 48.59 1.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.055 . . . . 0.0 109.116 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 61' ' ' ASN . 4.7 t0 -163.54 -36.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.549 -0.719 . . . . 0.0 109.877 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.477 ' CG1' ' HD3' ' A' ' 52' ' ' ARG . 12.7 t -103.09 -56.8 4.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 122.78 1.276 . . . . 0.0 108.388 179.482 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.66 101.46 24.33 Favored Pre-proline 0 C--N 1.29 -1.983 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.181 -178.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -76.13 3.13 6.45 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.719 1.613 . . . . 0.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 p -106.77 -21.58 12.99 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.131 -0.981 . . . . 0.0 109.841 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.49 HG23 ' CE1' ' A' ' 75' ' ' PHE . 7.2 p -81.89 2.54 29.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 110.308 -178.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -95.94 57.1 1.77 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.954 -1.091 . . . . 0.0 108.905 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.442 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -139.5 175.55 3.17 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.412 -0.805 . . . . 0.0 109.507 -179.599 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.7 Cg_endo -77.15 77.29 3.85 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 122.505 2.137 . . . . 0.0 110.369 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 174.28 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.5 ' CD1' ' HE2' ' A' ' 109' ' ' MET . 1.4 t80 -103.3 -68.73 0.82 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.468 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 16.5 t80 -74.83 -19.22 60.27 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.42 -62.26 5.77 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.451 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -62.19 -18.28 60.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 109.541 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.468 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 10.1 t80 -76.38 -38.23 56.03 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -5.61 52.89 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 108.757 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.402 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 1.5 mm-40 -95.41 -42.02 8.69 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.41 -40.64 68.67 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 178.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.502 HG23 ' CE1' ' A' ' 118' ' ' TYR . 100.0 t -61.39 -40.27 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.746 -0.855 . . . . 0.0 109.948 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.68 -22.08 40.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.216 -0.927 . . . . 0.0 111.059 -178.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -12.08 28.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.817 -1.177 . . . . 0.0 110.526 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.85 14.58 80.69 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -150.62 100.82 2.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -1.171 . . . . 0.0 108.606 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.74 117.58 32.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 110.109 -179.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.58 75.53 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.506 -0.746 . . . . 0.0 109.118 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -116.21 131.55 56.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.028 -1.045 . . . . 0.0 110.497 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.6 ttt -118.47 126.17 51.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.536 ' CZ ' HG23 ' A' ' 107' ' ' VAL . 2.0 p90 -152.39 -172.5 4.25 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.134 -0.979 . . . . 0.0 110.056 -178.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -121.87 117.42 26.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.409 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 13.0 t80 -126.79 163.65 23.1 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 109.422 -179.134 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 95.2 m -131.77 119.99 22.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.486 ' CD1' ' H2 ' ' A' ' 126' ' ' HC4 . 6.5 m-85 -92.01 125.0 36.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.431 -0.793 . . . . 0.0 109.035 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -144.41 46.77 1.4 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 14.3 p90 -77.98 141.58 38.86 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.527 ' C ' ' O ' ' A' ' 98' ' ' TYR . 15.0 pt20 3.67 64.73 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.093 0 CA-C-O 121.432 0.634 . . . . 0.0 112.161 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER 179.78 175.52 0.76 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.557 -0.714 . . . . 0.0 109.118 -177.787 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.424 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 0.6 OUTLIER -57.88 151.43 43.62 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.96 . . . . 0.0 109.032 179.348 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 32.9 Cg_endo -74.28 145.08 33.96 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 121.945 1.763 . . . . 0.0 109.972 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -142.32 111.68 6.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.106 -0.996 . . . . 0.0 110.151 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.421 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 25.3 tttm -82.28 151.67 26.67 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.479 ' O ' HG21 ' A' ' 105' ' ' VAL . 28.2 m -153.98 144.09 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 118.526 -1.269 . . . . 0.0 112.09 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -80.75 123.6 28.35 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 102.23 -3.248 . . . . 0.0 102.23 174.675 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.536 HG23 ' CZ ' ' A' ' 92' ' ' PHE . 31.4 m -118.37 152.36 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 121.058 1.754 . . . . 0.0 111.845 -176.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -143.1 104.64 4.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.218 178.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.5 ' HE2' ' CD1' ' A' ' 75' ' ' PHE . 14.2 mtp -99.79 121.18 40.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.891 -1.131 . . . . 0.0 108.913 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.573 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 2.3 tttt -125.79 -165.8 1.47 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 117.625 -1.63 . . . . 0.0 110.309 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -113.11 98.59 7.24 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.138 -0.976 . . . . 0.0 109.167 -179.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.528 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -54.56 135.18 46.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.682 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.71 -19.44 9.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.723 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 m -52.89 -49.05 66.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.0 109.567 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.49 44.95 0.05 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 117' ' ' SER . 52.7 m-20 -138.81 -90.15 0.21 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.116 -1.226 . . . . 0.0 109.242 179.584 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 116' ' ' ASP . 0.4 OUTLIER 160.85 -76.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.498 -0.751 . . . . 0.0 110.795 179.372 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.502 ' CE1' HG23 ' A' ' 83' ' ' VAL . 3.6 m-85 -125.4 129.35 49.7 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.235 -0.916 . . . . 0.0 110.179 -177.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.672 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 22.7 p-90 -129.17 163.05 26.39 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.343 178.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.45 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 50.2 t -144.23 113.94 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.688 -0.632 . . . . 0.0 109.422 -178.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.672 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.4 m-30 -95.66 140.79 29.96 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.412 HG11 ' HB ' ' A' ' 105' ' ' VAL . 1.9 t -117.4 109.53 27.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 118.951 -1.099 . . . . 0.0 110.046 -179.213 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 4.7 tptp -84.53 146.24 27.67 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -96.18 129.88 43.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.702 -1.249 . . . . 0.0 110.181 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.458 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.104 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.486 ' H2 ' ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptt? . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 55.24 58.44 4.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 109.581 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -102.81 93.25 4.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.311 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.45 ' O ' ' C ' ' A' ' 5' ' ' ALA . 14.5 p -154.8 129.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 109.897 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.453 ' C ' ' CG ' ' A' ' 6' ' ' PHE . . . 21.91 81.01 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.065 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER 57.51 -87.7 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.243 -0.911 . . . . 0.0 109.135 179.558 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . -140.41 42.68 1.18 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -65.32 163.39 15.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.67 -0.9 . . . . 0.0 110.87 -178.543 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -109.1 60.54 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.5 72.63 0.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.562 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 3.7 mm -72.89 -66.86 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 O-C-N 121.488 -0.757 . . . . 0.0 110.444 -178.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -36.46 -49.68 0.74 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.961 -0.462 . . . . 0.0 112.037 -177.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.63 -44.37 82.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.788 -1.195 . . . . 0.0 108.614 179.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.442 ' CG2' HD21 ' A' ' 23' ' ' LEU . 3.4 m -71.24 -8.43 53.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 109.948 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.54 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 42.6 mt -97.79 -24.04 15.62 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.97 -1.081 . . . . 0.0 109.371 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.94 -26.5 31.35 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.83 . . . . 0.0 109.576 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 -17.75 8.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.052 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.31 145.39 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.343 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.62 154.87 0.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 108.861 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 56.88 78.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 108.601 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.56 21.46 72.69 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 51.85 31.63 8.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.386 -1.067 . . . . 0.0 109.952 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.463 HD11 ' CD1' ' A' ' 26' ' ' LEU . 1.1 tm? 60.68 67.81 0.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.191 -0.943 . . . . 0.0 108.776 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -149.07 -24.64 0.3 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.552 -0.717 . . . . 0.0 111.112 -179.239 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.32 24.35 30.75 Favored Glycine 0 N--CA 1.492 2.429 0 O-C-N 120.525 -1.359 . . . . 0.0 111.041 -178.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.496 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -78.7 -172.28 2.91 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.766 -1.432 . . . . 0.0 108.349 179.168 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.74 20.54 16.08 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.549 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -159.36 137.04 10.06 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.143 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -71.66 139.73 29.28 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.411 ' HB1' HD12 ' A' ' 23' ' ' LEU . . . -116.87 89.75 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.498 HG23 ' CE1' ' A' ' 42' ' ' TYR . 1.4 pp -91.98 148.97 4.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.449 -0.782 . . . . 0.0 110.654 -177.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.5 mm100 -116.86 170.51 8.56 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 73.4 mt -152.32 145.63 24.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.876 -1.14 . . . . 0.0 110.187 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' ASP . 8.8 m-20 -115.7 134.67 54.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.257 178.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -11.49 72.39 0.0 OUTLIER Glycine 0 N--CA 1.511 3.679 0 C-N-CA 124.804 1.192 . . . . 0.0 113.294 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER 161.75 -23.33 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.565 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.41 17.9 22.95 Favored Glycine 0 N--CA 1.479 1.551 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.033 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 28.7 m120 -85.25 131.78 34.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.142 -1.211 . . . . 0.0 108.769 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.505 ' CG2' ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -65.99 138.81 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.016 -1.053 . . . . 0.0 111.404 -178.37 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.451 HD23 ' CB ' ' A' ' 34' ' ' ASP . 3.0 mt -103.74 -29.48 11.01 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -161.94 142.96 10.74 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.089 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.605 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 15.9 t80 -109.28 -77.24 0.6 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.338 -1.476 . . . . 0.0 111.504 -178.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 39.9 t-20 130.49 142.24 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.857 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -178.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -73.24 -49.09 29.75 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.581 -0.699 . . . . 0.0 111.125 -178.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.76 -55.32 3.69 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.35 -0.844 . . . . 0.0 111.619 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.498 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 14.0 pt-20 -63.75 -44.55 93.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.143 -0.973 . . . . 0.0 110.233 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -63.24 -13.2 48.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.05 -36.72 16.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.328 . . . . 0.0 109.658 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.425 HG22 ' CD ' ' A' ' 124' ' ' ARG . 47.7 mm -77.71 -29.35 16.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 O-C-N 121.043 -1.036 . . . . 0.0 110.249 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 52' ' ' ARG . 1.6 p -114.09 -24.58 8.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 109.504 -178.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 100.55 -2.04 55.89 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.498 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -71.88 85.83 0.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -1.219 . . . . 0.0 109.727 -179.74 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 38.9 m-20 -60.48 164.42 7.05 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.148 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.49 -50.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.117 1.878 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.85 -29.4 68.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.215 -0.928 . . . . 0.0 109.906 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -78.78 -43.12 26.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 0.0 109.885 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 18.5 m -76.35 -1.81 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.038 -1.038 . . . . 0.0 109.903 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.505 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.5 OUTLIER -70.89 123.58 25.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.016 -1.053 . . . . 0.0 108.446 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.95 -18.2 56.49 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 -178.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -79.25 138.45 37.79 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.184 -1.186 . . . . 0.0 108.992 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.22 104.33 6.69 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.451 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 85.6 t80 -56.08 -20.62 17.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.371 -0.831 . . . . 0.0 110.224 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 7.7 m-85 -100.04 -19.69 16.41 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.083 -1.01 . . . . 0.0 110.401 -178.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.2 46.99 1.42 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.116 -0.99 . . . . 0.0 109.449 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.6 -28.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 111.024 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.498 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 5.1 t -108.48 -58.34 3.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' HA ' ' NH2' ' A' ' 52' ' ' ARG . . . -112.09 100.98 50.87 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.485 -179.184 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.74 1.05 8.5 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.056 1.837 . . . . 0.0 111.336 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.1 p -98.95 -22.88 15.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 109.418 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.439 HG23 ' CE1' ' A' ' 75' ' ' PHE . 31.1 p -76.14 -2.21 29.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.408 -0.808 . . . . 0.0 110.269 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -88.63 56.42 3.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.975 . . . . 0.0 109.255 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -129.04 177.18 2.28 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.413 -0.805 . . . . 0.0 108.941 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -78.04 2.01 8.37 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.219 1.946 . . . . 0.0 111.561 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.4 mt-10 -111.28 -29.52 7.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.86 -1.15 . . . . 0.0 109.319 179.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CE1' ' SD ' ' A' ' 109' ' ' MET . 1.8 t80 -100.29 -69.49 0.77 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.55 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 21.2 t80 -71.22 -15.57 62.46 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.22 -61.56 6.24 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 9.4 mmtt -62.8 -16.49 58.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.607 -0.937 . . . . 0.0 109.287 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.55 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 10.4 t80 -78.72 -37.89 40.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -78.52 -7.41 57.46 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -95.78 -40.76 9.19 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -69.92 -40.04 74.46 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 178.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 118' ' ' TYR . 58.2 t -64.71 -39.78 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.646 -0.914 . . . . 0.0 109.656 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.74 -8.7 55.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.334 -0.854 . . . . 0.0 110.829 -178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 t -102.19 -16.98 16.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.829 -1.169 . . . . 0.0 110.06 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.47 22.48 64.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -163.75 72.11 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -1.104 . . . . 0.0 109.316 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.416 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.3 OUTLIER -72.92 118.35 15.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 109.81 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -160.62 86.79 0.73 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.523 -0.736 . . . . 0.0 109.099 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 t -137.25 161.52 36.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.081 -1.012 . . . . 0.0 109.786 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -149.53 144.04 26.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.415 -0.803 . . . . 0.0 108.982 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.541 ' CD2' HG23 ' A' ' 107' ' ' VAL . 10.8 p90 -156.33 -173.96 4.73 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 109.839 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.26 114.19 26.36 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.59 -176.28 2.89 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.147 -0.971 . . . . 0.0 110.804 -178.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.0 m -154.38 109.77 3.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.534 ' CE2' " C6'" ' A' ' 126' ' ' HC4 . 7.9 m-30 -85.71 126.6 34.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.643 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -154.3 51.06 0.65 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.738 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 9.9 p90 -77.91 136.42 38.02 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.53 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.7 pt20 5.25 62.95 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.186 0 CA-C-O 121.421 0.629 . . . . 0.0 112.264 -178.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -175.22 -154.43 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.358 -0.839 . . . . 0.0 109.252 -177.98 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.15 159.74 61.69 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.46 157.27 28.94 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.28 1.987 . . . . 0.0 110.521 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.4 m -151.13 85.92 1.35 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.782 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.404 ' C ' HG22 ' A' ' 125' ' ' VAL . 8.7 ttmt -69.83 139.18 53.1 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.45 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 14.8 m -151.77 148.24 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.897 -1.127 . . . . 0.0 111.404 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.559 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 2.8 mptp? -79.36 120.16 23.4 Favored 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 103.22 -2.881 . . . . 0.0 103.22 174.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.541 HG23 ' CD2' ' A' ' 92' ' ' PHE . 34.5 m -104.19 150.91 7.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 117.863 -1.535 . . . . 0.0 110.523 -177.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -149.49 106.91 3.62 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 119' ' ' TRP . 12.8 mtm -108.85 134.55 51.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.057 -1.027 . . . . 0.0 110.369 -178.259 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.576 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.4 tttp -135.09 -169.38 2.36 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.401 -1.437 . . . . 0.0 109.989 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -104.46 100.43 10.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.126 -0.983 . . . . 0.0 108.56 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.452 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -47.02 144.53 2.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.729 . . . . 0.0 110.617 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.452 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 3.4 tm? -79.09 -19.29 51.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.776 -179.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.0 m -44.07 -27.71 0.41 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.371 -0.831 . . . . 0.0 110.58 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 162.53 58.62 0.02 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.7 32.34 21.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -1.183 . . . . 0.0 109.074 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.466 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -72.16 -160.74 0.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.889 -179.692 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.501 ' CE1' HG23 ' A' ' 83' ' ' VAL . 13.8 m-85 -152.42 116.28 4.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.649 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 16.6 p-90 -122.06 149.37 43.64 Favored 'General case' 0 C--O 1.202 -1.401 0 C-N-CA 118.705 -1.198 . . . . 0.0 112.075 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.445 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 58.5 t -124.54 107.97 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.649 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 9.9 m-30 -92.03 120.58 32.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.312 -0.867 . . . . 0.0 109.199 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 28' ' ' PHE . 1.1 t -102.21 117.92 48.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.839 -1.144 . . . . 0.0 110.837 -179.251 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 4.2 tptp -88.28 113.91 24.37 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.425 ' CD ' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -73.94 120.62 19.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.492 -1.38 . . . . 0.0 109.016 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.458 ' CG2' ' HD2' ' A' ' 106' ' ' LYS . 3.7 t . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.319 -179.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.534 " C6'" ' CE2' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.326 0.584 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 4' ' ' VAL . 1.2 tm-20 -84.37 -65.14 1.04 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.917 . . . . 0.0 109.595 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 52.34 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 109.426 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.512 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 32.4 m -101.11 94.89 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.775 -1.203 . . . . 0.0 109.402 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.65 -149.48 0.33 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.39 -1.444 . . . . 0.0 108.652 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.585 ' CE1' ' HD2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -90.78 51.06 1.9 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.595 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.85 0.79 45.64 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -177.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.614 ' HA ' ' CZ ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -96.66 112.53 24.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.11 -1.229 . . . . 0.0 112.128 -178.694 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 10' ' ' ASP . 22.7 mt-10 -47.55 103.4 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.642 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' C ' ' O ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER 16.66 77.36 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.708 0 CA-C-O 121.415 0.626 . . . . 0.0 111.826 178.483 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.635 ' HB ' ' CE2' ' A' ' 121' ' ' PHE . 4.9 mm -64.83 -61.96 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.597 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -37.24 -30.51 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.939 -0.476 . . . . 0.0 111.833 -178.13 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' ILE . 54.4 t-20 -84.48 -45.64 12.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.891 -1.131 . . . . 0.0 108.504 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -67.59 -10.6 53.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.591 -0.693 . . . . 0.0 109.665 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.516 ' CD1' ' CG2' ' A' ' 11' ' ' ILE . 20.6 mt -96.82 -25.71 15.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.013 -1.054 . . . . 0.0 109.327 -179.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.81 -16.89 24.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.383 -0.823 . . . . 0.0 109.988 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 35.81 4.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 0.0 109.853 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.433 ' HE1' ' CD2' ' A' ' 23' ' ' LEU . 11.9 tmm? -131.41 134.18 45.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.199 -0.938 . . . . 0.0 109.112 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.25 -79.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.97 . . . . 0.0 109.296 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -175.58 68.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -0.961 . . . . 0.0 109.239 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.3 40.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -132.1 -37.69 1.12 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.405 -1.056 . . . . 0.0 109.781 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.467 ' HB2' ' CD1' ' A' ' 26' ' ' LEU . 0.5 OUTLIER -105.6 15.28 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 110.351 -179.736 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.21 -15.61 63.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.956 -1.09 . . . . 0.0 109.887 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.58 22.61 39.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.467 ' CD1' ' HB2' ' A' ' 23' ' ' LEU . 55.9 mt -70.67 176.65 4.01 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.939 -1.33 . . . . 0.0 108.947 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.15 17.43 21.63 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.614 ' CZ ' ' HA ' ' A' ' 8' ' ' SER . 0.2 OUTLIER -154.81 132.25 11.2 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.186 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.11 129.28 9.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.416 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -102.32 118.78 37.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.946 -1.326 . . . . 0.0 108.513 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.539 HG23 ' CD1' ' A' ' 42' ' ' TYR . 1.1 pp -111.81 148.88 14.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.163 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' CB ' ' HB2' ' A' ' 40' ' ' LEU . 8.1 mt-30 -117.99 166.06 12.97 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.465 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 18.3 mt -152.78 140.84 20.32 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.599 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.442 ' N ' HD22 ' A' ' 40' ' ' LEU . 16.1 t0 -93.67 167.88 11.38 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.37 -22.23 1.49 Allowed Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.556 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -92.12 11.46 25.4 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.466 -1.608 . . . . 0.0 110.692 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.66 27.24 63.44 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 79.1 m-20 -97.03 127.86 43.42 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.993 -1.298 . . . . 0.0 111.639 -177.587 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -55.29 135.72 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.12 -0.988 . . . . 0.0 110.67 -179.83 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 34' ' ' ASP . 3.3 mt -111.4 -27.96 8.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -158.08 159.89 36.76 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.812 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.539 ' CD1' HG23 ' A' ' 31' ' ' ILE . 2.8 t80 -143.7 -64.74 0.38 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.601 -1.312 . . . . 0.0 109.246 -178.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 2.0 p-10 99.6 177.58 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 123.36 0.664 . . . . 0.0 109.641 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.25 -14.72 23.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.1 -1.0 . . . . 0.0 112.002 -177.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.22 -63.25 1.33 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.616 -1.302 . . . . 0.0 109.671 -179.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.533 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 7.3 pt-20 -61.6 -49.81 75.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.208 -0.933 . . . . 0.0 109.286 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.426 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -58.74 -14.53 22.89 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -80.55 -39.09 28.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.735 -1.45 . . . . 0.0 109.823 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.432 HG23 HG21 ' A' ' 50' ' ' THR . 0.2 OUTLIER -84.58 -43.43 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.001 -1.062 . . . . 0.0 109.032 -179.644 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.472 HG23 " C3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -89.47 -31.46 17.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.743 -0.598 . . . . 0.0 109.693 -178.68 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 100.82 -2.91 55.76 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.535 ' NE ' ' CG1' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -68.97 104.19 2.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.02 -1.283 . . . . 0.0 110.592 -179.322 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.17 166.14 43.94 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.87 -38.47 0.86 Allowed 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.948 1.765 . . . . 0.0 110.3 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -22.95 61.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.275 -0.891 . . . . 0.0 109.415 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.429 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 38.1 tt0 -83.14 -47.19 11.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.497 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.5 m -66.57 -11.37 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.599 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.403 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -68.32 121.12 16.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.082 -1.011 . . . . 0.0 108.722 -179.804 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.1 -19.0 52.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -178.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 56' ' ' GLN . 25.8 mmtt -79.87 132.66 36.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.373 -1.075 . . . . 0.0 109.215 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.59 122.71 21.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.603 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 87.2 t80 -68.69 -2.86 10.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 0.0 111.036 -179.313 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.42 ' CE2' HD12 ' A' ' 33' ' ' LEU . 44.9 m-85 -110.94 -17.2 13.36 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.614 -1.304 . . . . 0.0 111.982 -177.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.28 -38.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.767 -1.208 . . . . 0.0 110.631 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -90.58 1.88 56.34 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.083 -1.01 . . . . 0.0 110.585 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 24.2 t -127.5 -75.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -97.97 106.67 35.89 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.416 -179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 34.5 Cg_endo -75.6 0.15 9.48 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.746 1.631 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.2 p -106.08 -19.49 13.71 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.959 -1.088 . . . . 0.0 109.668 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.431 HG23 ' CE1' ' A' ' 75' ' ' PHE . 15.6 p -75.19 -2.24 26.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.177 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -90.12 51.75 2.11 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.857 -1.152 . . . . 0.0 108.869 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.472 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -121.01 177.64 1.42 Allowed Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.946 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.8 Cg_endo -78.27 -5.45 15.03 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 122.203 1.935 . . . . 0.0 111.272 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -107.98 -21.14 12.94 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.912 -1.118 . . . . 0.0 109.489 179.799 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.431 ' CE1' HG23 ' A' ' 70' ' ' THR . 1.1 t80 -104.09 -72.19 0.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.221 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 25.0 t80 -70.93 -18.16 62.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.29 -61.57 6.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HA ' ' HG2' ' A' ' 81' ' ' GLU . 1.8 mmtt -61.53 -16.34 46.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.652 -0.91 . . . . 0.0 109.698 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.504 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 11.7 t80 -81.17 -38.2 27.5 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.53 -0.731 . . . . 0.0 109.674 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.01 -11.17 59.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.969 -1.082 . . . . 0.0 109.419 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 17.1 pt-20 -97.25 -38.98 9.47 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -66.51 -39.18 93.92 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 79' ' ' PHE . 99.1 t -59.76 -39.71 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.636 -0.92 . . . . 0.0 110.667 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.4 -45.57 31.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.003 -1.061 . . . . 0.0 111.038 -178.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -20.84 65.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.098 -179.131 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.64 14.96 80.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -142.84 56.0 1.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.119 -1.224 . . . . 0.0 109.025 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.48 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -54.78 123.38 13.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.498 -0.751 . . . . 0.0 109.491 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.4 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 33.0 p-10 -161.94 87.78 0.66 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.032 -1.042 . . . . 0.0 109.553 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 t -138.78 164.87 28.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.983 -1.073 . . . . 0.0 110.335 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -156.9 146.64 20.74 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.553 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 9.6 p90 -162.1 -175.11 4.43 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 109.637 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.4 102.51 11.61 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -105.65 147.91 27.96 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 110.041 -178.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.6 m -115.71 109.67 18.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.487 ' CE2' HG12 ' A' ' 122' ' ' VAL . 21.3 m-30 -78.97 107.57 11.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.183 -0.948 . . . . 0.0 109.004 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.13 32.75 5.96 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.521 -0.737 . . . . 0.0 109.28 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -79.21 162.4 25.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.895 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 98' ' ' TYR . 7.7 mt-30 -4.38 66.59 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 C-N-CA 123.388 0.675 . . . . 0.0 112.642 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.593 ' N ' ' O ' ' A' ' 98' ' ' TYR . 1.6 ttp 175.67 -158.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.341 -178.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.467 ' CB ' ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -93.74 179.16 1.32 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.788 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 101' ' ' THR . 34.2 Cg_endo -78.09 107.25 2.29 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 121.873 1.715 . . . . 0.0 110.365 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.6 m -106.83 134.13 50.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' C ' HG21 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -100.78 150.4 22.83 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.548 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.486 ' HB ' HG11 ' A' ' 122' ' ' VAL . 32.6 m -154.75 144.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 118.384 -1.326 . . . . 0.0 112.006 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.58 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -81.41 98.25 8.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 175.771 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.553 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 31.4 m -90.45 150.11 3.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 118.144 -1.423 . . . . 0.0 110.734 -176.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.497 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 13.5 t-160 -148.15 107.16 3.85 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 119' ' ' TRP . 26.2 mtm -102.98 118.6 37.18 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.773 -1.204 . . . . 0.0 108.952 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.575 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -140.27 145.63 37.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.227 -1.546 . . . . 0.0 110.223 -179.083 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -53.91 138.88 35.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.373 -0.829 . . . . 0.0 109.204 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.441 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -90.53 160.03 16.18 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.333 -0.854 . . . . 0.0 109.45 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.49 -7.07 57.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.205 -0.935 . . . . 0.0 110.632 -179.069 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 p -53.8 -32.02 51.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.564 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 143.34 86.97 0.09 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 55.75 61.57 2.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -1.171 . . . . 0.0 109.217 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.421 ' C ' ' CG ' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -117.68 -174.11 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 109.919 -179.725 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.49 ' CE1' HG23 ' A' ' 83' ' ' VAL . 19.4 m-85 -152.08 114.41 4.51 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.638 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 19.6 p-90 -118.06 165.32 13.89 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.319 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.46 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 84.4 t -146.02 104.54 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.346 0.593 . . . . 0.0 109.488 -178.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.638 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.3 m-30 -84.45 129.14 34.89 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 96' ' ' PHE . 2.2 t -112.4 112.18 39.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.277 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.585 ' HD2' ' CE1' ' A' ' 6' ' ' PHE . 1.1 tttm -86.63 159.95 19.05 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.432 ' CD ' HG13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -107.06 120.93 43.42 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.743 -1.183 . . . . 0.0 109.869 -179.232 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.419 HG21 ' C ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.175 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.497 " H2'" ' CE2' ' A' ' 98' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mtt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 66.44 16.25 10.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 109.785 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.0 t60 60.1 31.52 20.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 109.967 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 8' ' ' SER . 25.4 m -72.69 124.56 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.053 -1.029 . . . . 0.0 109.465 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.454 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . 38.56 -158.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.956 0.884 . . . . 0.0 111.849 178.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.576 ' CD2' ' HD2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -58.2 -27.51 63.96 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.848 0.832 . . . . 0.0 108.802 178.973 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.01 35.55 0.02 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -178.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.527 ' HA ' ' CZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -64.66 -170.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.555 -0.968 . . . . 0.0 111.043 -179.342 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -126.56 59.02 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.07 74.21 0.45 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.503 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.544 HG13 ' CE2' ' A' ' 121' ' ' PHE . 4.6 mm -80.26 -60.59 2.15 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 110.151 -178.494 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -46.83 -23.49 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.541 -1.349 . . . . 0.0 110.992 -178.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.19 -42.42 11.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.909 -1.119 . . . . 0.0 109.808 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -56.88 8.12 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.467 ' CD1' HG23 ' A' ' 11' ' ' ILE . 27.9 mt -38.08 -31.76 0.05 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.189 179.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.444 ' CB ' ' HB2' ' A' ' 114' ' ' SER . . . -86.18 -65.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.763 . . . . 0.0 110.119 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.7 55.4 3.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.91 . . . . 0.0 109.835 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.441 ' HE3' ' CD1' ' A' ' 23' ' ' LEU . 7.8 tmm? -117.56 149.45 40.62 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.174 -0.954 . . . . 0.0 108.773 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.2 -61.52 1.36 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.14 -50.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.643 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.17 63.72 3.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.415 ' HB2' ' CG ' ' A' ' 18' ' ' MET . 9.8 mt-30 -149.15 -43.01 0.14 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -1.165 . . . . 0.0 109.246 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.441 ' CD1' ' HE3' ' A' ' 18' ' ' MET . 2.1 pt? -82.42 -12.22 58.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.336 -0.852 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -92.64 -0.59 57.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.901 -1.125 . . . . 0.0 110.312 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.71 33.61 6.26 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.482 HD21 ' CE2' ' A' ' 28' ' ' PHE . 4.1 mp -121.61 149.3 43.38 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.305 -1.115 . . . . 0.0 109.052 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.58 8.0 10.77 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.625 -0.672 . . . . 0.0 110.179 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.587 ' CD2' ' HB3' ' A' ' 121' ' ' PHE . 1.5 p90 -133.51 150.82 51.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 109.646 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.34 114.3 3.85 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 178.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.423 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -91.38 97.79 11.3 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.49 HG21 ' CD1' ' A' ' 42' ' ' TYR . 1.7 pp -105.26 145.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.095 -177.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -115.36 167.29 10.99 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 62' ' ' PHE . 85.2 mt -153.39 157.24 39.68 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.087 -1.008 . . . . 0.0 109.132 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 36' ' ' ASP . 36.8 p-10 -133.89 121.44 21.74 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.606 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.46 -78.38 0.0 OUTLIER Glycine 0 N--CA 1.502 3.069 0 C-N-CA 124.457 1.027 . . . . 0.0 113.144 178.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 34' ' ' ASP . 26.2 m-20 -68.43 -6.0 22.28 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.653 -0.91 . . . . 0.0 110.415 -178.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 88.81 18.06 55.21 Favored Glycine 0 N--CA 1.479 1.552 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.1 m-80 -72.22 138.83 47.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.078 -1.248 . . . . 0.0 108.338 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.92 136.04 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 122.064 0.935 . . . . 0.0 111.496 -178.043 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -108.5 -29.11 8.96 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -163.36 163.3 25.17 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.946 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.551 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 1.8 t80 -143.83 -65.45 0.37 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.141 -1.6 . . . . 0.0 110.714 -177.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 5.4 p-10 106.84 171.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.586 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.44 -20.7 18.86 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.664 -1.272 . . . . 0.0 112.164 -177.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.16 -59.83 3.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.715 -1.241 . . . . 0.0 110.311 -179.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.551 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 11.1 pt-20 -62.55 -45.95 90.61 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.745 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA2' ' N ' ' A' ' 52' ' ' ARG . . . -59.13 -15.94 31.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.26 -34.65 25.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.805 -1.409 . . . . 0.0 109.99 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.95 -40.88 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.158 -0.964 . . . . 0.0 109.766 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.536 HG23 " C3'" ' A' ' 126' ' ' HC4 . 0.4 OUTLIER -105.24 -0.25 26.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.55 -0.719 . . . . 0.0 110.111 -179.295 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.83 -2.78 72.7 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.627 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' NH1' ' HA ' ' A' ' 66' ' ' VAL . 0.9 OUTLIER -78.13 81.89 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.879 -1.365 . . . . 0.0 110.871 -179.155 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -57.8 176.7 0.23 Allowed Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.886 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 34.2 Cg_endo -76.52 -34.55 2.55 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.792 1.661 . . . . 0.0 110.341 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.2 -23.24 41.12 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -79.0 -41.42 29.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.613 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.489 HG12 ' CD2' ' A' ' 42' ' ' TYR . 26.8 m -71.47 -7.6 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 109.78 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.33 122.9 21.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.66 -23.07 35.67 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -178.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -80.53 136.16 36.23 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.409 -1.053 . . . . 0.0 109.189 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.9 126.84 31.24 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.587 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.593 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 76.3 t80 -61.66 -13.08 19.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.054 -1.029 . . . . 0.0 110.636 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.47 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 38.2 m-85 -118.95 28.94 7.98 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.945 -1.097 . . . . 0.0 110.506 -178.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.38 -50.63 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.767 -1.208 . . . . 0.0 110.826 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -111.86 7.71 20.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.856 -1.153 . . . . 0.0 110.653 -179.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 89.3 t -120.53 -41.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 120.777 -1.202 . . . . 0.0 108.342 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.442 ' CB ' ' C2 ' ' A' ' 126' ' ' HC4 . . . -141.19 95.35 7.47 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -72.63 -7.84 21.49 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.875 1.717 . . . . 0.0 110.427 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.1 p -94.39 -21.46 18.93 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.232 -0.918 . . . . 0.0 109.042 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.506 HG23 ' CD2' ' A' ' 75' ' ' PHE . 20.7 p -75.3 -0.63 20.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -88.97 55.33 3.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.884 -1.135 . . . . 0.0 108.887 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.457 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -130.48 177.57 2.15 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.858 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -78.08 -2.2 12.31 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.257 1.971 . . . . 0.0 111.418 -179.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 23.1 mm-40 -106.39 -25.98 11.66 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.8 -1.188 . . . . 0.0 109.298 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.506 ' CD2' HG23 ' A' ' 70' ' ' THR . 1.7 t80 -101.99 -71.26 0.72 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.026 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.573 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 10.1 t80 -70.84 -17.7 62.73 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.245 178.024 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.84 -59.8 8.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 6.7 mmtt -64.85 -14.7 60.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.469 -1.018 . . . . 0.0 109.351 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.573 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 10.5 t80 -80.82 -37.44 30.09 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.46 -8.29 58.36 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 108.707 178.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.64 -39.71 9.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA3' ' CD1' ' A' ' 88' ' ' LEU . . . -68.11 -39.83 88.48 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.497 HG23 ' CZ ' ' A' ' 118' ' ' TYR . 98.9 t -62.89 -39.39 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.766 -0.844 . . . . 0.0 109.765 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.95 -3.94 56.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.947 . . . . 0.0 111.104 -178.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.5 t -104.43 -19.68 13.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.082 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.35 19.59 71.36 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -156.27 72.57 0.76 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.096 -1.238 . . . . 0.0 109.287 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -76.1 110.43 10.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 109.629 -179.982 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -160.26 79.83 0.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.079 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.9 t -137.62 151.39 48.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 110.262 -179.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -133.38 146.52 51.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.572 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 18.5 p90 -153.58 -175.88 5.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.054 -1.029 . . . . 0.0 109.941 -179.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.71 115.79 30.17 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.408 ' HB2' HG12 ' A' ' 107' ' ' VAL . 0.3 OUTLIER -118.04 176.94 4.97 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.159 -0.963 . . . . 0.0 110.136 -178.417 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.1 m -144.88 109.33 4.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.488 ' CE2' HG23 ' A' ' 122' ' ' VAL . 21.3 m-30 -83.01 119.85 24.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 108.963 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -149.43 47.51 0.97 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.001 -1.062 . . . . 0.0 110.331 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 35.0 p90 -78.56 135.9 37.4 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.134 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.535 ' C ' ' O ' ' A' ' 98' ' ' TYR . 11.7 pt20 3.52 64.07 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 CA-C-O 121.524 0.678 . . . . 0.0 112.106 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.5 tmm? -172.92 175.77 3.22 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.29 162.18 1.21 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.0 109.213 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.28 152.78 30.97 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.05 1.834 . . . . 0.0 110.195 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.424 HG21 HG12 ' A' ' 105' ' ' VAL . 54.5 m -147.76 127.53 13.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 110.305 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -110.44 137.24 48.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.534 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 17.7 m -150.49 142.83 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 118.649 -1.22 . . . . 0.0 111.494 -178.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.553 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.92 124.21 30.14 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 174.38 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.572 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 33.1 m -108.57 152.12 10.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 120.88 -1.138 . . . . 0.0 111.744 -174.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.433 ' ND1' ' HA ' ' A' ' 5' ' ' ALA . 18.6 t-160 -142.12 108.46 5.28 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 119' ' ' TRP . 20.5 mtm -106.42 123.93 48.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.767 -1.208 . . . . 0.0 109.457 -179.139 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.575 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -126.24 -165.89 1.5 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.098 -179.677 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.61 94.21 4.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.546 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.509 ' CB ' ' HD1' ' A' ' 119' ' ' TRP . . . -53.21 127.59 24.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.073 -1.017 . . . . 0.0 109.481 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.2 tp -114.5 -15.97 11.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.066 -1.021 . . . . 0.0 109.638 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.444 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 80.8 p -54.48 -40.79 68.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.122 -0.986 . . . . 0.0 109.654 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.43 39.86 0.02 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.191 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 117' ' ' SER . 10.2 m-20 -137.49 -91.17 0.23 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.161 -1.199 . . . . 0.0 109.208 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.49 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER 165.07 -80.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.204 -0.935 . . . . 0.0 111.367 179.473 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.497 ' CZ ' HG23 ' A' ' 83' ' ' VAL . 8.9 m-85 -123.07 131.1 53.56 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.214 -0.929 . . . . 0.0 110.061 -177.4 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.729 ' CE3' ' CE1' ' A' ' 121' ' ' PHE . 15.0 p-90 -130.59 166.47 20.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.836 -1.165 . . . . 0.0 111.853 179.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.444 ' CG1' ' HG2' ' A' ' 109' ' ' MET . 90.7 t -147.71 115.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.767 -0.583 . . . . 0.0 110.441 -178.188 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.729 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.6 m-30 -94.41 104.69 16.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.064 -1.022 . . . . 0.0 108.836 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.488 HG23 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -88.04 105.9 15.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.576 ' HD2' ' CD2' ' A' ' 6' ' ' PHE . 9.5 mttp -89.67 112.42 23.66 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.42 ' HA ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -56.98 133.19 54.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.966 -1.084 . . . . 0.0 109.43 -179.0 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.366 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.536 " C3'" HG23 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ttt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.306 0.574 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.91 30.07 7.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.607 -179.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -114.76 167.27 10.91 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.21 125.15 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 0.0 109.874 -179.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.483 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . 44.38 -167.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.033 0.92 . . . . 0.0 111.189 179.146 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.563 ' CE1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -46.51 -76.35 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.532 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -144.83 29.59 1.84 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 178.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.528 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -50.41 175.49 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.739 0.781 . . . . 0.0 110.786 -178.734 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -110.08 60.82 0.6 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.39 75.88 0.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -178.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.542 HG13 ' CE2' ' A' ' 121' ' ' PHE . 5.2 mm -79.16 -56.92 6.0 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.371 -178.083 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -43.04 -26.88 0.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.304 -0.873 . . . . 0.0 111.431 -178.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -91.09 -38.14 12.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.925 -1.109 . . . . 0.0 108.428 178.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.508 ' CG2' ' CE ' ' A' ' 18' ' ' MET . 4.7 m -71.26 -13.01 61.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.627 -0.671 . . . . 0.0 110.02 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 11' ' ' ILE . 11.1 mt -97.62 -21.62 16.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.059 -1.025 . . . . 0.0 109.385 -179.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.53 -31.51 16.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.873 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -111.42 65.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.04 . . . . 0.0 108.986 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.511 ' HG2' ' HB2' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -158.64 -165.36 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.386 -0.821 . . . . 0.0 109.547 -179.163 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 6.1 m-20 -116.25 -68.94 0.88 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.313 -0.867 . . . . 0.0 109.064 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 4.3 t70 179.87 -45.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 109.679 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.82 33.56 5.64 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.511 ' HB2' ' HG2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -102.98 -41.12 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -1.207 . . . . 0.0 109.699 -179.937 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.475 ' HB3' ' CE ' ' A' ' 18' ' ' MET . 1.7 pt? -79.05 19.41 0.55 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.051 -1.03 . . . . 0.0 111.303 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -66.28 -7.98 22.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.4 -1.437 . . . . 0.0 111.002 -179.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.64 35.02 4.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.469 HD21 ' CZ ' ' A' ' 28' ' ' PHE . 28.7 mt -107.09 129.43 54.82 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.593 -0.945 . . . . 0.0 109.662 -179.639 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.27 -7.24 28.96 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.591 0.71 . . . . 0.0 109.353 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.527 ' CZ ' ' HA ' ' A' ' 8' ' ' SER . 6.8 p90 -129.99 135.96 48.89 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.098 -1.001 . . . . 0.0 109.016 179.762 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.44 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -70.03 132.33 23.7 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.327 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -105.1 103.03 12.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.327 . . . . 0.0 108.239 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.515 HG23 ' CD1' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -102.82 143.47 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.558 -178.875 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.457 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 22.0 mt-30 -116.92 164.23 15.0 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.243 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.52 ' CD1' ' CE2' ' A' ' 63' ' ' PHE . 95.9 mt -148.38 148.49 30.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.017 -1.052 . . . . 0.0 109.945 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 36' ' ' ASP . 4.0 p30 -123.92 122.18 37.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 110.419 179.223 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.32 -79.32 0.0 OUTLIER Glycine 0 N--CA 1.497 2.741 0 C-N-CA 124.028 0.823 . . . . 0.0 113.392 178.276 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -70.14 -5.48 27.44 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.769 -0.841 . . . . 0.0 111.078 -177.762 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 94.02 17.84 39.21 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.768 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 38.5 m-80 -75.41 134.39 40.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.962 -1.316 . . . . 0.0 108.983 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -59.59 138.5 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.938 0.875 . . . . 0.0 111.442 -178.504 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 32' ' ' GLN . 7.9 mt -104.63 -33.66 8.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.12 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -157.48 -176.55 6.02 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.284 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.519 ' OH ' " O4'" ' A' ' 126' ' ' HC4 . 6.9 t80 -160.54 -67.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.906 -1.121 . . . . 0.0 110.826 -178.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.6 p-10 103.01 176.27 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.633 0 C-N-CA 123.779 0.832 . . . . 0.0 109.206 -179.379 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.81 -16.51 21.83 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.821 -1.174 . . . . 0.0 112.806 -177.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.24 -62.08 2.1 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.376 -1.453 . . . . 0.0 110.138 -179.131 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.501 ' CD ' ' CE1' ' A' ' 42' ' ' TYR . 3.3 pt-20 -59.61 -53.11 61.8 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.694 0.759 . . . . 0.0 109.569 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.411 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -60.52 -13.78 32.21 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.23 -37.29 33.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.753 -1.439 . . . . 0.0 110.188 -179.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.44 HG23 HG21 ' A' ' 50' ' ' THR . 1.1 mp -84.78 -43.02 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.858 -1.152 . . . . 0.0 109.236 -179.575 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.478 ' CG2' " H3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -92.44 -27.8 17.24 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.248 -0.908 . . . . 0.0 109.974 -178.896 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 100.69 -3.32 56.06 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.333 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.552 ' CD ' " C3'" ' A' ' 126' ' ' HC4 . 0.0 OUTLIER -60.88 100.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.97 -1.312 . . . . 0.0 109.749 -179.749 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -73.44 162.35 74.75 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 0.0 108.728 179.371 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.47 -51.22 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.187 1.925 . . . . 0.0 110.756 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -26.04 68.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 110.181 -179.5 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -85.12 -42.81 14.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.955 -1.091 . . . . 0.0 109.905 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 53' ' ' ASP . 27.1 m -74.81 -3.2 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.157 -0.964 . . . . 0.0 109.675 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -71.49 123.13 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 O-C-N 120.947 -1.096 . . . . 0.0 108.058 179.448 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.33 -14.76 60.16 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -178.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -79.9 136.97 36.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -1.205 . . . . 0.0 109.2 179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.62 110.01 12.07 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.237 -0.915 . . . . 0.0 108.616 179.392 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.47 ' CZ ' HG22 ' A' ' 70' ' ' THR . 46.5 t80 -64.37 -12.63 44.51 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.52 ' CE2' ' CD1' ' A' ' 33' ' ' LEU . 31.9 m-85 -94.92 13.08 26.02 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.054 -1.029 . . . . 0.0 110.745 -177.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -179.39 -50.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.057 -1.027 . . . . 0.0 109.944 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -14.16 62.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 110.424 -179.038 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.476 HG12 ' CZ ' ' A' ' 52' ' ' ARG . 3.8 t -125.89 -57.64 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 120.679 -1.263 . . . . 0.0 108.736 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.15 98.01 50.54 Favored Pre-proline 0 C--N 1.295 -1.8 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.614 -178.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -74.75 -1.53 11.26 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 121.858 1.705 . . . . 0.0 110.985 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 p -91.65 -26.51 18.63 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.988 -1.07 . . . . 0.0 109.335 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.474 HG23 ' CE1' ' A' ' 75' ' ' PHE . 35.2 p -75.0 -1.62 23.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.509 -0.744 . . . . 0.0 110.067 -179.163 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -89.69 52.13 2.25 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.93 -1.106 . . . . 0.0 108.597 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.463 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -124.87 178.5 1.42 Allowed Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.87 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.4 Cg_endo -78.42 -1.09 11.29 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 122.257 1.971 . . . . 0.0 111.476 -179.655 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 13.5 mt-10 -108.46 -29.02 9.02 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.877 -1.139 . . . . 0.0 109.301 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.2 t80 -100.06 -70.54 0.73 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.067 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.528 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 20.4 t80 -72.4 -15.31 61.84 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.813 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.77 -62.47 5.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 178.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 1.2 mmtt -62.87 -16.09 57.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.562 -0.964 . . . . 0.0 109.251 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 76' ' ' TYR . 6.9 t80 -77.36 -40.45 43.89 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.12 -7.87 56.51 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.969 . . . . 0.0 109.045 179.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -95.98 -41.17 8.9 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.408 ' HA3' ' CD1' ' A' ' 88' ' ' LEU . . . -69.41 -40.01 80.02 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 178.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.493 HG23 ' CE1' ' A' ' 118' ' ' TYR . 94.0 t -60.01 -38.71 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.693 -0.887 . . . . 0.0 109.535 179.388 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.35 -6.87 58.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.336 -0.853 . . . . 0.0 110.704 -178.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.06 -18.89 16.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.848 -1.157 . . . . 0.0 109.938 -179.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.58 16.07 78.44 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.44 66.89 0.39 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.055 -1.262 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.408 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -58.74 124.53 20.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.853 . . . . 0.0 109.985 -179.948 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -161.27 83.78 0.64 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.943 -1.098 . . . . 0.0 109.072 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.411 ' CG2' ' SD ' ' A' ' 109' ' ' MET . 8.8 t -144.73 172.48 12.95 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.055 -1.058 . . . . 0.0 110.754 -179.405 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.8 ptm -157.21 171.07 21.09 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.65 ' CZ ' HG22 ' A' ' 107' ' ' VAL . 7.7 p90 177.82 154.15 0.31 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.03 -1.044 . . . . 0.0 109.94 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.3 128.38 33.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 109.07 179.378 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.08 170.04 16.24 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.13 -0.981 . . . . 0.0 110.061 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.0 m -140.88 118.01 11.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.488 ' CD1' ' C2 ' ' A' ' 126' ' ' HC4 . 20.1 m-30 -90.24 121.27 32.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.107 -0.995 . . . . 0.0 109.76 -179.648 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -142.77 46.27 1.58 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.477 -0.764 . . . . 0.0 109.029 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.508 ' CZ ' " H2'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -85.36 66.52 9.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.466 -0.771 . . . . 0.0 110.855 -179.302 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.475 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 77.49 30.2 0.51 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.871 0.843 . . . . 0.0 109.318 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -141.34 171.08 14.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.055 -1.028 . . . . 0.0 108.5 179.452 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.44 170.6 0.2 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.015 -1.053 . . . . 0.0 109.235 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.66 92.03 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.007 1.805 . . . . 0.0 110.261 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.7 m -88.18 131.24 34.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 109.895 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -110.24 142.63 41.57 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.872 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.497 ' HA ' ' CG2' ' A' ' 125' ' ' VAL . 12.6 m -157.73 144.57 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.412 -179.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.11 119.12 36.19 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 174.782 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.65 HG22 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -87.78 162.47 2.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 120.665 -1.272 . . . . 0.0 111.376 -174.844 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.48 ' CG ' ' HA ' ' A' ' 5' ' ' ALA . 1.8 t-160 -160.46 103.71 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.164 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.461 ' HB3' ' O ' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -112.41 150.59 30.91 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.72 -0.613 . . . . 0.0 110.009 -176.932 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 119' ' ' TRP . 0.1 OUTLIER -150.38 164.94 34.56 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.512 -1.367 . . . . 0.0 109.084 179.041 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 118.87 13.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.879 -1.138 . . . . 0.0 109.739 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.428 ' CB ' ' HB2' ' A' ' 117' ' ' SER . . . -65.65 133.21 50.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 109.424 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.491 HD11 ' N ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -74.55 -3.15 29.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.052 -1.03 . . . . 0.0 110.817 -179.274 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.491 ' N ' HD11 ' A' ' 113' ' ' LEU . 1.0 OUTLIER -60.92 -24.64 66.18 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.783 -1.198 . . . . 0.0 109.019 179.676 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 170.07 45.01 0.03 OUTLIER Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t0 61.92 33.3 17.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.423 -1.045 . . . . 0.0 108.89 -179.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.447 ' O ' ' CD1' ' A' ' 118' ' ' TYR . 0.9 OUTLIER -70.95 -157.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.45 -0.781 . . . . 0.0 109.687 -179.742 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.493 ' CE1' HG23 ' A' ' 83' ' ' VAL . 3.3 m-85 -150.22 109.31 3.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -0.837 . . . . 0.0 108.834 -179.398 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.641 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 9.7 p-90 -115.37 144.46 43.76 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.583 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.454 HG12 ' CE1' ' A' ' 75' ' ' PHE . 18.8 t -120.01 109.0 24.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.641 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 12.6 m-30 -89.61 134.4 34.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 108.701 179.358 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.459 HG13 ' NH2' ' A' ' 124' ' ' ARG . 1.3 t -111.26 117.96 56.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 121.322 -0.861 . . . . 0.0 108.841 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.563 ' HD3' ' CE1' ' A' ' 6' ' ' PHE . 4.9 tptp -90.39 110.15 21.25 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.459 ' NH2' HG13 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -64.74 117.62 7.76 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.205 -179.515 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.317 -179.356 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' HC4 . . . . . 0.552 " C3'" ' CD ' ' A' ' 52' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.516 2.852 0 CA-C-O 121.237 0.541 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.059 HG22 HD11 ' A' ' 15' ' ' LEU . 1.5 mm -54.21 -67.29 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.275 -0.89 . . . . 0.0 110.493 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 11' ' ' ILE . 19.8 pt-20 -35.06 -47.59 0.38 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -63.69 -47.84 79.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.858 -1.151 . . . . 0.0 109.106 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 14' ' ' THR . 13.1 m -69.57 -13.33 62.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.537 -0.727 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.059 HD11 HG22 ' A' ' 11' ' ' ILE . 18.4 mt -95.43 -16.35 22.34 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.772 -1.205 . . . . 0.0 109.502 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.384 0 O-C-N 121.144 -0.973 . . . . 0.0 108.535 178.761 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 44' ' ' ALA . 53.2 m-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.905 0.383 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.37 27.85 18.5 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.682 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 5.0 mt -84.62 -172.01 3.94 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.951 -1.323 . . . . 0.0 109.028 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.35 -5.93 14.08 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.682 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 10.3 p90 -124.12 117.22 24.16 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.27 -0.894 . . . . 0.0 108.648 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.465 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -57.06 141.03 43.97 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.526 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -117.17 114.82 24.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.851 -1.382 . . . . 0.0 108.047 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.579 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.6 pp -118.22 150.12 20.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.896 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.65 ' HB3' HD12 ' A' ' 40' ' ' LEU . 2.1 mt-30 -117.47 172.51 7.29 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.844 HD22 ' C ' ' A' ' 37' ' ' GLY . 27.9 mt -152.8 149.49 28.38 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.12 -0.988 . . . . 0.0 109.247 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.539 ' HB2' HD21 ' A' ' 40' ' ' LEU . 3.2 m-20 -119.25 133.16 55.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.141 -0.974 . . . . 0.0 109.417 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -7.58 70.0 0.0 OUTLIER Glycine 0 N--CA 1.514 3.873 0 C-N-CA 124.618 1.104 . . . . 0.0 113.273 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER 161.25 -23.84 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.844 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.68 23.05 10.38 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 3.3 m120 -86.08 123.51 31.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.417 -1.049 . . . . 0.0 108.792 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -56.32 136.19 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 121.913 0.863 . . . . 0.0 110.884 -178.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.65 HD12 ' HB3' ' A' ' 32' ' ' GLN . 5.6 mt -108.13 -30.83 8.2 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.621 ' NE2' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -159.96 160.6 33.61 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.601 ' HH ' ' HE1' ' A' ' 62' ' ' PHE . 2.7 t80 -140.08 -42.47 0.42 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.362 -1.461 . . . . 0.0 109.975 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.594 HD21 ' HB3' ' A' ' 45' ' ' ALA . 0.4 OUTLIER 87.54 171.58 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . . . -96.35 -15.38 21.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.004 -1.06 . . . . 0.0 112.637 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.594 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -58.77 -67.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.386 -1.446 . . . . 0.0 110.135 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 12.0 pt-20 -63.71 -44.95 92.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 109.021 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.43 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -61.11 -13.85 36.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 14.8 t70 -87.24 -32.72 19.59 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.627 -1.513 . . . . 0.0 108.819 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -73.45 -48.47 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.883 0.849 . . . . 0.0 108.731 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.487 ' HA ' ' HE1' ' A' ' 100' ' ' MET . 0.1 OUTLIER -95.09 -29.54 14.53 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.371 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 100.94 -2.69 55.54 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.589 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.955 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 1.1 mtt85 -47.52 -58.72 3.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.968 -1.313 . . . . 0.0 111.027 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.819 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER 68.46 152.45 0.13 Allowed Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.85 -50.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.78 1.654 . . . . 0.0 111.312 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.693 ' HA ' HD12 ' A' ' 58' ' ' ILE . 10.4 pttt -57.99 -18.47 24.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 110.344 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -96.1 -43.19 7.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 0.0 109.411 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 53' ' ' ASP . 32.3 m -82.51 3.96 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.646 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -70.04 123.6 24.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.8 -22.86 36.95 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -79.99 130.59 35.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -1.054 . . . . 0.0 109.25 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.564 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -68.23 125.55 26.74 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.135 -0.978 . . . . 0.0 108.568 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.681 ' CE2' HG21 ' A' ' 70' ' ' THR . 90.2 t80 -71.88 -6.22 40.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.896 -1.128 . . . . 0.0 110.263 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CE2' HD13 ' A' ' 33' ' ' LEU . 30.0 m-85 -96.4 -41.69 8.49 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.935 -1.103 . . . . 0.0 111.545 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.79 -15.39 4.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.705 -1.247 . . . . 0.0 111.522 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.73 -2.35 30.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.679 -1.263 . . . . 0.0 110.858 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.955 HG12 ' CZ ' ' A' ' 52' ' ' ARG . 45.7 t -131.79 -47.89 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 120.732 -1.23 . . . . 0.0 108.504 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.719 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . . . -128.96 106.7 18.15 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.61 2.36 6.49 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.765 1.643 . . . . 0.0 111.662 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.9 p -99.31 -27.69 13.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.889 -1.132 . . . . 0.0 109.234 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.74 HG22 ' CD2' ' A' ' 75' ' ' PHE . 18.0 p -72.13 -5.95 39.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -0.823 . . . . 0.0 109.965 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -89.66 51.72 2.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.018 -1.051 . . . . 0.0 108.742 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.483 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -128.43 178.82 1.47 Allowed Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.07 -0.15 10.42 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 122.095 1.864 . . . . 0.0 111.447 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 5.4 mm-40 -107.85 -28.19 9.78 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.813 -1.18 . . . . 0.0 109.453 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.748 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.9 t80 -102.67 -69.15 0.8 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.487 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 26.0 t80 -69.67 -17.92 63.52 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.18 -62.12 5.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.72 ' CB ' HG21 ' A' ' 90' ' ' THR . 0.9 OUTLIER -63.42 -15.58 58.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.519 -0.989 . . . . 0.0 109.593 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.827 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.9 t80 -81.66 -34.79 30.57 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -8.13 58.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 2.0 mt-10 -96.13 -42.47 8.2 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -66.83 -41.22 93.66 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 79' ' ' PHE . 93.1 t -62.02 -40.09 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.654 -0.909 . . . . 0.0 109.508 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.64 -4.92 58.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -0.871 . . . . 0.0 110.43 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.5 t -96.09 -25.58 15.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.92 -1.112 . . . . 0.0 109.87 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.92 28.89 27.5 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -179.02 59.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.303 -1.116 . . . . 0.0 109.058 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 6.2 tt -49.0 121.54 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.332 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.434 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 62.1 t-20 -160.69 88.27 0.77 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.394 -0.816 . . . . 0.0 109.032 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.72 HG21 ' CB ' ' A' ' 78' ' ' LYS . 2.3 t -149.15 167.17 26.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 110.189 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -150.04 167.1 27.74 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.973 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 10.2 p90 -175.93 153.84 1.4 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.971 -1.081 . . . . 0.0 110.042 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -82.21 116.49 21.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.944 . . . . 0.0 109.167 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.96 175.24 6.0 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 103' ' ' THR . 48.0 m -140.81 111.99 7.24 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.845 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 18.6 m-30 -82.81 93.64 7.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.135 -0.978 . . . . 0.0 109.2 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -115.35 32.78 5.84 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.329 -0.857 . . . . 0.0 108.963 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.59 155.5 29.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.506 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.8 mt-30 -0.85 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.466 0.706 . . . . 0.0 112.394 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.2 ttp 178.12 -154.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.465 -0.772 . . . . 0.0 109.653 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.538 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -92.12 176.89 2.39 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 108.975 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.538 ' CD ' HG22 ' A' ' 101' ' ' THR . 36.4 Cg_endo -78.31 106.51 2.15 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.919 1.746 . . . . 0.0 110.2 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 95' ' ' THR . 4.2 m -101.07 143.83 30.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -117.0 139.24 50.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.599 ' HB ' HG13 ' A' ' 122' ' ' VAL . 7.7 m -156.25 141.62 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.771 -1.205 . . . . 0.0 111.261 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -91.05 114.78 27.39 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.973 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -87.07 161.24 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.807 -1.183 . . . . 0.0 110.543 -176.377 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -159.74 99.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.859 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -110.64 148.41 32.29 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.452 -0.78 . . . . 0.0 109.628 -177.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.647 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 2.3 ttmt -145.51 -179.01 6.38 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.483 -1.287 . . . . 0.0 109.423 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -87.42 109.23 19.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.933 -1.105 . . . . 0.0 109.185 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.75 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -53.67 140.52 28.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.566 -0.709 . . . . 0.0 109.868 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.6 -179.039 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.677 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.613 0.72 . . . . 0.0 110.434 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.754 ' CE1' HG22 ' A' ' 83' ' ' VAL . 24.7 m-85 -151.03 112.32 4.37 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.75 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 15.8 p-90 -114.68 140.99 48.4 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 118.578 -1.249 . . . . 0.0 112.373 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.859 HG13 ' CG ' ' A' ' 109' ' ' MET . 21.2 t -116.42 108.62 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.637 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 15.3 m-30 -92.49 121.33 33.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.396 -0.815 . . . . 0.0 109.65 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.845 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.4 t -103.95 117.35 49.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.403 -0.81 . . . . 0.0 108.927 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.467 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 2.7 tttm -98.97 110.57 23.16 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.447 ' HA ' HG12 ' A' ' 105' ' ' VAL . 33.4 ttt180 -56.27 135.85 53.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.847 -1.158 . . . . 0.0 109.528 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.346 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 N--CA 1.51 2.56 0 CA-C-O 120.75 0.31 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.031 HG22 HD11 ' A' ' 15' ' ' LEU . 3.0 mm -56.98 -67.45 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.645 0 O-C-N 121.051 -1.031 . . . . 0.0 109.594 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.6 pt-20 -37.31 -29.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.836 -0.54 . . . . 0.0 112.205 -178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' ILE . 5.0 m-20 -76.97 -53.13 8.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.805 -1.184 . . . . 0.0 109.906 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -62.85 -40.05 96.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.192 -0.943 . . . . 0.0 109.357 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.031 HD11 HG22 ' A' ' 11' ' ' ILE . 28.9 mt -61.03 -24.0 65.84 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 O-C-N 121.416 -0.802 . . . . 0.0 108.961 179.204 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.4 p30 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.963 0.411 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.38 31.8 8.09 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.974 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 15.5 mt -103.31 121.85 43.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.461 -1.023 . . . . 0.0 108.765 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.01 -12.09 7.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 109.965 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.974 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 10.3 p90 -121.49 116.96 25.67 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.003 -1.06 . . . . 0.0 109.289 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.519 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -55.14 148.64 24.18 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.469 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -128.61 100.88 5.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.833 -1.392 . . . . 0.0 108.222 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.737 HG22 ' CD1' ' A' ' 42' ' ' TYR . 2.2 pp -105.6 159.99 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.718 0.77 . . . . 0.0 110.953 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.79 ' HB3' HD12 ' A' ' 40' ' ' LEU . 33.7 mt-30 -122.08 174.86 6.67 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.678 HD11 ' HD2' ' A' ' 62' ' ' PHE . 22.7 mt -154.37 151.93 29.61 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.951 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.568 ' HB2' HD21 ' A' ' 40' ' ' LEU . 34.5 t70 -102.11 165.63 11.05 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.65 -20.65 0.14 Allowed Glycine 0 N--CA 1.499 2.884 0 O-C-N 121.792 -0.568 . . . . 0.0 113.507 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.58 20.02 19.32 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 119.814 1.807 . . . . 0.0 111.227 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.38 25.25 68.65 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.2 m-20 -90.0 125.22 35.31 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.051 -1.264 . . . . 0.0 110.767 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.659 HD12 HD21 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -59.5 139.2 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.869 -1.145 . . . . 0.0 110.706 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.79 HD12 ' HB3' ' A' ' 32' ' ' GLN . 9.2 mt -108.43 -31.31 7.87 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.444 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -157.69 -176.49 5.97 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.451 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.737 ' CD1' HG22 ' A' ' 31' ' ' ILE . 20.5 t80 -160.01 -72.81 0.07 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.706 -1.247 . . . . 0.0 111.488 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.9 p-10 105.28 179.34 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 C-N-CA 123.719 0.808 . . . . 0.0 109.096 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.26 -26.64 15.33 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.948 -1.095 . . . . 0.0 113.287 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -50.12 -64.63 0.75 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.332 -1.48 . . . . 0.0 110.796 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.9 pt-20 -57.86 -53.08 62.24 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 121.671 -0.643 . . . . 0.0 110.03 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 52' ' ' ARG . . . -58.38 -15.42 23.84 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.376 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.83 -34.23 39.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.894 -1.356 . . . . 0.0 108.892 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -84.86 -54.41 8.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.423 -0.798 . . . . 0.0 109.673 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.2 p -84.99 -23.11 28.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 110.34 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.36 -13.65 61.37 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.669 ' CD ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -47.89 107.23 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.184 -1.186 . . . . 0.0 110.817 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.742 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -74.39 153.71 87.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.165 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.2 -48.81 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.579 1.519 . . . . 0.0 111.13 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -18.26 60.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.077 -1.014 . . . . 0.0 110.281 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -88.61 -41.99 12.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.947 -1.096 . . . . 0.0 109.66 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 53' ' ' ASP . 26.4 m -73.22 -5.55 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.236 -0.915 . . . . 0.0 109.741 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.591 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -70.27 122.82 22.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.1 -1.0 . . . . 0.0 108.357 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.31 -16.58 59.47 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -79.25 139.91 37.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -1.204 . . . . 0.0 109.336 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 65' ' ' ASP . 0.7 OUTLIER -79.45 97.39 6.38 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.678 ' HD2' HD11 ' A' ' 33' ' ' LEU . 1.3 t80 -46.94 -39.9 13.24 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.508 -0.745 . . . . 0.0 110.63 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CG ' ' CD1' ' A' ' 76' ' ' TYR . 23.9 m-85 -86.1 -23.94 26.47 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.708 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.06 43.98 2.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 109.586 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 19.5 t0 -174.46 -20.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.766 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.664 HG11 ' HD3' ' A' ' 52' ' ' ARG . 5.4 t -117.96 -59.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 120.354 -1.466 . . . . 0.0 109.706 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' CB ' ' HE1' ' A' ' 62' ' ' PHE . . . -106.08 103.25 43.98 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.592 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.54 1.52 7.9 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.875 1.717 . . . . 0.0 110.97 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 p -106.39 -20.89 13.24 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.886 -1.134 . . . . 0.0 109.976 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.668 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 35.2 p -81.74 2.32 30.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.089 -1.007 . . . . 0.0 110.049 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -95.14 55.01 1.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.899 -1.125 . . . . 0.0 108.877 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.473 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -135.9 176.31 2.93 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.524 -0.735 . . . . 0.0 109.348 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.5 Cg_endo -77.04 77.86 3.63 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 122.413 2.075 . . . . 0.0 110.492 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 172.06 -36.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.5 t80 -105.63 -66.02 1.02 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.566 ' CD1' ' CG ' ' A' ' 63' ' ' PHE . 5.7 t80 -77.6 -20.51 53.84 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.032 -1.042 . . . . 0.0 108.265 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.39 -60.41 7.12 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.5 ' HB3' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -66.23 -15.43 63.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.752 -0.852 . . . . 0.0 110.085 -179.117 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.872 ' O ' HG23 ' A' ' 83' ' ' VAL . 5.1 t80 -84.15 -36.41 22.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -10.92 59.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 1.1 pp20? -97.5 -36.01 10.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.87 -39.63 85.33 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 79' ' ' PHE . 98.5 t -58.31 -56.2 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.89 -0.77 . . . . 0.0 109.408 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.39 -20.14 65.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 0.0 109.948 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 -29.25 51.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.9 24.1 42.96 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -172.68 57.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.42 -1.047 . . . . 0.0 108.991 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.846 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -49.4 124.7 9.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.804 . . . . 0.0 109.993 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.437 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 2.6 t30 -161.02 88.92 0.77 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.459 -0.776 . . . . 0.0 109.043 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 78' ' ' LYS . 3.3 t -156.75 168.21 28.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.018 -1.051 . . . . 0.0 110.728 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -145.57 170.21 16.87 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.058 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 13.3 p90 -176.31 158.37 1.87 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.893 -1.129 . . . . 0.0 110.307 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -92.08 116.25 28.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.979 -1.076 . . . . 0.0 109.289 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.38 -175.23 3.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.03 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.727 HG22 ' OD1' ' A' ' 97' ' ' ASP . 75.6 m -150.06 114.15 5.12 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' ' 122' ' ' VAL . 16.7 m-30 -85.83 118.88 25.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.148 -0.97 . . . . 0.0 110.394 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.727 ' OD1' HG22 ' A' ' 95' ' ' THR . 0.9 OUTLIER -131.4 35.93 3.82 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.711 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -80.5 80.72 6.9 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 123.032 1.396 . . . . 0.0 111.201 -178.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 98' ' ' TYR . 7.6 mm-40 72.9 27.19 2.17 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 119.925 -1.734 . . . . 0.0 109.051 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 50' ' ' THR . 1.5 tmm? -150.11 168.84 22.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.234 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -52.25 171.09 0.21 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 109.37 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.1 Cg_endo -76.59 79.45 3.03 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.927 1.751 . . . . 0.0 110.421 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.455 HG22 HG13 ' A' ' 105' ' ' VAL . 3.1 m -72.96 133.52 44.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 109.573 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.762 ' CB ' HG21 ' A' ' 125' ' ' VAL . 0.1 OUTLIER -106.45 148.55 28.02 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.251 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.582 ' HA ' HG13 ' A' ' 125' ' ' VAL . 19.7 m -158.31 140.41 5.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 118.578 -1.249 . . . . 0.0 110.536 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -87.43 130.92 34.5 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 103.309 -2.848 . . . . 0.0 103.309 175.066 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.058 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -104.67 160.06 5.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 120.543 -1.348 . . . . 0.0 110.513 -176.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -156.84 101.6 1.97 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.867 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -117.02 149.07 40.89 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.23 -0.919 . . . . 0.0 110.136 -177.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.645 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.7 tttt -145.28 -176.94 5.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.674 -1.266 . . . . 0.0 109.297 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -89.67 109.13 20.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.805 -1.184 . . . . 0.0 108.893 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.768 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -60.61 137.46 58.17 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.358 -0.839 . . . . 0.0 109.868 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.943 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.742 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.267 0.556 . . . . 0.0 109.822 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.841 ' CE1' HG22 ' A' ' 83' ' ' VAL . 28.1 m-85 -154.07 109.33 3.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.303 -0.873 . . . . 0.0 108.883 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.768 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 11.0 p-90 -108.62 143.43 37.69 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 118.646 -1.221 . . . . 0.0 111.914 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.867 HG13 ' CG ' ' A' ' 109' ' ' MET . 21.3 t -122.83 104.77 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.489 0.661 . . . . 0.0 109.248 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.667 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 8.7 m-30 -85.8 114.22 22.57 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -98.17 115.8 39.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.149 -1.021 . . . . 0.0 109.224 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.501 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 4.1 tttm -98.64 125.86 44.05 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HA ' HG12 ' A' ' 105' ' ' VAL . 6.7 ttt-85 -63.66 144.45 57.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.576 -1.328 . . . . 0.0 109.212 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.762 HG21 ' CB ' ' A' ' 104' ' ' LYS . 22.6 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.594 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.135 HG22 HD11 ' A' ' 15' ' ' LEU . 3.1 mm -80.54 -63.78 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.69 0 O-C-N 121.465 -0.772 . . . . 0.0 111.294 -176.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -44.2 -27.08 0.37 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.949 . . . . 0.0 110.962 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -90.0 -38.48 13.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.988 . . . . 0.0 108.359 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 14' ' ' THR . 2.3 m -75.39 -6.78 51.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.515 -0.74 . . . . 0.0 109.269 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.135 HD11 HG22 ' A' ' 11' ' ' ILE . 38.4 mt -98.82 -27.5 13.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.193 -0.942 . . . . 0.0 109.07 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.589 -0.694 . . . . 0.0 109.837 -179.557 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 120.935 0.398 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.41 33.97 6.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.48 147.8 33.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.236 -1.155 . . . . 0.0 109.293 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -93.23 22.35 5.21 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.797 0.808 . . . . 0.0 109.312 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.66 ' HZ ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -155.69 115.8 3.72 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -51.04 126.95 27.88 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.523 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -106.71 82.58 1.73 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.579 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.6 pp -91.77 153.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.374 -0.829 . . . . 0.0 110.817 -177.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.781 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -127.19 166.36 17.86 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.939 ' O ' HD11 ' A' ' 40' ' ' LEU . 84.3 mt -147.63 163.32 36.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.664 -1.273 . . . . 0.0 109.885 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.556 ' HB3' HD21 ' A' ' 40' ' ' LEU . 17.6 p-10 -134.07 122.3 22.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.104 -0.998 . . . . 0.0 110.725 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.08 -78.75 0.0 OUTLIER Glycine 0 N--CA 1.5 2.966 0 C-N-CA 124.424 1.011 . . . . 0.0 113.3 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 34' ' ' ASP . 27.8 t70 -70.84 -2.35 14.66 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.763 -0.845 . . . . 0.0 110.796 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.715 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 88.95 13.53 62.19 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.6 m-20 -66.99 148.09 52.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.903 -1.351 . . . . 0.0 108.02 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.655 HD11 ' HD1' ' A' ' 42' ' ' TYR . 2.4 tp -70.36 137.75 23.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.133 0.968 . . . . 0.0 112.648 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.939 HD11 ' O ' ' A' ' 33' ' ' LEU . 3.3 mt -107.59 -31.39 8.13 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 175.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.509 ' N ' ' HG3' ' A' ' 32' ' ' GLN . 33.8 tp60 -164.25 166.71 20.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.727 -0.608 . . . . 0.0 109.634 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.655 ' HD1' HD11 ' A' ' 39' ' ' ILE . 1.4 t80 -147.12 -69.41 0.24 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.166 -0.959 . . . . 0.0 110.289 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.2 p-10 102.88 152.3 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.26 -14.82 59.68 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.102 -0.999 . . . . 0.0 112.405 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -57.79 -62.09 2.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.623 -1.298 . . . . 0.0 109.565 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.556 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 14.0 pt-20 -64.81 -42.81 94.71 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.139 -0.976 . . . . 0.0 108.887 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.449 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -59.26 -16.6 35.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -86.18 -30.64 22.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.77 -1.429 . . . . 0.0 109.465 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.539 HG22 HG22 ' A' ' 50' ' ' THR . 1.2 mp -78.75 -42.05 24.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.539 HG22 HG22 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -109.18 1.7 20.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.437 -0.789 . . . . 0.0 109.81 -179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 81.84 -2.4 83.5 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.897 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.91 ' CD ' HG13 ' A' ' 66' ' ' VAL . 1.3 mtm-85 -79.33 81.42 5.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.797 -1.414 . . . . 0.0 111.327 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.575 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -64.46 -179.65 0.31 Allowed Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 34.2 Cg_endo -77.65 -35.63 1.46 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.681 1.587 . . . . 0.0 110.487 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HA ' HD12 ' A' ' 58' ' ' ILE . 1.9 tptp -73.09 -24.57 60.66 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.193 -0.942 . . . . 0.0 109.634 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -84.68 -43.46 14.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.609 HG21 ' CG ' ' A' ' 42' ' ' TYR . 35.9 m -71.6 -6.55 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.607 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.488 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -71.06 119.84 18.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 O-C-N 121.114 -0.991 . . . . 0.0 108.354 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.17 -19.85 52.16 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -78.79 143.41 36.1 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.41 -1.053 . . . . 0.0 108.911 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -89.59 123.95 34.12 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.871 ' HB2' HD21 ' A' ' 33' ' ' LEU . 65.3 t80 -56.44 -15.61 4.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.024 -1.047 . . . . 0.0 110.8 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -122.06 36.83 4.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.932 -1.105 . . . . 0.0 109.539 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.86 -52.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 110.32 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.24 10.04 8.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.977 -1.077 . . . . 0.0 110.778 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.91 HG13 ' CD ' ' A' ' 52' ' ' ARG . 41.1 t -115.82 -33.95 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.867 -1.146 . . . . 0.0 108.533 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.42 91.23 3.61 Favored Pre-proline 0 C--N 1.291 -1.964 0 O-C-N 121.41 -0.806 . . . . 0.0 109.146 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -73.64 -11.54 24.21 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.96 1.773 . . . . 0.0 110.123 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.9 p -86.41 -27.84 23.93 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.308 -0.87 . . . . 0.0 108.985 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.894 HG22 ' CD2' ' A' ' 75' ' ' PHE . 18.4 p -72.04 -4.96 31.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.619 -0.676 . . . . 0.0 110.161 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.22 74.84 9.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.075 -1.016 . . . . 0.0 108.651 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -162.31 172.37 5.55 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.346 -0.846 . . . . 0.0 109.228 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 36.1 Cg_endo -77.54 77.13 3.97 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 122.579 2.186 . . . . 0.0 110.42 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.1 tt0 173.13 -37.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.894 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.9 t80 -105.98 -65.76 1.04 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.562 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 10.4 t80 -77.33 -17.84 57.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.427 ' O ' ' CG ' ' A' ' 81' ' ' GLU . . . -62.5 -59.4 9.4 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.54 ' HB2' HG21 ' A' ' 90' ' ' THR . 10.7 mmtt -62.12 -19.36 62.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.689 -0.889 . . . . 0.0 109.399 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.841 ' O ' HG23 ' A' ' 83' ' ' VAL . 11.4 t80 -76.11 -40.41 52.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.275 -0.89 . . . . 0.0 108.729 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -6.6 55.45 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.211 -0.93 . . . . 0.0 108.887 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 77' ' ' GLY . 1.5 mm-40 -95.44 -39.6 9.91 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.425 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -70.03 -45.16 58.1 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.863 HG22 ' CE1' ' A' ' 118' ' ' TYR . 48.5 t -59.01 -37.6 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.776 -0.838 . . . . 0.0 109.58 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 -4.25 48.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 111.067 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -101.89 -16.91 16.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.845 -1.159 . . . . 0.0 110.025 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.15 17.35 74.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.03 85.97 0.53 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -1.202 . . . . 0.0 108.663 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.464 HD13 ' HD1' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -81.23 119.0 23.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 89' ' ' ASN . 2.4 p-10 -160.5 89.01 0.81 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.834 HG23 ' SD ' ' A' ' 109' ' ' MET . 1.6 t -138.77 171.51 14.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.075 -1.015 . . . . 0.0 110.569 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.452 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -158.3 148.27 19.9 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.05 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 12.6 p90 -168.96 153.25 5.57 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.7 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.4 115.32 23.07 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.82 -176.56 2.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.129 -0.982 . . . . 0.0 110.113 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.537 HG22 ' OD1' ' A' ' 97' ' ' ASP . 42.7 m -151.23 110.8 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.73 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 18.5 m-30 -83.52 110.62 18.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.537 ' OD1' HG22 ' A' ' 95' ' ' THR . 17.2 m-20 -133.32 42.43 3.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.829 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.567 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 21.4 p90 -77.33 137.07 38.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER 4.5 64.36 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 CA-C-O 121.447 0.642 . . . . 0.0 111.893 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.717 ' SD ' HG22 ' A' ' 101' ' ' THR . 0.7 OUTLIER -175.84 -176.2 0.82 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.117 -0.989 . . . . 0.0 109.749 -177.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.717 HG22 ' SD ' ' A' ' 100' ' ' MET . 1.2 t -64.14 150.95 91.35 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 108.86 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.433 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 31.5 Cg_endo -73.76 130.52 14.75 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 121.846 1.697 . . . . 0.0 110.682 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 95' ' ' THR . 3.3 m -123.46 142.84 50.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.495 -0.753 . . . . 0.0 109.222 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.409 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -118.06 139.77 50.73 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.305 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.675 ' HA ' HG23 ' A' ' 125' ' ' VAL . 11.0 m -154.36 144.71 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.962 -1.086 . . . . 0.0 110.399 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -94.2 116.02 28.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.05 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -89.24 164.24 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 122.307 1.051 . . . . 0.0 111.232 -175.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -160.57 102.65 1.36 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.847 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -114.35 151.12 33.51 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.393 -0.817 . . . . 0.0 110.203 -177.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 3.3 tttt -147.66 176.24 10.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.552 -1.343 . . . . 0.0 109.114 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.446 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 4.4 ttpt -85.02 107.39 17.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.923 -1.111 . . . . 0.0 109.45 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.82 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -56.69 152.16 12.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.415 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.112 -0.992 . . . . 0.0 110.197 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 1.6 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.421 0.629 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.863 ' CE1' HG22 ' A' ' 83' ' ' VAL . 8.9 m-85 -147.21 106.75 3.92 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.82 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 9.9 p-90 -103.23 139.38 38.77 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.783 -1.167 . . . . 0.0 112.557 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.847 HG13 ' HG2' ' A' ' 109' ' ' MET . 30.1 t -116.61 110.46 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.657 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.6 m-30 -92.69 118.53 31.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.313 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -101.3 122.77 53.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.955 -1.091 . . . . 0.0 109.355 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.584 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -99.13 123.11 43.18 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -75.05 118.45 18.01 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.931 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.412 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t0 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.119 HG22 HD11 ' A' ' 15' ' ' LEU . 14.2 mm -61.9 -57.11 13.56 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.226 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.9 mt-10 -35.87 -43.21 0.3 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.875 -0.516 . . . . 0.0 111.709 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -76.3 -42.42 45.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.009 -1.057 . . . . 0.0 108.986 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 11' ' ' ILE . 7.2 m -66.53 -14.04 61.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.665 -0.647 . . . . 0.0 110.233 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.119 HD11 HG22 ' A' ' 11' ' ' ILE . 9.6 mt -97.34 -23.13 16.26 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.918 -1.114 . . . . 0.0 109.051 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.34 -0.85 . . . . 0.0 109.609 179.487 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 3.8 p30 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.75 21.18 42.78 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.527 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 14.6 mt -68.41 152.29 45.63 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.972 -1.311 . . . . 0.0 108.759 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.56 9.03 17.12 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.655 ' CZ ' HD11 ' A' ' 11' ' ' ILE . 1.2 p90 -153.5 117.29 4.74 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.486 ' HA3' ' HG2' ' A' ' 46' ' ' GLU . . . -53.97 161.61 3.8 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.382 -0.913 . . . . 0.0 110.859 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -136.88 116.0 12.48 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.583 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.5 pp -118.9 157.7 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.212 -0.93 . . . . 0.0 109.733 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.726 ' HB3' HD12 ' A' ' 40' ' ' LEU . 12.3 mt-30 -123.04 168.08 12.81 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.833 HD11 ' HB3' ' A' ' 62' ' ' PHE . 15.9 mt -151.69 150.38 30.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.007 . . . . 0.0 110.001 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.524 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -104.85 168.79 8.83 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -46.5 -29.44 3.95 Favored Glycine 0 N--CA 1.504 3.174 0 CA-C-N 118.621 0.646 . . . . 0.0 112.959 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.16 9.98 13.51 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.485 -1.597 . . . . 0.0 110.581 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.586 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.01 26.22 67.18 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.497 ' C ' HD23 ' A' ' 33' ' ' LEU . 61.9 m-20 -93.25 134.14 35.76 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.227 -1.16 . . . . 0.0 111.229 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.471 HG21 HG23 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -62.61 138.25 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 111.058 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 32' ' ' GLN . 5.7 mt -109.68 -29.23 8.44 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -161.66 159.32 27.32 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.897 ' CE2' HG11 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -138.02 -50.63 0.59 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.38 -1.45 . . . . 0.0 109.311 -178.361 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.585 HD21 ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER 87.57 171.25 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . . . -96.03 -15.36 22.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.015 -1.053 . . . . 0.0 112.822 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.585 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -59.17 -64.74 0.83 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.429 -1.419 . . . . 0.0 109.488 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.575 ' OE2' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -59.72 -51.74 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 109.3 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' N ' ' OE2' ' A' ' 46' ' ' GLU . . . -56.96 -15.92 15.66 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.3 t70 -76.6 -40.73 48.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.821 -1.399 . . . . 0.0 108.181 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -73.33 -59.29 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.428 -0.795 . . . . 0.0 108.89 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.574 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -78.15 -8.55 58.41 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.347 -0.846 . . . . 0.0 110.319 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 82.77 -3.47 83.21 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.401 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.819 ' CZ ' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -60.91 165.73 3.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.743 -1.445 . . . . 0.0 110.078 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.808 ' O ' HG22 ' A' ' 57' ' ' VAL . 7.1 m-20 -133.05 168.11 19.58 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 53' ' ' ASP . 34.4 Cg_endo -77.27 -38.38 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.475 1.45 . . . . 0.0 110.074 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -79.04 -24.56 43.52 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.312 -0.867 . . . . 0.0 109.487 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -45.3 18.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.897 HG11 ' CE2' ' A' ' 42' ' ' TYR . 20.4 m -69.28 -9.66 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.198 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.459 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -68.98 120.72 16.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.96 -24.31 32.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 6.8 mmmt -78.9 130.38 35.57 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -79.19 132.58 36.57 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.567 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.868 ' CE2' HG21 ' A' ' 70' ' ' THR . 64.9 t80 -60.32 -14.37 18.01 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.068 -1.02 . . . . 0.0 110.118 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 99.5 m-85 -124.31 33.39 5.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.019 -1.051 . . . . 0.0 110.378 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -154.57 -40.7 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.882 -1.136 . . . . 0.0 110.377 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.53 7.86 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.007 -1.058 . . . . 0.0 110.881 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.819 HG13 ' CZ ' ' A' ' 52' ' ' ARG . 94.3 t -114.11 -33.85 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 120.673 -1.267 . . . . 0.0 108.448 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.478 ' HB1' HG23 ' A' ' 70' ' ' THR . . . -155.06 100.62 2.31 Favored Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.544 -0.722 . . . . 0.0 109.182 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.97 -1.23 10.94 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.913 1.742 . . . . 0.0 110.876 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.5 p -97.37 -25.32 15.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.133 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.868 HG21 ' CE2' ' A' ' 62' ' ' PHE . 67.7 p -66.98 -10.68 52.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.638 -0.663 . . . . 0.0 110.187 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.28 64.62 8.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 109.626 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.428 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -147.44 172.53 5.09 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.181 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -76.66 78.4 3.35 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 122.514 2.142 . . . . 0.0 110.314 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.8 tt0 169.36 -36.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.669 ' CD1' ' HE1' ' A' ' 109' ' ' MET . 1.3 t80 -104.21 -68.06 0.87 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.509 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 14.4 t80 -75.53 -20.69 58.53 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.69 -59.08 9.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.544 ' HB2' HG21 ' A' ' 90' ' ' THR . 8.5 mmtt -66.45 -14.17 61.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.523 -0.986 . . . . 0.0 109.915 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.846 ' O ' HG23 ' A' ' 83' ' ' VAL . 15.7 t80 -83.33 -35.02 25.51 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.371 -0.83 . . . . 0.0 109.048 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -11.95 59.88 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.157 -0.964 . . . . 0.0 109.246 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 23.5 pt-20 -97.84 -42.2 7.68 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.595 ' C ' HD12 ' A' ' 88' ' ' LEU . . . -61.61 -38.49 95.94 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.705 -2.158 . . . . 0.0 107.705 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.849 HG22 ' CE1' ' A' ' 118' ' ' TYR . 98.0 t -65.07 -40.15 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.795 -0.827 . . . . 0.0 110.042 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.61 0.36 57.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.0 111.135 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 t -109.74 -19.64 13.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.879 -1.138 . . . . 0.0 109.998 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.21 14.59 81.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -144.31 59.07 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -1.203 . . . . 0.0 109.275 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -68.25 113.48 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.656 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -161.04 79.44 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.386 -0.822 . . . . 0.0 108.908 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 78' ' ' LYS . 4.2 t -120.92 167.8 12.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.031 -1.043 . . . . 0.0 110.181 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 4.0 ttt -154.88 154.33 32.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.78 . . . . 0.0 109.222 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.069 ' CE2' HG21 ' A' ' 107' ' ' VAL . 15.4 p90 -176.85 178.04 1.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -0.95 . . . . 0.0 109.869 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.91 100.23 10.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.047 -1.033 . . . . 0.0 108.299 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.496 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -101.6 151.72 21.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 110.06 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -119.01 111.09 17.88 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.934 ' CE2' HG21 ' A' ' 122' ' ' VAL . 19.1 m-30 -79.28 115.78 19.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.402 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -137.51 46.3 2.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -85.32 43.95 1.06 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.623 -0.673 . . . . 0.0 111.688 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER 100.9 27.82 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.698 0 CA-C-O 121.603 0.716 . . . . 0.0 109.271 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.408 ' CE ' ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -139.28 175.15 9.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.09 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 19.5 p -54.52 161.27 2.18 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.024 -1.048 . . . . 0.0 109.287 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.4 Cg_endo -75.94 96.66 1.07 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.776 1.65 . . . . 0.0 110.049 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.462 HG22 HG13 ' A' ' 105' ' ' VAL . 1.0 OUTLIER -104.42 125.09 50.32 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.377 -0.827 . . . . 0.0 109.8 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.459 ' C ' HG23 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -88.7 159.92 17.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 175.847 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.672 HG23 HG13 ' A' ' 107' ' ' VAL . 35.6 m -156.17 142.49 10.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -79.13 103.5 9.12 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 175.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.069 HG21 ' CE2' ' A' ' 92' ' ' PHE . 33.7 m -94.8 151.88 3.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.806 -1.184 . . . . 0.0 110.24 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -153.96 103.3 2.56 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.783 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -104.75 131.82 51.74 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.079 -1.013 . . . . 0.0 109.297 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.588 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 3.9 tttt -130.34 -174.69 3.41 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.209 -1.396 . . . . 0.0 109.894 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 10.7 tttt -99.79 102.64 14.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.102 -0.999 . . . . 0.0 108.713 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.904 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -56.03 142.36 36.48 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.349 -0.844 . . . . 0.0 110.056 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.88 . . . . 0.0 109.985 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.86 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.52 0.676 . . . . 0.0 110.104 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.849 ' CE1' HG22 ' A' ' 83' ' ' VAL . 14.9 m-85 -151.91 111.35 3.94 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.904 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 20.1 p-90 -113.01 149.79 32.84 Favored 'General case' 0 C--O 1.202 -1.405 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.531 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.783 HG13 ' HG2' ' A' ' 109' ' ' MET . 46.6 t -128.24 106.25 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.726 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.666 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 7.5 m-30 -91.72 128.31 37.51 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.934 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.7 t -105.96 129.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.625 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -101.34 153.43 19.66 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -101.51 127.87 48.0 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.277 -1.369 . . . . 0.0 109.068 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.437 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 13' ' ' ASN . 18.0 t0 . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.945 HG22 HD11 ' A' ' 15' ' ' LEU . 4.4 mm -90.82 -59.45 2.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.302 -0.874 . . . . 0.0 110.553 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -22.92 0.77 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.578 -1.327 . . . . 0.0 110.558 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.4 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . 6.5 t-20 -94.29 -36.81 11.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 109.399 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -69.51 -59.8 2.74 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.945 HD11 HG22 ' A' ' 11' ' ' ILE . 18.1 mt -40.76 -34.61 0.4 Allowed 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.434 0.635 . . . . 0.0 109.793 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.485 -0.759 . . . . 0.0 109.865 -179.689 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.958 0.409 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.09 29.23 12.97 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 120.824 -1.172 . . . . 0.0 110.282 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.644 HD13 ' CE2' ' A' ' 28' ' ' PHE . 3.2 mt -105.35 -177.01 3.24 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.051 -1.264 . . . . 0.0 109.025 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.44 4.5 48.41 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.644 ' CE2' HD13 ' A' ' 26' ' ' LEU . 8.1 p90 -135.96 129.24 31.85 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -63.41 122.49 26.99 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.547 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -100.88 96.3 7.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.074 -1.25 . . . . 0.0 107.752 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.543 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.3 pp -98.24 148.82 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 110.787 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.595 ' HB3' HD12 ' A' ' 40' ' ' LEU . 5.5 mm-40 -113.56 167.32 10.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.884 HD22 ' O ' ' A' ' 37' ' ' GLY . 55.4 mt -155.46 139.89 16.79 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.165 -0.959 . . . . 0.0 108.91 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.598 ' HB2' HD21 ' A' ' 40' ' ' LEU . 8.1 t0 -120.52 131.71 54.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.919 -1.113 . . . . 0.0 110.433 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 35.87 -77.04 0.0 OUTLIER Glycine 0 N--CA 1.501 2.978 0 C-N-CA 124.71 1.148 . . . . 0.0 113.403 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -73.37 2.56 7.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.659 -0.907 . . . . 0.0 111.109 -178.353 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.884 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 82.4 17.34 69.09 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -72.58 136.34 45.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.087 -1.243 . . . . 0.0 108.693 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.599 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -64.44 135.59 27.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.224 -0.922 . . . . 0.0 111.094 -178.356 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 34' ' ' ASP . 1.5 mt -105.56 -29.39 10.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -163.51 164.09 24.47 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.632 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 7.4 t80 -133.36 -75.95 0.48 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 119.955 -1.716 . . . . 0.0 110.599 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.632 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 8.0 t-20 134.25 150.04 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.691 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -77.47 -55.88 5.01 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.335 -0.853 . . . . 0.0 109.834 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -34.0 -57.58 0.46 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' O ' HG23 ' A' ' 50' ' ' THR . 15.5 pt-20 -64.22 -46.73 82.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.948 -1.095 . . . . 0.0 109.676 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . -62.63 -12.2 39.51 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.08 -32.87 17.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.631 -1.511 . . . . 0.0 110.355 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.65 -35.08 11.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.179 -0.951 . . . . 0.0 108.899 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -107.3 -21.46 12.94 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.029 -179.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 97.93 -3.33 60.47 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.546 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 1.003 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 1.8 mtt85 -68.09 95.23 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.86 -1.376 . . . . 0.0 110.666 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.777 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -72.52 162.29 74.79 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 34.7 Cg_endo -76.98 -29.53 5.16 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.959 1.773 . . . . 0.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.79 -33.97 34.43 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.269 -0.894 . . . . 0.0 109.899 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -41.73 49.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.717 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 53' ' ' ASP . 34.1 m -74.26 -4.48 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 109.914 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.555 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.21 123.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.82 -19.37 52.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -82.66 133.69 35.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -1.139 . . . . 0.0 109.102 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.485 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.8 OUTLIER -75.0 119.78 19.65 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.204 -0.935 . . . . 0.0 108.501 179.2 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.599 ' HB2' HD12 ' A' ' 39' ' ' ILE . 90.9 t80 -66.32 -8.89 28.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.895 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.639 ' CE2' HD13 ' A' ' 33' ' ' LEU . 34.3 m-85 -96.93 -60.19 1.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.202 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -112.96 20.89 15.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.902 -1.124 . . . . 0.0 110.851 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.485 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.4 OUTLIER -137.01 -14.91 1.54 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.872 -1.142 . . . . 0.0 111.44 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 1.003 HG12 ' CZ ' ' A' ' 52' ' ' ARG . 31.5 t -122.43 -47.99 2.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 120.55 -1.344 . . . . 0.0 108.559 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.655 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . . . -122.65 109.96 32.19 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -75.17 0.79 8.55 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.912 1.742 . . . . 0.0 111.505 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.2 p -98.68 -24.84 14.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.87 -1.144 . . . . 0.0 109.658 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.596 HG21 ' CE2' ' A' ' 62' ' ' PHE . 61.2 p -73.67 -4.04 31.9 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.332 -0.855 . . . . 0.0 109.863 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -88.44 50.82 2.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.014 -1.054 . . . . 0.0 109.148 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.418 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -127.1 174.84 3.82 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.8 Cg_endo -76.77 -1.33 11.45 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 122.101 1.867 . . . . 0.0 111.387 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 14.9 mp0 -105.34 -28.42 10.9 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.916 -1.115 . . . . 0.0 109.357 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.631 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.7 t80 -100.57 -71.99 0.69 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.44 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 11.4 t80 -72.96 -16.11 61.54 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 120.947 -1.096 . . . . 0.0 108.234 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.65 -62.6 4.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.58 ' CB ' HG21 ' A' ' 90' ' ' THR . 2.2 mmtp -64.06 -14.89 57.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.672 -0.899 . . . . 0.0 109.551 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.867 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.3 t80 -80.53 -41.18 24.66 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -9.35 58.51 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 108.689 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 85' ' ' SER . 2.1 mm-40 -95.9 -40.17 9.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.7 95.02 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 79' ' ' PHE . 61.8 t -62.96 -40.61 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.943 -0.74 . . . . 0.0 109.975 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.37 1.4 54.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.256 -0.902 . . . . 0.0 111.218 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 81' ' ' GLU . 97.5 p -104.69 -24.13 12.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.863 -1.148 . . . . 0.0 110.142 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.03 21.17 47.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 87' ' ' ASN . 1.4 p-10 -160.16 57.08 0.35 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -1.189 . . . . 0.0 109.333 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.538 HD13 ' CD1' ' A' ' 118' ' ' TYR . 1.5 tt -66.29 102.39 0.85 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.422 -0.798 . . . . 0.0 109.447 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -161.6 82.95 0.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.58 HG21 ' CB ' ' A' ' 78' ' ' LYS . 10.1 t -139.79 174.58 10.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.904 -1.123 . . . . 0.0 110.233 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -149.75 168.77 22.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.05 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 8.8 p90 -174.47 154.29 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.079 -1.013 . . . . 0.0 109.929 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -80.47 117.16 20.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.41 -0.806 . . . . 0.0 108.943 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.03 169.3 11.8 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.249 -0.907 . . . . 0.0 109.435 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.446 HG22 ' OD1' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -140.19 111.31 7.04 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.376 -0.828 . . . . 0.0 109.313 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.827 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 20.6 m-30 -79.64 85.04 5.4 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.455 -0.778 . . . . 0.0 109.12 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.446 ' OD1' HG22 ' A' ' 95' ' ' THR . 1.2 m-20 -102.99 29.47 5.43 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.548 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -77.59 153.39 33.32 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 98' ' ' TYR . 10.0 mt-30 -2.0 67.35 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 123.365 0.666 . . . . 0.0 112.457 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.9 -157.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.0 109.845 -178.236 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -91.22 174.17 4.7 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 0.0 108.882 179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.3 Cg_endo -76.71 87.79 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.949 1.766 . . . . 0.0 110.509 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.46 HG22 HG13 ' A' ' 105' ' ' VAL . 1.8 m -87.52 106.9 18.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.443 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.42 139.33 31.61 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.786 ' HA ' HG23 ' A' ' 125' ' ' VAL . 13.7 m -149.94 146.14 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.131 -0.981 . . . . 0.0 110.115 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.572 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.22 115.79 29.09 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 175.248 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.05 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -85.97 159.96 3.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 120.82 -1.175 . . . . 0.0 110.925 -175.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -157.15 98.42 1.73 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.881 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -109.09 149.38 29.4 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.395 -0.816 . . . . 0.0 109.748 -177.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.673 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -141.07 -175.04 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.374 -1.33 . . . . 0.0 109.695 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -89.63 101.79 14.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 109.258 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.643 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -56.85 156.93 6.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.615 -0.678 . . . . 0.0 110.871 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.305 -1.331 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.58 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.31 0.576 . . . . 0.0 109.929 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CE1' HG22 ' A' ' 83' ' ' VAL . 1.7 m-85 -149.74 127.54 11.76 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.673 ' CH2' ' HB2' ' A' ' 110' ' ' LYS . 10.2 p-90 -123.8 148.24 46.86 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.968 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.881 HG13 ' CG ' ' A' ' 109' ' ' MET . 11.7 t -123.0 109.49 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.314 0.578 . . . . 0.0 109.827 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.653 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 9.2 m-30 -88.24 126.37 35.12 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.827 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.2 t -103.88 114.71 44.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.572 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -89.52 111.79 22.8 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.606 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -66.95 109.03 2.79 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.948 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.786 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.161 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.988 HG22 HD11 ' A' ' 15' ' ' LEU . 4.9 mm -83.6 -56.77 5.23 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 110.732 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.459 ' HA ' HD12 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -40.35 -29.23 0.08 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.773 . . . . 0.0 111.559 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 11' ' ' ILE . 4.8 m120 -89.37 -40.83 12.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.966 -1.083 . . . . 0.0 108.258 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 m -69.2 -10.18 56.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.719 -0.613 . . . . 0.0 109.794 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.988 HD11 HG22 ' A' ' 11' ' ' ILE . 15.4 mt -97.48 -24.54 15.54 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.019 -1.05 . . . . 0.0 109.172 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.423 -0.798 . . . . 0.0 109.627 179.917 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.96 30.09 9.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.604 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 31.8 mt -80.17 128.3 33.36 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.51 -0.994 . . . . 0.0 109.207 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.17 -13.78 8.42 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.599 0.714 . . . . 0.0 109.227 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.732 ' HZ ' HD11 ' A' ' 11' ' ' ILE . 14.6 p90 -129.16 150.7 50.44 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.068 -1.02 . . . . 0.0 108.843 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.528 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -76.69 152.03 40.32 Favored Glycine 0 C--N 1.293 -1.81 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.517 ' O ' ' NE2' ' A' ' 32' ' ' GLN . . . -123.7 90.61 3.31 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.832 -1.393 . . . . 0.0 107.536 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.527 HG22 ' CD1' ' A' ' 42' ' ' TYR . 1.1 pp -94.71 142.6 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.489 -0.757 . . . . 0.0 110.762 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 6.1 mm-40 -114.11 168.33 9.91 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.847 HD22 ' O ' ' A' ' 37' ' ' GLY . 73.3 mt -153.94 146.92 24.49 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.842 -1.161 . . . . 0.0 110.379 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 36' ' ' ASP . 45.1 m-20 -123.63 124.07 41.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.394 -0.816 . . . . 0.0 109.659 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.54 -77.32 0.0 OUTLIER Glycine 0 N--CA 1.5 2.951 0 C-N-CA 124.561 1.077 . . . . 0.0 113.679 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -70.57 -2.86 15.51 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.598 -0.942 . . . . 0.0 111.197 -177.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.847 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 88.02 20.52 49.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -75.5 130.16 38.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.086 -1.244 . . . . 0.0 108.201 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.648 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -59.78 139.01 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 110.561 -178.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 2.7 mt -107.07 -26.59 11.07 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.488 HE22 ' N ' ' A' ' 43' ' ' ASN . 14.0 tm0? -160.31 142.11 12.66 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.527 ' CD1' HG22 ' A' ' 31' ' ' ILE . 6.2 t80 -121.95 -64.22 1.23 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.756 -1.215 . . . . 0.0 110.729 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 45' ' ' ALA . 3.2 p-10 101.86 175.6 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.59 -19.42 19.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.855 -1.153 . . . . 0.0 112.615 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.555 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -56.84 -63.44 1.2 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.51 -1.369 . . . . 0.0 110.163 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.9 pt-20 -60.77 -53.18 60.46 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.579 -0.701 . . . . 0.0 109.392 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -57.96 -14.38 16.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.46 -30.78 20.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.786 -1.42 . . . . 0.0 110.205 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.36 -38.12 14.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.122 -0.986 . . . . 0.0 109.074 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.433 ' HA ' ' CE ' ' A' ' 100' ' ' MET . 0.7 OUTLIER -102.86 -18.28 15.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.5 -0.75 . . . . 0.0 109.669 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 92.72 -3.76 74.89 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.606 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -58.39 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.239 . . . . 0.0 109.213 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.719 ' O ' HG22 ' A' ' 57' ' ' VAL . 12.1 m-20 -54.74 152.93 11.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 108.919 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.55 -42.81 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 122.07 1.847 . . . . 0.0 110.68 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -74.73 -27.81 60.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.13 -0.981 . . . . 0.0 109.94 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -80.66 -39.65 26.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.613 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 53' ' ' ASP . 24.0 m -76.66 -1.99 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.837 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -71.71 122.1 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.061 -1.024 . . . . 0.0 108.48 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.06 -13.13 65.58 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 35.1 mmtt -79.13 136.23 37.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.048 -1.266 . . . . 0.0 108.93 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -72.41 95.03 1.71 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.459 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 30.1 t80 -53.92 -22.71 10.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 109.794 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -91.78 -31.98 15.55 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.72 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -138.15 44.98 2.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 109.114 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.455 ' HB3' ' N ' ' A' ' 61' ' ' ASN . 34.0 t0 -164.26 -31.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 110.517 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.606 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 3.9 t -112.2 -50.57 5.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 O-C-N 120.754 -1.216 . . . . 0.0 108.674 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.63 94.74 48.36 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.709 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.22 -6.02 17.82 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.886 1.724 . . . . 0.0 110.462 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.7 p -77.82 -32.87 52.54 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.151 -0.968 . . . . 0.0 108.692 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.457 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 19.1 p -69.1 -9.44 52.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.604 -0.685 . . . . 0.0 109.764 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.87 76.74 9.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.997 -1.064 . . . . 0.0 108.635 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.426 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -165.07 173.46 3.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 109.085 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.6 Cg_endo -77.4 76.71 4.12 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 122.497 2.132 . . . . 0.0 110.416 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 3.6 tt0 174.27 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.617 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.3 t80 -105.65 -64.03 1.19 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.506 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.4 t80 -79.61 -20.43 46.85 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.081 -1.012 . . . . 0.0 108.56 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.46 -57.81 13.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.717 ' CB ' HG21 ' A' ' 90' ' ' THR . 12.1 mmtt -65.38 -16.69 63.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.658 -0.907 . . . . 0.0 109.802 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.89 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.4 t80 -82.62 -35.12 27.29 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -76.32 -12.88 60.14 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.103 -0.998 . . . . 0.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 18.7 pt-20 -96.92 -41.34 8.46 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.461 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -60.18 -39.86 96.48 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 107.454 -2.258 . . . . 0.0 107.454 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 79' ' ' PHE . 99.1 t -59.88 -47.59 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.794 -0.827 . . . . 0.0 109.296 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.76 5.58 45.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.386 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.3 m -102.0 -25.75 13.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.042 -1.037 . . . . 0.0 109.612 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.78 22.29 64.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 87' ' ' ASN . 2.0 p-10 -166.03 58.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.134 -1.216 . . . . 0.0 109.51 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.5 OUTLIER -52.94 116.35 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.895 . . . . 0.0 109.515 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -160.2 78.34 0.66 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.168 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.717 HG21 ' CB ' ' A' ' 78' ' ' LYS . 9.1 t -136.44 154.91 50.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.96 163.0 34.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 0.0 108.923 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.021 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 8.6 p90 -175.27 151.59 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.041 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 1.5 pt-20 -81.73 112.39 18.86 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.195 -0.941 . . . . 0.0 108.636 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.79 -179.63 3.71 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.181 -0.949 . . . . 0.0 109.99 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.3 m -147.52 107.56 4.02 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.848 ' CE2' HG21 ' A' ' 122' ' ' VAL . 17.8 m-30 -84.13 92.58 7.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.377 -0.827 . . . . 0.0 109.718 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -108.01 25.21 11.85 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.264 -0.898 . . . . 0.0 109.338 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.576 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -78.65 155.39 29.54 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.52 ' C ' ' O ' ' A' ' 98' ' ' TYR . 24.1 mt-30 -0.32 65.85 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.187 0 CA-C-O 121.631 0.729 . . . . 0.0 112.099 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.576 ' N ' ' O ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER 173.64 158.36 0.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -53.68 168.44 0.4 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.114 -0.991 . . . . 0.0 109.088 179.135 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 32.8 Cg_endo -74.75 113.34 3.77 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.831 1.688 . . . . 0.0 110.194 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.522 HG22 HG13 ' A' ' 105' ' ' VAL . 4.3 m -116.25 114.93 25.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.844 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 125' ' ' VAL . 5.4 tttt -92.05 136.65 33.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.852 ' HA ' HG23 ' A' ' 125' ' ' VAL . 32.6 m -147.44 146.27 18.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.146 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.86 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -91.71 116.37 28.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 175.258 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.021 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -88.27 164.12 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.787 -1.196 . . . . 0.0 111.516 -175.319 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -150.83 98.7 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.876 ' HG2' HG13 ' A' ' 120' ' ' VAL . 19.5 mtm -96.85 125.4 41.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.682 -1.261 . . . . 0.0 109.503 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.553 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 3.9 tttt -132.15 172.12 12.79 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 117.525 -1.67 . . . . 0.0 109.706 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.445 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 2.1 tttp -90.29 107.68 19.29 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.979 -1.076 . . . . 0.0 108.384 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.876 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.21 -177.17 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.28 0.562 . . . . 0.0 110.154 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.027 . . . . 0.0 110.461 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.577 ' N ' ' HB3' ' A' ' 112' ' ' ALA . 4.6 t . . . . . 0 N--CA 1.502 2.163 0 CA-C-O 120.661 0.267 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.618 ' OH ' HG13 ' A' ' 83' ' ' VAL . 12.6 m-85 -127.3 122.8 34.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.742 -1.224 . . . . 0.0 109.227 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.876 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 22.1 p-90 -128.11 152.42 48.02 Favored 'General case' 0 C--O 1.201 -1.455 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.919 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.876 HG13 ' HG2' ' A' ' 109' ' ' MET . 60.9 t -132.36 110.31 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.305 0.574 . . . . 0.0 109.648 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.686 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 9.1 m-30 -94.34 122.09 36.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 108.987 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.848 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -103.03 116.84 47.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.01 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 1.6 tptp -88.09 114.18 24.45 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.828 ' HA ' HG12 ' A' ' 105' ' ' VAL . 1.2 ttp85 -67.85 111.6 4.42 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.456 -1.297 . . . . 0.0 108.544 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.86 HG22 ' HD2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.058 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.046 HG22 HD11 ' A' ' 15' ' ' LEU . 1.9 mm -88.64 -67.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.117 -0.989 . . . . 0.0 111.142 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -41.16 -36.06 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.624 -0.672 . . . . 0.0 111.592 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -77.54 -42.76 34.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.872 -1.143 . . . . 0.0 108.455 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.435 ' O ' HG22 ' A' ' 14' ' ' THR . 2.0 m -76.03 -4.38 40.95 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.046 HD11 HG22 ' A' ' 11' ' ' ILE . 81.2 mt -97.85 -23.03 16.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.855 -1.153 . . . . 0.0 109.149 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 O-C-N 121.483 -0.761 . . . . 0.0 108.994 179.522 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.16 28.88 13.68 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.85 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 1.7 mt -73.68 -171.91 1.14 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.128 -1.219 . . . . 0.0 108.798 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.85 13.22 23.63 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.85 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 18.8 p90 -146.12 177.2 9.16 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.684 -0.635 . . . . 0.0 109.509 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 46' ' ' GLU . . . -108.66 118.8 5.44 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.471 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -94.81 89.39 5.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.919 -1.342 . . . . 0.0 109.061 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.656 HD12 ' N ' ' A' ' 32' ' ' GLN . 1.1 pp -96.0 161.47 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.494 -0.754 . . . . 0.0 109.403 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.656 ' N ' HD12 ' A' ' 31' ' ' ILE . 8.9 mt-30 -132.16 175.77 8.96 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.825 HD21 ' HB2' ' A' ' 62' ' ' PHE . 22.3 mt -155.77 146.25 21.88 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.756 ' HB2' HD21 ' A' ' 40' ' ' LEU . 14.6 t70 -99.16 169.96 9.02 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.86 -21.82 1.74 Allowed Glycine 0 N--CA 1.499 2.893 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.449 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -94.98 13.51 24.77 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.547 -1.56 . . . . 0.0 110.549 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.07 26.68 65.9 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 2.0 m-20 -97.25 126.22 42.31 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.987 -1.302 . . . . 0.0 111.929 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.499 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -53.09 133.41 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.117 -0.99 . . . . 0.0 110.709 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 34' ' ' ASP . 11.6 mt -102.74 -32.2 9.95 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -155.54 -175.16 5.29 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.26 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.883 ' CE2' HG11 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -160.62 -62.8 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.97 -1.081 . . . . 0.0 110.239 -178.407 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.623 HD21 ' HB3' ' A' ' 45' ' ' ALA . 4.8 p-10 103.92 176.49 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.22 -37.03 11.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.974 -1.079 . . . . 0.0 110.758 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.623 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -46.76 -48.18 20.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.233 -0.917 . . . . 0.0 111.047 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.571 ' OE2' ' HB2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -61.83 -47.51 84.78 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.388 -0.82 . . . . 0.0 109.34 -177.643 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . -61.27 -15.87 46.71 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -80.64 -32.32 36.24 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.121 -1.223 . . . . 0.0 109.464 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.599 HD11 ' HD3' ' A' ' 124' ' ' ARG . 0.6 OUTLIER -85.06 -50.61 14.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.075 -1.015 . . . . 0.0 109.441 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.624 ' HA ' ' HE1' ' A' ' 100' ' ' MET . 0.1 OUTLIER -88.58 -13.88 38.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.759 -1.213 . . . . 0.0 109.524 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 89.09 -11.77 68.35 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.716 ' CD ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -57.78 175.54 0.19 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -1.165 . . . . 0.0 109.525 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.656 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -127.86 158.85 69.2 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 108.943 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.97 -37.99 1.8 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.865 1.71 . . . . 0.0 110.656 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -89.23 -25.26 21.83 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.171 -0.955 . . . . 0.0 109.279 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.411 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 1.2 tt0 -73.89 -37.88 64.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 108.689 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.883 HG11 ' CE2' ' A' ' 42' ' ' TYR . 26.6 m -70.9 -8.45 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.815 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -70.97 122.56 23.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.345 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.08 -19.7 51.71 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 40.4 mmtt -78.73 130.94 36.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.451 -1.029 . . . . 0.0 108.927 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 128.1 34.66 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.825 ' HB2' HD21 ' A' ' 33' ' ' LEU . 63.2 t80 -62.33 -11.53 15.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.584 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -122.52 32.17 5.86 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.95 -1.094 . . . . 0.0 110.271 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -150.09 -45.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.07 . . . . 0.0 110.563 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -128.15 4.33 5.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.994 -1.067 . . . . 0.0 110.762 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.716 HG13 ' CD ' ' A' ' 52' ' ' ARG . 39.2 t -113.62 -28.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.801 -1.187 . . . . 0.0 108.72 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.645 ' HB1' HG23 ' A' ' 70' ' ' THR . . . -156.58 88.79 2.74 Favored Pre-proline 0 C--N 1.292 -1.915 0 O-C-N 121.346 -0.847 . . . . 0.0 109.214 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -74.61 -4.41 15.37 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.986 1.791 . . . . 0.0 110.158 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.5 p -94.27 -27.63 16.03 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.355 -0.84 . . . . 0.0 109.074 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.645 HG23 ' HB1' ' A' ' 67' ' ' ALA . 69.9 p -64.41 -18.89 65.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.62 -0.675 . . . . 0.0 109.666 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -60.5 91.84 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.052 -1.03 . . . . 0.0 108.842 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.414 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -174.95 172.8 1.11 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.229 -179.604 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.1 Cg_endo -78.16 -4.44 14.33 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 122.599 2.199 . . . . 0.0 111.729 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 17.7 mt-10 -102.46 -29.95 11.3 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.754 -1.216 . . . . 0.0 109.822 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.443 ' HB3' ' O ' ' A' ' 70' ' ' THR . 1.6 t80 -101.62 -68.91 0.8 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.469 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.8 t80 -73.62 -17.32 61.18 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 81' ' ' GLU . . . -64.84 -61.42 5.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.595 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.2 OUTLIER -65.03 -14.66 60.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.646 -0.914 . . . . 0.0 109.841 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.901 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.9 t80 -82.89 -36.75 25.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -78.32 -9.47 59.26 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 85' ' ' SER . 1.3 mm-40 -95.61 -39.6 9.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.612 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -65.25 -41.69 96.66 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.3 t -59.67 -40.57 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.788 -0.831 . . . . 0.0 109.585 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.66 1.17 53.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.275 -0.891 . . . . 0.0 111.503 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 8.7 t -106.39 -20.1 13.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.808 -1.182 . . . . 0.0 110.147 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.63 26.03 57.4 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -168.66 67.26 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.397 -1.06 . . . . 0.0 109.217 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.83 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -71.37 115.88 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.905 . . . . 0.0 110.032 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.45 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 64.1 t-20 -162.03 88.4 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.541 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 78' ' ' LYS . 4.6 t -128.92 168.32 16.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.992 -1.068 . . . . 0.0 109.96 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.413 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 0.6 OUTLIER -155.14 151.11 27.87 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.064 ' CE2' HG21 ' A' ' 107' ' ' VAL . 12.3 p90 -173.03 -176.58 1.42 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.293 -0.88 . . . . 0.0 109.547 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.82 100.03 8.6 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.19 179.12 4.7 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.591 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.3 m -144.03 105.9 4.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.383 -0.823 . . . . 0.0 109.271 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.948 ' CE2' HG21 ' A' ' 122' ' ' VAL . 15.5 m-30 -80.59 110.15 15.8 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -134.7 43.26 2.76 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.364 -0.835 . . . . 0.0 109.485 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 21.4 p90 -77.41 139.58 39.72 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.533 ' C ' ' O ' ' A' ' 98' ' ' TYR . 3.3 pt20 2.31 66.98 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.191 0 CA-C-O 121.879 0.847 . . . . 0.0 111.783 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.624 ' HE1' ' HA ' ' A' ' 50' ' ' THR . 2.6 tmm? -176.85 -179.38 0.94 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 p -65.0 163.08 32.67 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.0 109.06 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.02 148.67 27.98 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.147 1.898 . . . . 0.0 110.416 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.577 HG22 HG13 ' A' ' 105' ' ' VAL . 3.2 m -151.36 118.87 6.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 110.116 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -95.36 142.9 27.21 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.961 ' HA ' HG23 ' A' ' 125' ' ' VAL . 32.5 m -144.12 146.67 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 118.266 -1.373 . . . . 0.0 112.411 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.561 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -78.8 95.33 5.34 Favored 'General case' 0 C--O 1.2 -1.536 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 175.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.064 HG21 ' CE2' ' A' ' 92' ' ' PHE . 33.3 m -87.63 152.6 3.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 120.731 -1.231 . . . . 0.0 110.151 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -160.44 97.53 1.22 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.817 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -106.12 142.27 36.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.188 -0.945 . . . . 0.0 109.327 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 5.3 tttt -133.01 -162.49 1.24 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.753 -1.217 . . . . 0.0 109.416 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -110.84 98.53 7.64 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.119 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.958 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.49 123.97 12.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 tp . . . . . 0 C--N 1.301 -1.541 0 O-C-N 121.037 -1.039 . . . . 0.0 109.695 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.499 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.037 0 CA-C-O 121.103 0.478 . . . . 0.0 111.534 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.862 ' CE1' HG22 ' A' ' 83' ' ' VAL . 15.9 m-85 -128.75 127.45 42.07 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.037 -1.04 . . . . 0.0 110.106 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.958 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 17.6 p-90 -125.56 146.87 49.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.601 -1.312 . . . . 0.0 112.269 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.817 HG13 ' HG2' ' A' ' 109' ' ' MET . 40.7 t -123.32 117.85 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.741 -0.599 . . . . 0.0 109.949 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.643 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.0 m-30 -100.92 120.0 39.53 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.988 -1.07 . . . . 0.0 108.639 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.948 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.4 t -105.58 111.71 35.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 122.244 1.021 . . . . 0.0 108.297 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.487 ' O ' ' HB ' ' A' ' 105' ' ' VAL . 1.5 tptp -92.71 154.49 18.3 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.599 ' HD3' HD11 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -91.47 123.55 34.98 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.493 -1.379 . . . . 0.0 109.008 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.961 HG23 ' HA ' ' A' ' 105' ' ' VAL . 9.3 t . . . . . 0 C--N 1.305 -1.355 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.481 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.009 HG22 HD11 ' A' ' 15' ' ' LEU . 2.9 mm -82.48 -56.14 6.45 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 111.464 -177.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 15' ' ' LEU . 1.5 tt0 -40.43 -27.91 0.06 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.454 -0.779 . . . . 0.0 111.524 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' ILE . 96.6 m-20 -86.79 -42.52 13.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 109.007 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -70.48 -14.42 62.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.347 -0.846 . . . . 0.0 110.21 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.009 HD11 HG22 ' A' ' 11' ' ' ILE . 8.9 mt -93.56 -18.92 21.7 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.014 -1.054 . . . . 0.0 109.069 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 108.824 179.172 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.916 0.389 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.51 35.53 4.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.706 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 13.6 mt -121.27 149.64 42.58 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.487 -1.008 . . . . 0.0 109.352 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.04 24.58 4.2 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.029 0.918 . . . . 0.0 108.851 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.716 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 1.2 p90 -153.53 134.12 13.66 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -68.18 125.2 21.07 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.96 -1.115 . . . . 0.0 110.857 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.523 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -106.21 110.41 22.64 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.529 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.4 pp -117.11 151.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.939 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.602 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -113.0 167.91 10.13 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.757 HD11 ' CB ' ' A' ' 62' ' ' PHE . 13.2 mt -150.07 139.9 21.83 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.916 -1.115 . . . . 0.0 110.036 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.438 ' N ' HD21 ' A' ' 40' ' ' LEU . 37.1 t70 -92.14 167.56 11.97 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -48.93 -21.04 2.14 Favored Glycine 0 N--CA 1.497 2.747 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.421 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.51 12.52 22.65 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.458 -1.613 . . . . 0.0 110.498 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.652 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.3 26.9 64.89 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.569 ' C ' HD23 ' A' ' 33' ' ' LEU . 16.3 m120 -97.4 127.83 43.69 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.013 -1.287 . . . . 0.0 111.872 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.626 HD12 HD21 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -59.52 134.83 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.86 -1.15 . . . . 0.0 110.528 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 32' ' ' GLN . 2.3 mt -106.47 -29.56 9.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -155.46 161.38 40.97 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.832 ' CG ' HG21 ' A' ' 57' ' ' VAL . 3.7 t80 -143.7 -60.93 0.4 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.552 -1.342 . . . . 0.0 109.972 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.601 HD21 ' HB3' ' A' ' 45' ' ' ALA . 3.5 p-10 99.89 173.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 123.745 0.818 . . . . 0.0 108.871 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.59 -13.73 25.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.755 -1.215 . . . . 0.0 111.84 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.601 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -58.93 -65.06 0.73 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.585 -1.322 . . . . 0.0 109.904 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.591 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 7.0 pt-20 -60.31 -50.0 75.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.959 . . . . 0.0 109.737 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -56.47 -18.64 23.4 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 45' ' ' ALA . 1.2 m-20 -76.13 -38.47 56.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.829 -1.395 . . . . 0.0 108.422 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.627 HG22 HG23 ' A' ' 50' ' ' THR . 0.3 OUTLIER -79.32 -59.5 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.45 -0.781 . . . . 0.0 109.294 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.627 HG23 HG22 ' A' ' 49' ' ' ILE . 19.0 p -78.36 -9.63 59.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.275 -0.891 . . . . 0.0 110.474 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.444 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 81.0 -2.34 81.23 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.925 ' CD ' HG13 ' A' ' 66' ' ' VAL . 1.3 mtt-85 -73.86 84.71 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.169 -1.195 . . . . 0.0 109.925 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.533 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -54.29 173.73 0.21 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.301 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 35.8 Cg_endo -77.94 -32.22 2.7 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.018 1.812 . . . . 0.0 110.856 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -80.97 -33.42 33.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.193 -0.942 . . . . 0.0 109.987 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 4.8 tt0 -71.56 -42.67 67.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.097 -1.002 . . . . 0.0 109.658 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.832 HG21 ' CG ' ' A' ' 42' ' ' TYR . 28.6 m -68.65 -9.08 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.963 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.484 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -70.11 123.16 23.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.8 -14.67 59.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 56' ' ' GLN . 65.7 mmtt -79.51 127.45 32.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.266 -1.138 . . . . 0.0 109.18 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -67.53 128.01 34.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 108.659 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.757 ' CB ' HD11 ' A' ' 33' ' ' LEU . 78.2 t80 -62.21 -14.2 35.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 0.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.4 5.72 11.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.057 -1.027 . . . . 0.0 111.12 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 4.5 mttt -151.45 47.26 0.81 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.785 -1.197 . . . . 0.0 109.825 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER 163.56 -22.59 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.609 -0.682 . . . . 0.0 109.683 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.925 HG13 ' CD ' ' A' ' 52' ' ' ARG . 21.2 t -112.76 -28.66 2.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.22 -0.925 . . . . 0.0 108.505 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.496 ' HB1' HG23 ' A' ' 70' ' ' THR . . . -159.81 94.99 1.64 Allowed Pre-proline 0 C--N 1.293 -1.864 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.947 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.88 -18.53 16.84 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.856 1.704 . . . . 0.0 109.241 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.7 p -79.45 -20.35 47.64 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.532 -0.73 . . . . 0.0 109.376 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.496 HG23 ' HB1' ' A' ' 67' ' ' ALA . 47.7 p -80.94 5.82 15.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 110.032 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -89.28 52.58 2.41 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.937 -1.102 . . . . 0.0 108.402 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.48 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.8 p -125.39 -179.42 0.87 Allowed Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.99 -12.81 14.44 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 122.146 1.897 . . . . 0.0 111.593 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.6 OUTLIER -96.37 -26.68 15.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.835 -1.165 . . . . 0.0 109.746 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -100.59 -72.61 0.67 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.277 -0.89 . . . . 0.0 108.604 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 5.8 t80 -72.24 -18.91 61.79 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.032 -1.042 . . . . 0.0 109.045 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -64.44 -59.77 7.89 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.879 ' HB2' HG21 ' A' ' 90' ' ' THR . 2.0 mmtp -65.14 -14.58 60.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.633 -0.922 . . . . 0.0 109.983 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.885 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.5 t80 -84.95 -36.14 21.6 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.387 -0.821 . . . . 0.0 109.39 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -76.1 -12.32 60.09 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 108.84 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 25.2 pt-20 -97.27 -41.43 8.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.456 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -59.6 -39.52 95.21 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.461 -2.256 . . . . 0.0 107.461 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 79' ' ' PHE . 97.5 t -63.93 -44.79 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.91 -0.759 . . . . 0.0 110.113 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.58 4.39 51.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.181 -0.949 . . . . 0.0 110.729 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.3 t -106.21 -25.35 12.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.932 -1.105 . . . . 0.0 109.87 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.73 29.31 32.56 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -171.88 60.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -1.17 . . . . 0.0 109.212 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 5.3 tt -60.03 119.3 7.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.711 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.44 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 18.8 p-10 -160.34 85.1 0.72 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 109.254 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.879 HG21 ' HB2' ' A' ' 78' ' ' LYS . 3.5 t -134.36 149.48 50.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.031 -1.043 . . . . 0.0 109.99 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.6 ptp -140.33 166.07 25.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.426 -0.796 . . . . 0.0 108.987 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.079 ' CE1' HG21 ' A' ' 107' ' ' VAL . 20.4 p90 176.4 178.16 0.23 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.812 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -105.14 114.92 29.4 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.94 173.88 6.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.274 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.2 m -146.45 108.63 4.42 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.463 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 16.6 m-85 -81.1 120.88 25.39 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.131 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.78 47.23 2.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 108.75 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -79.02 72.83 5.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.068 -0.395 . . . . 0.0 111.274 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.5 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER 64.58 31.41 12.26 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.318 -0.864 . . . . 0.0 109.9 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.45 ' SD ' HG22 ' A' ' 101' ' ' THR . 0.0 OUTLIER -149.69 -177.82 6.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.236 -0.915 . . . . 0.0 108.844 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.451 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 0.5 OUTLIER -55.14 152.67 14.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 109.253 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.451 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 32.1 Cg_endo -73.45 82.72 1.6 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.716 1.61 . . . . 0.0 109.883 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.705 HG22 ' CG1' ' A' ' 105' ' ' VAL . 1.9 m -69.64 93.71 0.73 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.648 -0.658 . . . . 0.0 109.846 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.9 137.14 47.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.937 ' HA ' HG23 ' A' ' 125' ' ' VAL . 4.1 m -146.37 147.0 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.48 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.85 150.75 36.05 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 173.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.079 HG21 ' CE1' ' A' ' 92' ' ' PHE . 30.2 m -137.77 149.28 25.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 119.945 -1.722 . . . . 0.0 109.366 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -160.2 101.87 1.41 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.774 ' HB3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -109.03 140.42 42.57 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.241 -178.308 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.636 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 9.7 tttt -135.23 -162.48 1.26 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.571 -1.331 . . . . 0.0 109.888 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -108.14 103.26 12.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.928 . . . . 0.0 108.83 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.885 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -51.07 147.71 5.03 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.599 -0.688 . . . . 0.0 110.443 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.451 -0.781 . . . . 0.0 110.047 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.846 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.307 0.575 . . . . 0.0 109.813 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.744 ' CE1' HG22 ' A' ' 83' ' ' VAL . 14.7 m-85 -152.0 116.39 5.03 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.885 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 14.6 p-90 -118.69 153.74 33.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.06 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.774 HG22 ' HB3' ' A' ' 109' ' ' MET . 24.0 t -127.5 112.6 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.652 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 12.5 m-30 -96.47 104.11 16.07 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -92.6 115.11 30.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.339 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -90.7 142.42 27.77 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.592 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.431 ' NH2' HD11 ' A' ' 49' ' ' ILE . 5.8 ttt180 -89.46 119.37 29.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.516 -1.365 . . . . 0.0 108.961 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.937 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.312 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.13 HG22 HD11 ' A' ' 15' ' ' LEU . 4.5 mm -78.43 -59.67 2.85 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.517 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.406 ' HA ' HD12 ' A' ' 15' ' ' LEU . 7.8 pt-20 -40.95 -31.22 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.511 -0.743 . . . . 0.0 111.716 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.64 -40.23 16.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.802 -1.186 . . . . 0.0 108.577 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 14' ' ' THR . 6.5 m -71.32 -10.88 60.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.627 -0.671 . . . . 0.0 110.055 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.13 HD11 HG22 ' A' ' 11' ' ' ILE . 13.4 mt -96.7 -9.31 29.33 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.952 -1.093 . . . . 0.0 109.747 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.041 -1.037 . . . . 0.0 109.134 179.481 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.93 0.395 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.75 28.07 15.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.045 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 18.8 mt -98.6 164.27 12.32 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.204 -1.174 . . . . 0.0 108.333 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.447 ' HB3' ' NZ ' ' A' ' 123' ' ' LYS . . . -94.42 19.35 9.75 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.045 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 2.7 p90 -152.89 179.2 8.87 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -107.69 125.8 8.08 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -96.06 96.88 9.16 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.027 -1.278 . . . . 0.0 108.465 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.634 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.4 pp -102.63 146.18 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.23 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.721 ' HB3' HD12 ' A' ' 40' ' ' LEU . 12.6 mt-30 -119.65 171.88 8.07 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 39' ' ' ILE . 72.0 mt -152.78 147.11 25.67 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 109.738 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.575 ' HB2' HD21 ' A' ' 40' ' ' LEU . 1.9 m-20 -119.05 136.49 54.11 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.358 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -9.01 71.06 0.0 OUTLIER Glycine 0 N--CA 1.51 3.629 0 C-N-CA 124.659 1.123 . . . . 0.0 113.428 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER 161.64 -24.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.632 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.03 17.53 24.92 Favored Glycine 0 N--CA 1.481 1.697 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 29.5 m120 -82.7 128.67 34.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -1.123 . . . . 0.0 108.426 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.747 HD13 ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -62.45 138.51 22.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 122.059 0.933 . . . . 0.0 111.568 -178.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.721 HD12 ' HB3' ' A' ' 32' ' ' GLN . 6.0 mt -105.0 -31.18 9.33 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.521 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -158.4 -176.33 5.84 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 1.6 t80 -161.11 -62.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.072 -1.018 . . . . 0.0 109.677 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' ' 45' ' ' ALA . 3.3 p-10 100.42 175.55 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.493 0 C-N-CA 123.666 0.786 . . . . 0.0 109.48 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.89 -15.68 22.27 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.004 -1.06 . . . . 0.0 111.983 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.59 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -57.9 -64.95 0.73 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.662 -1.274 . . . . 0.0 109.846 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 13.2 pt-20 -64.43 -43.29 94.79 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.219 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.435 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -60.11 -16.01 39.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -87.26 -28.53 22.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.723 -1.457 . . . . 0.0 109.673 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.431 HG13 ' HD3' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -82.22 -39.62 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.542 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.419 HG22 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -113.91 -0.31 14.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.833 -0.542 . . . . 0.0 110.627 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.81 -3.26 70.46 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.649 -1.263 . . . . 0.0 110.942 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.991 ' NH2' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -63.87 91.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.826 -1.397 . . . . 0.0 110.388 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.835 ' O ' HG22 ' A' ' 57' ' ' VAL . 14.5 m-20 -72.32 158.46 87.46 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.97 -42.04 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.85 1.7 . . . . 0.0 110.821 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.568 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -67.26 -27.55 67.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.992 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -84.87 -42.49 15.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.0 109.612 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 53' ' ' ASP . 34.7 m -78.42 -0.03 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.0 109.743 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.645 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -70.42 122.01 21.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.013 -1.054 . . . . 0.0 108.702 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.98 -19.72 52.65 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -80.06 137.42 36.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.276 -1.132 . . . . 0.0 108.894 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.504 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.7 OUTLIER -77.58 97.98 5.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.747 ' HB2' HD13 ' A' ' 39' ' ' ILE . 62.3 t80 -56.35 -18.29 10.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.665 -0.647 . . . . 0.0 110.337 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.453 ' CD1' ' CD1' ' A' ' 76' ' ' TYR . 3.0 m-85 -95.42 -30.87 13.66 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.065 -1.022 . . . . 0.0 110.458 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -139.15 42.1 2.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 110.027 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -157.34 -37.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.048 -1.033 . . . . 0.0 110.254 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.716 HG12 ' NH1' ' A' ' 52' ' ' ARG . 1.8 t -104.9 -58.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 122.902 1.335 . . . . 0.0 108.923 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.991 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . . . -106.56 100.99 33.56 Favored Pre-proline 0 C--N 1.289 -2.061 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.563 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.59 -4.04 14.7 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.845 1.696 . . . . 0.0 110.698 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.1 p -88.19 -24.75 23.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.959 -1.088 . . . . 0.0 109.332 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.481 HG21 ' CE2' ' A' ' 62' ' ' PHE . 2.2 p -76.58 -2.0 30.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.285 -0.885 . . . . 0.0 109.866 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.31 50.53 1.52 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.889 -1.132 . . . . 0.0 108.23 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.485 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -113.97 178.99 0.85 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -77.96 -14.44 15.34 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 122.072 1.848 . . . . 0.0 111.227 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 29.9 mt-10 -100.54 -22.8 14.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.782 -1.199 . . . . 0.0 109.545 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.519 ' CE1' ' HE3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -100.48 -73.45 0.64 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 9.2 t80 -70.35 -19.24 63.06 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.878 -1.139 . . . . 0.0 108.873 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.93 -59.75 8.66 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -63.56 -15.3 57.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.453 -1.028 . . . . 0.0 109.682 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.87 ' O ' HG23 ' A' ' 83' ' ' VAL . 13.1 t80 -81.88 -38.05 25.95 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.545 -0.722 . . . . 0.0 109.788 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -11.9 60.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.021 -1.05 . . . . 0.0 109.362 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 12.9 pt-20 -97.28 -41.73 8.13 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -61.32 -39.54 97.38 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 79' ' ' PHE . 85.1 t -63.52 -41.57 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.862 -0.787 . . . . 0.0 110.009 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.2 4.78 53.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.246 -0.909 . . . . 0.0 111.036 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.4 p -106.11 -26.74 11.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.89 -1.131 . . . . 0.0 110.131 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.09 23.52 37.73 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -171.39 87.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -1.125 . . . . 0.0 109.036 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 79' ' ' PHE . 1.9 tt -84.36 123.09 29.81 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.306 -0.872 . . . . 0.0 109.787 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 4.9 p-10 -160.56 81.78 0.67 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.235 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -121.85 154.34 37.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.118 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -148.02 139.26 23.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.788 . . . . 0.0 109.04 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.067 ' CE2' HG21 ' A' ' 107' ' ' VAL . 8.9 p90 -162.83 -174.92 4.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.053 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -112.91 108.76 17.82 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.65 -179.48 3.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.35 -0.844 . . . . 0.0 110.083 -178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.7 m -149.47 108.51 3.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.521 -0.737 . . . . 0.0 109.062 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.845 ' CE2' HG21 ' A' ' 122' ' ' VAL . 13.8 m-30 -81.09 92.28 6.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.351 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -105.67 24.24 12.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.251 -0.906 . . . . 0.0 109.637 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.554 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.69 155.72 29.32 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.508 ' HG3' ' CD2' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 0.28 65.72 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 CA-C-O 121.549 0.69 . . . . 0.0 112.317 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER 175.66 164.78 0.34 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.427 -0.796 . . . . 0.0 109.126 -178.127 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.545 HG22 ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -57.75 175.66 0.27 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.302 -0.874 . . . . 0.0 108.883 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.545 ' HD2' HG22 ' A' ' 101' ' ' THR . 34.6 Cg_endo -76.6 107.64 2.49 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.846 1.697 . . . . 0.0 109.801 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.439 HG22 HG13 ' A' ' 105' ' ' VAL . 4.2 m -109.38 122.54 47.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.807 . . . . 0.0 110.365 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -102.59 145.06 30.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.981 ' HA ' HG23 ' A' ' 125' ' ' VAL . 22.7 m -152.01 145.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.654 -1.279 . . . . 0.0 111.859 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.9 ' HD2' HG22 ' A' ' 125' ' ' VAL . 7.5 mptt -77.44 117.13 18.61 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 102.876 -3.009 . . . . 0.0 102.876 174.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.067 HG21 ' CE2' ' A' ' 92' ' ' PHE . 35.7 m -102.31 151.14 5.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 117.898 -1.521 . . . . 0.0 109.767 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -154.9 103.68 2.43 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.8 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -105.66 139.16 40.68 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.457 -0.777 . . . . 0.0 109.335 -178.344 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.606 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.9 ttmt -137.57 -157.77 0.8 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.562 -1.336 . . . . 0.0 109.476 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -105.37 137.87 42.47 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 108.994 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.909 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -98.89 -179.07 4.16 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 110.058 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.899 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.25 0.548 . . . . 0.0 109.625 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.762 ' OH ' HG13 ' A' ' 83' ' ' VAL . 12.3 m-85 -147.64 123.08 10.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.261 -0.899 . . . . 0.0 108.739 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.909 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 18.6 p-90 -127.14 146.32 50.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 118.386 -1.326 . . . . 0.0 112.833 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.8 HG13 ' HG2' ' A' ' 109' ' ' MET . 58.9 t -118.58 110.36 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.636 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.662 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 12.4 m-30 -95.44 133.53 39.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.984 -1.073 . . . . 0.0 108.406 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.845 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.5 t -116.01 113.57 43.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 C-N-CA 119.054 -1.059 . . . . 0.0 109.532 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 5.2 tptp -90.02 131.13 36.07 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.431 ' HD3' HG13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -80.21 123.93 28.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.53 -1.356 . . . . 0.0 109.561 -178.676 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.981 HG23 ' HA ' ' A' ' 105' ' ' VAL . 5.3 t . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.612 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.041 HG22 HD11 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -79.63 -69.2 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.973 -1.079 . . . . 0.0 110.513 -177.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -44.73 -25.79 0.32 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 111.134 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.434 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -75.4 -49.21 19.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.036 -1.04 . . . . 0.0 109.501 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -61.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.041 HD11 HG22 ' A' ' 11' ' ' ILE . 72.6 mt -37.27 -32.42 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.363 0.601 . . . . 0.0 110.676 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 110.165 -179.272 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.996 0.427 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.14 34.77 5.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.84 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 7.3 mt -110.41 158.93 17.94 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.408 -1.054 . . . . 0.0 109.282 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.94 6.93 33.37 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.45 0.643 . . . . 0.0 109.349 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.84 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 26.3 p90 -134.04 -169.67 2.36 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.273 -0.892 . . . . 0.0 108.868 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -118.3 149.57 18.34 Favored Glycine 0 C--N 1.297 -1.595 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -126.14 84.8 2.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.754 -1.439 . . . . 0.0 107.936 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.643 HG22 ' CD1' ' A' ' 42' ' ' TYR . 1.3 pp -91.71 149.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.168 0.985 . . . . 0.0 110.862 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.557 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 3.2 mm100 -115.23 162.43 17.08 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.611 HD22 ' C ' ' A' ' 37' ' ' GLY . 21.7 mt -150.09 146.08 26.72 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.404 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.544 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -99.28 173.62 6.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -40.06 -57.08 2.59 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 121.619 -0.324 . . . . 0.0 113.001 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.83 -17.64 61.65 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.63 -1.512 . . . . 0.0 110.337 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.611 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 102.42 28.73 6.26 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 22.6 m-80 -84.74 136.68 33.61 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.442 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' A' ' 31' ' ' ILE . 3.0 tp -63.73 135.85 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.762 -1.211 . . . . 0.0 111.387 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -110.06 -28.49 8.67 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.303 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.557 ' HB2' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.76 153.02 22.11 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.144 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.643 ' CD1' HG22 ' A' ' 31' ' ' ILE . 17.5 t80 -134.76 -66.68 0.58 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.169 -1.582 . . . . 0.0 111.414 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.3 p-10 102.39 174.79 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.657 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.09 -23.97 15.98 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.8 -1.188 . . . . 0.0 112.898 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.68 -62.43 1.65 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.464 -1.398 . . . . 0.0 110.741 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.1 pt-20 -58.72 -55.25 37.53 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.675 0.75 . . . . 0.0 109.64 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.413 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -56.79 -15.22 11.89 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.015 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -40.61 61.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.783 -1.422 . . . . 0.0 108.799 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -84.74 -56.89 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.414 -0.804 . . . . 0.0 109.235 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.55 ' N ' HG22 ' A' ' 49' ' ' ILE . 18.9 p -72.71 -24.66 61.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.509 -0.744 . . . . 0.0 109.916 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 94.37 -19.22 54.65 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.914 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -43.9 97.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.608 -0.936 . . . . 0.0 110.626 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.67 ' O ' HG13 ' A' ' 57' ' ' VAL . 42.4 m-20 -69.51 158.29 87.28 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.16 -61.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.942 1.762 . . . . 0.0 110.829 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -62.52 -18.13 61.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.215 -0.928 . . . . 0.0 110.151 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -86.87 -41.37 14.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.016 -1.053 . . . . 0.0 109.528 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 53' ' ' ASP . 22.4 m -79.61 2.01 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.831 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.24 121.05 20.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 120.979 -1.075 . . . . 0.0 109.034 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.31 -13.68 64.5 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 16.7 mmtp -78.89 139.8 38.23 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.084 -1.245 . . . . 0.0 109.066 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 65' ' ' ASP . 1.0 OUTLIER -80.95 96.52 7.1 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.947 ' CZ ' HG21 ' A' ' 70' ' ' THR . 16.7 t80 -55.06 -34.46 63.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.024 -1.048 . . . . 0.0 109.722 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.605 ' HD2' HD13 ' A' ' 33' ' ' LEU . 2.5 m-85 -80.42 -23.34 40.39 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.251 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -148.1 49.07 1.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.983 -1.073 . . . . 0.0 109.631 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ASN . 8.8 t0 -174.54 -29.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 111.047 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.914 HG11 ' HD3' ' A' ' 52' ' ' ARG . 13.5 t -106.08 -58.41 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.617 -1.302 . . . . 0.0 109.004 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.635 ' HB3' ' OG1' ' A' ' 70' ' ' THR . . . -99.01 106.65 39.35 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 114.618 -1.173 . . . . 0.0 109.861 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -77.36 1.41 8.79 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 C-N-CA 121.614 1.543 . . . . 0.0 109.896 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.4 p -107.03 -19.58 13.58 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 121.216 -0.927 . . . . 0.0 109.778 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.947 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 11.0 p -85.93 9.57 16.52 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.124 -0.985 . . . . 0.0 110.133 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -106.54 59.9 0.64 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.118 -0.989 . . . . 0.0 108.956 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.473 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -144.3 176.26 2.35 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.352 -0.843 . . . . 0.0 109.675 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 33.6 Cg_endo -76.71 78.64 3.29 Favored 'Trans proline' 0 C--N 1.323 -0.763 0 C-N-CA 122.375 2.05 . . . . 0.0 110.415 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 171.54 -37.86 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.6 t80 -105.38 -67.68 0.9 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.479 ' CD1' ' CD1' ' A' ' 63' ' ' PHE . 9.3 t80 -73.22 -18.12 61.27 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.1 -63.66 4.21 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.528 ' HB2' HG21 ' A' ' 90' ' ' THR . 10.8 mmtt -61.09 -17.54 53.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -1.047 . . . . 0.0 109.864 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.865 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.3 t80 -82.22 -38.24 24.82 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.484 -0.76 . . . . 0.0 109.53 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -13.29 60.37 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 109.382 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -98.05 -36.46 10.1 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.639 -1.225 . . . . 0.0 108.151 178.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.66 -39.33 96.63 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.3 t -63.21 -51.87 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.958 -0.731 . . . . 0.0 109.928 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.18 -2.88 46.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -0.922 . . . . 0.0 110.793 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.8 t -96.34 -29.94 13.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.131 . . . . 0.0 109.629 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.06 15.05 46.52 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -165.87 86.87 0.36 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.118 -1.225 . . . . 0.0 109.131 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -76.98 122.93 25.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.472 -0.768 . . . . 0.0 110.088 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -160.97 82.4 0.64 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.528 HG21 ' HB2' ' A' ' 78' ' ' LYS . 8.7 t -127.48 169.5 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 111.212 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 107' ' ' VAL . 1.8 ttm -159.77 149.23 18.08 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.109 ' CE1' HG21 ' A' ' 107' ' ' VAL . 18.7 p90 -172.42 165.55 5.75 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -96.82 105.77 17.96 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.56 -177.32 3.33 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.817 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 103' ' ' THR . 92.9 m -151.02 108.51 3.63 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.825 ' CE2' HG21 ' A' ' 122' ' ' VAL . 18.7 m-30 -84.06 114.91 22.08 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 109.703 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -139.61 42.29 2.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.665 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.537 ' O ' ' C ' ' A' ' 99' ' ' GLN . 10.1 p90 -78.69 148.06 33.26 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.537 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.0 tt0 1.89 67.95 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 121.781 0.8 . . . . 0.0 111.482 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.9 ttp 177.29 -159.1 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 109.386 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.477 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 2.3 t -85.37 153.61 59.14 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.5 Cg_endo -75.74 141.18 24.28 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.713 1.609 . . . . 0.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.446 HG22 HG13 ' A' ' 105' ' ' VAL . 1.8 m -140.08 140.17 36.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.336 -0.852 . . . . 0.0 109.605 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -111.18 141.6 44.47 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.801 ' HA ' HG23 ' A' ' 125' ' ' VAL . 24.5 m -149.68 144.05 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.921 -1.112 . . . . 0.0 110.681 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.42 102.31 13.94 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 175.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.109 HG21 ' CE1' ' A' ' 92' ' ' PHE . 18.1 m -85.55 156.91 3.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 110.885 -175.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -160.36 106.88 1.54 Allowed 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.807 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.92 149.49 35.11 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.477 -0.764 . . . . 0.0 109.606 -177.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.578 ' HB3' ' CZ2' ' A' ' 119' ' ' TRP . 9.5 ttpt -144.34 170.64 15.62 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.474 -1.391 . . . . 0.0 109.213 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.456 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 11.0 tttt -80.11 104.18 10.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.771 -1.206 . . . . 0.0 108.787 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.837 ' HB3' ' HB3' ' A' ' 117' ' ' SER . . . -52.09 155.51 1.88 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 109.652 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.987 . . . . 0.0 110.119 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.837 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.269 0.557 . . . . 0.0 109.836 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.844 ' CE1' HG22 ' A' ' 83' ' ' VAL . 12.6 m-85 -153.47 108.36 3.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.301 -0.874 . . . . 0.0 109.06 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.736 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.2 p-90 -108.22 142.09 39.01 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.695 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.807 HG13 ' HG2' ' A' ' 109' ' ' MET . 96.1 t -117.41 118.69 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.651 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 16.0 m-30 -101.86 121.93 43.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.146 -0.971 . . . . 0.0 109.349 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.825 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.7 t -109.66 116.05 51.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.249 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.459 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 6.8 tttm -101.87 133.99 45.76 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.405 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.51 ' HA ' HG12 ' A' ' 105' ' ' VAL . 8.1 ttp85 -73.54 117.89 15.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.983 -1.073 . . . . 0.0 109.65 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.801 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.205 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.069 HG22 HD11 ' A' ' 15' ' ' LEU . 2.4 mm -65.39 -67.58 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.212 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HA ' HD12 ' A' ' 15' ' ' LEU . 3.3 pt-20 -37.55 -30.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.032 0.444 . . . . 0.0 111.656 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' ILE . 20.3 t-20 -76.19 -50.36 14.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.022 -1.049 . . . . 0.0 108.673 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 m -67.36 -14.91 63.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.548 -0.72 . . . . 0.0 109.811 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.069 HD11 HG22 ' A' ' 11' ' ' ILE . 11.4 mt -96.68 -26.49 15.17 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.094 -1.004 . . . . 0.0 109.168 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.307 -179.857 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.979 0.419 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.77 35.1 5.08 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 mt -114.74 134.68 54.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.403 -1.057 . . . . 0.0 109.458 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.86 -6.55 27.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.385 0.612 . . . . 0.0 109.792 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.709 ' HE2' HD12 ' A' ' 11' ' ' ILE . 7.6 p90 -124.01 114.37 19.66 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.027 -1.046 . . . . 0.0 108.324 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -51.94 158.29 3.05 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' N ' ' OE2' ' A' ' 46' ' ' GLU . . . -139.44 99.52 3.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.066 -1.255 . . . . 0.0 107.973 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.622 HD12 ' N ' ' A' ' 32' ' ' GLN . 0.7 OUTLIER -99.41 172.36 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.884 0.849 . . . . 0.0 110.511 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.71 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -141.61 164.93 28.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.506 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 38' ' ' ASN . 28.0 mt -148.32 154.18 39.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.904 -1.122 . . . . 0.0 109.893 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.541 ' N ' HD21 ' A' ' 40' ' ' LEU . 1.3 p30 -116.33 128.83 55.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 108.892 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -15.9 76.53 0.0 OUTLIER Glycine 0 N--CA 1.508 3.486 0 C-N-CA 124.505 1.05 . . . . 0.0 112.951 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.8 OUTLIER 162.58 -23.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 101.06 17.93 21.3 Favored Glycine 0 N--CA 1.48 1.589 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.783 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -86.16 152.17 23.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.016 -1.285 . . . . 0.0 107.787 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' ' 57' ' ' VAL . 2.1 tp -79.52 144.91 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.829 -1.169 . . . . 0.0 113.034 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.714 HD11 ' O ' ' A' ' 33' ' ' LEU . 2.0 mt -113.11 -33.85 5.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 174.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 35.3 tp60 -169.02 158.75 8.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.588 -0.695 . . . . 0.0 110.227 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.578 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 13.2 t80 -135.75 -54.33 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.375 -0.828 . . . . 0.0 110.128 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 0.8 OUTLIER 95.72 177.59 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 C-N-CA 123.02 0.528 . . . . 0.0 109.641 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.12 -22.5 17.27 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.996 -1.065 . . . . 0.0 113.039 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -57.0 -68.53 0.21 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.428 -1.42 . . . . 0.0 110.012 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.578 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 6.2 pt-20 -63.07 -42.79 99.75 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.749 0.785 . . . . 0.0 109.593 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 52' ' ' ARG . . . -60.78 -17.91 51.45 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -83.68 -29.86 27.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.245 . . . . 0.0 108.423 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.83 HG22 HG23 ' A' ' 50' ' ' THR . 0.3 OUTLIER -73.65 -57.48 6.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.619 -0.676 . . . . 0.0 109.287 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.83 HG23 HG22 ' A' ' 49' ' ' ILE . 15.6 p -89.84 -8.01 52.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.15 -0.969 . . . . 0.0 110.191 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 89.59 -8.1 80.51 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.599 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -53.58 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.315 -1.109 . . . . 0.0 109.809 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.798 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -68.9 162.75 62.08 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.17 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.27 -57.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.839 1.693 . . . . 0.0 111.124 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -18.51 65.4 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.915 -1.116 . . . . 0.0 110.206 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 -31.64 16.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 109.642 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 53' ' ' ASP . 34.5 m -86.7 10.91 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.043 -1.036 . . . . 0.0 109.499 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.485 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -86.87 121.78 38.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 108.487 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.76 -18.56 54.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HD2' ' CG2' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -78.19 167.84 20.77 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.924 -1.339 . . . . 0.0 109.898 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -106.19 103.65 13.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.77 ' CZ ' HG21 ' A' ' 70' ' ' THR . 3.1 t80 -50.27 -42.74 52.67 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.521 -0.737 . . . . 0.0 112.245 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.536 ' CG ' ' CD1' ' A' ' 76' ' ' TYR . 36.5 m-85 -89.74 1.9 55.52 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.678 -1.264 . . . . 0.0 112.799 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 4.5 tmtm? -154.32 52.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.62 -1.3 . . . . 0.0 110.495 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 169.93 -15.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.163 -0.96 . . . . 0.0 111.641 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.599 HG11 ' HD3' ' A' ' 52' ' ' ARG . 1.4 t -120.17 -57.79 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 122.916 1.341 . . . . 0.0 109.582 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.15 101.36 50.07 Favored Pre-proline 0 C--N 1.288 -2.075 0 CA-C-N 114.183 -1.372 . . . . 0.0 109.134 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -72.97 -4.87 16.18 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 122.163 1.909 . . . . 0.0 112.34 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 23.9 p -105.72 -18.53 14.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.727 -1.233 . . . . 0.0 109.57 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.77 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 35.5 p -74.04 -5.35 40.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.996 -1.065 . . . . 0.0 109.486 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -93.28 52.11 1.73 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 108.718 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.495 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -117.04 -178.78 0.56 Allowed Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 36.1 Cg_endo -78.34 -12.54 15.57 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.147 1.898 . . . . 0.0 111.564 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 2.2 mt-10 -100.73 -24.98 14.29 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.867 -1.145 . . . . 0.0 109.618 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.2 t80 -101.31 -70.82 0.73 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 108.702 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CD1' ' CG ' ' A' ' 63' ' ' PHE . 6.0 t80 -72.93 -18.24 61.41 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.981 -1.074 . . . . 0.0 108.672 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.52 -60.89 6.48 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.826 ' CB ' HG21 ' A' ' 90' ' ' THR . 7.9 mmtt -65.58 -15.22 62.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.938 . . . . 0.0 109.824 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.838 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.8 t80 -83.14 -35.76 25.3 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -8.93 58.91 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -96.51 -42.35 8.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.551 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -64.2 -39.49 97.14 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.865 HG22 ' CE1' ' A' ' 118' ' ' TYR . 63.3 t -67.14 -39.62 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.938 -0.743 . . . . 0.0 110.148 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.72 -7.28 59.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.172 -0.955 . . . . 0.0 110.856 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.5 -18.16 13.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.799 -1.188 . . . . 0.0 110.002 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.38 19.68 71.09 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -152.69 57.82 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.247 . . . . 0.0 109.538 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.761 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -58.66 120.36 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 109.94 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -160.68 88.78 0.79 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.301 -0.875 . . . . 0.0 108.878 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.826 HG21 ' CB ' ' A' ' 78' ' ' LYS . 9.7 t -157.42 158.81 36.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.899 -1.126 . . . . 0.0 110.379 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.9 173.58 11.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 0.0 108.857 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.001 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 7.2 p90 -179.07 152.11 0.54 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.125 -0.984 . . . . 0.0 109.81 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.19 111.38 18.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 109.046 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.425 ' OH ' ' HB2' ' A' ' 72' ' ' SER . 0.1 OUTLIER -112.57 -178.66 3.46 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.206 -0.934 . . . . 0.0 109.646 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.3 m -151.9 108.74 3.5 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.382 -0.824 . . . . 0.0 109.834 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -81.24 118.7 22.82 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -152.3 48.76 0.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.878 -1.139 . . . . 0.0 110.987 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 22.1 p90 -78.31 139.03 38.86 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 98' ' ' TYR . 7.2 pt20 0.68 68.11 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.268 0 CA-C-O 121.847 0.832 . . . . 0.0 111.937 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 98' ' ' TYR . 20.1 ttp -176.71 174.65 1.79 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 4.9 t -52.71 148.17 13.69 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.048 . . . . 0.0 109.044 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.9 Cg_endo -75.88 146.41 29.6 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.96 1.773 . . . . 0.0 110.994 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.449 HG22 HG13 ' A' ' 105' ' ' VAL . 6.8 m -140.25 123.39 16.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.775 . . . . 0.0 109.264 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -102.83 140.28 37.31 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.848 ' HA ' HG23 ' A' ' 125' ' ' VAL . 14.0 m -151.99 143.4 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.905 -1.122 . . . . 0.0 110.697 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -92.35 116.82 29.31 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 176.04 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.001 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -91.39 164.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 120.966 -1.084 . . . . 0.0 110.086 -176.644 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.94 102.36 1.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.885 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -116.14 147.53 41.27 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.095 -1.003 . . . . 0.0 110.239 -177.231 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.622 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 11.9 ttmt -144.4 179.66 7.12 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.593 -1.317 . . . . 0.0 109.434 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.16 106.91 18.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.04 -1.037 . . . . 0.0 109.248 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.776 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -55.88 137.44 50.34 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.515 -0.741 . . . . 0.0 109.569 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.809 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.73 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 10.0 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.526 0.679 . . . . 0.0 109.998 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.865 ' CE1' HG22 ' A' ' 83' ' ' VAL . 28.4 m-85 -149.28 103.0 3.27 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.776 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 11.5 p-90 -103.77 148.03 26.57 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.455 -1.298 . . . . 0.0 112.078 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.885 HG13 ' CG ' ' A' ' 109' ' ' MET . 19.3 t -130.48 107.36 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.618 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.667 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 5.1 m-30 -91.53 123.9 35.3 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.294 -0.879 . . . . 0.0 109.609 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.611 HG13 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -105.27 116.8 49.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.019 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 1.9 tttm -94.96 107.8 19.85 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.532 ' HA ' HG12 ' A' ' 105' ' ' VAL . 18.2 ttp180 -57.47 128.33 36.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.896 -1.127 . . . . 0.0 109.646 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.848 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.248 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.506 2.369 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.963 HG22 HD11 ' A' ' 15' ' ' LEU . 4.9 mm -79.22 -57.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.775 -177.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.559 ' HA ' HD12 ' A' ' 15' ' ' LEU . 21.4 tt0 -39.36 -29.75 0.05 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.459 -0.776 . . . . 0.0 111.738 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' ILE . 7.6 m120 -90.59 -40.01 12.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.908 -1.12 . . . . 0.0 108.226 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 14' ' ' THR . 4.2 m -69.11 -9.91 55.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.601 -0.687 . . . . 0.0 109.68 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.963 HD11 HG22 ' A' ' 11' ' ' ILE . 12.4 mt -96.6 -28.01 14.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.012 -1.055 . . . . 0.0 108.787 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.443 0 O-C-N 121.627 -0.671 . . . . 0.0 109.636 179.651 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.917 0.389 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.41 18.52 51.85 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.817 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 16.8 mt -54.97 123.36 13.26 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.291 -1.123 . . . . 0.0 109.796 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.01 -18.81 3.91 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.769 0.795 . . . . 0.0 109.075 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.817 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 17.2 p90 -126.25 148.02 49.57 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.232 -0.918 . . . . 0.0 109.016 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.528 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -76.84 144.03 29.6 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.521 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -115.91 92.07 3.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.905 -1.35 . . . . 0.0 108.331 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.564 HG22 ' CE1' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -96.32 150.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 -178.742 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.657 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.0 161.16 31.58 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.377 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.777 ' O ' HD11 ' A' ' 40' ' ' LEU . 23.3 mt -148.18 155.47 41.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.011 -1.056 . . . . 0.0 109.276 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.654 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -123.45 138.9 54.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.0 109.411 178.488 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -5.31 67.95 0.0 OUTLIER Glycine 0 N--CA 1.514 3.87 0 C-N-CA 124.834 1.207 . . . . 0.0 113.364 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 161.25 -23.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 97.98 18.91 25.71 Favored Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 8.2 p30 -84.39 129.96 34.82 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.217 -1.167 . . . . 0.0 108.831 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.518 HG21 ' HA ' ' A' ' 58' ' ' ILE . 1.9 tp -54.5 138.12 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 122.202 1.001 . . . . 0.0 112.998 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.777 HD11 ' O ' ' A' ' 33' ' ' LEU . 3.5 mt -111.35 -31.08 7.17 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 1.1 tp-100 -167.39 168.81 12.83 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.564 ' CE1' HG22 ' A' ' 31' ' ' ILE . 14.9 t80 -146.09 -70.65 0.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.073 -1.017 . . . . 0.0 111.16 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.3 p-10 109.45 178.83 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.858 0 C-N-CA 123.931 0.892 . . . . 0.0 108.749 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.4 -26.55 14.82 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.005 -1.059 . . . . 0.0 113.281 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.78 -65.11 0.61 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.316 -1.49 . . . . 0.0 110.707 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 2.0 pt-20 -58.79 -53.76 54.7 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.387 0.613 . . . . 0.0 110.071 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.85 -15.75 14.41 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.095 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.47 -37.42 36.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.775 -1.427 . . . . 0.0 108.98 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.617 HG22 HG23 ' A' ' 50' ' ' THR . 1.0 OUTLIER -79.52 -55.18 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 108.886 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.617 HG23 HG22 ' A' ' 49' ' ' ILE . 59.2 p -76.98 -20.45 56.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.67 -0.644 . . . . 0.0 110.115 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.46 -2.33 78.22 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.635 HH11 HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -46.54 -47.14 19.64 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.367 -1.078 . . . . 0.0 111.481 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.518 ' O ' HG13 ' A' ' 57' ' ' VAL . 0.3 OUTLIER 67.88 147.14 0.11 Allowed Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -178.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.464 ' HA ' HG22 ' A' ' 57' ' ' VAL . 35.3 Cg_endo -76.76 -36.57 1.51 Allowed 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.128 1.885 . . . . 0.0 111.647 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -26.83 62.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.56 -40.52 19.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 109.523 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.635 HG11 HH11 ' A' ' 52' ' ' ARG . 27.6 m -73.04 -6.62 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 110.006 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.518 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -70.63 119.56 17.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.081 -1.012 . . . . 0.0 108.386 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.68 -20.95 48.47 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -79.61 145.89 32.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.543 -0.974 . . . . 0.0 108.674 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -89.85 122.21 32.69 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 108.967 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.574 ' HB2' HD21 ' A' ' 33' ' ' LEU . 79.4 t80 -60.02 -18.12 43.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.038 -1.039 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.462 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 35.9 m-85 -118.19 32.06 6.34 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.035 -1.041 . . . . 0.0 109.611 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.42 -53.6 0.1 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.013 -1.055 . . . . 0.0 110.954 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.32 16.4 9.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.846 -1.159 . . . . 0.0 111.778 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.577 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 41.0 t -118.88 -56.31 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.388 -1.445 . . . . 0.0 108.5 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -118.19 99.07 51.8 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.66 0.71 7.81 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.926 1.751 . . . . 0.0 111.062 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 p -103.31 -25.95 13.12 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.031 -1.043 . . . . 0.0 109.403 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.462 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 59.9 p -71.69 -7.16 46.25 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.381 -0.824 . . . . 0.0 110.096 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -84.81 72.53 10.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 108.984 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.433 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -160.6 172.61 5.67 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.96 . . . . 0.0 109.643 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 36.1 Cg_endo -77.92 77.42 3.93 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.358 2.039 . . . . 0.0 110.304 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER 172.36 -36.85 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.684 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.9 t80 -104.14 -65.9 0.99 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.416 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 8.3 t80 -75.55 -20.3 58.74 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -62.82 -60.67 7.37 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.495 ' CB ' HG21 ' A' ' 90' ' ' THR . 4.4 mmtp -64.87 -17.54 64.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.424 -1.045 . . . . 0.0 109.953 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.83 ' O ' HG23 ' A' ' 83' ' ' VAL . 4.2 t80 -79.35 -36.29 39.61 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -6.9 56.8 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.35 -0.844 . . . . 0.0 108.741 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.1 mm-40 -96.14 -42.63 8.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.47 -40.59 86.5 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.849 HG22 ' CE1' ' A' ' 118' ' ' TYR . 79.3 t -62.32 -38.58 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.619 -0.93 . . . . 0.0 109.386 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.17 -5.5 56.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 110.716 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 8.6 t -98.2 -21.91 16.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.772 -1.205 . . . . 0.0 109.788 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.79 25.51 45.58 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -169.85 70.66 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.332 -1.099 . . . . 0.0 108.935 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -69.76 117.66 11.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.088 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -161.59 82.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.498 HG23 ' SD ' ' A' ' 109' ' ' MET . 3.8 t -140.72 172.18 13.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.028 -1.045 . . . . 0.0 110.487 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 3.2 ptt? -152.69 171.03 18.83 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.944 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 14.8 p90 179.73 152.32 0.43 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.001 -1.062 . . . . 0.0 109.929 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -78.88 116.26 19.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.135 -0.978 . . . . 0.0 109.322 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.87 175.1 5.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.337 -0.852 . . . . 0.0 109.589 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -146.03 109.98 4.91 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.788 ' CE2' HG21 ' A' ' 122' ' ' VAL . 16.0 m-30 -85.25 119.6 25.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.956 . . . . 0.0 109.632 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -147.93 56.79 1.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.456 ' OH ' ' HB ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.61 66.06 4.96 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.045 -0.409 . . . . 0.0 111.439 -178.435 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.459 ' CG ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER 73.62 25.74 2.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.066 -1.021 . . . . 0.0 109.658 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.81 -171.52 3.1 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.083 -1.01 . . . . 0.0 108.569 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 71.6 p -57.65 160.99 6.76 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.165 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 32.7 Cg_endo -75.18 124.95 8.89 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.9 1.734 . . . . 0.0 110.257 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.455 HG22 HG13 ' A' ' 105' ' ' VAL . 13.1 m -118.43 125.76 50.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.431 -0.793 . . . . 0.0 109.408 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.417 ' O ' HG23 ' A' ' 125' ' ' VAL . 2.3 ttpt -107.51 138.43 43.73 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.673 ' HA ' HG23 ' A' ' 125' ' ' VAL . 5.7 m -152.69 142.3 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.048 -1.032 . . . . 0.0 110.194 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.64 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -91.01 127.69 36.53 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 174.593 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.944 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 1.4 m -97.93 160.19 3.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 O-C-N 120.634 -1.291 . . . . 0.0 111.475 -174.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -158.06 100.47 1.71 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.817 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -111.09 146.7 36.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.584 -0.698 . . . . 0.0 109.535 -177.677 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.641 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.5 tttm -138.76 -163.47 1.47 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.599 -1.313 . . . . 0.0 109.311 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.1 117.23 34.1 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.064 -1.022 . . . . 0.0 108.807 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.892 ' HB3' ' HB2' ' A' ' 117' ' ' SER . . . -72.0 166.63 21.81 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.382 -0.824 . . . . 0.0 110.615 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.591 HD13 ' OG ' ' A' ' 117' ' ' SER . 1.7 mp . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.892 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.543 0.687 . . . . 0.0 110.679 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.849 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.6 m-85 -149.71 121.35 8.04 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.851 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 13.5 p-90 -120.34 144.8 47.66 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.182 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.817 HG13 ' CG ' ' A' ' 109' ' ' MET . 27.4 t -116.83 112.15 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.759 -0.588 . . . . 0.0 109.78 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.637 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.6 m-30 -95.61 126.7 41.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 109.41 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.788 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -107.11 119.55 56.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 110.037 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.543 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 3.3 tptp -89.6 109.48 20.43 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.514 ' HA ' HG12 ' A' ' 105' ' ' VAL . 7.2 ttp-105 -68.64 114.82 7.35 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.114 -1.434 . . . . 0.0 109.433 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.673 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.096 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.031 HG22 HD11 ' A' ' 15' ' ' LEU . 2.9 mm -81.71 -67.37 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 O-C-N 121.305 -0.872 . . . . 0.0 110.592 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.88 -25.49 0.2 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.017 -1.052 . . . . 0.0 111.462 -178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -82.87 -46.62 12.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.856 -1.153 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -66.95 -58.29 5.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.031 HD11 HG22 ' A' ' 11' ' ' ILE . 34.7 mt -38.87 -32.72 0.09 Allowed 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.017 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.446 -0.784 . . . . 0.0 109.16 179.813 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 9.4 m-20 . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.32 26.9 22.81 Favored Glycine 0 N--CA 1.491 2.335 0 O-C-N 120.857 -1.152 . . . . 0.0 110.387 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 4.8 mt -75.57 -175.14 2.74 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.862 -1.376 . . . . 0.0 108.427 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.98 16.0 22.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 1.9 p90 -151.44 -173.77 4.62 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -112.65 137.11 14.0 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.55 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -109.43 89.2 2.93 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.39 1.595 . . . . 0.0 107.755 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.696 HG22 ' CD1' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -99.53 148.51 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.303 -0.873 . . . . 0.0 110.113 -178.022 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.677 ' HB3' HD12 ' A' ' 40' ' ' LEU . 4.6 mt-30 -120.01 164.54 15.95 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 37' ' ' GLY . 98.5 mt -152.32 146.05 25.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.094 -1.004 . . . . 0.0 109.083 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.547 ' OD1' HD11 ' A' ' 40' ' ' LEU . 7.8 m-20 -124.88 129.9 51.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.943 -1.098 . . . . 0.0 110.522 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 37.4 -77.18 0.0 OUTLIER Glycine 0 N--CA 1.503 3.1 0 C-N-CA 124.589 1.09 . . . . 0.0 113.605 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' ASP . 11.3 m-20 -71.46 -0.57 10.7 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.646 -0.914 . . . . 0.0 111.081 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.875 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 84.2 17.63 64.41 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.65 131.33 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.922 -1.34 . . . . 0.0 108.919 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.756 HD12 HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -59.93 135.33 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 0.0 110.204 -179.018 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.677 HD12 ' HB3' ' A' ' 32' ' ' GLN . 2.0 mt -105.46 -26.68 11.82 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.772 ' NE2' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -167.04 163.15 15.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.696 ' CD1' HG22 ' A' ' 31' ' ' ILE . 38.4 t80 -135.34 -107.3 0.22 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.353 -1.467 . . . . 0.0 110.69 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 44' ' ' ALA . 14.3 t-20 157.65 145.91 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.744 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -70.14 -53.12 18.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.548 -0.72 . . . . 0.0 111.587 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.67 -54.39 4.05 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.31 -0.869 . . . . 0.0 111.053 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.503 ' CD ' ' CE1' ' A' ' 42' ' ' TYR . 3.8 pt-20 -63.67 -44.1 94.75 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.739 0.781 . . . . 0.0 109.671 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -59.77 -17.16 41.4 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -85.17 -29.63 24.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.912 -1.346 . . . . 0.0 108.908 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.611 HG22 ' CG2' ' A' ' 50' ' ' THR . 0.5 OUTLIER -77.03 -49.7 22.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.511 -0.743 . . . . 0.0 109.64 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.611 ' CG2' HG22 ' A' ' 49' ' ' ILE . 1.3 p -104.12 -7.23 20.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.963 -1.086 . . . . 0.0 110.748 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 81.83 -2.4 83.48 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.813 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.858 ' CD ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -39.52 -59.31 1.12 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -1.004 . . . . 0.0 112.666 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.754 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.6 OUTLIER 67.28 146.24 0.11 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.648 -1.282 . . . . 0.0 107.559 -178.108 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.42 -67.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.94 1.76 . . . . 0.0 111.89 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -48.32 -23.95 1.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.184 -0.948 . . . . 0.0 110.898 -178.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.66 -45.48 10.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.788 -1.195 . . . . 0.0 110.081 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.858 HG11 ' CD ' ' A' ' 52' ' ' ARG . 26.0 m -76.87 -0.63 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.056 -1.028 . . . . 0.0 110.036 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -70.84 124.86 28.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.287 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.6 -19.87 52.87 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -79.2 146.38 33.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -1.138 . . . . 0.0 109.138 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -88.55 118.62 28.33 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.617 ' HB2' HD21 ' A' ' 33' ' ' LEU . 74.5 t80 -52.92 -22.11 5.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.515 -0.741 . . . . 0.0 110.22 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -113.11 -10.85 13.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.937 -1.102 . . . . 0.0 111.459 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -135.51 39.74 2.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.78 -1.2 . . . . 0.0 110.217 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 171.93 -14.28 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.91 -1.119 . . . . 0.0 111.966 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.713 HG11 ' NE ' ' A' ' 52' ' ' ARG . 10.2 t -115.7 -53.36 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.346 -1.471 . . . . 0.0 109.358 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.43 96.92 50.1 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.059 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.71 -2.46 12.61 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.902 1.735 . . . . 0.0 110.409 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.3 p -95.5 -17.04 21.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.099 -1.001 . . . . 0.0 109.75 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.729 HG22 ' CD2' ' A' ' 75' ' ' PHE . 64.5 p -86.62 11.31 13.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -89.37 54.14 2.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 108.87 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . 3.2 p -139.48 173.17 5.39 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 72' ' ' SER . 35.4 Cg_endo -77.14 3.55 6.58 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 C-N-CA 122.109 1.872 . . . . 0.0 111.781 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 32.7 mt-10 -106.45 -28.0 10.59 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.94 -1.1 . . . . 0.0 109.151 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.729 ' CD2' HG22 ' A' ' 70' ' ' THR . 2.0 t80 -102.92 -71.19 0.73 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.6 t80 -71.04 -17.18 62.63 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.47 -60.9 6.82 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.895 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -61.87 -17.61 57.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -1.059 . . . . 0.0 109.577 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.901 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.4 t80 -81.01 -38.8 26.88 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.488 -0.757 . . . . 0.0 109.768 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -76.11 -11.67 59.98 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 109.491 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 13.6 pt-20 -96.87 -40.36 8.96 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.89 -39.95 97.86 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 79' ' ' PHE . 97.0 t -58.03 -44.24 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.719 -0.871 . . . . 0.0 109.268 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.17 -3.48 58.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 110.652 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 t -94.72 -23.3 17.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.916 -1.115 . . . . 0.0 109.579 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 25.5 50.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -174.28 62.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.347 -1.09 . . . . 0.0 108.991 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.767 HD11 ' HA ' ' A' ' 79' ' ' PHE . 1.5 tt -55.51 123.73 14.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.145 -0.972 . . . . 0.0 109.584 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.449 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 40.2 t30 -160.21 84.52 0.72 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.381 -0.824 . . . . 0.0 109.118 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.895 HG21 ' HB2' ' A' ' 78' ' ' LYS . 9.2 t -138.11 170.99 15.07 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.915 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -159.6 168.59 25.71 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.917 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 11.8 p90 176.69 154.97 0.23 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.035 -1.041 . . . . 0.0 109.987 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 1.4 pt-20 -80.96 107.06 13.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.043 -1.035 . . . . 0.0 108.496 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.06 178.97 4.3 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.363 -0.835 . . . . 0.0 109.825 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 103' ' ' THR . 90.6 m -147.12 110.37 4.82 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.753 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 20.1 m-30 -80.96 118.11 22.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.935 . . . . 0.0 109.472 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -148.27 47.01 1.06 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.272 -0.893 . . . . 0.0 110.132 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 29.1 p90 -78.11 136.83 37.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.529 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 1.96 66.1 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.332 0 CA-C-O 121.696 0.76 . . . . 0.0 112.075 -178.575 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 98' ' ' TYR . 6.0 ttp -177.01 -174.26 0.51 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 t -63.47 149.2 92.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.944 . . . . 0.0 108.917 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.81 156.28 39.39 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.82 1.68 . . . . 0.0 110.894 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 95' ' ' THR . 3.1 m -147.39 148.45 31.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.5 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.432 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -119.93 140.68 50.51 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.425 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.756 ' HA ' HG23 ' A' ' 125' ' ' VAL . 10.1 m -158.24 144.42 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.092 -1.005 . . . . 0.0 110.489 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.669 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -92.38 112.52 24.5 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 174.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.917 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 1.4 m -83.27 161.24 3.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 O-C-N 121.366 -0.834 . . . . 0.0 111.86 -174.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -157.23 98.34 1.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.884 ' HG2' HG13 ' A' ' 120' ' ' VAL . 13.7 mtm -107.97 144.98 34.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.985 -1.072 . . . . 0.0 110.237 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.64 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 5.0 tttt -141.39 -163.4 1.55 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.169 -1.412 . . . . 0.0 110.168 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -103.28 106.55 17.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.953 . . . . 0.0 109.111 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.799 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -54.45 149.07 10.87 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.445 -0.784 . . . . 0.0 110.174 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.452 -0.78 . . . . 0.0 110.221 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.767 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.424 0.631 . . . . 0.0 110.135 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.768 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.7 m-85 -151.11 122.01 7.6 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.799 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.2 p-90 -121.25 156.61 32.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.707 -1.245 . . . . 0.0 111.954 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.884 HG13 ' HG2' ' A' ' 109' ' ' MET . 46.5 t -124.88 112.52 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.353 0.597 . . . . 0.0 110.373 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.642 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 11.2 m-30 -96.91 112.29 24.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.753 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.1 t -100.02 116.58 43.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.39 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.593 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 5.6 tptp -89.38 120.5 30.77 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.567 ' HD3' HD11 ' A' ' 49' ' ' ILE . 9.2 ttp180 -73.72 117.69 15.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.77 -1.206 . . . . 0.0 109.35 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.756 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.229 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.504 2.232 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.932 HG22 HD11 ' A' ' 15' ' ' LEU . 1.1 mm -85.77 -62.0 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 111.318 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -45.54 -24.56 0.34 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.972 -1.08 . . . . 0.0 111.023 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -81.66 -46.14 14.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.091 -1.005 . . . . 0.0 109.428 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -58.45 4.02 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.932 HD11 HG22 ' A' ' 11' ' ' ILE . 43.4 mt -39.47 -31.45 0.09 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.422 0.63 . . . . 0.0 110.102 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 179.882 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.927 0.394 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.73 21.26 34.05 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 68.8 mt -81.21 140.3 35.01 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.141 -1.211 . . . . 0.0 108.735 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.19 3.83 14.19 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.771 0.796 . . . . 0.0 109.177 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 2.5 p90 -136.55 139.76 42.43 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -74.09 129.5 11.72 Favored Glycine 0 C--N 1.293 -1.832 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.519 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -103.18 117.14 33.87 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.884 -1.363 . . . . 0.0 107.941 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.653 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.1 pp -115.78 144.35 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.33 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 2.9 tt0 -108.71 168.56 9.26 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.716 ' C ' HD11 ' A' ' 40' ' ' LEU . 21.1 mt -156.64 135.8 12.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.53 -1.356 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.429 ' N ' HD11 ' A' ' 40' ' ' LEU . 15.7 t0 -93.96 175.9 6.54 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.87 -55.68 5.43 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.358 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -18.93 57.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.677 -1.484 . . . . 0.0 109.569 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 102.5 29.09 6.08 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 107.331 -2.307 . . . . 0.0 107.331 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -86.53 130.03 34.64 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.673 -0.898 . . . . 0.0 110.78 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -62.73 131.76 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.563 -1.336 . . . . 0.0 110.997 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.716 HD11 ' C ' ' A' ' 33' ' ' LEU . 2.3 mp -104.76 -19.88 13.78 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 7.9 tm0? -156.57 161.06 39.98 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.572 ' CE1' HG22 ' A' ' 31' ' ' ILE . 9.3 t80 -147.7 -61.96 0.27 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.588 -1.32 . . . . 0.0 111.035 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.636 HD21 ' HB3' ' A' ' 45' ' ' ALA . 1.4 p-10 97.43 175.08 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.5 -17.33 20.59 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.872 -1.143 . . . . 0.0 112.58 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.636 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -55.42 -63.73 1.07 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.549 -1.345 . . . . 0.0 110.298 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.6 pt-20 -57.78 -56.44 21.92 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.629 0.728 . . . . 0.0 109.309 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.1 -16.56 8.67 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -70.86 -43.62 68.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.733 -1.451 . . . . 0.0 108.759 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -85.1 -55.99 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.443 -0.785 . . . . 0.0 109.552 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.507 ' N ' HG22 ' A' ' 49' ' ' ILE . 33.2 p -72.98 -20.18 61.08 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 0.0 110.318 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.9 -6.34 79.08 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.679 ' HB3' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -57.19 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -1.182 . . . . 0.0 110.133 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.744 ' O ' HG22 ' A' ' 57' ' ' VAL . 2.7 m-20 -61.2 159.67 27.92 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.05 -63.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.791 1.661 . . . . 0.0 110.983 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -56.12 -20.24 16.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.18 -0.95 . . . . 0.0 110.345 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -90.13 -47.37 7.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.914 -1.116 . . . . 0.0 110.021 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 53' ' ' ASP . 18.4 m -72.86 -4.93 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.03 . . . . 0.0 109.668 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.679 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.78 124.83 26.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.16 -17.05 59.11 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.421 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 7.6 mmtt -78.65 138.35 38.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.191 -1.182 . . . . 0.0 109.04 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.466 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.7 OUTLIER -75.55 104.31 6.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.809 ' CZ ' HG21 ' A' ' 70' ' ' THR . 31.3 t80 -58.52 -19.71 39.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.489 -0.757 . . . . 0.0 110.586 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.676 ' CE2' HD13 ' A' ' 33' ' ' LEU . 22.2 m-85 -85.75 -48.69 8.58 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.297 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.36 37.36 4.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.925 -1.109 . . . . 0.0 109.789 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.466 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 1.2 t0 -149.31 -30.91 0.24 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 110.615 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.601 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 5.0 t -110.77 -58.91 3.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 120.745 -1.222 . . . . 0.0 108.679 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -104.71 105.66 51.56 Favored Pre-proline 0 C--N 1.29 -1.987 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.594 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.62 3.85 6.08 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.058 1.838 . . . . 0.0 111.26 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.2 p -107.15 -17.06 14.26 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.847 -1.158 . . . . 0.0 109.862 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.809 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 24.8 p -83.5 6.0 21.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.962 . . . . 0.0 110.046 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -97.79 52.29 1.08 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.08 -1.012 . . . . 0.0 108.921 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.7 p -129.63 -179.81 1.11 Allowed Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.23 2.19 8.25 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 122.049 1.833 . . . . 0.0 112.028 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.9 mp0 -109.65 -27.96 9.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.86 -1.15 . . . . 0.0 108.985 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.649 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.1 t80 -102.52 -70.76 0.74 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.7 t80 -68.72 -17.48 64.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.81 -62.84 4.89 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.818 ' HB3' HG21 ' A' ' 90' ' ' THR . 5.3 mmtt -61.64 -16.53 49.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.448 -1.031 . . . . 0.0 109.502 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.872 ' O ' HG23 ' A' ' 83' ' ' VAL . 17.1 t80 -82.11 -39.43 23.35 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.58 -0.7 . . . . 0.0 110.195 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.9 -12.15 60.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.925 -1.109 . . . . 0.0 109.311 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 19.9 pt-20 -97.1 -41.01 8.55 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.07 -39.89 98.57 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 79' ' ' PHE . 97.4 t -60.11 -54.33 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.746 -0.856 . . . . 0.0 109.188 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.86 -2.14 35.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.398 -0.814 . . . . 0.0 110.454 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.1 t -90.63 -34.27 15.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.045 -1.034 . . . . 0.0 109.543 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.31 19.4 30.47 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 87' ' ' ASN . 3.6 p-10 -175.43 64.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -1.138 . . . . 0.0 108.945 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.569 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -51.27 123.68 10.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.856 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -161.1 89.67 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.115 -0.991 . . . . 0.0 108.77 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.818 HG21 ' HB3' ' A' ' 78' ' ' LYS . 9.4 t -153.23 172.65 16.65 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.825 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.62 174.51 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.005 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 7.3 p90 178.69 152.79 0.34 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.769 -1.207 . . . . 0.0 110.441 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -79.46 117.18 20.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.893 . . . . 0.0 108.777 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.19 175.18 6.07 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.038 -1.039 . . . . 0.0 110.359 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.7 m -147.25 110.32 4.78 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -80.14 119.79 23.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -131.14 42.41 3.22 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.604 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -78.29 79.55 4.73 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.3 0.572 . . . . 0.0 110.391 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.577 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 5.3 pt20 52.52 38.94 26.94 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.675 0.75 . . . . 0.0 109.656 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.73 -168.9 3.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.387 -0.821 . . . . 0.0 109.369 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.42 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.6 t -67.24 150.54 97.84 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.8 . . . . 0.0 108.921 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.42 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.5 Cg_endo -74.56 82.64 1.87 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.86 1.707 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.681 HG22 HG13 ' A' ' 105' ' ' VAL . 11.4 m -69.93 98.9 1.33 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.497 -0.752 . . . . 0.0 109.607 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.1 OUTLIER -73.24 133.95 44.13 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.208 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.704 ' HA ' HG23 ' A' ' 125' ' ' VAL . 16.3 m -150.0 146.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.365 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -94.62 116.78 29.17 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 175.106 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.005 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -88.26 164.4 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.741 -1.224 . . . . 0.0 111.553 -175.223 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.419 ' CD2' ' HH2' ' A' ' 119' ' ' TRP . 2.8 t60 -147.42 146.88 29.74 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 175.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.915 ' HB3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -152.33 137.86 17.74 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.6 -1.312 . . . . 0.0 109.345 -178.393 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.592 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 25.4 tttt -150.3 158.9 44.66 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.402 -1.319 . . . . 0.0 109.904 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.462 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 4.7 ttmt -72.36 109.88 6.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 109.048 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.959 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -72.03 176.24 5.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.442 -0.787 . . . . 0.0 111.008 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 O-C-N 121.551 -0.718 . . . . 0.0 109.119 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.76 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 55.7 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.584 0.706 . . . . 0.0 110.594 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.838 ' CE1' HG22 ' A' ' 83' ' ' VAL . 16.6 m-85 -132.38 132.11 42.53 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.959 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 17.4 p-90 -136.28 155.24 50.37 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.63 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.915 HG22 ' HB3' ' A' ' 109' ' ' MET . 83.3 t -140.42 109.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.804 -0.56 . . . . 0.0 110.049 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.683 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 3.8 m-30 -91.36 135.13 34.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.991 -1.068 . . . . 0.0 109.319 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.666 HG13 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -110.42 119.23 58.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.24 -0.912 . . . . 0.0 109.72 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.574 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -89.03 108.55 19.65 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.632 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -67.56 116.91 8.82 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.474 -1.29 . . . . 0.0 109.468 -178.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.704 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.115 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.093 HG22 HD11 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -75.16 -68.67 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.529 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.558 -177.355 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.431 ' HA ' HD12 ' A' ' 15' ' ' LEU . 3.2 tm-20 -37.98 -33.63 0.09 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.697 -0.627 . . . . 0.0 111.663 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.39 -44.28 16.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.919 -1.113 . . . . 0.0 108.597 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -69.55 -8.54 48.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.746 -0.597 . . . . 0.0 109.605 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.093 HD11 HG22 ' A' ' 11' ' ' ILE . 28.7 mt -97.97 -22.06 16.5 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.819 -1.175 . . . . 0.0 109.316 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.969 -179.563 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 19.4 p30 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.132 0.491 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -100.83 35.83 4.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.996 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 85.1 mt -99.63 124.57 44.98 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.44 -1.035 . . . . 0.0 109.838 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.12 -12.92 14.05 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.824 0.821 . . . . 0.0 108.916 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.996 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 2.7 p90 -113.82 -172.43 2.08 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.164 -0.96 . . . . 0.0 108.612 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.484 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -122.98 136.16 10.43 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 108.131 -1.988 . . . . 0.0 108.131 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -113.91 111.25 21.39 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.894 -1.356 . . . . 0.0 108.318 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.667 HG22 ' CD1' ' A' ' 42' ' ' TYR . 0.8 OUTLIER -120.81 140.27 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.493 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.672 ' HB3' HD12 ' A' ' 40' ' ' LEU . 9.3 mt-30 -107.23 170.55 7.89 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.747 HD21 HD12 ' A' ' 39' ' ' ILE . 80.1 mt -151.47 142.84 23.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.988 -1.07 . . . . 0.0 109.971 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.598 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -115.11 137.43 52.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.077 -1.014 . . . . 0.0 109.365 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -10.89 71.21 0.0 OUTLIER Glycine 0 N--CA 1.513 3.824 0 C-N-CA 124.674 1.13 . . . . 0.0 113.378 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER 162.58 -24.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.04 18.37 22.44 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 16.3 p-10 -84.9 129.04 34.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.146 -1.208 . . . . 0.0 108.893 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.747 HD12 HD21 ' A' ' 33' ' ' LEU . 1.1 mp -63.24 137.26 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.075 0.94 . . . . 0.0 111.282 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 32' ' ' GLN . 1.7 mt -108.27 -28.45 9.44 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.548 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -155.0 161.14 41.46 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.667 ' CD1' HG22 ' A' ' 31' ' ' ILE . 48.3 t80 -149.14 -73.35 0.18 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.54 -1.35 . . . . 0.0 111.071 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 10.1 p-10 109.06 178.19 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 123.999 0.92 . . . . 0.0 109.641 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.9 15.09 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.051 -1.031 . . . . 0.0 113.258 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -51.75 -63.77 1.03 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.254 -1.528 . . . . 0.0 110.563 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' OE1' ' CE1' ' A' ' 42' ' ' TYR . 1.2 pt-20 -57.39 -54.62 44.74 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.625 0.726 . . . . 0.0 109.609 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.41 -14.87 21.81 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.57 -34.89 46.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.874 -1.368 . . . . 0.0 109.478 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -47.91 15.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.251 -0.905 . . . . 0.0 109.679 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.449 ' HA ' ' CE ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -86.41 -31.92 21.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.176 -0.952 . . . . 0.0 109.74 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.41 -3.41 56.5 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.928 -1.129 . . . . 0.0 110.438 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.953 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -41.9 -48.04 4.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.321 -1.105 . . . . 0.0 112.492 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.646 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER 66.1 146.18 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.727 -1.233 . . . . 0.0 107.737 -178.244 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.77 -63.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.949 1.766 . . . . 0.0 112.118 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.767 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -55.22 -21.65 14.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.011 . . . . 0.0 111.193 -178.446 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -88.07 -41.1 13.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.868 -1.145 . . . . 0.0 109.878 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 52' ' ' ARG . 15.2 m -81.89 3.32 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 110.021 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.767 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.44 120.84 20.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.091 -1.006 . . . . 0.0 108.546 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.8 -11.4 70.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -80.36 141.4 35.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.949 -1.324 . . . . 0.0 109.849 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.451 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -81.59 92.99 6.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.907 . . . . 0.0 109.005 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.719 ' CZ ' HG21 ' A' ' 70' ' ' THR . 25.8 t80 -54.1 -22.33 10.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 76' ' ' TYR . 7.0 m-85 -85.84 -31.45 22.27 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.48 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.39 47.4 1.39 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 108.935 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.451 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.7 OUTLIER -165.47 -33.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.388 -0.82 . . . . 0.0 110.345 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.953 HG11 ' HD3' ' A' ' 52' ' ' ARG . 9.9 t -106.93 -56.97 4.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 120.76 -1.213 . . . . 0.0 109.002 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . . . -104.4 101.26 26.26 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.902 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.2 Cg_endo -75.98 -0.38 10.2 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 C-N-CA 121.803 1.669 . . . . 0.0 110.522 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 p -100.54 -23.2 14.75 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.072 -1.017 . . . . 0.0 109.694 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.719 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 10.8 p -82.12 3.88 25.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.168 -0.958 . . . . 0.0 110.044 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -91.21 51.16 1.87 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.924 -1.11 . . . . 0.0 108.77 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.48 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -121.13 179.05 1.01 Allowed Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -78.85 -6.09 14.97 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.931 1.754 . . . . 0.0 111.223 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 14.3 mm-40 -103.18 -24.15 13.59 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.896 -1.127 . . . . 0.0 109.656 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.571 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.5 t80 -103.61 -70.44 0.76 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 21.0 t80 -71.83 -19.67 61.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.92 -1.113 . . . . 0.0 108.442 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.48 -61.51 6.21 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.664 ' HB2' HG21 ' A' ' 90' ' ' THR . 2.3 mmtp -63.04 -15.78 57.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.964 . . . . 0.0 109.496 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.863 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.9 t80 -78.65 -40.49 34.01 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -77.91 -7.02 56.19 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -95.75 -39.51 9.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.433 ' C ' HD12 ' A' ' 88' ' ' LEU . . . -70.27 -43.08 64.3 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.898 HG22 ' CE1' ' A' ' 118' ' ' TYR . 59.1 t -58.25 -37.3 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.738 -0.86 . . . . 0.0 109.192 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.12 -4.22 46.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.459 -0.776 . . . . 0.0 110.982 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 m -100.38 -18.22 16.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.781 -1.199 . . . . 0.0 110.224 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.77 16.3 77.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.86 63.43 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -1.207 . . . . 0.0 108.846 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -65.31 112.68 3.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 109.854 -179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.419 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 19.3 p30 -160.78 85.07 0.69 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.409 -0.807 . . . . 0.0 108.912 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.664 HG21 ' HB2' ' A' ' 78' ' ' LYS . 8.9 t -133.1 144.93 50.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.061 -1.024 . . . . 0.0 110.434 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.5 ptp -132.74 154.64 50.01 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.058 ' CE2' HG21 ' A' ' 107' ' ' VAL . 9.9 p90 -169.19 -173.3 1.71 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.755 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.63 110.37 20.47 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.95 172.71 6.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.495 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 103' ' ' THR . 89.3 m -143.41 111.72 6.27 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.442 -0.787 . . . . 0.0 109.042 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.941 ' CE2' HG21 ' A' ' 122' ' ' VAL . 15.5 m-30 -83.8 117.13 23.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.281 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -147.13 47.04 1.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.94 . . . . 0.0 109.88 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 21.3 p90 -78.6 137.08 37.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.515 ' C ' ' O ' ' A' ' 98' ' ' TYR . 5.3 pt20 1.51 66.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.114 0 CA-C-O 121.539 0.685 . . . . 0.0 112.371 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 98' ' ' TYR . 67.7 ttp -162.98 -93.54 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.502 -0.749 . . . . 0.0 109.396 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 100' ' ' MET . 0.2 OUTLIER -149.17 161.5 31.99 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.812 -1.18 . . . . 0.0 108.664 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.95 115.36 4.0 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.024 1.816 . . . . 0.0 110.357 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' THR . 2.5 m -123.58 128.08 49.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.662 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.42 143.61 33.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.798 ' HA ' HG23 ' A' ' 125' ' ' VAL . 15.2 m -152.82 141.97 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.773 -1.204 . . . . 0.0 110.777 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -83.43 115.94 22.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 174.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.058 HG21 ' CE2' ' A' ' 92' ' ' PHE . 32.7 m -98.85 156.22 3.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 120.838 -1.164 . . . . 0.0 110.929 -175.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -159.99 104.48 1.52 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.904 ' HG2' HG13 ' A' ' 120' ' ' VAL . 6.4 mtm -110.23 145.53 37.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.429 -0.794 . . . . 0.0 109.772 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.624 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.9 tttm -138.0 -177.59 4.89 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.873 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.43 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 5.1 ttmm -91.04 99.9 12.85 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.701 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -48.07 123.94 6.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.408 -0.807 . . . . 0.0 110.057 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.962 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.519 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.592 0.71 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.898 ' CE1' HG22 ' A' ' 83' ' ' VAL . 22.7 m-85 -139.54 113.46 8.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.724 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 11.1 p-90 -114.95 141.68 47.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.527 -1.269 . . . . 0.0 112.325 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.904 HG13 ' HG2' ' A' ' 109' ' ' MET . 61.5 t -113.99 116.23 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.724 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 18.9 m-30 -99.05 127.63 45.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.002 -1.061 . . . . 0.0 109.287 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.941 HG21 ' CE2' ' A' ' 96' ' ' PHE . 2.0 t -116.3 113.09 42.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.025 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.1 tttm -96.62 120.73 37.49 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.466 ' HA ' HG12 ' A' ' 105' ' ' VAL . 1.9 ttt180 -65.67 121.34 14.74 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.707 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.798 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.183 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 . . . . . 0 N--CA 1.516 2.848 0 CA-C-O 121.122 0.487 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.965 HG22 HD11 ' A' ' 15' ' ' LEU . 1.2 mm -58.38 -68.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.148 -0.97 . . . . 0.0 110.053 -177.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.89 -28.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.8 -0.562 . . . . 0.0 112.31 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 11' ' ' ILE . 16.1 m120 -72.94 -50.87 20.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.758 -1.213 . . . . 0.0 109.576 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -68.24 -54.85 14.82 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.965 HD11 HG22 ' A' ' 11' ' ' ILE . 51.8 mt -43.34 -32.05 0.75 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.249 0.547 . . . . 0.0 110.244 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.84 -179.47 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.017 0.437 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.56 27.74 16.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mt -71.59 -168.43 0.34 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.149 -1.206 . . . . 0.0 109.13 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.98 -4.24 14.58 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.595 ' CE2' HD12 ' A' ' 11' ' ' ILE . 7.2 p90 -134.68 112.09 10.51 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.216 -0.928 . . . . 0.0 109.072 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.707 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -49.82 161.62 0.92 Allowed Glycine 0 C--N 1.289 -2.048 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.49 129.82 17.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.819 -1.401 . . . . 0.0 108.457 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.63 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.8 pp -131.84 157.63 43.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.772 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.713 ' HB3' HD12 ' A' ' 40' ' ' LEU . 45.8 mt-30 -116.39 163.27 16.29 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 37' ' ' GLY . 17.6 mt -147.57 144.0 28.16 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.867 -1.145 . . . . 0.0 110.467 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.444 ' N ' HD21 ' A' ' 40' ' ' LEU . 30.5 t70 -96.54 165.87 11.96 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -44.08 -22.48 0.33 Allowed Glycine 0 N--CA 1.5 2.931 0 C-N-CA 121.336 -0.459 . . . . 0.0 113.281 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.1 15.94 22.71 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.342 -1.681 . . . . 0.0 110.858 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.628 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.03 26.25 67.06 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.8 m120 -94.33 131.19 40.21 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.99 -1.3 . . . . 0.0 110.964 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.608 HG22 ' HA ' ' A' ' 58' ' ' ILE . 1.1 tp -61.83 138.07 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.825 -1.172 . . . . 0.0 111.286 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 32' ' ' GLN . 2.3 mt -110.64 -28.24 8.56 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 177.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.451 HE22 ' N ' ' A' ' 43' ' ' ASN . 15.0 tm0? -152.68 150.12 29.13 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.536 ' CD1' ' OE2' ' A' ' 46' ' ' GLU . 4.7 t80 -130.89 -54.03 1.06 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.323 -1.486 . . . . 0.0 111.374 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.501 ' OD1' ' HG3' ' A' ' 46' ' ' GLU . 0.4 OUTLIER 89.6 177.77 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.37 -38.39 9.65 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.937 -1.102 . . . . 0.0 113.681 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.87 -62.68 1.13 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.64 -1.287 . . . . 0.0 111.552 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.707 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -59.09 -49.16 78.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.47 -0.769 . . . . 0.0 110.932 -179.199 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.21 -15.08 42.97 Favored Glycine 0 C--N 1.281 -2.477 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -83.63 -30.0 27.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.96 -1.317 . . . . 0.0 108.888 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -82.01 -55.32 8.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.405 -0.809 . . . . 0.0 109.144 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.487 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.2 p -84.41 -11.49 56.15 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.242 -0.911 . . . . 0.0 109.903 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.36 -5.84 81.91 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.765 ' NE ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -52.35 123.6 11.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -1.159 . . . . 0.0 110.478 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.76 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.4 m-20 -89.85 154.97 47.93 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 -54.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.708 1.605 . . . . 0.0 111.37 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -22.15 66.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 110.668 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.81 -41.85 11.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.955 -1.091 . . . . 0.0 109.96 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 53' ' ' ASP . 14.4 m -77.61 -1.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.728 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.608 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -71.65 122.48 23.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.64 -15.07 61.25 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -79.13 138.76 38.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.139 -1.212 . . . . 0.0 108.877 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 66' ' ' VAL . 87.3 m-20 -76.38 109.35 10.02 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 1.031 ' CZ ' HG21 ' A' ' 70' ' ' THR . 8.5 t80 -68.79 -20.54 64.34 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.632 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 3.6 m-85 -85.06 -4.05 59.02 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.957 -1.097 . . . . 0.0 111.393 -177.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 23.0 mttt -155.99 -46.37 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.731 -1.231 . . . . 0.0 110.857 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.53 -3.41 53.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.984 -1.072 . . . . 0.0 112.299 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.765 HG11 ' NE ' ' A' ' 52' ' ' ARG . 5.7 t -126.45 -59.37 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 120.304 -1.498 . . . . 0.0 109.286 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.65 106.95 59.67 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.625 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.12 2.32 7.3 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.796 1.664 . . . . 0.0 111.698 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.7 p -105.33 -18.83 13.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.861 -1.149 . . . . 0.0 109.78 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 1.031 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 71.1 p -75.35 -2.12 26.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 110.28 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -90.68 53.31 2.39 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.878 -1.139 . . . . 0.0 108.789 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -124.71 178.18 1.53 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.488 -0.758 . . . . 0.0 109.237 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.39 -1.2 11.39 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 122.238 1.959 . . . . 0.0 111.428 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.4 mp0 -109.44 -25.83 10.3 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.92 -1.112 . . . . 0.0 109.248 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -100.98 -70.36 0.74 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.063 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -72.12 -18.27 61.91 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.094 -1.004 . . . . 0.0 108.341 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.82 -64.9 3.23 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.914 ' HB2' HG21 ' A' ' 90' ' ' THR . 1.4 mmtp -62.48 -16.77 57.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.561 -0.964 . . . . 0.0 109.878 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.87 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.1 t80 -83.5 -36.98 23.68 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.602 -0.687 . . . . 0.0 109.872 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.22 -12.57 60.11 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.173 -0.954 . . . . 0.0 109.081 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 19.4 pt-20 -97.23 -42.36 7.85 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.487 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -60.03 -39.25 95.45 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 107.521 -2.232 . . . . 0.0 107.521 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 79' ' ' PHE . 90.3 t -60.88 -45.36 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.784 -0.833 . . . . 0.0 109.46 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.19 -3.11 57.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.219 -0.926 . . . . 0.0 110.622 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.49 -24.61 15.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.85 -1.156 . . . . 0.0 109.451 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.71 15.1 74.06 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -156.19 56.01 0.58 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -1.176 . . . . 0.0 108.66 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -50.24 120.73 4.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 110.113 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.442 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 17.1 p30 -160.52 88.41 0.79 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 108.947 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.914 HG21 ' HB2' ' A' ' 78' ' ' LYS . 10.1 t -146.86 169.02 19.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.209 -0.932 . . . . 0.0 110.129 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -154.98 170.38 21.89 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.003 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 6.5 p90 179.53 152.52 0.42 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.872 -1.142 . . . . 0.0 110.222 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -80.75 111.93 17.65 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 -178.85 3.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.084 -1.01 . . . . 0.0 109.984 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 103' ' ' THR . 79.6 m -146.09 109.73 4.81 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.669 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 18.5 m-30 -79.3 93.41 5.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 108.665 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -115.84 31.17 6.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.37 -0.831 . . . . 0.0 109.686 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.582 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.85 159.11 27.96 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.817 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.494 ' C ' ' O ' ' A' ' 98' ' ' TYR . 1.5 pp0? -4.56 67.65 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 123.532 0.733 . . . . 0.0 112.547 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.582 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.78 -157.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.608 -0.683 . . . . 0.0 109.195 -178.438 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.459 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -90.96 174.78 4.15 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 108.834 179.154 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.459 ' CD ' HG22 ' A' ' 101' ' ' THR . 36.1 Cg_endo -79.15 103.77 1.68 Allowed 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.07 1.847 . . . . 0.0 110.749 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 95' ' ' THR . 9.2 m -99.11 145.27 27.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.114 -0.991 . . . . 0.0 108.926 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -119.43 135.82 54.58 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.771 ' HA ' HG23 ' A' ' 125' ' ' VAL . 11.5 m -153.5 145.67 14.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.973 -1.079 . . . . 0.0 110.862 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 3.0 ptmt -94.28 114.7 26.83 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.573 -2.381 . . . . 0.0 104.573 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.003 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -86.72 164.76 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.882 -1.136 . . . . 0.0 110.315 -176.588 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -159.71 101.94 1.5 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.827 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.89 148.77 36.19 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.109 -0.995 . . . . 0.0 110.002 -177.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.2 tttt -144.11 178.82 7.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.669 -1.269 . . . . 0.0 109.309 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.49 106.81 15.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.885 -1.134 . . . . 0.0 108.693 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.642 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.5 155.55 2.12 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 110.5 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.548 -0.72 . . . . 0.0 109.837 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.635 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.449 0.643 . . . . 0.0 109.904 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.742 ' CE1' HG22 ' A' ' 83' ' ' VAL . 12.0 m-85 -145.76 102.66 3.69 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.657 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 11.2 p-90 -106.32 143.69 34.07 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.551 -1.26 . . . . 0.0 111.973 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.827 HG13 ' HG2' ' A' ' 109' ' ' MET . 43.9 t -121.45 107.87 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.497 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.657 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 8.9 m-30 -92.94 123.08 35.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -0.854 . . . . 0.0 109.575 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.669 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.3 t -102.56 118.1 48.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.37 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.546 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 1.4 tttp -96.85 106.68 19.04 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.501 ' HA ' HG12 ' A' ' 105' ' ' VAL . 6.3 ttt180 -53.92 135.92 41.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.795 -1.191 . . . . 0.0 109.671 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.194 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.854 HG22 ' CG ' ' A' ' 15' ' ' LEU . 3.4 mm -75.1 -57.37 6.54 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 O-C-N 121.372 -0.83 . . . . 0.0 110.428 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.587 ' HA ' HD12 ' A' ' 15' ' ' LEU . 2.4 tt0 -36.18 -33.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.848 -0.532 . . . . 0.0 112.066 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 11' ' ' ILE . 1.5 m120 -84.74 -43.18 14.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.938 -1.101 . . . . 0.0 108.316 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 11' ' ' ILE . 2.9 m -69.78 -8.1 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.727 -0.608 . . . . 0.0 109.987 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.854 ' CG ' HG22 ' A' ' 11' ' ' ILE . 15.2 mt -96.77 -22.2 17.09 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.951 -1.093 . . . . 0.0 109.278 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.399 0 O-C-N 121.328 -0.857 . . . . 0.0 108.77 179.335 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.53 24.65 24.69 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.029 HD23 ' CZ ' ' A' ' 28' ' ' PHE . 3.5 mp -77.19 157.21 31.04 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.32 -1.106 . . . . 0.0 108.446 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.32 12.67 13.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.029 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -154.06 112.75 3.64 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.512 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -49.6 159.03 1.22 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -134.85 114.63 12.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.605 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.6 pp -117.1 158.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 110.636 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.836 ' HB3' HD12 ' A' ' 40' ' ' LEU . 24.3 mm-40 -125.89 170.36 11.73 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.856 HD22 ' O ' ' A' ' 37' ' ' GLY . 83.8 mt -157.39 147.56 20.8 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.28 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' ASP . 29.1 m-20 -126.64 127.03 44.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.059 -1.026 . . . . 0.0 109.913 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.02 -77.54 0.0 OUTLIER Glycine 0 N--CA 1.502 3.041 0 C-N-CA 124.578 1.085 . . . . 0.0 113.609 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -69.69 -3.23 14.35 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.535 -0.979 . . . . 0.0 110.933 -178.075 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.856 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 87.36 17.59 58.6 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 34' ' ' ASP . 8.1 p30 -73.7 129.5 38.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -1.199 . . . . 0.0 108.835 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.688 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -58.56 136.45 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 110.441 -178.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.836 HD12 ' HB3' ' A' ' 32' ' ' GLN . 6.9 mt -101.6 -29.59 11.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.453 HE22 HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -160.0 176.97 11.22 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.54 ' CD1' HG22 ' A' ' 31' ' ' ILE . 12.9 t80 -156.11 -48.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.695 -1.253 . . . . 0.0 110.076 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.646 HD21 ' HB3' ' A' ' 45' ' ' ALA . 0.6 OUTLIER 89.43 176.5 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.257 0.551 . . . . 0.0 109.929 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.83 -20.54 18.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.244 -0.91 . . . . 0.0 112.485 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.646 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -56.3 -66.62 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.547 -1.345 . . . . 0.0 110.33 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 5.1 pt-20 -61.23 -49.4 77.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.956 . . . . 0.0 110.03 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -61.03 -14.24 37.9 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 21.7 t0 -80.76 -34.11 34.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.725 -1.456 . . . . 0.0 108.846 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.48 HG22 HG23 ' A' ' 50' ' ' THR . 1.0 OUTLIER -82.94 -54.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.197 -0.94 . . . . 0.0 108.849 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.48 HG23 HG22 ' A' ' 49' ' ' ILE . 26.7 p -78.82 -24.14 44.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.402 -0.811 . . . . 0.0 109.768 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 97.14 -13.8 64.39 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.797 ' NE ' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -58.35 90.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -1.207 . . . . 0.0 109.971 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.739 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -61.54 166.86 4.97 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.176 -0.952 . . . . 0.0 109.284 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.15 -54.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 122.149 1.899 . . . . 0.0 110.759 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -65.93 -24.23 66.78 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.974 -1.079 . . . . 0.0 109.848 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -44.39 17.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.88 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 53' ' ' ASP . 33.1 m -73.96 -3.13 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.189 -0.944 . . . . 0.0 109.836 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.67 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.73 123.31 23.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 120.976 -1.078 . . . . 0.0 108.422 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.41 -18.77 53.75 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -79.64 127.2 31.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.228 -1.16 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.446 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -67.61 104.69 1.67 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.287 -0.883 . . . . 0.0 108.714 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.688 ' HB2' HD12 ' A' ' 39' ' ' ILE . 84.6 t80 -55.45 -17.21 4.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.48 -0.763 . . . . 0.0 110.651 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CE2' HD13 ' A' ' 33' ' ' LEU . 29.3 m-85 -94.11 -38.15 11.25 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.048 -1.032 . . . . 0.0 110.73 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 0.1 OUTLIER -134.67 42.8 2.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.962 -1.086 . . . . 0.0 109.201 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.3 OUTLIER -159.2 -32.52 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 110.235 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.797 HG12 ' NE ' ' A' ' 52' ' ' ARG . 9.3 t -109.12 -51.4 6.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 O-C-N 120.787 -1.196 . . . . 0.0 108.14 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.455 ' HB2' HH21 ' A' ' 52' ' ' ARG . . . -116.43 97.41 49.89 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.141 -178.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.22 -1.41 10.91 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.113 1.875 . . . . 0.0 111.251 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 p -95.35 -26.73 15.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.655 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 72' ' ' SER . 70.9 p -66.62 -36.37 82.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.387 -0.82 . . . . 0.0 109.744 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.92 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.168 -0.957 . . . . 0.0 109.054 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 177.67 170.52 0.44 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 109.291 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.3 80.83 2.61 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.558 2.172 . . . . 0.0 110.809 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER 168.08 -36.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.497 ' CD1' ' HE1' ' A' ' 109' ' ' MET . 1.8 t80 -109.84 -67.06 1.01 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 9.3 t80 -75.58 -17.24 60.11 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.68 -58.2 11.97 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -61.89 -18.62 60.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.609 -0.936 . . . . 0.0 109.594 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.913 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.7 t80 -81.02 -38.47 27.42 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.452 -0.78 . . . . 0.0 109.639 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.83 -12.42 60.38 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.01 -1.056 . . . . 0.0 109.463 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 12.8 pt-20 -96.85 -41.0 8.65 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -62.21 -39.11 97.26 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 79' ' ' PHE . 90.8 t -61.68 -39.85 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.789 -0.83 . . . . 0.0 109.891 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.14 -0.19 53.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.236 -0.915 . . . . 0.0 111.274 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 2.5 t -104.88 -24.21 12.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.899 -1.126 . . . . 0.0 110.161 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.64 16.17 78.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -148.45 58.85 1.08 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.031 -1.276 . . . . 0.0 109.098 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.529 HD13 ' HD1' ' A' ' 118' ' ' TYR . 0.4 OUTLIER -68.83 111.99 5.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -0.814 . . . . 0.0 109.694 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -160.14 82.87 0.71 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -131.46 172.8 11.78 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.917 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.54 171.11 19.56 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.932 ' CE1' HG21 ' A' ' 107' ' ' VAL . 17.2 p90 171.98 -177.11 0.05 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.088 -1.008 . . . . 0.0 109.992 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -109.92 105.59 14.82 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -104.41 -179.86 4.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.1 m -143.83 111.67 6.12 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.713 ' CE2' HG21 ' A' ' 122' ' ' VAL . 13.1 m-30 -86.71 131.02 34.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 108.871 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -160.98 63.89 0.29 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.534 ' CE1' ' HB2' ' A' ' 100' ' ' MET . 0.6 OUTLIER -84.11 41.08 0.8 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.488 -0.758 . . . . 0.0 111.776 -178.727 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER 89.61 29.76 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.683 0.754 . . . . 0.0 109.511 179.607 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.534 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -129.44 -71.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.947 . . . . 0.0 109.636 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.411 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.5 t -159.14 150.18 16.24 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.417 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.411 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 34.9 Cg_endo -76.25 79.75 2.87 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 122.063 1.842 . . . . 0.0 110.89 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 103' ' ' THR . 1.1 m -84.45 105.63 15.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.701 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -74.51 149.21 40.36 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.047 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.601 ' HB ' HG13 ' A' ' 122' ' ' VAL . 4.8 m -156.03 144.86 12.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 118.588 -1.245 . . . . 0.0 111.53 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -78.05 151.41 33.51 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.932 HG21 ' CE1' ' A' ' 92' ' ' PHE . 4.0 m -128.24 154.04 38.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 117.931 -1.507 . . . . 0.0 110.856 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 6.4 t-160 -147.42 125.59 12.18 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.872 ' HB3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -133.69 126.97 31.91 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 120.99 -1.069 . . . . 0.0 108.898 -178.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.583 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 17.8 tttm -138.5 157.82 45.44 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.112 -1.435 . . . . 0.0 110.129 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.499 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 ptmt -75.63 94.18 3.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 109.626 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.981 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -53.27 123.54 12.15 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.252 -0.905 . . . . 0.0 109.617 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.054 -1.029 . . . . 0.0 110.124 -179.745 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.504 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 121.157 0.503 . . . . 0.0 110.452 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.901 ' CE1' HG22 ' A' ' 83' ' ' VAL . 7.3 m-85 -125.05 136.03 53.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.981 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.6 p-90 -135.6 150.65 49.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.002 -1.061 . . . . 0.0 110.519 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.872 HG22 ' HB3' ' A' ' 109' ' ' MET . 89.5 t -138.09 105.45 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.741 -0.599 . . . . 0.0 110.326 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.658 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 2.1 m-85 -88.87 138.14 31.68 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.713 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -110.76 114.19 46.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.51 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -81.67 142.38 32.77 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 176.323 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -98.85 134.42 41.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.495 -1.378 . . . . 0.0 109.637 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.031 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.015 HG22 HD11 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -69.28 -66.26 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.488 0 O-C-N 121.477 -0.764 . . . . 0.0 110.322 -178.292 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 11' ' ' ILE . 14.4 pt-20 -36.52 -33.74 0.05 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.867 -0.521 . . . . 0.0 111.994 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -82.64 -44.7 15.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.768 -1.208 . . . . 0.0 108.489 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 14' ' ' THR . 5.4 m -67.59 -10.38 51.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.693 -0.629 . . . . 0.0 109.691 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.015 HD11 HG22 ' A' ' 11' ' ' ILE . 42.2 mt -97.79 -20.48 17.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.842 -1.161 . . . . 0.0 109.749 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.33 -0.856 . . . . 0.0 110.16 -179.858 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.22 32.24 7.55 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.15 158.7 16.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.416 -1.049 . . . . 0.0 108.789 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -93.48 14.44 18.69 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.756 -0.59 . . . . 0.0 109.59 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.536 ' CE2' HG12 ' A' ' 11' ' ' ILE . 25.2 p90 -148.9 154.18 39.08 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.175 -0.953 . . . . 0.0 109.596 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.96 114.4 3.85 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.617 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -91.21 87.7 6.62 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.534 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.3 pp -98.48 148.89 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.649 -0.657 . . . . 0.0 109.79 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.726 ' HB3' HD12 ' A' ' 40' ' ' LEU . 18.1 mt-30 -118.25 174.63 6.12 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 108.501 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.845 HD22 ' O ' ' A' ' 37' ' ' GLY . 62.1 mt -154.33 149.64 27.11 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.21 -0.932 . . . . 0.0 109.171 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.621 ' CG ' HD21 ' A' ' 40' ' ' LEU . 30.4 p30 -130.45 121.03 25.11 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.607 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.6 -79.23 0.0 OUTLIER Glycine 0 N--CA 1.5 2.904 0 C-N-CA 124.362 0.982 . . . . 0.0 113.021 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -66.67 -7.59 21.73 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 121.851 -0.794 . . . . 0.0 110.436 -178.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.845 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 89.89 18.54 50.63 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 m120 -73.26 136.13 44.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.243 . . . . 0.0 108.272 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.594 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -62.13 133.8 27.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.395 -0.815 . . . . 0.0 110.8 -178.499 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 32' ' ' GLN . 10.4 mt -98.85 -32.46 11.33 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.465 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -155.99 -173.73 4.64 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.825 ' CG ' HG21 ' A' ' 57' ' ' VAL . 1.2 t80 -160.96 -67.98 0.06 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.212 -0.93 . . . . 0.0 108.903 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.724 HD21 ' HB3' ' A' ' 45' ' ' ALA . 9.2 p-10 107.02 160.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 124.154 0.982 . . . . 0.0 109.169 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.99 -13.93 55.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.293 -0.88 . . . . 0.0 110.819 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.724 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -59.45 -62.33 1.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 0.0 109.803 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 11.5 pt-20 -66.05 -41.6 90.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.094 -1.003 . . . . 0.0 108.614 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -58.57 -18.06 36.08 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -29.55 22.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.778 -1.425 . . . . 0.0 109.579 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.412 HG12 ' HD2' ' A' ' 124' ' ' ARG . 1.1 mp -80.31 -41.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.324 -0.86 . . . . 0.0 109.394 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.07 4.08 19.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.607 -0.683 . . . . 0.0 110.189 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.72 -2.2 74.72 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.677 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.535 ' CZ ' ' HA ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -73.33 84.49 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.922 -1.34 . . . . 0.0 111.81 -178.369 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -63.99 175.96 0.74 Allowed Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 35.5 Cg_endo -77.05 -44.23 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.553 1.502 . . . . 0.0 110.682 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -16.41 63.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.107 -0.996 . . . . 0.0 110.268 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -48.67 6.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.972 -1.08 . . . . 0.0 110.025 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.825 HG21 ' CG ' ' A' ' 42' ' ' TYR . 32.8 m -70.71 -8.27 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.754 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.495 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -69.65 124.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.587 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.76 -19.62 50.26 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -79.02 132.88 36.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.317 -1.108 . . . . 0.0 108.976 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.71 125.27 27.09 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.7 ' HB2' HD21 ' A' ' 33' ' ' LEU . 75.4 t80 -63.97 -10.94 24.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.024 -1.048 . . . . 0.0 110.444 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CE2' HD13 ' A' ' 33' ' ' LEU . 83.5 m-85 -112.58 26.06 10.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.959 -1.088 . . . . 0.0 110.275 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -166.71 -58.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.978 -1.076 . . . . 0.0 110.891 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.58 -7.18 55.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.933 -1.105 . . . . 0.0 110.981 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.563 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 17.4 t -117.4 -26.43 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.63 -1.294 . . . . 0.0 109.526 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.71 96.84 1.0 Allowed Pre-proline 0 C--N 1.288 -2.076 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.961 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.42 -2.15 11.99 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.891 1.727 . . . . 0.0 110.564 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.2 p -90.1 -25.06 20.93 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.264 -0.897 . . . . 0.0 109.204 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.595 HG21 ' CE2' ' A' ' 62' ' ' PHE . 46.0 p -72.77 -5.37 37.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.466 -0.771 . . . . 0.0 110.139 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -88.39 59.63 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.967 -1.083 . . . . 0.0 109.317 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.404 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.6 OUTLIER -146.54 171.96 5.79 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.171 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 33.7 Cg_endo -75.75 79.54 2.81 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 122.373 2.048 . . . . 0.0 110.292 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.9 OUTLIER 169.21 -34.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.467 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.4 t80 -106.28 -67.07 0.96 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.559 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 27.7 t80 -78.48 -21.94 48.26 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -61.6 -56.67 21.76 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' CB ' HG21 ' A' ' 90' ' ' THR . 4.1 mmtt -65.62 -16.4 63.69 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.57 -0.959 . . . . 0.0 109.334 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.851 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.5 t80 -76.73 -37.68 55.57 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.66 -6.38 55.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.2 mm-40 -95.76 -39.06 10.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -70.36 -42.49 65.09 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.886 HG22 ' CE1' ' A' ' 118' ' ' TYR . 57.4 t -59.5 -40.13 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.843 -0.798 . . . . 0.0 109.73 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.14 -17.18 43.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -0.926 . . . . 0.0 110.744 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 m -88.28 -20.87 24.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.944 -1.097 . . . . 0.0 109.805 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.45 21.3 64.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -165.82 57.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -1.151 . . . . 0.0 109.355 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.498 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 6.3 tt -46.93 124.62 6.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.531 -0.731 . . . . 0.0 110.222 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.427 ' HB3' ' HE3' ' A' ' 110' ' ' LYS . 16.6 p-10 -161.42 89.59 0.77 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.533 HG23 ' SD ' ' A' ' 109' ' ' MET . 4.0 t -152.27 152.65 32.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.807 -1.183 . . . . 0.0 110.545 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.406 ' C ' ' CD2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -140.13 179.91 6.35 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.105 ' CE1' HG21 ' A' ' 107' ' ' VAL . 18.0 p90 172.47 171.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.838 . . . . 0.0 109.252 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.99 108.95 20.71 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.408 ' HB2' HG11 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -111.46 169.94 8.46 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.724 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' THR . 87.7 m -136.15 108.36 7.26 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 109.266 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.976 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 12.3 m-30 -80.29 85.62 5.77 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -108.44 34.38 3.67 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.69 158.33 28.37 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.502 ' C ' ' O ' ' A' ' 98' ' ' TYR . 2.0 mt-30 0.08 64.86 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.46 0.704 . . . . 0.0 112.525 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.22 -153.55 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -178.447 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.537 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -93.7 177.41 1.97 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 0.0 108.726 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.537 ' CD ' HG22 ' A' ' 101' ' ' THR . 34.1 Cg_endo -77.07 112.8 3.49 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.686 1.591 . . . . 0.0 110.013 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.457 HG22 HG13 ' A' ' 105' ' ' VAL . 2.8 m -113.29 130.34 56.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.727 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -104.52 145.21 30.62 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.041 ' HA ' HG23 ' A' ' 125' ' ' VAL . 26.3 m -154.57 144.8 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.615 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -78.26 117.55 19.63 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 174.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.105 HG21 ' CE1' ' A' ' 92' ' ' PHE . 23.2 m -99.2 151.96 4.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 117.852 -1.539 . . . . 0.0 108.235 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -156.32 102.68 2.11 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.851 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.17 144.89 41.9 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.192 -0.942 . . . . 0.0 109.529 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -141.04 -178.51 5.6 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.653 -1.28 . . . . 0.0 109.815 -179.273 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 103.74 16.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.027 -1.045 . . . . 0.0 108.857 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.839 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -51.59 146.13 8.05 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.616 -0.677 . . . . 0.0 109.884 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.269 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.763 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.271 0.558 . . . . 0.0 109.717 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.886 ' CE1' HG22 ' A' ' 83' ' ' VAL . 10.4 m-85 -149.9 111.59 4.52 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.839 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 15.1 p-90 -117.16 144.7 44.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.701 -1.249 . . . . 0.0 111.684 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.851 HG13 ' CG ' ' A' ' 109' ' ' MET . 13.8 t -120.85 114.57 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.554 0.692 . . . . 0.0 109.932 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.795 ' HE2' HD13 ' A' ' 11' ' ' ILE . 13.5 m-30 -95.33 121.9 37.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.976 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.3 t -107.02 112.79 41.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.889 -1.125 . . . . 0.0 108.468 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.481 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 14.3 tptp -89.21 125.17 34.96 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.539 ' HA ' HG12 ' A' ' 105' ' ' VAL . 28.6 ttt180 -74.33 123.65 25.01 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.688 -1.258 . . . . 0.0 109.458 -178.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 1.041 HG23 ' HA ' ' A' ' 105' ' ' VAL . 25.5 t . . . . . 0 C--N 1.301 -1.516 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.699 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.884 HG22 HD11 ' A' ' 15' ' ' LEU . 3.2 mm -50.73 -51.62 19.29 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.713 0 O-C-N 121.696 -0.628 . . . . 0.0 110.155 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' ILE . 4.0 tt0 -34.19 -41.51 0.11 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.15 -42.35 38.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.806 -1.184 . . . . 0.0 109.263 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 15' ' ' LEU . 1.2 m -60.7 -26.11 66.9 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.522 -0.737 . . . . 0.0 109.855 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.884 HD11 HG22 ' A' ' 11' ' ' ILE . 5.7 mt -96.77 -17.06 20.51 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.941 -1.1 . . . . 0.0 109.812 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.401 0 O-C-N 121.047 -1.033 . . . . 0.0 110.198 -179.947 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.079 0.466 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.74 31.56 8.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.506 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -104.1 173.54 6.26 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.159 -1.201 . . . . 0.0 108.888 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.7 21.27 11.61 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 122.262 1.03 . . . . 0.0 108.23 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.542 ' N ' ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -160.51 113.1 2.01 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.396 1.093 . . . . 0.0 108.395 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' HA2' ' ND2' ' A' ' 43' ' ' ASN . . . -46.96 143.41 5.31 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.346 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.495 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -125.34 92.34 3.6 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.692 HD12 ' N ' ' A' ' 32' ' ' GLN . 1.2 pp -99.1 167.33 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.454 -0.779 . . . . 0.0 111.109 -177.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.692 ' N ' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -134.22 166.59 22.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.81 HD22 ' C ' ' A' ' 37' ' ' GLY . 19.2 mt -149.64 148.35 29.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.971 -1.081 . . . . 0.0 110.065 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 36' ' ' ASP . 2.3 p30 -115.86 133.06 56.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.144 -0.972 . . . . 0.0 109.533 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -12.55 74.53 0.0 OUTLIER Glycine 0 N--CA 1.51 3.631 0 C-N-CA 124.697 1.142 . . . . 0.0 113.307 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER 162.44 -24.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.53 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.81 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.63 20.7 14.11 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.622 ' O ' HD23 ' A' ' 33' ' ' LEU . 23.0 m120 -87.67 131.99 34.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -1.139 . . . . 0.0 108.538 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.667 HD13 ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -67.77 138.39 22.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.113 -0.992 . . . . 0.0 111.161 -178.362 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' A' ' 32' ' ' GLN . 6.4 mt -99.61 -32.1 11.25 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.19 -179.59 6.24 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.576 ' CD1' HG22 ' A' ' 31' ' ' ILE . 27.7 t80 -140.63 -95.15 0.15 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.609 -1.307 . . . . 0.0 111.05 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 2.0 t-20 153.91 150.26 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -74.68 -58.45 3.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.4 -0.812 . . . . 0.0 110.173 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -38.94 -59.28 0.99 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.848 -0.533 . . . . 0.0 111.567 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.498 ' OE1' ' CG ' ' A' ' 42' ' ' TYR . 8.0 pt-20 -63.25 -43.58 97.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 0.0 110.009 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.418 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -63.3 -14.37 53.54 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.13 -25.12 20.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.959 -1.318 . . . . 0.0 109.149 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.576 HG22 HG23 ' A' ' 50' ' ' THR . 1.1 mp -79.17 -47.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.576 HG23 HG22 ' A' ' 49' ' ' ILE . 4.8 p -100.42 -6.83 25.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.438 -0.788 . . . . 0.0 110.217 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 84.75 -5.75 80.81 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.73 ' CD ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -53.26 115.31 1.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.026 -1.279 . . . . 0.0 110.884 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 57' ' ' VAL . 17.6 m-20 -90.98 156.98 43.84 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.81 -50.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.787 1.658 . . . . 0.0 111.282 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -20.84 65.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 110.329 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -89.95 -42.95 10.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.003 -1.061 . . . . 0.0 109.826 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 53' ' ' ASP . 19.3 m -76.51 -1.25 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.0 109.824 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.638 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -70.59 122.93 23.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.01 -17.47 58.15 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -79.73 135.02 36.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -1.168 . . . . 0.0 109.492 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.43 102.17 3.7 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.951 ' CZ ' HG21 ' A' ' 70' ' ' THR . 8.3 t80 -63.61 -15.0 57.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 76' ' ' TYR . 2.7 m-85 -88.38 12.68 13.54 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.62 -1.232 . . . . 0.0 110.602 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.04 -52.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 0.0 110.552 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.75 -3.88 24.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.02 -1.05 . . . . 0.0 111.064 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.622 HG11 ' NE ' ' A' ' 52' ' ' ARG . 11.8 t -128.12 -57.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.673 -1.267 . . . . 0.0 109.043 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB1' HG23 ' A' ' 70' ' ' THR . . . -109.1 105.64 57.52 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.574 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.63 -1.1 10.63 Favored 'Trans proline' 0 C--N 1.32 -0.934 0 C-N-CA 121.847 1.698 . . . . 0.0 111.557 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.8 p -104.45 -19.89 13.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.836 -1.165 . . . . 0.0 109.665 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.951 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 63.9 p -72.68 -6.11 42.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.965 -1.084 . . . . 0.0 109.915 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -88.86 53.71 2.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.985 -1.072 . . . . 0.0 109.11 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.463 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -126.98 177.49 1.99 Allowed Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.8 Cg_endo -77.94 -3.54 13.59 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.126 1.884 . . . . 0.0 111.45 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -105.8 -25.94 11.97 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.809 -1.182 . . . . 0.0 109.521 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.5 t80 -102.02 -70.39 0.75 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 9.2 t80 -72.86 -17.7 61.51 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.45 -63.45 4.28 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.9 ' CB ' HG21 ' A' ' 90' ' ' THR . 5.1 mmtt -63.52 -15.63 58.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.626 -0.926 . . . . 0.0 109.544 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.859 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.4 t80 -79.63 -39.63 31.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -79.62 -6.41 57.04 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 108.829 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.86 -40.12 9.48 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -70.55 -44.33 58.22 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.931 HG22 ' CE1' ' A' ' 118' ' ' TYR . 94.3 t -54.32 -38.68 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.952 . . . . 0.0 109.243 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.96 -16.93 34.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.444 -0.785 . . . . 0.0 110.637 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.6 -18.25 30.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.937 -1.102 . . . . 0.0 110.178 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.3 18.13 74.77 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -162.39 57.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.128 -1.219 . . . . 0.0 109.408 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.557 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -49.25 122.3 5.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.405 -0.81 . . . . 0.0 110.257 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 58.5 t30 -160.65 83.9 0.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 108.826 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.9 HG21 ' CB ' ' A' ' 78' ' ' LYS . 8.9 t -147.73 153.03 38.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 0.0 110.724 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -137.42 173.66 11.43 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.992 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 6.2 p90 179.52 153.09 0.44 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.027 -1.046 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.67 106.85 13.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.78 175.53 5.45 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.249 -0.907 . . . . 0.0 110.163 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 103' ' ' THR . 22.2 m -143.35 111.41 6.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.766 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 17.4 m-30 -79.62 96.46 6.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.182 -0.948 . . . . 0.0 109.147 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -113.44 30.06 7.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.237 -0.914 . . . . 0.0 110.052 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.578 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -79.1 159.56 27.44 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.517 ' C ' ' O ' ' A' ' 98' ' ' TYR . 2.9 pt20 -0.67 65.03 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 123.37 0.668 . . . . 0.0 112.31 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.578 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER 174.39 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.546 -0.721 . . . . 0.0 109.117 -177.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.25 171.69 5.75 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 108.971 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.97 80.75 2.89 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 122.004 1.802 . . . . 0.0 111.277 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 95' ' ' THR . 3.2 m -70.53 145.88 50.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 109.0 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.437 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -116.79 138.85 51.2 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.589 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.718 ' HA ' HG23 ' A' ' 125' ' ' VAL . 15.0 m -155.75 144.81 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.995 -1.065 . . . . 0.0 110.003 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.514 ' HG2' ' CB ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -95.61 114.33 26.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 175.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.992 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -88.04 166.99 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.285 1.041 . . . . 0.0 110.666 -176.088 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -161.47 101.93 1.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.903 ' HG2' HG13 ' A' ' 120' ' ' VAL . 4.5 mtm -112.5 150.04 31.81 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.267 -0.896 . . . . 0.0 110.57 -177.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.607 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.9 tttt -144.65 174.27 11.11 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.181 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.43 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 10.4 tttm -83.17 104.6 13.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.83 -1.169 . . . . 0.0 109.108 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.755 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.93 137.48 32.44 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.49 -0.756 . . . . 0.0 109.671 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.593 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.747 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.463 0.649 . . . . 0.0 109.984 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.931 ' CE1' HG22 ' A' ' 83' ' ' VAL . 25.4 m-85 -150.66 104.48 3.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.755 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 11.3 p-90 -106.08 141.5 37.34 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 118.553 -1.259 . . . . 0.0 112.011 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.903 HG13 ' HG2' ' A' ' 109' ' ' MET . 57.8 t -116.85 117.77 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.665 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 16.1 m-30 -102.18 118.83 37.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.1 -1.0 . . . . 0.0 109.091 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.766 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -101.22 129.22 52.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.836 -1.165 . . . . 0.0 110.09 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.514 ' CB ' ' HG2' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -102.93 123.55 46.77 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.134 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HA ' HG12 ' A' ' 105' ' ' VAL . 12.4 ttt180 -77.57 121.14 23.51 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.109 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.718 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.236 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.022 HG22 HD11 ' A' ' 15' ' ' LEU . 3.8 mm -63.57 -63.1 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -37.85 -33.58 0.09 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.949 -0.469 . . . . 0.0 111.851 -178.012 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -81.06 -44.74 17.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.876 -1.14 . . . . 0.0 108.339 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -70.04 -9.07 54.11 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.642 -0.661 . . . . 0.0 109.724 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.022 HD11 HG22 ' A' ' 11' ' ' ILE . 21.1 mt -97.44 -21.88 16.9 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.954 -1.091 . . . . 0.0 109.197 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 0.0 109.945 -179.747 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.751 ' OD1' ' HB3' ' A' ' 44' ' ' ALA . 55.5 t0 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.838 0.352 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.22 32.16 7.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 29.3 mt -105.3 151.46 24.11 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.459 -1.024 . . . . 0.0 108.689 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.24 24.7 4.8 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.589 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -160.16 122.14 3.24 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -179.32 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.515 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -58.8 154.55 27.35 Favored Glycine 0 C--N 1.288 -2.099 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.874 -177.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -127.78 85.15 2.32 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.621 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.1 pp -86.29 144.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.885 0.85 . . . . 0.0 110.724 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.53 ' HB3' HD12 ' A' ' 40' ' ' LEU . 15.3 mm100 -114.24 159.52 20.06 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 37' ' ' GLY . 72.3 mt -151.82 149.7 29.3 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.9 -1.125 . . . . 0.0 109.71 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.504 ' CB ' HD21 ' A' ' 40' ' ' LEU . 41.5 p-10 -131.99 123.29 27.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 110.476 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 42.88 -79.36 0.0 OUTLIER Glycine 0 N--CA 1.498 2.798 0 C-N-CA 124.398 0.999 . . . . 0.0 113.053 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -69.52 -5.96 27.62 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.736 -0.861 . . . . 0.0 110.358 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.83 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 87.4 24.33 36.96 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 36' ' ' ASP . 2.1 m120 -78.63 133.09 37.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.137 -1.214 . . . . 0.0 108.102 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.54 HD11 ' HB ' ' A' ' 31' ' ' ILE . 1.7 tp -56.77 136.38 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 111.711 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 33' ' ' LEU . 1.3 mt -110.67 -24.41 10.52 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 0.1 OUTLIER -169.74 113.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.399 -0.813 . . . . 0.0 109.422 179.331 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.619 ' CD1' HG22 ' A' ' 31' ' ' ILE . 19.1 t80 -98.71 -67.68 0.84 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.164 -0.96 . . . . 0.0 111.361 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 5.6 p-10 105.86 177.43 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 0 C-N-CA 124.021 0.929 . . . . 0.0 108.863 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.751 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -97.29 -25.17 15.35 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.845 -1.159 . . . . 0.0 113.171 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.56 -64.31 0.85 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.331 -1.481 . . . . 0.0 110.601 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.515 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.5 pt-20 -57.88 -54.4 47.37 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.508 0.671 . . . . 0.0 109.935 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.427 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -57.93 -14.86 18.17 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -76.0 -38.88 56.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.766 -1.432 . . . . 0.0 108.698 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 50' ' ' THR . 1.0 OUTLIER -82.78 -56.72 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.381 -0.824 . . . . 0.0 109.27 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.525 ' N ' HG22 ' A' ' 49' ' ' ILE . 30.0 p -75.24 -24.42 57.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.365 -0.834 . . . . 0.0 109.957 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 95.6 -15.74 62.59 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -50.07 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.352 -1.087 . . . . 0.0 109.841 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 57' ' ' VAL . 15.9 m-20 -64.65 160.87 49.5 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 108.699 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.35 -58.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.877 1.718 . . . . 0.0 110.807 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.618 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -62.62 -19.55 63.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.176 -179.445 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -88.5 -41.63 12.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 109.828 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 53' ' ' ASP . 23.4 m -79.59 0.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.822 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -71.0 121.74 21.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.053 -1.029 . . . . 0.0 108.699 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.49 -15.47 61.31 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -79.3 137.07 37.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.239 . . . . 0.0 109.459 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.95 103.99 6.28 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.661 ' CZ ' HG21 ' A' ' 70' ' ' THR . 26.1 t80 -60.17 -16.63 34.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -0.885 . . . . 0.0 111.089 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 2.4 m-85 -91.32 15.09 12.75 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.023 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -176.66 -52.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.008 -1.057 . . . . 0.0 110.419 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.15 -6.7 41.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 110.926 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.581 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 11.0 t -126.07 -60.43 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 O-C-N 120.636 -1.29 . . . . 0.0 109.07 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -108.87 103.96 53.4 Favored Pre-proline 0 C--N 1.293 -1.874 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.267 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.84 7.26 3.27 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.907 1.738 . . . . 0.0 111.777 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.6 p -108.58 -20.4 13.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.819 -1.176 . . . . 0.0 109.869 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.661 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 30.2 p -77.42 -2.63 36.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.952 . . . . 0.0 110.611 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -88.53 55.2 3.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.125 -0.985 . . . . 0.0 109.156 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.445 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -124.84 175.25 3.12 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.46 -0.775 . . . . 0.0 109.124 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.9 Cg_endo -77.56 -2.19 12.36 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 122.265 1.977 . . . . 0.0 111.288 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 59.5 mt-10 -107.96 -25.72 11.04 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.939 -1.101 . . . . 0.0 109.509 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.565 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 2.1 t80 -102.13 -70.53 0.75 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 18.1 t80 -70.59 -17.37 62.9 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.12 -61.2 6.6 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.663 ' CB ' HG21 ' A' ' 90' ' ' THR . 1.2 mmtp -63.38 -15.92 58.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.999 . . . . 0.0 109.487 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.9 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.8 t80 -79.63 -38.17 34.42 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -8.72 58.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 77' ' ' GLY . 1.3 mt-10 -95.52 -40.12 9.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.83 -41.05 89.3 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.4 t -60.0 -40.81 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.662 -0.905 . . . . 0.0 109.497 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.18 -5.06 58.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.284 -0.885 . . . . 0.0 110.785 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.5 p -100.19 -19.06 16.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.836 -1.165 . . . . 0.0 109.945 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.03 16.47 78.79 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -155.62 57.97 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -1.22 . . . . 0.0 109.335 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.461 HD13 ' CD1' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -56.51 114.17 1.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.823 . . . . 0.0 109.733 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -161.25 83.79 0.64 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.432 -0.792 . . . . 0.0 109.033 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.663 HG21 ' CB ' ' A' ' 78' ' ' LYS . 5.0 t -139.35 173.8 11.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.073 -1.017 . . . . 0.0 109.952 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -157.9 171.55 20.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.928 ' CE1' HG21 ' A' ' 107' ' ' VAL . 8.9 p90 178.7 161.01 0.66 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.863 -1.148 . . . . 0.0 110.506 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -88.3 110.12 20.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.45 178.56 4.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.109 -0.995 . . . . 0.0 110.073 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 84.4 m -141.85 107.99 5.22 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.801 ' CE2' HG21 ' A' ' 122' ' ' VAL . 16.5 m-30 -86.53 121.31 28.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.176 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -154.21 48.86 0.62 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.544 ' O ' ' C ' ' A' ' 99' ' ' GLN . 7.5 p90 -78.9 148.07 32.86 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 98' ' ' TYR . 4.6 tt0 2.09 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 CA-C-O 121.851 0.834 . . . . 0.0 111.589 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 98' ' ' TYR . 6.0 ttp 178.29 -149.07 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.28 169.47 8.59 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 0.0 109.233 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.85 155.21 30.49 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 122.16 1.907 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.588 HG22 ' O ' ' A' ' 103' ' ' THR . 1.6 m -149.17 94.79 2.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 109.289 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.43 ' C ' HG13 ' A' ' 105' ' ' VAL . 1.2 ptpp? -69.77 142.57 53.19 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.994 -1.066 . . . . 0.0 108.168 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.757 ' HA ' HG23 ' A' ' 125' ' ' VAL . 10.9 m -156.2 142.17 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.908 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -95.03 111.6 23.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 175.06 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.928 HG21 ' CE1' ' A' ' 92' ' ' PHE . 1.4 m -86.29 162.35 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.818 0.818 . . . . 0.0 111.893 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -160.55 102.0 1.35 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.885 ' HG2' HG13 ' A' ' 120' ' ' VAL . 3.2 mtm -112.66 148.08 35.4 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.56 -0.713 . . . . 0.0 109.435 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.63 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.4 tttm -138.18 -165.47 1.81 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.68 -1.263 . . . . 0.0 108.985 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 12.9 tttt -107.51 98.2 7.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.03 -1.044 . . . . 0.0 109.0 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.923 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -50.74 130.81 25.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 109.435 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.041 -1.037 . . . . 0.0 109.777 -179.803 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.502 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.037 0 CA-C-O 121.138 0.494 . . . . 0.0 110.862 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.787 ' CE1' HG22 ' A' ' 83' ' ' VAL . 5.4 m-85 -138.58 130.32 27.85 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.136 -0.978 . . . . 0.0 109.358 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.923 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 12.1 p-90 -125.92 138.15 53.76 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.677 -1.264 . . . . 0.0 111.883 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.885 HG13 ' HG2' ' A' ' 109' ' ' MET . 61.6 t -113.74 115.87 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.071 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.641 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 15.8 m-30 -100.46 126.91 46.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.178 -0.951 . . . . 0.0 108.84 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.801 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.5 t -109.49 122.71 64.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.937 -1.102 . . . . 0.0 110.344 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.589 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -99.22 124.71 44.5 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.461 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.438 ' NH1' ' CG1' ' A' ' 49' ' ' ILE . 23.3 ttt180 -74.4 121.89 22.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.64 -1.224 . . . . 0.0 109.125 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.341 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.806 HG22 HD11 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -80.9 -64.84 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.45 0 O-C-N 121.308 -0.87 . . . . 0.0 111.332 -177.155 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -41.78 -26.66 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.174 -0.954 . . . . 0.0 111.457 -177.369 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' ILE . 2.1 t-20 -89.67 -39.27 13.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.046 -1.034 . . . . 0.0 109.516 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -65.88 -59.63 3.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.806 HD11 HG22 ' A' ' 11' ' ' ILE . 11.6 mt -49.76 -23.75 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.754 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.665 0 O-C-N 120.849 -1.157 . . . . 0.0 109.31 -179.783 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.898 0.38 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.72 28.75 14.57 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.951 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.0 mt -97.02 -172.68 2.5 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.691 -1.476 . . . . 0.0 109.544 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.52 -0.36 22.19 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.717 0.77 . . . . 0.0 109.288 179.272 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CZ ' HG12 ' A' ' 11' ' ' ILE . 46.0 p90 -141.72 133.53 27.24 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.158 -0.964 . . . . 0.0 109.218 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.555 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -59.1 135.95 51.48 Favored Glycine 0 C--N 1.292 -1.87 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -116.23 113.87 23.62 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.893 -1.357 . . . . 0.0 107.781 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.687 HG22 ' CD1' ' A' ' 42' ' ' TYR . 1.4 pp -118.84 160.14 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-O 121.851 0.834 . . . . 0.0 110.303 -178.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.908 ' HB3' HD12 ' A' ' 40' ' ' LEU . 19.6 mt-30 -126.96 168.09 15.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.886 HD22 ' O ' ' A' ' 37' ' ' GLY . 83.0 mt -152.68 146.79 25.43 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.91 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' ASP . 18.4 m-20 -121.26 123.65 42.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 0.0 110.023 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 37.16 -76.9 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 0 C-N-CA 124.695 1.14 . . . . 0.0 113.647 178.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ASP . 19.7 t0 -69.33 -3.6 14.76 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.658 -0.907 . . . . 0.0 111.011 -178.176 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.886 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 90.21 14.61 58.67 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 19.8 m-80 -70.03 135.59 49.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.931 -1.335 . . . . 0.0 108.425 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.694 HD12 HD21 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -64.78 140.1 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 122.032 0.92 . . . . 0.0 111.219 -178.328 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.908 HD12 ' HB3' ' A' ' 32' ' ' GLN . 1.8 mt -112.37 -26.06 8.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -163.06 159.4 23.22 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.863 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.687 ' CD1' HG22 ' A' ' 31' ' ' ILE . 23.4 t80 -144.75 -70.62 0.28 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.673 -1.267 . . . . 0.0 110.819 -178.05 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 7.6 p-10 107.09 178.47 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 0 C-N-CA 123.876 0.87 . . . . 0.0 109.098 -179.186 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.65 -26.03 15.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.99 -1.069 . . . . 0.0 112.849 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -51.06 -64.09 0.92 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.356 -1.465 . . . . 0.0 110.639 -178.479 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.555 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 2.0 pt-20 -58.84 -52.91 63.72 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.0 110.016 -179.059 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.2 -15.79 24.1 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.048 -178.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -77.62 -36.14 51.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.717 -1.46 . . . . 0.0 108.746 179.655 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.52 HG22 HG23 ' A' ' 50' ' ' THR . 0.2 OUTLIER -85.94 -55.97 5.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.426 -0.797 . . . . 0.0 109.235 179.76 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 49' ' ' ILE . 29.9 p -78.21 -22.27 48.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.459 -0.776 . . . . 0.0 110.438 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 94.52 -18.4 57.13 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.642 ' NE ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -45.63 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.493 -1.004 . . . . 0.0 110.254 179.455 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.764 ' O ' HG22 ' A' ' 57' ' ' VAL . 95.9 m-20 -67.71 157.83 84.98 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.149 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.2 -40.11 0.39 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.739 1.626 . . . . 0.0 110.4 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -25.77 51.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.87 . . . . 0.0 110.126 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 7.6 tp60 -83.8 -44.88 13.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.108 -0.995 . . . . 0.0 109.953 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 53' ' ' ASP . 24.6 m -69.85 -7.84 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.138 -0.976 . . . . 0.0 109.814 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.598 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -68.8 121.95 19.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 121.053 -1.029 . . . . 0.0 108.349 179.831 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.48 -15.38 58.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 56' ' ' GLN . 67.6 mmtt -79.9 144.06 33.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.17 -1.194 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.71 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.9 OUTLIER -81.51 115.2 20.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.293 -0.879 . . . . 0.0 108.822 179.401 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.754 ' HD2' HD11 ' A' ' 33' ' ' LEU . 1.7 t80 -61.08 -34.05 74.31 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.029 -1.044 . . . . 0.0 110.025 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 52.2 m-85 -97.18 13.34 29.65 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 118.472 -1.291 . . . . 0.0 111.96 -177.262 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -139.72 -53.31 0.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.646 -1.284 . . . . 0.0 111.115 -179.719 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.24 16.08 21.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.832 -1.167 . . . . 0.0 112.003 -178.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 61' ' ' ASN . 15.5 t -125.43 -53.1 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.269 -1.519 . . . . 0.0 109.468 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB3' ' OG1' ' A' ' 70' ' ' THR . . . -117.88 103.03 50.79 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.628 -177.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.52 1.37 8.05 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 121.822 1.681 . . . . 0.0 110.577 179.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 p -111.13 -20.69 12.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.975 -1.078 . . . . 0.0 109.802 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.672 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 67.2 p -82.58 1.6 37.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.981 . . . . 0.0 110.223 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -88.62 61.47 6.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.945 -1.097 . . . . 0.0 109.259 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.461 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -136.01 177.3 2.27 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.188 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.5 Cg_endo -79.08 1.46 9.15 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.295 1.997 . . . . 0.0 111.143 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 4.3 mm-40 -107.83 -28.1 9.85 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 120.879 -1.138 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.406 ' HZ ' HG11 ' A' ' 120' ' ' VAL . 1.8 t80 -102.46 -69.82 0.77 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 15.5 t80 -72.06 -16.7 62.04 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.037 -1.039 . . . . 0.0 108.206 177.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.81 -60.94 6.65 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.624 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -63.49 -16.29 60.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.956 . . . . 0.0 109.414 -179.499 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.876 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.8 t80 -80.75 -37.9 29.61 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -8.23 57.25 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 108.442 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.91 -40.6 9.22 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -69.19 -39.61 82.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 79' ' ' PHE . 62.7 t -63.3 -37.19 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.69 -0.888 . . . . 0.0 109.583 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.87 -3.47 55.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 110.83 -179.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.3 t -106.17 -18.67 13.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.79 -1.194 . . . . 0.0 110.124 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.18 19.49 72.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -157.06 55.93 0.52 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -1.222 . . . . 0.0 109.641 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 1.7 tt -54.61 120.34 6.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.801 . . . . 0.0 110.047 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 30.9 p-10 -160.47 82.49 0.68 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 78' ' ' LYS . 7.3 t -128.34 162.4 27.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 110.44 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -154.52 149.06 26.31 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.032 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 12.7 p90 -172.83 149.17 1.93 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.431 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -79.89 107.3 12.57 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.68 172.87 6.57 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.1 -1.0 . . . . 0.0 110.039 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m -143.12 109.58 5.39 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.527 ' CE2' HG21 ' A' ' 122' ' ' VAL . 21.3 m-85 -80.71 115.83 20.42 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -128.51 41.69 3.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -78.07 78.89 4.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.807 -0.558 . . . . 0.0 110.126 -179.721 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.568 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER 53.74 37.8 27.05 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.63 -0.668 . . . . 0.0 110.233 -179.512 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -150.08 -179.12 6.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.018 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.437 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 5.2 t -56.54 149.28 40.91 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 108.716 179.159 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.437 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 31.4 Cg_endo -72.91 86.21 1.1 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.55 1.5 . . . . 0.0 110.417 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.438 HG22 HG13 ' A' ' 105' ' ' VAL . 16.0 m -75.9 142.55 42.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.476 -0.765 . . . . 0.0 109.473 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -115.32 136.34 53.19 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.803 ' HA ' HG23 ' A' ' 125' ' ' VAL . 26.2 m -151.87 144.51 16.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 109.812 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.75 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -94.57 109.75 21.63 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 175.789 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.032 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -80.85 162.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 122.339 1.066 . . . . 0.0 110.963 -175.729 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -161.48 101.05 1.19 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.799 ' HG2' HG13 ' A' ' 120' ' ' VAL . 3.4 mtm -113.01 146.19 39.52 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.393 -0.817 . . . . 0.0 109.316 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.8 tttt -141.84 178.94 7.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.459 -1.401 . . . . 0.0 109.785 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.447 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -86.01 102.89 14.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.916 -1.115 . . . . 0.0 109.15 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.718 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -51.59 132.61 30.54 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.455 -0.778 . . . . 0.0 109.812 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.404 ' H ' HD12 ' A' ' 113' ' ' LEU . 1.7 mp . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.501 ' N ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 120.733 0.302 . . . . 0.0 111.66 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.846 ' OH ' HG13 ' A' ' 83' ' ' VAL . 4.7 m-85 -143.37 116.88 9.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.712 -1.242 . . . . 0.0 110.197 -177.482 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.718 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.1 p-90 -113.66 142.11 46.41 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.863 -1.148 . . . . 0.0 111.665 179.073 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.799 HG13 ' HG2' ' A' ' 109' ' ' MET . 63.5 t -113.53 125.94 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.716 ' HE2' HD13 ' A' ' 11' ' ' ILE . 20.0 m-30 -111.74 117.65 33.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.019 -1.05 . . . . 0.0 109.574 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -100.19 114.41 38.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.277 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -97.76 119.92 37.21 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.099 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.541 ' HA ' HG12 ' A' ' 105' ' ' VAL . 6.8 ttt-85 -66.97 124.82 24.07 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.983 -1.087 . . . . 0.0 109.61 -178.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.803 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.005 . . . . 0.0 109.335 -179.217 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.04 HG22 HD11 ' A' ' 15' ' ' LEU . 5.1 mm -73.93 -65.58 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.548 0 O-C-N 121.424 -0.797 . . . . 0.0 109.759 -178.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 13' ' ' ASN . 15.7 pt-20 -38.84 -35.92 0.23 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.719 -0.613 . . . . 0.0 111.706 -178.18 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.1 m120 -81.6 -41.96 20.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.921 -1.112 . . . . 0.0 108.341 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 14' ' ' THR . 2.9 m -72.1 -7.18 47.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.619 -0.676 . . . . 0.0 109.49 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.04 HD11 HG22 ' A' ' 11' ' ' ILE . 39.8 mt -96.83 0.41 49.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.905 -1.122 . . . . 0.0 109.01 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 O-C-N 121.284 -0.885 . . . . 0.0 109.106 179.737 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.39 16.31 58.06 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.941 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 4.0 mt -67.86 168.3 11.87 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.953 -1.322 . . . . 0.0 108.448 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.43 23.0 8.07 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.564 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.941 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 3.3 p90 -156.51 -171.1 3.56 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -118.17 154.74 16.43 Favored Glycine 0 C--N 1.291 -1.932 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 178.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -122.88 107.26 11.67 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.32 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.592 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.1 pp -114.93 142.21 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.303 -177.729 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.829 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -112.16 165.96 11.69 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.873 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 37' ' ' GLY . 97.1 mt -152.27 154.66 36.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.866 -1.147 . . . . 0.0 109.681 -179.129 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.554 ' HB2' HD21 ' A' ' 40' ' ' LEU . 5.5 m-20 -129.08 125.74 37.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 110.178 178.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.43 -77.93 0.0 OUTLIER Glycine 0 N--CA 1.5 2.901 0 C-N-CA 124.496 1.046 . . . . 0.0 113.818 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.518 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 73.4 m-20 -72.65 -1.55 16.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.717 -0.872 . . . . 0.0 111.443 -177.541 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.665 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 89.32 18.65 52.44 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 16.4 m120 -72.04 134.99 46.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -1.223 . . . . 0.0 107.772 179.047 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -64.8 138.44 23.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 O-C-N 121.28 -0.887 . . . . 0.0 111.259 -178.067 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.829 HD12 ' HB3' ' A' ' 32' ' ' GLN . 5.4 mt -109.0 -28.39 9.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.133 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.583 ' NE2' HD22 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -163.29 160.28 23.62 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.897 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.568 ' CD1' HG22 ' A' ' 31' ' ' ILE . 14.6 t80 -142.1 -71.96 0.33 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.715 -1.241 . . . . 0.0 110.774 -178.419 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.3 p-10 109.1 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.785 0 C-N-CA 123.923 0.889 . . . . 0.0 108.876 -179.166 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 45' ' ' ALA . . . -96.99 -52.5 3.84 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.215 -0.928 . . . . 0.0 113.438 -177.504 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 44' ' ' ALA . . . -34.69 -62.02 0.37 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.418 -0.801 . . . . 0.0 112.96 -177.181 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.9 pt-20 -60.13 -49.4 77.79 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.158 -0.964 . . . . 0.0 110.35 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.36 -13.58 44.39 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -81.53 -36.17 29.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.835 -1.391 . . . . 0.0 109.82 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -84.14 -47.32 17.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.124 -0.985 . . . . 0.0 109.45 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.546 ' HA ' ' HE1' ' A' ' 100' ' ' MET . 2.7 p -89.33 -24.9 21.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.271 -0.893 . . . . 0.0 110.203 -179.079 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.49 -3.47 63.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.931 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -55.68 105.15 0.16 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.032 -1.276 . . . . 0.0 109.941 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -72.98 154.19 90.86 Favored Pre-proline 0 C--N 1.298 -1.653 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.801 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.02 -53.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.742 1.628 . . . . 0.0 110.528 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -20.4 63.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.856 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.403 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 1.5 tt0 -85.33 -41.72 15.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.018 -1.051 . . . . 0.0 109.837 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 53' ' ' ASP . 26.7 m -76.48 -2.31 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.068 -1.02 . . . . 0.0 109.922 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.654 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -70.19 122.42 21.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.025 -1.047 . . . . 0.0 108.429 179.845 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.04 -13.82 62.21 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.18 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 56' ' ' GLN . 11.8 mmtp -80.12 137.54 36.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.267 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -78.05 95.93 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.142 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.722 ' CZ ' HG21 ' A' ' 70' ' ' THR . 14.1 t80 -55.82 -24.65 37.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 0.0 109.932 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.523 ' CE2' HD13 ' A' ' 33' ' ' LEU . 12.3 m-85 -82.09 -32.16 30.38 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.746 -177.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 48.59 1.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.055 . . . . 0.0 109.116 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 4.7 t0 -163.54 -36.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.549 -0.719 . . . . 0.0 109.877 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.931 HG11 ' HD3' ' A' ' 52' ' ' ARG . 12.7 t -103.09 -56.8 4.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 122.78 1.276 . . . . 0.0 108.388 179.482 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.418 ' HB3' ' OG1' ' A' ' 70' ' ' THR . . . -103.66 101.46 24.33 Favored Pre-proline 0 C--N 1.29 -1.983 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.181 -178.11 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -76.13 3.13 6.45 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.719 1.613 . . . . 0.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 p -106.77 -21.58 12.99 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.131 -0.981 . . . . 0.0 109.841 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.722 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 7.2 p -81.89 2.54 29.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 110.308 -178.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -95.94 57.1 1.77 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.954 -1.091 . . . . 0.0 108.905 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.458 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -139.5 175.55 3.17 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.412 -0.805 . . . . 0.0 109.507 -179.599 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.7 Cg_endo -77.15 77.29 3.85 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 122.505 2.137 . . . . 0.0 110.369 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 174.28 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE1' ' HE3' ' A' ' 109' ' ' MET . 1.4 t80 -103.3 -68.73 0.82 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.468 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 16.5 t80 -74.83 -19.22 60.27 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.42 -62.26 5.77 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.638 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -62.19 -18.28 60.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 109.541 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.813 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.1 t80 -76.38 -38.23 56.03 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.489 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -5.61 52.89 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 108.757 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 1.5 mm-40 -95.41 -42.02 8.69 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.41 -40.64 68.67 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 178.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.872 HG22 ' CE1' ' A' ' 118' ' ' TYR . 100.0 t -61.39 -40.27 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.746 -0.855 . . . . 0.0 109.948 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.68 -22.08 40.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.216 -0.927 . . . . 0.0 111.059 -178.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -12.08 28.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.817 -1.177 . . . . 0.0 110.526 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.85 14.58 80.69 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -150.62 100.82 2.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -1.171 . . . . 0.0 108.606 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -97.74 117.58 32.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 110.109 -179.161 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -160.58 75.53 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.506 -0.746 . . . . 0.0 109.118 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 78' ' ' LYS . 8.8 t -116.21 131.55 56.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.028 -1.045 . . . . 0.0 110.497 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.6 ttt -118.47 126.17 51.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.621 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 2.0 p90 -152.39 -172.5 4.25 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.134 -0.979 . . . . 0.0 110.056 -178.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 93' ' ' GLU . 22.6 pt-20 -121.87 117.42 26.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.42 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 13.0 t80 -126.79 163.65 23.1 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 109.422 -179.134 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 95.2 m -131.77 119.99 22.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.576 ' CE2' HG21 ' A' ' 105' ' ' VAL . 6.5 m-85 -92.01 125.0 36.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.431 -0.793 . . . . 0.0 109.035 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -144.41 46.77 1.4 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 14.3 p90 -77.98 141.58 38.86 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.645 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.527 ' C ' ' O ' ' A' ' 98' ' ' TYR . 15.0 pt20 3.67 64.73 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.093 0 CA-C-O 121.432 0.634 . . . . 0.0 112.161 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.701 ' SD ' HG22 ' A' ' 101' ' ' THR . 0.6 OUTLIER 179.78 175.52 0.76 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.557 -0.714 . . . . 0.0 109.118 -177.787 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.701 HG22 ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -57.88 151.43 43.62 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.96 . . . . 0.0 109.032 179.348 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 32.9 Cg_endo -74.28 145.08 33.96 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 121.945 1.763 . . . . 0.0 109.972 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.502 HG22 HG13 ' A' ' 105' ' ' VAL . 1.2 m -142.32 111.68 6.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.106 -0.996 . . . . 0.0 110.151 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.434 ' C ' HG13 ' A' ' 105' ' ' VAL . 25.3 tttm -82.28 151.67 26.67 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.769 HG23 HG13 ' A' ' 107' ' ' VAL . 28.2 m -153.98 144.09 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 118.526 -1.269 . . . . 0.0 112.09 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -80.75 123.6 28.35 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 102.23 -3.248 . . . . 0.0 102.23 174.675 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.769 HG13 HG23 ' A' ' 105' ' ' VAL . 31.4 m -118.37 152.36 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 121.058 1.754 . . . . 0.0 111.845 -176.17 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -143.1 104.64 4.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.218 178.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.655 ' HG2' HG13 ' A' ' 120' ' ' VAL . 14.2 mtp -99.79 121.18 40.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.891 -1.131 . . . . 0.0 108.913 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.573 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 2.3 tttt -125.79 -165.8 1.47 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 117.625 -1.63 . . . . 0.0 110.309 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -113.11 98.59 7.24 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.138 -0.976 . . . . 0.0 109.167 -179.14 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.931 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -54.56 135.18 46.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.682 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.723 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.248 0 CA-C-O 121.281 0.563 . . . . 0.0 110.795 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.872 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.6 m-85 -125.4 129.35 49.7 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.235 -0.916 . . . . 0.0 110.179 -177.748 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.931 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 22.7 p-90 -129.17 163.05 26.39 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.343 178.493 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.655 HG13 ' HG2' ' A' ' 109' ' ' MET . 50.2 t -144.23 113.94 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.688 -0.632 . . . . 0.0 109.422 -178.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.672 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.4 m-30 -95.66 140.79 29.96 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.466 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.717 HG22 HG12 ' A' ' 107' ' ' VAL . 1.9 t -117.4 109.53 27.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 118.951 -1.099 . . . . 0.0 110.046 -179.213 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 4.7 tptp -84.53 146.24 27.67 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.04 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -96.18 129.88 43.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.702 -1.249 . . . . 0.0 110.181 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.104 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.074 HG22 HD11 ' A' ' 15' ' ' LEU . 3.7 mm -72.89 -66.86 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 O-C-N 121.488 -0.757 . . . . 0.0 110.444 -178.043 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HA ' HD12 ' A' ' 15' ' ' LEU . 18.3 pt-20 -36.46 -49.68 0.74 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.961 -0.462 . . . . 0.0 112.037 -177.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.63 -44.37 82.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.788 -1.195 . . . . 0.0 108.614 179.447 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 14' ' ' THR . 3.4 m -71.24 -8.43 53.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 109.948 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.074 HD11 HG22 ' A' ' 11' ' ' ILE . 42.6 mt -97.79 -24.04 15.62 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.97 -1.081 . . . . 0.0 109.371 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.83 . . . . 0.0 109.576 -179.879 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 120.654 0.264 . . . . 0.0 111.112 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.32 24.35 30.75 Favored Glycine 0 N--CA 1.492 2.429 0 O-C-N 120.525 -1.359 . . . . 0.0 111.041 -178.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.521 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -78.7 -172.28 2.91 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.766 -1.432 . . . . 0.0 108.349 179.168 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.74 20.54 16.08 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.59 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -159.36 137.04 10.06 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.143 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -71.66 139.73 29.28 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.405 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -116.87 89.75 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.537 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.623 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.4 pp -91.98 148.97 4.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.449 -0.782 . . . . 0.0 110.654 -177.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.592 ' OE1' HD13 ' A' ' 15' ' ' LEU . 17.5 mm100 -116.86 170.51 8.56 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.527 HD22 ' C ' ' A' ' 37' ' ' GLY . 73.4 mt -152.32 145.63 24.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.876 -1.14 . . . . 0.0 110.187 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' ASP . 8.8 m-20 -115.7 134.67 54.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.257 178.691 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -11.49 72.39 0.0 OUTLIER Glycine 0 N--CA 1.511 3.679 0 C-N-CA 124.804 1.192 . . . . 0.0 113.294 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER 161.75 -23.33 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.565 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.41 17.9 22.95 Favored Glycine 0 N--CA 1.479 1.551 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.033 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 28.7 m120 -85.25 131.78 34.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.142 -1.211 . . . . 0.0 108.769 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.569 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -65.99 138.81 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.016 -1.053 . . . . 0.0 111.404 -178.37 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.451 HD11 ' OD1' ' A' ' 34' ' ' ASP . 3.0 mt -103.74 -29.48 11.01 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.375 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -161.94 142.96 10.74 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.089 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.605 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 15.9 t80 -109.28 -77.24 0.6 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.338 -1.476 . . . . 0.0 111.504 -178.263 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 39.9 t-20 130.49 142.24 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.857 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -178.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -73.24 -49.09 29.75 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.581 -0.699 . . . . 0.0 111.125 -178.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.76 -55.32 3.69 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.35 -0.844 . . . . 0.0 111.619 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.489 ' OE1' ' CG ' ' A' ' 42' ' ' TYR . 14.0 pt-20 -63.75 -44.55 93.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.143 -0.973 . . . . 0.0 110.233 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -63.24 -13.2 48.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.05 -36.72 16.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.328 . . . . 0.0 109.658 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.71 -29.35 16.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 O-C-N 121.043 -1.036 . . . . 0.0 110.249 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.517 ' OG1' ' HD2' ' A' ' 52' ' ' ARG . 1.6 p -114.09 -24.58 8.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 109.504 -178.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 100.55 -2.04 55.89 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.903 ' NE ' HG12 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -71.88 85.83 0.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -1.219 . . . . 0.0 109.727 -179.74 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.726 ' O ' HG22 ' A' ' 57' ' ' VAL . 38.9 m-20 -60.48 164.42 7.05 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.148 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.49 -50.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.117 1.878 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.753 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -67.85 -29.4 68.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.215 -0.928 . . . . 0.0 109.906 -179.555 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -78.78 -43.12 26.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 0.0 109.885 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 53' ' ' ASP . 18.5 m -76.35 -1.81 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.038 -1.038 . . . . 0.0 109.903 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -70.89 123.58 25.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.016 -1.053 . . . . 0.0 108.446 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.95 -18.2 56.49 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 -178.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -79.25 138.45 37.79 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.184 -1.186 . . . . 0.0 108.992 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -76.22 104.33 6.69 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.469 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 85.6 t80 -56.08 -20.62 17.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.371 -0.831 . . . . 0.0 110.224 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 7.7 m-85 -100.04 -19.69 16.41 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.083 -1.01 . . . . 0.0 110.401 -178.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.2 46.99 1.42 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.116 -0.99 . . . . 0.0 109.449 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.6 -28.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 111.024 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.903 HG12 ' NE ' ' A' ' 52' ' ' ARG . 5.1 t -108.48 -58.34 3.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HA ' ' NH2' ' A' ' 52' ' ' ARG . . . -112.09 100.98 50.87 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.485 -179.184 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.74 1.05 8.5 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.056 1.837 . . . . 0.0 111.336 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.1 p -98.95 -22.88 15.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 109.418 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 31.1 p -76.14 -2.21 29.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.408 -0.808 . . . . 0.0 110.269 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -88.63 56.42 3.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.975 . . . . 0.0 109.255 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -129.04 177.18 2.28 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.413 -0.805 . . . . 0.0 108.941 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -78.04 2.01 8.37 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.219 1.946 . . . . 0.0 111.561 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.4 mt-10 -111.28 -29.52 7.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.86 -1.15 . . . . 0.0 109.319 179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CE1' ' SD ' ' A' ' 109' ' ' MET . 1.8 t80 -100.29 -69.49 0.77 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.55 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 21.2 t80 -71.22 -15.57 62.46 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.501 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -63.22 -61.56 6.24 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 178.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.769 ' HB2' HG21 ' A' ' 90' ' ' THR . 9.4 mmtt -62.8 -16.49 58.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.607 -0.937 . . . . 0.0 109.287 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.944 ' HA ' HD11 ' A' ' 88' ' ' LEU . 10.4 t80 -78.72 -37.89 40.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.564 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -78.52 -7.41 57.46 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.8 mm-40 -95.78 -40.76 9.19 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -69.92 -40.04 74.46 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 178.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.978 HG22 ' CE1' ' A' ' 118' ' ' TYR . 58.2 t -64.71 -39.78 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.646 -0.914 . . . . 0.0 109.656 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.74 -8.7 55.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.334 -0.854 . . . . 0.0 110.829 -178.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 t -102.19 -16.98 16.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.829 -1.169 . . . . 0.0 110.06 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.47 22.48 64.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -163.75 72.11 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -1.104 . . . . 0.0 109.316 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.944 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -72.92 118.35 15.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 109.81 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -160.62 86.79 0.73 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.523 -0.736 . . . . 0.0 109.099 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.769 HG21 ' HB2' ' A' ' 78' ' ' LYS . 3.3 t -137.25 161.52 36.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.081 -1.012 . . . . 0.0 109.786 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -149.53 144.04 26.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.415 -0.803 . . . . 0.0 108.982 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.058 ' CE2' HG21 ' A' ' 107' ' ' VAL . 10.8 p90 -156.33 -173.96 4.73 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 109.839 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.26 114.19 26.36 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.59 -176.28 2.89 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.147 -0.971 . . . . 0.0 110.804 -178.382 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.0 m -154.38 109.77 3.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.857 ' CE2' HG21 ' A' ' 122' ' ' VAL . 7.9 m-30 -85.71 126.6 34.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.643 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -154.3 51.06 0.65 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.738 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 9.9 p90 -77.91 136.42 38.02 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.53 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.7 pt20 5.25 62.95 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.186 0 CA-C-O 121.421 0.629 . . . . 0.0 112.264 -178.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -175.22 -154.43 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.358 -0.839 . . . . 0.0 109.252 -177.98 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.15 159.74 61.69 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.46 157.27 28.94 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.28 1.987 . . . . 0.0 110.521 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 103' ' ' THR . 5.4 m -151.13 85.92 1.35 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.782 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -69.83 139.18 53.1 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.023 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.931 ' HA ' HG23 ' A' ' 125' ' ' VAL . 14.8 m -151.77 148.24 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.897 -1.127 . . . . 0.0 111.404 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.807 ' CD ' HG22 ' A' ' 125' ' ' VAL . 2.8 mptp? -79.36 120.16 23.4 Favored 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 103.22 -2.881 . . . . 0.0 103.22 174.242 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.058 HG21 ' CE2' ' A' ' 92' ' ' PHE . 34.5 m -104.19 150.91 7.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 117.863 -1.535 . . . . 0.0 110.523 -177.462 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -149.49 106.91 3.62 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.066 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.909 ' HG2' HG13 ' A' ' 120' ' ' VAL . 12.8 mtm -108.85 134.55 51.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.057 -1.027 . . . . 0.0 110.369 -178.259 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.606 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.4 tttp -135.09 -169.38 2.36 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.401 -1.437 . . . . 0.0 109.989 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -104.46 100.43 10.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.126 -0.983 . . . . 0.0 108.56 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.871 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -47.02 144.53 2.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.729 . . . . 0.0 110.617 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.93 HD13 ' O ' ' A' ' 113' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.776 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.748 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.344 0.593 . . . . 0.0 109.889 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.978 ' CE1' HG22 ' A' ' 83' ' ' VAL . 13.8 m-85 -152.42 116.28 4.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.871 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 16.6 p-90 -122.06 149.37 43.64 Favored 'General case' 0 C--O 1.202 -1.401 0 C-N-CA 118.705 -1.198 . . . . 0.0 112.075 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.909 HG13 ' HG2' ' A' ' 109' ' ' MET . 58.5 t -124.54 107.97 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.649 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 9.9 m-30 -92.03 120.58 32.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.312 -0.867 . . . . 0.0 109.199 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.857 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.1 t -102.21 117.92 48.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.839 -1.144 . . . . 0.0 110.837 -179.251 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 4.2 tptp -88.28 113.91 24.37 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.4 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.577 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -73.94 120.62 19.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.492 -1.38 . . . . 0.0 109.016 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.931 HG23 ' HA ' ' A' ' 105' ' ' VAL . 3.7 t . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.319 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.513 2.708 0 CA-C-O 121.415 0.626 . . . . 0.0 111.826 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.041 HG22 HD11 ' A' ' 15' ' ' LEU . 4.9 mm -64.83 -61.96 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.597 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -37.24 -30.51 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.939 -0.476 . . . . 0.0 111.833 -178.13 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' ILE . 54.4 t-20 -84.48 -45.64 12.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.891 -1.131 . . . . 0.0 108.504 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -67.59 -10.6 53.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.591 -0.693 . . . . 0.0 109.665 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.041 HD11 HG22 ' A' ' 11' ' ' ILE . 20.6 mt -96.82 -25.71 15.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.013 -1.054 . . . . 0.0 109.327 -179.223 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.383 -0.823 . . . . 0.0 109.988 -179.898 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.086 0.47 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.58 22.61 39.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.781 HD22 ' CE1' ' A' ' 28' ' ' PHE . 55.9 mt -70.67 176.65 4.01 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.939 -1.33 . . . . 0.0 108.947 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.15 17.43 21.63 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.05 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.781 ' CE1' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -154.81 132.25 11.2 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.186 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.11 129.28 9.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.416 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -102.32 118.78 37.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.946 -1.326 . . . . 0.0 108.513 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.628 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.1 pp -111.81 148.88 14.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.163 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.646 ' HB3' HD12 ' A' ' 40' ' ' LEU . 8.1 mt-30 -117.99 166.06 12.97 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.465 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 62' ' ' PHE . 18.3 mt -152.78 140.84 20.32 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.599 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.569 ' HB2' HD21 ' A' ' 40' ' ' LEU . 16.1 t0 -93.67 167.88 11.38 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.543 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.37 -22.23 1.49 Allowed Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.556 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -92.12 11.46 25.4 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.466 -1.608 . . . . 0.0 110.692 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.66 27.24 63.44 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 79.1 m-20 -97.03 127.86 43.42 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.993 -1.298 . . . . 0.0 111.639 -177.587 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.696 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -55.29 135.72 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.12 -0.988 . . . . 0.0 110.67 -179.83 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 32' ' ' GLN . 3.3 mt -111.4 -27.96 8.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.252 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -158.08 159.89 36.76 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.812 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.528 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 2.8 t80 -143.7 -64.74 0.38 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.601 -1.312 . . . . 0.0 109.246 -178.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.574 HD21 ' HB3' ' A' ' 45' ' ' ALA . 2.0 p-10 99.6 177.58 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 123.36 0.664 . . . . 0.0 109.641 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -95.25 -14.72 23.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.1 -1.0 . . . . 0.0 112.002 -177.772 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -58.22 -63.25 1.33 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.616 -1.302 . . . . 0.0 109.671 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 50' ' ' THR . 7.3 pt-20 -61.6 -49.81 75.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.208 -0.933 . . . . 0.0 109.286 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -58.74 -14.53 22.89 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 11.3 t70 -80.55 -39.09 28.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.735 -1.45 . . . . 0.0 109.823 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -84.58 -43.43 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.001 -1.062 . . . . 0.0 109.032 -179.644 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -89.47 -31.46 17.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.743 -0.598 . . . . 0.0 109.693 -178.68 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 100.82 -2.91 55.76 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.787 ' NE ' HG13 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -68.97 104.19 2.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.02 -1.283 . . . . 0.0 110.592 -179.322 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -72.17 166.14 43.94 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.656 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.87 -38.47 0.86 Allowed 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.948 1.765 . . . . 0.0 110.3 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.424 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -72.1 -22.95 61.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.275 -0.891 . . . . 0.0 109.415 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.429 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 38.1 tt0 -83.14 -47.19 11.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.497 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 53' ' ' ASP . 6.5 m -66.57 -11.37 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.599 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.509 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -68.32 121.12 16.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.082 -1.011 . . . . 0.0 108.722 -179.804 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.1 -19.0 52.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -178.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 56' ' ' GLN . 25.8 mmtt -79.87 132.66 36.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.373 -1.075 . . . . 0.0 109.215 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.59 122.71 21.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.696 ' HB2' HD12 ' A' ' 39' ' ' ILE . 87.2 t80 -68.69 -2.86 10.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 0.0 111.036 -179.313 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CE2' HD13 ' A' ' 33' ' ' LEU . 44.9 m-85 -110.94 -17.2 13.36 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.614 -1.304 . . . . 0.0 111.982 -177.924 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.28 -38.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.767 -1.208 . . . . 0.0 110.631 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -90.58 1.88 56.34 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.083 -1.01 . . . . 0.0 110.585 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.787 HG13 ' NE ' ' A' ' 52' ' ' ARG . 24.2 t -127.5 -75.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.409 ' HB3' ' OG1' ' A' ' 70' ' ' THR . . . -97.97 106.67 35.89 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.416 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 34.5 Cg_endo -75.6 0.15 9.48 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.746 1.631 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.2 p -106.08 -19.49 13.71 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.959 -1.088 . . . . 0.0 109.668 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.456 HG21 ' CE2' ' A' ' 62' ' ' PHE . 15.6 p -75.19 -2.24 26.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.177 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -90.12 51.75 2.11 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.857 -1.152 . . . . 0.0 108.869 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -121.01 177.64 1.42 Allowed Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.946 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.8 Cg_endo -78.27 -5.45 15.03 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 122.203 1.935 . . . . 0.0 111.272 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -107.98 -21.14 12.94 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.912 -1.118 . . . . 0.0 109.489 179.799 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 70' ' ' THR . 1.1 t80 -104.09 -72.19 0.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.221 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 25.0 t80 -70.93 -18.16 62.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.29 -61.57 6.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.647 ' HB2' HG21 ' A' ' 90' ' ' THR . 1.8 mmtt -61.53 -16.34 46.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.652 -0.91 . . . . 0.0 109.698 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.891 ' O ' HG23 ' A' ' 83' ' ' VAL . 11.7 t80 -81.17 -38.2 27.5 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.53 -0.731 . . . . 0.0 109.674 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.01 -11.17 59.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.969 -1.082 . . . . 0.0 109.419 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 17.1 pt-20 -97.25 -38.98 9.47 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -66.51 -39.18 93.92 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 79' ' ' PHE . 99.1 t -59.76 -39.71 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.636 -0.92 . . . . 0.0 110.667 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.4 -45.57 31.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.003 -1.061 . . . . 0.0 111.038 -178.425 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -20.84 65.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.098 -179.131 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.64 14.96 80.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -142.84 56.0 1.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.119 -1.224 . . . . 0.0 109.025 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.849 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -54.78 123.38 13.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.498 -0.751 . . . . 0.0 109.491 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 33.0 p-10 -161.94 87.78 0.66 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.032 -1.042 . . . . 0.0 109.553 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.647 HG21 ' HB2' ' A' ' 78' ' ' LYS . 1.5 t -138.78 164.87 28.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.983 -1.073 . . . . 0.0 110.335 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -156.9 146.64 20.74 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.07 ' CE2' HG21 ' A' ' 107' ' ' VAL . 9.6 p90 -162.1 -175.11 4.43 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 109.637 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.4 102.51 11.61 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.46 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -105.65 147.91 27.96 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 110.041 -178.622 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 103' ' ' THR . 31.6 m -115.71 109.67 18.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.71 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 21.3 m-30 -78.97 107.57 11.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.183 -0.948 . . . . 0.0 109.004 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.13 32.75 5.96 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.521 -0.737 . . . . 0.0 109.28 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -79.21 162.4 25.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.895 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 98' ' ' TYR . 7.7 mt-30 -4.38 66.59 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 C-N-CA 123.388 0.675 . . . . 0.0 112.642 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.593 ' N ' ' O ' ' A' ' 98' ' ' TYR . 1.6 ttp 175.67 -158.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.341 -178.38 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.582 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -93.74 179.16 1.32 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.788 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.582 ' CD ' HG22 ' A' ' 101' ' ' THR . 34.2 Cg_endo -78.09 107.25 2.29 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 121.873 1.715 . . . . 0.0 110.365 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.46 HG22 HG13 ' A' ' 105' ' ' VAL . 1.6 m -106.83 134.13 50.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.611 ' HB3' HG23 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -100.78 150.4 22.83 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.548 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.676 HG23 HG13 ' A' ' 107' ' ' VAL . 32.6 m -154.75 144.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 118.384 -1.326 . . . . 0.0 112.006 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.572 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -81.41 98.25 8.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 175.771 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.07 HG21 ' CE2' ' A' ' 92' ' ' PHE . 31.4 m -90.45 150.11 3.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 118.144 -1.423 . . . . 0.0 110.734 -176.398 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -148.15 107.16 3.85 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.263 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.772 ' HG2' HG13 ' A' ' 120' ' ' VAL . 26.2 mtm -102.98 118.6 37.18 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.773 -1.204 . . . . 0.0 108.952 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.608 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -140.27 145.63 37.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.227 -1.546 . . . . 0.0 110.223 -179.083 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -53.91 138.88 35.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.373 -0.829 . . . . 0.0 109.204 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.815 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -90.53 160.03 16.18 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.333 -0.854 . . . . 0.0 109.45 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.205 -0.935 . . . . 0.0 110.632 -179.069 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.76 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.427 0.632 . . . . 0.0 109.919 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.86 ' CE1' HG22 ' A' ' 83' ' ' VAL . 19.4 m-85 -152.08 114.41 4.51 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.815 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 19.6 p-90 -118.06 165.32 13.89 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.319 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.772 HG13 ' HG2' ' A' ' 109' ' ' MET . 84.4 t -146.02 104.54 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.346 0.593 . . . . 0.0 109.488 -178.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.672 ' CE2' ' HB ' ' A' ' 11' ' ' ILE . 5.3 m-30 -84.45 129.14 34.89 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.736 HG22 HG12 ' A' ' 107' ' ' VAL . 2.2 t -112.4 112.18 39.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.277 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 1.1 tttm -86.63 159.95 19.05 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.446 ' CD ' HG13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -107.06 120.93 43.42 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.743 -1.183 . . . . 0.0 109.869 -179.232 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.611 HG23 ' HB3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.175 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.982 HG22 HD11 ' A' ' 15' ' ' LEU . 4.6 mm -80.26 -60.59 2.15 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 110.151 -178.494 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.517 ' HA ' HD12 ' A' ' 15' ' ' LEU . 10.6 tt0 -46.83 -23.49 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.541 -1.349 . . . . 0.0 110.992 -178.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.19 -42.42 11.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.909 -1.119 . . . . 0.0 109.808 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -56.88 8.12 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.982 HD11 HG22 ' A' ' 11' ' ' ILE . 27.9 mt -38.08 -31.76 0.05 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.189 179.236 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.763 . . . . 0.0 110.119 -179.659 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.002 0.429 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.71 33.61 6.26 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.637 HD23 ' CZ ' ' A' ' 28' ' ' PHE . 4.1 mp -121.61 149.3 43.38 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.305 -1.115 . . . . 0.0 109.052 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.58 8.0 10.77 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.625 -0.672 . . . . 0.0 110.179 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.637 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 1.5 p90 -133.51 150.82 51.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 109.646 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.54 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.34 114.3 3.85 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 178.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.481 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -91.38 97.79 11.3 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.596 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.7 pp -105.26 145.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.095 -177.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.679 ' HB3' HD12 ' A' ' 40' ' ' LEU . 35.6 mt-30 -115.36 167.29 10.99 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.839 HD22 ' O ' ' A' ' 37' ' ' GLY . 85.2 mt -153.39 157.24 39.68 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.087 -1.008 . . . . 0.0 109.132 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.576 ' CG ' HD21 ' A' ' 40' ' ' LEU . 36.8 p-10 -133.89 121.44 21.74 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.606 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.46 -78.38 0.0 OUTLIER Glycine 0 N--CA 1.502 3.069 0 C-N-CA 124.457 1.027 . . . . 0.0 113.144 178.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 34' ' ' ASP . 26.2 m-20 -68.43 -6.0 22.28 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.653 -0.91 . . . . 0.0 110.415 -178.58 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.839 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 88.81 18.06 55.21 Favored Glycine 0 N--CA 1.479 1.552 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.1 m-80 -72.22 138.83 47.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.078 -1.248 . . . . 0.0 108.338 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.562 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.92 136.04 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 122.064 0.935 . . . . 0.0 111.496 -178.043 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.774 HD11 ' O ' ' A' ' 33' ' ' LEU . 3.3 mt -108.5 -29.11 8.96 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.608 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -163.36 163.3 25.17 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.946 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.841 ' CG ' HG21 ' A' ' 57' ' ' VAL . 1.8 t80 -143.83 -65.45 0.37 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.141 -1.6 . . . . 0.0 110.714 -177.449 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.536 HD21 ' HB3' ' A' ' 45' ' ' ALA . 5.4 p-10 106.84 171.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.586 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.44 -20.7 18.86 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.664 -1.272 . . . . 0.0 112.164 -177.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.536 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -52.16 -59.83 3.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.715 -1.241 . . . . 0.0 110.311 -179.088 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 11.1 pt-20 -62.55 -45.95 90.61 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.745 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.449 ' HA2' ' N ' ' A' ' 52' ' ' ARG . . . -59.13 -15.94 31.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.26 -34.65 25.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.805 -1.409 . . . . 0.0 109.99 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.95 -40.88 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.158 -0.964 . . . . 0.0 109.766 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.24 -0.25 26.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.55 -0.719 . . . . 0.0 110.111 -179.295 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.83 -2.78 72.7 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.627 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.871 ' CD ' HG13 ' A' ' 66' ' ' VAL . 0.9 OUTLIER -78.13 81.89 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.879 -1.365 . . . . 0.0 110.871 -179.155 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.453 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -57.8 176.7 0.23 Allowed Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.886 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 34.2 Cg_endo -76.52 -34.55 2.55 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.792 1.661 . . . . 0.0 110.341 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.2 -23.24 41.12 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -79.0 -41.42 29.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.613 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.841 HG21 ' CG ' ' A' ' 42' ' ' TYR . 26.8 m -71.47 -7.6 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 109.78 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.33 122.9 21.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.66 -23.07 35.67 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -178.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -80.53 136.16 36.23 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.409 -1.053 . . . . 0.0 109.189 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.9 126.84 31.24 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.587 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.76 ' HB2' HD21 ' A' ' 33' ' ' LEU . 76.3 t80 -61.66 -13.08 19.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.054 -1.029 . . . . 0.0 110.636 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 38.2 m-85 -118.95 28.94 7.98 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.945 -1.097 . . . . 0.0 110.506 -178.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.38 -50.63 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.767 -1.208 . . . . 0.0 110.826 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -111.86 7.71 20.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.856 -1.153 . . . . 0.0 110.653 -179.072 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.871 HG13 ' CD ' ' A' ' 52' ' ' ARG . 89.3 t -120.53 -41.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 120.777 -1.202 . . . . 0.0 108.342 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.19 95.35 7.47 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -72.63 -7.84 21.49 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.875 1.717 . . . . 0.0 110.427 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.1 p -94.39 -21.46 18.93 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.232 -0.918 . . . . 0.0 109.042 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.517 HG22 ' CD2' ' A' ' 75' ' ' PHE . 20.7 p -75.3 -0.63 20.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -88.97 55.33 3.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.884 -1.135 . . . . 0.0 108.887 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.476 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -130.48 177.57 2.15 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.858 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -78.08 -2.2 12.31 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.257 1.971 . . . . 0.0 111.418 -179.344 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 23.1 mm-40 -106.39 -25.98 11.66 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.8 -1.188 . . . . 0.0 109.298 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.7 t80 -101.99 -71.26 0.72 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.026 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.573 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 10.1 t80 -70.84 -17.7 62.73 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.245 178.024 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.84 -59.8 8.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.087 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.613 ' CB ' HG21 ' A' ' 90' ' ' THR . 6.7 mmtt -64.85 -14.7 60.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.469 -1.018 . . . . 0.0 109.351 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.84 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.5 t80 -80.82 -37.44 30.09 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.46 -8.29 58.36 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 108.707 178.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.64 -39.71 9.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.573 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -68.11 -39.83 88.48 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.712 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 79' ' ' PHE . 98.9 t -62.89 -39.39 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.766 -0.844 . . . . 0.0 109.765 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.95 -3.94 56.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.947 . . . . 0.0 111.104 -178.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.5 t -104.43 -19.68 13.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.082 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.35 19.59 71.36 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -156.27 72.57 0.76 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.096 -1.238 . . . . 0.0 109.287 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.573 HD12 ' HA3' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -76.1 110.43 10.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 109.629 -179.982 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -160.26 79.83 0.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.079 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 78' ' ' LYS . 9.9 t -137.62 151.39 48.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 110.262 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -133.38 146.52 51.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.086 ' CE2' HG21 ' A' ' 107' ' ' VAL . 18.5 p90 -153.58 -175.88 5.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.054 -1.029 . . . . 0.0 109.941 -179.752 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.71 115.79 30.17 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.04 176.94 4.97 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.159 -0.963 . . . . 0.0 110.136 -178.417 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.1 m -144.88 109.33 4.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.979 ' CE2' HG21 ' A' ' 122' ' ' VAL . 21.3 m-30 -83.01 119.85 24.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 108.963 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -149.43 47.51 0.97 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.001 -1.062 . . . . 0.0 110.331 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 35.0 p90 -78.56 135.9 37.4 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.134 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.535 ' C ' ' O ' ' A' ' 98' ' ' TYR . 11.7 pt20 3.52 64.07 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 CA-C-O 121.524 0.678 . . . . 0.0 112.106 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.5 tmm? -172.92 175.77 3.22 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.29 162.18 1.21 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.0 109.213 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.28 152.78 30.97 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.05 1.834 . . . . 0.0 110.195 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.48 HG22 HG13 ' A' ' 105' ' ' VAL . 54.5 m -147.76 127.53 13.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 110.305 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -110.44 137.24 48.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.228 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.898 ' HA ' HG23 ' A' ' 125' ' ' VAL . 17.7 m -150.49 142.83 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 118.649 -1.22 . . . . 0.0 111.494 -178.649 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.534 ' HD3' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -82.92 124.21 30.14 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 174.38 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.086 HG21 ' CE2' ' A' ' 92' ' ' PHE . 33.1 m -108.57 152.12 10.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 120.88 -1.138 . . . . 0.0 111.744 -174.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -142.12 108.46 5.28 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.434 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.692 ' HG2' HG13 ' A' ' 120' ' ' VAL . 20.5 mtm -106.42 123.93 48.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.767 -1.208 . . . . 0.0 109.457 -179.139 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.575 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -126.24 -165.89 1.5 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.098 -179.677 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.61 94.21 4.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.546 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.982 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -53.21 127.59 24.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.073 -1.017 . . . . 0.0 109.481 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.066 -1.021 . . . . 0.0 109.638 179.86 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.499 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 121.209 0.528 . . . . 0.0 111.367 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CE1' HG22 ' A' ' 83' ' ' VAL . 8.9 m-85 -123.07 131.1 53.56 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.214 -0.929 . . . . 0.0 110.061 -177.4 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.982 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 15.0 p-90 -130.59 166.47 20.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.836 -1.165 . . . . 0.0 111.853 179.01 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.692 HG13 ' HG2' ' A' ' 109' ' ' MET . 90.7 t -147.71 115.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.767 -0.583 . . . . 0.0 110.441 -178.188 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.729 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.6 m-30 -94.41 104.69 16.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.064 -1.022 . . . . 0.0 108.836 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.979 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -88.04 105.9 15.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.507 ' HE3' ' CD1' ' A' ' 28' ' ' PHE . 9.5 mttp -89.67 112.42 23.66 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.531 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -56.98 133.19 54.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.966 -1.084 . . . . 0.0 109.43 -179.0 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.898 HG23 ' HA ' ' A' ' 105' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.366 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.062 HG22 HD11 ' A' ' 15' ' ' LEU . 5.2 mm -79.16 -56.92 6.0 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.371 -178.083 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.406 ' HB2' HD12 ' A' ' 113' ' ' LEU . 2.0 pt-20 -43.04 -26.88 0.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.304 -0.873 . . . . 0.0 111.431 -178.088 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -91.09 -38.14 12.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.925 -1.109 . . . . 0.0 108.428 178.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.7 m -71.26 -13.01 61.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.627 -0.671 . . . . 0.0 110.02 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.062 HD11 HG22 ' A' ' 11' ' ' ILE . 11.1 mt -97.62 -21.62 16.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.059 -1.025 . . . . 0.0 109.385 -179.569 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.873 -179.765 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.768 ' OD1' ' HB3' ' A' ' 44' ' ' ALA . 52.0 t0 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 120.797 0.332 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.64 35.02 4.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.948 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 28.7 mt -107.09 129.43 54.82 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.593 -0.945 . . . . 0.0 109.662 -179.639 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.27 -7.24 28.96 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.591 0.71 . . . . 0.0 109.353 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.948 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 6.8 p90 -129.99 135.96 48.89 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.098 -1.001 . . . . 0.0 109.016 179.762 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.477 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -70.03 132.33 23.7 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.327 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.477 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -105.1 103.03 12.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.327 . . . . 0.0 108.239 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.609 ' C ' HD12 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -102.82 143.47 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.558 -178.875 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.665 ' HB3' HD12 ' A' ' 40' ' ' LEU . 22.0 mt-30 -116.92 164.23 15.0 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.243 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.736 HD13 ' CE2' ' A' ' 63' ' ' PHE . 95.9 mt -148.38 148.49 30.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.017 -1.052 . . . . 0.0 109.945 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.62 ' HB3' HD21 ' A' ' 40' ' ' LEU . 4.0 p30 -123.92 122.18 37.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 110.419 179.223 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.32 -79.32 0.0 OUTLIER Glycine 0 N--CA 1.497 2.741 0 C-N-CA 124.028 0.823 . . . . 0.0 113.392 178.276 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -70.14 -5.48 27.44 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.769 -0.841 . . . . 0.0 111.078 -177.762 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.731 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 94.02 17.84 39.21 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.768 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 38.5 m-80 -75.41 134.39 40.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.962 -1.316 . . . . 0.0 108.983 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.564 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -59.59 138.5 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.938 0.875 . . . . 0.0 111.442 -178.504 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 32' ' ' GLN . 7.9 mt -104.63 -33.66 8.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.12 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.702 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -157.48 -176.55 6.02 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.284 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.515 ' CD1' HG22 ' A' ' 31' ' ' ILE . 6.9 t80 -160.54 -67.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.906 -1.121 . . . . 0.0 110.826 -178.476 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' OD1' ' HG2' ' A' ' 46' ' ' GLU . 4.6 p-10 103.01 176.27 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.633 0 C-N-CA 123.779 0.832 . . . . 0.0 109.206 -179.379 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -95.81 -16.51 21.83 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.821 -1.174 . . . . 0.0 112.806 -177.388 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.24 -62.08 2.1 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.376 -1.453 . . . . 0.0 110.138 -179.131 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.513 ' HG2' ' OD1' ' A' ' 43' ' ' ASN . 3.3 pt-20 -59.61 -53.11 61.8 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.694 0.759 . . . . 0.0 109.569 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 52' ' ' ARG . . . -60.52 -13.78 32.21 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.23 -37.29 33.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.753 -1.439 . . . . 0.0 110.188 -179.453 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.78 -43.02 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.858 -1.152 . . . . 0.0 109.236 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.44 -27.8 17.24 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.248 -0.908 . . . . 0.0 109.974 -178.896 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 100.69 -3.32 56.06 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.333 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.541 HH11 HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -60.88 100.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.97 -1.312 . . . . 0.0 109.749 -179.749 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.725 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -73.44 162.35 74.75 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 0.0 108.728 179.371 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.47 -51.22 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.187 1.925 . . . . 0.0 110.756 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -63.67 -26.04 68.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 110.181 -179.5 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -85.12 -42.81 14.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.955 -1.091 . . . . 0.0 109.905 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 53' ' ' ASP . 27.1 m -74.81 -3.2 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.157 -0.964 . . . . 0.0 109.675 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.564 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -71.49 123.13 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 O-C-N 120.947 -1.096 . . . . 0.0 108.058 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.33 -14.76 60.16 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -178.75 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.405 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 5.6 mmtt -79.9 136.97 36.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -1.205 . . . . 0.0 109.2 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.62 110.01 12.07 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.237 -0.915 . . . . 0.0 108.616 179.392 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.801 ' CZ ' HG21 ' A' ' 70' ' ' THR . 46.5 t80 -64.37 -12.63 44.51 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.736 ' CE2' HD13 ' A' ' 33' ' ' LEU . 31.9 m-85 -94.92 13.08 26.02 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.054 -1.029 . . . . 0.0 110.745 -177.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -179.39 -50.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.057 -1.027 . . . . 0.0 109.944 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -14.16 62.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 110.424 -179.038 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 3.8 t -125.89 -57.64 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 120.679 -1.263 . . . . 0.0 108.736 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.15 98.01 50.54 Favored Pre-proline 0 C--N 1.295 -1.8 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.614 -178.302 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -74.75 -1.53 11.26 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 121.858 1.705 . . . . 0.0 110.985 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 p -91.65 -26.51 18.63 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.988 -1.07 . . . . 0.0 109.335 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.801 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 35.2 p -75.0 -1.62 23.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.509 -0.744 . . . . 0.0 110.067 -179.163 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -89.69 52.13 2.25 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.93 -1.106 . . . . 0.0 108.597 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.481 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -124.87 178.5 1.42 Allowed Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.87 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.4 Cg_endo -78.42 -1.09 11.29 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 122.257 1.971 . . . . 0.0 111.476 -179.655 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 13.5 mt-10 -108.46 -29.02 9.02 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.877 -1.139 . . . . 0.0 109.301 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.685 ' CE1' HG11 ' A' ' 120' ' ' VAL . 1.2 t80 -100.06 -70.54 0.73 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.067 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.528 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 20.4 t80 -72.4 -15.31 61.84 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.813 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.77 -62.47 5.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 178.882 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.791 ' CB ' HG21 ' A' ' 90' ' ' THR . 1.2 mmtt -62.87 -16.09 57.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.562 -0.964 . . . . 0.0 109.251 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.863 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.9 t80 -77.36 -40.45 43.89 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.441 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.12 -7.87 56.51 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.969 . . . . 0.0 109.045 179.349 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -95.98 -41.17 8.9 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.507 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -69.41 -40.01 80.02 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 178.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.93 HG22 ' CE1' ' A' ' 118' ' ' TYR . 94.0 t -60.01 -38.71 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.693 -0.887 . . . . 0.0 109.535 179.388 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.35 -6.87 58.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.336 -0.853 . . . . 0.0 110.704 -178.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.06 -18.89 16.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.848 -1.157 . . . . 0.0 109.938 -179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.58 16.07 78.44 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.44 66.89 0.39 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.055 -1.262 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -58.74 124.53 20.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.853 . . . . 0.0 109.985 -179.948 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.426 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 36.5 t30 -161.27 83.78 0.64 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.943 -1.098 . . . . 0.0 109.072 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.826 HG23 ' SD ' ' A' ' 109' ' ' MET . 8.8 t -144.73 172.48 12.95 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.055 -1.058 . . . . 0.0 110.754 -179.405 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.8 ptm -157.21 171.07 21.09 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 1.031 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 7.7 p90 177.82 154.15 0.31 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.03 -1.044 . . . . 0.0 109.94 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.3 128.38 33.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 109.07 179.378 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.08 170.04 16.24 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.13 -0.981 . . . . 0.0 110.061 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.0 m -140.88 118.01 11.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 122' ' ' VAL . 20.1 m-30 -90.24 121.27 32.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.107 -0.995 . . . . 0.0 109.76 -179.648 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -142.77 46.27 1.58 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.477 -0.764 . . . . 0.0 109.029 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.499 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -85.36 66.52 9.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.466 -0.771 . . . . 0.0 110.855 -179.302 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.475 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 77.49 30.2 0.51 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.871 0.843 . . . . 0.0 109.318 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -141.34 171.08 14.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.055 -1.028 . . . . 0.0 108.5 179.452 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.44 170.6 0.2 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.015 -1.053 . . . . 0.0 109.235 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.66 92.03 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.007 1.805 . . . . 0.0 110.261 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.454 HG22 HG13 ' A' ' 105' ' ' VAL . 18.7 m -88.18 131.24 34.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 109.895 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.439 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -110.24 142.63 41.57 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.872 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.633 ' HA ' HG23 ' A' ' 125' ' ' VAL . 12.6 m -157.73 144.57 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.412 -179.476 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.578 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.11 119.12 36.19 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 174.782 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 1.031 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -87.78 162.47 2.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 120.665 -1.272 . . . . 0.0 111.376 -174.844 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -160.46 103.71 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.164 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.86 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -112.41 150.59 30.91 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.72 -0.613 . . . . 0.0 110.009 -176.932 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.572 ' HB3' ' CZ2' ' A' ' 119' ' ' TRP . 0.1 OUTLIER -150.38 164.94 34.56 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.512 -1.367 . . . . 0.0 109.084 179.041 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 118.87 13.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.879 -1.138 . . . . 0.0 109.739 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.77 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -65.65 133.21 50.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 109.424 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.746 HD22 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.052 -1.03 . . . . 0.0 110.817 -179.274 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.723 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.354 0.597 . . . . 0.0 109.687 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.93 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.3 m-85 -150.22 109.31 3.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -0.837 . . . . 0.0 108.834 -179.398 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.77 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 9.7 p-90 -115.37 144.46 43.76 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.583 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.86 HG13 ' CG ' ' A' ' 109' ' ' MET . 18.8 t -120.01 109.0 24.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.641 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 12.6 m-30 -89.61 134.4 34.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 108.701 179.358 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -111.26 117.96 56.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 121.322 -0.861 . . . . 0.0 108.841 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.578 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 4.9 tptp -90.39 110.15 21.25 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.502 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -64.74 117.62 7.76 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.205 -179.515 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.317 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.24 -174.28 2.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -173.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.54 138.57 17.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.702 ' HB3' ' HA ' ' A' ' 8' ' ' SER . . . -86.02 140.39 30.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.728 . . . . 0.0 109.742 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.548 ' CZ ' ' O ' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -61.35 -64.24 1.01 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' HD11 ' A' ' 11' ' ' ILE . . . -53.19 -27.71 32.26 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 177.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.702 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 0.2 OUTLIER 43.31 -168.73 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.293 1.044 . . . . 0.0 112.236 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 10' ' ' ASP . 11.6 tt0 -55.43 84.58 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.701 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 9' ' ' GLU . 2.2 m-20 22.43 74.66 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.852 0 CA-C-O 121.237 0.541 . . . . 0.0 110.471 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.059 HG22 HD11 ' A' ' 15' ' ' LEU . 1.5 mm -54.21 -67.29 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.275 -0.89 . . . . 0.0 110.493 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 11' ' ' ILE . 19.8 pt-20 -35.06 -47.59 0.38 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -63.69 -47.84 79.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.858 -1.151 . . . . 0.0 109.106 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.985 HG21 HD12 ' A' ' 23' ' ' LEU . 13.1 m -69.57 -13.33 62.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.537 -0.727 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.059 HD11 HG22 ' A' ' 11' ' ' ILE . 18.4 mt -95.43 -16.35 22.34 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.772 -1.205 . . . . 0.0 109.502 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.71 -27.21 22.54 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.144 -0.973 . . . . 0.0 108.535 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.0 -1.07 8.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.465 ' CE ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER 63.52 159.45 0.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.847 -1.158 . . . . 0.0 109.674 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.561 ' HB2' HG23 ' A' ' 14' ' ' THR . 0.3 OUTLIER -116.61 -154.21 0.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.241 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.27 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.067 -1.021 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.9 47.7 3.2 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.449 ' OE1' ' CA ' ' A' ' 22' ' ' GLN . 0.7 OUTLIER 55.17 26.58 8.51 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.433 -1.039 . . . . 0.0 108.402 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.985 HD12 HG21 ' A' ' 14' ' ' THR . 0.7 OUTLIER 43.16 43.99 4.15 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.409 0.623 . . . . 0.0 110.008 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 44' ' ' ALA . 53.2 m-20 -88.31 4.48 45.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.09 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.37 27.85 18.5 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.682 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 5.0 mt -84.62 -172.01 3.94 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.951 -1.323 . . . . 0.0 109.028 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.35 -5.93 14.08 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.682 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 10.3 p90 -124.12 117.22 24.16 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.27 -0.894 . . . . 0.0 108.648 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.465 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -57.06 141.03 43.97 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.526 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -117.17 114.82 24.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.851 -1.382 . . . . 0.0 108.047 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.579 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.6 pp -118.22 150.12 20.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.896 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.65 ' HB3' HD12 ' A' ' 40' ' ' LEU . 2.1 mt-30 -117.47 172.51 7.29 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.844 HD22 ' C ' ' A' ' 37' ' ' GLY . 27.9 mt -152.8 149.49 28.38 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.12 -0.988 . . . . 0.0 109.247 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.539 ' HB2' HD21 ' A' ' 40' ' ' LEU . 3.2 m-20 -119.25 133.16 55.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.141 -0.974 . . . . 0.0 109.417 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -7.58 70.0 0.0 OUTLIER Glycine 0 N--CA 1.514 3.873 0 C-N-CA 124.618 1.104 . . . . 0.0 113.273 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER 161.25 -23.84 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.844 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.68 23.05 10.38 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 3.3 m120 -86.08 123.51 31.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.417 -1.049 . . . . 0.0 108.792 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -56.32 136.19 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 121.913 0.863 . . . . 0.0 110.884 -178.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.65 HD12 ' HB3' ' A' ' 32' ' ' GLN . 5.6 mt -108.13 -30.83 8.2 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.621 ' NE2' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -159.96 160.6 33.61 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.601 ' HH ' ' HE1' ' A' ' 62' ' ' PHE . 2.7 t80 -140.08 -42.47 0.42 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.362 -1.461 . . . . 0.0 109.975 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.594 HD21 ' HB3' ' A' ' 45' ' ' ALA . 0.4 OUTLIER 87.54 171.58 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . . . -96.35 -15.38 21.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.004 -1.06 . . . . 0.0 112.637 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.594 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -58.77 -67.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.386 -1.446 . . . . 0.0 110.135 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 12.0 pt-20 -63.71 -44.95 92.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 109.021 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -61.11 -13.85 36.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 14.8 t70 -87.24 -32.72 19.59 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.627 -1.513 . . . . 0.0 108.819 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -73.45 -48.47 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.883 0.849 . . . . 0.0 108.731 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.768 HG21 " H3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -95.09 -29.54 14.53 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.371 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 100.94 -2.69 55.54 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.589 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.955 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 1.1 mtt85 -47.52 -58.72 3.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.968 -1.313 . . . . 0.0 111.027 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.819 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER 68.46 152.45 0.13 Allowed Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.85 -50.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.78 1.654 . . . . 0.0 111.312 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.693 ' HA ' HD12 ' A' ' 58' ' ' ILE . 10.4 pttt -57.99 -18.47 24.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 110.344 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -96.1 -43.19 7.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 0.0 109.411 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 53' ' ' ASP . 32.3 m -82.51 3.96 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.646 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -70.04 123.6 24.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.8 -22.86 36.95 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -79.99 130.59 35.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -1.054 . . . . 0.0 109.25 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.564 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -68.23 125.55 26.74 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.135 -0.978 . . . . 0.0 108.568 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.681 ' CE2' HG21 ' A' ' 70' ' ' THR . 90.2 t80 -71.88 -6.22 40.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.896 -1.128 . . . . 0.0 110.263 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CE2' HD13 ' A' ' 33' ' ' LEU . 30.0 m-85 -96.4 -41.69 8.49 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.935 -1.103 . . . . 0.0 111.545 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.79 -15.39 4.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.705 -1.247 . . . . 0.0 111.522 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.73 -2.35 30.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.679 -1.263 . . . . 0.0 110.858 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.955 HG12 ' CZ ' ' A' ' 52' ' ' ARG . 45.7 t -131.79 -47.89 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 120.732 -1.23 . . . . 0.0 108.504 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.719 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . . . -128.96 106.7 18.15 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.61 2.36 6.49 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.765 1.643 . . . . 0.0 111.662 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.9 p -99.31 -27.69 13.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.889 -1.132 . . . . 0.0 109.234 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.74 HG22 ' CD2' ' A' ' 75' ' ' PHE . 18.0 p -72.13 -5.95 39.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -0.823 . . . . 0.0 109.965 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -89.66 51.72 2.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.018 -1.051 . . . . 0.0 108.742 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.483 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -128.43 178.82 1.47 Allowed Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.07 -0.15 10.42 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 122.095 1.864 . . . . 0.0 111.447 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 5.4 mm-40 -107.85 -28.19 9.78 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.813 -1.18 . . . . 0.0 109.453 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.748 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.9 t80 -102.67 -69.15 0.8 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.487 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 26.0 t80 -69.67 -17.92 63.52 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.18 -62.12 5.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.72 ' CB ' HG21 ' A' ' 90' ' ' THR . 0.9 OUTLIER -63.42 -15.58 58.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.519 -0.989 . . . . 0.0 109.593 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.827 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.9 t80 -81.66 -34.79 30.57 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -8.13 58.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 2.0 mt-10 -96.13 -42.47 8.2 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -66.83 -41.22 93.66 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 79' ' ' PHE . 93.1 t -62.02 -40.09 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.654 -0.909 . . . . 0.0 109.508 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.64 -4.92 58.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -0.871 . . . . 0.0 110.43 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.5 t -96.09 -25.58 15.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.92 -1.112 . . . . 0.0 109.87 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.92 28.89 27.5 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -179.02 59.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.303 -1.116 . . . . 0.0 109.058 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 6.2 tt -49.0 121.54 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.332 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.434 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 62.1 t-20 -160.69 88.27 0.77 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.394 -0.816 . . . . 0.0 109.032 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.72 HG21 ' CB ' ' A' ' 78' ' ' LYS . 2.3 t -149.15 167.17 26.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 110.189 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -150.04 167.1 27.74 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.973 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 10.2 p90 -175.93 153.84 1.4 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.971 -1.081 . . . . 0.0 110.042 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -82.21 116.49 21.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.944 . . . . 0.0 109.167 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.96 175.24 6.0 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 103' ' ' THR . 48.0 m -140.81 111.99 7.24 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.845 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 18.6 m-30 -82.81 93.64 7.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.135 -0.978 . . . . 0.0 109.2 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -115.35 32.78 5.84 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.329 -0.857 . . . . 0.0 108.963 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.59 155.5 29.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.506 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.8 mt-30 -0.85 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.466 0.706 . . . . 0.0 112.394 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.2 ttp 178.12 -154.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.465 -0.772 . . . . 0.0 109.653 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.538 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -92.12 176.89 2.39 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 108.975 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.538 ' CD ' HG22 ' A' ' 101' ' ' THR . 36.4 Cg_endo -78.31 106.51 2.15 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.919 1.746 . . . . 0.0 110.2 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 95' ' ' THR . 4.2 m -101.07 143.83 30.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -117.0 139.24 50.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.599 ' HB ' HG13 ' A' ' 122' ' ' VAL . 7.7 m -156.25 141.62 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.771 -1.205 . . . . 0.0 111.261 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.548 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -91.05 114.78 27.39 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.973 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -87.07 161.24 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.807 -1.183 . . . . 0.0 110.543 -176.377 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.532 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 15.0 t-160 -159.74 99.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.859 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -110.64 148.41 32.29 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.452 -0.78 . . . . 0.0 109.628 -177.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.647 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 2.3 ttmt -145.51 -179.01 6.38 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.483 -1.287 . . . . 0.0 109.423 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -87.42 109.23 19.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.933 -1.105 . . . . 0.0 109.185 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.75 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -53.67 140.52 28.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.566 -0.709 . . . . 0.0 109.868 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.1 mt -86.93 9.56 18.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.6 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 m -59.68 -19.24 48.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.797 -1.19 . . . . 0.0 109.411 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 116' ' ' ASP . . . 148.75 -29.54 1.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 0.4 OUTLIER 167.96 68.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.5 -1.0 . . . . 0.0 108.668 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.677 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -124.2 -168.07 1.74 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.0 110.434 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.754 ' CE1' HG22 ' A' ' 83' ' ' VAL . 24.7 m-85 -151.03 112.32 4.37 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.75 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 15.8 p-90 -114.68 140.99 48.4 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 118.578 -1.249 . . . . 0.0 112.373 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.859 HG13 ' CG ' ' A' ' 109' ' ' MET . 21.2 t -116.42 108.62 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.637 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 15.3 m-30 -92.49 121.33 33.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.396 -0.815 . . . . 0.0 109.65 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.845 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.4 t -103.95 117.35 49.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.403 -0.81 . . . . 0.0 108.927 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.502 ' CD ' ' HA ' ' A' ' 6' ' ' PHE . 2.7 tttm -98.97 110.57 23.16 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.447 ' HA ' HG12 ' A' ' 105' ' ' VAL . 33.4 ttt180 -56.27 135.85 53.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.847 -1.158 . . . . 0.0 109.528 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.346 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.768 " H3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.291 0.567 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -72.14 132.74 44.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.709 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -177.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.086 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 5' ' ' ALA . 94.2 t -66.14 159.85 4.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.235 -0.915 . . . . 0.0 109.121 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.626 ' HB3' ' HA ' ' A' ' 8' ' ' SER . . . -137.12 150.88 48.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.546 -0.722 . . . . 0.0 109.781 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -65.19 -63.59 1.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.288 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 11' ' ' ILE . . . -53.1 -28.34 33.25 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 106.723 -2.551 . . . . 0.0 106.723 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.681 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER 42.37 -166.73 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 122.275 1.035 . . . . 0.0 112.518 176.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 10' ' ' ASP . 4.4 tt0 -58.25 83.25 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.575 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 9' ' ' GLU . 58.5 m-20 28.63 77.95 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.56 0 CA-C-N 118.37 0.532 . . . . 0.0 110.178 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.031 HG22 HD11 ' A' ' 15' ' ' LEU . 3.0 mm -56.98 -67.45 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.645 0 O-C-N 121.051 -1.031 . . . . 0.0 109.594 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.6 pt-20 -37.31 -29.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.836 -0.54 . . . . 0.0 112.205 -178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' ILE . 5.0 m-20 -76.97 -53.13 8.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.805 -1.184 . . . . 0.0 109.906 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -62.85 -40.05 96.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.192 -0.943 . . . . 0.0 109.357 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.031 HD11 HG22 ' A' ' 11' ' ' ILE . 28.9 mt -61.03 -24.0 65.84 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.31 -23.33 22.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.416 -0.802 . . . . 0.0 108.961 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.37 69.2 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.481 ' HG2' ' CB ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -66.75 152.84 44.72 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.135 -0.978 . . . . 0.0 109.308 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 18' ' ' MET . 0.8 OUTLIER 162.6 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.715 -0.615 . . . . 0.0 110.502 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.3 68.75 9.89 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.14 22.14 66.71 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.789 ' C ' HD23 ' A' ' 23' ' ' LEU . 6.5 mt-30 49.82 56.84 7.26 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.698 -0.884 . . . . 0.0 109.697 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.928 HD12 HD12 ' A' ' 26' ' ' LEU . 1.2 pt? 40.96 42.66 1.57 Allowed 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.1 0.476 . . . . 0.0 111.201 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.4 p30 -78.13 -7.67 57.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 109.964 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.38 31.8 8.09 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.974 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 15.5 mt -103.31 121.85 43.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.461 -1.023 . . . . 0.0 108.765 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.01 -12.09 7.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 109.965 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.974 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 10.3 p90 -121.49 116.96 25.67 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.003 -1.06 . . . . 0.0 109.289 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.519 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -55.14 148.64 24.18 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.469 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -128.61 100.88 5.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.833 -1.392 . . . . 0.0 108.222 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.737 HG22 ' CD1' ' A' ' 42' ' ' TYR . 2.2 pp -105.6 159.99 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.718 0.77 . . . . 0.0 110.953 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.79 ' HB3' HD12 ' A' ' 40' ' ' LEU . 33.7 mt-30 -122.08 174.86 6.67 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.678 HD11 ' HD2' ' A' ' 62' ' ' PHE . 22.7 mt -154.37 151.93 29.61 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.951 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.568 ' HB2' HD21 ' A' ' 40' ' ' LEU . 34.5 t70 -102.11 165.63 11.05 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.65 -20.65 0.14 Allowed Glycine 0 N--CA 1.499 2.884 0 O-C-N 121.792 -0.568 . . . . 0.0 113.507 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.58 20.02 19.32 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 119.814 1.807 . . . . 0.0 111.227 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.38 25.25 68.65 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.2 m-20 -90.0 125.22 35.31 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.051 -1.264 . . . . 0.0 110.767 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.659 HD12 HD21 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -59.5 139.2 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.869 -1.145 . . . . 0.0 110.706 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.79 HD12 ' HB3' ' A' ' 32' ' ' GLN . 9.2 mt -108.43 -31.31 7.87 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -157.69 -176.49 5.97 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.737 ' CD1' HG22 ' A' ' 31' ' ' ILE . 20.5 t80 -160.01 -72.81 0.07 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.706 -1.247 . . . . 0.0 111.488 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.9 p-10 105.28 179.34 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 C-N-CA 123.719 0.808 . . . . 0.0 109.096 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.26 -26.64 15.33 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.948 -1.095 . . . . 0.0 113.287 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -50.12 -64.63 0.75 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.332 -1.48 . . . . 0.0 110.796 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.9 pt-20 -57.86 -53.08 62.24 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 121.671 -0.643 . . . . 0.0 110.03 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 52' ' ' ARG . . . -58.38 -15.42 23.84 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.376 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.83 -34.23 39.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.894 -1.356 . . . . 0.0 108.892 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -84.86 -54.41 8.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.423 -0.798 . . . . 0.0 109.673 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.2 p -84.99 -23.11 28.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 110.34 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.36 -13.65 61.37 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.669 ' CD ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -47.89 107.23 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.184 -1.186 . . . . 0.0 110.817 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.742 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -74.39 153.71 87.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.165 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.2 -48.81 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.579 1.519 . . . . 0.0 111.13 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -18.26 60.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.077 -1.014 . . . . 0.0 110.281 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -88.61 -41.99 12.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.947 -1.096 . . . . 0.0 109.66 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 53' ' ' ASP . 26.4 m -73.22 -5.55 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.236 -0.915 . . . . 0.0 109.741 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.591 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -70.27 122.82 22.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.1 -1.0 . . . . 0.0 108.357 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.31 -16.58 59.47 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -79.25 139.91 37.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -1.204 . . . . 0.0 109.336 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 65' ' ' ASP . 0.7 OUTLIER -79.45 97.39 6.38 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.678 ' HD2' HD11 ' A' ' 33' ' ' LEU . 1.3 t80 -46.94 -39.9 13.24 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.508 -0.745 . . . . 0.0 110.63 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CG ' ' CD1' ' A' ' 76' ' ' TYR . 23.9 m-85 -86.1 -23.94 26.47 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.708 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.06 43.98 2.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 109.586 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 19.5 t0 -174.46 -20.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.766 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.664 HG11 ' HD3' ' A' ' 52' ' ' ARG . 5.4 t -117.96 -59.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 120.354 -1.466 . . . . 0.0 109.706 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.472 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -106.08 103.25 43.98 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.592 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.54 1.52 7.9 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.875 1.717 . . . . 0.0 110.97 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 p -106.39 -20.89 13.24 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.886 -1.134 . . . . 0.0 109.976 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.668 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 35.2 p -81.74 2.32 30.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.089 -1.007 . . . . 0.0 110.049 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -95.14 55.01 1.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.899 -1.125 . . . . 0.0 108.877 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.473 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -135.9 176.31 2.93 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.524 -0.735 . . . . 0.0 109.348 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.5 Cg_endo -77.04 77.86 3.63 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 122.413 2.075 . . . . 0.0 110.492 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 172.06 -36.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.5 t80 -105.63 -66.02 1.02 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.566 ' CD1' ' CG ' ' A' ' 63' ' ' PHE . 5.7 t80 -77.6 -20.51 53.84 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.032 -1.042 . . . . 0.0 108.265 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.39 -60.41 7.12 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.5 ' HB3' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -66.23 -15.43 63.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.752 -0.852 . . . . 0.0 110.085 -179.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.872 ' O ' HG23 ' A' ' 83' ' ' VAL . 5.1 t80 -84.15 -36.41 22.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -10.92 59.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 1.1 pp20? -97.5 -36.01 10.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.87 -39.63 85.33 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 79' ' ' PHE . 98.5 t -58.31 -56.2 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.89 -0.77 . . . . 0.0 109.408 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.39 -20.14 65.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 0.0 109.948 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 -29.25 51.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.9 24.1 42.96 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -172.68 57.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.42 -1.047 . . . . 0.0 108.991 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.846 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -49.4 124.7 9.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.804 . . . . 0.0 109.993 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.437 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 2.6 t30 -161.02 88.92 0.77 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.459 -0.776 . . . . 0.0 109.043 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 78' ' ' LYS . 3.3 t -156.75 168.21 28.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.018 -1.051 . . . . 0.0 110.728 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -145.57 170.21 16.87 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.058 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 13.3 p90 -176.31 158.37 1.87 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.893 -1.129 . . . . 0.0 110.307 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -92.08 116.25 28.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.979 -1.076 . . . . 0.0 109.289 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.38 -175.23 3.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.03 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.727 HG22 ' OD1' ' A' ' 97' ' ' ASP . 75.6 m -150.06 114.15 5.12 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' ' 122' ' ' VAL . 16.7 m-30 -85.83 118.88 25.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.148 -0.97 . . . . 0.0 110.394 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.727 ' OD1' HG22 ' A' ' 95' ' ' THR . 0.9 OUTLIER -131.4 35.93 3.82 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.711 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -80.5 80.72 6.9 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 123.032 1.396 . . . . 0.0 111.201 -178.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 98' ' ' TYR . 7.6 mm-40 72.9 27.19 2.17 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 119.925 -1.734 . . . . 0.0 109.051 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 50' ' ' THR . 1.5 tmm? -150.11 168.84 22.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.234 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -52.25 171.09 0.21 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 109.37 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.1 Cg_endo -76.59 79.45 3.03 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.927 1.751 . . . . 0.0 110.421 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.455 HG22 HG13 ' A' ' 105' ' ' VAL . 3.1 m -72.96 133.52 44.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 109.573 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.762 ' CB ' HG21 ' A' ' 125' ' ' VAL . 0.1 OUTLIER -106.45 148.55 28.02 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.251 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.582 ' HA ' HG13 ' A' ' 125' ' ' VAL . 19.7 m -158.31 140.41 5.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 118.578 -1.249 . . . . 0.0 110.536 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -87.43 130.92 34.5 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 103.309 -2.848 . . . . 0.0 103.309 175.066 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.058 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -104.67 160.06 5.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 120.543 -1.348 . . . . 0.0 110.513 -176.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.43 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 7.8 t-160 -156.84 101.6 1.97 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.867 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -117.02 149.07 40.89 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.23 -0.919 . . . . 0.0 110.136 -177.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.645 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.7 tttt -145.28 -176.94 5.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.674 -1.266 . . . . 0.0 109.297 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -89.67 109.13 20.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.805 -1.184 . . . . 0.0 108.893 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.768 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -60.61 137.46 58.17 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.358 -0.839 . . . . 0.0 109.868 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.5 mp -71.06 -9.04 57.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.943 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.48 -28.09 4.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.021 -1.049 . . . . 0.0 109.983 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.2 89.6 0.17 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 51.8 31.22 7.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -1.164 . . . . 0.0 109.794 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.742 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -86.63 -175.71 5.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.822 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.841 ' CE1' HG22 ' A' ' 83' ' ' VAL . 28.1 m-85 -154.07 109.33 3.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.303 -0.873 . . . . 0.0 108.883 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.768 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 11.0 p-90 -108.62 143.43 37.69 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 118.646 -1.221 . . . . 0.0 111.914 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.867 HG13 ' CG ' ' A' ' 109' ' ' MET . 21.3 t -122.83 104.77 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.489 0.661 . . . . 0.0 109.248 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.667 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 8.7 m-30 -85.8 114.22 22.57 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -98.17 115.8 39.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.149 -1.021 . . . . 0.0 109.224 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 4.1 tttm -98.64 125.86 44.05 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HA ' HG12 ' A' ' 105' ' ' VAL . 6.7 ttt-85 -63.66 144.45 57.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.576 -1.328 . . . . 0.0 109.212 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.762 HG21 ' CB ' ' A' ' 104' ' ' LYS . 22.6 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.594 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.509 " H2'" ' CZ ' ' A' ' 98' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.7 mtt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.54 123.9 28.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.61 149.75 33.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.919 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.717 HG13 ' N ' ' A' ' 5' ' ' ALA . 0.8 OUTLIER -75.65 -153.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.717 ' N ' HG13 ' A' ' 4' ' ' VAL . . . -59.48 -137.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.544 ' CD1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -89.22 46.27 1.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.178 -1.576 . . . . 0.0 107.144 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.524 ' HA3' ' HE3' ' A' ' 123' ' ' LYS . . . 98.96 25.74 9.44 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 -178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.717 ' HB3' HD11 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -112.06 107.42 16.36 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.226 -1.161 . . . . 0.0 111.566 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.42 -71.48 0.08 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.167 0.984 . . . . 0.0 109.992 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -163.22 88.75 0.6 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.135 HG22 HD11 ' A' ' 15' ' ' LEU . 3.1 mm -80.54 -63.78 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.69 0 O-C-N 121.465 -0.772 . . . . 0.0 111.294 -176.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -44.2 -27.08 0.37 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.949 . . . . 0.0 110.962 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -90.0 -38.48 13.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.988 . . . . 0.0 108.359 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 14' ' ' THR . 2.3 m -75.39 -6.78 51.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.515 -0.74 . . . . 0.0 109.269 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.135 HD11 HG22 ' A' ' 11' ' ' ILE . 38.4 mt -98.82 -27.5 13.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.193 -0.942 . . . . 0.0 109.07 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.29 -26.48 18.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.589 -0.694 . . . . 0.0 109.837 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -104.04 28.04 7.11 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 108.947 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.638 ' HE1' HD13 ' A' ' 23' ' ' LEU . 8.3 tmm? -125.68 142.79 51.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -91.91 -46.53 7.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.293 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -178.82 -36.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.912 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.68 68.71 0.4 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -151.25 -50.3 0.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.424 -1.045 . . . . 0.0 108.976 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.638 HD13 ' HE1' ' A' ' 18' ' ' MET . 1.9 pt? -79.6 -1.48 38.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 110.322 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -72.05 -6.89 45.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.853 -1.154 . . . . 0.0 110.306 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.41 33.97 6.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.56 HD12 ' O ' ' A' ' 23' ' ' LEU . 12.5 mt -110.48 147.8 33.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.236 -1.155 . . . . 0.0 109.293 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -93.23 22.35 5.21 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.797 0.808 . . . . 0.0 109.312 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.66 ' HZ ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -155.69 115.8 3.72 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -51.04 126.95 27.88 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.523 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -106.71 82.58 1.73 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.579 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.6 pp -91.77 153.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.374 -0.829 . . . . 0.0 110.817 -177.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.781 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -127.19 166.36 17.86 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.939 ' O ' HD11 ' A' ' 40' ' ' LEU . 84.3 mt -147.63 163.32 36.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.664 -1.273 . . . . 0.0 109.885 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.556 ' HB3' HD21 ' A' ' 40' ' ' LEU . 17.6 p-10 -134.07 122.3 22.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.104 -0.998 . . . . 0.0 110.725 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.08 -78.75 0.0 OUTLIER Glycine 0 N--CA 1.5 2.966 0 C-N-CA 124.424 1.011 . . . . 0.0 113.3 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 34' ' ' ASP . 27.8 t70 -70.84 -2.35 14.66 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.763 -0.845 . . . . 0.0 110.796 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.715 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 88.95 13.53 62.19 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.6 m-20 -66.99 148.09 52.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.903 -1.351 . . . . 0.0 108.02 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.655 HD11 ' HD1' ' A' ' 42' ' ' TYR . 2.4 tp -70.36 137.75 23.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.133 0.968 . . . . 0.0 112.648 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.939 HD11 ' O ' ' A' ' 33' ' ' LEU . 3.3 mt -107.59 -31.39 8.13 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 175.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.509 ' N ' ' HG3' ' A' ' 32' ' ' GLN . 33.8 tp60 -164.25 166.71 20.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.727 -0.608 . . . . 0.0 109.634 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.655 ' HD1' HD11 ' A' ' 39' ' ' ILE . 1.4 t80 -147.12 -69.41 0.24 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.166 -0.959 . . . . 0.0 110.289 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.2 p-10 102.88 152.3 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.26 -14.82 59.68 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.102 -0.999 . . . . 0.0 112.405 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -57.79 -62.09 2.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.623 -1.298 . . . . 0.0 109.565 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.556 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 14.0 pt-20 -64.81 -42.81 94.71 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.139 -0.976 . . . . 0.0 108.887 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.449 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -59.26 -16.6 35.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -86.18 -30.64 22.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.77 -1.429 . . . . 0.0 109.465 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.539 HG22 HG22 ' A' ' 50' ' ' THR . 1.2 mp -78.75 -42.05 24.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.939 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.6 OUTLIER -109.18 1.7 20.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.437 -0.789 . . . . 0.0 109.81 -179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 81.84 -2.4 83.5 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.897 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.91 ' CD ' HG13 ' A' ' 66' ' ' VAL . 1.3 mtm-85 -79.33 81.42 5.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.797 -1.414 . . . . 0.0 111.327 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.575 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -64.46 -179.65 0.31 Allowed Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 34.2 Cg_endo -77.65 -35.63 1.46 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.681 1.587 . . . . 0.0 110.487 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HA ' HD12 ' A' ' 58' ' ' ILE . 1.9 tptp -73.09 -24.57 60.66 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.193 -0.942 . . . . 0.0 109.634 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -84.68 -43.46 14.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.609 HG21 ' CG ' ' A' ' 42' ' ' TYR . 35.9 m -71.6 -6.55 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.607 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.488 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -71.06 119.84 18.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 O-C-N 121.114 -0.991 . . . . 0.0 108.354 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.17 -19.85 52.16 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -78.79 143.41 36.1 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.41 -1.053 . . . . 0.0 108.911 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -89.59 123.95 34.12 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.871 ' HB2' HD21 ' A' ' 33' ' ' LEU . 65.3 t80 -56.44 -15.61 4.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.024 -1.047 . . . . 0.0 110.8 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -122.06 36.83 4.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.932 -1.105 . . . . 0.0 109.539 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.86 -52.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 110.32 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.24 10.04 8.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.977 -1.077 . . . . 0.0 110.778 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.91 HG13 ' CD ' ' A' ' 52' ' ' ARG . 41.1 t -115.82 -33.95 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.867 -1.146 . . . . 0.0 108.533 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -152.42 91.23 3.61 Favored Pre-proline 0 C--N 1.291 -1.964 0 O-C-N 121.41 -0.806 . . . . 0.0 109.146 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -73.64 -11.54 24.21 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.96 1.773 . . . . 0.0 110.123 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.9 p -86.41 -27.84 23.93 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.308 -0.87 . . . . 0.0 108.985 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.894 HG22 ' CD2' ' A' ' 75' ' ' PHE . 18.4 p -72.04 -4.96 31.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.619 -0.676 . . . . 0.0 110.161 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.22 74.84 9.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.075 -1.016 . . . . 0.0 108.651 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -162.31 172.37 5.55 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.346 -0.846 . . . . 0.0 109.228 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 36.1 Cg_endo -77.54 77.13 3.97 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 122.579 2.186 . . . . 0.0 110.42 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.1 tt0 173.13 -37.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.894 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.9 t80 -105.98 -65.76 1.04 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.562 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 10.4 t80 -77.33 -17.84 57.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' O ' ' CG ' ' A' ' 81' ' ' GLU . . . -62.5 -59.4 9.4 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.54 ' HB2' HG21 ' A' ' 90' ' ' THR . 10.7 mmtt -62.12 -19.36 62.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.689 -0.889 . . . . 0.0 109.399 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.841 ' O ' HG23 ' A' ' 83' ' ' VAL . 11.4 t80 -76.11 -40.41 52.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.275 -0.89 . . . . 0.0 108.729 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -6.6 55.45 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.211 -0.93 . . . . 0.0 108.887 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 77' ' ' GLY . 1.5 mm-40 -95.44 -39.6 9.91 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.425 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -70.03 -45.16 58.1 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.863 HG22 ' CE1' ' A' ' 118' ' ' TYR . 48.5 t -59.01 -37.6 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.776 -0.838 . . . . 0.0 109.58 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 -4.25 48.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 111.067 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -101.89 -16.91 16.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.845 -1.159 . . . . 0.0 110.025 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.15 17.35 74.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.03 85.97 0.53 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -1.202 . . . . 0.0 108.663 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.464 HD13 ' HD1' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -81.23 119.0 23.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 89' ' ' ASN . 2.4 p-10 -160.5 89.01 0.81 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.834 HG23 ' SD ' ' A' ' 109' ' ' MET . 1.6 t -138.77 171.51 14.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.075 -1.015 . . . . 0.0 110.569 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.452 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -158.3 148.27 19.9 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.05 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 12.6 p90 -168.96 153.25 5.57 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.7 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.4 115.32 23.07 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.82 -176.56 2.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.129 -0.982 . . . . 0.0 110.113 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.537 HG22 ' OD1' ' A' ' 97' ' ' ASP . 42.7 m -151.23 110.8 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.73 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 18.5 m-30 -83.52 110.62 18.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.537 ' OD1' HG22 ' A' ' 95' ' ' THR . 17.2 m-20 -133.32 42.43 3.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.829 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.567 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 21.4 p90 -77.33 137.07 38.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER 4.5 64.36 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 CA-C-O 121.447 0.642 . . . . 0.0 111.893 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.717 ' SD ' HG22 ' A' ' 101' ' ' THR . 0.7 OUTLIER -175.84 -176.2 0.82 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.117 -0.989 . . . . 0.0 109.749 -177.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.717 HG22 ' SD ' ' A' ' 100' ' ' MET . 1.2 t -64.14 150.95 91.35 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 108.86 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.433 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 31.5 Cg_endo -73.76 130.52 14.75 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 121.846 1.697 . . . . 0.0 110.682 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 95' ' ' THR . 3.3 m -123.46 142.84 50.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.495 -0.753 . . . . 0.0 109.222 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.409 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -118.06 139.77 50.73 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.675 ' HA ' HG23 ' A' ' 125' ' ' VAL . 11.0 m -154.36 144.71 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.962 -1.086 . . . . 0.0 110.399 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -94.2 116.02 28.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.05 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -89.24 164.24 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 122.307 1.051 . . . . 0.0 111.232 -175.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.49 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 21.2 t-160 -160.57 102.65 1.36 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.847 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -114.35 151.12 33.51 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.393 -0.817 . . . . 0.0 110.203 -177.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 3.3 tttt -147.66 176.24 10.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.552 -1.343 . . . . 0.0 109.114 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.446 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 4.4 ttpt -85.02 107.39 17.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.923 -1.111 . . . . 0.0 109.45 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.82 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -56.69 152.16 12.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.415 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.41 5.13 46.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.112 -0.992 . . . . 0.0 110.197 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.5 t -62.37 -44.1 97.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.888 -1.133 . . . . 0.0 109.571 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.42 91.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 52.32 36.74 20.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -1.103 . . . . 0.0 109.696 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 1.6 t -94.55 174.41 7.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.578 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.863 ' CE1' HG22 ' A' ' 83' ' ' VAL . 8.9 m-85 -147.21 106.75 3.92 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.82 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 9.9 p-90 -103.23 139.38 38.77 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.783 -1.167 . . . . 0.0 112.557 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.847 HG13 ' HG2' ' A' ' 109' ' ' MET . 30.1 t -116.61 110.46 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.657 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.6 m-30 -92.69 118.53 31.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.313 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -101.3 122.77 53.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.955 -1.091 . . . . 0.0 109.355 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.584 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -99.13 123.11 43.18 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -75.05 118.45 18.01 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.931 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.412 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.939 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 mtt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.79 86.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.368 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 178.55 -35.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.641 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.772 HG11 ' H ' ' A' ' 10' ' ' ASP . 7.2 p -154.7 120.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.142 -0.974 . . . . 0.0 109.734 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.625 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 52.84 -175.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.845 . . . . 0.0 110.101 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.549 ' CG ' ' CD ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -36.29 -49.15 0.68 Allowed 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 122.566 1.174 . . . . 0.0 109.231 178.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.26 41.18 0.05 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 106.245 -2.742 . . . . 0.0 106.245 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.738 ' HB3' HD11 ' A' ' 11' ' ' ILE . 2.0 m -74.11 165.07 25.79 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.698 0.761 . . . . 0.0 111.463 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -88.01 58.47 4.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.619 -0.675 . . . . 0.0 109.257 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.772 ' H ' HG11 ' A' ' 4' ' ' VAL . 20.7 t0 55.84 63.78 1.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.854 -1.154 . . . . 0.0 108.256 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.119 HG22 HD11 ' A' ' 15' ' ' LEU . 14.2 mm -61.9 -57.11 13.56 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.226 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.9 mt-10 -35.87 -43.21 0.3 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.875 -0.516 . . . . 0.0 111.709 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -76.3 -42.42 45.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.009 -1.057 . . . . 0.0 108.986 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.747 HG21 HD22 ' A' ' 23' ' ' LEU . 7.2 m -66.53 -14.04 61.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.665 -0.647 . . . . 0.0 110.233 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.119 HD11 HG22 ' A' ' 11' ' ' ILE . 9.6 mt -97.34 -23.13 16.26 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.918 -1.114 . . . . 0.0 109.051 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.97 -12.82 34.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.34 -0.85 . . . . 0.0 109.609 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.39 -63.4 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.038 -1.039 . . . . 0.0 109.466 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.449 ' CE ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 mtt 64.74 147.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.726 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 18' ' ' MET . 0.4 OUTLIER 166.71 -41.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.362 -0.836 . . . . 0.0 109.575 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -87.99 61.24 6.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.235 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.97 78.39 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.449 ' HG3' ' CE ' ' A' ' 18' ' ' MET . 26.2 tt0 58.11 25.62 12.65 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.24 -1.153 . . . . 0.0 109.232 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.028 HD23 HD21 ' A' ' 26' ' ' LEU . 0.6 OUTLIER 50.99 38.39 20.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.284 -0.885 . . . . 0.0 110.157 179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 3.8 p30 -69.27 -9.44 53.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.128 -0.982 . . . . 0.0 109.767 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.75 21.18 42.78 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.028 HD21 HD23 ' A' ' 23' ' ' LEU . 14.6 mt -68.41 152.29 45.63 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.972 -1.311 . . . . 0.0 108.759 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.56 9.03 17.12 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.655 ' CZ ' HD11 ' A' ' 11' ' ' ILE . 1.2 p90 -153.5 117.29 4.74 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' HA3' ' HG2' ' A' ' 46' ' ' GLU . . . -53.97 161.61 3.8 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.382 -0.913 . . . . 0.0 110.859 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -136.88 116.0 12.48 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.583 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.5 pp -118.9 157.7 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.212 -0.93 . . . . 0.0 109.733 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.726 ' HB3' HD12 ' A' ' 40' ' ' LEU . 12.3 mt-30 -123.04 168.08 12.81 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.833 HD11 ' HB3' ' A' ' 62' ' ' PHE . 15.9 mt -151.69 150.38 30.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.007 . . . . 0.0 110.001 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.524 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -104.85 168.79 8.83 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -46.5 -29.44 3.95 Favored Glycine 0 N--CA 1.504 3.174 0 CA-C-N 118.621 0.646 . . . . 0.0 112.959 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.16 9.98 13.51 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.485 -1.597 . . . . 0.0 110.581 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.586 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.01 26.22 67.18 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.497 ' C ' HD23 ' A' ' 33' ' ' LEU . 61.9 m-20 -93.25 134.14 35.76 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.227 -1.16 . . . . 0.0 111.229 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG21 HG23 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -62.61 138.25 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 111.058 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 32' ' ' GLN . 5.7 mt -109.68 -29.23 8.44 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -161.66 159.32 27.32 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.897 ' CE2' HG11 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -138.02 -50.63 0.59 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.38 -1.45 . . . . 0.0 109.311 -178.361 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.585 HD21 ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER 87.57 171.25 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . . . -96.03 -15.36 22.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.015 -1.053 . . . . 0.0 112.822 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.585 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -59.17 -64.74 0.83 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.429 -1.419 . . . . 0.0 109.488 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.575 ' OE2' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -59.72 -51.74 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 109.3 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' N ' ' OE2' ' A' ' 46' ' ' GLU . . . -56.96 -15.92 15.66 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.3 t70 -76.6 -40.73 48.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.821 -1.399 . . . . 0.0 108.181 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -73.33 -59.29 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.428 -0.795 . . . . 0.0 108.89 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.787 HG21 " O4'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -78.15 -8.55 58.41 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.347 -0.846 . . . . 0.0 110.319 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 82.77 -3.47 83.21 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.401 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.819 ' CZ ' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -60.91 165.73 3.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.743 -1.445 . . . . 0.0 110.078 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.808 ' O ' HG22 ' A' ' 57' ' ' VAL . 7.1 m-20 -133.05 168.11 19.58 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 53' ' ' ASP . 34.4 Cg_endo -77.27 -38.38 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.475 1.45 . . . . 0.0 110.074 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -79.04 -24.56 43.52 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.312 -0.867 . . . . 0.0 109.487 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -45.3 18.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.897 HG11 ' CE2' ' A' ' 42' ' ' TYR . 20.4 m -69.28 -9.66 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.198 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.459 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -68.98 120.72 16.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.96 -24.31 32.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 6.8 mmmt -78.9 130.38 35.57 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -79.19 132.58 36.57 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.567 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.868 ' CE2' HG21 ' A' ' 70' ' ' THR . 64.9 t80 -60.32 -14.37 18.01 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.068 -1.02 . . . . 0.0 110.118 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 99.5 m-85 -124.31 33.39 5.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.019 -1.051 . . . . 0.0 110.378 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -154.57 -40.7 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.882 -1.136 . . . . 0.0 110.377 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.53 7.86 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.007 -1.058 . . . . 0.0 110.881 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.819 HG13 ' CZ ' ' A' ' 52' ' ' ARG . 94.3 t -114.11 -33.85 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 120.673 -1.267 . . . . 0.0 108.448 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.633 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -155.06 100.62 2.31 Favored Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.544 -0.722 . . . . 0.0 109.182 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.97 -1.23 10.94 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.913 1.742 . . . . 0.0 110.876 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.5 p -97.37 -25.32 15.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.133 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.868 HG21 ' CE2' ' A' ' 62' ' ' PHE . 67.7 p -66.98 -10.68 52.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.638 -0.663 . . . . 0.0 110.187 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.28 64.62 8.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 109.626 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.428 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -147.44 172.53 5.09 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.181 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -76.66 78.4 3.35 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 122.514 2.142 . . . . 0.0 110.314 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.8 tt0 169.36 -36.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.669 ' CD1' ' HE1' ' A' ' 109' ' ' MET . 1.3 t80 -104.21 -68.06 0.87 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.509 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 14.4 t80 -75.53 -20.69 58.53 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.69 -59.08 9.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.544 ' HB2' HG21 ' A' ' 90' ' ' THR . 8.5 mmtt -66.45 -14.17 61.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.523 -0.986 . . . . 0.0 109.915 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.846 ' O ' HG23 ' A' ' 83' ' ' VAL . 15.7 t80 -83.33 -35.02 25.51 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.371 -0.83 . . . . 0.0 109.048 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -11.95 59.88 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.157 -0.964 . . . . 0.0 109.246 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 23.5 pt-20 -97.84 -42.2 7.68 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.595 ' C ' HD12 ' A' ' 88' ' ' LEU . . . -61.61 -38.49 95.94 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.705 -2.158 . . . . 0.0 107.705 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.849 HG22 ' CE1' ' A' ' 118' ' ' TYR . 98.0 t -65.07 -40.15 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.795 -0.827 . . . . 0.0 110.042 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.61 0.36 57.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.0 111.135 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 t -109.74 -19.64 13.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.879 -1.138 . . . . 0.0 109.998 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.21 14.59 81.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -144.31 59.07 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -1.203 . . . . 0.0 109.275 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -68.25 113.48 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.656 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -161.04 79.44 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.386 -0.822 . . . . 0.0 108.908 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 78' ' ' LYS . 4.2 t -120.92 167.8 12.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.031 -1.043 . . . . 0.0 110.181 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 4.0 ttt -154.88 154.33 32.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.78 . . . . 0.0 109.222 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.069 ' CE2' HG21 ' A' ' 107' ' ' VAL . 15.4 p90 -176.85 178.04 1.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -0.95 . . . . 0.0 109.869 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.91 100.23 10.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.047 -1.033 . . . . 0.0 108.299 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.496 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -101.6 151.72 21.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 110.06 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -119.01 111.09 17.88 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.934 ' CE2' HG21 ' A' ' 122' ' ' VAL . 19.1 m-30 -79.28 115.78 19.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.402 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -137.51 46.3 2.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -85.32 43.95 1.06 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.623 -0.673 . . . . 0.0 111.688 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER 100.9 27.82 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.698 0 CA-C-O 121.603 0.716 . . . . 0.0 109.271 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.408 ' CE ' ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -139.28 175.15 9.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.09 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 19.5 p -54.52 161.27 2.18 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.024 -1.048 . . . . 0.0 109.287 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.4 Cg_endo -75.94 96.66 1.07 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.776 1.65 . . . . 0.0 110.049 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.462 HG22 HG13 ' A' ' 105' ' ' VAL . 1.0 OUTLIER -104.42 125.09 50.32 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.377 -0.827 . . . . 0.0 109.8 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' C ' HG23 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -88.7 159.92 17.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 175.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.672 HG23 HG13 ' A' ' 107' ' ' VAL . 35.6 m -156.17 142.49 10.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -79.13 103.5 9.12 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 175.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.069 HG21 ' CE2' ' A' ' 92' ' ' PHE . 33.7 m -94.8 151.88 3.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.806 -1.184 . . . . 0.0 110.24 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.509 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 3.5 t-160 -153.96 103.3 2.56 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.783 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -104.75 131.82 51.74 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.079 -1.013 . . . . 0.0 109.297 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.588 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 3.9 tttt -130.34 -174.69 3.41 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.209 -1.396 . . . . 0.0 109.894 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 10.7 tttt -99.79 102.64 14.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.102 -0.999 . . . . 0.0 108.713 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.904 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -56.03 142.36 36.48 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.349 -0.844 . . . . 0.0 110.056 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.59 0.52 52.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.88 . . . . 0.0 109.985 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 p -59.03 -20.69 55.5 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.859 -1.15 . . . . 0.0 109.503 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.98 53.36 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 56.67 62.12 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -1.161 . . . . 0.0 109.253 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.86 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -111.51 -161.79 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.354 -0.841 . . . . 0.0 110.104 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.849 ' CE1' HG22 ' A' ' 83' ' ' VAL . 14.9 m-85 -151.91 111.35 3.94 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.904 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 20.1 p-90 -113.01 149.79 32.84 Favored 'General case' 0 C--O 1.202 -1.405 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.531 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.783 HG13 ' HG2' ' A' ' 109' ' ' MET . 46.6 t -128.24 106.25 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.726 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.666 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 7.5 m-30 -91.72 128.31 37.51 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.934 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.7 t -105.96 129.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.625 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -101.34 153.43 19.66 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -101.51 127.87 48.0 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.277 -1.369 . . . . 0.0 109.068 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.437 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.787 " O4'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.6 179.77 5.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.487 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 62.57 29.96 17.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.853 . . . . 0.0 109.53 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.887 HG11 ' O ' ' A' ' 8' ' ' SER . 0.3 OUTLIER 43.17 -161.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.574 0.702 . . . . 0.0 110.342 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.677 ' N ' HG13 ' A' ' 4' ' ' VAL . . . -63.38 -144.42 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CE1' ' HD3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -86.92 46.02 1.33 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.063 -1.023 . . . . 0.0 109.02 178.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.39 16.93 11.22 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.887 ' O ' HG11 ' A' ' 4' ' ' VAL . 97.8 p -78.75 165.33 23.72 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.263 -1.139 . . . . 0.0 109.266 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.73 74.9 0.9 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.147 -0.971 . . . . 0.0 110.061 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.716 ' H ' HG21 ' A' ' 4' ' ' VAL . 18.0 t0 50.05 84.86 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.945 HG22 HD11 ' A' ' 15' ' ' LEU . 4.4 mm -90.82 -59.45 2.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.302 -0.874 . . . . 0.0 110.553 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -22.92 0.77 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.578 -1.327 . . . . 0.0 110.558 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.4 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . 6.5 t-20 -94.29 -36.81 11.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 109.399 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.465 HG23 ' CB ' ' A' ' 18' ' ' MET . 1.1 m -69.51 -59.8 2.74 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.945 HD11 HG22 ' A' ' 11' ' ' ILE . 18.1 mt -40.76 -34.61 0.4 Allowed 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.434 0.635 . . . . 0.0 109.793 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.52 -56.01 7.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.485 -0.759 . . . . 0.0 109.865 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -138.55 85.94 2.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.811 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.629 ' CE ' HD22 ' A' ' 23' ' ' LEU . 1.3 pmm? -108.82 -170.95 1.75 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 109.169 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.486 ' N ' ' HG2' ' A' ' 18' ' ' MET . 1.3 m-20 -87.41 27.28 1.1 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.941 -1.099 . . . . 0.0 111.192 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 61.34 97.65 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.143 -0.973 . . . . 0.0 109.304 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.19 13.21 20.08 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.44 ' HB2' ' CG ' ' A' ' 18' ' ' MET . 1.7 mt-30 -101.62 -29.52 11.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.14 -1.212 . . . . 0.0 109.345 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -73.4 -19.47 60.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.903 . . . . 0.0 109.593 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -102.98 0.22 31.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 110.048 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.09 29.23 12.97 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 120.824 -1.172 . . . . 0.0 110.282 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.644 HD13 ' CE2' ' A' ' 28' ' ' PHE . 3.2 mt -105.35 -177.01 3.24 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.051 -1.264 . . . . 0.0 109.025 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.44 4.5 48.41 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.644 ' CE2' HD13 ' A' ' 26' ' ' LEU . 8.1 p90 -135.96 129.24 31.85 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -63.41 122.49 26.99 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.479 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -100.88 96.3 7.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.074 -1.25 . . . . 0.0 107.752 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.543 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.3 pp -98.24 148.82 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 110.787 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.595 ' HB3' HD12 ' A' ' 40' ' ' LEU . 5.5 mm-40 -113.56 167.32 10.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.884 HD22 ' O ' ' A' ' 37' ' ' GLY . 55.4 mt -155.46 139.89 16.79 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.165 -0.959 . . . . 0.0 108.91 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.598 ' HB2' HD21 ' A' ' 40' ' ' LEU . 8.1 t0 -120.52 131.71 54.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.919 -1.113 . . . . 0.0 110.433 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 35.87 -77.04 0.0 OUTLIER Glycine 0 N--CA 1.501 2.978 0 C-N-CA 124.71 1.148 . . . . 0.0 113.403 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -73.37 2.56 7.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.659 -0.907 . . . . 0.0 111.109 -178.353 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.884 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 82.4 17.34 69.09 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -72.58 136.34 45.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.087 -1.243 . . . . 0.0 108.693 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.599 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -64.44 135.59 27.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.224 -0.922 . . . . 0.0 111.094 -178.356 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 34' ' ' ASP . 1.5 mt -105.56 -29.39 10.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -163.51 164.09 24.47 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.632 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 7.4 t80 -133.36 -75.95 0.48 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 119.955 -1.716 . . . . 0.0 110.599 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.632 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 8.0 t-20 134.25 150.04 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.691 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -77.47 -55.88 5.01 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.335 -0.853 . . . . 0.0 109.834 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -34.0 -57.58 0.46 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' O ' HG23 ' A' ' 50' ' ' THR . 15.5 pt-20 -64.22 -46.73 82.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.948 -1.095 . . . . 0.0 109.676 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . -62.63 -12.2 39.51 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.08 -32.87 17.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.631 -1.511 . . . . 0.0 110.355 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.65 -35.08 11.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.179 -0.951 . . . . 0.0 108.899 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.598 HG21 " H3'" ' A' ' 126' ' ' HC4 . 0.2 OUTLIER -107.3 -21.46 12.94 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.029 -179.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 97.93 -3.33 60.47 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.546 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 1.003 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 1.8 mtt85 -68.09 95.23 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.86 -1.376 . . . . 0.0 110.666 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.777 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -72.52 162.29 74.79 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 34.7 Cg_endo -76.98 -29.53 5.16 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.959 1.773 . . . . 0.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.79 -33.97 34.43 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.269 -0.894 . . . . 0.0 109.899 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -41.73 49.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.717 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 53' ' ' ASP . 34.1 m -74.26 -4.48 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 109.914 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.555 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.21 123.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.82 -19.37 52.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -82.66 133.69 35.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -1.139 . . . . 0.0 109.102 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.485 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.8 OUTLIER -75.0 119.78 19.65 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.204 -0.935 . . . . 0.0 108.501 179.2 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.599 ' HB2' HD12 ' A' ' 39' ' ' ILE . 90.9 t80 -66.32 -8.89 28.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.895 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.639 ' CE2' HD13 ' A' ' 33' ' ' LEU . 34.3 m-85 -96.93 -60.19 1.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.202 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -112.96 20.89 15.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.902 -1.124 . . . . 0.0 110.851 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.485 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.4 OUTLIER -137.01 -14.91 1.54 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.872 -1.142 . . . . 0.0 111.44 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 1.003 HG12 ' CZ ' ' A' ' 52' ' ' ARG . 31.5 t -122.43 -47.99 2.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 120.55 -1.344 . . . . 0.0 108.559 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.655 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . . . -122.65 109.96 32.19 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -75.17 0.79 8.55 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.912 1.742 . . . . 0.0 111.505 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.2 p -98.68 -24.84 14.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.87 -1.144 . . . . 0.0 109.658 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.596 HG21 ' CE2' ' A' ' 62' ' ' PHE . 61.2 p -73.67 -4.04 31.9 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.332 -0.855 . . . . 0.0 109.863 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -88.44 50.82 2.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.014 -1.054 . . . . 0.0 109.148 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.418 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -127.1 174.84 3.82 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.8 Cg_endo -76.77 -1.33 11.45 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 122.101 1.867 . . . . 0.0 111.387 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 14.9 mp0 -105.34 -28.42 10.9 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.916 -1.115 . . . . 0.0 109.357 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.631 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.7 t80 -100.57 -71.99 0.69 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.44 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 11.4 t80 -72.96 -16.11 61.54 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 120.947 -1.096 . . . . 0.0 108.234 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.65 -62.6 4.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.58 ' CB ' HG21 ' A' ' 90' ' ' THR . 2.2 mmtp -64.06 -14.89 57.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.672 -0.899 . . . . 0.0 109.551 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.867 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.3 t80 -80.53 -41.18 24.66 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -9.35 58.51 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 108.689 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 85' ' ' SER . 2.1 mm-40 -95.9 -40.17 9.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.7 95.02 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 79' ' ' PHE . 61.8 t -62.96 -40.61 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.943 -0.74 . . . . 0.0 109.975 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.37 1.4 54.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.256 -0.902 . . . . 0.0 111.218 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 81' ' ' GLU . 97.5 p -104.69 -24.13 12.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.863 -1.148 . . . . 0.0 110.142 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.03 21.17 47.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 87' ' ' ASN . 1.4 p-10 -160.16 57.08 0.35 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -1.189 . . . . 0.0 109.333 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.538 HD13 ' CD1' ' A' ' 118' ' ' TYR . 1.5 tt -66.29 102.39 0.85 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.422 -0.798 . . . . 0.0 109.447 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -161.6 82.95 0.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.58 HG21 ' CB ' ' A' ' 78' ' ' LYS . 10.1 t -139.79 174.58 10.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.904 -1.123 . . . . 0.0 110.233 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -149.75 168.77 22.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.05 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 8.8 p90 -174.47 154.29 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.079 -1.013 . . . . 0.0 109.929 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -80.47 117.16 20.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.41 -0.806 . . . . 0.0 108.943 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.03 169.3 11.8 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.249 -0.907 . . . . 0.0 109.435 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.446 HG22 ' OD1' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -140.19 111.31 7.04 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.376 -0.828 . . . . 0.0 109.313 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.827 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 20.6 m-30 -79.64 85.04 5.4 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.455 -0.778 . . . . 0.0 109.12 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.446 ' OD1' HG22 ' A' ' 95' ' ' THR . 1.2 m-20 -102.99 29.47 5.43 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.548 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -77.59 153.39 33.32 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 98' ' ' TYR . 10.0 mt-30 -2.0 67.35 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 123.365 0.666 . . . . 0.0 112.457 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.9 -157.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.0 109.845 -178.236 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -91.22 174.17 4.7 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 0.0 108.882 179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.3 Cg_endo -76.71 87.79 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.949 1.766 . . . . 0.0 110.509 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.46 HG22 HG13 ' A' ' 105' ' ' VAL . 1.8 m -87.52 106.9 18.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.443 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.42 139.33 31.61 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.786 ' HA ' HG23 ' A' ' 125' ' ' VAL . 13.7 m -149.94 146.14 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.131 -0.981 . . . . 0.0 110.115 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.572 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.22 115.79 29.09 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 175.248 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.05 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -85.97 159.96 3.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 120.82 -1.175 . . . . 0.0 110.925 -175.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 6.3 t-160 -157.15 98.42 1.73 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.881 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -109.09 149.38 29.4 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.395 -0.816 . . . . 0.0 109.748 -177.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.673 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -141.07 -175.04 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.374 -1.33 . . . . 0.0 109.695 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.458 ' CE ' ' HA2' ' A' ' 115' ' ' GLY . 5.0 ttpm? -89.63 101.79 14.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 109.258 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.643 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -56.85 156.93 6.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.615 -0.678 . . . . 0.0 110.871 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 0.4 OUTLIER 62.23 15.29 7.41 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.52 23.12 5.66 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.132 -0.98 . . . . 0.0 109.252 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA2' ' CE ' ' A' ' 111' ' ' LYS . . . 140.66 75.56 0.04 OUTLIER Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.003 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 113' ' ' LEU . 0.4 OUTLIER 174.66 -60.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -1.129 . . . . 0.0 109.714 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.58 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -108.57 -168.56 1.37 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.996 -1.065 . . . . 0.0 109.929 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CE1' HG22 ' A' ' 83' ' ' VAL . 1.7 m-85 -149.74 127.54 11.76 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.673 ' CH2' ' HB2' ' A' ' 110' ' ' LYS . 10.2 p-90 -123.8 148.24 46.86 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.968 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.881 HG13 ' CG ' ' A' ' 109' ' ' MET . 11.7 t -123.0 109.49 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.314 0.578 . . . . 0.0 109.827 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.653 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 9.2 m-30 -88.24 126.37 35.12 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.827 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.2 t -103.88 114.71 44.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.572 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -89.52 111.79 22.8 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.606 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -66.95 109.03 2.79 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.948 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.786 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.161 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.598 " H3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.5 mtt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.1 145.29 40.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.283 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.61 -173.06 1.13 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.286 -0.884 . . . . 0.0 109.789 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.864 HG12 ' OG ' ' A' ' 8' ' ' SER . 5.0 t -91.26 107.38 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.816 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 41.11 -158.28 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.592 0.711 . . . . 0.0 111.195 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -49.85 -55.15 15.36 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.09 31.08 0.28 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.864 ' OG ' HG12 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -59.1 156.7 11.54 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.595 -0.944 . . . . 0.0 111.251 -178.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.38 60.52 1.93 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.636 ' H ' HG11 ' A' ' 4' ' ' VAL . 7.6 m-20 54.74 80.8 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.525 -1.359 . . . . 0.0 107.714 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.988 HG22 HD11 ' A' ' 15' ' ' LEU . 4.9 mm -83.6 -56.77 5.23 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 110.732 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.459 ' HA ' HD12 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -40.35 -29.23 0.08 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.773 . . . . 0.0 111.559 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 11' ' ' ILE . 4.8 m120 -89.37 -40.83 12.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.966 -1.083 . . . . 0.0 108.258 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.845 ' CG2' HD13 ' A' ' 23' ' ' LEU . 4.1 m -69.2 -10.18 56.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.719 -0.613 . . . . 0.0 109.794 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.988 HD11 HG22 ' A' ' 11' ' ' ILE . 15.4 mt -97.48 -24.54 15.54 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.019 -1.05 . . . . 0.0 109.172 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.56 -15.98 26.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.423 -0.798 . . . . 0.0 109.627 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -128.88 56.54 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.021 -1.049 . . . . 0.0 109.881 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.453 ' HG2' ' CG ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -56.94 150.11 17.38 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.239 -0.913 . . . . 0.0 108.884 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.29 -45.43 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.228 -0.92 . . . . 0.0 110.227 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.78 64.94 7.49 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.84 17.29 67.19 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.453 ' CG ' ' HG2' ' A' ' 18' ' ' MET . 42.1 mt-30 50.51 28.95 3.66 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.495 -1.003 . . . . 0.0 109.448 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.845 HD13 ' CG2' ' A' ' 14' ' ' THR . 1.2 mp 50.93 62.81 2.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.461 -0.774 . . . . 0.0 109.825 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.83 -3.33 57.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.861 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.96 30.09 9.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.604 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 31.8 mt -80.17 128.3 33.36 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.51 -0.994 . . . . 0.0 109.207 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.17 -13.78 8.42 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.599 0.714 . . . . 0.0 109.227 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.732 ' HZ ' HD11 ' A' ' 11' ' ' ILE . 14.6 p90 -129.16 150.7 50.44 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.068 -1.02 . . . . 0.0 108.843 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.528 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -76.69 152.03 40.32 Favored Glycine 0 C--N 1.293 -1.81 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.517 ' O ' ' NE2' ' A' ' 32' ' ' GLN . . . -123.7 90.61 3.31 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.832 -1.393 . . . . 0.0 107.536 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.527 HG22 ' CD1' ' A' ' 42' ' ' TYR . 1.1 pp -94.71 142.6 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.489 -0.757 . . . . 0.0 110.762 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 6.1 mm-40 -114.11 168.33 9.91 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.847 HD22 ' O ' ' A' ' 37' ' ' GLY . 73.3 mt -153.94 146.92 24.49 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.842 -1.161 . . . . 0.0 110.379 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 36' ' ' ASP . 45.1 m-20 -123.63 124.07 41.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.394 -0.816 . . . . 0.0 109.659 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.54 -77.32 0.0 OUTLIER Glycine 0 N--CA 1.5 2.951 0 C-N-CA 124.561 1.077 . . . . 0.0 113.679 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -70.57 -2.86 15.51 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.598 -0.942 . . . . 0.0 111.197 -177.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.847 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 88.02 20.52 49.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -75.5 130.16 38.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.086 -1.244 . . . . 0.0 108.201 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.648 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -59.78 139.01 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 110.561 -178.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 116' ' ' ASP . 2.7 mt -107.07 -26.59 11.07 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.488 HE22 ' N ' ' A' ' 43' ' ' ASN . 14.0 tm0? -160.31 142.11 12.66 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.527 ' CD1' HG22 ' A' ' 31' ' ' ILE . 6.2 t80 -121.95 -64.22 1.23 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.756 -1.215 . . . . 0.0 110.729 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 45' ' ' ALA . 3.2 p-10 101.86 175.6 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.59 -19.42 19.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.855 -1.153 . . . . 0.0 112.615 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.555 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -56.84 -63.44 1.2 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.51 -1.369 . . . . 0.0 110.163 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.9 pt-20 -60.77 -53.18 60.46 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.579 -0.701 . . . . 0.0 109.392 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -57.96 -14.38 16.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.46 -30.78 20.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.786 -1.42 . . . . 0.0 110.205 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.36 -38.12 14.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.122 -0.986 . . . . 0.0 109.074 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.836 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.7 OUTLIER -102.86 -18.28 15.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.5 -0.75 . . . . 0.0 109.669 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 92.72 -3.76 74.89 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.606 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -58.39 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.239 . . . . 0.0 109.213 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.719 ' O ' HG22 ' A' ' 57' ' ' VAL . 12.1 m-20 -54.74 152.93 11.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 108.919 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.55 -42.81 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 122.07 1.847 . . . . 0.0 110.68 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -74.73 -27.81 60.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.13 -0.981 . . . . 0.0 109.94 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -80.66 -39.65 26.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.613 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 53' ' ' ASP . 24.0 m -76.66 -1.99 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.837 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -71.71 122.1 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.061 -1.024 . . . . 0.0 108.48 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.06 -13.13 65.58 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 35.1 mmtt -79.13 136.23 37.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.048 -1.266 . . . . 0.0 108.93 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -72.41 95.03 1.71 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.459 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 30.1 t80 -53.92 -22.71 10.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 109.794 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -91.78 -31.98 15.55 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.72 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -138.15 44.98 2.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 109.114 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.455 ' HB3' ' N ' ' A' ' 61' ' ' ASN . 34.0 t0 -164.26 -31.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 110.517 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.606 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 3.9 t -112.2 -50.57 5.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 O-C-N 120.754 -1.216 . . . . 0.0 108.674 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.546 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -121.63 94.74 48.36 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.709 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.22 -6.02 17.82 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.886 1.724 . . . . 0.0 110.462 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.7 p -77.82 -32.87 52.54 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.151 -0.968 . . . . 0.0 108.692 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.457 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 19.1 p -69.1 -9.44 52.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.604 -0.685 . . . . 0.0 109.764 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.87 76.74 9.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.997 -1.064 . . . . 0.0 108.635 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.426 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -165.07 173.46 3.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 109.085 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.6 Cg_endo -77.4 76.71 4.12 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 122.497 2.132 . . . . 0.0 110.416 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 3.6 tt0 174.27 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.617 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.3 t80 -105.65 -64.03 1.19 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.506 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.4 t80 -79.61 -20.43 46.85 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.081 -1.012 . . . . 0.0 108.56 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.46 -57.81 13.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.717 ' CB ' HG21 ' A' ' 90' ' ' THR . 12.1 mmtt -65.38 -16.69 63.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.658 -0.907 . . . . 0.0 109.802 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.89 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.4 t80 -82.62 -35.12 27.29 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -76.32 -12.88 60.14 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.103 -0.998 . . . . 0.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 18.7 pt-20 -96.92 -41.34 8.46 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.461 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -60.18 -39.86 96.48 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 107.454 -2.258 . . . . 0.0 107.454 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 79' ' ' PHE . 99.1 t -59.88 -47.59 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.794 -0.827 . . . . 0.0 109.296 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.76 5.58 45.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.386 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.3 m -102.0 -25.75 13.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.042 -1.037 . . . . 0.0 109.612 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.78 22.29 64.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 87' ' ' ASN . 2.0 p-10 -166.03 58.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.134 -1.216 . . . . 0.0 109.51 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.5 OUTLIER -52.94 116.35 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.895 . . . . 0.0 109.515 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -160.2 78.34 0.66 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.168 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.717 HG21 ' CB ' ' A' ' 78' ' ' LYS . 9.1 t -136.44 154.91 50.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.96 163.0 34.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 0.0 108.923 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.021 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 8.6 p90 -175.27 151.59 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.041 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 1.5 pt-20 -81.73 112.39 18.86 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.195 -0.941 . . . . 0.0 108.636 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.79 -179.63 3.71 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.181 -0.949 . . . . 0.0 109.99 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.3 m -147.52 107.56 4.02 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.848 ' CE2' HG21 ' A' ' 122' ' ' VAL . 17.8 m-30 -84.13 92.58 7.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.377 -0.827 . . . . 0.0 109.718 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -108.01 25.21 11.85 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.264 -0.898 . . . . 0.0 109.338 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.576 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -78.65 155.39 29.54 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.52 ' C ' ' O ' ' A' ' 98' ' ' TYR . 24.1 mt-30 -0.32 65.85 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.187 0 CA-C-O 121.631 0.729 . . . . 0.0 112.099 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.576 ' N ' ' O ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER 173.64 158.36 0.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -53.68 168.44 0.4 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.114 -0.991 . . . . 0.0 109.088 179.135 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 32.8 Cg_endo -74.75 113.34 3.77 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.831 1.688 . . . . 0.0 110.194 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.522 HG22 HG13 ' A' ' 105' ' ' VAL . 4.3 m -116.25 114.93 25.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.844 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 125' ' ' VAL . 5.4 tttt -92.05 136.65 33.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.852 ' HA ' HG23 ' A' ' 125' ' ' VAL . 32.6 m -147.44 146.27 18.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.146 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.86 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -91.71 116.37 28.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 175.258 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.021 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -88.27 164.12 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.787 -1.196 . . . . 0.0 111.516 -175.319 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -150.83 98.7 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.876 ' HG2' HG13 ' A' ' 120' ' ' VAL . 19.5 mtm -96.85 125.4 41.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.682 -1.261 . . . . 0.0 109.503 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.553 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 3.9 tttt -132.15 172.12 12.79 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 117.525 -1.67 . . . . 0.0 109.706 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.445 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 2.1 tttp -90.29 107.68 19.29 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.979 -1.076 . . . . 0.0 108.384 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.876 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.21 -177.17 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.28 0.562 . . . . 0.0 110.154 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.12 81.21 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.027 . . . . 0.0 110.461 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.7 m 57.02 100.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.656 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 131.35 -11.27 5.54 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.56 ' HA ' HD12 ' A' ' 40' ' ' LEU . 13.9 m-20 -147.61 -39.56 0.19 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.211 -1.17 . . . . 0.0 109.546 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.577 ' N ' ' HB3' ' A' ' 112' ' ' ALA . 4.6 t 77.75 -75.5 0.06 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.307 -0.871 . . . . 0.0 111.146 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.618 ' OH ' HG13 ' A' ' 83' ' ' VAL . 12.6 m-85 -127.3 122.8 34.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.742 -1.224 . . . . 0.0 109.227 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.876 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 22.1 p-90 -128.11 152.42 48.02 Favored 'General case' 0 C--O 1.201 -1.455 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.919 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.876 HG13 ' HG2' ' A' ' 109' ' ' MET . 60.9 t -132.36 110.31 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.305 0.574 . . . . 0.0 109.648 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.686 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 9.1 m-30 -94.34 122.09 36.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 108.987 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.848 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -103.03 116.84 47.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.01 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 1.6 tptp -88.09 114.18 24.45 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.828 ' HA ' HG12 ' A' ' 105' ' ' VAL . 1.2 ttp85 -67.85 111.6 4.42 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.456 -1.297 . . . . 0.0 108.544 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.86 HG22 ' HD2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.058 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.836 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.307 0.575 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 59.08 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.27 -0.894 . . . . 0.0 109.741 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -155.22 67.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 4' ' ' VAL . 10.2 p -57.15 114.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.42 -0.8 . . . . 0.0 110.305 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.573 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 50.75 -175.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.166 -0.958 . . . . 0.0 110.856 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.61 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -42.08 -53.77 3.83 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-O 122.009 0.909 . . . . 0.0 109.138 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.36 42.16 0.18 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.976 ' CB ' HD11 ' A' ' 11' ' ' ILE . 1.5 m -83.13 -169.49 2.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.908 -0.76 . . . . 0.0 111.28 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -119.07 76.04 1.08 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.477 -0.764 . . . . 0.0 110.628 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.676 ' H ' HG11 ' A' ' 4' ' ' VAL . 14.7 m-20 47.56 86.57 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.975 -1.078 . . . . 0.0 108.482 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.046 HG22 HD11 ' A' ' 15' ' ' LEU . 1.9 mm -88.64 -67.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.117 -0.989 . . . . 0.0 111.142 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -41.16 -36.06 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.624 -0.672 . . . . 0.0 111.592 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -77.54 -42.76 34.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.872 -1.143 . . . . 0.0 108.455 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.069 HG21 HD22 ' A' ' 23' ' ' LEU . 2.0 m -76.03 -4.38 40.95 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.046 HD11 HG22 ' A' ' 11' ' ' ILE . 81.2 mt -97.85 -23.03 16.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.855 -1.153 . . . . 0.0 109.149 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.9 -29.62 63.29 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.483 -0.761 . . . . 0.0 108.994 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -124.07 62.34 1.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.408 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.637 ' CE ' HD23 ' A' ' 15' ' ' LEU . 3.3 ttm -129.03 98.45 4.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.999 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 11.5 t0 -68.48 -52.96 26.65 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 108.61 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER 167.16 92.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.554 -0.716 . . . . 0.0 109.118 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.3 -23.68 3.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.672 ' O ' HD12 ' A' ' 23' ' ' LEU . 2.3 tt0 -56.26 -47.83 77.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -1.154 . . . . 0.0 109.233 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.069 HD22 HG21 ' A' ' 14' ' ' THR . 0.5 OUTLIER -141.0 69.55 1.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -109.99 -6.58 15.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.935 . . . . 0.0 109.842 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.16 28.88 13.68 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.915 HD21 HD23 ' A' ' 23' ' ' LEU . 1.7 mt -73.68 -171.91 1.14 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.128 -1.219 . . . . 0.0 108.798 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.85 13.22 23.63 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.85 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 18.8 p90 -146.12 177.2 9.16 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.684 -0.635 . . . . 0.0 109.509 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 46' ' ' GLU . . . -108.66 118.8 5.44 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.471 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -94.81 89.39 5.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.919 -1.342 . . . . 0.0 109.061 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.656 HD12 ' N ' ' A' ' 32' ' ' GLN . 1.1 pp -96.0 161.47 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.494 -0.754 . . . . 0.0 109.403 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.656 ' N ' HD12 ' A' ' 31' ' ' ILE . 8.9 mt-30 -132.16 175.77 8.96 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.825 HD21 ' HB2' ' A' ' 62' ' ' PHE . 22.3 mt -155.77 146.25 21.88 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.756 ' HB2' HD21 ' A' ' 40' ' ' LEU . 14.6 t70 -99.16 169.96 9.02 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.86 -21.82 1.74 Allowed Glycine 0 N--CA 1.499 2.893 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.449 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -94.98 13.51 24.77 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.547 -1.56 . . . . 0.0 110.549 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.07 26.68 65.9 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 2.0 m-20 -97.25 126.22 42.31 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.987 -1.302 . . . . 0.0 111.929 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.499 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -53.09 133.41 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.117 -0.99 . . . . 0.0 110.709 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 34' ' ' ASP . 11.6 mt -102.74 -32.2 9.95 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -155.54 -175.16 5.29 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.26 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.883 ' CE2' HG11 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -160.62 -62.8 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.97 -1.081 . . . . 0.0 110.239 -178.407 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.623 HD21 ' HB3' ' A' ' 45' ' ' ALA . 4.8 p-10 103.92 176.49 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.22 -37.03 11.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.974 -1.079 . . . . 0.0 110.758 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.623 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -46.76 -48.18 20.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.233 -0.917 . . . . 0.0 111.047 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' OE2' ' HB2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -61.83 -47.51 84.78 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.388 -0.82 . . . . 0.0 109.34 -177.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . -61.27 -15.87 46.71 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -80.64 -32.32 36.24 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.121 -1.223 . . . . 0.0 109.464 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.599 HD11 ' HD3' ' A' ' 124' ' ' ARG . 0.6 OUTLIER -85.06 -50.61 14.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.075 -1.015 . . . . 0.0 109.441 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.777 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -88.58 -13.88 38.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.759 -1.213 . . . . 0.0 109.524 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 89.09 -11.77 68.35 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.716 ' CD ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -57.78 175.54 0.19 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -1.165 . . . . 0.0 109.525 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.656 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -127.86 158.85 69.2 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 108.943 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.97 -37.99 1.8 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.865 1.71 . . . . 0.0 110.656 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -89.23 -25.26 21.83 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.171 -0.955 . . . . 0.0 109.279 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.411 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 1.2 tt0 -73.89 -37.88 64.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 108.689 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.883 HG11 ' CE2' ' A' ' 42' ' ' TYR . 26.6 m -70.9 -8.45 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.815 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -70.97 122.56 23.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.345 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.08 -19.7 51.71 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 40.4 mmtt -78.73 130.94 36.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.451 -1.029 . . . . 0.0 108.927 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 128.1 34.66 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.825 ' HB2' HD21 ' A' ' 33' ' ' LEU . 63.2 t80 -62.33 -11.53 15.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.584 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -122.52 32.17 5.86 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.95 -1.094 . . . . 0.0 110.271 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -150.09 -45.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.07 . . . . 0.0 110.563 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -128.15 4.33 5.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.994 -1.067 . . . . 0.0 110.762 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.716 HG13 ' CD ' ' A' ' 52' ' ' ARG . 39.2 t -113.62 -28.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.801 -1.187 . . . . 0.0 108.72 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.645 ' HB1' HG23 ' A' ' 70' ' ' THR . . . -156.58 88.79 2.74 Favored Pre-proline 0 C--N 1.292 -1.915 0 O-C-N 121.346 -0.847 . . . . 0.0 109.214 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -74.61 -4.41 15.37 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.986 1.791 . . . . 0.0 110.158 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.5 p -94.27 -27.63 16.03 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.355 -0.84 . . . . 0.0 109.074 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.645 HG23 ' HB1' ' A' ' 67' ' ' ALA . 69.9 p -64.41 -18.89 65.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.62 -0.675 . . . . 0.0 109.666 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -60.5 91.84 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.052 -1.03 . . . . 0.0 108.842 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.414 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -174.95 172.8 1.11 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.229 -179.604 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.1 Cg_endo -78.16 -4.44 14.33 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 122.599 2.199 . . . . 0.0 111.729 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 17.7 mt-10 -102.46 -29.95 11.3 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.754 -1.216 . . . . 0.0 109.822 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.443 ' HB3' ' O ' ' A' ' 70' ' ' THR . 1.6 t80 -101.62 -68.91 0.8 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.469 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.8 t80 -73.62 -17.32 61.18 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 81' ' ' GLU . . . -64.84 -61.42 5.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.595 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.2 OUTLIER -65.03 -14.66 60.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.646 -0.914 . . . . 0.0 109.841 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.901 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.9 t80 -82.89 -36.75 25.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -78.32 -9.47 59.26 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 85' ' ' SER . 1.3 mm-40 -95.61 -39.6 9.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.612 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -65.25 -41.69 96.66 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.3 t -59.67 -40.57 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.788 -0.831 . . . . 0.0 109.585 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.66 1.17 53.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.275 -0.891 . . . . 0.0 111.503 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 8.7 t -106.39 -20.1 13.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.808 -1.182 . . . . 0.0 110.147 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.63 26.03 57.4 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -168.66 67.26 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.397 -1.06 . . . . 0.0 109.217 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.83 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -71.37 115.88 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.905 . . . . 0.0 110.032 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.45 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 64.1 t-20 -162.03 88.4 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.541 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 78' ' ' LYS . 4.6 t -128.92 168.32 16.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.992 -1.068 . . . . 0.0 109.96 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.413 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 0.6 OUTLIER -155.14 151.11 27.87 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.064 ' CE2' HG21 ' A' ' 107' ' ' VAL . 12.3 p90 -173.03 -176.58 1.42 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.293 -0.88 . . . . 0.0 109.547 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.82 100.03 8.6 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.19 179.12 4.7 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.591 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.3 m -144.03 105.9 4.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.383 -0.823 . . . . 0.0 109.271 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.948 ' CE2' HG21 ' A' ' 122' ' ' VAL . 15.5 m-30 -80.59 110.15 15.8 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -134.7 43.26 2.76 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.364 -0.835 . . . . 0.0 109.485 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 21.4 p90 -77.41 139.58 39.72 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.533 ' C ' ' O ' ' A' ' 98' ' ' TYR . 3.3 pt20 2.31 66.98 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.191 0 CA-C-O 121.879 0.847 . . . . 0.0 111.783 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.624 ' HE1' ' HA ' ' A' ' 50' ' ' THR . 2.6 tmm? -176.85 -179.38 0.94 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 p -65.0 163.08 32.67 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.0 109.06 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.02 148.67 27.98 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.147 1.898 . . . . 0.0 110.416 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.577 HG22 HG13 ' A' ' 105' ' ' VAL . 3.2 m -151.36 118.87 6.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 110.116 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -95.36 142.9 27.21 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.961 ' HA ' HG23 ' A' ' 125' ' ' VAL . 32.5 m -144.12 146.67 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 118.266 -1.373 . . . . 0.0 112.411 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.61 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -78.8 95.33 5.34 Favored 'General case' 0 C--O 1.2 -1.536 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 175.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.064 HG21 ' CE2' ' A' ' 92' ' ' PHE . 33.3 m -87.63 152.6 3.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 120.731 -1.231 . . . . 0.0 110.151 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.428 ' ND1' ' HA ' ' A' ' 5' ' ' ALA . 9.8 t-160 -160.44 97.53 1.22 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.817 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -106.12 142.27 36.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.188 -0.945 . . . . 0.0 109.327 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 5.3 tttt -133.01 -162.49 1.24 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.753 -1.217 . . . . 0.0 109.416 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -110.84 98.53 7.64 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.119 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.958 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.49 123.97 12.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 tp -111.82 -18.11 12.78 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.037 -1.039 . . . . 0.0 109.695 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 m -52.6 -29.71 27.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.007 . . . . 0.0 109.274 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 148.49 43.07 0.03 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 117' ' ' SER . 1.3 m-20 -132.9 -89.08 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.131 -1.217 . . . . 0.0 109.684 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.778 ' H ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER 168.07 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.06 -1.025 . . . . 0.0 111.534 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.862 ' CE1' HG22 ' A' ' 83' ' ' VAL . 15.9 m-85 -128.75 127.45 42.07 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.037 -1.04 . . . . 0.0 110.106 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.958 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 17.6 p-90 -125.56 146.87 49.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.601 -1.312 . . . . 0.0 112.269 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.817 HG13 ' HG2' ' A' ' 109' ' ' MET . 40.7 t -123.32 117.85 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.741 -0.599 . . . . 0.0 109.949 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.643 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.0 m-30 -100.92 120.0 39.53 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.988 -1.07 . . . . 0.0 108.639 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.948 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.4 t -105.58 111.71 35.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 122.244 1.021 . . . . 0.0 108.297 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.549 ' HD3' ' CE1' ' A' ' 6' ' ' PHE . 1.5 tptp -92.71 154.49 18.3 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.599 ' HD3' HD11 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -91.47 123.55 34.98 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.493 -1.379 . . . . 0.0 109.008 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.961 HG23 ' HA ' ' A' ' 105' ' ' VAL . 9.3 t . . . . . 0 C--N 1.305 -1.355 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.481 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.777 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.43 0.633 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -95.37 20.12 9.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.262 -0.899 . . . . 0.0 109.648 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.31 45.79 22.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 109.381 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 8' ' ' SER . 7.5 p -63.85 103.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 8' ' ' SER . . . 51.11 61.47 3.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.495 -1.378 . . . . 0.0 110.765 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.622 ' CD2' ' HD3' ' A' ' 123' ' ' LYS . 58.1 t80 62.78 20.64 12.27 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 120.844 1.657 . . . . 0.0 106.835 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.652 ' C ' HG13 ' A' ' 4' ' ' VAL . . . 96.76 -22.15 42.05 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.921 ' HB3' HD11 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -74.96 165.98 24.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.694 1.235 . . . . 0.0 113.142 -177.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -112.83 65.64 0.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 54.25 81.75 0.1 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.009 HG22 HD11 ' A' ' 15' ' ' LEU . 2.9 mm -82.48 -56.14 6.45 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 111.464 -177.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 15' ' ' LEU . 1.5 tt0 -40.43 -27.91 0.06 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.454 -0.779 . . . . 0.0 111.524 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' ILE . 96.6 m-20 -86.79 -42.52 13.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 109.007 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -70.48 -14.42 62.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.347 -0.846 . . . . 0.0 110.21 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.009 HD11 HG22 ' A' ' 11' ' ' ILE . 8.9 mt -93.56 -18.92 21.7 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.014 -1.054 . . . . 0.0 109.069 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.61 -41.34 12.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 108.824 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.36 57.57 0.68 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.499 ' HG3' ' CB ' ' A' ' 22' ' ' GLN . 1.0 OUTLIER -108.79 -179.08 3.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.228 -0.92 . . . . 0.0 110.171 -179.287 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.36 -56.75 0.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.546 -0.721 . . . . 0.0 109.307 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -177.64 -52.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 109.564 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.51 49.1 1.86 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.499 ' CB ' ' HG3' ' A' ' 18' ' ' MET . 2.7 mt-30 -121.65 -56.02 1.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -1.182 . . . . 0.0 109.484 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -67.5 -9.49 42.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.271 -0.893 . . . . 0.0 110.453 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.656 ' N ' HD12 ' A' ' 23' ' ' LEU . 9.3 m-20 -84.72 -2.88 58.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.838 -1.164 . . . . 0.0 110.331 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.51 35.53 4.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.706 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 13.6 mt -121.27 149.64 42.58 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.487 -1.008 . . . . 0.0 109.352 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.04 24.58 4.2 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.029 0.918 . . . . 0.0 108.851 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.716 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 1.2 p90 -153.53 134.12 13.66 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -68.18 125.2 21.07 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.96 -1.115 . . . . 0.0 110.857 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.523 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -106.21 110.41 22.64 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.529 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.4 pp -117.11 151.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.939 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.602 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -113.0 167.91 10.13 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.757 HD11 ' CB ' ' A' ' 62' ' ' PHE . 13.2 mt -150.07 139.9 21.83 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.916 -1.115 . . . . 0.0 110.036 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.438 ' N ' HD21 ' A' ' 40' ' ' LEU . 37.1 t70 -92.14 167.56 11.97 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -48.93 -21.04 2.14 Favored Glycine 0 N--CA 1.497 2.747 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.421 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -92.51 12.52 22.65 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.458 -1.613 . . . . 0.0 110.498 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.652 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.3 26.9 64.89 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.569 ' C ' HD23 ' A' ' 33' ' ' LEU . 16.3 m120 -97.4 127.83 43.69 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.013 -1.287 . . . . 0.0 111.872 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.626 HD12 HD21 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -59.52 134.83 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.86 -1.15 . . . . 0.0 110.528 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 32' ' ' GLN . 2.3 mt -106.47 -29.56 9.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -155.46 161.38 40.97 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.832 ' CG ' HG21 ' A' ' 57' ' ' VAL . 3.7 t80 -143.7 -60.93 0.4 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.552 -1.342 . . . . 0.0 109.972 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.601 HD21 ' HB3' ' A' ' 45' ' ' ALA . 3.5 p-10 99.89 173.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 123.745 0.818 . . . . 0.0 108.871 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.59 -13.73 25.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.755 -1.215 . . . . 0.0 111.84 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.601 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -58.93 -65.06 0.73 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.585 -1.322 . . . . 0.0 109.904 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.591 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 7.0 pt-20 -60.31 -50.0 75.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.959 . . . . 0.0 109.737 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -56.47 -18.64 23.4 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 45' ' ' ALA . 1.2 m-20 -76.13 -38.47 56.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.829 -1.395 . . . . 0.0 108.422 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.627 HG22 HG23 ' A' ' 50' ' ' THR . 0.3 OUTLIER -79.32 -59.5 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.45 -0.781 . . . . 0.0 109.294 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 1.015 HG21 " C3'" ' A' ' 126' ' ' HC4 . 19.0 p -78.36 -9.63 59.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.275 -0.891 . . . . 0.0 110.474 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.444 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 81.0 -2.34 81.23 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.925 ' CD ' HG13 ' A' ' 66' ' ' VAL . 1.3 mtt-85 -73.86 84.71 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.169 -1.195 . . . . 0.0 109.925 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.533 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -54.29 173.73 0.21 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.301 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 35.8 Cg_endo -77.94 -32.22 2.7 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.018 1.812 . . . . 0.0 110.856 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -80.97 -33.42 33.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.193 -0.942 . . . . 0.0 109.987 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 4.8 tt0 -71.56 -42.67 67.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.097 -1.002 . . . . 0.0 109.658 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.832 HG21 ' CG ' ' A' ' 42' ' ' TYR . 28.6 m -68.65 -9.08 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.963 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.484 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -70.11 123.16 23.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.8 -14.67 59.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 56' ' ' GLN . 65.7 mmtt -79.51 127.45 32.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.266 -1.138 . . . . 0.0 109.18 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -67.53 128.01 34.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 108.659 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.757 ' CB ' HD11 ' A' ' 33' ' ' LEU . 78.2 t80 -62.21 -14.2 35.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 0.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.4 5.72 11.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.057 -1.027 . . . . 0.0 111.12 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 4.5 mttt -151.45 47.26 0.81 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.785 -1.197 . . . . 0.0 109.825 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER 163.56 -22.59 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.609 -0.682 . . . . 0.0 109.683 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.925 HG13 ' CD ' ' A' ' 52' ' ' ARG . 21.2 t -112.76 -28.66 2.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.22 -0.925 . . . . 0.0 108.505 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.496 ' HB1' HG23 ' A' ' 70' ' ' THR . . . -159.81 94.99 1.64 Allowed Pre-proline 0 C--N 1.293 -1.864 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.947 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.88 -18.53 16.84 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.856 1.704 . . . . 0.0 109.241 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.7 p -79.45 -20.35 47.64 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.532 -0.73 . . . . 0.0 109.376 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.496 HG23 ' HB1' ' A' ' 67' ' ' ALA . 47.7 p -80.94 5.82 15.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 110.032 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -89.28 52.58 2.41 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.937 -1.102 . . . . 0.0 108.402 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.48 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.8 p -125.39 -179.42 0.87 Allowed Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.99 -12.81 14.44 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 122.146 1.897 . . . . 0.0 111.593 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.6 OUTLIER -96.37 -26.68 15.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.835 -1.165 . . . . 0.0 109.746 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -100.59 -72.61 0.67 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.277 -0.89 . . . . 0.0 108.604 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 5.8 t80 -72.24 -18.91 61.79 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.032 -1.042 . . . . 0.0 109.045 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -64.44 -59.77 7.89 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.879 ' HB2' HG21 ' A' ' 90' ' ' THR . 2.0 mmtp -65.14 -14.58 60.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.633 -0.922 . . . . 0.0 109.983 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.885 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.5 t80 -84.95 -36.14 21.6 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.387 -0.821 . . . . 0.0 109.39 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -76.1 -12.32 60.09 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 108.84 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 25.2 pt-20 -97.27 -41.43 8.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.456 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -59.6 -39.52 95.21 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.461 -2.256 . . . . 0.0 107.461 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 79' ' ' PHE . 97.5 t -63.93 -44.79 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.91 -0.759 . . . . 0.0 110.113 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.58 4.39 51.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.181 -0.949 . . . . 0.0 110.729 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.3 t -106.21 -25.35 12.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.932 -1.105 . . . . 0.0 109.87 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.73 29.31 32.56 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -171.88 60.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -1.17 . . . . 0.0 109.212 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 5.3 tt -60.03 119.3 7.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.711 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.44 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 18.8 p-10 -160.34 85.1 0.72 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 109.254 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.879 HG21 ' HB2' ' A' ' 78' ' ' LYS . 3.5 t -134.36 149.48 50.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.031 -1.043 . . . . 0.0 109.99 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.6 ptp -140.33 166.07 25.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.426 -0.796 . . . . 0.0 108.987 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.079 ' CE1' HG21 ' A' ' 107' ' ' VAL . 20.4 p90 176.4 178.16 0.23 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.812 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -105.14 114.92 29.4 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.94 173.88 6.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.274 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.2 m -146.45 108.63 4.42 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.463 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 16.6 m-85 -81.1 120.88 25.39 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.131 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.78 47.23 2.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 108.75 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -79.02 72.83 5.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.068 -0.395 . . . . 0.0 111.274 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.5 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER 64.58 31.41 12.26 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.318 -0.864 . . . . 0.0 109.9 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.45 ' SD ' HG22 ' A' ' 101' ' ' THR . 0.0 OUTLIER -149.69 -177.82 6.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.236 -0.915 . . . . 0.0 108.844 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.451 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 0.5 OUTLIER -55.14 152.67 14.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 109.253 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.451 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 32.1 Cg_endo -73.45 82.72 1.6 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.716 1.61 . . . . 0.0 109.883 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.705 HG22 ' CG1' ' A' ' 105' ' ' VAL . 1.9 m -69.64 93.71 0.73 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.648 -0.658 . . . . 0.0 109.846 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.9 137.14 47.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.937 ' HA ' HG23 ' A' ' 125' ' ' VAL . 4.1 m -146.37 147.0 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.48 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.6 OUTLIER -76.85 150.75 36.05 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 173.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.079 HG21 ' CE1' ' A' ' 92' ' ' PHE . 30.2 m -137.77 149.28 25.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 119.945 -1.722 . . . . 0.0 109.366 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.554 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . 10.8 t-160 -160.2 101.87 1.41 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.774 ' HB3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -109.03 140.42 42.57 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.241 -178.308 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.636 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 9.7 tttt -135.23 -162.48 1.26 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.571 -1.331 . . . . 0.0 109.888 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -108.14 103.26 12.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.928 . . . . 0.0 108.83 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.885 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -51.07 147.71 5.03 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.599 -0.688 . . . . 0.0 110.443 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.3 -10.26 59.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.451 -0.781 . . . . 0.0 110.047 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.79 -24.64 3.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.098 -1.001 . . . . 0.0 109.713 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.74 100.04 0.52 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.3 p30 41.83 37.62 0.82 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.836 -0.802 . . . . 0.0 110.559 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.846 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -89.24 -177.49 5.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.886 . . . . 0.0 109.813 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.744 ' CE1' HG22 ' A' ' 83' ' ' VAL . 14.7 m-85 -152.0 116.39 5.03 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.885 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 14.6 p-90 -118.69 153.74 33.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.06 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.774 HG22 ' HB3' ' A' ' 109' ' ' MET . 24.0 t -127.5 112.6 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.652 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 12.5 m-30 -96.47 104.11 16.07 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -92.6 115.11 30.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.339 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -90.7 142.42 27.77 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.592 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.431 ' NH2' HD11 ' A' ' 49' ' ' ILE . 5.8 ttt180 -89.46 119.37 29.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.516 -1.365 . . . . 0.0 108.961 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.937 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.312 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 1.015 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ttt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.264 0.554 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.22 109.19 20.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.363 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -81.08 -70.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 109.575 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 4' ' ' VAL . 5.2 p 178.82 115.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.298 -0.876 . . . . 0.0 109.364 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.997 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 58.09 93.59 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.228 -0.92 . . . . 0.0 109.881 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' CE1' ' O ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER 48.62 -89.33 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.366 -0.834 . . . . 0.0 109.691 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . -148.16 53.06 0.53 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.997 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 1.0 OUTLIER -73.17 148.28 43.97 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.606 -0.937 . . . . 0.0 109.881 -178.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.72 67.93 9.69 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.313 -0.867 . . . . 0.0 110.247 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 49.25 75.39 0.15 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.986 -1.071 . . . . 0.0 108.179 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.13 HG22 HD11 ' A' ' 15' ' ' LEU . 4.5 mm -78.43 -59.67 2.85 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.517 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.406 ' HA ' HD12 ' A' ' 15' ' ' LEU . 7.8 pt-20 -40.95 -31.22 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.511 -0.743 . . . . 0.0 111.716 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.64 -40.23 16.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.802 -1.186 . . . . 0.0 108.577 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 14' ' ' THR . 6.5 m -71.32 -10.88 60.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.627 -0.671 . . . . 0.0 110.055 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.13 HD11 HG22 ' A' ' 11' ' ' ILE . 13.4 mt -96.7 -9.31 29.33 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.952 -1.093 . . . . 0.0 109.747 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.06 -34.89 12.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.041 -1.037 . . . . 0.0 109.134 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -121.06 76.91 1.26 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.782 ' CE ' HD22 ' A' ' 23' ' ' LEU . 3.5 ttp -130.38 179.2 6.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.301 -0.874 . . . . 0.0 110.24 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -142.95 -61.43 0.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 14.6 t70 175.31 104.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.63 23.57 6.19 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.466 ' CB ' ' HG3' ' A' ' 18' ' ' MET . 0.3 OUTLIER -108.67 -24.98 11.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.305 -1.115 . . . . 0.0 109.545 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.782 HD22 ' CE ' ' A' ' 18' ' ' MET . 2.0 pt? -116.89 -6.28 11.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.257 -0.902 . . . . 0.0 110.257 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -66.78 -11.3 54.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.829 -1.17 . . . . 0.0 109.936 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.75 28.07 15.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.045 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 18.8 mt -98.6 164.27 12.32 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.204 -1.174 . . . . 0.0 108.333 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.447 ' HB3' ' NZ ' ' A' ' 123' ' ' LYS . . . -94.42 19.35 9.75 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.045 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 2.7 p90 -152.89 179.2 8.87 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -107.69 125.8 8.08 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.744 ' HB3' HD12 ' A' ' 23' ' ' LEU . . . -96.06 96.88 9.16 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.027 -1.278 . . . . 0.0 108.465 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.634 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.4 pp -102.63 146.18 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.23 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.721 ' HB3' HD12 ' A' ' 40' ' ' LEU . 12.6 mt-30 -119.65 171.88 8.07 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 39' ' ' ILE . 72.0 mt -152.78 147.11 25.67 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 109.738 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.575 ' HB2' HD21 ' A' ' 40' ' ' LEU . 1.9 m-20 -119.05 136.49 54.11 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.358 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -9.01 71.06 0.0 OUTLIER Glycine 0 N--CA 1.51 3.629 0 C-N-CA 124.659 1.123 . . . . 0.0 113.428 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER 161.64 -24.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.632 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.03 17.53 24.92 Favored Glycine 0 N--CA 1.481 1.697 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 29.5 m120 -82.7 128.67 34.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -1.123 . . . . 0.0 108.426 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.747 HD13 ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -62.45 138.51 22.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 122.059 0.933 . . . . 0.0 111.568 -178.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.721 HD12 ' HB3' ' A' ' 32' ' ' GLN . 6.0 mt -105.0 -31.18 9.33 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -158.4 -176.33 5.84 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 1.6 t80 -161.11 -62.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.072 -1.018 . . . . 0.0 109.677 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' ' 45' ' ' ALA . 3.3 p-10 100.42 175.55 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.493 0 C-N-CA 123.666 0.786 . . . . 0.0 109.48 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.89 -15.68 22.27 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.004 -1.06 . . . . 0.0 111.983 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.59 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -57.9 -64.95 0.73 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.662 -1.274 . . . . 0.0 109.846 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 13.2 pt-20 -64.43 -43.29 94.79 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.219 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.435 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -60.11 -16.01 39.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -87.26 -28.53 22.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.723 -1.457 . . . . 0.0 109.673 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.431 HG13 ' HD3' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -82.22 -39.62 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.542 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.906 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -113.91 -0.31 14.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.833 -0.542 . . . . 0.0 110.627 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.81 -3.26 70.46 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.649 -1.263 . . . . 0.0 110.942 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.991 ' NH2' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -63.87 91.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.826 -1.397 . . . . 0.0 110.388 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.835 ' O ' HG22 ' A' ' 57' ' ' VAL . 14.5 m-20 -72.32 158.46 87.46 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.97 -42.04 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.85 1.7 . . . . 0.0 110.821 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.568 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -67.26 -27.55 67.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.992 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -84.87 -42.49 15.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.0 109.612 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 53' ' ' ASP . 34.7 m -78.42 -0.03 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.0 109.743 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.645 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -70.42 122.01 21.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.013 -1.054 . . . . 0.0 108.702 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.98 -19.72 52.65 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -80.06 137.42 36.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.276 -1.132 . . . . 0.0 108.894 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.504 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.7 OUTLIER -77.58 97.98 5.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.747 ' HB2' HD13 ' A' ' 39' ' ' ILE . 62.3 t80 -56.35 -18.29 10.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.665 -0.647 . . . . 0.0 110.337 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.453 ' CD1' ' CD1' ' A' ' 76' ' ' TYR . 3.0 m-85 -95.42 -30.87 13.66 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.065 -1.022 . . . . 0.0 110.458 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -139.15 42.1 2.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 110.027 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -157.34 -37.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.048 -1.033 . . . . 0.0 110.254 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.716 HG12 ' NH1' ' A' ' 52' ' ' ARG . 1.8 t -104.9 -58.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 122.902 1.335 . . . . 0.0 108.923 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.991 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . . . -106.56 100.99 33.56 Favored Pre-proline 0 C--N 1.289 -2.061 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.563 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.59 -4.04 14.7 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.845 1.696 . . . . 0.0 110.698 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.1 p -88.19 -24.75 23.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.959 -1.088 . . . . 0.0 109.332 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.481 HG21 ' CE2' ' A' ' 62' ' ' PHE . 2.2 p -76.58 -2.0 30.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.285 -0.885 . . . . 0.0 109.866 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.31 50.53 1.52 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.889 -1.132 . . . . 0.0 108.23 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.485 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -113.97 178.99 0.85 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -77.96 -14.44 15.34 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 122.072 1.848 . . . . 0.0 111.227 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 29.9 mt-10 -100.54 -22.8 14.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.782 -1.199 . . . . 0.0 109.545 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.519 ' CE1' ' HE3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -100.48 -73.45 0.64 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 9.2 t80 -70.35 -19.24 63.06 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.878 -1.139 . . . . 0.0 108.873 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.93 -59.75 8.66 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -63.56 -15.3 57.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.453 -1.028 . . . . 0.0 109.682 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.87 ' O ' HG23 ' A' ' 83' ' ' VAL . 13.1 t80 -81.88 -38.05 25.95 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.545 -0.722 . . . . 0.0 109.788 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -11.9 60.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.021 -1.05 . . . . 0.0 109.362 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 12.9 pt-20 -97.28 -41.73 8.13 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -61.32 -39.54 97.38 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 79' ' ' PHE . 85.1 t -63.52 -41.57 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.862 -0.787 . . . . 0.0 110.009 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.2 4.78 53.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.246 -0.909 . . . . 0.0 111.036 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.4 p -106.11 -26.74 11.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.89 -1.131 . . . . 0.0 110.131 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.09 23.52 37.73 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -171.39 87.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -1.125 . . . . 0.0 109.036 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 79' ' ' PHE . 1.9 tt -84.36 123.09 29.81 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.306 -0.872 . . . . 0.0 109.787 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 4.9 p-10 -160.56 81.78 0.67 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.235 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -121.85 154.34 37.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.118 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -148.02 139.26 23.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.788 . . . . 0.0 109.04 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.067 ' CE2' HG21 ' A' ' 107' ' ' VAL . 8.9 p90 -162.83 -174.92 4.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.053 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -112.91 108.76 17.82 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.65 -179.48 3.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.35 -0.844 . . . . 0.0 110.083 -178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.7 m -149.47 108.51 3.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.521 -0.737 . . . . 0.0 109.062 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.845 ' CE2' HG21 ' A' ' 122' ' ' VAL . 13.8 m-30 -81.09 92.28 6.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.351 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -105.67 24.24 12.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.251 -0.906 . . . . 0.0 109.637 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.554 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.69 155.72 29.32 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.508 ' HG3' ' CD2' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 0.28 65.72 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 CA-C-O 121.549 0.69 . . . . 0.0 112.317 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER 175.66 164.78 0.34 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.427 -0.796 . . . . 0.0 109.126 -178.127 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.545 HG22 ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -57.75 175.66 0.27 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.302 -0.874 . . . . 0.0 108.883 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.545 ' HD2' HG22 ' A' ' 101' ' ' THR . 34.6 Cg_endo -76.6 107.64 2.49 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.846 1.697 . . . . 0.0 109.801 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.439 HG22 HG13 ' A' ' 105' ' ' VAL . 4.2 m -109.38 122.54 47.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.807 . . . . 0.0 110.365 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -102.59 145.06 30.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.981 ' HA ' HG23 ' A' ' 125' ' ' VAL . 22.7 m -152.01 145.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.654 -1.279 . . . . 0.0 111.859 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.9 ' HD2' HG22 ' A' ' 125' ' ' VAL . 7.5 mptt -77.44 117.13 18.61 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 102.876 -3.009 . . . . 0.0 102.876 174.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.067 HG21 ' CE2' ' A' ' 92' ' ' PHE . 35.7 m -102.31 151.14 5.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 117.898 -1.521 . . . . 0.0 109.767 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.475 ' ND1' ' HA ' ' A' ' 5' ' ' ALA . 2.2 t-160 -154.9 103.68 2.43 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.8 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -105.66 139.16 40.68 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.457 -0.777 . . . . 0.0 109.335 -178.344 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.606 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.9 ttmt -137.57 -157.77 0.8 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.562 -1.336 . . . . 0.0 109.476 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -105.37 137.87 42.47 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 108.994 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.909 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -98.89 -179.07 4.16 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 110.058 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 116' ' ' ASP . 1.0 OUTLIER 58.85 25.57 13.76 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.3 m 61.41 39.49 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.475 -0.766 . . . . 0.0 109.171 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.18 74.19 0.94 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.429 ' CB ' ' HB3' ' A' ' 113' ' ' LEU . 1.6 t0 -176.7 -65.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -1.14 . . . . 0.0 109.389 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.899 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -78.05 -163.64 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.762 ' OH ' HG13 ' A' ' 83' ' ' VAL . 12.3 m-85 -147.64 123.08 10.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.261 -0.899 . . . . 0.0 108.739 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.909 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 18.6 p-90 -127.14 146.32 50.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 118.386 -1.326 . . . . 0.0 112.833 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.8 HG13 ' HG2' ' A' ' 109' ' ' MET . 58.9 t -118.58 110.36 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.636 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.662 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 12.4 m-30 -95.44 133.53 39.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.984 -1.073 . . . . 0.0 108.406 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.845 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.5 t -116.01 113.57 43.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 C-N-CA 119.054 -1.059 . . . . 0.0 109.532 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 5.2 tptp -90.02 131.13 36.07 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.431 ' HD3' HG13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -80.21 123.93 28.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.53 -1.356 . . . . 0.0 109.561 -178.676 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.981 HG23 ' HA ' ' A' ' 105' ' ' VAL . 5.3 t . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.612 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.906 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.78 148.56 29.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -82.67 123.2 29.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.798 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.876 HG21 ' HA ' ' A' ' 10' ' ' ASP . 11.2 p -177.47 121.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.353 -0.842 . . . . 0.0 109.246 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.564 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 62.3 -89.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.811 . . . . 0.0 109.445 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.58 ' CD1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -176.03 45.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.37 35.41 2.68 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.958 ' CB ' HD11 ' A' ' 11' ' ' ILE . 13.1 m -104.69 -166.67 1.26 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.73 -0.865 . . . . 0.0 111.142 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -115.88 64.68 0.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.804 -0.56 . . . . 0.0 110.342 -178.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.876 ' HA ' HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER 52.7 90.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.499 -1.376 . . . . 0.0 107.947 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.041 HG22 HD11 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -79.63 -69.2 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.973 -1.079 . . . . 0.0 110.513 -177.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -44.73 -25.79 0.32 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 111.134 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.434 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -75.4 -49.21 19.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.036 -1.04 . . . . 0.0 109.501 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 18' ' ' MET . 1.0 OUTLIER -70.15 -61.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.092 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.041 HD11 HG22 ' A' ' 11' ' ' ILE . 72.6 mt -37.27 -32.42 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.363 0.601 . . . . 0.0 110.676 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.98 -61.33 1.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 110.165 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 68.52 1.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 0.0 109.974 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.505 ' HG3' ' CB ' ' A' ' 22' ' ' GLN . 34.6 ttp -129.63 152.27 49.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -0.886 . . . . 0.0 109.132 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -92.59 -69.92 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.623 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 21.8 p-10 177.62 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -0.817 . . . . 0.0 108.905 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.01 21.54 5.93 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.505 ' CB ' ' HG3' ' A' ' 18' ' ' MET . 0.1 OUTLIER -108.13 -19.29 13.54 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.312 -1.111 . . . . 0.0 109.651 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -109.82 14.02 23.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.141 -0.975 . . . . 0.0 110.225 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.38 -3.21 58.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.966 -1.084 . . . . 0.0 110.208 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.14 34.77 5.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.84 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 7.3 mt -110.41 158.93 17.94 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.408 -1.054 . . . . 0.0 109.282 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.94 6.93 33.37 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.45 0.643 . . . . 0.0 109.349 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.84 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 26.3 p90 -134.04 -169.67 2.36 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.273 -0.892 . . . . 0.0 108.868 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -118.3 149.57 18.34 Favored Glycine 0 C--N 1.297 -1.595 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -126.14 84.8 2.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.754 -1.439 . . . . 0.0 107.936 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.643 HG22 ' CD1' ' A' ' 42' ' ' TYR . 1.3 pp -91.71 149.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.168 0.985 . . . . 0.0 110.862 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.557 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 3.2 mm100 -115.23 162.43 17.08 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.611 HD22 ' C ' ' A' ' 37' ' ' GLY . 21.7 mt -150.09 146.08 26.72 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.404 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.544 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -99.28 173.62 6.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -40.06 -57.08 2.59 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 121.619 -0.324 . . . . 0.0 113.001 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.83 -17.64 61.65 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.63 -1.512 . . . . 0.0 110.337 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.611 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 102.42 28.73 6.26 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 22.6 m-80 -84.74 136.68 33.61 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.442 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' A' ' 31' ' ' ILE . 3.0 tp -63.73 135.85 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.762 -1.211 . . . . 0.0 111.387 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -110.06 -28.49 8.67 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.303 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.557 ' HB2' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.76 153.02 22.11 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.144 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.643 ' CD1' HG22 ' A' ' 31' ' ' ILE . 17.5 t80 -134.76 -66.68 0.58 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.169 -1.582 . . . . 0.0 111.414 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.3 p-10 102.39 174.79 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.657 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.09 -23.97 15.98 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.8 -1.188 . . . . 0.0 112.898 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.68 -62.43 1.65 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.464 -1.398 . . . . 0.0 110.741 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.1 pt-20 -58.72 -55.25 37.53 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.675 0.75 . . . . 0.0 109.64 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.413 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -56.79 -15.22 11.89 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.015 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -40.61 61.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.783 -1.422 . . . . 0.0 108.799 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -84.74 -56.89 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.414 -0.804 . . . . 0.0 109.235 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.55 ' N ' HG22 ' A' ' 49' ' ' ILE . 18.9 p -72.71 -24.66 61.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.509 -0.744 . . . . 0.0 109.916 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 94.37 -19.22 54.65 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.914 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -43.9 97.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.608 -0.936 . . . . 0.0 110.626 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.67 ' O ' HG13 ' A' ' 57' ' ' VAL . 42.4 m-20 -69.51 158.29 87.28 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.16 -61.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.942 1.762 . . . . 0.0 110.829 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -62.52 -18.13 61.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.215 -0.928 . . . . 0.0 110.151 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -86.87 -41.37 14.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.016 -1.053 . . . . 0.0 109.528 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 53' ' ' ASP . 22.4 m -79.61 2.01 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.831 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.24 121.05 20.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 120.979 -1.075 . . . . 0.0 109.034 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.31 -13.68 64.5 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 16.7 mmtp -78.89 139.8 38.23 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.084 -1.245 . . . . 0.0 109.066 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 65' ' ' ASP . 1.0 OUTLIER -80.95 96.52 7.1 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.947 ' CZ ' HG21 ' A' ' 70' ' ' THR . 16.7 t80 -55.06 -34.46 63.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.024 -1.048 . . . . 0.0 109.722 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.605 ' HD2' HD13 ' A' ' 33' ' ' LEU . 2.5 m-85 -80.42 -23.34 40.39 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.251 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -148.1 49.07 1.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.983 -1.073 . . . . 0.0 109.631 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ASN . 8.8 t0 -174.54 -29.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 111.047 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.914 HG11 ' HD3' ' A' ' 52' ' ' ARG . 13.5 t -106.08 -58.41 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.617 -1.302 . . . . 0.0 109.004 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.635 ' HB3' ' OG1' ' A' ' 70' ' ' THR . . . -99.01 106.65 39.35 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 114.618 -1.173 . . . . 0.0 109.861 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -77.36 1.41 8.79 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 C-N-CA 121.614 1.543 . . . . 0.0 109.896 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.4 p -107.03 -19.58 13.58 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 121.216 -0.927 . . . . 0.0 109.778 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.947 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 11.0 p -85.93 9.57 16.52 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.124 -0.985 . . . . 0.0 110.133 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -106.54 59.9 0.64 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.118 -0.989 . . . . 0.0 108.956 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.473 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -144.3 176.26 2.35 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.352 -0.843 . . . . 0.0 109.675 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 33.6 Cg_endo -76.71 78.64 3.29 Favored 'Trans proline' 0 C--N 1.323 -0.763 0 C-N-CA 122.375 2.05 . . . . 0.0 110.415 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 171.54 -37.86 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.6 t80 -105.38 -67.68 0.9 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.479 ' CD1' ' CD1' ' A' ' 63' ' ' PHE . 9.3 t80 -73.22 -18.12 61.27 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.1 -63.66 4.21 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.528 ' HB2' HG21 ' A' ' 90' ' ' THR . 10.8 mmtt -61.09 -17.54 53.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -1.047 . . . . 0.0 109.864 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.865 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.3 t80 -82.22 -38.24 24.82 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.484 -0.76 . . . . 0.0 109.53 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -13.29 60.37 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 109.382 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -98.05 -36.46 10.1 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.639 -1.225 . . . . 0.0 108.151 178.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.66 -39.33 96.63 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.3 t -63.21 -51.87 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.958 -0.731 . . . . 0.0 109.928 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.18 -2.88 46.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -0.922 . . . . 0.0 110.793 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.8 t -96.34 -29.94 13.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.131 . . . . 0.0 109.629 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.06 15.05 46.52 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -165.87 86.87 0.36 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.118 -1.225 . . . . 0.0 109.131 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -76.98 122.93 25.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.472 -0.768 . . . . 0.0 110.088 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -160.97 82.4 0.64 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.528 HG21 ' HB2' ' A' ' 78' ' ' LYS . 8.7 t -127.48 169.5 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 111.212 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 107' ' ' VAL . 1.8 ttm -159.77 149.23 18.08 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.109 ' CE1' HG21 ' A' ' 107' ' ' VAL . 18.7 p90 -172.42 165.55 5.75 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -96.82 105.77 17.96 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.56 -177.32 3.33 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.817 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 103' ' ' THR . 92.9 m -151.02 108.51 3.63 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.825 ' CE2' HG21 ' A' ' 122' ' ' VAL . 18.7 m-30 -84.06 114.91 22.08 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 109.703 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -139.61 42.29 2.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.665 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.537 ' O ' ' C ' ' A' ' 99' ' ' GLN . 10.1 p90 -78.69 148.06 33.26 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.537 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.0 tt0 1.89 67.95 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 121.781 0.8 . . . . 0.0 111.482 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.9 ttp 177.29 -159.1 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 109.386 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.477 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 2.3 t -85.37 153.61 59.14 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.5 Cg_endo -75.74 141.18 24.28 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.713 1.609 . . . . 0.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.446 HG22 HG13 ' A' ' 105' ' ' VAL . 1.8 m -140.08 140.17 36.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.336 -0.852 . . . . 0.0 109.605 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -111.18 141.6 44.47 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.801 ' HA ' HG23 ' A' ' 125' ' ' VAL . 24.5 m -149.68 144.05 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.921 -1.112 . . . . 0.0 110.681 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.504 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -86.42 102.31 13.94 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 175.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.109 HG21 ' CE1' ' A' ' 92' ' ' PHE . 18.1 m -85.55 156.91 3.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 110.885 -175.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.405 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 2.2 t-160 -160.36 106.88 1.54 Allowed 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.807 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.92 149.49 35.11 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.477 -0.764 . . . . 0.0 109.606 -177.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.578 ' HB3' ' CZ2' ' A' ' 119' ' ' TRP . 9.5 ttpt -144.34 170.64 15.62 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.474 -1.391 . . . . 0.0 109.213 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.456 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 11.0 tttt -80.11 104.18 10.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.771 -1.206 . . . . 0.0 108.787 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.837 ' HB3' ' HB3' ' A' ' 117' ' ' SER . . . -52.09 155.51 1.88 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 109.652 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.85 14.14 32.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.987 . . . . 0.0 110.119 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -24.85 63.67 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.092 -1.005 . . . . 0.0 109.081 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 150.78 68.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 61.19 62.32 1.41 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -1.17 . . . . 0.0 109.239 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.837 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -116.99 -169.61 1.68 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.179 -0.95 . . . . 0.0 109.836 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.844 ' CE1' HG22 ' A' ' 83' ' ' VAL . 12.6 m-85 -153.47 108.36 3.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.301 -0.874 . . . . 0.0 109.06 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.736 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.2 p-90 -108.22 142.09 39.01 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.695 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.807 HG13 ' HG2' ' A' ' 109' ' ' MET . 96.1 t -117.41 118.69 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.651 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 16.0 m-30 -101.86 121.93 43.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.146 -0.971 . . . . 0.0 109.349 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.825 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.7 t -109.66 116.05 51.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.249 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.58 ' HD3' ' CD1' ' A' ' 6' ' ' PHE . 6.8 tttm -101.87 133.99 45.76 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.405 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.51 ' HA ' HG12 ' A' ' 105' ' ' VAL . 8.1 ttp85 -73.54 117.89 15.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.983 -1.073 . . . . 0.0 109.65 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.801 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.205 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.539 " C6'" ' CE2' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.292 0.568 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -175.4 171.16 2.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.434 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 61.65 97.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 109.207 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 5' ' ' ALA . 60.0 t -75.2 160.08 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.204 -0.935 . . . . 0.0 109.61 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.681 ' HB3' ' HA ' ' A' ' 8' ' ' SER . . . -95.33 129.85 42.32 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.622 -0.674 . . . . 0.0 109.55 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.547 ' CZ ' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -60.85 -59.13 5.87 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.4 -1.32 . . . . 0.0 107.531 178.495 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.61 -27.41 34.6 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.681 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 45.96 -161.48 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.88 0.848 . . . . 0.0 111.565 177.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -69.81 77.29 0.46 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.271 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 9' ' ' GLU . 1.8 m-20 37.43 84.69 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.457 -0.777 . . . . 0.0 109.702 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.069 HG22 HD11 ' A' ' 15' ' ' LEU . 2.4 mm -65.39 -67.58 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.212 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HA ' HD12 ' A' ' 15' ' ' LEU . 3.3 pt-20 -37.55 -30.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.032 0.444 . . . . 0.0 111.656 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' ILE . 20.3 t-20 -76.19 -50.36 14.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.022 -1.049 . . . . 0.0 108.673 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 m -67.36 -14.91 63.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.548 -0.72 . . . . 0.0 109.811 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.069 HD11 HG22 ' A' ' 11' ' ' ILE . 11.4 mt -96.68 -26.49 15.17 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.094 -1.004 . . . . 0.0 109.168 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.89 -10.76 27.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.307 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.62 60.49 1.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.865 -1.147 . . . . 0.0 110.212 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.483 ' CE ' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -149.21 157.26 43.21 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 18' ' ' MET . 49.1 t0 -88.61 -59.61 2.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.87 106.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.154 -0.966 . . . . 0.0 109.124 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.5 22.87 5.63 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.86 -21.38 12.86 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.329 -1.101 . . . . 0.0 109.562 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 43' ' ' ASN . 0.7 OUTLIER -110.08 21.14 17.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 110.116 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -88.8 -3.23 58.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.055 . . . . 0.0 110.33 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.77 35.1 5.08 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 mt -114.74 134.68 54.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.403 -1.057 . . . . 0.0 109.458 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.86 -6.55 27.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.385 0.612 . . . . 0.0 109.792 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.709 ' HE2' HD12 ' A' ' 11' ' ' ILE . 7.6 p90 -124.01 114.37 19.66 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.027 -1.046 . . . . 0.0 108.324 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -51.94 158.29 3.05 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' N ' ' OE2' ' A' ' 46' ' ' GLU . . . -139.44 99.52 3.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.066 -1.255 . . . . 0.0 107.973 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.622 HD12 ' N ' ' A' ' 32' ' ' GLN . 0.7 OUTLIER -99.41 172.36 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.884 0.849 . . . . 0.0 110.511 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.71 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -141.61 164.93 28.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 38' ' ' ASN . 28.0 mt -148.32 154.18 39.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.904 -1.122 . . . . 0.0 109.893 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.541 ' N ' HD21 ' A' ' 40' ' ' LEU . 1.3 p30 -116.33 128.83 55.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 108.892 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -15.9 76.53 0.0 OUTLIER Glycine 0 N--CA 1.508 3.486 0 C-N-CA 124.505 1.05 . . . . 0.0 112.951 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.8 OUTLIER 162.58 -23.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 101.06 17.93 21.3 Favored Glycine 0 N--CA 1.48 1.589 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.783 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -86.16 152.17 23.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.016 -1.285 . . . . 0.0 107.787 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' ' 57' ' ' VAL . 2.1 tp -79.52 144.91 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.829 -1.169 . . . . 0.0 113.034 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.714 HD11 ' O ' ' A' ' 33' ' ' LEU . 2.0 mt -113.11 -33.85 5.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 174.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 35.3 tp60 -169.02 158.75 8.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.588 -0.695 . . . . 0.0 110.227 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.578 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 13.2 t80 -135.75 -54.33 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.375 -0.828 . . . . 0.0 110.128 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.587 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.8 OUTLIER 95.72 177.59 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 C-N-CA 123.02 0.528 . . . . 0.0 109.641 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.12 -22.5 17.27 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.996 -1.065 . . . . 0.0 113.039 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -57.0 -68.53 0.21 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.428 -1.42 . . . . 0.0 110.012 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.578 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 6.2 pt-20 -63.07 -42.79 99.75 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.749 0.785 . . . . 0.0 109.593 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 52' ' ' ARG . . . -60.78 -17.91 51.45 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -83.68 -29.86 27.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.245 . . . . 0.0 108.423 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.83 HG22 HG23 ' A' ' 50' ' ' THR . 0.3 OUTLIER -73.65 -57.48 6.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.619 -0.676 . . . . 0.0 109.287 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.83 HG23 HG22 ' A' ' 49' ' ' ILE . 15.6 p -89.84 -8.01 52.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.15 -0.969 . . . . 0.0 110.191 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 89.59 -8.1 80.51 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.599 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -53.58 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.315 -1.109 . . . . 0.0 109.809 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.798 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -68.9 162.75 62.08 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.17 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.27 -57.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.839 1.693 . . . . 0.0 111.124 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -18.51 65.4 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.915 -1.116 . . . . 0.0 110.206 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 -31.64 16.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 109.642 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 53' ' ' ASP . 34.5 m -86.7 10.91 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.043 -1.036 . . . . 0.0 109.499 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.485 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -86.87 121.78 38.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 108.487 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.76 -18.56 54.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HD2' ' CG2' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -78.19 167.84 20.77 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.924 -1.339 . . . . 0.0 109.898 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -106.19 103.65 13.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.77 ' CZ ' HG21 ' A' ' 70' ' ' THR . 3.1 t80 -50.27 -42.74 52.67 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.521 -0.737 . . . . 0.0 112.245 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.536 ' CG ' ' CD1' ' A' ' 76' ' ' TYR . 36.5 m-85 -89.74 1.9 55.52 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.678 -1.264 . . . . 0.0 112.799 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 4.5 tmtm? -154.32 52.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.62 -1.3 . . . . 0.0 110.495 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 169.93 -15.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.163 -0.96 . . . . 0.0 111.641 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.599 HG11 ' HD3' ' A' ' 52' ' ' ARG . 1.4 t -120.17 -57.79 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 122.916 1.341 . . . . 0.0 109.582 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -111.15 101.36 50.07 Favored Pre-proline 0 C--N 1.288 -2.075 0 CA-C-N 114.183 -1.372 . . . . 0.0 109.134 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -72.97 -4.87 16.18 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 122.163 1.909 . . . . 0.0 112.34 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 23.9 p -105.72 -18.53 14.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.727 -1.233 . . . . 0.0 109.57 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.77 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 35.5 p -74.04 -5.35 40.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.996 -1.065 . . . . 0.0 109.486 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -93.28 52.11 1.73 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 108.718 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.495 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -117.04 -178.78 0.56 Allowed Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 36.1 Cg_endo -78.34 -12.54 15.57 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.147 1.898 . . . . 0.0 111.564 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 2.2 mt-10 -100.73 -24.98 14.29 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.867 -1.145 . . . . 0.0 109.618 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.2 t80 -101.31 -70.82 0.73 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 108.702 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CD1' ' CG ' ' A' ' 63' ' ' PHE . 6.0 t80 -72.93 -18.24 61.41 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.981 -1.074 . . . . 0.0 108.672 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.52 -60.89 6.48 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.826 ' CB ' HG21 ' A' ' 90' ' ' THR . 7.9 mmtt -65.58 -15.22 62.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.938 . . . . 0.0 109.824 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.838 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.8 t80 -83.14 -35.76 25.3 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -8.93 58.91 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -96.51 -42.35 8.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.551 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -64.2 -39.49 97.14 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.865 HG22 ' CE1' ' A' ' 118' ' ' TYR . 63.3 t -67.14 -39.62 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.938 -0.743 . . . . 0.0 110.148 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.72 -7.28 59.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.172 -0.955 . . . . 0.0 110.856 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.5 -18.16 13.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.799 -1.188 . . . . 0.0 110.002 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.38 19.68 71.09 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -152.69 57.82 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.247 . . . . 0.0 109.538 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.761 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -58.66 120.36 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 109.94 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -160.68 88.78 0.79 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.301 -0.875 . . . . 0.0 108.878 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.826 HG21 ' CB ' ' A' ' 78' ' ' LYS . 9.7 t -157.42 158.81 36.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.899 -1.126 . . . . 0.0 110.379 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.9 173.58 11.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 0.0 108.857 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.001 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 7.2 p90 -179.07 152.11 0.54 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.125 -0.984 . . . . 0.0 109.81 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.19 111.38 18.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 109.046 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.425 ' OH ' ' HB2' ' A' ' 72' ' ' SER . 0.1 OUTLIER -112.57 -178.66 3.46 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.206 -0.934 . . . . 0.0 109.646 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.3 m -151.9 108.74 3.5 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.382 -0.824 . . . . 0.0 109.834 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.48 ' CD1' ' H2 ' ' A' ' 126' ' ' HC4 . 15.8 m-30 -81.24 118.7 22.82 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -152.3 48.76 0.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.878 -1.139 . . . . 0.0 110.987 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 22.1 p90 -78.31 139.03 38.86 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 98' ' ' TYR . 7.2 pt20 0.68 68.11 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.268 0 CA-C-O 121.847 0.832 . . . . 0.0 111.937 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 98' ' ' TYR . 20.1 ttp -176.71 174.65 1.79 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 4.9 t -52.71 148.17 13.69 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.048 . . . . 0.0 109.044 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.9 Cg_endo -75.88 146.41 29.6 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.96 1.773 . . . . 0.0 110.994 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.449 HG22 HG13 ' A' ' 105' ' ' VAL . 6.8 m -140.25 123.39 16.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.775 . . . . 0.0 109.264 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -102.83 140.28 37.31 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.848 ' HA ' HG23 ' A' ' 125' ' ' VAL . 14.0 m -151.99 143.4 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.905 -1.122 . . . . 0.0 110.697 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -92.35 116.82 29.31 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 176.04 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.001 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -91.39 164.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 120.966 -1.084 . . . . 0.0 110.086 -176.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.438 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 0.8 OUTLIER -159.94 102.36 1.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.467 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.885 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -116.14 147.53 41.27 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.095 -1.003 . . . . 0.0 110.239 -177.231 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.622 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 11.9 ttmt -144.4 179.66 7.12 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.593 -1.317 . . . . 0.0 109.434 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.16 106.91 18.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.04 -1.037 . . . . 0.0 109.248 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.776 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -55.88 137.44 50.34 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.515 -0.741 . . . . 0.0 109.569 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.91 23.19 7.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.809 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.7 m -87.82 -24.06 23.85 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.125 -0.985 . . . . 0.0 109.359 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 177.13 39.85 0.06 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.2 t0 62.7 63.37 0.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -1.121 . . . . 0.0 109.38 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.73 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 10.0 m -114.57 -159.16 0.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.998 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.865 ' CE1' HG22 ' A' ' 83' ' ' VAL . 28.4 m-85 -149.28 103.0 3.27 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.776 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 11.5 p-90 -103.77 148.03 26.57 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.455 -1.298 . . . . 0.0 112.078 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.885 HG13 ' CG ' ' A' ' 109' ' ' MET . 19.3 t -130.48 107.36 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.618 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.667 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 5.1 m-30 -91.53 123.9 35.3 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.294 -0.879 . . . . 0.0 109.609 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.611 HG13 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -105.27 116.8 49.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.019 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 1.9 tttm -94.96 107.8 19.85 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.532 ' HA ' HG12 ' A' ' 105' ' ' VAL . 18.2 ttp180 -57.47 128.33 36.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.896 -1.127 . . . . 0.0 109.646 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.848 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.248 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.521 " O4'" ' OH ' ' A' ' 42' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 64.81 -178.47 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.7 27.23 0.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.805 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.65 HG22 ' H ' ' A' ' 5' ' ' ALA . 2.7 p -91.17 -177.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.043 -1.036 . . . . 0.0 109.114 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.926 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . -58.1 -161.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.444 -0.785 . . . . 0.0 109.412 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -38.98 -67.23 0.22 Allowed 'General case' 0 N--CA 1.518 2.941 0 CA-C-O 122.205 1.003 . . . . 0.0 109.019 179.344 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.16 28.21 1.24 Allowed Glycine 0 C--N 1.295 -1.739 0 N-CA-C 106.659 -2.576 . . . . 0.0 106.659 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.926 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 2.1 m -65.8 126.12 27.48 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.884 -0.774 . . . . 0.0 109.739 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -70.71 83.22 0.62 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.568 -0.707 . . . . 0.0 110.969 -178.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 9' ' ' GLU . 4.7 p-10 37.55 79.39 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.685 -0.635 . . . . 0.0 109.539 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.963 HG22 HD11 ' A' ' 15' ' ' LEU . 4.9 mm -79.22 -57.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.775 -177.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.559 ' HA ' HD12 ' A' ' 15' ' ' LEU . 21.4 tt0 -39.36 -29.75 0.05 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.459 -0.776 . . . . 0.0 111.738 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' ILE . 7.6 m120 -90.59 -40.01 12.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.908 -1.12 . . . . 0.0 108.226 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.99 HG21 HD12 ' A' ' 23' ' ' LEU . 4.2 m -69.11 -9.91 55.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.601 -0.687 . . . . 0.0 109.68 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.963 HD11 HG22 ' A' ' 11' ' ' ILE . 12.4 mt -96.6 -28.01 14.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.012 -1.055 . . . . 0.0 108.787 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.87 2.1 56.75 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.627 -0.671 . . . . 0.0 109.636 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.14 -48.91 0.45 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.936 -1.102 . . . . 0.0 110.167 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.574 ' HE2' ' HA ' ' A' ' 15' ' ' LEU . 20.4 mmt 59.08 168.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.008 -1.058 . . . . 0.0 108.327 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 18' ' ' MET . 0.1 OUTLIER 172.04 -57.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.754 -1.216 . . . . 0.0 111.131 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -87.68 64.77 8.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.009 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.76 20.48 70.9 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.418 ' HG2' ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER 56.42 29.14 14.71 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.387 -1.067 . . . . 0.0 109.204 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.99 HD12 HG21 ' A' ' 14' ' ' THR . 2.6 mt 45.47 50.14 10.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.573 -0.705 . . . . 0.0 110.236 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -75.32 -17.62 60.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 109.976 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.41 18.52 51.85 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.885 HD21 HD13 ' A' ' 23' ' ' LEU . 16.8 mt -54.97 123.36 13.26 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.291 -1.123 . . . . 0.0 109.796 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.01 -18.81 3.91 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.769 0.795 . . . . 0.0 109.075 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.817 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 17.2 p90 -126.25 148.02 49.57 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.232 -0.918 . . . . 0.0 109.016 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.528 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -76.84 144.03 29.6 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.521 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -115.91 92.07 3.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.905 -1.35 . . . . 0.0 108.331 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.564 HG22 ' CE1' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -96.32 150.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 -178.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.657 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.0 161.16 31.58 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.377 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.777 ' O ' HD11 ' A' ' 40' ' ' LEU . 23.3 mt -148.18 155.47 41.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.011 -1.056 . . . . 0.0 109.276 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.654 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -123.45 138.9 54.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.0 109.411 178.488 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -5.31 67.95 0.0 OUTLIER Glycine 0 N--CA 1.514 3.87 0 C-N-CA 124.834 1.207 . . . . 0.0 113.364 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 161.25 -23.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 97.98 18.91 25.71 Favored Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 8.2 p30 -84.39 129.96 34.82 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.217 -1.167 . . . . 0.0 108.831 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.518 HG21 ' HA ' ' A' ' 58' ' ' ILE . 1.9 tp -54.5 138.12 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 122.202 1.001 . . . . 0.0 112.998 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.777 HD11 ' O ' ' A' ' 33' ' ' LEU . 3.5 mt -111.35 -31.08 7.17 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 1.1 tp-100 -167.39 168.81 12.83 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.564 ' CE1' HG22 ' A' ' 31' ' ' ILE . 14.9 t80 -146.09 -70.65 0.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.073 -1.017 . . . . 0.0 111.16 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.3 p-10 109.45 178.83 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.858 0 C-N-CA 123.931 0.892 . . . . 0.0 108.749 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.4 -26.55 14.82 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.005 -1.059 . . . . 0.0 113.281 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.78 -65.11 0.61 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.316 -1.49 . . . . 0.0 110.707 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 2.0 pt-20 -58.79 -53.76 54.7 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.387 0.613 . . . . 0.0 110.071 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.85 -15.75 14.41 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.095 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.47 -37.42 36.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.775 -1.427 . . . . 0.0 108.98 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.617 HG22 HG23 ' A' ' 50' ' ' THR . 1.0 OUTLIER -79.52 -55.18 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 108.886 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.871 HG21 " C3'" ' A' ' 126' ' ' HC4 . 59.2 p -76.98 -20.45 56.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.67 -0.644 . . . . 0.0 110.115 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.46 -2.33 78.22 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.635 HH11 HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -46.54 -47.14 19.64 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.367 -1.078 . . . . 0.0 111.481 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.518 ' O ' HG13 ' A' ' 57' ' ' VAL . 0.3 OUTLIER 67.88 147.14 0.11 Allowed Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -178.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.464 ' HA ' HG22 ' A' ' 57' ' ' VAL . 35.3 Cg_endo -76.76 -36.57 1.51 Allowed 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.128 1.885 . . . . 0.0 111.647 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -26.83 62.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.56 -40.52 19.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 109.523 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.635 HG11 HH11 ' A' ' 52' ' ' ARG . 27.6 m -73.04 -6.62 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 110.006 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.518 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -70.63 119.56 17.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.081 -1.012 . . . . 0.0 108.386 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.68 -20.95 48.47 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -79.61 145.89 32.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.543 -0.974 . . . . 0.0 108.674 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -89.85 122.21 32.69 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 108.967 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.574 ' HB2' HD21 ' A' ' 33' ' ' LEU . 79.4 t80 -60.02 -18.12 43.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.038 -1.039 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.462 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 35.9 m-85 -118.19 32.06 6.34 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.035 -1.041 . . . . 0.0 109.611 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.42 -53.6 0.1 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.013 -1.055 . . . . 0.0 110.954 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.32 16.4 9.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.846 -1.159 . . . . 0.0 111.778 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.577 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 41.0 t -118.88 -56.31 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.388 -1.445 . . . . 0.0 108.5 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.507 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -118.19 99.07 51.8 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.66 0.71 7.81 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.926 1.751 . . . . 0.0 111.062 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 p -103.31 -25.95 13.12 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.031 -1.043 . . . . 0.0 109.403 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.462 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 59.9 p -71.69 -7.16 46.25 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.381 -0.824 . . . . 0.0 110.096 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -84.81 72.53 10.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 108.984 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.433 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -160.6 172.61 5.67 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.96 . . . . 0.0 109.643 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 36.1 Cg_endo -77.92 77.42 3.93 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.358 2.039 . . . . 0.0 110.304 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER 172.36 -36.85 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.684 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.9 t80 -104.14 -65.9 0.99 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.416 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 8.3 t80 -75.55 -20.3 58.74 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -62.82 -60.67 7.37 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.495 ' CB ' HG21 ' A' ' 90' ' ' THR . 4.4 mmtp -64.87 -17.54 64.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.424 -1.045 . . . . 0.0 109.953 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.83 ' O ' HG23 ' A' ' 83' ' ' VAL . 4.2 t80 -79.35 -36.29 39.61 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -6.9 56.8 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.35 -0.844 . . . . 0.0 108.741 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.1 mm-40 -96.14 -42.63 8.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.47 -40.59 86.5 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.849 HG22 ' CE1' ' A' ' 118' ' ' TYR . 79.3 t -62.32 -38.58 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.619 -0.93 . . . . 0.0 109.386 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.17 -5.5 56.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 110.716 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 8.6 t -98.2 -21.91 16.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.772 -1.205 . . . . 0.0 109.788 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.79 25.51 45.58 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -169.85 70.66 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.332 -1.099 . . . . 0.0 108.935 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -69.76 117.66 11.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.088 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -161.59 82.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.498 HG23 ' SD ' ' A' ' 109' ' ' MET . 3.8 t -140.72 172.18 13.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.028 -1.045 . . . . 0.0 110.487 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 3.2 ptt? -152.69 171.03 18.83 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.944 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 14.8 p90 179.73 152.32 0.43 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.001 -1.062 . . . . 0.0 109.929 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -78.88 116.26 19.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.135 -0.978 . . . . 0.0 109.322 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.87 175.1 5.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.337 -0.852 . . . . 0.0 109.589 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -146.03 109.98 4.91 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.788 ' CE2' HG21 ' A' ' 122' ' ' VAL . 16.0 m-30 -85.25 119.6 25.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.956 . . . . 0.0 109.632 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -147.93 56.79 1.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.456 ' OH ' ' HB ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.61 66.06 4.96 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.045 -0.409 . . . . 0.0 111.439 -178.435 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.459 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER 73.62 25.74 2.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.066 -1.021 . . . . 0.0 109.658 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.81 -171.52 3.1 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.083 -1.01 . . . . 0.0 108.569 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 71.6 p -57.65 160.99 6.76 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.165 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 32.7 Cg_endo -75.18 124.95 8.89 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.9 1.734 . . . . 0.0 110.257 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.455 HG22 HG13 ' A' ' 105' ' ' VAL . 13.1 m -118.43 125.76 50.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.431 -0.793 . . . . 0.0 109.408 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.417 ' O ' HG23 ' A' ' 125' ' ' VAL . 2.3 ttpt -107.51 138.43 43.73 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.673 ' HA ' HG23 ' A' ' 125' ' ' VAL . 5.7 m -152.69 142.3 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.048 -1.032 . . . . 0.0 110.194 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.64 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -91.01 127.69 36.53 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 174.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.944 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 1.4 m -97.93 160.19 3.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 O-C-N 120.634 -1.291 . . . . 0.0 111.475 -174.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 1.8 t-160 -158.06 100.47 1.71 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.817 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -111.09 146.7 36.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.584 -0.698 . . . . 0.0 109.535 -177.677 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.641 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.5 tttm -138.76 -163.47 1.47 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.599 -1.313 . . . . 0.0 109.311 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.477 ' HG2' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -103.1 117.23 34.1 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.064 -1.022 . . . . 0.0 108.807 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.892 ' HB3' ' HB2' ' A' ' 117' ' ' SER . . . -72.0 166.63 21.81 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.382 -0.824 . . . . 0.0 110.615 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.591 HD13 ' OG ' ' A' ' 117' ' ' SER . 1.7 mp 59.94 18.03 7.15 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 m 53.37 29.88 9.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.477 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.477 ' HA2' ' HG2' ' A' ' 111' ' ' LYS . . . 134.3 59.77 0.07 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.341 -1.409 . . . . 0.0 109.78 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.457 ' CB ' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t0 -164.89 -60.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.237 . . . . 0.0 110.228 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.892 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.9 OUTLIER -106.16 -161.44 0.8 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.925 -1.109 . . . . 0.0 110.679 -179.241 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.849 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.6 m-85 -149.71 121.35 8.04 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.851 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 13.5 p-90 -120.34 144.8 47.66 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.182 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.817 HG13 ' CG ' ' A' ' 109' ' ' MET . 27.4 t -116.83 112.15 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.759 -0.588 . . . . 0.0 109.78 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.637 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.6 m-30 -95.61 126.7 41.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 109.41 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.788 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -107.11 119.55 56.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 110.037 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.573 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 3.3 tptp -89.6 109.48 20.43 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.514 ' HA ' HG12 ' A' ' 105' ' ' VAL . 7.2 ttp-105 -68.64 114.82 7.35 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.114 -1.434 . . . . 0.0 109.433 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.673 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.096 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.871 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' HA ' ' CE1' ' A' ' 3' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.49 76.01 1.5 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.403 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.455 ' CE1' ' HA ' ' A' ' 1' ' ' MET . 11.5 p-80 -169.53 -178.61 3.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.283 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.909 HG22 ' OG ' ' A' ' 8' ' ' SER . 8.3 p -117.77 99.52 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.949 . . . . 0.0 109.655 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.846 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 49.43 -153.52 0.12 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.198 -0.939 . . . . 0.0 109.85 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.596 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -64.02 -46.85 82.63 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.114 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.74 39.05 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.9 -2.08 . . . . 0.0 107.9 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.909 ' OG ' HG22 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -68.03 -173.91 0.42 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.12 0.962 . . . . 0.0 111.405 -178.497 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -125.98 52.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.805 ' H ' HG21 ' A' ' 4' ' ' VAL . 0.5 OUTLIER 60.96 82.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -177.602 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.031 HG22 HD11 ' A' ' 15' ' ' LEU . 2.9 mm -81.71 -67.37 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 O-C-N 121.305 -0.872 . . . . 0.0 110.592 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.88 -25.49 0.2 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.017 -1.052 . . . . 0.0 111.462 -178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -82.87 -46.62 12.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.856 -1.153 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.747 HG21 ' HB2' ' A' ' 23' ' ' LEU . 1.1 m -66.95 -58.29 5.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.031 HD11 HG22 ' A' ' 11' ' ' ILE . 34.7 mt -38.87 -32.72 0.09 Allowed 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.017 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.75 -56.63 8.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.446 -0.784 . . . . 0.0 109.16 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.55 67.26 0.65 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.379 -0.825 . . . . 0.0 109.111 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.444 ' HG3' ' HB3' ' A' ' 22' ' ' GLN . 7.1 ttp -119.46 153.38 35.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.882 . . . . 0.0 109.76 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.29 -57.95 1.98 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 109.044 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -179.22 -57.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.838 . . . . 0.0 109.438 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.86 33.46 5.35 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.444 ' HB3' ' HG3' ' A' ' 18' ' ' MET . 0.8 OUTLIER -93.63 -44.59 8.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -1.174 . . . . 0.0 109.701 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.747 ' HB2' HG21 ' A' ' 14' ' ' THR . 1.9 tp -130.86 11.15 5.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.06 -1.025 . . . . 0.0 110.327 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 9.4 m-20 -71.62 -6.26 39.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.612 -1.305 . . . . 0.0 109.515 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.32 26.9 22.81 Favored Glycine 0 N--CA 1.491 2.335 0 O-C-N 120.857 -1.152 . . . . 0.0 110.387 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.706 HD21 ' HG ' ' A' ' 23' ' ' LEU . 4.8 mt -75.57 -175.14 2.74 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.862 -1.376 . . . . 0.0 108.427 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.98 16.0 22.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 1.9 p90 -151.44 -173.77 4.62 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -112.65 137.11 14.0 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.55 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -109.43 89.2 2.93 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.39 1.595 . . . . 0.0 107.755 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.696 HG22 ' CD1' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -99.53 148.51 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.303 -0.873 . . . . 0.0 110.113 -178.022 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.677 ' HB3' HD12 ' A' ' 40' ' ' LEU . 4.6 mt-30 -120.01 164.54 15.95 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 37' ' ' GLY . 98.5 mt -152.32 146.05 25.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.094 -1.004 . . . . 0.0 109.083 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.547 ' OD1' HD11 ' A' ' 40' ' ' LEU . 7.8 m-20 -124.88 129.9 51.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.943 -1.098 . . . . 0.0 110.522 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 37.4 -77.18 0.0 OUTLIER Glycine 0 N--CA 1.503 3.1 0 C-N-CA 124.589 1.09 . . . . 0.0 113.605 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' ASP . 11.3 m-20 -71.46 -0.57 10.7 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.646 -0.914 . . . . 0.0 111.081 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.875 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 84.2 17.63 64.41 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.65 131.33 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.922 -1.34 . . . . 0.0 108.919 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.756 HD12 HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -59.93 135.33 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 0.0 110.204 -179.018 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.677 HD12 ' HB3' ' A' ' 32' ' ' GLN . 2.0 mt -105.46 -26.68 11.82 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.772 ' NE2' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -167.04 163.15 15.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.696 ' CD1' HG22 ' A' ' 31' ' ' ILE . 38.4 t80 -135.34 -107.3 0.22 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.353 -1.467 . . . . 0.0 110.69 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 44' ' ' ALA . 14.3 t-20 157.65 145.91 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.744 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -70.14 -53.12 18.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.548 -0.72 . . . . 0.0 111.587 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.67 -54.39 4.05 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.31 -0.869 . . . . 0.0 111.053 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' CD ' ' CE1' ' A' ' 42' ' ' TYR . 3.8 pt-20 -63.67 -44.1 94.75 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.739 0.781 . . . . 0.0 109.671 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -59.77 -17.16 41.4 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -85.17 -29.63 24.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.912 -1.346 . . . . 0.0 108.908 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.611 HG22 ' CG2' ' A' ' 50' ' ' THR . 0.5 OUTLIER -77.03 -49.7 22.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.511 -0.743 . . . . 0.0 109.64 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.64 HG21 " C3'" ' A' ' 126' ' ' HC4 . 1.3 p -104.12 -7.23 20.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.963 -1.086 . . . . 0.0 110.748 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 81.83 -2.4 83.48 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.813 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.858 ' CD ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -39.52 -59.31 1.12 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -1.004 . . . . 0.0 112.666 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.754 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.6 OUTLIER 67.28 146.24 0.11 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.648 -1.282 . . . . 0.0 107.559 -178.108 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.42 -67.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.94 1.76 . . . . 0.0 111.89 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -48.32 -23.95 1.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.184 -0.948 . . . . 0.0 110.898 -178.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.66 -45.48 10.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.788 -1.195 . . . . 0.0 110.081 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.858 HG11 ' CD ' ' A' ' 52' ' ' ARG . 26.0 m -76.87 -0.63 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.056 -1.028 . . . . 0.0 110.036 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -70.84 124.86 28.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.287 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.6 -19.87 52.87 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -79.2 146.38 33.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -1.138 . . . . 0.0 109.138 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -88.55 118.62 28.33 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.617 ' HB2' HD21 ' A' ' 33' ' ' LEU . 74.5 t80 -52.92 -22.11 5.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.515 -0.741 . . . . 0.0 110.22 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -113.11 -10.85 13.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.937 -1.102 . . . . 0.0 111.459 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -135.51 39.74 2.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.78 -1.2 . . . . 0.0 110.217 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 171.93 -14.28 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.91 -1.119 . . . . 0.0 111.966 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.713 HG11 ' NE ' ' A' ' 52' ' ' ARG . 10.2 t -115.7 -53.36 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.346 -1.471 . . . . 0.0 109.358 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.465 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -119.43 96.92 50.1 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.059 -177.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.71 -2.46 12.61 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.902 1.735 . . . . 0.0 110.409 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.3 p -95.5 -17.04 21.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.099 -1.001 . . . . 0.0 109.75 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.729 HG22 ' CD2' ' A' ' 75' ' ' PHE . 64.5 p -86.62 11.31 13.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -89.37 54.14 2.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 108.87 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . 3.2 p -139.48 173.17 5.39 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 72' ' ' SER . 35.4 Cg_endo -77.14 3.55 6.58 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 C-N-CA 122.109 1.872 . . . . 0.0 111.781 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 32.7 mt-10 -106.45 -28.0 10.59 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.94 -1.1 . . . . 0.0 109.151 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.729 ' CD2' HG22 ' A' ' 70' ' ' THR . 2.0 t80 -102.92 -71.19 0.73 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.6 t80 -71.04 -17.18 62.63 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.47 -60.9 6.82 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.895 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -61.87 -17.61 57.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -1.059 . . . . 0.0 109.577 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.901 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.4 t80 -81.01 -38.8 26.88 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.488 -0.757 . . . . 0.0 109.768 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -76.11 -11.67 59.98 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 109.491 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 13.6 pt-20 -96.87 -40.36 8.96 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.89 -39.95 97.86 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 79' ' ' PHE . 97.0 t -58.03 -44.24 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.719 -0.871 . . . . 0.0 109.268 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.17 -3.48 58.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 110.652 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 t -94.72 -23.3 17.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.916 -1.115 . . . . 0.0 109.579 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 25.5 50.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -174.28 62.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.347 -1.09 . . . . 0.0 108.991 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.767 HD11 ' HA ' ' A' ' 79' ' ' PHE . 1.5 tt -55.51 123.73 14.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.145 -0.972 . . . . 0.0 109.584 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.449 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 40.2 t30 -160.21 84.52 0.72 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.381 -0.824 . . . . 0.0 109.118 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.895 HG21 ' HB2' ' A' ' 78' ' ' LYS . 9.2 t -138.11 170.99 15.07 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.915 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -159.6 168.59 25.71 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.917 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 11.8 p90 176.69 154.97 0.23 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.035 -1.041 . . . . 0.0 109.987 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 1.4 pt-20 -80.96 107.06 13.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.043 -1.035 . . . . 0.0 108.496 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.06 178.97 4.3 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.363 -0.835 . . . . 0.0 109.825 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 103' ' ' THR . 90.6 m -147.12 110.37 4.82 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.753 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 20.1 m-30 -80.96 118.11 22.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.935 . . . . 0.0 109.472 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -148.27 47.01 1.06 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.272 -0.893 . . . . 0.0 110.132 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.562 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 29.1 p90 -78.11 136.83 37.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.529 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 1.96 66.1 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.332 0 CA-C-O 121.696 0.76 . . . . 0.0 112.075 -178.575 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 98' ' ' TYR . 6.0 ttp -177.01 -174.26 0.51 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 t -63.47 149.2 92.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.944 . . . . 0.0 108.917 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.81 156.28 39.39 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.82 1.68 . . . . 0.0 110.894 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 95' ' ' THR . 3.1 m -147.39 148.45 31.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.5 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.432 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -119.93 140.68 50.51 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.425 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.756 ' HA ' HG23 ' A' ' 125' ' ' VAL . 10.1 m -158.24 144.42 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.092 -1.005 . . . . 0.0 110.489 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.669 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -92.38 112.52 24.5 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 174.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.917 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 1.4 m -83.27 161.24 3.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 O-C-N 121.366 -0.834 . . . . 0.0 111.86 -174.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -157.23 98.34 1.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.884 ' HG2' HG13 ' A' ' 120' ' ' VAL . 13.7 mtm -107.97 144.98 34.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.985 -1.072 . . . . 0.0 110.237 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.64 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 5.0 tttt -141.39 -163.4 1.55 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.169 -1.412 . . . . 0.0 110.168 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -103.28 106.55 17.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.953 . . . . 0.0 109.111 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.799 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -54.45 149.07 10.87 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.445 -0.784 . . . . 0.0 110.174 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.52 0.24 57.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.452 -0.78 . . . . 0.0 110.221 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -45.98 82.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.847 -1.158 . . . . 0.0 109.51 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.12 75.19 0.04 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 57.35 62.92 2.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -1.135 . . . . 0.0 109.18 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.767 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -118.74 -169.91 1.81 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.135 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.768 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.7 m-85 -151.11 122.01 7.6 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.799 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.2 p-90 -121.25 156.61 32.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.707 -1.245 . . . . 0.0 111.954 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.884 HG13 ' HG2' ' A' ' 109' ' ' MET . 46.5 t -124.88 112.52 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.353 0.597 . . . . 0.0 110.373 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.642 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 11.2 m-30 -96.91 112.29 24.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.753 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.1 t -100.02 116.58 43.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.39 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.596 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 5.6 tptp -89.38 120.5 30.77 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.567 ' HD3' HD11 ' A' ' 49' ' ' ILE . 9.2 ttp180 -73.72 117.69 15.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.77 -1.206 . . . . 0.0 109.35 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.756 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.229 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.64 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttp . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 55.01 37.7 29.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.491 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -121.41 -25.93 5.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.121 -0.987 . . . . 0.0 110.271 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.639 ' O ' HG13 ' A' ' 4' ' ' VAL . 9.1 p -173.23 113.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.89 -1.131 . . . . 0.0 109.994 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.521 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 54.84 -166.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.008 -1.058 . . . . 0.0 109.592 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -51.72 -58.26 6.9 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.07 33.03 0.3 Allowed Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.96 ' HB3' HD11 ' A' ' 11' ' ' ILE . 1.4 m -71.38 -174.44 1.06 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.837 -0.802 . . . . 0.0 110.93 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -121.14 70.85 0.93 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.426 -0.796 . . . . 0.0 110.536 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.46 ' H ' HG21 ' A' ' 4' ' ' VAL . 0.9 OUTLIER 48.67 83.56 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.482 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.96 HD11 ' HB3' ' A' ' 8' ' ' SER . 1.1 mm -85.77 -62.0 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 111.318 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -45.54 -24.56 0.34 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.972 -1.08 . . . . 0.0 111.023 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -81.66 -46.14 14.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.091 -1.005 . . . . 0.0 109.428 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.02 HG21 HD12 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -69.23 -58.45 4.02 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.331 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.932 HD11 HG22 ' A' ' 11' ' ' ILE . 43.4 mt -39.47 -31.45 0.09 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.422 0.63 . . . . 0.0 110.102 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.83 -60.1 4.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.27 31.52 2.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.243 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.439 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -106.35 123.89 48.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.387 -0.82 . . . . 0.0 109.553 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -79.52 -51.91 8.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.323 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' OD2' ' CB ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER 176.55 -35.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.418 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.94 27.09 20.23 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.939 -1.265 . . . . 0.0 109.939 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.43 ' HB3' ' HG3' ' A' ' 18' ' ' MET . 2.4 tt0 -89.61 -37.58 14.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -1.167 . . . . 0.0 109.444 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.02 HD12 HG21 ' A' ' 14' ' ' THR . 3.3 mt -138.03 58.81 1.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.404 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -85.87 -1.86 57.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 110.016 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.73 21.26 34.05 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.499 HD21 HD22 ' A' ' 23' ' ' LEU . 68.8 mt -81.21 140.3 35.01 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.141 -1.211 . . . . 0.0 108.735 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.19 3.83 14.19 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.771 0.796 . . . . 0.0 109.177 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 8' ' ' SER . 2.5 p90 -136.55 139.76 42.43 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -74.09 129.5 11.72 Favored Glycine 0 C--N 1.293 -1.832 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.519 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -103.18 117.14 33.87 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.884 -1.363 . . . . 0.0 107.941 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.653 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.1 pp -115.78 144.35 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.33 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 2.9 tt0 -108.71 168.56 9.26 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.716 ' C ' HD11 ' A' ' 40' ' ' LEU . 21.1 mt -156.64 135.8 12.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.53 -1.356 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.429 ' N ' HD11 ' A' ' 40' ' ' LEU . 15.7 t0 -93.96 175.9 6.54 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.87 -55.68 5.43 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.358 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -18.93 57.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.677 -1.484 . . . . 0.0 109.569 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 102.5 29.09 6.08 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 107.331 -2.307 . . . . 0.0 107.331 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -86.53 130.03 34.64 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.673 -0.898 . . . . 0.0 110.78 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -62.73 131.76 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.563 -1.336 . . . . 0.0 110.997 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.716 HD11 ' C ' ' A' ' 33' ' ' LEU . 2.3 mp -104.76 -19.88 13.78 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 7.9 tm0? -156.57 161.06 39.98 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.572 ' CE1' HG22 ' A' ' 31' ' ' ILE . 9.3 t80 -147.7 -61.96 0.27 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.588 -1.32 . . . . 0.0 111.035 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.636 HD21 ' HB3' ' A' ' 45' ' ' ALA . 1.4 p-10 97.43 175.08 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.5 -17.33 20.59 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.872 -1.143 . . . . 0.0 112.58 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.636 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -55.42 -63.73 1.07 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.549 -1.345 . . . . 0.0 110.298 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.6 pt-20 -57.78 -56.44 21.92 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.629 0.728 . . . . 0.0 109.309 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.1 -16.56 8.67 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -70.86 -43.62 68.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.733 -1.451 . . . . 0.0 108.759 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -85.1 -55.99 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.443 -0.785 . . . . 0.0 109.552 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.942 HG21 " C3'" ' A' ' 126' ' ' HC4 . 33.2 p -72.98 -20.18 61.08 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 0.0 110.318 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.9 -6.34 79.08 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.679 ' HB3' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -57.19 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -1.182 . . . . 0.0 110.133 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.744 ' O ' HG22 ' A' ' 57' ' ' VAL . 2.7 m-20 -61.2 159.67 27.92 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' CB ' ' OD2' ' A' ' 20' ' ' ASP . 36.6 Cg_endo -79.05 -63.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.791 1.661 . . . . 0.0 110.983 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -56.12 -20.24 16.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.18 -0.95 . . . . 0.0 110.345 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -90.13 -47.37 7.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.914 -1.116 . . . . 0.0 110.021 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 53' ' ' ASP . 18.4 m -72.86 -4.93 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.03 . . . . 0.0 109.668 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.679 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.78 124.83 26.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.16 -17.05 59.11 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.421 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 7.6 mmtt -78.65 138.35 38.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.191 -1.182 . . . . 0.0 109.04 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.7 OUTLIER -75.55 104.31 6.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.809 ' CZ ' HG21 ' A' ' 70' ' ' THR . 31.3 t80 -58.52 -19.71 39.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.489 -0.757 . . . . 0.0 110.586 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.676 ' CE2' HD13 ' A' ' 33' ' ' LEU . 22.2 m-85 -85.75 -48.69 8.58 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.297 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.36 37.36 4.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.925 -1.109 . . . . 0.0 109.789 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.466 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 1.2 t0 -149.31 -30.91 0.24 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 110.615 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.601 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 5.0 t -110.77 -58.91 3.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 120.745 -1.222 . . . . 0.0 108.679 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.415 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -104.71 105.66 51.56 Favored Pre-proline 0 C--N 1.29 -1.987 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.594 -178.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.62 3.85 6.08 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.058 1.838 . . . . 0.0 111.26 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.2 p -107.15 -17.06 14.26 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.847 -1.158 . . . . 0.0 109.862 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.809 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 24.8 p -83.5 6.0 21.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.962 . . . . 0.0 110.046 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -97.79 52.29 1.08 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.08 -1.012 . . . . 0.0 108.921 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.7 p -129.63 -179.81 1.11 Allowed Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.23 2.19 8.25 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 122.049 1.833 . . . . 0.0 112.028 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.9 mp0 -109.65 -27.96 9.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.86 -1.15 . . . . 0.0 108.985 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.649 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.1 t80 -102.52 -70.76 0.74 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.7 t80 -68.72 -17.48 64.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.81 -62.84 4.89 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.818 ' HB3' HG21 ' A' ' 90' ' ' THR . 5.3 mmtt -61.64 -16.53 49.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.448 -1.031 . . . . 0.0 109.502 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.872 ' O ' HG23 ' A' ' 83' ' ' VAL . 17.1 t80 -82.11 -39.43 23.35 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.58 -0.7 . . . . 0.0 110.195 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.9 -12.15 60.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.925 -1.109 . . . . 0.0 109.311 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 19.9 pt-20 -97.1 -41.01 8.55 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.07 -39.89 98.57 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 79' ' ' PHE . 97.4 t -60.11 -54.33 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.746 -0.856 . . . . 0.0 109.188 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.86 -2.14 35.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.398 -0.814 . . . . 0.0 110.454 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.1 t -90.63 -34.27 15.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.045 -1.034 . . . . 0.0 109.543 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.31 19.4 30.47 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 87' ' ' ASN . 3.6 p-10 -175.43 64.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -1.138 . . . . 0.0 108.945 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.569 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -51.27 123.68 10.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.856 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -161.1 89.67 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.115 -0.991 . . . . 0.0 108.77 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.818 HG21 ' HB3' ' A' ' 78' ' ' LYS . 9.4 t -153.23 172.65 16.65 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.825 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.62 174.51 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.005 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 7.3 p90 178.69 152.79 0.34 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.769 -1.207 . . . . 0.0 110.441 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -79.46 117.18 20.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.893 . . . . 0.0 108.777 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.19 175.18 6.07 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.038 -1.039 . . . . 0.0 110.359 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.7 m -147.25 110.32 4.78 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.517 ' CD1' ' C2 ' ' A' ' 126' ' ' HC4 . 19.7 m-85 -80.14 119.79 23.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -131.14 42.41 3.22 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.604 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -78.29 79.55 4.73 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.3 0.572 . . . . 0.0 110.391 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.577 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 5.3 pt20 52.52 38.94 26.94 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.675 0.75 . . . . 0.0 109.656 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.73 -168.9 3.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.387 -0.821 . . . . 0.0 109.369 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.42 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.6 t -67.24 150.54 97.84 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.8 . . . . 0.0 108.921 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.42 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.5 Cg_endo -74.56 82.64 1.87 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.86 1.707 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.681 HG22 HG13 ' A' ' 105' ' ' VAL . 11.4 m -69.93 98.9 1.33 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.497 -0.752 . . . . 0.0 109.607 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.1 OUTLIER -73.24 133.95 44.13 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.208 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.704 ' HA ' HG23 ' A' ' 125' ' ' VAL . 16.3 m -150.0 146.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.365 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -94.62 116.78 29.17 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 175.106 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.005 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -88.26 164.4 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.741 -1.224 . . . . 0.0 111.553 -175.223 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.435 ' ND1' ' HA ' ' A' ' 5' ' ' ALA . 21.3 t-160 -147.42 146.88 29.74 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 175.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.915 ' HB3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -152.33 137.86 17.74 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.6 -1.312 . . . . 0.0 109.345 -178.393 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.592 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 25.4 tttt -150.3 158.9 44.66 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.402 -1.319 . . . . 0.0 109.904 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.462 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 4.7 ttmt -72.36 109.88 6.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 109.048 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.959 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -72.03 176.24 5.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.442 -0.787 . . . . 0.0 111.008 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.466 HD13 ' HB3' ' A' ' 116' ' ' ASP . 0.2 OUTLIER 63.28 21.07 12.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.551 -0.718 . . . . 0.0 109.119 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.4 m 55.44 25.17 7.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.318 -0.864 . . . . 0.0 109.076 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' ' 111' ' ' LYS . . . 126.63 74.49 0.21 Allowed Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.508 -1.33 . . . . 0.0 110.13 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.466 ' HB3' HD13 ' A' ' 113' ' ' LEU . 0.9 OUTLIER 178.52 -42.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.9 -1.353 . . . . 0.0 110.533 179.718 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.76 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 55.7 m -113.8 179.48 3.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.006 -1.059 . . . . 0.0 110.594 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.838 ' CE1' HG22 ' A' ' 83' ' ' VAL . 16.6 m-85 -132.38 132.11 42.53 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.959 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 17.4 p-90 -136.28 155.24 50.37 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.63 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.915 HG22 ' HB3' ' A' ' 109' ' ' MET . 83.3 t -140.42 109.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.804 -0.56 . . . . 0.0 110.049 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.683 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 3.8 m-30 -91.36 135.13 34.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.991 -1.068 . . . . 0.0 109.319 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.666 HG13 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -110.42 119.23 58.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.24 -0.912 . . . . 0.0 109.72 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -89.03 108.55 19.65 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.632 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -67.56 116.91 8.82 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.474 -1.29 . . . . 0.0 109.468 -178.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.704 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.115 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.942 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.72 -38.36 67.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.92 . . . . 0.0 109.684 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 63.02 113.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.401 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.673 HG13 ' OG ' ' A' ' 8' ' ' SER . 7.3 p -161.09 146.67 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.896 ' HB1' ' CE1' ' A' ' 6' ' ' PHE . . . 46.22 -85.5 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.307 0.575 . . . . 0.0 111.592 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.896 ' CE1' ' HB1' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -164.73 -45.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 -178.179 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.46 24.34 0.96 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.673 ' OG ' HG13 ' A' ' 4' ' ' VAL . 84.0 p -76.94 142.46 40.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -1.082 . . . . 0.0 109.634 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -53.17 -34.96 59.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.234 1.016 . . . . 0.0 108.567 178.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.644 ' HA ' HG11 ' A' ' 4' ' ' VAL . 0.8 OUTLIER 157.74 95.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.093 HG22 HD11 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -75.16 -68.67 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.529 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.558 -177.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.431 ' HA ' HD12 ' A' ' 15' ' ' LEU . 3.2 tm-20 -37.98 -33.63 0.09 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.697 -0.627 . . . . 0.0 111.663 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.39 -44.28 16.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.919 -1.113 . . . . 0.0 108.597 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 18' ' ' MET . 2.7 m -69.55 -8.54 48.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.746 -0.597 . . . . 0.0 109.605 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.093 HD11 HG22 ' A' ' 11' ' ' ILE . 28.7 mt -97.97 -22.06 16.5 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.819 -1.175 . . . . 0.0 109.316 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.98 -21.3 18.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.969 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -136.0 73.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.831 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.48 ' CE ' HD13 ' A' ' 23' ' ' LEU . 11.0 tmm? -139.13 116.45 11.17 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.291 -0.881 . . . . 0.0 109.311 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.21 -74.78 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.694 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.87 58.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.077 -1.015 . . . . 0.0 109.611 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.08 37.88 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.441 ' HB3' ' HG3' ' A' ' 18' ' ' MET . 8.5 tt0 -132.39 -27.59 1.75 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -1.074 . . . . 0.0 110.483 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -103.33 -13.48 16.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.723 -1.236 . . . . 0.0 110.207 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.727 ' N ' HD23 ' A' ' 23' ' ' LEU . 19.4 p30 -68.94 -17.41 63.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.955 -1.09 . . . . 0.0 110.028 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -100.83 35.83 4.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.996 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 85.1 mt -99.63 124.57 44.98 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.44 -1.035 . . . . 0.0 109.838 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.12 -12.92 14.05 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.824 0.821 . . . . 0.0 108.916 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.996 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 2.7 p90 -113.82 -172.43 2.08 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.164 -0.96 . . . . 0.0 108.612 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.484 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -122.98 136.16 10.43 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 108.131 -1.988 . . . . 0.0 108.131 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -113.91 111.25 21.39 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.894 -1.356 . . . . 0.0 108.318 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.667 HG22 ' CD1' ' A' ' 42' ' ' TYR . 0.8 OUTLIER -120.81 140.27 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.493 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.672 ' HB3' HD12 ' A' ' 40' ' ' LEU . 9.3 mt-30 -107.23 170.55 7.89 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.747 HD21 HD12 ' A' ' 39' ' ' ILE . 80.1 mt -151.47 142.84 23.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.988 -1.07 . . . . 0.0 109.971 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.598 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -115.11 137.43 52.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.077 -1.014 . . . . 0.0 109.365 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -10.89 71.21 0.0 OUTLIER Glycine 0 N--CA 1.513 3.824 0 C-N-CA 124.674 1.13 . . . . 0.0 113.378 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER 162.58 -24.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.04 18.37 22.44 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 16.3 p-10 -84.9 129.04 34.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.146 -1.208 . . . . 0.0 108.893 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.747 HD12 HD21 ' A' ' 33' ' ' LEU . 1.1 mp -63.24 137.26 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.075 0.94 . . . . 0.0 111.282 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 32' ' ' GLN . 1.7 mt -108.27 -28.45 9.44 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.548 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -155.0 161.14 41.46 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.667 ' CD1' HG22 ' A' ' 31' ' ' ILE . 48.3 t80 -149.14 -73.35 0.18 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.54 -1.35 . . . . 0.0 111.071 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 10.1 p-10 109.06 178.19 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 123.999 0.92 . . . . 0.0 109.641 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.9 15.09 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.051 -1.031 . . . . 0.0 113.258 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -51.75 -63.77 1.03 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.254 -1.528 . . . . 0.0 110.563 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' OE1' ' CE1' ' A' ' 42' ' ' TYR . 1.2 pt-20 -57.39 -54.62 44.74 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.625 0.726 . . . . 0.0 109.609 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.41 -14.87 21.81 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.57 -34.89 46.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.874 -1.368 . . . . 0.0 109.478 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -47.91 15.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.251 -0.905 . . . . 0.0 109.679 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.649 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -86.41 -31.92 21.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.176 -0.952 . . . . 0.0 109.74 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.41 -3.41 56.5 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.928 -1.129 . . . . 0.0 110.438 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.953 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -41.9 -48.04 4.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.321 -1.105 . . . . 0.0 112.492 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.646 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER 66.1 146.18 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.727 -1.233 . . . . 0.0 107.737 -178.244 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.77 -63.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.949 1.766 . . . . 0.0 112.118 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.767 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -55.22 -21.65 14.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.011 . . . . 0.0 111.193 -178.446 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -88.07 -41.1 13.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.868 -1.145 . . . . 0.0 109.878 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 52' ' ' ARG . 15.2 m -81.89 3.32 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 110.021 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.767 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.44 120.84 20.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.091 -1.006 . . . . 0.0 108.546 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.8 -11.4 70.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -80.36 141.4 35.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.949 -1.324 . . . . 0.0 109.849 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.451 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -81.59 92.99 6.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.907 . . . . 0.0 109.005 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.719 ' CZ ' HG21 ' A' ' 70' ' ' THR . 25.8 t80 -54.1 -22.33 10.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 76' ' ' TYR . 7.0 m-85 -85.84 -31.45 22.27 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.48 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.39 47.4 1.39 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 108.935 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.451 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.7 OUTLIER -165.47 -33.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.388 -0.82 . . . . 0.0 110.345 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.953 HG11 ' HD3' ' A' ' 52' ' ' ARG . 9.9 t -106.93 -56.97 4.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 120.76 -1.213 . . . . 0.0 109.002 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.499 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -104.4 101.26 26.26 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.902 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.2 Cg_endo -75.98 -0.38 10.2 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 C-N-CA 121.803 1.669 . . . . 0.0 110.522 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 p -100.54 -23.2 14.75 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.072 -1.017 . . . . 0.0 109.694 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.719 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 10.8 p -82.12 3.88 25.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.168 -0.958 . . . . 0.0 110.044 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -91.21 51.16 1.87 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.924 -1.11 . . . . 0.0 108.77 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.48 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -121.13 179.05 1.01 Allowed Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -78.85 -6.09 14.97 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.931 1.754 . . . . 0.0 111.223 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 14.3 mm-40 -103.18 -24.15 13.59 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.896 -1.127 . . . . 0.0 109.656 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.571 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.5 t80 -103.61 -70.44 0.76 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 21.0 t80 -71.83 -19.67 61.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.92 -1.113 . . . . 0.0 108.442 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.48 -61.51 6.21 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.664 ' HB2' HG21 ' A' ' 90' ' ' THR . 2.3 mmtp -63.04 -15.78 57.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.964 . . . . 0.0 109.496 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.863 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.9 t80 -78.65 -40.49 34.01 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -77.91 -7.02 56.19 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -95.75 -39.51 9.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.433 ' C ' HD12 ' A' ' 88' ' ' LEU . . . -70.27 -43.08 64.3 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.898 HG22 ' CE1' ' A' ' 118' ' ' TYR . 59.1 t -58.25 -37.3 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.738 -0.86 . . . . 0.0 109.192 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.12 -4.22 46.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.459 -0.776 . . . . 0.0 110.982 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 m -100.38 -18.22 16.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.781 -1.199 . . . . 0.0 110.224 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.77 16.3 77.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.86 63.43 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -1.207 . . . . 0.0 108.846 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -65.31 112.68 3.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 109.854 -179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.419 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 19.3 p30 -160.78 85.07 0.69 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.409 -0.807 . . . . 0.0 108.912 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.664 HG21 ' HB2' ' A' ' 78' ' ' LYS . 8.9 t -133.1 144.93 50.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.061 -1.024 . . . . 0.0 110.434 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.5 ptp -132.74 154.64 50.01 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.058 ' CE2' HG21 ' A' ' 107' ' ' VAL . 9.9 p90 -169.19 -173.3 1.71 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.755 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.63 110.37 20.47 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.95 172.71 6.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.495 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 103' ' ' THR . 89.3 m -143.41 111.72 6.27 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.442 -0.787 . . . . 0.0 109.042 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.941 ' CE2' HG21 ' A' ' 122' ' ' VAL . 15.5 m-30 -83.8 117.13 23.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.281 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -147.13 47.04 1.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.94 . . . . 0.0 109.88 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.572 ' CD1' ' O ' ' A' ' 98' ' ' TYR . 21.3 p90 -78.6 137.08 37.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.515 ' C ' ' O ' ' A' ' 98' ' ' TYR . 5.3 pt20 1.51 66.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.114 0 CA-C-O 121.539 0.685 . . . . 0.0 112.371 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 98' ' ' TYR . 67.7 ttp -162.98 -93.54 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.502 -0.749 . . . . 0.0 109.396 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 100' ' ' MET . 0.2 OUTLIER -149.17 161.5 31.99 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.812 -1.18 . . . . 0.0 108.664 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.95 115.36 4.0 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.024 1.816 . . . . 0.0 110.357 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' THR . 2.5 m -123.58 128.08 49.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.662 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.42 143.61 33.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.798 ' HA ' HG23 ' A' ' 125' ' ' VAL . 15.2 m -152.82 141.97 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.773 -1.204 . . . . 0.0 110.777 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.543 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -83.43 115.94 22.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 174.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.058 HG21 ' CE2' ' A' ' 92' ' ' PHE . 32.7 m -98.85 156.22 3.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 120.838 -1.164 . . . . 0.0 110.929 -175.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -159.99 104.48 1.52 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.904 ' HG2' HG13 ' A' ' 120' ' ' VAL . 6.4 mtm -110.23 145.53 37.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.429 -0.794 . . . . 0.0 109.772 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.624 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.9 tttm -138.0 -177.59 4.89 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.873 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.43 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 5.1 ttmm -91.04 99.9 12.85 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.701 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -48.07 123.94 6.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.408 -0.807 . . . . 0.0 110.057 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.63 -17.85 37.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.962 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 m -53.62 -27.46 27.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.009 -1.057 . . . . 0.0 109.188 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -166.18 33.24 0.23 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t70 57.12 33.87 24.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -1.127 . . . . 0.0 109.163 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.519 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -84.48 -163.23 0.77 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.375 -0.828 . . . . 0.0 110.166 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.898 ' CE1' HG22 ' A' ' 83' ' ' VAL . 22.7 m-85 -139.54 113.46 8.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.724 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 11.1 p-90 -114.95 141.68 47.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.527 -1.269 . . . . 0.0 112.325 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.904 HG13 ' HG2' ' A' ' 109' ' ' MET . 61.5 t -113.99 116.23 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.724 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 18.9 m-30 -99.05 127.63 45.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.002 -1.061 . . . . 0.0 109.287 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.941 HG21 ' CE2' ' A' ' 96' ' ' PHE . 2.0 t -116.3 113.09 42.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.025 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.604 ' CD ' ' CD1' ' A' ' 6' ' ' PHE . 8.1 tttm -96.62 120.73 37.49 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.466 ' HA ' HG12 ' A' ' 105' ' ' VAL . 1.9 ttt180 -65.67 121.34 14.74 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.707 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.798 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.183 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.649 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 57.86 -93.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.834 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -64.43 177.7 0.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.732 -1.23 . . . . 0.0 109.551 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.725 HG12 ' HZ1' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -76.05 -160.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.681 ' N ' HG13 ' A' ' 4' ' ' VAL . . . -85.63 133.99 34.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.35 -0.844 . . . . 0.0 110.545 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.548 ' CZ ' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -65.74 -56.84 9.9 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.214 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.533 ' O ' HD11 ' A' ' 11' ' ' ILE . . . -54.44 -26.9 39.18 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.55 -2.22 . . . . 0.0 107.55 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.624 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.2 OUTLIER 44.86 -165.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.198 0.999 . . . . 0.0 112.013 177.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -61.08 81.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.98 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' C ' ' O ' ' A' ' 9' ' ' GLU . 69.1 m-20 26.64 76.91 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.848 0 CA-C-N 118.571 0.623 . . . . 0.0 110.29 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.965 HG22 HD11 ' A' ' 15' ' ' LEU . 1.2 mm -58.38 -68.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.148 -0.97 . . . . 0.0 110.053 -177.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.89 -28.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.8 -0.562 . . . . 0.0 112.31 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 11' ' ' ILE . 16.1 m120 -72.94 -50.87 20.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.758 -1.213 . . . . 0.0 109.576 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.833 HG21 HD22 ' A' ' 23' ' ' LEU . 1.1 m -68.24 -54.85 14.82 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.965 HD11 HG22 ' A' ' 11' ' ' ILE . 51.8 mt -43.34 -32.05 0.75 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.249 0.547 . . . . 0.0 110.244 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.72 -44.07 29.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.84 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -114.66 62.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.629 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.467 ' CG ' ' HB3' ' A' ' 22' ' ' GLN . 9.0 tmm? -129.4 143.36 50.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.346 -0.846 . . . . 0.0 109.17 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -81.33 -65.8 0.97 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.264 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.25 -48.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.679 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.29 25.92 21.98 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.467 ' HB3' ' CG ' ' A' ' 18' ' ' MET . 15.0 tt0 -88.48 -60.5 1.94 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -1.19 . . . . 0.0 109.274 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.833 HD22 HG21 ' A' ' 14' ' ' THR . 1.8 mp -126.63 60.47 1.34 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 0.0 109.339 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -109.27 -11.03 14.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.092 -1.005 . . . . 0.0 110.038 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.56 27.74 16.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.501 HD11 ' O ' ' A' ' 23' ' ' LEU . 1.7 mt -71.59 -168.43 0.34 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.149 -1.206 . . . . 0.0 109.13 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.98 -4.24 14.58 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.595 ' CE2' HD12 ' A' ' 11' ' ' ILE . 7.2 p90 -134.68 112.09 10.51 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.216 -0.928 . . . . 0.0 109.072 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.707 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -49.82 161.62 0.92 Allowed Glycine 0 C--N 1.289 -2.048 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.49 129.82 17.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.819 -1.401 . . . . 0.0 108.457 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.63 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.8 pp -131.84 157.63 43.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.772 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.713 ' HB3' HD12 ' A' ' 40' ' ' LEU . 45.8 mt-30 -116.39 163.27 16.29 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 37' ' ' GLY . 17.6 mt -147.57 144.0 28.16 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.867 -1.145 . . . . 0.0 110.467 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.444 ' N ' HD21 ' A' ' 40' ' ' LEU . 30.5 t70 -96.54 165.87 11.96 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -44.08 -22.48 0.33 Allowed Glycine 0 N--CA 1.5 2.931 0 C-N-CA 121.336 -0.459 . . . . 0.0 113.281 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.1 15.94 22.71 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.342 -1.681 . . . . 0.0 110.858 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.628 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.03 26.25 67.06 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.8 m120 -94.33 131.19 40.21 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.99 -1.3 . . . . 0.0 110.964 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.608 HG22 ' HA ' ' A' ' 58' ' ' ILE . 1.1 tp -61.83 138.07 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.825 -1.172 . . . . 0.0 111.286 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 32' ' ' GLN . 2.3 mt -110.64 -28.24 8.56 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 177.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.451 HE22 ' N ' ' A' ' 43' ' ' ASN . 15.0 tm0? -152.68 150.12 29.13 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.589 ' OH ' " O4'" ' A' ' 126' ' ' HC4 . 4.7 t80 -130.89 -54.03 1.06 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.323 -1.486 . . . . 0.0 111.374 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.501 ' OD1' ' HG3' ' A' ' 46' ' ' GLU . 0.4 OUTLIER 89.6 177.77 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.37 -38.39 9.65 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.937 -1.102 . . . . 0.0 113.681 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.87 -62.68 1.13 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.64 -1.287 . . . . 0.0 111.552 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.707 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -59.09 -49.16 78.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.47 -0.769 . . . . 0.0 110.932 -179.199 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.21 -15.08 42.97 Favored Glycine 0 C--N 1.281 -2.477 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -83.63 -30.0 27.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.96 -1.317 . . . . 0.0 108.888 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -82.01 -55.32 8.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.405 -0.809 . . . . 0.0 109.144 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.645 HG21 " C4'" ' A' ' 126' ' ' HC4 . 1.2 p -84.41 -11.49 56.15 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.242 -0.911 . . . . 0.0 109.903 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.36 -5.84 81.91 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.765 ' NE ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -52.35 123.6 11.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -1.159 . . . . 0.0 110.478 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.76 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.4 m-20 -89.85 154.97 47.93 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 -54.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.708 1.605 . . . . 0.0 111.37 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -22.15 66.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 110.668 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.81 -41.85 11.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.955 -1.091 . . . . 0.0 109.96 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 53' ' ' ASP . 14.4 m -77.61 -1.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.728 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.608 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -71.65 122.48 23.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.64 -15.07 61.25 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -79.13 138.76 38.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.139 -1.212 . . . . 0.0 108.877 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 66' ' ' VAL . 87.3 m-20 -76.38 109.35 10.02 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 1.031 ' CZ ' HG21 ' A' ' 70' ' ' THR . 8.5 t80 -68.79 -20.54 64.34 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.632 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 3.6 m-85 -85.06 -4.05 59.02 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.957 -1.097 . . . . 0.0 111.393 -177.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 23.0 mttt -155.99 -46.37 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.731 -1.231 . . . . 0.0 110.857 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.53 -3.41 53.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.984 -1.072 . . . . 0.0 112.299 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.765 HG11 ' NE ' ' A' ' 52' ' ' ARG . 5.7 t -126.45 -59.37 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 120.304 -1.498 . . . . 0.0 109.286 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.644 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -107.65 106.95 59.67 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.625 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.12 2.32 7.3 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.796 1.664 . . . . 0.0 111.698 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.7 p -105.33 -18.83 13.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.861 -1.149 . . . . 0.0 109.78 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 1.031 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 71.1 p -75.35 -2.12 26.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 110.28 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -90.68 53.31 2.39 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.878 -1.139 . . . . 0.0 108.789 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -124.71 178.18 1.53 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.488 -0.758 . . . . 0.0 109.237 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.39 -1.2 11.39 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 122.238 1.959 . . . . 0.0 111.428 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.4 mp0 -109.44 -25.83 10.3 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.92 -1.112 . . . . 0.0 109.248 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -100.98 -70.36 0.74 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.063 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -72.12 -18.27 61.91 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.094 -1.004 . . . . 0.0 108.341 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.82 -64.9 3.23 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.914 ' HB2' HG21 ' A' ' 90' ' ' THR . 1.4 mmtp -62.48 -16.77 57.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.561 -0.964 . . . . 0.0 109.878 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.87 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.1 t80 -83.5 -36.98 23.68 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.602 -0.687 . . . . 0.0 109.872 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.22 -12.57 60.11 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.173 -0.954 . . . . 0.0 109.081 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 19.4 pt-20 -97.23 -42.36 7.85 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.487 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -60.03 -39.25 95.45 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 107.521 -2.232 . . . . 0.0 107.521 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 79' ' ' PHE . 90.3 t -60.88 -45.36 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.784 -0.833 . . . . 0.0 109.46 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.19 -3.11 57.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.219 -0.926 . . . . 0.0 110.622 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.49 -24.61 15.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.85 -1.156 . . . . 0.0 109.451 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.71 15.1 74.06 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -156.19 56.01 0.58 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -1.176 . . . . 0.0 108.66 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -50.24 120.73 4.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 110.113 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.442 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 17.1 p30 -160.52 88.41 0.79 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 108.947 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.914 HG21 ' HB2' ' A' ' 78' ' ' LYS . 10.1 t -146.86 169.02 19.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.209 -0.932 . . . . 0.0 110.129 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -154.98 170.38 21.89 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.003 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 6.5 p90 179.53 152.52 0.42 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.872 -1.142 . . . . 0.0 110.222 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -80.75 111.93 17.65 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 -178.85 3.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.084 -1.01 . . . . 0.0 109.984 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 103' ' ' THR . 79.6 m -146.09 109.73 4.81 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.669 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 18.5 m-30 -79.3 93.41 5.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 108.665 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -115.84 31.17 6.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.37 -0.831 . . . . 0.0 109.686 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.582 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.85 159.11 27.96 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.817 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.494 ' C ' ' O ' ' A' ' 98' ' ' TYR . 1.5 pp0? -4.56 67.65 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 123.532 0.733 . . . . 0.0 112.547 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.582 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.78 -157.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.608 -0.683 . . . . 0.0 109.195 -178.438 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.459 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -90.96 174.78 4.15 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 108.834 179.154 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.459 ' CD ' HG22 ' A' ' 101' ' ' THR . 36.1 Cg_endo -79.15 103.77 1.68 Allowed 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.07 1.847 . . . . 0.0 110.749 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 95' ' ' THR . 9.2 m -99.11 145.27 27.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.114 -0.991 . . . . 0.0 108.926 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -119.43 135.82 54.58 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.771 ' HA ' HG23 ' A' ' 125' ' ' VAL . 11.5 m -153.5 145.67 14.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.973 -1.079 . . . . 0.0 110.862 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.548 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 3.0 ptmt -94.28 114.7 26.83 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.573 -2.381 . . . . 0.0 104.573 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.003 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -86.72 164.76 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.882 -1.136 . . . . 0.0 110.315 -176.588 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.516 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -159.71 101.94 1.5 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.039 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.827 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.89 148.77 36.19 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.109 -0.995 . . . . 0.0 110.002 -177.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.2 tttt -144.11 178.82 7.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.669 -1.269 . . . . 0.0 109.309 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.49 106.81 15.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.885 -1.134 . . . . 0.0 108.693 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.642 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.5 155.55 2.12 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 110.5 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.1 -15.43 18.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.548 -0.72 . . . . 0.0 109.837 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 t -50.34 -25.31 3.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.13 -0.981 . . . . 0.0 109.651 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 170.84 47.59 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.85 57.12 4.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.29 -1.123 . . . . 0.0 108.828 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.635 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -100.64 -157.69 0.62 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.428 -0.795 . . . . 0.0 109.904 -179.44 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.742 ' CE1' HG22 ' A' ' 83' ' ' VAL . 12.0 m-85 -145.76 102.66 3.69 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.657 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 11.2 p-90 -106.32 143.69 34.07 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.551 -1.26 . . . . 0.0 111.973 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.827 HG13 ' HG2' ' A' ' 109' ' ' MET . 43.9 t -121.45 107.87 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.497 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.657 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 8.9 m-30 -92.94 123.08 35.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -0.854 . . . . 0.0 109.575 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.669 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.3 t -102.56 118.1 48.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.37 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.725 ' HZ1' HG12 ' A' ' 4' ' ' VAL . 1.4 tttp -96.85 106.68 19.04 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.501 ' HA ' HG12 ' A' ' 105' ' ' VAL . 6.3 ttt180 -53.92 135.92 41.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.795 -1.191 . . . . 0.0 109.671 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.194 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.645 " C4'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.07 -79.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.226 -0.921 . . . . 0.0 109.603 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -137.23 -172.35 3.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.058 -1.026 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 8' ' ' SER . 7.6 p -113.76 91.84 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.056 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.491 ' O ' ' OG ' ' A' ' 8' ' ' SER . . . 60.36 50.23 6.28 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.041 -1.037 . . . . 0.0 110.27 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.597 ' CE1' ' CD ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER 68.57 14.73 9.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.866 -1.771 . . . . 0.0 107.134 -178.267 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.567 ' CA ' ' HE3' ' A' ' 123' ' ' LYS . . . 106.24 -10.91 43.71 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.853 ' O ' HG22 ' A' ' 4' ' ' VAL . 1.6 p -80.22 147.2 31.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.887 -1.36 . . . . 0.0 112.594 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -96.81 54.5 1.3 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.77 74.38 0.44 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.854 HG22 ' CG ' ' A' ' 15' ' ' LEU . 3.4 mm -75.1 -57.37 6.54 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 O-C-N 121.372 -0.83 . . . . 0.0 110.428 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.587 ' HA ' HD12 ' A' ' 15' ' ' LEU . 2.4 tt0 -36.18 -33.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.848 -0.532 . . . . 0.0 112.066 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 11' ' ' ILE . 1.5 m120 -84.74 -43.18 14.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.938 -1.101 . . . . 0.0 108.316 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.513 HG23 ' CB ' ' A' ' 19' ' ' ASP . 2.9 m -69.78 -8.1 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.727 -0.608 . . . . 0.0 109.987 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.854 ' CG ' HG22 ' A' ' 11' ' ' ILE . 15.2 mt -96.77 -22.2 17.09 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.951 -1.093 . . . . 0.0 109.278 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.92 -31.04 61.44 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.328 -0.857 . . . . 0.0 108.77 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -133.74 16.01 3.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.269 -0.894 . . . . 0.0 109.698 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.464 ' HA ' ' CE ' ' A' ' 18' ' ' MET . 0.0 OUTLIER 61.13 163.59 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.978 -1.076 . . . . 0.0 109.535 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.513 ' CB ' HG23 ' A' ' 14' ' ' THR . 0.1 OUTLIER 167.8 153.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.14 87.41 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.091 -1.006 . . . . 0.0 109.137 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.59 21.38 66.9 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 50.25 35.75 11.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -1.173 . . . . 0.0 109.844 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.736 HD22 HD13 ' A' ' 26' ' ' LEU . 1.1 tm? 61.28 81.6 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 109.225 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.34 -39.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 109.197 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.53 24.65 24.69 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.029 HD23 ' CZ ' ' A' ' 28' ' ' PHE . 3.5 mp -77.19 157.21 31.04 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.32 -1.106 . . . . 0.0 108.446 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.32 12.67 13.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.029 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -154.06 112.75 3.64 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.512 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -49.6 159.03 1.22 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' A' ' 23' ' ' LEU . . . -134.85 114.63 12.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.605 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.6 pp -117.1 158.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 110.636 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.836 ' HB3' HD12 ' A' ' 40' ' ' LEU . 24.3 mm-40 -125.89 170.36 11.73 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.856 HD22 ' O ' ' A' ' 37' ' ' GLY . 83.8 mt -157.39 147.56 20.8 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.28 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' ASP . 29.1 m-20 -126.64 127.03 44.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.059 -1.026 . . . . 0.0 109.913 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.02 -77.54 0.0 OUTLIER Glycine 0 N--CA 1.502 3.041 0 C-N-CA 124.578 1.085 . . . . 0.0 113.609 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -69.69 -3.23 14.35 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.535 -0.979 . . . . 0.0 110.933 -178.075 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.856 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 87.36 17.59 58.6 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 34' ' ' ASP . 8.1 p30 -73.7 129.5 38.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -1.199 . . . . 0.0 108.835 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.688 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -58.56 136.45 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 110.441 -178.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.836 HD12 ' HB3' ' A' ' 32' ' ' GLN . 6.9 mt -101.6 -29.59 11.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.453 HE22 HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -160.0 176.97 11.22 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.54 ' CD1' HG22 ' A' ' 31' ' ' ILE . 12.9 t80 -156.11 -48.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.695 -1.253 . . . . 0.0 110.076 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.646 HD21 ' HB3' ' A' ' 45' ' ' ALA . 0.6 OUTLIER 89.43 176.5 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.257 0.551 . . . . 0.0 109.929 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.83 -20.54 18.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.244 -0.91 . . . . 0.0 112.485 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.646 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -56.3 -66.62 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.547 -1.345 . . . . 0.0 110.33 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 5.1 pt-20 -61.23 -49.4 77.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.956 . . . . 0.0 110.03 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -61.03 -14.24 37.9 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 21.7 t0 -80.76 -34.11 34.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.725 -1.456 . . . . 0.0 108.846 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.48 HG22 HG23 ' A' ' 50' ' ' THR . 1.0 OUTLIER -82.94 -54.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.197 -0.94 . . . . 0.0 108.849 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.971 HG21 " C3'" ' A' ' 126' ' ' HC4 . 26.7 p -78.82 -24.14 44.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.402 -0.811 . . . . 0.0 109.768 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 97.14 -13.8 64.39 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.797 ' NE ' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -58.35 90.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -1.207 . . . . 0.0 109.971 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.739 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -61.54 166.86 4.97 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.176 -0.952 . . . . 0.0 109.284 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.15 -54.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 122.149 1.899 . . . . 0.0 110.759 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -65.93 -24.23 66.78 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.974 -1.079 . . . . 0.0 109.848 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -44.39 17.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.88 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 53' ' ' ASP . 33.1 m -73.96 -3.13 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.189 -0.944 . . . . 0.0 109.836 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.67 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.73 123.31 23.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 120.976 -1.078 . . . . 0.0 108.422 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.41 -18.77 53.75 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -79.64 127.2 31.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.228 -1.16 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.446 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -67.61 104.69 1.67 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.287 -0.883 . . . . 0.0 108.714 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.688 ' HB2' HD12 ' A' ' 39' ' ' ILE . 84.6 t80 -55.45 -17.21 4.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.48 -0.763 . . . . 0.0 110.651 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CE2' HD13 ' A' ' 33' ' ' LEU . 29.3 m-85 -94.11 -38.15 11.25 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.048 -1.032 . . . . 0.0 110.73 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 0.1 OUTLIER -134.67 42.8 2.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.962 -1.086 . . . . 0.0 109.201 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.3 OUTLIER -159.2 -32.52 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 110.235 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.797 HG12 ' NE ' ' A' ' 52' ' ' ARG . 9.3 t -109.12 -51.4 6.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 O-C-N 120.787 -1.196 . . . . 0.0 108.14 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.455 ' HB2' HH21 ' A' ' 52' ' ' ARG . . . -116.43 97.41 49.89 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.141 -178.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.22 -1.41 10.91 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.113 1.875 . . . . 0.0 111.251 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 p -95.35 -26.73 15.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.655 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 72' ' ' SER . 70.9 p -66.62 -36.37 82.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.387 -0.82 . . . . 0.0 109.744 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.92 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.168 -0.957 . . . . 0.0 109.054 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 177.67 170.52 0.44 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 109.291 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.3 80.83 2.61 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.558 2.172 . . . . 0.0 110.809 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER 168.08 -36.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.497 ' CD1' ' HE1' ' A' ' 109' ' ' MET . 1.8 t80 -109.84 -67.06 1.01 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 9.3 t80 -75.58 -17.24 60.11 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.68 -58.2 11.97 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -61.89 -18.62 60.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.609 -0.936 . . . . 0.0 109.594 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.913 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.7 t80 -81.02 -38.47 27.42 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.452 -0.78 . . . . 0.0 109.639 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.83 -12.42 60.38 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.01 -1.056 . . . . 0.0 109.463 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 12.8 pt-20 -96.85 -41.0 8.65 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -62.21 -39.11 97.26 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 79' ' ' PHE . 90.8 t -61.68 -39.85 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.789 -0.83 . . . . 0.0 109.891 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.14 -0.19 53.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.236 -0.915 . . . . 0.0 111.274 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 2.5 t -104.88 -24.21 12.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.899 -1.126 . . . . 0.0 110.161 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.64 16.17 78.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -148.45 58.85 1.08 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.031 -1.276 . . . . 0.0 109.098 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.529 HD13 ' HD1' ' A' ' 118' ' ' TYR . 0.4 OUTLIER -68.83 111.99 5.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -0.814 . . . . 0.0 109.694 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -160.14 82.87 0.71 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -131.46 172.8 11.78 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.917 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.54 171.11 19.56 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.932 ' CE1' HG21 ' A' ' 107' ' ' VAL . 17.2 p90 171.98 -177.11 0.05 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.088 -1.008 . . . . 0.0 109.992 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -109.92 105.59 14.82 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -104.41 -179.86 4.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.1 m -143.83 111.67 6.12 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.713 ' CE2' HG21 ' A' ' 122' ' ' VAL . 13.1 m-30 -86.71 131.02 34.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 108.871 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -160.98 63.89 0.29 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.534 ' CE1' ' HB2' ' A' ' 100' ' ' MET . 0.6 OUTLIER -84.11 41.08 0.8 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.488 -0.758 . . . . 0.0 111.776 -178.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER 89.61 29.76 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.683 0.754 . . . . 0.0 109.511 179.607 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.534 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -129.44 -71.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.947 . . . . 0.0 109.636 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.411 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.5 t -159.14 150.18 16.24 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.417 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.411 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 34.9 Cg_endo -76.25 79.75 2.87 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 122.063 1.842 . . . . 0.0 110.89 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.545 ' O ' HG22 ' A' ' 103' ' ' THR . 1.1 m -84.45 105.63 15.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.701 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -74.51 149.21 40.36 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.047 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.601 ' HB ' HG13 ' A' ' 122' ' ' VAL . 4.8 m -156.03 144.86 12.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 118.588 -1.245 . . . . 0.0 111.53 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -78.05 151.41 33.51 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.932 HG21 ' CE1' ' A' ' 92' ' ' PHE . 4.0 m -128.24 154.04 38.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 117.931 -1.507 . . . . 0.0 110.856 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.577 ' HB2' ' CG ' ' A' ' 6' ' ' PHE . 6.4 t-160 -147.42 125.59 12.18 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.872 ' HB3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -133.69 126.97 31.91 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 120.99 -1.069 . . . . 0.0 108.898 -178.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.583 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 17.8 tttm -138.5 157.82 45.44 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.112 -1.435 . . . . 0.0 110.129 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.499 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 ptmt -75.63 94.18 3.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 109.626 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.981 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -53.27 123.54 12.15 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.252 -0.905 . . . . 0.0 109.617 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 pp -109.38 -13.16 14.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.054 -1.029 . . . . 0.0 110.124 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -42.73 69.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.93 -1.106 . . . . 0.0 109.339 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.85 39.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 117' ' ' SER . 74.5 m-20 -135.33 -90.82 0.31 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.243 -1.151 . . . . 0.0 109.23 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.653 ' H ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER 164.17 -79.57 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.216 -0.927 . . . . 0.0 110.452 179.486 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.901 ' CE1' HG22 ' A' ' 83' ' ' VAL . 7.3 m-85 -125.05 136.03 53.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.981 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.6 p-90 -135.6 150.65 49.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.002 -1.061 . . . . 0.0 110.519 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.872 HG22 ' HB3' ' A' ' 109' ' ' MET . 89.5 t -138.09 105.45 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.741 -0.599 . . . . 0.0 110.326 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.658 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 2.1 m-85 -88.87 138.14 31.68 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.713 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -110.76 114.19 46.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.51 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -81.67 142.38 32.77 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 176.323 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -98.85 134.42 41.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.495 -1.378 . . . . 0.0 109.637 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.031 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.971 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 ptm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -175.78 45.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 109.544 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -107.71 23.62 14.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.883 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 5' ' ' ALA . 0.3 OUTLIER -132.33 -175.11 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.926 -1.109 . . . . 0.0 109.64 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.738 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . -59.17 -160.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 109.538 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.522 ' CD1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -38.07 -41.39 0.57 Allowed 'General case' 0 N--CA 1.517 2.896 0 CA-C-O 122.493 1.14 . . . . 0.0 109.059 178.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.98 39.13 0.05 OUTLIER Glycine 0 N--CA 1.486 1.979 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.738 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 0.2 OUTLIER -67.73 174.96 3.2 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.705 -0.88 . . . . 0.0 110.64 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.33 61.44 0.78 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.61 70.62 0.63 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.015 HG22 HD11 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -69.28 -66.26 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.488 0 O-C-N 121.477 -0.764 . . . . 0.0 110.322 -178.292 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 11' ' ' ILE . 14.4 pt-20 -36.52 -33.74 0.05 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.867 -0.521 . . . . 0.0 111.994 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -82.64 -44.7 15.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.768 -1.208 . . . . 0.0 108.489 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.624 HG23 ' OE1' ' A' ' 22' ' ' GLN . 5.4 m -67.59 -10.38 51.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.693 -0.629 . . . . 0.0 109.691 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.015 HD11 HG22 ' A' ' 11' ' ' ILE . 42.2 mt -97.79 -20.48 17.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.842 -1.161 . . . . 0.0 109.749 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.47 -12.37 25.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.33 -0.856 . . . . 0.0 110.16 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.64 -23.34 6.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.937 -1.102 . . . . 0.0 110.286 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.699 ' CE ' HD13 ' A' ' 23' ' ' LEU . 5.9 tmm? -58.27 146.44 34.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.106 -0.996 . . . . 0.0 109.516 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.56 -40.28 9.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p30 174.06 -47.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.502 -0.749 . . . . 0.0 109.691 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.05 56.92 0.55 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.624 ' OE1' HG23 ' A' ' 14' ' ' THR . 0.7 OUTLIER -132.51 -40.34 0.99 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -1.194 . . . . 0.0 109.795 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.699 HD13 ' CE ' ' A' ' 18' ' ' MET . 1.2 pt? -92.0 8.62 36.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.208 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -71.95 -6.68 43.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.929 -1.107 . . . . 0.0 110.046 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.22 32.24 7.55 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 23' ' ' LEU . 86.9 mt -105.15 158.7 16.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.416 -1.049 . . . . 0.0 108.789 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -93.48 14.44 18.69 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.756 -0.59 . . . . 0.0 109.59 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.536 ' CE2' HG12 ' A' ' 11' ' ' ILE . 25.2 p90 -148.9 154.18 39.08 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.175 -0.953 . . . . 0.0 109.596 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.96 114.4 3.85 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.617 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -91.21 87.7 6.62 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.534 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.3 pp -98.48 148.89 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.649 -0.657 . . . . 0.0 109.79 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.726 ' HB3' HD12 ' A' ' 40' ' ' LEU . 18.1 mt-30 -118.25 174.63 6.12 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 108.501 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.845 HD22 ' O ' ' A' ' 37' ' ' GLY . 62.1 mt -154.33 149.64 27.11 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.21 -0.932 . . . . 0.0 109.171 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.621 ' CG ' HD21 ' A' ' 40' ' ' LEU . 30.4 p30 -130.45 121.03 25.11 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.607 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.6 -79.23 0.0 OUTLIER Glycine 0 N--CA 1.5 2.904 0 C-N-CA 124.362 0.982 . . . . 0.0 113.021 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -66.67 -7.59 21.73 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 121.851 -0.794 . . . . 0.0 110.436 -178.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.845 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 89.89 18.54 50.63 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 m120 -73.26 136.13 44.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.243 . . . . 0.0 108.272 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.594 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -62.13 133.8 27.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.395 -0.815 . . . . 0.0 110.8 -178.499 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 32' ' ' GLN . 10.4 mt -98.85 -32.46 11.33 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.465 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -155.99 -173.73 4.64 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.825 ' CG ' HG21 ' A' ' 57' ' ' VAL . 1.2 t80 -160.96 -67.98 0.06 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.212 -0.93 . . . . 0.0 108.903 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.724 HD21 ' HB3' ' A' ' 45' ' ' ALA . 9.2 p-10 107.02 160.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 124.154 0.982 . . . . 0.0 109.169 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.99 -13.93 55.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.293 -0.88 . . . . 0.0 110.819 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.724 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -59.45 -62.33 1.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 0.0 109.803 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 11.5 pt-20 -66.05 -41.6 90.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.094 -1.003 . . . . 0.0 108.614 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -58.57 -18.06 36.08 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -29.55 22.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.778 -1.425 . . . . 0.0 109.579 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.412 HG12 ' HD2' ' A' ' 124' ' ' ARG . 1.1 mp -80.31 -41.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.324 -0.86 . . . . 0.0 109.394 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.659 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -111.07 4.08 19.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.607 -0.683 . . . . 0.0 110.189 -179.531 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.72 -2.2 74.72 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.677 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.547 ' HD3' " H3'" ' A' ' 126' ' ' HC4 . 0.0 OUTLIER -73.33 84.49 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.922 -1.34 . . . . 0.0 111.81 -178.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -63.99 175.96 0.74 Allowed Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 35.5 Cg_endo -77.05 -44.23 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.553 1.502 . . . . 0.0 110.682 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -16.41 63.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.107 -0.996 . . . . 0.0 110.268 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -48.67 6.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.972 -1.08 . . . . 0.0 110.025 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.825 HG21 ' CG ' ' A' ' 42' ' ' TYR . 32.8 m -70.71 -8.27 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.754 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.495 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -69.65 124.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.587 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.76 -19.62 50.26 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -79.02 132.88 36.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.317 -1.108 . . . . 0.0 108.976 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.71 125.27 27.09 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.7 ' HB2' HD21 ' A' ' 33' ' ' LEU . 75.4 t80 -63.97 -10.94 24.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.024 -1.048 . . . . 0.0 110.444 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CE2' HD13 ' A' ' 33' ' ' LEU . 83.5 m-85 -112.58 26.06 10.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.959 -1.088 . . . . 0.0 110.275 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -166.71 -58.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.978 -1.076 . . . . 0.0 110.891 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.58 -7.18 55.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.933 -1.105 . . . . 0.0 110.981 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.563 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 17.4 t -117.4 -26.43 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.63 -1.294 . . . . 0.0 109.526 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.656 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -163.71 96.84 1.0 Allowed Pre-proline 0 C--N 1.288 -2.076 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.961 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.42 -2.15 11.99 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.891 1.727 . . . . 0.0 110.564 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.2 p -90.1 -25.06 20.93 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.264 -0.897 . . . . 0.0 109.204 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.595 HG21 ' CE2' ' A' ' 62' ' ' PHE . 46.0 p -72.77 -5.37 37.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.466 -0.771 . . . . 0.0 110.139 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -88.39 59.63 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.967 -1.083 . . . . 0.0 109.317 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.404 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.6 OUTLIER -146.54 171.96 5.79 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.171 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 33.7 Cg_endo -75.75 79.54 2.81 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 122.373 2.048 . . . . 0.0 110.292 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.9 OUTLIER 169.21 -34.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.467 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.4 t80 -106.28 -67.07 0.96 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.559 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 27.7 t80 -78.48 -21.94 48.26 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -61.6 -56.67 21.76 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' CB ' HG21 ' A' ' 90' ' ' THR . 4.1 mmtt -65.62 -16.4 63.69 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.57 -0.959 . . . . 0.0 109.334 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.851 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.5 t80 -76.73 -37.68 55.57 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.66 -6.38 55.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.2 mm-40 -95.76 -39.06 10.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -70.36 -42.49 65.09 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.886 HG22 ' CE1' ' A' ' 118' ' ' TYR . 57.4 t -59.5 -40.13 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.843 -0.798 . . . . 0.0 109.73 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.14 -17.18 43.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -0.926 . . . . 0.0 110.744 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 m -88.28 -20.87 24.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.944 -1.097 . . . . 0.0 109.805 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.45 21.3 64.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -165.82 57.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -1.151 . . . . 0.0 109.355 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.498 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 6.3 tt -46.93 124.62 6.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.531 -0.731 . . . . 0.0 110.222 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.427 ' HB3' ' HE3' ' A' ' 110' ' ' LYS . 16.6 p-10 -161.42 89.59 0.77 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.533 HG23 ' SD ' ' A' ' 109' ' ' MET . 4.0 t -152.27 152.65 32.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.807 -1.183 . . . . 0.0 110.545 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.406 ' C ' ' CD2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -140.13 179.91 6.35 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.105 ' CE1' HG21 ' A' ' 107' ' ' VAL . 18.0 p90 172.47 171.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.838 . . . . 0.0 109.252 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.99 108.95 20.71 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.408 ' HB2' HG11 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -111.46 169.94 8.46 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.724 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' THR . 87.7 m -136.15 108.36 7.26 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 109.266 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.976 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 12.3 m-30 -80.29 85.62 5.77 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -108.44 34.38 3.67 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.69 158.33 28.37 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.502 ' C ' ' O ' ' A' ' 98' ' ' TYR . 2.0 mt-30 0.08 64.86 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.46 0.704 . . . . 0.0 112.525 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.22 -153.55 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -178.447 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.537 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -93.7 177.41 1.97 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 0.0 108.726 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.537 ' CD ' HG22 ' A' ' 101' ' ' THR . 34.1 Cg_endo -77.07 112.8 3.49 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.686 1.591 . . . . 0.0 110.013 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.457 HG22 HG13 ' A' ' 105' ' ' VAL . 2.8 m -113.29 130.34 56.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.727 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -104.52 145.21 30.62 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.041 ' HA ' HG23 ' A' ' 125' ' ' VAL . 26.3 m -154.57 144.8 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.615 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -78.26 117.55 19.63 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 174.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.105 HG21 ' CE1' ' A' ' 92' ' ' PHE . 23.2 m -99.2 151.96 4.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 117.852 -1.539 . . . . 0.0 108.235 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -156.32 102.68 2.11 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.851 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.17 144.89 41.9 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.192 -0.942 . . . . 0.0 109.529 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -141.04 -178.51 5.6 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.653 -1.28 . . . . 0.0 109.815 -179.273 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 103.74 16.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.027 -1.045 . . . . 0.0 108.857 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.839 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -51.59 146.13 8.05 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.616 -0.677 . . . . 0.0 109.884 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.29 12.81 21.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.269 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.54 9.16 12.01 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.045 -1.034 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 136.56 45.58 0.09 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.23 52.88 6.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.114 . . . . 0.0 109.32 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.763 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.8 OUTLIER -93.76 -162.28 0.93 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.882 . . . . 0.0 109.717 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.886 ' CE1' HG22 ' A' ' 83' ' ' VAL . 10.4 m-85 -149.9 111.59 4.52 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.839 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 15.1 p-90 -117.16 144.7 44.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.701 -1.249 . . . . 0.0 111.684 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.851 HG13 ' CG ' ' A' ' 109' ' ' MET . 13.8 t -120.85 114.57 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.554 0.692 . . . . 0.0 109.932 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.795 ' HE2' HD13 ' A' ' 11' ' ' ILE . 13.5 m-30 -95.33 121.9 37.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.976 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.3 t -107.02 112.79 41.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.889 -1.125 . . . . 0.0 108.468 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.522 ' HD3' ' CD1' ' A' ' 6' ' ' PHE . 14.3 tptp -89.21 125.17 34.96 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.539 ' HA ' HG12 ' A' ' 105' ' ' VAL . 28.6 ttt180 -74.33 123.65 25.01 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.688 -1.258 . . . . 0.0 109.458 -178.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 1.041 HG23 ' HA ' ' A' ' 105' ' ' VAL . 25.5 t . . . . . 0 C--N 1.301 -1.516 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.699 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.659 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -114.06 94.93 5.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.579 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -66.85 95.67 0.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.123 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 8' ' ' SER . 9.7 p -138.53 55.55 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.077 -1.014 . . . . 0.0 110.067 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 4' ' ' VAL . . . 61.86 -152.67 0.36 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.744 -1.222 . . . . 0.0 108.707 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CE1' ' CD ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -85.54 10.56 12.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.955 -1.091 . . . . 0.0 108.728 177.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.51 ' HA3' ' HE3' ' A' ' 123' ' ' LYS . . . 133.27 25.5 0.65 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.715 ' O ' HG22 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -104.71 123.62 47.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.24 . . . . 0.0 110.159 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.51 71.75 6.11 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.29 50.29 14.62 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.884 HG22 HD11 ' A' ' 15' ' ' LEU . 3.2 mm -50.73 -51.62 19.29 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.713 0 O-C-N 121.696 -0.628 . . . . 0.0 110.155 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' ILE . 4.0 tt0 -34.19 -41.51 0.11 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.15 -42.35 38.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.806 -1.184 . . . . 0.0 109.263 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.959 HG23 ' CE ' ' A' ' 18' ' ' MET . 1.2 m -60.7 -26.11 66.9 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.522 -0.737 . . . . 0.0 109.855 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.917 HD22 HD22 ' A' ' 23' ' ' LEU . 5.7 mt -96.77 -17.06 20.51 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.941 -1.1 . . . . 0.0 109.812 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.85 -12.24 25.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.047 -1.033 . . . . 0.0 110.198 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.19 61.89 1.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.883 -1.136 . . . . 0.0 109.709 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.959 ' CE ' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -150.74 -160.58 1.19 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.165 -0.96 . . . . 0.0 110.203 -179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.02 -73.37 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.947 . . . . 0.0 110.25 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -171.55 102.9 0.19 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.196 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.0 39.94 0.4 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.618 ' HB2' ' HE3' ' A' ' 18' ' ' MET . 5.4 pm0 -124.62 -36.68 2.58 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.666 -0.902 . . . . 0.0 109.103 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.917 HD22 HD22 ' A' ' 15' ' ' LEU . 2.3 pp -105.18 31.9 4.58 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.5 -15.39 11.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 109.907 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.74 31.56 8.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.702 HD11 ' HA ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -104.1 173.54 6.26 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.159 -1.201 . . . . 0.0 108.888 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.7 21.27 11.61 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 122.262 1.03 . . . . 0.0 108.23 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.542 ' HD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -160.51 113.1 2.01 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.396 1.093 . . . . 0.0 108.395 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' HA2' ' ND2' ' A' ' 43' ' ' ASN . . . -46.96 143.41 5.31 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.346 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.704 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -125.34 92.34 3.6 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.692 HD12 ' N ' ' A' ' 32' ' ' GLN . 1.2 pp -99.1 167.33 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.454 -0.779 . . . . 0.0 111.109 -177.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.692 ' N ' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -134.22 166.59 22.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.81 HD22 ' C ' ' A' ' 37' ' ' GLY . 19.2 mt -149.64 148.35 29.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.971 -1.081 . . . . 0.0 110.065 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 36' ' ' ASP . 2.3 p30 -115.86 133.06 56.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.144 -0.972 . . . . 0.0 109.533 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -12.55 74.53 0.0 OUTLIER Glycine 0 N--CA 1.51 3.631 0 C-N-CA 124.697 1.142 . . . . 0.0 113.307 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER 162.44 -24.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.53 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.81 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.63 20.7 14.11 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.622 ' O ' HD23 ' A' ' 33' ' ' LEU . 23.0 m120 -87.67 131.99 34.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -1.139 . . . . 0.0 108.538 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.667 HD13 ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -67.77 138.39 22.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.113 -0.992 . . . . 0.0 111.161 -178.362 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' A' ' 32' ' ' GLN . 6.4 mt -99.61 -32.1 11.25 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.19 -179.59 6.24 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.576 ' CD1' HG22 ' A' ' 31' ' ' ILE . 27.7 t80 -140.63 -95.15 0.15 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.609 -1.307 . . . . 0.0 111.05 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.646 ' HB2' HD12 ' A' ' 23' ' ' LEU . 2.0 t-20 153.91 150.26 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -74.68 -58.45 3.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.4 -0.812 . . . . 0.0 110.173 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -38.94 -59.28 0.99 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.848 -0.533 . . . . 0.0 111.567 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.498 ' OE1' ' CG ' ' A' ' 42' ' ' TYR . 8.0 pt-20 -63.25 -43.58 97.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 0.0 110.009 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.418 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -63.3 -14.37 53.54 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.13 -25.12 20.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.959 -1.318 . . . . 0.0 109.149 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.576 HG22 HG23 ' A' ' 50' ' ' THR . 1.1 mp -79.17 -47.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.576 HG23 HG22 ' A' ' 49' ' ' ILE . 4.8 p -100.42 -6.83 25.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.438 -0.788 . . . . 0.0 110.217 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 84.75 -5.75 80.81 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.73 ' CD ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -53.26 115.31 1.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.026 -1.279 . . . . 0.0 110.884 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 57' ' ' VAL . 17.6 m-20 -90.98 156.98 43.84 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.81 -50.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.787 1.658 . . . . 0.0 111.282 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -20.84 65.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 110.329 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -89.95 -42.95 10.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.003 -1.061 . . . . 0.0 109.826 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 53' ' ' ASP . 19.3 m -76.51 -1.25 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.0 109.824 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.638 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -70.59 122.93 23.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.01 -17.47 58.15 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -79.73 135.02 36.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -1.168 . . . . 0.0 109.492 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.43 102.17 3.7 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.951 ' CZ ' HG21 ' A' ' 70' ' ' THR . 8.3 t80 -63.61 -15.0 57.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 76' ' ' TYR . 2.7 m-85 -88.38 12.68 13.54 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.62 -1.232 . . . . 0.0 110.602 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.04 -52.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 0.0 110.552 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.75 -3.88 24.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.02 -1.05 . . . . 0.0 111.064 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.622 HG11 ' NE ' ' A' ' 52' ' ' ARG . 11.8 t -128.12 -57.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.673 -1.267 . . . . 0.0 109.043 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.513 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -109.1 105.64 57.52 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.574 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.63 -1.1 10.63 Favored 'Trans proline' 0 C--N 1.32 -0.934 0 C-N-CA 121.847 1.698 . . . . 0.0 111.557 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.8 p -104.45 -19.89 13.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.836 -1.165 . . . . 0.0 109.665 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.951 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 63.9 p -72.68 -6.11 42.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.965 -1.084 . . . . 0.0 109.915 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -88.86 53.71 2.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.985 -1.072 . . . . 0.0 109.11 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.463 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -126.98 177.49 1.99 Allowed Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.8 Cg_endo -77.94 -3.54 13.59 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.126 1.884 . . . . 0.0 111.45 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -105.8 -25.94 11.97 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.809 -1.182 . . . . 0.0 109.521 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.5 t80 -102.02 -70.39 0.75 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 9.2 t80 -72.86 -17.7 61.51 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.45 -63.45 4.28 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.9 ' CB ' HG21 ' A' ' 90' ' ' THR . 5.1 mmtt -63.52 -15.63 58.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.626 -0.926 . . . . 0.0 109.544 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.859 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.4 t80 -79.63 -39.63 31.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -79.62 -6.41 57.04 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 108.829 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.86 -40.12 9.48 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -70.55 -44.33 58.22 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.931 HG22 ' CE1' ' A' ' 118' ' ' TYR . 94.3 t -54.32 -38.68 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.952 . . . . 0.0 109.243 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.96 -16.93 34.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.444 -0.785 . . . . 0.0 110.637 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.6 -18.25 30.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.937 -1.102 . . . . 0.0 110.178 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.3 18.13 74.77 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -162.39 57.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.128 -1.219 . . . . 0.0 109.408 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.557 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -49.25 122.3 5.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.405 -0.81 . . . . 0.0 110.257 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 58.5 t30 -160.65 83.9 0.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 108.826 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.9 HG21 ' CB ' ' A' ' 78' ' ' LYS . 8.9 t -147.73 153.03 38.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 0.0 110.724 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -137.42 173.66 11.43 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.992 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 6.2 p90 179.52 153.09 0.44 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.027 -1.046 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.67 106.85 13.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.78 175.53 5.45 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.249 -0.907 . . . . 0.0 110.163 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 103' ' ' THR . 22.2 m -143.35 111.41 6.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.766 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 17.4 m-30 -79.62 96.46 6.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.182 -0.948 . . . . 0.0 109.147 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -113.44 30.06 7.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.237 -0.914 . . . . 0.0 110.052 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.578 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -79.1 159.56 27.44 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.517 ' C ' ' O ' ' A' ' 98' ' ' TYR . 2.9 pt20 -0.67 65.03 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 123.37 0.668 . . . . 0.0 112.31 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.578 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER 174.39 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.546 -0.721 . . . . 0.0 109.117 -177.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.25 171.69 5.75 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 108.971 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.97 80.75 2.89 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 122.004 1.802 . . . . 0.0 111.277 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 95' ' ' THR . 3.2 m -70.53 145.88 50.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 109.0 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -116.79 138.85 51.2 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.589 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.718 ' HA ' HG23 ' A' ' 125' ' ' VAL . 15.0 m -155.75 144.81 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.995 -1.065 . . . . 0.0 110.003 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.514 ' HG2' ' CB ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -95.61 114.33 26.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 175.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.992 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -88.04 166.99 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.285 1.041 . . . . 0.0 110.666 -176.088 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.449 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 23.3 t-160 -161.47 101.93 1.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.903 ' HG2' HG13 ' A' ' 120' ' ' VAL . 4.5 mtm -112.5 150.04 31.81 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.267 -0.896 . . . . 0.0 110.57 -177.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.607 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.9 tttt -144.65 174.27 11.11 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.181 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.43 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 10.4 tttm -83.17 104.6 13.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.83 -1.169 . . . . 0.0 109.108 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.755 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.93 137.48 32.44 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.49 -0.756 . . . . 0.0 109.671 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.67 3.29 54.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.593 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 t -60.8 -35.21 75.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.836 -1.165 . . . . 0.0 109.559 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.72 60.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 60.24 70.7 0.61 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -1.125 . . . . 0.0 109.135 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.747 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -123.59 -168.14 1.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.984 -179.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.931 ' CE1' HG22 ' A' ' 83' ' ' VAL . 25.4 m-85 -150.66 104.48 3.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.755 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 11.3 p-90 -106.08 141.5 37.34 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 118.553 -1.259 . . . . 0.0 112.011 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.903 HG13 ' HG2' ' A' ' 109' ' ' MET . 57.8 t -116.85 117.77 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.665 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 16.1 m-30 -102.18 118.83 37.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.1 -1.0 . . . . 0.0 109.091 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.766 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -101.22 129.22 52.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.836 -1.165 . . . . 0.0 110.09 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.526 ' CD ' ' CE1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -102.93 123.55 46.77 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.134 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HA ' HG12 ' A' ' 105' ' ' VAL . 12.4 ttt180 -77.57 121.14 23.51 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.109 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.718 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.236 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.513 ' C2 ' ' HB1' ' A' ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.14 60.56 1.7 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -112.01 119.81 39.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.199 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 4' ' ' VAL . 9.7 p -177.03 62.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.738 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.441 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . 59.56 -146.1 0.5 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.094 -1.004 . . . . 0.0 108.391 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.58 ' CD1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -94.66 32.17 1.66 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.771 -1.206 . . . . 0.0 108.263 177.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.522 ' CA ' ' HE3' ' A' ' 123' ' ' LYS . . . 110.75 17.67 8.95 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.664 ' CA ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -93.48 104.47 16.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.333 -1.098 . . . . 0.0 110.362 -179.535 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -71.41 80.53 0.77 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.065 -0.397 . . . . 0.0 110.479 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 9' ' ' GLU . 12.7 m-20 45.11 61.21 2.63 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.147 -0.971 . . . . 0.0 108.884 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.022 HG22 HD11 ' A' ' 15' ' ' LEU . 3.8 mm -63.57 -63.1 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -37.85 -33.58 0.09 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.949 -0.469 . . . . 0.0 111.851 -178.012 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -81.06 -44.74 17.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.876 -1.14 . . . . 0.0 108.339 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 18' ' ' MET . 2.6 m -70.04 -9.07 54.11 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.642 -0.661 . . . . 0.0 109.724 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.022 HD11 HG22 ' A' ' 11' ' ' ILE . 21.1 mt -97.44 -21.88 16.9 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.954 -1.091 . . . . 0.0 109.197 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 114' ' ' SER . . . -91.8 -34.26 14.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 0.0 109.945 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.56 49.72 0.82 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.05 -1.031 . . . . 0.0 108.755 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.812 ' CE ' HD22 ' A' ' 23' ' ' LEU . 5.8 tmm? -133.55 129.26 36.81 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.17 -71.66 0.14 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.446 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.89 -39.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 109.685 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -100.78 52.59 0.92 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.446 ' HB3' ' HG3' ' A' ' 18' ' ' MET . 1.7 tt0 -122.8 -41.11 2.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -1.195 . . . . 0.0 109.215 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.812 HD22 ' CE ' ' A' ' 18' ' ' MET . 2.4 pt? -90.58 0.24 57.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 110.079 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.751 ' OD1' ' HB3' ' A' ' 44' ' ' ALA . 55.5 t0 -70.16 -6.45 34.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.847 -1.158 . . . . 0.0 110.271 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.22 32.16 7.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 23' ' ' LEU . 29.3 mt -105.3 151.46 24.11 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.459 -1.024 . . . . 0.0 108.689 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.24 24.7 4.8 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.589 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -160.16 122.14 3.24 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -179.32 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.515 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -58.8 154.55 27.35 Favored Glycine 0 C--N 1.288 -2.099 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.874 -177.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -127.78 85.15 2.32 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.621 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.1 pp -86.29 144.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.885 0.85 . . . . 0.0 110.724 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.53 ' HB3' HD12 ' A' ' 40' ' ' LEU . 15.3 mm100 -114.24 159.52 20.06 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 37' ' ' GLY . 72.3 mt -151.82 149.7 29.3 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.9 -1.125 . . . . 0.0 109.71 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.504 ' CB ' HD21 ' A' ' 40' ' ' LEU . 41.5 p-10 -131.99 123.29 27.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 110.476 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 42.88 -79.36 0.0 OUTLIER Glycine 0 N--CA 1.498 2.798 0 C-N-CA 124.398 0.999 . . . . 0.0 113.053 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -69.52 -5.96 27.62 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.736 -0.861 . . . . 0.0 110.358 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.83 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 87.4 24.33 36.96 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 36' ' ' ASP . 2.1 m120 -78.63 133.09 37.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.137 -1.214 . . . . 0.0 108.102 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.54 HD11 ' HB ' ' A' ' 31' ' ' ILE . 1.7 tp -56.77 136.38 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 111.711 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 33' ' ' LEU . 1.3 mt -110.67 -24.41 10.52 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.491 ' NE2' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -169.74 113.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.399 -0.813 . . . . 0.0 109.422 179.331 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.619 ' CD1' HG22 ' A' ' 31' ' ' ILE . 19.1 t80 -98.71 -67.68 0.84 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.164 -0.96 . . . . 0.0 111.361 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 5.6 p-10 105.86 177.43 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 0 C-N-CA 124.021 0.929 . . . . 0.0 108.863 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.751 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -97.29 -25.17 15.35 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.845 -1.159 . . . . 0.0 113.171 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.56 -64.31 0.85 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.331 -1.481 . . . . 0.0 110.601 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.515 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.5 pt-20 -57.88 -54.4 47.37 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.508 0.671 . . . . 0.0 109.935 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.427 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -57.93 -14.86 18.17 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -76.0 -38.88 56.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.766 -1.432 . . . . 0.0 108.698 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 50' ' ' THR . 1.0 OUTLIER -82.78 -56.72 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.381 -0.824 . . . . 0.0 109.27 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.878 HG21 " C3'" ' A' ' 126' ' ' HC4 . 30.0 p -75.24 -24.42 57.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.365 -0.834 . . . . 0.0 109.957 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 95.6 -15.74 62.59 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -50.07 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.352 -1.087 . . . . 0.0 109.841 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 57' ' ' VAL . 15.9 m-20 -64.65 160.87 49.5 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 108.699 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.35 -58.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.877 1.718 . . . . 0.0 110.807 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.618 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -62.62 -19.55 63.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.176 -179.445 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -88.5 -41.63 12.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 109.828 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 53' ' ' ASP . 23.4 m -79.59 0.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.822 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -71.0 121.74 21.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.053 -1.029 . . . . 0.0 108.699 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.49 -15.47 61.31 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -79.3 137.07 37.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.239 . . . . 0.0 109.459 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.95 103.99 6.28 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.661 ' CZ ' HG21 ' A' ' 70' ' ' THR . 26.1 t80 -60.17 -16.63 34.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -0.885 . . . . 0.0 111.089 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 2.4 m-85 -91.32 15.09 12.75 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.023 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -176.66 -52.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.008 -1.057 . . . . 0.0 110.419 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.15 -6.7 41.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 110.926 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.581 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 11.0 t -126.07 -60.43 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 O-C-N 120.636 -1.29 . . . . 0.0 109.07 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.414 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -108.87 103.96 53.4 Favored Pre-proline 0 C--N 1.293 -1.874 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.267 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.84 7.26 3.27 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.907 1.738 . . . . 0.0 111.777 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.6 p -108.58 -20.4 13.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.819 -1.176 . . . . 0.0 109.869 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.661 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 30.2 p -77.42 -2.63 36.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.952 . . . . 0.0 110.611 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -88.53 55.2 3.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.125 -0.985 . . . . 0.0 109.156 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.445 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -124.84 175.25 3.12 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.46 -0.775 . . . . 0.0 109.124 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.9 Cg_endo -77.56 -2.19 12.36 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 122.265 1.977 . . . . 0.0 111.288 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 59.5 mt-10 -107.96 -25.72 11.04 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.939 -1.101 . . . . 0.0 109.509 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.565 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 2.1 t80 -102.13 -70.53 0.75 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 18.1 t80 -70.59 -17.37 62.9 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.12 -61.2 6.6 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.663 ' CB ' HG21 ' A' ' 90' ' ' THR . 1.2 mmtp -63.38 -15.92 58.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.999 . . . . 0.0 109.487 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.9 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.8 t80 -79.63 -38.17 34.42 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -8.72 58.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 77' ' ' GLY . 1.3 mt-10 -95.52 -40.12 9.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.83 -41.05 89.3 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.4 t -60.0 -40.81 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.662 -0.905 . . . . 0.0 109.497 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.18 -5.06 58.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.284 -0.885 . . . . 0.0 110.785 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.5 p -100.19 -19.06 16.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.836 -1.165 . . . . 0.0 109.945 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.03 16.47 78.79 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -155.62 57.97 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -1.22 . . . . 0.0 109.335 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.461 HD13 ' CD1' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -56.51 114.17 1.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.823 . . . . 0.0 109.733 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -161.25 83.79 0.64 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.432 -0.792 . . . . 0.0 109.033 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.663 HG21 ' CB ' ' A' ' 78' ' ' LYS . 5.0 t -139.35 173.8 11.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.073 -1.017 . . . . 0.0 109.952 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -157.9 171.55 20.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.928 ' CE1' HG21 ' A' ' 107' ' ' VAL . 8.9 p90 178.7 161.01 0.66 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.863 -1.148 . . . . 0.0 110.506 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -88.3 110.12 20.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.45 178.56 4.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.109 -0.995 . . . . 0.0 110.073 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 84.4 m -141.85 107.99 5.22 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.801 ' CE2' HG21 ' A' ' 122' ' ' VAL . 16.5 m-30 -86.53 121.31 28.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.176 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -154.21 48.86 0.62 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.544 ' O ' ' C ' ' A' ' 99' ' ' GLN . 7.5 p90 -78.9 148.07 32.86 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 98' ' ' TYR . 4.6 tt0 2.09 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 CA-C-O 121.851 0.834 . . . . 0.0 111.589 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 98' ' ' TYR . 6.0 ttp 178.29 -149.07 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.28 169.47 8.59 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 0.0 109.233 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.85 155.21 30.49 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 122.16 1.907 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.588 ' O ' HG22 ' A' ' 103' ' ' THR . 1.6 m -149.17 94.79 2.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 109.289 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.43 ' C ' HG13 ' A' ' 105' ' ' VAL . 1.2 ptpp? -69.77 142.57 53.19 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.994 -1.066 . . . . 0.0 108.168 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.757 ' HA ' HG23 ' A' ' 125' ' ' VAL . 10.9 m -156.2 142.17 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.908 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.522 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -95.03 111.6 23.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 175.06 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.928 HG21 ' CE1' ' A' ' 92' ' ' PHE . 1.4 m -86.29 162.35 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.818 0.818 . . . . 0.0 111.893 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 7.7 t-160 -160.55 102.0 1.35 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 175.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.885 ' HG2' HG13 ' A' ' 120' ' ' VAL . 3.2 mtm -112.66 148.08 35.4 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.56 -0.713 . . . . 0.0 109.435 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.63 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.4 tttm -138.18 -165.47 1.81 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.68 -1.263 . . . . 0.0 108.985 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 12.9 tttt -107.51 98.2 7.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.03 -1.044 . . . . 0.0 109.0 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.923 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -50.74 130.81 25.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 109.435 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mp -115.96 -18.98 10.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.041 -1.037 . . . . 0.0 109.777 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -52.98 -27.7 20.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 109.37 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.02 41.92 0.05 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 117' ' ' SER . 4.0 m-20 -127.59 -88.51 0.55 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -1.156 . . . . 0.0 109.552 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.748 ' H ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER 165.53 -75.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.216 -0.927 . . . . 0.0 110.862 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.787 ' CE1' HG22 ' A' ' 83' ' ' VAL . 5.4 m-85 -138.58 130.32 27.85 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.136 -0.978 . . . . 0.0 109.358 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.923 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 12.1 p-90 -125.92 138.15 53.76 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.677 -1.264 . . . . 0.0 111.883 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.885 HG13 ' HG2' ' A' ' 109' ' ' MET . 61.6 t -113.74 115.87 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.071 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.641 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 15.8 m-30 -100.46 126.91 46.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.178 -0.951 . . . . 0.0 108.84 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.801 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.5 t -109.49 122.71 64.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.937 -1.102 . . . . 0.0 110.344 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.589 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -99.22 124.71 44.5 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.461 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.438 ' NH1' ' CG1' ' A' ' 49' ' ' ILE . 23.3 ttt180 -74.4 121.89 22.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.64 -1.224 . . . . 0.0 109.125 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.341 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.878 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.73 133.42 12.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 109.344 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -165.97 39.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.742 HG21 ' HA ' ' A' ' 10' ' ' ASP . 1.3 p -166.66 -166.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 109.194 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.816 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . -55.25 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.075 -1.016 . . . . 0.0 109.751 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.556 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -51.29 87.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.0 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 48.41 24.93 4.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.816 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 68.0 m -63.98 171.57 2.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.985 -1.303 . . . . 0.0 109.317 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.62 57.04 1.57 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.742 ' HA ' HG21 ' A' ' 4' ' ' VAL . 4.4 m-20 54.84 83.12 0.09 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.137 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.806 HG22 HD11 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -80.9 -64.84 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.45 0 O-C-N 121.308 -0.87 . . . . 0.0 111.332 -177.155 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -41.78 -26.66 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.174 -0.954 . . . . 0.0 111.457 -177.369 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' ILE . 2.1 t-20 -89.67 -39.27 13.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.046 -1.034 . . . . 0.0 109.516 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.731 HG23 ' HE1' ' A' ' 18' ' ' MET . 1.3 m -65.88 -59.63 3.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.146 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.806 HD11 HG22 ' A' ' 11' ' ' ILE . 11.6 mt -49.76 -23.75 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.754 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.31 62.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.849 -1.157 . . . . 0.0 109.31 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -60.43 -16.57 37.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.518 -0.739 . . . . 0.0 110.606 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.731 ' HE1' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -160.01 -150.96 0.23 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.744 -1.223 . . . . 0.0 110.231 -179.462 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -158.04 -38.21 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.785 -1.197 . . . . 0.0 110.679 -178.71 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 38.0 p-10 -155.69 90.68 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.929 -1.107 . . . . 0.0 110.198 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 153.85 -27.65 0.74 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.545 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.602 ' CB ' ' HG3' ' A' ' 18' ' ' MET . 0.0 OUTLIER -107.86 -42.71 4.63 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 109.283 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.583 HD23 ' CD2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -77.8 4.16 12.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.511 -0.743 . . . . 0.0 110.238 179.484 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' N ' HD12 ' A' ' 23' ' ' LEU . 38.4 p-10 -76.73 -3.01 35.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.51 -1.369 . . . . 0.0 110.129 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.72 28.75 14.57 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.951 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 8.0 mt -97.02 -172.68 2.5 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.691 -1.476 . . . . 0.0 109.544 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.52 -0.36 22.19 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.717 0.77 . . . . 0.0 109.288 179.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CZ ' HG12 ' A' ' 11' ' ' ILE . 46.0 p90 -141.72 133.53 27.24 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.158 -0.964 . . . . 0.0 109.218 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.555 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -59.1 135.95 51.48 Favored Glycine 0 C--N 1.292 -1.87 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -116.23 113.87 23.62 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.893 -1.357 . . . . 0.0 107.781 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.687 HG22 ' CD1' ' A' ' 42' ' ' TYR . 1.4 pp -118.84 160.14 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-O 121.851 0.834 . . . . 0.0 110.303 -178.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.908 ' HB3' HD12 ' A' ' 40' ' ' LEU . 34.2 mt-30 -126.96 168.09 15.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.886 HD22 ' O ' ' A' ' 37' ' ' GLY . 83.0 mt -152.68 146.79 25.43 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.91 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' ASP . 18.4 m-20 -121.26 123.65 42.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 0.0 110.023 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 37.16 -76.9 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 0 C-N-CA 124.695 1.14 . . . . 0.0 113.647 178.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ASP . 19.7 t0 -69.33 -3.6 14.76 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.658 -0.907 . . . . 0.0 111.011 -178.176 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.886 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 90.21 14.61 58.67 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 19.8 m-80 -70.03 135.59 49.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.931 -1.335 . . . . 0.0 108.425 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.694 HD12 HD21 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -64.78 140.1 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 122.032 0.92 . . . . 0.0 111.219 -178.328 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.908 HD12 ' HB3' ' A' ' 32' ' ' GLN . 1.8 mt -112.37 -26.06 8.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -163.06 159.4 23.22 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.863 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.687 ' CD1' HG22 ' A' ' 31' ' ' ILE . 23.4 t80 -144.75 -70.62 0.28 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.673 -1.267 . . . . 0.0 110.819 -178.05 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.54 ' CB ' HD13 ' A' ' 23' ' ' LEU . 7.6 p-10 107.09 178.47 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 0 C-N-CA 123.876 0.87 . . . . 0.0 109.098 -179.186 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.65 -26.03 15.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.99 -1.069 . . . . 0.0 112.849 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -51.06 -64.09 0.92 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.356 -1.465 . . . . 0.0 110.639 -178.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.555 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 2.0 pt-20 -58.84 -52.91 63.72 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.0 110.016 -179.059 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.2 -15.79 24.1 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.048 -178.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -77.62 -36.14 51.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.717 -1.46 . . . . 0.0 108.746 179.655 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.52 HG22 HG23 ' A' ' 50' ' ' THR . 0.2 OUTLIER -85.94 -55.97 5.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.426 -0.797 . . . . 0.0 109.235 179.76 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 49' ' ' ILE . 29.9 p -78.21 -22.27 48.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.459 -0.776 . . . . 0.0 110.438 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 94.52 -18.4 57.13 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.642 ' NE ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -45.63 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.493 -1.004 . . . . 0.0 110.254 179.455 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.764 ' O ' HG22 ' A' ' 57' ' ' VAL . 95.9 m-20 -67.71 157.83 84.98 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.149 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.2 -40.11 0.39 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.739 1.626 . . . . 0.0 110.4 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -25.77 51.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.87 . . . . 0.0 110.126 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 7.6 tp60 -83.8 -44.88 13.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.108 -0.995 . . . . 0.0 109.953 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 53' ' ' ASP . 24.6 m -69.85 -7.84 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.138 -0.976 . . . . 0.0 109.814 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.598 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -68.8 121.95 19.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 121.053 -1.029 . . . . 0.0 108.349 179.831 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.48 -15.38 58.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 56' ' ' GLN . 67.6 mmtt -79.9 144.06 33.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.17 -1.194 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.71 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.9 OUTLIER -81.51 115.2 20.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.293 -0.879 . . . . 0.0 108.822 179.401 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.754 ' HD2' HD11 ' A' ' 33' ' ' LEU . 1.7 t80 -61.08 -34.05 74.31 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.029 -1.044 . . . . 0.0 110.025 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 52.2 m-85 -97.18 13.34 29.65 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 118.472 -1.291 . . . . 0.0 111.96 -177.262 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -139.72 -53.31 0.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.646 -1.284 . . . . 0.0 111.115 -179.719 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.24 16.08 21.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.832 -1.167 . . . . 0.0 112.003 -178.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 61' ' ' ASN . 15.5 t -125.43 -53.1 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.269 -1.519 . . . . 0.0 109.468 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB3' ' OG1' ' A' ' 70' ' ' THR . . . -117.88 103.03 50.79 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.628 -177.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.52 1.37 8.05 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 121.822 1.681 . . . . 0.0 110.577 179.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 p -111.13 -20.69 12.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.975 -1.078 . . . . 0.0 109.802 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.672 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 67.2 p -82.58 1.6 37.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.981 . . . . 0.0 110.223 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -88.62 61.47 6.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.945 -1.097 . . . . 0.0 109.259 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.461 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -136.01 177.3 2.27 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.188 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.5 Cg_endo -79.08 1.46 9.15 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.295 1.997 . . . . 0.0 111.143 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 4.3 mm-40 -107.83 -28.1 9.85 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 120.879 -1.138 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.406 ' HZ ' HG11 ' A' ' 120' ' ' VAL . 1.8 t80 -102.46 -69.82 0.77 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 15.5 t80 -72.06 -16.7 62.04 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.037 -1.039 . . . . 0.0 108.206 177.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.81 -60.94 6.65 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.624 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -63.49 -16.29 60.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.956 . . . . 0.0 109.414 -179.499 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.876 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.8 t80 -80.75 -37.9 29.61 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -8.23 57.25 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 108.442 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.91 -40.6 9.22 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -69.19 -39.61 82.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 79' ' ' PHE . 62.7 t -63.3 -37.19 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.69 -0.888 . . . . 0.0 109.583 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.87 -3.47 55.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 110.83 -179.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.3 t -106.17 -18.67 13.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.79 -1.194 . . . . 0.0 110.124 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.18 19.49 72.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -157.06 55.93 0.52 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -1.222 . . . . 0.0 109.641 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 1.7 tt -54.61 120.34 6.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.801 . . . . 0.0 110.047 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 30.9 p-10 -160.47 82.49 0.68 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 78' ' ' LYS . 7.3 t -128.34 162.4 27.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 110.44 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -154.52 149.06 26.31 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.032 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 12.7 p90 -172.83 149.17 1.93 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.431 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -79.89 107.3 12.57 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.68 172.87 6.57 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.1 -1.0 . . . . 0.0 110.039 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m -143.12 109.58 5.39 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.527 ' CE2' HG21 ' A' ' 122' ' ' VAL . 21.3 m-85 -80.71 115.83 20.42 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -128.51 41.69 3.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.591 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -78.07 78.89 4.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.807 -0.558 . . . . 0.0 110.126 -179.721 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.568 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER 53.74 37.8 27.05 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.63 -0.668 . . . . 0.0 110.233 -179.512 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -150.08 -179.12 6.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.018 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.437 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 5.2 t -56.54 149.28 40.91 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 108.716 179.159 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.437 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 31.4 Cg_endo -72.91 86.21 1.1 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.55 1.5 . . . . 0.0 110.417 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.438 HG22 HG13 ' A' ' 105' ' ' VAL . 16.0 m -75.9 142.55 42.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.476 -0.765 . . . . 0.0 109.473 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -115.32 136.34 53.19 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.803 ' HA ' HG23 ' A' ' 125' ' ' VAL . 26.2 m -151.87 144.51 16.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 109.812 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.75 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -94.57 109.75 21.63 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 175.789 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.032 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -80.85 162.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 122.339 1.066 . . . . 0.0 110.963 -175.729 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.451 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 3.7 t-160 -161.48 101.05 1.19 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.799 ' HG2' HG13 ' A' ' 120' ' ' VAL . 3.4 mtm -113.01 146.19 39.52 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.393 -0.817 . . . . 0.0 109.316 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.8 tttt -141.84 178.94 7.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.459 -1.401 . . . . 0.0 109.785 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.447 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -86.01 102.89 14.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.916 -1.115 . . . . 0.0 109.15 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.718 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -51.59 132.61 30.54 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.455 -0.778 . . . . 0.0 109.812 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.404 ' H ' HD12 ' A' ' 113' ' ' LEU . 1.7 mp -101.63 -33.31 9.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.4 p -54.09 -46.11 71.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.955 . . . . 0.0 109.299 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 154.35 39.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.469 ' HB2' ' CB ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -116.1 -14.03 11.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.059 -1.259 . . . . 0.0 109.444 179.707 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.501 ' N ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER 80.51 -70.05 0.09 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.478 -0.763 . . . . 0.0 111.66 178.727 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.846 ' OH ' HG13 ' A' ' 83' ' ' VAL . 4.7 m-85 -143.37 116.88 9.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.712 -1.242 . . . . 0.0 110.197 -177.482 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.718 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.1 p-90 -113.66 142.11 46.41 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.863 -1.148 . . . . 0.0 111.665 179.073 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.799 HG13 ' HG2' ' A' ' 109' ' ' MET . 63.5 t -113.53 125.94 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.716 ' HE2' HD13 ' A' ' 11' ' ' ILE . 20.0 m-30 -111.74 117.65 33.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.019 -1.05 . . . . 0.0 109.574 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -100.19 114.41 38.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.277 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.529 ' HD3' ' CE1' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -97.76 119.92 37.21 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.099 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.541 ' HA ' HG12 ' A' ' 105' ' ' VAL . 6.8 ttt-85 -66.97 124.82 24.07 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.983 -1.087 . . . . 0.0 109.61 -178.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.803 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.005 . . . . 0.0 109.335 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.507 ' C2 ' ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -106.54 163.09 13.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.967 . . . . 0.0 109.725 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.42 172.63 0.62 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.698 HG11 ' H ' ' A' ' 10' ' ' ASP . 11.9 p -77.99 123.66 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.263 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.888 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 47.65 -158.84 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.317 -0.864 . . . . 0.0 109.836 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CD2' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -48.87 -59.04 3.91 Favored 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.8 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.46 32.56 0.26 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 107.255 -2.338 . . . . 0.0 107.255 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.888 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 0.2 OUTLIER -55.91 -175.84 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.761 -0.847 . . . . 0.0 110.846 -178.566 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -126.82 61.04 1.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.698 ' H ' HG11 ' A' ' 4' ' ' VAL . 0.4 OUTLIER 59.79 70.09 0.66 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -178.427 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.04 HG22 HD11 ' A' ' 15' ' ' LEU . 5.1 mm -73.93 -65.58 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.548 0 O-C-N 121.424 -0.797 . . . . 0.0 109.759 -178.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 13' ' ' ASN . 15.7 pt-20 -38.84 -35.92 0.23 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.719 -0.613 . . . . 0.0 111.706 -178.18 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.1 m120 -81.6 -41.96 20.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.921 -1.112 . . . . 0.0 108.341 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.114 HG21 HD22 ' A' ' 23' ' ' LEU . 2.9 m -72.1 -7.18 47.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.619 -0.676 . . . . 0.0 109.49 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.04 HD11 HG22 ' A' ' 11' ' ' ILE . 39.8 mt -96.83 0.41 49.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.905 -1.122 . . . . 0.0 109.01 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.02 -25.05 16.64 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.284 -0.885 . . . . 0.0 109.106 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -132.27 39.14 3.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 14' ' ' THR . 11.1 tmm? -129.21 146.0 51.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.21 -0.932 . . . . 0.0 109.437 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.55 -61.31 1.14 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.293 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -167.15 96.02 0.49 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.378 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.43 -20.83 3.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.426 ' HB3' ' CG ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -81.87 -45.83 14.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.096 -1.238 . . . . 0.0 109.598 179.992 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.114 HD22 HG21 ' A' ' 14' ' ' THR . 4.2 tp -128.76 45.41 2.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.117 -0.99 . . . . 0.0 109.687 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -93.16 -1.61 56.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.163 -0.961 . . . . 0.0 109.698 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.39 16.31 58.06 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.941 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 4.0 mt -67.86 168.3 11.87 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.953 -1.322 . . . . 0.0 108.448 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.43 23.0 8.07 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.941 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 3.3 p90 -156.51 -171.1 3.56 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -118.17 154.74 16.43 Favored Glycine 0 C--N 1.291 -1.932 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 178.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -122.88 107.26 11.67 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.32 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.592 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.1 pp -114.93 142.21 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.303 -177.729 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.829 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -112.16 165.96 11.69 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.873 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 37' ' ' GLY . 97.1 mt -152.27 154.66 36.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.866 -1.147 . . . . 0.0 109.681 -179.129 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.554 ' HB2' HD21 ' A' ' 40' ' ' LEU . 5.5 m-20 -129.08 125.74 37.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 110.178 178.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.43 -77.93 0.0 OUTLIER Glycine 0 N--CA 1.5 2.901 0 C-N-CA 124.496 1.046 . . . . 0.0 113.818 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.518 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 73.4 m-20 -72.65 -1.55 16.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.717 -0.872 . . . . 0.0 111.443 -177.541 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.665 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 89.32 18.65 52.44 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 16.4 m120 -72.04 134.99 46.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -1.223 . . . . 0.0 107.772 179.047 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -64.8 138.44 23.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 O-C-N 121.28 -0.887 . . . . 0.0 111.259 -178.067 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.829 HD12 ' HB3' ' A' ' 32' ' ' GLN . 5.4 mt -109.0 -28.39 9.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.133 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.583 ' NE2' HD22 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -163.29 160.28 23.62 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.897 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.568 ' CD1' HG22 ' A' ' 31' ' ' ILE . 14.6 t80 -142.1 -71.96 0.33 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.715 -1.241 . . . . 0.0 110.774 -178.419 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.3 p-10 109.1 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.785 0 C-N-CA 123.923 0.889 . . . . 0.0 108.876 -179.166 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 45' ' ' ALA . . . -96.99 -52.5 3.84 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.215 -0.928 . . . . 0.0 113.438 -177.504 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 44' ' ' ALA . . . -34.69 -62.02 0.37 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.418 -0.801 . . . . 0.0 112.96 -177.181 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.9 pt-20 -60.13 -49.4 77.79 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.158 -0.964 . . . . 0.0 110.35 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.36 -13.58 44.39 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -81.53 -36.17 29.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.835 -1.391 . . . . 0.0 109.82 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -84.14 -47.32 17.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.124 -0.985 . . . . 0.0 109.45 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.546 ' HA ' ' HE1' ' A' ' 100' ' ' MET . 2.7 p -89.33 -24.9 21.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.271 -0.893 . . . . 0.0 110.203 -179.079 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.49 -3.47 63.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.931 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -55.68 105.15 0.16 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.032 -1.276 . . . . 0.0 109.941 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -72.98 154.19 90.86 Favored Pre-proline 0 C--N 1.298 -1.653 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.801 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.02 -53.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.742 1.628 . . . . 0.0 110.528 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -20.4 63.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.856 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.403 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 1.5 tt0 -85.33 -41.72 15.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.018 -1.051 . . . . 0.0 109.837 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 53' ' ' ASP . 26.7 m -76.48 -2.31 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.068 -1.02 . . . . 0.0 109.922 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.654 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -70.19 122.42 21.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.025 -1.047 . . . . 0.0 108.429 179.845 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.04 -13.82 62.21 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 56' ' ' GLN . 11.8 mmtp -80.12 137.54 36.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.267 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -78.05 95.93 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.142 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.722 ' CZ ' HG21 ' A' ' 70' ' ' THR . 14.1 t80 -55.82 -24.65 37.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 0.0 109.932 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.523 ' CE2' HD13 ' A' ' 33' ' ' LEU . 12.3 m-85 -82.09 -32.16 30.38 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.746 -177.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 48.59 1.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.055 . . . . 0.0 109.116 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 4.7 t0 -163.54 -36.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.549 -0.719 . . . . 0.0 109.877 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.931 HG11 ' HD3' ' A' ' 52' ' ' ARG . 12.7 t -103.09 -56.8 4.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 122.78 1.276 . . . . 0.0 108.388 179.482 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.52 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -103.66 101.46 24.33 Favored Pre-proline 0 C--N 1.29 -1.983 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.181 -178.11 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -76.13 3.13 6.45 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.719 1.613 . . . . 0.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 p -106.77 -21.58 12.99 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.131 -0.981 . . . . 0.0 109.841 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.722 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 7.2 p -81.89 2.54 29.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 110.308 -178.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -95.94 57.1 1.77 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.954 -1.091 . . . . 0.0 108.905 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.458 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -139.5 175.55 3.17 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.412 -0.805 . . . . 0.0 109.507 -179.599 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.7 Cg_endo -77.15 77.29 3.85 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 122.505 2.137 . . . . 0.0 110.369 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 174.28 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE1' ' HE3' ' A' ' 109' ' ' MET . 1.4 t80 -103.3 -68.73 0.82 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.468 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 16.5 t80 -74.83 -19.22 60.27 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.42 -62.26 5.77 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.638 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -62.19 -18.28 60.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 109.541 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.813 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.1 t80 -76.38 -38.23 56.03 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.489 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -5.61 52.89 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 108.757 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 1.5 mm-40 -95.41 -42.02 8.69 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.41 -40.64 68.67 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 178.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.872 HG22 ' CE1' ' A' ' 118' ' ' TYR . 100.0 t -61.39 -40.27 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.746 -0.855 . . . . 0.0 109.948 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.68 -22.08 40.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.216 -0.927 . . . . 0.0 111.059 -178.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -12.08 28.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.817 -1.177 . . . . 0.0 110.526 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.85 14.58 80.69 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -150.62 100.82 2.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -1.171 . . . . 0.0 108.606 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -97.74 117.58 32.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 110.109 -179.161 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -160.58 75.53 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.506 -0.746 . . . . 0.0 109.118 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 78' ' ' LYS . 8.8 t -116.21 131.55 56.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.028 -1.045 . . . . 0.0 110.497 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.6 ttt -118.47 126.17 51.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.621 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 2.0 p90 -152.39 -172.5 4.25 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.134 -0.979 . . . . 0.0 110.056 -178.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 93' ' ' GLU . 22.6 pt-20 -121.87 117.42 26.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.42 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 13.0 t80 -126.79 163.65 23.1 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 109.422 -179.134 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 95.2 m -131.77 119.99 22.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.576 ' CE2' HG21 ' A' ' 105' ' ' VAL . 6.5 m-85 -92.01 125.0 36.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.431 -0.793 . . . . 0.0 109.035 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -144.41 46.77 1.4 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 14.3 p90 -77.98 141.58 38.86 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.527 ' C ' ' O ' ' A' ' 98' ' ' TYR . 15.0 pt20 3.67 64.73 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.093 0 CA-C-O 121.432 0.634 . . . . 0.0 112.161 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.701 ' SD ' HG22 ' A' ' 101' ' ' THR . 0.6 OUTLIER 179.78 175.52 0.76 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.557 -0.714 . . . . 0.0 109.118 -177.787 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.701 HG22 ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -57.88 151.43 43.62 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.96 . . . . 0.0 109.032 179.348 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 32.9 Cg_endo -74.28 145.08 33.96 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 121.945 1.763 . . . . 0.0 109.972 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.502 HG22 HG13 ' A' ' 105' ' ' VAL . 1.2 m -142.32 111.68 6.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.106 -0.996 . . . . 0.0 110.151 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.434 ' C ' HG13 ' A' ' 105' ' ' VAL . 25.3 tttm -82.28 151.67 26.67 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.769 HG23 HG13 ' A' ' 107' ' ' VAL . 28.2 m -153.98 144.09 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 118.526 -1.269 . . . . 0.0 112.09 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -80.75 123.6 28.35 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 102.23 -3.248 . . . . 0.0 102.23 174.675 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.769 HG13 HG23 ' A' ' 105' ' ' VAL . 31.4 m -118.37 152.36 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 121.058 1.754 . . . . 0.0 111.845 -176.17 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -143.1 104.64 4.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.218 178.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.655 ' HG2' HG13 ' A' ' 120' ' ' VAL . 14.2 mtp -99.79 121.18 40.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.891 -1.131 . . . . 0.0 108.913 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.573 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 2.3 tttt -125.79 -165.8 1.47 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 117.625 -1.63 . . . . 0.0 110.309 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -113.11 98.59 7.24 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.138 -0.976 . . . . 0.0 109.167 -179.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.931 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -54.56 135.18 46.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.682 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.71 -19.44 9.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.723 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 m -52.89 -49.05 66.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.0 109.567 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.49 44.95 0.05 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 117' ' ' SER . 52.7 m-20 -138.81 -90.15 0.21 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.116 -1.226 . . . . 0.0 109.242 179.584 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.786 ' H ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER 160.85 -76.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.498 -0.751 . . . . 0.0 110.795 179.372 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.872 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.6 m-85 -125.4 129.35 49.7 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.235 -0.916 . . . . 0.0 110.179 -177.748 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.931 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 22.7 p-90 -129.17 163.05 26.39 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.343 178.493 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.655 HG13 ' HG2' ' A' ' 109' ' ' MET . 50.2 t -144.23 113.94 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.688 -0.632 . . . . 0.0 109.422 -178.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.672 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.4 m-30 -95.66 140.79 29.96 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.466 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.717 HG22 HG12 ' A' ' 107' ' ' VAL . 1.9 t -117.4 109.53 27.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 118.951 -1.099 . . . . 0.0 110.046 -179.213 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 4.7 tptp -84.53 146.24 27.67 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.04 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -96.18 129.88 43.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.702 -1.249 . . . . 0.0 110.181 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.104 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.52 ' C2 ' ' HB1' ' A' ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptt? . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 55.24 58.44 4.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 109.581 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -102.81 93.25 4.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.311 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.532 HG22 ' OG ' ' A' ' 8' ' ' SER . 14.5 p -154.8 129.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 109.897 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.86 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 21.91 81.01 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.065 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER 57.51 -87.7 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.243 -0.911 . . . . 0.0 109.135 179.558 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . -140.41 42.68 1.18 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.86 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -65.32 163.39 15.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.67 -0.9 . . . . 0.0 110.87 -178.543 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -109.1 60.54 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.5 72.63 0.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.074 HG22 HD11 ' A' ' 15' ' ' LEU . 3.7 mm -72.89 -66.86 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 O-C-N 121.488 -0.757 . . . . 0.0 110.444 -178.043 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HA ' HD12 ' A' ' 15' ' ' LEU . 18.3 pt-20 -36.46 -49.68 0.74 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.961 -0.462 . . . . 0.0 112.037 -177.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.63 -44.37 82.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.788 -1.195 . . . . 0.0 108.614 179.447 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.919 HG21 HD23 ' A' ' 23' ' ' LEU . 3.4 m -71.24 -8.43 53.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 109.948 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.074 HD11 HG22 ' A' ' 11' ' ' ILE . 42.6 mt -97.79 -24.04 15.62 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.97 -1.081 . . . . 0.0 109.371 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.94 -26.5 31.35 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.83 . . . . 0.0 109.576 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 -17.75 8.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.052 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.31 145.39 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.343 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.62 154.87 0.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 108.861 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 56.88 78.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 108.601 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.56 21.46 72.69 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 51.85 31.63 8.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.386 -1.067 . . . . 0.0 109.952 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.919 HD23 HG21 ' A' ' 14' ' ' THR . 1.1 tm? 60.68 67.81 0.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.191 -0.943 . . . . 0.0 108.776 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -149.07 -24.64 0.3 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.552 -0.717 . . . . 0.0 111.112 -179.239 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.32 24.35 30.75 Favored Glycine 0 N--CA 1.492 2.429 0 O-C-N 120.525 -1.359 . . . . 0.0 111.041 -178.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.853 HD11 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -78.7 -172.28 2.91 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.766 -1.432 . . . . 0.0 108.349 179.168 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.74 20.54 16.08 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.41 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.59 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -159.36 137.04 10.06 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.143 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -71.66 139.73 29.28 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.518 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . . . -116.87 89.75 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.623 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.4 pp -91.98 148.97 4.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.449 -0.782 . . . . 0.0 110.654 -177.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.592 ' OE1' HD13 ' A' ' 15' ' ' LEU . 17.5 mm100 -116.86 170.51 8.56 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.527 HD22 ' C ' ' A' ' 37' ' ' GLY . 73.4 mt -152.32 145.63 24.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.876 -1.14 . . . . 0.0 110.187 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' ASP . 8.8 m-20 -115.7 134.67 54.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.257 178.691 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -11.49 72.39 0.0 OUTLIER Glycine 0 N--CA 1.511 3.679 0 C-N-CA 124.804 1.192 . . . . 0.0 113.294 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER 161.75 -23.33 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.565 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.41 17.9 22.95 Favored Glycine 0 N--CA 1.479 1.551 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.033 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 28.7 m120 -85.25 131.78 34.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.142 -1.211 . . . . 0.0 108.769 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.569 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -65.99 138.81 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.016 -1.053 . . . . 0.0 111.404 -178.37 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.451 HD11 ' OD1' ' A' ' 34' ' ' ASP . 3.0 mt -103.74 -29.48 11.01 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.375 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -161.94 142.96 10.74 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.089 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.605 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 15.9 t80 -109.28 -77.24 0.6 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.338 -1.476 . . . . 0.0 111.504 -178.263 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 39.9 t-20 130.49 142.24 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.857 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -178.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -73.24 -49.09 29.75 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.581 -0.699 . . . . 0.0 111.125 -178.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.76 -55.32 3.69 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.35 -0.844 . . . . 0.0 111.619 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.489 ' OE1' ' CG ' ' A' ' 42' ' ' TYR . 14.0 pt-20 -63.75 -44.55 93.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.143 -0.973 . . . . 0.0 110.233 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -63.24 -13.2 48.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.05 -36.72 16.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.328 . . . . 0.0 109.658 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.71 -29.35 16.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 O-C-N 121.043 -1.036 . . . . 0.0 110.249 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.835 HG21 " C3'" ' A' ' 126' ' ' HC4 . 1.6 p -114.09 -24.58 8.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 109.504 -178.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 100.55 -2.04 55.89 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.903 ' NE ' HG12 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -71.88 85.83 0.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -1.219 . . . . 0.0 109.727 -179.74 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.726 ' O ' HG22 ' A' ' 57' ' ' VAL . 38.9 m-20 -60.48 164.42 7.05 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.148 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.49 -50.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.117 1.878 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.753 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -67.85 -29.4 68.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.215 -0.928 . . . . 0.0 109.906 -179.555 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -78.78 -43.12 26.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 0.0 109.885 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 53' ' ' ASP . 18.5 m -76.35 -1.81 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.038 -1.038 . . . . 0.0 109.903 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -70.89 123.58 25.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.016 -1.053 . . . . 0.0 108.446 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.95 -18.2 56.49 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 -178.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -79.25 138.45 37.79 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.184 -1.186 . . . . 0.0 108.992 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -76.22 104.33 6.69 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.469 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 85.6 t80 -56.08 -20.62 17.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.371 -0.831 . . . . 0.0 110.224 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 7.7 m-85 -100.04 -19.69 16.41 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.083 -1.01 . . . . 0.0 110.401 -178.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.2 46.99 1.42 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.116 -0.99 . . . . 0.0 109.449 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.6 -28.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 111.024 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.903 HG12 ' NE ' ' A' ' 52' ' ' ARG . 5.1 t -108.48 -58.34 3.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -112.09 100.98 50.87 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.485 -179.184 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.74 1.05 8.5 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.056 1.837 . . . . 0.0 111.336 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.1 p -98.95 -22.88 15.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 109.418 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 31.1 p -76.14 -2.21 29.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.408 -0.808 . . . . 0.0 110.269 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -88.63 56.42 3.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.975 . . . . 0.0 109.255 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -129.04 177.18 2.28 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.413 -0.805 . . . . 0.0 108.941 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -78.04 2.01 8.37 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.219 1.946 . . . . 0.0 111.561 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.4 mt-10 -111.28 -29.52 7.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.86 -1.15 . . . . 0.0 109.319 179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CE1' ' SD ' ' A' ' 109' ' ' MET . 1.8 t80 -100.29 -69.49 0.77 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.55 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 21.2 t80 -71.22 -15.57 62.46 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.501 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -63.22 -61.56 6.24 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 178.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.769 ' HB2' HG21 ' A' ' 90' ' ' THR . 9.4 mmtt -62.8 -16.49 58.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.607 -0.937 . . . . 0.0 109.287 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.944 ' HA ' HD11 ' A' ' 88' ' ' LEU . 10.4 t80 -78.72 -37.89 40.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -78.52 -7.41 57.46 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.8 mm-40 -95.78 -40.76 9.19 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -69.92 -40.04 74.46 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 178.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.978 HG22 ' CE1' ' A' ' 118' ' ' TYR . 58.2 t -64.71 -39.78 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.646 -0.914 . . . . 0.0 109.656 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.74 -8.7 55.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.334 -0.854 . . . . 0.0 110.829 -178.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 t -102.19 -16.98 16.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.829 -1.169 . . . . 0.0 110.06 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.47 22.48 64.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -163.75 72.11 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -1.104 . . . . 0.0 109.316 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.944 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -72.92 118.35 15.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 109.81 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -160.62 86.79 0.73 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.523 -0.736 . . . . 0.0 109.099 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.769 HG21 ' HB2' ' A' ' 78' ' ' LYS . 3.3 t -137.25 161.52 36.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.081 -1.012 . . . . 0.0 109.786 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -149.53 144.04 26.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.415 -0.803 . . . . 0.0 108.982 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.058 ' CE2' HG21 ' A' ' 107' ' ' VAL . 10.8 p90 -156.33 -173.96 4.73 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 109.839 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.26 114.19 26.36 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.59 -176.28 2.89 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.147 -0.971 . . . . 0.0 110.804 -178.382 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.0 m -154.38 109.77 3.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.857 ' CE2' HG21 ' A' ' 122' ' ' VAL . 7.9 m-30 -85.71 126.6 34.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.643 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -154.3 51.06 0.65 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.738 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.603 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 9.9 p90 -77.91 136.42 38.02 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.53 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.7 pt20 5.25 62.95 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.186 0 CA-C-O 121.421 0.629 . . . . 0.0 112.264 -178.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -175.22 -154.43 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.358 -0.839 . . . . 0.0 109.252 -177.98 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.15 159.74 61.69 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.46 157.27 28.94 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.28 1.987 . . . . 0.0 110.521 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.587 ' O ' HG22 ' A' ' 103' ' ' THR . 5.4 m -151.13 85.92 1.35 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.782 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -69.83 139.18 53.1 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.023 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.931 ' HA ' HG23 ' A' ' 125' ' ' VAL . 14.8 m -151.77 148.24 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.897 -1.127 . . . . 0.0 111.404 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.807 ' CD ' HG22 ' A' ' 125' ' ' VAL . 2.8 mptp? -79.36 120.16 23.4 Favored 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 103.22 -2.881 . . . . 0.0 103.22 174.242 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.058 HG21 ' CE2' ' A' ' 92' ' ' PHE . 34.5 m -104.19 150.91 7.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 117.863 -1.535 . . . . 0.0 110.523 -177.462 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -149.49 106.91 3.62 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.066 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.909 ' HG2' HG13 ' A' ' 120' ' ' VAL . 12.8 mtm -108.85 134.55 51.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.057 -1.027 . . . . 0.0 110.369 -178.259 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.606 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.4 tttp -135.09 -169.38 2.36 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.401 -1.437 . . . . 0.0 109.989 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -104.46 100.43 10.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.126 -0.983 . . . . 0.0 108.56 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.871 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -47.02 144.53 2.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.729 . . . . 0.0 110.617 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.93 ' O ' HD13 ' A' ' 113' ' ' LEU . 3.4 tm? -79.09 -19.29 51.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.776 -179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.0 m -44.07 -27.71 0.41 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.371 -0.831 . . . . 0.0 110.58 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 162.53 58.62 0.02 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.7 32.34 21.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -1.183 . . . . 0.0 109.074 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.748 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -72.16 -160.74 0.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.889 -179.692 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.978 ' CE1' HG22 ' A' ' 83' ' ' VAL . 13.8 m-85 -152.42 116.28 4.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.871 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 16.6 p-90 -122.06 149.37 43.64 Favored 'General case' 0 C--O 1.202 -1.401 0 C-N-CA 118.705 -1.198 . . . . 0.0 112.075 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.909 HG13 ' HG2' ' A' ' 109' ' ' MET . 58.5 t -124.54 107.97 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.649 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 9.9 m-30 -92.03 120.58 32.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.312 -0.867 . . . . 0.0 109.199 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.857 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.1 t -102.21 117.92 48.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.839 -1.144 . . . . 0.0 110.837 -179.251 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 4.2 tptp -88.28 113.91 24.37 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.577 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -73.94 120.62 19.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.492 -1.38 . . . . 0.0 109.016 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.931 HG23 ' HA ' ' A' ' 105' ' ' VAL . 3.7 t . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.319 -179.58 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.835 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.326 0.584 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 4' ' ' VAL . 1.2 tm-20 -84.37 -65.14 1.04 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.917 . . . . 0.0 109.595 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 52.34 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 109.426 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.742 ' O ' HG23 ' A' ' 4' ' ' VAL . 32.4 m -101.11 94.89 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.775 -1.203 . . . . 0.0 109.402 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.45 ' HB3' ' CB ' ' A' ' 8' ' ' SER . . . 51.65 -149.48 0.33 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.39 -1.444 . . . . 0.0 108.652 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.629 ' CE1' ' HD2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -90.78 51.06 1.9 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.595 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.85 0.79 45.64 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -177.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.967 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -96.66 112.53 24.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.11 -1.229 . . . . 0.0 112.128 -178.694 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.54 ' HA ' ' HB ' ' A' ' 4' ' ' VAL . 22.7 mt-10 -47.55 103.4 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.642 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' C ' ' O ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER 16.66 77.36 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.708 0 CA-C-O 121.415 0.626 . . . . 0.0 111.826 178.483 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.041 HG22 HD11 ' A' ' 15' ' ' LEU . 4.9 mm -64.83 -61.96 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.597 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -37.24 -30.51 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.939 -0.476 . . . . 0.0 111.833 -178.13 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' ILE . 54.4 t-20 -84.48 -45.64 12.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.891 -1.131 . . . . 0.0 108.504 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.707 HG22 HD23 ' A' ' 23' ' ' LEU . 2.9 m -67.59 -10.6 53.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.591 -0.693 . . . . 0.0 109.665 179.146 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.041 HD11 HG22 ' A' ' 11' ' ' ILE . 20.6 mt -96.82 -25.71 15.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.013 -1.054 . . . . 0.0 109.327 -179.223 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.81 -16.89 24.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.383 -0.823 . . . . 0.0 109.988 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 35.81 4.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 0.0 109.853 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.63 ' CE ' HD21 ' A' ' 23' ' ' LEU . 11.9 tmm? -131.41 134.18 45.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.199 -0.938 . . . . 0.0 109.112 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.25 -79.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.97 . . . . 0.0 109.296 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -175.58 68.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -0.961 . . . . 0.0 109.239 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.3 40.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -132.1 -37.69 1.12 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.405 -1.056 . . . . 0.0 109.781 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.715 ' CD2' HD23 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -105.6 15.28 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 110.351 -179.736 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.21 -15.61 63.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.956 -1.09 . . . . 0.0 109.887 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.58 22.61 39.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.781 HD22 ' CE1' ' A' ' 28' ' ' PHE . 55.9 mt -70.67 176.65 4.01 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.939 -1.33 . . . . 0.0 108.947 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.15 17.43 21.63 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.05 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.781 ' CE1' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -154.81 132.25 11.2 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.186 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.11 129.28 9.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.416 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -102.32 118.78 37.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.946 -1.326 . . . . 0.0 108.513 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.628 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.1 pp -111.81 148.88 14.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.163 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.646 ' HB3' HD12 ' A' ' 40' ' ' LEU . 8.1 mt-30 -117.99 166.06 12.97 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.465 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 62' ' ' PHE . 18.3 mt -152.78 140.84 20.32 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.599 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.569 ' HB2' HD21 ' A' ' 40' ' ' LEU . 16.1 t0 -93.67 167.88 11.38 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.37 -22.23 1.49 Allowed Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.556 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -92.12 11.46 25.4 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.466 -1.608 . . . . 0.0 110.692 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.66 27.24 63.44 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 79.1 m-20 -97.03 127.86 43.42 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.993 -1.298 . . . . 0.0 111.639 -177.587 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.696 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -55.29 135.72 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.12 -0.988 . . . . 0.0 110.67 -179.83 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 32' ' ' GLN . 3.3 mt -111.4 -27.96 8.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.252 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -158.08 159.89 36.76 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.812 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.555 ' HH ' " C4'" ' A' ' 126' ' ' HC4 . 2.8 t80 -143.7 -64.74 0.38 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.601 -1.312 . . . . 0.0 109.246 -178.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.574 HD21 ' HB3' ' A' ' 45' ' ' ALA . 2.0 p-10 99.6 177.58 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 123.36 0.664 . . . . 0.0 109.641 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -95.25 -14.72 23.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.1 -1.0 . . . . 0.0 112.002 -177.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -58.22 -63.25 1.33 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.616 -1.302 . . . . 0.0 109.671 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 50' ' ' THR . 7.3 pt-20 -61.6 -49.81 75.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.208 -0.933 . . . . 0.0 109.286 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -58.74 -14.53 22.89 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 11.3 t70 -80.55 -39.09 28.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.735 -1.45 . . . . 0.0 109.823 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.483 ' HA ' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -84.58 -43.43 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.001 -1.062 . . . . 0.0 109.032 -179.644 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -89.47 -31.46 17.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.743 -0.598 . . . . 0.0 109.693 -178.68 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 100.82 -2.91 55.76 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.787 ' NE ' HG13 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -68.97 104.19 2.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.02 -1.283 . . . . 0.0 110.592 -179.322 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -72.17 166.14 43.94 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.656 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.87 -38.47 0.86 Allowed 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.948 1.765 . . . . 0.0 110.3 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -72.1 -22.95 61.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.275 -0.891 . . . . 0.0 109.415 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.429 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 38.1 tt0 -83.14 -47.19 11.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.497 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 53' ' ' ASP . 6.5 m -66.57 -11.37 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.599 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.509 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -68.32 121.12 16.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.082 -1.011 . . . . 0.0 108.722 -179.804 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.1 -19.0 52.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -178.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 56' ' ' GLN . 25.8 mmtt -79.87 132.66 36.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.373 -1.075 . . . . 0.0 109.215 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.59 122.71 21.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.696 ' HB2' HD12 ' A' ' 39' ' ' ILE . 87.2 t80 -68.69 -2.86 10.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 0.0 111.036 -179.313 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CE2' HD13 ' A' ' 33' ' ' LEU . 44.9 m-85 -110.94 -17.2 13.36 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.614 -1.304 . . . . 0.0 111.982 -177.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.28 -38.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.767 -1.208 . . . . 0.0 110.631 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -90.58 1.88 56.34 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.083 -1.01 . . . . 0.0 110.585 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.787 HG13 ' NE ' ' A' ' 52' ' ' ARG . 24.2 t -127.5 -75.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.425 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -97.97 106.67 35.89 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.416 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 34.5 Cg_endo -75.6 0.15 9.48 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.746 1.631 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.2 p -106.08 -19.49 13.71 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.959 -1.088 . . . . 0.0 109.668 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.456 HG21 ' CE2' ' A' ' 62' ' ' PHE . 15.6 p -75.19 -2.24 26.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.177 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -90.12 51.75 2.11 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.857 -1.152 . . . . 0.0 108.869 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -121.01 177.64 1.42 Allowed Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.946 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.8 Cg_endo -78.27 -5.45 15.03 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 122.203 1.935 . . . . 0.0 111.272 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -107.98 -21.14 12.94 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.912 -1.118 . . . . 0.0 109.489 179.799 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 70' ' ' THR . 1.1 t80 -104.09 -72.19 0.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.221 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 25.0 t80 -70.93 -18.16 62.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.29 -61.57 6.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.647 ' HB2' HG21 ' A' ' 90' ' ' THR . 1.8 mmtt -61.53 -16.34 46.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.652 -0.91 . . . . 0.0 109.698 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.891 ' O ' HG23 ' A' ' 83' ' ' VAL . 11.7 t80 -81.17 -38.2 27.5 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.53 -0.731 . . . . 0.0 109.674 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.01 -11.17 59.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.969 -1.082 . . . . 0.0 109.419 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 17.1 pt-20 -97.25 -38.98 9.47 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -66.51 -39.18 93.92 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 79' ' ' PHE . 99.1 t -59.76 -39.71 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.636 -0.92 . . . . 0.0 110.667 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.4 -45.57 31.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.003 -1.061 . . . . 0.0 111.038 -178.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -20.84 65.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.098 -179.131 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.64 14.96 80.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -142.84 56.0 1.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.119 -1.224 . . . . 0.0 109.025 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.849 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -54.78 123.38 13.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.498 -0.751 . . . . 0.0 109.491 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 33.0 p-10 -161.94 87.78 0.66 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.032 -1.042 . . . . 0.0 109.553 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.647 HG21 ' HB2' ' A' ' 78' ' ' LYS . 1.5 t -138.78 164.87 28.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.983 -1.073 . . . . 0.0 110.335 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -156.9 146.64 20.74 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.07 ' CE2' HG21 ' A' ' 107' ' ' VAL . 9.6 p90 -162.1 -175.11 4.43 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 109.637 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.4 102.51 11.61 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.46 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -105.65 147.91 27.96 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 110.041 -178.622 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 103' ' ' THR . 31.6 m -115.71 109.67 18.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.71 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 21.3 m-30 -78.97 107.57 11.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.183 -0.948 . . . . 0.0 109.004 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.13 32.75 5.96 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.521 -0.737 . . . . 0.0 109.28 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -79.21 162.4 25.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.895 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 98' ' ' TYR . 7.7 mt-30 -4.38 66.59 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 C-N-CA 123.388 0.675 . . . . 0.0 112.642 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.593 ' N ' ' O ' ' A' ' 98' ' ' TYR . 1.6 ttp 175.67 -158.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.341 -178.38 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.582 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -93.74 179.16 1.32 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.788 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.582 ' CD ' HG22 ' A' ' 101' ' ' THR . 34.2 Cg_endo -78.09 107.25 2.29 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 121.873 1.715 . . . . 0.0 110.365 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.46 HG22 HG13 ' A' ' 105' ' ' VAL . 1.6 m -106.83 134.13 50.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.611 ' HB3' HG23 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -100.78 150.4 22.83 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.548 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.676 HG23 HG13 ' A' ' 107' ' ' VAL . 32.6 m -154.75 144.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 118.384 -1.326 . . . . 0.0 112.006 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.58 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -81.41 98.25 8.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 175.771 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.07 HG21 ' CE2' ' A' ' 92' ' ' PHE . 31.4 m -90.45 150.11 3.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 118.144 -1.423 . . . . 0.0 110.734 -176.398 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 13.5 t-160 -148.15 107.16 3.85 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.772 ' HG2' HG13 ' A' ' 120' ' ' VAL . 26.2 mtm -102.98 118.6 37.18 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.773 -1.204 . . . . 0.0 108.952 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.608 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -140.27 145.63 37.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.227 -1.546 . . . . 0.0 110.223 -179.083 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -53.91 138.88 35.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.373 -0.829 . . . . 0.0 109.204 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.815 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -90.53 160.03 16.18 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.333 -0.854 . . . . 0.0 109.45 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.49 -7.07 57.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.205 -0.935 . . . . 0.0 110.632 -179.069 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 p -53.8 -32.02 51.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.564 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 143.34 86.97 0.09 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 55.75 61.57 2.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -1.171 . . . . 0.0 109.217 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.76 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -117.68 -174.11 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 109.919 -179.725 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.86 ' CE1' HG22 ' A' ' 83' ' ' VAL . 19.4 m-85 -152.08 114.41 4.51 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.815 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 19.6 p-90 -118.06 165.32 13.89 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.319 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.772 HG13 ' HG2' ' A' ' 109' ' ' MET . 84.4 t -146.02 104.54 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.346 0.593 . . . . 0.0 109.488 -178.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.672 ' CE2' ' HB ' ' A' ' 11' ' ' ILE . 5.3 m-30 -84.45 129.14 34.89 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.736 HG22 HG12 ' A' ' 107' ' ' VAL . 2.2 t -112.4 112.18 39.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.277 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.629 ' HD2' ' CE1' ' A' ' 6' ' ' PHE . 1.1 tttm -86.63 159.95 19.05 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.446 ' CD ' HG13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -107.06 120.93 43.42 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.743 -1.183 . . . . 0.0 109.869 -179.232 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.611 HG23 ' HB3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.175 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.735 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.529 ' O ' HG13 ' A' ' 4' ' ' VAL . 4.5 mtt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 66.44 16.25 10.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 109.785 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.0 t60 60.1 31.52 20.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 109.967 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.568 ' O ' HG23 ' A' ' 4' ' ' VAL . 25.4 m -72.69 124.56 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.053 -1.029 . . . . 0.0 109.465 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.781 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 38.56 -158.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.956 0.884 . . . . 0.0 111.849 178.427 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.57 ' CD2' ' HD2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -58.2 -27.51 63.96 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.848 0.832 . . . . 0.0 108.802 178.973 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.01 35.55 0.02 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -178.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.781 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -64.66 -170.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.555 -0.968 . . . . 0.0 111.043 -179.342 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.493 ' H ' HD11 ' A' ' 11' ' ' ILE . 7.4 mt-10 -126.56 59.02 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.07 74.21 0.45 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.503 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.982 HG22 HD11 ' A' ' 15' ' ' LEU . 4.6 mm -80.26 -60.59 2.15 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 110.151 -178.494 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.517 ' HA ' HD12 ' A' ' 15' ' ' LEU . 10.6 tt0 -46.83 -23.49 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.541 -1.349 . . . . 0.0 110.992 -178.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.19 -42.42 11.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.909 -1.119 . . . . 0.0 109.808 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -56.88 8.12 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.982 HD11 HG22 ' A' ' 11' ' ' ILE . 27.9 mt -38.08 -31.76 0.05 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.189 179.236 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.609 ' HB2' ' CB ' ' A' ' 114' ' ' SER . . . -86.18 -65.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.763 . . . . 0.0 110.119 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.7 55.4 3.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.91 . . . . 0.0 109.835 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.675 ' HE1' HD13 ' A' ' 23' ' ' LEU . 7.8 tmm? -117.56 149.45 40.62 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.174 -0.954 . . . . 0.0 108.773 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.2 -61.52 1.36 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.14 -50.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.643 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.17 63.72 3.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 18' ' ' MET . 9.8 mt-30 -149.15 -43.01 0.14 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -1.165 . . . . 0.0 109.246 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.675 HD13 ' HE1' ' A' ' 18' ' ' MET . 2.1 pt? -82.42 -12.22 58.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.336 -0.852 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -92.64 -0.59 57.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.901 -1.125 . . . . 0.0 110.312 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.71 33.61 6.26 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.637 HD23 ' CZ ' ' A' ' 28' ' ' PHE . 4.1 mp -121.61 149.3 43.38 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.305 -1.115 . . . . 0.0 109.052 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.58 8.0 10.77 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.625 -0.672 . . . . 0.0 110.179 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.637 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 1.5 p90 -133.51 150.82 51.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 109.646 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.54 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.34 114.3 3.85 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 178.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.481 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -91.38 97.79 11.3 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.596 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.7 pp -105.26 145.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.095 -177.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.679 ' HB3' HD12 ' A' ' 40' ' ' LEU . 35.6 mt-30 -115.36 167.29 10.99 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.839 HD22 ' O ' ' A' ' 37' ' ' GLY . 85.2 mt -153.39 157.24 39.68 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.087 -1.008 . . . . 0.0 109.132 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.576 ' CG ' HD21 ' A' ' 40' ' ' LEU . 36.8 p-10 -133.89 121.44 21.74 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.606 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.46 -78.38 0.0 OUTLIER Glycine 0 N--CA 1.502 3.069 0 C-N-CA 124.457 1.027 . . . . 0.0 113.144 178.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 34' ' ' ASP . 26.2 m-20 -68.43 -6.0 22.28 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.653 -0.91 . . . . 0.0 110.415 -178.58 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.839 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 88.81 18.06 55.21 Favored Glycine 0 N--CA 1.479 1.552 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.1 m-80 -72.22 138.83 47.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.078 -1.248 . . . . 0.0 108.338 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.562 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.92 136.04 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 122.064 0.935 . . . . 0.0 111.496 -178.043 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.774 HD11 ' O ' ' A' ' 33' ' ' LEU . 3.3 mt -108.5 -29.11 8.96 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.608 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -163.36 163.3 25.17 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.946 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.841 ' CG ' HG21 ' A' ' 57' ' ' VAL . 1.8 t80 -143.83 -65.45 0.37 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.141 -1.6 . . . . 0.0 110.714 -177.449 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.536 HD21 ' HB3' ' A' ' 45' ' ' ALA . 5.4 p-10 106.84 171.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.586 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.44 -20.7 18.86 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.664 -1.272 . . . . 0.0 112.164 -177.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.536 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -52.16 -59.83 3.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.715 -1.241 . . . . 0.0 110.311 -179.088 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 11.1 pt-20 -62.55 -45.95 90.61 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.745 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.449 ' HA2' ' N ' ' A' ' 52' ' ' ARG . . . -59.13 -15.94 31.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.26 -34.65 25.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.805 -1.409 . . . . 0.0 109.99 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.95 -40.88 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.158 -0.964 . . . . 0.0 109.766 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.815 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.4 OUTLIER -105.24 -0.25 26.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.55 -0.719 . . . . 0.0 110.111 -179.295 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.83 -2.78 72.7 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.627 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.871 ' CD ' HG13 ' A' ' 66' ' ' VAL . 0.9 OUTLIER -78.13 81.89 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.879 -1.365 . . . . 0.0 110.871 -179.155 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.453 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -57.8 176.7 0.23 Allowed Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.886 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 34.2 Cg_endo -76.52 -34.55 2.55 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.792 1.661 . . . . 0.0 110.341 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.2 -23.24 41.12 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -79.0 -41.42 29.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.613 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.841 HG21 ' CG ' ' A' ' 42' ' ' TYR . 26.8 m -71.47 -7.6 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 109.78 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.33 122.9 21.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.66 -23.07 35.67 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -178.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -80.53 136.16 36.23 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.409 -1.053 . . . . 0.0 109.189 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.9 126.84 31.24 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.587 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.76 ' HB2' HD21 ' A' ' 33' ' ' LEU . 76.3 t80 -61.66 -13.08 19.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.054 -1.029 . . . . 0.0 110.636 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 38.2 m-85 -118.95 28.94 7.98 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.945 -1.097 . . . . 0.0 110.506 -178.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.38 -50.63 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.767 -1.208 . . . . 0.0 110.826 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -111.86 7.71 20.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.856 -1.153 . . . . 0.0 110.653 -179.072 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.871 HG13 ' CD ' ' A' ' 52' ' ' ARG . 89.3 t -120.53 -41.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 120.777 -1.202 . . . . 0.0 108.342 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.575 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -141.19 95.35 7.47 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -72.63 -7.84 21.49 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.875 1.717 . . . . 0.0 110.427 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.1 p -94.39 -21.46 18.93 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.232 -0.918 . . . . 0.0 109.042 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.517 HG22 ' CD2' ' A' ' 75' ' ' PHE . 20.7 p -75.3 -0.63 20.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -88.97 55.33 3.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.884 -1.135 . . . . 0.0 108.887 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.476 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -130.48 177.57 2.15 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.858 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -78.08 -2.2 12.31 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.257 1.971 . . . . 0.0 111.418 -179.344 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 23.1 mm-40 -106.39 -25.98 11.66 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.8 -1.188 . . . . 0.0 109.298 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.7 t80 -101.99 -71.26 0.72 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.026 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.573 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 10.1 t80 -70.84 -17.7 62.73 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.245 178.024 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.84 -59.8 8.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.087 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.613 ' CB ' HG21 ' A' ' 90' ' ' THR . 6.7 mmtt -64.85 -14.7 60.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.469 -1.018 . . . . 0.0 109.351 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.84 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.5 t80 -80.82 -37.44 30.09 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.46 -8.29 58.36 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 108.707 178.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.64 -39.71 9.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.573 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -68.11 -39.83 88.48 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 79' ' ' PHE . 98.9 t -62.89 -39.39 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.766 -0.844 . . . . 0.0 109.765 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.95 -3.94 56.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.947 . . . . 0.0 111.104 -178.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.5 t -104.43 -19.68 13.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.082 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.35 19.59 71.36 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -156.27 72.57 0.76 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.096 -1.238 . . . . 0.0 109.287 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.573 HD12 ' HA3' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -76.1 110.43 10.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 109.629 -179.982 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -160.26 79.83 0.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.079 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 78' ' ' LYS . 9.9 t -137.62 151.39 48.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 110.262 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -133.38 146.52 51.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.086 ' CE2' HG21 ' A' ' 107' ' ' VAL . 18.5 p90 -153.58 -175.88 5.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.054 -1.029 . . . . 0.0 109.941 -179.752 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.71 115.79 30.17 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.04 176.94 4.97 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.159 -0.963 . . . . 0.0 110.136 -178.417 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.1 m -144.88 109.33 4.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.979 ' CE2' HG21 ' A' ' 122' ' ' VAL . 21.3 m-30 -83.01 119.85 24.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 108.963 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -149.43 47.51 0.97 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.001 -1.062 . . . . 0.0 110.331 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.558 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 35.0 p90 -78.56 135.9 37.4 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.134 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.535 ' C ' ' O ' ' A' ' 98' ' ' TYR . 11.7 pt20 3.52 64.07 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 CA-C-O 121.524 0.678 . . . . 0.0 112.106 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.5 tmm? -172.92 175.77 3.22 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.29 162.18 1.21 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.0 109.213 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.28 152.78 30.97 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.05 1.834 . . . . 0.0 110.195 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.48 HG22 HG13 ' A' ' 105' ' ' VAL . 54.5 m -147.76 127.53 13.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 110.305 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -110.44 137.24 48.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.228 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.898 ' HA ' HG23 ' A' ' 125' ' ' VAL . 17.7 m -150.49 142.83 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 118.649 -1.22 . . . . 0.0 111.494 -178.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.553 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.92 124.21 30.14 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 174.38 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.086 HG21 ' CE2' ' A' ' 92' ' ' PHE . 33.1 m -108.57 152.12 10.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 120.88 -1.138 . . . . 0.0 111.744 -174.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.411 ' ND1' ' HA ' ' A' ' 5' ' ' ALA . 18.6 t-160 -142.12 108.46 5.28 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.692 ' HG2' HG13 ' A' ' 120' ' ' VAL . 20.5 mtm -106.42 123.93 48.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.767 -1.208 . . . . 0.0 109.457 -179.139 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.575 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -126.24 -165.89 1.5 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.098 -179.677 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.61 94.21 4.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.546 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.982 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -53.21 127.59 24.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.073 -1.017 . . . . 0.0 109.481 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.2 tp -114.5 -15.97 11.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.066 -1.021 . . . . 0.0 109.638 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.609 ' CB ' ' HB2' ' A' ' 16' ' ' ALA . 80.8 p -54.48 -40.79 68.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.122 -0.986 . . . . 0.0 109.654 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.43 39.86 0.02 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.191 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.57 ' HB3' HD12 ' A' ' 40' ' ' LEU . 10.2 m-20 -137.49 -91.17 0.23 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.161 -1.199 . . . . 0.0 109.208 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.75 ' H ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER 165.07 -80.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.204 -0.935 . . . . 0.0 111.367 179.473 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CE1' HG22 ' A' ' 83' ' ' VAL . 8.9 m-85 -123.07 131.1 53.56 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.214 -0.929 . . . . 0.0 110.061 -177.4 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.982 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 15.0 p-90 -130.59 166.47 20.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.836 -1.165 . . . . 0.0 111.853 179.01 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.692 HG13 ' HG2' ' A' ' 109' ' ' MET . 90.7 t -147.71 115.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.767 -0.583 . . . . 0.0 110.441 -178.188 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.729 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.6 m-30 -94.41 104.69 16.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.064 -1.022 . . . . 0.0 108.836 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.979 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -88.04 105.9 15.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.57 ' HD2' ' CD2' ' A' ' 6' ' ' PHE . 9.5 mttp -89.67 112.42 23.66 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.531 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -56.98 133.19 54.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.966 -1.084 . . . . 0.0 109.43 -179.0 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.898 HG23 ' HA ' ' A' ' 105' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.366 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.815 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ttt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.306 0.574 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.91 30.07 7.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.607 -179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -114.76 167.27 10.91 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.603 HG11 ' H ' ' A' ' 10' ' ' ASP . 7.4 p -109.21 125.15 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 0.0 109.874 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 1.009 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 44.38 -167.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.033 0.92 . . . . 0.0 111.189 179.146 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.568 ' CE1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -46.51 -76.35 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.532 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -144.83 29.59 1.84 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 178.665 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' SER . . . . . 1.009 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -50.41 175.49 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.739 0.781 . . . . 0.0 110.786 -178.734 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -110.08 60.82 0.6 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.603 ' H ' HG11 ' A' ' 4' ' ' VAL . 0.2 OUTLIER 56.39 75.88 0.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -178.312 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.062 HG22 HD11 ' A' ' 15' ' ' LEU . 5.2 mm -79.16 -56.92 6.0 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.371 -178.083 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.406 ' HB2' HD12 ' A' ' 113' ' ' LEU . 2.0 pt-20 -43.04 -26.88 0.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.304 -0.873 . . . . 0.0 111.431 -178.088 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -91.09 -38.14 12.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.925 -1.109 . . . . 0.0 108.428 178.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.508 ' CG2' ' CE ' ' A' ' 18' ' ' MET . 4.7 m -71.26 -13.01 61.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.627 -0.671 . . . . 0.0 110.02 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.062 HD11 HG22 ' A' ' 11' ' ' ILE . 11.1 mt -97.62 -21.62 16.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.059 -1.025 . . . . 0.0 109.385 -179.569 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.53 -31.51 16.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.873 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -111.42 65.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.04 . . . . 0.0 108.986 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.576 ' HG2' ' HB2' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -158.64 -165.36 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.386 -0.821 . . . . 0.0 109.547 -179.163 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -116.25 -68.94 0.88 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.313 -0.867 . . . . 0.0 109.064 179.582 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t70 179.87 -45.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 109.679 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.82 33.56 5.64 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.576 ' HB2' ' HG2' ' A' ' 18' ' ' MET . 0.9 OUTLIER -102.98 -41.12 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -1.207 . . . . 0.0 109.699 -179.937 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.554 HD21 ' CB ' ' A' ' 43' ' ' ASN . 1.7 pt? -79.05 19.41 0.55 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.051 -1.03 . . . . 0.0 111.303 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.768 ' OD1' ' HB3' ' A' ' 44' ' ' ALA . 52.0 t0 -66.28 -7.98 22.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.4 -1.437 . . . . 0.0 111.002 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.64 35.02 4.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.948 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 28.7 mt -107.09 129.43 54.82 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.593 -0.945 . . . . 0.0 109.662 -179.639 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.27 -7.24 28.96 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.591 0.71 . . . . 0.0 109.353 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.948 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 6.8 p90 -129.99 135.96 48.89 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.098 -1.001 . . . . 0.0 109.016 179.762 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.477 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -70.03 132.33 23.7 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.327 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.477 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -105.1 103.03 12.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.327 . . . . 0.0 108.239 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -102.82 143.47 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.558 -178.875 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.665 ' HB3' HD12 ' A' ' 40' ' ' LEU . 22.0 mt-30 -116.92 164.23 15.0 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.243 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.736 HD13 ' CE2' ' A' ' 63' ' ' PHE . 95.9 mt -148.38 148.49 30.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.017 -1.052 . . . . 0.0 109.945 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.62 ' HB3' HD21 ' A' ' 40' ' ' LEU . 4.0 p30 -123.92 122.18 37.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 110.419 179.223 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.32 -79.32 0.0 OUTLIER Glycine 0 N--CA 1.497 2.741 0 C-N-CA 124.028 0.823 . . . . 0.0 113.392 178.276 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -70.14 -5.48 27.44 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.769 -0.841 . . . . 0.0 111.078 -177.762 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.731 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 94.02 17.84 39.21 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.768 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 38.5 m-80 -75.41 134.39 40.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.962 -1.316 . . . . 0.0 108.983 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.564 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -59.59 138.5 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.938 0.875 . . . . 0.0 111.442 -178.504 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 32' ' ' GLN . 7.9 mt -104.63 -33.66 8.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.12 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.702 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -157.48 -176.55 6.02 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.284 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.519 ' OH ' " O4'" ' A' ' 126' ' ' HC4 . 6.9 t80 -160.54 -67.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.906 -1.121 . . . . 0.0 110.826 -178.476 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.554 ' CB ' HD21 ' A' ' 23' ' ' LEU . 4.6 p-10 103.01 176.27 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.633 0 C-N-CA 123.779 0.832 . . . . 0.0 109.206 -179.379 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -95.81 -16.51 21.83 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.821 -1.174 . . . . 0.0 112.806 -177.388 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.24 -62.08 2.1 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.376 -1.453 . . . . 0.0 110.138 -179.131 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.513 ' HG2' ' OD1' ' A' ' 43' ' ' ASN . 3.3 pt-20 -59.61 -53.11 61.8 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.694 0.759 . . . . 0.0 109.569 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 52' ' ' ARG . . . -60.52 -13.78 32.21 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.23 -37.29 33.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.753 -1.439 . . . . 0.0 110.188 -179.453 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.78 -43.02 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.858 -1.152 . . . . 0.0 109.236 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.796 HG21 " H3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -92.44 -27.8 17.24 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.248 -0.908 . . . . 0.0 109.974 -178.896 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 100.69 -3.32 56.06 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.333 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.552 ' CD ' " C3'" ' A' ' 126' ' ' HC4 . 0.0 OUTLIER -60.88 100.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.97 -1.312 . . . . 0.0 109.749 -179.749 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.725 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -73.44 162.35 74.75 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 0.0 108.728 179.371 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.47 -51.22 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.187 1.925 . . . . 0.0 110.756 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -63.67 -26.04 68.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 110.181 -179.5 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -85.12 -42.81 14.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.955 -1.091 . . . . 0.0 109.905 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 53' ' ' ASP . 27.1 m -74.81 -3.2 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.157 -0.964 . . . . 0.0 109.675 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.564 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -71.49 123.13 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 O-C-N 120.947 -1.096 . . . . 0.0 108.058 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.33 -14.76 60.16 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -178.75 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.405 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 5.6 mmtt -79.9 136.97 36.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -1.205 . . . . 0.0 109.2 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.62 110.01 12.07 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.237 -0.915 . . . . 0.0 108.616 179.392 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.801 ' CZ ' HG21 ' A' ' 70' ' ' THR . 46.5 t80 -64.37 -12.63 44.51 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.736 ' CE2' HD13 ' A' ' 33' ' ' LEU . 31.9 m-85 -94.92 13.08 26.02 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.054 -1.029 . . . . 0.0 110.745 -177.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -179.39 -50.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.057 -1.027 . . . . 0.0 109.944 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -14.16 62.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 110.424 -179.038 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 3.8 t -125.89 -57.64 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 120.679 -1.263 . . . . 0.0 108.736 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -116.15 98.01 50.54 Favored Pre-proline 0 C--N 1.295 -1.8 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.614 -178.302 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -74.75 -1.53 11.26 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 121.858 1.705 . . . . 0.0 110.985 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 p -91.65 -26.51 18.63 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.988 -1.07 . . . . 0.0 109.335 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.801 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 35.2 p -75.0 -1.62 23.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.509 -0.744 . . . . 0.0 110.067 -179.163 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -89.69 52.13 2.25 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.93 -1.106 . . . . 0.0 108.597 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.481 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -124.87 178.5 1.42 Allowed Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.87 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.4 Cg_endo -78.42 -1.09 11.29 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 122.257 1.971 . . . . 0.0 111.476 -179.655 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 13.5 mt-10 -108.46 -29.02 9.02 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.877 -1.139 . . . . 0.0 109.301 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.685 ' CE1' HG11 ' A' ' 120' ' ' VAL . 1.2 t80 -100.06 -70.54 0.73 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.067 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.528 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 20.4 t80 -72.4 -15.31 61.84 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.813 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.77 -62.47 5.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 178.882 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.791 ' CB ' HG21 ' A' ' 90' ' ' THR . 1.2 mmtt -62.87 -16.09 57.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.562 -0.964 . . . . 0.0 109.251 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.863 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.9 t80 -77.36 -40.45 43.89 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.441 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.12 -7.87 56.51 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.969 . . . . 0.0 109.045 179.349 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -95.98 -41.17 8.9 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.507 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -69.41 -40.01 80.02 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 178.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.93 HG22 ' CE1' ' A' ' 118' ' ' TYR . 94.0 t -60.01 -38.71 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.693 -0.887 . . . . 0.0 109.535 179.388 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.35 -6.87 58.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.336 -0.853 . . . . 0.0 110.704 -178.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.06 -18.89 16.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.848 -1.157 . . . . 0.0 109.938 -179.685 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.58 16.07 78.44 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.44 66.89 0.39 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.055 -1.262 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -58.74 124.53 20.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.853 . . . . 0.0 109.985 -179.948 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.426 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 36.5 t30 -161.27 83.78 0.64 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.943 -1.098 . . . . 0.0 109.072 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.826 HG23 ' SD ' ' A' ' 109' ' ' MET . 8.8 t -144.73 172.48 12.95 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.055 -1.058 . . . . 0.0 110.754 -179.405 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.8 ptm -157.21 171.07 21.09 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.031 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 7.7 p90 177.82 154.15 0.31 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.03 -1.044 . . . . 0.0 109.94 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.3 128.38 33.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 109.07 179.378 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.08 170.04 16.24 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.13 -0.981 . . . . 0.0 110.061 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.0 m -140.88 118.01 11.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 122' ' ' VAL . 20.1 m-30 -90.24 121.27 32.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.107 -0.995 . . . . 0.0 109.76 -179.648 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -142.77 46.27 1.58 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.477 -0.764 . . . . 0.0 109.029 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.521 ' CZ ' " H2'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -85.36 66.52 9.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.466 -0.771 . . . . 0.0 110.855 -179.302 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.475 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 77.49 30.2 0.51 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.871 0.843 . . . . 0.0 109.318 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -141.34 171.08 14.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.055 -1.028 . . . . 0.0 108.5 179.452 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.44 170.6 0.2 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.015 -1.053 . . . . 0.0 109.235 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.66 92.03 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.007 1.805 . . . . 0.0 110.261 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.454 HG22 HG13 ' A' ' 105' ' ' VAL . 18.7 m -88.18 131.24 34.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 109.895 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.439 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -110.24 142.63 41.57 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.872 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.633 ' HA ' HG23 ' A' ' 125' ' ' VAL . 12.6 m -157.73 144.57 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.412 -179.476 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.578 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.11 119.12 36.19 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 174.782 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 1.031 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -87.78 162.47 2.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 120.665 -1.272 . . . . 0.0 111.376 -174.844 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.487 ' CG ' ' HA ' ' A' ' 5' ' ' ALA . 1.8 t-160 -160.46 103.71 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.164 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.86 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -112.41 150.59 30.91 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.72 -0.613 . . . . 0.0 110.009 -176.932 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.572 ' HB3' ' CZ2' ' A' ' 119' ' ' TRP . 0.1 OUTLIER -150.38 164.94 34.56 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.512 -1.367 . . . . 0.0 109.084 179.041 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 118.87 13.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.879 -1.138 . . . . 0.0 109.739 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.77 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -65.65 133.21 50.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 109.424 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.746 HD22 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -74.55 -3.15 29.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.052 -1.03 . . . . 0.0 110.817 -179.274 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.542 ' N ' HD13 ' A' ' 113' ' ' LEU . 1.0 OUTLIER -60.92 -24.64 66.18 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.783 -1.198 . . . . 0.0 109.019 179.676 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 170.07 45.01 0.03 OUTLIER Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t0 61.92 33.3 17.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.423 -1.045 . . . . 0.0 108.89 -179.354 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.723 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.9 OUTLIER -70.95 -157.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.45 -0.781 . . . . 0.0 109.687 -179.742 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.93 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.3 m-85 -150.22 109.31 3.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -0.837 . . . . 0.0 108.834 -179.398 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.77 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 9.7 p-90 -115.37 144.46 43.76 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.583 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.86 HG13 ' CG ' ' A' ' 109' ' ' MET . 18.8 t -120.01 109.0 24.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.641 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 12.6 m-30 -89.61 134.4 34.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 108.701 179.358 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -111.26 117.96 56.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 121.322 -0.861 . . . . 0.0 108.841 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.578 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 4.9 tptp -90.39 110.15 21.25 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.502 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -64.74 117.62 7.76 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.205 -179.515 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.317 -179.356 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' HC4 . . . . . 0.796 " H3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.516 2.852 0 CA-C-O 121.237 0.541 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.059 HG22 HD11 ' A' ' 15' ' ' LEU . 1.5 mm -54.21 -67.29 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.275 -0.89 . . . . 0.0 110.493 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 11' ' ' ILE . 19.8 pt-20 -35.06 -47.59 0.38 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -63.69 -47.84 79.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.858 -1.151 . . . . 0.0 109.106 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 14' ' ' THR . 13.1 m -69.57 -13.33 62.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.537 -0.727 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.059 HD11 HG22 ' A' ' 11' ' ' ILE . 18.4 mt -95.43 -16.35 22.34 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.772 -1.205 . . . . 0.0 109.502 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.384 0 O-C-N 121.144 -0.973 . . . . 0.0 108.535 178.761 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 44' ' ' ALA . 53.2 m-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.905 0.383 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.37 27.85 18.5 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.682 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 5.0 mt -84.62 -172.01 3.94 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.951 -1.323 . . . . 0.0 109.028 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.35 -5.93 14.08 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.682 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 10.3 p90 -124.12 117.22 24.16 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.27 -0.894 . . . . 0.0 108.648 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.465 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -57.06 141.03 43.97 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -117.17 114.82 24.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.851 -1.382 . . . . 0.0 108.047 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.579 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.6 pp -118.22 150.12 20.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.896 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.65 ' HB3' HD12 ' A' ' 40' ' ' LEU . 2.1 mt-30 -117.47 172.51 7.29 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.844 HD22 ' C ' ' A' ' 37' ' ' GLY . 27.9 mt -152.8 149.49 28.38 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.12 -0.988 . . . . 0.0 109.247 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.539 ' HB2' HD21 ' A' ' 40' ' ' LEU . 3.2 m-20 -119.25 133.16 55.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.141 -0.974 . . . . 0.0 109.417 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -7.58 70.0 0.0 OUTLIER Glycine 0 N--CA 1.514 3.873 0 C-N-CA 124.618 1.104 . . . . 0.0 113.273 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER 161.25 -23.84 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.844 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.68 23.05 10.38 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 3.3 m120 -86.08 123.51 31.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.417 -1.049 . . . . 0.0 108.792 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -56.32 136.19 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 121.913 0.863 . . . . 0.0 110.884 -178.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.65 HD12 ' HB3' ' A' ' 32' ' ' GLN . 5.6 mt -108.13 -30.83 8.2 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.47 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -159.96 160.6 33.61 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.601 ' HH ' ' HE1' ' A' ' 62' ' ' PHE . 2.7 t80 -140.08 -42.47 0.42 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.362 -1.461 . . . . 0.0 109.975 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.594 HD21 ' HB3' ' A' ' 45' ' ' ALA . 0.4 OUTLIER 87.54 171.58 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . . . -96.35 -15.38 21.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.004 -1.06 . . . . 0.0 112.637 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.594 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -58.77 -67.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.386 -1.446 . . . . 0.0 110.135 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 12.0 pt-20 -63.71 -44.95 92.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 109.021 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.43 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -61.11 -13.85 36.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 14.8 t70 -87.24 -32.72 19.59 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.627 -1.513 . . . . 0.0 108.819 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -73.45 -48.47 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.883 0.849 . . . . 0.0 108.731 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.487 ' HA ' ' HE1' ' A' ' 100' ' ' MET . 0.1 OUTLIER -95.09 -29.54 14.53 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.371 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 100.94 -2.69 55.54 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.589 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.955 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 1.1 mtt85 -47.52 -58.72 3.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.968 -1.313 . . . . 0.0 111.027 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.819 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER 68.46 152.45 0.13 Allowed Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.85 -50.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.78 1.654 . . . . 0.0 111.312 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.693 ' HA ' HD12 ' A' ' 58' ' ' ILE . 10.4 pttt -57.99 -18.47 24.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 110.344 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -96.1 -43.19 7.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 0.0 109.411 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 53' ' ' ASP . 32.3 m -82.51 3.96 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.646 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -70.04 123.6 24.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.8 -22.86 36.95 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -79.99 130.59 35.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -1.054 . . . . 0.0 109.25 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.564 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -68.23 125.55 26.74 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.135 -0.978 . . . . 0.0 108.568 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.681 ' CE2' HG21 ' A' ' 70' ' ' THR . 90.2 t80 -71.88 -6.22 40.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.896 -1.128 . . . . 0.0 110.263 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CE2' HD13 ' A' ' 33' ' ' LEU . 30.0 m-85 -96.4 -41.69 8.49 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.935 -1.103 . . . . 0.0 111.545 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.79 -15.39 4.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.705 -1.247 . . . . 0.0 111.522 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.73 -2.35 30.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.679 -1.263 . . . . 0.0 110.858 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.955 HG12 ' CZ ' ' A' ' 52' ' ' ARG . 45.7 t -131.79 -47.89 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 120.732 -1.23 . . . . 0.0 108.504 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.719 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . . . -128.96 106.7 18.15 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.61 2.36 6.49 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.765 1.643 . . . . 0.0 111.662 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.9 p -99.31 -27.69 13.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.889 -1.132 . . . . 0.0 109.234 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.74 HG22 ' CD2' ' A' ' 75' ' ' PHE . 18.0 p -72.13 -5.95 39.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -0.823 . . . . 0.0 109.965 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -89.66 51.72 2.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.018 -1.051 . . . . 0.0 108.742 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.483 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -128.43 178.82 1.47 Allowed Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.07 -0.15 10.42 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 122.095 1.864 . . . . 0.0 111.447 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 5.4 mm-40 -107.85 -28.19 9.78 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.813 -1.18 . . . . 0.0 109.453 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.748 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.9 t80 -102.67 -69.15 0.8 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.487 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 26.0 t80 -69.67 -17.92 63.52 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.18 -62.12 5.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.72 ' CB ' HG21 ' A' ' 90' ' ' THR . 0.9 OUTLIER -63.42 -15.58 58.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.519 -0.989 . . . . 0.0 109.593 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.827 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.9 t80 -81.66 -34.79 30.57 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -8.13 58.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 2.0 mt-10 -96.13 -42.47 8.2 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -66.83 -41.22 93.66 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 79' ' ' PHE . 93.1 t -62.02 -40.09 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.654 -0.909 . . . . 0.0 109.508 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.64 -4.92 58.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -0.871 . . . . 0.0 110.43 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.5 t -96.09 -25.58 15.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.92 -1.112 . . . . 0.0 109.87 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.92 28.89 27.5 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -179.02 59.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.303 -1.116 . . . . 0.0 109.058 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 6.2 tt -49.0 121.54 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.332 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.434 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 62.1 t-20 -160.69 88.27 0.77 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.394 -0.816 . . . . 0.0 109.032 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.72 HG21 ' CB ' ' A' ' 78' ' ' LYS . 2.3 t -149.15 167.17 26.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 110.189 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -150.04 167.1 27.74 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.973 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 10.2 p90 -175.93 153.84 1.4 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.971 -1.081 . . . . 0.0 110.042 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -82.21 116.49 21.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.944 . . . . 0.0 109.167 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.96 175.24 6.0 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 103' ' ' THR . 48.0 m -140.81 111.99 7.24 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.845 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 18.6 m-30 -82.81 93.64 7.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.135 -0.978 . . . . 0.0 109.2 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -115.35 32.78 5.84 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.329 -0.857 . . . . 0.0 108.963 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.59 155.5 29.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.506 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.8 mt-30 -0.85 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.466 0.706 . . . . 0.0 112.394 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.2 ttp 178.12 -154.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.465 -0.772 . . . . 0.0 109.653 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.538 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -92.12 176.89 2.39 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 108.975 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.538 ' CD ' HG22 ' A' ' 101' ' ' THR . 36.4 Cg_endo -78.31 106.51 2.15 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.919 1.746 . . . . 0.0 110.2 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 95' ' ' THR . 4.2 m -101.07 143.83 30.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -117.0 139.24 50.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.599 ' HB ' HG13 ' A' ' 122' ' ' VAL . 7.7 m -156.25 141.62 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.771 -1.205 . . . . 0.0 111.261 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -91.05 114.78 27.39 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.973 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -87.07 161.24 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.807 -1.183 . . . . 0.0 110.543 -176.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -159.74 99.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.859 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -110.64 148.41 32.29 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.452 -0.78 . . . . 0.0 109.628 -177.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.647 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 2.3 ttmt -145.51 -179.01 6.38 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.483 -1.287 . . . . 0.0 109.423 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -87.42 109.23 19.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.933 -1.105 . . . . 0.0 109.185 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.75 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -53.67 140.52 28.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.566 -0.709 . . . . 0.0 109.868 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.6 -179.039 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.677 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.613 0.72 . . . . 0.0 110.434 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.754 ' CE1' HG22 ' A' ' 83' ' ' VAL . 24.7 m-85 -151.03 112.32 4.37 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.75 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 15.8 p-90 -114.68 140.99 48.4 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 118.578 -1.249 . . . . 0.0 112.373 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.859 HG13 ' CG ' ' A' ' 109' ' ' MET . 21.2 t -116.42 108.62 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.637 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 15.3 m-30 -92.49 121.33 33.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.396 -0.815 . . . . 0.0 109.65 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.845 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.4 t -103.95 117.35 49.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.403 -0.81 . . . . 0.0 108.927 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.467 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 2.7 tttm -98.97 110.57 23.16 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.447 ' HA ' HG12 ' A' ' 105' ' ' VAL . 33.4 ttt180 -56.27 135.85 53.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.847 -1.158 . . . . 0.0 109.528 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.346 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 N--CA 1.51 2.56 0 CA-C-O 120.75 0.31 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.031 HG22 HD11 ' A' ' 15' ' ' LEU . 3.0 mm -56.98 -67.45 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.645 0 O-C-N 121.051 -1.031 . . . . 0.0 109.594 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.6 pt-20 -37.31 -29.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.836 -0.54 . . . . 0.0 112.205 -178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' ILE . 5.0 m-20 -76.97 -53.13 8.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.805 -1.184 . . . . 0.0 109.906 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -62.85 -40.05 96.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.192 -0.943 . . . . 0.0 109.357 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.031 HD11 HG22 ' A' ' 11' ' ' ILE . 28.9 mt -61.03 -24.0 65.84 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 O-C-N 121.416 -0.802 . . . . 0.0 108.961 179.204 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.4 p30 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.963 0.411 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.38 31.8 8.09 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.974 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 15.5 mt -103.31 121.85 43.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.461 -1.023 . . . . 0.0 108.765 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.01 -12.09 7.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 109.965 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.974 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 10.3 p90 -121.49 116.96 25.67 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.003 -1.06 . . . . 0.0 109.289 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.519 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -55.14 148.64 24.18 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.469 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -128.61 100.88 5.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.833 -1.392 . . . . 0.0 108.222 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.737 HG22 ' CD1' ' A' ' 42' ' ' TYR . 2.2 pp -105.6 159.99 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.718 0.77 . . . . 0.0 110.953 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.79 ' HB3' HD12 ' A' ' 40' ' ' LEU . 33.7 mt-30 -122.08 174.86 6.67 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.678 HD11 ' HD2' ' A' ' 62' ' ' PHE . 22.7 mt -154.37 151.93 29.61 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.951 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.568 ' HB2' HD21 ' A' ' 40' ' ' LEU . 34.5 t70 -102.11 165.63 11.05 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.65 -20.65 0.14 Allowed Glycine 0 N--CA 1.499 2.884 0 O-C-N 121.792 -0.568 . . . . 0.0 113.507 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.58 20.02 19.32 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 119.814 1.807 . . . . 0.0 111.227 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.38 25.25 68.65 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.2 m-20 -90.0 125.22 35.31 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.051 -1.264 . . . . 0.0 110.767 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.659 HD12 HD21 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -59.5 139.2 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.869 -1.145 . . . . 0.0 110.706 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.79 HD12 ' HB3' ' A' ' 32' ' ' GLN . 9.2 mt -108.43 -31.31 7.87 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.444 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -157.69 -176.49 5.97 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.737 ' CD1' HG22 ' A' ' 31' ' ' ILE . 20.5 t80 -160.01 -72.81 0.07 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.706 -1.247 . . . . 0.0 111.488 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.9 p-10 105.28 179.34 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 C-N-CA 123.719 0.808 . . . . 0.0 109.096 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.26 -26.64 15.33 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.948 -1.095 . . . . 0.0 113.287 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -50.12 -64.63 0.75 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.332 -1.48 . . . . 0.0 110.796 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.9 pt-20 -57.86 -53.08 62.24 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 121.671 -0.643 . . . . 0.0 110.03 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 52' ' ' ARG . . . -58.38 -15.42 23.84 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.376 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.83 -34.23 39.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.894 -1.356 . . . . 0.0 108.892 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -84.86 -54.41 8.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.423 -0.798 . . . . 0.0 109.673 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.2 p -84.99 -23.11 28.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 110.34 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.36 -13.65 61.37 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.669 ' CD ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -47.89 107.23 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.184 -1.186 . . . . 0.0 110.817 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.742 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -74.39 153.71 87.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.2 -48.81 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.579 1.519 . . . . 0.0 111.13 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -18.26 60.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.077 -1.014 . . . . 0.0 110.281 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -88.61 -41.99 12.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.947 -1.096 . . . . 0.0 109.66 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 53' ' ' ASP . 26.4 m -73.22 -5.55 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.236 -0.915 . . . . 0.0 109.741 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.591 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -70.27 122.82 22.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.1 -1.0 . . . . 0.0 108.357 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.31 -16.58 59.47 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -79.25 139.91 37.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -1.204 . . . . 0.0 109.336 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -79.45 97.39 6.38 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.678 ' HD2' HD11 ' A' ' 33' ' ' LEU . 1.3 t80 -46.94 -39.9 13.24 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.508 -0.745 . . . . 0.0 110.63 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CG ' ' CD1' ' A' ' 76' ' ' TYR . 23.9 m-85 -86.1 -23.94 26.47 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.708 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.06 43.98 2.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 109.586 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 19.5 t0 -174.46 -20.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.766 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.664 HG11 ' HD3' ' A' ' 52' ' ' ARG . 5.4 t -117.96 -59.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 120.354 -1.466 . . . . 0.0 109.706 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' CB ' ' HE1' ' A' ' 62' ' ' PHE . . . -106.08 103.25 43.98 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.592 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.54 1.52 7.9 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.875 1.717 . . . . 0.0 110.97 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 p -106.39 -20.89 13.24 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.886 -1.134 . . . . 0.0 109.976 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.668 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 35.2 p -81.74 2.32 30.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.089 -1.007 . . . . 0.0 110.049 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -95.14 55.01 1.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.899 -1.125 . . . . 0.0 108.877 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.473 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -135.9 176.31 2.93 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.524 -0.735 . . . . 0.0 109.348 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.5 Cg_endo -77.04 77.86 3.63 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 122.413 2.075 . . . . 0.0 110.492 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 172.06 -36.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.5 t80 -105.63 -66.02 1.02 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.566 ' CD1' ' CG ' ' A' ' 63' ' ' PHE . 5.7 t80 -77.6 -20.51 53.84 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.032 -1.042 . . . . 0.0 108.265 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.39 -60.41 7.12 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.5 ' HB3' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -66.23 -15.43 63.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.752 -0.852 . . . . 0.0 110.085 -179.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.872 ' O ' HG23 ' A' ' 83' ' ' VAL . 5.1 t80 -84.15 -36.41 22.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -10.92 59.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 1.1 pp20? -97.5 -36.01 10.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.87 -39.63 85.33 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 79' ' ' PHE . 98.5 t -58.31 -56.2 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.89 -0.77 . . . . 0.0 109.408 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.39 -20.14 65.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 0.0 109.948 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 -29.25 51.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.9 24.1 42.96 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -172.68 57.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.42 -1.047 . . . . 0.0 108.991 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.846 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -49.4 124.7 9.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.804 . . . . 0.0 109.993 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.437 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 21.8 t-20 -161.02 88.92 0.77 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.459 -0.776 . . . . 0.0 109.043 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 78' ' ' LYS . 3.3 t -156.75 168.21 28.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.018 -1.051 . . . . 0.0 110.728 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -145.57 170.21 16.87 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.058 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 13.3 p90 -176.31 158.37 1.87 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.893 -1.129 . . . . 0.0 110.307 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -92.08 116.25 28.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.979 -1.076 . . . . 0.0 109.289 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.38 -175.23 3.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.03 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.727 HG22 ' OD1' ' A' ' 97' ' ' ASP . 75.6 m -150.06 114.15 5.12 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' ' 122' ' ' VAL . 16.7 m-30 -85.83 118.88 25.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.148 -0.97 . . . . 0.0 110.394 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.727 ' OD1' HG22 ' A' ' 95' ' ' THR . 0.9 OUTLIER -131.4 35.93 3.82 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.711 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -80.5 80.72 6.9 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 123.032 1.396 . . . . 0.0 111.201 -178.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 98' ' ' TYR . 2.4 mm100 72.9 27.19 2.17 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 119.925 -1.734 . . . . 0.0 109.051 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 50' ' ' THR . 1.5 tmm? -150.11 168.84 22.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.234 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -52.25 171.09 0.21 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 109.37 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.1 Cg_endo -76.59 79.45 3.03 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.927 1.751 . . . . 0.0 110.421 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.455 HG22 HG13 ' A' ' 105' ' ' VAL . 3.1 m -72.96 133.52 44.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 109.573 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.762 ' CB ' HG21 ' A' ' 125' ' ' VAL . 0.1 OUTLIER -106.45 148.55 28.02 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.251 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.582 ' HA ' HG13 ' A' ' 125' ' ' VAL . 19.7 m -158.31 140.41 5.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 118.578 -1.249 . . . . 0.0 110.536 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -87.43 130.92 34.5 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 103.309 -2.848 . . . . 0.0 103.309 175.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.058 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -104.67 160.06 5.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 120.543 -1.348 . . . . 0.0 110.513 -176.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -156.84 101.6 1.97 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.867 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -117.02 149.07 40.89 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.23 -0.919 . . . . 0.0 110.136 -177.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.645 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.7 tttt -145.28 -176.94 5.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.674 -1.266 . . . . 0.0 109.297 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -89.67 109.13 20.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.805 -1.184 . . . . 0.0 108.893 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.768 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -60.61 137.46 58.17 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.358 -0.839 . . . . 0.0 109.868 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.943 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.742 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.267 0.556 . . . . 0.0 109.822 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.841 ' CE1' HG22 ' A' ' 83' ' ' VAL . 28.1 m-85 -154.07 109.33 3.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.303 -0.873 . . . . 0.0 108.883 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.768 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 11.0 p-90 -108.62 143.43 37.69 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 118.646 -1.221 . . . . 0.0 111.914 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.867 HG13 ' CG ' ' A' ' 109' ' ' MET . 21.3 t -122.83 104.77 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.489 0.661 . . . . 0.0 109.248 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.667 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 8.7 m-30 -85.8 114.22 22.57 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -98.17 115.8 39.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.149 -1.021 . . . . 0.0 109.224 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.501 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 4.1 tttm -98.64 125.86 44.05 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HA ' HG12 ' A' ' 105' ' ' VAL . 6.7 ttt-85 -63.66 144.45 57.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.576 -1.328 . . . . 0.0 109.212 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.762 HG21 ' CB ' ' A' ' 104' ' ' LYS . 22.6 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.594 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.135 HG22 HD11 ' A' ' 15' ' ' LEU . 3.1 mm -80.54 -63.78 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.69 0 O-C-N 121.465 -0.772 . . . . 0.0 111.294 -176.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -44.2 -27.08 0.37 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.949 . . . . 0.0 110.962 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -90.0 -38.48 13.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.988 . . . . 0.0 108.359 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 14' ' ' THR . 2.3 m -75.39 -6.78 51.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.515 -0.74 . . . . 0.0 109.269 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.135 HD11 HG22 ' A' ' 11' ' ' ILE . 38.4 mt -98.82 -27.5 13.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.193 -0.942 . . . . 0.0 109.07 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.589 -0.694 . . . . 0.0 109.837 -179.557 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 120.935 0.398 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.41 33.97 6.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.48 147.8 33.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.236 -1.155 . . . . 0.0 109.293 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -93.23 22.35 5.21 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.797 0.808 . . . . 0.0 109.312 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.66 ' HZ ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -155.69 115.8 3.72 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -51.04 126.95 27.88 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.523 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -106.71 82.58 1.73 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.579 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.6 pp -91.77 153.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.374 -0.829 . . . . 0.0 110.817 -177.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.781 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -127.19 166.36 17.86 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.939 ' O ' HD11 ' A' ' 40' ' ' LEU . 84.3 mt -147.63 163.32 36.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.664 -1.273 . . . . 0.0 109.885 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.556 ' HB3' HD21 ' A' ' 40' ' ' LEU . 17.6 p-10 -134.07 122.3 22.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.104 -0.998 . . . . 0.0 110.725 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.08 -78.75 0.0 OUTLIER Glycine 0 N--CA 1.5 2.966 0 C-N-CA 124.424 1.011 . . . . 0.0 113.3 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 34' ' ' ASP . 27.8 t70 -70.84 -2.35 14.66 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.763 -0.845 . . . . 0.0 110.796 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.715 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 88.95 13.53 62.19 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.6 m-20 -66.99 148.09 52.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.903 -1.351 . . . . 0.0 108.02 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.655 HD11 ' HD1' ' A' ' 42' ' ' TYR . 2.4 tp -70.36 137.75 23.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.133 0.968 . . . . 0.0 112.648 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.939 HD11 ' O ' ' A' ' 33' ' ' LEU . 3.3 mt -107.59 -31.39 8.13 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 175.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.567 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 6.4 tp-100 -164.25 166.71 20.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.727 -0.608 . . . . 0.0 109.634 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.655 ' HD1' HD11 ' A' ' 39' ' ' ILE . 1.4 t80 -147.12 -69.41 0.24 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.166 -0.959 . . . . 0.0 110.289 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.2 p-10 102.88 152.3 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.26 -14.82 59.68 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.102 -0.999 . . . . 0.0 112.405 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -57.79 -62.09 2.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.623 -1.298 . . . . 0.0 109.565 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.556 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 14.0 pt-20 -64.81 -42.81 94.71 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.139 -0.976 . . . . 0.0 108.887 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.449 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -59.26 -16.6 35.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -86.18 -30.64 22.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.77 -1.429 . . . . 0.0 109.465 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.539 HG22 HG22 ' A' ' 50' ' ' THR . 1.2 mp -78.75 -42.05 24.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.539 HG22 HG22 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -109.18 1.7 20.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.437 -0.789 . . . . 0.0 109.81 -179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 81.84 -2.4 83.5 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.897 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.91 ' CD ' HG13 ' A' ' 66' ' ' VAL . 1.3 mtm-85 -79.33 81.42 5.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.797 -1.414 . . . . 0.0 111.327 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.575 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -64.46 -179.65 0.31 Allowed Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 34.2 Cg_endo -77.65 -35.63 1.46 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.681 1.587 . . . . 0.0 110.487 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HA ' HD12 ' A' ' 58' ' ' ILE . 1.9 tptp -73.09 -24.57 60.66 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.193 -0.942 . . . . 0.0 109.634 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -84.68 -43.46 14.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.609 HG21 ' CG ' ' A' ' 42' ' ' TYR . 35.9 m -71.6 -6.55 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.607 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.488 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -71.06 119.84 18.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 O-C-N 121.114 -0.991 . . . . 0.0 108.354 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.17 -19.85 52.16 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -78.79 143.41 36.1 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.41 -1.053 . . . . 0.0 108.911 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.59 123.95 34.12 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.871 ' HB2' HD21 ' A' ' 33' ' ' LEU . 65.3 t80 -56.44 -15.61 4.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.024 -1.047 . . . . 0.0 110.8 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -122.06 36.83 4.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.932 -1.105 . . . . 0.0 109.539 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.86 -52.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 110.32 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.24 10.04 8.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.977 -1.077 . . . . 0.0 110.778 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.91 HG13 ' CD ' ' A' ' 52' ' ' ARG . 41.1 t -115.82 -33.95 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.867 -1.146 . . . . 0.0 108.533 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.42 91.23 3.61 Favored Pre-proline 0 C--N 1.291 -1.964 0 O-C-N 121.41 -0.806 . . . . 0.0 109.146 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -73.64 -11.54 24.21 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.96 1.773 . . . . 0.0 110.123 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.9 p -86.41 -27.84 23.93 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.308 -0.87 . . . . 0.0 108.985 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.894 HG22 ' CD2' ' A' ' 75' ' ' PHE . 18.4 p -72.04 -4.96 31.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.619 -0.676 . . . . 0.0 110.161 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.22 74.84 9.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.075 -1.016 . . . . 0.0 108.651 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -162.31 172.37 5.55 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.346 -0.846 . . . . 0.0 109.228 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 36.1 Cg_endo -77.54 77.13 3.97 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 122.579 2.186 . . . . 0.0 110.42 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.1 tt0 173.13 -37.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.894 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.9 t80 -105.98 -65.76 1.04 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.562 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 10.4 t80 -77.33 -17.84 57.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.427 ' O ' ' CG ' ' A' ' 81' ' ' GLU . . . -62.5 -59.4 9.4 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.54 ' HB2' HG21 ' A' ' 90' ' ' THR . 10.7 mmtt -62.12 -19.36 62.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.689 -0.889 . . . . 0.0 109.399 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.841 ' O ' HG23 ' A' ' 83' ' ' VAL . 11.4 t80 -76.11 -40.41 52.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.275 -0.89 . . . . 0.0 108.729 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -6.6 55.45 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.211 -0.93 . . . . 0.0 108.887 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 77' ' ' GLY . 1.5 mm-40 -95.44 -39.6 9.91 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.425 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -70.03 -45.16 58.1 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.863 HG22 ' CE1' ' A' ' 118' ' ' TYR . 48.5 t -59.01 -37.6 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.776 -0.838 . . . . 0.0 109.58 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 -4.25 48.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 111.067 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -101.89 -16.91 16.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.845 -1.159 . . . . 0.0 110.025 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.15 17.35 74.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.03 85.97 0.53 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -1.202 . . . . 0.0 108.663 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.464 HD13 ' HD1' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -81.23 119.0 23.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.445 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 2.9 p30 -160.5 89.01 0.81 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.834 HG23 ' SD ' ' A' ' 109' ' ' MET . 1.6 t -138.77 171.51 14.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.075 -1.015 . . . . 0.0 110.569 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.452 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -158.3 148.27 19.9 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.05 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 12.6 p90 -168.96 153.25 5.57 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.7 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.4 115.32 23.07 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.82 -176.56 2.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.129 -0.982 . . . . 0.0 110.113 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.537 HG22 ' OD1' ' A' ' 97' ' ' ASP . 42.7 m -151.23 110.8 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.73 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 18.5 m-30 -83.52 110.62 18.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.537 ' OD1' HG22 ' A' ' 95' ' ' THR . 17.2 m-20 -133.32 42.43 3.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.829 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.567 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 21.4 p90 -77.33 137.07 38.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER 4.5 64.36 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 CA-C-O 121.447 0.642 . . . . 0.0 111.893 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.717 ' SD ' HG22 ' A' ' 101' ' ' THR . 0.7 OUTLIER -175.84 -176.2 0.82 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.117 -0.989 . . . . 0.0 109.749 -177.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.717 HG22 ' SD ' ' A' ' 100' ' ' MET . 1.2 t -64.14 150.95 91.35 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 108.86 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.433 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 31.5 Cg_endo -73.76 130.52 14.75 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 121.846 1.697 . . . . 0.0 110.682 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 95' ' ' THR . 3.3 m -123.46 142.84 50.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.495 -0.753 . . . . 0.0 109.222 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.409 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -118.06 139.77 50.73 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.675 ' HA ' HG23 ' A' ' 125' ' ' VAL . 11.0 m -154.36 144.71 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.962 -1.086 . . . . 0.0 110.399 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -94.2 116.02 28.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.05 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -89.24 164.24 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 122.307 1.051 . . . . 0.0 111.232 -175.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -160.57 102.65 1.36 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.847 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -114.35 151.12 33.51 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.393 -0.817 . . . . 0.0 110.203 -177.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 3.3 tttt -147.66 176.24 10.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.552 -1.343 . . . . 0.0 109.114 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.446 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 4.4 ttpt -85.02 107.39 17.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.923 -1.111 . . . . 0.0 109.45 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.82 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -56.69 152.16 12.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.415 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.112 -0.992 . . . . 0.0 110.197 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 1.6 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.421 0.629 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.863 ' CE1' HG22 ' A' ' 83' ' ' VAL . 8.9 m-85 -147.21 106.75 3.92 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.82 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 9.9 p-90 -103.23 139.38 38.77 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.783 -1.167 . . . . 0.0 112.557 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.847 HG13 ' HG2' ' A' ' 109' ' ' MET . 30.1 t -116.61 110.46 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.657 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.6 m-30 -92.69 118.53 31.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.313 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -101.3 122.77 53.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.955 -1.091 . . . . 0.0 109.355 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.584 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -99.13 123.11 43.18 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -75.05 118.45 18.01 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.931 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.412 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.7 t0 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.119 HG22 HD11 ' A' ' 15' ' ' LEU . 14.2 mm -61.9 -57.11 13.56 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.226 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.9 mt-10 -35.87 -43.21 0.3 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.875 -0.516 . . . . 0.0 111.709 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -76.3 -42.42 45.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.009 -1.057 . . . . 0.0 108.986 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 11' ' ' ILE . 7.2 m -66.53 -14.04 61.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.665 -0.647 . . . . 0.0 110.233 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.119 HD11 HG22 ' A' ' 11' ' ' ILE . 9.6 mt -97.34 -23.13 16.26 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.918 -1.114 . . . . 0.0 109.051 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.34 -0.85 . . . . 0.0 109.609 179.487 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 3.8 p30 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.75 21.18 42.78 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.527 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 14.6 mt -68.41 152.29 45.63 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.972 -1.311 . . . . 0.0 108.759 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.56 9.03 17.12 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.655 ' CZ ' HD11 ' A' ' 11' ' ' ILE . 1.2 p90 -153.5 117.29 4.74 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.486 ' HA3' ' HG2' ' A' ' 46' ' ' GLU . . . -53.97 161.61 3.8 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.382 -0.913 . . . . 0.0 110.859 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -136.88 116.0 12.48 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.583 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.5 pp -118.9 157.7 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.212 -0.93 . . . . 0.0 109.733 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.726 ' HB3' HD12 ' A' ' 40' ' ' LEU . 12.3 mt-30 -123.04 168.08 12.81 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.833 HD11 ' HB3' ' A' ' 62' ' ' PHE . 15.9 mt -151.69 150.38 30.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.007 . . . . 0.0 110.001 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.524 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -104.85 168.79 8.83 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -46.5 -29.44 3.95 Favored Glycine 0 N--CA 1.504 3.174 0 CA-C-N 118.621 0.646 . . . . 0.0 112.959 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.16 9.98 13.51 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.485 -1.597 . . . . 0.0 110.581 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.586 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.01 26.22 67.18 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.497 ' C ' HD23 ' A' ' 33' ' ' LEU . 13.6 m120 -93.25 134.14 35.76 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.227 -1.16 . . . . 0.0 111.229 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.471 HG21 HG23 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -62.61 138.25 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 111.058 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 32' ' ' GLN . 5.7 mt -109.68 -29.23 8.44 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -161.66 159.32 27.32 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.897 ' CE2' HG11 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -138.02 -50.63 0.59 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.38 -1.45 . . . . 0.0 109.311 -178.361 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.585 HD21 ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER 87.57 171.25 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . . . -96.03 -15.36 22.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.015 -1.053 . . . . 0.0 112.822 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.585 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -59.17 -64.74 0.83 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.429 -1.419 . . . . 0.0 109.488 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.575 ' OE2' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -59.72 -51.74 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 109.3 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' N ' ' OE2' ' A' ' 46' ' ' GLU . . . -56.96 -15.92 15.66 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.3 t70 -76.6 -40.73 48.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.821 -1.399 . . . . 0.0 108.181 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -73.33 -59.29 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.428 -0.795 . . . . 0.0 108.89 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.574 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -78.15 -8.55 58.41 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.347 -0.846 . . . . 0.0 110.319 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 82.77 -3.47 83.21 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.401 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.819 ' CZ ' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -60.91 165.73 3.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.743 -1.445 . . . . 0.0 110.078 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.808 ' O ' HG22 ' A' ' 57' ' ' VAL . 7.1 m-20 -133.05 168.11 19.58 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 53' ' ' ASP . 34.4 Cg_endo -77.27 -38.38 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.475 1.45 . . . . 0.0 110.074 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -79.04 -24.56 43.52 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.312 -0.867 . . . . 0.0 109.487 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -45.3 18.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.897 HG11 ' CE2' ' A' ' 42' ' ' TYR . 20.4 m -69.28 -9.66 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.198 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.459 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -68.98 120.72 16.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.96 -24.31 32.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 6.8 mmmt -78.9 130.38 35.57 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.466 ' ND2' ' ND2' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -79.19 132.58 36.57 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.567 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.868 ' CE2' HG21 ' A' ' 70' ' ' THR . 64.9 t80 -60.32 -14.37 18.01 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.068 -1.02 . . . . 0.0 110.118 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 99.5 m-85 -124.31 33.39 5.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.019 -1.051 . . . . 0.0 110.378 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -154.57 -40.7 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.882 -1.136 . . . . 0.0 110.377 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.53 7.86 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.007 -1.058 . . . . 0.0 110.881 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.819 HG13 ' CZ ' ' A' ' 52' ' ' ARG . 94.3 t -114.11 -33.85 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 120.673 -1.267 . . . . 0.0 108.448 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.478 ' HB1' HG23 ' A' ' 70' ' ' THR . . . -155.06 100.62 2.31 Favored Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.544 -0.722 . . . . 0.0 109.182 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.97 -1.23 10.94 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.913 1.742 . . . . 0.0 110.876 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.5 p -97.37 -25.32 15.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.133 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.868 HG21 ' CE2' ' A' ' 62' ' ' PHE . 67.7 p -66.98 -10.68 52.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.638 -0.663 . . . . 0.0 110.187 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.28 64.62 8.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 109.626 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.428 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -147.44 172.53 5.09 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.181 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -76.66 78.4 3.35 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 122.514 2.142 . . . . 0.0 110.314 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.8 tt0 169.36 -36.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.669 ' CD1' ' HE1' ' A' ' 109' ' ' MET . 1.3 t80 -104.21 -68.06 0.87 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.509 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 14.4 t80 -75.53 -20.69 58.53 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.69 -59.08 9.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.544 ' HB2' HG21 ' A' ' 90' ' ' THR . 8.5 mmtt -66.45 -14.17 61.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.523 -0.986 . . . . 0.0 109.915 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.846 ' O ' HG23 ' A' ' 83' ' ' VAL . 15.7 t80 -83.33 -35.02 25.51 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.371 -0.83 . . . . 0.0 109.048 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -11.95 59.88 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.157 -0.964 . . . . 0.0 109.246 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 23.5 pt-20 -97.84 -42.2 7.68 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.595 ' C ' HD12 ' A' ' 88' ' ' LEU . . . -61.61 -38.49 95.94 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.705 -2.158 . . . . 0.0 107.705 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.849 HG22 ' CE1' ' A' ' 118' ' ' TYR . 98.0 t -65.07 -40.15 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.795 -0.827 . . . . 0.0 110.042 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.61 0.36 57.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.0 111.135 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 t -109.74 -19.64 13.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.879 -1.138 . . . . 0.0 109.998 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.21 14.59 81.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -144.31 59.07 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -1.203 . . . . 0.0 109.275 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -68.25 113.48 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.656 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -161.04 79.44 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.386 -0.822 . . . . 0.0 108.908 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 78' ' ' LYS . 4.2 t -120.92 167.8 12.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.031 -1.043 . . . . 0.0 110.181 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 4.0 ttt -154.88 154.33 32.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.78 . . . . 0.0 109.222 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.069 ' CE2' HG21 ' A' ' 107' ' ' VAL . 15.4 p90 -176.85 178.04 1.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -0.95 . . . . 0.0 109.869 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.91 100.23 10.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.047 -1.033 . . . . 0.0 108.299 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.496 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -101.6 151.72 21.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 110.06 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -119.01 111.09 17.88 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.934 ' CE2' HG21 ' A' ' 122' ' ' VAL . 19.1 m-30 -79.28 115.78 19.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.402 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -137.51 46.3 2.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -85.32 43.95 1.06 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.623 -0.673 . . . . 0.0 111.688 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER 100.9 27.82 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.698 0 CA-C-O 121.603 0.716 . . . . 0.0 109.271 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.408 ' CE ' ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -139.28 175.15 9.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 19.5 p -54.52 161.27 2.18 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.024 -1.048 . . . . 0.0 109.287 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.4 Cg_endo -75.94 96.66 1.07 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.776 1.65 . . . . 0.0 110.049 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.462 HG22 HG13 ' A' ' 105' ' ' VAL . 1.0 OUTLIER -104.42 125.09 50.32 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.377 -0.827 . . . . 0.0 109.8 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.459 ' C ' HG23 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -88.7 159.92 17.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 175.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.672 HG23 HG13 ' A' ' 107' ' ' VAL . 35.6 m -156.17 142.49 10.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -79.13 103.5 9.12 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 175.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.069 HG21 ' CE2' ' A' ' 92' ' ' PHE . 33.7 m -94.8 151.88 3.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.806 -1.184 . . . . 0.0 110.24 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -153.96 103.3 2.56 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.783 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -104.75 131.82 51.74 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.079 -1.013 . . . . 0.0 109.297 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.588 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 3.9 tttt -130.34 -174.69 3.41 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.209 -1.396 . . . . 0.0 109.894 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 10.7 tttt -99.79 102.64 14.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.102 -0.999 . . . . 0.0 108.713 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.904 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -56.03 142.36 36.48 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.349 -0.844 . . . . 0.0 110.056 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.88 . . . . 0.0 109.985 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.86 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.52 0.676 . . . . 0.0 110.104 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.849 ' CE1' HG22 ' A' ' 83' ' ' VAL . 14.9 m-85 -151.91 111.35 3.94 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.904 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 20.1 p-90 -113.01 149.79 32.84 Favored 'General case' 0 C--O 1.202 -1.405 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.531 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.783 HG13 ' HG2' ' A' ' 109' ' ' MET . 46.6 t -128.24 106.25 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.726 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.666 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 7.5 m-30 -91.72 128.31 37.51 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.934 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.7 t -105.96 129.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.625 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -101.34 153.43 19.66 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -101.51 127.87 48.0 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.277 -1.369 . . . . 0.0 109.068 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.437 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 13' ' ' ASN . 18.0 t0 . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.945 HG22 HD11 ' A' ' 15' ' ' LEU . 4.4 mm -90.82 -59.45 2.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.302 -0.874 . . . . 0.0 110.553 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -22.92 0.77 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.578 -1.327 . . . . 0.0 110.558 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.4 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . 6.5 t-20 -94.29 -36.81 11.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 109.399 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -69.51 -59.8 2.74 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.945 HD11 HG22 ' A' ' 11' ' ' ILE . 18.1 mt -40.76 -34.61 0.4 Allowed 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.434 0.635 . . . . 0.0 109.793 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.485 -0.759 . . . . 0.0 109.865 -179.689 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.958 0.409 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.09 29.23 12.97 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 120.824 -1.172 . . . . 0.0 110.282 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.644 HD13 ' CE2' ' A' ' 28' ' ' PHE . 3.2 mt -105.35 -177.01 3.24 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.051 -1.264 . . . . 0.0 109.025 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.44 4.5 48.41 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.644 ' CE2' HD13 ' A' ' 26' ' ' LEU . 8.1 p90 -135.96 129.24 31.85 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -63.41 122.49 26.99 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.479 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -100.88 96.3 7.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.074 -1.25 . . . . 0.0 107.752 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.543 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.3 pp -98.24 148.82 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 110.787 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.595 ' HB3' HD12 ' A' ' 40' ' ' LEU . 5.5 mm-40 -113.56 167.32 10.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.884 HD22 ' O ' ' A' ' 37' ' ' GLY . 55.4 mt -155.46 139.89 16.79 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.165 -0.959 . . . . 0.0 108.91 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.598 ' HB2' HD21 ' A' ' 40' ' ' LEU . 8.1 t0 -120.52 131.71 54.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.919 -1.113 . . . . 0.0 110.433 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 35.87 -77.04 0.0 OUTLIER Glycine 0 N--CA 1.501 2.978 0 C-N-CA 124.71 1.148 . . . . 0.0 113.403 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -73.37 2.56 7.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.659 -0.907 . . . . 0.0 111.109 -178.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.884 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 82.4 17.34 69.09 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -72.58 136.34 45.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.087 -1.243 . . . . 0.0 108.693 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.599 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -64.44 135.59 27.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.224 -0.922 . . . . 0.0 111.094 -178.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 34' ' ' ASP . 1.5 mt -105.56 -29.39 10.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -163.51 164.09 24.47 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.632 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 7.4 t80 -133.36 -75.95 0.48 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 119.955 -1.716 . . . . 0.0 110.599 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.632 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 8.0 t-20 134.25 150.04 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.691 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -77.47 -55.88 5.01 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.335 -0.853 . . . . 0.0 109.834 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -34.0 -57.58 0.46 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.475 ' O ' HG23 ' A' ' 50' ' ' THR . 15.5 pt-20 -64.22 -46.73 82.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.948 -1.095 . . . . 0.0 109.676 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . -62.63 -12.2 39.51 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.08 -32.87 17.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.631 -1.511 . . . . 0.0 110.355 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.65 -35.08 11.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.179 -0.951 . . . . 0.0 108.899 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -107.3 -21.46 12.94 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.029 -179.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 97.93 -3.33 60.47 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.546 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 1.003 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 1.8 mtt85 -68.09 95.23 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.86 -1.376 . . . . 0.0 110.666 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.777 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -72.52 162.29 74.79 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 34.7 Cg_endo -76.98 -29.53 5.16 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.959 1.773 . . . . 0.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.79 -33.97 34.43 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.269 -0.894 . . . . 0.0 109.899 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -41.73 49.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.717 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 53' ' ' ASP . 34.1 m -74.26 -4.48 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 109.914 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.555 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.21 123.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.82 -19.37 52.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -82.66 133.69 35.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -1.139 . . . . 0.0 109.102 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.485 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -75.0 119.78 19.65 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.204 -0.935 . . . . 0.0 108.501 179.2 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.599 ' HB2' HD12 ' A' ' 39' ' ' ILE . 90.9 t80 -66.32 -8.89 28.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.895 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.639 ' CE2' HD13 ' A' ' 33' ' ' LEU . 34.3 m-85 -96.93 -60.19 1.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.202 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -112.96 20.89 15.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.902 -1.124 . . . . 0.0 110.851 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.485 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.4 OUTLIER -137.01 -14.91 1.54 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.872 -1.142 . . . . 0.0 111.44 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 1.003 HG12 ' CZ ' ' A' ' 52' ' ' ARG . 31.5 t -122.43 -47.99 2.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 120.55 -1.344 . . . . 0.0 108.559 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.655 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . . . -122.65 109.96 32.19 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -75.17 0.79 8.55 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.912 1.742 . . . . 0.0 111.505 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.2 p -98.68 -24.84 14.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.87 -1.144 . . . . 0.0 109.658 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.596 HG21 ' CE2' ' A' ' 62' ' ' PHE . 61.2 p -73.67 -4.04 31.9 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.332 -0.855 . . . . 0.0 109.863 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -88.44 50.82 2.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.014 -1.054 . . . . 0.0 109.148 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.418 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -127.1 174.84 3.82 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.8 Cg_endo -76.77 -1.33 11.45 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 122.101 1.867 . . . . 0.0 111.387 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 14.9 mp0 -105.34 -28.42 10.9 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.916 -1.115 . . . . 0.0 109.357 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.631 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.7 t80 -100.57 -71.99 0.69 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.44 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 11.4 t80 -72.96 -16.11 61.54 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 120.947 -1.096 . . . . 0.0 108.234 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.65 -62.6 4.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.58 ' CB ' HG21 ' A' ' 90' ' ' THR . 2.2 mmtp -64.06 -14.89 57.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.672 -0.899 . . . . 0.0 109.551 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.867 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.3 t80 -80.53 -41.18 24.66 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -9.35 58.51 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 108.689 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 85' ' ' SER . 2.1 mm-40 -95.9 -40.17 9.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.7 95.02 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 79' ' ' PHE . 61.8 t -62.96 -40.61 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.943 -0.74 . . . . 0.0 109.975 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.37 1.4 54.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.256 -0.902 . . . . 0.0 111.218 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 81' ' ' GLU . 97.5 p -104.69 -24.13 12.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.863 -1.148 . . . . 0.0 110.142 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.03 21.17 47.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -160.16 57.08 0.35 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -1.189 . . . . 0.0 109.333 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.538 HD13 ' CD1' ' A' ' 118' ' ' TYR . 1.5 tt -66.29 102.39 0.85 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.422 -0.798 . . . . 0.0 109.447 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -161.6 82.95 0.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.58 HG21 ' CB ' ' A' ' 78' ' ' LYS . 10.1 t -139.79 174.58 10.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.904 -1.123 . . . . 0.0 110.233 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -149.75 168.77 22.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.05 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 8.8 p90 -174.47 154.29 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.079 -1.013 . . . . 0.0 109.929 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -80.47 117.16 20.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.41 -0.806 . . . . 0.0 108.943 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.03 169.3 11.8 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.249 -0.907 . . . . 0.0 109.435 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.446 HG22 ' OD1' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -140.19 111.31 7.04 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.376 -0.828 . . . . 0.0 109.313 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.827 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 20.6 m-30 -79.64 85.04 5.4 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.455 -0.778 . . . . 0.0 109.12 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.446 ' OD1' HG22 ' A' ' 95' ' ' THR . 1.2 m-20 -102.99 29.47 5.43 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.548 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -77.59 153.39 33.32 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 98' ' ' TYR . 10.0 mt-30 -2.0 67.35 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 123.365 0.666 . . . . 0.0 112.457 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.9 -157.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.0 109.845 -178.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -91.22 174.17 4.7 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 0.0 108.882 179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.3 Cg_endo -76.71 87.79 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.949 1.766 . . . . 0.0 110.509 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.46 HG22 HG13 ' A' ' 105' ' ' VAL . 1.8 m -87.52 106.9 18.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.443 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.42 139.33 31.61 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.786 ' HA ' HG23 ' A' ' 125' ' ' VAL . 13.7 m -149.94 146.14 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.131 -0.981 . . . . 0.0 110.115 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.572 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.22 115.79 29.09 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 175.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.05 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -85.97 159.96 3.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 120.82 -1.175 . . . . 0.0 110.925 -175.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -157.15 98.42 1.73 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.881 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -109.09 149.38 29.4 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.395 -0.816 . . . . 0.0 109.748 -177.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.673 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -141.07 -175.04 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.374 -1.33 . . . . 0.0 109.695 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -89.63 101.79 14.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 109.258 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.643 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -56.85 156.93 6.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.615 -0.678 . . . . 0.0 110.871 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.305 -1.331 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.58 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.31 0.576 . . . . 0.0 109.929 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CE1' HG22 ' A' ' 83' ' ' VAL . 1.7 m-85 -149.74 127.54 11.76 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.673 ' CH2' ' HB2' ' A' ' 110' ' ' LYS . 10.2 p-90 -123.8 148.24 46.86 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.968 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.881 HG13 ' CG ' ' A' ' 109' ' ' MET . 11.7 t -123.0 109.49 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.314 0.578 . . . . 0.0 109.827 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.653 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 9.2 m-30 -88.24 126.37 35.12 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.827 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.2 t -103.88 114.71 44.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.572 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -89.52 111.79 22.8 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.606 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -66.95 109.03 2.79 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.948 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.786 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.161 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.988 HG22 HD11 ' A' ' 15' ' ' LEU . 4.9 mm -83.6 -56.77 5.23 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 110.732 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.459 ' HA ' HD12 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -40.35 -29.23 0.08 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.773 . . . . 0.0 111.559 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 11' ' ' ILE . 4.8 m120 -89.37 -40.83 12.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.966 -1.083 . . . . 0.0 108.258 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 m -69.2 -10.18 56.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.719 -0.613 . . . . 0.0 109.794 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.988 HD11 HG22 ' A' ' 11' ' ' ILE . 15.4 mt -97.48 -24.54 15.54 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.019 -1.05 . . . . 0.0 109.172 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.423 -0.798 . . . . 0.0 109.627 179.917 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.96 30.09 9.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.604 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 31.8 mt -80.17 128.3 33.36 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.51 -0.994 . . . . 0.0 109.207 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.17 -13.78 8.42 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.599 0.714 . . . . 0.0 109.227 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.732 ' HZ ' HD11 ' A' ' 11' ' ' ILE . 14.6 p90 -129.16 150.7 50.44 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.068 -1.02 . . . . 0.0 108.843 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.528 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -76.69 152.03 40.32 Favored Glycine 0 C--N 1.293 -1.81 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -123.7 90.61 3.31 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.832 -1.393 . . . . 0.0 107.536 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.527 HG22 ' CD1' ' A' ' 42' ' ' TYR . 1.1 pp -94.71 142.6 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.489 -0.757 . . . . 0.0 110.762 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.472 ' CG ' ' HB3' ' A' ' 41' ' ' GLN . 2.0 mm100 -114.11 168.33 9.91 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.847 HD22 ' O ' ' A' ' 37' ' ' GLY . 73.3 mt -153.94 146.92 24.49 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.842 -1.161 . . . . 0.0 110.379 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 36' ' ' ASP . 45.1 m-20 -123.63 124.07 41.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.394 -0.816 . . . . 0.0 109.659 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.54 -77.32 0.0 OUTLIER Glycine 0 N--CA 1.5 2.951 0 C-N-CA 124.561 1.077 . . . . 0.0 113.679 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -70.57 -2.86 15.51 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.598 -0.942 . . . . 0.0 111.197 -177.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.847 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 88.02 20.52 49.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -75.5 130.16 38.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.086 -1.244 . . . . 0.0 108.201 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.648 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -59.78 139.01 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 110.561 -178.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 32' ' ' GLN . 2.7 mt -107.07 -26.59 11.07 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.472 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 0.9 OUTLIER -160.31 142.11 12.66 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.527 ' CD1' HG22 ' A' ' 31' ' ' ILE . 6.2 t80 -121.95 -64.22 1.23 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.756 -1.215 . . . . 0.0 110.729 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 45' ' ' ALA . 3.2 p-10 101.86 175.6 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.59 -19.42 19.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.855 -1.153 . . . . 0.0 112.615 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.555 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -56.84 -63.44 1.2 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.51 -1.369 . . . . 0.0 110.163 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.9 pt-20 -60.77 -53.18 60.46 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.579 -0.701 . . . . 0.0 109.392 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -57.96 -14.38 16.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.46 -30.78 20.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.786 -1.42 . . . . 0.0 110.205 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.36 -38.12 14.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.122 -0.986 . . . . 0.0 109.074 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.433 ' HA ' ' CE ' ' A' ' 100' ' ' MET . 0.7 OUTLIER -102.86 -18.28 15.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.5 -0.75 . . . . 0.0 109.669 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 92.72 -3.76 74.89 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.606 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -58.39 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.239 . . . . 0.0 109.213 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.719 ' O ' HG22 ' A' ' 57' ' ' VAL . 12.1 m-20 -54.74 152.93 11.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 108.919 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.55 -42.81 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 122.07 1.847 . . . . 0.0 110.68 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -74.73 -27.81 60.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.13 -0.981 . . . . 0.0 109.94 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -80.66 -39.65 26.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.613 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 53' ' ' ASP . 24.0 m -76.66 -1.99 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.837 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -71.71 122.1 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.061 -1.024 . . . . 0.0 108.48 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.06 -13.13 65.58 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 35.1 mmtt -79.13 136.23 37.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.048 -1.266 . . . . 0.0 108.93 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.455 ' N ' ' HB3' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -72.41 95.03 1.71 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.459 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 30.1 t80 -53.92 -22.71 10.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 109.794 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -91.78 -31.98 15.55 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.72 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -138.15 44.98 2.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 109.114 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.455 ' HB3' ' N ' ' A' ' 61' ' ' ASN . 34.0 t0 -164.26 -31.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 110.517 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.606 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 3.9 t -112.2 -50.57 5.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 O-C-N 120.754 -1.216 . . . . 0.0 108.674 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -121.63 94.74 48.36 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.709 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.22 -6.02 17.82 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.886 1.724 . . . . 0.0 110.462 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.7 p -77.82 -32.87 52.54 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.151 -0.968 . . . . 0.0 108.692 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.457 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 19.1 p -69.1 -9.44 52.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.604 -0.685 . . . . 0.0 109.764 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.87 76.74 9.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.997 -1.064 . . . . 0.0 108.635 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.426 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -165.07 173.46 3.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 109.085 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.6 Cg_endo -77.4 76.71 4.12 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 122.497 2.132 . . . . 0.0 110.416 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 3.6 tt0 174.27 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.617 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.3 t80 -105.65 -64.03 1.19 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.506 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.4 t80 -79.61 -20.43 46.85 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.081 -1.012 . . . . 0.0 108.56 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.46 -57.81 13.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.717 ' CB ' HG21 ' A' ' 90' ' ' THR . 12.1 mmtt -65.38 -16.69 63.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.658 -0.907 . . . . 0.0 109.802 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.89 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.4 t80 -82.62 -35.12 27.29 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -76.32 -12.88 60.14 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.103 -0.998 . . . . 0.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 18.7 pt-20 -96.92 -41.34 8.46 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.461 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -60.18 -39.86 96.48 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 107.454 -2.258 . . . . 0.0 107.454 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 79' ' ' PHE . 99.1 t -59.88 -47.59 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.794 -0.827 . . . . 0.0 109.296 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.76 5.58 45.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.386 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.3 m -102.0 -25.75 13.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.042 -1.037 . . . . 0.0 109.612 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.78 22.29 64.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -166.03 58.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.134 -1.216 . . . . 0.0 109.51 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.5 OUTLIER -52.94 116.35 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.895 . . . . 0.0 109.515 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.425 ' ND2' ' HE3' ' A' ' 110' ' ' LYS . 2.4 t-20 -160.2 78.34 0.66 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.168 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.717 HG21 ' CB ' ' A' ' 78' ' ' LYS . 9.1 t -136.44 154.91 50.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.96 163.0 34.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 0.0 108.923 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.021 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 8.6 p90 -175.27 151.59 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.041 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 1.5 pt-20 -81.73 112.39 18.86 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.195 -0.941 . . . . 0.0 108.636 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.79 -179.63 3.71 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.181 -0.949 . . . . 0.0 109.99 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.3 m -147.52 107.56 4.02 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.848 ' CE2' HG21 ' A' ' 122' ' ' VAL . 17.8 m-30 -84.13 92.58 7.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.377 -0.827 . . . . 0.0 109.718 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -108.01 25.21 11.85 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.264 -0.898 . . . . 0.0 109.338 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.576 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -78.65 155.39 29.54 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.52 ' C ' ' O ' ' A' ' 98' ' ' TYR . 24.1 mt-30 -0.32 65.85 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.187 0 CA-C-O 121.631 0.729 . . . . 0.0 112.099 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.576 ' N ' ' O ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER 173.64 158.36 0.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -53.68 168.44 0.4 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.114 -0.991 . . . . 0.0 109.088 179.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 32.8 Cg_endo -74.75 113.34 3.77 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.831 1.688 . . . . 0.0 110.194 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.522 HG22 HG13 ' A' ' 105' ' ' VAL . 4.3 m -116.25 114.93 25.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.844 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 125' ' ' VAL . 5.4 tttt -92.05 136.65 33.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.852 ' HA ' HG23 ' A' ' 125' ' ' VAL . 32.6 m -147.44 146.27 18.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.146 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.86 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -91.71 116.37 28.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 175.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.021 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -88.27 164.12 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.787 -1.196 . . . . 0.0 111.516 -175.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -150.83 98.7 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.876 ' HG2' HG13 ' A' ' 120' ' ' VAL . 19.5 mtm -96.85 125.4 41.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.682 -1.261 . . . . 0.0 109.503 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.553 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 3.9 tttt -132.15 172.12 12.79 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 117.525 -1.67 . . . . 0.0 109.706 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.445 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 2.1 tttp -90.29 107.68 19.29 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.979 -1.076 . . . . 0.0 108.384 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.876 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.21 -177.17 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.28 0.562 . . . . 0.0 110.154 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.027 . . . . 0.0 110.461 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.577 ' N ' ' HB3' ' A' ' 112' ' ' ALA . 4.6 t . . . . . 0 N--CA 1.502 2.163 0 CA-C-O 120.661 0.267 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.618 ' OH ' HG13 ' A' ' 83' ' ' VAL . 12.6 m-85 -127.3 122.8 34.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.742 -1.224 . . . . 0.0 109.227 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.876 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 22.1 p-90 -128.11 152.42 48.02 Favored 'General case' 0 C--O 1.201 -1.455 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.919 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.876 HG13 ' HG2' ' A' ' 109' ' ' MET . 60.9 t -132.36 110.31 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.305 0.574 . . . . 0.0 109.648 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.686 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 9.1 m-30 -94.34 122.09 36.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 108.987 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.848 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -103.03 116.84 47.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.01 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 1.6 tptp -88.09 114.18 24.45 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.828 ' HA ' HG12 ' A' ' 105' ' ' VAL . 1.2 ttp85 -67.85 111.6 4.42 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.456 -1.297 . . . . 0.0 108.544 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.86 HG22 ' HD2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.058 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 N--CA 1.502 2.156 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.046 HG22 HD11 ' A' ' 15' ' ' LEU . 1.9 mm -88.64 -67.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.117 -0.989 . . . . 0.0 111.142 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -41.16 -36.06 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.624 -0.672 . . . . 0.0 111.592 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -77.54 -42.76 34.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.872 -1.143 . . . . 0.0 108.455 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.435 ' O ' HG22 ' A' ' 14' ' ' THR . 2.0 m -76.03 -4.38 40.95 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.046 HD11 HG22 ' A' ' 11' ' ' ILE . 81.2 mt -97.85 -23.03 16.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.855 -1.153 . . . . 0.0 109.149 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 O-C-N 121.483 -0.761 . . . . 0.0 108.994 179.522 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.16 28.88 13.68 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.85 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 1.7 mt -73.68 -171.91 1.14 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.128 -1.219 . . . . 0.0 108.798 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.85 13.22 23.63 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.85 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 18.8 p90 -146.12 177.2 9.16 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.684 -0.635 . . . . 0.0 109.509 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 46' ' ' GLU . . . -108.66 118.8 5.44 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.471 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -94.81 89.39 5.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.919 -1.342 . . . . 0.0 109.061 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.656 HD12 ' N ' ' A' ' 32' ' ' GLN . 1.1 pp -96.0 161.47 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.494 -0.754 . . . . 0.0 109.403 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.656 ' N ' HD12 ' A' ' 31' ' ' ILE . 8.9 mt-30 -132.16 175.77 8.96 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.825 HD21 ' HB2' ' A' ' 62' ' ' PHE . 22.3 mt -155.77 146.25 21.88 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.756 ' HB2' HD21 ' A' ' 40' ' ' LEU . 14.6 t70 -99.16 169.96 9.02 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.86 -21.82 1.74 Allowed Glycine 0 N--CA 1.499 2.893 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.449 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -94.98 13.51 24.77 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.547 -1.56 . . . . 0.0 110.549 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.07 26.68 65.9 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 2.0 m-20 -97.25 126.22 42.31 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.987 -1.302 . . . . 0.0 111.929 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.499 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -53.09 133.41 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.117 -0.99 . . . . 0.0 110.709 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 34' ' ' ASP . 11.6 mt -102.74 -32.2 9.95 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -155.54 -175.16 5.29 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.883 ' CE2' HG11 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -160.62 -62.8 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.97 -1.081 . . . . 0.0 110.239 -178.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.623 HD21 ' HB3' ' A' ' 45' ' ' ALA . 4.8 p-10 103.92 176.49 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.22 -37.03 11.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.974 -1.079 . . . . 0.0 110.758 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.623 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -46.76 -48.18 20.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.233 -0.917 . . . . 0.0 111.047 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.571 ' OE2' ' HB2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -61.83 -47.51 84.78 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.388 -0.82 . . . . 0.0 109.34 -177.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . -61.27 -15.87 46.71 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -80.64 -32.32 36.24 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.121 -1.223 . . . . 0.0 109.464 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.599 HD11 ' HD3' ' A' ' 124' ' ' ARG . 0.6 OUTLIER -85.06 -50.61 14.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.075 -1.015 . . . . 0.0 109.441 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.624 ' HA ' ' HE1' ' A' ' 100' ' ' MET . 0.1 OUTLIER -88.58 -13.88 38.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.759 -1.213 . . . . 0.0 109.524 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 89.09 -11.77 68.35 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.716 ' CD ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -57.78 175.54 0.19 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -1.165 . . . . 0.0 109.525 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.656 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -127.86 158.85 69.2 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 108.943 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.97 -37.99 1.8 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.865 1.71 . . . . 0.0 110.656 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -89.23 -25.26 21.83 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.171 -0.955 . . . . 0.0 109.279 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.411 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 1.2 tt0 -73.89 -37.88 64.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 108.689 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.883 HG11 ' CE2' ' A' ' 42' ' ' TYR . 26.6 m -70.9 -8.45 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.815 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -70.97 122.56 23.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.08 -19.7 51.71 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 40.4 mmtt -78.73 130.94 36.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.451 -1.029 . . . . 0.0 108.927 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 128.1 34.66 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.825 ' HB2' HD21 ' A' ' 33' ' ' LEU . 63.2 t80 -62.33 -11.53 15.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.584 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -122.52 32.17 5.86 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.95 -1.094 . . . . 0.0 110.271 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -150.09 -45.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.07 . . . . 0.0 110.563 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -128.15 4.33 5.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.994 -1.067 . . . . 0.0 110.762 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.716 HG13 ' CD ' ' A' ' 52' ' ' ARG . 39.2 t -113.62 -28.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.801 -1.187 . . . . 0.0 108.72 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.645 ' HB1' HG23 ' A' ' 70' ' ' THR . . . -156.58 88.79 2.74 Favored Pre-proline 0 C--N 1.292 -1.915 0 O-C-N 121.346 -0.847 . . . . 0.0 109.214 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -74.61 -4.41 15.37 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.986 1.791 . . . . 0.0 110.158 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.5 p -94.27 -27.63 16.03 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.355 -0.84 . . . . 0.0 109.074 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.645 HG23 ' HB1' ' A' ' 67' ' ' ALA . 69.9 p -64.41 -18.89 65.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.62 -0.675 . . . . 0.0 109.666 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -60.5 91.84 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.052 -1.03 . . . . 0.0 108.842 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.414 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -174.95 172.8 1.11 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.229 -179.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.1 Cg_endo -78.16 -4.44 14.33 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 122.599 2.199 . . . . 0.0 111.729 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 17.7 mt-10 -102.46 -29.95 11.3 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.754 -1.216 . . . . 0.0 109.822 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.443 ' HB3' ' O ' ' A' ' 70' ' ' THR . 1.6 t80 -101.62 -68.91 0.8 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.469 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.8 t80 -73.62 -17.32 61.18 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 81' ' ' GLU . . . -64.84 -61.42 5.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.595 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.2 OUTLIER -65.03 -14.66 60.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.646 -0.914 . . . . 0.0 109.841 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.901 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.9 t80 -82.89 -36.75 25.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -78.32 -9.47 59.26 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 85' ' ' SER . 1.3 mm-40 -95.61 -39.6 9.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.612 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -65.25 -41.69 96.66 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.3 t -59.67 -40.57 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.788 -0.831 . . . . 0.0 109.585 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.66 1.17 53.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.275 -0.891 . . . . 0.0 111.503 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 8.7 t -106.39 -20.1 13.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.808 -1.182 . . . . 0.0 110.147 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.63 26.03 57.4 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -168.66 67.26 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.397 -1.06 . . . . 0.0 109.217 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.83 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -71.37 115.88 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.905 . . . . 0.0 110.032 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.45 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 64.1 t-20 -162.03 88.4 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.541 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 78' ' ' LYS . 4.6 t -128.92 168.32 16.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.992 -1.068 . . . . 0.0 109.96 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.413 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 0.6 OUTLIER -155.14 151.11 27.87 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.064 ' CE2' HG21 ' A' ' 107' ' ' VAL . 12.3 p90 -173.03 -176.58 1.42 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.293 -0.88 . . . . 0.0 109.547 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.82 100.03 8.6 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.19 179.12 4.7 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.591 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.3 m -144.03 105.9 4.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.383 -0.823 . . . . 0.0 109.271 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.948 ' CE2' HG21 ' A' ' 122' ' ' VAL . 15.5 m-30 -80.59 110.15 15.8 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -134.7 43.26 2.76 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.364 -0.835 . . . . 0.0 109.485 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 21.4 p90 -77.41 139.58 39.72 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.533 ' C ' ' O ' ' A' ' 98' ' ' TYR . 3.3 pt20 2.31 66.98 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.191 0 CA-C-O 121.879 0.847 . . . . 0.0 111.783 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.624 ' HE1' ' HA ' ' A' ' 50' ' ' THR . 2.6 tmm? -176.85 -179.38 0.94 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 p -65.0 163.08 32.67 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.0 109.06 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.02 148.67 27.98 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.147 1.898 . . . . 0.0 110.416 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.577 HG22 HG13 ' A' ' 105' ' ' VAL . 3.2 m -151.36 118.87 6.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 110.116 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -95.36 142.9 27.21 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.961 ' HA ' HG23 ' A' ' 125' ' ' VAL . 32.5 m -144.12 146.67 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 118.266 -1.373 . . . . 0.0 112.411 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.561 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -78.8 95.33 5.34 Favored 'General case' 0 C--O 1.2 -1.536 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 175.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.064 HG21 ' CE2' ' A' ' 92' ' ' PHE . 33.3 m -87.63 152.6 3.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 120.731 -1.231 . . . . 0.0 110.151 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -160.44 97.53 1.22 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.817 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -106.12 142.27 36.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.188 -0.945 . . . . 0.0 109.327 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 5.3 tttt -133.01 -162.49 1.24 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.753 -1.217 . . . . 0.0 109.416 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -110.84 98.53 7.64 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.119 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.958 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.49 123.97 12.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 tp . . . . . 0 C--N 1.301 -1.541 0 O-C-N 121.037 -1.039 . . . . 0.0 109.695 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.499 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.037 0 CA-C-O 121.103 0.478 . . . . 0.0 111.534 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.862 ' CE1' HG22 ' A' ' 83' ' ' VAL . 15.9 m-85 -128.75 127.45 42.07 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.037 -1.04 . . . . 0.0 110.106 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.958 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 17.6 p-90 -125.56 146.87 49.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.601 -1.312 . . . . 0.0 112.269 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.817 HG13 ' HG2' ' A' ' 109' ' ' MET . 40.7 t -123.32 117.85 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.741 -0.599 . . . . 0.0 109.949 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.643 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.0 m-30 -100.92 120.0 39.53 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.988 -1.07 . . . . 0.0 108.639 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.948 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.4 t -105.58 111.71 35.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 122.244 1.021 . . . . 0.0 108.297 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.487 ' O ' ' HB ' ' A' ' 105' ' ' VAL . 1.5 tptp -92.71 154.49 18.3 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.599 ' HD3' HD11 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -91.47 123.55 34.98 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.493 -1.379 . . . . 0.0 109.008 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.961 HG23 ' HA ' ' A' ' 105' ' ' VAL . 9.3 t . . . . . 0 C--N 1.305 -1.355 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.481 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.009 HG22 HD11 ' A' ' 15' ' ' LEU . 2.9 mm -82.48 -56.14 6.45 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 111.464 -177.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 15' ' ' LEU . 1.5 tt0 -40.43 -27.91 0.06 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.454 -0.779 . . . . 0.0 111.524 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' ILE . 96.6 m-20 -86.79 -42.52 13.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 109.007 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -70.48 -14.42 62.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.347 -0.846 . . . . 0.0 110.21 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.009 HD11 HG22 ' A' ' 11' ' ' ILE . 8.9 mt -93.56 -18.92 21.7 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.014 -1.054 . . . . 0.0 109.069 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 108.824 179.172 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 120.916 0.389 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.51 35.53 4.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.706 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 13.6 mt -121.27 149.64 42.58 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.487 -1.008 . . . . 0.0 109.352 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.04 24.58 4.2 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.029 0.918 . . . . 0.0 108.851 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.716 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 1.2 p90 -153.53 134.12 13.66 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -68.18 125.2 21.07 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.96 -1.115 . . . . 0.0 110.857 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.432 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -106.21 110.41 22.64 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.529 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.4 pp -117.11 151.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.939 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.602 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -113.0 167.91 10.13 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.757 HD11 ' CB ' ' A' ' 62' ' ' PHE . 13.2 mt -150.07 139.9 21.83 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.916 -1.115 . . . . 0.0 110.036 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.438 ' N ' HD21 ' A' ' 40' ' ' LEU . 37.1 t70 -92.14 167.56 11.97 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -48.93 -21.04 2.14 Favored Glycine 0 N--CA 1.497 2.747 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.421 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.42 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 1.3 m-20 -92.51 12.52 22.65 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.458 -1.613 . . . . 0.0 110.498 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.652 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.3 26.9 64.89 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.569 ' C ' HD23 ' A' ' 33' ' ' LEU . 69.1 m-20 -97.4 127.83 43.69 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.013 -1.287 . . . . 0.0 111.872 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.626 HD12 HD21 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -59.52 134.83 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.86 -1.15 . . . . 0.0 110.528 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 32' ' ' GLN . 2.3 mt -106.47 -29.56 9.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.456 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -155.46 161.38 40.97 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.832 ' CG ' HG21 ' A' ' 57' ' ' VAL . 3.7 t80 -143.7 -60.93 0.4 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.552 -1.342 . . . . 0.0 109.972 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.601 HD21 ' HB3' ' A' ' 45' ' ' ALA . 3.5 p-10 99.89 173.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 123.745 0.818 . . . . 0.0 108.871 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.59 -13.73 25.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.755 -1.215 . . . . 0.0 111.84 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.601 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -58.93 -65.06 0.73 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.585 -1.322 . . . . 0.0 109.904 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.591 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 7.0 pt-20 -60.31 -50.0 75.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.959 . . . . 0.0 109.737 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -56.47 -18.64 23.4 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 45' ' ' ALA . 1.2 m-20 -76.13 -38.47 56.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.829 -1.395 . . . . 0.0 108.422 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.627 HG22 HG23 ' A' ' 50' ' ' THR . 0.3 OUTLIER -79.32 -59.5 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.45 -0.781 . . . . 0.0 109.294 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.627 HG23 HG22 ' A' ' 49' ' ' ILE . 19.0 p -78.36 -9.63 59.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.275 -0.891 . . . . 0.0 110.474 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.444 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 81.0 -2.34 81.23 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.925 ' CD ' HG13 ' A' ' 66' ' ' VAL . 1.3 mtt-85 -73.86 84.71 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.169 -1.195 . . . . 0.0 109.925 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.533 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -54.29 173.73 0.21 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.301 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 35.8 Cg_endo -77.94 -32.22 2.7 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.018 1.812 . . . . 0.0 110.856 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -80.97 -33.42 33.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.193 -0.942 . . . . 0.0 109.987 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 4.8 tt0 -71.56 -42.67 67.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.097 -1.002 . . . . 0.0 109.658 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.832 HG21 ' CG ' ' A' ' 42' ' ' TYR . 28.6 m -68.65 -9.08 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.963 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.484 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -70.11 123.16 23.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.8 -14.67 59.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 56' ' ' GLN . 65.7 mmtt -79.51 127.45 32.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.266 -1.138 . . . . 0.0 109.18 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -67.53 128.01 34.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 108.659 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.757 ' CB ' HD11 ' A' ' 33' ' ' LEU . 78.2 t80 -62.21 -14.2 35.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 0.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.4 5.72 11.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.057 -1.027 . . . . 0.0 111.12 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 4.5 mttt -151.45 47.26 0.81 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.785 -1.197 . . . . 0.0 109.825 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER 163.56 -22.59 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.609 -0.682 . . . . 0.0 109.683 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.925 HG13 ' CD ' ' A' ' 52' ' ' ARG . 21.2 t -112.76 -28.66 2.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.22 -0.925 . . . . 0.0 108.505 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.496 ' HB1' HG23 ' A' ' 70' ' ' THR . . . -159.81 94.99 1.64 Allowed Pre-proline 0 C--N 1.293 -1.864 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.947 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.88 -18.53 16.84 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.856 1.704 . . . . 0.0 109.241 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.7 p -79.45 -20.35 47.64 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.532 -0.73 . . . . 0.0 109.376 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.496 HG23 ' HB1' ' A' ' 67' ' ' ALA . 47.7 p -80.94 5.82 15.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 110.032 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -89.28 52.58 2.41 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.937 -1.102 . . . . 0.0 108.402 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.48 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.8 p -125.39 -179.42 0.87 Allowed Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.99 -12.81 14.44 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 122.146 1.897 . . . . 0.0 111.593 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.6 OUTLIER -96.37 -26.68 15.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.835 -1.165 . . . . 0.0 109.746 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -100.59 -72.61 0.67 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.277 -0.89 . . . . 0.0 108.604 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 5.8 t80 -72.24 -18.91 61.79 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.032 -1.042 . . . . 0.0 109.045 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -64.44 -59.77 7.89 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.879 ' HB2' HG21 ' A' ' 90' ' ' THR . 2.0 mmtp -65.14 -14.58 60.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.633 -0.922 . . . . 0.0 109.983 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.885 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.5 t80 -84.95 -36.14 21.6 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.387 -0.821 . . . . 0.0 109.39 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -76.1 -12.32 60.09 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 108.84 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 25.2 pt-20 -97.27 -41.43 8.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.456 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -59.6 -39.52 95.21 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.461 -2.256 . . . . 0.0 107.461 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 79' ' ' PHE . 97.5 t -63.93 -44.79 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.91 -0.759 . . . . 0.0 110.113 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.58 4.39 51.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.181 -0.949 . . . . 0.0 110.729 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.3 t -106.21 -25.35 12.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.932 -1.105 . . . . 0.0 109.87 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.73 29.31 32.56 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -171.88 60.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -1.17 . . . . 0.0 109.212 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 5.3 tt -60.03 119.3 7.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.711 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.44 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 18.8 p-10 -160.34 85.1 0.72 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 109.254 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.879 HG21 ' HB2' ' A' ' 78' ' ' LYS . 3.5 t -134.36 149.48 50.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.031 -1.043 . . . . 0.0 109.99 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.6 ptp -140.33 166.07 25.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.426 -0.796 . . . . 0.0 108.987 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.079 ' CE1' HG21 ' A' ' 107' ' ' VAL . 20.4 p90 176.4 178.16 0.23 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.812 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -105.14 114.92 29.4 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.94 173.88 6.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.274 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.2 m -146.45 108.63 4.42 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.463 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 16.6 m-85 -81.1 120.88 25.39 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.131 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.78 47.23 2.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 108.75 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.508 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -79.02 72.83 5.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.068 -0.395 . . . . 0.0 111.274 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.472 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 64.58 31.41 12.26 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.318 -0.864 . . . . 0.0 109.9 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.45 ' SD ' HG22 ' A' ' 101' ' ' THR . 0.0 OUTLIER -149.69 -177.82 6.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.236 -0.915 . . . . 0.0 108.844 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.451 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 0.5 OUTLIER -55.14 152.67 14.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 109.253 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.451 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 32.1 Cg_endo -73.45 82.72 1.6 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.716 1.61 . . . . 0.0 109.883 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.705 HG22 ' CG1' ' A' ' 105' ' ' VAL . 1.9 m -69.64 93.71 0.73 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.648 -0.658 . . . . 0.0 109.846 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.9 137.14 47.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.937 ' HA ' HG23 ' A' ' 125' ' ' VAL . 4.1 m -146.37 147.0 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.48 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.85 150.75 36.05 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 173.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.079 HG21 ' CE1' ' A' ' 92' ' ' PHE . 30.2 m -137.77 149.28 25.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 119.945 -1.722 . . . . 0.0 109.366 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -160.2 101.87 1.41 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.774 ' HB3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -109.03 140.42 42.57 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.241 -178.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.636 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 9.7 tttt -135.23 -162.48 1.26 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.571 -1.331 . . . . 0.0 109.888 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -108.14 103.26 12.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.928 . . . . 0.0 108.83 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.885 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -51.07 147.71 5.03 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.599 -0.688 . . . . 0.0 110.443 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.451 -0.781 . . . . 0.0 110.047 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.846 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.307 0.575 . . . . 0.0 109.813 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.744 ' CE1' HG22 ' A' ' 83' ' ' VAL . 14.7 m-85 -152.0 116.39 5.03 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.885 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 14.6 p-90 -118.69 153.74 33.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.06 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.774 HG22 ' HB3' ' A' ' 109' ' ' MET . 24.0 t -127.5 112.6 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.652 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 12.5 m-30 -96.47 104.11 16.07 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -92.6 115.11 30.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.339 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -90.7 142.42 27.77 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.431 ' NH2' HD11 ' A' ' 49' ' ' ILE . 5.8 ttt180 -89.46 119.37 29.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.516 -1.365 . . . . 0.0 108.961 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.937 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.312 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.13 HG22 HD11 ' A' ' 15' ' ' LEU . 4.5 mm -78.43 -59.67 2.85 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.517 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.406 ' HA ' HD12 ' A' ' 15' ' ' LEU . 7.8 pt-20 -40.95 -31.22 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.511 -0.743 . . . . 0.0 111.716 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.64 -40.23 16.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.802 -1.186 . . . . 0.0 108.577 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 14' ' ' THR . 6.5 m -71.32 -10.88 60.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.627 -0.671 . . . . 0.0 110.055 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.13 HD11 HG22 ' A' ' 11' ' ' ILE . 13.4 mt -96.7 -9.31 29.33 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.952 -1.093 . . . . 0.0 109.747 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.041 -1.037 . . . . 0.0 109.134 179.481 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.93 0.395 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.75 28.07 15.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.045 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 18.8 mt -98.6 164.27 12.32 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.204 -1.174 . . . . 0.0 108.333 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.447 ' HB3' ' NZ ' ' A' ' 123' ' ' LYS . . . -94.42 19.35 9.75 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.045 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 2.7 p90 -152.89 179.2 8.87 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -107.69 125.8 8.08 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -96.06 96.88 9.16 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.027 -1.278 . . . . 0.0 108.465 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.634 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.4 pp -102.63 146.18 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.23 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.721 ' HB3' HD12 ' A' ' 40' ' ' LEU . 12.6 mt-30 -119.65 171.88 8.07 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 39' ' ' ILE . 72.0 mt -152.78 147.11 25.67 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 109.738 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.575 ' HB2' HD21 ' A' ' 40' ' ' LEU . 1.9 m-20 -119.05 136.49 54.11 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.358 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -9.01 71.06 0.0 OUTLIER Glycine 0 N--CA 1.51 3.629 0 C-N-CA 124.659 1.123 . . . . 0.0 113.428 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER 161.64 -24.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.632 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.03 17.53 24.92 Favored Glycine 0 N--CA 1.481 1.697 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 69.2 m-80 -82.7 128.67 34.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -1.123 . . . . 0.0 108.426 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.747 HD13 ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -62.45 138.51 22.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 122.059 0.933 . . . . 0.0 111.568 -178.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.721 HD12 ' HB3' ' A' ' 32' ' ' GLN . 6.0 mt -105.0 -31.18 9.33 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.521 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -158.4 -176.33 5.84 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 1.6 t80 -161.11 -62.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.072 -1.018 . . . . 0.0 109.677 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' ' 45' ' ' ALA . 3.3 p-10 100.42 175.55 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.493 0 C-N-CA 123.666 0.786 . . . . 0.0 109.48 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.89 -15.68 22.27 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.004 -1.06 . . . . 0.0 111.983 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.59 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -57.9 -64.95 0.73 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.662 -1.274 . . . . 0.0 109.846 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 13.2 pt-20 -64.43 -43.29 94.79 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.219 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.435 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -60.11 -16.01 39.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -87.26 -28.53 22.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.723 -1.457 . . . . 0.0 109.673 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.431 HG13 ' HD3' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -82.22 -39.62 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.542 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.419 HG22 HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -113.91 -0.31 14.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.833 -0.542 . . . . 0.0 110.627 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.81 -3.26 70.46 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.649 -1.263 . . . . 0.0 110.942 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.991 ' NH2' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -63.87 91.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.826 -1.397 . . . . 0.0 110.388 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.835 ' O ' HG22 ' A' ' 57' ' ' VAL . 14.5 m-20 -72.32 158.46 87.46 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.97 -42.04 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.85 1.7 . . . . 0.0 110.821 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.568 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -67.26 -27.55 67.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.992 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -84.87 -42.49 15.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.0 109.612 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 53' ' ' ASP . 34.7 m -78.42 -0.03 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.0 109.743 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.645 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -70.42 122.01 21.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.013 -1.054 . . . . 0.0 108.702 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.98 -19.72 52.65 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -80.06 137.42 36.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.276 -1.132 . . . . 0.0 108.894 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.504 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -77.58 97.98 5.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.747 ' HB2' HD13 ' A' ' 39' ' ' ILE . 62.3 t80 -56.35 -18.29 10.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.665 -0.647 . . . . 0.0 110.337 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.453 ' CD1' ' CD1' ' A' ' 76' ' ' TYR . 3.0 m-85 -95.42 -30.87 13.66 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.065 -1.022 . . . . 0.0 110.458 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -139.15 42.1 2.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 110.027 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -157.34 -37.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.048 -1.033 . . . . 0.0 110.254 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.716 HG12 ' NH1' ' A' ' 52' ' ' ARG . 1.8 t -104.9 -58.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 122.902 1.335 . . . . 0.0 108.923 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.991 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . . . -106.56 100.99 33.56 Favored Pre-proline 0 C--N 1.289 -2.061 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.563 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.59 -4.04 14.7 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.845 1.696 . . . . 0.0 110.698 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.1 p -88.19 -24.75 23.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.959 -1.088 . . . . 0.0 109.332 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.481 HG21 ' CE2' ' A' ' 62' ' ' PHE . 2.2 p -76.58 -2.0 30.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.285 -0.885 . . . . 0.0 109.866 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.31 50.53 1.52 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.889 -1.132 . . . . 0.0 108.23 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.485 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -113.97 178.99 0.85 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -77.96 -14.44 15.34 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 122.072 1.848 . . . . 0.0 111.227 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 29.9 mt-10 -100.54 -22.8 14.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.782 -1.199 . . . . 0.0 109.545 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.519 ' CE1' ' HE3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -100.48 -73.45 0.64 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 9.2 t80 -70.35 -19.24 63.06 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.878 -1.139 . . . . 0.0 108.873 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.93 -59.75 8.66 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -63.56 -15.3 57.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.453 -1.028 . . . . 0.0 109.682 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.87 ' O ' HG23 ' A' ' 83' ' ' VAL . 13.1 t80 -81.88 -38.05 25.95 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.545 -0.722 . . . . 0.0 109.788 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -11.9 60.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.021 -1.05 . . . . 0.0 109.362 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 12.9 pt-20 -97.28 -41.73 8.13 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -61.32 -39.54 97.38 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 79' ' ' PHE . 85.1 t -63.52 -41.57 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.862 -0.787 . . . . 0.0 110.009 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.2 4.78 53.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.246 -0.909 . . . . 0.0 111.036 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.4 p -106.11 -26.74 11.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.89 -1.131 . . . . 0.0 110.131 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.09 23.52 37.73 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -171.39 87.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -1.125 . . . . 0.0 109.036 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 79' ' ' PHE . 1.9 tt -84.36 123.09 29.81 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.306 -0.872 . . . . 0.0 109.787 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 4.9 p-10 -160.56 81.78 0.67 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.235 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -121.85 154.34 37.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.118 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -148.02 139.26 23.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.788 . . . . 0.0 109.04 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.067 ' CE2' HG21 ' A' ' 107' ' ' VAL . 8.9 p90 -162.83 -174.92 4.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.053 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -112.91 108.76 17.82 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.65 -179.48 3.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.35 -0.844 . . . . 0.0 110.083 -178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.7 m -149.47 108.51 3.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.521 -0.737 . . . . 0.0 109.062 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.845 ' CE2' HG21 ' A' ' 122' ' ' VAL . 13.8 m-30 -81.09 92.28 6.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.351 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -105.67 24.24 12.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.251 -0.906 . . . . 0.0 109.637 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.554 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.69 155.72 29.32 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.508 ' HG3' ' CD2' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 0.28 65.72 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 CA-C-O 121.549 0.69 . . . . 0.0 112.317 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER 175.66 164.78 0.34 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.427 -0.796 . . . . 0.0 109.126 -178.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.545 HG22 ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -57.75 175.66 0.27 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.302 -0.874 . . . . 0.0 108.883 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.545 ' HD2' HG22 ' A' ' 101' ' ' THR . 34.6 Cg_endo -76.6 107.64 2.49 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.846 1.697 . . . . 0.0 109.801 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.439 HG22 HG13 ' A' ' 105' ' ' VAL . 4.2 m -109.38 122.54 47.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.807 . . . . 0.0 110.365 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -102.59 145.06 30.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.981 ' HA ' HG23 ' A' ' 125' ' ' VAL . 22.7 m -152.01 145.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.654 -1.279 . . . . 0.0 111.859 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.9 ' HD2' HG22 ' A' ' 125' ' ' VAL . 7.5 mptt -77.44 117.13 18.61 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 102.876 -3.009 . . . . 0.0 102.876 174.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.067 HG21 ' CE2' ' A' ' 92' ' ' PHE . 35.7 m -102.31 151.14 5.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 117.898 -1.521 . . . . 0.0 109.767 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -154.9 103.68 2.43 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.8 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -105.66 139.16 40.68 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.457 -0.777 . . . . 0.0 109.335 -178.344 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.606 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.9 ttmt -137.57 -157.77 0.8 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.562 -1.336 . . . . 0.0 109.476 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -105.37 137.87 42.47 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 108.994 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.909 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -98.89 -179.07 4.16 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 110.058 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.899 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.25 0.548 . . . . 0.0 109.625 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.762 ' OH ' HG13 ' A' ' 83' ' ' VAL . 12.3 m-85 -147.64 123.08 10.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.261 -0.899 . . . . 0.0 108.739 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.909 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 18.6 p-90 -127.14 146.32 50.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 118.386 -1.326 . . . . 0.0 112.833 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.8 HG13 ' HG2' ' A' ' 109' ' ' MET . 58.9 t -118.58 110.36 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.636 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.662 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 12.4 m-30 -95.44 133.53 39.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.984 -1.073 . . . . 0.0 108.406 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.845 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.5 t -116.01 113.57 43.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 C-N-CA 119.054 -1.059 . . . . 0.0 109.532 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 5.2 tptp -90.02 131.13 36.07 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.431 ' HD3' HG13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -80.21 123.93 28.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.53 -1.356 . . . . 0.0 109.561 -178.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.981 HG23 ' HA ' ' A' ' 105' ' ' VAL . 5.3 t . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.612 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.98 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.041 HG22 HD11 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -79.63 -69.2 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.973 -1.079 . . . . 0.0 110.513 -177.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -44.73 -25.79 0.32 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 111.134 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.434 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -75.4 -49.21 19.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.036 -1.04 . . . . 0.0 109.501 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.15 -61.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.041 HD11 HG22 ' A' ' 11' ' ' ILE . 72.6 mt -37.27 -32.42 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.363 0.601 . . . . 0.0 110.676 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 110.165 -179.272 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.996 0.427 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.14 34.77 5.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.84 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 7.3 mt -110.41 158.93 17.94 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.408 -1.054 . . . . 0.0 109.282 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.94 6.93 33.37 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.45 0.643 . . . . 0.0 109.349 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.84 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 26.3 p90 -134.04 -169.67 2.36 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.273 -0.892 . . . . 0.0 108.868 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -118.3 149.57 18.34 Favored Glycine 0 C--N 1.297 -1.595 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -126.14 84.8 2.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.754 -1.439 . . . . 0.0 107.936 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.643 HG22 ' CD1' ' A' ' 42' ' ' TYR . 1.3 pp -91.71 149.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.168 0.985 . . . . 0.0 110.862 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.557 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 3.2 mm100 -115.23 162.43 17.08 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.611 HD22 ' C ' ' A' ' 37' ' ' GLY . 21.7 mt -150.09 146.08 26.72 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.404 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.544 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -99.28 173.62 6.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -40.06 -57.08 2.59 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 121.619 -0.324 . . . . 0.0 113.001 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.83 -17.64 61.65 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.63 -1.512 . . . . 0.0 110.337 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.611 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 102.42 28.73 6.26 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 7.0 m120 -84.74 136.68 33.61 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.442 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' A' ' 31' ' ' ILE . 3.0 tp -63.73 135.85 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.762 -1.211 . . . . 0.0 111.387 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -110.06 -28.49 8.67 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.557 ' HB2' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.76 153.02 22.11 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.643 ' CD1' HG22 ' A' ' 31' ' ' ILE . 17.5 t80 -134.76 -66.68 0.58 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.169 -1.582 . . . . 0.0 111.414 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.3 p-10 102.39 174.79 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.657 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.09 -23.97 15.98 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.8 -1.188 . . . . 0.0 112.898 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.68 -62.43 1.65 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.464 -1.398 . . . . 0.0 110.741 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.1 pt-20 -58.72 -55.25 37.53 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.675 0.75 . . . . 0.0 109.64 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.413 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -56.79 -15.22 11.89 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.015 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -40.61 61.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.783 -1.422 . . . . 0.0 108.799 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -84.74 -56.89 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.414 -0.804 . . . . 0.0 109.235 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.55 ' N ' HG22 ' A' ' 49' ' ' ILE . 18.9 p -72.71 -24.66 61.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.509 -0.744 . . . . 0.0 109.916 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 94.37 -19.22 54.65 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.914 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -43.9 97.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.608 -0.936 . . . . 0.0 110.626 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.67 ' O ' HG22 ' A' ' 57' ' ' VAL . 42.4 m-20 -69.51 158.29 87.28 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.16 -61.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.942 1.762 . . . . 0.0 110.829 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -62.52 -18.13 61.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.215 -0.928 . . . . 0.0 110.151 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -86.87 -41.37 14.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.016 -1.053 . . . . 0.0 109.528 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 53' ' ' ASP . 22.4 m -79.61 2.01 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.831 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.24 121.05 20.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 120.979 -1.075 . . . . 0.0 109.034 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.31 -13.68 64.5 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 16.7 mmtp -78.89 139.8 38.23 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.084 -1.245 . . . . 0.0 109.066 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -80.95 96.52 7.1 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.947 ' CZ ' HG21 ' A' ' 70' ' ' THR . 16.7 t80 -55.06 -34.46 63.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.024 -1.048 . . . . 0.0 109.722 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.605 ' HD2' HD13 ' A' ' 33' ' ' LEU . 2.5 m-85 -80.42 -23.34 40.39 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.251 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -148.1 49.07 1.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.983 -1.073 . . . . 0.0 109.631 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ASN . 8.8 t0 -174.54 -29.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 111.047 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.914 HG11 ' HD3' ' A' ' 52' ' ' ARG . 13.5 t -106.08 -58.41 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.617 -1.302 . . . . 0.0 109.004 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.635 ' HB3' ' OG1' ' A' ' 70' ' ' THR . . . -99.01 106.65 39.35 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 114.618 -1.173 . . . . 0.0 109.861 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -77.36 1.41 8.79 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 C-N-CA 121.614 1.543 . . . . 0.0 109.896 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.4 p -107.03 -19.58 13.58 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 121.216 -0.927 . . . . 0.0 109.778 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.947 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 11.0 p -85.93 9.57 16.52 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.124 -0.985 . . . . 0.0 110.133 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -106.54 59.9 0.64 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.118 -0.989 . . . . 0.0 108.956 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.473 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -144.3 176.26 2.35 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.352 -0.843 . . . . 0.0 109.675 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 33.6 Cg_endo -76.71 78.64 3.29 Favored 'Trans proline' 0 C--N 1.323 -0.763 0 C-N-CA 122.375 2.05 . . . . 0.0 110.415 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 171.54 -37.86 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.6 t80 -105.38 -67.68 0.9 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.479 ' CD1' ' CD1' ' A' ' 63' ' ' PHE . 9.3 t80 -73.22 -18.12 61.27 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.1 -63.66 4.21 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.528 ' HB2' HG21 ' A' ' 90' ' ' THR . 10.8 mmtt -61.09 -17.54 53.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -1.047 . . . . 0.0 109.864 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.865 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.3 t80 -82.22 -38.24 24.82 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.484 -0.76 . . . . 0.0 109.53 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -13.29 60.37 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 109.382 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -98.05 -36.46 10.1 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.639 -1.225 . . . . 0.0 108.151 178.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.66 -39.33 96.63 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.3 t -63.21 -51.87 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.958 -0.731 . . . . 0.0 109.928 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.18 -2.88 46.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -0.922 . . . . 0.0 110.793 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.8 t -96.34 -29.94 13.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.131 . . . . 0.0 109.629 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.06 15.05 46.52 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -165.87 86.87 0.36 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.118 -1.225 . . . . 0.0 109.131 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -76.98 122.93 25.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.472 -0.768 . . . . 0.0 110.088 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -160.97 82.4 0.64 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.528 HG21 ' HB2' ' A' ' 78' ' ' LYS . 8.7 t -127.48 169.5 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 111.212 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 107' ' ' VAL . 1.8 ttm -159.77 149.23 18.08 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.109 ' CE1' HG21 ' A' ' 107' ' ' VAL . 18.7 p90 -172.42 165.55 5.75 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -96.82 105.77 17.96 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.56 -177.32 3.33 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.817 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 103' ' ' THR . 92.9 m -151.02 108.51 3.63 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.825 ' CE2' HG21 ' A' ' 122' ' ' VAL . 18.7 m-30 -84.06 114.91 22.08 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 109.703 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -139.61 42.29 2.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.665 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.537 ' O ' ' C ' ' A' ' 99' ' ' GLN . 10.1 p90 -78.69 148.06 33.26 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.537 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.0 tt0 1.89 67.95 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 121.781 0.8 . . . . 0.0 111.482 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.9 ttp 177.29 -159.1 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 109.386 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.477 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 2.3 t -85.37 153.61 59.14 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.5 Cg_endo -75.74 141.18 24.28 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.713 1.609 . . . . 0.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.446 HG22 HG13 ' A' ' 105' ' ' VAL . 1.8 m -140.08 140.17 36.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.336 -0.852 . . . . 0.0 109.605 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -111.18 141.6 44.47 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.801 ' HA ' HG23 ' A' ' 125' ' ' VAL . 24.5 m -149.68 144.05 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.921 -1.112 . . . . 0.0 110.681 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -86.42 102.31 13.94 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 175.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.109 HG21 ' CE1' ' A' ' 92' ' ' PHE . 18.1 m -85.55 156.91 3.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 110.885 -175.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -160.36 106.88 1.54 Allowed 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.807 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.92 149.49 35.11 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.477 -0.764 . . . . 0.0 109.606 -177.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.578 ' HB3' ' CZ2' ' A' ' 119' ' ' TRP . 9.5 ttpt -144.34 170.64 15.62 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.474 -1.391 . . . . 0.0 109.213 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.456 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 11.0 tttt -80.11 104.18 10.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.771 -1.206 . . . . 0.0 108.787 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.837 ' HB3' ' HB3' ' A' ' 117' ' ' SER . . . -52.09 155.51 1.88 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 109.652 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.987 . . . . 0.0 110.119 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.837 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.269 0.557 . . . . 0.0 109.836 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.844 ' CE1' HG22 ' A' ' 83' ' ' VAL . 12.6 m-85 -153.47 108.36 3.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.301 -0.874 . . . . 0.0 109.06 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.736 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.2 p-90 -108.22 142.09 39.01 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.695 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.807 HG13 ' HG2' ' A' ' 109' ' ' MET . 96.1 t -117.41 118.69 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.651 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 16.0 m-30 -101.86 121.93 43.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.146 -0.971 . . . . 0.0 109.349 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.825 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.7 t -109.66 116.05 51.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.249 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.459 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 6.8 tttm -101.87 133.99 45.76 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.405 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.51 ' HA ' HG12 ' A' ' 105' ' ' VAL . 8.1 ttp85 -73.54 117.89 15.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.983 -1.073 . . . . 0.0 109.65 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.801 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.205 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.069 HG22 HD11 ' A' ' 15' ' ' LEU . 2.4 mm -65.39 -67.58 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.212 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HA ' HD12 ' A' ' 15' ' ' LEU . 3.3 pt-20 -37.55 -30.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.032 0.444 . . . . 0.0 111.656 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' ILE . 1.2 t30 -76.19 -50.36 14.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.022 -1.049 . . . . 0.0 108.673 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 m -67.36 -14.91 63.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.548 -0.72 . . . . 0.0 109.811 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.069 HD11 HG22 ' A' ' 11' ' ' ILE . 11.4 mt -96.68 -26.49 15.17 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.094 -1.004 . . . . 0.0 109.168 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.307 -179.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.979 0.419 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.77 35.1 5.08 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 mt -114.74 134.68 54.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.403 -1.057 . . . . 0.0 109.458 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.86 -6.55 27.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.385 0.612 . . . . 0.0 109.792 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.709 ' HE2' HD12 ' A' ' 11' ' ' ILE . 7.6 p90 -124.01 114.37 19.66 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.027 -1.046 . . . . 0.0 108.324 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -51.94 158.29 3.05 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' N ' ' OE2' ' A' ' 46' ' ' GLU . . . -139.44 99.52 3.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.066 -1.255 . . . . 0.0 107.973 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.622 HD12 ' N ' ' A' ' 32' ' ' GLN . 0.7 OUTLIER -99.41 172.36 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.884 0.849 . . . . 0.0 110.511 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.71 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -141.61 164.93 28.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 38' ' ' ASN . 28.0 mt -148.32 154.18 39.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.904 -1.122 . . . . 0.0 109.893 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.541 ' N ' HD21 ' A' ' 40' ' ' LEU . 1.3 p30 -116.33 128.83 55.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 108.892 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -15.9 76.53 0.0 OUTLIER Glycine 0 N--CA 1.508 3.486 0 C-N-CA 124.505 1.05 . . . . 0.0 112.951 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.8 OUTLIER 162.58 -23.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 101.06 17.93 21.3 Favored Glycine 0 N--CA 1.48 1.589 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.783 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -86.16 152.17 23.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.016 -1.285 . . . . 0.0 107.787 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' ' 57' ' ' VAL . 2.1 tp -79.52 144.91 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.829 -1.169 . . . . 0.0 113.034 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.714 HD11 ' O ' ' A' ' 33' ' ' LEU . 2.0 mt -113.11 -33.85 5.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 174.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.563 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 6.5 tp-100 -169.02 158.75 8.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.588 -0.695 . . . . 0.0 110.227 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.578 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 13.2 t80 -135.75 -54.33 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.375 -0.828 . . . . 0.0 110.128 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 0.8 OUTLIER 95.72 177.59 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 C-N-CA 123.02 0.528 . . . . 0.0 109.641 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.12 -22.5 17.27 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.996 -1.065 . . . . 0.0 113.039 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -57.0 -68.53 0.21 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.428 -1.42 . . . . 0.0 110.012 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.578 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 6.2 pt-20 -63.07 -42.79 99.75 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.749 0.785 . . . . 0.0 109.593 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 52' ' ' ARG . . . -60.78 -17.91 51.45 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -83.68 -29.86 27.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.245 . . . . 0.0 108.423 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.83 HG22 HG23 ' A' ' 50' ' ' THR . 0.3 OUTLIER -73.65 -57.48 6.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.619 -0.676 . . . . 0.0 109.287 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.83 HG23 HG22 ' A' ' 49' ' ' ILE . 15.6 p -89.84 -8.01 52.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.15 -0.969 . . . . 0.0 110.191 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 89.59 -8.1 80.51 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.599 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -53.58 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.315 -1.109 . . . . 0.0 109.809 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.798 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -68.9 162.75 62.08 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.17 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.27 -57.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.839 1.693 . . . . 0.0 111.124 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -18.51 65.4 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.915 -1.116 . . . . 0.0 110.206 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 -31.64 16.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 109.642 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 53' ' ' ASP . 34.5 m -86.7 10.91 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.043 -1.036 . . . . 0.0 109.499 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.485 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -86.87 121.78 38.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 108.487 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.76 -18.56 54.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HD2' ' CG2' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -78.19 167.84 20.77 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.924 -1.339 . . . . 0.0 109.898 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -106.19 103.65 13.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.77 ' CZ ' HG21 ' A' ' 70' ' ' THR . 3.1 t80 -50.27 -42.74 52.67 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.521 -0.737 . . . . 0.0 112.245 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.536 ' CG ' ' CD1' ' A' ' 76' ' ' TYR . 36.5 m-85 -89.74 1.9 55.52 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.678 -1.264 . . . . 0.0 112.799 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 4.5 tmtm? -154.32 52.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.62 -1.3 . . . . 0.0 110.495 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 169.93 -15.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.163 -0.96 . . . . 0.0 111.641 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.599 HG11 ' HD3' ' A' ' 52' ' ' ARG . 1.4 t -120.17 -57.79 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 122.916 1.341 . . . . 0.0 109.582 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.15 101.36 50.07 Favored Pre-proline 0 C--N 1.288 -2.075 0 CA-C-N 114.183 -1.372 . . . . 0.0 109.134 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -72.97 -4.87 16.18 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 122.163 1.909 . . . . 0.0 112.34 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 23.9 p -105.72 -18.53 14.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.727 -1.233 . . . . 0.0 109.57 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.77 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 35.5 p -74.04 -5.35 40.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.996 -1.065 . . . . 0.0 109.486 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -93.28 52.11 1.73 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 108.718 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.495 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -117.04 -178.78 0.56 Allowed Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 36.1 Cg_endo -78.34 -12.54 15.57 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.147 1.898 . . . . 0.0 111.564 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 2.2 mt-10 -100.73 -24.98 14.29 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.867 -1.145 . . . . 0.0 109.618 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.2 t80 -101.31 -70.82 0.73 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 108.702 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CD1' ' CG ' ' A' ' 63' ' ' PHE . 6.0 t80 -72.93 -18.24 61.41 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.981 -1.074 . . . . 0.0 108.672 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.52 -60.89 6.48 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.826 ' CB ' HG21 ' A' ' 90' ' ' THR . 7.9 mmtt -65.58 -15.22 62.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.938 . . . . 0.0 109.824 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.838 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.8 t80 -83.14 -35.76 25.3 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -8.93 58.91 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -96.51 -42.35 8.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.551 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -64.2 -39.49 97.14 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.865 HG22 ' CE1' ' A' ' 118' ' ' TYR . 63.3 t -67.14 -39.62 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.938 -0.743 . . . . 0.0 110.148 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.72 -7.28 59.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.172 -0.955 . . . . 0.0 110.856 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.5 -18.16 13.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.799 -1.188 . . . . 0.0 110.002 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.38 19.68 71.09 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -152.69 57.82 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.247 . . . . 0.0 109.538 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.761 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -58.66 120.36 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 109.94 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -160.68 88.78 0.79 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.301 -0.875 . . . . 0.0 108.878 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.826 HG21 ' CB ' ' A' ' 78' ' ' LYS . 9.7 t -157.42 158.81 36.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.899 -1.126 . . . . 0.0 110.379 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.9 173.58 11.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 0.0 108.857 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.001 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 7.2 p90 -179.07 152.11 0.54 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.125 -0.984 . . . . 0.0 109.81 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.19 111.38 18.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 109.046 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.425 ' OH ' ' HB2' ' A' ' 72' ' ' SER . 0.1 OUTLIER -112.57 -178.66 3.46 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.206 -0.934 . . . . 0.0 109.646 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.3 m -151.9 108.74 3.5 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.382 -0.824 . . . . 0.0 109.834 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -81.24 118.7 22.82 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -152.3 48.76 0.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.878 -1.139 . . . . 0.0 110.987 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 22.1 p90 -78.31 139.03 38.86 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 98' ' ' TYR . 7.2 pt20 0.68 68.11 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.268 0 CA-C-O 121.847 0.832 . . . . 0.0 111.937 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 98' ' ' TYR . 20.1 ttp -176.71 174.65 1.79 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 4.9 t -52.71 148.17 13.69 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.048 . . . . 0.0 109.044 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.9 Cg_endo -75.88 146.41 29.6 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.96 1.773 . . . . 0.0 110.994 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.449 HG22 HG13 ' A' ' 105' ' ' VAL . 6.8 m -140.25 123.39 16.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.775 . . . . 0.0 109.264 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -102.83 140.28 37.31 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.848 ' HA ' HG23 ' A' ' 125' ' ' VAL . 14.0 m -151.99 143.4 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.905 -1.122 . . . . 0.0 110.697 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -92.35 116.82 29.31 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 176.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.001 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -91.39 164.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 120.966 -1.084 . . . . 0.0 110.086 -176.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -159.94 102.36 1.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.885 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -116.14 147.53 41.27 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.095 -1.003 . . . . 0.0 110.239 -177.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.622 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 11.9 ttmt -144.4 179.66 7.12 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.593 -1.317 . . . . 0.0 109.434 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.16 106.91 18.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.04 -1.037 . . . . 0.0 109.248 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.776 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -55.88 137.44 50.34 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.515 -0.741 . . . . 0.0 109.569 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.809 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.73 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 10.0 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.526 0.679 . . . . 0.0 109.998 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.865 ' CE1' HG22 ' A' ' 83' ' ' VAL . 28.4 m-85 -149.28 103.0 3.27 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.776 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 11.5 p-90 -103.77 148.03 26.57 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.455 -1.298 . . . . 0.0 112.078 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.885 HG13 ' CG ' ' A' ' 109' ' ' MET . 19.3 t -130.48 107.36 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.618 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.667 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 5.1 m-30 -91.53 123.9 35.3 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.294 -0.879 . . . . 0.0 109.609 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.611 HG13 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -105.27 116.8 49.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.019 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 1.9 tttm -94.96 107.8 19.85 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.532 ' HA ' HG12 ' A' ' 105' ' ' VAL . 18.2 ttp180 -57.47 128.33 36.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.896 -1.127 . . . . 0.0 109.646 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.848 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.248 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 N--CA 1.506 2.369 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.963 HG22 HD11 ' A' ' 15' ' ' LEU . 4.9 mm -79.22 -57.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.775 -177.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.559 ' HA ' HD12 ' A' ' 15' ' ' LEU . 21.4 tt0 -39.36 -29.75 0.05 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.459 -0.776 . . . . 0.0 111.738 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' ILE . 9.8 m-80 -90.59 -40.01 12.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.908 -1.12 . . . . 0.0 108.226 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 14' ' ' THR . 4.2 m -69.11 -9.91 55.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.601 -0.687 . . . . 0.0 109.68 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.963 HD11 HG22 ' A' ' 11' ' ' ILE . 12.4 mt -96.6 -28.01 14.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.012 -1.055 . . . . 0.0 108.787 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.443 0 O-C-N 121.627 -0.671 . . . . 0.0 109.636 179.651 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.917 0.389 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.41 18.52 51.85 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.817 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 16.8 mt -54.97 123.36 13.26 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.291 -1.123 . . . . 0.0 109.796 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.01 -18.81 3.91 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.769 0.795 . . . . 0.0 109.075 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.817 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 17.2 p90 -126.25 148.02 49.57 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.232 -0.918 . . . . 0.0 109.016 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.528 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -76.84 144.03 29.6 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.521 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -115.91 92.07 3.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.905 -1.35 . . . . 0.0 108.331 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.564 HG22 ' CE1' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -96.32 150.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 -178.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.657 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.0 161.16 31.58 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.777 ' O ' HD11 ' A' ' 40' ' ' LEU . 23.3 mt -148.18 155.47 41.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.011 -1.056 . . . . 0.0 109.276 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.654 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -123.45 138.9 54.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.0 109.411 178.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -5.31 67.95 0.0 OUTLIER Glycine 0 N--CA 1.514 3.87 0 C-N-CA 124.834 1.207 . . . . 0.0 113.364 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 161.25 -23.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 97.98 18.91 25.71 Favored Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 8.2 p30 -84.39 129.96 34.82 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.217 -1.167 . . . . 0.0 108.831 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.518 HG21 ' HA ' ' A' ' 58' ' ' ILE . 1.9 tp -54.5 138.12 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 122.202 1.001 . . . . 0.0 112.998 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.777 HD11 ' O ' ' A' ' 33' ' ' LEU . 3.5 mt -111.35 -31.08 7.17 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.588 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 0.5 OUTLIER -167.39 168.81 12.83 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.564 ' CE1' HG22 ' A' ' 31' ' ' ILE . 14.9 t80 -146.09 -70.65 0.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.073 -1.017 . . . . 0.0 111.16 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.3 p-10 109.45 178.83 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.858 0 C-N-CA 123.931 0.892 . . . . 0.0 108.749 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.4 -26.55 14.82 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.005 -1.059 . . . . 0.0 113.281 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.78 -65.11 0.61 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.316 -1.49 . . . . 0.0 110.707 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 2.0 pt-20 -58.79 -53.76 54.7 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.387 0.613 . . . . 0.0 110.071 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.85 -15.75 14.41 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.095 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.47 -37.42 36.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.775 -1.427 . . . . 0.0 108.98 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.617 HG22 HG23 ' A' ' 50' ' ' THR . 1.0 OUTLIER -79.52 -55.18 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 108.886 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.617 HG23 HG22 ' A' ' 49' ' ' ILE . 59.2 p -76.98 -20.45 56.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.67 -0.644 . . . . 0.0 110.115 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.46 -2.33 78.22 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.635 HH11 HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -46.54 -47.14 19.64 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.367 -1.078 . . . . 0.0 111.481 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.518 ' O ' HG13 ' A' ' 57' ' ' VAL . 0.3 OUTLIER 67.88 147.14 0.11 Allowed Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -178.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.464 ' HA ' HG22 ' A' ' 57' ' ' VAL . 35.3 Cg_endo -76.76 -36.57 1.51 Allowed 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.128 1.885 . . . . 0.0 111.647 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -26.83 62.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.56 -40.52 19.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 109.523 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.635 HG11 HH11 ' A' ' 52' ' ' ARG . 27.6 m -73.04 -6.62 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 110.006 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.518 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -70.63 119.56 17.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.081 -1.012 . . . . 0.0 108.386 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.68 -20.95 48.47 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -79.61 145.89 32.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.543 -0.974 . . . . 0.0 108.674 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -89.85 122.21 32.69 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 108.967 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.574 ' HB2' HD21 ' A' ' 33' ' ' LEU . 79.4 t80 -60.02 -18.12 43.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.038 -1.039 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.462 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 35.9 m-85 -118.19 32.06 6.34 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.035 -1.041 . . . . 0.0 109.611 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.42 -53.6 0.1 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.013 -1.055 . . . . 0.0 110.954 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.32 16.4 9.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.846 -1.159 . . . . 0.0 111.778 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.577 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 41.0 t -118.88 -56.31 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.388 -1.445 . . . . 0.0 108.5 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -118.19 99.07 51.8 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.66 0.71 7.81 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.926 1.751 . . . . 0.0 111.062 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 p -103.31 -25.95 13.12 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.031 -1.043 . . . . 0.0 109.403 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.462 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 59.9 p -71.69 -7.16 46.25 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.381 -0.824 . . . . 0.0 110.096 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -84.81 72.53 10.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 108.984 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.433 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -160.6 172.61 5.67 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.96 . . . . 0.0 109.643 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 36.1 Cg_endo -77.92 77.42 3.93 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.358 2.039 . . . . 0.0 110.304 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER 172.36 -36.85 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.684 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.9 t80 -104.14 -65.9 0.99 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.416 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 8.3 t80 -75.55 -20.3 58.74 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -62.82 -60.67 7.37 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.495 ' CB ' HG21 ' A' ' 90' ' ' THR . 4.4 mmtp -64.87 -17.54 64.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.424 -1.045 . . . . 0.0 109.953 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.83 ' O ' HG23 ' A' ' 83' ' ' VAL . 4.2 t80 -79.35 -36.29 39.61 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -6.9 56.8 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.35 -0.844 . . . . 0.0 108.741 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.1 mm-40 -96.14 -42.63 8.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.47 -40.59 86.5 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.849 HG22 ' CE1' ' A' ' 118' ' ' TYR . 79.3 t -62.32 -38.58 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.619 -0.93 . . . . 0.0 109.386 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.17 -5.5 56.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 110.716 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 8.6 t -98.2 -21.91 16.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.772 -1.205 . . . . 0.0 109.788 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.79 25.51 45.58 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -169.85 70.66 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.332 -1.099 . . . . 0.0 108.935 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -69.76 117.66 11.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.088 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -161.59 82.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.498 HG23 ' SD ' ' A' ' 109' ' ' MET . 3.8 t -140.72 172.18 13.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.028 -1.045 . . . . 0.0 110.487 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 3.2 ptt? -152.69 171.03 18.83 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.944 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 14.8 p90 179.73 152.32 0.43 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.001 -1.062 . . . . 0.0 109.929 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -78.88 116.26 19.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.135 -0.978 . . . . 0.0 109.322 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.87 175.1 5.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.337 -0.852 . . . . 0.0 109.589 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -146.03 109.98 4.91 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.788 ' CE2' HG21 ' A' ' 122' ' ' VAL . 16.0 m-30 -85.25 119.6 25.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.956 . . . . 0.0 109.632 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -147.93 56.79 1.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.456 ' OH ' ' HB ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.61 66.06 4.96 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.045 -0.409 . . . . 0.0 111.439 -178.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.459 ' CG ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER 73.62 25.74 2.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.066 -1.021 . . . . 0.0 109.658 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.81 -171.52 3.1 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.083 -1.01 . . . . 0.0 108.569 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 71.6 p -57.65 160.99 6.76 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.165 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 32.7 Cg_endo -75.18 124.95 8.89 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.9 1.734 . . . . 0.0 110.257 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.455 HG22 HG13 ' A' ' 105' ' ' VAL . 13.1 m -118.43 125.76 50.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.431 -0.793 . . . . 0.0 109.408 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.417 ' O ' HG23 ' A' ' 125' ' ' VAL . 2.3 ttpt -107.51 138.43 43.73 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.673 ' HA ' HG23 ' A' ' 125' ' ' VAL . 5.7 m -152.69 142.3 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.048 -1.032 . . . . 0.0 110.194 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.64 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -91.01 127.69 36.53 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 174.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.944 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 1.4 m -97.93 160.19 3.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 O-C-N 120.634 -1.291 . . . . 0.0 111.475 -174.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -158.06 100.47 1.71 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.817 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -111.09 146.7 36.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.584 -0.698 . . . . 0.0 109.535 -177.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.641 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.5 tttm -138.76 -163.47 1.47 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.599 -1.313 . . . . 0.0 109.311 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.1 117.23 34.1 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.064 -1.022 . . . . 0.0 108.807 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.892 ' HB3' ' HB2' ' A' ' 117' ' ' SER . . . -72.0 166.63 21.81 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.382 -0.824 . . . . 0.0 110.615 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.591 HD13 ' OG ' ' A' ' 117' ' ' SER . 1.7 mp . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.892 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.543 0.687 . . . . 0.0 110.679 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.849 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.6 m-85 -149.71 121.35 8.04 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.851 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 13.5 p-90 -120.34 144.8 47.66 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.182 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.817 HG13 ' CG ' ' A' ' 109' ' ' MET . 27.4 t -116.83 112.15 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.759 -0.588 . . . . 0.0 109.78 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.637 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.6 m-30 -95.61 126.7 41.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 109.41 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.788 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -107.11 119.55 56.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 110.037 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.543 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 3.3 tptp -89.6 109.48 20.43 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.514 ' HA ' HG12 ' A' ' 105' ' ' VAL . 7.2 ttp-105 -68.64 114.82 7.35 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.114 -1.434 . . . . 0.0 109.433 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.673 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.096 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.031 HG22 HD11 ' A' ' 15' ' ' LEU . 2.9 mm -81.71 -67.37 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 O-C-N 121.305 -0.872 . . . . 0.0 110.592 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.88 -25.49 0.2 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.017 -1.052 . . . . 0.0 111.462 -178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -82.87 -46.62 12.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.856 -1.153 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -66.95 -58.29 5.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.031 HD11 HG22 ' A' ' 11' ' ' ILE . 34.7 mt -38.87 -32.72 0.09 Allowed 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.017 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.446 -0.784 . . . . 0.0 109.16 179.813 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 9.4 m-20 . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.32 26.9 22.81 Favored Glycine 0 N--CA 1.491 2.335 0 O-C-N 120.857 -1.152 . . . . 0.0 110.387 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 4.8 mt -75.57 -175.14 2.74 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.862 -1.376 . . . . 0.0 108.427 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.98 16.0 22.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 1.9 p90 -151.44 -173.77 4.62 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -112.65 137.11 14.0 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.527 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -109.43 89.2 2.93 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.39 1.595 . . . . 0.0 107.755 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.696 HG22 ' CD1' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -99.53 148.51 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.303 -0.873 . . . . 0.0 110.113 -178.022 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.677 ' HB3' HD12 ' A' ' 40' ' ' LEU . 4.1 mt-30 -120.01 164.54 15.95 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 37' ' ' GLY . 98.5 mt -152.32 146.05 25.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.094 -1.004 . . . . 0.0 109.083 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.547 ' OD1' HD11 ' A' ' 40' ' ' LEU . 7.8 m-20 -124.88 129.9 51.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.943 -1.098 . . . . 0.0 110.522 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 37.4 -77.18 0.0 OUTLIER Glycine 0 N--CA 1.503 3.1 0 C-N-CA 124.589 1.09 . . . . 0.0 113.605 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' ASP . 11.3 m-20 -71.46 -0.57 10.7 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.646 -0.914 . . . . 0.0 111.081 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.875 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 84.2 17.63 64.41 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.65 131.33 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.922 -1.34 . . . . 0.0 108.919 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.756 HD12 HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -59.93 135.33 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 0.0 110.204 -179.018 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.677 HD12 ' HB3' ' A' ' 32' ' ' GLN . 2.0 mt -105.46 -26.68 11.82 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.619 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -167.04 163.15 15.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.696 ' CD1' HG22 ' A' ' 31' ' ' ILE . 38.4 t80 -135.34 -107.3 0.22 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.353 -1.467 . . . . 0.0 110.69 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 44' ' ' ALA . 14.3 t-20 157.65 145.91 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.744 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -70.14 -53.12 18.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.548 -0.72 . . . . 0.0 111.587 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.67 -54.39 4.05 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.31 -0.869 . . . . 0.0 111.053 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.503 ' CD ' ' CE1' ' A' ' 42' ' ' TYR . 3.8 pt-20 -63.67 -44.1 94.75 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.739 0.781 . . . . 0.0 109.671 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -59.77 -17.16 41.4 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -85.17 -29.63 24.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.912 -1.346 . . . . 0.0 108.908 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.611 HG22 ' CG2' ' A' ' 50' ' ' THR . 0.5 OUTLIER -77.03 -49.7 22.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.511 -0.743 . . . . 0.0 109.64 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.611 ' CG2' HG22 ' A' ' 49' ' ' ILE . 1.3 p -104.12 -7.23 20.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.963 -1.086 . . . . 0.0 110.748 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 81.83 -2.4 83.48 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.813 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.858 ' CD ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -39.52 -59.31 1.12 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -1.004 . . . . 0.0 112.666 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.754 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.6 OUTLIER 67.28 146.24 0.11 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.648 -1.282 . . . . 0.0 107.559 -178.108 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.42 -67.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.94 1.76 . . . . 0.0 111.89 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -48.32 -23.95 1.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.184 -0.948 . . . . 0.0 110.898 -178.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.66 -45.48 10.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.788 -1.195 . . . . 0.0 110.081 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.858 HG11 ' CD ' ' A' ' 52' ' ' ARG . 26.0 m -76.87 -0.63 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.056 -1.028 . . . . 0.0 110.036 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -70.84 124.86 28.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.287 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.6 -19.87 52.87 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -79.2 146.38 33.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -1.138 . . . . 0.0 109.138 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -88.55 118.62 28.33 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.617 ' HB2' HD21 ' A' ' 33' ' ' LEU . 74.5 t80 -52.92 -22.11 5.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.515 -0.741 . . . . 0.0 110.22 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -113.11 -10.85 13.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.937 -1.102 . . . . 0.0 111.459 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -135.51 39.74 2.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.78 -1.2 . . . . 0.0 110.217 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 171.93 -14.28 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.91 -1.119 . . . . 0.0 111.966 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.713 HG11 ' NE ' ' A' ' 52' ' ' ARG . 10.2 t -115.7 -53.36 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.346 -1.471 . . . . 0.0 109.358 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.43 96.92 50.1 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.059 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.71 -2.46 12.61 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.902 1.735 . . . . 0.0 110.409 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.3 p -95.5 -17.04 21.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.099 -1.001 . . . . 0.0 109.75 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.729 HG22 ' CD2' ' A' ' 75' ' ' PHE . 64.5 p -86.62 11.31 13.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -89.37 54.14 2.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 108.87 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . 3.2 p -139.48 173.17 5.39 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 72' ' ' SER . 35.4 Cg_endo -77.14 3.55 6.58 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 C-N-CA 122.109 1.872 . . . . 0.0 111.781 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 32.7 mt-10 -106.45 -28.0 10.59 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.94 -1.1 . . . . 0.0 109.151 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.729 ' CD2' HG22 ' A' ' 70' ' ' THR . 2.0 t80 -102.92 -71.19 0.73 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.6 t80 -71.04 -17.18 62.63 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.47 -60.9 6.82 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.895 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -61.87 -17.61 57.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -1.059 . . . . 0.0 109.577 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.901 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.4 t80 -81.01 -38.8 26.88 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.488 -0.757 . . . . 0.0 109.768 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -76.11 -11.67 59.98 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 109.491 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 13.6 pt-20 -96.87 -40.36 8.96 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.89 -39.95 97.86 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 79' ' ' PHE . 97.0 t -58.03 -44.24 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.719 -0.871 . . . . 0.0 109.268 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.17 -3.48 58.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 110.652 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 t -94.72 -23.3 17.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.916 -1.115 . . . . 0.0 109.579 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 25.5 50.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -174.28 62.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.347 -1.09 . . . . 0.0 108.991 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.767 HD11 ' HA ' ' A' ' 79' ' ' PHE . 1.5 tt -55.51 123.73 14.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.145 -0.972 . . . . 0.0 109.584 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.449 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 40.2 t30 -160.21 84.52 0.72 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.381 -0.824 . . . . 0.0 109.118 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.895 HG21 ' HB2' ' A' ' 78' ' ' LYS . 9.2 t -138.11 170.99 15.07 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.915 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -159.6 168.59 25.71 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.917 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 11.8 p90 176.69 154.97 0.23 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.035 -1.041 . . . . 0.0 109.987 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 1.4 pt-20 -80.96 107.06 13.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.043 -1.035 . . . . 0.0 108.496 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.06 178.97 4.3 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.363 -0.835 . . . . 0.0 109.825 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 103' ' ' THR . 90.6 m -147.12 110.37 4.82 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.753 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 20.1 m-30 -80.96 118.11 22.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.935 . . . . 0.0 109.472 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -148.27 47.01 1.06 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.272 -0.893 . . . . 0.0 110.132 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.562 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 29.1 p90 -78.11 136.83 37.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.529 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 1.96 66.1 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.332 0 CA-C-O 121.696 0.76 . . . . 0.0 112.075 -178.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 98' ' ' TYR . 6.0 ttp -177.01 -174.26 0.51 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 t -63.47 149.2 92.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.944 . . . . 0.0 108.917 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.81 156.28 39.39 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.82 1.68 . . . . 0.0 110.894 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 95' ' ' THR . 3.1 m -147.39 148.45 31.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.5 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.432 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -119.93 140.68 50.51 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.756 ' HA ' HG23 ' A' ' 125' ' ' VAL . 10.1 m -158.24 144.42 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.092 -1.005 . . . . 0.0 110.489 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.669 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -92.38 112.52 24.5 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 174.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.917 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 1.4 m -83.27 161.24 3.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 O-C-N 121.366 -0.834 . . . . 0.0 111.86 -174.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -157.23 98.34 1.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.884 ' HG2' HG13 ' A' ' 120' ' ' VAL . 13.7 mtm -107.97 144.98 34.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.985 -1.072 . . . . 0.0 110.237 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.64 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 5.0 tttt -141.39 -163.4 1.55 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.169 -1.412 . . . . 0.0 110.168 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -103.28 106.55 17.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.953 . . . . 0.0 109.111 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.799 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -54.45 149.07 10.87 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.445 -0.784 . . . . 0.0 110.174 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.452 -0.78 . . . . 0.0 110.221 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.767 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.424 0.631 . . . . 0.0 110.135 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.768 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.7 m-85 -151.11 122.01 7.6 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.799 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.2 p-90 -121.25 156.61 32.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.707 -1.245 . . . . 0.0 111.954 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.884 HG13 ' HG2' ' A' ' 109' ' ' MET . 46.5 t -124.88 112.52 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.353 0.597 . . . . 0.0 110.373 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.642 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 11.2 m-30 -96.91 112.29 24.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.753 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.1 t -100.02 116.58 43.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.39 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.593 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 5.6 tptp -89.38 120.5 30.77 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.567 ' HD3' HD11 ' A' ' 49' ' ' ILE . 9.2 ttp180 -73.72 117.69 15.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.77 -1.206 . . . . 0.0 109.35 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.756 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.229 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.504 2.232 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.932 HG22 HD11 ' A' ' 15' ' ' LEU . 1.1 mm -85.77 -62.0 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 111.318 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -45.54 -24.56 0.34 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.972 -1.08 . . . . 0.0 111.023 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -81.66 -46.14 14.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.091 -1.005 . . . . 0.0 109.428 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -58.45 4.02 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.932 HD11 HG22 ' A' ' 11' ' ' ILE . 43.4 mt -39.47 -31.45 0.09 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.422 0.63 . . . . 0.0 110.102 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 179.882 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.927 0.394 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.73 21.26 34.05 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.443 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 68.8 mt -81.21 140.3 35.01 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.141 -1.211 . . . . 0.0 108.735 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.19 3.83 14.19 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.771 0.796 . . . . 0.0 109.177 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 2.5 p90 -136.55 139.76 42.43 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -74.09 129.5 11.72 Favored Glycine 0 C--N 1.293 -1.832 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -103.18 117.14 33.87 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.884 -1.363 . . . . 0.0 107.941 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.653 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.1 pp -115.78 144.35 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.33 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 2.9 tt0 -108.71 168.56 9.26 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.716 ' C ' HD11 ' A' ' 40' ' ' LEU . 21.1 mt -156.64 135.8 12.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.53 -1.356 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.429 ' N ' HD11 ' A' ' 40' ' ' LEU . 15.7 t0 -93.96 175.9 6.54 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.87 -55.68 5.43 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.358 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -18.93 57.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.677 -1.484 . . . . 0.0 109.569 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 102.5 29.09 6.08 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 107.331 -2.307 . . . . 0.0 107.331 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -86.53 130.03 34.64 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.673 -0.898 . . . . 0.0 110.78 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -62.73 131.76 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.563 -1.336 . . . . 0.0 110.997 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.716 HD11 ' C ' ' A' ' 33' ' ' LEU . 2.3 mp -104.76 -19.88 13.78 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.6 ' NE2' HD22 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -156.57 161.06 39.98 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.572 ' CE1' HG22 ' A' ' 31' ' ' ILE . 9.3 t80 -147.7 -61.96 0.27 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.588 -1.32 . . . . 0.0 111.035 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.636 HD21 ' HB3' ' A' ' 45' ' ' ALA . 1.4 p-10 97.43 175.08 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.5 -17.33 20.59 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.872 -1.143 . . . . 0.0 112.58 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.636 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -55.42 -63.73 1.07 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.549 -1.345 . . . . 0.0 110.298 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.6 pt-20 -57.78 -56.44 21.92 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.629 0.728 . . . . 0.0 109.309 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.1 -16.56 8.67 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -70.86 -43.62 68.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.733 -1.451 . . . . 0.0 108.759 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -85.1 -55.99 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.443 -0.785 . . . . 0.0 109.552 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.507 ' N ' HG22 ' A' ' 49' ' ' ILE . 33.2 p -72.98 -20.18 61.08 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 0.0 110.318 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.9 -6.34 79.08 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.679 ' HB3' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -57.19 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -1.182 . . . . 0.0 110.133 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.744 ' O ' HG22 ' A' ' 57' ' ' VAL . 2.7 m-20 -61.2 159.67 27.92 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.05 -63.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.791 1.661 . . . . 0.0 110.983 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -56.12 -20.24 16.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.18 -0.95 . . . . 0.0 110.345 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -90.13 -47.37 7.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.914 -1.116 . . . . 0.0 110.021 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 53' ' ' ASP . 18.4 m -72.86 -4.93 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.03 . . . . 0.0 109.668 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.679 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.78 124.83 26.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.16 -17.05 59.11 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.421 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 7.6 mmtt -78.65 138.35 38.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.191 -1.182 . . . . 0.0 109.04 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.466 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -75.55 104.31 6.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.809 ' CZ ' HG21 ' A' ' 70' ' ' THR . 31.3 t80 -58.52 -19.71 39.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.489 -0.757 . . . . 0.0 110.586 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.676 ' CE2' HD13 ' A' ' 33' ' ' LEU . 22.2 m-85 -85.75 -48.69 8.58 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.297 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.36 37.36 4.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.925 -1.109 . . . . 0.0 109.789 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.466 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 1.2 t0 -149.31 -30.91 0.24 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 110.615 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.601 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 5.0 t -110.77 -58.91 3.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 120.745 -1.222 . . . . 0.0 108.679 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -104.71 105.66 51.56 Favored Pre-proline 0 C--N 1.29 -1.987 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.594 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.62 3.85 6.08 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.058 1.838 . . . . 0.0 111.26 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.2 p -107.15 -17.06 14.26 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.847 -1.158 . . . . 0.0 109.862 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.809 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 24.8 p -83.5 6.0 21.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.962 . . . . 0.0 110.046 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -97.79 52.29 1.08 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.08 -1.012 . . . . 0.0 108.921 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.7 p -129.63 -179.81 1.11 Allowed Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.23 2.19 8.25 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 122.049 1.833 . . . . 0.0 112.028 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.9 mp0 -109.65 -27.96 9.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.86 -1.15 . . . . 0.0 108.985 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.649 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.1 t80 -102.52 -70.76 0.74 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.7 t80 -68.72 -17.48 64.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.81 -62.84 4.89 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.818 ' HB3' HG21 ' A' ' 90' ' ' THR . 5.3 mmtt -61.64 -16.53 49.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.448 -1.031 . . . . 0.0 109.502 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.872 ' O ' HG23 ' A' ' 83' ' ' VAL . 17.1 t80 -82.11 -39.43 23.35 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.58 -0.7 . . . . 0.0 110.195 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.9 -12.15 60.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.925 -1.109 . . . . 0.0 109.311 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 19.9 pt-20 -97.1 -41.01 8.55 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.07 -39.89 98.57 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 79' ' ' PHE . 97.4 t -60.11 -54.33 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.746 -0.856 . . . . 0.0 109.188 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.86 -2.14 35.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.398 -0.814 . . . . 0.0 110.454 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.1 t -90.63 -34.27 15.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.045 -1.034 . . . . 0.0 109.543 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.31 19.4 30.47 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -175.43 64.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -1.138 . . . . 0.0 108.945 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.569 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -51.27 123.68 10.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.856 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -161.1 89.67 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.115 -0.991 . . . . 0.0 108.77 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.818 HG21 ' HB3' ' A' ' 78' ' ' LYS . 9.4 t -153.23 172.65 16.65 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.825 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.62 174.51 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.005 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 7.3 p90 178.69 152.79 0.34 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.769 -1.207 . . . . 0.0 110.441 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -79.46 117.18 20.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.893 . . . . 0.0 108.777 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.19 175.18 6.07 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.038 -1.039 . . . . 0.0 110.359 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.7 m -147.25 110.32 4.78 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -80.14 119.79 23.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -131.14 42.41 3.22 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.604 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -78.29 79.55 4.73 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.3 0.572 . . . . 0.0 110.391 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.577 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 5.3 pt20 52.52 38.94 26.94 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.675 0.75 . . . . 0.0 109.656 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.73 -168.9 3.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.387 -0.821 . . . . 0.0 109.369 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.42 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.6 t -67.24 150.54 97.84 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.8 . . . . 0.0 108.921 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.42 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.5 Cg_endo -74.56 82.64 1.87 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.86 1.707 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.681 HG22 HG13 ' A' ' 105' ' ' VAL . 11.4 m -69.93 98.9 1.33 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.497 -0.752 . . . . 0.0 109.607 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.1 OUTLIER -73.24 133.95 44.13 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.208 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.704 ' HA ' HG23 ' A' ' 125' ' ' VAL . 16.3 m -150.0 146.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.365 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -94.62 116.78 29.17 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 175.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.005 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -88.26 164.4 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.741 -1.224 . . . . 0.0 111.553 -175.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 21.3 t-160 -147.42 146.88 29.74 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 175.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.915 ' HB3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -152.33 137.86 17.74 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.6 -1.312 . . . . 0.0 109.345 -178.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.592 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 25.4 tttt -150.3 158.9 44.66 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.402 -1.319 . . . . 0.0 109.904 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.462 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 4.7 ttmt -72.36 109.88 6.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 109.048 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.959 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -72.03 176.24 5.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.442 -0.787 . . . . 0.0 111.008 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 O-C-N 121.551 -0.718 . . . . 0.0 109.119 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.76 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 55.7 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.584 0.706 . . . . 0.0 110.594 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.838 ' CE1' HG22 ' A' ' 83' ' ' VAL . 16.6 m-85 -132.38 132.11 42.53 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.959 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 17.4 p-90 -136.28 155.24 50.37 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.63 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.915 HG22 ' HB3' ' A' ' 109' ' ' MET . 83.3 t -140.42 109.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.804 -0.56 . . . . 0.0 110.049 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.683 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 3.8 m-30 -91.36 135.13 34.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.991 -1.068 . . . . 0.0 109.319 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.666 HG13 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -110.42 119.23 58.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.24 -0.912 . . . . 0.0 109.72 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.574 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -89.03 108.55 19.65 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.632 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -67.56 116.91 8.82 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.474 -1.29 . . . . 0.0 109.468 -178.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.704 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.115 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.093 HG22 HD11 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -75.16 -68.67 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.529 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.558 -177.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.431 ' HA ' HD12 ' A' ' 15' ' ' LEU . 3.2 tm-20 -37.98 -33.63 0.09 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.697 -0.627 . . . . 0.0 111.663 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.39 -44.28 16.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.919 -1.113 . . . . 0.0 108.597 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -69.55 -8.54 48.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.746 -0.597 . . . . 0.0 109.605 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.093 HD11 HG22 ' A' ' 11' ' ' ILE . 28.7 mt -97.97 -22.06 16.5 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.819 -1.175 . . . . 0.0 109.316 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.969 -179.563 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 25' ' ' GLY . 19.4 p30 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.132 0.491 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -100.83 35.83 4.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.996 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 85.1 mt -99.63 124.57 44.98 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.44 -1.035 . . . . 0.0 109.838 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.12 -12.92 14.05 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.824 0.821 . . . . 0.0 108.916 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.996 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 2.7 p90 -113.82 -172.43 2.08 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.164 -0.96 . . . . 0.0 108.612 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.484 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -122.98 136.16 10.43 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 108.131 -1.988 . . . . 0.0 108.131 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -113.91 111.25 21.39 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.894 -1.356 . . . . 0.0 108.318 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.667 HG22 ' CD1' ' A' ' 42' ' ' TYR . 0.8 OUTLIER -120.81 140.27 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.493 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.672 ' HB3' HD12 ' A' ' 40' ' ' LEU . 9.3 mt-30 -107.23 170.55 7.89 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.747 HD21 HD12 ' A' ' 39' ' ' ILE . 80.1 mt -151.47 142.84 23.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.988 -1.07 . . . . 0.0 109.971 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.598 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -115.11 137.43 52.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.077 -1.014 . . . . 0.0 109.365 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -10.89 71.21 0.0 OUTLIER Glycine 0 N--CA 1.513 3.824 0 C-N-CA 124.674 1.13 . . . . 0.0 113.378 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER 162.58 -24.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.04 18.37 22.44 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 16.3 p-10 -84.9 129.04 34.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.146 -1.208 . . . . 0.0 108.893 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.747 HD12 HD21 ' A' ' 33' ' ' LEU . 1.1 mp -63.24 137.26 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.075 0.94 . . . . 0.0 111.282 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 32' ' ' GLN . 1.7 mt -108.27 -28.45 9.44 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.548 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -155.0 161.14 41.46 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.667 ' CD1' HG22 ' A' ' 31' ' ' ILE . 48.3 t80 -149.14 -73.35 0.18 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.54 -1.35 . . . . 0.0 111.071 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 10.1 p-10 109.06 178.19 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 123.999 0.92 . . . . 0.0 109.641 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.9 15.09 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.051 -1.031 . . . . 0.0 113.258 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -51.75 -63.77 1.03 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.254 -1.528 . . . . 0.0 110.563 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' OE1' ' CE1' ' A' ' 42' ' ' TYR . 1.2 pt-20 -57.39 -54.62 44.74 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.625 0.726 . . . . 0.0 109.609 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.41 -14.87 21.81 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.57 -34.89 46.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.874 -1.368 . . . . 0.0 109.478 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -47.91 15.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.251 -0.905 . . . . 0.0 109.679 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.449 ' HA ' ' CE ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -86.41 -31.92 21.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.176 -0.952 . . . . 0.0 109.74 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.41 -3.41 56.5 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.928 -1.129 . . . . 0.0 110.438 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.953 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -41.9 -48.04 4.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.321 -1.105 . . . . 0.0 112.492 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.646 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER 66.1 146.18 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.727 -1.233 . . . . 0.0 107.737 -178.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.77 -63.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.949 1.766 . . . . 0.0 112.118 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.767 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -55.22 -21.65 14.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.011 . . . . 0.0 111.193 -178.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -88.07 -41.1 13.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.868 -1.145 . . . . 0.0 109.878 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 52' ' ' ARG . 15.2 m -81.89 3.32 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 110.021 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.767 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.44 120.84 20.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.091 -1.006 . . . . 0.0 108.546 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.8 -11.4 70.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -80.36 141.4 35.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.949 -1.324 . . . . 0.0 109.849 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.451 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -81.59 92.99 6.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.907 . . . . 0.0 109.005 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.719 ' CZ ' HG21 ' A' ' 70' ' ' THR . 25.8 t80 -54.1 -22.33 10.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 76' ' ' TYR . 7.0 m-85 -85.84 -31.45 22.27 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.48 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.39 47.4 1.39 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 108.935 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.451 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.7 OUTLIER -165.47 -33.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.388 -0.82 . . . . 0.0 110.345 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.953 HG11 ' HD3' ' A' ' 52' ' ' ARG . 9.9 t -106.93 -56.97 4.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 120.76 -1.213 . . . . 0.0 109.002 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . . . -104.4 101.26 26.26 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.902 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.2 Cg_endo -75.98 -0.38 10.2 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 C-N-CA 121.803 1.669 . . . . 0.0 110.522 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 p -100.54 -23.2 14.75 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.072 -1.017 . . . . 0.0 109.694 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.719 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 10.8 p -82.12 3.88 25.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.168 -0.958 . . . . 0.0 110.044 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -91.21 51.16 1.87 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.924 -1.11 . . . . 0.0 108.77 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.48 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -121.13 179.05 1.01 Allowed Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -78.85 -6.09 14.97 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.931 1.754 . . . . 0.0 111.223 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 14.3 mm-40 -103.18 -24.15 13.59 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.896 -1.127 . . . . 0.0 109.656 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.571 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.5 t80 -103.61 -70.44 0.76 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 21.0 t80 -71.83 -19.67 61.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.92 -1.113 . . . . 0.0 108.442 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.48 -61.51 6.21 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.664 ' HB2' HG21 ' A' ' 90' ' ' THR . 2.3 mmtp -63.04 -15.78 57.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.964 . . . . 0.0 109.496 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.863 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.9 t80 -78.65 -40.49 34.01 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -77.91 -7.02 56.19 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -95.75 -39.51 9.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.433 ' C ' HD12 ' A' ' 88' ' ' LEU . . . -70.27 -43.08 64.3 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.898 HG22 ' CE1' ' A' ' 118' ' ' TYR . 59.1 t -58.25 -37.3 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.738 -0.86 . . . . 0.0 109.192 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.12 -4.22 46.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.459 -0.776 . . . . 0.0 110.982 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 m -100.38 -18.22 16.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.781 -1.199 . . . . 0.0 110.224 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.77 16.3 77.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.86 63.43 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -1.207 . . . . 0.0 108.846 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -65.31 112.68 3.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 109.854 -179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.419 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 19.3 p30 -160.78 85.07 0.69 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.409 -0.807 . . . . 0.0 108.912 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.664 HG21 ' HB2' ' A' ' 78' ' ' LYS . 8.9 t -133.1 144.93 50.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.061 -1.024 . . . . 0.0 110.434 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.5 ptp -132.74 154.64 50.01 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.058 ' CE2' HG21 ' A' ' 107' ' ' VAL . 9.9 p90 -169.19 -173.3 1.71 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.755 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.63 110.37 20.47 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.95 172.71 6.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.495 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 103' ' ' THR . 89.3 m -143.41 111.72 6.27 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.442 -0.787 . . . . 0.0 109.042 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.941 ' CE2' HG21 ' A' ' 122' ' ' VAL . 15.5 m-30 -83.8 117.13 23.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.281 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -147.13 47.04 1.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.94 . . . . 0.0 109.88 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 21.3 p90 -78.6 137.08 37.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.515 ' C ' ' O ' ' A' ' 98' ' ' TYR . 5.3 pt20 1.51 66.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.114 0 CA-C-O 121.539 0.685 . . . . 0.0 112.371 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 98' ' ' TYR . 67.7 ttp -162.98 -93.54 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.502 -0.749 . . . . 0.0 109.396 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 100' ' ' MET . 0.2 OUTLIER -149.17 161.5 31.99 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.812 -1.18 . . . . 0.0 108.664 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.95 115.36 4.0 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.024 1.816 . . . . 0.0 110.357 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' THR . 2.5 m -123.58 128.08 49.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.662 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.42 143.61 33.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.798 ' HA ' HG23 ' A' ' 125' ' ' VAL . 15.2 m -152.82 141.97 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.773 -1.204 . . . . 0.0 110.777 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -83.43 115.94 22.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 174.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.058 HG21 ' CE2' ' A' ' 92' ' ' PHE . 32.7 m -98.85 156.22 3.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 120.838 -1.164 . . . . 0.0 110.929 -175.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -159.99 104.48 1.52 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.904 ' HG2' HG13 ' A' ' 120' ' ' VAL . 6.4 mtm -110.23 145.53 37.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.429 -0.794 . . . . 0.0 109.772 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.624 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.9 tttm -138.0 -177.59 4.89 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.873 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.43 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 5.1 ttmm -91.04 99.9 12.85 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.701 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -48.07 123.94 6.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.408 -0.807 . . . . 0.0 110.057 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.962 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.519 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.592 0.71 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.898 ' CE1' HG22 ' A' ' 83' ' ' VAL . 22.7 m-85 -139.54 113.46 8.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.724 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 11.1 p-90 -114.95 141.68 47.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.527 -1.269 . . . . 0.0 112.325 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.904 HG13 ' HG2' ' A' ' 109' ' ' MET . 61.5 t -113.99 116.23 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.724 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 18.9 m-30 -99.05 127.63 45.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.002 -1.061 . . . . 0.0 109.287 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.941 HG21 ' CE2' ' A' ' 96' ' ' PHE . 2.0 t -116.3 113.09 42.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.025 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.1 tttm -96.62 120.73 37.49 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.466 ' HA ' HG12 ' A' ' 105' ' ' VAL . 1.9 ttt180 -65.67 121.34 14.74 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.707 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.798 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.183 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 . . . . . 0 N--CA 1.516 2.848 0 CA-C-O 121.122 0.487 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.965 HG22 HD11 ' A' ' 15' ' ' LEU . 1.2 mm -58.38 -68.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.148 -0.97 . . . . 0.0 110.053 -177.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.89 -28.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.8 -0.562 . . . . 0.0 112.31 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 11' ' ' ILE . 16.1 m120 -72.94 -50.87 20.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.758 -1.213 . . . . 0.0 109.576 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.1 m -68.24 -54.85 14.82 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.965 HD11 HG22 ' A' ' 11' ' ' ILE . 51.8 mt -43.34 -32.05 0.75 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.249 0.547 . . . . 0.0 110.244 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.84 -179.47 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.017 0.437 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.56 27.74 16.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mt -71.59 -168.43 0.34 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.149 -1.206 . . . . 0.0 109.13 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.98 -4.24 14.58 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.595 ' CE2' HD12 ' A' ' 11' ' ' ILE . 7.2 p90 -134.68 112.09 10.51 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.216 -0.928 . . . . 0.0 109.072 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.707 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -49.82 161.62 0.92 Allowed Glycine 0 C--N 1.289 -2.048 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.49 129.82 17.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.819 -1.401 . . . . 0.0 108.457 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.63 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.8 pp -131.84 157.63 43.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.772 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.713 ' HB3' HD12 ' A' ' 40' ' ' LEU . 45.8 mt-30 -116.39 163.27 16.29 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 37' ' ' GLY . 17.6 mt -147.57 144.0 28.16 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.867 -1.145 . . . . 0.0 110.467 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.444 ' N ' HD21 ' A' ' 40' ' ' LEU . 30.5 t70 -96.54 165.87 11.96 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -44.08 -22.48 0.33 Allowed Glycine 0 N--CA 1.5 2.931 0 C-N-CA 121.336 -0.459 . . . . 0.0 113.281 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.1 15.94 22.71 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.342 -1.681 . . . . 0.0 110.858 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.628 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.03 26.25 67.06 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 34.2 m-80 -94.33 131.19 40.21 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.99 -1.3 . . . . 0.0 110.964 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.608 HG22 ' HA ' ' A' ' 58' ' ' ILE . 1.1 tp -61.83 138.07 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.825 -1.172 . . . . 0.0 111.286 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 32' ' ' GLN . 2.3 mt -110.64 -28.24 8.56 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 177.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.459 ' NE2' ' N ' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -152.68 150.12 29.13 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.536 ' CD1' ' OE2' ' A' ' 46' ' ' GLU . 4.7 t80 -130.89 -54.03 1.06 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.323 -1.486 . . . . 0.0 111.374 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.501 ' OD1' ' HG3' ' A' ' 46' ' ' GLU . 0.4 OUTLIER 89.6 177.77 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.37 -38.39 9.65 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.937 -1.102 . . . . 0.0 113.681 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.87 -62.68 1.13 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.64 -1.287 . . . . 0.0 111.552 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.707 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -59.09 -49.16 78.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.47 -0.769 . . . . 0.0 110.932 -179.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.21 -15.08 42.97 Favored Glycine 0 C--N 1.281 -2.477 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -83.63 -30.0 27.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.96 -1.317 . . . . 0.0 108.888 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -82.01 -55.32 8.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.405 -0.809 . . . . 0.0 109.144 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.487 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.2 p -84.41 -11.49 56.15 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.242 -0.911 . . . . 0.0 109.903 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.36 -5.84 81.91 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.765 ' NE ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -52.35 123.6 11.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -1.159 . . . . 0.0 110.478 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.76 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.4 m-20 -89.85 154.97 47.93 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 -54.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.708 1.605 . . . . 0.0 111.37 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -22.15 66.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 110.668 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.81 -41.85 11.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.955 -1.091 . . . . 0.0 109.96 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 53' ' ' ASP . 14.4 m -77.61 -1.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.728 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.608 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -71.65 122.48 23.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.64 -15.07 61.25 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -79.13 138.76 38.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.139 -1.212 . . . . 0.0 108.877 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 66' ' ' VAL . 23.0 m120 -76.38 109.35 10.02 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 1.031 ' CZ ' HG21 ' A' ' 70' ' ' THR . 8.5 t80 -68.79 -20.54 64.34 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.632 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 3.6 m-85 -85.06 -4.05 59.02 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.957 -1.097 . . . . 0.0 111.393 -177.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 23.0 mttt -155.99 -46.37 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.731 -1.231 . . . . 0.0 110.857 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.53 -3.41 53.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.984 -1.072 . . . . 0.0 112.299 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.765 HG11 ' NE ' ' A' ' 52' ' ' ARG . 5.7 t -126.45 -59.37 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 120.304 -1.498 . . . . 0.0 109.286 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.65 106.95 59.67 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.625 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.12 2.32 7.3 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.796 1.664 . . . . 0.0 111.698 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.7 p -105.33 -18.83 13.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.861 -1.149 . . . . 0.0 109.78 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 1.031 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 71.1 p -75.35 -2.12 26.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 110.28 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -90.68 53.31 2.39 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.878 -1.139 . . . . 0.0 108.789 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -124.71 178.18 1.53 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.488 -0.758 . . . . 0.0 109.237 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.39 -1.2 11.39 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 122.238 1.959 . . . . 0.0 111.428 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.4 mp0 -109.44 -25.83 10.3 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.92 -1.112 . . . . 0.0 109.248 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -100.98 -70.36 0.74 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -72.12 -18.27 61.91 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.094 -1.004 . . . . 0.0 108.341 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.82 -64.9 3.23 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.914 ' HB2' HG21 ' A' ' 90' ' ' THR . 1.4 mmtp -62.48 -16.77 57.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.561 -0.964 . . . . 0.0 109.878 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.87 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.1 t80 -83.5 -36.98 23.68 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.602 -0.687 . . . . 0.0 109.872 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.22 -12.57 60.11 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.173 -0.954 . . . . 0.0 109.081 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 19.4 pt-20 -97.23 -42.36 7.85 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.487 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -60.03 -39.25 95.45 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 107.521 -2.232 . . . . 0.0 107.521 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 79' ' ' PHE . 90.3 t -60.88 -45.36 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.784 -0.833 . . . . 0.0 109.46 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.19 -3.11 57.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.219 -0.926 . . . . 0.0 110.622 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.49 -24.61 15.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.85 -1.156 . . . . 0.0 109.451 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.71 15.1 74.06 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -156.19 56.01 0.58 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -1.176 . . . . 0.0 108.66 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -50.24 120.73 4.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 110.113 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.442 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 17.1 p30 -160.52 88.41 0.79 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 108.947 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.914 HG21 ' HB2' ' A' ' 78' ' ' LYS . 10.1 t -146.86 169.02 19.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.209 -0.932 . . . . 0.0 110.129 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -154.98 170.38 21.89 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.003 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 6.5 p90 179.53 152.52 0.42 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.872 -1.142 . . . . 0.0 110.222 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -80.75 111.93 17.65 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 -178.85 3.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.084 -1.01 . . . . 0.0 109.984 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 103' ' ' THR . 79.6 m -146.09 109.73 4.81 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.669 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 18.5 m-30 -79.3 93.41 5.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 108.665 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -115.84 31.17 6.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.37 -0.831 . . . . 0.0 109.686 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.582 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.85 159.11 27.96 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.494 ' C ' ' O ' ' A' ' 98' ' ' TYR . 1.5 pp0? -4.56 67.65 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 123.532 0.733 . . . . 0.0 112.547 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.582 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.78 -157.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.608 -0.683 . . . . 0.0 109.195 -178.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.459 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -90.96 174.78 4.15 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 108.834 179.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.459 ' CD ' HG22 ' A' ' 101' ' ' THR . 36.1 Cg_endo -79.15 103.77 1.68 Allowed 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.07 1.847 . . . . 0.0 110.749 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 95' ' ' THR . 9.2 m -99.11 145.27 27.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.114 -0.991 . . . . 0.0 108.926 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -119.43 135.82 54.58 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.771 ' HA ' HG23 ' A' ' 125' ' ' VAL . 11.5 m -153.5 145.67 14.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.973 -1.079 . . . . 0.0 110.862 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 3.0 ptmt -94.28 114.7 26.83 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.573 -2.381 . . . . 0.0 104.573 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.003 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -86.72 164.76 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.882 -1.136 . . . . 0.0 110.315 -176.588 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -159.71 101.94 1.5 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.827 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.89 148.77 36.19 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.109 -0.995 . . . . 0.0 110.002 -177.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.2 tttt -144.11 178.82 7.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.669 -1.269 . . . . 0.0 109.309 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.49 106.81 15.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.885 -1.134 . . . . 0.0 108.693 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.642 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.5 155.55 2.12 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 110.5 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.548 -0.72 . . . . 0.0 109.837 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.635 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.449 0.643 . . . . 0.0 109.904 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.742 ' CE1' HG22 ' A' ' 83' ' ' VAL . 12.0 m-85 -145.76 102.66 3.69 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.657 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 11.2 p-90 -106.32 143.69 34.07 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.551 -1.26 . . . . 0.0 111.973 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.827 HG13 ' HG2' ' A' ' 109' ' ' MET . 43.9 t -121.45 107.87 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.497 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.657 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 8.9 m-30 -92.94 123.08 35.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -0.854 . . . . 0.0 109.575 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.669 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.3 t -102.56 118.1 48.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.37 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.546 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 1.4 tttp -96.85 106.68 19.04 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.501 ' HA ' HG12 ' A' ' 105' ' ' VAL . 6.3 ttt180 -53.92 135.92 41.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.795 -1.191 . . . . 0.0 109.671 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.194 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.854 HG22 ' CG ' ' A' ' 15' ' ' LEU . 3.4 mm -75.1 -57.37 6.54 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 O-C-N 121.372 -0.83 . . . . 0.0 110.428 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.587 ' HA ' HD12 ' A' ' 15' ' ' LEU . 2.4 tt0 -36.18 -33.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.848 -0.532 . . . . 0.0 112.066 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 11' ' ' ILE . 1.5 m120 -84.74 -43.18 14.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.938 -1.101 . . . . 0.0 108.316 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 11' ' ' ILE . 2.9 m -69.78 -8.1 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.727 -0.608 . . . . 0.0 109.987 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.854 ' CG ' HG22 ' A' ' 11' ' ' ILE . 15.2 mt -96.77 -22.2 17.09 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.951 -1.093 . . . . 0.0 109.278 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.399 0 O-C-N 121.328 -0.857 . . . . 0.0 108.77 179.335 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.53 24.65 24.69 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.029 HD23 ' CZ ' ' A' ' 28' ' ' PHE . 3.5 mp -77.19 157.21 31.04 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.32 -1.106 . . . . 0.0 108.446 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.32 12.67 13.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.029 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -154.06 112.75 3.64 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.512 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -49.6 159.03 1.22 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -134.85 114.63 12.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.605 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.6 pp -117.1 158.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 110.636 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.836 ' HB3' HD12 ' A' ' 40' ' ' LEU . 24.3 mm-40 -125.89 170.36 11.73 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.856 HD22 ' O ' ' A' ' 37' ' ' GLY . 83.8 mt -157.39 147.56 20.8 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.28 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' ASP . 29.1 m-20 -126.64 127.03 44.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.059 -1.026 . . . . 0.0 109.913 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.02 -77.54 0.0 OUTLIER Glycine 0 N--CA 1.502 3.041 0 C-N-CA 124.578 1.085 . . . . 0.0 113.609 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -69.69 -3.23 14.35 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.535 -0.979 . . . . 0.0 110.933 -178.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.856 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 87.36 17.59 58.6 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 34' ' ' ASP . 8.1 p30 -73.7 129.5 38.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -1.199 . . . . 0.0 108.835 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.688 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -58.56 136.45 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 110.441 -178.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.836 HD12 ' HB3' ' A' ' 32' ' ' GLN . 6.9 mt -101.6 -29.59 11.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -160.0 176.97 11.22 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.54 ' CD1' HG22 ' A' ' 31' ' ' ILE . 12.9 t80 -156.11 -48.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.695 -1.253 . . . . 0.0 110.076 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.646 HD21 ' HB3' ' A' ' 45' ' ' ALA . 0.6 OUTLIER 89.43 176.5 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.257 0.551 . . . . 0.0 109.929 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.83 -20.54 18.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.244 -0.91 . . . . 0.0 112.485 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.646 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -56.3 -66.62 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.547 -1.345 . . . . 0.0 110.33 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 5.1 pt-20 -61.23 -49.4 77.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.956 . . . . 0.0 110.03 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -61.03 -14.24 37.9 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 21.7 t0 -80.76 -34.11 34.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.725 -1.456 . . . . 0.0 108.846 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.48 HG22 HG23 ' A' ' 50' ' ' THR . 1.0 OUTLIER -82.94 -54.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.197 -0.94 . . . . 0.0 108.849 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.48 HG23 HG22 ' A' ' 49' ' ' ILE . 26.7 p -78.82 -24.14 44.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.402 -0.811 . . . . 0.0 109.768 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 97.14 -13.8 64.39 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.797 ' NE ' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -58.35 90.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -1.207 . . . . 0.0 109.971 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.739 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -61.54 166.86 4.97 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.176 -0.952 . . . . 0.0 109.284 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.15 -54.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 122.149 1.899 . . . . 0.0 110.759 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -65.93 -24.23 66.78 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.974 -1.079 . . . . 0.0 109.848 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -44.39 17.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.88 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 53' ' ' ASP . 33.1 m -73.96 -3.13 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.189 -0.944 . . . . 0.0 109.836 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.67 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.73 123.31 23.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 120.976 -1.078 . . . . 0.0 108.422 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.41 -18.77 53.75 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -79.64 127.2 31.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.228 -1.16 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.446 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -67.61 104.69 1.67 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.287 -0.883 . . . . 0.0 108.714 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.688 ' HB2' HD12 ' A' ' 39' ' ' ILE . 84.6 t80 -55.45 -17.21 4.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.48 -0.763 . . . . 0.0 110.651 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CE2' HD13 ' A' ' 33' ' ' LEU . 29.3 m-85 -94.11 -38.15 11.25 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.048 -1.032 . . . . 0.0 110.73 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 0.1 OUTLIER -134.67 42.8 2.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.962 -1.086 . . . . 0.0 109.201 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.3 OUTLIER -159.2 -32.52 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 110.235 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.797 HG12 ' NE ' ' A' ' 52' ' ' ARG . 9.3 t -109.12 -51.4 6.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 O-C-N 120.787 -1.196 . . . . 0.0 108.14 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.455 ' HB2' HH21 ' A' ' 52' ' ' ARG . . . -116.43 97.41 49.89 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.141 -178.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.22 -1.41 10.91 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.113 1.875 . . . . 0.0 111.251 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 p -95.35 -26.73 15.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.655 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 72' ' ' SER . 70.9 p -66.62 -36.37 82.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.387 -0.82 . . . . 0.0 109.744 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.92 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.168 -0.957 . . . . 0.0 109.054 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 177.67 170.52 0.44 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 109.291 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.3 80.83 2.61 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.558 2.172 . . . . 0.0 110.809 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER 168.08 -36.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.497 ' CD1' ' HE1' ' A' ' 109' ' ' MET . 1.8 t80 -109.84 -67.06 1.01 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 9.3 t80 -75.58 -17.24 60.11 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.68 -58.2 11.97 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.488 ' CD ' ' N ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -61.89 -18.62 60.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.609 -0.936 . . . . 0.0 109.594 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.913 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.7 t80 -81.02 -38.47 27.42 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.452 -0.78 . . . . 0.0 109.639 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.83 -12.42 60.38 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.01 -1.056 . . . . 0.0 109.463 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 12.8 pt-20 -96.85 -41.0 8.65 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -62.21 -39.11 97.26 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 79' ' ' PHE . 90.8 t -61.68 -39.85 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.789 -0.83 . . . . 0.0 109.891 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.14 -0.19 53.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.236 -0.915 . . . . 0.0 111.274 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 2.5 t -104.88 -24.21 12.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.899 -1.126 . . . . 0.0 110.161 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.64 16.17 78.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -148.45 58.85 1.08 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.031 -1.276 . . . . 0.0 109.098 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.529 HD13 ' HD1' ' A' ' 118' ' ' TYR . 0.4 OUTLIER -68.83 111.99 5.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -0.814 . . . . 0.0 109.694 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -160.14 82.87 0.71 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -131.46 172.8 11.78 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.917 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.54 171.11 19.56 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.932 ' CE1' HG21 ' A' ' 107' ' ' VAL . 17.2 p90 171.98 -177.11 0.05 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.088 -1.008 . . . . 0.0 109.992 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -109.92 105.59 14.82 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -104.41 -179.86 4.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.1 m -143.83 111.67 6.12 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.713 ' CE2' HG21 ' A' ' 122' ' ' VAL . 13.1 m-30 -86.71 131.02 34.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 108.871 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -160.98 63.89 0.29 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.534 ' CE1' ' HB2' ' A' ' 100' ' ' MET . 0.6 OUTLIER -84.11 41.08 0.8 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.488 -0.758 . . . . 0.0 111.776 -178.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER 89.61 29.76 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.683 0.754 . . . . 0.0 109.511 179.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.534 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -129.44 -71.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.947 . . . . 0.0 109.636 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.411 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.5 t -159.14 150.18 16.24 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.417 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.411 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 34.9 Cg_endo -76.25 79.75 2.87 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 122.063 1.842 . . . . 0.0 110.89 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.545 ' O ' HG22 ' A' ' 103' ' ' THR . 1.1 m -84.45 105.63 15.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.701 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -74.51 149.21 40.36 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.601 ' HB ' HG13 ' A' ' 122' ' ' VAL . 4.8 m -156.03 144.86 12.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 118.588 -1.245 . . . . 0.0 111.53 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -78.05 151.41 33.51 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.932 HG21 ' CE1' ' A' ' 92' ' ' PHE . 4.0 m -128.24 154.04 38.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 117.931 -1.507 . . . . 0.0 110.856 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 6.4 t-160 -147.42 125.59 12.18 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.872 ' HB3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -133.69 126.97 31.91 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 120.99 -1.069 . . . . 0.0 108.898 -178.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.583 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 17.8 tttm -138.5 157.82 45.44 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.112 -1.435 . . . . 0.0 110.129 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.499 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 ptmt -75.63 94.18 3.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 109.626 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.981 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -53.27 123.54 12.15 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.252 -0.905 . . . . 0.0 109.617 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.054 -1.029 . . . . 0.0 110.124 -179.745 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.504 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 121.157 0.503 . . . . 0.0 110.452 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.901 ' CE1' HG22 ' A' ' 83' ' ' VAL . 7.3 m-85 -125.05 136.03 53.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.981 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.6 p-90 -135.6 150.65 49.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.002 -1.061 . . . . 0.0 110.519 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.872 HG22 ' HB3' ' A' ' 109' ' ' MET . 89.5 t -138.09 105.45 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.741 -0.599 . . . . 0.0 110.326 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.658 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 2.1 m-85 -88.87 138.14 31.68 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.713 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -110.76 114.19 46.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.51 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -81.67 142.38 32.77 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 176.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -98.85 134.42 41.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.495 -1.378 . . . . 0.0 109.637 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.031 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.015 HG22 HD11 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -69.28 -66.26 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.488 0 O-C-N 121.477 -0.764 . . . . 0.0 110.322 -178.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 11' ' ' ILE . 14.4 pt-20 -36.52 -33.74 0.05 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.867 -0.521 . . . . 0.0 111.994 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -82.64 -44.7 15.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.768 -1.208 . . . . 0.0 108.489 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.406 ' O ' HG22 ' A' ' 14' ' ' THR . 5.4 m -67.59 -10.38 51.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.693 -0.629 . . . . 0.0 109.691 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.015 HD11 HG22 ' A' ' 11' ' ' ILE . 42.2 mt -97.79 -20.48 17.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.842 -1.161 . . . . 0.0 109.749 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.33 -0.856 . . . . 0.0 110.16 -179.858 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.22 32.24 7.55 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.15 158.7 16.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.416 -1.049 . . . . 0.0 108.789 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -93.48 14.44 18.69 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.756 -0.59 . . . . 0.0 109.59 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.536 ' CE2' HG12 ' A' ' 11' ' ' ILE . 25.2 p90 -148.9 154.18 39.08 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.175 -0.953 . . . . 0.0 109.596 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.96 114.4 3.85 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.617 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -91.21 87.7 6.62 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.534 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.3 pp -98.48 148.89 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.649 -0.657 . . . . 0.0 109.79 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.726 ' HB3' HD12 ' A' ' 40' ' ' LEU . 18.1 mt-30 -118.25 174.63 6.12 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 108.501 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.845 HD22 ' O ' ' A' ' 37' ' ' GLY . 62.1 mt -154.33 149.64 27.11 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.21 -0.932 . . . . 0.0 109.171 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.621 ' CG ' HD21 ' A' ' 40' ' ' LEU . 30.4 p30 -130.45 121.03 25.11 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.607 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.6 -79.23 0.0 OUTLIER Glycine 0 N--CA 1.5 2.904 0 C-N-CA 124.362 0.982 . . . . 0.0 113.021 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -66.67 -7.59 21.73 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 121.851 -0.794 . . . . 0.0 110.436 -178.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.845 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 89.89 18.54 50.63 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 m120 -73.26 136.13 44.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.243 . . . . 0.0 108.272 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.594 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -62.13 133.8 27.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.395 -0.815 . . . . 0.0 110.8 -178.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 32' ' ' GLN . 10.4 mt -98.85 -32.46 11.33 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.465 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -155.99 -173.73 4.64 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.825 ' CG ' HG21 ' A' ' 57' ' ' VAL . 1.2 t80 -160.96 -67.98 0.06 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.212 -0.93 . . . . 0.0 108.903 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.724 HD21 ' HB3' ' A' ' 45' ' ' ALA . 9.2 p-10 107.02 160.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 124.154 0.982 . . . . 0.0 109.169 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.99 -13.93 55.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.293 -0.88 . . . . 0.0 110.819 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.724 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -59.45 -62.33 1.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 0.0 109.803 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 11.5 pt-20 -66.05 -41.6 90.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.094 -1.003 . . . . 0.0 108.614 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -58.57 -18.06 36.08 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -29.55 22.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.778 -1.425 . . . . 0.0 109.579 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.412 HG12 ' HD2' ' A' ' 124' ' ' ARG . 1.1 mp -80.31 -41.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.324 -0.86 . . . . 0.0 109.394 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.07 4.08 19.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.607 -0.683 . . . . 0.0 110.189 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.72 -2.2 74.72 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.677 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.535 ' CZ ' ' HA ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -73.33 84.49 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.922 -1.34 . . . . 0.0 111.81 -178.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -63.99 175.96 0.74 Allowed Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 35.5 Cg_endo -77.05 -44.23 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.553 1.502 . . . . 0.0 110.682 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -16.41 63.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.107 -0.996 . . . . 0.0 110.268 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -48.67 6.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.972 -1.08 . . . . 0.0 110.025 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.825 HG21 ' CG ' ' A' ' 42' ' ' TYR . 32.8 m -70.71 -8.27 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.754 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.495 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -69.65 124.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.587 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.76 -19.62 50.26 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -79.02 132.88 36.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.317 -1.108 . . . . 0.0 108.976 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.71 125.27 27.09 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.7 ' HB2' HD21 ' A' ' 33' ' ' LEU . 75.4 t80 -63.97 -10.94 24.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.024 -1.048 . . . . 0.0 110.444 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CE2' HD13 ' A' ' 33' ' ' LEU . 83.5 m-85 -112.58 26.06 10.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.959 -1.088 . . . . 0.0 110.275 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -166.71 -58.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.978 -1.076 . . . . 0.0 110.891 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.58 -7.18 55.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.933 -1.105 . . . . 0.0 110.981 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.563 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 17.4 t -117.4 -26.43 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.63 -1.294 . . . . 0.0 109.526 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.71 96.84 1.0 Allowed Pre-proline 0 C--N 1.288 -2.076 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.961 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.42 -2.15 11.99 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.891 1.727 . . . . 0.0 110.564 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.2 p -90.1 -25.06 20.93 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.264 -0.897 . . . . 0.0 109.204 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.595 HG21 ' CE2' ' A' ' 62' ' ' PHE . 46.0 p -72.77 -5.37 37.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.466 -0.771 . . . . 0.0 110.139 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -88.39 59.63 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.967 -1.083 . . . . 0.0 109.317 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.404 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.6 OUTLIER -146.54 171.96 5.79 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.171 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 33.7 Cg_endo -75.75 79.54 2.81 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 122.373 2.048 . . . . 0.0 110.292 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.9 OUTLIER 169.21 -34.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.467 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.4 t80 -106.28 -67.07 0.96 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.559 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 27.7 t80 -78.48 -21.94 48.26 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -61.6 -56.67 21.76 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' CB ' HG21 ' A' ' 90' ' ' THR . 4.1 mmtt -65.62 -16.4 63.69 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.57 -0.959 . . . . 0.0 109.334 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.851 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.5 t80 -76.73 -37.68 55.57 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.66 -6.38 55.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.2 mm-40 -95.76 -39.06 10.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -70.36 -42.49 65.09 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.886 HG22 ' CE1' ' A' ' 118' ' ' TYR . 57.4 t -59.5 -40.13 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.843 -0.798 . . . . 0.0 109.73 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.14 -17.18 43.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -0.926 . . . . 0.0 110.744 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 m -88.28 -20.87 24.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.944 -1.097 . . . . 0.0 109.805 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.45 21.3 64.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -165.82 57.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -1.151 . . . . 0.0 109.355 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.498 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 6.3 tt -46.93 124.62 6.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.531 -0.731 . . . . 0.0 110.222 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.427 ' HB3' ' HE3' ' A' ' 110' ' ' LYS . 16.6 p-10 -161.42 89.59 0.77 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.533 HG23 ' SD ' ' A' ' 109' ' ' MET . 4.0 t -152.27 152.65 32.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.807 -1.183 . . . . 0.0 110.545 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.406 ' C ' ' CD2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -140.13 179.91 6.35 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.105 ' CE1' HG21 ' A' ' 107' ' ' VAL . 18.0 p90 172.47 171.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.838 . . . . 0.0 109.252 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.99 108.95 20.71 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.408 ' HB2' HG11 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -111.46 169.94 8.46 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.724 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' THR . 87.7 m -136.15 108.36 7.26 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 109.266 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.976 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 12.3 m-30 -80.29 85.62 5.77 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -108.44 34.38 3.67 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.69 158.33 28.37 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.502 ' C ' ' O ' ' A' ' 98' ' ' TYR . 2.0 mt-30 0.08 64.86 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.46 0.704 . . . . 0.0 112.525 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.22 -153.55 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -178.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.537 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -93.7 177.41 1.97 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 0.0 108.726 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.537 ' CD ' HG22 ' A' ' 101' ' ' THR . 34.1 Cg_endo -77.07 112.8 3.49 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.686 1.591 . . . . 0.0 110.013 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.457 HG22 HG13 ' A' ' 105' ' ' VAL . 2.8 m -113.29 130.34 56.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.727 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -104.52 145.21 30.62 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.041 ' HA ' HG23 ' A' ' 125' ' ' VAL . 26.3 m -154.57 144.8 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.615 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -78.26 117.55 19.63 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 174.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.105 HG21 ' CE1' ' A' ' 92' ' ' PHE . 23.2 m -99.2 151.96 4.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 117.852 -1.539 . . . . 0.0 108.235 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -156.32 102.68 2.11 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.851 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.17 144.89 41.9 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.192 -0.942 . . . . 0.0 109.529 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -141.04 -178.51 5.6 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.653 -1.28 . . . . 0.0 109.815 -179.273 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 103.74 16.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.027 -1.045 . . . . 0.0 108.857 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.839 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -51.59 146.13 8.05 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.616 -0.677 . . . . 0.0 109.884 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.269 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.763 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.271 0.558 . . . . 0.0 109.717 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.886 ' CE1' HG22 ' A' ' 83' ' ' VAL . 10.4 m-85 -149.9 111.59 4.52 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.839 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 15.1 p-90 -117.16 144.7 44.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.701 -1.249 . . . . 0.0 111.684 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.851 HG13 ' CG ' ' A' ' 109' ' ' MET . 13.8 t -120.85 114.57 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.554 0.692 . . . . 0.0 109.932 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.795 ' HE2' HD13 ' A' ' 11' ' ' ILE . 13.5 m-30 -95.33 121.9 37.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.976 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.3 t -107.02 112.79 41.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.889 -1.125 . . . . 0.0 108.468 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.481 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 14.3 tptp -89.21 125.17 34.96 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.539 ' HA ' HG12 ' A' ' 105' ' ' VAL . 28.6 ttt180 -74.33 123.65 25.01 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.688 -1.258 . . . . 0.0 109.458 -178.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 1.041 HG23 ' HA ' ' A' ' 105' ' ' VAL . 25.5 t . . . . . 0 C--N 1.301 -1.516 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.699 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.884 HG22 HD11 ' A' ' 15' ' ' LEU . 3.2 mm -50.73 -51.62 19.29 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.713 0 O-C-N 121.696 -0.628 . . . . 0.0 110.155 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' ILE . 4.0 tt0 -34.19 -41.51 0.11 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.15 -42.35 38.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.806 -1.184 . . . . 0.0 109.263 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 15' ' ' LEU . 1.2 m -60.7 -26.11 66.9 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.522 -0.737 . . . . 0.0 109.855 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.884 HD11 HG22 ' A' ' 11' ' ' ILE . 5.7 mt -96.77 -17.06 20.51 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.941 -1.1 . . . . 0.0 109.812 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.401 0 O-C-N 121.047 -1.033 . . . . 0.0 110.198 -179.947 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.079 0.466 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.74 31.56 8.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.506 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -104.1 173.54 6.26 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.159 -1.201 . . . . 0.0 108.888 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.7 21.27 11.61 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 122.262 1.03 . . . . 0.0 108.23 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.542 ' HD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -160.51 113.1 2.01 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.396 1.093 . . . . 0.0 108.395 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' HA2' ' ND2' ' A' ' 43' ' ' ASN . . . -46.96 143.41 5.31 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.346 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.495 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -125.34 92.34 3.6 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.692 HD12 ' N ' ' A' ' 32' ' ' GLN . 1.2 pp -99.1 167.33 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.454 -0.779 . . . . 0.0 111.109 -177.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.692 ' N ' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -134.22 166.59 22.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.81 HD22 ' C ' ' A' ' 37' ' ' GLY . 19.2 mt -149.64 148.35 29.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.971 -1.081 . . . . 0.0 110.065 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 36' ' ' ASP . 2.3 p30 -115.86 133.06 56.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.144 -0.972 . . . . 0.0 109.533 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -12.55 74.53 0.0 OUTLIER Glycine 0 N--CA 1.51 3.631 0 C-N-CA 124.697 1.142 . . . . 0.0 113.307 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER 162.44 -24.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.53 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.81 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.63 20.7 14.11 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.622 ' O ' HD23 ' A' ' 33' ' ' LEU . 23.0 m120 -87.67 131.99 34.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -1.139 . . . . 0.0 108.538 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.667 HD13 ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -67.77 138.39 22.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.113 -0.992 . . . . 0.0 111.161 -178.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' A' ' 32' ' ' GLN . 6.4 mt -99.61 -32.1 11.25 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -164.19 -179.59 6.24 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.576 ' CD1' HG22 ' A' ' 31' ' ' ILE . 27.7 t80 -140.63 -95.15 0.15 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.609 -1.307 . . . . 0.0 111.05 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 2.0 t-20 153.91 150.26 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.492 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -74.68 -58.45 3.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.4 -0.812 . . . . 0.0 110.173 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -38.94 -59.28 0.99 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.848 -0.533 . . . . 0.0 111.567 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.498 ' OE1' ' CG ' ' A' ' 42' ' ' TYR . 8.0 pt-20 -63.25 -43.58 97.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 0.0 110.009 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.418 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -63.3 -14.37 53.54 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.13 -25.12 20.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.959 -1.318 . . . . 0.0 109.149 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.576 HG22 HG23 ' A' ' 50' ' ' THR . 1.1 mp -79.17 -47.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.576 HG23 HG22 ' A' ' 49' ' ' ILE . 4.8 p -100.42 -6.83 25.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.438 -0.788 . . . . 0.0 110.217 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 84.75 -5.75 80.81 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.73 ' CD ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -53.26 115.31 1.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.026 -1.279 . . . . 0.0 110.884 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 57' ' ' VAL . 17.6 m-20 -90.98 156.98 43.84 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.81 -50.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.787 1.658 . . . . 0.0 111.282 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -20.84 65.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 110.329 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -89.95 -42.95 10.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.003 -1.061 . . . . 0.0 109.826 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 53' ' ' ASP . 19.3 m -76.51 -1.25 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.0 109.824 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.638 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -70.59 122.93 23.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.01 -17.47 58.15 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -79.73 135.02 36.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -1.168 . . . . 0.0 109.492 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.43 102.17 3.7 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.951 ' CZ ' HG21 ' A' ' 70' ' ' THR . 8.3 t80 -63.61 -15.0 57.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 76' ' ' TYR . 2.7 m-85 -88.38 12.68 13.54 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.62 -1.232 . . . . 0.0 110.602 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.04 -52.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 0.0 110.552 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.75 -3.88 24.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.02 -1.05 . . . . 0.0 111.064 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.622 HG11 ' NE ' ' A' ' 52' ' ' ARG . 11.8 t -128.12 -57.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.673 -1.267 . . . . 0.0 109.043 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB1' HG23 ' A' ' 70' ' ' THR . . . -109.1 105.64 57.52 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.574 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.63 -1.1 10.63 Favored 'Trans proline' 0 C--N 1.32 -0.934 0 C-N-CA 121.847 1.698 . . . . 0.0 111.557 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.8 p -104.45 -19.89 13.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.836 -1.165 . . . . 0.0 109.665 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.951 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 63.9 p -72.68 -6.11 42.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.965 -1.084 . . . . 0.0 109.915 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -88.86 53.71 2.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.985 -1.072 . . . . 0.0 109.11 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.463 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -126.98 177.49 1.99 Allowed Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.8 Cg_endo -77.94 -3.54 13.59 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.126 1.884 . . . . 0.0 111.45 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -105.8 -25.94 11.97 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.809 -1.182 . . . . 0.0 109.521 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.5 t80 -102.02 -70.39 0.75 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 9.2 t80 -72.86 -17.7 61.51 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.45 -63.45 4.28 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.9 ' CB ' HG21 ' A' ' 90' ' ' THR . 5.1 mmtt -63.52 -15.63 58.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.626 -0.926 . . . . 0.0 109.544 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.859 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.4 t80 -79.63 -39.63 31.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -79.62 -6.41 57.04 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 108.829 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.86 -40.12 9.48 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -70.55 -44.33 58.22 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.931 HG22 ' CE1' ' A' ' 118' ' ' TYR . 94.3 t -54.32 -38.68 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.952 . . . . 0.0 109.243 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.96 -16.93 34.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.444 -0.785 . . . . 0.0 110.637 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.6 -18.25 30.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.937 -1.102 . . . . 0.0 110.178 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.3 18.13 74.77 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -162.39 57.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.128 -1.219 . . . . 0.0 109.408 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.557 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -49.25 122.3 5.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.405 -0.81 . . . . 0.0 110.257 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 58.5 t30 -160.65 83.9 0.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 108.826 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.9 HG21 ' CB ' ' A' ' 78' ' ' LYS . 8.9 t -147.73 153.03 38.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 0.0 110.724 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -137.42 173.66 11.43 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.992 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 6.2 p90 179.52 153.09 0.44 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.027 -1.046 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.67 106.85 13.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.78 175.53 5.45 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.249 -0.907 . . . . 0.0 110.163 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 103' ' ' THR . 22.2 m -143.35 111.41 6.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.766 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 17.4 m-30 -79.62 96.46 6.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.182 -0.948 . . . . 0.0 109.147 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -113.44 30.06 7.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.237 -0.914 . . . . 0.0 110.052 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.578 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -79.1 159.56 27.44 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.517 ' C ' ' O ' ' A' ' 98' ' ' TYR . 2.9 pt20 -0.67 65.03 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 123.37 0.668 . . . . 0.0 112.31 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.578 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER 174.39 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.546 -0.721 . . . . 0.0 109.117 -177.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.25 171.69 5.75 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 108.971 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.97 80.75 2.89 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 122.004 1.802 . . . . 0.0 111.277 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 95' ' ' THR . 3.2 m -70.53 145.88 50.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 109.0 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.437 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -116.79 138.85 51.2 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.718 ' HA ' HG23 ' A' ' 125' ' ' VAL . 15.0 m -155.75 144.81 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.995 -1.065 . . . . 0.0 110.003 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.514 ' HG2' ' CB ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -95.61 114.33 26.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 175.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.992 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -88.04 166.99 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.285 1.041 . . . . 0.0 110.666 -176.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -161.47 101.93 1.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.903 ' HG2' HG13 ' A' ' 120' ' ' VAL . 4.5 mtm -112.5 150.04 31.81 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.267 -0.896 . . . . 0.0 110.57 -177.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.607 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.9 tttt -144.65 174.27 11.11 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.181 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.43 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 10.4 tttm -83.17 104.6 13.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.83 -1.169 . . . . 0.0 109.108 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.755 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.93 137.48 32.44 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.49 -0.756 . . . . 0.0 109.671 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.593 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.747 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.463 0.649 . . . . 0.0 109.984 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.931 ' CE1' HG22 ' A' ' 83' ' ' VAL . 25.4 m-85 -150.66 104.48 3.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.755 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 11.3 p-90 -106.08 141.5 37.34 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 118.553 -1.259 . . . . 0.0 112.011 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.903 HG13 ' HG2' ' A' ' 109' ' ' MET . 57.8 t -116.85 117.77 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.665 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 16.1 m-30 -102.18 118.83 37.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.1 -1.0 . . . . 0.0 109.091 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.766 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -101.22 129.22 52.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.836 -1.165 . . . . 0.0 110.09 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.514 ' CE ' ' CD2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -102.93 123.55 46.77 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HA ' HG12 ' A' ' 105' ' ' VAL . 12.4 ttt180 -77.57 121.14 23.51 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.109 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.718 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.236 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.022 HG22 HD11 ' A' ' 15' ' ' LEU . 3.8 mm -63.57 -63.1 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -37.85 -33.58 0.09 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.949 -0.469 . . . . 0.0 111.851 -178.012 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -81.06 -44.74 17.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.876 -1.14 . . . . 0.0 108.339 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -70.04 -9.07 54.11 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.642 -0.661 . . . . 0.0 109.724 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.022 HD11 HG22 ' A' ' 11' ' ' ILE . 21.1 mt -97.44 -21.88 16.9 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.954 -1.091 . . . . 0.0 109.197 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 0.0 109.945 -179.747 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.751 ' OD1' ' HB3' ' A' ' 44' ' ' ALA . 55.5 t0 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.838 0.352 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.22 32.16 7.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 29.3 mt -105.3 151.46 24.11 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.459 -1.024 . . . . 0.0 108.689 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.24 24.7 4.8 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.589 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -160.16 122.14 3.24 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -179.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.515 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -58.8 154.55 27.35 Favored Glycine 0 C--N 1.288 -2.099 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.874 -177.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -127.78 85.15 2.32 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.621 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.1 pp -86.29 144.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.885 0.85 . . . . 0.0 110.724 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.53 ' HB3' HD12 ' A' ' 40' ' ' LEU . 15.3 mm100 -114.24 159.52 20.06 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 37' ' ' GLY . 72.3 mt -151.82 149.7 29.3 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.9 -1.125 . . . . 0.0 109.71 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.504 ' CB ' HD21 ' A' ' 40' ' ' LEU . 41.5 p-10 -131.99 123.29 27.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 110.476 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 42.88 -79.36 0.0 OUTLIER Glycine 0 N--CA 1.498 2.798 0 C-N-CA 124.398 0.999 . . . . 0.0 113.053 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -69.52 -5.96 27.62 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.736 -0.861 . . . . 0.0 110.358 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.83 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 87.4 24.33 36.96 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 36' ' ' ASP . 2.1 m120 -78.63 133.09 37.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.137 -1.214 . . . . 0.0 108.102 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.54 HD11 ' HB ' ' A' ' 31' ' ' ILE . 1.7 tp -56.77 136.38 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 111.711 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 33' ' ' LEU . 1.3 mt -110.67 -24.41 10.52 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' NE2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -169.74 113.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.399 -0.813 . . . . 0.0 109.422 179.331 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.619 ' CD1' HG22 ' A' ' 31' ' ' ILE . 19.1 t80 -98.71 -67.68 0.84 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.164 -0.96 . . . . 0.0 111.361 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 5.6 p-10 105.86 177.43 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 0 C-N-CA 124.021 0.929 . . . . 0.0 108.863 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.751 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -97.29 -25.17 15.35 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.845 -1.159 . . . . 0.0 113.171 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.56 -64.31 0.85 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.331 -1.481 . . . . 0.0 110.601 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.515 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.5 pt-20 -57.88 -54.4 47.37 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.508 0.671 . . . . 0.0 109.935 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.427 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -57.93 -14.86 18.17 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -76.0 -38.88 56.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.766 -1.432 . . . . 0.0 108.698 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 50' ' ' THR . 1.0 OUTLIER -82.78 -56.72 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.381 -0.824 . . . . 0.0 109.27 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.525 ' N ' HG22 ' A' ' 49' ' ' ILE . 30.0 p -75.24 -24.42 57.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.365 -0.834 . . . . 0.0 109.957 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 95.6 -15.74 62.59 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -50.07 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.352 -1.087 . . . . 0.0 109.841 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 57' ' ' VAL . 15.9 m-20 -64.65 160.87 49.5 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 108.699 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.35 -58.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.877 1.718 . . . . 0.0 110.807 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.618 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -62.62 -19.55 63.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.176 -179.445 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -88.5 -41.63 12.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 109.828 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 53' ' ' ASP . 23.4 m -79.59 0.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.822 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -71.0 121.74 21.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.053 -1.029 . . . . 0.0 108.699 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.49 -15.47 61.31 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -79.3 137.07 37.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.239 . . . . 0.0 109.459 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.95 103.99 6.28 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.661 ' CZ ' HG21 ' A' ' 70' ' ' THR . 26.1 t80 -60.17 -16.63 34.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -0.885 . . . . 0.0 111.089 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 2.4 m-85 -91.32 15.09 12.75 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.023 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -176.66 -52.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.008 -1.057 . . . . 0.0 110.419 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.15 -6.7 41.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 110.926 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.581 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 11.0 t -126.07 -60.43 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 O-C-N 120.636 -1.29 . . . . 0.0 109.07 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -108.87 103.96 53.4 Favored Pre-proline 0 C--N 1.293 -1.874 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.267 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.84 7.26 3.27 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.907 1.738 . . . . 0.0 111.777 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.6 p -108.58 -20.4 13.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.819 -1.176 . . . . 0.0 109.869 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.661 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 30.2 p -77.42 -2.63 36.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.952 . . . . 0.0 110.611 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -88.53 55.2 3.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.125 -0.985 . . . . 0.0 109.156 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.445 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -124.84 175.25 3.12 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.46 -0.775 . . . . 0.0 109.124 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.9 Cg_endo -77.56 -2.19 12.36 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 122.265 1.977 . . . . 0.0 111.288 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 59.5 mt-10 -107.96 -25.72 11.04 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.939 -1.101 . . . . 0.0 109.509 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.565 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 2.1 t80 -102.13 -70.53 0.75 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 18.1 t80 -70.59 -17.37 62.9 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.12 -61.2 6.6 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.663 ' CB ' HG21 ' A' ' 90' ' ' THR . 1.2 mmtp -63.38 -15.92 58.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.999 . . . . 0.0 109.487 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.9 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.8 t80 -79.63 -38.17 34.42 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -8.72 58.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 77' ' ' GLY . 1.3 mt-10 -95.52 -40.12 9.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.83 -41.05 89.3 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.4 t -60.0 -40.81 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.662 -0.905 . . . . 0.0 109.497 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.18 -5.06 58.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.284 -0.885 . . . . 0.0 110.785 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.5 p -100.19 -19.06 16.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.836 -1.165 . . . . 0.0 109.945 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.03 16.47 78.79 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -155.62 57.97 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -1.22 . . . . 0.0 109.335 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.461 HD13 ' CD1' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -56.51 114.17 1.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.823 . . . . 0.0 109.733 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -161.25 83.79 0.64 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.432 -0.792 . . . . 0.0 109.033 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.663 HG21 ' CB ' ' A' ' 78' ' ' LYS . 5.0 t -139.35 173.8 11.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.073 -1.017 . . . . 0.0 109.952 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -157.9 171.55 20.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.928 ' CE1' HG21 ' A' ' 107' ' ' VAL . 8.9 p90 178.7 161.01 0.66 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.863 -1.148 . . . . 0.0 110.506 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -88.3 110.12 20.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.45 178.56 4.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.109 -0.995 . . . . 0.0 110.073 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 84.4 m -141.85 107.99 5.22 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.801 ' CE2' HG21 ' A' ' 122' ' ' VAL . 16.5 m-30 -86.53 121.31 28.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.176 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -154.21 48.86 0.62 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.544 ' O ' ' C ' ' A' ' 99' ' ' GLN . 7.5 p90 -78.9 148.07 32.86 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 98' ' ' TYR . 4.6 tt0 2.09 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 CA-C-O 121.851 0.834 . . . . 0.0 111.589 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 98' ' ' TYR . 6.0 ttp 178.29 -149.07 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.28 169.47 8.59 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 0.0 109.233 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.85 155.21 30.49 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 122.16 1.907 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.588 ' O ' HG22 ' A' ' 103' ' ' THR . 1.6 m -149.17 94.79 2.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 109.289 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.43 ' C ' HG13 ' A' ' 105' ' ' VAL . 1.2 ptpp? -69.77 142.57 53.19 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.994 -1.066 . . . . 0.0 108.168 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.757 ' HA ' HG23 ' A' ' 125' ' ' VAL . 10.9 m -156.2 142.17 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.908 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -95.03 111.6 23.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 175.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.928 HG21 ' CE1' ' A' ' 92' ' ' PHE . 1.4 m -86.29 162.35 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.818 0.818 . . . . 0.0 111.893 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -160.55 102.0 1.35 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.885 ' HG2' HG13 ' A' ' 120' ' ' VAL . 3.2 mtm -112.66 148.08 35.4 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.56 -0.713 . . . . 0.0 109.435 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.63 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.4 tttm -138.18 -165.47 1.81 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.68 -1.263 . . . . 0.0 108.985 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 12.9 tttt -107.51 98.2 7.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.03 -1.044 . . . . 0.0 109.0 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.923 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -50.74 130.81 25.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 109.435 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.041 -1.037 . . . . 0.0 109.777 -179.803 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.502 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.037 0 CA-C-O 121.138 0.494 . . . . 0.0 110.862 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.787 ' CE1' HG22 ' A' ' 83' ' ' VAL . 5.4 m-85 -138.58 130.32 27.85 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.136 -0.978 . . . . 0.0 109.358 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.923 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 12.1 p-90 -125.92 138.15 53.76 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.677 -1.264 . . . . 0.0 111.883 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.885 HG13 ' HG2' ' A' ' 109' ' ' MET . 61.6 t -113.74 115.87 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.071 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.641 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 15.8 m-30 -100.46 126.91 46.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.178 -0.951 . . . . 0.0 108.84 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.801 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.5 t -109.49 122.71 64.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.937 -1.102 . . . . 0.0 110.344 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.589 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -99.22 124.71 44.5 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.438 ' NH1' ' CG1' ' A' ' 49' ' ' ILE . 23.3 ttt180 -74.4 121.89 22.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.64 -1.224 . . . . 0.0 109.125 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.341 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.806 HG22 HD11 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -80.9 -64.84 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.45 0 O-C-N 121.308 -0.87 . . . . 0.0 111.332 -177.155 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -41.78 -26.66 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.174 -0.954 . . . . 0.0 111.457 -177.369 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' ILE . 2.1 t-20 -89.67 -39.27 13.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.046 -1.034 . . . . 0.0 109.516 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -65.88 -59.63 3.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.806 HD11 HG22 ' A' ' 11' ' ' ILE . 11.6 mt -49.76 -23.75 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.754 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.665 0 O-C-N 120.849 -1.157 . . . . 0.0 109.31 -179.783 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.898 0.38 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.72 28.75 14.57 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.951 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.0 mt -97.02 -172.68 2.5 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.691 -1.476 . . . . 0.0 109.544 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.52 -0.36 22.19 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.717 0.77 . . . . 0.0 109.288 179.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CZ ' HG12 ' A' ' 11' ' ' ILE . 46.0 p90 -141.72 133.53 27.24 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.158 -0.964 . . . . 0.0 109.218 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.555 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -59.1 135.95 51.48 Favored Glycine 0 C--N 1.292 -1.87 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -116.23 113.87 23.62 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.893 -1.357 . . . . 0.0 107.781 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.687 HG22 ' CD1' ' A' ' 42' ' ' TYR . 1.4 pp -118.84 160.14 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-O 121.851 0.834 . . . . 0.0 110.303 -178.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.908 ' HB3' HD12 ' A' ' 40' ' ' LEU . 34.2 mt-30 -126.96 168.09 15.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.886 HD22 ' O ' ' A' ' 37' ' ' GLY . 83.0 mt -152.68 146.79 25.43 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.91 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' ASP . 18.4 m-20 -121.26 123.65 42.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 0.0 110.023 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 37.16 -76.9 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 0 C-N-CA 124.695 1.14 . . . . 0.0 113.647 178.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ASP . 19.7 t0 -69.33 -3.6 14.76 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.658 -0.907 . . . . 0.0 111.011 -178.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.886 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 90.21 14.61 58.67 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 19.8 m-80 -70.03 135.59 49.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.931 -1.335 . . . . 0.0 108.425 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.694 HD12 HD21 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -64.78 140.1 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 122.032 0.92 . . . . 0.0 111.219 -178.328 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.908 HD12 ' HB3' ' A' ' 32' ' ' GLN . 1.8 mt -112.37 -26.06 8.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -163.06 159.4 23.22 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.687 ' CD1' HG22 ' A' ' 31' ' ' ILE . 23.4 t80 -144.75 -70.62 0.28 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.673 -1.267 . . . . 0.0 110.819 -178.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 7.6 p-10 107.09 178.47 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 0 C-N-CA 123.876 0.87 . . . . 0.0 109.098 -179.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.65 -26.03 15.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.99 -1.069 . . . . 0.0 112.849 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -51.06 -64.09 0.92 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.356 -1.465 . . . . 0.0 110.639 -178.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.555 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 2.0 pt-20 -58.84 -52.91 63.72 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.0 110.016 -179.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.2 -15.79 24.1 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.048 -178.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -77.62 -36.14 51.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.717 -1.46 . . . . 0.0 108.746 179.655 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.52 HG22 HG23 ' A' ' 50' ' ' THR . 0.2 OUTLIER -85.94 -55.97 5.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.426 -0.797 . . . . 0.0 109.235 179.76 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 49' ' ' ILE . 29.9 p -78.21 -22.27 48.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.459 -0.776 . . . . 0.0 110.438 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 94.52 -18.4 57.13 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.642 ' NE ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -45.63 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.493 -1.004 . . . . 0.0 110.254 179.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.764 ' O ' HG22 ' A' ' 57' ' ' VAL . 95.9 m-20 -67.71 157.83 84.98 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.2 -40.11 0.39 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.739 1.626 . . . . 0.0 110.4 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -25.77 51.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.87 . . . . 0.0 110.126 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 7.6 tp60 -83.8 -44.88 13.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.108 -0.995 . . . . 0.0 109.953 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 53' ' ' ASP . 24.6 m -69.85 -7.84 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.138 -0.976 . . . . 0.0 109.814 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.598 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -68.8 121.95 19.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 121.053 -1.029 . . . . 0.0 108.349 179.831 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.48 -15.38 58.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 56' ' ' GLN . 67.6 mmtt -79.9 144.06 33.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.17 -1.194 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.71 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.9 OUTLIER -81.51 115.2 20.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.293 -0.879 . . . . 0.0 108.822 179.401 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.754 ' HD2' HD11 ' A' ' 33' ' ' LEU . 1.7 t80 -61.08 -34.05 74.31 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.029 -1.044 . . . . 0.0 110.025 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 52.2 m-85 -97.18 13.34 29.65 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 118.472 -1.291 . . . . 0.0 111.96 -177.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -139.72 -53.31 0.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.646 -1.284 . . . . 0.0 111.115 -179.719 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.24 16.08 21.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.832 -1.167 . . . . 0.0 112.003 -178.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 61' ' ' ASN . 15.5 t -125.43 -53.1 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.269 -1.519 . . . . 0.0 109.468 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB3' ' OG1' ' A' ' 70' ' ' THR . . . -117.88 103.03 50.79 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.628 -177.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.52 1.37 8.05 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 121.822 1.681 . . . . 0.0 110.577 179.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 p -111.13 -20.69 12.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.975 -1.078 . . . . 0.0 109.802 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.672 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 67.2 p -82.58 1.6 37.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.981 . . . . 0.0 110.223 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -88.62 61.47 6.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.945 -1.097 . . . . 0.0 109.259 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.461 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -136.01 177.3 2.27 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.188 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.5 Cg_endo -79.08 1.46 9.15 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.295 1.997 . . . . 0.0 111.143 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 4.3 mm-40 -107.83 -28.1 9.85 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 120.879 -1.138 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.406 ' HZ ' HG11 ' A' ' 120' ' ' VAL . 1.8 t80 -102.46 -69.82 0.77 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 15.5 t80 -72.06 -16.7 62.04 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.037 -1.039 . . . . 0.0 108.206 177.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.81 -60.94 6.65 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.624 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -63.49 -16.29 60.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.956 . . . . 0.0 109.414 -179.499 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.876 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.8 t80 -80.75 -37.9 29.61 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -8.23 57.25 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 108.442 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.91 -40.6 9.22 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -69.19 -39.61 82.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 79' ' ' PHE . 62.7 t -63.3 -37.19 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.69 -0.888 . . . . 0.0 109.583 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.87 -3.47 55.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 110.83 -179.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.3 t -106.17 -18.67 13.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.79 -1.194 . . . . 0.0 110.124 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.18 19.49 72.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -157.06 55.93 0.52 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -1.222 . . . . 0.0 109.641 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 1.7 tt -54.61 120.34 6.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.801 . . . . 0.0 110.047 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 30.9 p-10 -160.47 82.49 0.68 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 78' ' ' LYS . 7.3 t -128.34 162.4 27.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 110.44 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -154.52 149.06 26.31 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.032 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 12.7 p90 -172.83 149.17 1.93 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.431 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -79.89 107.3 12.57 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.68 172.87 6.57 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.1 -1.0 . . . . 0.0 110.039 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m -143.12 109.58 5.39 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.527 ' CE2' HG21 ' A' ' 122' ' ' VAL . 21.3 m-85 -80.71 115.83 20.42 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -128.51 41.69 3.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.591 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -78.07 78.89 4.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.807 -0.558 . . . . 0.0 110.126 -179.721 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.568 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER 53.74 37.8 27.05 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.63 -0.668 . . . . 0.0 110.233 -179.512 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -150.08 -179.12 6.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.018 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.437 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 5.2 t -56.54 149.28 40.91 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 108.716 179.159 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.437 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 31.4 Cg_endo -72.91 86.21 1.1 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.55 1.5 . . . . 0.0 110.417 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.438 HG22 HG13 ' A' ' 105' ' ' VAL . 16.0 m -75.9 142.55 42.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.476 -0.765 . . . . 0.0 109.473 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -115.32 136.34 53.19 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.803 ' HA ' HG23 ' A' ' 125' ' ' VAL . 26.2 m -151.87 144.51 16.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 109.812 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.75 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -94.57 109.75 21.63 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 175.789 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.032 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -80.85 162.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 122.339 1.066 . . . . 0.0 110.963 -175.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -161.48 101.05 1.19 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.799 ' HG2' HG13 ' A' ' 120' ' ' VAL . 3.4 mtm -113.01 146.19 39.52 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.393 -0.817 . . . . 0.0 109.316 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.8 tttt -141.84 178.94 7.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.459 -1.401 . . . . 0.0 109.785 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.447 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -86.01 102.89 14.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.916 -1.115 . . . . 0.0 109.15 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.718 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -51.59 132.61 30.54 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.455 -0.778 . . . . 0.0 109.812 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.404 ' H ' HD12 ' A' ' 113' ' ' LEU . 1.7 mp . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.501 ' N ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 120.733 0.302 . . . . 0.0 111.66 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.846 ' OH ' HG13 ' A' ' 83' ' ' VAL . 4.7 m-85 -143.37 116.88 9.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.712 -1.242 . . . . 0.0 110.197 -177.482 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.718 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.1 p-90 -113.66 142.11 46.41 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.863 -1.148 . . . . 0.0 111.665 179.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.799 HG13 ' HG2' ' A' ' 109' ' ' MET . 63.5 t -113.53 125.94 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.716 ' HE2' HD13 ' A' ' 11' ' ' ILE . 20.0 m-30 -111.74 117.65 33.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.019 -1.05 . . . . 0.0 109.574 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -100.19 114.41 38.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -97.76 119.92 37.21 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.099 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.541 ' HA ' HG12 ' A' ' 105' ' ' VAL . 6.8 ttt-85 -66.97 124.82 24.07 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.983 -1.087 . . . . 0.0 109.61 -178.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.803 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.005 . . . . 0.0 109.335 -179.217 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.04 HG22 HD11 ' A' ' 15' ' ' LEU . 5.1 mm -73.93 -65.58 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.548 0 O-C-N 121.424 -0.797 . . . . 0.0 109.759 -178.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 13' ' ' ASN . 15.7 pt-20 -38.84 -35.92 0.23 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.719 -0.613 . . . . 0.0 111.706 -178.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.1 m120 -81.6 -41.96 20.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.921 -1.112 . . . . 0.0 108.341 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 14' ' ' THR . 2.9 m -72.1 -7.18 47.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.619 -0.676 . . . . 0.0 109.49 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.04 HD11 HG22 ' A' ' 11' ' ' ILE . 39.8 mt -96.83 0.41 49.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.905 -1.122 . . . . 0.0 109.01 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 O-C-N 121.284 -0.885 . . . . 0.0 109.106 179.737 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.39 16.31 58.06 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.941 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 4.0 mt -67.86 168.3 11.87 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.953 -1.322 . . . . 0.0 108.448 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.43 23.0 8.07 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.941 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 3.3 p90 -156.51 -171.1 3.56 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -118.17 154.74 16.43 Favored Glycine 0 C--N 1.291 -1.932 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 178.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -122.88 107.26 11.67 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.32 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.592 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.1 pp -114.93 142.21 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.303 -177.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.829 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -112.16 165.96 11.69 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.873 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 37' ' ' GLY . 97.1 mt -152.27 154.66 36.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.866 -1.147 . . . . 0.0 109.681 -179.129 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.554 ' HB2' HD21 ' A' ' 40' ' ' LEU . 5.5 m-20 -129.08 125.74 37.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 110.178 178.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.43 -77.93 0.0 OUTLIER Glycine 0 N--CA 1.5 2.901 0 C-N-CA 124.496 1.046 . . . . 0.0 113.818 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 34' ' ' ASP . 73.4 m-20 -72.65 -1.55 16.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.717 -0.872 . . . . 0.0 111.443 -177.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.665 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 89.32 18.65 52.44 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 53.1 m-80 -72.04 134.99 46.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -1.223 . . . . 0.0 107.772 179.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -64.8 138.44 23.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 O-C-N 121.28 -0.887 . . . . 0.0 111.259 -178.067 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.829 HD12 ' HB3' ' A' ' 32' ' ' GLN . 5.4 mt -109.0 -28.39 9.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -163.29 160.28 23.62 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.897 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.568 ' CD1' HG22 ' A' ' 31' ' ' ILE . 14.6 t80 -142.1 -71.96 0.33 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.715 -1.241 . . . . 0.0 110.774 -178.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.3 p-10 109.1 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.785 0 C-N-CA 123.923 0.889 . . . . 0.0 108.876 -179.166 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 45' ' ' ALA . . . -96.99 -52.5 3.84 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.215 -0.928 . . . . 0.0 113.438 -177.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 44' ' ' ALA . . . -34.69 -62.02 0.37 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.418 -0.801 . . . . 0.0 112.96 -177.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.9 pt-20 -60.13 -49.4 77.79 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.158 -0.964 . . . . 0.0 110.35 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.36 -13.58 44.39 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -81.53 -36.17 29.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.835 -1.391 . . . . 0.0 109.82 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -84.14 -47.32 17.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.124 -0.985 . . . . 0.0 109.45 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.546 ' HA ' ' HE1' ' A' ' 100' ' ' MET . 2.7 p -89.33 -24.9 21.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.271 -0.893 . . . . 0.0 110.203 -179.079 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.49 -3.47 63.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.931 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -55.68 105.15 0.16 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.032 -1.276 . . . . 0.0 109.941 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -72.98 154.19 90.86 Favored Pre-proline 0 C--N 1.298 -1.653 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.801 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.02 -53.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.742 1.628 . . . . 0.0 110.528 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -20.4 63.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.856 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.403 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 1.5 tt0 -85.33 -41.72 15.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.018 -1.051 . . . . 0.0 109.837 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 53' ' ' ASP . 26.7 m -76.48 -2.31 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.068 -1.02 . . . . 0.0 109.922 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.654 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -70.19 122.42 21.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.025 -1.047 . . . . 0.0 108.429 179.845 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.04 -13.82 62.21 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 56' ' ' GLN . 11.8 mmtp -80.12 137.54 36.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.267 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -78.05 95.93 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.142 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.722 ' CZ ' HG21 ' A' ' 70' ' ' THR . 14.1 t80 -55.82 -24.65 37.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 0.0 109.932 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.523 ' CE2' HD13 ' A' ' 33' ' ' LEU . 12.3 m-85 -82.09 -32.16 30.38 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.746 -177.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 48.59 1.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.055 . . . . 0.0 109.116 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 4.7 t0 -163.54 -36.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.549 -0.719 . . . . 0.0 109.877 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.931 HG11 ' HD3' ' A' ' 52' ' ' ARG . 12.7 t -103.09 -56.8 4.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 122.78 1.276 . . . . 0.0 108.388 179.482 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.418 ' HB3' ' OG1' ' A' ' 70' ' ' THR . . . -103.66 101.46 24.33 Favored Pre-proline 0 C--N 1.29 -1.983 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.181 -178.11 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -76.13 3.13 6.45 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.719 1.613 . . . . 0.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 p -106.77 -21.58 12.99 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.131 -0.981 . . . . 0.0 109.841 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.722 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 7.2 p -81.89 2.54 29.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 110.308 -178.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -95.94 57.1 1.77 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.954 -1.091 . . . . 0.0 108.905 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.458 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -139.5 175.55 3.17 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.412 -0.805 . . . . 0.0 109.507 -179.599 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.7 Cg_endo -77.15 77.29 3.85 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 122.505 2.137 . . . . 0.0 110.369 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 174.28 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE1' ' HE3' ' A' ' 109' ' ' MET . 1.4 t80 -103.3 -68.73 0.82 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.468 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 16.5 t80 -74.83 -19.22 60.27 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.42 -62.26 5.77 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.638 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -62.19 -18.28 60.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 109.541 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.813 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.1 t80 -76.38 -38.23 56.03 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -5.61 52.89 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 108.757 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 1.5 mm-40 -95.41 -42.02 8.69 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.41 -40.64 68.67 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 178.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.872 HG22 ' CE1' ' A' ' 118' ' ' TYR . 100.0 t -61.39 -40.27 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.746 -0.855 . . . . 0.0 109.948 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.68 -22.08 40.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.216 -0.927 . . . . 0.0 111.059 -178.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -12.08 28.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.817 -1.177 . . . . 0.0 110.526 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.85 14.58 80.69 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -150.62 100.82 2.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -1.171 . . . . 0.0 108.606 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -97.74 117.58 32.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 110.109 -179.161 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.58 75.53 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.506 -0.746 . . . . 0.0 109.118 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 78' ' ' LYS . 8.8 t -116.21 131.55 56.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.028 -1.045 . . . . 0.0 110.497 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.6 ttt -118.47 126.17 51.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.621 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 2.0 p90 -152.39 -172.5 4.25 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.134 -0.979 . . . . 0.0 110.056 -178.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 22.6 pt-20 -121.87 117.42 26.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.42 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 13.0 t80 -126.79 163.65 23.1 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 109.422 -179.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 95.2 m -131.77 119.99 22.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.576 ' CE2' HG21 ' A' ' 105' ' ' VAL . 6.5 m-85 -92.01 125.0 36.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.431 -0.793 . . . . 0.0 109.035 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -144.41 46.77 1.4 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 14.3 p90 -77.98 141.58 38.86 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.527 ' C ' ' O ' ' A' ' 98' ' ' TYR . 15.0 pt20 3.67 64.73 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.093 0 CA-C-O 121.432 0.634 . . . . 0.0 112.161 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.701 ' SD ' HG22 ' A' ' 101' ' ' THR . 0.6 OUTLIER 179.78 175.52 0.76 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.557 -0.714 . . . . 0.0 109.118 -177.787 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.701 HG22 ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -57.88 151.43 43.62 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.96 . . . . 0.0 109.032 179.348 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 32.9 Cg_endo -74.28 145.08 33.96 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 121.945 1.763 . . . . 0.0 109.972 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.502 HG22 HG13 ' A' ' 105' ' ' VAL . 1.2 m -142.32 111.68 6.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.106 -0.996 . . . . 0.0 110.151 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.434 ' C ' HG13 ' A' ' 105' ' ' VAL . 25.3 tttm -82.28 151.67 26.67 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.769 HG23 HG13 ' A' ' 107' ' ' VAL . 28.2 m -153.98 144.09 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 118.526 -1.269 . . . . 0.0 112.09 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -80.75 123.6 28.35 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 102.23 -3.248 . . . . 0.0 102.23 174.675 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.769 HG13 HG23 ' A' ' 105' ' ' VAL . 31.4 m -118.37 152.36 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 121.058 1.754 . . . . 0.0 111.845 -176.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -143.1 104.64 4.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.218 178.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.655 ' HG2' HG13 ' A' ' 120' ' ' VAL . 14.2 mtp -99.79 121.18 40.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.891 -1.131 . . . . 0.0 108.913 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.573 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 2.3 tttt -125.79 -165.8 1.47 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 117.625 -1.63 . . . . 0.0 110.309 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -113.11 98.59 7.24 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.138 -0.976 . . . . 0.0 109.167 -179.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.931 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -54.56 135.18 46.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.682 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.723 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.504 2.248 0 CA-C-O 121.281 0.563 . . . . 0.0 110.795 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.872 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.6 m-85 -125.4 129.35 49.7 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.235 -0.916 . . . . 0.0 110.179 -177.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.931 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 22.7 p-90 -129.17 163.05 26.39 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.343 178.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.655 HG13 ' HG2' ' A' ' 109' ' ' MET . 50.2 t -144.23 113.94 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.688 -0.632 . . . . 0.0 109.422 -178.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.672 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.4 m-30 -95.66 140.79 29.96 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.717 HG22 HG12 ' A' ' 107' ' ' VAL . 1.9 t -117.4 109.53 27.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 118.951 -1.099 . . . . 0.0 110.046 -179.213 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 4.7 tptp -84.53 146.24 27.67 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.04 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -96.18 129.88 43.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.702 -1.249 . . . . 0.0 110.181 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.104 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.074 HG22 HD11 ' A' ' 15' ' ' LEU . 3.7 mm -72.89 -66.86 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 O-C-N 121.488 -0.757 . . . . 0.0 110.444 -178.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HA ' HD12 ' A' ' 15' ' ' LEU . 18.3 pt-20 -36.46 -49.68 0.74 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.961 -0.462 . . . . 0.0 112.037 -177.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.63 -44.37 82.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.788 -1.195 . . . . 0.0 108.614 179.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 14' ' ' THR . 3.4 m -71.24 -8.43 53.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 109.948 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.074 HD11 HG22 ' A' ' 11' ' ' ILE . 42.6 mt -97.79 -24.04 15.62 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.97 -1.081 . . . . 0.0 109.371 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.83 . . . . 0.0 109.576 -179.879 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 120.654 0.264 . . . . 0.0 111.112 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.32 24.35 30.75 Favored Glycine 0 N--CA 1.492 2.429 0 O-C-N 120.525 -1.359 . . . . 0.0 111.041 -178.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.521 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -78.7 -172.28 2.91 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.766 -1.432 . . . . 0.0 108.349 179.168 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.74 20.54 16.08 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.59 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -159.36 137.04 10.06 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.143 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -71.66 139.73 29.28 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.405 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -116.87 89.75 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.623 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.4 pp -91.98 148.97 4.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.449 -0.782 . . . . 0.0 110.654 -177.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.592 ' OE1' HD13 ' A' ' 15' ' ' LEU . 17.5 mm100 -116.86 170.51 8.56 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.527 HD22 ' C ' ' A' ' 37' ' ' GLY . 73.4 mt -152.32 145.63 24.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.876 -1.14 . . . . 0.0 110.187 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' ASP . 8.8 m-20 -115.7 134.67 54.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.257 178.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -11.49 72.39 0.0 OUTLIER Glycine 0 N--CA 1.511 3.679 0 C-N-CA 124.804 1.192 . . . . 0.0 113.294 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER 161.75 -23.33 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.565 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.41 17.9 22.95 Favored Glycine 0 N--CA 1.479 1.551 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.033 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 28.7 m120 -85.25 131.78 34.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.142 -1.211 . . . . 0.0 108.769 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.569 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -65.99 138.81 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.016 -1.053 . . . . 0.0 111.404 -178.37 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.451 HD11 ' OD1' ' A' ' 34' ' ' ASP . 3.0 mt -103.74 -29.48 11.01 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -161.94 142.96 10.74 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.089 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.605 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 15.9 t80 -109.28 -77.24 0.6 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.338 -1.476 . . . . 0.0 111.504 -178.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 39.9 t-20 130.49 142.24 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.857 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -178.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -73.24 -49.09 29.75 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.581 -0.699 . . . . 0.0 111.125 -178.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.76 -55.32 3.69 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.35 -0.844 . . . . 0.0 111.619 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.489 ' OE1' ' CG ' ' A' ' 42' ' ' TYR . 14.0 pt-20 -63.75 -44.55 93.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.143 -0.973 . . . . 0.0 110.233 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -63.24 -13.2 48.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.05 -36.72 16.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.328 . . . . 0.0 109.658 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.71 -29.35 16.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 O-C-N 121.043 -1.036 . . . . 0.0 110.249 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.517 ' OG1' ' HD2' ' A' ' 52' ' ' ARG . 1.6 p -114.09 -24.58 8.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 109.504 -178.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 100.55 -2.04 55.89 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.903 ' NE ' HG12 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -71.88 85.83 0.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -1.219 . . . . 0.0 109.727 -179.74 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.726 ' O ' HG22 ' A' ' 57' ' ' VAL . 38.9 m-20 -60.48 164.42 7.05 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.148 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.49 -50.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.117 1.878 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.753 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -67.85 -29.4 68.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.215 -0.928 . . . . 0.0 109.906 -179.555 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -78.78 -43.12 26.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 0.0 109.885 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 53' ' ' ASP . 18.5 m -76.35 -1.81 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.038 -1.038 . . . . 0.0 109.903 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -70.89 123.58 25.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.016 -1.053 . . . . 0.0 108.446 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.95 -18.2 56.49 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 -178.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -79.25 138.45 37.79 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.184 -1.186 . . . . 0.0 108.992 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.22 104.33 6.69 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.469 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 85.6 t80 -56.08 -20.62 17.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.371 -0.831 . . . . 0.0 110.224 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 7.7 m-85 -100.04 -19.69 16.41 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.083 -1.01 . . . . 0.0 110.401 -178.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.2 46.99 1.42 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.116 -0.99 . . . . 0.0 109.449 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.6 -28.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 111.024 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.903 HG12 ' NE ' ' A' ' 52' ' ' ARG . 5.1 t -108.48 -58.34 3.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HA ' ' NH2' ' A' ' 52' ' ' ARG . . . -112.09 100.98 50.87 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.485 -179.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.74 1.05 8.5 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.056 1.837 . . . . 0.0 111.336 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.1 p -98.95 -22.88 15.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 109.418 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 31.1 p -76.14 -2.21 29.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.408 -0.808 . . . . 0.0 110.269 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -88.63 56.42 3.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.975 . . . . 0.0 109.255 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -129.04 177.18 2.28 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.413 -0.805 . . . . 0.0 108.941 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -78.04 2.01 8.37 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.219 1.946 . . . . 0.0 111.561 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.4 mt-10 -111.28 -29.52 7.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.86 -1.15 . . . . 0.0 109.319 179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CE1' ' SD ' ' A' ' 109' ' ' MET . 1.8 t80 -100.29 -69.49 0.77 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.55 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 21.2 t80 -71.22 -15.57 62.46 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -63.22 -61.56 6.24 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 178.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.769 ' HB2' HG21 ' A' ' 90' ' ' THR . 9.4 mmtt -62.8 -16.49 58.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.607 -0.937 . . . . 0.0 109.287 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.944 ' HA ' HD11 ' A' ' 88' ' ' LEU . 10.4 t80 -78.72 -37.89 40.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -78.52 -7.41 57.46 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.8 mm-40 -95.78 -40.76 9.19 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -69.92 -40.04 74.46 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 178.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.978 HG22 ' CE1' ' A' ' 118' ' ' TYR . 58.2 t -64.71 -39.78 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.646 -0.914 . . . . 0.0 109.656 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.74 -8.7 55.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.334 -0.854 . . . . 0.0 110.829 -178.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 t -102.19 -16.98 16.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.829 -1.169 . . . . 0.0 110.06 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.47 22.48 64.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -163.75 72.11 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -1.104 . . . . 0.0 109.316 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.944 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -72.92 118.35 15.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 109.81 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -160.62 86.79 0.73 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.523 -0.736 . . . . 0.0 109.099 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.769 HG21 ' HB2' ' A' ' 78' ' ' LYS . 3.3 t -137.25 161.52 36.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.081 -1.012 . . . . 0.0 109.786 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -149.53 144.04 26.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.415 -0.803 . . . . 0.0 108.982 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.058 ' CE2' HG21 ' A' ' 107' ' ' VAL . 10.8 p90 -156.33 -173.96 4.73 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 109.839 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.26 114.19 26.36 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.59 -176.28 2.89 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.147 -0.971 . . . . 0.0 110.804 -178.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.0 m -154.38 109.77 3.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.857 ' CE2' HG21 ' A' ' 122' ' ' VAL . 7.9 m-30 -85.71 126.6 34.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.643 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -154.3 51.06 0.65 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.738 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.603 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 9.9 p90 -77.91 136.42 38.02 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.53 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.7 pt20 5.25 62.95 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.186 0 CA-C-O 121.421 0.629 . . . . 0.0 112.264 -178.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -175.22 -154.43 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.358 -0.839 . . . . 0.0 109.252 -177.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.15 159.74 61.69 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.46 157.27 28.94 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.28 1.987 . . . . 0.0 110.521 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.587 ' O ' HG22 ' A' ' 103' ' ' THR . 5.4 m -151.13 85.92 1.35 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.782 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -69.83 139.18 53.1 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.931 ' HA ' HG23 ' A' ' 125' ' ' VAL . 14.8 m -151.77 148.24 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.897 -1.127 . . . . 0.0 111.404 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.807 ' CD ' HG22 ' A' ' 125' ' ' VAL . 2.8 mptp? -79.36 120.16 23.4 Favored 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 103.22 -2.881 . . . . 0.0 103.22 174.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.058 HG21 ' CE2' ' A' ' 92' ' ' PHE . 34.5 m -104.19 150.91 7.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 117.863 -1.535 . . . . 0.0 110.523 -177.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -149.49 106.91 3.62 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.909 ' HG2' HG13 ' A' ' 120' ' ' VAL . 12.8 mtm -108.85 134.55 51.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.057 -1.027 . . . . 0.0 110.369 -178.259 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.606 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.4 tttp -135.09 -169.38 2.36 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.401 -1.437 . . . . 0.0 109.989 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -104.46 100.43 10.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.126 -0.983 . . . . 0.0 108.56 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.871 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -47.02 144.53 2.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.729 . . . . 0.0 110.617 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.93 HD13 ' O ' ' A' ' 113' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.776 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.748 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.344 0.593 . . . . 0.0 109.889 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.978 ' CE1' HG22 ' A' ' 83' ' ' VAL . 13.8 m-85 -152.42 116.28 4.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.871 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 16.6 p-90 -122.06 149.37 43.64 Favored 'General case' 0 C--O 1.202 -1.401 0 C-N-CA 118.705 -1.198 . . . . 0.0 112.075 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.909 HG13 ' HG2' ' A' ' 109' ' ' MET . 58.5 t -124.54 107.97 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.649 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 9.9 m-30 -92.03 120.58 32.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.312 -0.867 . . . . 0.0 109.199 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.857 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.1 t -102.21 117.92 48.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.839 -1.144 . . . . 0.0 110.837 -179.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 4.2 tptp -88.28 113.91 24.37 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.577 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -73.94 120.62 19.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.492 -1.38 . . . . 0.0 109.016 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.931 HG23 ' HA ' ' A' ' 105' ' ' VAL . 3.7 t . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.319 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.513 2.708 0 CA-C-O 121.415 0.626 . . . . 0.0 111.826 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.041 HG22 HD11 ' A' ' 15' ' ' LEU . 4.9 mm -64.83 -61.96 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.597 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -37.24 -30.51 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.939 -0.476 . . . . 0.0 111.833 -178.13 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' ILE . 54.4 t-20 -84.48 -45.64 12.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.891 -1.131 . . . . 0.0 108.504 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -67.59 -10.6 53.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.591 -0.693 . . . . 0.0 109.665 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.041 HD11 HG22 ' A' ' 11' ' ' ILE . 20.6 mt -96.82 -25.71 15.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.013 -1.054 . . . . 0.0 109.327 -179.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.383 -0.823 . . . . 0.0 109.988 -179.898 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.086 0.47 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.58 22.61 39.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.781 HD22 ' CE1' ' A' ' 28' ' ' PHE . 55.9 mt -70.67 176.65 4.01 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.939 -1.33 . . . . 0.0 108.947 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.15 17.43 21.63 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.781 ' CE1' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -154.81 132.25 11.2 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.186 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.11 129.28 9.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.416 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -102.32 118.78 37.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.946 -1.326 . . . . 0.0 108.513 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.628 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.1 pp -111.81 148.88 14.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.163 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.646 ' HB3' HD12 ' A' ' 40' ' ' LEU . 8.1 mt-30 -117.99 166.06 12.97 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 62' ' ' PHE . 18.3 mt -152.78 140.84 20.32 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.599 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.569 ' HB2' HD21 ' A' ' 40' ' ' LEU . 16.1 t0 -93.67 167.88 11.38 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.37 -22.23 1.49 Allowed Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.556 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -92.12 11.46 25.4 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.466 -1.608 . . . . 0.0 110.692 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.66 27.24 63.44 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 79.1 m-20 -97.03 127.86 43.42 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.993 -1.298 . . . . 0.0 111.639 -177.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.696 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -55.29 135.72 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.12 -0.988 . . . . 0.0 110.67 -179.83 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 32' ' ' GLN . 3.3 mt -111.4 -27.96 8.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -158.08 159.89 36.76 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.812 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.528 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 2.8 t80 -143.7 -64.74 0.38 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.601 -1.312 . . . . 0.0 109.246 -178.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.574 HD21 ' HB3' ' A' ' 45' ' ' ALA . 2.0 p-10 99.6 177.58 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 123.36 0.664 . . . . 0.0 109.641 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -95.25 -14.72 23.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.1 -1.0 . . . . 0.0 112.002 -177.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -58.22 -63.25 1.33 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.616 -1.302 . . . . 0.0 109.671 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 50' ' ' THR . 7.3 pt-20 -61.6 -49.81 75.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.208 -0.933 . . . . 0.0 109.286 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -58.74 -14.53 22.89 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 11.3 t70 -80.55 -39.09 28.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.735 -1.45 . . . . 0.0 109.823 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.483 ' HA ' HD13 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -84.58 -43.43 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.001 -1.062 . . . . 0.0 109.032 -179.644 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -89.47 -31.46 17.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.743 -0.598 . . . . 0.0 109.693 -178.68 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 100.82 -2.91 55.76 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.787 ' NE ' HG13 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -68.97 104.19 2.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.02 -1.283 . . . . 0.0 110.592 -179.322 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -72.17 166.14 43.94 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.656 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.87 -38.47 0.86 Allowed 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.948 1.765 . . . . 0.0 110.3 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.424 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -72.1 -22.95 61.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.275 -0.891 . . . . 0.0 109.415 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.429 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 38.1 tt0 -83.14 -47.19 11.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.497 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 53' ' ' ASP . 6.5 m -66.57 -11.37 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.599 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.509 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -68.32 121.12 16.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.082 -1.011 . . . . 0.0 108.722 -179.804 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.1 -19.0 52.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -178.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 56' ' ' GLN . 25.8 mmtt -79.87 132.66 36.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.373 -1.075 . . . . 0.0 109.215 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.59 122.71 21.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.696 ' HB2' HD12 ' A' ' 39' ' ' ILE . 87.2 t80 -68.69 -2.86 10.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 0.0 111.036 -179.313 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CE2' HD13 ' A' ' 33' ' ' LEU . 44.9 m-85 -110.94 -17.2 13.36 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.614 -1.304 . . . . 0.0 111.982 -177.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.28 -38.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.767 -1.208 . . . . 0.0 110.631 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -90.58 1.88 56.34 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.083 -1.01 . . . . 0.0 110.585 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.787 HG13 ' NE ' ' A' ' 52' ' ' ARG . 24.2 t -127.5 -75.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.409 ' HB3' ' OG1' ' A' ' 70' ' ' THR . . . -97.97 106.67 35.89 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.416 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 34.5 Cg_endo -75.6 0.15 9.48 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.746 1.631 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.2 p -106.08 -19.49 13.71 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.959 -1.088 . . . . 0.0 109.668 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.456 HG21 ' CE2' ' A' ' 62' ' ' PHE . 15.6 p -75.19 -2.24 26.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.177 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -90.12 51.75 2.11 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.857 -1.152 . . . . 0.0 108.869 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -121.01 177.64 1.42 Allowed Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.946 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.8 Cg_endo -78.27 -5.45 15.03 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 122.203 1.935 . . . . 0.0 111.272 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -107.98 -21.14 12.94 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.912 -1.118 . . . . 0.0 109.489 179.799 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 70' ' ' THR . 1.1 t80 -104.09 -72.19 0.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.221 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 25.0 t80 -70.93 -18.16 62.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.29 -61.57 6.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.647 ' HB2' HG21 ' A' ' 90' ' ' THR . 1.8 mmtt -61.53 -16.34 46.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.652 -0.91 . . . . 0.0 109.698 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.891 ' O ' HG23 ' A' ' 83' ' ' VAL . 11.7 t80 -81.17 -38.2 27.5 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.53 -0.731 . . . . 0.0 109.674 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.01 -11.17 59.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.969 -1.082 . . . . 0.0 109.419 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 17.1 pt-20 -97.25 -38.98 9.47 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -66.51 -39.18 93.92 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 79' ' ' PHE . 99.1 t -59.76 -39.71 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.636 -0.92 . . . . 0.0 110.667 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.4 -45.57 31.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.003 -1.061 . . . . 0.0 111.038 -178.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -20.84 65.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.098 -179.131 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.64 14.96 80.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -142.84 56.0 1.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.119 -1.224 . . . . 0.0 109.025 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.849 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -54.78 123.38 13.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.498 -0.751 . . . . 0.0 109.491 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 33.0 p-10 -161.94 87.78 0.66 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.032 -1.042 . . . . 0.0 109.553 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.647 HG21 ' HB2' ' A' ' 78' ' ' LYS . 1.5 t -138.78 164.87 28.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.983 -1.073 . . . . 0.0 110.335 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -156.9 146.64 20.74 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.07 ' CE2' HG21 ' A' ' 107' ' ' VAL . 9.6 p90 -162.1 -175.11 4.43 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 109.637 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.4 102.51 11.61 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.46 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -105.65 147.91 27.96 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 110.041 -178.622 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 103' ' ' THR . 31.6 m -115.71 109.67 18.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.71 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 21.3 m-30 -78.97 107.57 11.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.183 -0.948 . . . . 0.0 109.004 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.13 32.75 5.96 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.521 -0.737 . . . . 0.0 109.28 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -79.21 162.4 25.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.895 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 98' ' ' TYR . 7.7 mt-30 -4.38 66.59 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 C-N-CA 123.388 0.675 . . . . 0.0 112.642 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.593 ' N ' ' O ' ' A' ' 98' ' ' TYR . 1.6 ttp 175.67 -158.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.341 -178.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.582 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -93.74 179.16 1.32 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.788 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.582 ' CD ' HG22 ' A' ' 101' ' ' THR . 34.2 Cg_endo -78.09 107.25 2.29 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 121.873 1.715 . . . . 0.0 110.365 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.46 HG22 HG13 ' A' ' 105' ' ' VAL . 1.6 m -106.83 134.13 50.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.611 ' HB3' HG23 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -100.78 150.4 22.83 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.548 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.676 HG23 HG13 ' A' ' 107' ' ' VAL . 32.6 m -154.75 144.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 118.384 -1.326 . . . . 0.0 112.006 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.572 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -81.41 98.25 8.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 175.771 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.07 HG21 ' CE2' ' A' ' 92' ' ' PHE . 31.4 m -90.45 150.11 3.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 118.144 -1.423 . . . . 0.0 110.734 -176.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -148.15 107.16 3.85 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.772 ' HG2' HG13 ' A' ' 120' ' ' VAL . 26.2 mtm -102.98 118.6 37.18 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.773 -1.204 . . . . 0.0 108.952 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.608 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -140.27 145.63 37.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.227 -1.546 . . . . 0.0 110.223 -179.083 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -53.91 138.88 35.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.373 -0.829 . . . . 0.0 109.204 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.815 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -90.53 160.03 16.18 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.333 -0.854 . . . . 0.0 109.45 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.205 -0.935 . . . . 0.0 110.632 -179.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.76 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.427 0.632 . . . . 0.0 109.919 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.86 ' CE1' HG22 ' A' ' 83' ' ' VAL . 19.4 m-85 -152.08 114.41 4.51 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.815 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 19.6 p-90 -118.06 165.32 13.89 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.319 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.772 HG13 ' HG2' ' A' ' 109' ' ' MET . 84.4 t -146.02 104.54 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.346 0.593 . . . . 0.0 109.488 -178.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.672 ' CE2' ' HB ' ' A' ' 11' ' ' ILE . 5.3 m-30 -84.45 129.14 34.89 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.736 HG22 HG12 ' A' ' 107' ' ' VAL . 2.2 t -112.4 112.18 39.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.277 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 1.1 tttm -86.63 159.95 19.05 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.446 ' CD ' HG13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -107.06 120.93 43.42 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.743 -1.183 . . . . 0.0 109.869 -179.232 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.611 HG23 ' HB3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.175 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.982 HG22 HD11 ' A' ' 15' ' ' LEU . 4.6 mm -80.26 -60.59 2.15 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 110.151 -178.494 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.517 ' HA ' HD12 ' A' ' 15' ' ' LEU . 10.6 tt0 -46.83 -23.49 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.541 -1.349 . . . . 0.0 110.992 -178.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.19 -42.42 11.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.909 -1.119 . . . . 0.0 109.808 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -56.88 8.12 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.982 HD11 HG22 ' A' ' 11' ' ' ILE . 27.9 mt -38.08 -31.76 0.05 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.189 179.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.763 . . . . 0.0 110.119 -179.659 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.002 0.429 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.71 33.61 6.26 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.637 HD23 ' CZ ' ' A' ' 28' ' ' PHE . 4.1 mp -121.61 149.3 43.38 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.305 -1.115 . . . . 0.0 109.052 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.58 8.0 10.77 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.625 -0.672 . . . . 0.0 110.179 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.637 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 1.5 p90 -133.51 150.82 51.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 109.646 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.54 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.34 114.3 3.85 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 178.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.481 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -91.38 97.79 11.3 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.596 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.7 pp -105.26 145.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.095 -177.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.679 ' HB3' HD12 ' A' ' 40' ' ' LEU . 35.6 mt-30 -115.36 167.29 10.99 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.839 HD22 ' O ' ' A' ' 37' ' ' GLY . 85.2 mt -153.39 157.24 39.68 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.087 -1.008 . . . . 0.0 109.132 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.576 ' CG ' HD21 ' A' ' 40' ' ' LEU . 36.8 p-10 -133.89 121.44 21.74 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.606 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.46 -78.38 0.0 OUTLIER Glycine 0 N--CA 1.502 3.069 0 C-N-CA 124.457 1.027 . . . . 0.0 113.144 178.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 34' ' ' ASP . 26.2 m-20 -68.43 -6.0 22.28 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.653 -0.91 . . . . 0.0 110.415 -178.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.839 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 88.81 18.06 55.21 Favored Glycine 0 N--CA 1.479 1.552 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.1 m-80 -72.22 138.83 47.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.078 -1.248 . . . . 0.0 108.338 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.562 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.92 136.04 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 122.064 0.935 . . . . 0.0 111.496 -178.043 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.774 HD11 ' O ' ' A' ' 33' ' ' LEU . 3.3 mt -108.5 -29.11 8.96 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.608 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -163.36 163.3 25.17 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.946 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.841 ' CG ' HG21 ' A' ' 57' ' ' VAL . 1.8 t80 -143.83 -65.45 0.37 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.141 -1.6 . . . . 0.0 110.714 -177.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.536 HD21 ' HB3' ' A' ' 45' ' ' ALA . 5.4 p-10 106.84 171.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.586 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.44 -20.7 18.86 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.664 -1.272 . . . . 0.0 112.164 -177.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.536 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -52.16 -59.83 3.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.715 -1.241 . . . . 0.0 110.311 -179.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 11.1 pt-20 -62.55 -45.95 90.61 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.745 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.449 ' HA2' ' N ' ' A' ' 52' ' ' ARG . . . -59.13 -15.94 31.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.26 -34.65 25.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.805 -1.409 . . . . 0.0 109.99 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.95 -40.88 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.158 -0.964 . . . . 0.0 109.766 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.24 -0.25 26.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.55 -0.719 . . . . 0.0 110.111 -179.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.83 -2.78 72.7 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.627 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.871 ' CD ' HG13 ' A' ' 66' ' ' VAL . 0.9 OUTLIER -78.13 81.89 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.879 -1.365 . . . . 0.0 110.871 -179.155 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.453 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -57.8 176.7 0.23 Allowed Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.886 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 34.2 Cg_endo -76.52 -34.55 2.55 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.792 1.661 . . . . 0.0 110.341 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.2 -23.24 41.12 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -79.0 -41.42 29.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.613 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.841 HG21 ' CG ' ' A' ' 42' ' ' TYR . 26.8 m -71.47 -7.6 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 109.78 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.33 122.9 21.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.66 -23.07 35.67 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -178.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -80.53 136.16 36.23 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.409 -1.053 . . . . 0.0 109.189 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.9 126.84 31.24 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.587 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.76 ' HB2' HD21 ' A' ' 33' ' ' LEU . 76.3 t80 -61.66 -13.08 19.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.054 -1.029 . . . . 0.0 110.636 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 38.2 m-85 -118.95 28.94 7.98 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.945 -1.097 . . . . 0.0 110.506 -178.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.38 -50.63 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.767 -1.208 . . . . 0.0 110.826 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -111.86 7.71 20.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.856 -1.153 . . . . 0.0 110.653 -179.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.871 HG13 ' CD ' ' A' ' 52' ' ' ARG . 89.3 t -120.53 -41.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 120.777 -1.202 . . . . 0.0 108.342 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.19 95.35 7.47 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -72.63 -7.84 21.49 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.875 1.717 . . . . 0.0 110.427 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.1 p -94.39 -21.46 18.93 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.232 -0.918 . . . . 0.0 109.042 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.517 HG22 ' CD2' ' A' ' 75' ' ' PHE . 20.7 p -75.3 -0.63 20.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -88.97 55.33 3.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.884 -1.135 . . . . 0.0 108.887 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.476 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -130.48 177.57 2.15 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.858 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -78.08 -2.2 12.31 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.257 1.971 . . . . 0.0 111.418 -179.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 23.1 mm-40 -106.39 -25.98 11.66 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.8 -1.188 . . . . 0.0 109.298 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.7 t80 -101.99 -71.26 0.72 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.026 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.573 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 10.1 t80 -70.84 -17.7 62.73 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.245 178.024 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.84 -59.8 8.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.613 ' CB ' HG21 ' A' ' 90' ' ' THR . 6.7 mmtt -64.85 -14.7 60.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.469 -1.018 . . . . 0.0 109.351 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.84 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.5 t80 -80.82 -37.44 30.09 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.46 -8.29 58.36 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 108.707 178.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.64 -39.71 9.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.573 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -68.11 -39.83 88.48 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 79' ' ' PHE . 98.9 t -62.89 -39.39 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.766 -0.844 . . . . 0.0 109.765 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.95 -3.94 56.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.947 . . . . 0.0 111.104 -178.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.5 t -104.43 -19.68 13.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.082 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.35 19.59 71.36 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -156.27 72.57 0.76 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.096 -1.238 . . . . 0.0 109.287 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.573 HD12 ' HA3' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -76.1 110.43 10.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 109.629 -179.982 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -160.26 79.83 0.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.079 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 78' ' ' LYS . 9.9 t -137.62 151.39 48.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 110.262 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -133.38 146.52 51.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.086 ' CE2' HG21 ' A' ' 107' ' ' VAL . 18.5 p90 -153.58 -175.88 5.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.054 -1.029 . . . . 0.0 109.941 -179.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.71 115.79 30.17 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.04 176.94 4.97 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.159 -0.963 . . . . 0.0 110.136 -178.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.1 m -144.88 109.33 4.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.979 ' CE2' HG21 ' A' ' 122' ' ' VAL . 21.3 m-30 -83.01 119.85 24.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 108.963 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -149.43 47.51 0.97 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.001 -1.062 . . . . 0.0 110.331 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.558 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 35.0 p90 -78.56 135.9 37.4 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.134 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.535 ' C ' ' O ' ' A' ' 98' ' ' TYR . 11.7 pt20 3.52 64.07 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 CA-C-O 121.524 0.678 . . . . 0.0 112.106 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.5 tmm? -172.92 175.77 3.22 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.29 162.18 1.21 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.0 109.213 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.28 152.78 30.97 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.05 1.834 . . . . 0.0 110.195 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.48 HG22 HG13 ' A' ' 105' ' ' VAL . 54.5 m -147.76 127.53 13.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 110.305 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -110.44 137.24 48.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.898 ' HA ' HG23 ' A' ' 125' ' ' VAL . 17.7 m -150.49 142.83 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 118.649 -1.22 . . . . 0.0 111.494 -178.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.534 ' HD3' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -82.92 124.21 30.14 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 174.38 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.086 HG21 ' CE2' ' A' ' 92' ' ' PHE . 33.1 m -108.57 152.12 10.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 120.88 -1.138 . . . . 0.0 111.744 -174.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -142.12 108.46 5.28 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.434 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.692 ' HG2' HG13 ' A' ' 120' ' ' VAL . 20.5 mtm -106.42 123.93 48.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.767 -1.208 . . . . 0.0 109.457 -179.139 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.575 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -126.24 -165.89 1.5 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.098 -179.677 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.61 94.21 4.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.546 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.982 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -53.21 127.59 24.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.073 -1.017 . . . . 0.0 109.481 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.066 -1.021 . . . . 0.0 109.638 179.86 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.499 ' HB3' ' CD2' ' A' ' 118' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 121.209 0.528 . . . . 0.0 111.367 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CE1' HG22 ' A' ' 83' ' ' VAL . 8.9 m-85 -123.07 131.1 53.56 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.214 -0.929 . . . . 0.0 110.061 -177.4 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.982 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 15.0 p-90 -130.59 166.47 20.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.836 -1.165 . . . . 0.0 111.853 179.01 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.692 HG13 ' HG2' ' A' ' 109' ' ' MET . 90.7 t -147.71 115.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.767 -0.583 . . . . 0.0 110.441 -178.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.729 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.6 m-30 -94.41 104.69 16.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.064 -1.022 . . . . 0.0 108.836 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.979 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -88.04 105.9 15.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.507 ' HE3' ' CD1' ' A' ' 28' ' ' PHE . 9.5 mttp -89.67 112.42 23.66 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.531 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -56.98 133.19 54.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.966 -1.084 . . . . 0.0 109.43 -179.0 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.898 HG23 ' HA ' ' A' ' 105' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.366 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.062 HG22 HD11 ' A' ' 15' ' ' LEU . 5.2 mm -79.16 -56.92 6.0 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.371 -178.083 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.406 ' HB2' HD12 ' A' ' 113' ' ' LEU . 2.0 pt-20 -43.04 -26.88 0.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.304 -0.873 . . . . 0.0 111.431 -178.088 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -91.09 -38.14 12.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.925 -1.109 . . . . 0.0 108.428 178.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.7 m -71.26 -13.01 61.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.627 -0.671 . . . . 0.0 110.02 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.062 HD11 HG22 ' A' ' 11' ' ' ILE . 11.1 mt -97.62 -21.62 16.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.059 -1.025 . . . . 0.0 109.385 -179.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.873 -179.765 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.768 ' OD1' ' HB3' ' A' ' 44' ' ' ALA . 52.0 t0 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 120.797 0.332 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.64 35.02 4.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.948 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 28.7 mt -107.09 129.43 54.82 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.593 -0.945 . . . . 0.0 109.662 -179.639 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.27 -7.24 28.96 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.591 0.71 . . . . 0.0 109.353 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.948 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 6.8 p90 -129.99 135.96 48.89 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.098 -1.001 . . . . 0.0 109.016 179.762 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.477 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -70.03 132.33 23.7 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.477 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -105.1 103.03 12.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.327 . . . . 0.0 108.239 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.609 ' C ' HD12 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -102.82 143.47 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.558 -178.875 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.665 ' HB3' HD12 ' A' ' 40' ' ' LEU . 22.0 mt-30 -116.92 164.23 15.0 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.243 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.736 HD13 ' CE2' ' A' ' 63' ' ' PHE . 95.9 mt -148.38 148.49 30.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.017 -1.052 . . . . 0.0 109.945 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.62 ' HB3' HD21 ' A' ' 40' ' ' LEU . 4.0 p30 -123.92 122.18 37.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 110.419 179.223 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.32 -79.32 0.0 OUTLIER Glycine 0 N--CA 1.497 2.741 0 C-N-CA 124.028 0.823 . . . . 0.0 113.392 178.276 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -70.14 -5.48 27.44 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.769 -0.841 . . . . 0.0 111.078 -177.762 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.731 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 94.02 17.84 39.21 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.768 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 38.5 m-80 -75.41 134.39 40.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.962 -1.316 . . . . 0.0 108.983 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.564 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -59.59 138.5 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.938 0.875 . . . . 0.0 111.442 -178.504 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 32' ' ' GLN . 7.9 mt -104.63 -33.66 8.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.12 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.702 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -157.48 -176.55 6.02 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.284 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.515 ' CD1' HG22 ' A' ' 31' ' ' ILE . 6.9 t80 -160.54 -67.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.906 -1.121 . . . . 0.0 110.826 -178.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' OD1' ' HG2' ' A' ' 46' ' ' GLU . 4.6 p-10 103.01 176.27 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.633 0 C-N-CA 123.779 0.832 . . . . 0.0 109.206 -179.379 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -95.81 -16.51 21.83 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.821 -1.174 . . . . 0.0 112.806 -177.388 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.24 -62.08 2.1 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.376 -1.453 . . . . 0.0 110.138 -179.131 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.513 ' HG2' ' OD1' ' A' ' 43' ' ' ASN . 3.3 pt-20 -59.61 -53.11 61.8 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.694 0.759 . . . . 0.0 109.569 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 52' ' ' ARG . . . -60.52 -13.78 32.21 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.23 -37.29 33.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.753 -1.439 . . . . 0.0 110.188 -179.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.78 -43.02 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.858 -1.152 . . . . 0.0 109.236 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.44 -27.8 17.24 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.248 -0.908 . . . . 0.0 109.974 -178.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 100.69 -3.32 56.06 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.333 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.541 HH11 HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -60.88 100.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.97 -1.312 . . . . 0.0 109.749 -179.749 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.725 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -73.44 162.35 74.75 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 0.0 108.728 179.371 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.47 -51.22 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.187 1.925 . . . . 0.0 110.756 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -63.67 -26.04 68.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 110.181 -179.5 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -85.12 -42.81 14.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.955 -1.091 . . . . 0.0 109.905 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 53' ' ' ASP . 27.1 m -74.81 -3.2 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.157 -0.964 . . . . 0.0 109.675 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.564 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -71.49 123.13 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 O-C-N 120.947 -1.096 . . . . 0.0 108.058 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.33 -14.76 60.16 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -178.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.405 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 5.6 mmtt -79.9 136.97 36.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -1.205 . . . . 0.0 109.2 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.62 110.01 12.07 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.237 -0.915 . . . . 0.0 108.616 179.392 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.801 ' CZ ' HG21 ' A' ' 70' ' ' THR . 46.5 t80 -64.37 -12.63 44.51 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.736 ' CE2' HD13 ' A' ' 33' ' ' LEU . 31.9 m-85 -94.92 13.08 26.02 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.054 -1.029 . . . . 0.0 110.745 -177.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -179.39 -50.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.057 -1.027 . . . . 0.0 109.944 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -14.16 62.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 110.424 -179.038 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 3.8 t -125.89 -57.64 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 120.679 -1.263 . . . . 0.0 108.736 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -116.15 98.01 50.54 Favored Pre-proline 0 C--N 1.295 -1.8 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.614 -178.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -74.75 -1.53 11.26 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 121.858 1.705 . . . . 0.0 110.985 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 p -91.65 -26.51 18.63 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.988 -1.07 . . . . 0.0 109.335 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.801 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 35.2 p -75.0 -1.62 23.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.509 -0.744 . . . . 0.0 110.067 -179.163 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -89.69 52.13 2.25 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.93 -1.106 . . . . 0.0 108.597 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.481 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -124.87 178.5 1.42 Allowed Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.87 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.4 Cg_endo -78.42 -1.09 11.29 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 122.257 1.971 . . . . 0.0 111.476 -179.655 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 13.5 mt-10 -108.46 -29.02 9.02 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.877 -1.139 . . . . 0.0 109.301 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.685 ' CE1' HG11 ' A' ' 120' ' ' VAL . 1.2 t80 -100.06 -70.54 0.73 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.067 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.528 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 20.4 t80 -72.4 -15.31 61.84 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.77 -62.47 5.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 178.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.791 ' CB ' HG21 ' A' ' 90' ' ' THR . 1.2 mmtt -62.87 -16.09 57.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.562 -0.964 . . . . 0.0 109.251 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.863 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.9 t80 -77.36 -40.45 43.89 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.12 -7.87 56.51 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.969 . . . . 0.0 109.045 179.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -95.98 -41.17 8.9 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.507 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -69.41 -40.01 80.02 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 178.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.93 HG22 ' CE1' ' A' ' 118' ' ' TYR . 94.0 t -60.01 -38.71 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.693 -0.887 . . . . 0.0 109.535 179.388 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.35 -6.87 58.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.336 -0.853 . . . . 0.0 110.704 -178.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.06 -18.89 16.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.848 -1.157 . . . . 0.0 109.938 -179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.58 16.07 78.44 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.44 66.89 0.39 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.055 -1.262 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -58.74 124.53 20.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.853 . . . . 0.0 109.985 -179.948 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.426 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 4.3 t-20 -161.27 83.78 0.64 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.943 -1.098 . . . . 0.0 109.072 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.826 HG23 ' SD ' ' A' ' 109' ' ' MET . 8.8 t -144.73 172.48 12.95 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.055 -1.058 . . . . 0.0 110.754 -179.405 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.8 ptm -157.21 171.07 21.09 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 1.031 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 7.7 p90 177.82 154.15 0.31 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.03 -1.044 . . . . 0.0 109.94 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.3 128.38 33.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 109.07 179.378 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.08 170.04 16.24 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.13 -0.981 . . . . 0.0 110.061 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.0 m -140.88 118.01 11.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 122' ' ' VAL . 20.1 m-30 -90.24 121.27 32.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.107 -0.995 . . . . 0.0 109.76 -179.648 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -142.77 46.27 1.58 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.477 -0.764 . . . . 0.0 109.029 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.499 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -85.36 66.52 9.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.466 -0.771 . . . . 0.0 110.855 -179.302 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.475 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 77.49 30.2 0.51 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.871 0.843 . . . . 0.0 109.318 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -141.34 171.08 14.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.055 -1.028 . . . . 0.0 108.5 179.452 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.44 170.6 0.2 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.015 -1.053 . . . . 0.0 109.235 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.66 92.03 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.007 1.805 . . . . 0.0 110.261 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.454 HG22 HG13 ' A' ' 105' ' ' VAL . 18.7 m -88.18 131.24 34.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 109.895 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.439 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -110.24 142.63 41.57 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.872 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.633 ' HA ' HG23 ' A' ' 125' ' ' VAL . 12.6 m -157.73 144.57 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.412 -179.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.578 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.11 119.12 36.19 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 174.782 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 1.031 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -87.78 162.47 2.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 120.665 -1.272 . . . . 0.0 111.376 -174.844 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -160.46 103.71 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.164 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.86 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -112.41 150.59 30.91 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.72 -0.613 . . . . 0.0 110.009 -176.932 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.572 ' HB3' ' CZ2' ' A' ' 119' ' ' TRP . 0.1 OUTLIER -150.38 164.94 34.56 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.512 -1.367 . . . . 0.0 109.084 179.041 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 118.87 13.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.879 -1.138 . . . . 0.0 109.739 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.77 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -65.65 133.21 50.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 109.424 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.746 ' O ' HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.052 -1.03 . . . . 0.0 110.817 -179.274 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.723 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.354 0.597 . . . . 0.0 109.687 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.93 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.3 m-85 -150.22 109.31 3.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -0.837 . . . . 0.0 108.834 -179.398 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.77 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 9.7 p-90 -115.37 144.46 43.76 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.583 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.86 HG13 ' CG ' ' A' ' 109' ' ' MET . 18.8 t -120.01 109.0 24.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.641 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 12.6 m-30 -89.61 134.4 34.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 108.701 179.358 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -111.26 117.96 56.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 121.322 -0.861 . . . . 0.0 108.841 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.578 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 4.9 tptp -90.39 110.15 21.25 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.502 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -64.74 117.62 7.76 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.205 -179.515 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.317 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.24 -174.28 2.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -173.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.54 138.57 17.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.702 ' HB3' ' HA ' ' A' ' 8' ' ' SER . . . -86.02 140.39 30.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.728 . . . . 0.0 109.742 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.548 ' CZ ' ' O ' ' A' ' 106' ' ' LYS . 0.5 OUTLIER -61.35 -64.24 1.01 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.461 ' O ' HD11 ' A' ' 11' ' ' ILE . . . -53.19 -27.71 32.26 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 177.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.702 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 0.2 OUTLIER 43.31 -168.73 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.293 1.044 . . . . 0.0 112.236 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 10' ' ' ASP . 11.6 tt0 -55.43 84.58 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.701 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 9' ' ' GLU . 2.2 m-20 22.43 74.66 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.852 0 CA-C-O 121.237 0.541 . . . . 0.0 110.471 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.059 HG22 HD11 ' A' ' 15' ' ' LEU . 1.5 mm -54.21 -67.29 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.275 -0.89 . . . . 0.0 110.493 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 11' ' ' ILE . 19.8 pt-20 -35.06 -47.59 0.38 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -63.69 -47.84 79.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.858 -1.151 . . . . 0.0 109.106 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.985 HG21 HD12 ' A' ' 23' ' ' LEU . 13.1 m -69.57 -13.33 62.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.537 -0.727 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.059 HD11 HG22 ' A' ' 11' ' ' ILE . 18.4 mt -95.43 -16.35 22.34 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.772 -1.205 . . . . 0.0 109.502 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.71 -27.21 22.54 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.144 -0.973 . . . . 0.0 108.535 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.0 -1.07 8.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.465 ' CE ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER 63.52 159.45 0.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.847 -1.158 . . . . 0.0 109.674 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.561 ' HB2' HG23 ' A' ' 14' ' ' THR . 0.3 OUTLIER -116.61 -154.21 0.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.241 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.27 -83.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.067 -1.021 . . . . 0.0 109.569 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.9 47.7 3.2 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.449 ' OE1' ' CA ' ' A' ' 22' ' ' GLN . 0.7 OUTLIER 55.17 26.58 8.51 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.433 -1.039 . . . . 0.0 108.402 -178.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.985 HD12 HG21 ' A' ' 14' ' ' THR . 0.7 OUTLIER 43.16 43.99 4.15 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.409 0.623 . . . . 0.0 110.008 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 44' ' ' ALA . 53.2 m-20 -88.31 4.48 45.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 110.09 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.37 27.85 18.5 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.682 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 5.0 mt -84.62 -172.01 3.94 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.951 -1.323 . . . . 0.0 109.028 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.35 -5.93 14.08 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.682 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 10.3 p90 -124.12 117.22 24.16 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.27 -0.894 . . . . 0.0 108.648 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.465 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -57.06 141.03 43.97 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.44 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -117.17 114.82 24.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.851 -1.382 . . . . 0.0 108.047 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.579 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.6 pp -118.22 150.12 20.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.896 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.65 ' HB3' HD12 ' A' ' 40' ' ' LEU . 2.1 mt-30 -117.47 172.51 7.29 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.844 HD22 ' C ' ' A' ' 37' ' ' GLY . 27.9 mt -152.8 149.49 28.38 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.12 -0.988 . . . . 0.0 109.247 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.539 ' HB2' HD21 ' A' ' 40' ' ' LEU . 3.2 m-20 -119.25 133.16 55.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.141 -0.974 . . . . 0.0 109.417 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -7.58 70.0 0.0 OUTLIER Glycine 0 N--CA 1.514 3.873 0 C-N-CA 124.618 1.104 . . . . 0.0 113.273 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER 161.25 -23.84 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.844 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.68 23.05 10.38 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 3.3 m120 -86.08 123.51 31.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.417 -1.049 . . . . 0.0 108.792 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -56.32 136.19 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 121.913 0.863 . . . . 0.0 110.884 -178.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.65 HD12 ' HB3' ' A' ' 32' ' ' GLN . 5.6 mt -108.13 -30.83 8.2 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.47 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -159.96 160.6 33.61 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.601 ' HH ' ' HE1' ' A' ' 62' ' ' PHE . 2.7 t80 -140.08 -42.47 0.42 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.362 -1.461 . . . . 0.0 109.975 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.594 HD21 ' HB3' ' A' ' 45' ' ' ALA . 0.4 OUTLIER 87.54 171.58 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . . . -96.35 -15.38 21.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.004 -1.06 . . . . 0.0 112.637 -177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.594 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -58.77 -67.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.386 -1.446 . . . . 0.0 110.135 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 12.0 pt-20 -63.71 -44.95 92.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 109.021 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -61.11 -13.85 36.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 14.8 t70 -87.24 -32.72 19.59 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.627 -1.513 . . . . 0.0 108.819 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -73.45 -48.47 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.883 0.849 . . . . 0.0 108.731 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.768 HG21 " H3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -95.09 -29.54 14.53 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.371 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 100.94 -2.69 55.54 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.589 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.955 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 1.1 mtt85 -47.52 -58.72 3.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.968 -1.313 . . . . 0.0 111.027 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.819 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER 68.46 152.45 0.13 Allowed Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -178.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.85 -50.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.78 1.654 . . . . 0.0 111.312 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.693 ' HA ' HD12 ' A' ' 58' ' ' ILE . 10.4 pttt -57.99 -18.47 24.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -0.999 . . . . 0.0 110.344 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -96.1 -43.19 7.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 0.0 109.411 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 53' ' ' ASP . 32.3 m -82.51 3.96 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.646 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.7 OUTLIER -70.04 123.6 24.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.8 -22.86 36.95 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -79.99 130.59 35.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -1.054 . . . . 0.0 109.25 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.564 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -68.23 125.55 26.74 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.135 -0.978 . . . . 0.0 108.568 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.681 ' CE2' HG21 ' A' ' 70' ' ' THR . 90.2 t80 -71.88 -6.22 40.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.896 -1.128 . . . . 0.0 110.263 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CE2' HD13 ' A' ' 33' ' ' LEU . 30.0 m-85 -96.4 -41.69 8.49 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.935 -1.103 . . . . 0.0 111.545 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.79 -15.39 4.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.705 -1.247 . . . . 0.0 111.522 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.73 -2.35 30.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.679 -1.263 . . . . 0.0 110.858 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.955 HG12 ' CZ ' ' A' ' 52' ' ' ARG . 45.7 t -131.79 -47.89 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 O-C-N 120.732 -1.23 . . . . 0.0 108.504 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.719 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . . . -128.96 106.7 18.15 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.61 2.36 6.49 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.765 1.643 . . . . 0.0 111.662 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.9 p -99.31 -27.69 13.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.889 -1.132 . . . . 0.0 109.234 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.74 HG22 ' CD2' ' A' ' 75' ' ' PHE . 18.0 p -72.13 -5.95 39.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -0.823 . . . . 0.0 109.965 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -89.66 51.72 2.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.018 -1.051 . . . . 0.0 108.742 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.483 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -128.43 178.82 1.47 Allowed Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.07 -0.15 10.42 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 122.095 1.864 . . . . 0.0 111.447 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 5.4 mm-40 -107.85 -28.19 9.78 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.813 -1.18 . . . . 0.0 109.453 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.748 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.9 t80 -102.67 -69.15 0.8 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.487 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 26.0 t80 -69.67 -17.92 63.52 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.18 -62.12 5.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.72 ' CB ' HG21 ' A' ' 90' ' ' THR . 0.9 OUTLIER -63.42 -15.58 58.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.519 -0.989 . . . . 0.0 109.593 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.827 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.9 t80 -81.66 -34.79 30.57 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.19 -8.13 58.77 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 2.0 mt-10 -96.13 -42.47 8.2 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -66.83 -41.22 93.66 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.154 -1.979 . . . . 0.0 108.154 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 79' ' ' PHE . 93.1 t -62.02 -40.09 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.654 -0.909 . . . . 0.0 109.508 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.64 -4.92 58.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -0.871 . . . . 0.0 110.43 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.5 t -96.09 -25.58 15.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.92 -1.112 . . . . 0.0 109.87 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.92 28.89 27.5 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -179.02 59.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.303 -1.116 . . . . 0.0 109.058 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 6.2 tt -49.0 121.54 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 110.332 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.434 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 62.1 t-20 -160.69 88.27 0.77 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.394 -0.816 . . . . 0.0 109.032 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.72 HG21 ' CB ' ' A' ' 78' ' ' LYS . 2.3 t -149.15 167.17 26.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 110.189 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -150.04 167.1 27.74 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.973 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 10.2 p90 -175.93 153.84 1.4 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.971 -1.081 . . . . 0.0 110.042 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -82.21 116.49 21.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.189 -0.944 . . . . 0.0 109.167 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.96 175.24 6.0 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.22 -0.925 . . . . 0.0 109.753 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 103' ' ' THR . 48.0 m -140.81 111.99 7.24 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.845 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 18.6 m-30 -82.81 93.64 7.49 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.135 -0.978 . . . . 0.0 109.2 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -115.35 32.78 5.84 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.329 -0.857 . . . . 0.0 108.963 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.59 155.5 29.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.506 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.8 mt-30 -0.85 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.466 0.706 . . . . 0.0 112.394 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.2 ttp 178.12 -154.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.465 -0.772 . . . . 0.0 109.653 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.538 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -92.12 176.89 2.39 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 108.975 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.538 ' CD ' HG22 ' A' ' 101' ' ' THR . 36.4 Cg_endo -78.31 106.51 2.15 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 121.919 1.746 . . . . 0.0 110.2 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 95' ' ' THR . 4.2 m -101.07 143.83 30.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.236 -0.915 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -117.0 139.24 50.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.599 ' HB ' HG13 ' A' ' 122' ' ' VAL . 7.7 m -156.25 141.62 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.771 -1.205 . . . . 0.0 111.261 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.548 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -91.05 114.78 27.39 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.973 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -87.07 161.24 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.807 -1.183 . . . . 0.0 110.543 -176.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.532 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 15.0 t-160 -159.74 99.36 1.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.859 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -110.64 148.41 32.29 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.452 -0.78 . . . . 0.0 109.628 -177.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.647 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 2.3 ttmt -145.51 -179.01 6.38 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.483 -1.287 . . . . 0.0 109.423 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -87.42 109.23 19.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.933 -1.105 . . . . 0.0 109.185 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.75 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -53.67 140.52 28.96 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.566 -0.709 . . . . 0.0 109.868 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.1 mt -86.93 9.56 18.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.6 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 m -59.68 -19.24 48.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.797 -1.19 . . . . 0.0 109.411 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 116' ' ' ASP . . . 148.75 -29.54 1.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 115' ' ' GLY . 0.4 OUTLIER 167.96 68.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.5 -1.0 . . . . 0.0 108.668 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.677 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -124.2 -168.07 1.74 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.0 110.434 -179.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.754 ' CE1' HG22 ' A' ' 83' ' ' VAL . 24.7 m-85 -151.03 112.32 4.37 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.75 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 15.8 p-90 -114.68 140.99 48.4 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 118.578 -1.249 . . . . 0.0 112.373 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.859 HG13 ' CG ' ' A' ' 109' ' ' MET . 21.2 t -116.42 108.62 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.637 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 15.3 m-30 -92.49 121.33 33.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.396 -0.815 . . . . 0.0 109.65 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.845 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.4 t -103.95 117.35 49.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.403 -0.81 . . . . 0.0 108.927 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.502 ' CD ' ' HA ' ' A' ' 6' ' ' PHE . 2.7 tttm -98.97 110.57 23.16 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.447 ' HA ' HG12 ' A' ' 105' ' ' VAL . 33.4 ttt180 -56.27 135.85 53.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.847 -1.158 . . . . 0.0 109.528 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.346 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.768 " H3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.291 0.567 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -72.14 132.74 44.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.709 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.92 -177.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.086 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 5' ' ' ALA . 94.2 t -66.14 159.85 4.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.235 -0.915 . . . . 0.0 109.121 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.626 ' HB3' ' HA ' ' A' ' 8' ' ' SER . . . -137.12 150.88 48.27 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.546 -0.722 . . . . 0.0 109.781 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -65.19 -63.59 1.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.288 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.421 ' O ' ' CD1' ' A' ' 11' ' ' ILE . . . -53.1 -28.34 33.25 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 106.723 -2.551 . . . . 0.0 106.723 176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.681 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER 42.37 -166.73 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 122.275 1.035 . . . . 0.0 112.518 176.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 10' ' ' ASP . 4.4 tt0 -58.25 83.25 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.575 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 9' ' ' GLU . 58.5 m-20 28.63 77.95 0.03 OUTLIER 'General case' 0 N--CA 1.51 2.56 0 CA-C-N 118.37 0.532 . . . . 0.0 110.178 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.031 HG22 HD11 ' A' ' 15' ' ' LEU . 3.0 mm -56.98 -67.45 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.198 -1.645 0 O-C-N 121.051 -1.031 . . . . 0.0 109.594 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.6 pt-20 -37.31 -29.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.836 -0.54 . . . . 0.0 112.205 -178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' ILE . 5.0 m-20 -76.97 -53.13 8.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.805 -1.184 . . . . 0.0 109.906 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -62.85 -40.05 96.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.192 -0.943 . . . . 0.0 109.357 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.031 HD11 HG22 ' A' ' 11' ' ' ILE . 28.9 mt -61.03 -24.0 65.84 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.31 -23.33 22.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.416 -0.802 . . . . 0.0 108.961 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.37 69.2 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.886 . . . . 0.0 109.337 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.481 ' HG2' ' CB ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -66.75 152.84 44.72 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.135 -0.978 . . . . 0.0 109.308 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 18' ' ' MET . 0.8 OUTLIER 162.6 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.715 -0.615 . . . . 0.0 110.502 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.3 68.75 9.89 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.14 22.14 66.71 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.789 ' C ' HD23 ' A' ' 23' ' ' LEU . 4.2 mt-30 49.82 56.84 7.26 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.698 -0.884 . . . . 0.0 109.697 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.928 HD12 HD12 ' A' ' 26' ' ' LEU . 1.2 pt? 40.96 42.66 1.57 Allowed 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.1 0.476 . . . . 0.0 111.201 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.4 p30 -78.13 -7.67 57.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 109.964 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.38 31.8 8.09 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.974 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 15.5 mt -103.31 121.85 43.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.461 -1.023 . . . . 0.0 108.765 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.01 -12.09 7.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 109.965 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.974 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 10.3 p90 -121.49 116.96 25.67 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.003 -1.06 . . . . 0.0 109.289 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.519 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -55.14 148.64 24.18 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.469 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -128.61 100.88 5.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.833 -1.392 . . . . 0.0 108.222 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.737 HG22 ' CD1' ' A' ' 42' ' ' TYR . 2.2 pp -105.6 159.99 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.718 0.77 . . . . 0.0 110.953 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.79 ' HB3' HD12 ' A' ' 40' ' ' LEU . 33.7 mt-30 -122.08 174.86 6.67 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.678 HD11 ' HD2' ' A' ' 62' ' ' PHE . 22.7 mt -154.37 151.93 29.61 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.794 -1.162 . . . . 0.0 109.951 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.568 ' HB2' HD21 ' A' ' 40' ' ' LEU . 34.5 t70 -102.11 165.63 11.05 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.65 -20.65 0.14 Allowed Glycine 0 N--CA 1.499 2.884 0 O-C-N 121.792 -0.568 . . . . 0.0 113.507 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.58 20.02 19.32 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 119.814 1.807 . . . . 0.0 111.227 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.38 25.25 68.65 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.2 m-20 -90.0 125.22 35.31 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.051 -1.264 . . . . 0.0 110.767 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.659 HD12 HD21 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -59.5 139.2 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.869 -1.145 . . . . 0.0 110.706 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.79 HD12 ' HB3' ' A' ' 32' ' ' GLN . 9.2 mt -108.43 -31.31 7.87 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -157.69 -176.49 5.97 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.737 ' CD1' HG22 ' A' ' 31' ' ' ILE . 20.5 t80 -160.01 -72.81 0.07 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.706 -1.247 . . . . 0.0 111.488 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.9 p-10 105.28 179.34 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 C-N-CA 123.719 0.808 . . . . 0.0 109.096 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.26 -26.64 15.33 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.948 -1.095 . . . . 0.0 113.287 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -50.12 -64.63 0.75 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.332 -1.48 . . . . 0.0 110.796 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.9 pt-20 -57.86 -53.08 62.24 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 121.671 -0.643 . . . . 0.0 110.03 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 52' ' ' ARG . . . -58.38 -15.42 23.84 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.376 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.83 -34.23 39.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.894 -1.356 . . . . 0.0 108.892 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -84.86 -54.41 8.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.423 -0.798 . . . . 0.0 109.673 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.503 ' N ' HG22 ' A' ' 49' ' ' ILE . 1.2 p -84.99 -23.11 28.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 110.34 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.36 -13.65 61.37 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.669 ' CD ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -47.89 107.23 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.184 -1.186 . . . . 0.0 110.817 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.742 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -74.39 153.71 87.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.2 -48.81 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.579 1.519 . . . . 0.0 111.13 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -18.26 60.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.077 -1.014 . . . . 0.0 110.281 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -88.61 -41.99 12.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.947 -1.096 . . . . 0.0 109.66 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 53' ' ' ASP . 26.4 m -73.22 -5.55 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.236 -0.915 . . . . 0.0 109.741 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.591 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -70.27 122.82 22.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.1 -1.0 . . . . 0.0 108.357 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.31 -16.58 59.47 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -79.25 139.91 37.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -1.204 . . . . 0.0 109.336 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -79.45 97.39 6.38 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.678 ' HD2' HD11 ' A' ' 33' ' ' LEU . 1.3 t80 -46.94 -39.9 13.24 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.508 -0.745 . . . . 0.0 110.63 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CG ' ' CD1' ' A' ' 76' ' ' TYR . 23.9 m-85 -86.1 -23.94 26.47 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.708 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.06 43.98 2.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 109.586 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 19.5 t0 -174.46 -20.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.359 -0.936 . . . . 0.0 111.766 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.664 HG11 ' HD3' ' A' ' 52' ' ' ARG . 5.4 t -117.96 -59.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 120.354 -1.466 . . . . 0.0 109.706 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.472 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -106.08 103.25 43.98 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.592 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.54 1.52 7.9 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.875 1.717 . . . . 0.0 110.97 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.0 p -106.39 -20.89 13.24 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.886 -1.134 . . . . 0.0 109.976 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.668 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 35.2 p -81.74 2.32 30.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.089 -1.007 . . . . 0.0 110.049 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -95.14 55.01 1.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.899 -1.125 . . . . 0.0 108.877 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.473 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -135.9 176.31 2.93 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.524 -0.735 . . . . 0.0 109.348 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.5 Cg_endo -77.04 77.86 3.63 Favored 'Trans proline' 0 C--N 1.325 -0.691 0 C-N-CA 122.413 2.075 . . . . 0.0 110.492 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 172.06 -36.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.5 t80 -105.63 -66.02 1.02 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.566 ' CD1' ' CG ' ' A' ' 63' ' ' PHE . 5.7 t80 -77.6 -20.51 53.84 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.032 -1.042 . . . . 0.0 108.265 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.39 -60.41 7.12 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.5 ' HB3' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -66.23 -15.43 63.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.752 -0.852 . . . . 0.0 110.085 -179.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.872 ' O ' HG23 ' A' ' 83' ' ' VAL . 5.1 t80 -84.15 -36.41 22.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.88 -10.92 59.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 1.1 pp20? -97.5 -36.01 10.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.87 -39.63 85.33 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 79' ' ' PHE . 98.5 t -58.31 -56.2 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.89 -0.77 . . . . 0.0 109.408 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.39 -20.14 65.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.858 . . . . 0.0 109.948 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.63 -29.25 51.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.9 24.1 42.96 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -172.68 57.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.42 -1.047 . . . . 0.0 108.991 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.846 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -49.4 124.7 9.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.804 . . . . 0.0 109.993 -179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.437 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 21.8 t-20 -161.02 88.92 0.77 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.459 -0.776 . . . . 0.0 109.043 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 78' ' ' LYS . 3.3 t -156.75 168.21 28.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.018 -1.051 . . . . 0.0 110.728 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -145.57 170.21 16.87 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.058 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 13.3 p90 -176.31 158.37 1.87 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.893 -1.129 . . . . 0.0 110.307 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -92.08 116.25 28.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.979 -1.076 . . . . 0.0 109.289 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.38 -175.23 3.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.03 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.727 HG22 ' OD1' ' A' ' 97' ' ' ASP . 75.6 m -150.06 114.15 5.12 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' ' 122' ' ' VAL . 16.7 m-30 -85.83 118.88 25.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.148 -0.97 . . . . 0.0 110.394 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.727 ' OD1' HG22 ' A' ' 95' ' ' THR . 0.9 OUTLIER -131.4 35.93 3.82 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.711 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -80.5 80.72 6.9 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 123.032 1.396 . . . . 0.0 111.201 -178.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 98' ' ' TYR . 2.4 mm100 72.9 27.19 2.17 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 119.925 -1.734 . . . . 0.0 109.051 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 50' ' ' THR . 1.5 tmm? -150.11 168.84 22.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.234 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.418 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -52.25 171.09 0.21 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 0.0 109.37 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.1 Cg_endo -76.59 79.45 3.03 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.927 1.751 . . . . 0.0 110.421 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.455 HG22 HG13 ' A' ' 105' ' ' VAL . 3.1 m -72.96 133.52 44.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 109.573 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.762 ' CB ' HG21 ' A' ' 125' ' ' VAL . 0.1 OUTLIER -106.45 148.55 28.02 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.251 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.582 ' HA ' HG13 ' A' ' 125' ' ' VAL . 19.7 m -158.31 140.41 5.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 118.578 -1.249 . . . . 0.0 110.536 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -87.43 130.92 34.5 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 103.309 -2.848 . . . . 0.0 103.309 175.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.058 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -104.67 160.06 5.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 O-C-N 120.543 -1.348 . . . . 0.0 110.513 -176.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.43 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 7.8 t-160 -156.84 101.6 1.97 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.867 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -117.02 149.07 40.89 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.23 -0.919 . . . . 0.0 110.136 -177.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.645 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.7 tttt -145.28 -176.94 5.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.674 -1.266 . . . . 0.0 109.297 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -89.67 109.13 20.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.805 -1.184 . . . . 0.0 108.893 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.768 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -60.61 137.46 58.17 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.358 -0.839 . . . . 0.0 109.868 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.5 mp -71.06 -9.04 57.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.943 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.48 -28.09 4.98 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.021 -1.049 . . . . 0.0 109.983 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.2 89.6 0.17 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 51.8 31.22 7.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -1.164 . . . . 0.0 109.794 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.742 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -86.63 -175.71 5.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.822 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.841 ' CE1' HG22 ' A' ' 83' ' ' VAL . 28.1 m-85 -154.07 109.33 3.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.303 -0.873 . . . . 0.0 108.883 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.768 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 11.0 p-90 -108.62 143.43 37.69 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 118.646 -1.221 . . . . 0.0 111.914 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.867 HG13 ' CG ' ' A' ' 109' ' ' MET . 21.3 t -122.83 104.77 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.489 0.661 . . . . 0.0 109.248 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.667 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 8.7 m-30 -85.8 114.22 22.57 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.564 -0.71 . . . . 0.0 109.351 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -98.17 115.8 39.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.149 -1.021 . . . . 0.0 109.224 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 4.1 tttm -98.64 125.86 44.05 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HA ' HG12 ' A' ' 105' ' ' VAL . 6.7 ttt-85 -63.66 144.45 57.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.576 -1.328 . . . . 0.0 109.212 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.762 HG21 ' CB ' ' A' ' 104' ' ' LYS . 22.6 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.594 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.509 " H2'" ' CZ ' ' A' ' 98' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.7 mtt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.54 123.9 28.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.215 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.61 149.75 33.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -0.875 . . . . 0.0 109.919 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.717 HG13 ' N ' ' A' ' 5' ' ' ALA . 0.8 OUTLIER -75.65 -153.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.717 ' N ' HG13 ' A' ' 4' ' ' VAL . . . -59.48 -137.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.544 ' CD1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -89.22 46.27 1.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.178 -1.576 . . . . 0.0 107.144 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.524 ' HA3' ' HE3' ' A' ' 123' ' ' LYS . . . 98.96 25.74 9.44 Favored Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 -178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.717 ' HB3' HD11 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -112.06 107.42 16.36 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.226 -1.161 . . . . 0.0 111.566 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.42 -71.48 0.08 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.167 0.984 . . . . 0.0 109.992 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -163.22 88.75 0.6 Allowed 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.135 HG22 HD11 ' A' ' 15' ' ' LEU . 3.1 mm -80.54 -63.78 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.197 -1.69 0 O-C-N 121.465 -0.772 . . . . 0.0 111.294 -176.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -44.2 -27.08 0.37 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.182 -0.949 . . . . 0.0 110.962 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -90.0 -38.48 13.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.988 . . . . 0.0 108.359 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 14' ' ' THR . 2.3 m -75.39 -6.78 51.75 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.515 -0.74 . . . . 0.0 109.269 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.135 HD11 HG22 ' A' ' 11' ' ' ILE . 38.4 mt -98.82 -27.5 13.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.193 -0.942 . . . . 0.0 109.07 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.29 -26.48 18.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.589 -0.694 . . . . 0.0 109.837 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -104.04 28.04 7.11 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 108.947 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.638 ' HE1' HD13 ' A' ' 23' ' ' LEU . 8.3 tmm? -125.68 142.79 51.33 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -91.91 -46.53 7.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.293 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -178.82 -36.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.912 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.68 68.71 0.4 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -151.25 -50.3 0.12 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.424 -1.045 . . . . 0.0 108.976 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.638 HD13 ' HE1' ' A' ' 18' ' ' MET . 1.9 pt? -79.6 -1.48 38.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.43 -0.794 . . . . 0.0 110.322 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -72.05 -6.89 45.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.853 -1.154 . . . . 0.0 110.306 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.41 33.97 6.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.56 HD12 ' O ' ' A' ' 23' ' ' LEU . 12.5 mt -110.48 147.8 33.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.236 -1.155 . . . . 0.0 109.293 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -93.23 22.35 5.21 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.797 0.808 . . . . 0.0 109.312 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.66 ' HZ ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -155.69 115.8 3.72 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -51.04 126.95 27.88 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.523 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -106.71 82.58 1.73 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.579 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.6 pp -91.77 153.01 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.374 -0.829 . . . . 0.0 110.817 -177.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.781 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -127.19 166.36 17.86 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.047 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.939 ' O ' HD11 ' A' ' 40' ' ' LEU . 84.3 mt -147.63 163.32 36.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.664 -1.273 . . . . 0.0 109.885 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.556 ' HB3' HD21 ' A' ' 40' ' ' LEU . 17.6 p-10 -134.07 122.3 22.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.104 -0.998 . . . . 0.0 110.725 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 40.08 -78.75 0.0 OUTLIER Glycine 0 N--CA 1.5 2.966 0 C-N-CA 124.424 1.011 . . . . 0.0 113.3 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 34' ' ' ASP . 27.8 t70 -70.84 -2.35 14.66 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.763 -0.845 . . . . 0.0 110.796 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.715 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 88.95 13.53 62.19 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.6 m-20 -66.99 148.09 52.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.903 -1.351 . . . . 0.0 108.02 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.655 HD11 ' HD1' ' A' ' 42' ' ' TYR . 2.4 tp -70.36 137.75 23.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.133 0.968 . . . . 0.0 112.648 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.939 HD11 ' O ' ' A' ' 33' ' ' LEU . 3.3 mt -107.59 -31.39 8.13 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 175.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.567 ' NE2' ' HA ' ' A' ' 41' ' ' GLN . 6.4 tp-100 -164.25 166.71 20.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.727 -0.608 . . . . 0.0 109.634 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.655 ' HD1' HD11 ' A' ' 39' ' ' ILE . 1.4 t80 -147.12 -69.41 0.24 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.166 -0.959 . . . . 0.0 110.289 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.2 p-10 102.88 152.3 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.537 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.26 -14.82 59.68 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.102 -0.999 . . . . 0.0 112.405 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -57.79 -62.09 2.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.623 -1.298 . . . . 0.0 109.565 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.556 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 14.0 pt-20 -64.81 -42.81 94.71 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.139 -0.976 . . . . 0.0 108.887 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.449 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -59.26 -16.6 35.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -86.18 -30.64 22.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.77 -1.429 . . . . 0.0 109.465 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.539 HG22 HG22 ' A' ' 50' ' ' THR . 1.2 mp -78.75 -42.05 24.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.939 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.6 OUTLIER -109.18 1.7 20.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.437 -0.789 . . . . 0.0 109.81 -179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 81.84 -2.4 83.5 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.897 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.91 ' CD ' HG13 ' A' ' 66' ' ' VAL . 1.3 mtm-85 -79.33 81.42 5.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.797 -1.414 . . . . 0.0 111.327 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.575 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -64.46 -179.65 0.31 Allowed Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 34.2 Cg_endo -77.65 -35.63 1.46 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.681 1.587 . . . . 0.0 110.487 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HA ' HD12 ' A' ' 58' ' ' ILE . 1.9 tptp -73.09 -24.57 60.66 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.193 -0.942 . . . . 0.0 109.634 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -84.68 -43.46 14.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.539 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.609 HG21 ' CG ' ' A' ' 42' ' ' TYR . 35.9 m -71.6 -6.55 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.607 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.488 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -71.06 119.84 18.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 O-C-N 121.114 -0.991 . . . . 0.0 108.354 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.17 -19.85 52.16 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -78.79 143.41 36.1 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.41 -1.053 . . . . 0.0 108.911 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.59 123.95 34.12 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.871 ' HB2' HD21 ' A' ' 33' ' ' LEU . 65.3 t80 -56.44 -15.61 4.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.024 -1.047 . . . . 0.0 110.8 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -122.06 36.83 4.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.932 -1.105 . . . . 0.0 109.539 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.86 -52.29 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 110.32 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.24 10.04 8.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.977 -1.077 . . . . 0.0 110.778 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.91 HG13 ' CD ' ' A' ' 52' ' ' ARG . 41.1 t -115.82 -33.95 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.867 -1.146 . . . . 0.0 108.533 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -152.42 91.23 3.61 Favored Pre-proline 0 C--N 1.291 -1.964 0 O-C-N 121.41 -0.806 . . . . 0.0 109.146 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -73.64 -11.54 24.21 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.96 1.773 . . . . 0.0 110.123 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.9 p -86.41 -27.84 23.93 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.308 -0.87 . . . . 0.0 108.985 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.894 HG22 ' CD2' ' A' ' 75' ' ' PHE . 18.4 p -72.04 -4.96 31.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.619 -0.676 . . . . 0.0 110.161 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.22 74.84 9.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.075 -1.016 . . . . 0.0 108.651 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -162.31 172.37 5.55 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.346 -0.846 . . . . 0.0 109.228 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 36.1 Cg_endo -77.54 77.13 3.97 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 122.579 2.186 . . . . 0.0 110.42 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.1 tt0 173.13 -37.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.894 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.9 t80 -105.98 -65.76 1.04 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.562 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 10.4 t80 -77.33 -17.84 57.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' O ' ' CG ' ' A' ' 81' ' ' GLU . . . -62.5 -59.4 9.4 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.54 ' HB2' HG21 ' A' ' 90' ' ' THR . 10.7 mmtt -62.12 -19.36 62.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.689 -0.889 . . . . 0.0 109.399 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.841 ' O ' HG23 ' A' ' 83' ' ' VAL . 11.4 t80 -76.11 -40.41 52.98 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.275 -0.89 . . . . 0.0 108.729 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -6.6 55.45 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.211 -0.93 . . . . 0.0 108.887 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 77' ' ' GLY . 1.5 mm-40 -95.44 -39.6 9.91 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.425 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -70.03 -45.16 58.1 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.863 HG22 ' CE1' ' A' ' 118' ' ' TYR . 48.5 t -59.01 -37.6 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.776 -0.838 . . . . 0.0 109.58 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 -4.25 48.48 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 111.067 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -101.89 -16.91 16.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.845 -1.159 . . . . 0.0 110.025 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.15 17.35 74.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.03 85.97 0.53 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -1.202 . . . . 0.0 108.663 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.464 HD13 ' HD1' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -81.23 119.0 23.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.445 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 2.9 p30 -160.5 89.01 0.81 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.834 HG23 ' SD ' ' A' ' 109' ' ' MET . 1.6 t -138.77 171.51 14.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.075 -1.015 . . . . 0.0 110.569 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.452 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -158.3 148.27 19.9 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.05 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 12.6 p90 -168.96 153.25 5.57 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.7 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.4 115.32 23.07 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.82 -176.56 2.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.129 -0.982 . . . . 0.0 110.113 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.537 HG22 ' OD1' ' A' ' 97' ' ' ASP . 42.7 m -151.23 110.8 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.73 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 18.5 m-30 -83.52 110.62 18.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.537 ' OD1' HG22 ' A' ' 95' ' ' THR . 17.2 m-20 -133.32 42.43 3.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.829 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.567 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 21.4 p90 -77.33 137.07 38.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER 4.5 64.36 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 CA-C-O 121.447 0.642 . . . . 0.0 111.893 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.717 ' SD ' HG22 ' A' ' 101' ' ' THR . 0.7 OUTLIER -175.84 -176.2 0.82 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.117 -0.989 . . . . 0.0 109.749 -177.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.717 HG22 ' SD ' ' A' ' 100' ' ' MET . 1.2 t -64.14 150.95 91.35 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.881 . . . . 0.0 108.86 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.433 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 31.5 Cg_endo -73.76 130.52 14.75 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 121.846 1.697 . . . . 0.0 110.682 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 95' ' ' THR . 3.3 m -123.46 142.84 50.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.495 -0.753 . . . . 0.0 109.222 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.409 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -118.06 139.77 50.73 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.675 ' HA ' HG23 ' A' ' 125' ' ' VAL . 11.0 m -154.36 144.71 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.962 -1.086 . . . . 0.0 110.399 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -94.2 116.02 28.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.05 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -89.24 164.24 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 122.307 1.051 . . . . 0.0 111.232 -175.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.49 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 21.2 t-160 -160.57 102.65 1.36 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.847 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -114.35 151.12 33.51 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.393 -0.817 . . . . 0.0 110.203 -177.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 3.3 tttt -147.66 176.24 10.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.552 -1.343 . . . . 0.0 109.114 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.446 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 4.4 ttpt -85.02 107.39 17.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.923 -1.111 . . . . 0.0 109.45 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.82 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -56.69 152.16 12.68 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.415 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.41 5.13 46.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.112 -0.992 . . . . 0.0 110.197 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.5 t -62.37 -44.1 97.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.888 -1.133 . . . . 0.0 109.571 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.42 91.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 52.32 36.74 20.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -1.103 . . . . 0.0 109.696 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.608 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 1.6 t -94.55 174.41 7.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.578 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.863 ' CE1' HG22 ' A' ' 83' ' ' VAL . 8.9 m-85 -147.21 106.75 3.92 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.82 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 9.9 p-90 -103.23 139.38 38.77 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.783 -1.167 . . . . 0.0 112.557 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.847 HG13 ' HG2' ' A' ' 109' ' ' MET . 30.1 t -116.61 110.46 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.657 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.6 m-30 -92.69 118.53 31.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.313 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.73 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -101.3 122.77 53.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.955 -1.091 . . . . 0.0 109.355 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.584 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -99.13 123.11 43.18 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -75.05 118.45 18.01 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.931 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.412 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.939 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 mtt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.79 86.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.368 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 178.55 -35.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.641 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.772 HG11 ' H ' ' A' ' 10' ' ' ASP . 7.2 p -154.7 120.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.142 -0.974 . . . . 0.0 109.734 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.625 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 52.84 -175.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.845 . . . . 0.0 110.101 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.549 ' CG ' ' CD ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -36.29 -49.15 0.68 Allowed 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 122.566 1.174 . . . . 0.0 109.231 178.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.26 41.18 0.05 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 106.245 -2.742 . . . . 0.0 106.245 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.738 ' HB3' HD11 ' A' ' 11' ' ' ILE . 2.0 m -74.11 165.07 25.79 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.698 0.761 . . . . 0.0 111.463 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -88.01 58.47 4.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.619 -0.675 . . . . 0.0 109.257 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.772 ' H ' HG11 ' A' ' 4' ' ' VAL . 20.7 t0 55.84 63.78 1.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.854 -1.154 . . . . 0.0 108.256 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.119 HG22 HD11 ' A' ' 15' ' ' LEU . 14.2 mm -61.9 -57.11 13.56 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.226 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' ILE . 2.9 mt-10 -35.87 -43.21 0.3 Allowed 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.875 -0.516 . . . . 0.0 111.709 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -76.3 -42.42 45.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.009 -1.057 . . . . 0.0 108.986 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.747 HG21 HD22 ' A' ' 23' ' ' LEU . 7.2 m -66.53 -14.04 61.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.665 -0.647 . . . . 0.0 110.233 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.119 HD11 HG22 ' A' ' 11' ' ' ILE . 9.6 mt -97.34 -23.13 16.26 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.918 -1.114 . . . . 0.0 109.051 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.97 -12.82 34.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.34 -0.85 . . . . 0.0 109.609 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.39 -63.4 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.038 -1.039 . . . . 0.0 109.466 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.449 ' CE ' ' HG3' ' A' ' 22' ' ' GLN . 1.3 mtt 64.74 147.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.726 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 18' ' ' MET . 0.4 OUTLIER 166.71 -41.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.362 -0.836 . . . . 0.0 109.575 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -87.99 61.24 6.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.235 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.97 78.39 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.449 ' HG3' ' CE ' ' A' ' 18' ' ' MET . 5.5 tt0 58.11 25.62 12.65 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.24 -1.153 . . . . 0.0 109.232 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.028 HD23 HD21 ' A' ' 26' ' ' LEU . 0.6 OUTLIER 50.99 38.39 20.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.284 -0.885 . . . . 0.0 110.157 179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 44' ' ' ALA . 3.8 p30 -69.27 -9.44 53.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.128 -0.982 . . . . 0.0 109.767 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.75 21.18 42.78 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.028 HD21 HD23 ' A' ' 23' ' ' LEU . 14.6 mt -68.41 152.29 45.63 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 120.972 -1.311 . . . . 0.0 108.759 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.56 9.03 17.12 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.655 ' CZ ' HD11 ' A' ' 11' ' ' ILE . 1.2 p90 -153.5 117.29 4.74 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' HA3' ' HG2' ' A' ' 46' ' ' GLU . . . -53.97 161.61 3.8 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.382 -0.913 . . . . 0.0 110.859 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -136.88 116.0 12.48 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.583 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.5 pp -118.9 157.7 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.212 -0.93 . . . . 0.0 109.733 -178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.726 ' HB3' HD12 ' A' ' 40' ' ' LEU . 12.3 mt-30 -123.04 168.08 12.81 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.833 HD11 ' HB3' ' A' ' 62' ' ' PHE . 15.9 mt -151.69 150.38 30.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.007 . . . . 0.0 110.001 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.524 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -104.85 168.79 8.83 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -46.5 -29.44 3.95 Favored Glycine 0 N--CA 1.504 3.174 0 CA-C-N 118.621 0.646 . . . . 0.0 112.959 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.16 9.98 13.51 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.485 -1.597 . . . . 0.0 110.581 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.586 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.01 26.22 67.18 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.497 ' C ' HD23 ' A' ' 33' ' ' LEU . 13.6 m120 -93.25 134.14 35.76 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.227 -1.16 . . . . 0.0 111.229 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG21 HG23 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -62.61 138.25 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 111.058 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 32' ' ' GLN . 5.7 mt -109.68 -29.23 8.44 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -161.66 159.32 27.32 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.897 ' CE2' HG11 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -138.02 -50.63 0.59 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.38 -1.45 . . . . 0.0 109.311 -178.361 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.585 HD21 ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER 87.57 171.25 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . . . -96.03 -15.36 22.3 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.015 -1.053 . . . . 0.0 112.822 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.585 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -59.17 -64.74 0.83 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.429 -1.419 . . . . 0.0 109.488 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.575 ' OE2' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -59.72 -51.74 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 109.3 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' N ' ' OE2' ' A' ' 46' ' ' GLU . . . -56.96 -15.92 15.66 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 31.3 t70 -76.6 -40.73 48.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.821 -1.399 . . . . 0.0 108.181 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -73.33 -59.29 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.428 -0.795 . . . . 0.0 108.89 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.787 HG21 " O4'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -78.15 -8.55 58.41 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.347 -0.846 . . . . 0.0 110.319 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 82.77 -3.47 83.21 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.401 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.819 ' CZ ' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -60.91 165.73 3.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.743 -1.445 . . . . 0.0 110.078 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.808 ' O ' HG22 ' A' ' 57' ' ' VAL . 7.1 m-20 -133.05 168.11 19.58 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 53' ' ' ASP . 34.4 Cg_endo -77.27 -38.38 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.475 1.45 . . . . 0.0 110.074 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -79.04 -24.56 43.52 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.312 -0.867 . . . . 0.0 109.487 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -45.3 18.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.897 HG11 ' CE2' ' A' ' 42' ' ' TYR . 20.4 m -69.28 -9.66 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.198 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.459 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -68.98 120.72 16.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.96 -24.31 32.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 60' ' ' LYS . 6.8 mmmt -78.9 130.38 35.57 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' ND2' ' ND2' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -79.19 132.58 36.57 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.567 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.868 ' CE2' HG21 ' A' ' 70' ' ' THR . 64.9 t80 -60.32 -14.37 18.01 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.068 -1.02 . . . . 0.0 110.118 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 99.5 m-85 -124.31 33.39 5.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.019 -1.051 . . . . 0.0 110.378 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -154.57 -40.7 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.882 -1.136 . . . . 0.0 110.377 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.53 7.86 3.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.007 -1.058 . . . . 0.0 110.881 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.819 HG13 ' CZ ' ' A' ' 52' ' ' ARG . 94.3 t -114.11 -33.85 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 120.673 -1.267 . . . . 0.0 108.448 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.633 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -155.06 100.62 2.31 Favored Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.544 -0.722 . . . . 0.0 109.182 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.97 -1.23 10.94 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.913 1.742 . . . . 0.0 110.876 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.5 p -97.37 -25.32 15.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.219 -0.926 . . . . 0.0 109.133 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.868 HG21 ' CE2' ' A' ' 62' ' ' PHE . 67.7 p -66.98 -10.68 52.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.638 -0.663 . . . . 0.0 110.187 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.28 64.62 8.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 109.626 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.428 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -147.44 172.53 5.09 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.232 -0.917 . . . . 0.0 109.181 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -76.66 78.4 3.35 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 122.514 2.142 . . . . 0.0 110.314 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.8 tt0 169.36 -36.14 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.669 ' CD1' ' HE1' ' A' ' 109' ' ' MET . 1.3 t80 -104.21 -68.06 0.87 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.509 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 14.4 t80 -75.53 -20.69 58.53 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.69 -59.08 9.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.544 ' HB2' HG21 ' A' ' 90' ' ' THR . 8.5 mmtt -66.45 -14.17 61.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.523 -0.986 . . . . 0.0 109.915 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.846 ' O ' HG23 ' A' ' 83' ' ' VAL . 15.7 t80 -83.33 -35.02 25.51 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.371 -0.83 . . . . 0.0 109.048 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -11.95 59.88 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.157 -0.964 . . . . 0.0 109.246 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 23.5 pt-20 -97.84 -42.2 7.68 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.595 ' C ' HD12 ' A' ' 88' ' ' LEU . . . -61.61 -38.49 95.94 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.705 -2.158 . . . . 0.0 107.705 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.849 HG22 ' CE1' ' A' ' 118' ' ' TYR . 98.0 t -65.07 -40.15 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.795 -0.827 . . . . 0.0 110.042 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.61 0.36 57.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.0 111.135 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 t -109.74 -19.64 13.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.879 -1.138 . . . . 0.0 109.998 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.21 14.59 81.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -144.31 59.07 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.156 -1.203 . . . . 0.0 109.275 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.595 HD12 ' C ' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -68.25 113.48 5.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.357 -0.839 . . . . 0.0 109.656 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -161.04 79.44 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.386 -0.822 . . . . 0.0 108.908 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 78' ' ' LYS . 4.2 t -120.92 167.8 12.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.031 -1.043 . . . . 0.0 110.181 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 4.0 ttt -154.88 154.33 32.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.451 -0.78 . . . . 0.0 109.222 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.069 ' CE2' HG21 ' A' ' 107' ' ' VAL . 15.4 p90 -176.85 178.04 1.24 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.181 -0.95 . . . . 0.0 109.869 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.91 100.23 10.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.047 -1.033 . . . . 0.0 108.299 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.496 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -101.6 151.72 21.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 110.06 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -119.01 111.09 17.88 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.934 ' CE2' HG21 ' A' ' 122' ' ' VAL . 19.1 m-30 -79.28 115.78 19.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.402 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -137.51 46.3 2.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -85.32 43.95 1.06 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.623 -0.673 . . . . 0.0 111.688 -178.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 98' ' ' TYR . 0.1 OUTLIER 100.9 27.82 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.698 0 CA-C-O 121.603 0.716 . . . . 0.0 109.271 179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.408 ' CE ' ' HA ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -139.28 175.15 9.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 19.5 p -54.52 161.27 2.18 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.024 -1.048 . . . . 0.0 109.287 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.4 Cg_endo -75.94 96.66 1.07 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.776 1.65 . . . . 0.0 110.049 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.462 HG22 HG13 ' A' ' 105' ' ' VAL . 1.0 OUTLIER -104.42 125.09 50.32 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.377 -0.827 . . . . 0.0 109.8 -179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' C ' HG23 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -88.7 159.92 17.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 104.756 -2.312 . . . . 0.0 104.756 175.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.672 HG23 HG13 ' A' ' 107' ' ' VAL . 35.6 m -156.17 142.49 10.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 118.456 -1.298 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -79.13 103.5 9.12 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 175.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.069 HG21 ' CE2' ' A' ' 92' ' ' PHE . 33.7 m -94.8 151.88 3.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 O-C-N 120.806 -1.184 . . . . 0.0 110.24 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.509 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 3.5 t-160 -153.96 103.3 2.56 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.783 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -104.75 131.82 51.74 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.079 -1.013 . . . . 0.0 109.297 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.588 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 3.9 tttt -130.34 -174.69 3.41 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.209 -1.396 . . . . 0.0 109.894 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 10.7 tttt -99.79 102.64 14.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.102 -0.999 . . . . 0.0 108.713 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.904 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -56.03 142.36 36.48 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.349 -0.844 . . . . 0.0 110.056 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.59 0.52 52.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.88 . . . . 0.0 109.985 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 p -59.03 -20.69 55.5 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.859 -1.15 . . . . 0.0 109.503 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.98 53.36 0.02 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 56.67 62.12 2.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.227 -1.161 . . . . 0.0 109.253 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.86 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -111.51 -161.79 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.354 -0.841 . . . . 0.0 110.104 -179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.849 ' CE1' HG22 ' A' ' 83' ' ' VAL . 14.9 m-85 -151.91 111.35 3.94 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.904 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 20.1 p-90 -113.01 149.79 32.84 Favored 'General case' 0 C--O 1.202 -1.405 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.531 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.783 HG13 ' HG2' ' A' ' 109' ' ' MET . 46.6 t -128.24 106.25 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.726 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.666 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 7.5 m-30 -91.72 128.31 37.51 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.934 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.7 t -105.96 129.35 59.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.625 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -101.34 153.43 19.66 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.1 ttt-85 -101.51 127.87 48.0 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.277 -1.369 . . . . 0.0 109.068 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.437 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.787 " O4'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.6 179.77 5.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.487 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 62.57 29.96 17.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.853 . . . . 0.0 109.53 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.887 HG11 ' O ' ' A' ' 8' ' ' SER . 0.3 OUTLIER 43.17 -161.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.574 0.702 . . . . 0.0 110.342 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.677 ' N ' HG13 ' A' ' 4' ' ' VAL . . . -63.38 -144.42 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CE1' ' HD3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -86.92 46.02 1.33 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.063 -1.023 . . . . 0.0 109.02 178.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.39 16.93 11.22 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.887 ' O ' HG11 ' A' ' 4' ' ' VAL . 97.8 p -78.75 165.33 23.72 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.263 -1.139 . . . . 0.0 109.266 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.73 74.9 0.9 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.147 -0.971 . . . . 0.0 110.061 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.716 ' H ' HG21 ' A' ' 4' ' ' VAL . 18.0 t0 50.05 84.86 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.945 HG22 HD11 ' A' ' 15' ' ' LEU . 4.4 mm -90.82 -59.45 2.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.302 -0.874 . . . . 0.0 110.553 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -22.92 0.77 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.578 -1.327 . . . . 0.0 110.558 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.4 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . 6.5 t-20 -94.29 -36.81 11.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 109.399 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.465 HG23 ' CB ' ' A' ' 18' ' ' MET . 1.1 m -69.51 -59.8 2.74 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.945 HD11 HG22 ' A' ' 11' ' ' ILE . 18.1 mt -40.76 -34.61 0.4 Allowed 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.434 0.635 . . . . 0.0 109.793 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.52 -56.01 7.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.485 -0.759 . . . . 0.0 109.865 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -138.55 85.94 2.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.212 -0.93 . . . . 0.0 109.811 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.629 ' CE ' HD22 ' A' ' 23' ' ' LEU . 1.3 pmm? -108.82 -170.95 1.75 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 109.169 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.486 ' N ' ' HG2' ' A' ' 18' ' ' MET . 1.3 m-20 -87.41 27.28 1.1 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.941 -1.099 . . . . 0.0 111.192 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 61.34 97.65 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.143 -0.973 . . . . 0.0 109.304 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.19 13.21 20.08 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.44 ' HB2' ' CG ' ' A' ' 18' ' ' MET . 1.7 mt-30 -101.62 -29.52 11.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.14 -1.212 . . . . 0.0 109.345 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -73.4 -19.47 60.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.903 . . . . 0.0 109.593 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -102.98 0.22 31.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 110.048 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.09 29.23 12.97 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 120.824 -1.172 . . . . 0.0 110.282 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.644 HD13 ' CE2' ' A' ' 28' ' ' PHE . 3.2 mt -105.35 -177.01 3.24 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.051 -1.264 . . . . 0.0 109.025 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.44 4.5 48.41 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.644 ' CE2' HD13 ' A' ' 26' ' ' LEU . 8.1 p90 -135.96 129.24 31.85 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -63.41 122.49 26.99 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.479 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -100.88 96.3 7.19 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.074 -1.25 . . . . 0.0 107.752 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.543 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.3 pp -98.24 148.82 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 110.787 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.595 ' HB3' HD12 ' A' ' 40' ' ' LEU . 5.5 mm-40 -113.56 167.32 10.7 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.884 HD22 ' O ' ' A' ' 37' ' ' GLY . 55.4 mt -155.46 139.89 16.79 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.165 -0.959 . . . . 0.0 108.91 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.598 ' HB2' HD21 ' A' ' 40' ' ' LEU . 8.1 t0 -120.52 131.71 54.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.919 -1.113 . . . . 0.0 110.433 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 35.87 -77.04 0.0 OUTLIER Glycine 0 N--CA 1.501 2.978 0 C-N-CA 124.71 1.148 . . . . 0.0 113.403 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -73.37 2.56 7.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.659 -0.907 . . . . 0.0 111.109 -178.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.884 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 82.4 17.34 69.09 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -72.58 136.34 45.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.087 -1.243 . . . . 0.0 108.693 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.599 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -64.44 135.59 27.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.224 -0.922 . . . . 0.0 111.094 -178.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 34' ' ' ASP . 1.5 mt -105.56 -29.39 10.19 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 177.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HG2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -163.51 164.09 24.47 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.632 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 7.4 t80 -133.36 -75.95 0.48 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 119.955 -1.716 . . . . 0.0 110.599 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.632 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 8.0 t-20 134.25 150.04 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.691 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -77.47 -55.88 5.01 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.335 -0.853 . . . . 0.0 109.834 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -34.0 -57.58 0.46 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.475 ' O ' HG23 ' A' ' 50' ' ' THR . 15.5 pt-20 -64.22 -46.73 82.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.948 -1.095 . . . . 0.0 109.676 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . -62.63 -12.2 39.51 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.08 -32.87 17.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.631 -1.511 . . . . 0.0 110.355 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.65 -35.08 11.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.179 -0.951 . . . . 0.0 108.899 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.598 HG21 " H3'" ' A' ' 126' ' ' HC4 . 0.2 OUTLIER -107.3 -21.46 12.94 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.029 -179.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 97.93 -3.33 60.47 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.546 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 1.003 ' CZ ' HG12 ' A' ' 66' ' ' VAL . 1.8 mtt85 -68.09 95.23 0.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.86 -1.376 . . . . 0.0 110.666 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.777 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -72.52 162.29 74.79 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 53' ' ' ASP . 34.7 Cg_endo -76.98 -29.53 5.16 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.959 1.773 . . . . 0.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.79 -33.97 34.43 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.269 -0.894 . . . . 0.0 109.899 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -41.73 49.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.717 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 53' ' ' ASP . 34.1 m -74.26 -4.48 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.875 . . . . 0.0 109.914 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.555 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.21 123.64 23.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.82 -19.37 52.0 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -82.66 133.69 35.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -1.139 . . . . 0.0 109.102 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.485 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -75.0 119.78 19.65 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.204 -0.935 . . . . 0.0 108.501 179.2 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.599 ' HB2' HD12 ' A' ' 39' ' ' ILE . 90.9 t80 -66.32 -8.89 28.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.895 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.639 ' CE2' HD13 ' A' ' 33' ' ' LEU . 34.3 m-85 -96.93 -60.19 1.64 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.202 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -112.96 20.89 15.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.902 -1.124 . . . . 0.0 110.851 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.485 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.4 OUTLIER -137.01 -14.91 1.54 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.872 -1.142 . . . . 0.0 111.44 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 1.003 HG12 ' CZ ' ' A' ' 52' ' ' ARG . 31.5 t -122.43 -47.99 2.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 120.55 -1.344 . . . . 0.0 108.559 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.655 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . . . -122.65 109.96 32.19 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -75.17 0.79 8.55 Favored 'Trans proline' 0 C--N 1.32 -0.964 0 C-N-CA 121.912 1.742 . . . . 0.0 111.505 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.2 p -98.68 -24.84 14.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.87 -1.144 . . . . 0.0 109.658 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.596 HG21 ' CE2' ' A' ' 62' ' ' PHE . 61.2 p -73.67 -4.04 31.9 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.332 -0.855 . . . . 0.0 109.863 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.9 p30 -88.44 50.82 2.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.014 -1.054 . . . . 0.0 109.148 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.418 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -127.1 174.84 3.82 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.8 Cg_endo -76.77 -1.33 11.45 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 122.101 1.867 . . . . 0.0 111.387 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 14.9 mp0 -105.34 -28.42 10.9 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.916 -1.115 . . . . 0.0 109.357 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.631 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.7 t80 -100.57 -71.99 0.69 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.44 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 11.4 t80 -72.96 -16.11 61.54 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 120.947 -1.096 . . . . 0.0 108.234 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.65 -62.6 4.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.58 ' CB ' HG21 ' A' ' 90' ' ' THR . 2.2 mmtp -64.06 -14.89 57.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.672 -0.899 . . . . 0.0 109.551 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.867 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.3 t80 -80.53 -41.18 24.66 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 -9.35 58.51 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.276 -0.89 . . . . 0.0 108.689 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 85' ' ' SER . 2.1 mm-40 -95.9 -40.17 9.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.7 95.02 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 79' ' ' PHE . 61.8 t -62.96 -40.61 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.943 -0.74 . . . . 0.0 109.975 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.37 1.4 54.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.256 -0.902 . . . . 0.0 111.218 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 81' ' ' GLU . 97.5 p -104.69 -24.13 12.98 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.863 -1.148 . . . . 0.0 110.142 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.03 21.17 47.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -160.16 57.08 0.35 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -1.189 . . . . 0.0 109.333 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.538 HD13 ' CD1' ' A' ' 118' ' ' TYR . 1.5 tt -66.29 102.39 0.85 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.422 -0.798 . . . . 0.0 109.447 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -161.6 82.95 0.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.58 HG21 ' CB ' ' A' ' 78' ' ' LYS . 10.1 t -139.79 174.58 10.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.904 -1.123 . . . . 0.0 110.233 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -149.75 168.77 22.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.05 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 8.8 p90 -174.47 154.29 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.079 -1.013 . . . . 0.0 109.929 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -80.47 117.16 20.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.41 -0.806 . . . . 0.0 108.943 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.03 169.3 11.8 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.249 -0.907 . . . . 0.0 109.435 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.446 HG22 ' OD1' ' A' ' 97' ' ' ASP . 0.7 OUTLIER -140.19 111.31 7.04 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.376 -0.828 . . . . 0.0 109.313 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.827 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 20.6 m-30 -79.64 85.04 5.4 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.455 -0.778 . . . . 0.0 109.12 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.446 ' OD1' HG22 ' A' ' 95' ' ' THR . 1.2 m-20 -102.99 29.47 5.43 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.548 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -77.59 153.39 33.32 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 98' ' ' TYR . 10.0 mt-30 -2.0 67.35 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 123.365 0.666 . . . . 0.0 112.457 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.9 -157.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.0 109.845 -178.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -91.22 174.17 4.7 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 0.0 108.882 179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 34.3 Cg_endo -76.71 87.79 1.44 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.949 1.766 . . . . 0.0 110.509 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.46 HG22 HG13 ' A' ' 105' ' ' VAL . 1.8 m -87.52 106.9 18.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 109.443 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.42 139.33 31.61 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.786 ' HA ' HG23 ' A' ' 125' ' ' VAL . 13.7 m -149.94 146.14 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.131 -0.981 . . . . 0.0 110.115 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.572 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.22 115.79 29.09 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 175.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.05 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -85.97 159.96 3.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 120.82 -1.175 . . . . 0.0 110.925 -175.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 6.3 t-160 -157.15 98.42 1.73 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.881 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -109.09 149.38 29.4 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.395 -0.816 . . . . 0.0 109.748 -177.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.673 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -141.07 -175.04 4.17 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.374 -1.33 . . . . 0.0 109.695 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.458 ' CE ' ' HA2' ' A' ' 115' ' ' GLY . 5.0 ttpm? -89.63 101.79 14.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 109.258 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.643 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -56.85 156.93 6.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.615 -0.678 . . . . 0.0 110.871 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 0.4 OUTLIER 62.23 15.29 7.41 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.575 -0.703 . . . . 0.0 109.389 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.52 23.12 5.66 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.132 -0.98 . . . . 0.0 109.252 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA2' ' CE ' ' A' ' 111' ' ' LYS . . . 140.66 75.56 0.04 OUTLIER Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.003 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 113' ' ' LEU . 0.4 OUTLIER 174.66 -60.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -1.129 . . . . 0.0 109.714 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.58 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -108.57 -168.56 1.37 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.996 -1.065 . . . . 0.0 109.929 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CE1' HG22 ' A' ' 83' ' ' VAL . 1.7 m-85 -149.74 127.54 11.76 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.673 ' CH2' ' HB2' ' A' ' 110' ' ' LYS . 10.2 p-90 -123.8 148.24 46.86 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.968 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.881 HG13 ' CG ' ' A' ' 109' ' ' MET . 11.7 t -123.0 109.49 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.314 0.578 . . . . 0.0 109.827 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.653 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 9.2 m-30 -88.24 126.37 35.12 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.827 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.2 t -103.88 114.71 44.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.572 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -89.52 111.79 22.8 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.606 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -66.95 109.03 2.79 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.948 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.786 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.161 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.598 " H3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.5 mtt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.1 145.29 40.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.283 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.61 -173.06 1.13 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.286 -0.884 . . . . 0.0 109.789 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.864 HG12 ' OG ' ' A' ' 8' ' ' SER . 5.0 t -91.26 107.38 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.816 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 41.11 -158.28 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.592 0.711 . . . . 0.0 111.195 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -49.85 -55.15 15.36 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.09 31.08 0.28 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.864 ' OG ' HG12 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -59.1 156.7 11.54 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.595 -0.944 . . . . 0.0 111.251 -178.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.38 60.52 1.93 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.636 ' H ' HG11 ' A' ' 4' ' ' VAL . 7.6 m-20 54.74 80.8 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.525 -1.359 . . . . 0.0 107.714 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.988 HG22 HD11 ' A' ' 15' ' ' LEU . 4.9 mm -83.6 -56.77 5.23 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 110.732 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.459 ' HA ' HD12 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -40.35 -29.23 0.08 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.773 . . . . 0.0 111.559 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 11' ' ' ILE . 4.8 m120 -89.37 -40.83 12.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.966 -1.083 . . . . 0.0 108.258 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.845 ' CG2' HD13 ' A' ' 23' ' ' LEU . 4.1 m -69.2 -10.18 56.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.719 -0.613 . . . . 0.0 109.794 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.988 HD11 HG22 ' A' ' 11' ' ' ILE . 15.4 mt -97.48 -24.54 15.54 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.019 -1.05 . . . . 0.0 109.172 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.56 -15.98 26.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.423 -0.798 . . . . 0.0 109.627 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -128.88 56.54 1.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.021 -1.049 . . . . 0.0 109.881 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.453 ' HG2' ' CG ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -56.94 150.11 17.38 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.239 -0.913 . . . . 0.0 108.884 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.29 -45.43 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.228 -0.92 . . . . 0.0 110.227 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.78 64.94 7.49 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.84 17.29 67.19 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.453 ' CG ' ' HG2' ' A' ' 18' ' ' MET . 42.1 mt-30 50.51 28.95 3.66 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.495 -1.003 . . . . 0.0 109.448 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.845 HD13 ' CG2' ' A' ' 14' ' ' THR . 1.2 mp 50.93 62.81 2.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.461 -0.774 . . . . 0.0 109.825 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.83 -3.33 57.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.861 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.96 30.09 9.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.604 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 31.8 mt -80.17 128.3 33.36 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.51 -0.994 . . . . 0.0 109.207 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.17 -13.78 8.42 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.599 0.714 . . . . 0.0 109.227 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.732 ' HZ ' HD11 ' A' ' 11' ' ' ILE . 14.6 p90 -129.16 150.7 50.44 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.068 -1.02 . . . . 0.0 108.843 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.528 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -76.69 152.03 40.32 Favored Glycine 0 C--N 1.293 -1.81 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -123.7 90.61 3.31 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.832 -1.393 . . . . 0.0 107.536 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.527 HG22 ' CD1' ' A' ' 42' ' ' TYR . 1.1 pp -94.71 142.6 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.489 -0.757 . . . . 0.0 110.762 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.472 ' CG ' ' HB3' ' A' ' 41' ' ' GLN . 2.0 mm100 -114.11 168.33 9.91 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.847 HD22 ' O ' ' A' ' 37' ' ' GLY . 73.3 mt -153.94 146.92 24.49 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.842 -1.161 . . . . 0.0 110.379 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 36' ' ' ASP . 45.1 m-20 -123.63 124.07 41.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.394 -0.816 . . . . 0.0 109.659 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.54 -77.32 0.0 OUTLIER Glycine 0 N--CA 1.5 2.951 0 C-N-CA 124.561 1.077 . . . . 0.0 113.679 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -70.57 -2.86 15.51 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.598 -0.942 . . . . 0.0 111.197 -177.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.847 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 88.02 20.52 49.54 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -75.5 130.16 38.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.086 -1.244 . . . . 0.0 108.201 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.648 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -59.78 139.01 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 110.561 -178.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 116' ' ' ASP . 2.7 mt -107.07 -26.59 11.07 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.472 ' HB3' ' CG ' ' A' ' 32' ' ' GLN . 0.9 OUTLIER -160.31 142.11 12.66 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.527 ' CD1' HG22 ' A' ' 31' ' ' ILE . 6.2 t80 -121.95 -64.22 1.23 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.756 -1.215 . . . . 0.0 110.729 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.555 HD21 ' HB3' ' A' ' 45' ' ' ALA . 3.2 p-10 101.86 175.6 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.59 -19.42 19.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.855 -1.153 . . . . 0.0 112.615 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.555 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -56.84 -63.44 1.2 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.51 -1.369 . . . . 0.0 110.163 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.9 pt-20 -60.77 -53.18 60.46 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.579 -0.701 . . . . 0.0 109.392 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -57.96 -14.38 16.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.46 -30.78 20.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.786 -1.42 . . . . 0.0 110.205 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.36 -38.12 14.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.122 -0.986 . . . . 0.0 109.074 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.836 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.7 OUTLIER -102.86 -18.28 15.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.5 -0.75 . . . . 0.0 109.669 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 92.72 -3.76 74.89 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.606 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -58.39 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.239 . . . . 0.0 109.213 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.719 ' O ' HG22 ' A' ' 57' ' ' VAL . 12.1 m-20 -54.74 152.93 11.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 108.919 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.55 -42.81 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 122.07 1.847 . . . . 0.0 110.68 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -74.73 -27.81 60.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.13 -0.981 . . . . 0.0 109.94 -179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -80.66 -39.65 26.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.154 -0.966 . . . . 0.0 109.613 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 53' ' ' ASP . 24.0 m -76.66 -1.99 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.837 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -71.71 122.1 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.061 -1.024 . . . . 0.0 108.48 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.06 -13.13 65.58 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 35.1 mmtt -79.13 136.23 37.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.048 -1.266 . . . . 0.0 108.93 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.455 ' N ' ' HB3' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -72.41 95.03 1.71 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.459 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 30.1 t80 -53.92 -22.71 10.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 109.794 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -91.78 -31.98 15.55 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.72 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -138.15 44.98 2.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 109.114 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.455 ' HB3' ' N ' ' A' ' 61' ' ' ASN . 34.0 t0 -164.26 -31.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.388 -0.82 . . . . 0.0 110.517 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.606 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 3.9 t -112.2 -50.57 5.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 O-C-N 120.754 -1.216 . . . . 0.0 108.674 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.546 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -121.63 94.74 48.36 Favored Pre-proline 0 C--N 1.292 -1.9 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.709 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.22 -6.02 17.82 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.886 1.724 . . . . 0.0 110.462 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.7 p -77.82 -32.87 52.54 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.151 -0.968 . . . . 0.0 108.692 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.457 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 19.1 p -69.1 -9.44 52.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.604 -0.685 . . . . 0.0 109.764 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.87 76.74 9.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.997 -1.064 . . . . 0.0 108.635 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.426 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -165.07 173.46 3.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 109.085 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.6 Cg_endo -77.4 76.71 4.12 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 122.497 2.132 . . . . 0.0 110.416 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 3.6 tt0 174.27 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.617 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.3 t80 -105.65 -64.03 1.19 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.506 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.4 t80 -79.61 -20.43 46.85 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.081 -1.012 . . . . 0.0 108.56 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.46 -57.81 13.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.717 ' CB ' HG21 ' A' ' 90' ' ' THR . 12.1 mmtt -65.38 -16.69 63.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.658 -0.907 . . . . 0.0 109.802 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.89 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.4 t80 -82.62 -35.12 27.29 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 109.517 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -76.32 -12.88 60.14 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.103 -0.998 . . . . 0.0 109.032 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 18.7 pt-20 -96.92 -41.34 8.46 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.461 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -60.18 -39.86 96.48 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 107.454 -2.258 . . . . 0.0 107.454 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 79' ' ' PHE . 99.1 t -59.88 -47.59 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.794 -0.827 . . . . 0.0 109.296 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.76 5.58 45.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.386 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.3 m -102.0 -25.75 13.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.042 -1.037 . . . . 0.0 109.612 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.78 22.29 64.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -166.03 58.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.134 -1.216 . . . . 0.0 109.51 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 0.5 OUTLIER -52.94 116.35 2.31 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.895 . . . . 0.0 109.515 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.425 ' ND2' ' HE3' ' A' ' 110' ' ' LYS . 2.4 t-20 -160.2 78.34 0.66 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.168 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.717 HG21 ' CB ' ' A' ' 78' ' ' LYS . 9.1 t -136.44 154.91 50.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 109.63 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.96 163.0 34.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 0.0 108.923 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.021 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 8.6 p90 -175.27 151.59 1.29 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.041 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 1.5 pt-20 -81.73 112.39 18.86 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.195 -0.941 . . . . 0.0 108.636 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.79 -179.63 3.71 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.181 -0.949 . . . . 0.0 109.99 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.3 m -147.52 107.56 4.02 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.848 ' CE2' HG21 ' A' ' 122' ' ' VAL . 17.8 m-30 -84.13 92.58 7.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.377 -0.827 . . . . 0.0 109.718 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -108.01 25.21 11.85 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.264 -0.898 . . . . 0.0 109.338 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.576 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.2 OUTLIER -78.65 155.39 29.54 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.52 ' C ' ' O ' ' A' ' 98' ' ' TYR . 24.1 mt-30 -0.32 65.85 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.187 0 CA-C-O 121.631 0.729 . . . . 0.0 112.099 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.576 ' N ' ' O ' ' A' ' 98' ' ' TYR . 1.0 OUTLIER 173.64 158.36 0.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -53.68 168.44 0.4 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.114 -0.991 . . . . 0.0 109.088 179.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 32.8 Cg_endo -74.75 113.34 3.77 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.831 1.688 . . . . 0.0 110.194 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.522 HG22 HG13 ' A' ' 105' ' ' VAL . 4.3 m -116.25 114.93 25.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.844 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 125' ' ' VAL . 5.4 tttt -92.05 136.65 33.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.852 ' HA ' HG23 ' A' ' 125' ' ' VAL . 32.6 m -147.44 146.27 18.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.146 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.86 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -91.71 116.37 28.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 175.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.021 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -88.27 164.12 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.787 -1.196 . . . . 0.0 111.516 -175.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -150.83 98.7 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.876 ' HG2' HG13 ' A' ' 120' ' ' VAL . 19.5 mtm -96.85 125.4 41.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.682 -1.261 . . . . 0.0 109.503 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.553 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 3.9 tttt -132.15 172.12 12.79 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 117.525 -1.67 . . . . 0.0 109.706 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.445 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 2.1 tttp -90.29 107.68 19.29 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.979 -1.076 . . . . 0.0 108.384 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.876 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.21 -177.17 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.28 0.562 . . . . 0.0 110.154 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.12 81.21 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.027 . . . . 0.0 110.461 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.7 m 57.02 100.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.656 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 131.35 -11.27 5.54 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.56 ' HA ' HD12 ' A' ' 40' ' ' LEU . 13.9 m-20 -147.61 -39.56 0.19 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.211 -1.17 . . . . 0.0 109.546 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.577 ' N ' ' HB3' ' A' ' 112' ' ' ALA . 4.6 t 77.75 -75.5 0.06 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.307 -0.871 . . . . 0.0 111.146 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.618 ' OH ' HG13 ' A' ' 83' ' ' VAL . 12.6 m-85 -127.3 122.8 34.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.742 -1.224 . . . . 0.0 109.227 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.876 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 22.1 p-90 -128.11 152.42 48.02 Favored 'General case' 0 C--O 1.201 -1.455 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.919 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.876 HG13 ' HG2' ' A' ' 109' ' ' MET . 60.9 t -132.36 110.31 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.305 0.574 . . . . 0.0 109.648 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.686 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 9.1 m-30 -94.34 122.09 36.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 108.987 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.848 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -103.03 116.84 47.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.01 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 1.6 tptp -88.09 114.18 24.45 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.828 ' HA ' HG12 ' A' ' 105' ' ' VAL . 1.2 ttp85 -67.85 111.6 4.42 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.456 -1.297 . . . . 0.0 108.544 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.86 HG22 ' HD2' ' A' ' 106' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.058 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.836 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.307 0.575 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 59.08 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.27 -0.894 . . . . 0.0 109.741 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 3' ' ' HIS . 3.2 p80 -155.22 67.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.679 ' O ' HG13 ' A' ' 4' ' ' VAL . 10.2 p -57.15 114.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.42 -0.8 . . . . 0.0 110.305 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.573 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 50.75 -175.14 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.166 -0.958 . . . . 0.0 110.856 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.61 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -42.08 -53.77 3.83 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-O 122.009 0.909 . . . . 0.0 109.138 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.36 42.16 0.18 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 106.926 -2.47 . . . . 0.0 106.926 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.976 ' CB ' HD11 ' A' ' 11' ' ' ILE . 1.5 m -83.13 -169.49 2.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.908 -0.76 . . . . 0.0 111.28 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -119.07 76.04 1.08 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.477 -0.764 . . . . 0.0 110.628 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.676 ' H ' HG11 ' A' ' 4' ' ' VAL . 14.7 m-20 47.56 86.57 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.975 -1.078 . . . . 0.0 108.482 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.046 HG22 HD11 ' A' ' 15' ' ' LEU . 1.9 mm -88.64 -67.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.117 -0.989 . . . . 0.0 111.142 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -41.16 -36.06 0.68 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.624 -0.672 . . . . 0.0 111.592 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -77.54 -42.76 34.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.872 -1.143 . . . . 0.0 108.455 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.069 HG21 HD22 ' A' ' 23' ' ' LEU . 2.0 m -76.03 -4.38 40.95 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.046 HD11 HG22 ' A' ' 11' ' ' ILE . 81.2 mt -97.85 -23.03 16.04 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.855 -1.153 . . . . 0.0 109.149 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.9 -29.62 63.29 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.483 -0.761 . . . . 0.0 108.994 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -124.07 62.34 1.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.408 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.637 ' CE ' HD23 ' A' ' 15' ' ' LEU . 3.3 ttm -129.03 98.45 4.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.999 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 20' ' ' ASP . 11.5 t0 -68.48 -52.96 26.65 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.178 -0.951 . . . . 0.0 108.61 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' ASP . 0.2 OUTLIER 167.16 92.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.554 -0.716 . . . . 0.0 109.118 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.3 -23.68 3.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.672 ' O ' HD12 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -56.26 -47.83 77.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -1.154 . . . . 0.0 109.233 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.069 HD22 HG21 ' A' ' 14' ' ' THR . 0.5 OUTLIER -141.0 69.55 1.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -109.99 -6.58 15.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.935 . . . . 0.0 109.842 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.16 28.88 13.68 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.915 HD21 HD23 ' A' ' 23' ' ' LEU . 1.7 mt -73.68 -171.91 1.14 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.128 -1.219 . . . . 0.0 108.798 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.85 13.22 23.63 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.85 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 18.8 p90 -146.12 177.2 9.16 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.684 -0.635 . . . . 0.0 109.509 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 46' ' ' GLU . . . -108.66 118.8 5.44 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.471 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -94.81 89.39 5.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.919 -1.342 . . . . 0.0 109.061 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.656 HD12 ' N ' ' A' ' 32' ' ' GLN . 1.1 pp -96.0 161.47 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.494 -0.754 . . . . 0.0 109.403 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.656 ' N ' HD12 ' A' ' 31' ' ' ILE . 8.9 mt-30 -132.16 175.77 8.96 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.825 HD21 ' HB2' ' A' ' 62' ' ' PHE . 22.3 mt -155.77 146.25 21.88 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.756 ' HB2' HD21 ' A' ' 40' ' ' LEU . 14.6 t70 -99.16 169.96 9.02 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.86 -21.82 1.74 Allowed Glycine 0 N--CA 1.499 2.893 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.449 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -94.98 13.51 24.77 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.547 -1.56 . . . . 0.0 110.549 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.07 26.68 65.9 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 2.0 m-20 -97.25 126.22 42.31 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.987 -1.302 . . . . 0.0 111.929 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.499 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -53.09 133.41 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.117 -0.99 . . . . 0.0 110.709 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 34' ' ' ASP . 11.6 mt -102.74 -32.2 9.95 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -155.54 -175.16 5.29 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.883 ' CE2' HG11 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -160.62 -62.8 0.06 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.97 -1.081 . . . . 0.0 110.239 -178.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.623 HD21 ' HB3' ' A' ' 45' ' ' ALA . 4.8 p-10 103.92 176.49 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.22 -37.03 11.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.974 -1.079 . . . . 0.0 110.758 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.623 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -46.76 -48.18 20.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.233 -0.917 . . . . 0.0 111.047 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' OE2' ' HB2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -61.83 -47.51 84.78 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.388 -0.82 . . . . 0.0 109.34 -177.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . -61.27 -15.87 46.71 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -80.64 -32.32 36.24 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.121 -1.223 . . . . 0.0 109.464 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.599 HD11 ' HD3' ' A' ' 124' ' ' ARG . 0.6 OUTLIER -85.06 -50.61 14.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.075 -1.015 . . . . 0.0 109.441 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.777 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -88.58 -13.88 38.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.759 -1.213 . . . . 0.0 109.524 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 89.09 -11.77 68.35 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.716 ' CD ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -57.78 175.54 0.19 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -1.165 . . . . 0.0 109.525 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.656 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -127.86 158.85 69.2 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 108.943 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.97 -37.99 1.8 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.865 1.71 . . . . 0.0 110.656 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -89.23 -25.26 21.83 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.171 -0.955 . . . . 0.0 109.279 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.411 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 1.2 tt0 -73.89 -37.88 64.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.229 -0.919 . . . . 0.0 108.689 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.883 HG11 ' CE2' ' A' ' 42' ' ' TYR . 26.6 m -70.9 -8.45 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.815 . . . . 0.0 109.393 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -70.97 122.56 23.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.08 -19.7 51.71 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 40.4 mmtt -78.73 130.94 36.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.451 -1.029 . . . . 0.0 108.927 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.09 128.1 34.66 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.825 ' HB2' HD21 ' A' ' 33' ' ' LEU . 63.2 t80 -62.33 -11.53 15.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.149 -0.969 . . . . 0.0 110.584 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -122.52 32.17 5.86 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.95 -1.094 . . . . 0.0 110.271 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -150.09 -45.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.07 . . . . 0.0 110.563 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -128.15 4.33 5.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.994 -1.067 . . . . 0.0 110.762 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.716 HG13 ' CD ' ' A' ' 52' ' ' ARG . 39.2 t -113.62 -28.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.801 -1.187 . . . . 0.0 108.72 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.645 ' HB1' HG23 ' A' ' 70' ' ' THR . . . -156.58 88.79 2.74 Favored Pre-proline 0 C--N 1.292 -1.915 0 O-C-N 121.346 -0.847 . . . . 0.0 109.214 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -74.61 -4.41 15.37 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.986 1.791 . . . . 0.0 110.158 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.5 p -94.27 -27.63 16.03 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.355 -0.84 . . . . 0.0 109.074 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.645 HG23 ' HB1' ' A' ' 67' ' ' ALA . 69.9 p -64.41 -18.89 65.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.62 -0.675 . . . . 0.0 109.666 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -60.5 91.84 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.052 -1.03 . . . . 0.0 108.842 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.414 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -174.95 172.8 1.11 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.229 -179.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.1 Cg_endo -78.16 -4.44 14.33 Favored 'Trans proline' 0 C--N 1.32 -0.938 0 C-N-CA 122.599 2.199 . . . . 0.0 111.729 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 17.7 mt-10 -102.46 -29.95 11.3 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.754 -1.216 . . . . 0.0 109.822 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.443 ' HB3' ' O ' ' A' ' 70' ' ' THR . 1.6 t80 -101.62 -68.91 0.8 Allowed 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.469 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.8 t80 -73.62 -17.32 61.18 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 81' ' ' GLU . . . -64.84 -61.42 5.87 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.595 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.2 OUTLIER -65.03 -14.66 60.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.646 -0.914 . . . . 0.0 109.841 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.901 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.9 t80 -82.89 -36.75 25.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -78.32 -9.47 59.26 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 85' ' ' SER . 1.3 mm-40 -95.61 -39.6 9.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.612 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -65.25 -41.69 96.66 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.3 t -59.67 -40.57 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.788 -0.831 . . . . 0.0 109.585 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.66 1.17 53.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.275 -0.891 . . . . 0.0 111.503 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 8.7 t -106.39 -20.1 13.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.808 -1.182 . . . . 0.0 110.147 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.63 26.03 57.4 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -168.66 67.26 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.397 -1.06 . . . . 0.0 109.217 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.83 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -71.37 115.88 11.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.905 . . . . 0.0 110.032 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.45 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 64.1 t-20 -162.03 88.4 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.482 -0.761 . . . . 0.0 109.541 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 78' ' ' LYS . 4.6 t -128.92 168.32 16.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.992 -1.068 . . . . 0.0 109.96 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.413 ' CG ' ' O ' ' A' ' 107' ' ' VAL . 0.6 OUTLIER -155.14 151.11 27.87 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.064 ' CE2' HG21 ' A' ' 107' ' ' VAL . 12.3 p90 -173.03 -176.58 1.42 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.293 -0.88 . . . . 0.0 109.547 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -111.82 100.03 8.6 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.19 179.12 4.7 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.591 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.3 m -144.03 105.9 4.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.383 -0.823 . . . . 0.0 109.271 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.948 ' CE2' HG21 ' A' ' 122' ' ' VAL . 15.5 m-30 -80.59 110.15 15.8 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -134.7 43.26 2.76 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.364 -0.835 . . . . 0.0 109.485 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 21.4 p90 -77.41 139.58 39.72 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.533 ' C ' ' O ' ' A' ' 98' ' ' TYR . 3.3 pt20 2.31 66.98 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.191 0 CA-C-O 121.879 0.847 . . . . 0.0 111.783 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.624 ' HE1' ' HA ' ' A' ' 50' ' ' THR . 2.6 tmm? -176.85 -179.38 0.94 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 p -65.0 163.08 32.67 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.058 -1.026 . . . . 0.0 109.06 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.02 148.67 27.98 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.147 1.898 . . . . 0.0 110.416 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.577 HG22 HG13 ' A' ' 105' ' ' VAL . 3.2 m -151.36 118.87 6.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 110.116 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -95.36 142.9 27.21 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.961 ' HA ' HG23 ' A' ' 125' ' ' VAL . 32.5 m -144.12 146.67 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 118.266 -1.373 . . . . 0.0 112.411 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.61 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -78.8 95.33 5.34 Favored 'General case' 0 C--O 1.2 -1.536 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 175.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.064 HG21 ' CE2' ' A' ' 92' ' ' PHE . 33.3 m -87.63 152.6 3.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 120.731 -1.231 . . . . 0.0 110.151 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.428 ' ND1' ' HA ' ' A' ' 5' ' ' ALA . 9.8 t-160 -160.44 97.53 1.22 Allowed 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.817 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -106.12 142.27 36.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.188 -0.945 . . . . 0.0 109.327 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 5.3 tttt -133.01 -162.49 1.24 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.753 -1.217 . . . . 0.0 109.416 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -110.84 98.53 7.64 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.112 -0.993 . . . . 0.0 109.119 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.958 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.49 123.97 12.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 tp -111.82 -18.11 12.78 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.037 -1.039 . . . . 0.0 109.695 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 m -52.6 -29.71 27.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.007 . . . . 0.0 109.274 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 148.49 43.07 0.03 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 117' ' ' SER . 1.3 m-20 -132.9 -89.08 0.42 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.131 -1.217 . . . . 0.0 109.684 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.778 ' H ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER 168.07 -85.68 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.06 -1.025 . . . . 0.0 111.534 179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.862 ' CE1' HG22 ' A' ' 83' ' ' VAL . 15.9 m-85 -128.75 127.45 42.07 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.037 -1.04 . . . . 0.0 110.106 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.958 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 17.6 p-90 -125.56 146.87 49.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.601 -1.312 . . . . 0.0 112.269 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.817 HG13 ' HG2' ' A' ' 109' ' ' MET . 40.7 t -123.32 117.85 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.741 -0.599 . . . . 0.0 109.949 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.643 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.0 m-30 -100.92 120.0 39.53 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.988 -1.07 . . . . 0.0 108.639 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.948 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.4 t -105.58 111.71 35.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 122.244 1.021 . . . . 0.0 108.297 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.549 ' HD3' ' CE1' ' A' ' 6' ' ' PHE . 1.5 tptp -92.71 154.49 18.3 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.599 ' HD3' HD11 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -91.47 123.55 34.98 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.493 -1.379 . . . . 0.0 109.008 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.961 HG23 ' HA ' ' A' ' 105' ' ' VAL . 9.3 t . . . . . 0 C--N 1.305 -1.355 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.481 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.777 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.43 0.633 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -95.37 20.12 9.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.262 -0.899 . . . . 0.0 109.648 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.31 45.79 22.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 109.381 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 8' ' ' SER . 7.5 p -63.85 103.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 8' ' ' SER . . . 51.11 61.47 3.22 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.495 -1.378 . . . . 0.0 110.765 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.622 ' CD2' ' HD3' ' A' ' 123' ' ' LYS . 58.1 t80 62.78 20.64 12.27 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 120.844 1.657 . . . . 0.0 106.835 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.652 ' C ' HG13 ' A' ' 4' ' ' VAL . . . 96.76 -22.15 42.05 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.921 ' HB3' HD11 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -74.96 165.98 24.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.694 1.235 . . . . 0.0 113.142 -177.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -112.83 65.64 0.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 54.25 81.75 0.1 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.009 HG22 HD11 ' A' ' 15' ' ' LEU . 2.9 mm -82.48 -56.14 6.45 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 111.464 -177.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 15' ' ' LEU . 1.5 tt0 -40.43 -27.91 0.06 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.454 -0.779 . . . . 0.0 111.524 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' ILE . 96.6 m-20 -86.79 -42.52 13.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 109.007 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -70.48 -14.42 62.53 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.347 -0.846 . . . . 0.0 110.21 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.009 HD11 HG22 ' A' ' 11' ' ' ILE . 8.9 mt -93.56 -18.92 21.7 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.014 -1.054 . . . . 0.0 109.069 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.61 -41.34 12.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 108.824 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.36 57.57 0.68 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.499 ' HG3' ' CB ' ' A' ' 22' ' ' GLN . 1.0 OUTLIER -108.79 -179.08 3.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.228 -0.92 . . . . 0.0 110.171 -179.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.36 -56.75 0.7 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.546 -0.721 . . . . 0.0 109.307 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -177.64 -52.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.939 . . . . 0.0 109.564 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.51 49.1 1.86 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.499 ' CB ' ' HG3' ' A' ' 18' ' ' MET . 0.7 OUTLIER -121.65 -56.02 1.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -1.182 . . . . 0.0 109.484 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -67.5 -9.49 42.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.271 -0.893 . . . . 0.0 110.453 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.656 ' N ' HD12 ' A' ' 23' ' ' LEU . 9.3 m-20 -84.72 -2.88 58.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.838 -1.164 . . . . 0.0 110.331 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.51 35.53 4.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.706 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 13.6 mt -121.27 149.64 42.58 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.487 -1.008 . . . . 0.0 109.352 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.04 24.58 4.2 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.029 0.918 . . . . 0.0 108.851 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.716 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 1.2 p90 -153.53 134.12 13.66 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.497 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -68.18 125.2 21.07 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.96 -1.115 . . . . 0.0 110.857 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.432 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -106.21 110.41 22.64 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.529 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.4 pp -117.11 151.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.939 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.602 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -113.0 167.91 10.13 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.757 HD11 ' CB ' ' A' ' 62' ' ' PHE . 13.2 mt -150.07 139.9 21.83 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.916 -1.115 . . . . 0.0 110.036 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.438 ' N ' HD21 ' A' ' 40' ' ' LEU . 37.1 t70 -92.14 167.56 11.97 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -48.93 -21.04 2.14 Favored Glycine 0 N--CA 1.497 2.747 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.421 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.42 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 1.3 m-20 -92.51 12.52 22.65 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.458 -1.613 . . . . 0.0 110.498 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.652 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.3 26.9 64.89 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.569 ' C ' HD23 ' A' ' 33' ' ' LEU . 69.1 m-20 -97.4 127.83 43.69 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.013 -1.287 . . . . 0.0 111.872 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.626 HD12 HD21 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -59.52 134.83 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.86 -1.15 . . . . 0.0 110.528 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 32' ' ' GLN . 2.3 mt -106.47 -29.56 9.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.456 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -155.46 161.38 40.97 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.832 ' CG ' HG21 ' A' ' 57' ' ' VAL . 3.7 t80 -143.7 -60.93 0.4 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.552 -1.342 . . . . 0.0 109.972 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.601 HD21 ' HB3' ' A' ' 45' ' ' ALA . 3.5 p-10 99.89 173.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 123.745 0.818 . . . . 0.0 108.871 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.59 -13.73 25.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.755 -1.215 . . . . 0.0 111.84 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.601 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -58.93 -65.06 0.73 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.585 -1.322 . . . . 0.0 109.904 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.591 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 7.0 pt-20 -60.31 -50.0 75.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.959 . . . . 0.0 109.737 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -56.47 -18.64 23.4 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 45' ' ' ALA . 1.2 m-20 -76.13 -38.47 56.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.829 -1.395 . . . . 0.0 108.422 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.627 HG22 HG23 ' A' ' 50' ' ' THR . 0.3 OUTLIER -79.32 -59.5 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.45 -0.781 . . . . 0.0 109.294 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 1.015 HG21 " C3'" ' A' ' 126' ' ' HC4 . 19.0 p -78.36 -9.63 59.35 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.275 -0.891 . . . . 0.0 110.474 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.444 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 81.0 -2.34 81.23 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.925 ' CD ' HG13 ' A' ' 66' ' ' VAL . 1.3 mtt-85 -73.86 84.71 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.169 -1.195 . . . . 0.0 109.925 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.533 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -54.29 173.73 0.21 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.417 -0.802 . . . . 0.0 109.301 179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 35.8 Cg_endo -77.94 -32.22 2.7 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.018 1.812 . . . . 0.0 110.856 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -80.97 -33.42 33.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.193 -0.942 . . . . 0.0 109.987 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 60' ' ' LYS . 4.8 tt0 -71.56 -42.67 67.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.097 -1.002 . . . . 0.0 109.658 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.832 HG21 ' CG ' ' A' ' 42' ' ' TYR . 28.6 m -68.65 -9.08 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.963 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.484 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -70.11 123.16 23.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.8 -14.67 59.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 56' ' ' GLN . 65.7 mmtt -79.51 127.45 32.15 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.266 -1.138 . . . . 0.0 109.18 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -67.53 128.01 34.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 108.659 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.757 ' CB ' HD11 ' A' ' 33' ' ' LEU . 78.2 t80 -62.21 -14.2 35.56 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.879 -1.138 . . . . 0.0 110.004 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -119.4 5.72 11.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.057 -1.027 . . . . 0.0 111.12 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 4.5 mttt -151.45 47.26 0.81 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.785 -1.197 . . . . 0.0 109.825 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER 163.56 -22.59 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.609 -0.682 . . . . 0.0 109.683 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.925 HG13 ' CD ' ' A' ' 52' ' ' ARG . 21.2 t -112.76 -28.66 2.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.22 -0.925 . . . . 0.0 108.505 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.496 ' HB1' HG23 ' A' ' 70' ' ' THR . . . -159.81 94.99 1.64 Allowed Pre-proline 0 C--N 1.293 -1.864 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.947 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.88 -18.53 16.84 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.856 1.704 . . . . 0.0 109.241 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.7 p -79.45 -20.35 47.64 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.532 -0.73 . . . . 0.0 109.376 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.496 HG23 ' HB1' ' A' ' 67' ' ' ALA . 47.7 p -80.94 5.82 15.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 110.032 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -89.28 52.58 2.41 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 120.937 -1.102 . . . . 0.0 108.402 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.48 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.8 p -125.39 -179.42 0.87 Allowed Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.99 -12.81 14.44 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 122.146 1.897 . . . . 0.0 111.593 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.6 OUTLIER -96.37 -26.68 15.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.835 -1.165 . . . . 0.0 109.746 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -100.59 -72.61 0.67 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.277 -0.89 . . . . 0.0 108.604 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 5.8 t80 -72.24 -18.91 61.79 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.032 -1.042 . . . . 0.0 109.045 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 73' ' ' PRO . . . -64.44 -59.77 7.89 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.879 ' HB2' HG21 ' A' ' 90' ' ' THR . 2.0 mmtp -65.14 -14.58 60.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.633 -0.922 . . . . 0.0 109.983 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.885 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.5 t80 -84.95 -36.14 21.6 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.387 -0.821 . . . . 0.0 109.39 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -76.1 -12.32 60.09 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.109 -0.994 . . . . 0.0 108.84 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 25.2 pt-20 -97.27 -41.43 8.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.456 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -59.6 -39.52 95.21 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.461 -2.256 . . . . 0.0 107.461 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 79' ' ' PHE . 97.5 t -63.93 -44.79 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.91 -0.759 . . . . 0.0 110.113 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.58 4.39 51.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.181 -0.949 . . . . 0.0 110.729 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.3 t -106.21 -25.35 12.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.932 -1.105 . . . . 0.0 109.87 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.73 29.31 32.56 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -171.88 60.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -1.17 . . . . 0.0 109.212 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 5.3 tt -60.03 119.3 7.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 0.0 109.711 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.44 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 18.8 p-10 -160.34 85.1 0.72 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 109.254 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.879 HG21 ' HB2' ' A' ' 78' ' ' LYS . 3.5 t -134.36 149.48 50.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.031 -1.043 . . . . 0.0 109.99 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.6 ptp -140.33 166.07 25.69 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.426 -0.796 . . . . 0.0 108.987 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.079 ' CE1' HG21 ' A' ' 107' ' ' VAL . 20.4 p90 176.4 178.16 0.23 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.812 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -105.14 114.92 29.4 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.94 173.88 6.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 110.274 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.2 m -146.45 108.63 4.42 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.463 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 16.6 m-85 -81.1 120.88 25.39 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.131 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -136.78 47.23 2.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 108.75 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.508 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -79.02 72.83 5.56 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.068 -0.395 . . . . 0.0 111.274 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.472 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 64.58 31.41 12.26 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.318 -0.864 . . . . 0.0 109.9 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.45 ' SD ' HG22 ' A' ' 101' ' ' THR . 0.0 OUTLIER -149.69 -177.82 6.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.236 -0.915 . . . . 0.0 108.844 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.451 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 0.5 OUTLIER -55.14 152.67 14.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.13 -0.981 . . . . 0.0 109.253 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.451 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 32.1 Cg_endo -73.45 82.72 1.6 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.716 1.61 . . . . 0.0 109.883 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.705 HG22 ' CG1' ' A' ' 105' ' ' VAL . 1.9 m -69.64 93.71 0.73 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.648 -0.658 . . . . 0.0 109.846 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.9 137.14 47.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.937 ' HA ' HG23 ' A' ' 125' ' ' VAL . 4.1 m -146.37 147.0 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.48 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HB3' ' CE1' ' A' ' 6' ' ' PHE . 0.6 OUTLIER -76.85 150.75 36.05 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 173.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.079 HG21 ' CE1' ' A' ' 92' ' ' PHE . 30.2 m -137.77 149.28 25.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 O-C-N 119.945 -1.722 . . . . 0.0 109.366 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.554 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . 10.8 t-160 -160.2 101.87 1.41 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.774 ' HB3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -109.03 140.42 42.57 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.241 -178.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.636 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 9.7 tttt -135.23 -162.48 1.26 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.571 -1.331 . . . . 0.0 109.888 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -108.14 103.26 12.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.928 . . . . 0.0 108.83 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.885 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -51.07 147.71 5.03 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.599 -0.688 . . . . 0.0 110.443 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.3 -10.26 59.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.451 -0.781 . . . . 0.0 110.047 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.79 -24.64 3.62 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.098 -1.001 . . . . 0.0 109.713 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 137.74 100.04 0.52 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.3 p30 41.83 37.62 0.82 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.836 -0.802 . . . . 0.0 110.559 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.846 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.6 OUTLIER -89.24 -177.49 5.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.282 -0.886 . . . . 0.0 109.813 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.744 ' CE1' HG22 ' A' ' 83' ' ' VAL . 14.7 m-85 -152.0 116.39 5.03 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.885 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 14.6 p-90 -118.69 153.74 33.86 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.06 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.774 HG22 ' HB3' ' A' ' 109' ' ' MET . 24.0 t -127.5 112.6 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.652 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 12.5 m-30 -96.47 104.11 16.07 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 107' ' ' VAL . 0.9 OUTLIER -92.6 115.11 30.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.339 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -90.7 142.42 27.77 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.431 ' NH2' HD11 ' A' ' 49' ' ' ILE . 5.8 ttt180 -89.46 119.37 29.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.516 -1.365 . . . . 0.0 108.961 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.937 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.312 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 1.015 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ttt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.264 0.554 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.22 109.19 20.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -0.934 . . . . 0.0 109.363 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -81.08 -70.74 0.51 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 109.575 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 4' ' ' VAL . 5.2 p 178.82 115.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.298 -0.876 . . . . 0.0 109.364 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.997 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 58.09 93.59 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.228 -0.92 . . . . 0.0 109.881 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' CE1' ' O ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER 48.62 -89.33 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.366 -0.834 . . . . 0.0 109.691 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . -148.16 53.06 0.53 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.997 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 1.0 OUTLIER -73.17 148.28 43.97 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.606 -0.937 . . . . 0.0 109.881 -178.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.72 67.93 9.69 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.313 -0.867 . . . . 0.0 110.247 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 49.25 75.39 0.15 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.986 -1.071 . . . . 0.0 108.179 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.13 HG22 HD11 ' A' ' 15' ' ' LEU . 4.5 mm -78.43 -59.67 2.85 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 110.517 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.406 ' HA ' HD12 ' A' ' 15' ' ' LEU . 7.8 pt-20 -40.95 -31.22 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.511 -0.743 . . . . 0.0 111.716 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.64 -40.23 16.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.802 -1.186 . . . . 0.0 108.577 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' HG22 ' A' ' 14' ' ' THR . 6.5 m -71.32 -10.88 60.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.627 -0.671 . . . . 0.0 110.055 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.13 HD11 HG22 ' A' ' 11' ' ' ILE . 13.4 mt -96.7 -9.31 29.33 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.952 -1.093 . . . . 0.0 109.747 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.06 -34.89 12.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.041 -1.037 . . . . 0.0 109.134 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -121.06 76.91 1.26 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.782 ' CE ' HD22 ' A' ' 23' ' ' LEU . 3.5 ttp -130.38 179.2 6.06 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.301 -0.874 . . . . 0.0 110.24 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -142.95 -61.43 0.43 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 14.6 t70 175.31 104.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.63 23.57 6.19 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.466 ' CB ' ' HG3' ' A' ' 18' ' ' MET . 1.0 OUTLIER -108.67 -24.98 11.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.305 -1.115 . . . . 0.0 109.545 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.782 HD22 ' CE ' ' A' ' 18' ' ' MET . 2.0 pt? -116.89 -6.28 11.48 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.257 -0.902 . . . . 0.0 110.257 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -66.78 -11.3 54.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.829 -1.17 . . . . 0.0 109.936 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.75 28.07 15.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.045 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 18.8 mt -98.6 164.27 12.32 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.204 -1.174 . . . . 0.0 108.333 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.447 ' HB3' ' NZ ' ' A' ' 123' ' ' LYS . . . -94.42 19.35 9.75 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.045 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 2.7 p90 -152.89 179.2 8.87 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -107.69 125.8 8.08 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.744 ' HB3' HD12 ' A' ' 23' ' ' LEU . . . -96.06 96.88 9.16 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.027 -1.278 . . . . 0.0 108.465 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.634 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.4 pp -102.63 146.18 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.23 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.721 ' HB3' HD12 ' A' ' 40' ' ' LEU . 12.6 mt-30 -119.65 171.88 8.07 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 39' ' ' ILE . 72.0 mt -152.78 147.11 25.67 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 109.738 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.575 ' HB2' HD21 ' A' ' 40' ' ' LEU . 1.9 m-20 -119.05 136.49 54.11 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.358 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -9.01 71.06 0.0 OUTLIER Glycine 0 N--CA 1.51 3.629 0 C-N-CA 124.659 1.123 . . . . 0.0 113.428 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER 161.64 -24.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.632 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.03 17.53 24.92 Favored Glycine 0 N--CA 1.481 1.697 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 69.2 m-80 -82.7 128.67 34.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -1.123 . . . . 0.0 108.426 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.747 HD13 ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -62.45 138.51 22.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 122.059 0.933 . . . . 0.0 111.568 -178.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.721 HD12 ' HB3' ' A' ' 32' ' ' GLN . 6.0 mt -105.0 -31.18 9.33 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -158.4 -176.33 5.84 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 1.6 t80 -161.11 -62.03 0.06 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.072 -1.018 . . . . 0.0 109.677 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.59 HD21 ' HB3' ' A' ' 45' ' ' ALA . 3.3 p-10 100.42 175.55 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.493 0 C-N-CA 123.666 0.786 . . . . 0.0 109.48 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.89 -15.68 22.27 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.004 -1.06 . . . . 0.0 111.983 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.59 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -57.9 -64.95 0.73 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.662 -1.274 . . . . 0.0 109.846 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 13.2 pt-20 -64.43 -43.29 94.79 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.219 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.435 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -60.11 -16.01 39.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -87.26 -28.53 22.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.723 -1.457 . . . . 0.0 109.673 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.431 HG13 ' HD3' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -82.22 -39.62 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 109.542 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.906 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -113.91 -0.31 14.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.833 -0.542 . . . . 0.0 110.627 -178.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.81 -3.26 70.46 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.649 -1.263 . . . . 0.0 110.942 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.991 ' NH2' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -63.87 91.0 0.06 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.826 -1.397 . . . . 0.0 110.388 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.835 ' O ' HG22 ' A' ' 57' ' ' VAL . 14.5 m-20 -72.32 158.46 87.46 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.97 -42.04 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.85 1.7 . . . . 0.0 110.821 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.568 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -67.26 -27.55 67.3 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.992 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -84.87 -42.49 15.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.0 109.612 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 53' ' ' ASP . 34.7 m -78.42 -0.03 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.0 109.743 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.645 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -70.42 122.01 21.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.013 -1.054 . . . . 0.0 108.702 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.98 -19.72 52.65 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -80.06 137.42 36.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.276 -1.132 . . . . 0.0 108.894 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.504 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -77.58 97.98 5.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.747 ' HB2' HD13 ' A' ' 39' ' ' ILE . 62.3 t80 -56.35 -18.29 10.45 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.665 -0.647 . . . . 0.0 110.337 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.453 ' CD1' ' CD1' ' A' ' 76' ' ' TYR . 3.0 m-85 -95.42 -30.87 13.66 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.065 -1.022 . . . . 0.0 110.458 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -139.15 42.1 2.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 110.027 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.504 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -157.34 -37.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.048 -1.033 . . . . 0.0 110.254 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.716 HG12 ' NH1' ' A' ' 52' ' ' ARG . 1.8 t -104.9 -58.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 122.902 1.335 . . . . 0.0 108.923 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.991 ' HB2' ' NH2' ' A' ' 52' ' ' ARG . . . -106.56 100.99 33.56 Favored Pre-proline 0 C--N 1.289 -2.061 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.563 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.59 -4.04 14.7 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.845 1.696 . . . . 0.0 110.698 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.1 p -88.19 -24.75 23.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.959 -1.088 . . . . 0.0 109.332 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.481 HG21 ' CE2' ' A' ' 62' ' ' PHE . 2.2 p -76.58 -2.0 30.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.285 -0.885 . . . . 0.0 109.866 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.31 50.53 1.52 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.889 -1.132 . . . . 0.0 108.23 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.485 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -113.97 178.99 0.85 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -77.96 -14.44 15.34 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 122.072 1.848 . . . . 0.0 111.227 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 29.9 mt-10 -100.54 -22.8 14.86 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.782 -1.199 . . . . 0.0 109.545 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.519 ' CE1' ' HE3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -100.48 -73.45 0.64 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.537 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 9.2 t80 -70.35 -19.24 63.06 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.878 -1.139 . . . . 0.0 108.873 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.93 -59.75 8.66 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -63.56 -15.3 57.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.453 -1.028 . . . . 0.0 109.682 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.87 ' O ' HG23 ' A' ' 83' ' ' VAL . 13.1 t80 -81.88 -38.05 25.95 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.545 -0.722 . . . . 0.0 109.788 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -11.9 60.11 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.021 -1.05 . . . . 0.0 109.362 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 12.9 pt-20 -97.28 -41.73 8.13 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -61.32 -39.54 97.38 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 79' ' ' PHE . 85.1 t -63.52 -41.57 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.862 -0.787 . . . . 0.0 110.009 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.2 4.78 53.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.246 -0.909 . . . . 0.0 111.036 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.4 p -106.11 -26.74 11.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.89 -1.131 . . . . 0.0 110.131 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.09 23.52 37.73 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -171.39 87.1 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -1.125 . . . . 0.0 109.036 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 79' ' ' PHE . 1.9 tt -84.36 123.09 29.81 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.306 -0.872 . . . . 0.0 109.787 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.422 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 4.9 p-10 -160.56 81.78 0.67 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.235 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -121.85 154.34 37.19 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.159 -0.963 . . . . 0.0 110.118 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -148.02 139.26 23.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.44 -0.788 . . . . 0.0 109.04 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.067 ' CE2' HG21 ' A' ' 107' ' ' VAL . 8.9 p90 -162.83 -174.92 4.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.053 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -112.91 108.76 17.82 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -109.65 -179.48 3.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.35 -0.844 . . . . 0.0 110.083 -178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.7 m -149.47 108.51 3.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.521 -0.737 . . . . 0.0 109.062 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.845 ' CE2' HG21 ' A' ' 122' ' ' VAL . 13.8 m-30 -81.09 92.28 6.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.351 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -105.67 24.24 12.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.251 -0.906 . . . . 0.0 109.637 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.554 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.69 155.72 29.32 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.508 ' HG3' ' CD2' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 0.28 65.72 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 CA-C-O 121.549 0.69 . . . . 0.0 112.317 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.554 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER 175.66 164.78 0.34 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.427 -0.796 . . . . 0.0 109.126 -178.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.545 HG22 ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -57.75 175.66 0.27 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.302 -0.874 . . . . 0.0 108.883 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.545 ' HD2' HG22 ' A' ' 101' ' ' THR . 34.6 Cg_endo -76.6 107.64 2.49 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 121.846 1.697 . . . . 0.0 109.801 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.439 HG22 HG13 ' A' ' 105' ' ' VAL . 4.2 m -109.38 122.54 47.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.807 . . . . 0.0 110.365 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -102.59 145.06 30.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.981 ' HA ' HG23 ' A' ' 125' ' ' VAL . 22.7 m -152.01 145.65 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.654 -1.279 . . . . 0.0 111.859 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.9 ' HD2' HG22 ' A' ' 125' ' ' VAL . 7.5 mptt -77.44 117.13 18.61 Favored 'General case' 0 C--O 1.199 -1.555 0 N-CA-C 102.876 -3.009 . . . . 0.0 102.876 174.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.067 HG21 ' CE2' ' A' ' 92' ' ' PHE . 35.7 m -102.31 151.14 5.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 117.898 -1.521 . . . . 0.0 109.767 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.475 ' ND1' ' HA ' ' A' ' 5' ' ' ALA . 2.2 t-160 -154.9 103.68 2.43 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.8 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -105.66 139.16 40.68 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.457 -0.777 . . . . 0.0 109.335 -178.344 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.606 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.9 ttmt -137.57 -157.77 0.8 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.562 -1.336 . . . . 0.0 109.476 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -105.37 137.87 42.47 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 108.994 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.909 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -98.89 -179.07 4.16 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 110.058 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 116' ' ' ASP . 1.0 OUTLIER 58.85 25.57 13.76 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.3 m 61.41 39.49 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.475 -0.766 . . . . 0.0 109.171 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.18 74.19 0.94 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.429 ' CB ' ' HB3' ' A' ' 113' ' ' LEU . 1.6 t0 -176.7 -65.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -1.14 . . . . 0.0 109.389 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.899 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -78.05 -163.64 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.625 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.762 ' OH ' HG13 ' A' ' 83' ' ' VAL . 12.3 m-85 -147.64 123.08 10.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.261 -0.899 . . . . 0.0 108.739 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.909 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 18.6 p-90 -127.14 146.32 50.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 118.386 -1.326 . . . . 0.0 112.833 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.8 HG13 ' HG2' ' A' ' 109' ' ' MET . 58.9 t -118.58 110.36 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.636 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.662 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 12.4 m-30 -95.44 133.53 39.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.984 -1.073 . . . . 0.0 108.406 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.845 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.5 t -116.01 113.57 43.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 C-N-CA 119.054 -1.059 . . . . 0.0 109.532 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . 5.2 tptp -90.02 131.13 36.07 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.431 ' HD3' HG13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -80.21 123.93 28.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.53 -1.356 . . . . 0.0 109.561 -178.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.981 HG23 ' HA ' ' A' ' 105' ' ' VAL . 5.3 t . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.612 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.906 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.78 148.56 29.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -82.67 123.2 29.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.798 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.876 HG21 ' HA ' ' A' ' 10' ' ' ASP . 11.2 p -177.47 121.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.353 -0.842 . . . . 0.0 109.246 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.564 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 62.3 -89.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.811 . . . . 0.0 109.445 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.58 ' CD1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -176.03 45.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.37 35.41 2.68 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.958 ' CB ' HD11 ' A' ' 11' ' ' ILE . 13.1 m -104.69 -166.67 1.26 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.73 -0.865 . . . . 0.0 111.142 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -115.88 64.68 0.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.804 -0.56 . . . . 0.0 110.342 -178.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.876 ' HA ' HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER 52.7 90.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.499 -1.376 . . . . 0.0 107.947 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.041 HG22 HD11 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -79.63 -69.2 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 120.973 -1.079 . . . . 0.0 110.513 -177.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -44.73 -25.79 0.32 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 111.134 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.434 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -75.4 -49.21 19.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.036 -1.04 . . . . 0.0 109.501 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 18' ' ' MET . 1.0 OUTLIER -70.15 -61.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.041 HD11 HG22 ' A' ' 11' ' ' ILE . 72.6 mt -37.27 -32.42 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.363 0.601 . . . . 0.0 110.676 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.98 -61.33 1.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.367 -0.833 . . . . 0.0 110.165 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 68.52 1.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 0.0 109.974 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.505 ' HG3' ' CB ' ' A' ' 22' ' ' GLN . 34.6 ttp -129.63 152.27 49.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.282 -0.886 . . . . 0.0 109.132 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -92.59 -69.92 0.72 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.623 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 21.8 p-10 177.62 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -0.817 . . . . 0.0 108.905 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.01 21.54 5.93 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.505 ' CB ' ' HG3' ' A' ' 18' ' ' MET . 1.1 tt0 -108.13 -19.29 13.54 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.312 -1.111 . . . . 0.0 109.651 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -109.82 14.02 23.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.141 -0.975 . . . . 0.0 110.225 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.38 -3.21 58.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.966 -1.084 . . . . 0.0 110.208 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.14 34.77 5.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.84 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 7.3 mt -110.41 158.93 17.94 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.408 -1.054 . . . . 0.0 109.282 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.94 6.93 33.37 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.45 0.643 . . . . 0.0 109.349 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.84 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 26.3 p90 -134.04 -169.67 2.36 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.273 -0.892 . . . . 0.0 108.868 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -118.3 149.57 18.34 Favored Glycine 0 C--N 1.297 -1.595 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -126.14 84.8 2.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.754 -1.439 . . . . 0.0 107.936 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.643 HG22 ' CD1' ' A' ' 42' ' ' TYR . 1.3 pp -91.71 149.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.168 0.985 . . . . 0.0 110.862 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.557 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 3.2 mm100 -115.23 162.43 17.08 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.611 HD22 ' C ' ' A' ' 37' ' ' GLY . 21.7 mt -150.09 146.08 26.72 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.404 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.544 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -99.28 173.62 6.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -40.06 -57.08 2.59 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 121.619 -0.324 . . . . 0.0 113.001 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.83 -17.64 61.65 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.63 -1.512 . . . . 0.0 110.337 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.611 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 102.42 28.73 6.26 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 7.0 m120 -84.74 136.68 33.61 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.442 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' A' ' 31' ' ' ILE . 3.0 tp -63.73 135.85 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.762 -1.211 . . . . 0.0 111.387 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -110.06 -28.49 8.67 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.557 ' HB2' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -159.76 153.02 22.11 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.643 ' CD1' HG22 ' A' ' 31' ' ' ILE . 17.5 t80 -134.76 -66.68 0.58 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.169 -1.582 . . . . 0.0 111.414 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 4.3 p-10 102.39 174.79 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.657 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.09 -23.97 15.98 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.8 -1.188 . . . . 0.0 112.898 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.68 -62.43 1.65 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.464 -1.398 . . . . 0.0 110.741 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.1 pt-20 -58.72 -55.25 37.53 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.675 0.75 . . . . 0.0 109.64 -179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.413 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -56.79 -15.22 11.89 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.015 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -40.61 61.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.783 -1.422 . . . . 0.0 108.799 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -84.74 -56.89 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.414 -0.804 . . . . 0.0 109.235 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.55 ' N ' HG22 ' A' ' 49' ' ' ILE . 18.9 p -72.71 -24.66 61.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.509 -0.744 . . . . 0.0 109.916 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 94.37 -19.22 54.65 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.914 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -43.9 97.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.608 -0.936 . . . . 0.0 110.626 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.67 ' O ' HG13 ' A' ' 57' ' ' VAL . 42.4 m-20 -69.51 158.29 87.28 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.16 -61.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.942 1.762 . . . . 0.0 110.829 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -62.52 -18.13 61.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.215 -0.928 . . . . 0.0 110.151 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -86.87 -41.37 14.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.016 -1.053 . . . . 0.0 109.528 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 53' ' ' ASP . 22.4 m -79.61 2.01 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.831 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.589 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.24 121.05 20.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 120.979 -1.075 . . . . 0.0 109.034 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.31 -13.68 64.5 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 16.7 mmtp -78.89 139.8 38.23 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.084 -1.245 . . . . 0.0 109.066 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -80.95 96.52 7.1 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.947 ' CZ ' HG21 ' A' ' 70' ' ' THR . 16.7 t80 -55.06 -34.46 63.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.024 -1.048 . . . . 0.0 109.722 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.605 ' HD2' HD13 ' A' ' 33' ' ' LEU . 2.5 m-85 -80.42 -23.34 40.39 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.251 -177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -148.1 49.07 1.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.983 -1.073 . . . . 0.0 109.631 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' ASN . 8.8 t0 -174.54 -29.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 111.047 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.914 HG11 ' HD3' ' A' ' 52' ' ' ARG . 13.5 t -106.08 -58.41 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.617 -1.302 . . . . 0.0 109.004 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.635 ' HB3' ' OG1' ' A' ' 70' ' ' THR . . . -99.01 106.65 39.35 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 114.618 -1.173 . . . . 0.0 109.861 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -77.36 1.41 8.79 Favored 'Trans proline' 0 C--N 1.319 -0.982 0 C-N-CA 121.614 1.543 . . . . 0.0 109.896 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.4 p -107.03 -19.58 13.58 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 121.216 -0.927 . . . . 0.0 109.778 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.947 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 11.0 p -85.93 9.57 16.52 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.124 -0.985 . . . . 0.0 110.133 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -106.54 59.9 0.64 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.118 -0.989 . . . . 0.0 108.956 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.473 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -144.3 176.26 2.35 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.352 -0.843 . . . . 0.0 109.675 -179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 33.6 Cg_endo -76.71 78.64 3.29 Favored 'Trans proline' 0 C--N 1.323 -0.763 0 C-N-CA 122.375 2.05 . . . . 0.0 110.415 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 171.54 -37.86 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.6 t80 -105.38 -67.68 0.9 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.479 ' CD1' ' CD1' ' A' ' 63' ' ' PHE . 9.3 t80 -73.22 -18.12 61.27 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.1 -63.66 4.21 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.528 ' HB2' HG21 ' A' ' 90' ' ' THR . 10.8 mmtt -61.09 -17.54 53.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -1.047 . . . . 0.0 109.864 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.865 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.3 t80 -82.22 -38.24 24.82 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.484 -0.76 . . . . 0.0 109.53 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -13.29 60.37 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 109.382 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -98.05 -36.46 10.1 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.639 -1.225 . . . . 0.0 108.151 178.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.66 -39.33 96.63 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 79' ' ' PHE . 87.3 t -63.21 -51.87 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.958 -0.731 . . . . 0.0 109.928 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.18 -2.88 46.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -0.922 . . . . 0.0 110.793 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.8 t -96.34 -29.94 13.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.131 . . . . 0.0 109.629 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.06 15.05 46.52 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -165.87 86.87 0.36 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.118 -1.225 . . . . 0.0 109.131 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -76.98 122.93 25.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.472 -0.768 . . . . 0.0 110.088 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -160.97 82.4 0.64 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.528 HG21 ' HB2' ' A' ' 78' ' ' LYS . 8.7 t -127.48 169.5 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.031 . . . . 0.0 111.212 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 107' ' ' VAL . 1.8 ttm -159.77 149.23 18.08 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.109 ' CE1' HG21 ' A' ' 107' ' ' VAL . 18.7 p90 -172.42 165.55 5.75 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -96.82 105.77 17.96 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -104.56 -177.32 3.33 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.817 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 103' ' ' THR . 92.9 m -151.02 108.51 3.63 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.825 ' CE2' HG21 ' A' ' 122' ' ' VAL . 18.7 m-30 -84.06 114.91 22.08 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 109.703 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -139.61 42.29 2.01 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.665 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.537 ' O ' ' C ' ' A' ' 99' ' ' GLN . 10.1 p90 -78.69 148.06 33.26 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.537 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.0 tt0 1.89 67.95 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 121.781 0.8 . . . . 0.0 111.482 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.526 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.9 ttp 177.29 -159.1 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 109.386 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.477 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 2.3 t -85.37 153.61 59.14 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.5 Cg_endo -75.74 141.18 24.28 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 C-N-CA 121.713 1.609 . . . . 0.0 110.349 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.446 HG22 HG13 ' A' ' 105' ' ' VAL . 1.8 m -140.08 140.17 36.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.336 -0.852 . . . . 0.0 109.605 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -111.18 141.6 44.47 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.801 ' HA ' HG23 ' A' ' 125' ' ' VAL . 24.5 m -149.68 144.05 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.921 -1.112 . . . . 0.0 110.681 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.504 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -86.42 102.31 13.94 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 175.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.109 HG21 ' CE1' ' A' ' 92' ' ' PHE . 18.1 m -85.55 156.91 3.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 110.885 -175.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.405 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 2.2 t-160 -160.36 106.88 1.54 Allowed 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.807 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.92 149.49 35.11 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.477 -0.764 . . . . 0.0 109.606 -177.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.578 ' HB3' ' CZ2' ' A' ' 119' ' ' TRP . 9.5 ttpt -144.34 170.64 15.62 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.474 -1.391 . . . . 0.0 109.213 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.456 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 11.0 tttt -80.11 104.18 10.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.771 -1.206 . . . . 0.0 108.787 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.837 ' HB3' ' HB3' ' A' ' 117' ' ' SER . . . -52.09 155.51 1.88 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 109.652 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.85 14.14 32.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -0.987 . . . . 0.0 110.119 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -24.85 63.67 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.092 -1.005 . . . . 0.0 109.081 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 150.78 68.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 61.19 62.32 1.41 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -1.17 . . . . 0.0 109.239 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.837 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -116.99 -169.61 1.68 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.179 -0.95 . . . . 0.0 109.836 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.844 ' CE1' HG22 ' A' ' 83' ' ' VAL . 12.6 m-85 -153.47 108.36 3.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.301 -0.874 . . . . 0.0 109.06 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.736 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.2 p-90 -108.22 142.09 39.01 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.695 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.807 HG13 ' HG2' ' A' ' 109' ' ' MET . 96.1 t -117.41 118.69 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.651 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 16.0 m-30 -101.86 121.93 43.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.146 -0.971 . . . . 0.0 109.349 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.825 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.7 t -109.66 116.05 51.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.249 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.58 ' HD3' ' CD1' ' A' ' 6' ' ' PHE . 6.8 tttm -101.87 133.99 45.76 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.405 178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.51 ' HA ' HG12 ' A' ' 105' ' ' VAL . 8.1 ttp85 -73.54 117.89 15.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.983 -1.073 . . . . 0.0 109.65 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.801 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.205 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.539 " C6'" ' CE2' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.292 0.568 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -175.4 171.16 2.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.434 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 61.65 97.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 109.207 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 5' ' ' ALA . 60.0 t -75.2 160.08 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.204 -0.935 . . . . 0.0 109.61 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.681 ' HB3' ' HA ' ' A' ' 8' ' ' SER . . . -95.33 129.85 42.32 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.622 -0.674 . . . . 0.0 109.55 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.547 ' CZ ' ' O ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -60.85 -59.13 5.87 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.4 -1.32 . . . . 0.0 107.531 178.495 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.61 -27.41 34.6 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.681 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 45.96 -161.48 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.88 0.848 . . . . 0.0 111.565 177.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -69.81 77.29 0.46 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.271 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 9' ' ' GLU . 1.8 m-20 37.43 84.69 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.457 -0.777 . . . . 0.0 109.702 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.069 HG22 HD11 ' A' ' 15' ' ' LEU . 2.4 mm -65.39 -67.58 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.54 0 C-N-CA 118.799 -1.16 . . . . 0.0 109.212 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HA ' HD12 ' A' ' 15' ' ' LEU . 3.3 pt-20 -37.55 -30.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.032 0.444 . . . . 0.0 111.656 -178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' ILE . 1.2 t30 -76.19 -50.36 14.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.022 -1.049 . . . . 0.0 108.673 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 m -67.36 -14.91 63.35 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.548 -0.72 . . . . 0.0 109.811 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.069 HD11 HG22 ' A' ' 11' ' ' ILE . 11.4 mt -96.68 -26.49 15.17 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.094 -1.004 . . . . 0.0 109.168 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.89 -10.76 27.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.307 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.62 60.49 1.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.865 -1.147 . . . . 0.0 110.212 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.483 ' CE ' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -149.21 157.26 43.21 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 18' ' ' MET . 49.1 t0 -88.61 -59.61 2.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.87 106.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.154 -0.966 . . . . 0.0 109.124 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.5 22.87 5.63 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.86 -21.38 12.86 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.329 -1.101 . . . . 0.0 109.562 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 43' ' ' ASN . 0.7 OUTLIER -110.08 21.14 17.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 110.116 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -88.8 -3.23 58.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.055 . . . . 0.0 110.33 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.77 35.1 5.08 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 mt -114.74 134.68 54.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.403 -1.057 . . . . 0.0 109.458 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.86 -6.55 27.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.385 0.612 . . . . 0.0 109.792 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.709 ' HE2' HD12 ' A' ' 11' ' ' ILE . 7.6 p90 -124.01 114.37 19.66 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.027 -1.046 . . . . 0.0 108.324 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.553 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -51.94 158.29 3.05 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' N ' ' OE2' ' A' ' 46' ' ' GLU . . . -139.44 99.52 3.75 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.066 -1.255 . . . . 0.0 107.973 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.622 HD12 ' N ' ' A' ' 32' ' ' GLN . 0.7 OUTLIER -99.41 172.36 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.884 0.849 . . . . 0.0 110.511 -177.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.71 ' HB2' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -141.61 164.93 28.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 38' ' ' ASN . 28.0 mt -148.32 154.18 39.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.904 -1.122 . . . . 0.0 109.893 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.541 ' N ' HD21 ' A' ' 40' ' ' LEU . 1.3 p30 -116.33 128.83 55.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 108.892 178.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -15.9 76.53 0.0 OUTLIER Glycine 0 N--CA 1.508 3.486 0 C-N-CA 124.505 1.05 . . . . 0.0 112.951 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.8 OUTLIER 162.58 -23.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 101.06 17.93 21.3 Favored Glycine 0 N--CA 1.48 1.589 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.783 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -86.16 152.17 23.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.016 -1.285 . . . . 0.0 107.787 178.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' ' 57' ' ' VAL . 2.1 tp -79.52 144.91 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.829 -1.169 . . . . 0.0 113.034 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.714 HD11 ' O ' ' A' ' 33' ' ' LEU . 2.0 mt -113.11 -33.85 5.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 174.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.563 ' NE2' ' HA ' ' A' ' 41' ' ' GLN . 6.5 tp-100 -169.02 158.75 8.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.588 -0.695 . . . . 0.0 110.227 178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.578 ' CE2' ' HG3' ' A' ' 46' ' ' GLU . 13.2 t80 -135.75 -54.33 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.375 -0.828 . . . . 0.0 110.128 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.587 ' HB3' HD11 ' A' ' 23' ' ' LEU . 0.8 OUTLIER 95.72 177.59 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 C-N-CA 123.02 0.528 . . . . 0.0 109.641 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.12 -22.5 17.27 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.996 -1.065 . . . . 0.0 113.039 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -57.0 -68.53 0.21 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.428 -1.42 . . . . 0.0 110.012 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.578 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 6.2 pt-20 -63.07 -42.79 99.75 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.749 0.785 . . . . 0.0 109.593 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 52' ' ' ARG . . . -60.78 -17.91 51.45 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -83.68 -29.86 27.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.245 . . . . 0.0 108.423 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.83 HG22 HG23 ' A' ' 50' ' ' THR . 0.3 OUTLIER -73.65 -57.48 6.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.619 -0.676 . . . . 0.0 109.287 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.83 HG23 HG22 ' A' ' 49' ' ' ILE . 15.6 p -89.84 -8.01 52.99 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.15 -0.969 . . . . 0.0 110.191 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 89.59 -8.1 80.51 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.599 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -53.58 90.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.315 -1.109 . . . . 0.0 109.809 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.798 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -68.9 162.75 62.08 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.17 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.27 -57.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.839 1.693 . . . . 0.0 111.124 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -18.51 65.4 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.915 -1.116 . . . . 0.0 110.206 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 -31.64 16.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 109.642 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 53' ' ' ASP . 34.5 m -86.7 10.91 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.043 -1.036 . . . . 0.0 109.499 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.485 ' HA ' ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -86.87 121.78 38.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 108.487 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.76 -18.56 54.78 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HD2' ' CG2' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -78.19 167.84 20.77 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.924 -1.339 . . . . 0.0 109.898 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -106.19 103.65 13.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.77 ' CZ ' HG21 ' A' ' 70' ' ' THR . 3.1 t80 -50.27 -42.74 52.67 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.521 -0.737 . . . . 0.0 112.245 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.536 ' CG ' ' CD1' ' A' ' 76' ' ' TYR . 36.5 m-85 -89.74 1.9 55.52 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.678 -1.264 . . . . 0.0 112.799 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 4.5 tmtm? -154.32 52.86 0.67 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.62 -1.3 . . . . 0.0 110.495 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 169.93 -15.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.163 -0.96 . . . . 0.0 111.641 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.599 HG11 ' HD3' ' A' ' 52' ' ' ARG . 1.4 t -120.17 -57.79 3.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 122.916 1.341 . . . . 0.0 109.582 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -111.15 101.36 50.07 Favored Pre-proline 0 C--N 1.288 -2.075 0 CA-C-N 114.183 -1.372 . . . . 0.0 109.134 -177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -72.97 -4.87 16.18 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 122.163 1.909 . . . . 0.0 112.34 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 23.9 p -105.72 -18.53 14.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.727 -1.233 . . . . 0.0 109.57 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.77 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 35.5 p -74.04 -5.35 40.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.996 -1.065 . . . . 0.0 109.486 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -93.28 52.11 1.73 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.87 -1.144 . . . . 0.0 108.718 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.495 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -117.04 -178.78 0.56 Allowed Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 36.1 Cg_endo -78.34 -12.54 15.57 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.147 1.898 . . . . 0.0 111.564 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 2.2 mt-10 -100.73 -24.98 14.29 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.867 -1.145 . . . . 0.0 109.618 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.2 t80 -101.31 -70.82 0.73 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.316 -0.865 . . . . 0.0 108.702 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' CD1' ' CG ' ' A' ' 63' ' ' PHE . 6.0 t80 -72.93 -18.24 61.41 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.981 -1.074 . . . . 0.0 108.672 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.52 -60.89 6.48 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.826 ' CB ' HG21 ' A' ' 90' ' ' THR . 7.9 mmtt -65.58 -15.22 62.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.605 -0.938 . . . . 0.0 109.824 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.838 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.8 t80 -83.14 -35.76 25.3 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -8.93 58.91 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -96.51 -42.35 8.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.551 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -64.2 -39.49 97.14 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.865 HG22 ' CE1' ' A' ' 118' ' ' TYR . 63.3 t -67.14 -39.62 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.938 -0.743 . . . . 0.0 110.148 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.72 -7.28 59.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.172 -0.955 . . . . 0.0 110.856 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.5 -18.16 13.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.799 -1.188 . . . . 0.0 110.002 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.38 19.68 71.09 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -152.69 57.82 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.247 . . . . 0.0 109.538 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.761 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -58.66 120.36 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 109.94 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -160.68 88.78 0.79 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.301 -0.875 . . . . 0.0 108.878 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.826 HG21 ' CB ' ' A' ' 78' ' ' LYS . 9.7 t -157.42 158.81 36.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.899 -1.126 . . . . 0.0 110.379 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.9 173.58 11.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 0.0 108.857 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.001 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 7.2 p90 -179.07 152.11 0.54 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.125 -0.984 . . . . 0.0 109.81 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.19 111.38 18.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 109.046 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.425 ' OH ' ' HB2' ' A' ' 72' ' ' SER . 0.1 OUTLIER -112.57 -178.66 3.46 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.206 -0.934 . . . . 0.0 109.646 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.3 m -151.9 108.74 3.5 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.382 -0.824 . . . . 0.0 109.834 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.48 ' CD1' ' H2 ' ' A' ' 126' ' ' HC4 . 15.8 m-30 -81.24 118.7 22.82 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -152.3 48.76 0.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.878 -1.139 . . . . 0.0 110.987 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 22.1 p90 -78.31 139.03 38.86 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.528 ' C ' ' O ' ' A' ' 98' ' ' TYR . 7.2 pt20 0.68 68.11 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.268 0 CA-C-O 121.847 0.832 . . . . 0.0 111.937 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 98' ' ' TYR . 20.1 ttp -176.71 174.65 1.79 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 4.9 t -52.71 148.17 13.69 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.048 . . . . 0.0 109.044 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.9 Cg_endo -75.88 146.41 29.6 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.96 1.773 . . . . 0.0 110.994 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.449 HG22 HG13 ' A' ' 105' ' ' VAL . 6.8 m -140.25 123.39 16.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.775 . . . . 0.0 109.264 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -102.83 140.28 37.31 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.848 ' HA ' HG23 ' A' ' 125' ' ' VAL . 14.0 m -151.99 143.4 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.905 -1.122 . . . . 0.0 110.697 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -92.35 116.82 29.31 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 176.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.001 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -91.39 164.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 O-C-N 120.966 -1.084 . . . . 0.0 110.086 -176.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.438 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 19.0 t-160 -159.94 102.36 1.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.885 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -116.14 147.53 41.27 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.095 -1.003 . . . . 0.0 110.239 -177.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.622 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 11.9 ttmt -144.4 179.66 7.12 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.593 -1.317 . . . . 0.0 109.434 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.16 106.91 18.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.04 -1.037 . . . . 0.0 109.248 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.776 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -55.88 137.44 50.34 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.515 -0.741 . . . . 0.0 109.569 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.91 23.19 7.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.809 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.7 m -87.82 -24.06 23.85 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.125 -0.985 . . . . 0.0 109.359 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 177.13 39.85 0.06 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.2 t0 62.7 63.37 0.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -1.121 . . . . 0.0 109.38 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.73 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 10.0 m -114.57 -159.16 0.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.998 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.865 ' CE1' HG22 ' A' ' 83' ' ' VAL . 28.4 m-85 -149.28 103.0 3.27 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.776 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 11.5 p-90 -103.77 148.03 26.57 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.455 -1.298 . . . . 0.0 112.078 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.885 HG13 ' CG ' ' A' ' 109' ' ' MET . 19.3 t -130.48 107.36 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.618 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.667 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 5.1 m-30 -91.53 123.9 35.3 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.294 -0.879 . . . . 0.0 109.609 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.611 HG13 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -105.27 116.8 49.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.019 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 1.9 tttm -94.96 107.8 19.85 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.532 ' HA ' HG12 ' A' ' 105' ' ' VAL . 18.2 ttp180 -57.47 128.33 36.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.896 -1.127 . . . . 0.0 109.646 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.848 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.248 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.521 " O4'" ' OH ' ' A' ' 42' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 64.81 -178.47 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -156.7 27.23 0.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.805 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.65 HG22 ' H ' ' A' ' 5' ' ' ALA . 2.7 p -91.17 -177.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.043 -1.036 . . . . 0.0 109.114 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.926 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . -58.1 -161.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.444 -0.785 . . . . 0.0 109.412 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -38.98 -67.23 0.22 Allowed 'General case' 0 N--CA 1.518 2.941 0 CA-C-O 122.205 1.003 . . . . 0.0 109.019 179.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.16 28.21 1.24 Allowed Glycine 0 C--N 1.295 -1.739 0 N-CA-C 106.659 -2.576 . . . . 0.0 106.659 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.926 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 2.1 m -65.8 126.12 27.48 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.884 -0.774 . . . . 0.0 109.739 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -70.71 83.22 0.62 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.568 -0.707 . . . . 0.0 110.969 -178.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 9' ' ' GLU . 4.7 p-10 37.55 79.39 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.685 -0.635 . . . . 0.0 109.539 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.963 HG22 HD11 ' A' ' 15' ' ' LEU . 4.9 mm -79.22 -57.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.775 -177.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.559 ' HA ' HD12 ' A' ' 15' ' ' LEU . 21.4 tt0 -39.36 -29.75 0.05 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.459 -0.776 . . . . 0.0 111.738 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' ILE . 9.8 m-80 -90.59 -40.01 12.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.908 -1.12 . . . . 0.0 108.226 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.99 HG21 HD12 ' A' ' 23' ' ' LEU . 4.2 m -69.11 -9.91 55.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.601 -0.687 . . . . 0.0 109.68 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.963 HD11 HG22 ' A' ' 11' ' ' ILE . 12.4 mt -96.6 -28.01 14.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.012 -1.055 . . . . 0.0 108.787 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.87 2.1 56.75 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.627 -0.671 . . . . 0.0 109.636 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.14 -48.91 0.45 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.936 -1.102 . . . . 0.0 110.167 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.574 ' HE2' ' HA ' ' A' ' 15' ' ' LEU . 20.4 mmt 59.08 168.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.008 -1.058 . . . . 0.0 108.327 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 18' ' ' MET . 0.1 OUTLIER 172.04 -57.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.754 -1.216 . . . . 0.0 111.131 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -87.68 64.77 8.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 109.009 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.76 20.48 70.9 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.418 ' HG2' ' HB3' ' A' ' 18' ' ' MET . 0.0 OUTLIER 56.42 29.14 14.71 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.387 -1.067 . . . . 0.0 109.204 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.99 HD12 HG21 ' A' ' 14' ' ' THR . 2.6 mt 45.47 50.14 10.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.573 -0.705 . . . . 0.0 110.236 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -75.32 -17.62 60.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 109.976 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.41 18.52 51.85 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.885 HD21 HD13 ' A' ' 23' ' ' LEU . 16.8 mt -54.97 123.36 13.26 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.291 -1.123 . . . . 0.0 109.796 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.01 -18.81 3.91 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.769 0.795 . . . . 0.0 109.075 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.817 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 17.2 p90 -126.25 148.02 49.57 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.232 -0.918 . . . . 0.0 109.016 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.528 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -76.84 144.03 29.6 Favored Glycine 0 C--N 1.293 -1.842 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.521 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -115.91 92.07 3.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.905 -1.35 . . . . 0.0 108.331 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.564 HG22 ' CE1' ' A' ' 42' ' ' TYR . 0.6 OUTLIER -96.32 150.51 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 -178.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.657 ' O ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.0 161.16 31.58 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.777 ' O ' HD11 ' A' ' 40' ' ' LEU . 23.3 mt -148.18 155.47 41.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.011 -1.056 . . . . 0.0 109.276 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.654 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -123.45 138.9 54.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.0 109.411 178.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -5.31 67.95 0.0 OUTLIER Glycine 0 N--CA 1.514 3.87 0 C-N-CA 124.834 1.207 . . . . 0.0 113.364 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER 161.25 -23.87 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 33' ' ' LEU . . . 97.98 18.91 25.71 Favored Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 8.2 p30 -84.39 129.96 34.82 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.217 -1.167 . . . . 0.0 108.831 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.518 HG21 ' HA ' ' A' ' 58' ' ' ILE . 1.9 tp -54.5 138.12 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 122.202 1.001 . . . . 0.0 112.998 -177.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.777 HD11 ' O ' ' A' ' 33' ' ' LEU . 3.5 mt -111.35 -31.08 7.17 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 176.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.588 ' NE2' ' HA ' ' A' ' 41' ' ' GLN . 0.5 OUTLIER -167.39 168.81 12.83 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.564 ' CE1' HG22 ' A' ' 31' ' ' ILE . 14.9 t80 -146.09 -70.65 0.25 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.073 -1.017 . . . . 0.0 111.16 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.3 p-10 109.45 178.83 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.858 0 C-N-CA 123.931 0.892 . . . . 0.0 108.749 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.4 -26.55 14.82 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.005 -1.059 . . . . 0.0 113.281 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.78 -65.11 0.61 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.316 -1.49 . . . . 0.0 110.707 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 2.0 pt-20 -58.79 -53.76 54.7 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.387 0.613 . . . . 0.0 110.071 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.85 -15.75 14.41 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.095 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -79.47 -37.42 36.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.775 -1.427 . . . . 0.0 108.98 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.617 HG22 HG23 ' A' ' 50' ' ' THR . 1.0 OUTLIER -79.52 -55.18 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 108.886 179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.871 HG21 " C3'" ' A' ' 126' ' ' HC4 . 59.2 p -76.98 -20.45 56.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.67 -0.644 . . . . 0.0 110.115 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.46 -2.33 78.22 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.635 HH11 HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -46.54 -47.14 19.64 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.367 -1.078 . . . . 0.0 111.481 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.518 ' O ' HG13 ' A' ' 57' ' ' VAL . 0.3 OUTLIER 67.88 147.14 0.11 Allowed Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -178.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.464 ' HA ' HG22 ' A' ' 57' ' ' VAL . 35.3 Cg_endo -76.76 -36.57 1.51 Allowed 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.128 1.885 . . . . 0.0 111.647 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -26.83 62.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.56 -40.52 19.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 109.523 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.635 HG11 HH11 ' A' ' 52' ' ' ARG . 27.6 m -73.04 -6.62 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 110.006 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.518 ' HA ' HG21 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -70.63 119.56 17.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.081 -1.012 . . . . 0.0 108.386 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.68 -20.95 48.47 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -79.61 145.89 32.84 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.543 -0.974 . . . . 0.0 108.674 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -89.85 122.21 32.69 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 108.967 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.574 ' HB2' HD21 ' A' ' 33' ' ' LEU . 79.4 t80 -60.02 -18.12 43.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.038 -1.039 . . . . 0.0 109.932 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.462 ' CE1' ' HB ' ' A' ' 70' ' ' THR . 35.9 m-85 -118.19 32.06 6.34 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.035 -1.041 . . . . 0.0 109.611 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.42 -53.6 0.1 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.013 -1.055 . . . . 0.0 110.954 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.32 16.4 9.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.846 -1.159 . . . . 0.0 111.778 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.577 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 41.0 t -118.88 -56.31 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 120.388 -1.445 . . . . 0.0 108.5 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.507 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -118.19 99.07 51.8 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.66 0.71 7.81 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.926 1.751 . . . . 0.0 111.062 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.8 p -103.31 -25.95 13.12 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.031 -1.043 . . . . 0.0 109.403 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.462 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 59.9 p -71.69 -7.16 46.25 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.381 -0.824 . . . . 0.0 110.096 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -84.81 72.53 10.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 108.984 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.433 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -160.6 172.61 5.67 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.96 . . . . 0.0 109.643 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 36.1 Cg_endo -77.92 77.42 3.93 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.358 2.039 . . . . 0.0 110.304 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.1 OUTLIER 172.36 -36.85 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.684 ' CZ ' HG11 ' A' ' 120' ' ' VAL . 1.9 t80 -104.14 -65.9 0.99 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.416 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 8.3 t80 -75.55 -20.3 58.74 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -62.82 -60.67 7.37 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.495 ' CB ' HG21 ' A' ' 90' ' ' THR . 4.4 mmtp -64.87 -17.54 64.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.424 -1.045 . . . . 0.0 109.953 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.83 ' O ' HG23 ' A' ' 83' ' ' VAL . 4.2 t80 -79.35 -36.29 39.61 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -6.9 56.8 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.35 -0.844 . . . . 0.0 108.741 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.1 mm-40 -96.14 -42.63 8.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.47 -40.59 86.5 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.849 HG22 ' CE1' ' A' ' 118' ' ' TYR . 79.3 t -62.32 -38.58 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.619 -0.93 . . . . 0.0 109.386 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.17 -5.5 56.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 110.716 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 8.6 t -98.2 -21.91 16.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.772 -1.205 . . . . 0.0 109.788 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.79 25.51 45.58 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -169.85 70.66 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.332 -1.099 . . . . 0.0 108.935 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.5 OUTLIER -69.76 117.66 11.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 110.088 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -161.59 82.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.498 HG23 ' SD ' ' A' ' 109' ' ' MET . 3.8 t -140.72 172.18 13.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.028 -1.045 . . . . 0.0 110.487 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 107' ' ' VAL . 3.2 ptt? -152.69 171.03 18.83 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.944 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 14.8 p90 179.73 152.32 0.43 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.001 -1.062 . . . . 0.0 109.929 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -78.88 116.26 19.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.135 -0.978 . . . . 0.0 109.322 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.87 175.1 5.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.337 -0.852 . . . . 0.0 109.589 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.6 m -146.03 109.98 4.91 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.788 ' CE2' HG21 ' A' ' 122' ' ' VAL . 16.0 m-30 -85.25 119.6 25.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.956 . . . . 0.0 109.632 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -147.93 56.79 1.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.456 ' OH ' ' HB ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -79.61 66.06 4.96 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.045 -0.409 . . . . 0.0 111.439 -178.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.459 ' CG ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER 73.62 25.74 2.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.066 -1.021 . . . . 0.0 109.658 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -138.81 -171.52 3.1 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.083 -1.01 . . . . 0.0 108.569 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 102' ' ' PRO . 71.6 p -57.65 160.99 6.76 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.165 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 101' ' ' THR . 32.7 Cg_endo -75.18 124.95 8.89 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.9 1.734 . . . . 0.0 110.257 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.455 HG22 HG13 ' A' ' 105' ' ' VAL . 13.1 m -118.43 125.76 50.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.431 -0.793 . . . . 0.0 109.408 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.417 ' O ' HG23 ' A' ' 125' ' ' VAL . 2.3 ttpt -107.51 138.43 43.73 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.673 ' HA ' HG23 ' A' ' 125' ' ' VAL . 5.7 m -152.69 142.3 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.048 -1.032 . . . . 0.0 110.194 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.64 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -91.01 127.69 36.53 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 174.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.944 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 1.4 m -97.93 160.19 3.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 O-C-N 120.634 -1.291 . . . . 0.0 111.475 -174.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 6' ' ' PHE . 1.8 t-160 -158.06 100.47 1.71 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.817 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -111.09 146.7 36.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.584 -0.698 . . . . 0.0 109.535 -177.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.641 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.5 tttm -138.76 -163.47 1.47 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.599 -1.313 . . . . 0.0 109.311 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.477 ' HG2' ' HA2' ' A' ' 115' ' ' GLY . 0.0 OUTLIER -103.1 117.23 34.1 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.064 -1.022 . . . . 0.0 108.807 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.892 ' HB3' ' HB2' ' A' ' 117' ' ' SER . . . -72.0 166.63 21.81 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.382 -0.824 . . . . 0.0 110.615 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.591 HD13 ' OG ' ' A' ' 117' ' ' SER . 1.7 mp 59.94 18.03 7.15 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 m 53.37 29.88 9.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -0.916 . . . . 0.0 109.477 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.477 ' HA2' ' HG2' ' A' ' 111' ' ' LYS . . . 134.3 59.77 0.07 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.341 -1.409 . . . . 0.0 109.78 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.457 ' CB ' ' HB2' ' A' ' 113' ' ' LEU . 1.7 t0 -164.89 -60.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.237 . . . . 0.0 110.228 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.892 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.9 OUTLIER -106.16 -161.44 0.8 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.925 -1.109 . . . . 0.0 110.679 -179.241 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.849 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.6 m-85 -149.71 121.35 8.04 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.851 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 13.5 p-90 -120.34 144.8 47.66 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 118.635 -1.226 . . . . 0.0 112.182 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.817 HG13 ' CG ' ' A' ' 109' ' ' MET . 27.4 t -116.83 112.15 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.759 -0.588 . . . . 0.0 109.78 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.637 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 13.6 m-30 -95.61 126.7 41.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.228 -0.92 . . . . 0.0 109.41 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.788 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -107.11 119.55 56.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 110.037 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.573 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 3.3 tptp -89.6 109.48 20.43 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.514 ' HA ' HG12 ' A' ' 105' ' ' VAL . 7.2 ttp-105 -68.64 114.82 7.35 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.114 -1.434 . . . . 0.0 109.433 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.673 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.096 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.871 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' HA ' ' CE1' ' A' ' 3' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.49 76.01 1.5 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.403 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.455 ' CE1' ' HA ' ' A' ' 1' ' ' MET . 11.5 p-80 -169.53 -178.61 3.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.283 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.909 HG22 ' OG ' ' A' ' 8' ' ' SER . 8.3 p -117.77 99.52 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.949 . . . . 0.0 109.655 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.846 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 49.43 -153.52 0.12 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.198 -0.939 . . . . 0.0 109.85 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.596 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -64.02 -46.85 82.63 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.74 39.05 0.15 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 107.9 -2.08 . . . . 0.0 107.9 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.909 ' OG ' HG22 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -68.03 -173.91 0.42 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.12 0.962 . . . . 0.0 111.405 -178.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -125.98 52.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.805 ' H ' HG21 ' A' ' 4' ' ' VAL . 0.5 OUTLIER 60.96 82.79 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -177.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.031 HG22 HD11 ' A' ' 15' ' ' LEU . 2.9 mm -81.71 -67.37 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 O-C-N 121.305 -0.872 . . . . 0.0 110.592 -177.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.88 -25.49 0.2 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.017 -1.052 . . . . 0.0 111.462 -178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -82.87 -46.62 12.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.856 -1.153 . . . . 0.0 109.537 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.747 HG21 ' HB2' ' A' ' 23' ' ' LEU . 1.1 m -66.95 -58.29 5.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.031 HD11 HG22 ' A' ' 11' ' ' ILE . 34.7 mt -38.87 -32.72 0.09 Allowed 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.017 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.75 -56.63 8.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.446 -0.784 . . . . 0.0 109.16 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.55 67.26 0.65 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.379 -0.825 . . . . 0.0 109.111 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.444 ' HG3' ' HB3' ' A' ' 22' ' ' GLN . 7.1 ttp -119.46 153.38 35.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.882 . . . . 0.0 109.76 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -101.29 -57.95 1.98 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 109.044 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -179.22 -57.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.838 . . . . 0.0 109.438 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.86 33.46 5.35 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.444 ' HB3' ' HG3' ' A' ' 18' ' ' MET . 0.8 OUTLIER -93.63 -44.59 8.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -1.174 . . . . 0.0 109.701 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.747 ' HB2' HG21 ' A' ' 14' ' ' THR . 1.9 tp -130.86 11.15 5.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.06 -1.025 . . . . 0.0 110.327 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 9.4 m-20 -71.62 -6.26 39.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.612 -1.305 . . . . 0.0 109.515 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.32 26.9 22.81 Favored Glycine 0 N--CA 1.491 2.335 0 O-C-N 120.857 -1.152 . . . . 0.0 110.387 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.706 HD21 ' HG ' ' A' ' 23' ' ' LEU . 4.8 mt -75.57 -175.14 2.74 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.862 -1.376 . . . . 0.0 108.427 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.98 16.0 22.33 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.649 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 1.9 p90 -151.44 -173.77 4.62 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -112.65 137.11 14.0 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.527 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -109.43 89.2 2.93 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.39 1.595 . . . . 0.0 107.755 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.696 HG22 ' CD1' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -99.53 148.51 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.303 -0.873 . . . . 0.0 110.113 -178.022 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.677 ' HB3' HD12 ' A' ' 40' ' ' LEU . 4.1 mt-30 -120.01 164.54 15.95 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.875 HD22 ' O ' ' A' ' 37' ' ' GLY . 98.5 mt -152.32 146.05 25.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.094 -1.004 . . . . 0.0 109.083 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.547 ' OD1' HD11 ' A' ' 40' ' ' LEU . 7.8 m-20 -124.88 129.9 51.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.943 -1.098 . . . . 0.0 110.522 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 37.4 -77.18 0.0 OUTLIER Glycine 0 N--CA 1.503 3.1 0 C-N-CA 124.589 1.09 . . . . 0.0 113.605 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 34' ' ' ASP . 11.3 m-20 -71.46 -0.57 10.7 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.646 -0.914 . . . . 0.0 111.081 -178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.875 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 84.2 17.63 64.41 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -73.65 131.33 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.922 -1.34 . . . . 0.0 108.919 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.756 HD12 HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -59.93 135.33 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 0.0 110.204 -179.018 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.677 HD12 ' HB3' ' A' ' 32' ' ' GLN . 2.0 mt -105.46 -26.68 11.82 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.619 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -167.04 163.15 15.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.696 ' CD1' HG22 ' A' ' 31' ' ' ILE . 38.4 t80 -135.34 -107.3 0.22 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.353 -1.467 . . . . 0.0 110.69 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 44' ' ' ALA . 14.3 t-20 157.65 145.91 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.744 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -70.14 -53.12 18.65 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.548 -0.72 . . . . 0.0 111.587 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.67 -54.39 4.05 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.31 -0.869 . . . . 0.0 111.053 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' CD ' ' CE1' ' A' ' 42' ' ' TYR . 3.8 pt-20 -63.67 -44.1 94.75 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.739 0.781 . . . . 0.0 109.671 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -59.77 -17.16 41.4 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -85.17 -29.63 24.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.912 -1.346 . . . . 0.0 108.908 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.611 HG22 ' CG2' ' A' ' 50' ' ' THR . 0.5 OUTLIER -77.03 -49.7 22.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.511 -0.743 . . . . 0.0 109.64 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.64 HG21 " C3'" ' A' ' 126' ' ' HC4 . 1.3 p -104.12 -7.23 20.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.963 -1.086 . . . . 0.0 110.748 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 81.83 -2.4 83.48 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.813 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.858 ' CD ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -39.52 -59.31 1.12 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -1.004 . . . . 0.0 112.666 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.754 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.6 OUTLIER 67.28 146.24 0.11 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.648 -1.282 . . . . 0.0 107.559 -178.108 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.42 -67.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.94 1.76 . . . . 0.0 111.89 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -48.32 -23.95 1.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.184 -0.948 . . . . 0.0 110.898 -178.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.66 -45.48 10.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.788 -1.195 . . . . 0.0 110.081 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.858 HG11 ' CD ' ' A' ' 52' ' ' ARG . 26.0 m -76.87 -0.63 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.056 -1.028 . . . . 0.0 110.036 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.6 OUTLIER -70.84 124.86 28.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.287 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.6 -19.87 52.87 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -79.2 146.38 33.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -1.138 . . . . 0.0 109.138 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -88.55 118.62 28.33 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.617 ' HB2' HD21 ' A' ' 33' ' ' LEU . 74.5 t80 -52.92 -22.11 5.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.515 -0.741 . . . . 0.0 110.22 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -113.11 -10.85 13.39 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.937 -1.102 . . . . 0.0 111.459 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -135.51 39.74 2.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.78 -1.2 . . . . 0.0 110.217 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER 171.93 -14.28 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.91 -1.119 . . . . 0.0 111.966 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.713 HG11 ' NE ' ' A' ' 52' ' ' ARG . 10.2 t -115.7 -53.36 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 O-C-N 120.346 -1.471 . . . . 0.0 109.358 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.465 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -119.43 96.92 50.1 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.059 -177.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.71 -2.46 12.61 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.902 1.735 . . . . 0.0 110.409 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.3 p -95.5 -17.04 21.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.099 -1.001 . . . . 0.0 109.75 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.729 HG22 ' CD2' ' A' ' 75' ' ' PHE . 64.5 p -86.62 11.31 13.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -89.37 54.14 2.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 108.87 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . 3.2 p -139.48 173.17 5.39 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 72' ' ' SER . 35.4 Cg_endo -77.14 3.55 6.58 Favored 'Trans proline' 0 C--N 1.321 -0.892 0 C-N-CA 122.109 1.872 . . . . 0.0 111.781 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 32.7 mt-10 -106.45 -28.0 10.59 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.94 -1.1 . . . . 0.0 109.151 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.729 ' CD2' HG22 ' A' ' 70' ' ' THR . 2.0 t80 -102.92 -71.19 0.73 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.478 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.6 t80 -71.04 -17.18 62.63 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.47 -60.9 6.82 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.895 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -61.87 -17.61 57.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.399 -1.059 . . . . 0.0 109.577 -179.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.901 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.4 t80 -81.01 -38.8 26.88 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.488 -0.757 . . . . 0.0 109.768 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -76.11 -11.67 59.98 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.142 -0.974 . . . . 0.0 109.491 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 13.6 pt-20 -96.87 -40.36 8.96 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.89 -39.95 97.86 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 107.695 -2.162 . . . . 0.0 107.695 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 79' ' ' PHE . 97.0 t -58.03 -44.24 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.719 -0.871 . . . . 0.0 109.268 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.17 -3.48 58.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -0.834 . . . . 0.0 110.652 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 t -94.72 -23.3 17.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.916 -1.115 . . . . 0.0 109.579 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 25.5 50.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -174.28 62.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.347 -1.09 . . . . 0.0 108.991 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.767 HD11 ' HA ' ' A' ' 79' ' ' PHE . 1.5 tt -55.51 123.73 14.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.145 -0.972 . . . . 0.0 109.584 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.449 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 40.2 t30 -160.21 84.52 0.72 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.381 -0.824 . . . . 0.0 109.118 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.895 HG21 ' HB2' ' A' ' 78' ' ' LYS . 9.2 t -138.11 170.99 15.07 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.915 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -159.6 168.59 25.71 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.917 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 11.8 p90 176.69 154.97 0.23 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.035 -1.041 . . . . 0.0 109.987 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 1.4 pt-20 -80.96 107.06 13.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.043 -1.035 . . . . 0.0 108.496 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.06 178.97 4.3 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.363 -0.835 . . . . 0.0 109.825 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 103' ' ' THR . 90.6 m -147.12 110.37 4.82 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.753 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 20.1 m-30 -80.96 118.11 22.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.935 . . . . 0.0 109.472 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -148.27 47.01 1.06 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.272 -0.893 . . . . 0.0 110.132 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.562 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 29.1 p90 -78.11 136.83 37.95 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.529 ' C ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 1.96 66.1 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.332 0 CA-C-O 121.696 0.76 . . . . 0.0 112.075 -178.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 98' ' ' TYR . 6.0 ttp -177.01 -174.26 0.51 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 t -63.47 149.2 92.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.944 . . . . 0.0 108.917 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.81 156.28 39.39 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 121.82 1.68 . . . . 0.0 110.894 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 95' ' ' THR . 3.1 m -147.39 148.45 31.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.5 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.432 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 0.0 OUTLIER -119.93 140.68 50.51 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.756 ' HA ' HG23 ' A' ' 125' ' ' VAL . 10.1 m -158.24 144.42 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.092 -1.005 . . . . 0.0 110.489 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.669 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -92.38 112.52 24.5 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 174.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.917 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 1.4 m -83.27 161.24 3.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 O-C-N 121.366 -0.834 . . . . 0.0 111.86 -174.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -157.23 98.34 1.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.884 ' HG2' HG13 ' A' ' 120' ' ' VAL . 13.7 mtm -107.97 144.98 34.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.985 -1.072 . . . . 0.0 110.237 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.64 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 5.0 tttt -141.39 -163.4 1.55 Allowed 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 118.169 -1.412 . . . . 0.0 110.168 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp -103.28 106.55 17.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.953 . . . . 0.0 109.111 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.799 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -54.45 149.07 10.87 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.445 -0.784 . . . . 0.0 110.174 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.52 0.24 57.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.452 -0.78 . . . . 0.0 110.221 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -45.98 82.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.847 -1.158 . . . . 0.0 109.51 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.12 75.19 0.04 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 57.35 62.92 2.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -1.135 . . . . 0.0 109.18 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.767 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -118.74 -169.91 1.81 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.135 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.768 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.7 m-85 -151.11 122.01 7.6 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.799 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.2 p-90 -121.25 156.61 32.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.707 -1.245 . . . . 0.0 111.954 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.884 HG13 ' HG2' ' A' ' 109' ' ' MET . 46.5 t -124.88 112.52 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.353 0.597 . . . . 0.0 110.373 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.642 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 11.2 m-30 -96.91 112.29 24.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.753 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.1 t -100.02 116.58 43.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.39 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.596 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 5.6 tptp -89.38 120.5 30.77 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.567 ' HD3' HD11 ' A' ' 49' ' ' ILE . 9.2 ttp180 -73.72 117.69 15.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.77 -1.206 . . . . 0.0 109.35 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.756 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.229 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.64 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttp . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 55.01 37.7 29.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.491 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -121.41 -25.93 5.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.121 -0.987 . . . . 0.0 110.271 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.639 ' O ' HG13 ' A' ' 4' ' ' VAL . 9.1 p -173.23 113.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.89 -1.131 . . . . 0.0 109.994 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.521 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 54.84 -166.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.008 -1.058 . . . . 0.0 109.592 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -51.72 -58.26 6.9 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.07 33.03 0.3 Allowed Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.96 ' HB3' HD11 ' A' ' 11' ' ' ILE . 1.4 m -71.38 -174.44 1.06 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.837 -0.802 . . . . 0.0 110.93 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -121.14 70.85 0.93 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.426 -0.796 . . . . 0.0 110.536 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.46 ' H ' HG21 ' A' ' 4' ' ' VAL . 0.9 OUTLIER 48.67 83.56 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -179.482 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.96 HD11 ' HB3' ' A' ' 8' ' ' SER . 1.1 mm -85.77 -62.0 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.278 -0.889 . . . . 0.0 111.318 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -45.54 -24.56 0.34 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.972 -1.08 . . . . 0.0 111.023 -178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -81.66 -46.14 14.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.091 -1.005 . . . . 0.0 109.428 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.02 HG21 HD12 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -69.23 -58.45 4.02 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.932 HD11 HG22 ' A' ' 11' ' ' ILE . 43.4 mt -39.47 -31.45 0.09 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.422 0.63 . . . . 0.0 110.102 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.83 -60.1 4.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.27 31.52 2.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 109.243 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.439 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -106.35 123.89 48.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.387 -0.82 . . . . 0.0 109.553 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -79.52 -51.91 8.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.323 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' OD2' ' CB ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER 176.55 -35.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.418 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.94 27.09 20.23 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.939 -1.265 . . . . 0.0 109.939 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.43 ' HB3' ' HG3' ' A' ' 18' ' ' MET . 2.4 tt0 -89.61 -37.58 14.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -1.167 . . . . 0.0 109.444 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.02 HD12 HG21 ' A' ' 14' ' ' THR . 3.3 mt -138.03 58.81 1.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.404 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -85.87 -1.86 57.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 110.016 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.73 21.26 34.05 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.499 HD21 HD22 ' A' ' 23' ' ' LEU . 68.8 mt -81.21 140.3 35.01 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.141 -1.211 . . . . 0.0 108.735 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.19 3.83 14.19 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.771 0.796 . . . . 0.0 109.177 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 8' ' ' SER . 2.5 p90 -136.55 139.76 42.43 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -74.09 129.5 11.72 Favored Glycine 0 C--N 1.293 -1.832 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -103.18 117.14 33.87 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.884 -1.363 . . . . 0.0 107.941 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.653 ' C ' HD12 ' A' ' 31' ' ' ILE . 1.1 pp -115.78 144.35 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.33 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 2.9 tt0 -108.71 168.56 9.26 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.716 ' C ' HD11 ' A' ' 40' ' ' LEU . 21.1 mt -156.64 135.8 12.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.53 -1.356 . . . . 0.0 111.188 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.429 ' N ' HD11 ' A' ' 40' ' ' LEU . 15.7 t0 -93.96 175.9 6.54 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -43.87 -55.68 5.43 Favored Glycine 0 N--CA 1.498 2.774 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.358 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -18.93 57.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.677 -1.484 . . . . 0.0 109.569 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 102.5 29.09 6.08 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 107.331 -2.307 . . . . 0.0 107.331 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -86.53 130.03 34.64 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.673 -0.898 . . . . 0.0 110.78 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -62.73 131.76 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.563 -1.336 . . . . 0.0 110.997 -179.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.716 HD11 ' C ' ' A' ' 33' ' ' LEU . 2.3 mp -104.76 -19.88 13.78 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 176.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.6 ' NE2' HD22 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -156.57 161.06 39.98 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.572 ' CE1' HG22 ' A' ' 31' ' ' ILE . 9.3 t80 -147.7 -61.96 0.27 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.588 -1.32 . . . . 0.0 111.035 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.636 HD21 ' HB3' ' A' ' 45' ' ' ALA . 1.4 p-10 97.43 175.08 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.5 -17.33 20.59 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.872 -1.143 . . . . 0.0 112.58 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.636 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -55.42 -63.73 1.07 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.549 -1.345 . . . . 0.0 110.298 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.6 pt-20 -57.78 -56.44 21.92 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.629 0.728 . . . . 0.0 109.309 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.1 -16.56 8.67 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 0.3 OUTLIER -70.86 -43.62 68.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.733 -1.451 . . . . 0.0 108.759 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -85.1 -55.99 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.443 -0.785 . . . . 0.0 109.552 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.942 HG21 " C3'" ' A' ' 126' ' ' HC4 . 33.2 p -72.98 -20.18 61.08 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 0.0 110.318 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.9 -6.34 79.08 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.679 ' HB3' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -57.19 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -1.182 . . . . 0.0 110.133 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.744 ' O ' HG22 ' A' ' 57' ' ' VAL . 2.7 m-20 -61.2 159.67 27.92 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' CB ' ' OD2' ' A' ' 20' ' ' ASP . 36.6 Cg_endo -79.05 -63.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.791 1.661 . . . . 0.0 110.983 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -56.12 -20.24 16.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.18 -0.95 . . . . 0.0 110.345 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -90.13 -47.37 7.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.914 -1.116 . . . . 0.0 110.021 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 53' ' ' ASP . 18.4 m -72.86 -4.93 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.03 . . . . 0.0 109.668 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.679 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.78 124.83 26.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.16 -17.05 59.11 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.421 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 7.6 mmtt -78.65 138.35 38.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.191 -1.182 . . . . 0.0 109.04 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -75.55 104.31 6.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.809 ' CZ ' HG21 ' A' ' 70' ' ' THR . 31.3 t80 -58.52 -19.71 39.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.489 -0.757 . . . . 0.0 110.586 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.676 ' CE2' HD13 ' A' ' 33' ' ' LEU . 22.2 m-85 -85.75 -48.69 8.58 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.297 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.36 37.36 4.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.925 -1.109 . . . . 0.0 109.789 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.466 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 1.2 t0 -149.31 -30.91 0.24 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 110.615 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.601 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 5.0 t -110.77 -58.91 3.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 O-C-N 120.745 -1.222 . . . . 0.0 108.679 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.415 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -104.71 105.66 51.56 Favored Pre-proline 0 C--N 1.29 -1.987 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.594 -178.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.62 3.85 6.08 Favored 'Trans proline' 0 C--N 1.321 -0.916 0 C-N-CA 122.058 1.838 . . . . 0.0 111.26 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.2 p -107.15 -17.06 14.26 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.847 -1.158 . . . . 0.0 109.862 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.809 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 24.8 p -83.5 6.0 21.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.962 . . . . 0.0 110.046 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -97.79 52.29 1.08 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.08 -1.012 . . . . 0.0 108.921 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.7 p -129.63 -179.81 1.11 Allowed Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.23 2.19 8.25 Favored 'Trans proline' 0 C--N 1.321 -0.906 0 C-N-CA 122.049 1.833 . . . . 0.0 112.028 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.9 mp0 -109.65 -27.96 9.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.86 -1.15 . . . . 0.0 108.985 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.649 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.1 t80 -102.52 -70.76 0.74 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 7.7 t80 -68.72 -17.48 64.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.81 -62.84 4.89 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.818 ' HB3' HG21 ' A' ' 90' ' ' THR . 5.3 mmtt -61.64 -16.53 49.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.448 -1.031 . . . . 0.0 109.502 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.872 ' O ' HG23 ' A' ' 83' ' ' VAL . 17.1 t80 -82.11 -39.43 23.35 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.58 -0.7 . . . . 0.0 110.195 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.9 -12.15 60.1 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.925 -1.109 . . . . 0.0 109.311 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 19.9 pt-20 -97.1 -41.01 8.55 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.07 -39.89 98.57 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 79' ' ' PHE . 97.4 t -60.11 -54.33 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.746 -0.856 . . . . 0.0 109.188 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.86 -2.14 35.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.398 -0.814 . . . . 0.0 110.454 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.1 t -90.63 -34.27 15.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.045 -1.034 . . . . 0.0 109.543 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.31 19.4 30.47 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -175.43 64.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -1.138 . . . . 0.0 108.945 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.569 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -51.27 123.68 10.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.856 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -161.1 89.67 0.79 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.115 -0.991 . . . . 0.0 108.77 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.818 HG21 ' HB3' ' A' ' 78' ' ' LYS . 9.4 t -153.23 172.65 16.65 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.825 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.62 174.51 14.95 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.005 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 7.3 p90 178.69 152.79 0.34 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.769 -1.207 . . . . 0.0 110.441 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -79.46 117.18 20.19 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.893 . . . . 0.0 108.777 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -120.19 175.18 6.07 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.038 -1.039 . . . . 0.0 110.359 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.7 m -147.25 110.32 4.78 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.517 ' CD1' ' C2 ' ' A' ' 126' ' ' HC4 . 19.7 m-85 -80.14 119.79 23.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -131.14 42.41 3.22 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.604 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -78.29 79.55 4.73 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.3 0.572 . . . . 0.0 110.391 -179.465 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.577 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 5.3 pt20 52.52 38.94 26.94 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.675 0.75 . . . . 0.0 109.656 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.73 -168.9 3.04 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.387 -0.821 . . . . 0.0 109.369 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.42 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.6 t -67.24 150.54 97.84 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.8 . . . . 0.0 108.921 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.42 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 33.5 Cg_endo -74.56 82.64 1.87 Allowed 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 121.86 1.707 . . . . 0.0 110.088 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.681 HG22 HG13 ' A' ' 105' ' ' VAL . 11.4 m -69.93 98.9 1.33 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.497 -0.752 . . . . 0.0 109.607 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.1 OUTLIER -73.24 133.95 44.13 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.208 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.704 ' HA ' HG23 ' A' ' 125' ' ' VAL . 16.3 m -150.0 146.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.365 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -94.62 116.78 29.17 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 175.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.005 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -88.26 164.4 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.741 -1.224 . . . . 0.0 111.553 -175.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.435 ' ND1' ' HA ' ' A' ' 5' ' ' ALA . 21.3 t-160 -147.42 146.88 29.74 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 175.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.915 ' HB3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -152.33 137.86 17.74 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.6 -1.312 . . . . 0.0 109.345 -178.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.592 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 25.4 tttt -150.3 158.9 44.66 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.402 -1.319 . . . . 0.0 109.904 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.462 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 4.7 ttmt -72.36 109.88 6.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 109.048 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.959 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -72.03 176.24 5.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.442 -0.787 . . . . 0.0 111.008 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.466 HD13 ' HB3' ' A' ' 116' ' ' ASP . 0.2 OUTLIER 63.28 21.07 12.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.551 -0.718 . . . . 0.0 109.119 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.4 m 55.44 25.17 7.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.318 -0.864 . . . . 0.0 109.076 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' ' 111' ' ' LYS . . . 126.63 74.49 0.21 Allowed Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.508 -1.33 . . . . 0.0 110.13 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.466 ' HB3' HD13 ' A' ' 113' ' ' LEU . 0.9 OUTLIER 178.52 -42.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.9 -1.353 . . . . 0.0 110.533 179.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.76 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 55.7 m -113.8 179.48 3.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.006 -1.059 . . . . 0.0 110.594 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.838 ' CE1' HG22 ' A' ' 83' ' ' VAL . 16.6 m-85 -132.38 132.11 42.53 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.959 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 17.4 p-90 -136.28 155.24 50.37 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.63 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.915 HG22 ' HB3' ' A' ' 109' ' ' MET . 83.3 t -140.42 109.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.804 -0.56 . . . . 0.0 110.049 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.683 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 3.8 m-30 -91.36 135.13 34.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.991 -1.068 . . . . 0.0 109.319 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.666 HG13 ' HB ' ' A' ' 105' ' ' VAL . 1.3 t -110.42 119.23 58.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.24 -0.912 . . . . 0.0 109.72 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.575 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -89.03 108.55 19.65 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.632 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -67.56 116.91 8.82 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 118.474 -1.29 . . . . 0.0 109.468 -178.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.704 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.115 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.942 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.72 -38.36 67.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.227 -0.92 . . . . 0.0 109.684 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 63.02 113.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.401 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.673 HG13 ' OG ' ' A' ' 8' ' ' SER . 7.3 p -161.09 146.67 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.418 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.896 ' HB1' ' CE1' ' A' ' 6' ' ' PHE . . . 46.22 -85.5 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.307 0.575 . . . . 0.0 111.592 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.896 ' CE1' ' HB1' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -164.73 -45.89 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 -178.179 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.46 24.34 0.96 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.673 ' OG ' HG13 ' A' ' 4' ' ' VAL . 84.0 p -76.94 142.46 40.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.361 -1.082 . . . . 0.0 109.634 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -53.17 -34.96 59.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.234 1.016 . . . . 0.0 108.567 178.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.644 ' HA ' HG11 ' A' ' 4' ' ' VAL . 0.8 OUTLIER 157.74 95.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.093 HG22 HD11 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -75.16 -68.67 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.529 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.558 -177.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.431 ' HA ' HD12 ' A' ' 15' ' ' LEU . 3.2 tm-20 -37.98 -33.63 0.09 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.697 -0.627 . . . . 0.0 111.663 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.39 -44.28 16.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.919 -1.113 . . . . 0.0 108.597 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 18' ' ' MET . 2.7 m -69.55 -8.54 48.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.746 -0.597 . . . . 0.0 109.605 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.093 HD11 HG22 ' A' ' 11' ' ' ILE . 28.7 mt -97.97 -22.06 16.5 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.819 -1.175 . . . . 0.0 109.316 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.98 -21.3 18.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.399 -0.813 . . . . 0.0 109.969 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -136.0 73.16 1.45 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.831 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.48 ' CE ' HD13 ' A' ' 23' ' ' LEU . 11.0 tmm? -139.13 116.45 11.17 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.291 -0.881 . . . . 0.0 109.311 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.21 -74.78 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.694 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.87 58.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.077 -1.015 . . . . 0.0 109.611 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.08 37.88 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.441 ' HB3' ' HG3' ' A' ' 18' ' ' MET . 8.5 tt0 -132.39 -27.59 1.75 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -1.074 . . . . 0.0 110.483 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.727 HD23 ' N ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -103.33 -13.48 16.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.723 -1.236 . . . . 0.0 110.207 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.727 ' N ' HD23 ' A' ' 23' ' ' LEU . 19.4 p30 -68.94 -17.41 63.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.955 -1.09 . . . . 0.0 110.028 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' A' ' 24' ' ' ASP . . . -100.83 35.83 4.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.996 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 85.1 mt -99.63 124.57 44.98 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.44 -1.035 . . . . 0.0 109.838 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.12 -12.92 14.05 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.824 0.821 . . . . 0.0 108.916 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.996 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 2.7 p90 -113.82 -172.43 2.08 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.164 -0.96 . . . . 0.0 108.612 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.484 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -122.98 136.16 10.43 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 108.131 -1.988 . . . . 0.0 108.131 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -113.91 111.25 21.39 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.894 -1.356 . . . . 0.0 108.318 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.667 HG22 ' CD1' ' A' ' 42' ' ' TYR . 0.8 OUTLIER -120.81 140.27 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.493 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.672 ' HB3' HD12 ' A' ' 40' ' ' LEU . 9.3 mt-30 -107.23 170.55 7.89 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.747 HD21 HD12 ' A' ' 39' ' ' ILE . 80.1 mt -151.47 142.84 23.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.988 -1.07 . . . . 0.0 109.971 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.598 ' HB2' HD21 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -115.11 137.43 52.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.077 -1.014 . . . . 0.0 109.365 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -10.89 71.21 0.0 OUTLIER Glycine 0 N--CA 1.513 3.824 0 C-N-CA 124.674 1.13 . . . . 0.0 113.378 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER 162.58 -24.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.04 18.37 22.44 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 16.3 p-10 -84.9 129.04 34.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.146 -1.208 . . . . 0.0 108.893 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.747 HD12 HD21 ' A' ' 33' ' ' LEU . 1.1 mp -63.24 137.26 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.075 0.94 . . . . 0.0 111.282 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 32' ' ' GLN . 1.7 mt -108.27 -28.45 9.44 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.548 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -155.0 161.14 41.46 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.667 ' CD1' HG22 ' A' ' 31' ' ' ILE . 48.3 t80 -149.14 -73.35 0.18 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.54 -1.35 . . . . 0.0 111.071 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 10.1 p-10 109.06 178.19 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 123.999 0.92 . . . . 0.0 109.641 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.9 15.09 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.051 -1.031 . . . . 0.0 113.258 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 26' ' ' LEU . . . -51.75 -63.77 1.03 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.254 -1.528 . . . . 0.0 110.563 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' OE1' ' CE1' ' A' ' 42' ' ' TYR . 1.2 pt-20 -57.39 -54.62 44.74 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.625 0.726 . . . . 0.0 109.609 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.41 -14.87 21.81 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.57 -34.89 46.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.874 -1.368 . . . . 0.0 109.478 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -47.91 15.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.251 -0.905 . . . . 0.0 109.679 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.649 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -86.41 -31.92 21.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.176 -0.952 . . . . 0.0 109.74 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.41 -3.41 56.5 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.928 -1.129 . . . . 0.0 110.438 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.953 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -41.9 -48.04 4.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.321 -1.105 . . . . 0.0 112.492 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.646 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER 66.1 146.18 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.727 -1.233 . . . . 0.0 107.737 -178.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.77 -63.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.949 1.766 . . . . 0.0 112.118 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.767 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -55.22 -21.65 14.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.011 . . . . 0.0 111.193 -178.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -88.07 -41.1 13.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.868 -1.145 . . . . 0.0 109.878 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 52' ' ' ARG . 15.2 m -81.89 3.32 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 110.021 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.767 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -71.44 120.84 20.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.091 -1.006 . . . . 0.0 108.546 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.8 -11.4 70.55 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -80.36 141.4 35.43 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.949 -1.324 . . . . 0.0 109.849 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.451 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -81.59 92.99 6.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.25 -0.907 . . . . 0.0 109.005 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.719 ' CZ ' HG21 ' A' ' 70' ' ' THR . 25.8 t80 -54.1 -22.33 10.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 76' ' ' TYR . 7.0 m-85 -85.84 -31.45 22.27 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.48 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.39 47.4 1.39 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 108.935 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.451 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.7 OUTLIER -165.47 -33.94 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.388 -0.82 . . . . 0.0 110.345 -179.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.953 HG11 ' HD3' ' A' ' 52' ' ' ARG . 9.9 t -106.93 -56.97 4.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 120.76 -1.213 . . . . 0.0 109.002 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.499 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -104.4 101.26 26.26 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.902 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.2 Cg_endo -75.98 -0.38 10.2 Favored 'Trans proline' 0 C--N 1.317 -1.132 0 C-N-CA 121.803 1.669 . . . . 0.0 110.522 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 p -100.54 -23.2 14.75 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.072 -1.017 . . . . 0.0 109.694 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.719 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 10.8 p -82.12 3.88 25.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.168 -0.958 . . . . 0.0 110.044 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -91.21 51.16 1.87 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.924 -1.11 . . . . 0.0 108.77 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.48 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -121.13 179.05 1.01 Allowed Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -78.85 -6.09 14.97 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.931 1.754 . . . . 0.0 111.223 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 14.3 mm-40 -103.18 -24.15 13.59 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.896 -1.127 . . . . 0.0 109.656 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.571 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.5 t80 -103.61 -70.44 0.76 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 21.0 t80 -71.83 -19.67 61.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.92 -1.113 . . . . 0.0 108.442 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.48 -61.51 6.21 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.664 ' HB2' HG21 ' A' ' 90' ' ' THR . 2.3 mmtp -63.04 -15.78 57.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.964 . . . . 0.0 109.496 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.863 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.9 t80 -78.65 -40.49 34.01 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -77.91 -7.02 56.19 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -95.75 -39.51 9.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.433 ' C ' HD12 ' A' ' 88' ' ' LEU . . . -70.27 -43.08 64.3 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.898 HG22 ' CE1' ' A' ' 118' ' ' TYR . 59.1 t -58.25 -37.3 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.738 -0.86 . . . . 0.0 109.192 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.12 -4.22 46.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.459 -0.776 . . . . 0.0 110.982 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 m -100.38 -18.22 16.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.781 -1.199 . . . . 0.0 110.224 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.77 16.3 77.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.86 63.43 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -1.207 . . . . 0.0 108.846 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -65.31 112.68 3.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 109.854 -179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.419 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 19.3 p30 -160.78 85.07 0.69 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.409 -0.807 . . . . 0.0 108.912 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.664 HG21 ' HB2' ' A' ' 78' ' ' LYS . 8.9 t -133.1 144.93 50.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.061 -1.024 . . . . 0.0 110.434 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.5 ptp -132.74 154.64 50.01 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.058 ' CE2' HG21 ' A' ' 107' ' ' VAL . 9.9 p90 -169.19 -173.3 1.71 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.755 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.63 110.37 20.47 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.95 172.71 6.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.312 -0.867 . . . . 0.0 109.495 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 103' ' ' THR . 89.3 m -143.41 111.72 6.27 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.442 -0.787 . . . . 0.0 109.042 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.941 ' CE2' HG21 ' A' ' 122' ' ' VAL . 15.5 m-30 -83.8 117.13 23.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.281 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -147.13 47.04 1.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.94 . . . . 0.0 109.88 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 21.3 p90 -78.6 137.08 37.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.515 ' C ' ' O ' ' A' ' 98' ' ' TYR . 5.3 pt20 1.51 66.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.114 0 CA-C-O 121.539 0.685 . . . . 0.0 112.371 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 98' ' ' TYR . 67.7 ttp -162.98 -93.54 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.502 -0.749 . . . . 0.0 109.396 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 100' ' ' MET . 0.2 OUTLIER -149.17 161.5 31.99 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.812 -1.18 . . . . 0.0 108.664 179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.95 115.36 4.0 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 122.024 1.816 . . . . 0.0 110.357 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.549 ' O ' HG23 ' A' ' 95' ' ' THR . 2.5 m -123.58 128.08 49.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.662 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.42 143.61 33.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.798 ' HA ' HG23 ' A' ' 125' ' ' VAL . 15.2 m -152.82 141.97 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.773 -1.204 . . . . 0.0 110.777 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.543 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -83.43 115.94 22.28 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 174.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.058 HG21 ' CE2' ' A' ' 92' ' ' PHE . 32.7 m -98.85 156.22 3.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 120.838 -1.164 . . . . 0.0 110.929 -175.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -159.99 104.48 1.52 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.904 ' HG2' HG13 ' A' ' 120' ' ' VAL . 6.4 mtm -110.23 145.53 37.18 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.429 -0.794 . . . . 0.0 109.772 -178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.624 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.9 tttm -138.0 -177.59 4.89 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.873 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.43 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 5.1 ttmm -91.04 99.9 12.85 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.701 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -48.07 123.94 6.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.408 -0.807 . . . . 0.0 110.057 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.63 -17.85 37.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 109.962 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 m -53.62 -27.46 27.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.009 -1.057 . . . . 0.0 109.188 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -166.18 33.24 0.23 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t70 57.12 33.87 24.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -1.127 . . . . 0.0 109.163 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.519 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -84.48 -163.23 0.77 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.375 -0.828 . . . . 0.0 110.166 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.898 ' CE1' HG22 ' A' ' 83' ' ' VAL . 22.7 m-85 -139.54 113.46 8.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.724 ' CZ3' ' CE2' ' A' ' 121' ' ' PHE . 11.1 p-90 -114.95 141.68 47.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.527 -1.269 . . . . 0.0 112.325 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.904 HG13 ' HG2' ' A' ' 109' ' ' MET . 61.5 t -113.99 116.23 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.724 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 18.9 m-30 -99.05 127.63 45.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.002 -1.061 . . . . 0.0 109.287 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.941 HG21 ' CE2' ' A' ' 96' ' ' PHE . 2.0 t -116.3 113.09 42.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 118.962 -1.095 . . . . 0.0 109.025 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.604 ' CD ' ' CD1' ' A' ' 6' ' ' PHE . 8.1 tttm -96.62 120.73 37.49 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.466 ' HA ' HG12 ' A' ' 105' ' ' VAL . 1.9 ttt180 -65.67 121.34 14.74 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.707 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.798 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.183 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.649 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 57.86 -93.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.834 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -64.43 177.7 0.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.732 -1.23 . . . . 0.0 109.551 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.725 HG12 ' HZ1' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -76.05 -160.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.681 ' N ' HG13 ' A' ' 4' ' ' VAL . . . -85.63 133.99 34.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.35 -0.844 . . . . 0.0 110.545 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.548 ' CZ ' ' O ' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -65.74 -56.84 9.9 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.533 ' O ' HD11 ' A' ' 11' ' ' ILE . . . -54.44 -26.9 39.18 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.55 -2.22 . . . . 0.0 107.55 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.624 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.2 OUTLIER 44.86 -165.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.198 0.999 . . . . 0.0 112.013 177.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -61.08 81.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.98 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' C ' ' O ' ' A' ' 9' ' ' GLU . 69.1 m-20 26.64 76.91 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.848 0 CA-C-N 118.571 0.623 . . . . 0.0 110.29 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.965 HG22 HD11 ' A' ' 15' ' ' LEU . 1.2 mm -58.38 -68.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.148 -0.97 . . . . 0.0 110.053 -177.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.89 -28.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.8 -0.562 . . . . 0.0 112.31 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 11' ' ' ILE . 16.1 m120 -72.94 -50.87 20.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.758 -1.213 . . . . 0.0 109.576 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.833 HG21 HD22 ' A' ' 23' ' ' LEU . 1.1 m -68.24 -54.85 14.82 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.965 HD11 HG22 ' A' ' 11' ' ' ILE . 51.8 mt -43.34 -32.05 0.75 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.249 0.547 . . . . 0.0 110.244 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.72 -44.07 29.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.84 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -114.66 62.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.11 -0.994 . . . . 0.0 109.629 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.467 ' CG ' ' HB3' ' A' ' 22' ' ' GLN . 9.0 tmm? -129.4 143.36 50.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.346 -0.846 . . . . 0.0 109.17 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -81.33 -65.8 0.97 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.264 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.25 -48.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.679 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -95.29 25.92 21.98 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.467 ' HB3' ' CG ' ' A' ' 18' ' ' MET . 15.0 tt0 -88.48 -60.5 1.94 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.178 -1.19 . . . . 0.0 109.274 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.833 HD22 HG21 ' A' ' 14' ' ' THR . 1.8 mp -126.63 60.47 1.34 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 0.0 109.339 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -109.27 -11.03 14.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.092 -1.005 . . . . 0.0 110.038 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.56 27.74 16.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.501 HD11 ' O ' ' A' ' 23' ' ' LEU . 1.7 mt -71.59 -168.43 0.34 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.149 -1.206 . . . . 0.0 109.13 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.98 -4.24 14.58 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.595 ' CE2' HD12 ' A' ' 11' ' ' ILE . 7.2 p90 -134.68 112.09 10.51 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.216 -0.928 . . . . 0.0 109.072 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.707 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -49.82 161.62 0.92 Allowed Glycine 0 C--N 1.289 -2.048 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.49 129.82 17.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.819 -1.401 . . . . 0.0 108.457 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.63 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.8 pp -131.84 157.63 43.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.772 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.713 ' HB3' HD12 ' A' ' 40' ' ' LEU . 45.8 mt-30 -116.39 163.27 16.29 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 37' ' ' GLY . 17.6 mt -147.57 144.0 28.16 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.867 -1.145 . . . . 0.0 110.467 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.444 ' N ' HD21 ' A' ' 40' ' ' LEU . 30.5 t70 -96.54 165.87 11.96 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -44.08 -22.48 0.33 Allowed Glycine 0 N--CA 1.5 2.931 0 C-N-CA 121.336 -0.459 . . . . 0.0 113.281 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.1 15.94 22.71 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.342 -1.681 . . . . 0.0 110.858 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.628 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.03 26.25 67.06 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 34.2 m-80 -94.33 131.19 40.21 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 120.99 -1.3 . . . . 0.0 110.964 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.608 HG22 ' HA ' ' A' ' 58' ' ' ILE . 1.1 tp -61.83 138.07 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.825 -1.172 . . . . 0.0 111.286 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 32' ' ' GLN . 2.3 mt -110.64 -28.24 8.56 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 177.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.459 ' NE2' ' N ' ' A' ' 42' ' ' TYR . 0.9 OUTLIER -152.68 150.12 29.13 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.589 ' OH ' " O4'" ' A' ' 126' ' ' HC4 . 4.7 t80 -130.89 -54.03 1.06 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.323 -1.486 . . . . 0.0 111.374 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.501 ' OD1' ' HG3' ' A' ' 46' ' ' GLU . 0.4 OUTLIER 89.6 177.77 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.37 -38.39 9.65 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.937 -1.102 . . . . 0.0 113.681 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.87 -62.68 1.13 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.64 -1.287 . . . . 0.0 111.552 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.707 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -59.09 -49.16 78.95 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.47 -0.769 . . . . 0.0 110.932 -179.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.21 -15.08 42.97 Favored Glycine 0 C--N 1.281 -2.477 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -83.63 -30.0 27.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.96 -1.317 . . . . 0.0 108.888 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -82.01 -55.32 8.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.405 -0.809 . . . . 0.0 109.144 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.645 HG21 " C4'" ' A' ' 126' ' ' HC4 . 1.2 p -84.41 -11.49 56.15 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.242 -0.911 . . . . 0.0 109.903 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.36 -5.84 81.91 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.765 ' NE ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -52.35 123.6 11.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -1.159 . . . . 0.0 110.478 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.76 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.4 m-20 -89.85 154.97 47.93 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 -54.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.708 1.605 . . . . 0.0 111.37 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -22.15 66.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 110.668 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.81 -41.85 11.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.955 -1.091 . . . . 0.0 109.96 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 53' ' ' ASP . 14.4 m -77.61 -1.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.728 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.608 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -71.65 122.48 23.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.64 -15.07 61.25 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -79.13 138.76 38.05 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.139 -1.212 . . . . 0.0 108.877 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 66' ' ' VAL . 23.0 m120 -76.38 109.35 10.02 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 1.031 ' CZ ' HG21 ' A' ' 70' ' ' THR . 8.5 t80 -68.79 -20.54 64.34 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.632 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 3.6 m-85 -85.06 -4.05 59.02 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.957 -1.097 . . . . 0.0 111.393 -177.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 23.0 mttt -155.99 -46.37 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.731 -1.231 . . . . 0.0 110.857 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.53 -3.41 53.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.984 -1.072 . . . . 0.0 112.299 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.765 HG11 ' NE ' ' A' ' 52' ' ' ARG . 5.7 t -126.45 -59.37 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 120.304 -1.498 . . . . 0.0 109.286 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.644 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -107.65 106.95 59.67 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.625 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.12 2.32 7.3 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.796 1.664 . . . . 0.0 111.698 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.7 p -105.33 -18.83 13.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.861 -1.149 . . . . 0.0 109.78 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 1.031 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 71.1 p -75.35 -2.12 26.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 110.28 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -90.68 53.31 2.39 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.878 -1.139 . . . . 0.0 108.789 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.47 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -124.71 178.18 1.53 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.488 -0.758 . . . . 0.0 109.237 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.6 Cg_endo -78.39 -1.2 11.39 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 122.238 1.959 . . . . 0.0 111.428 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.4 mp0 -109.44 -25.83 10.3 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.92 -1.112 . . . . 0.0 109.248 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.59 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -100.98 -70.36 0.74 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -72.12 -18.27 61.91 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.094 -1.004 . . . . 0.0 108.341 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.82 -64.9 3.23 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.914 ' HB2' HG21 ' A' ' 90' ' ' THR . 1.4 mmtp -62.48 -16.77 57.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.561 -0.964 . . . . 0.0 109.878 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.87 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.1 t80 -83.5 -36.98 23.68 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.602 -0.687 . . . . 0.0 109.872 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.22 -12.57 60.11 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.173 -0.954 . . . . 0.0 109.081 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 19.4 pt-20 -97.23 -42.36 7.85 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.487 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -60.03 -39.25 95.45 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 107.521 -2.232 . . . . 0.0 107.521 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 79' ' ' PHE . 90.3 t -60.88 -45.36 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.784 -0.833 . . . . 0.0 109.46 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.19 -3.11 57.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.219 -0.926 . . . . 0.0 110.622 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.49 -24.61 15.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.85 -1.156 . . . . 0.0 109.451 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.71 15.1 74.06 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -156.19 56.01 0.58 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -1.176 . . . . 0.0 108.66 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -50.24 120.73 4.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 110.113 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.442 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 17.1 p30 -160.52 88.41 0.79 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 108.947 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.914 HG21 ' HB2' ' A' ' 78' ' ' LYS . 10.1 t -146.86 169.02 19.98 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.209 -0.932 . . . . 0.0 110.129 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -154.98 170.38 21.89 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.003 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 6.5 p90 179.53 152.52 0.42 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.872 -1.142 . . . . 0.0 110.222 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -80.75 111.93 17.65 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 -178.85 3.49 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.084 -1.01 . . . . 0.0 109.984 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 103' ' ' THR . 79.6 m -146.09 109.73 4.81 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.669 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 18.5 m-30 -79.3 93.41 5.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 108.665 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -115.84 31.17 6.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.37 -0.831 . . . . 0.0 109.686 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.582 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.85 159.11 27.96 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.494 ' C ' ' O ' ' A' ' 98' ' ' TYR . 1.5 pp0? -4.56 67.65 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 123.532 0.733 . . . . 0.0 112.547 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.582 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.78 -157.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.608 -0.683 . . . . 0.0 109.195 -178.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.459 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -90.96 174.78 4.15 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 108.834 179.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.459 ' CD ' HG22 ' A' ' 101' ' ' THR . 36.1 Cg_endo -79.15 103.77 1.68 Allowed 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.07 1.847 . . . . 0.0 110.749 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 95' ' ' THR . 9.2 m -99.11 145.27 27.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.114 -0.991 . . . . 0.0 108.926 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -119.43 135.82 54.58 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.771 ' HA ' HG23 ' A' ' 125' ' ' VAL . 11.5 m -153.5 145.67 14.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.973 -1.079 . . . . 0.0 110.862 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.548 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 3.0 ptmt -94.28 114.7 26.83 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.573 -2.381 . . . . 0.0 104.573 175.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.003 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -86.72 164.76 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.882 -1.136 . . . . 0.0 110.315 -176.588 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.516 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 17.6 t-160 -159.71 101.94 1.5 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.827 ' HG2' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.89 148.77 36.19 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.109 -0.995 . . . . 0.0 110.002 -177.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.2 tttt -144.11 178.82 7.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.669 -1.269 . . . . 0.0 109.309 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.49 106.81 15.53 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.885 -1.134 . . . . 0.0 108.693 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.642 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.5 155.55 2.12 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.405 -0.809 . . . . 0.0 110.5 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.1 -15.43 18.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.548 -0.72 . . . . 0.0 109.837 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 t -50.34 -25.31 3.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.13 -0.981 . . . . 0.0 109.651 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 170.84 47.59 0.04 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.85 57.12 4.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.29 -1.123 . . . . 0.0 108.828 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.635 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.7 OUTLIER -100.64 -157.69 0.62 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.428 -0.795 . . . . 0.0 109.904 -179.44 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.742 ' CE1' HG22 ' A' ' 83' ' ' VAL . 12.0 m-85 -145.76 102.66 3.69 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.657 ' CE3' ' CZ ' ' A' ' 121' ' ' PHE . 11.2 p-90 -106.32 143.69 34.07 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.551 -1.26 . . . . 0.0 111.973 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.827 HG13 ' HG2' ' A' ' 109' ' ' MET . 43.9 t -121.45 107.87 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.497 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.657 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 8.9 m-30 -92.94 123.08 35.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -0.854 . . . . 0.0 109.575 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.669 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.3 t -102.56 118.1 48.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.37 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.725 ' HZ1' HG12 ' A' ' 4' ' ' VAL . 1.4 tttp -96.85 106.68 19.04 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.501 ' HA ' HG12 ' A' ' 105' ' ' VAL . 6.3 ttt180 -53.92 135.92 41.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.795 -1.191 . . . . 0.0 109.671 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.194 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.645 " C4'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.07 -79.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.226 -0.921 . . . . 0.0 109.603 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -137.23 -172.35 3.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.058 -1.026 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 8' ' ' SER . 7.6 p -113.76 91.84 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.056 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.491 ' O ' ' OG ' ' A' ' 8' ' ' SER . . . 60.36 50.23 6.28 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.041 -1.037 . . . . 0.0 110.27 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.597 ' CE1' ' CD ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER 68.57 14.73 9.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.866 -1.771 . . . . 0.0 107.134 -178.267 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.567 ' CA ' ' HE3' ' A' ' 123' ' ' LYS . . . 106.24 -10.91 43.71 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.853 ' O ' HG22 ' A' ' 4' ' ' VAL . 1.6 p -80.22 147.2 31.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.887 -1.36 . . . . 0.0 112.594 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -96.81 54.5 1.3 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.77 74.38 0.44 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.854 HG22 ' CG ' ' A' ' 15' ' ' LEU . 3.4 mm -75.1 -57.37 6.54 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 O-C-N 121.372 -0.83 . . . . 0.0 110.428 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.587 ' HA ' HD12 ' A' ' 15' ' ' LEU . 2.4 tt0 -36.18 -33.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.848 -0.532 . . . . 0.0 112.066 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 11' ' ' ILE . 1.5 m120 -84.74 -43.18 14.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.938 -1.101 . . . . 0.0 108.316 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.513 HG23 ' CB ' ' A' ' 19' ' ' ASP . 2.9 m -69.78 -8.1 45.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.727 -0.608 . . . . 0.0 109.987 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.854 ' CG ' HG22 ' A' ' 11' ' ' ILE . 15.2 mt -96.77 -22.2 17.09 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.951 -1.093 . . . . 0.0 109.278 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.92 -31.04 61.44 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.328 -0.857 . . . . 0.0 108.77 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -133.74 16.01 3.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.269 -0.894 . . . . 0.0 109.698 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.464 ' HA ' ' CE ' ' A' ' 18' ' ' MET . 0.0 OUTLIER 61.13 163.59 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.978 -1.076 . . . . 0.0 109.535 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.513 ' CB ' HG23 ' A' ' 14' ' ' THR . 0.1 OUTLIER 167.8 153.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.14 87.41 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.091 -1.006 . . . . 0.0 109.137 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.59 21.38 66.9 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 50.25 35.75 11.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -1.173 . . . . 0.0 109.844 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.736 HD22 HD13 ' A' ' 26' ' ' LEU . 1.1 tm? 61.28 81.6 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.928 . . . . 0.0 109.225 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.34 -39.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 109.197 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -93.53 24.65 24.69 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.029 HD23 ' CZ ' ' A' ' 28' ' ' PHE . 3.5 mp -77.19 157.21 31.04 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.32 -1.106 . . . . 0.0 108.446 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.32 12.67 13.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.029 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -154.06 112.75 3.64 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.512 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -49.6 159.03 1.22 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' A' ' 23' ' ' LEU . . . -134.85 114.63 12.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.605 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.6 pp -117.1 158.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 110.636 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.836 ' HB3' HD12 ' A' ' 40' ' ' LEU . 24.3 mm-40 -125.89 170.36 11.73 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.856 HD22 ' O ' ' A' ' 37' ' ' GLY . 83.8 mt -157.39 147.56 20.8 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.28 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' ASP . 29.1 m-20 -126.64 127.03 44.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.059 -1.026 . . . . 0.0 109.913 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.02 -77.54 0.0 OUTLIER Glycine 0 N--CA 1.502 3.041 0 C-N-CA 124.578 1.085 . . . . 0.0 113.609 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.9 OUTLIER -69.69 -3.23 14.35 Favored 'General case' 0 C--N 1.292 -1.901 0 O-C-N 121.535 -0.979 . . . . 0.0 110.933 -178.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.856 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 87.36 17.59 58.6 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 34' ' ' ASP . 8.1 p30 -73.7 129.5 38.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -1.199 . . . . 0.0 108.835 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.688 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -58.56 136.45 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.303 -0.873 . . . . 0.0 110.441 -178.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.836 HD12 ' HB3' ' A' ' 32' ' ' GLN . 6.9 mt -101.6 -29.59 11.86 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -160.0 176.97 11.22 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.54 ' CD1' HG22 ' A' ' 31' ' ' ILE . 12.9 t80 -156.11 -48.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.695 -1.253 . . . . 0.0 110.076 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.646 HD21 ' HB3' ' A' ' 45' ' ' ALA . 0.6 OUTLIER 89.43 176.5 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.257 0.551 . . . . 0.0 109.929 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -96.83 -20.54 18.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.244 -0.91 . . . . 0.0 112.485 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.646 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -56.3 -66.62 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.547 -1.345 . . . . 0.0 110.33 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 5.1 pt-20 -61.23 -49.4 77.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.956 . . . . 0.0 110.03 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -61.03 -14.24 37.9 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 21.7 t0 -80.76 -34.11 34.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.725 -1.456 . . . . 0.0 108.846 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.48 HG22 HG23 ' A' ' 50' ' ' THR . 1.0 OUTLIER -82.94 -54.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 O-C-N 121.197 -0.94 . . . . 0.0 108.849 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.971 HG21 " C3'" ' A' ' 126' ' ' HC4 . 26.7 p -78.82 -24.14 44.65 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.402 -0.811 . . . . 0.0 109.768 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 97.14 -13.8 64.39 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.797 ' NE ' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -58.35 90.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -1.207 . . . . 0.0 109.971 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.739 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -61.54 166.86 4.97 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.176 -0.952 . . . . 0.0 109.284 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.15 -54.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 122.149 1.899 . . . . 0.0 110.759 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -65.93 -24.23 66.78 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.974 -1.079 . . . . 0.0 109.848 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -44.39 17.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.132 -0.98 . . . . 0.0 109.88 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 53' ' ' ASP . 33.1 m -73.96 -3.13 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.189 -0.944 . . . . 0.0 109.836 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.67 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.73 123.31 23.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 120.976 -1.078 . . . . 0.0 108.422 179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.41 -18.77 53.75 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.7 mmtt -79.64 127.2 31.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.228 -1.16 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.446 ' CB ' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -67.61 104.69 1.67 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.287 -0.883 . . . . 0.0 108.714 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.688 ' HB2' HD12 ' A' ' 39' ' ' ILE . 84.6 t80 -55.45 -17.21 4.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.48 -0.763 . . . . 0.0 110.651 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CE2' HD13 ' A' ' 33' ' ' LEU . 29.3 m-85 -94.11 -38.15 11.25 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.048 -1.032 . . . . 0.0 110.73 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 0.1 OUTLIER -134.67 42.8 2.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.962 -1.086 . . . . 0.0 109.201 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' HB2' ' CB ' ' A' ' 61' ' ' ASN . 0.3 OUTLIER -159.2 -32.52 0.06 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 110.235 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.797 HG12 ' NE ' ' A' ' 52' ' ' ARG . 9.3 t -109.12 -51.4 6.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 O-C-N 120.787 -1.196 . . . . 0.0 108.14 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.455 ' HB2' HH21 ' A' ' 52' ' ' ARG . . . -116.43 97.41 49.89 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.141 -178.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -74.22 -1.41 10.91 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 122.113 1.875 . . . . 0.0 111.251 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 p -95.35 -26.73 15.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.655 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 72' ' ' SER . 70.9 p -66.62 -36.37 82.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.387 -0.82 . . . . 0.0 109.744 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.92 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.168 -0.957 . . . . 0.0 109.054 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 177.67 170.52 0.44 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 109.291 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.3 80.83 2.61 Favored 'Trans proline' 0 C--N 1.323 -0.798 0 C-N-CA 122.558 2.172 . . . . 0.0 110.809 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.3 OUTLIER 168.08 -36.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.497 ' CD1' ' HE1' ' A' ' 109' ' ' MET . 1.8 t80 -109.84 -67.06 1.01 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.515 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 9.3 t80 -75.58 -17.24 60.11 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.68 -58.2 11.97 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.488 ' N ' ' CD ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -61.89 -18.62 60.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.609 -0.936 . . . . 0.0 109.594 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.913 ' O ' HG23 ' A' ' 83' ' ' VAL . 9.7 t80 -81.02 -38.47 27.42 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.452 -0.78 . . . . 0.0 109.639 179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.83 -12.42 60.38 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.01 -1.056 . . . . 0.0 109.463 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 82' ' ' GLY . 12.8 pt-20 -96.85 -41.0 8.65 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -62.21 -39.11 97.26 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 107.727 -2.149 . . . . 0.0 107.727 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 79' ' ' PHE . 90.8 t -61.68 -39.85 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.789 -0.83 . . . . 0.0 109.891 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.14 -0.19 53.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.236 -0.915 . . . . 0.0 111.274 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 2.5 t -104.88 -24.21 12.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.899 -1.126 . . . . 0.0 110.161 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.64 16.17 78.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -148.45 58.85 1.08 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.031 -1.276 . . . . 0.0 109.098 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.529 HD13 ' HD1' ' A' ' 118' ' ' TYR . 0.4 OUTLIER -68.83 111.99 5.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.397 -0.814 . . . . 0.0 109.694 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -160.14 82.87 0.71 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -131.46 172.8 11.78 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.917 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.54 171.11 19.56 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.932 ' CE1' HG21 ' A' ' 107' ' ' VAL . 17.2 p90 171.98 -177.11 0.05 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.088 -1.008 . . . . 0.0 109.992 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -109.92 105.59 14.82 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -104.41 -179.86 4.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.1 m -143.83 111.67 6.12 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.713 ' CE2' HG21 ' A' ' 122' ' ' VAL . 13.1 m-30 -86.71 131.02 34.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 108.871 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -160.98 63.89 0.29 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.534 ' CE1' ' HB2' ' A' ' 100' ' ' MET . 0.6 OUTLIER -84.11 41.08 0.8 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.488 -0.758 . . . . 0.0 111.776 -178.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER 89.61 29.76 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.683 0.754 . . . . 0.0 109.511 179.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.534 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -129.44 -71.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -0.947 . . . . 0.0 109.636 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.411 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 1.5 t -159.14 150.18 16.24 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.417 -179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.411 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 34.9 Cg_endo -76.25 79.75 2.87 Favored 'Trans proline' 0 C--N 1.32 -0.956 0 C-N-CA 122.063 1.842 . . . . 0.0 110.89 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 103' ' ' THR . 1.1 m -84.45 105.63 15.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.701 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -74.51 149.21 40.36 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.601 ' HB ' HG13 ' A' ' 122' ' ' VAL . 4.8 m -156.03 144.86 12.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 118.588 -1.245 . . . . 0.0 111.53 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -78.05 151.41 33.51 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 173.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.932 HG21 ' CE1' ' A' ' 92' ' ' PHE . 4.0 m -128.24 154.04 38.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 117.931 -1.507 . . . . 0.0 110.856 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.577 ' HB2' ' CG ' ' A' ' 6' ' ' PHE . 6.4 t-160 -147.42 125.59 12.18 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.872 ' HB3' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -133.69 126.97 31.91 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 120.99 -1.069 . . . . 0.0 108.898 -178.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.583 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 17.8 tttm -138.5 157.82 45.44 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 118.112 -1.435 . . . . 0.0 110.129 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.499 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 ptmt -75.63 94.18 3.17 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 109.626 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.981 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -53.27 123.54 12.15 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.252 -0.905 . . . . 0.0 109.617 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 pp -109.38 -13.16 14.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.054 -1.029 . . . . 0.0 110.124 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -42.73 69.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.93 -1.106 . . . . 0.0 109.339 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.85 39.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 117' ' ' SER . 74.5 m-20 -135.33 -90.82 0.31 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.243 -1.151 . . . . 0.0 109.23 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.653 ' H ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER 164.17 -79.57 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.216 -0.927 . . . . 0.0 110.452 179.486 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.901 ' CE1' HG22 ' A' ' 83' ' ' VAL . 7.3 m-85 -125.05 136.03 53.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.981 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.6 p-90 -135.6 150.65 49.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.002 -1.061 . . . . 0.0 110.519 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.872 HG22 ' HB3' ' A' ' 109' ' ' MET . 89.5 t -138.09 105.45 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.741 -0.599 . . . . 0.0 110.326 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.658 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 2.1 m-85 -88.87 138.14 31.68 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.713 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -110.76 114.19 46.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.51 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -81.67 142.38 32.77 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 176.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -98.85 134.42 41.75 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.495 -1.378 . . . . 0.0 109.637 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.031 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.971 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 ptm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -175.78 45.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 109.544 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -107.71 23.62 14.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.883 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 5' ' ' ALA . 0.3 OUTLIER -132.33 -175.11 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.926 -1.109 . . . . 0.0 109.64 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.738 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . -59.17 -160.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.395 -0.816 . . . . 0.0 109.538 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.522 ' CD1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -38.07 -41.39 0.57 Allowed 'General case' 0 N--CA 1.517 2.896 0 CA-C-O 122.493 1.14 . . . . 0.0 109.059 178.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.98 39.13 0.05 OUTLIER Glycine 0 N--CA 1.486 1.979 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.738 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 0.2 OUTLIER -67.73 174.96 3.2 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.705 -0.88 . . . . 0.0 110.64 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.33 61.44 0.78 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.61 70.62 0.63 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.015 HG22 HD11 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -69.28 -66.26 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.488 0 O-C-N 121.477 -0.764 . . . . 0.0 110.322 -178.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 11' ' ' ILE . 14.4 pt-20 -36.52 -33.74 0.05 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.867 -0.521 . . . . 0.0 111.994 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -82.64 -44.7 15.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.768 -1.208 . . . . 0.0 108.489 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.624 HG23 ' OE1' ' A' ' 22' ' ' GLN . 5.4 m -67.59 -10.38 51.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.693 -0.629 . . . . 0.0 109.691 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.015 HD11 HG22 ' A' ' 11' ' ' ILE . 42.2 mt -97.79 -20.48 17.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.842 -1.161 . . . . 0.0 109.749 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.47 -12.37 25.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.33 -0.856 . . . . 0.0 110.16 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.64 -23.34 6.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.937 -1.102 . . . . 0.0 110.286 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.699 ' CE ' HD13 ' A' ' 23' ' ' LEU . 5.9 tmm? -58.27 146.44 34.13 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.106 -0.996 . . . . 0.0 109.516 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.56 -40.28 9.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p30 174.06 -47.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.502 -0.749 . . . . 0.0 109.691 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.05 56.92 0.55 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.624 ' OE1' HG23 ' A' ' 14' ' ' THR . 0.7 OUTLIER -132.51 -40.34 0.99 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -1.194 . . . . 0.0 109.795 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.699 HD13 ' CE ' ' A' ' 18' ' ' MET . 1.2 pt? -92.0 8.62 36.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 110.208 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -71.95 -6.68 43.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.929 -1.107 . . . . 0.0 110.046 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.22 32.24 7.55 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 23' ' ' LEU . 86.9 mt -105.15 158.7 16.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.416 -1.049 . . . . 0.0 108.789 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -93.48 14.44 18.69 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.756 -0.59 . . . . 0.0 109.59 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.536 ' CE2' HG12 ' A' ' 11' ' ' ILE . 25.2 p90 -148.9 154.18 39.08 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.175 -0.953 . . . . 0.0 109.596 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.96 114.4 3.85 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.617 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -91.21 87.7 6.62 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.534 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.3 pp -98.48 148.89 5.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.649 -0.657 . . . . 0.0 109.79 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.726 ' HB3' HD12 ' A' ' 40' ' ' LEU . 18.1 mt-30 -118.25 174.63 6.12 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 108.501 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.845 HD22 ' O ' ' A' ' 37' ' ' GLY . 62.1 mt -154.33 149.64 27.11 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.21 -0.932 . . . . 0.0 109.171 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.621 ' CG ' HD21 ' A' ' 40' ' ' LEU . 30.4 p30 -130.45 121.03 25.11 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.177 -1.009 . . . . 0.0 110.607 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.6 -79.23 0.0 OUTLIER Glycine 0 N--CA 1.5 2.904 0 C-N-CA 124.362 0.982 . . . . 0.0 113.021 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -66.67 -7.59 21.73 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 121.851 -0.794 . . . . 0.0 110.436 -178.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.845 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 89.89 18.54 50.63 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 m120 -73.26 136.13 44.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.243 . . . . 0.0 108.272 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.594 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -62.13 133.8 27.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.395 -0.815 . . . . 0.0 110.8 -178.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 32' ' ' GLN . 10.4 mt -98.85 -32.46 11.33 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.465 ' NE2' ' N ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -155.99 -173.73 4.64 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.825 ' CG ' HG21 ' A' ' 57' ' ' VAL . 1.2 t80 -160.96 -67.98 0.06 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.212 -0.93 . . . . 0.0 108.903 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.724 HD21 ' HB3' ' A' ' 45' ' ' ALA . 9.2 p-10 107.02 160.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 124.154 0.982 . . . . 0.0 109.169 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.99 -13.93 55.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.293 -0.88 . . . . 0.0 110.819 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.724 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -59.45 -62.33 1.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.806 -1.184 . . . . 0.0 109.803 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.526 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 11.5 pt-20 -66.05 -41.6 90.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.094 -1.003 . . . . 0.0 108.614 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -58.57 -18.06 36.08 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -29.55 22.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.778 -1.425 . . . . 0.0 109.579 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.412 HG12 ' HD2' ' A' ' 124' ' ' ARG . 1.1 mp -80.31 -41.67 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.324 -0.86 . . . . 0.0 109.394 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.659 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -111.07 4.08 19.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.607 -0.683 . . . . 0.0 110.189 -179.531 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.72 -2.2 74.72 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.677 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.547 ' HD3' " H3'" ' A' ' 126' ' ' HC4 . 0.0 OUTLIER -73.33 84.49 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.922 -1.34 . . . . 0.0 111.81 -178.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -63.99 175.96 0.74 Allowed Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 35.5 Cg_endo -77.05 -44.23 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.553 1.502 . . . . 0.0 110.682 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -16.41 63.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.107 -0.996 . . . . 0.0 110.268 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -48.67 6.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.972 -1.08 . . . . 0.0 110.025 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.825 HG21 ' CG ' ' A' ' 42' ' ' TYR . 32.8 m -70.71 -8.27 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.754 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.495 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -69.65 124.64 26.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.587 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.76 -19.62 50.26 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -79.02 132.88 36.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.317 -1.108 . . . . 0.0 108.976 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.71 125.27 27.09 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.7 ' HB2' HD21 ' A' ' 33' ' ' LEU . 75.4 t80 -63.97 -10.94 24.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.024 -1.048 . . . . 0.0 110.444 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CE2' HD13 ' A' ' 33' ' ' LEU . 83.5 m-85 -112.58 26.06 10.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.959 -1.088 . . . . 0.0 110.275 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -166.71 -58.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.978 -1.076 . . . . 0.0 110.891 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.58 -7.18 55.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.933 -1.105 . . . . 0.0 110.981 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.563 ' HB ' ' HA ' ' A' ' 62' ' ' PHE . 17.4 t -117.4 -26.43 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.63 -1.294 . . . . 0.0 109.526 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.656 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -163.71 96.84 1.0 Allowed Pre-proline 0 C--N 1.288 -2.076 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.961 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.42 -2.15 11.99 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.891 1.727 . . . . 0.0 110.564 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.2 p -90.1 -25.06 20.93 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.264 -0.897 . . . . 0.0 109.204 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.595 HG21 ' CE2' ' A' ' 62' ' ' PHE . 46.0 p -72.77 -5.37 37.47 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.466 -0.771 . . . . 0.0 110.139 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -88.39 59.63 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.967 -1.083 . . . . 0.0 109.317 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.404 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.6 OUTLIER -146.54 171.96 5.79 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.28 -0.887 . . . . 0.0 109.171 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 33.7 Cg_endo -75.75 79.54 2.81 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 122.373 2.048 . . . . 0.0 110.292 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.9 OUTLIER 169.21 -34.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.467 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.4 t80 -106.28 -67.07 0.96 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.559 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 27.7 t80 -78.48 -21.94 48.26 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -61.6 -56.67 21.76 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' CB ' HG21 ' A' ' 90' ' ' THR . 4.1 mmtt -65.62 -16.4 63.69 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.57 -0.959 . . . . 0.0 109.334 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.851 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.5 t80 -76.73 -37.68 55.57 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.66 -6.38 55.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.2 mm-40 -95.76 -39.06 10.05 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -70.36 -42.49 65.09 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.886 HG22 ' CE1' ' A' ' 118' ' ' TYR . 57.4 t -59.5 -40.13 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.843 -0.798 . . . . 0.0 109.73 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.14 -17.18 43.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -0.926 . . . . 0.0 110.744 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.1 m -88.28 -20.87 24.86 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.944 -1.097 . . . . 0.0 109.805 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.45 21.3 64.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -165.82 57.12 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -1.151 . . . . 0.0 109.355 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.498 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 6.3 tt -46.93 124.62 6.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.531 -0.731 . . . . 0.0 110.222 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.427 ' HB3' ' HE3' ' A' ' 110' ' ' LYS . 16.6 p-10 -161.42 89.59 0.77 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.533 HG23 ' SD ' ' A' ' 109' ' ' MET . 4.0 t -152.27 152.65 32.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.807 -1.183 . . . . 0.0 110.545 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.406 ' C ' ' CD2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -140.13 179.91 6.35 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.105 ' CE1' HG21 ' A' ' 107' ' ' VAL . 18.0 p90 172.47 171.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.838 . . . . 0.0 109.252 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.99 108.95 20.71 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.408 ' HB2' HG11 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -111.46 169.94 8.46 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.309 -0.957 . . . . 0.0 109.724 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' THR . 87.7 m -136.15 108.36 7.26 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.44 -0.787 . . . . 0.0 109.266 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.976 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 12.3 m-30 -80.29 85.62 5.77 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -108.44 34.38 3.67 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -78.69 158.33 28.37 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.502 ' C ' ' O ' ' A' ' 98' ' ' TYR . 2.0 mt-30 0.08 64.86 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.081 0 C-N-CA 123.46 0.704 . . . . 0.0 112.525 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 177.22 -153.55 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -178.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.537 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -93.7 177.41 1.97 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 0.0 108.726 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.537 ' CD ' HG22 ' A' ' 101' ' ' THR . 34.1 Cg_endo -77.07 112.8 3.49 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.686 1.591 . . . . 0.0 110.013 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.457 HG22 HG13 ' A' ' 105' ' ' VAL . 2.8 m -113.29 130.34 56.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.727 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -104.52 145.21 30.62 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.041 ' HA ' HG23 ' A' ' 125' ' ' VAL . 26.3 m -154.57 144.8 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 118.865 -1.134 . . . . 0.0 110.615 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -78.26 117.55 19.63 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 174.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.105 HG21 ' CE1' ' A' ' 92' ' ' PHE . 23.2 m -99.2 151.96 4.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 C-N-CA 117.852 -1.539 . . . . 0.0 108.235 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -156.32 102.68 2.11 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.851 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -113.17 144.89 41.9 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.192 -0.942 . . . . 0.0 109.529 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -141.04 -178.51 5.6 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.653 -1.28 . . . . 0.0 109.815 -179.273 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.93 103.74 16.42 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.027 -1.045 . . . . 0.0 108.857 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.839 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -51.59 146.13 8.05 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.616 -0.677 . . . . 0.0 109.884 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.29 12.81 21.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.269 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.54 9.16 12.01 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.045 -1.034 . . . . 0.0 110.056 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 136.56 45.58 0.09 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.23 52.88 6.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.114 . . . . 0.0 109.32 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.763 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.8 OUTLIER -93.76 -162.28 0.93 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.882 . . . . 0.0 109.717 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.886 ' CE1' HG22 ' A' ' 83' ' ' VAL . 10.4 m-85 -149.9 111.59 4.52 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.839 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 15.1 p-90 -117.16 144.7 44.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.701 -1.249 . . . . 0.0 111.684 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.851 HG13 ' CG ' ' A' ' 109' ' ' MET . 13.8 t -120.85 114.57 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.554 0.692 . . . . 0.0 109.932 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.795 ' HE2' HD13 ' A' ' 11' ' ' ILE . 13.5 m-30 -95.33 121.9 37.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.976 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 1.3 t -107.02 112.79 41.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.889 -1.125 . . . . 0.0 108.468 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.522 ' HD3' ' CD1' ' A' ' 6' ' ' PHE . 14.3 tptp -89.21 125.17 34.96 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.539 ' HA ' HG12 ' A' ' 105' ' ' VAL . 28.6 ttt180 -74.33 123.65 25.01 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.688 -1.258 . . . . 0.0 109.458 -178.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 1.041 HG23 ' HA ' ' A' ' 105' ' ' VAL . 25.5 t . . . . . 0 C--N 1.301 -1.516 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.699 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.659 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -114.06 94.93 5.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.579 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -66.85 95.67 0.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.123 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 8' ' ' SER . 9.7 p -138.53 55.55 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.077 -1.014 . . . . 0.0 110.067 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 4' ' ' VAL . . . 61.86 -152.67 0.36 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.744 -1.222 . . . . 0.0 108.707 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CE1' ' CD ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -85.54 10.56 12.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.955 -1.091 . . . . 0.0 108.728 177.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.51 ' HA3' ' HE3' ' A' ' 123' ' ' LYS . . . 133.27 25.5 0.65 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.715 ' O ' HG22 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -104.71 123.62 47.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.24 . . . . 0.0 110.159 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.51 71.75 6.11 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.29 50.29 14.62 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.884 HG22 HD11 ' A' ' 15' ' ' LEU . 3.2 mm -50.73 -51.62 19.29 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.713 0 O-C-N 121.696 -0.628 . . . . 0.0 110.155 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' ILE . 4.0 tt0 -34.19 -41.51 0.11 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.15 -42.35 38.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.806 -1.184 . . . . 0.0 109.263 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.959 HG23 ' CE ' ' A' ' 18' ' ' MET . 1.2 m -60.7 -26.11 66.9 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.522 -0.737 . . . . 0.0 109.855 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.917 HD22 HD22 ' A' ' 23' ' ' LEU . 5.7 mt -96.77 -17.06 20.51 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.941 -1.1 . . . . 0.0 109.812 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.85 -12.24 25.53 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.047 -1.033 . . . . 0.0 110.198 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.19 61.89 1.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.883 -1.136 . . . . 0.0 109.709 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.959 ' CE ' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -150.74 -160.58 1.19 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.165 -0.96 . . . . 0.0 110.203 -179.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.02 -73.37 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.947 . . . . 0.0 110.25 -179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -171.55 102.9 0.19 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.196 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.0 39.94 0.4 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.618 ' HB2' ' HE3' ' A' ' 18' ' ' MET . 5.4 pm0 -124.62 -36.68 2.58 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.666 -0.902 . . . . 0.0 109.103 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.917 HD22 HD22 ' A' ' 15' ' ' LEU . 2.3 pp -105.18 31.9 4.58 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.5 -15.39 11.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 109.907 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.74 31.56 8.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.702 HD11 ' HA ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -104.1 173.54 6.26 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.159 -1.201 . . . . 0.0 108.888 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.7 21.27 11.61 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 122.262 1.03 . . . . 0.0 108.23 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.542 ' HD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -160.51 113.1 2.01 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.396 1.093 . . . . 0.0 108.395 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' HA2' ' ND2' ' A' ' 43' ' ' ASN . . . -46.96 143.41 5.31 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.346 -178.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.704 ' O ' HD13 ' A' ' 23' ' ' LEU . . . -125.34 92.34 3.6 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.692 HD12 ' N ' ' A' ' 32' ' ' GLN . 1.2 pp -99.1 167.33 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.454 -0.779 . . . . 0.0 111.109 -177.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.692 ' N ' HD12 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -134.22 166.59 22.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.81 HD22 ' C ' ' A' ' 37' ' ' GLY . 19.2 mt -149.64 148.35 29.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.971 -1.081 . . . . 0.0 110.065 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 36' ' ' ASP . 2.3 p30 -115.86 133.06 56.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.144 -0.972 . . . . 0.0 109.533 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -12.55 74.53 0.0 OUTLIER Glycine 0 N--CA 1.51 3.631 0 C-N-CA 124.697 1.142 . . . . 0.0 113.307 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER 162.44 -24.61 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.53 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.81 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.63 20.7 14.11 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.622 ' O ' HD23 ' A' ' 33' ' ' LEU . 23.0 m120 -87.67 131.99 34.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.263 -1.139 . . . . 0.0 108.538 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.667 HD13 ' HB2' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -67.77 138.39 22.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.113 -0.992 . . . . 0.0 111.161 -178.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.629 HD12 ' HB3' ' A' ' 32' ' ' GLN . 6.4 mt -99.61 -32.1 11.25 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 176.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -164.19 -179.59 6.24 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.576 ' CD1' HG22 ' A' ' 31' ' ' ILE . 27.7 t80 -140.63 -95.15 0.15 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.609 -1.307 . . . . 0.0 111.05 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.646 ' HB2' HD12 ' A' ' 23' ' ' LEU . 2.0 t-20 153.91 150.26 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.492 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -74.68 -58.45 3.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.4 -0.812 . . . . 0.0 110.173 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -38.94 -59.28 0.99 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.848 -0.533 . . . . 0.0 111.567 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.498 ' OE1' ' CG ' ' A' ' 42' ' ' TYR . 8.0 pt-20 -63.25 -43.58 97.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 0.0 110.009 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.418 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -63.3 -14.37 53.54 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.13 -25.12 20.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.959 -1.318 . . . . 0.0 109.149 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.576 HG22 HG23 ' A' ' 50' ' ' THR . 1.1 mp -79.17 -47.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.576 HG23 HG22 ' A' ' 49' ' ' ILE . 4.8 p -100.42 -6.83 25.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.438 -0.788 . . . . 0.0 110.217 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 84.75 -5.75 80.81 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.73 ' CD ' HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -53.26 115.31 1.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.026 -1.279 . . . . 0.0 110.884 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 57' ' ' VAL . 17.6 m-20 -90.98 156.98 43.84 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.81 -50.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.787 1.658 . . . . 0.0 111.282 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -20.84 65.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 110.329 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -89.95 -42.95 10.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.003 -1.061 . . . . 0.0 109.826 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 53' ' ' ASP . 19.3 m -76.51 -1.25 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.0 109.824 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.638 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -70.59 122.93 23.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.01 -17.47 58.15 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -79.73 135.02 36.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -1.168 . . . . 0.0 109.492 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.43 102.17 3.7 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.951 ' CZ ' HG21 ' A' ' 70' ' ' THR . 8.3 t80 -63.61 -15.0 57.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 110.355 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 76' ' ' TYR . 2.7 m-85 -88.38 12.68 13.54 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.62 -1.232 . . . . 0.0 110.602 -177.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.04 -52.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 0.0 110.552 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.75 -3.88 24.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.02 -1.05 . . . . 0.0 111.064 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.622 HG11 ' NE ' ' A' ' 52' ' ' ARG . 11.8 t -128.12 -57.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.673 -1.267 . . . . 0.0 109.043 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.513 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -109.1 105.64 57.52 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.574 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.63 -1.1 10.63 Favored 'Trans proline' 0 C--N 1.32 -0.934 0 C-N-CA 121.847 1.698 . . . . 0.0 111.557 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.8 p -104.45 -19.89 13.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.836 -1.165 . . . . 0.0 109.665 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.951 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 63.9 p -72.68 -6.11 42.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.965 -1.084 . . . . 0.0 109.915 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -88.86 53.71 2.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.985 -1.072 . . . . 0.0 109.11 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.463 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -126.98 177.49 1.99 Allowed Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.8 Cg_endo -77.94 -3.54 13.59 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.126 1.884 . . . . 0.0 111.45 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -105.8 -25.94 11.97 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.809 -1.182 . . . . 0.0 109.521 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.544 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 1.5 t80 -102.02 -70.39 0.75 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 9.2 t80 -72.86 -17.7 61.51 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.45 -63.45 4.28 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.9 ' CB ' HG21 ' A' ' 90' ' ' THR . 5.1 mmtt -63.52 -15.63 58.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.626 -0.926 . . . . 0.0 109.544 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.859 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.4 t80 -79.63 -39.63 31.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -79.62 -6.41 57.04 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 108.829 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -95.86 -40.12 9.48 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -70.55 -44.33 58.22 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.931 HG22 ' CE1' ' A' ' 118' ' ' TYR . 94.3 t -54.32 -38.68 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.581 -0.952 . . . . 0.0 109.243 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.96 -16.93 34.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.444 -0.785 . . . . 0.0 110.637 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.6 -18.25 30.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.937 -1.102 . . . . 0.0 110.178 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.3 18.13 74.77 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -162.39 57.53 0.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.128 -1.219 . . . . 0.0 109.408 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.557 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -49.25 122.3 5.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.405 -0.81 . . . . 0.0 110.257 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.429 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 58.5 t30 -160.65 83.9 0.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 108.826 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.9 HG21 ' CB ' ' A' ' 78' ' ' LYS . 8.9 t -147.73 153.03 38.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.969 -1.082 . . . . 0.0 110.724 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -137.42 173.66 11.43 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.992 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 6.2 p90 179.52 153.09 0.44 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.027 -1.046 . . . . 0.0 110.143 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.67 106.85 13.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.78 175.53 5.45 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.249 -0.907 . . . . 0.0 110.163 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 103' ' ' THR . 22.2 m -143.35 111.41 6.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.766 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 17.4 m-30 -79.62 96.46 6.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.182 -0.948 . . . . 0.0 109.147 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -113.44 30.06 7.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.237 -0.914 . . . . 0.0 110.052 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.578 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -79.1 159.56 27.44 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.517 ' C ' ' O ' ' A' ' 98' ' ' TYR . 2.9 pt20 -0.67 65.03 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 123.37 0.668 . . . . 0.0 112.31 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.578 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER 174.39 -152.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.546 -0.721 . . . . 0.0 109.117 -177.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.25 171.69 5.75 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 108.971 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.97 80.75 2.89 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 122.004 1.802 . . . . 0.0 111.277 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 95' ' ' THR . 3.2 m -70.53 145.88 50.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 109.0 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -116.79 138.85 51.2 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.718 ' HA ' HG23 ' A' ' 125' ' ' VAL . 15.0 m -155.75 144.81 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.995 -1.065 . . . . 0.0 110.003 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.514 ' HG2' ' CB ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -95.61 114.33 26.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 175.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.992 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -88.04 166.99 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.285 1.041 . . . . 0.0 110.666 -176.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.449 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 23.3 t-160 -161.47 101.93 1.21 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.903 ' HG2' HG13 ' A' ' 120' ' ' VAL . 4.5 mtm -112.5 150.04 31.81 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.267 -0.896 . . . . 0.0 110.57 -177.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.607 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.9 tttt -144.65 174.27 11.11 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.181 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.43 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 10.4 tttm -83.17 104.6 13.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.83 -1.169 . . . . 0.0 109.108 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.755 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -52.93 137.48 32.44 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.49 -0.756 . . . . 0.0 109.671 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.67 3.29 54.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 0.0 110.593 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.4 t -60.8 -35.21 75.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.836 -1.165 . . . . 0.0 109.559 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.72 60.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 60.24 70.7 0.61 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -1.125 . . . . 0.0 109.135 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.747 ' HB3' ' HB3' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -123.59 -168.14 1.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.984 -179.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.931 ' CE1' HG22 ' A' ' 83' ' ' VAL . 25.4 m-85 -150.66 104.48 3.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.755 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 11.3 p-90 -106.08 141.5 37.34 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 118.553 -1.259 . . . . 0.0 112.011 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.903 HG13 ' HG2' ' A' ' 109' ' ' MET . 57.8 t -116.85 117.77 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.665 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 16.1 m-30 -102.18 118.83 37.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.1 -1.0 . . . . 0.0 109.091 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.766 HG21 ' CZ ' ' A' ' 96' ' ' PHE . 0.9 OUTLIER -101.22 129.22 52.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 120.836 -1.165 . . . . 0.0 110.09 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.526 ' CD ' ' CE1' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -102.93 123.55 46.77 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HA ' HG12 ' A' ' 105' ' ' VAL . 12.4 ttt180 -77.57 121.14 23.51 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.109 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.718 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.236 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.513 ' C2 ' ' HB1' ' A' ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.14 60.56 1.7 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -112.01 119.81 39.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.199 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 4' ' ' VAL . 9.7 p -177.03 62.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.738 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.441 ' CB ' ' OG ' ' A' ' 8' ' ' SER . . . 59.56 -146.1 0.5 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.094 -1.004 . . . . 0.0 108.391 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.58 ' CD1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -94.66 32.17 1.66 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.771 -1.206 . . . . 0.0 108.263 177.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.522 ' CA ' ' HE3' ' A' ' 123' ' ' LYS . . . 110.75 17.67 8.95 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.664 ' CA ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -93.48 104.47 16.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.333 -1.098 . . . . 0.0 110.362 -179.535 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -71.41 80.53 0.77 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 122.065 -0.397 . . . . 0.0 110.479 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 9' ' ' GLU . 12.7 m-20 45.11 61.21 2.63 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.147 -0.971 . . . . 0.0 108.884 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.022 HG22 HD11 ' A' ' 15' ' ' LEU . 3.8 mm -63.57 -63.1 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -37.85 -33.58 0.09 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.949 -0.469 . . . . 0.0 111.851 -178.012 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -81.06 -44.74 17.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.876 -1.14 . . . . 0.0 108.339 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 18' ' ' MET . 2.6 m -70.04 -9.07 54.11 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.642 -0.661 . . . . 0.0 109.724 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.022 HD11 HG22 ' A' ' 11' ' ' ILE . 21.1 mt -97.44 -21.88 16.9 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.954 -1.091 . . . . 0.0 109.197 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 114' ' ' SER . . . -91.8 -34.26 14.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 0.0 109.945 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.56 49.72 0.82 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.05 -1.031 . . . . 0.0 108.755 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.812 ' CE ' HD22 ' A' ' 23' ' ' LEU . 5.8 tmm? -133.55 129.26 36.81 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.17 -71.66 0.14 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.446 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.89 -39.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 109.685 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -100.78 52.59 0.92 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.446 ' HB3' ' HG3' ' A' ' 18' ' ' MET . 1.5 tt0 -122.8 -41.11 2.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -1.195 . . . . 0.0 109.215 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.812 HD22 ' CE ' ' A' ' 18' ' ' MET . 2.4 pt? -90.58 0.24 57.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 110.079 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.751 ' OD1' ' HB3' ' A' ' 44' ' ' ALA . 55.5 t0 -70.16 -6.45 34.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.847 -1.158 . . . . 0.0 110.271 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.22 32.16 7.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 23' ' ' LEU . 29.3 mt -105.3 151.46 24.11 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.459 -1.024 . . . . 0.0 108.689 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.24 24.7 4.8 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.589 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -160.16 122.14 3.24 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -179.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.515 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -58.8 154.55 27.35 Favored Glycine 0 C--N 1.288 -2.099 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.874 -177.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -127.78 85.15 2.32 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.621 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.1 pp -86.29 144.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.885 0.85 . . . . 0.0 110.724 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.53 ' HB3' HD12 ' A' ' 40' ' ' LEU . 15.3 mm100 -114.24 159.52 20.06 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 37' ' ' GLY . 72.3 mt -151.82 149.7 29.3 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.9 -1.125 . . . . 0.0 109.71 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.504 ' CB ' HD21 ' A' ' 40' ' ' LEU . 41.5 p-10 -131.99 123.29 27.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 110.476 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 42.88 -79.36 0.0 OUTLIER Glycine 0 N--CA 1.498 2.798 0 C-N-CA 124.398 0.999 . . . . 0.0 113.053 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.5 OUTLIER -69.52 -5.96 27.62 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.736 -0.861 . . . . 0.0 110.358 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.83 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 87.4 24.33 36.96 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 36' ' ' ASP . 2.1 m120 -78.63 133.09 37.29 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.137 -1.214 . . . . 0.0 108.102 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.54 HD11 ' HB ' ' A' ' 31' ' ' ILE . 1.7 tp -56.77 136.38 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 111.711 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 33' ' ' LEU . 1.3 mt -110.67 -24.41 10.52 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' NE2' ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -169.74 113.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.399 -0.813 . . . . 0.0 109.422 179.331 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.619 ' CD1' HG22 ' A' ' 31' ' ' ILE . 19.1 t80 -98.71 -67.68 0.84 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.164 -0.96 . . . . 0.0 111.361 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 5.6 p-10 105.86 177.43 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 0 C-N-CA 124.021 0.929 . . . . 0.0 108.863 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.751 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -97.29 -25.17 15.35 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.845 -1.159 . . . . 0.0 113.171 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.56 -64.31 0.85 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.331 -1.481 . . . . 0.0 110.601 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.515 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.5 pt-20 -57.88 -54.4 47.37 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.508 0.671 . . . . 0.0 109.935 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.427 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -57.93 -14.86 18.17 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -76.0 -38.88 56.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.766 -1.432 . . . . 0.0 108.698 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 50' ' ' THR . 1.0 OUTLIER -82.78 -56.72 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.381 -0.824 . . . . 0.0 109.27 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.878 HG21 " C3'" ' A' ' 126' ' ' HC4 . 30.0 p -75.24 -24.42 57.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.365 -0.834 . . . . 0.0 109.957 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 95.6 -15.74 62.59 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' CZ ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -50.07 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.352 -1.087 . . . . 0.0 109.841 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 57' ' ' VAL . 15.9 m-20 -64.65 160.87 49.5 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 108.699 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.35 -58.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.877 1.718 . . . . 0.0 110.807 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.618 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -62.62 -19.55 63.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 110.176 -179.445 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -88.5 -41.63 12.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.05 -1.031 . . . . 0.0 109.828 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 53' ' ' ASP . 23.4 m -79.59 0.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.822 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -71.0 121.74 21.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.053 -1.029 . . . . 0.0 108.699 -179.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 91.49 -15.47 61.31 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -79.3 137.07 37.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.239 . . . . 0.0 109.459 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.95 103.99 6.28 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.661 ' CZ ' HG21 ' A' ' 70' ' ' THR . 26.1 t80 -60.17 -16.63 34.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -0.885 . . . . 0.0 111.089 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 2.4 m-85 -91.32 15.09 12.75 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.023 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -176.66 -52.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.008 -1.057 . . . . 0.0 110.419 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.15 -6.7 41.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 110.926 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.581 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 11.0 t -126.07 -60.43 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 O-C-N 120.636 -1.29 . . . . 0.0 109.07 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.414 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -108.87 103.96 53.4 Favored Pre-proline 0 C--N 1.293 -1.874 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.267 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.84 7.26 3.27 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.907 1.738 . . . . 0.0 111.777 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.6 p -108.58 -20.4 13.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.819 -1.176 . . . . 0.0 109.869 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.661 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 30.2 p -77.42 -2.63 36.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.952 . . . . 0.0 110.611 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -88.53 55.2 3.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.125 -0.985 . . . . 0.0 109.156 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.445 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -124.84 175.25 3.12 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.46 -0.775 . . . . 0.0 109.124 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.9 Cg_endo -77.56 -2.19 12.36 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 122.265 1.977 . . . . 0.0 111.288 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 59.5 mt-10 -107.96 -25.72 11.04 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.939 -1.101 . . . . 0.0 109.509 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.565 ' CD2' ' CZ ' ' A' ' 92' ' ' PHE . 2.1 t80 -102.13 -70.53 0.75 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 18.1 t80 -70.59 -17.37 62.9 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 81' ' ' GLU . . . -63.12 -61.2 6.6 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.663 ' CB ' HG21 ' A' ' 90' ' ' THR . 1.2 mmtp -63.38 -15.92 58.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.501 -0.999 . . . . 0.0 109.487 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.9 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.8 t80 -79.63 -38.17 34.42 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -8.72 58.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 77' ' ' GLY . 1.3 mt-10 -95.52 -40.12 9.61 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.83 -41.05 89.3 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 79' ' ' PHE . 66.4 t -60.0 -40.81 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.662 -0.905 . . . . 0.0 109.497 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.18 -5.06 58.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.284 -0.885 . . . . 0.0 110.785 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.5 p -100.19 -19.06 16.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.836 -1.165 . . . . 0.0 109.945 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.03 16.47 78.79 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -155.62 57.97 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -1.22 . . . . 0.0 109.335 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.461 HD13 ' CD1' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -56.51 114.17 1.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.823 . . . . 0.0 109.733 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -161.25 83.79 0.64 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.432 -0.792 . . . . 0.0 109.033 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.663 HG21 ' CB ' ' A' ' 78' ' ' LYS . 5.0 t -139.35 173.8 11.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.073 -1.017 . . . . 0.0 109.952 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -157.9 171.55 20.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.928 ' CE1' HG21 ' A' ' 107' ' ' VAL . 8.9 p90 178.7 161.01 0.66 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.863 -1.148 . . . . 0.0 110.506 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -88.3 110.12 20.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -112.45 178.56 4.26 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.109 -0.995 . . . . 0.0 110.073 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 84.4 m -141.85 107.99 5.22 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.801 ' CE2' HG21 ' A' ' 122' ' ' VAL . 16.5 m-30 -86.53 121.31 28.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 109.176 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -154.21 48.86 0.62 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.544 ' O ' ' C ' ' A' ' 99' ' ' GLN . 7.5 p90 -78.9 148.07 32.86 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 98' ' ' TYR . 4.6 tt0 2.09 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 CA-C-O 121.851 0.834 . . . . 0.0 111.589 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.528 ' N ' ' O ' ' A' ' 98' ' ' TYR . 6.0 ttp 178.29 -149.07 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.28 169.47 8.59 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 0.0 109.233 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.85 155.21 30.49 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 122.16 1.907 . . . . 0.0 110.844 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.588 HG22 ' O ' ' A' ' 103' ' ' THR . 1.6 m -149.17 94.79 2.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 109.289 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.43 ' C ' HG13 ' A' ' 105' ' ' VAL . 1.2 ptpp? -69.77 142.57 53.19 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.994 -1.066 . . . . 0.0 108.168 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.757 ' HA ' HG23 ' A' ' 125' ' ' VAL . 10.9 m -156.2 142.17 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.908 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.522 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -95.03 111.6 23.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 175.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.928 HG21 ' CE1' ' A' ' 92' ' ' PHE . 1.4 m -86.29 162.35 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.818 0.818 . . . . 0.0 111.893 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 7.7 t-160 -160.55 102.0 1.35 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 175.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.885 ' HG2' HG13 ' A' ' 120' ' ' VAL . 3.2 mtm -112.66 148.08 35.4 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.56 -0.713 . . . . 0.0 109.435 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.63 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 4.4 tttm -138.18 -165.47 1.81 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.68 -1.263 . . . . 0.0 108.985 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HB2' ' CB ' ' A' ' 88' ' ' LEU . 12.9 tttt -107.51 98.2 7.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.03 -1.044 . . . . 0.0 109.0 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.923 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -50.74 130.81 25.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 109.435 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mp -115.96 -18.98 10.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.041 -1.037 . . . . 0.0 109.777 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -52.98 -27.7 20.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.089 -1.007 . . . . 0.0 109.37 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.02 41.92 0.05 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 117' ' ' SER . 4.0 m-20 -127.59 -88.51 0.55 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -1.156 . . . . 0.0 109.552 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.748 ' H ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER 165.53 -75.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.216 -0.927 . . . . 0.0 110.862 179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.787 ' CE1' HG22 ' A' ' 83' ' ' VAL . 5.4 m-85 -138.58 130.32 27.85 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.136 -0.978 . . . . 0.0 109.358 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.923 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 12.1 p-90 -125.92 138.15 53.76 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.677 -1.264 . . . . 0.0 111.883 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.885 HG13 ' HG2' ' A' ' 109' ' ' MET . 61.6 t -113.74 115.87 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.071 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.641 ' CE2' ' CZ3' ' A' ' 119' ' ' TRP . 15.8 m-30 -100.46 126.91 46.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.178 -0.951 . . . . 0.0 108.84 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.801 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.5 t -109.49 122.71 64.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 120.937 -1.102 . . . . 0.0 110.344 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.589 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -99.22 124.71 44.5 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.438 ' NH1' ' CG1' ' A' ' 49' ' ' ILE . 23.3 ttt180 -74.4 121.89 22.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.64 -1.224 . . . . 0.0 109.125 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.341 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.878 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.73 133.42 12.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 109.344 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -165.97 39.78 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.742 HG21 ' HA ' ' A' ' 10' ' ' ASP . 1.3 p -166.66 -166.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 109.194 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.816 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . -55.25 -172.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.075 -1.016 . . . . 0.0 109.751 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.556 ' CE2' ' O ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -51.29 87.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.0 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . 48.41 24.93 4.06 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.816 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 68.0 m -63.98 171.57 2.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.985 -1.303 . . . . 0.0 109.317 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.62 57.04 1.57 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.742 ' HA ' HG21 ' A' ' 4' ' ' VAL . 4.4 m-20 54.84 83.12 0.09 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.806 HG22 HD11 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -80.9 -64.84 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.45 0 O-C-N 121.308 -0.87 . . . . 0.0 111.332 -177.155 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -41.78 -26.66 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.174 -0.954 . . . . 0.0 111.457 -177.369 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' ILE . 2.1 t-20 -89.67 -39.27 13.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.046 -1.034 . . . . 0.0 109.516 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.731 HG23 ' HE1' ' A' ' 18' ' ' MET . 1.3 m -65.88 -59.63 3.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.806 HD11 HG22 ' A' ' 11' ' ' ILE . 11.6 mt -49.76 -23.75 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.754 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.86 -43.31 62.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.849 -1.157 . . . . 0.0 109.31 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -60.43 -16.57 37.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.518 -0.739 . . . . 0.0 110.606 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.731 ' HE1' HG23 ' A' ' 14' ' ' THR . 0.0 OUTLIER -160.01 -150.96 0.23 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.744 -1.223 . . . . 0.0 110.231 -179.462 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' O ' ' CG ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -158.04 -38.21 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.785 -1.197 . . . . 0.0 110.679 -178.71 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 38.0 p-10 -155.69 90.68 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.929 -1.107 . . . . 0.0 110.198 -179.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 153.85 -27.65 0.74 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.602 ' CB ' ' HG3' ' A' ' 18' ' ' MET . 0.1 OUTLIER -107.86 -42.71 4.63 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 109.283 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.583 HD23 ' CD2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -77.8 4.16 12.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.511 -0.743 . . . . 0.0 110.238 179.484 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' N ' HD12 ' A' ' 23' ' ' LEU . 38.4 p-10 -76.73 -3.01 35.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.51 -1.369 . . . . 0.0 110.129 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.72 28.75 14.57 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.951 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 8.0 mt -97.02 -172.68 2.5 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.691 -1.476 . . . . 0.0 109.544 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.52 -0.36 22.19 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.717 0.77 . . . . 0.0 109.288 179.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CZ ' HG12 ' A' ' 11' ' ' ILE . 46.0 p90 -141.72 133.53 27.24 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.158 -0.964 . . . . 0.0 109.218 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.555 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -59.1 135.95 51.48 Favored Glycine 0 C--N 1.292 -1.87 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -116.23 113.87 23.62 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.893 -1.357 . . . . 0.0 107.781 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.687 HG22 ' CD1' ' A' ' 42' ' ' TYR . 1.4 pp -118.84 160.14 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-O 121.851 0.834 . . . . 0.0 110.303 -178.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.908 ' HB3' HD12 ' A' ' 40' ' ' LEU . 34.2 mt-30 -126.96 168.09 15.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.886 HD22 ' O ' ' A' ' 37' ' ' GLY . 83.0 mt -152.68 146.79 25.43 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.91 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' ASP . 18.4 m-20 -121.26 123.65 42.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 0.0 110.023 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 37.16 -76.9 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 0 C-N-CA 124.695 1.14 . . . . 0.0 113.647 178.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' ASP . 19.7 t0 -69.33 -3.6 14.76 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.658 -0.907 . . . . 0.0 111.011 -178.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.886 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 90.21 14.61 58.67 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 19.8 m-80 -70.03 135.59 49.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.931 -1.335 . . . . 0.0 108.425 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.694 HD12 HD21 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -64.78 140.1 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 122.032 0.92 . . . . 0.0 111.219 -178.328 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.908 HD12 ' HB3' ' A' ' 32' ' ' GLN . 1.8 mt -112.37 -26.06 8.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -163.06 159.4 23.22 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.687 ' CD1' HG22 ' A' ' 31' ' ' ILE . 23.4 t80 -144.75 -70.62 0.28 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.673 -1.267 . . . . 0.0 110.819 -178.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.54 ' CB ' HD13 ' A' ' 23' ' ' LEU . 7.6 p-10 107.09 178.47 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 0 C-N-CA 123.876 0.87 . . . . 0.0 109.098 -179.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.65 -26.03 15.35 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.99 -1.069 . . . . 0.0 112.849 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -51.06 -64.09 0.92 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.356 -1.465 . . . . 0.0 110.639 -178.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.555 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 2.0 pt-20 -58.84 -52.91 63.72 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.0 110.016 -179.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.2 -15.79 24.1 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.048 -178.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -77.62 -36.14 51.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.717 -1.46 . . . . 0.0 108.746 179.655 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.52 HG22 HG23 ' A' ' 50' ' ' THR . 0.2 OUTLIER -85.94 -55.97 5.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.426 -0.797 . . . . 0.0 109.235 179.76 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.52 HG23 HG22 ' A' ' 49' ' ' ILE . 29.9 p -78.21 -22.27 48.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.459 -0.776 . . . . 0.0 110.438 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 53' ' ' ASP . . . 94.52 -18.4 57.13 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.642 ' NE ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -45.63 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.493 -1.004 . . . . 0.0 110.254 179.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.764 ' O ' HG22 ' A' ' 57' ' ' VAL . 95.9 m-20 -67.71 157.83 84.98 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.2 -40.11 0.39 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.739 1.626 . . . . 0.0 110.4 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -25.77 51.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.87 . . . . 0.0 110.126 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 7.6 tp60 -83.8 -44.88 13.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.108 -0.995 . . . . 0.0 109.953 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 53' ' ' ASP . 24.6 m -69.85 -7.84 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.138 -0.976 . . . . 0.0 109.814 179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.598 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -68.8 121.95 19.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 121.053 -1.029 . . . . 0.0 108.349 179.831 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.48 -15.38 58.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' CG ' ' O ' ' A' ' 56' ' ' GLN . 67.6 mmtt -79.9 144.06 33.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.17 -1.194 . . . . 0.0 109.39 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.71 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.9 OUTLIER -81.51 115.2 20.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.293 -0.879 . . . . 0.0 108.822 179.401 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.754 ' HD2' HD11 ' A' ' 33' ' ' LEU . 1.7 t80 -61.08 -34.05 74.31 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.029 -1.044 . . . . 0.0 110.025 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 52.2 m-85 -97.18 13.34 29.65 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 118.472 -1.291 . . . . 0.0 111.96 -177.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -139.72 -53.31 0.54 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.646 -1.284 . . . . 0.0 111.115 -179.719 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.24 16.08 21.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.832 -1.167 . . . . 0.0 112.003 -178.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 61' ' ' ASN . 15.5 t -125.43 -53.1 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.269 -1.519 . . . . 0.0 109.468 179.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB3' ' OG1' ' A' ' 70' ' ' THR . . . -117.88 103.03 50.79 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.628 -177.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.52 1.37 8.05 Favored 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 121.822 1.681 . . . . 0.0 110.577 179.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 p -111.13 -20.69 12.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.975 -1.078 . . . . 0.0 109.802 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.672 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 67.2 p -82.58 1.6 37.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.981 . . . . 0.0 110.223 -179.159 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -88.62 61.47 6.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.945 -1.097 . . . . 0.0 109.259 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.461 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -136.01 177.3 2.27 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.188 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.5 Cg_endo -79.08 1.46 9.15 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 122.295 1.997 . . . . 0.0 111.143 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 4.3 mm-40 -107.83 -28.1 9.85 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 120.879 -1.138 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.406 ' HZ ' HG11 ' A' ' 120' ' ' VAL . 1.8 t80 -102.46 -69.82 0.77 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 15.5 t80 -72.06 -16.7 62.04 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.037 -1.039 . . . . 0.0 108.206 177.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.81 -60.94 6.65 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.624 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -63.49 -16.29 60.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.956 . . . . 0.0 109.414 -179.499 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.876 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.8 t80 -80.75 -37.9 29.61 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -8.23 57.25 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 108.442 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.91 -40.6 9.22 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -69.19 -39.61 82.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 79' ' ' PHE . 62.7 t -63.3 -37.19 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.69 -0.888 . . . . 0.0 109.583 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.87 -3.47 55.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.492 -0.755 . . . . 0.0 110.83 -179.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.3 t -106.17 -18.67 13.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.79 -1.194 . . . . 0.0 110.124 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.18 19.49 72.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -157.06 55.93 0.52 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -1.222 . . . . 0.0 109.641 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HB3' ' N ' ' A' ' 111' ' ' LYS . 1.7 tt -54.61 120.34 6.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.419 -0.801 . . . . 0.0 110.047 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.428 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 30.9 p-10 -160.47 82.49 0.68 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.624 HG21 ' HB2' ' A' ' 78' ' ' LYS . 7.3 t -128.34 162.4 27.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 110.44 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -154.52 149.06 26.31 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.032 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 12.7 p90 -172.83 149.17 1.93 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.431 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -79.89 107.3 12.57 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.68 172.87 6.57 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.1 -1.0 . . . . 0.0 110.039 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.0 m -143.12 109.58 5.39 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.527 ' CE2' HG21 ' A' ' 122' ' ' VAL . 21.3 m-85 -80.71 115.83 20.42 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 -178.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -128.51 41.69 3.45 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.591 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -78.07 78.89 4.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.807 -0.558 . . . . 0.0 110.126 -179.721 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.568 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER 53.74 37.8 27.05 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.63 -0.668 . . . . 0.0 110.233 -179.512 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -150.08 -179.12 6.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.018 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.437 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 5.2 t -56.54 149.28 40.91 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 108.716 179.159 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.437 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 31.4 Cg_endo -72.91 86.21 1.1 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 121.55 1.5 . . . . 0.0 110.417 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.438 HG22 HG13 ' A' ' 105' ' ' VAL . 16.0 m -75.9 142.55 42.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.476 -0.765 . . . . 0.0 109.473 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -115.32 136.34 53.19 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.803 ' HA ' HG23 ' A' ' 125' ' ' VAL . 26.2 m -151.87 144.51 16.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 109.812 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.75 ' HD2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -94.57 109.75 21.63 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 175.789 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.032 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -80.85 162.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 122.339 1.066 . . . . 0.0 110.963 -175.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.451 ' HB2' ' CD2' ' A' ' 6' ' ' PHE . 3.7 t-160 -161.48 101.05 1.19 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.799 ' HG2' HG13 ' A' ' 120' ' ' VAL . 3.4 mtm -113.01 146.19 39.52 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.393 -0.817 . . . . 0.0 109.316 -178.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.613 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.8 tttt -141.84 178.94 7.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.459 -1.401 . . . . 0.0 109.785 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.447 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -86.01 102.89 14.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.916 -1.115 . . . . 0.0 109.15 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.718 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -51.59 132.61 30.54 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.455 -0.778 . . . . 0.0 109.812 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.404 ' H ' HD12 ' A' ' 113' ' ' LEU . 1.7 mp -101.63 -33.31 9.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.4 p -54.09 -46.11 71.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.955 . . . . 0.0 109.299 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 154.35 39.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.469 ' HB2' ' CB ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -116.1 -14.03 11.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.059 -1.259 . . . . 0.0 109.444 179.707 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.501 ' N ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER 80.51 -70.05 0.09 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.478 -0.763 . . . . 0.0 111.66 178.727 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.846 ' OH ' HG13 ' A' ' 83' ' ' VAL . 4.7 m-85 -143.37 116.88 9.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.712 -1.242 . . . . 0.0 110.197 -177.482 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.718 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 10.1 p-90 -113.66 142.11 46.41 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 120.863 -1.148 . . . . 0.0 111.665 179.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.799 HG13 ' HG2' ' A' ' 109' ' ' MET . 63.5 t -113.53 125.94 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.716 ' HE2' HD13 ' A' ' 11' ' ' ILE . 20.0 m-30 -111.74 117.65 33.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.019 -1.05 . . . . 0.0 109.574 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -100.19 114.41 38.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.529 ' HD3' ' CE1' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -97.76 119.92 37.21 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.099 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.541 ' HA ' HG12 ' A' ' 105' ' ' VAL . 6.8 ttt-85 -66.97 124.82 24.07 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.983 -1.087 . . . . 0.0 109.61 -178.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.803 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.005 . . . . 0.0 109.335 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.507 ' C2 ' ' CD1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -106.54 163.09 13.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.967 . . . . 0.0 109.725 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.42 172.63 0.62 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.698 HG11 ' H ' ' A' ' 10' ' ' ASP . 11.9 p -77.99 123.66 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.263 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.888 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 47.65 -158.84 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.317 -0.864 . . . . 0.0 109.836 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CD2' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -48.87 -59.04 3.91 Favored 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.8 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.46 32.56 0.26 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 107.255 -2.338 . . . . 0.0 107.255 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.888 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 0.2 OUTLIER -55.91 -175.84 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.761 -0.847 . . . . 0.0 110.846 -178.566 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -126.82 61.04 1.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.698 ' H ' HG11 ' A' ' 4' ' ' VAL . 0.4 OUTLIER 59.79 70.09 0.66 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -178.427 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.04 HG22 HD11 ' A' ' 15' ' ' LEU . 5.1 mm -73.93 -65.58 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.548 0 O-C-N 121.424 -0.797 . . . . 0.0 109.759 -178.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 13' ' ' ASN . 15.7 pt-20 -38.84 -35.92 0.23 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.719 -0.613 . . . . 0.0 111.706 -178.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.1 m120 -81.6 -41.96 20.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.921 -1.112 . . . . 0.0 108.341 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.114 HG21 HD22 ' A' ' 23' ' ' LEU . 2.9 m -72.1 -7.18 47.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.619 -0.676 . . . . 0.0 109.49 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.04 HD11 HG22 ' A' ' 11' ' ' ILE . 39.8 mt -96.83 0.41 49.24 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.905 -1.122 . . . . 0.0 109.01 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.02 -25.05 16.64 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.284 -0.885 . . . . 0.0 109.106 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -132.27 39.14 3.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 14' ' ' THR . 11.1 tmm? -129.21 146.0 51.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.21 -0.932 . . . . 0.0 109.437 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.55 -61.31 1.14 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.293 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -167.15 96.02 0.49 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.378 179.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.43 -20.83 3.49 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.578 HE22 HG23 ' A' ' 14' ' ' THR . 0.1 OUTLIER -81.87 -45.83 14.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.096 -1.238 . . . . 0.0 109.598 179.992 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.114 HD22 HG21 ' A' ' 14' ' ' THR . 4.2 tp -128.76 45.41 2.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.117 -0.99 . . . . 0.0 109.687 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -93.16 -1.61 56.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.163 -0.961 . . . . 0.0 109.698 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.39 16.31 58.06 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.941 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 4.0 mt -67.86 168.3 11.87 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.953 -1.322 . . . . 0.0 108.448 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.43 23.0 8.07 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.941 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 3.3 p90 -156.51 -171.1 3.56 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.52 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -118.17 154.74 16.43 Favored Glycine 0 C--N 1.291 -1.932 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 178.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -122.88 107.26 11.67 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 178.32 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.592 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.1 pp -114.93 142.21 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.303 -177.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.829 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -112.16 165.96 11.69 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.873 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 37' ' ' GLY . 97.1 mt -152.27 154.66 36.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.866 -1.147 . . . . 0.0 109.681 -179.129 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.554 ' HB2' HD21 ' A' ' 40' ' ' LEU . 5.5 m-20 -129.08 125.74 37.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 110.178 178.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 38.43 -77.93 0.0 OUTLIER Glycine 0 N--CA 1.5 2.901 0 C-N-CA 124.496 1.046 . . . . 0.0 113.818 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 34' ' ' ASP . 73.4 m-20 -72.65 -1.55 16.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.717 -0.872 . . . . 0.0 111.443 -177.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.665 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 89.32 18.65 52.44 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 53.1 m-80 -72.04 134.99 46.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -1.223 . . . . 0.0 107.772 179.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.654 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -64.8 138.44 23.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 O-C-N 121.28 -0.887 . . . . 0.0 111.259 -178.067 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.829 HD12 ' HB3' ' A' ' 32' ' ' GLN . 5.4 mt -109.0 -28.39 9.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -163.29 160.28 23.62 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.897 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.568 ' CD1' HG22 ' A' ' 31' ' ' ILE . 14.6 t80 -142.1 -71.96 0.33 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.715 -1.241 . . . . 0.0 110.774 -178.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 9.3 p-10 109.1 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.785 0 C-N-CA 123.923 0.889 . . . . 0.0 108.876 -179.166 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 45' ' ' ALA . . . -96.99 -52.5 3.84 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.215 -0.928 . . . . 0.0 113.438 -177.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 44' ' ' ALA . . . -34.69 -62.02 0.37 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.418 -0.801 . . . . 0.0 112.96 -177.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 1.9 pt-20 -60.13 -49.4 77.79 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.158 -0.964 . . . . 0.0 110.35 -178.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.36 -13.58 44.39 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -81.53 -36.17 29.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.835 -1.391 . . . . 0.0 109.82 -179.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.2 mp -84.14 -47.32 17.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 O-C-N 121.124 -0.985 . . . . 0.0 109.45 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.546 ' HA ' ' HE1' ' A' ' 100' ' ' MET . 2.7 p -89.33 -24.9 21.88 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.271 -0.893 . . . . 0.0 110.203 -179.079 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.49 -3.47 63.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.931 ' HD3' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -55.68 105.15 0.16 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.032 -1.276 . . . . 0.0 109.941 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -72.98 154.19 90.86 Favored Pre-proline 0 C--N 1.298 -1.653 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.801 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.02 -53.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.742 1.628 . . . . 0.0 110.528 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -20.4 63.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.856 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.403 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 1.5 tt0 -85.33 -41.72 15.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.018 -1.051 . . . . 0.0 109.837 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 53' ' ' ASP . 26.7 m -76.48 -2.31 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.068 -1.02 . . . . 0.0 109.922 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.654 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -70.19 122.42 21.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.025 -1.047 . . . . 0.0 108.429 179.845 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.04 -13.82 62.21 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 56' ' ' GLN . 11.8 mmtp -80.12 137.54 36.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.267 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -78.05 95.93 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.142 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.722 ' CZ ' HG21 ' A' ' 70' ' ' THR . 14.1 t80 -55.82 -24.65 37.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 0.0 109.932 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.523 ' CE2' HD13 ' A' ' 33' ' ' LEU . 12.3 m-85 -82.09 -32.16 30.38 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.746 -177.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 48.59 1.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.011 -1.055 . . . . 0.0 109.116 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 61' ' ' ASN . 4.7 t0 -163.54 -36.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.549 -0.719 . . . . 0.0 109.877 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.931 HG11 ' HD3' ' A' ' 52' ' ' ARG . 12.7 t -103.09 -56.8 4.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 122.78 1.276 . . . . 0.0 108.388 179.482 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.52 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -103.66 101.46 24.33 Favored Pre-proline 0 C--N 1.29 -1.983 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.181 -178.11 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -76.13 3.13 6.45 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.719 1.613 . . . . 0.0 110.485 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 p -106.77 -21.58 12.99 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.131 -0.981 . . . . 0.0 109.841 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.722 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 7.2 p -81.89 2.54 29.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 110.308 -178.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -95.94 57.1 1.77 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.954 -1.091 . . . . 0.0 108.905 179.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.458 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.3 OUTLIER -139.5 175.55 3.17 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.412 -0.805 . . . . 0.0 109.507 -179.599 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 34.7 Cg_endo -77.15 77.29 3.85 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 122.505 2.137 . . . . 0.0 110.369 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 174.28 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CE1' ' HE3' ' A' ' 109' ' ' MET . 1.4 t80 -103.3 -68.73 0.82 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.468 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 16.5 t80 -74.83 -19.22 60.27 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.42 -62.26 5.77 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.638 ' HB2' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -62.19 -18.28 60.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 109.541 -179.701 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.813 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.1 t80 -76.38 -38.23 56.03 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.42 -5.61 52.89 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 108.757 178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 1.5 mm-40 -95.41 -42.02 8.69 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.41 -40.64 68.67 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 178.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.872 HG22 ' CE1' ' A' ' 118' ' ' TYR . 100.0 t -61.39 -40.27 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.746 -0.855 . . . . 0.0 109.948 179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.68 -22.08 40.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.216 -0.927 . . . . 0.0 111.059 -178.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -12.08 28.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.817 -1.177 . . . . 0.0 110.526 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.85 14.58 80.69 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -150.62 100.82 2.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -1.171 . . . . 0.0 108.606 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -97.74 117.58 32.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 110.109 -179.161 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.58 75.53 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.506 -0.746 . . . . 0.0 109.118 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.638 HG21 ' HB2' ' A' ' 78' ' ' LYS . 8.8 t -116.21 131.55 56.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.028 -1.045 . . . . 0.0 110.497 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.6 ttt -118.47 126.17 51.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.621 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 2.0 p90 -152.39 -172.5 4.25 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.134 -0.979 . . . . 0.0 110.056 -178.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 22.6 pt-20 -121.87 117.42 26.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.42 ' HB2' ' CE2' ' A' ' 92' ' ' PHE . 13.0 t80 -126.79 163.65 23.1 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.143 -0.973 . . . . 0.0 109.422 -179.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 95.2 m -131.77 119.99 22.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.576 ' CE2' HG21 ' A' ' 105' ' ' VAL . 6.5 m-85 -92.01 125.0 36.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.431 -0.793 . . . . 0.0 109.035 179.359 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -144.41 46.77 1.4 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 14.3 p90 -77.98 141.58 38.86 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.527 ' C ' ' O ' ' A' ' 98' ' ' TYR . 15.0 pt20 3.67 64.73 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.093 0 CA-C-O 121.432 0.634 . . . . 0.0 112.161 -179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.701 ' SD ' HG22 ' A' ' 101' ' ' THR . 0.6 OUTLIER 179.78 175.52 0.76 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.557 -0.714 . . . . 0.0 109.118 -177.787 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.701 HG22 ' SD ' ' A' ' 100' ' ' MET . 0.6 OUTLIER -57.88 151.43 43.62 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.96 . . . . 0.0 109.032 179.348 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 32.9 Cg_endo -74.28 145.08 33.96 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 121.945 1.763 . . . . 0.0 109.972 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.502 HG22 HG13 ' A' ' 105' ' ' VAL . 1.2 m -142.32 111.68 6.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.106 -0.996 . . . . 0.0 110.151 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.434 ' C ' HG13 ' A' ' 105' ' ' VAL . 25.3 tttm -82.28 151.67 26.67 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.769 HG23 HG13 ' A' ' 107' ' ' VAL . 28.2 m -153.98 144.09 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 118.526 -1.269 . . . . 0.0 112.09 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -80.75 123.6 28.35 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 102.23 -3.248 . . . . 0.0 102.23 174.675 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.769 HG13 HG23 ' A' ' 105' ' ' VAL . 31.4 m -118.37 152.36 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 121.058 1.754 . . . . 0.0 111.845 -176.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.9 t-160 -143.1 104.64 4.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.218 178.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.655 ' HG2' HG13 ' A' ' 120' ' ' VAL . 14.2 mtp -99.79 121.18 40.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.891 -1.131 . . . . 0.0 108.913 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.573 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 2.3 tttt -125.79 -165.8 1.47 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 117.625 -1.63 . . . . 0.0 110.309 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -113.11 98.59 7.24 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.138 -0.976 . . . . 0.0 109.167 -179.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.931 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -54.56 135.18 46.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.682 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.71 -19.44 9.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 109.723 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 m -52.89 -49.05 66.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -0.971 . . . . 0.0 109.567 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.49 44.95 0.05 OUTLIER Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 117' ' ' SER . 52.7 m-20 -138.81 -90.15 0.21 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.116 -1.226 . . . . 0.0 109.242 179.584 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.786 ' H ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER 160.85 -76.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.498 -0.751 . . . . 0.0 110.795 179.372 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.872 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.6 m-85 -125.4 129.35 49.7 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.235 -0.916 . . . . 0.0 110.179 -177.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.931 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 22.7 p-90 -129.17 163.05 26.39 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.052 -1.059 . . . . 0.0 111.343 178.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.655 HG13 ' HG2' ' A' ' 109' ' ' MET . 50.2 t -144.23 113.94 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.688 -0.632 . . . . 0.0 109.422 -178.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.672 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.4 m-30 -95.66 140.79 29.96 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.717 HG22 HG12 ' A' ' 107' ' ' VAL . 1.9 t -117.4 109.53 27.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 118.951 -1.099 . . . . 0.0 110.046 -179.213 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 4.7 tptp -84.53 146.24 27.67 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 177.04 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -96.18 129.88 43.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.702 -1.249 . . . . 0.0 110.181 -178.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.104 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.52 ' C2 ' ' HB1' ' A' ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptt? . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 55.24 58.44 4.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 109.581 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -102.81 93.25 4.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.311 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.532 HG22 ' OG ' ' A' ' 8' ' ' SER . 14.5 p -154.8 129.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 109.897 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.86 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 21.91 81.01 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.065 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER 57.51 -87.7 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.243 -0.911 . . . . 0.0 109.135 179.558 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 5' ' ' ALA . . . -140.41 42.68 1.18 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.86 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -65.32 163.39 15.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.67 -0.9 . . . . 0.0 110.87 -178.543 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -109.1 60.54 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 57.5 72.63 0.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.074 HG22 HD11 ' A' ' 15' ' ' LEU . 3.7 mm -72.89 -66.86 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 O-C-N 121.488 -0.757 . . . . 0.0 110.444 -178.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HA ' HD12 ' A' ' 15' ' ' LEU . 18.3 pt-20 -36.46 -49.68 0.74 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.961 -0.462 . . . . 0.0 112.037 -177.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.63 -44.37 82.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.788 -1.195 . . . . 0.0 108.614 179.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.919 HG21 HD23 ' A' ' 23' ' ' LEU . 3.4 m -71.24 -8.43 53.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 109.948 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.074 HD11 HG22 ' A' ' 11' ' ' ILE . 42.6 mt -97.79 -24.04 15.62 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.97 -1.081 . . . . 0.0 109.371 -179.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.94 -26.5 31.35 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.83 . . . . 0.0 109.576 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.16 -17.75 8.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.052 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.31 145.39 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.343 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.62 154.87 0.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 108.861 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 56.88 78.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 108.601 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.56 21.46 72.69 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 51.85 31.63 8.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.386 -1.067 . . . . 0.0 109.952 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.919 HD23 HG21 ' A' ' 14' ' ' THR . 1.1 tm? 60.68 67.81 0.8 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.191 -0.943 . . . . 0.0 108.776 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -149.07 -24.64 0.3 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.552 -0.717 . . . . 0.0 111.112 -179.239 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.32 24.35 30.75 Favored Glycine 0 N--CA 1.492 2.429 0 O-C-N 120.525 -1.359 . . . . 0.0 111.041 -178.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.853 HD11 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -78.7 -172.28 2.91 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.766 -1.432 . . . . 0.0 108.349 179.168 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.74 20.54 16.08 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.59 ' HB3' ' HA ' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -159.36 137.04 10.06 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.143 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' PHE . . . -71.66 139.73 29.28 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.518 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . . . -116.87 89.75 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.623 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.4 pp -91.98 148.97 4.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.449 -0.782 . . . . 0.0 110.654 -177.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.592 ' OE1' HD13 ' A' ' 15' ' ' LEU . 17.5 mm100 -116.86 170.51 8.56 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.527 HD22 ' C ' ' A' ' 37' ' ' GLY . 73.4 mt -152.32 145.63 24.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.876 -1.14 . . . . 0.0 110.187 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' ASP . 8.8 m-20 -115.7 134.67 54.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.257 178.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 36' ' ' ASP . . . -11.49 72.39 0.0 OUTLIER Glycine 0 N--CA 1.511 3.679 0 C-N-CA 124.804 1.192 . . . . 0.0 113.294 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.7 OUTLIER 161.75 -23.33 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.565 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 100.41 17.9 22.95 Favored Glycine 0 N--CA 1.479 1.551 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.033 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 28.7 m120 -85.25 131.78 34.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.142 -1.211 . . . . 0.0 108.769 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.569 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -65.99 138.81 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.016 -1.053 . . . . 0.0 111.404 -178.37 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.451 HD11 ' OD1' ' A' ' 34' ' ' ASP . 3.0 mt -103.74 -29.48 11.01 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -161.94 142.96 10.74 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 179.089 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.605 ' O ' ' CB ' ' A' ' 43' ' ' ASN . 15.9 t80 -109.28 -77.24 0.6 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.338 -1.476 . . . . 0.0 111.504 -178.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 42' ' ' TYR . 39.9 t-20 130.49 142.24 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.857 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -178.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 43' ' ' ASN . . . -73.24 -49.09 29.75 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.581 -0.699 . . . . 0.0 111.125 -178.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.76 -55.32 3.69 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.35 -0.844 . . . . 0.0 111.619 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.489 ' OE1' ' CG ' ' A' ' 42' ' ' TYR . 14.0 pt-20 -63.75 -44.55 93.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.143 -0.973 . . . . 0.0 110.233 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' CA ' ' A' ' 51' ' ' GLY . . . -63.24 -13.2 48.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.05 -36.72 16.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.328 . . . . 0.0 109.658 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.7 mm -77.71 -29.35 16.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 O-C-N 121.043 -1.036 . . . . 0.0 110.249 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.835 HG21 " C3'" ' A' ' 126' ' ' HC4 . 1.6 p -114.09 -24.58 8.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 109.504 -178.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 100.55 -2.04 55.89 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.903 ' NE ' HG12 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -71.88 85.83 0.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.127 -1.219 . . . . 0.0 109.727 -179.74 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.726 ' O ' HG22 ' A' ' 57' ' ' VAL . 38.9 m-20 -60.48 164.42 7.05 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.148 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.49 -50.01 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.117 1.878 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.753 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -67.85 -29.4 68.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.215 -0.928 . . . . 0.0 109.906 -179.555 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -78.78 -43.12 26.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 0.0 109.885 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 53' ' ' ASP . 18.5 m -76.35 -1.81 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.038 -1.038 . . . . 0.0 109.903 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -70.89 123.58 25.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.016 -1.053 . . . . 0.0 108.446 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.95 -18.2 56.49 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 -178.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -79.25 138.45 37.79 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.184 -1.186 . . . . 0.0 108.992 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.22 104.33 6.69 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.469 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 85.6 t80 -56.08 -20.62 17.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.371 -0.831 . . . . 0.0 110.224 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 76' ' ' TYR . 7.7 m-85 -100.04 -19.69 16.41 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.083 -1.01 . . . . 0.0 110.401 -178.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.2 46.99 1.42 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.116 -0.99 . . . . 0.0 109.449 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.6 -28.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.118 -0.989 . . . . 0.0 111.024 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.903 HG12 ' NE ' ' A' ' 52' ' ' ARG . 5.1 t -108.48 -58.34 3.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -112.09 100.98 50.87 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.485 -179.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.74 1.05 8.5 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 122.056 1.837 . . . . 0.0 111.336 -179.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.1 p -98.95 -22.88 15.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 109.418 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 31.1 p -76.14 -2.21 29.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.408 -0.808 . . . . 0.0 110.269 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -88.63 56.42 3.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.975 . . . . 0.0 109.255 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -129.04 177.18 2.28 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.413 -0.805 . . . . 0.0 108.941 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 72' ' ' SER . 35.5 Cg_endo -78.04 2.01 8.37 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.219 1.946 . . . . 0.0 111.561 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 1.4 mt-10 -111.28 -29.52 7.8 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.86 -1.15 . . . . 0.0 109.319 179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CE1' ' SD ' ' A' ' 109' ' ' MET . 1.8 t80 -100.29 -69.49 0.77 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.55 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 21.2 t80 -71.22 -15.57 62.46 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -63.22 -61.56 6.24 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 178.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.769 ' HB2' HG21 ' A' ' 90' ' ' THR . 9.4 mmtt -62.8 -16.49 58.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.607 -0.937 . . . . 0.0 109.287 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.944 ' HA ' HD11 ' A' ' 88' ' ' LEU . 10.4 t80 -78.72 -37.89 40.33 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -78.52 -7.41 57.46 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 77' ' ' GLY . 3.8 mm-40 -95.78 -40.76 9.19 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -69.92 -40.04 74.46 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 178.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.978 HG22 ' CE1' ' A' ' 118' ' ' TYR . 58.2 t -64.71 -39.78 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.646 -0.914 . . . . 0.0 109.656 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.74 -8.7 55.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.334 -0.854 . . . . 0.0 110.829 -178.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.4 t -102.19 -16.98 16.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.829 -1.169 . . . . 0.0 110.06 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.47 22.48 64.68 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -163.75 72.11 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -1.104 . . . . 0.0 109.316 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.944 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -72.92 118.35 15.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.311 -0.868 . . . . 0.0 109.81 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -160.62 86.79 0.73 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.523 -0.736 . . . . 0.0 109.099 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.769 HG21 ' HB2' ' A' ' 78' ' ' LYS . 3.3 t -137.25 161.52 36.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.081 -1.012 . . . . 0.0 109.786 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -149.53 144.04 26.0 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.415 -0.803 . . . . 0.0 108.982 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.058 ' CE2' HG21 ' A' ' 107' ' ' VAL . 10.8 p90 -156.33 -173.96 4.73 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 109.839 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.26 114.19 26.36 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.59 -176.28 2.89 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.147 -0.971 . . . . 0.0 110.804 -178.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 27.0 m -154.38 109.77 3.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.857 ' CE2' HG21 ' A' ' 122' ' ' VAL . 7.9 m-30 -85.71 126.6 34.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.643 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -154.3 51.06 0.65 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.738 179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.603 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 9.9 p90 -77.91 136.42 38.02 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.53 ' C ' ' O ' ' A' ' 98' ' ' TYR . 6.7 pt20 5.25 62.95 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.186 0 CA-C-O 121.421 0.629 . . . . 0.0 112.264 -178.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.532 ' N ' ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -175.22 -154.43 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.358 -0.839 . . . . 0.0 109.252 -177.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.15 159.74 61.69 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.46 157.27 28.94 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.28 1.987 . . . . 0.0 110.521 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 103' ' ' THR . 5.4 m -151.13 85.92 1.35 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.782 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -69.83 139.18 53.1 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.931 ' HA ' HG23 ' A' ' 125' ' ' VAL . 14.8 m -151.77 148.24 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.897 -1.127 . . . . 0.0 111.404 -179.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.807 ' CD ' HG22 ' A' ' 125' ' ' VAL . 2.8 mptp? -79.36 120.16 23.4 Favored 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 103.22 -2.881 . . . . 0.0 103.22 174.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.058 HG21 ' CE2' ' A' ' 92' ' ' PHE . 34.5 m -104.19 150.91 7.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 117.863 -1.535 . . . . 0.0 110.523 -177.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -149.49 106.91 3.62 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.909 ' HG2' HG13 ' A' ' 120' ' ' VAL . 12.8 mtm -108.85 134.55 51.38 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.057 -1.027 . . . . 0.0 110.369 -178.259 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.606 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 1.4 tttp -135.09 -169.38 2.36 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.401 -1.437 . . . . 0.0 109.989 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -104.46 100.43 10.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.126 -0.983 . . . . 0.0 108.56 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.871 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -47.02 144.53 2.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.534 -0.729 . . . . 0.0 110.617 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.93 ' O ' HD13 ' A' ' 113' ' ' LEU . 3.4 tm? -79.09 -19.29 51.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.776 -179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.0 m -44.07 -27.71 0.41 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.371 -0.831 . . . . 0.0 110.58 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 162.53 58.62 0.02 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.7 32.34 21.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -1.183 . . . . 0.0 109.074 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.748 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.2 OUTLIER -72.16 -160.74 0.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.257 -0.902 . . . . 0.0 109.889 -179.692 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.978 ' CE1' HG22 ' A' ' 83' ' ' VAL . 13.8 m-85 -152.42 116.28 4.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.871 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 16.6 p-90 -122.06 149.37 43.64 Favored 'General case' 0 C--O 1.202 -1.401 0 C-N-CA 118.705 -1.198 . . . . 0.0 112.075 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.909 HG13 ' HG2' ' A' ' 109' ' ' MET . 58.5 t -124.54 107.97 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.649 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 9.9 m-30 -92.03 120.58 32.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.312 -0.867 . . . . 0.0 109.199 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.857 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.1 t -102.21 117.92 48.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 118.839 -1.144 . . . . 0.0 110.837 -179.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 4.2 tptp -88.28 113.91 24.37 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.577 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -73.94 120.62 19.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.492 -1.38 . . . . 0.0 109.016 -179.344 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.931 HG23 ' HA ' ' A' ' 105' ' ' VAL . 3.7 t . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.319 -179.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.835 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.326 0.584 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 4' ' ' VAL . 1.2 tm-20 -84.37 -65.14 1.04 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.917 . . . . 0.0 109.595 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 52.34 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 109.426 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 4' ' ' VAL . 32.4 m -101.11 94.89 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.775 -1.203 . . . . 0.0 109.402 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.45 ' HB3' ' CB ' ' A' ' 8' ' ' SER . . . 51.65 -149.48 0.33 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 120.39 -1.444 . . . . 0.0 108.652 179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.629 ' CE1' ' HD2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -90.78 51.06 1.9 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.595 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.85 0.79 45.64 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -177.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.967 ' CB ' HD11 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -96.66 112.53 24.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.11 -1.229 . . . . 0.0 112.128 -178.694 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.54 ' HA ' ' HB ' ' A' ' 4' ' ' VAL . 22.7 mt-10 -47.55 103.4 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.642 179.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' C ' ' O ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER 16.66 77.36 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.708 0 CA-C-O 121.415 0.626 . . . . 0.0 111.826 178.483 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.041 HG22 HD11 ' A' ' 15' ' ' LEU . 4.9 mm -64.83 -61.96 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.597 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -37.24 -30.51 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.939 -0.476 . . . . 0.0 111.833 -178.13 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' ILE . 54.4 t-20 -84.48 -45.64 12.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.891 -1.131 . . . . 0.0 108.504 179.059 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.707 HG22 HD23 ' A' ' 23' ' ' LEU . 2.9 m -67.59 -10.6 53.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.591 -0.693 . . . . 0.0 109.665 179.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.041 HD11 HG22 ' A' ' 11' ' ' ILE . 20.6 mt -96.82 -25.71 15.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.013 -1.054 . . . . 0.0 109.327 -179.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.81 -16.89 24.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.383 -0.823 . . . . 0.0 109.988 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 35.81 4.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 0.0 109.853 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.63 ' CE ' HD21 ' A' ' 23' ' ' LEU . 11.9 tmm? -131.41 134.18 45.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.199 -0.938 . . . . 0.0 109.112 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.25 -79.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.97 . . . . 0.0 109.296 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -175.58 68.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.163 -0.961 . . . . 0.0 109.239 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.3 40.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -132.1 -37.69 1.12 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.405 -1.056 . . . . 0.0 109.781 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.715 ' CD2' HD23 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -105.6 15.28 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 110.351 -179.736 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.21 -15.61 63.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.956 -1.09 . . . . 0.0 109.887 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.58 22.61 39.04 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.781 HD22 ' CE1' ' A' ' 28' ' ' PHE . 55.9 mt -70.67 176.65 4.01 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.939 -1.33 . . . . 0.0 108.947 179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.15 17.43 21.63 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.781 ' CE1' HD22 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -154.81 132.25 11.2 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.186 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.11 129.28 9.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.416 ' O ' ' NE2' ' A' ' 41' ' ' GLN . . . -102.32 118.78 37.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.946 -1.326 . . . . 0.0 108.513 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.628 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.1 pp -111.81 148.88 14.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.163 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.646 ' HB3' HD12 ' A' ' 40' ' ' LEU . 8.1 mt-30 -117.99 166.06 12.97 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 62' ' ' PHE . 18.3 mt -152.78 140.84 20.32 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.599 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.569 ' HB2' HD21 ' A' ' 40' ' ' LEU . 16.1 t0 -93.67 167.88 11.38 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.37 -22.23 1.49 Allowed Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.556 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -92.12 11.46 25.4 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.466 -1.608 . . . . 0.0 110.692 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' C ' HD22 ' A' ' 33' ' ' LEU . . . 75.66 27.24 63.44 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 79.1 m-20 -97.03 127.86 43.42 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.993 -1.298 . . . . 0.0 111.639 -177.587 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.696 HD12 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -55.29 135.72 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.12 -0.988 . . . . 0.0 110.67 -179.83 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 32' ' ' GLN . 3.3 mt -111.4 -27.96 8.4 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -158.08 159.89 36.76 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.812 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.555 ' HH ' " C4'" ' A' ' 126' ' ' HC4 . 2.8 t80 -143.7 -64.74 0.38 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.601 -1.312 . . . . 0.0 109.246 -178.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.574 HD21 ' HB3' ' A' ' 45' ' ' ALA . 2.0 p-10 99.6 177.58 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 123.36 0.664 . . . . 0.0 109.641 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASP . . . -95.25 -14.72 23.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.1 -1.0 . . . . 0.0 112.002 -177.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -58.22 -63.25 1.33 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.616 -1.302 . . . . 0.0 109.671 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 50' ' ' THR . 7.3 pt-20 -61.6 -49.81 75.11 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.208 -0.933 . . . . 0.0 109.286 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -58.74 -14.53 22.89 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' ALA . 11.3 t70 -80.55 -39.09 28.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.735 -1.45 . . . . 0.0 109.823 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -84.58 -43.43 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.001 -1.062 . . . . 0.0 109.032 -179.644 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -89.47 -31.46 17.67 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.743 -0.598 . . . . 0.0 109.693 -178.68 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 100.82 -2.91 55.76 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -178.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.787 ' NE ' HG13 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -68.97 104.19 2.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.02 -1.283 . . . . 0.0 110.592 -179.322 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.728 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -72.17 166.14 43.94 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.656 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.87 -38.47 0.86 Allowed 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.948 1.765 . . . . 0.0 110.3 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -72.1 -22.95 61.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.275 -0.891 . . . . 0.0 109.415 179.899 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.429 ' O ' ' CG ' ' A' ' 60' ' ' LYS . 38.1 tt0 -83.14 -47.19 11.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.497 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 53' ' ' ASP . 6.5 m -66.57 -11.37 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.599 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.509 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -68.32 121.12 16.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.082 -1.011 . . . . 0.0 108.722 -179.804 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.1 -19.0 52.1 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -178.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 56' ' ' GLN . 25.8 mmtt -79.87 132.66 36.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.373 -1.075 . . . . 0.0 109.215 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.59 122.71 21.0 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.696 ' HB2' HD12 ' A' ' 39' ' ' ILE . 87.2 t80 -68.69 -2.86 10.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 0.0 111.036 -179.313 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CE2' HD13 ' A' ' 33' ' ' LEU . 44.9 m-85 -110.94 -17.2 13.36 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.614 -1.304 . . . . 0.0 111.982 -177.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.28 -38.82 0.41 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.767 -1.208 . . . . 0.0 110.631 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -90.58 1.88 56.34 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.083 -1.01 . . . . 0.0 110.585 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.787 HG13 ' NE ' ' A' ' 52' ' ' ARG . 24.2 t -127.5 -75.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.425 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -97.97 106.67 35.89 Favored Pre-proline 0 C--N 1.292 -1.906 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.416 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 34.5 Cg_endo -75.6 0.15 9.48 Favored 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.746 1.631 . . . . 0.0 110.948 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.2 p -106.08 -19.49 13.71 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.959 -1.088 . . . . 0.0 109.668 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.456 HG21 ' CE2' ' A' ' 62' ' ' PHE . 15.6 p -75.19 -2.24 26.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.177 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -90.12 51.75 2.11 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.857 -1.152 . . . . 0.0 108.869 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -121.01 177.64 1.42 Allowed Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.946 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.8 Cg_endo -78.27 -5.45 15.03 Favored 'Trans proline' 0 C--N 1.32 -0.929 0 C-N-CA 122.203 1.935 . . . . 0.0 111.272 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -107.98 -21.14 12.94 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.912 -1.118 . . . . 0.0 109.489 179.799 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 70' ' ' THR . 1.1 t80 -104.09 -72.19 0.71 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.221 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.489 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 25.0 t80 -70.93 -18.16 62.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.29 -61.57 6.2 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 178.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.647 ' HB2' HG21 ' A' ' 90' ' ' THR . 1.8 mmtt -61.53 -16.34 46.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.652 -0.91 . . . . 0.0 109.698 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.891 ' O ' HG23 ' A' ' 83' ' ' VAL . 11.7 t80 -81.17 -38.2 27.5 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.53 -0.731 . . . . 0.0 109.674 179.117 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.01 -11.17 59.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.969 -1.082 . . . . 0.0 109.419 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 78' ' ' LYS . 17.1 pt-20 -97.25 -38.98 9.47 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.078 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -66.51 -39.18 93.92 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 79' ' ' PHE . 99.1 t -59.76 -39.71 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.636 -0.92 . . . . 0.0 110.667 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.4 -45.57 31.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.003 -1.061 . . . . 0.0 111.038 -178.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -20.84 65.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.098 -179.131 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.64 14.96 80.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -142.84 56.0 1.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.119 -1.224 . . . . 0.0 109.025 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.849 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -54.78 123.38 13.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.498 -0.751 . . . . 0.0 109.491 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.439 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 33.0 p-10 -161.94 87.78 0.66 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.032 -1.042 . . . . 0.0 109.553 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.647 HG21 ' HB2' ' A' ' 78' ' ' LYS . 1.5 t -138.78 164.87 28.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.983 -1.073 . . . . 0.0 110.335 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -156.9 146.64 20.74 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.07 ' CE2' HG21 ' A' ' 107' ' ' VAL . 9.6 p90 -162.1 -175.11 4.43 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.3 -0.875 . . . . 0.0 109.637 -179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.4 102.51 11.61 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.46 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -105.65 147.91 27.96 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 110.041 -178.622 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 103' ' ' THR . 31.6 m -115.71 109.67 18.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.71 ' CZ ' HG21 ' A' ' 122' ' ' VAL . 21.3 m-30 -78.97 107.57 11.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.183 -0.948 . . . . 0.0 109.004 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.13 32.75 5.96 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.521 -0.737 . . . . 0.0 109.28 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -79.21 162.4 25.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.895 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 98' ' ' TYR . 7.7 mt-30 -4.38 66.59 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.112 0 C-N-CA 123.388 0.675 . . . . 0.0 112.642 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.593 ' N ' ' O ' ' A' ' 98' ' ' TYR . 1.6 ttp 175.67 -158.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.341 -178.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.582 HG22 ' CD ' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -93.74 179.16 1.32 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.788 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.582 ' CD ' HG22 ' A' ' 101' ' ' THR . 34.2 Cg_endo -78.09 107.25 2.29 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 121.873 1.715 . . . . 0.0 110.365 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.46 HG22 HG13 ' A' ' 105' ' ' VAL . 1.6 m -106.83 134.13 50.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.611 ' HB3' HG23 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -100.78 150.4 22.83 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.548 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.676 HG23 HG13 ' A' ' 107' ' ' VAL . 32.6 m -154.75 144.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 118.384 -1.326 . . . . 0.0 112.006 -179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.58 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -81.41 98.25 8.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 175.771 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.07 HG21 ' CE2' ' A' ' 92' ' ' PHE . 31.4 m -90.45 150.11 3.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 118.144 -1.423 . . . . 0.0 110.734 -176.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . 13.5 t-160 -148.15 107.16 3.85 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.772 ' HG2' HG13 ' A' ' 120' ' ' VAL . 26.2 mtm -102.98 118.6 37.18 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 120.773 -1.204 . . . . 0.0 108.952 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.608 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -140.27 145.63 37.55 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.227 -1.546 . . . . 0.0 110.223 -179.083 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -53.91 138.88 35.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.373 -0.829 . . . . 0.0 109.204 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.815 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -90.53 160.03 16.18 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.333 -0.854 . . . . 0.0 109.45 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.49 -7.07 57.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.205 -0.935 . . . . 0.0 110.632 -179.069 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 p -53.8 -32.02 51.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.564 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 143.34 86.97 0.09 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 55.75 61.57 2.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -1.171 . . . . 0.0 109.217 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.76 ' CB ' ' HB3' ' A' ' 112' ' ' ALA . 0.3 OUTLIER -117.68 -174.11 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.92 . . . . 0.0 109.919 -179.725 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.86 ' CE1' HG22 ' A' ' 83' ' ' VAL . 19.4 m-85 -152.08 114.41 4.51 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.815 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 19.6 p-90 -118.06 165.32 13.89 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.976 -1.089 . . . . 0.0 111.319 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.772 HG13 ' HG2' ' A' ' 109' ' ' MET . 84.4 t -146.02 104.54 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.346 0.593 . . . . 0.0 109.488 -178.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.672 ' CE2' ' HB ' ' A' ' 11' ' ' ILE . 5.3 m-30 -84.45 129.14 34.89 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.736 HG22 HG12 ' A' ' 107' ' ' VAL . 2.2 t -112.4 112.18 39.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.277 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.629 ' HD2' ' CE1' ' A' ' 6' ' ' PHE . 1.1 tttm -86.63 159.95 19.05 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.446 ' CD ' HG13 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -107.06 120.93 43.42 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.743 -1.183 . . . . 0.0 109.869 -179.232 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.611 HG23 ' HB3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.175 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.735 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.529 ' O ' HG13 ' A' ' 4' ' ' VAL . 4.5 mtt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 66.44 16.25 10.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -0.856 . . . . 0.0 109.785 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.0 t60 60.1 31.52 20.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 109.967 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 4' ' ' VAL . 25.4 m -72.69 124.56 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.053 -1.029 . . . . 0.0 109.465 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.781 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 38.56 -158.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.956 0.884 . . . . 0.0 111.849 178.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.57 ' CD2' ' HD2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -58.2 -27.51 63.96 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.848 0.832 . . . . 0.0 108.802 178.973 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.01 35.55 0.02 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -178.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.781 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -64.66 -170.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.555 -0.968 . . . . 0.0 111.043 -179.342 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.493 ' H ' HD11 ' A' ' 11' ' ' ILE . 7.4 mt-10 -126.56 59.02 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.07 74.21 0.45 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.982 HG22 HD11 ' A' ' 15' ' ' LEU . 4.6 mm -80.26 -60.59 2.15 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 110.151 -178.494 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.517 ' HA ' HD12 ' A' ' 15' ' ' LEU . 10.6 tt0 -46.83 -23.49 0.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.541 -1.349 . . . . 0.0 110.992 -178.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -90.19 -42.42 11.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.909 -1.119 . . . . 0.0 109.808 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -56.88 8.12 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.982 HD11 HG22 ' A' ' 11' ' ' ILE . 27.9 mt -38.08 -31.76 0.05 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.189 179.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.609 ' HB2' ' CB ' ' A' ' 114' ' ' SER . . . -86.18 -65.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.763 . . . . 0.0 110.119 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.7 55.4 3.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.91 . . . . 0.0 109.835 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.675 ' HE1' HD13 ' A' ' 23' ' ' LEU . 7.8 tmm? -117.56 149.45 40.62 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.174 -0.954 . . . . 0.0 108.773 179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.2 -61.52 1.36 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.14 -50.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.643 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.17 63.72 3.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 18' ' ' MET . 9.8 mt-30 -149.15 -43.01 0.14 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -1.165 . . . . 0.0 109.246 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.675 HD13 ' HE1' ' A' ' 18' ' ' MET . 2.1 pt? -82.42 -12.22 58.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.336 -0.852 . . . . 0.0 110.064 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -92.64 -0.59 57.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.901 -1.125 . . . . 0.0 110.312 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.71 33.61 6.26 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.637 HD23 ' CZ ' ' A' ' 28' ' ' PHE . 4.1 mp -121.61 149.3 43.38 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.305 -1.115 . . . . 0.0 109.052 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.58 8.0 10.77 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.625 -0.672 . . . . 0.0 110.179 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.637 ' CZ ' HD23 ' A' ' 26' ' ' LEU . 1.5 p90 -133.51 150.82 51.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 109.646 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.54 ' HA3' ' HB3' ' A' ' 46' ' ' GLU . . . -79.34 114.3 3.85 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 178.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.481 ' CB ' HD21 ' A' ' 15' ' ' LEU . . . -91.38 97.79 11.3 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.596 HD12 ' C ' ' A' ' 31' ' ' ILE . 1.7 pp -105.26 145.76 13.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.095 -177.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.679 ' HB3' HD12 ' A' ' 40' ' ' LEU . 35.6 mt-30 -115.36 167.29 10.99 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.839 HD22 ' O ' ' A' ' 37' ' ' GLY . 85.2 mt -153.39 157.24 39.68 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.087 -1.008 . . . . 0.0 109.132 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.576 ' CG ' HD21 ' A' ' 40' ' ' LEU . 36.8 p-10 -133.89 121.44 21.74 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.606 178.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.46 -78.38 0.0 OUTLIER Glycine 0 N--CA 1.502 3.069 0 C-N-CA 124.457 1.027 . . . . 0.0 113.144 178.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 34' ' ' ASP . 26.2 m-20 -68.43 -6.0 22.28 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.653 -0.91 . . . . 0.0 110.415 -178.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.839 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 88.81 18.06 55.21 Favored Glycine 0 N--CA 1.479 1.552 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 9.1 m-80 -72.22 138.83 47.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.078 -1.248 . . . . 0.0 108.338 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.562 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.92 136.04 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 122.064 0.935 . . . . 0.0 111.496 -178.043 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.774 HD11 ' O ' ' A' ' 33' ' ' LEU . 3.3 mt -108.5 -29.11 8.96 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.608 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -163.36 163.3 25.17 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.946 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.841 ' CG ' HG21 ' A' ' 57' ' ' VAL . 1.8 t80 -143.83 -65.45 0.37 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.141 -1.6 . . . . 0.0 110.714 -177.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.536 HD21 ' HB3' ' A' ' 45' ' ' ALA . 5.4 p-10 106.84 171.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.586 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.44 -20.7 18.86 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.664 -1.272 . . . . 0.0 112.164 -177.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.536 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -52.16 -59.83 3.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.715 -1.241 . . . . 0.0 110.311 -179.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' HG3' ' CE2' ' A' ' 42' ' ' TYR . 11.1 pt-20 -62.55 -45.95 90.61 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.745 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.449 ' HA2' ' N ' ' A' ' 52' ' ' ARG . . . -59.13 -15.94 31.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.26 -34.65 25.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.805 -1.409 . . . . 0.0 109.99 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.95 -40.88 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.158 -0.964 . . . . 0.0 109.766 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.815 HG21 " C3'" ' A' ' 126' ' ' HC4 . 0.4 OUTLIER -105.24 -0.25 26.56 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.55 -0.719 . . . . 0.0 110.111 -179.295 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 47' ' ' GLY . . . 79.83 -2.78 72.7 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.627 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.871 ' CD ' HG13 ' A' ' 66' ' ' VAL . 0.9 OUTLIER -78.13 81.89 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.879 -1.365 . . . . 0.0 110.871 -179.155 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.453 ' CB ' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -57.8 176.7 0.23 Allowed Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.886 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 53' ' ' ASP . 34.2 Cg_endo -76.52 -34.55 2.55 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.792 1.661 . . . . 0.0 110.341 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.2 -23.24 41.12 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -79.0 -41.42 29.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.613 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.841 HG21 ' CG ' ' A' ' 42' ' ' TYR . 26.8 m -71.47 -7.6 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.212 -0.93 . . . . 0.0 109.78 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.33 122.9 21.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.66 -23.07 35.67 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -178.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -80.53 136.16 36.23 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.409 -1.053 . . . . 0.0 109.189 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.9 126.84 31.24 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.587 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.76 ' HB2' HD21 ' A' ' 33' ' ' LEU . 76.3 t80 -61.66 -13.08 19.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.054 -1.029 . . . . 0.0 110.636 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD2' ' HB2' ' A' ' 76' ' ' TYR . 38.2 m-85 -118.95 28.94 7.98 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.945 -1.097 . . . . 0.0 110.506 -178.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.38 -50.63 0.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.767 -1.208 . . . . 0.0 110.826 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -111.86 7.71 20.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.856 -1.153 . . . . 0.0 110.653 -179.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.871 HG13 ' CD ' ' A' ' 52' ' ' ARG . 89.3 t -120.53 -41.59 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 120.777 -1.202 . . . . 0.0 108.342 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.575 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -141.19 95.35 7.47 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -72.63 -7.84 21.49 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.875 1.717 . . . . 0.0 110.427 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.1 p -94.39 -21.46 18.93 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.232 -0.918 . . . . 0.0 109.042 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.517 HG22 ' CD2' ' A' ' 75' ' ' PHE . 20.7 p -75.3 -0.63 20.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.176 -179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -88.97 55.33 3.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.884 -1.135 . . . . 0.0 108.887 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.476 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -130.48 177.57 2.15 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.858 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 36.2 Cg_endo -78.08 -2.2 12.31 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.257 1.971 . . . . 0.0 111.418 -179.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 23.1 mm-40 -106.39 -25.98 11.66 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.8 -1.188 . . . . 0.0 109.298 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CD2' HG22 ' A' ' 70' ' ' THR . 1.7 t80 -101.99 -71.26 0.72 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.026 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.573 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 10.1 t80 -70.84 -17.7 62.73 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.245 178.024 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.84 -59.8 8.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.613 ' CB ' HG21 ' A' ' 90' ' ' THR . 6.7 mmtt -64.85 -14.7 60.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.469 -1.018 . . . . 0.0 109.351 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.84 ' O ' HG23 ' A' ' 83' ' ' VAL . 10.5 t80 -80.82 -37.44 30.09 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.46 -8.29 58.36 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.256 -0.902 . . . . 0.0 108.707 178.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.64 -39.71 9.37 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.573 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -68.11 -39.83 88.48 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 79' ' ' PHE . 98.9 t -62.89 -39.39 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.766 -0.844 . . . . 0.0 109.765 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.95 -3.94 56.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.186 -0.947 . . . . 0.0 111.104 -178.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.5 t -104.43 -19.68 13.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.082 -179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.35 19.59 71.36 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -156.27 72.57 0.76 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.096 -1.238 . . . . 0.0 109.287 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.573 HD12 ' HA3' ' A' ' 82' ' ' GLY . 0.2 OUTLIER -76.1 110.43 10.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 109.629 -179.982 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -160.26 79.83 0.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.079 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 78' ' ' LYS . 9.9 t -137.62 151.39 48.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.016 . . . . 0.0 110.262 -179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -133.38 146.52 51.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.086 ' CE2' HG21 ' A' ' 107' ' ' VAL . 18.5 p90 -153.58 -175.88 5.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.054 -1.029 . . . . 0.0 109.941 -179.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.71 115.79 30.17 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.04 176.94 4.97 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.159 -0.963 . . . . 0.0 110.136 -178.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.1 m -144.88 109.33 4.9 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.979 ' CE2' HG21 ' A' ' 122' ' ' VAL . 21.3 m-30 -83.01 119.85 24.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 108.963 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -149.43 47.51 0.97 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.001 -1.062 . . . . 0.0 110.331 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.558 ' O ' ' CD1' ' A' ' 98' ' ' TYR . 35.0 p90 -78.56 135.9 37.4 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.134 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.535 ' C ' ' O ' ' A' ' 98' ' ' TYR . 11.7 pt20 3.52 64.07 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 CA-C-O 121.524 0.678 . . . . 0.0 112.106 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 98' ' ' TYR . 2.5 tmm? -172.92 175.77 3.22 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.29 162.18 1.21 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.0 109.213 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.28 152.78 30.97 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.05 1.834 . . . . 0.0 110.195 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.48 HG22 HG13 ' A' ' 105' ' ' VAL . 54.5 m -147.76 127.53 13.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.199 -0.938 . . . . 0.0 110.305 -179.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -110.44 137.24 48.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.898 ' HA ' HG23 ' A' ' 125' ' ' VAL . 17.7 m -150.49 142.83 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 118.649 -1.22 . . . . 0.0 111.494 -178.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.553 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.92 124.21 30.14 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 174.38 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.086 HG21 ' CE2' ' A' ' 92' ' ' PHE . 33.1 m -108.57 152.12 10.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 120.88 -1.138 . . . . 0.0 111.744 -174.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.411 ' ND1' ' HA ' ' A' ' 5' ' ' ALA . 18.6 t-160 -142.12 108.46 5.28 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.692 ' HG2' HG13 ' A' ' 120' ' ' VAL . 20.5 mtm -106.42 123.93 48.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.767 -1.208 . . . . 0.0 109.457 -179.139 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.575 ' CB ' ' CZ2' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -126.24 -165.89 1.5 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.098 -179.677 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.61 94.21 4.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.546 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.982 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -53.21 127.59 24.96 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.073 -1.017 . . . . 0.0 109.481 179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.2 tp -114.5 -15.97 11.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.066 -1.021 . . . . 0.0 109.638 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.609 ' CB ' ' HB2' ' A' ' 16' ' ' ALA . 80.8 p -54.48 -40.79 68.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.122 -0.986 . . . . 0.0 109.654 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.43 39.86 0.02 OUTLIER Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.191 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.57 ' HB3' HD12 ' A' ' 40' ' ' LEU . 10.2 m-20 -137.49 -91.17 0.23 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.161 -1.199 . . . . 0.0 109.208 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.75 ' H ' ' HB3' ' A' ' 112' ' ' ALA . 0.4 OUTLIER 165.07 -80.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.204 -0.935 . . . . 0.0 111.367 179.473 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CE1' HG22 ' A' ' 83' ' ' VAL . 8.9 m-85 -123.07 131.1 53.56 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.214 -0.929 . . . . 0.0 110.061 -177.4 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.982 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 15.0 p-90 -130.59 166.47 20.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.836 -1.165 . . . . 0.0 111.853 179.01 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.692 HG13 ' HG2' ' A' ' 109' ' ' MET . 90.7 t -147.71 115.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.767 -0.583 . . . . 0.0 110.441 -178.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.729 ' CE1' ' CE3' ' A' ' 119' ' ' TRP . 5.6 m-30 -94.41 104.69 16.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.064 -1.022 . . . . 0.0 108.836 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.979 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -88.04 105.9 15.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.57 ' HD2' ' CD2' ' A' ' 6' ' ' PHE . 9.5 mttp -89.67 112.42 23.66 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.531 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -56.98 133.19 54.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.966 -1.084 . . . . 0.0 109.43 -179.0 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.898 HG23 ' HA ' ' A' ' 105' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.366 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.815 " C3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ttt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.306 0.574 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.91 30.07 7.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.607 -179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -114.76 167.27 10.91 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.603 HG11 ' H ' ' A' ' 10' ' ' ASP . 7.4 p -109.21 125.15 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 0.0 109.874 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 1.009 ' HB3' ' OG ' ' A' ' 8' ' ' SER . . . 44.38 -167.72 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.033 0.92 . . . . 0.0 111.189 179.146 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.568 ' CE1' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -46.51 -76.35 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.532 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -144.83 29.59 1.84 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 178.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 1.009 ' OG ' ' HB3' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -50.41 175.49 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.739 0.781 . . . . 0.0 110.786 -178.734 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -110.08 60.82 0.6 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.603 ' H ' HG11 ' A' ' 4' ' ' VAL . 0.2 OUTLIER 56.39 75.88 0.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -178.312 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.062 HG22 HD11 ' A' ' 15' ' ' LEU . 5.2 mm -79.16 -56.92 6.0 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.371 -178.083 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.406 ' HB2' HD12 ' A' ' 113' ' ' LEU . 2.0 pt-20 -43.04 -26.88 0.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.304 -0.873 . . . . 0.0 111.431 -178.088 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -91.09 -38.14 12.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.925 -1.109 . . . . 0.0 108.428 178.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.508 ' CG2' ' CE ' ' A' ' 18' ' ' MET . 4.7 m -71.26 -13.01 61.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.627 -0.671 . . . . 0.0 110.02 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.062 HD11 HG22 ' A' ' 11' ' ' ILE . 11.1 mt -97.62 -21.62 16.95 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.059 -1.025 . . . . 0.0 109.385 -179.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.53 -31.51 16.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.873 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -111.42 65.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.04 . . . . 0.0 108.986 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.576 ' HG2' ' HB2' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -158.64 -165.36 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.386 -0.821 . . . . 0.0 109.547 -179.163 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -116.25 -68.94 0.88 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.313 -0.867 . . . . 0.0 109.064 179.582 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t70 179.87 -45.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 109.679 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.82 33.56 5.64 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.576 ' HB2' ' HG2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -102.98 -41.12 6.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -1.207 . . . . 0.0 109.699 -179.937 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.554 HD21 ' CB ' ' A' ' 43' ' ' ASN . 1.7 pt? -79.05 19.41 0.55 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.051 -1.03 . . . . 0.0 111.303 179.671 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.768 ' OD1' ' HB3' ' A' ' 44' ' ' ALA . 52.0 t0 -66.28 -7.98 22.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.4 -1.437 . . . . 0.0 111.002 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.64 35.02 4.62 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.948 HD22 ' CZ ' ' A' ' 28' ' ' PHE . 28.7 mt -107.09 129.43 54.82 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.593 -0.945 . . . . 0.0 109.662 -179.639 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.27 -7.24 28.96 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.591 0.71 . . . . 0.0 109.353 178.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.948 ' CZ ' HD22 ' A' ' 26' ' ' LEU . 6.8 p90 -129.99 135.96 48.89 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 121.098 -1.001 . . . . 0.0 109.016 179.762 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.477 ' HA3' ' CG ' ' A' ' 46' ' ' GLU . . . -70.03 132.33 23.7 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.477 ' HA ' ' CD1' ' A' ' 121' ' ' PHE . . . -105.1 103.03 12.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.327 . . . . 0.0 108.239 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -102.82 143.47 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.558 -178.875 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.665 ' HB3' HD12 ' A' ' 40' ' ' LEU . 22.0 mt-30 -116.92 164.23 15.0 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.243 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.736 HD13 ' CE2' ' A' ' 63' ' ' PHE . 95.9 mt -148.38 148.49 30.41 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.017 -1.052 . . . . 0.0 109.945 -179.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.62 ' HB3' HD21 ' A' ' 40' ' ' LEU . 4.0 p30 -123.92 122.18 37.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 110.419 179.223 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 41.32 -79.32 0.0 OUTLIER Glycine 0 N--CA 1.497 2.741 0 C-N-CA 124.028 0.823 . . . . 0.0 113.392 178.276 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -70.14 -5.48 27.44 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.769 -0.841 . . . . 0.0 111.078 -177.762 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.731 ' O ' HD22 ' A' ' 33' ' ' LEU . . . 94.02 17.84 39.21 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.768 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 38.5 m-80 -75.41 134.39 40.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.962 -1.316 . . . . 0.0 108.983 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.564 HG22 ' HA ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -59.59 138.5 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.938 0.875 . . . . 0.0 111.442 -178.504 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 32' ' ' GLN . 7.9 mt -104.63 -33.66 8.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.12 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.702 ' OE1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -157.48 -176.55 6.02 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.284 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.519 ' OH ' " O4'" ' A' ' 126' ' ' HC4 . 6.9 t80 -160.54 -67.75 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.906 -1.121 . . . . 0.0 110.826 -178.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.554 ' CB ' HD21 ' A' ' 23' ' ' LEU . 4.6 p-10 103.01 176.27 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.633 0 C-N-CA 123.779 0.832 . . . . 0.0 109.206 -179.379 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -95.81 -16.51 21.83 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.821 -1.174 . . . . 0.0 112.806 -177.388 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.24 -62.08 2.1 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.376 -1.453 . . . . 0.0 110.138 -179.131 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.513 ' HG2' ' OD1' ' A' ' 43' ' ' ASN . 3.3 pt-20 -59.61 -53.11 61.8 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.694 0.759 . . . . 0.0 109.569 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 52' ' ' ARG . . . -60.52 -13.78 32.21 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.23 -37.29 33.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.753 -1.439 . . . . 0.0 110.188 -179.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.1 mp -84.78 -43.02 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.858 -1.152 . . . . 0.0 109.236 -179.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.796 HG21 " H3'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -92.44 -27.8 17.24 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.248 -0.908 . . . . 0.0 109.974 -178.896 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 47' ' ' GLY . . . 100.69 -3.32 56.06 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.333 -179.578 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.552 ' CD ' " C3'" ' A' ' 126' ' ' HC4 . 0.0 OUTLIER -60.88 100.98 0.12 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.97 -1.312 . . . . 0.0 109.749 -179.749 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.725 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -73.44 162.35 74.75 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 0.0 108.728 179.371 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.47 -51.22 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.187 1.925 . . . . 0.0 110.756 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HA ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -63.67 -26.04 68.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 110.181 -179.5 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -85.12 -42.81 14.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.955 -1.091 . . . . 0.0 109.905 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 53' ' ' ASP . 27.1 m -74.81 -3.2 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.157 -0.964 . . . . 0.0 109.675 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.564 ' HA ' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -71.49 123.13 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 O-C-N 120.947 -1.096 . . . . 0.0 108.058 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.33 -14.76 60.16 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -178.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.405 ' HG3' ' HA ' ' A' ' 57' ' ' VAL . 5.6 mmtt -79.9 136.97 36.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -1.205 . . . . 0.0 109.2 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.62 110.01 12.07 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.237 -0.915 . . . . 0.0 108.616 179.392 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.801 ' CZ ' HG21 ' A' ' 70' ' ' THR . 46.5 t80 -64.37 -12.63 44.51 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.736 ' CE2' HD13 ' A' ' 33' ' ' LEU . 31.9 m-85 -94.92 13.08 26.02 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.054 -1.029 . . . . 0.0 110.745 -177.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -179.39 -50.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.057 -1.027 . . . . 0.0 109.944 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -14.16 62.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 110.424 -179.038 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' A' ' 52' ' ' ARG . 3.8 t -125.89 -57.64 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 120.679 -1.263 . . . . 0.0 108.736 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' HB1' ' C2 ' ' A' ' 126' ' ' HC4 . . . -116.15 98.01 50.54 Favored Pre-proline 0 C--N 1.295 -1.8 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.614 -178.302 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -74.75 -1.53 11.26 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 121.858 1.705 . . . . 0.0 110.985 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.3 p -91.65 -26.51 18.63 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.988 -1.07 . . . . 0.0 109.335 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.801 HG21 ' CZ ' ' A' ' 62' ' ' PHE . 35.2 p -75.0 -1.62 23.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.509 -0.744 . . . . 0.0 110.067 -179.163 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -89.69 52.13 2.25 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.93 -1.106 . . . . 0.0 108.597 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.481 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.7 OUTLIER -124.87 178.5 1.42 Allowed Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.87 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 72' ' ' SER . 35.4 Cg_endo -78.42 -1.09 11.29 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 122.257 1.971 . . . . 0.0 111.476 -179.655 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 13.5 mt-10 -108.46 -29.02 9.02 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.877 -1.139 . . . . 0.0 109.301 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.685 ' CE1' HG11 ' A' ' 120' ' ' VAL . 1.2 t80 -100.06 -70.54 0.73 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.067 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.528 ' CE1' ' CD1' ' A' ' 79' ' ' PHE . 20.4 t80 -72.4 -15.31 61.84 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.77 -62.47 5.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 178.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.791 ' CB ' HG21 ' A' ' 90' ' ' THR . 1.2 mmtt -62.87 -16.09 57.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.562 -0.964 . . . . 0.0 109.251 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.863 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.9 t80 -77.36 -40.45 43.89 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.12 -7.87 56.51 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.969 . . . . 0.0 109.045 179.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -95.98 -41.17 8.9 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.507 ' HA3' HD12 ' A' ' 88' ' ' LEU . . . -69.41 -40.01 80.02 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 178.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.93 HG22 ' CE1' ' A' ' 118' ' ' TYR . 94.0 t -60.01 -38.71 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.693 -0.887 . . . . 0.0 109.535 179.388 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.35 -6.87 58.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.336 -0.853 . . . . 0.0 110.704 -178.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.06 -18.89 16.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.848 -1.157 . . . . 0.0 109.938 -179.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.58 16.07 78.44 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.44 66.89 0.39 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.055 -1.262 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -58.74 124.53 20.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.853 . . . . 0.0 109.985 -179.948 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.426 ' HA ' ' HG3' ' A' ' 110' ' ' LYS . 4.3 t-20 -161.27 83.78 0.64 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.943 -1.098 . . . . 0.0 109.072 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.826 HG23 ' SD ' ' A' ' 109' ' ' MET . 8.8 t -144.73 172.48 12.95 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.055 -1.058 . . . . 0.0 110.754 -179.405 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.8 ptm -157.21 171.07 21.09 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.031 ' CZ ' HG21 ' A' ' 107' ' ' VAL . 7.7 p90 177.82 154.15 0.31 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.03 -1.044 . . . . 0.0 109.94 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.3 128.38 33.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 109.07 179.378 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.08 170.04 16.24 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.13 -0.981 . . . . 0.0 110.061 -179.602 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.0 m -140.88 118.01 11.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 122' ' ' VAL . 20.1 m-30 -90.24 121.27 32.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.107 -0.995 . . . . 0.0 109.76 -179.648 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -142.77 46.27 1.58 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.477 -0.764 . . . . 0.0 109.029 179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.521 ' CZ ' " H2'" ' A' ' 126' ' ' HC4 . 0.1 OUTLIER -85.36 66.52 9.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.466 -0.771 . . . . 0.0 110.855 -179.302 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.475 ' CG ' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER 77.49 30.2 0.51 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.871 0.843 . . . . 0.0 109.318 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.1 tmm? -141.34 171.08 14.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.055 -1.028 . . . . 0.0 108.5 179.452 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.44 170.6 0.2 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.015 -1.053 . . . . 0.0 109.235 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.66 92.03 1.15 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.007 1.805 . . . . 0.0 110.261 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.454 HG22 HG13 ' A' ' 105' ' ' VAL . 18.7 m -88.18 131.24 34.8 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 109.895 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.439 ' C ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -110.24 142.63 41.57 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.872 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.633 ' HA ' HG23 ' A' ' 125' ' ' VAL . 12.6 m -157.73 144.57 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.412 -179.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.578 ' HG2' ' HB3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -98.11 119.12 36.19 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 174.782 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 1.031 HG21 ' CZ ' ' A' ' 92' ' ' PHE . 0.7 OUTLIER -87.78 162.47 2.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 120.665 -1.272 . . . . 0.0 111.376 -174.844 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.487 ' CG ' ' HA ' ' A' ' 5' ' ' ALA . 1.8 t-160 -160.46 103.71 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.164 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.86 ' CG ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -112.41 150.59 30.91 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.72 -0.613 . . . . 0.0 110.009 -176.932 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.572 ' HB3' ' CZ2' ' A' ' 119' ' ' TRP . 0.1 OUTLIER -150.38 164.94 34.56 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.512 -1.367 . . . . 0.0 109.084 179.041 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 118.87 13.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.879 -1.138 . . . . 0.0 109.739 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.77 ' HB2' ' HD1' ' A' ' 119' ' ' TRP . . . -65.65 133.21 50.63 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.53 -0.731 . . . . 0.0 109.424 179.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.746 HD22 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -74.55 -3.15 29.2 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.052 -1.03 . . . . 0.0 110.817 -179.274 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.542 ' N ' HD13 ' A' ' 113' ' ' LEU . 1.0 OUTLIER -60.92 -24.64 66.18 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.783 -1.198 . . . . 0.0 109.019 179.676 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 170.07 45.01 0.03 OUTLIER Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t0 61.92 33.3 17.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.423 -1.045 . . . . 0.0 108.89 -179.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.723 ' HB2' ' HB3' ' A' ' 112' ' ' ALA . 0.9 OUTLIER -70.95 -157.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.45 -0.781 . . . . 0.0 109.687 -179.742 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.93 ' CE1' HG22 ' A' ' 83' ' ' VAL . 3.3 m-85 -150.22 109.31 3.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.36 -0.837 . . . . 0.0 108.834 -179.398 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.77 ' HD1' ' HB2' ' A' ' 112' ' ' ALA . 9.7 p-90 -115.37 144.46 43.76 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.016 -1.074 . . . . 0.0 111.583 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.86 HG13 ' CG ' ' A' ' 109' ' ' MET . 18.8 t -120.01 109.0 24.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.641 ' CZ ' ' CE3' ' A' ' 119' ' ' TRP . 12.6 m-30 -89.61 134.4 34.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 108.701 179.358 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 96' ' ' PHE . 1.3 t -111.26 117.96 56.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 121.322 -0.861 . . . . 0.0 108.841 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.578 ' HB3' ' HG2' ' A' ' 106' ' ' LYS . 4.9 tptp -90.39 110.15 21.25 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.502 ' HA ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -64.74 117.62 7.76 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.205 -179.515 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.317 -179.356 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' HC4 . . . . . 0.796 " H3'" HG21 ' A' ' 50' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_